CWI_ID,TCMBank_ID,Gene_name,Gene_alias,Description,Map_location,Gene_Type,TTD_gene_type
CWITA000001,TCMBANKGE000001,CXCR2,CD182; CDw128b; CMKAR2; IL8R2; IL8RA; IL8RB,C-X-C motif chemokine receptor 2,2q35,protein-coding,Successful target
CWITA000002,TCMBANKGE000002,CXCL3,CINC-2b; GRO3; GROg; MIP-2b; MIP2B; SCYB3,C-X-C motif chemokine ligand 3,4q13.3,protein-coding,/
CWITA000003,TCMBANKGE000003,ASAH1,AC; ACDase; ASAH; PHP; PHP32; SMAPME,N-acylsphingosine amidohydrolase 1,8p22,protein-coding,/
CWITA000004,TCMBANKGE000004,PWAR4,PAR-4; PAR4,Prader Willi/Angelman region RNA 4,15q11.2,ncRNA,/
CWITA000005,TCMBANKGE000005,UGCG,GCS; GLCT1,UDP-glucose ceramide glucosyltransferase,9q31.3,protein-coding,Successful target
CWITA000006,TCMBANKGE000006,MIR16-2,MIRN16-2; mir-16-2; mir-16-3,microRNA 16-2,3q25.33,ncRNA,/
CWITA000007,TCMBANKGE000007,IL12B,CLMF; CLMF2; IL-12B; IMD28; IMD29; NKSF; NKSF2,interleukin 12B,5q33.3,protein-coding,Successful target
CWITA000008,TCMBANKGE000008,CD40,Bp50; CDW40; TNFRSF5; p50,CD40 molecule,20q13.12,protein-coding,Research target
CWITA000009,TCMBANKGE000009,GJA1,AVSD3; CMDR; CX43; EKVP; EKVP3; GJAL; HLHS1; HSS; ODDD; PPKCA,gap junction protein alpha 1,6q22.31,protein-coding,Clinical Trial target
CWITA000010,TCMBANKGE000010,CDK5R1,CDK5P35; CDK5R; NCK5A; p23; p25; p35; p35nck5a,cyclin dependent kinase 5 regulatory subunit 1,17q11.2,protein-coding,Research target
CWITA000011,TCMBANKGE000011,DCX,DBCN; DC; LISX; SCLH; XLIS,doublecortin,Xq23,protein-coding,/
CWITA000012,TCMBANKGE000012,TAGLN,SM22; SM22-alpha; SMCC; TAGLN1; WS3-10,transgelin,11q23.3,protein-coding,Research target
CWITA000013,TCMBANKGE000013,G6PC,G6PC1; G6PT; G6Pase; GSD1; GSD1a,glucose-6-phosphatase catalytic subunit,17q21.31,protein-coding,Research target
CWITA000014,TCMBANKGE000014,PCK1,PCKDC; PEPCK-C; PEPCK1; PEPCKC,phosphoenolpyruvate carboxykinase 1,20q13.31,protein-coding,/
CWITA000015,TCMBANKGE000015,ADORA2A,A2aR; ADORA2; RDC8,adenosine A2a receptor,22q11.23,protein-coding,Successful target
CWITA000016,TCMBANKGE000016,MYH6,ASD3; CMD1EE; CMH14; MYHC; MYHCA; SSS3; alpha-MHC,myosin heavy chain 6,14q11.2,protein-coding,/
CWITA000017,TCMBANKGE000017,MAPT,DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU,microtubule associated protein tau,17q21.31,protein-coding,Clinical Trial target
CWITA000018,TCMBANKGE000018,KAT2B,CAF; P/CAF; PCAF,lysine acetyltransferase 2B,3p24.3,protein-coding,Research target
CWITA000019,TCMBANKGE000019,RAB5A,RAB5,"RAB5A, member RAS oncogene family",3p24.3,protein-coding,/
CWITA000020,TCMBANKGE000020,NDUFS4,AQDQ; CI-18; CI-18 kDa; CI-AQDQ; MC1DN1,NADH:ubiquinone oxidoreductase subunit S4,5q11.2,protein-coding,/
CWITA000021,TCMBANKGE000021,MB,PVALB,myoglobin,22q12.3,protein-coding,/
CWITA000022,TCMBANKGE000022,CAMK2A,CAMKA; CaMKIINalpha; CaMKIIalpha; MRD53; MRT63,calcium/calmodulin dependent protein kinase II alpha,5q32,protein-coding,/
CWITA000023,TCMBANKGE000023,CNTNAP1,CASPR; CHN3; CNTNAP; NRXN4; P190,contactin associated protein 1,17q21.2,protein-coding,/
CWITA000024,TCMBANKGE000024,NDUFV1,CI-51K; CI51KD; MC1DN4; UQOR1,NADH:ubiquinone oxidoreductase core subunit V1,11q13.2,protein-coding,/
CWITA000025,TCMBANKGE000025,TNFRSF10D,CD264; DCR2; TRAIL-R4; TRAILR4; TRUNDD,TNF receptor superfamily member 10d,8p21.3,protein-coding,/
CWITA000026,TCMBANKGE000026,FYN,SLK; SYN; p59-FYN,"FYN proto-oncogene, Src family tyrosine kinase",6q21,protein-coding,Successful target
CWITA000027,TCMBANKGE000027,MKNK1,MNK1,MAPK interacting serine/threonine kinase 1,1p33,protein-coding,Clinical Trial target
CWITA000028,TCMBANKGE000028,PHB,HEL-215; HEL-S-54e; PHB1,prohibitin,17q21.33,protein-coding,Research target
CWITA000029,TCMBANKGE000029,GZMB,C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT,granzyme B,14q12,protein-coding,Research target
CWITA000030,TCMBANKGE000030,FKRP,FKTR; LGMD2I; LGMDR9; MDC1C; MDDGA5; MDDGB5; MDDGC5,fukutin related protein,19q13.32,protein-coding,/
CWITA000031,TCMBANKGE000031,DNMT3A,DNMT3A2; HESJAS; M.HsaIIIA; TBRS,DNA methyltransferase 3 alpha,2p23.3,protein-coding,Patented target
CWITA000032,TCMBANKGE000032,ARHGEF2,GEF; GEF-H1; GEFH1; LFP40; Lfc; NEDMHM; P40,Rho/Rac guanine nucleotide exchange factor 2,1q22,protein-coding,/
CWITA000033,TCMBANKGE000033,SOS1,GF1; GGF1; GINGF; HGF; NS4; SOS-1,SOS Ras/Rac guanine nucleotide exchange factor 1,2p22.1,protein-coding,/
CWITA000034,TCMBANKGE000034,PFKFB3,IPFK2; PFK2; iPFK-2,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",10p15.1,protein-coding,Clinical Trial target
CWITA000035,TCMBANKGE000035,PDK2,PDHK2; PDKII,pyruvate dehydrogenase kinase 2,17q21.33,protein-coding,Research target
CWITA000036,TCMBANKGE000036,SOCS1,CIS1; CISH1; JAB; SOCS-1; SSI-1; SSI1; TIP-3; TIP3,suppressor of cytokine signaling 1,16p13.13,protein-coding,Research target
CWITA000037,TCMBANKGE000037,CSF1,CSF-1; MCSF,colony stimulating factor 1,1p13.3,protein-coding,Clinical Trial target
CWITA000038,TCMBANKGE000038,SLC11A1,LSH; NRAMP; NRAMP1,solute carrier family 11 member 1,2q35,protein-coding,/
CWITA000039,TCMBANKGE000039,TMEM171,PRP2,transmembrane protein 171,5q13.2,protein-coding,/
CWITA000040,TCMBANKGE000040,IRF2,IRF-2,interferon regulatory factor 2,4q35.1,protein-coding,/
CWITA000041,TCMBANKGE000041,IRF1,IRF-1; MAR,interferon regulatory factor 1,5q31.1,protein-coding,Research target
CWITA000042,TCMBANKGE000042,GPR35,-,G protein-coupled receptor 35,2q37.3,protein-coding,Research target
CWITA000043,TCMBANKGE000043,BHLHE40,BHLHB2; Clast5; DEC1; HLHB2; SHARP-2; SHARP2; STRA13; Stra14,basic helix-loop-helix family member e40,3p26.1,protein-coding,/
CWITA000044,TCMBANKGE000044,SIK3,L19; QSK; SEMDK; SIK-3,SIK family kinase 3,11q23.3,protein-coding,Research target
CWITA000045,TCMBANKGE000045,IRS2,IRS-2,insulin receptor substrate 2,13q34,protein-coding,/
CWITA000046,TCMBANKGE000046,PIK3R1,AGM7; GRB1; IMD36; p85; p85-ALPHA,phosphoinositide-3-kinase regulatory subunit 1,5q13.1,protein-coding,/
CWITA000047,TCMBANKGE000047,AKT1,AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA,AKT serine/threonine kinase 1,14q32.33,protein-coding,Clinical Trial target
CWITA000048,TCMBANKGE000048,PRKN,AR-JP; LPRS2; PARK2; PDJ,parkin RBR E3 ubiquitin protein ligase,6q26,protein-coding,/
CWITA000049,TCMBANKGE000049,CCDC88B,BRLZ; CCDC88; HKRP3; gipie,coiled-coil domain containing 88B,11q13.1,protein-coding,/
CWITA000050,TCMBANKGE000050,MERTK,MER; RP38; Tyro12; c-Eyk; c-mer,"MER proto-oncogene, tyrosine kinase",2q13,protein-coding,Clinical Trial target
CWITA000051,TCMBANKGE000051,IL1B,IL-1; IL1-BETA; IL1F2; IL1beta,interleukin 1 beta,2q14.1,protein-coding,Successful target
CWITA000052,TCMBANKGE000052,TNF,DIF; TNF-alpha; TNFA; TNFSF2; TNLG1F,tumor necrosis factor,6p21.33,protein-coding,Successful target
CWITA000053,TCMBANKGE000053,NFKB1,CVID12; EBP-1; KBF1; NF-kB; NF-kB1; NF-kappa-B1; NF-kappaB; NF-kappabeta; NFKB-p105; NFKB-p50; NFkappaB,nuclear factor kappa B subunit 1,4q24,protein-coding,Clinical Trial target
CWITA000054,TCMBANKGE000054,GAD1,CPSQ1; GAD; SCP,glutamate decarboxylase 1,2q31.1,protein-coding,Research target
CWITA000055,TCMBANKGE000055,Ntf5,2900040K06Rik; AI462899; NT-4; NT-5; NT4; NT4/5; Ntf-5; Ntf4,neurotrophin 5,7 B3|7 29.3 cM,protein-coding,/
CWITA000056,TCMBANKGE000056,SLC8B1,NCKX6; NCLX; SLC24A6,solute carrier family 8 member B1,12q24.13,protein-coding,Research target
CWITA000057,TCMBANKGE000057,MCU,C10orf42; CCDC109A; HsMCU,mitochondrial calcium uniporter,10q22.1,protein-coding,/
CWITA000058,TCMBANKGE000058,SCN4A,CMS16; HOKPP2; HYKPP; HYPP; NAC1A; Na(V)1.4; Nav1.4; SkM1,sodium voltage-gated channel alpha subunit 4,17q23.3,protein-coding,Clinical Trial target
CWITA000059,TCMBANKGE000059,NGFR,CD271; Gp80-LNGFR; TNFRSF16; p75(NTR); p75NTR,nerve growth factor receptor,17q21.33,protein-coding,Successful target
CWITA000060,TCMBANKGE000060,CRHR1,CRF-R; CRF-R-1; CRF-R1; CRF1; CRFR-1; CRFR1; CRH-R-1; CRH-R1; CRHR; CRHR1L,corticotropin releasing hormone receptor 1,17q21.31,protein-coding,Successful target
CWITA000061,TCMBANKGE000061,OXTR,OT-R,oxytocin receptor,3p25.3,protein-coding,Successful target
CWITA000062,TCMBANKGE000062,SCN1A,EIEE6; FEB3; FEB3A; FHM3; GEFSP2; HBSCI; NAC1; Nav1.1; SCN1; SMEI,sodium voltage-gated channel alpha subunit 1,2q24.3,protein-coding,Research target
CWITA000063,TCMBANKGE000063,SCN8A,BFIS5; CERIII; CIAT; EIEE13; MED; MYOCL2; NaCh6; Nav1.6; PN4,sodium voltage-gated channel alpha subunit 8,12q13.13,protein-coding,Clinical Trial target
CWITA000064,TCMBANKGE000064,SCN3A,EIEE62; FFEVF4; NAC3; Nav1.3,sodium voltage-gated channel alpha subunit 3,2q24.3,protein-coding,Successful target
CWITA000065,TCMBANKGE000065,SCN9A,ETHA; FEB3B; GEFSP7; HSAN2D; NE-NA; NENA; Nav1.7; PN1; SFNP,sodium voltage-gated channel alpha subunit 9,2q24.3,protein-coding,Clinical Trial target
CWITA000066,TCMBANKGE000066,YY1,DELTA; GADEVS; INO80S; NF-E1; UCRBP; YIN-YANG-1,YY1 transcription factor,14q32.2,protein-coding,/
CWITA000067,TCMBANKGE000067,NCF1,NCF1A; NOXO2; SH3PXD1A; p47phox,neutrophil cytosolic factor 1,7q11.23,protein-coding,Research target
CWITA000068,TCMBANKGE000068,VEGFC,Flt4-L; LMPH1D; LMPHM4; VRP,vascular endothelial growth factor C,4q34.3,protein-coding,Clinical Trial target
CWITA000069,TCMBANKGE000069,CCL17,A-152E5.3; ABCD-2; SCYA17; TARC,C-C motif chemokine ligand 17,16q21,protein-coding,/
CWITA000070,TCMBANKGE000070,CAV1,BSCL3; CGL3; LCCNS; MSTP085; PPH3; VIP21,caveolin 1,7q31.2,protein-coding,Research target
CWITA000071,TCMBANKGE000071,BTG2,APRO1; PC3; TIS21,BTG anti-proliferation factor 2,1q32.1,protein-coding,/
CWITA000072,TCMBANKGE000072,CXCL12,IRH; PBSF; SCYB12; SDF1; TLSF; TPAR1,C-X-C motif chemokine ligand 12,10q11.21,protein-coding,Clinical Trial target
CWITA000073,TCMBANKGE000073,CD4,CD4mut,CD4 molecule,12p13.31,protein-coding,Successful target
CWITA000074,TCMBANKGE000074,MIR221,MIRN221; miRNA221; mir-221,microRNA 221,Xp11.3,ncRNA,/
CWITA000075,TCMBANKGE000075,IL1RN,DIRA; ICIL-1RA; IL-1RN; IL-1ra; IL-1ra3; IL1F3; IL1RA; IRAP; MVCD4,interleukin 1 receptor antagonist,2q14.1,protein-coding,/
CWITA000076,TCMBANKGE000076,RPS14,EMTB; S14,ribosomal protein S14,5q33.1,protein-coding,/
CWITA000077,TCMBANKGE000077,ROCK2,ROCK-II,Rho associated coiled-coil containing protein kinase 2,2p25.1,protein-coding,Clinical Trial target
CWITA000078,TCMBANKGE000078,BRD4,CAP; HUNK1; HUNKI; MCAP,bromodomain containing 4,19p13.12,protein-coding,Clinical Trial target
CWITA000079,TCMBANKGE000079,RHOD,ARHD; RHOHP1; RHOM; Rho,ras homolog family member D,11q13.2,protein-coding,/
CWITA000080,TCMBANKGE000080,CYP4F2,CPF2,cytochrome P450 family 4 subfamily F member 2,19p13.12,protein-coding,/
CWITA000081,TCMBANKGE000081,EPHX2,ABHD20; CEH; SEH,epoxide hydrolase 2,8p21.2-p21.1,protein-coding,Clinical Trial target
CWITA000082,TCMBANKGE000082,HMOX2,HO-2,heme oxygenase 2,16p13.3,protein-coding,Research target
CWITA000083,TCMBANKGE000083,CYP2J2,CPJ2; CYPIIJ2,cytochrome P450 family 2 subfamily J member 2,1p32.1,protein-coding,/
CWITA000084,TCMBANKGE000084,MYLK3,MLCK; MLCK2; caMLCK,myosin light chain kinase 3,16q11.2,protein-coding,/
CWITA000085,TCMBANKGE000085,EIF4A1,DDX2A; EIF-4A; EIF4A; eIF-4A-I; eIF4A-I,eukaryotic translation initiation factor 4A1,17p13.1,protein-coding,/
CWITA000086,TCMBANKGE000086,VKORC1,EDTP308; MST134; MST576; VKCFD2; VKOR,vitamin K epoxide reductase complex subunit 1,16p11.2,protein-coding,Successful target
CWITA000087,TCMBANKGE000087,TNFRSF10C,CD263; DCR1; DCR1-TNFR; LIT; TRAIL-R3; TRAILR3; TRID,TNF receptor superfamily member 10c,8p21.3,protein-coding,/
CWITA000088,TCMBANKGE000088,PPP5C,PP5; PPP5; PPT,protein phosphatase 5 catalytic subunit,19q13.32,protein-coding,Patented target
CWITA000089,TCMBANKGE000089,PIK3R2,MPPH; MPPH1; P85B; p85; p85-BETA,phosphoinositide-3-kinase regulatory subunit 2,19p13.11,protein-coding,/
CWITA000090,TCMBANKGE000090,SART3,DSAP1; P100; RP11-13G14; TIP110; p110; p110(nrb),"spliceosome associated factor 3, U4/U6 recycling protein",12q23.3,protein-coding,/
CWITA000091,TCMBANKGE000091,PRDM4,PFM1,PR/SET domain 4,12q23.3,protein-coding,/
CWITA000092,TCMBANKGE000092,DDX58,RIG-I; RIG1; RIGI; RLR-1; SGMRT2,DExD/H-box helicase 58,9p21.1,protein-coding,Clinical Trial target
CWITA000093,TCMBANKGE000093,IFNB1,IFB; IFF; IFN-beta; IFNB,interferon beta 1,9p21.3,protein-coding,Successful target
CWITA000094,TCMBANKGE000094,NR5A1,AD4BP; ELP; FTZ1; FTZF1; POF7; SF-1; SF1; SPGF8; SRXX4; SRXY3; hSF-1,nuclear receptor subfamily 5 group A member 1,9q33.3,protein-coding,/
CWITA000095,TCMBANKGE000095,CYP11B2,ALDOS; CPN2; CYP11B; CYP11BL; CYPXIB2; P-450C18; P450C18; P450aldo,cytochrome P450 family 11 subfamily B member 2,8q24.3,protein-coding,Clinical Trial target
CWITA000096,TCMBANKGE000096,TBK1,FTDALS4; IIAE8; NAK; T2K,TANK binding kinase 1,12q14.2,protein-coding,Patented target
CWITA000097,TCMBANKGE000097,IRF3,IIAE7,interferon regulatory factor 3,19q13.33,protein-coding,Research target
CWITA000098,TCMBANKGE000098,ATP1A4,ATP1A1; ATP1AL2,ATPase Na+/K+ transporting subunit alpha 4,1q23.2,protein-coding,/
CWITA000099,TCMBANKGE000099,EIF5AL1,EIF5A; EIF5AP1; bA342M3.3; eIF-4D; eIF-5A; eIF-5A-1; eIF-5A1,eukaryotic translation initiation factor 5A like 1,10q22.3,protein-coding,/
CWITA000100,TCMBANKGE000100,EIF5A,EIF-5A; EIF5A1; eIF-4D; eIF5AI,eukaryotic translation initiation factor 5A,17p13.1,protein-coding,Research target
CWITA000101,TCMBANKGE000101,PGF,D12S1900; PGFL; PIGF; PLGF; PlGF-2; SHGC-10760,placental growth factor,14q24.3,protein-coding,Successful target
CWITA000102,TCMBANKGE000102,MAFG,hMAF,MAF bZIP transcription factor G,17q25.3,protein-coding,/
CWITA000103,TCMBANKGE000103,MAFF,U-MAF; hMafF,MAF bZIP transcription factor F,22q13.1,protein-coding,/
CWITA000104,TCMBANKGE000104,GSTZ1,GSTZ1-1; MAAI; MAAID; MAI,glutathione S-transferase zeta 1,14q24.3,protein-coding,/
CWITA000105,TCMBANKGE000105,KIF5B,HEL-S-61; KINH; KNS; KNS1; UKHC,kinesin family member 5B,10p11.22,protein-coding,/
CWITA000106,TCMBANKGE000106,SCN10A,FEPS2; Nav1.8; PN3; SNS; hPN3,sodium voltage-gated channel alpha subunit 10,3p22.2,protein-coding,Successful target
CWITA000107,TCMBANKGE000107,ARFGEF3,A7322; BIG3; C6orf92; KIAA1244; PPP1R33; dJ171N11.1,ARFGEF family member 3,6q23.3-q24.1,protein-coding,/
CWITA000108,TCMBANKGE000108,COMP,EDM1; EPD1; MED; PSACH; THBS5; TSP5,cartilage oligomeric matrix protein,19p13.11,protein-coding,/
CWITA000109,TCMBANKGE000109,ACTB,BRWS1; PS1TP5BP1,actin beta,7p22.1,protein-coding,/
CWITA000110,TCMBANKGE000110,DPYSL2,CRMP-2; CRMP2; DHPRP2; DRP-2; DRP2; N2A3; ULIP-2; ULIP2,dihydropyrimidinase like 2,8p21.2,protein-coding,Successful target
CWITA000111,TCMBANKGE000111,BCL10,CARMEN; CIPER; CLAP; IMD37; c-E10; mE10,BCL10 immune signaling adaptor,1p22.3,protein-coding,/
CWITA000112,TCMBANKGE000112,MGLL,HU-K5; HUK5; MAGL; MGL,monoglyceride lipase,3q21.3,protein-coding,Clinical Trial target
CWITA000113,TCMBANKGE000113,CCNA1,CT146,cyclin A1,13q13.3,protein-coding,/
CWITA000114,TCMBANKGE000114,PLA2G6,CaI-PLA2; GVI; INAD1; IPLA2-VIA; NBIA2; NBIA2A; NBIA2B; PARK14; PLA2; PNPLA9; iPLA2; iPLA2beta,phospholipase A2 group VI,22q13.1,protein-coding,/
CWITA000115,TCMBANKGE000115,DEPP1,C10orf10; DEPP; FIG; Fseg,DEPP1 autophagy regulator,10q11.21,protein-coding,/
CWITA000116,TCMBANKGE000116,ZHX2,AFR1; RAF,zinc fingers and homeoboxes 2,8q24.13,protein-coding,/
CWITA000117,TCMBANKGE000117,RUNX3,AML2; CBFA3; PEBP2aC,RUNX family transcription factor 3,1p36.11,protein-coding,Research target
CWITA000118,TCMBANKGE000118,CAPN2,CANP2; CANPL2; CANPml; mCANP,calpain 2,1q41,protein-coding,Clinical Trial target
CWITA000119,TCMBANKGE000119,PDE4D,ACRDYS2; DPDE3; HSPDE4D; PDE43; PDE4DN2; STRK1,phosphodiesterase 4D,5q11.2-q12.1,protein-coding,Successful target
CWITA000120,TCMBANKGE000120,PDK1,-,pyruvate dehydrogenase kinase 1,2q31.1,protein-coding,Patented target
CWITA000121,TCMBANKGE000121,KCNH2,ERG-1; ERG1; H-ERG; HERG; HERG1; Kv11.1; LQT2; SQT1,potassium voltage-gated channel subfamily H member 2,7q36.1,protein-coding,Successful target
CWITA000122,TCMBANKGE000122,PTGES3,P23; TEBP; cPGES,prostaglandin E synthase 3,12q13.3|12,protein-coding,/
CWITA000123,TCMBANKGE000123,RPA1,HSSB; MST075; REPA1; RF-A; RP-A; RPA70,replication protein A1,17p13.3,protein-coding,/
CWITA000124,TCMBANKGE000124,EEF2,EEF-2; EF-2; EF2; SCA26,eukaryotic translation elongation factor 2,19p13.3,protein-coding,/
CWITA000125,TCMBANKGE000125,AGMAT,-,agmatinase,1p36.21,protein-coding,/
CWITA000126,TCMBANKGE000126,NFE2L1,LCR-F1; NRF1; TCF11,"nuclear factor, erythroid 2 like 1",17q21.32,protein-coding,/
CWITA000127,TCMBANKGE000127,MFN2,CMT2A; CMT2A2; CMT2A2A; CMT2A2B; CPRP1; HMSN6A; HSG; MARF,mitofusin 2,1p36.22,protein-coding,/
CWITA000128,TCMBANKGE000128,PRDX1,MSP23; NKEF-A; NKEFA; PAG; PAGA; PAGB; PRX1; PRXI; TDPX2,peroxiredoxin 1,1p34.1,protein-coding,/
CWITA000129,TCMBANKGE000129,MAP3K14,FTDCR1B|HS|HSNIK|NIK,mitogen-activated protein kinase kinase kinase 14,17q21.31,protein-coding,Research target
CWITA000130,TCMBANKGE000130,TOP2A,TOP2; TP2A,DNA topoisomerase II alpha,17q21.2,protein-coding,Clinical Trial target
CWITA000131,TCMBANKGE000131,CDC25C,CDC25; PPP1R60,cell division cycle 25C,5q31.2,protein-coding,Research target
CWITA000132,TCMBANKGE000132,MAT2A,MATA2; MATII; SAMS2,methionine adenosyltransferase 2A,2p11.2,protein-coding,Clinical Trial target
CWITA000133,TCMBANKGE000133,MAP2K5,HsT17454; MAPKK5; MEK5; PRKMK5,mitogen-activated protein kinase kinase 5,15q23,protein-coding,Research target
CWITA000134,TCMBANKGE000134,EPO,DBAL; ECYT5; EP; MVCD2,erythropoietin,7q22.1,protein-coding,Clinical Trial target
CWITA000135,TCMBANKGE000135,CXCR4,CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS,C-X-C motif chemokine receptor 4,2q22.1,protein-coding,Successful target
CWITA000136,TCMBANKGE000136,MKI67,KIA; MIB-; MIB-1; PPP1R105,marker of proliferation Ki-67,10q26.2,protein-coding,Research target
CWITA000137,TCMBANKGE000137,PLAU,ATF; BDPLT5; QPD; UPA; URK; u-PA,"plasminogen activator, urokinase",10q22.2,protein-coding,Successful target
CWITA000138,TCMBANKGE000138,PRKCE,PKCE; nPKC-epsilon,protein kinase C epsilon,2p21,protein-coding,Research target
CWITA000139,TCMBANKGE000139,POR,CPR; CYPOR; P450R,cytochrome p450 oxidoreductase,7q11.23,protein-coding,Discontinued target
CWITA000140,TCMBANKGE000140,EIF4EBP1,4E-BP1; 4EBP1; BP-1; PHAS-I,eukaryotic translation initiation factor 4E binding protein 1,8p11.23,protein-coding,Research target
CWITA000141,TCMBANKGE000141,CALR,CRT; HEL-S-99n; RO; SSA; cC1qR,calreticulin,19p13.13,protein-coding,Research target
CWITA000142,TCMBANKGE000142,CALCR,CRT; CT-R; CTR; CTR1,calcitonin receptor,7q21.3,protein-coding,Successful target
CWITA000143,TCMBANKGE000143,POU5F1P4,OCT3; OCT4; OTF-3; OTF3; Oct-3; Oct-4; Oct4-pg4; POU5F1; POU5FLC1,POU class 5 homeobox 1 pseudogene 4,1q22,pseudo,/
CWITA000144,TCMBANKGE000144,POU5F1P3,OCT3; OCT4; OCT4-pg3; OTF-3; OTF3; OTF3L; Oct-3; Oct-4; POU5F1; POU5F1L; POU5FLC12,POU class 5 homeobox 1 pseudogene 3,12p13.31,pseudo,/
CWITA000145,TCMBANKGE000145,ADAMTS5,ADAM-TS 11; ADAM-TS 5; ADAM-TS5; ADAMTS-11; ADAMTS-5; ADAMTS11; ADMP-2,ADAM metallopeptidase with thrombospondin type 1 motif 5,21q21.3,protein-coding,Clinical Trial target
CWITA000146,TCMBANKGE000146,CAPN10,CANP10; NIDDM1,calpain 10,2q37.3,protein-coding,/
CWITA000147,TCMBANKGE000147,OPA1,BERHS; MGM1; MTDPS14; NPG; NTG; largeG,OPA1 mitochondrial dynamin like GTPase,3q29,protein-coding,Research target
CWITA000148,TCMBANKGE000148,USP51,-,ubiquitin specific peptidase 51,Xp11.21,protein-coding,/
CWITA000149,TCMBANKGE000149,MAP3K12,DLK; MEKK12; MUK; ZPK; ZPKP1,mitogen-activated protein kinase kinase kinase 12,12q13.13,protein-coding,/
CWITA000150,TCMBANKGE000150,MIR192,MIRN192; miR-192; miRNA192,microRNA 192,11q13.1,ncRNA,/
CWITA000151,TCMBANKGE000151,UBE2C,UBCH10; dJ447F3.2,ubiquitin conjugating enzyme E2 C,20q13.12,protein-coding,/
CWITA000152,TCMBANKGE000152,RANBP10,-,RAN binding protein 10,16q22.1,protein-coding,/
CWITA000153,TCMBANKGE000153,USP7,HAUSP; TEF1,ubiquitin specific peptidase 7,16p13.2,protein-coding,Patented target
CWITA000154,TCMBANKGE000154,CCR2,CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R,C-C motif chemokine receptor 2,3p21.31,protein-coding,Clinical Trial target
CWITA000155,TCMBANKGE000155,SPAG5,DEEPEST; MAP126; hMAP126,sperm associated antigen 5,17q11.2,protein-coding,/
CWITA000156,TCMBANKGE000156,Atat1,0610011P08Rik; 2610008K08Rik; 2610110G12Rik; 3110080J08Rik; MEC-17; Mec17; TAT,alpha tubulin acetyltransferase 1,17|17 B1,protein-coding,
CWITA000157,TCMBANKGE000157,PRC1,ASE1,protein regulator of cytokinesis 1,15q26.1,protein-coding,/
CWITA000158,TCMBANKGE000158,RHOA,ARH12; ARHA; EDFAOB; RHO12; RHOH12,ras homolog family member A,3p21.31,protein-coding,Discontinued target
CWITA000159,TCMBANKGE000159,RHOH,ARHH; TTF,ras homolog family member H,4p14,protein-coding,/
CWITA000160,TCMBANKGE000160,COL2A1,ANFH; AOM; COL11A3; SEDC; STL1,collagen type II alpha 1 chain,12q13.11,protein-coding,/
CWITA000161,TCMBANKGE000161,ADAMTS4,ADAMTS-2; ADAMTS-4; ADMP-1,ADAM metallopeptidase with thrombospondin type 1 motif 4,1q23.3,protein-coding,Research target
CWITA000162,TCMBANKGE000162,MMP13,CLG3; MANDP1; MDST; MMP-13,matrix metallopeptidase 13,11q22.2,protein-coding,Clinical Trial target
CWITA000163,TCMBANKGE000163,TNFRSF1B,CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR,TNF receptor superfamily member 1B,1p36.22,protein-coding,Research target
CWITA000164,TCMBANKGE000164,MIR203A,MIR203; MIRN203; hsa-mir-203a; miR-203; miRNA203; mir-203a,microRNA 203a,14q32.33,ncRNA,/
CWITA000165,TCMBANKGE000165,ETFDH,ETFQO; MADD,electron transfer flavoprotein dehydrogenase,4q32.1,protein-coding,/
CWITA000166,TCMBANKGE000166,EP300,KAT3B; MKHK2; RSTS2; p300,E1A binding protein p300,22q13.2,protein-coding,Research target
CWITA000167,TCMBANKGE000167,EZR,CVIL; CVL; HEL-S-105; VIL2,ezrin,6q25.3,protein-coding,Research target
CWITA000168,TCMBANKGE000168,NR3C1,GCCR; GCR; GCRST; GR; GRL,nuclear receptor subfamily 3 group C member 1,5q31.3,protein-coding,Successful target
CWITA000169,TCMBANKGE000169,BBC3,JFY-1; JFY1; PUMA,BCL2 binding component 3,19q13.32,protein-coding,Research target
CWITA000170,TCMBANKGE000170,GLRX,GRX; GRX1,glutaredoxin,5q15,protein-coding,Research target
CWITA000171,TCMBANKGE000171,DNMT1,ADCADN; AIM; CXXC9; DNMT; HSN1E; MCMT; m.HsaI,DNA methyltransferase 1,19p13.2,protein-coding,Clinical Trial target
CWITA000172,TCMBANKGE000172,IGFBP1,AFBP; IBP1; IGF-BP25; PP12; hIGFBP-1,insulin like growth factor binding protein 1,7p12.3,protein-coding,Research target
CWITA000173,TCMBANKGE000173,BRAF,B-RAF1; B-raf; BRAF1; NS7; RAFB1,"B-Raf proto-oncogene, serine/threonine kinase",7q34,protein-coding,Successful target
CWITA000174,TCMBANKGE000174,MSTN,GDF8; MSLHP,myostatin,2q32.2,protein-coding,Clinical Trial target
CWITA000175,TCMBANKGE000175,FBXW7,AGO; CDC4; FBW6; FBW7; FBX30; FBXO30; FBXW6; SEL-10; SEL10; hAgo; hCdc4,F-box and WD repeat domain containing 7,4q31.3,protein-coding,Research target
CWITA000176,TCMBANKGE000176,RRN3,A-270G1.2; TIFIA,"RRN3 homolog, RNA polymerase I transcription factor",16p13.11,protein-coding,/
CWITA000177,TCMBANKGE000177,NOP2,NOL1; NOP120; NSUN1; p120,NOP2 nucleolar protein,12p13.31,protein-coding,Research target
CWITA000178,TCMBANKGE000178,WDR12,YTM1,WD repeat domain 12,2q33.2,protein-coding,/
CWITA000179,TCMBANKGE000179,CT45A2,CT45-2; CT45.2; CT45A8; CT45A9,cancer/testis antigen family 45 member A2,Xq26.3,protein-coding,/
CWITA000180,TCMBANKGE000180,TCF4,CDG2T; E2-2; FECD3; ITF-2; ITF2; PTHS; SEF-2; SEF2; SEF2-1; SEF2-1A; SEF2-1B; SEF2-1D; TCF-4; bHLHb19,transcription factor 4,18q21.2,protein-coding,/
CWITA000181,TCMBANKGE000181,PIM1,PIM,"Pim-1 proto-oncogene, serine/threonine kinase",6p21.2,protein-coding,Clinical Trial target
CWITA000182,TCMBANKGE000182,B4galnt2,AI593864; Dlb-1; Dlb1; Galg2; Galgt2; Ggm3; Igf2bp1,"beta-1,4-N-acetyl-galactosaminyl transferase 2",11 D|11 59.02 cM,protein-coding,/
CWITA000183,TCMBANKGE000183,D7Zem2,Igf2; MAR2,"DNA segment, Chr 7, Zemel 2",-,unknown,/
CWITA000184,TCMBANKGE000184,IGF2BP1,CRD-BP; CRDBP; IMP-1; IMP1; VICKZ1; ZBP1,insulin like growth factor 2 mRNA binding protein 1,17q21.32,protein-coding,/
CWITA000185,TCMBANKGE000185,D7Zem3,Igf2; MAR3,"DNA segment, Chr 7, Zemel 3",-,unknown,/
CWITA000186,TCMBANKGE000186,IGF2,C11orf43; GRDF; IGF-II; PP9974,insulin like growth factor 2,11p15.5,protein-coding,Clinical Trial target
CWITA000187,TCMBANKGE000187,D7Zem1,Igf2; MAR1,"DNA segment, Chr 7, Zemel 1",-,unknown,/
CWITA000188,TCMBANKGE000188,TNFRSF25,APO-3; DDR3; DR3; GEF720; LARD; PLEKHG5; TNFRSF12; TR3; TRAMP; WSL-1; WSL-LR,TNF receptor superfamily member 25,1p36.31,protein-coding,/
CWITA000189,TCMBANKGE000189,TICAM1,IIAE6; MyD88-3; PRVTIRB; TICAM-1; TRIF,toll like receptor adaptor molecule 1,19p13.3,protein-coding,Patented target
CWITA000190,TCMBANKGE000190,SMPD1,ASM; ASMASE; NPD,sphingomyelin phosphodiesterase 1,11p15.4,protein-coding,/
CWITA000191,TCMBANKGE000191,GUCY2C,DIAR6; GC-C; GUC2C; MECIL; MUCIL; STAR,guanylate cyclase 2C,12p12.3,protein-coding,Successful target
CWITA000192,TCMBANKGE000192,CDH5,7B4; CD144,cadherin 5,16q21,protein-coding,Research target
CWITA000193,TCMBANKGE000193,USP32,NY-REN-60; USP10,ubiquitin specific peptidase 32,17q23.1-q23.2,protein-coding,/
CWITA000194,TCMBANKGE000194,G3BP1,G3BP; HDH-VIII,G3BP stress granule assembly factor 1,5q33.1,protein-coding,Research target
CWITA000195,TCMBANKGE000195,RASA1,CM-AVM; CMAVM; CMAVM1; GAP; PKWS; RASA; RASGAP; p120; p120GAP; p120RASGAP,RAS p21 protein activator 1,5q14.3,protein-coding,Research target
CWITA000196,TCMBANKGE000196,FAS,ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6,Fas cell surface death receptor,10q23.31,protein-coding,Clinical Trial target
CWITA000197,TCMBANKGE000197,KCNJ11,BIR; HHF2; IKATP; KIR6.2; MODY13; PHHI; PNDM2; TNDM3,potassium inwardly rectifying channel subfamily J member 11,11p15.1,protein-coding,Research target
CWITA000198,TCMBANKGE000198,KCNMA1,BKTM; CADEDS; IEG16; KCa1.1; LIWAS; MaxiK; PNKD3; SAKCA; SLO; SLO-ALPHA; SLO1; bA205K10.1; hSlo; mSLO1,potassium calcium-activated channel subfamily M alpha 1,10q22.3,protein-coding,Research target
CWITA000199,TCMBANKGE000199,ICAM1,BB2; CD54; P3.58,intercellular adhesion molecule 1,19p13.2,protein-coding,Successful target
CWITA000200,TCMBANKGE000200,CYP1B1,ASGD6; CP1B; CYPIB1; GLC3A; P4501B1,cytochrome P450 family 1 subfamily B member 1,2p22.2,protein-coding,Clinical Trial target
CWITA000201,TCMBANKGE000201,ESR1,ER; ESR; ESRA; ESTRR; Era; NR3A1,estrogen receptor 1,6q25.1-q25.2,protein-coding,Successful target
CWITA000202,TCMBANKGE000202,RUNX2,AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA,RUNX family transcription factor 2,6p21.1,protein-coding,Research target
CWITA000203,TCMBANKGE000203,KHSRP,FBP2; FUBP2; KSRP; p75,KH-type splicing regulatory protein,19p13.3,protein-coding,/
CWITA000204,TCMBANKGE000204,CXCL8,GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8,C-X-C motif chemokine ligand 8,4q13.3,protein-coding,Successful target
CWITA000205,TCMBANKGE000205,NOS2,HEP-NOS; INOS; NOS; NOS2A,nitric oxide synthase 2,17q11.2,protein-coding,Clinical Trial target
CWITA000206,TCMBANKGE000206,FOXC2,FKHL14; LD; MFH-1; MFH1,forkhead box C2,16q24.1,protein-coding,Research target
CWITA000207,TCMBANKGE000207,DDX5,G17P1; HLR1; HUMP68; p68,DEAD-box helicase 5,17q23.3,protein-coding,Clinical Trial target
CWITA000208,TCMBANKGE000208,APOM,G3a; HSPC336; NG20; apo-M,apolipoprotein M,6p21.33,protein-coding,/
CWITA000209,TCMBANKGE000209,IZUMO1R,FOLR4; FR-delta; Folbp3; JUNO,"IZUMO1 receptor, JUNO",11q21,protein-coding,/
CWITA000210,TCMBANKGE000210,TRPC5,PPP1R159; TRP5,transient receptor potential cation channel subfamily C member 5,Xq23,protein-coding,Clinical Trial target
CWITA000211,TCMBANKGE000211,CLIP1,CLIP; CLIP-170; CLIP170; CYLN1; RSN,CAP-Gly domain containing linker protein 1,12q24.31,protein-coding,/
CWITA000212,TCMBANKGE000212,GRIN1,GluN1; MRD8; NDHMSD; NDHMSR; NMD-R1; NMDA1; NMDAR1; NR1,glutamate ionotropic receptor NMDA type subunit 1,9q34.3,protein-coding,Successful target
CWITA000213,TCMBANKGE000213,TRPM3,GON-2; LTRPC3; MLSN2,transient receptor potential cation channel subfamily M member 3,9q21.12-q21.13,protein-coding,Research target
CWITA000214,TCMBANKGE000214,SCD,FADS5; MSTP008; SCD1; SCDOS; hSCD1,stearoyl-CoA desaturase,10q24.31,protein-coding,Successful target
CWITA000215,TCMBANKGE000215,AMH,MIF; MIS,anti-Mullerian hormone,19p13.3,protein-coding,/
CWITA000216,TCMBANKGE000216,Hsp84-3,84kDa; Hsp90; hsp3,"heat shock protein, 3",-,other,/
CWITA000217,TCMBANKGE000217,P2RX7,P2X7,purinergic receptor P2X 7,12q24.31,protein-coding,Clinical Trial target
CWITA000218,TCMBANKGE000218,P2RX2,DFNA41; P2X2,purinergic receptor P2X 2,12q24.33,protein-coding,/
CWITA000219,TCMBANKGE000219,CCR5,CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22,C-C motif chemokine receptor 5,3p21.31,protein-coding,Successful target
CWITA000220,TCMBANKGE000220,EGR3,EGR-3; PILOT,early growth response 3,8p21.3,protein-coding,/
CWITA000221,TCMBANKGE000221,GRIA2,GLUR2; GLURB; GluA2; GluR-K2; HBGR2; gluR-2; gluR-B,glutamate ionotropic receptor AMPA type subunit 2,4q32.1,protein-coding,Research target
CWITA000222,TCMBANKGE000222,EDN1,ARCND3; ET1; HDLCQ7; PPET1; QME,endothelin 1,6p24.1,protein-coding,Research target
CWITA000223,TCMBANKGE000223,KEAP1,INrf2; KLHL19,kelch like ECH associated protein 1,19p13.2,protein-coding,Patented target
CWITA000224,TCMBANKGE000224,AGT,ANHU; SERPINA8; hFLT1,angiotensinogen,1q42.2,protein-coding,Research target
CWITA000225,TCMBANKGE000225,TFAM,MTDPS15; MTTF1; MTTFA; TCF6; TCF6L1; TCF6L2; TCF6L3,"transcription factor A, mitochondrial",10q21.1,protein-coding,/
CWITA000226,TCMBANKGE000226,UCP2,BMIQ4; SLC25A8; UCPH,uncoupling protein 2,11q13.4,protein-coding,Clinical Trial target
CWITA000227,TCMBANKGE000227,BMI1,FLVI2/BMI1; PCGF4; RNF51; flvi-2/bmi-1,"BMI1 proto-oncogene, polycomb ring finger",10p12.2,protein-coding,Research target
CWITA000228,TCMBANKGE000228,CRTC1,MAML2; MECT1; Mam-2; TORC-1; TORC1; WAMTP1,CREB regulated transcription coactivator 1,19p13.11,protein-coding,Research target
CWITA000229,TCMBANKGE000229,ACE2,ACEH,angiotensin I converting enzyme 2,Xp22.2,protein-coding,Clinical Trial target
CWITA000230,TCMBANKGE000230,ADIPOQ,ACDC; ACRP30; ADIPQTL1; ADPN; APM-1; APM1; GBP28,"adiponectin, C1Q and collagen domain containing",3q27.3,protein-coding,Research target
CWITA000231,TCMBANKGE000231,MAP2K1,CFC3; MAPKK1; MEK1; MKK1; PRKMK1,mitogen-activated protein kinase kinase 1,15q22.31,protein-coding,Clinical Trial target
CWITA000232,TCMBANKGE000232,ACTG2,ACT; ACTA3; ACTE; ACTL3; ACTSG; VSCM,"actin gamma 2, smooth muscle",2p13.1,protein-coding,/
CWITA000233,TCMBANKGE000233,DES,CDCD3; CSM1; CSM2; LGMD1D; LGMD1E; LGMD2R,desmin,2q35,protein-coding,/
CWITA000234,TCMBANKGE000234,Cyp2d22,2D22,"cytochrome P450, family 2, subfamily d, polypeptide 22",15|15 E1,protein-coding,/
CWITA000235,TCMBANKGE000235,NTRK2,EIEE58; GP145-TrkB; OBHD; TRKB; trk-B,neurotrophic receptor tyrosine kinase 2,9q21.33,protein-coding,Successful target
CWITA000236,TCMBANKGE000236,BDNF,ANON2; BULN2,brain derived neurotrophic factor,11p14.1,protein-coding,Clinical Trial target
CWITA000237,TCMBANKGE000237,CAMK2G,CAMK; CAMK-II; CAMKG; MRD59,calcium/calmodulin dependent protein kinase II gamma,10q22.2,protein-coding,/
CWITA000238,TCMBANKGE000238,IL10,CSIF; GVHDS; IL-10; IL10A; TGIF,interleukin 10,1q32.1,protein-coding,Clinical Trial target
CWITA000239,TCMBANKGE000239,UTRN,DMDL; DRP; DRP1,utrophin,6q24.2,protein-coding,Clinical Trial target
CWITA000240,TCMBANKGE000240,IL17A,CTLA-8; CTLA8; IL-17; IL-17A; IL17,interleukin 17A,6p12.2,protein-coding,Successful target
CWITA000241,TCMBANKGE000241,CASP8,ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5,caspase 8,2q33.1,protein-coding,Research target
CWITA000242,TCMBANKGE000242,SAA1,PIG4; SAA; SAA2; TP53I4,serum amyloid A1,11p15.1,protein-coding,Research target
CWITA000243,TCMBANKGE000243,LMNA,CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1,lamin A/C,1q22,protein-coding,/
CWITA000244,TCMBANKGE000244,ZMPSTE24,FACE-1; FACE1; HGPS; PRO1; STE24; Ste24p,zinc metallopeptidase STE24,1p34.2,protein-coding,/
CWITA000245,TCMBANKGE000245,CYBB,AMCBX2; CGD; GP91-1; GP91-PHOX; GP91PHOX; IMD34; NOX2; p91-PHOX,cytochrome b-245 beta chain,Xp21.1-p11.4,protein-coding,Research target
CWITA000246,TCMBANKGE000246,FOXO1,FKH1; FKHR; FOXO1A,forkhead box O1,13q14.11,protein-coding,Research target
CWITA000247,TCMBANKGE000247,SLC2A4,GLUT4,solute carrier family 2 member 4,17p13.1,protein-coding,Clinical Trial target
CWITA000248,TCMBANKGE000248,MMP10,SL-2; STMY2,matrix metallopeptidase 10,11q22.2,protein-coding,Research target
CWITA000249,TCMBANKGE000249,CCL22,A-152E5.1; ABCD-1; DC/B-CK; MDC; SCYA22; STCP-1,C-C motif chemokine ligand 22,16q21,protein-coding,Research target
CWITA000250,TCMBANKGE000250,CCL5,D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP,C-C motif chemokine ligand 5,17q12,protein-coding,Clinical Trial target
CWITA000251,TCMBANKGE000251,FGF2,BFGF; FGF-2; FGFB; HBGF-2,fibroblast growth factor 2,4q28.1,protein-coding,Successful target
CWITA000252,TCMBANKGE000252,PDE4A,DPDE2; PDE4; PDE46,phosphodiesterase 4A,19p13.2,protein-coding,Successful target
CWITA000253,TCMBANKGE000253,RAPGEF3,CAMP-GEFI; EPAC; EPAC1; HSU79275; bcm910,Rap guanine nucleotide exchange factor 3,12q13.11,protein-coding,/
CWITA000254,TCMBANKGE000254,VAMP5,-,vesicle associated membrane protein 5,2p11.2,protein-coding,/
CWITA000255,TCMBANKGE000255,CHAMP1,C13orf8; CAMP; CHAMP; MRD40; ZNF828,chromosome alignment maintaining phosphoprotein 1,13q34,protein-coding,/
CWITA000256,TCMBANKGE000256,PRKCA,AAG6; PKC-alpha; PKCA; PKCI+/-; PKCalpha; PRKACA,protein kinase C alpha,17q24.2,protein-coding,Successful target
CWITA000257,TCMBANKGE000257,FLT1,FLT; FLT-1; VEGFR-1; VEGFR1,fms related receptor tyrosine kinase 1,13q12.3,protein-coding,Successful target
CWITA000258,TCMBANKGE000258,EGR1,AT225; G0S30; KROX-24; NGFI-A; TIS8; ZIF-268; ZNF225,early growth response 1,5q31.2,protein-coding,Clinical Trial target
CWITA000259,TCMBANKGE000259,SCARB1,CD36L1; CLA-1; CLA1; HDLQTL6; SR-BI; SRB1,scavenger receptor class B member 1,12q24.31,protein-coding,Research target
CWITA000260,TCMBANKGE000260,APOB,FCHL2; FLDB; LDLCQ4; apoB-100; apoB-48,apolipoprotein B,2p24.1,protein-coding,Successful target
CWITA000261,TCMBANKGE000261,INS,IDDM; IDDM1; IDDM2; ILPR; IRDN; MODY10; PNDM4,insulin,11p15.5,protein-coding,Successful target
CWITA000262,TCMBANKGE000262,TBC1D9,GRAMD9; MDR1,TBC1 domain family member 9,4q31.21,protein-coding,/
CWITA000263,TCMBANKGE000263,Abcb1b,Abcb1; Mdr1; Mdr1b; Pgy-1; Pgy1; mdr,"ATP-binding cassette, sub-family B (MDR/TAP), member 1B",5 A1|5 3.43 cM,protein-coding,/
CWITA000264,TCMBANKGE000264,ABCB1,ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1,ATP binding cassette subfamily B member 1,7q21.12,protein-coding,Successful target
CWITA000265,TCMBANKGE000265,SQSTM1,A170; DMRV; FTDALS3; NADGP; OSIL; PDB3; ZIP3; p60; p62; p62B,sequestosome 1,5q35.3,protein-coding,Research target
CWITA000266,TCMBANKGE000266,DCTN4,DYN4; P62,dynactin subunit 4,5q33.1,protein-coding,/
CWITA000267,TCMBANKGE000267,GTF2H1,BTF2; P62; TFB1; TFIIH,general transcription factor IIH subunit 1,11p15.1,protein-coding,/
CWITA000268,TCMBANKGE000268,NUP62,IBSN; SNDI; p62,nucleoporin 62,19q13.33,protein-coding,/
CWITA000269,TCMBANKGE000269,ATG5,APG5; APG5-LIKE; APG5L; ASP; SCAR25; hAPG5,autophagy related 5,6q21,protein-coding,/
CWITA000270,TCMBANKGE000270,KHDRBS1,Sam68; p62; p68,"KH RNA binding domain containing, signal transduction associated 1",1p35.2,protein-coding,Research target
CWITA000271,TCMBANKGE000271,APOE,AD2; APO-E; ApoE4; LDLCQ5; LPG,apolipoprotein E,19q13.32,protein-coding,Clinical Trial target
CWITA000272,TCMBANKGE000272,CUL5,CUL-5; VACM-1; VACM1,cullin 5,11q22.3,protein-coding,/
CWITA000273,TCMBANKGE000273,LOX,AAT10,lysyl oxidase,5q23.1,protein-coding,Research target
CWITA000274,TCMBANKGE000274,CCL2,GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF,C-C motif chemokine ligand 2,17q12,protein-coding,Clinical Trial target
CWITA000275,TCMBANKGE000275,STXBP1,MUNC18-1; N-Sec1; NSEC1; P67; RBSEC1; UNC18; unc-18A; unc18-1,syntaxin binding protein 1,9q34.11,protein-coding,/
CWITA000276,TCMBANKGE000276,NOS1,IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS,nitric oxide synthase 1,12q24.22,protein-coding,Clinical Trial target
CWITA000277,TCMBANKGE000277,CD33,SIGLEC-3; SIGLEC3; p67,CD33 molecule,19q13.41,protein-coding,Successful target
CWITA000278,TCMBANKGE000278,METAP2,MAP2; MNPEP; p67eIF2,methionyl aminopeptidase 2,12q22,protein-coding,Clinical Trial target
CWITA000279,TCMBANKGE000279,SPHK1,SPHK,sphingosine kinase 1,17q25.1,protein-coding,Clinical Trial target
CWITA000280,TCMBANKGE000280,VIM,-,vimentin,10p13,protein-coding,/
CWITA000281,TCMBANKGE000281,SNAI2,SLUG; SLUGH; SLUGH1; SNAIL2; WS2D,snail family transcriptional repressor 2,8q11.21,protein-coding,/
CWITA000282,TCMBANKGE000282,ELN,ADCL1; SVAS; WBS; WS,elastin,7q11.23,protein-coding,/
CWITA000283,TCMBANKGE000283,YARS2,CGI-04; MLASA2; MT-TYRRS; TYRRS,tyrosyl-tRNA synthetase 2,12p11.21,protein-coding,/
CWITA000284,TCMBANKGE000284,YARS1,CMTDIC; TYRRS; YARS; YRS; YTS,tyrosyl-tRNA synthetase 1,1p35.1,protein-coding,/
CWITA000285,TCMBANKGE000285,ENTPD5,CD39L4; NTPDase-5; PCPH,ectonucleoside triphosphate diphosphohydrolase 5 (inactive),14q24.3,protein-coding,/
CWITA000286,TCMBANKGE000286,GSK3B,-,glycogen synthase kinase 3 beta,3q13.33,protein-coding,Clinical Trial target
CWITA000287,TCMBANKGE000287,LAMP1,CD107a; LAMPA; LGP120,lysosomal associated membrane protein 1,13q34,protein-coding,Research target
CWITA000288,TCMBANKGE000288,ATF6,ACHM7; ATF6A,activating transcription factor 6,1q23.3,protein-coding,/
CWITA000289,TCMBANKGE000289,EIF2AK3,PEK; PERK; WRS,eukaryotic translation initiation factor 2 alpha kinase 3,2p11.2,protein-coding,Research target
CWITA000290,TCMBANKGE000290,NQO1,DHQU; DIA4; DTD; NMOR1; NMORI; QR1,NAD(P)H quinone dehydrogenase 1,16q22.1,protein-coding,Clinical Trial target
CWITA000291,TCMBANKGE000291,NSG1,D4S234; D4S234E; NEEP21; P21,neuronal vesicle trafficking associated 1,4p16.3,protein-coding,/
CWITA000292,TCMBANKGE000292,TCEAL1,SIIR; WEX9; p21; pp21,transcription elongation factor A like 1,Xq22.2,protein-coding,/
CWITA000293,TCMBANKGE000293,TPT1,HRF; TCTP; p02; p23,"tumor protein, translationally-controlled 1",13q14.13,protein-coding,Discontinued target
CWITA000294,TCMBANKGE000294,CDKN1A,CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1,cyclin dependent kinase inhibitor 1A,6p21.2,protein-coding,Research target
CWITA000295,TCMBANKGE000295,FOXO3,AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A,forkhead box O3,6q21,protein-coding,/
CWITA000296,TCMBANKGE000296,PRDX2,HEL-S-2a; NKEF-B; NKEFB; PRP; PRX2; PRXII; PTX1; TDPX1; TPX1; TSA,peroxiredoxin 2,19p13.13,protein-coding,/
CWITA000297,TCMBANKGE000297,JAK2,JTK10; THCYT3,Janus kinase 2,9p24.1,protein-coding,Successful target
CWITA000298,TCMBANKGE000298,SOD1,ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer,superoxide dismutase 1,21q22.11,protein-coding,Clinical Trial target
CWITA000299,TCMBANKGE000299,HMGCR,LDLCQ3,3-hydroxy-3-methylglutaryl-CoA reductase,5q13.3,protein-coding,Successful target
CWITA000300,TCMBANKGE000300,SLC1A3,EA6; EAAT1; GLAST; GLAST1,solute carrier family 1 member 3,5p13.2,protein-coding,Research target
CWITA000301,TCMBANKGE000301,SLC2A1,CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; PED; SDCHCN,solute carrier family 2 member 1,1p34.2,protein-coding,Research target
CWITA000302,TCMBANKGE000302,KCNQ1,ATFB1; ATFB3; JLNS1; KCNA8; KCNA9; KVLQT1; Kv1.9; Kv7.1; LQT; LQT1; RWS; SQT2; WRS,potassium voltage-gated channel subfamily Q member 1,11p15.5-p15.4,protein-coding,Successful target
CWITA000303,TCMBANKGE000303,KCNA4,HBK4; HK1; HPCN2; HUKII; KCNA4L; KCNA8; KV1.4; MCIDDS; PCN2,potassium voltage-gated channel subfamily A member 4,11p14.1,protein-coding,/
CWITA000304,TCMBANKGE000304,KCNA5,ATFB7; HCK1; HK2; HPCN1; KV1.5; PCN1,potassium voltage-gated channel subfamily A member 5,12p13.32,protein-coding,Successful target
CWITA000305,TCMBANKGE000305,PIK3CD,APDS; IMD14; P110DELTA; PI3K; p110D,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",1p36.22,protein-coding,Successful target
CWITA000306,TCMBANKGE000306,PIK3CG,PI3CG; PI3K; PI3Kgamma; PIK3; p110gamma; p120-PI3K,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",7q22.3,protein-coding,Successful target
CWITA000307,TCMBANKGE000307,PIK3CB,P110BETA; PI3K; PI3KBETA; PIK3C1,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",3q22.3,protein-coding,Research target
CWITA000308,TCMBANKGE000308,PIK3CA,CLAPO; CLOVE; CWS5; MCAP; MCM; MCMTC; PI3K; PI3K-alpha; p110-alpha,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32,protein-coding,Successful target
CWITA000309,TCMBANKGE000309,SCN5A,CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1,sodium voltage-gated channel alpha subunit 5,3p22.2,protein-coding,Successful target
CWITA000310,TCMBANKGE000310,FOSB,AP-1; G0S3; GOS3; GOSB,"FosB proto-oncogene, AP-1 transcription factor subunit",19q13.32,protein-coding,/
CWITA000311,TCMBANKGE000311,JUND,AP-1,"JunD proto-oncogene, AP-1 transcription factor subunit",19p13.11,protein-coding,/
CWITA000312,TCMBANKGE000312,JUNB,AP-1,"JunB proto-oncogene, AP-1 transcription factor subunit",19p13.13,protein-coding,/
CWITA000313,TCMBANKGE000313,JUN,AP-1; AP1; c-Jun; cJUN; p39,"Jun proto-oncogene, AP-1 transcription factor subunit",1p32.1,protein-coding,Discontinued target
CWITA000314,TCMBANKGE000314,LTC4S,-,leukotriene C4 synthase,5q35.3,protein-coding,Research target
CWITA000315,TCMBANKGE000315,IL4,BCGF-1; BCGF1; BSF-1; BSF1; IL-4,interleukin 4,5q31.1,protein-coding,Clinical Trial target
CWITA000316,TCMBANKGE000316,IL5,EDF; IL-5; TRF,interleukin 5,5q31.1,protein-coding,Successful target
CWITA000317,TCMBANKGE000317,LXN,ECI; TCI,latexin,3q25.32,protein-coding,/
CWITA000318,TCMBANKGE000318,HMGB1,HMG-1; HMG1; HMG3; SBP-1,high mobility group box 1,13q12.3,protein-coding,Research target
CWITA000319,TCMBANKGE000319,GPX1,GPXD; GSHPX1,glutathione peroxidase 1,3p21.31,protein-coding,Research target
CWITA000320,TCMBANKGE000320,SOD2-OT1,SOD2,SOD2 overlapping transcript 1,6q25.3,ncRNA,/
CWITA000321,TCMBANKGE000321,NOX4,KOX; KOX-1; RENOX,NADPH oxidase 4,11q14.3,protein-coding,Clinical Trial target
CWITA000322,TCMBANKGE000322,H2AX,H2A.X; H2A/X; H2AFX,H2A.X variant histone,11q23.3,protein-coding,/
CWITA000323,TCMBANKGE000323,BRCA1,BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53,BRCA1 DNA repair associated,17q21.31,protein-coding,/
CWITA000324,TCMBANKGE000324,BTK,AGMX1; AT; ATK; BPK; IGHD3; IMD1; PSCTK1; XLA,Bruton tyrosine kinase,Xq22.1,protein-coding,Successful target
CWITA000325,TCMBANKGE000325,VAV1,VAV,vav guanine nucleotide exchange factor 1,19p13.3,protein-coding,/
CWITA000326,TCMBANKGE000326,SELP,CD62; CD62P; GMP140; GRMP; LECAM3; PADGEM; PSEL,selectin P,1q24.2,protein-coding,Clinical Trial target
CWITA000327,TCMBANKGE000327,SYK,p72-Syk,spleen associated tyrosine kinase,9q22.2,protein-coding,Successful target
CWITA000328,TCMBANKGE000328,PTPN11,BPTP3; CFC; JMML; METCDS; NS1; PTP-1D; PTP2C; SH-PTP2; SH-PTP3; SHP2,protein tyrosine phosphatase non-receptor type 11,12q24.13,protein-coding,Clinical Trial target
CWITA000329,TCMBANKGE000329,STAT6,D12S1644; IL-4-STAT; STAT6B; STAT6C,signal transducer and activator of transcription 6,12q13.3,protein-coding,Research target
CWITA000330,TCMBANKGE000330,HMOX1,HMOX1D; HO-1; HSP32; bK286B10,heme oxygenase 1,22q12.3,protein-coding,Clinical Trial target
CWITA000331,TCMBANKGE000331,CALCA,CALC1; CGRP; CGRP-I; CGRP-alpha; CGRP1; CT; KC; PCT,calcitonin related polypeptide alpha,11p15.2,protein-coding,Clinical Trial target
CWITA000332,TCMBANKGE000332,CCL20,CKb4; Exodus; LARC; MIP-3-alpha; MIP-3a; MIP3A; SCYA20; ST38,C-C motif chemokine ligand 20,2q36.3,protein-coding,Clinical Trial target
CWITA000333,TCMBANKGE000333,CCR6,BN-1; C-C CKR-6; CC-CKR-6; CCR-6; CD196; CKR-L3; CKRL3; CMKBR6; DCR2; DRY6; GPR29; GPRCY4; STRL22,C-C motif chemokine receptor 6,6q27,protein-coding,/
CWITA000334,TCMBANKGE000334,GATA1,ERYF1; GATA-1; GF-1; GF1; NF-E1; NFE1; XLANP; XLTDA; XLTT,GATA binding protein 1,Xp11.23,protein-coding,/
CWITA000335,TCMBANKGE000335,ITPR1,ACV; CLA4; INSP3R1; IP3R; IP3R1; PPP1R94; SCA15; SCA16; SCA29,"inositol 1,4,5-trisphosphate receptor type 1",3p26.1,protein-coding,Research target
CWITA000336,TCMBANKGE000336,PLSCR1,MMTRA1B,phospholipid scramblase 1,3q24,protein-coding,/
CWITA000337,TCMBANKGE000337,TRAF4,CART1; MLN62; RNF83,TNF receptor associated factor 4,17q11.2,protein-coding,/
CWITA000338,TCMBANKGE000338,CHUK,IKBKA; IKK-alpha; IKK1; IKKA; NFKBIKA; TCF16,component of inhibitor of nuclear factor kappa B kinase complex,10q24.31,protein-coding,Research target
CWITA000339,TCMBANKGE000339,TNFRSF11A,CD265; FEO; LOH18CR1; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TRANCER,TNF receptor superfamily member 11a,18q21.33,protein-coding,Research target
CWITA000340,TCMBANKGE000340,ACP5,HPAP; TRACP5a; TRACP5b; TRAP; TrATPase,"acid phosphatase 5, tartrate resistant",19p13.2,protein-coding,/
CWITA000341,TCMBANKGE000341,RNF216,CAHH; TRIAD3; U7I1; UBCE7IP1; ZIN,ring finger protein 216,7p22.1,protein-coding,/
CWITA000342,TCMBANKGE000342,SMURF2,-,SMAD specific E3 ubiquitin protein ligase 2,17q23.3-q24.1,protein-coding,/
CWITA000343,TCMBANKGE000343,RPS6KA2,HU-2; MAPKAPK1C; RSK; RSK3; S6K-alpha; S6K-alpha2; p90-RSK3; p90RSK2; pp90RSK3,ribosomal protein S6 kinase A2,6q27,protein-coding,Patented target
CWITA000344,TCMBANKGE000344,RPS6KA1,HU-1; MAPKAPK1; MAPKAPK1A; RSK; RSK1; p90Rsk,ribosomal protein S6 kinase A1,1p36.11,protein-coding,Patented target
CWITA000345,TCMBANKGE000345,ELK1,-,ETS transcription factor ELK1,Xp11.23,protein-coding,/
CWITA000346,TCMBANKGE000346,RPS6KA3,CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; RSK; RSK2; S6K-alpha3; p90-RSK2; pp90RSK2,ribosomal protein S6 kinase A3,Xp22.12,protein-coding,Patented target
CWITA000347,TCMBANKGE000347,Trp73,TAp73; Tp73; deltaNp73; p73,transformation related protein 73,4 E2|4 83.79 cM,protein-coding,/
CWITA000348,TCMBANKGE000348,PAWR,PAR4; Par-4,pro-apoptotic WT1 regulator,12q21.2,protein-coding,Research target
CWITA000349,TCMBANKGE000349,NBN,AT-V1; AT-V2; ATV; NBS; NBS1; P95,nibrin,8q21.3,protein-coding,/
CWITA000350,TCMBANKGE000350,PML,MYL; PP8675; RNF71; TRIM19,PML nuclear body scaffold,15q24.1,protein-coding,Research target
CWITA000351,TCMBANKGE000351,PTPA,PP2A; PPP2R4; PR53,protein phosphatase 2 phosphatase activator,9q34.11,protein-coding,/
CWITA000352,TCMBANKGE000352,AK4,AK 4; AK3; AK3L1; AK3L2,adenylate kinase 4,1p31.3,protein-coding,/
CWITA000353,TCMBANKGE000353,RAB7B,RAB7,"RAB7B, member RAS oncogene family",1q32.1,protein-coding,/
CWITA000354,TCMBANKGE000354,FPR2,ALXR; FMLP-R-II; FMLPX; FPR2A; FPRH1; FPRH2; FPRL1; HM63; LXA4R,formyl peptide receptor 2,19q13.41,protein-coding,Research target
CWITA000355,TCMBANKGE000355,HFM1,MER3; POF9; SEC63D1; Si-11; Si-11-6; helicase,helicase for meiosis 1,1p22.2,protein-coding,/
CWITA000356,TCMBANKGE000356,SLC12A2,BSC; BSC2; NKCC1; PPP1R141,solute carrier family 12 member 2,5q23.3,protein-coding,/
CWITA000357,TCMBANKGE000357,MGP,GIG36; MGLAP; NTI,matrix Gla protein,12p12.3,protein-coding,/
CWITA000358,TCMBANKGE000358,GLA,GALA,galactosidase alpha,Xq22.1,protein-coding,Successful target
CWITA000359,TCMBANKGE000359,MDH2,EIEE51; M-MDH; MDH; MGC:3559; MOR1,malate dehydrogenase 2,7q11.23,protein-coding,/
CWITA000360,TCMBANKGE000360,CCNA2,CCN1; CCNA,cyclin A2,4q27,protein-coding,Research target
CWITA000361,TCMBANKGE000361,ERCC2,COFS2; EM9; TFIIH; TTD; TTD1; XPD,"ERCC excision repair 2, TFIIH core complex helicase subunit",19q13.32,protein-coding,/
CWITA000362,TCMBANKGE000362,DNAH8,ATPase; hdhc9,dynein axonemal heavy chain 8,6p21.2,protein-coding,/
CWITA000363,TCMBANKGE000363,GEMIN2,SIP1; SIP1-delta,gem nuclear organelle associated protein 2,14q21.1,protein-coding,/
CWITA000364,TCMBANKGE000364,SMN1,BCD541; GEMIN1; SMA; SMA1; SMA2; SMA3; SMA4; SMA@; SMN; SMNT; T-BCD541; TDRD16A,"survival of motor neuron 1, telomeric",5q13.2,protein-coding,Research target
CWITA000365,TCMBANKGE000365,DDX20,DP103; GEMIN3,DEAD-box helicase 20,1p13.2,protein-coding,/
CWITA000366,TCMBANKGE000366,DUSP6,HH19; MKP3; PYST1,dual specificity phosphatase 6,12q21.33,protein-coding,/
CWITA000367,TCMBANKGE000367,POLR2A,NEDHIB; POLR2; POLRA; RPB1; RPBh1; RPO2; RPOL2; RpIILS; hRPB220; hsRPB1,RNA polymerase II subunit A,17p13.1,protein-coding,/
CWITA000368,TCMBANKGE000368,PLAUR,CD87; U-PAR; UPAR; URKR,"plasminogen activator, urokinase receptor",19q13.31,protein-coding,Successful target
CWITA000369,TCMBANKGE000369,IFNA1,IFL; IFN; IFN-ALPHA; IFN-alphaD; IFNA13; IFNA@; leIF D,interferon alpha 1,9p21.3,protein-coding,/
CWITA000370,TCMBANKGE000370,MIR204,MIRN204; RDICC; miRNA204; mir-204,microRNA 204,9q21.12,ncRNA,/
CWITA000371,TCMBANKGE000371,MLC1,LVM; MLC; VL,modulator of VRAC current 1,22q13.33,protein-coding,/
CWITA000372,TCMBANKGE000372,Hand2,AI225906; AI661148; Ehand2; Hed; Th2; Thing2; bHLHa26; dHAND,heart and neural crest derivatives expressed 2,8 B2|8 29.8 cM,protein-coding,/
CWITA000373,TCMBANKGE000373,ATG12,APG12; APG12L; FBR93; HAPG12,autophagy related 12,5q22.3,protein-coding,/
CWITA000374,TCMBANKGE000374,CDK6,MCPH12; PLSTIRE,cyclin dependent kinase 6,7q21.2,protein-coding,Successful target
CWITA000375,TCMBANKGE000375,MACC1,7A5; SH3BP4L,MET transcriptional regulator MACC1,7p21.1,protein-coding,/
CWITA000376,TCMBANKGE000376,CRTC3,TORC-3; TORC3,CREB regulated transcription coactivator 3,15q26.1,protein-coding,/
CWITA000377,TCMBANKGE000377,MITF,CMM8; COMMAD; MI; WS2; WS2A; bHLHe32,melanocyte inducing transcription factor,3p13,protein-coding,/
CWITA000378,TCMBANKGE000378,LCMT1,CGI-68; LCMT; PPMT1,leucine carboxyl methyltransferase 1,16p12.1,protein-coding,/
CWITA000379,TCMBANKGE000379,PPP2R1A,MRD36; PP2A-Aalpha; PP2AA; PP2AAALPHA; PR65A,protein phosphatase 2 scaffold subunit Aalpha,19q13.41,protein-coding,/
CWITA000380,TCMBANKGE000380,ras,asr,resistance to audiogenic seizures,-,unknown,/
CWITA000381,TCMBANKGE000381,RHOB,ARH6; ARHB; MST081; MSTP081; RHOH6,ras homolog family member B,2p24.1,protein-coding,Research target
CWITA000382,TCMBANKGE000382,PARK7,DJ-1; DJ1; GATD2; HEL-S-67p,Parkinsonism associated deglycase,1p36.23,protein-coding,/
CWITA000383,TCMBANKGE000383,PSENEN,ACNINV2; MDS033; MSTP064; PEN-2; PEN2,"presenilin enhancer, gamma-secretase subunit",19q13.12,protein-coding,/
CWITA000384,TCMBANKGE000384,AIFM1,AIF; AUNX1; CMT2D; CMTX4; COWCK; COXPD6; DFNX5; NADMR; NAMSD; PDCD8; SEMDHL,apoptosis inducing factor mitochondria associated 1,Xq26.1,protein-coding,/
CWITA000385,TCMBANKGE000385,LINC01391,-,long intergenic non-protein coding RNA 1391,3q22.3,ncRNA,/
CWITA000386,TCMBANKGE000386,GPR83,GIR; GPR72,G protein-coupled receptor 83,11q21,protein-coding,/
CWITA000387,TCMBANKGE000387,CTBP1,BARS; HADDTS,C-terminal binding protein 1,4p16.3,protein-coding,/
CWITA000388,TCMBANKGE000388,ZEB1,AREB6; BZP; DELTAEF1; FECD6; NIL2A; PPCD3; TCF8; ZFHEP; ZFHX1A,zinc finger E-box binding homeobox 1,10p11.22,protein-coding,/
CWITA000389,TCMBANKGE000389,MMP3,CHDS6; MMP-3; SL-1; STMY; STMY1; STR1,matrix metallopeptidase 3,11q22.2,protein-coding,Patented target
CWITA000390,TCMBANKGE000390,ABCC4,MOAT-B; MOATB; MRP4,ATP binding cassette subfamily C member 4,13q32.1,protein-coding,Research target
CWITA000391,TCMBANKGE000391,MANF,ARMET; ARP,mesencephalic astrocyte derived neurotrophic factor,3p21.2,protein-coding,Research target
CWITA000392,TCMBANKGE000392,PGD,6PGD,phosphogluconate dehydrogenase,1p36.22,protein-coding,Successful target
CWITA000393,TCMBANKGE000393,PHLPP1,PHLPP; PLEKHE1; PPM3A; SCOP,PH domain and leucine rich repeat protein phosphatase 1,18q21.33,protein-coding,/
CWITA000394,TCMBANKGE000394,CXCR3,CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR,C-X-C motif chemokine receptor 3,Xq13.1,protein-coding,Discontinued target
CWITA000395,TCMBANKGE000395,CXCL9,CMK; Humig; MIG; SCYB9; crg-10,C-X-C motif chemokine ligand 9,4q21.1,protein-coding,/
CWITA000396,TCMBANKGE000396,TOP1,TOPI,DNA topoisomerase I,20q12,protein-coding,Successful target
CWITA000397,TCMBANKGE000397,AXL,ARK; JTK11; Tyro7; UFO,AXL receptor tyrosine kinase,19q13.2,protein-coding,Successful target
CWITA000398,TCMBANKGE000398,MIR137,MIRN137; miR-137,microRNA 137,1p21.3,ncRNA,/
CWITA000399,TCMBANKGE000399,USP28,-,ubiquitin specific peptidase 28,11q23.2,protein-coding,/
CWITA000400,TCMBANKGE000400,CSK,-,C-terminal Src kinase,15q24.1,protein-coding,Research target
CWITA000401,TCMBANKGE000401,WEE1,WEE1A; WEE1hu,WEE1 G2 checkpoint kinase,11p15.4,protein-coding,Clinical Trial target
CWITA000402,TCMBANKGE000402,MID1,BBBG1; FXY; GBBB1; MIDIN; OGS1; OS; OSX; RNF59; TRIM18; XPRF; ZNFXY,midline 1,Xp22.2,protein-coding,/
CWITA000403,TCMBANKGE000403,ATF2,CRE-BP1; CREB-2; CREB2; HB16; TREB7,activating transcription factor 2,2q31.1,protein-coding,/
CWITA000404,TCMBANKGE000404,ZFYVE9,MADHIP; NSP; PPP1R173; SARA; SMADIP,zinc finger FYVE-type containing 9,1p32.3,protein-coding,/
CWITA000405,TCMBANKGE000405,LONP1,CODASS; LON; LONP; LonHS; PIM1; PRSS15; hLON,"lon peptidase 1, mitochondrial",19p13.3,protein-coding,Research target
CWITA000406,TCMBANKGE000406,CDKL5,CFAP247; EIEE2; ISSX; STK9,cyclin dependent kinase like 5,Xp22.13,protein-coding,/
CWITA000407,TCMBANKGE000407,DYRK1A,DYRK; DYRK1; HP86; MNB; MNBH; MRD7,dual specificity tyrosine phosphorylation regulated kinase 1A,21q22.13,protein-coding,Patented target
CWITA000408,TCMBANKGE000408,CCR3,C C CKR3; CC-CKR-3; CD193; CKR 3; CKR3; CMKBR3,C-C motif chemokine receptor 3,3p21.31,protein-coding,Clinical Trial target
CWITA000409,TCMBANKGE000409,CCR4,CC-CKR-4; CD194; CKR4; CMKBR4; ChemR13; HGCN:14099; K5-5,C-C motif chemokine receptor 4,3p22.3,protein-coding,Successful target
CWITA000410,TCMBANKGE000410,NTNG1,Lmnt1,netrin G1,1p13.3,protein-coding,/
CWITA000411,TCMBANKGE000411,IRF6,LPS; OFC6; PIT; PPS; PPS1; VWS; VWS1,interferon regulatory factor 6,1q32.2,protein-coding,/
CWITA000412,TCMBANKGE000412,PRDX6,1-Cys; AOP2; HEL-S-128m; NSGPx; PRX; aiPLA2; p29,peroxiredoxin 6,1q25.1,protein-coding,/
CWITA000413,TCMBANKGE000413,Akr1b3,ALR2; AR; Ahr-1; Ahr1; Akr1b1; Aldor1; Aldr1,"aldo-keto reductase family 1, member B3 (aldose reductase)",6 14.87 cM|6 B1,protein-coding,/
CWITA000414,TCMBANKGE000414,CYP19A1,ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM,cytochrome P450 family 19 subfamily A member 1,15q21.2,protein-coding,Successful target
CWITA000415,TCMBANKGE000415,Akr1b7,AR; Avdp; MVDP,"aldo-keto reductase family 1, member B7",6 B1|6 14.95 cM,protein-coding,/
CWITA000416,TCMBANKGE000416,Akr1b8,FR-1; Fgfrp; Fgrp,"aldo-keto reductase family 1, member B8",6 B1|6 14.91 cM,protein-coding,/
CWITA000417,TCMBANKGE000417,FDXR,ADR; ADXR; ANOA,ferredoxin reductase,17q25.1,protein-coding,Research target
CWITA000418,TCMBANKGE000418,SLCO2B1,OATP-B; OATP2B1; OATPB; SLC21A9,solute carrier organic anion transporter family member 2B1,11q13.4,protein-coding,Research target
CWITA000419,TCMBANKGE000419,SMS,MRSR; SPMSY; SRS; SpS,spermine synthase,Xp22.11,protein-coding,/
CWITA000420,TCMBANKGE000420,SPI1,OF; PU.1; SFPI1; SPI-1; SPI-A,Spi-1 proto-oncogene,11p11.2,protein-coding,/
CWITA000421,TCMBANKGE000421,IL9,HP40; IL-9; P40,interleukin 9,5q31.1,protein-coding,Clinical Trial target
CWITA000422,TCMBANKGE000422,MIR15A,MIRN15A; hsa-mir-15a; miRNA15A; mir-15a,microRNA 15a,13q14.2,ncRNA,/
CWITA000423,TCMBANKGE000423,MIR16-1,MIRN16-1; miRNA16-1; mir-16-1,microRNA 16-1,13q14.2,ncRNA,/
CWITA000424,TCMBANKGE000424,WT1,AWT1; GUD; NPHS4; WAGR; WIT-2; WT33,WT1 transcription factor,11p13,protein-coding,Clinical Trial target
CWITA000425,TCMBANKGE000425,DRD1,DADR; DRD1A,dopamine receptor D1,5q35.2,protein-coding,Successful target
CWITA000426,TCMBANKGE000426,PPP1R1B,DARPP-32; DARPP32,protein phosphatase 1 regulatory inhibitor subunit 1B,17q12,protein-coding,/
CWITA000427,TCMBANKGE000427,PPP1R1A,I1; IPP1,protein phosphatase 1 regulatory inhibitor subunit 1A,12q13.2,protein-coding,/
CWITA000428,TCMBANKGE000428,SERPINA1,A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT; nNIF,serpin family A member 1,14q32.13,protein-coding,Successful target
CWITA000429,TCMBANKGE000429,CD36,BDPLT10; CHDS7; FAT; GP3B; GP4; GPIV; PASIV; SCARB3,CD36 molecule,7q21.11,protein-coding,Research target
CWITA000430,TCMBANKGE000430,LRRK2,AURA17; DARDARIN; PARK8; RIPK7; ROCO2,leucine rich repeat kinase 2,12q12,protein-coding,Patented target
CWITA000431,TCMBANKGE000431,NKX2-5,CHNG5; CSX; CSX1; HLHS2; NKX2.5; NKX2E; NKX4-1; VSD3,NK2 homeobox 5,5q35.1,protein-coding,/
CWITA000432,TCMBANKGE000432,ADAM17,ADAM18; CD156B; CSVP; NISBD; NISBD1; TACE,ADAM metallopeptidase domain 17,2p25.1,protein-coding,Clinical Trial target
CWITA000433,TCMBANKGE000433,IL37,FIL1; FIL1(ZETA); FIL1Z; IL-1F7; IL-1H; IL-1H4; IL-1RP1; IL-37; IL1F7; IL1H4; IL1RP1,interleukin 37,2q14.1,protein-coding,Successful target
CWITA000434,TCMBANKGE000434,PTGER2,EP2,prostaglandin E receptor 2,14q22.1,protein-coding,Successful target
CWITA000435,TCMBANKGE000435,PROM1,AC133; CD133; CORD12; MCDR2; MSTP061; PROML1; RP41; STGD4,prominin 1,4p15.32,protein-coding,Clinical Trial target
CWITA000436,TCMBANKGE000436,ERBB4,ALS19; HER4; p180erbB4,erb-b2 receptor tyrosine kinase 4,2q34,protein-coding,Successful target
CWITA000437,TCMBANKGE000437,FZD1,-,frizzled class receptor 1,7q21.13,protein-coding,/
CWITA000438,TCMBANKGE000438,LRP6,ADCAD2; STHAG7,LDL receptor related protein 6,12p13.2,protein-coding,Research target
CWITA000439,TCMBANKGE000439,CDK7,CAK; CAK1; CDKN7; HCAK; MO15; STK1; p39MO15,cyclin dependent kinase 7,5q13.2,protein-coding,Clinical Trial target
CWITA000440,TCMBANKGE000440,HDAC1,GON-10; HD1; KDAC1; RPD3; RPD3L1,histone deacetylase 1,1p35.2-p35.1,protein-coding,Successful target
CWITA000441,TCMBANKGE000441,ERCC3,BTF2; GTF2H; RAD25; TFIIH; TTD2; XPB,"ERCC excision repair 3, TFIIH core complex helicase subunit",2q14.3,protein-coding,/
CWITA000442,TCMBANKGE000442,ZFP36L1,BRF1; Berg36; ERF-1; ERF1; RNF162B; TIS11B; cMG1,ZFP36 ring finger protein like 1,14q24.1,protein-coding,Research target
CWITA000443,TCMBANKGE000443,TBP,GTF2D; GTF2D1; HDL4; SCA17; TFIID,TATA-box binding protein,6q27,protein-coding,/
CWITA000444,TCMBANKGE000444,Cd24a,Cd24; HSA; Ly-52; nectadrin,CD24a antigen,10 B2|10 23.01 cM,protein-coding,/
CWITA000445,TCMBANKGE000445,CD44,CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1,CD44 molecule (Indian blood group),11p13,protein-coding,Clinical Trial target
CWITA000446,TCMBANKGE000446,PIK3C3,VPS34; Vps34; hVps34,phosphatidylinositol 3-kinase catalytic subunit type 3,18q12.3,protein-coding,/
CWITA000447,TCMBANKGE000447,TSC2,LAM; PPP1R160; TSC4,TSC complex subunit 2,16p13.3,protein-coding,/
CWITA000448,TCMBANKGE000448,MTA1,-,metastasis associated 1,14q32.33,protein-coding,Research target
CWITA000449,TCMBANKGE000449,CCK,-,cholecystokinin,3p22.1,protein-coding,Research target
CWITA000450,TCMBANKGE000450,DIO2,5DII; D2; DIOII; SelY; TXDI2,iodothyronine deiodinase 2,14q31.1,protein-coding,/
CWITA000451,TCMBANKGE000451,FGF19,-,fibroblast growth factor 19,11q13.3,protein-coding,/
CWITA000452,TCMBANKGE000452,CFTR,ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1,CF transmembrane conductance regulator,7q31.2,protein-coding,Successful target
CWITA000453,TCMBANKGE000453,NR1I3,CAR; CAR1; MB67,nuclear receptor subfamily 1 group I member 3,1q23.3,protein-coding,Successful target
CWITA000454,TCMBANKGE000454,Cyp2b9,Cyp2b,"cytochrome P450, family 2, subfamily b, polypeptide 9",7 A3|7 14.11 cM,protein-coding,/
CWITA000455,TCMBANKGE000455,CYP2A13,CPAD; CYP2A; CYPIIA13,cytochrome P450 family 2 subfamily A member 13,19q13.2,protein-coding,/
CWITA000456,TCMBANKGE000456,CXADRP1,CAR; CXADRP,CXADR pseudogene 1,21q11.2,pseudo,/
CWITA000457,TCMBANKGE000457,CXADR,CAR; CAR4/6; HCAR,CXADR Ig-like cell adhesion molecule,21q21.1,protein-coding,/
CWITA000458,TCMBANKGE000458,CYP2B6,CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; EFVM; IIB1; P450,cytochrome P450 family 2 subfamily B member 6,19q13.2,protein-coding,Research target
CWITA000459,TCMBANKGE000459,PRKAR1A,ACRDYS1; ADOHR; CAR; CNC; CNC1; PKR1; PPNAD1; PRKAR1; TSE1,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2,protein-coding,Research target
CWITA000460,TCMBANKGE000460,CYP2A7,CPA7; CPAD; CYP2A; CYPIIA7; P450-IIA4,cytochrome P450 family 2 subfamily A member 7,19q13.2,protein-coding,/
CWITA000461,TCMBANKGE000461,RCVRN,RCV1,recoverin,17p13.1,protein-coding,Research target
CWITA000462,TCMBANKGE000462,ARR3,ARRX; MYP26; cArr,arrestin 3,Xq13.1,protein-coding,/
CWITA000463,TCMBANKGE000463,SPG7,CAR; CMAR; PGN; SPG5C,"SPG7 matrix AAA peptidase subunit, paraplegin",16q24.3,protein-coding,/
CWITA000464,TCMBANKGE000464,TRIM13,CAR; DLEU5; LEU5; RFP2; RNF77,tripartite motif containing 13,13q14.2,protein-coding,/
CWITA000465,TCMBANKGE000465,CASR,CAR; EIG8; FHH; FIH; GPRC2A; HHC; HHC1; HYPOC1; NSHPT; PCAR1; hCasR,calcium sensing receptor,3q13.33-q21.1,protein-coding,Successful target
CWITA000466,TCMBANKGE000466,CYP2A6,CPA6; CYP2A; CYP2A3; CYPIIA6; P450C2A; P450PB,cytochrome P450 family 2 subfamily A member 6,19q13.2,protein-coding,Successful target
CWITA000467,TCMBANKGE000467,ABCC10,EST182763; MRP7; SIMRP7,ATP binding cassette subfamily C member 10,6p21.1,protein-coding,/
CWITA000468,TCMBANKGE000468,CTSB,APPS; CPSB; RECEUP,cathepsin B,8p23.1,protein-coding,Patented target
CWITA000469,TCMBANKGE000469,CTSD,CLN10; CPSD; HEL-S-130P,cathepsin D,11p15.5,protein-coding,Clinical Trial target
CWITA000470,TCMBANKGE000470,MYO1C,MMI-beta; MMIb; NMI; myr2,myosin IC,17p13.3,protein-coding,/
CWITA000471,TCMBANKGE000471,POMC,ACTH; CLIP; LPH; MSH; NPP; OBAIRH; POC,proopiomelanocortin,2p23.3,protein-coding,Research target
CWITA000472,TCMBANKGE000472,KLHL1,MRP2,kelch like family member 1,13q21.33,protein-coding,/
CWITA000473,TCMBANKGE000473,TRPC6,FSGS2; TRP6,transient receptor potential cation channel subfamily C member 6,11q22.1,protein-coding,Research target
CWITA000474,TCMBANKGE000474,NCOA1,F-SRC-1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74,nuclear receptor coactivator 1,2p23.3,protein-coding,/
CWITA000475,TCMBANKGE000475,NCOA3,ACTR; AIB-1; AIB1; CAGH16; CTG26; KAT13B; RAC3; SRC-3; SRC3; TNRC14; TNRC16; TRAM-1; bHLHe42; pCIP,nuclear receptor coactivator 3,20q13.12,protein-coding,Research target
CWITA000476,TCMBANKGE000476,NCOA2,GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75,nuclear receptor coactivator 2,8q13.3,protein-coding,/
CWITA000477,TCMBANKGE000477,EZH2,ENX-1; ENX1; EZH2b; KMT6; KMT6A; WVS; WVS2,enhancer of zeste 2 polycomb repressive complex 2 subunit,7q36.1,protein-coding,Clinical Trial target
CWITA000478,TCMBANKGE000478,CHEK1,CHK1,checkpoint kinase 1,11q24.2,protein-coding,Clinical Trial target
CWITA000479,TCMBANKGE000479,TIMP1,CLGI; EPA; EPO; HCI; TIMP; TIMP-1,TIMP metallopeptidase inhibitor 1,Xp11.3,protein-coding,/
CWITA000480,TCMBANKGE000480,COQ10A,-,coenzyme Q10A,12q13.3,protein-coding,/
CWITA000481,TCMBANKGE000481,EIF2AK2,EIF2AK1; LEUDEN; PKR; PPP1R83; PRKR,eukaryotic translation initiation factor 2 alpha kinase 2,2p22.2,protein-coding,Research target
CWITA000482,TCMBANKGE000482,IDH1,HEL-216; HEL-S-26; IDCD; IDH; IDP; IDPC; PICD,isocitrate dehydrogenase (NADP(+)) 1,2q34,protein-coding,Clinical Trial target
CWITA000483,TCMBANKGE000483,TRPV2,VRL; VRL-1; VRL1,transient receptor potential cation channel subfamily V member 2,17p11.2,protein-coding,Research target
CWITA000484,TCMBANKGE000484,ID1,ID; bHLHb24,"inhibitor of DNA binding 1, HLH protein",20q11.21,protein-coding,Research target
CWITA000485,TCMBANKGE000485,CASP4,ICE(rel)II; ICEREL-II; ICH-2; Mih1; Mih1/TX; TX,caspase 4,11q22.3,protein-coding,Patented target
CWITA000486,TCMBANKGE000486,IL2RA,CD25; IDDM10; IL2R; IMD41; TCGFR; p55,interleukin 2 receptor subunit alpha,10p15.1,protein-coding,Successful target
CWITA000487,TCMBANKGE000487,ICOS,AILIM; CD278; CVID1,inducible T cell costimulator,2q33.2,protein-coding,Clinical Trial target
CWITA000488,TCMBANKGE000488,XCL1,ATAC; LPTN; LTN; SCM-1; SCM-1a; SCM1; SCM1A; SCYC1,X-C motif chemokine ligand 1,1q24.2,protein-coding,/
CWITA000489,TCMBANKGE000489,IL3,IL-3; MCGF; MULTI-CSF,interleukin 3,5q31.1,protein-coding,/
CWITA000490,TCMBANKGE000490,IFIT2,G10P2; GARG-39; IFI-54; IFI-54K; IFI54; IFIT-2; ISG-54 K; ISG-54K; ISG54; P54; cig42,interferon induced protein with tetratricopeptide repeats 2,10q23.31,protein-coding,/
CWITA000491,TCMBANKGE000491,TRAT1,HSPC062|TCRIM|TRIM|pp29/30,T cell receptor associated transmembrane adaptor 1,3q13.13,protein-coding,/
CWITA000492,TCMBANKGE000492,IRF4,LSIRF; MUM1; NF-EM5; SHEP8,interferon regulatory factor 4,6p25.3,protein-coding,/
CWITA000493,TCMBANKGE000493,NR4A3,CHN; CSMF; MINOR; NOR1; TEC,nuclear receptor subfamily 4 group A member 3,9q31.1,protein-coding,Research target
CWITA000494,TCMBANKGE000494,BTLA,BTLA1|CD272,B and T lymphocyte associated,3q13.2,protein-coding,Patented target
CWITA000495,TCMBANKGE000495,SLC30A1,ZNT1; ZRC1,solute carrier family 30 member 1,1q32.3,protein-coding,/
CWITA000496,TCMBANKGE000496,RGS16,A28-RGS14; A28-RGS14P; RGS-R,regulator of G protein signaling 16,1q25.3,protein-coding,Research target
CWITA000497,TCMBANKGE000497,ETS2,ETS2IT1,"ETS proto-oncogene 2, transcription factor",21q22.2,protein-coding,Clinical Trial target
CWITA000498,TCMBANKGE000498,TBX21,T-PET; T-bet; TBET; TBLYM,T-box transcription factor 21,17q21.32,protein-coding,Research target
CWITA000499,TCMBANKGE000499,IER3,DIF-2; DIF2; GLY96; IEX-1; IEX-1L; IEX1; PRG1,immediate early response 3,6p21.33,protein-coding,/
CWITA000500,TCMBANKGE000500,EPHX1,EPHX; EPOX; HYL1; MEH,epoxide hydrolase 1,1q42.12,protein-coding,/
CWITA000501,TCMBANKGE000501,MT1F,MT1,metallothionein 1F,16q13,protein-coding,/
CWITA000502,TCMBANKGE000502,MX2,MXB,MX dynamin like GTPase 2,21q22.3,protein-coding,/
CWITA000503,TCMBANKGE000503,CREM,CREM-2; ICER; hCREM-2,cAMP responsive element modulator,10p11.21,protein-coding,/
CWITA000504,TCMBANKGE000504,IL12A,CLMF; IL-12A; NFSK; NKSF1; P35,interleukin 12A,3q25.33,protein-coding,Successful target
CWITA000505,TCMBANKGE000505,ATF3,-,activating transcription factor 3,1q32.3,protein-coding,Research target
CWITA000506,TCMBANKGE000506,LAG3,CD223,lymphocyte activating 3,12p13.31,protein-coding,Clinical Trial target
CWITA000507,TCMBANKGE000507,EGR2,AT591; CHN1; CMT1D; CMT4E; KROX20,early growth response 2,10q21.3,protein-coding,/
CWITA000508,TCMBANKGE000508,CD69,AIM; BL-AC/P26; CLEC2C; EA1; GP32/28; MLR-3,CD69 molecule,12p13.31,protein-coding,Research target
CWITA000509,TCMBANKGE000509,GPR55,LPIR1,G protein-coupled receptor 55,2q37.1,protein-coding,Successful target
CWITA000510,TCMBANKGE000510,KRT17,39.1; CK-17; K17; PC; PC2; PCHC1,keratin 17,17q21.2,protein-coding,Research target
CWITA000511,TCMBANKGE000511,KRT16,CK16|FNEPPK|K16|K1CP|KRT16A|NEPPK|PC1,keratin 16,17q21.2,protein-coding,/
CWITA000512,TCMBANKGE000512,BACH1,BACH-1; BTBD24,BTB domain and CNC homolog 1,21q21.3,protein-coding,Patented target
CWITA000513,TCMBANKGE000513,CYP2C19,CPCJ; CYP2C; CYPIIC17; CYPIIC19; P450C2C; P450IIC19,cytochrome P450 family 2 subfamily C member 19,10q23.33,protein-coding,/
CWITA000514,TCMBANKGE000514,CNR1,CANN6; CB-R; CB1; CB1A; CB1K5; CB1R; CNR,cannabinoid receptor 1,6q15,protein-coding,Successful target
CWITA000515,TCMBANKGE000515,DIABLO,DFNA64; SMAC,diablo IAP-binding mitochondrial protein,12q24.31,protein-coding,Research target
CWITA000516,TCMBANKGE000516,IL25,IL17E,interleukin 25,14q11.2,protein-coding,Clinical Trial target
CWITA000517,TCMBANKGE000517,WDR7,TRAG,WD repeat domain 7,18q21.31,protein-coding,/
CWITA000518,TCMBANKGE000518,GPER1,CEPR; CMKRL2; DRY12; FEG-1; GPCR-Br; GPER; GPR30; LERGU; LERGU2; LyGPR; mER,G protein-coupled estrogen receptor 1,7p22.3,protein-coding,Successful target
CWITA000519,TCMBANKGE000519,BATF2,SARI,basic leucine zipper ATF-like transcription factor 2,11q13.1,protein-coding,/
CWITA000520,TCMBANKGE000520,LYN,JTK8; p53Lyn; p56Lyn,"LYN proto-oncogene, Src family tyrosine kinase",8q12.1,protein-coding,Clinical Trial target
CWITA000521,TCMBANKGE000521,PLCG1,NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1,phospholipase C gamma 1,20q12,protein-coding,/
CWITA000522,TCMBANKGE000522,AGTR1,AG2S; AGTR1B; AT1; AT1AR; AT1B; AT1BR; AT1R; AT2R1; HAT1R,angiotensin II receptor type 1,3q24,protein-coding,Successful target
CWITA000523,TCMBANKGE000523,BMP4,BMP2B; BMP2B1; MCOPS6; OFC11; ZYME,bone morphogenetic protein 4,14q22.2,protein-coding,Research target
CWITA000524,TCMBANKGE000524,CNTNAP2,AUTS15; CASPR2; CDFE; NRXN4; PTHSL1,contactin associated protein 2,7q35-q36.1,protein-coding,/
CWITA000525,TCMBANKGE000525,PDX1,GSF; IDX-1; IPF1; IUF1; MODY4; PAGEN1; PDX-1; STF-1,pancreatic and duodenal homeobox 1,13q12.2,protein-coding,Research target
CWITA000526,TCMBANKGE000526,ATXN1,ATX1; D6S504E; SCA1,ataxin 1,6p22.3,protein-coding,/
CWITA000527,TCMBANKGE000527,Pbsn,PB; Prbs,probasin,X|X B,protein-coding,/
CWITA000528,TCMBANKGE000528,Ly6a,Ly-6A.2; Ly-6A/E; Ly-6E.1; Sca-1; Sca1; TAP,"lymphocyte antigen 6 complex, locus A",15 D3|15 34.29 cM,protein-coding,/
CWITA000529,TCMBANKGE000529,H2-Pb,672505; Gm46572; Gm9566; H-2Ab; H-2I; H-2Pb; H2-Ab; H2-Ab3; Ia7; Pb,"histocompatibility 2, P region beta locus",17 B1|17,pseudo,/
CWITA000530,TCMBANKGE000530,SPINT2,DIAR3; HAI-2; HAI2; Kop; PB,"serine peptidase inhibitor, Kunitz type 2",19q13.2,protein-coding,/
CWITA000531,TCMBANKGE000531,HTN3,HIS2; HTN2; HTN5; PB,histatin 3,4q13.3,protein-coding,/
CWITA000532,TCMBANKGE000532,PECAM1,CD31; CD31/EndoCAM; GPIIA'; PECA1; PECAM-1; endoCAM,platelet and endothelial cell adhesion molecule 1,17q23.3,protein-coding,Research target
CWITA000533,TCMBANKGE000533,SLCO1B1,HBLRR; LST-1; LST1; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6,solute carrier organic anion transporter family member 1B1,12p12.1,protein-coding,Research target
CWITA000534,TCMBANKGE000534,SLC51B,OSTB; OSTBETA,solute carrier family 51 subunit beta,15q22.31,protein-coding,/
CWITA000535,TCMBANKGE000535,GGT1,CD224; D22S672; D22S732; GGT; GGT 1; GGTD; GTG,gamma-glutamyltransferase 1,22q11.23,protein-coding,/
CWITA000536,TCMBANKGE000536,EDNRB,ABCDS; ET-B; ET-BR; ETB; ETB1; ETBR; ETRB; HSCR; HSCR2; WS4A,endothelin receptor type B,13q22.3,protein-coding,Successful target
CWITA000537,TCMBANKGE000537,ABCC1,ABC29; ABCC; GS-X; MRP; MRP1,ATP binding cassette subfamily C member 1,16p13.11,protein-coding,Successful target
CWITA000538,TCMBANKGE000538,CYP27A1,CP27; CTX; CYP27,cytochrome P450 family 27 subfamily A member 1,2q35,protein-coding,/
CWITA000539,TCMBANKGE000539,FAT1,CDHF7; CDHR8; FAT; ME5; hFat1,FAT atypical cadherin 1,4q35.2,protein-coding,Research target
CWITA000540,TCMBANKGE000540,CASP12,CASP-12; CASP12P1,caspase 12 (gene/pseudogene),11q22.3,protein-coding,/
CWITA000541,TCMBANKGE000541,CRYAB,CMD1II; CRYA2; CTPP2; CTRCT16; HEL-S-101; HSPB5; MFM2,crystallin alpha B,11q23.1,protein-coding,/
CWITA000542,TCMBANKGE000542,NLRP1,AIADK; CARD7; CIDED; CLR17.1; DEFCAP; DEFCAP-L/S; JRRP; MSPC; NAC; NALP1; PP1044; SLEV1; VAMAS1,NLR family pyrin domain containing 1,17p13.2,protein-coding,Research target
CWITA000543,TCMBANKGE000543,OSCAR,PIGR3; PIgR-3,osteoclast associated Ig-like receptor,19q13.42,protein-coding,Research target
CWITA000544,TCMBANKGE000544,CXCR1,C-C; C-C-CKR-1; CD128; CD181; CDw128a; CKR-1; CMKAR1; IL8R1; IL8RA; IL8RBA,C-X-C motif chemokine receptor 1,2q35,protein-coding,Successful target
CWITA000545,TCMBANKGE000545,CXCL2,CINC-2a; GRO2; GROb; MGSA-b; MIP-2a; MIP2; MIP2A; SCYB2,C-X-C motif chemokine ligand 2,4q13.3,protein-coding,Clinical Trial target
CWITA000546,TCMBANKGE000546,DCLK1,CL1; CLICK1; DCAMKL1; DCDC3A; DCLK,doublecortin like kinase 1,13q13.3,protein-coding,Research target
CWITA000547,TCMBANKGE000547,LGR5,FEX; GPR49; GPR67; GRP49; HG38,leucine rich repeat containing G protein-coupled receptor 5,12q21.1,protein-coding,Research target
CWITA000548,TCMBANKGE000548,MFGE8,BA46; EDIL1; HMFG; HsT19888; MFG-E8; MFGM; OAcGD3S; SED1; SPAG10; hP47,milk fat globule EGF and factor V/VIII domain containing,15q26.1,protein-coding,Research target
CWITA000549,TCMBANKGE000549,GBF1,ARF1GEF,golgi brefeldin A resistant guanine nucleotide exchange factor 1,10q24.32,protein-coding,/
CWITA000550,TCMBANKGE000550,PI4KB,NPIK; PI4K-BETA; PI4K92; PI4KBETA; PI4KIII; PI4KIIIBETA; PIK4CB,phosphatidylinositol 4-kinase beta,1q21.3,protein-coding,Research target
CWITA000551,TCMBANKGE000551,NOL3,ARC; FCM; MYOCL1; MYP; NOP; NOP30,nucleolar protein 3,16q22.1,protein-coding,/
CWITA000552,TCMBANKGE000552,XBP1P1,XBP; XBP1; XBPP1,X-box binding protein 1 pseudogene 1,5q22.2,pseudo,/
CWITA000553,TCMBANKGE000553,GDF10,BIP; BMP-3b; BMP3B,growth differentiation factor 10,10q11.22,protein-coding,/
CWITA000554,TCMBANKGE000554,CRP,PTX1,C-reactive protein,1q23.2,protein-coding,Clinical Trial target
CWITA000555,TCMBANKGE000555,SST,SMST,somatostatin,3q27.3,protein-coding,Successful target
CWITA000556,TCMBANKGE000556,MAPK10,JNK3; JNK3A; PRKM10; SAPK1b; p493F12; p54bSAPK,mitogen-activated protein kinase 10,4q21.3,protein-coding,Patented target
CWITA000557,TCMBANKGE000557,ATP9B,ATPASEP; ATPIIB; HUSSY-20; NEO1L; hMMR1,ATPase phospholipid transporting 9B (putative),18q23,protein-coding,/
CWITA000558,TCMBANKGE000558,CLDN4,CPE-R; CPER; CPETR; CPETR1; WBSCR8; hCPE-R,claudin 4,7q11.23,protein-coding,Research target
CWITA000559,TCMBANKGE000559,SCNN1G,BESC3; ENaCg; ENaCgamma; LDLS2; PHA1; SCNEG,sodium channel epithelial 1 subunit gamma,16p12.2,protein-coding,/
CWITA000560,TCMBANKGE000560,CLDN5,AWAL; BEC1; CPETRL1; TMDVCF; TMVCF,claudin 5,22q11.21,protein-coding,/
CWITA000561,TCMBANKGE000561,JAM3,JAM-2; JAM-3; JAM-C; JAMC,junctional adhesion molecule 3,11q25,protein-coding,/
CWITA000562,TCMBANKGE000562,IL18,IGIF; IL-18; IL-1g; IL1F4,interleukin 18,11q23.1,protein-coding,Clinical Trial target
CWITA000563,TCMBANKGE000563,CLU,AAG4; APO-J; APOJ; CLI; CLU1; CLU2; KUB1; NA1/NA2; SGP-2; SGP2; SP-40; TRPM-2; TRPM2,clusterin,8p21.1,protein-coding,Research target
CWITA000564,TCMBANKGE000564,ATP8A2,ATP; ATPIB; CAMRQ4; IB; ML-1,ATPase phospholipid transporting 8A2,13q12.13,protein-coding,/
CWITA000565,TCMBANKGE000565,CX3CR1,CCRL1; CMKBRL1; CMKDR1; GPR13; GPRV28; V28,C-X3-C motif chemokine receptor 1,3p22.2,protein-coding,Research target
CWITA000566,TCMBANKGE000566,HMGA1,HMG-R; HMGA1A; HMGIY,high mobility group AT-hook 1,6p21.31,protein-coding,Research target
CWITA000567,TCMBANKGE000567,CDKN2A,ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16,cyclin dependent kinase inhibitor 2A,9p21.3,protein-coding,Research target
CWITA000568,TCMBANKGE000568,MET,AUTS9; DFNB97; HGFR; RCCP2; c-Met,"MET proto-oncogene, receptor tyrosine kinase",7q31.2,protein-coding,Successful target
CWITA000569,TCMBANKGE000569,CD34,-,CD34 molecule,1q32.2,protein-coding,Clinical Trial target
CWITA000570,TCMBANKGE000570,MIR1275,MIRN1275; hsa-mir-1275; mir-1275,microRNA 1275,6p21.31,ncRNA,/
CWITA000571,TCMBANKGE000571,COPS5,CSN5; JAB1; MOV-34; SGN5,COP9 signalosome subunit 5,8q13.1,protein-coding,Research target
CWITA000572,TCMBANKGE000572,POLG,MDP1; MIRAS; MTDPS4A; MTDPS4B; PEO; POLG1; POLGA; SANDO; SCAE,"DNA polymerase gamma, catalytic subunit",15q26.1,protein-coding,/
CWITA000573,TCMBANKGE000573,CDX2,CDX-3; CDX2/AS; CDX3,caudal type homeobox 2,13q12.2,protein-coding,/
CWITA000574,TCMBANKGE000574,GAST,GAS,gastrin,17q21.2,protein-coding,Clinical Trial target
CWITA000575,TCMBANKGE000575,ULK1,ATG1; ATG1A; UNC51; Unc51.1; hATG1,unc-51 like autophagy activating kinase 1,12q24.33,protein-coding,Research target
CWITA000576,TCMBANKGE000576,CHAT,CHOACTASE; CMS1A; CMS1A2; CMS6,choline O-acetyltransferase,10q11.23,protein-coding,/
CWITA000577,TCMBANKGE000577,SLC18A3,CMS21; VACHT,solute carrier family 18 member A3,10q11.23,protein-coding,Discontinued target
CWITA000578,TCMBANKGE000578,ANGPTL4,ARP4; FIAF; HARP; HFARP; NL2; PGAR; TGQTL; UNQ171; pp1158,angiopoietin like 4,19p13.2,protein-coding,Research target
CWITA000579,TCMBANKGE000579,PDK4,-,pyruvate dehydrogenase kinase 4,7q21.3,protein-coding,/
CWITA000580,TCMBANKGE000580,RICTOR,AVO3; PIA; hAVO3,RPTOR independent companion of MTOR complex 2,5p13.1,protein-coding,Research target
CWITA000581,TCMBANKGE000581,DYRK2,-,dual specificity tyrosine phosphorylation regulated kinase 2,12q15,protein-coding,Patented target
CWITA000582,TCMBANKGE000582,IPO7,Imp7; RANBP7,importin 7,11p15.4,protein-coding,/
CWITA000583,TCMBANKGE000583,MIR22,MIRN22; hsa-mir-22; miR-22,microRNA 22,17p13.3,ncRNA,/
CWITA000584,TCMBANKGE000584,TXNIP,ARRDC6; EST01027; HHCPA78; THIF; VDUP1,thioredoxin interacting protein,1q21.1,protein-coding,Research target
CWITA000585,TCMBANKGE000585,BCL2L11,BAM; BIM; BOD,BCL2 like 11,2q13,protein-coding,/
CWITA000586,TCMBANKGE000586,IL17F,CANDF6; IL-17F; ML-1; ML1,interleukin 17F,6p12.2,protein-coding,Clinical Trial target
CWITA000587,TCMBANKGE000587,ITGAM,CD11B; CR3A; MAC-1; MAC1A; MO1A; SLEB6,integrin subunit alpha M,16p11.2,protein-coding,Research target
CWITA000588,TCMBANKGE000588,TYROBP,DAP12; KARAP; PLOSL; PLOSL1,transmembrane immune signaling adaptor TYROBP,19q13.12,protein-coding,/
CWITA000589,TCMBANKGE000589,CD68,GP110; LAMP4; SCARD1,CD68 molecule,17p13.1,protein-coding,/
CWITA000590,TCMBANKGE000590,ILK,HEL-S-28; ILK-1; ILK-2; P59; p59ILK,integrin linked kinase,11p15.4,protein-coding,Research target
CWITA000591,TCMBANKGE000591,NUPR1,COM1; P8,"nuclear protein 1, transcriptional regulator",16p11.2,protein-coding,/
CWITA000592,TCMBANKGE000592,PPP1CC,PP-1G; PP1C; PPP1G,protein phosphatase 1 catalytic subunit gamma,12q24.11,protein-coding,/
CWITA000593,TCMBANKGE000593,PPA1,HEL-S-66p; IOPPP; PP; PP1; SID6-8061,inorganic pyrophosphatase 1,10q22.1,protein-coding,/
CWITA000594,TCMBANKGE000594,ZNRD2,SSSCA1; p27,zinc ribbon domain containing 2,11q13.1,protein-coding,/
CWITA000595,TCMBANKGE000595,ADAM9,CORD9; MCMP; MDC9; Mltng,ADAM metallopeptidase domain 9,8p11.22,protein-coding,/
CWITA000596,TCMBANKGE000596,PSMD9,Rpn4; p27,"proteasome 26S subunit, non-ATPase 9",12q24.31,protein-coding,/
CWITA000597,TCMBANKGE000597,TMED7,CGI-109; p24g3; p24gamma3; p27,transmembrane p24 trafficking protein 7,5q22.3,protein-coding,/
CWITA000598,TCMBANKGE000598,MDK,ARAP; MK; NEGF2,midkine,11p11.2,protein-coding,Research target
CWITA000599,TCMBANKGE000599,H3P23,p27,H3 histone pseudogene 23,5q14.3,pseudo,/
CWITA000600,TCMBANKGE000600,IFI27,FAM14D; ISG12; ISG12A; P27,interferon alpha inducible protein 27,14q32.12,protein-coding,/
CWITA000601,TCMBANKGE000601,DCTN6,WS-3; WS3; p27,dynactin subunit 6,8p12,protein-coding,/
CWITA000602,TCMBANKGE000602,HAND1,Hxt; Thing1; bHLHa27; eHand,heart and neural crest derivatives expressed 1,5q33.2,protein-coding,/
CWITA000603,TCMBANKGE000603,NELFCD,HSPC130; NELF-C; NELF-D; TH1; TH1L,negative elongation factor complex member C/D,20q13.32,protein-coding,/
CWITA000604,TCMBANKGE000604,RSAD2,2510004L01Rik; cig33; cig5; vig1,radical S-adenosyl methionine domain containing 2,2p25.2,protein-coding,/
CWITA000605,TCMBANKGE000605,STK25,SOK1; YSK1,serine/threonine kinase 25,2q37.3,protein-coding,/
CWITA000606,TCMBANKGE000606,NRG1,ARIA; GGF; GGF2; HGL; HRG; HRG1; HRGA; MST131; MSTP131; NDF; NRG1-IT2; SMDF,neuregulin 1,8p12,protein-coding,Clinical Trial target
CWITA000607,TCMBANKGE000607,CD80,B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7,CD80 molecule,3q13.33,protein-coding,Successful target
CWITA000608,TCMBANKGE000608,CD83,BL11; HB15,CD83 molecule,6p23,protein-coding,Research target
CWITA000609,TCMBANKGE000609,CD86,B7-2; B7.2; B70; CD28LG2; LAB72,CD86 molecule,3q13.33,protein-coding,Research target
CWITA000610,TCMBANKGE000610,CD1A,CD1; FCB6; HTA1; R4; T6,CD1a molecule,1q23.1,protein-coding,Successful target
CWITA000611,TCMBANKGE000611,CSF2,CSF; GMCSF,colony stimulating factor 2,5q31.1,protein-coding,Successful target
CWITA000612,TCMBANKGE000612,IQCB1,NPHP5; PIQ; SLSN5,IQ motif containing B1,3q13.33|3q21.1,protein-coding,/
CWITA000613,TCMBANKGE000613,CEP290,3H11Ag; BBS14; CT87; JBTS5; LCA10; MKS4; NPHP6; POC3; SLSN6; rd16,centrosomal protein 290,12q21.32,protein-coding,/
CWITA000614,TCMBANKGE000614,LTBP1,-,latent transforming growth factor beta binding protein 1,2p22.3,protein-coding,/
CWITA000615,TCMBANKGE000615,TRPM8,LTRPC6; LTrpC-6; TRPP8; trp-p8,transient receptor potential cation channel subfamily M member 8,2q37.1,protein-coding,Successful target
CWITA000616,TCMBANKGE000616,SLC7A1,ATRC1; CAT-1; ERR; HCAT1; REC1L,solute carrier family 7 member 1,13q12.3,protein-coding,Research target
CWITA000617,TCMBANKGE000617,JAK1,JAK1A; JAK1B; JTK3,Janus kinase 1,1p31.3,protein-coding,Successful target
CWITA000618,TCMBANKGE000618,PPP1R14A,CPI-17; CPI17; PPP1INL,protein phosphatase 1 regulatory inhibitor subunit 14A,19q13.2,protein-coding,/
CWITA000619,TCMBANKGE000619,ASRGL1,ALP; ALP1; CRASH,asparaginase and isoaspartyl peptidase 1,11q12.3,protein-coding,Successful target
CWITA000620,TCMBANKGE000620,ATHS,ALP,atherosclerosis susceptibility (lipoprotein associated),19p13.3-p13.2,unknown,/
CWITA000621,TCMBANKGE000621,PDLIM3,ALP,PDZ and LIM domain 3,4q35.1,protein-coding,/
CWITA000622,TCMBANKGE000622,SLPI,ALK1; ALP; BLPI; HUSI; HUSI-I; MPI; WAP4; WFDC4,secretory leukocyte peptidase inhibitor,20q13.12,protein-coding,/
CWITA000623,TCMBANKGE000623,CCL27,ALP; CTACK; CTAK; ESKINE; ILC; PESKY; SCYA27,C-C motif chemokine ligand 27,9p13.3,protein-coding,/
CWITA000624,TCMBANKGE000624,ALPL,AP-TNAP; APTNAP; HOPS; TNALP; TNAP; TNSALP,"alkaline phosphatase, biomineralization associated",1p36.12,protein-coding,Successful target
CWITA000625,TCMBANKGE000625,NAT10,ALP; Kre33; NET43,N-acetyltransferase 10,11p13,protein-coding,/
CWITA000626,TCMBANKGE000626,ATRNL1,ALP; bA338L11.1; bA454H24.1,attractin like 1,10q25.3,protein-coding,/
CWITA000627,TCMBANKGE000627,BGLAP,BGP; OC; OCN,bone gamma-carboxyglutamate protein,1q22,protein-coding,/
CWITA000628,TCMBANKGE000628,CTSS,-,cathepsin S,1q21.3,protein-coding,Clinical Trial target
CWITA000629,TCMBANKGE000629,FBXO32,Fbx32; MAFbx,F-box protein 32,8q24.13,protein-coding,/
CWITA000630,TCMBANKGE000630,TRIM63,IRF; MURF1; MURF2; RNF28; SMRZ,tripartite motif containing 63,1p36.11,protein-coding,/
CWITA000631,TCMBANKGE000631,PTPRU,FMI; PCP-2; PTP; PTP-J; PTP-PI; PTP-RO; PTPPSI; PTPRO; PTPU2; R-PTP-PSI; R-PTP-U; hPTP-J,protein tyrosine phosphatase receptor type U,1p35.3,protein-coding,/
CWITA000632,TCMBANKGE000632,ROCK1,P160ROCK; ROCK-I,Rho associated coiled-coil containing protein kinase 1,18q11.1,protein-coding,Successful target
CWITA000633,TCMBANKGE000633,ADRB2,ADRB2R; ADRBR; B2AR; BAR; BETA2AR,adrenoceptor beta 2,5q32,protein-coding,Successful target
CWITA000634,TCMBANKGE000634,CYC1,MC3DN6; UQCR4,cytochrome c1,8q24.3,protein-coding,/
CWITA000635,TCMBANKGE000635,AURKA,AIK; ARK1; AURA; BTAK; PPP1R47; STK15; STK6; STK7,aurora kinase A,20q13.2,protein-coding,Clinical Trial target
CWITA000636,TCMBANKGE000636,NDUFA5,B13; CI-13KD-B; CI-13kB; NUFM; UQOR13,NADH:ubiquinone oxidoreductase subunit A5,7q31.32,protein-coding,/
CWITA000637,TCMBANKGE000637,SDHB,CWS2; IP; PGL4; SDH; SDH1; SDH2; SDHIP,succinate dehydrogenase complex iron sulfur subunit B,1p36.13,protein-coding,/
CWITA000638,TCMBANKGE000638,REM1,GD:REM; GES,RRAD and GEM like GTPase 1,20q11.21,protein-coding,/
CWITA000639,TCMBANKGE000639,HRAS,C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras,"HRas proto-oncogene, GTPase",11p15.5,protein-coding,Research target
CWITA000640,TCMBANKGE000640,GLIS1,-,GLIS family zinc finger 1,1p32.3,protein-coding,/
CWITA000641,TCMBANKGE000641,PAK4,-,p21 (RAC1) activated kinase 4,19q13.2,protein-coding,Clinical Trial target
CWITA000642,TCMBANKGE000642,PAK1,IDDMSSD; PAKalpha; alpha-PAK; p65-PAK,p21 (RAC1) activated kinase 1,11q13.5-q14.1,protein-coding,Research target
CWITA000643,TCMBANKGE000643,TTR,ATTR; CTS; CTS1; HEL111; HsT2651; PALB; TBPA,transthyretin,18q12.1,protein-coding,Successful target
CWITA000644,TCMBANKGE000644,TNFRSF1A,CD120a; FPF; TBP1; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR1; TNFR55; TNFR60; p55; p55-R; p60,TNF receptor superfamily member 1A,12p13.31,protein-coding,Clinical Trial target
CWITA000645,TCMBANKGE000645,PIGU,CDC91L1; GAB1; GPIBD21; NEDBSS,phosphatidylinositol glycan anchor biosynthesis class U,20q11.22,protein-coding,Research target
CWITA000646,TCMBANKGE000646,DECR1,DECR; NADPH; SDR18C1,"2,4-dienoyl-CoA reductase 1",8q21.3,protein-coding,/
CWITA000647,TCMBANKGE000647,ATG7,APG7-LIKE; APG7L; GSA7,autophagy related 7,3p25.3,protein-coding,Research target
CWITA000648,TCMBANKGE000648,UBA2,ARX; HRIHFB2115; SAE2,ubiquitin like modifier activating enzyme 2,19q13.11,protein-coding,/
CWITA000649,TCMBANKGE000649,SAE1,AOS1; HSPC140; SUA1; UBLE1A,SUMO1 activating enzyme subunit 1,19q13.32,protein-coding,/
CWITA000650,TCMBANKGE000650,SUMO1,DAP1; GMP1; OFC10; PIC1; SENP2; SMT3; SMT3C; SMT3H3; UBL1,small ubiquitin like modifier 1,2q33.1,protein-coding,/
CWITA000651,TCMBANKGE000651,TRIM5,RNF88; TRIM5alpha,tripartite motif containing 5,11p15.4,protein-coding,/
CWITA000652,TCMBANKGE000652,STAT5B,STAT5,signal transducer and activator of transcription 5B,17q21.2,protein-coding,/
CWITA000653,TCMBANKGE000653,TCF7L2,TCF-4; TCF4,transcription factor 7 like 2,10q25.2-q25.3,protein-coding,Research target
CWITA000654,TCMBANKGE000654,CAPN1,CANP; CANP1; CANPL1; SPG76; muCANP; muCL,calpain 1,11q13.1,protein-coding,Patented target
CWITA000655,TCMBANKGE000655,Lamp2,CD107b; LGP-B; Lamp II; Lamp-2; Lamp-2a; Lamp-2b; Lamp-2c; Mac3,lysosomal-associated membrane protein 2,X A3.3|X 22.67 cM,protein-coding,/
CWITA000656,TCMBANKGE000656,RAB7A,CMT2B; PRO2706; RAB7,"RAB7A, member RAS oncogene family",3q21.3,protein-coding,Research target
CWITA000657,TCMBANKGE000657,ATG3,APG3; APG3-LIKE; APG3L; PC3-96,autophagy related 3,3q13.2,protein-coding,/
CWITA000658,TCMBANKGE000658,GAPDHP44,GAPDH,glyceraldehyde 3 phosphate dehydrogenase pseudogene 44,12q14.2,pseudo,/
CWITA000659,TCMBANKGE000659,TLR3,CD283; IIAE2,toll like receptor 3,4q35.1,protein-coding,Clinical Trial target
CWITA000660,TCMBANKGE000660,DNMT3B,ICF; ICF1; M.HsaIIIB,DNA methyltransferase 3 beta,20q11.21,protein-coding,Clinical Trial target
CWITA000661,TCMBANKGE000661,HDAC2,HD2; KDAC2; RPD3; YAF1,histone deacetylase 2,6q21,protein-coding,Clinical Trial target
CWITA000662,TCMBANKGE000662,MIR181D,MIRN181D; mir-181d,microRNA 181d,19p13.12,ncRNA,/
CWITA000663,TCMBANKGE000663,AQP4,MIWC; WCH4,aquaporin 4,18q11.2,protein-coding,/
CWITA000664,TCMBANKGE000664,ATP1A3,AHC2; ATP1A1; CAPOS; DYT12; RDP,ATPase Na+/K+ transporting subunit alpha 3,19q13.2,protein-coding,/
CWITA000665,TCMBANKGE000665,CASP6,MCH2,caspase 6,4q25,protein-coding,Research target
CWITA000666,TCMBANKGE000666,RELB,I-REL; IMD53; IREL; REL-B,"RELB proto-oncogene, NF-kB subunit",19q13.32,protein-coding,/
CWITA000667,TCMBANKGE000667,NFKB2,CVID10; H2TF1; LYT-10; LYT10; NF-kB2; p100; p49/p100; p52,nuclear factor kappa B subunit 2,10q24.32,protein-coding,Clinical Trial target
CWITA000668,TCMBANKGE000668,ITGB1,CD29; FNRB; GPIIA; MDF2; MSK12; VLA-BETA; VLAB,integrin subunit beta 1,10p11.22,protein-coding,Clinical Trial target
CWITA000669,TCMBANKGE000669,LAS1L,Las1; Las1-like; WTS; dJ475B7.2,LAS1 like ribosome biogenesis factor,Xq12,protein-coding,/
CWITA000670,TCMBANKGE000670,HDAC8,CDA07; CDLS5; HD8; HDACL1; KDAC8; MRXS6; RPD3; WTS,histone deacetylase 8,Xq13.1,protein-coding,Patented target
CWITA000671,TCMBANKGE000671,SLCO1A2,OATP; OATP-A; OATP1A2; SLC21A3,solute carrier organic anion transporter family member 1A2,12p12.1,protein-coding,Research target
CWITA000672,TCMBANKGE000672,RPL17-C18orf32,PD-1; RPL17,RPL17-C18orf32 readthrough,18q21.1,protein-coding,/
CWITA000673,TCMBANKGE000673,RPL17,L17; PD-1; RPL23,ribosomal protein L17,18q21.1,protein-coding,/
CWITA000674,TCMBANKGE000674,PDCD1,CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1,programmed cell death 1,2q37.3,protein-coding,Successful target
CWITA000675,TCMBANKGE000675,ACADM,ACAD1; MCAD; MCADH,acyl-CoA dehydrogenase medium chain,1p31.1,protein-coding,/
CWITA000676,TCMBANKGE000676,SFN,YWHAS,stratifin,1p36.11,protein-coding,/
CWITA000677,TCMBANKGE000677,LRP5,BMND1; EVR1; EVR4; HBM; LR3; LRP-5; LRP-7; LRP7; OPPG; OPS; OPTA1; PCLD4; VBCH2,LDL receptor related protein 5,11q13.2,protein-coding,/
CWITA000678,TCMBANKGE000678,EREG,EPR; ER; Ep,epiregulin,4q13.3,protein-coding,Clinical Trial target
CWITA000679,TCMBANKGE000679,BTF3P11,BTF3L1; HUMBTFB; OCIF; OPG; TNFRSF11B,basic transcription factor 3 pseudogene 11,13q22.3,pseudo,/
CWITA000680,TCMBANKGE000680,CTSK,CTS02; CTSO; CTSO1; CTSO2; PKND; PYCD,cathepsin K,1q21.3,protein-coding,Clinical Trial target
CWITA000681,TCMBANKGE000681,TNFRSF11B,OCIF; OPG; PDB5; TR1,TNF receptor superfamily member 11b,8q24.12,protein-coding,Research target
CWITA000682,TCMBANKGE000682,MIRLET7I,LET7I; MIRNLET7I; hsa-let-7i; let-7i,microRNA let-7i,12q14.1,ncRNA,/
CWITA000683,TCMBANKGE000683,MIR34A,MIRN34A; miRNA34A; mir-34; mir-34a,microRNA 34a,1p36.22|1p36.22,ncRNA,/
CWITA000684,TCMBANKGE000684,EGLN1,C1orf12; ECYT3; HALAH; HIF-PH2; HIFPH2; HPH-2; HPH2; PHD2; SM20; ZMYND6,egl-9 family hypoxia inducible factor 1,1q42.2,protein-coding,Research target
CWITA000685,TCMBANKGE000685,ABL1,ABL; BCR-ABL; CHDSKM; JTK7; bcr/abl; c-ABL; c-ABL1; p150; v-abl,"ABL proto-oncogene 1, non-receptor tyrosine kinase",9q34.12,protein-coding,Discontinued target
CWITA000686,TCMBANKGE000686,GARS1,CMT2D; DSMAV; GARS; GlyRS; HMN5; SMAD1,glycyl-tRNA synthetase 1,7p14.3,protein-coding,/
CWITA000687,TCMBANKGE000687,POLDIP2,PDIP38; POLD4; p38,DNA polymerase delta interacting protein 2,17q11.2,protein-coding,/
CWITA000688,TCMBANKGE000688,AIMP2,HLD17; JTV-1; JTV1; P38,aminoacyl tRNA synthetase complex interacting multifunctional protein 2,7p22.1,protein-coding,Research target
CWITA000689,TCMBANKGE000689,GRAP2,GADS; GRAP-2; GRB2L; GRBLG; GRID; GRPL; GrbX; Grf40; Mona; P38,GRB2 related adaptor protein 2,22q13.1,protein-coding,/
CWITA000690,TCMBANKGE000690,SYP,MRX96; MRXSYP,synaptophysin,Xp11.23,protein-coding,/
CWITA000691,TCMBANKGE000691,SIRT2,SIR2; SIR2L; SIR2L2,sirtuin 2,19q13.2,protein-coding,Research target
CWITA000692,TCMBANKGE000692,PNPLA2,1110001C14Rik; ATGL; FP17548; PEDF-R; TTS-2.2; TTS2; iPLA2zeta,patatin like phospholipase domain containing 2,11p15.5,protein-coding,/
CWITA000693,TCMBANKGE000693,NCOA6,AIB3; ASC2; NRC; PRIP; RAP250; TRBP,nuclear receptor coactivator 6,20q11.22,protein-coding,/
CWITA000694,TCMBANKGE000694,SIRT6,SIR2L6,sirtuin 6,19p13.3,protein-coding,/
CWITA000695,TCMBANKGE000695,MAPK13,MAPK 13; MAPK-13; PRKM13; SAPK4; p38delta,mitogen-activated protein kinase 13,6p21.31,protein-coding,/
CWITA000696,TCMBANKGE000696,PKD1,PBP; PC1; Pc-1; TRPP1,"polycystin 1, transient receptor potential channel interacting",16p13.3,protein-coding,/
CWITA000697,TCMBANKGE000697,APAF1,APAF-1; CED4,apoptotic peptidase activating factor 1,12q23.1,protein-coding,/
CWITA000698,TCMBANKGE000698,TIGAR,C12orf5; FR2BP,TP53 induced glycolysis regulatory phosphatase,12p13.32,protein-coding,/
CWITA000699,TCMBANKGE000699,CYBA,p22-PHOX,cytochrome b-245 alpha chain,16q24.2,protein-coding,/
CWITA000700,TCMBANKGE000700,LCP1,CP64; HEL-S-37; L-PLASTIN; LC64P; LPL; PLS2,lymphocyte cytosolic protein 1,13q14.13,protein-coding,/
CWITA000701,TCMBANKGE000701,ESR2,ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8,estrogen receptor 2,14q23.2-q23.3,protein-coding,Successful target
CWITA000702,TCMBANKGE000702,GPX2,GI-GPx; GPRP; GPRP-2; GPx-2; GPx-GI; GSHPX-GI; GSHPx-2,glutathione peroxidase 2,14q23.3,protein-coding,/
CWITA000703,TCMBANKGE000703,AREG,AR; AREGB; CRDGF; SDGF,amphiregulin,4q13.3,protein-coding,Research target
CWITA000704,TCMBANKGE000704,MTA3,-,metastasis associated 1 family member 3,2p21,protein-coding,/
CWITA000705,TCMBANKGE000705,GPR84,EX33; GPCR4,G protein-coupled receptor 84,12q13.13,protein-coding,Research target
CWITA000706,TCMBANKGE000706,ARG1,-,arginase 1,6q23.2,protein-coding,/
CWITA000707,TCMBANKGE000707,PTK2B,CADTK; CAKB; FADK2; FAK2; PKB; PTK; PYK2; RAFTK,protein tyrosine kinase 2 beta,8p21.2,protein-coding,Research target
CWITA000708,TCMBANKGE000708,FGB,HEL-S-78p,fibrinogen beta chain,4q31.3,protein-coding,/
CWITA000709,TCMBANKGE000709,ALDH3A1,ALDH3; ALDHIII,aldehyde dehydrogenase 3 family member A1,17p11.2,protein-coding,/
CWITA000710,TCMBANKGE000710,TEAD2,ETF; TEAD-2; TEF-4; TEF4,TEA domain transcription factor 2,19q13.33,protein-coding,/
CWITA000711,TCMBANKGE000711,SOX4,CSS10; EVI16,SRY-box transcription factor 4,6p22.3,protein-coding,/
CWITA000712,TCMBANKGE000712,COL1A1,CAFYD; EDSARTH1; EDSC; OI1; OI2; OI3; OI4,collagen type I alpha 1 chain,17q21.33,protein-coding,/
CWITA000713,TCMBANKGE000713,CCN2,CTGF; HCS24; IGFBP8; NOV2,cellular communication network factor 2,6q23.2,protein-coding,/
CWITA000714,TCMBANKGE000714,SHC1,SHC; SHCA,SHC adaptor protein 1,1q21.3,protein-coding,/
CWITA000715,TCMBANKGE000715,BID,FP497,BH3 interacting domain death agonist,22q11.21,protein-coding,/
CWITA000716,TCMBANKGE000716,MT2A,MT-2; MT-II; MT2,metallothionein 2A,16q13,protein-coding,/
CWITA000717,TCMBANKGE000717,CTH,-,cystathionine gamma-lyase,1p31.1,protein-coding,Research target
CWITA000718,TCMBANKGE000718,H3P16,H3F3AP6; p21,H3 histone pseudogene 16,4q31.1,pseudo,/
CWITA000719,TCMBANKGE000719,Casp14,MICE; mini-ICE,caspase 14,10|10 C1,protein-coding,/
CWITA000720,TCMBANKGE000720,KRT1,CK1; EHK; EHK1; EPPK; K1; KRT1A; NEPPK,keratin 1,12q13.13,protein-coding,/
CWITA000721,TCMBANKGE000721,LOXL2,LOR; LOR2; WS9-14,lysyl oxidase like 2,8p21.3,protein-coding,Clinical Trial target
CWITA000722,TCMBANKGE000722,KRT10,BCIE; BIE; CK10; EHK; K10; KPP,keratin 10,17q21.2,protein-coding,/
CWITA000723,TCMBANKGE000723,FOSL2,FRA2,"FOS like 2, AP-1 transcription factor subunit",2p23.2,protein-coding,Research target
CWITA000724,TCMBANKGE000724,KRT14,CK14|EBS3|EBS4|K14|NFJ,keratin 14,17q21.2,protein-coding,/
CWITA000725,TCMBANKGE000725,FOSL1,FRA; FRA1; fra-1,"FOS like 1, AP-1 transcription factor subunit",11q13.1,protein-coding,Research target
CWITA000726,TCMBANKGE000726,CRYZ,-,crystallin zeta,1p31.1,protein-coding,Research target
CWITA000727,TCMBANKGE000727,MAP1LC3A,ATG8E; LC3; LC3A; MAP1ALC3; MAP1BLC3,microtubule associated protein 1 light chain 3 alpha,20q11.22,protein-coding,/
CWITA000728,TCMBANKGE000728,MGMT,-,O-6-methylguanine-DNA methyltransferase,10q26.3,protein-coding,Clinical Trial target
CWITA000729,TCMBANKGE000729,CASP1,ICE; IL1BC; P45,caspase 1,11q22.3,protein-coding,Clinical Trial target
CWITA000730,TCMBANKGE000730,HSPB2,HSP27; Hs.78846; LOH11CR1K; MKBP,heat shock protein family B (small) member 2,11q23.1,protein-coding,/
CWITA000731,TCMBANKGE000731,DNTT,TDT,DNA nucleotidylexotransferase,10q24.1,protein-coding,/
CWITA000732,TCMBANKGE000732,PLIN1,FPLD4|PERI|PLIN,perilipin 1,15q26.1,protein-coding,Research target
CWITA000733,TCMBANKGE000733,GCH1,DYT14; DYT5; DYT5a; GCH; GTP-CH-1; GTPCH1; HPABH4B,GTP cyclohydrolase 1,14q22.2,protein-coding,Clinical Trial target
CWITA000734,TCMBANKGE000734,GCLC,GCL; GCS; GLCL; GLCLC,glutamate-cysteine ligase catalytic subunit,6p12.1,protein-coding,/
CWITA000735,TCMBANKGE000735,VDAC1,PORIN; VDAC-1,voltage dependent anion channel 1,5q31.1,protein-coding,Clinical Trial target
CWITA000736,TCMBANKGE000736,TNFAIP3,A20; AISBL; OTUD7C; TNFA1P2,TNF alpha induced protein 3,6q23.3,protein-coding,Research target
CWITA000737,TCMBANKGE000737,PGR,NR3C3; PR,progesterone receptor,11q22.1,protein-coding,Successful target
CWITA000738,TCMBANKGE000738,MYB,Cmyb; c-myb; c-myb_CDS; efg,"MYB proto-oncogene, transcription factor",6q23.3,protein-coding,Clinical Trial target
CWITA000739,TCMBANKGE000739,NOX5,-,NADPH oxidase 5,15q23,protein-coding,/
CWITA000740,TCMBANKGE000740,NOX1,GP91-2; MOX1; NOH-1; NOH1,NADPH oxidase 1,Xq22.1,protein-coding,/
CWITA000741,TCMBANKGE000741,HSPA1B,HSP70-1; HSP70-1B; HSP70-2; HSP70.1; HSP70.2; HSP72; HSPA1; HSX70,heat shock protein family A (Hsp70) member 1B,6p21.33,protein-coding,/
CWITA000742,TCMBANKGE000742,SMAD7,CRCS3; MADH7; MADH8,SMAD family member 7,18q21.1,protein-coding,Clinical Trial target
CWITA000743,TCMBANKGE000743,TOMM22,1C9-2; MST065; MSTP065; TOM22,translocase of outer mitochondrial membrane 22,22q13.1,protein-coding,/
CWITA000744,TCMBANKGE000744,ERP29,C12orf8; ERp28; ERp31; HEL-S-107; PDI-DB; PDIA9,endoplasmic reticulum protein 29,12q24.13,protein-coding,/
CWITA000745,TCMBANKGE000745,BAG3,BAG-3; BIS; CAIR-1; MFM6,BAG cochaperone 3,10q26.11,protein-coding,/
CWITA000746,TCMBANKGE000746,HSPA1A,HEL-S-103; HSP70-1; HSP70-1A; HSP70-2; HSP70.1; HSP70.2; HSP70I; HSP72; HSPA1,heat shock protein family A (Hsp70) member 1A,6p21.33,protein-coding,/
CWITA000747,TCMBANKGE000747,GAPDH,G3PD; GAPD; HEL-S-162eP,glyceraldehyde-3-phosphate dehydrogenase,12p13.31,protein-coding,Clinical Trial target
CWITA000748,TCMBANKGE000748,PLA2G2A,MOM1; PLA2; PLA2B; PLA2L; PLA2S; PLAS1; sPLA2,phospholipase A2 group IIA,1p36.13,protein-coding,Clinical Trial target
CWITA000749,TCMBANKGE000749,ALOX5,5-LO; 5-LOX; 5LPG; LOG5,arachidonate 5-lipoxygenase,10q11.21,protein-coding,Discontinued target
CWITA000750,TCMBANKGE000750,NR4A1,GFRP1; HMR; N10; NAK-1; NGFIB; NP10; NUR77; TR3,nuclear receptor subfamily 4 group A member 1,12q13.13,protein-coding,Research target
CWITA000751,TCMBANKGE000751,TRAF2,MGC:45012; RNF117; TRAP; TRAP3,TNF receptor associated factor 2,9q34.3,protein-coding,/
CWITA000752,TCMBANKGE000752,Il33,9230117N10Rik; Il-33; Il1f11; NF-HEV,interleukin 33,19|19 C1,protein-coding,
CWITA000753,TCMBANKGE000753,CNR2,CB-2; CB2; CX5,cannabinoid receptor 2,1p36.11,protein-coding,Successful target
CWITA000754,TCMBANKGE000754,GMCL1,BTBD13; GCL; GCL1; SPATA29,"germ cell-less 1, spermatogenesis associated",2p13.3,protein-coding,/
CWITA000755,TCMBANKGE000755,PPIA,CYPA; CYPH; HEL-S-69p,peptidylprolyl isomerase A,7p13,protein-coding,Successful target
CWITA000756,TCMBANKGE000756,BSG,5F7; CD147; EMMPRIN; EMPRIN; OK; SLC7A11; TCSF,basigin (Ok blood group),19p13.3,protein-coding,Clinical Trial target
CWITA000757,TCMBANKGE000757,PTPN2,PTN2; PTPT; TC-PTP; TCELLPTP; TCPTP,protein tyrosine phosphatase non-receptor type 2,18p11.21,protein-coding,/
CWITA000758,TCMBANKGE000758,HSF1,HSTF1,heat shock transcription factor 1,8q24.3,protein-coding,/
CWITA000759,TCMBANKGE000759,MAP1LC3B,ATG8F; LC3B; MAP1A/1BLC3; MAP1LC3B-a,microtubule associated protein 1 light chain 3 beta,16q24.2,protein-coding,/
CWITA000760,TCMBANKGE000760,WWTR1,TAZ,WW domain containing transcription regulator 1,3q25.1,protein-coding,/
CWITA000761,TCMBANKGE000761,FANCD2,FA-D2; FA4; FACD; FAD; FAD2; FANCD,FA complementation group D2,3p25.3,protein-coding,/
CWITA000762,TCMBANKGE000762,Abcb1a,Abcb4; Evi32; Mdr1a; Mdr3; P-gp; Pgp; Pgy-3; Pgy3; mdr-3,"ATP-binding cassette, sub-family B (MDR/TAP), member 1A",5 A1|5 3.43 cM,protein-coding,/
CWITA000763,TCMBANKGE000763,TRPV3,FNEPPK2; OLMS; VRL3,transient receptor potential cation channel subfamily V member 3,17p13.2,protein-coding,Clinical Trial target
CWITA000764,TCMBANKGE000764,TRPV1,VR1,transient receptor potential cation channel subfamily V member 1,17p13.2,protein-coding,Successful target
CWITA000765,TCMBANKGE000765,TRPM7,ALSPDC; CHAK; CHAK1; LTRPC7; LTrpC-7; TRP-PLIK,transient receptor potential cation channel subfamily M member 7,15q21.2,protein-coding,Research target
CWITA000766,TCMBANKGE000766,ACHE,ACEE; ARACHE; N-ACHE; YT,acetylcholinesterase (Cartwright blood group),7q22.1,protein-coding,Successful target
CWITA000767,TCMBANKGE000767,GSK3A,-,glycogen synthase kinase 3 alpha,19q13.2,protein-coding,Patented target
CWITA000768,TCMBANKGE000768,LGALS13,GAL13; PLAC8; PP13,galectin 13,19q13.2,protein-coding,/
CWITA000769,TCMBANKGE000769,EIF2AK4,GCN2; PVOD2,eukaryotic translation initiation factor 2 alpha kinase 4,15q15.1,protein-coding,Research target
CWITA000770,TCMBANKGE000770,SESN2,HI95; SES2; SEST2,sestrin 2,1p35.3,protein-coding,/
CWITA000771,TCMBANKGE000771,TWIST1,ACS3; BPES2; BPES3; CRS; CRS1; CSO; SCS; SWCOS; TWIST; bHLHa38,twist family bHLH transcription factor 1,7p21.1,protein-coding,Research target
CWITA000772,TCMBANKGE000772,ELL2,MRCCAT1,elongation factor for RNA polymerase II 2,5q15,protein-coding,/
CWITA000773,TCMBANKGE000773,SIAH1,SIAH1A,siah E3 ubiquitin protein ligase 1,16q12.1,protein-coding,/
CWITA000774,TCMBANKGE000774,PRRT2,BFIC2; BFIS2; DSPB3; DYT10; EKD1; FICCA; ICCA; IFITMD1; PKC,proline rich transmembrane protein 2,16p11.2,protein-coding,/
CWITA000775,TCMBANKGE000775,MAP2K2,CFC4; MAPKK2; MEK2; MKK2; PRKMK2,mitogen-activated protein kinase kinase 2,19p13.3,protein-coding,Clinical Trial target
CWITA000776,TCMBANKGE000776,MAPRE1,EB1,microtubule associated protein RP/EB family member 1,20q11.21,protein-coding,/
CWITA000777,TCMBANKGE000777,MAPRE2,CSCSC2; EB1; EB2; RP1,microtubule associated protein RP/EB family member 2,18q12.1-q12.2,protein-coding,/
CWITA000778,TCMBANKGE000778,TAC1,Hs.2563; NK2; NKNA; NPK; TAC2,tachykinin precursor 1,7q21.3,protein-coding,/
CWITA000779,TCMBANKGE000779,GAS6,AXLLG; AXSF,growth arrest specific 6,13q34,protein-coding,Research target
CWITA000780,TCMBANKGE000780,RYR2,ARVC2; ARVD2; RYR-2; RyR; VTSIP,ryanodine receptor 2,1q43,protein-coding,/
CWITA000781,TCMBANKGE000781,LDLR,FH; FHC; FHCL1; LDLCQ2,low density lipoprotein receptor,19p13.2,protein-coding,Successful target
CWITA000782,TCMBANKGE000782,GCK,FGQTL3; GK; GLK; HHF3; HK4; HKIV; HXKP; LGLK; MODY2; PNDM1,glucokinase,7p13,protein-coding,Clinical Trial target
CWITA000783,TCMBANKGE000783,PCSK9,FH3; FHCL3; HCHOLA3; LDLCQ1; NARC-1; NARC1; PC9,proprotein convertase subtilisin/kexin type 9,1p32.3,protein-coding,Clinical Trial target
CWITA000784,TCMBANKGE000784,CALM3,CALM; CAM1; CAM2; CAMB; CPVT6; CaM; CaMIII; HEL-S-72; LQT16; PHKD; PHKD3,calmodulin 3,19q13.32,protein-coding,/
CWITA000785,TCMBANKGE000785,G6PD,G6PD1,glucose-6-phosphate dehydrogenase,Xq28,protein-coding,Successful target
CWITA000786,TCMBANKGE000786,MIR200A,MIRN200A; mir-200a,microRNA 200a,1p36.33,ncRNA,/
CWITA000787,TCMBANKGE000787,VCAM1,CD106; INCAM-100,vascular cell adhesion molecule 1,1p21.2,protein-coding,Research target
CWITA000788,TCMBANKGE000788,SELE,CD62E; ELAM; ELAM1; ESEL; LECAM2,selectin E,1q24.2,protein-coding,Research target
CWITA000789,TCMBANKGE000789,NFE2,NF-E2; p45,"nuclear factor, erythroid 2",12q13.13,protein-coding,/
CWITA000790,TCMBANKGE000790,DUSP4,HVH2; MKP-2; MKP2; TYP,dual specificity phosphatase 4,8p12,protein-coding,/
CWITA000791,TCMBANKGE000791,DUSP1,CL100; HVH1; MKP-1; MKP1; PTPN10,dual specificity phosphatase 1,5q35.1,protein-coding,Clinical Trial target
CWITA000792,TCMBANKGE000792,FASLG,ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A,Fas ligand,1q24.3,protein-coding,Research target
CWITA000793,TCMBANKGE000793,ALDH1A1,ALDC; ALDH-E1; ALDH1; ALDH11; HEL-9; HEL-S-53e; HEL12; PUMB1; RALDH1,aldehyde dehydrogenase 1 family member A1,9q21.13,protein-coding,/
CWITA000794,TCMBANKGE000794,NANOG,-,Nanog homeobox,12p13.31,protein-coding,/
CWITA000795,TCMBANKGE000795,POU5F1,OCT3; OCT4; OTF-3; OTF3; OTF4; Oct-3; Oct-4,POU class 5 homeobox 1,6p21.33,protein-coding,/
CWITA000796,TCMBANKGE000796,MAPKAPK2,MAPKAP-K2; MK-2; MK2,MAPK activated protein kinase 2,1q32.1,protein-coding,Clinical Trial target
CWITA000797,TCMBANKGE000797,HSPB1,CMT2F; HEL-S-102; HMN2B; HS.76067; HSP27; HSP28; Hsp25; SRP27,heat shock protein family B (small) member 1,7q11.23,protein-coding,Clinical Trial target
CWITA000798,TCMBANKGE000798,MYD88,MYD88D,MYD88 innate immune signal transduction adaptor,3p22.2,protein-coding,Patented target
CWITA000799,TCMBANKGE000799,AGER,RAGE; SCARJ1,advanced glycosylation end-product specific receptor,6p21.32,protein-coding,Clinical Trial target
CWITA000800,TCMBANKGE000800,GABRB3,ECA5; EIEE43,gamma-aminobutyric acid type A receptor subunit beta3,15q12,protein-coding,/
CWITA000801,TCMBANKGE000801,HTR1A,5-HT-1A; 5-HT1A; 5HT1a; ADRB2RL1; ADRBRL1; G-21; PFMCD,5-hydroxytryptamine receptor 1A,5q12.3,protein-coding,Successful target
CWITA000802,TCMBANKGE000802,RENBP,RBP; RNBP,renin binding protein,Xq28,protein-coding,Research target
CWITA000803,TCMBANKGE000803,ATP2B4,ATP2B2; MXRA1; PMCA4; PMCA4b; PMCA4x,ATPase plasma membrane Ca2+ transporting 4,1q32.1,protein-coding,/
CWITA000804,TCMBANKGE000804,POLR2D,HSRBP4; HSRPB4; RBP4; RPB16; RPB4,RNA polymerase II subunit D,2q14.3,protein-coding,/
CWITA000805,TCMBANKGE000805,SOCS3,ATOD4; CIS3; Cish3; SOCS-3; SSI-3; SSI3,suppressor of cytokine signaling 3,17q25.3,protein-coding,Research target
CWITA000806,TCMBANKGE000806,HSPA4,APG-2; HEL-S-5a; HS24/P52; HSPH2; RY; hsp70; hsp70RY,heat shock protein family A (Hsp70) member 4,5q31.1,protein-coding,/
CWITA000807,TCMBANKGE000807,NAIP,BIRC1; NLRB1; psiNAIP,NLR family apoptosis inhibitory protein,5q13.2,protein-coding,/
CWITA000808,TCMBANKGE000808,Naip1,AV364616; Birc1a; D13Lsd1; Naip; Naip-rs1,"NLR family, apoptosis inhibitory protein 1",13 D1|13 53.18 cM,protein-coding,/
CWITA000809,TCMBANKGE000809,BIRC3,AIP1; API2; CIAP2; HAIP1; HIAP1; IAP-1; MALT2; MIHC; RNF49; c-IAP2,baculoviral IAP repeat containing 3,11q22.2,protein-coding,Research target
CWITA000810,TCMBANKGE000810,BIRC2,API1; HIAP2; Hiap-2; MIHB; RNF48; c-IAP1; cIAP1,baculoviral IAP repeat containing 2,11q22.2,protein-coding,Clinical Trial target
CWITA000811,TCMBANKGE000811,KL,HFTC3,klotho,13q13.1,protein-coding,/
CWITA000812,TCMBANKGE000812,REL,C-Rel,"REL proto-oncogene, NF-kB subunit",2p16.1,protein-coding,Research target
CWITA000813,TCMBANKGE000813,DPP4,ADABP; ADCP2; CD26; DPPIV; TP103,dipeptidyl peptidase 4,2q24.2,protein-coding,Successful target
CWITA000814,TCMBANKGE000814,DPP9,DP9; DPLP9; DPP IX; DPRP-2; DPRP2,dipeptidyl peptidase 9,19p13.3,protein-coding,Clinical Trial target
CWITA000815,TCMBANKGE000815,DPP8,DP8; DPRP-1; DPRP1; MST097; MSTP097; MSTP135; MSTP141,dipeptidyl peptidase 8,15q22.31,protein-coding,Clinical Trial target
CWITA000816,TCMBANKGE000816,Txn1,ADF; AW550880; Trx1; Txn,thioredoxin 1,4 B3|4 31.87 cM,protein-coding,/
CWITA000817,TCMBANKGE000817,PGAM5,BXLBV68,"PGAM family member 5, mitochondrial serine/threonine protein phosphatase",12q24.33,protein-coding,/
CWITA000818,TCMBANKGE000818,ROS1,MCF3; ROS; c-ros-1,"ROS proto-oncogene 1, receptor tyrosine kinase",6q22.1,protein-coding,Successful target
CWITA000819,TCMBANKGE000819,TRPA1,ANKTM1; FEPS; FEPS1,transient receptor potential cation channel subfamily A member 1,8q21.11,protein-coding,Successful target
CWITA000820,TCMBANKGE000820,CFLAR,CASH; CASP8AP1; CLARP; Casper; FLAME; FLAME-1; FLAME1; FLIP; I-FLICE; MRIT; c-FLIP; c-FLIPL; c-FLIPR; c-FLIPS; cFLIP,CASP8 and FADD like apoptosis regulator,2q33.1,protein-coding,Research target
CWITA000821,TCMBANKGE000821,PMAIP1,APR; NOXA,phorbol-12-myristate-13-acetate-induced protein 1,18q21.32,protein-coding,/
CWITA000822,TCMBANKGE000822,ANXA5,ANX5; ENX2; HEL-S-7; PP4; RPRGL3,annexin A5,4q27,protein-coding,Clinical Trial target
CWITA000823,TCMBANKGE000823,GABPA,E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; RCH04A07,GA binding protein transcription factor subunit alpha,21q21.3,protein-coding,/
CWITA000824,TCMBANKGE000824,RB1,OSRC; PPP1R130; RB; p105-Rb; p110-RB1; pRb; pp110,RB transcriptional corepressor 1,13q14.2,protein-coding,/
CWITA000825,TCMBANKGE000825,CDKN1B,CDKN4; KIP1; MEN1B; MEN4; P27KIP1,cyclin dependent kinase inhibitor 1B,12p13.1,protein-coding,Research target
CWITA000826,TCMBANKGE000826,SKP2,FBL1; FBXL1; FLB1; p45,S-phase kinase associated protein 2,5p13.2,protein-coding,Research target
CWITA000827,TCMBANKGE000827,CBL,C-CBL; CBL2; FRA11B; NSLL; RNF55,Cbl proto-oncogene,11q23.3,protein-coding,Research target
CWITA000828,TCMBANKGE000828,TREM2,PLOSL2; TREM-2; Trem2a; Trem2b; Trem2c,triggering receptor expressed on myeloid cells 2,6p21.1,protein-coding,Research target
CWITA000829,TCMBANKGE000829,FABP4,A-FABP; AFABP; ALBP; HEL-S-104; aP2,fatty acid binding protein 4,8q21.13,protein-coding,Patented target
CWITA000830,TCMBANKGE000830,GOT2,KAT4; KATIV; KYAT4; mitAAT,glutamic-oxaloacetic transaminase 2,16q21,protein-coding,/
CWITA000831,TCMBANKGE000831,PRKACA,PKACA; PPNAD4,protein kinase cAMP-activated catalytic subunit alpha,19p13.12,protein-coding,Research target
CWITA000832,TCMBANKGE000832,ABCG8,GBD4; STSL; STSL1,ATP binding cassette subfamily G member 8,2p21,protein-coding,/
CWITA000833,TCMBANKGE000833,ABCG5,STSL; STSL2,ATP binding cassette subfamily G member 5,2p21,protein-coding,Research target
CWITA000834,TCMBANKGE000834,NR1H3,LXR-a; LXRA; RLD-1,nuclear receptor subfamily 1 group H member 3,11p11.2,protein-coding,Research target
CWITA000835,TCMBANKGE000835,APP,AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; preA4,amyloid beta precursor protein,21q21.3,protein-coding,Successful target
CWITA000836,TCMBANKGE000836,BACE1,ASP2; BACE; HSPC104,beta-secretase 1,11q23.3,protein-coding,Clinical Trial target
CWITA000837,TCMBANKGE000837,ISYNA1,INO1; INOS; IPS; IPS 1; IPS-1,inositol-3-phosphate synthase 1,19p13.11,protein-coding,/
CWITA000838,TCMBANKGE000838,PTGES,MGST-IV; MGST1-L1; MGST1L1; MPGES; PGES; PIG12; PP102; PP1294; TP53I12; mPGES-1,prostaglandin E synthase,9q34.11,protein-coding,Clinical Trial target
CWITA000839,TCMBANKGE000839,PSG1,B1G1; CD66f; DHFRP2; FL-NCA-1/2; PBG1; PS-beta-C/D; PS-beta-G-1; PSBG-1; PSBG1; PSG95; PSGGA; PSGIIA; SP1,pregnancy specific beta-1-glycoprotein 1,19q13.2,protein-coding,/
CWITA000840,TCMBANKGE000840,CARM1,PRMT4,coactivator associated arginine methyltransferase 1,19p13.2,protein-coding,Research target
CWITA000841,TCMBANKGE000841,MTCO2P12,COII; COX2; COXII; MT-CO2; MTCO2,MT-CO2 pseudogene 12,1p36.33,pseudo,/
CWITA000842,TCMBANKGE000842,SLC18A2,PKDYS2; SVAT; SVMT; VAT2; VMAT2,solute carrier family 18 member A2,10q25.3,protein-coding,Successful target
CWITA000843,TCMBANKGE000843,GSTA4,GSTA4-4; GTA4,glutathione S-transferase alpha 4,6p12.2,protein-coding,/
CWITA000844,TCMBANKGE000844,CYP2E1,CPE1; CYP2E; P450-J; P450C2E,cytochrome P450 family 2 subfamily E member 1,10q26.3,protein-coding,/
CWITA000845,TCMBANKGE000845,CCL4,ACT2; AT744.1; G-26; HC21; LAG-1; LAG1; MIP-1-beta; MIP1B; MIP1B1; SCYA2; SCYA4,C-C motif chemokine ligand 4,17q12,protein-coding,/
CWITA000846,TCMBANKGE000846,MMP14,MMP-14; MMP-X1; MT-MMP; MT-MMP 1; MT1-MMP; MT1MMP; MTMMP1; WNCHRS,matrix metallopeptidase 14,14q11.2,protein-coding,Clinical Trial target
CWITA000847,TCMBANKGE000847,Cyp2b10,Cyp2b; Cyp2b20; p16,"cytochrome P450, family 2, subfamily b, polypeptide 10",7 A3|7 14.11 cM,protein-coding,/
CWITA000848,TCMBANKGE000848,LY96,ESOP-1; MD-2; MD2; ly-96,lymphocyte antigen 96,8q21.11,protein-coding,Research target
CWITA000849,TCMBANKGE000849,HK2,HKII; HXK2,hexokinase 2,2p12,protein-coding,Clinical Trial target
CWITA000850,TCMBANKGE000850,CYLD,BRSS; CDMT; CYLD1; CYLDI; EAC; MFT; MFT1; SBS; TEM; USPL2,CYLD lysine 63 deubiquitinase,16q12.1,protein-coding,/
CWITA000851,TCMBANKGE000851,PKM,CTHBP; HEL-S-30; OIP3; PK3; PKM2; TCB; THBP1; p58,pyruvate kinase M1/2,15q23,protein-coding,Clinical Trial target
CWITA000852,TCMBANKGE000852,FFAR3,FFA3R; GPR41; GPR42,free fatty acid receptor 3,19q13.12,protein-coding,Research target
CWITA000853,TCMBANKGE000853,FFAR2,FFA2R; GPR43,free fatty acid receptor 2,19q13.12,protein-coding,Clinical Trial target
CWITA000854,TCMBANKGE000854,SRGN,PPG; PRG; PRG1,serglycin,10q22.1,protein-coding,Research target
CWITA000855,TCMBANKGE000855,NKX3-1,BAPX2; NKX3; NKX3.1; NKX3A,NK3 homeobox 1,8p21.2,protein-coding,Research target
CWITA000856,TCMBANKGE000856,CRK,CRKII; p38,"CRK proto-oncogene, adaptor protein",17p13.3,protein-coding,Research target
CWITA000857,TCMBANKGE000857,AHSA1,AHA1; C14orf3; hAha1; p38,activator of HSP90 ATPase activity 1,14q24.3,protein-coding,/
CWITA000858,TCMBANKGE000858,RBPJ,AOS3; CBF-1; CBF1; IGKJRB; IGKJRB1; KBF2; RBP-J; RBP-J kappa; RBP-JK; RBPJK; RBPSUH; SUH; csl,recombination signal binding protein for immunoglobulin kappa J region,4p15.2,protein-coding,Research target
CWITA000859,TCMBANKGE000859,PRKCD,ALPS3; CVID9; MAY1; PKCD; nPKC-delta,protein kinase C delta,3p21.1,protein-coding,Research target
CWITA000860,TCMBANKGE000860,LGALS3,CBP35; GAL3; GALBP; GALIG; L31; LGALS2; MAC2,galectin 3,14q22.3,protein-coding,Clinical Trial target
CWITA000861,TCMBANKGE000861,PTGER4,EP4; EP4R,prostaglandin E receptor 4,5p13.1,protein-coding,Clinical Trial target
CWITA000862,TCMBANKGE000862,SLC27A5,ACSB; ACSVL6; BACS; BAL; FACVL3; FATP-5; FATP5; VLACSR; VLCS-H2; VLCSH2,solute carrier family 27 member 5,19q13.43,protein-coding,/
CWITA000863,TCMBANKGE000863,GPBAR1,BG37; GPCR19; GPR131; M-BAR; TGR5,G protein-coupled bile acid receptor 1,2q35,protein-coding,Clinical Trial target
CWITA000864,TCMBANKGE000864,FHL2,AAG11; DRAL; FHL-2; SLIM-3; SLIM3,four and a half LIM domains 2,2q12.2,protein-coding,/
CWITA000865,TCMBANKGE000865,TGFA,TFGA,transforming growth factor alpha,2p13.3,protein-coding,Research target
CWITA000866,TCMBANKGE000866,PRKCB,PKC-beta; PKCB; PKCI(2); PKCbeta; PRKCB1; PRKCB2,protein kinase C beta,16p12.2-p12.1,protein-coding,Clinical Trial target
CWITA000867,TCMBANKGE000867,ITGB3,BDPLT16; BDPLT2; CD61; GP3A; GPIIIa; GT,integrin subunit beta 3,17q21.32,protein-coding,Research target
CWITA000868,TCMBANKGE000868,NFATC1,NF-ATC; NF-ATc1.2; NFAT2; NFATc,nuclear factor of activated T cells 1,18q23,protein-coding,/
CWITA000869,TCMBANKGE000869,DRD2,D2DR; D2R,dopamine receptor D2,11q23.2,protein-coding,Successful target
CWITA000870,TCMBANKGE000870,KRT18,CK-18; CYK18; K18,keratin 18,12q13.13,protein-coding,/
CWITA000871,TCMBANKGE000871,IGFBP3,BP-53; IBP3,insulin like growth factor binding protein 3,7p12.3,protein-coding,Research target
CWITA000872,TCMBANKGE000872,IGF1R,CD221; IGFIR; IGFR; JTK13,insulin like growth factor 1 receptor,15q26.3,protein-coding,Research target
CWITA000873,TCMBANKGE000873,AURKC,AIE2; AIK3; ARK3; AurC; HEL-S-90; SPGF5; STK13; aurora-C,aurora kinase C,19q13.43,protein-coding,Clinical Trial target
CWITA000874,TCMBANKGE000874,AURKB,AIK2; AIM-1; AIM1; ARK-2; ARK2; AurB; IPL1; PPP1R48; STK-1; STK12; STK5; aurkb-sv1; aurkb-sv2,aurora kinase B,17p13.1,protein-coding,Clinical Trial target
CWITA000875,TCMBANKGE000875,ATF4,CREB-2; CREB2; TAXREB67; TXREB,activating transcription factor 4,22q13.1,protein-coding,Research target
CWITA000876,TCMBANKGE000876,PRDX5,ACR1; AOEB166; B166; HEL-S-55; PLP; PMP20; PRDX6; PRXV; SBBI10; prx-V,peroxiredoxin 5,11q13.1,protein-coding,Successful target
CWITA000877,TCMBANKGE000877,ABCG2,ABC15; ABCP; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; UAQTL1,ATP binding cassette subfamily G member 2 (Junior blood group),4q22.1,protein-coding,Successful target
CWITA000878,TCMBANKGE000878,MIR7-3HG,C19orf30; Huh7; LINC00306; NCRNA00306; PGSF1; uc002mbe.2,MIR7-3 host gene,19p13.3,ncRNA,/
CWITA000879,TCMBANKGE000879,SERPINE2,GDN; GDNPF; PI-7; PI7; PN-1; PN1; PNI,serpin family E member 2,2q36.1,protein-coding,/
CWITA000880,TCMBANKGE000880,Psl1,Tpa,promotion susceptibility QTL 1,9 57.46 cM,unknown,/
CWITA000881,TCMBANKGE000881,PLAT,T-PA; TPA,"plasminogen activator, tissue type",8p11.21,protein-coding,Successful target
CWITA000882,TCMBANKGE000882,SERPINE1,PAI; PAI-1; PAI1; PLANH1,serpin family E member 1,7q22.1,protein-coding,Research target
CWITA000883,TCMBANKGE000883,MIR25,MIRN25; hsa-mir-25; miR-25,microRNA 25,7q22.1,ncRNA,/
CWITA000884,TCMBANKGE000884,FN1,CIG; ED-B; FINC; FN; FNZ; GFND; GFND2; LETS; MSF; SMDCF,fibronectin 1,2q35,protein-coding,Clinical Trial target
CWITA000885,TCMBANKGE000885,SPP1,BNSP; BSPI; ETA-1; OPN,secreted phosphoprotein 1,4q22.1,protein-coding,Research target
CWITA000886,TCMBANKGE000886,SOX9,CMD1; CMPD1; SRA1; SRXX2; SRXY10,SRY-box transcription factor 9,17q24.3,protein-coding,/
CWITA000887,TCMBANKGE000887,PPM1D,IDDGIP; JDVS; PP2C-DELTA; WIP1,"protein phosphatase, Mg2+/Mn2+ dependent 1D",17q23.2,protein-coding,Research target
CWITA000888,TCMBANKGE000888,PLK2,SNK; hPlk2; hSNK,polo like kinase 2,5q11.2,protein-coding,Research target
CWITA000889,TCMBANKGE000889,HFE,HFE1; HH; HLA-H; MVCD7; TFQTL2,homeostatic iron regulator,6p22.2,protein-coding,/
CWITA000890,TCMBANKGE000890,FUT1,H; HH; HSC,fucosyltransferase 1 (H blood group),19q13.33,protein-coding,/
CWITA000891,TCMBANKGE000891,ABCC3,ABC31; EST90757; MLP2; MOAT-D; MRP3; cMOAT2,ATP binding cassette subfamily C member 3,17q21.33,protein-coding,/
CWITA000892,TCMBANKGE000892,SP7,OI11; OI12; OSX; osterix,Sp7 transcription factor,12q13.13,protein-coding,/
CWITA000893,TCMBANKGE000893,IBSP,BNSP; BSP; BSP-II; SP-II,integrin binding sialoprotein,4q22.1,protein-coding,/
CWITA000894,TCMBANKGE000894,Bglap2,BGP2; Bglap1; Bgp; Og2; mOC-B,bone gamma-carboxyglutamate protein 2,3 F1|3 38.81 cM,protein-coding,/
CWITA000895,TCMBANKGE000895,SUFU,JBTS32; PRO1280; SUFUH; SUFUXL,SUFU negative regulator of hedgehog signaling,10q24.32,protein-coding,/
CWITA000896,TCMBANKGE000896,SFRP1,FRP; FRP-1; FRP1; FrzA; SARP2,secreted frizzled related protein 1,8p11.21,protein-coding,/
CWITA000897,TCMBANKGE000897,GLI3,ACLS; GCPS; GLI3-190; GLI3FL; PAP-A; PAPA; PAPA1; PAPB; PHS; PPDIV,GLI family zinc finger 3,7p14.1,protein-coding,/
CWITA000898,TCMBANKGE000898,MYC,MRTL; MYCC; bHLHe39; c-Myc,"MYC proto-oncogene, bHLH transcription factor",8q24.21,protein-coding,Clinical Trial target
CWITA000899,TCMBANKGE000899,GLI2,CJS; HPE9; PHS2; THP1; THP2,GLI family zinc finger 2,2q14.2,protein-coding,Research target
CWITA000900,TCMBANKGE000900,GALNT1,GALNAC-T1,polypeptide N-acetylgalactosaminyltransferase 1,18q12.2,protein-coding,/
CWITA000901,TCMBANKGE000901,ANGPT1,AGP1; AGPT; ANG1,angiopoietin 1,8q23.1,protein-coding,Clinical Trial target
CWITA000902,TCMBANKGE000902,HAS2,-,hyaluronan synthase 2,8q24.13,protein-coding,/
CWITA000903,TCMBANKGE000903,PTGS1,COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS,prostaglandin-endoperoxide synthase 1,9q33.2,protein-coding,Successful target
CWITA000904,TCMBANKGE000904,PTCH1,BCNS; NBCCS; PTC; PTC1; PTCH,patched 1,9q22.32,protein-coding,/
CWITA000905,TCMBANKGE000905,GATA6,-,GATA binding protein 6,18q11.2,protein-coding,/
CWITA000906,TCMBANKGE000906,FOXA2,HNF-3-beta; HNF3B; TCF3B,forkhead box A2,20p11.21,protein-coding,/
CWITA000907,TCMBANKGE000907,SPDEF,PDEF; bA375E1.3,SAM pointed domain containing ETS transcription factor,6p21.31,protein-coding,Research target
CWITA000908,TCMBANKGE000908,MUC5AC,MUC5; TBM; leB; mucin,"mucin 5AC, oligomeric mucus/gel-forming",11p15.5,protein-coding,Research target
CWITA000909,TCMBANKGE000909,GLI1,GLI; PAPA8; PPD1,GLI family zinc finger 1,12q13.3,protein-coding,Patented target
CWITA000910,TCMBANKGE000910,SLC22A3,EMT; EMTH; OCT3,solute carrier family 22 member 3,6q25.3,protein-coding,Research target
CWITA000911,TCMBANKGE000911,ITK,EMT; LPFS1; LYK; PSCTK2,IL2 inducible T cell kinase,5q33.3,protein-coding,Clinical Trial target
CWITA000912,TCMBANKGE000912,SHH,HHG1; HLP3; HPE3; MCOPCB5; SMMCI; ShhNC; TPT; TPTPS,sonic hedgehog signaling molecule,7q36.3,protein-coding,Research target
CWITA000913,TCMBANKGE000913,IHH,BDA1; HHG2,Indian hedgehog signaling molecule,2q35,protein-coding,/
CWITA000914,TCMBANKGE000914,SMOX,C20orf16; PAO; PAO-1; PAO1; PAOH; PAOH1; SMO,spermine oxidase,20p13,protein-coding,/
CWITA000915,TCMBANKGE000915,BMPR2,BMPR-II; BMPR3; BMR2; BRK-3; POVD1; PPH1; T-ALK,bone morphogenetic protein receptor type 2,2q33.1-q33.2,protein-coding,Research target
CWITA000916,TCMBANKGE000916,SMO,CRJS; FZD11; Gx; SMOH,"smoothened, frizzled class receptor",7q32.1,protein-coding,Successful target
CWITA000917,TCMBANKGE000917,IL17RA,CANDF5; CD217; CDw217; IL-17RA; IL17R; IMD51; hIL-17R,interleukin 17 receptor A,22q11.1,protein-coding,/
CWITA000918,TCMBANKGE000918,MAPK9,JNK-55; JNK2; JNK2A; JNK2ALPHA; JNK2B; JNK2BETA; PRKM9; SAPK; SAPK1a; p54a; p54aSAPK,mitogen-activated protein kinase 9,5q35.3,protein-coding,Patented target
CWITA000919,TCMBANKGE000919,GADD45B,GADD45BETA; MYD118,growth arrest and DNA damage inducible beta,19p13.3,protein-coding,Research target
CWITA000920,TCMBANKGE000920,GADD45A,DDIT1; GADD45,growth arrest and DNA damage inducible alpha,1p31.3,protein-coding,/
CWITA000921,TCMBANKGE000921,CCNB1,CCNB,cyclin B1,5q13.2,protein-coding,Patented target
CWITA000922,TCMBANKGE000922,GADD45G,CR6; DDIT2; GADD45gamma; GRP17,growth arrest and DNA damage inducible gamma,9q22.2,protein-coding,/
CWITA000923,TCMBANKGE000923,CDK1,CDC2; CDC28A; P34CDC2,cyclin dependent kinase 1,10q21.2,protein-coding,Clinical Trial target
CWITA000924,TCMBANKGE000924,MIR132,MIRN132; miRNA132; mir-132,microRNA 132,17p13.3,ncRNA,/
CWITA000925,TCMBANKGE000925,PCNA,ATLD2,proliferating cell nuclear antigen,20p12.3,protein-coding,Clinical Trial target
CWITA000926,TCMBANKGE000926,RRM2,C2orf48; R2; RR2; RR2M,ribonucleotide reductase regulatory subunit M2,2p25.1,protein-coding,Research target
CWITA000927,TCMBANKGE000927,MUC13,DRCC1; MUC-13,"mucin 13, cell surface associated",3q21.2,protein-coding,/
CWITA000928,TCMBANKGE000928,RRM1,R1; RIR1; RR1,ribonucleotide reductase catalytic subunit M1,11p15.4,protein-coding,Discontinued target
CWITA000929,TCMBANKGE000929,MIR145,MIRN145; miR-145; miRNA145,microRNA 145,5q32,ncRNA,/
CWITA000930,TCMBANKGE000930,ACLY,ACL; ATPCL; CLATP,ATP citrate lyase,17q21.2,protein-coding,Research target
CWITA000931,TCMBANKGE000931,CYP17A1,CPT7; CYP17; P450C17; S17AH,cytochrome P450 family 17 subfamily A member 1,10q24.32,protein-coding,Successful target
CWITA000932,TCMBANKGE000932,AKT2,HIHGHH; PKBB; PKBBETA; PRKBB; RAC-BETA,AKT serine/threonine kinase 2,19q13.2,protein-coding,Research target
CWITA000933,TCMBANKGE000933,IKBKB,IKK-beta; IKK2; IKKB; IMD15; IMD15A; IMD15B; NFKBIKB,inhibitor of nuclear factor kappa B kinase subunit beta,8p11.21,protein-coding,Clinical Trial target
CWITA000934,TCMBANKGE000934,GFAP,ALXDRD,glial fibrillary acidic protein,17q21.31,protein-coding,/
CWITA000935,TCMBANKGE000935,S100B,NEF; S100; S100-B; S100beta,S100 calcium binding protein B,21q22.3,protein-coding,Clinical Trial target
CWITA000936,TCMBANKGE000936,GLIS3,NDH; ZNF515,GLIS family zinc finger 3,9p24.2,protein-coding,/
CWITA000937,TCMBANKGE000937,PAX5,ALL3; BSAP,paired box 5,9p13.2,protein-coding,Research target
CWITA000938,TCMBANKGE000938,CDK2,CDKN2; p33(CDK2),cyclin dependent kinase 2,12q13.2,protein-coding,Clinical Trial target
CWITA000939,TCMBANKGE000939,DDR2,MIG20a; NTRKR3; TKT; TYRO10; WRCN,discoidin domain receptor tyrosine kinase 2,1q23.3,protein-coding,Research target
CWITA000940,TCMBANKGE000940,TERT,CMM9; DKCA2; DKCB4; EST2; PFBMFT1; TCS1; TP2; TRT; hEST2; hTRT,telomerase reverse transcriptase,5p15.33,protein-coding,Clinical Trial target
CWITA000941,TCMBANKGE000941,TXNRD1,GRIM-12; TR; TR1; TRXR1; TXNR,thioredoxin reductase 1,12q23.3,protein-coding,Successful target
CWITA000942,TCMBANKGE000942,PPM1G,PP2CG; PP2CGAMMA; PPP2CG,"protein phosphatase, Mg2+/Mn2+ dependent 1G",2p23.3,protein-coding,/
CWITA000943,TCMBANKGE000943,WWP2,AIP2; WWp2-like,WW domain containing E3 ubiquitin protein ligase 2,16q22.1,protein-coding,Research target
CWITA000944,TCMBANKGE000944,NOTCH3,CADASIL; CADASIL1; CASIL; IMF2; LMNS,notch receptor 3,19p13.12,protein-coding,Clinical Trial target
CWITA000945,TCMBANKGE000945,HES1,HES-1; HHL; HRY; bHLHb39,hes family bHLH transcription factor 1,3q29,protein-coding,/
CWITA000946,TCMBANKGE000946,RAD51,BRCC5; FANCR; HRAD51; HsRad51; HsT16930; MRMV2; RAD51A; RECA,RAD51 recombinase,15q15.1,protein-coding,Research target
CWITA000947,TCMBANKGE000947,NSFL1C,P47; UBX1; UBXD10; UBXN2C; dJ776F14.1,NSFL1 cofactor,20p13,protein-coding,/
CWITA000948,TCMBANKGE000948,ERN1,IRE1; IRE1P; IRE1a; hIRE1p,endoplasmic reticulum to nucleus signaling 1,17q23.3,protein-coding,Research target
CWITA000949,TCMBANKGE000949,UGT2B4,HLUG25; UDPGT2B4; UDPGTH1; UDPGTh-1; UGT2B11,UDP glucuronosyltransferase family 2 member B4,4q13.3,protein-coding,/
CWITA000950,TCMBANKGE000950,SULT2A1,DHEA-ST; DHEAS; HST; ST2; ST2A1; ST2A3; STD; hSTa,sulfotransferase family 2A member 1,19q13.33,protein-coding,/
CWITA000951,TCMBANKGE000951,CYP7B1,CBAS3; CP7B; SPG5A,cytochrome P450 family 7 subfamily B member 1,8q12.3,protein-coding,/
CWITA000952,TCMBANKGE000952,SLC10A1,NTCP,solute carrier family 10 member 1,14q24.1,protein-coding,Clinical Trial target
CWITA000953,TCMBANKGE000953,PTPN6,HCP; HCPH; HPTP1C; PTP-1C; SH-PTP1; SHP-1; SHP-1L; SHP1,protein tyrosine phosphatase non-receptor type 6,12p13.31,protein-coding,Research target
CWITA000954,TCMBANKGE000954,ABCB11,ABC16; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP,ATP binding cassette subfamily B member 11,2q31.1,protein-coding,Research target
CWITA000955,TCMBANKGE000955,ABCC2,ABC30; CMOAT; DJS; MRP2; cMRP,ATP binding cassette subfamily C member 2,10q24.2,protein-coding,Research target
CWITA000956,TCMBANKGE000956,NR1H4,BAR; FXR; HRR-1; HRR1; PFIC5; RIP14,nuclear receptor subfamily 1 group H member 4,12q23.1,protein-coding,Successful target
CWITA000957,TCMBANKGE000957,MAP2K4,JNKK; JNKK1; MAPKK4; MEK4; MKK4; PRKMK4; SAPKK-1; SAPKK1; SEK1; SERK1; SKK1,mitogen-activated protein kinase kinase 4,17p12,protein-coding,/
CWITA000958,TCMBANKGE000958,TIMM8A,DDP; DDP1; DFN1; MTS; TIM8,translocase of inner mitochondrial membrane 8A,Xq22.1,protein-coding,/
CWITA000959,TCMBANKGE000959,MYH9,BDPLT6; DFNA17; EPSTS; FTNS; MATINS; MHA; NMHC-II-A; NMMHC-IIA; NMMHCA,myosin heavy chain 9,22q12.3,protein-coding,/
CWITA000960,TCMBANKGE000960,STAT5A,MGF; STAT5,signal transducer and activator of transcription 5A,17q21.2,protein-coding,/
CWITA000961,TCMBANKGE000961,MBL2,COLEC1; HSMBPC; MBL; MBL2D; MBP; MBP-C; MBP1; MBPD,mannose binding lectin 2,10q21.1,protein-coding,Research target
CWITA000962,TCMBANKGE000962,TFEB,ALPHATFEB; BHLHE35; TCFEB,transcription factor EB,6p21.1,protein-coding,/
CWITA000963,TCMBANKGE000963,TRAF6,MGC:3310; RNF85,TNF receptor associated factor 6,11p12,protein-coding,Research target
CWITA000964,TCMBANKGE000964,MAP3K7,CSCF; FMD2; MEKK7; TAK1; TGF1a,mitogen-activated protein kinase kinase kinase 7,6q15,protein-coding,Research target
CWITA000965,TCMBANKGE000965,CHRNA7,CHRNA7-2; NACHRA7,cholinergic receptor nicotinic alpha 7 subunit,15q13.3,protein-coding,Successful target
CWITA000966,TCMBANKGE000966,SIGMAR1,ALS16; DSMA2; OPRS1; SIG-1R; SR-BP; SR-BP1; SRBP; hSigmaR1; sigma1R,sigma non-opioid intracellular receptor 1,9p13.3,protein-coding,Successful target
CWITA000967,TCMBANKGE000967,BIRC7,KIAP; LIVIN; ML-IAP; MLIAP; RNF50,baculoviral IAP repeat containing 7,20q13.33,protein-coding,Patented target
CWITA000968,TCMBANKGE000968,CYCS,CYC; HCS; THC4,"cytochrome c, somatic",7p15.3,protein-coding,/
CWITA000969,TCMBANKGE000969,TXN,TRDX; TRX; TRX1,thioredoxin,9q31.3,protein-coding,Clinical Trial target
CWITA000970,TCMBANKGE000970,FASN,FAS; OA-519; SDR27X1,fatty acid synthase,17q25.3,protein-coding,Successful target
CWITA000971,TCMBANKGE000971,MIR20A,C13orf25; MIR17HG; MIR20; MIRH1; MIRHG1; MIRN20; MIRN20A; hsa-mir-20; hsa-mir-20a; miR-20; miRNA20A; mir-20a,microRNA 20a,13q31.3,ncRNA,/
CWITA000972,TCMBANKGE000972,MIR17,MIR17-5p; MIR91; MIRN17; MIRN91; hsa-mir-17; miR-17; miR17-3p; miRNA17; miRNA91,microRNA 17,13q31.3,ncRNA,/
CWITA000973,TCMBANKGE000973,EGF,HOMG4; URG,epidermal growth factor,4q25,protein-coding,Successful target
CWITA000974,TCMBANKGE000974,SMAD5,DWFC; JV5-1; MADH5,SMAD family member 5,5q31.1,protein-coding,/
CWITA000975,TCMBANKGE000975,IFRD1,PC4; TIS7,interferon related developmental regulator 1,7q31.1,protein-coding,/
CWITA000976,TCMBANKGE000976,TNFSF11,CD254; ODF; OPGL; OPTB2; RANKL; TNLG6B; TRANCE; hRANKL2; sOdf,TNF superfamily member 11,13q14.11,protein-coding,Successful target
CWITA000977,TCMBANKGE000977,SMAD1,BSP-1; BSP1; JV4-1; JV41; MADH1; MADR1,SMAD family member 1,4q31.21,protein-coding,Research target
CWITA000978,TCMBANKGE000978,GCLM,GLCLR,glutamate-cysteine ligase modifier subunit,1p22.1,protein-coding,Research target
CWITA000979,TCMBANKGE000979,KDR,CD309; FLK1; VEGFR; VEGFR2,kinase insert domain receptor,4q12,protein-coding,Successful target
CWITA000980,TCMBANKGE000980,SOX2,ANOP3; MCOPS3,SRY-box transcription factor 2,3q26.33,protein-coding,Research target
CWITA000981,TCMBANKGE000981,UHRF1,ICBP90; Np95; RNF106; TDRD22; hNP95; hUHRF1; huNp95,ubiquitin like with PHD and ring finger domains 1,19p13.3,protein-coding,/
CWITA000982,TCMBANKGE000982,ROR1,NTRKR1; dJ537F10.1,receptor tyrosine kinase like orphan receptor 1,1p31.3,protein-coding,Clinical Trial target
CWITA000983,TCMBANKGE000983,DGKD,DGK-delta; DGKdelta; dgkd-2,diacylglycerol kinase delta,2q37.1,protein-coding,/
CWITA000984,TCMBANKGE000984,RYR1,CCO; MHS; MHS1; PPP1R137; RYDR; RYR; RYR-1; SKRR,ryanodine receptor 1,19q13.2,protein-coding,Discontinued target
CWITA000985,TCMBANKGE000985,GABRG1,-,gamma-aminobutyric acid type A receptor subunit gamma1,4p12,protein-coding,/
CWITA000986,TCMBANKGE000986,ERBB2,CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1,erb-b2 receptor tyrosine kinase 2,17q12,protein-coding,Clinical Trial target
CWITA000987,TCMBANKGE000987,COL11A2,DFNA13; DFNB53; FBCG2; HKE5; OSMEDA; OSMEDB; PARP; STL3,collagen type XI alpha 2 chain,6p21.32,protein-coding,/
CWITA000988,TCMBANKGE000988,HGF,DFNB39; F-TCF; HGFB; HPTA; SF,hepatocyte growth factor,7q21.11,protein-coding,Clinical Trial target
CWITA000989,TCMBANKGE000989,ACACA,ACAC; ACACAD; ACC; ACC1; ACCA,acetyl-CoA carboxylase alpha,17q12,protein-coding,/
CWITA000990,TCMBANKGE000990,EGFR,ERBB; ERBB1; HER1; NISBD2; PIG61; mENA,epidermal growth factor receptor,7p11.2,protein-coding,Clinical Trial target
CWITA000991,TCMBANKGE000991,TIPARP,ARTD14; PARP7; pART14,TCDD inducible poly(ADP-ribose) polymerase,3q25.31,protein-coding,/
CWITA000992,TCMBANKGE000992,KLK3,APS; KLK2A1; PSA; hK3,kallikrein related peptidase 3,19q13.33,protein-coding,Clinical Trial target
CWITA000993,TCMBANKGE000993,SGK1,SGK,serum/glucocorticoid regulated kinase 1,6q23.2,protein-coding,Clinical Trial target
CWITA000994,TCMBANKGE000994,AKR1B1,ADR; ALDR1; ALR2; AR,aldo-keto reductase family 1 member B,7q33,protein-coding,Successful target
CWITA000995,TCMBANKGE000995,CATSPER1,CATSPER; SPGF7,cation channel sperm associated 1,11q13.1,protein-coding,Research target
CWITA000996,TCMBANKGE000996,BNIP3,NIP3,BCL2 interacting protein 3,10q26.3,protein-coding,/
CWITA000997,TCMBANKGE000997,GCG,GLP-1; GLP1; GLP2; GRPP,glucagon,2q24.2,protein-coding,Clinical Trial target
CWITA000998,TCMBANKGE000998,WNT3A,-,Wnt family member 3A,1q42.13,protein-coding,/
CWITA000999,TCMBANKGE000999,FOXM1,FKHL16; FOXM1A; FOXM1B; FOXM1C; HFH-11; HFH11; HNF-3; INS-1; MPHOSPH2; MPP-2; MPP2; PIG29; TRIDENT,forkhead box M1,12p13.33,protein-coding,Research target
CWITA001000,TCMBANKGE001000,SNCAIP,SYPH1; Sph1,synuclein alpha interacting protein,5q23.2,protein-coding,/
CWITA001001,TCMBANKGE001001,SNCA,NACP; PARK1; PARK4; PD1,synuclein alpha,4q22.1,protein-coding,Research target
CWITA001002,TCMBANKGE001002,SYT1,BAGOS; P65; SVP65; SYT,synaptotagmin 1,12q21.2,protein-coding,/
CWITA001003,TCMBANKGE001003,LRIG1,LIG-1; LIG1,leucine rich repeats and immunoglobulin like domains 1,3p14.1,protein-coding,/
CWITA001004,TCMBANKGE001004,MIR301B,MIRN301B; mir-301b,microRNA 301b,22q11.21,ncRNA,/
CWITA001005,TCMBANKGE001005,CTTN,EMS1,cortactin,11q13.3,protein-coding,/
CWITA001006,TCMBANKGE001006,BAK1,BAK; BAK-LIKE; BCL2L7; CDN1,BCL2 antagonist/killer 1,6p21.31,protein-coding,Research target
CWITA001007,TCMBANKGE001007,NR1I2,BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR,nuclear receptor subfamily 1 group I member 2,3q13.33,protein-coding,Research target
CWITA001008,TCMBANKGE001008,CYP3A4,CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1,cytochrome P450 family 3 subfamily A member 4,7q22.1,protein-coding,Clinical Trial target
CWITA001009,TCMBANKGE001009,CRMP1,CRMP-1; DPYSL1; DRP-1; DRP1; ULIP-3,collapsin response mediator protein 1,4p16.2,protein-coding,/
CWITA001010,TCMBANKGE001010,TNFRSF10A,APO2; CD261; DR4; TRAILR-1; TRAILR1,TNF receptor superfamily member 10a,8p21.3,protein-coding,Clinical Trial target
CWITA001011,TCMBANKGE001011,TNFSF10,APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL,TNF superfamily member 10,3q26.31,protein-coding,Clinical Trial target
CWITA001012,TCMBANKGE001012,FOXP3,AIID; DIETER; IPEX; JM2; PIDX; XPID,forkhead box P3,Xp11.23,protein-coding,/
CWITA001013,TCMBANKGE001013,BIRC5,API4; EPR-1,baculoviral IAP repeat containing 5,17q25.3,protein-coding,Research target
CWITA001014,TCMBANKGE001014,TNFRSF10B,CD262; DR5; KILLER; KILLER/DR5; TRAIL-R2; TRAILR2; TRICK2; TRICK2A; TRICK2B; TRICKB; ZTNFR9,TNF receptor superfamily member 10b,8p21.3,protein-coding,Clinical Trial target
CWITA001015,TCMBANKGE001015,RAC1,MIG5; MRD48; Rac-1; TC-25; p21-Rac1,Rac family small GTPase 1,7p22.1,protein-coding,Research target
CWITA001016,TCMBANKGE001016,ATP1A1,CMT2DD; HOMGSMR2,ATPase Na+/K+ transporting subunit alpha 1,1p13.1,protein-coding,Successful target
CWITA001017,TCMBANKGE001017,IDO1,IDO; IDO-1; INDO,"indoleamine 2,3-dioxygenase 1",8p11.21,protein-coding,Successful target
CWITA001018,TCMBANKGE001018,MUC2,MLP; MUC-2; SMUC,"mucin 2, oligomeric mucus/gel-forming",11p15.5,protein-coding,/
CWITA001019,TCMBANKGE001019,TPH1,TPRH; TRPH,tryptophan hydroxylase 1,11p15.1,protein-coding,Clinical Trial target
CWITA001020,TCMBANKGE001020,TJP2,C9DUPq21.11; DFNA51; DUP9q21.11; PFIC4; X104; ZO2,tight junction protein 2,9q21.11,protein-coding,/
CWITA001021,TCMBANKGE001021,MUC1,ADMCKD; ADMCKD1; CA 15-3; CD227; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM,"mucin 1, cell surface associated",1q22,protein-coding,Clinical Trial target
CWITA001022,TCMBANKGE001022,TJP1,ZO-1,tight junction protein 1,15q13.1,protein-coding,/
CWITA001023,TCMBANKGE001023,CLDN1,CLD1; ILVASC; SEMP1,claudin 1,3q28,protein-coding,/
CWITA001024,TCMBANKGE001024,OCLN,BLCPMG; PPP1R115; PTORCH1,occludin,5q13.2,protein-coding,/
CWITA001025,TCMBANKGE001025,MLKL,hMLKL,mixed lineage kinase domain like pseudokinase,16q23.1,protein-coding,/
CWITA001026,TCMBANKGE001026,RIPK3,RIP3,receptor interacting serine/threonine kinase 3,14q12,protein-coding,/
CWITA001027,TCMBANKGE001027,STK11,LKB1; PJS; hLKB1,serine/threonine kinase 11,19p13.3,protein-coding,/
CWITA001028,TCMBANKGE001028,HSP90AB1,D6S182; HSP84; HSP90B; HSPC2; HSPCB,heat shock protein 90 alpha family class B member 1,6p21.1,protein-coding,Clinical Trial target
CWITA001029,TCMBANKGE001029,IL13,IL-13; P600,interleukin 13,5q31.1,protein-coding,Clinical Trial target
CWITA001030,TCMBANKGE001030,NOTCH1,AOS5; AOVD1; TAN1; hN1,notch receptor 1,9q34.3,protein-coding,Clinical Trial target
CWITA001031,TCMBANKGE001031,KLF3,BKLF,Kruppel like factor 3,4p14,protein-coding,/
CWITA001032,TCMBANKGE001032,WNT10B,SHFM6; STHAG8; WNT-12,Wnt family member 10B,12q13.12,protein-coding,/
CWITA001033,TCMBANKGE001033,FGFR1,BFGFR; CD331; CEK; ECCL; FGFBR; FGFR-1; FLG; FLT-2; FLT2; HBGFR; HH2; HRTFDS; KAL2; N-SAM; OGD; bFGF-R-1,fibroblast growth factor receptor 1,8p11.23,protein-coding,Successful target
CWITA001034,TCMBANKGE001034,TLR2,CD282; TIL4,toll like receptor 2,4q31.3,protein-coding,Clinical Trial target
CWITA001035,TCMBANKGE001035,PDRG1,C20orf126; PDRG,p53 and DNA damage regulated 1,20q11.21,protein-coding,/
CWITA001036,TCMBANKGE001036,BDNF-AS,ANTI-BDNF; BDNF; BDNF-AS1; BDNFAS; BDNFOS; NCRNA00049,BDNF antisense RNA,11p14.1,ncRNA,/
CWITA001037,TCMBANKGE001037,MMP2,CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1,matrix metallopeptidase 2,16q12.2,protein-coding,Successful target
CWITA001038,TCMBANKGE001038,SERPINF1,EPC-1; OI12; OI6; PEDF; PIG35,serpin family F member 1,17p13.3,protein-coding,Clinical Trial target
CWITA001039,TCMBANKGE001039,PINK1,BRPK; PARK6,PTEN induced kinase 1,1p36.12,protein-coding,/
CWITA001040,TCMBANKGE001040,AIF1,AIF-1; IBA1; IRT-1; IRT1,allograft inflammatory factor 1,6p21.33,protein-coding,Research target
CWITA001041,TCMBANKGE001041,ALOX15,12-LOX; 15-LOX; 15-LOX-1; LOG15,arachidonate 15-lipoxygenase,17p13.2,protein-coding,Patented target
CWITA001042,TCMBANKGE001042,PTPN1,PTP1B,protein tyrosine phosphatase non-receptor type 1,20q13.13,protein-coding,Successful target
CWITA001043,TCMBANKGE001043,PGPEP1,PAP-I; PGI; PGP; PGP-I; PGPI; Pcp,pyroglutamyl-peptidase I,19p13.11,protein-coding,/
CWITA001044,TCMBANKGE001044,RPS6KB1,PS6K; S6K; S6K-beta-1; S6K1; STK14A; p70 S6KA; p70(S6K)-alpha; p70-S6K; p70-alpha,ribosomal protein S6 kinase B1,17q23.1,protein-coding,Clinical Trial target
CWITA001045,TCMBANKGE001045,CCND1,BCL1; D11S287E; PRAD1; U21B31,cyclin D1,11q13.3,protein-coding,Clinical Trial target
CWITA001046,TCMBANKGE001046,PIN1,DOD; UBL5,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1",19p13.2,protein-coding,Clinical Trial target
CWITA001047,TCMBANKGE001047,E2F1,E2F-1; RBAP1; RBBP3; RBP3,E2F transcription factor 1,20q11.22,protein-coding,Clinical Trial target
CWITA001048,TCMBANKGE001048,TGM2,TG(C); TGC,transglutaminase 2,20q11.23,protein-coding,Patented target
CWITA001049,TCMBANKGE001049,ICMT,HSTE14; MST098; MSTP098; PCCMT; PCMT; PPMT,isoprenylcysteine carboxyl methyltransferase,1p36.31,protein-coding,/
CWITA001050,TCMBANKGE001050,PKD2,APKD2; PC2; PKD4; Pc-2; TRPP2,"polycystin 2, transient receptor potential cation channel",4q22.1,protein-coding,/
CWITA001051,TCMBANKGE001051,MAP2K7,JNKK2; MAPKK7; MEK; MEK 7; MKK7; PRKMK7; SAPKK-4; SAPKK4,mitogen-activated protein kinase kinase 7,19p13.2,protein-coding,Research target
CWITA001052,TCMBANKGE001052,NLRP3,AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1,NLR family pyrin domain containing 3,1q44,protein-coding,Clinical Trial target
CWITA001053,TCMBANKGE001053,ABCG1,ABC8; WHITE1,ATP binding cassette subfamily G member 1,21q22.3,protein-coding,Research target
CWITA001054,TCMBANKGE001054,ABCA1,ABC-1; ABC1; CERP; HDLCQTL13; HDLDT1; HPALP1; TGD,ATP binding cassette subfamily A member 1,9q31.1,protein-coding,Successful target
CWITA001055,TCMBANKGE001055,NR1H2,LXR-b; LXRB; NER; NER-I; RIP15; UNR,nuclear receptor subfamily 1 group H member 2,19q13.33,protein-coding,Clinical Trial target
CWITA001056,TCMBANKGE001056,KRAS,C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2,"KRAS proto-oncogene, GTPase",12p12.1,protein-coding,Clinical Trial target
CWITA001057,TCMBANKGE001057,DERL2,CGI-101; DERtrin-2; F-LAN-1; F-LANa; FLANa; derlin-2,derlin 2,17p13.2,protein-coding,/
CWITA001058,TCMBANKGE001058,LATS2,KPM,large tumor suppressor kinase 2,13q12.11,protein-coding,Research target
CWITA001059,TCMBANKGE001059,LATS1,WARTS; wts,large tumor suppressor kinase 1,6q25.1,protein-coding,/
CWITA001060,TCMBANKGE001060,YAP1,COB1; YAP; YAP2; YAP65; YKI,Yes1 associated transcriptional regulator,11q22.1,protein-coding,Research target
CWITA001061,TCMBANKGE001061,CDK5,LIS7; PSSALRE,cyclin dependent kinase 5,7q36.1,protein-coding,Patented target
CWITA001062,TCMBANKGE001062,PLK1,PLK; STPK13,polo like kinase 1,16p12.2,protein-coding,Clinical Trial target
CWITA001063,TCMBANKGE001063,CEBPB,C/EBP-beta; IL6DBP; NF-IL6; TCF5,CCAAT enhancer binding protein beta,20q13.13,protein-coding,Research target
CWITA001064,TCMBANKGE001064,GLP1R,GLP-1; GLP-1-R; GLP-1R,glucagon like peptide 1 receptor,6p21.2,protein-coding,Successful target
CWITA001065,TCMBANKGE001065,KLF4,EZF; GKLF,Kruppel like factor 4,9q31.2,protein-coding,Clinical Trial target
CWITA001066,TCMBANKGE001066,STAT4,SLEB11,signal transducer and activator of transcription 4,2q32.2-q32.3,protein-coding,/
CWITA001067,TCMBANKGE001067,S100A8,60B8AG; CAGA; CFAG; CGLA; CP-10; L1Ag; MA387; MIF; MRP8; NIF; P8,S100 calcium binding protein A8,1q21.3,protein-coding,Research target
CWITA001068,TCMBANKGE001068,CXCL1,FSP; GRO1; GROa; MGSA; MGSA-a; NAP-3; SCYB1,C-X-C motif chemokine ligand 1,4q13.3,protein-coding,Research target
CWITA001069,TCMBANKGE001069,MPO,-,myeloperoxidase,17q22,protein-coding,Clinical Trial target
CWITA001070,TCMBANKGE001070,UCP1,SLC25A7; UCP,uncoupling protein 1,4q31.1,protein-coding,Clinical Trial target
CWITA001071,TCMBANKGE001071,NPC1,NPC; POGZ; SLC65A1,NPC intracellular cholesterol transporter 1,18q11.2,protein-coding,/
CWITA001072,TCMBANKGE001072,DNM1L,DLP1; DRP1; DVLP; DYMPLE; EMPF; EMPF1; HDYNIV; OPA5,dynamin 1 like,12p11.21,protein-coding,/
CWITA001073,TCMBANKGE001073,PTGS2,COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2,prostaglandin-endoperoxide synthase 2,1q31.1,protein-coding,Successful target
CWITA001074,TCMBANKGE001074,ATM,AT1; ATA; ATC; ATD; ATDC; ATE; TEL1; TELO1,ATM serine/threonine kinase,11q22.3,protein-coding,Clinical Trial target
CWITA001075,TCMBANKGE001075,TXN2,COXPD29; MT-TRX; MTRX; TRX2; TXN,thioredoxin 2,22q12.3,protein-coding,/
CWITA001076,TCMBANKGE001076,SOD2,GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD,superoxide dismutase 2,6q25.3,protein-coding,Clinical Trial target
CWITA001077,TCMBANKGE001077,HSPA5,BIP; GRP78; HEL-S-89n; MIF2,heat shock protein family A (Hsp70) member 5,9q33.3,protein-coding,Clinical Trial target
CWITA001078,TCMBANKGE001078,XBP1,TREB-5; TREB5; XBP-1; XBP2,X-box binding protein 1,22q12.1|22q12,protein-coding,/
CWITA001079,TCMBANKGE001079,CYP1A1,AHH; AHRR; CP11; CYP1; CYPIA1; P1-450; P450-C; P450DX,cytochrome P450 family 1 subfamily A member 1,15q24.1,protein-coding,/
CWITA001080,TCMBANKGE001080,AHR,RP85; bHLHe76,aryl hydrocarbon receptor,7p21.1,protein-coding,Successful target
CWITA001081,TCMBANKGE001081,GAA,LYAG,"glucosidase alpha, acid",17q25.3,protein-coding,Clinical Trial target
CWITA001082,TCMBANKGE001082,MAPK7,BMK1; ERK4; ERK5; PRKM7,mitogen-activated protein kinase 7,17p11.2,protein-coding,Patented target
CWITA001083,TCMBANKGE001083,MAP3K5,ASK1; MAPKKK5; MEKK5,mitogen-activated protein kinase kinase kinase 5,6q23.3,protein-coding,Clinical Trial target
CWITA001084,TCMBANKGE001084,EPHB1,ELK; EPHT2; Hek6; NET,EPH receptor B1,3q22.2,protein-coding,Research target
CWITA001085,TCMBANKGE001085,MAPK8,JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c,mitogen-activated protein kinase 8,10q11.22,protein-coding,Clinical Trial target
CWITA001086,TCMBANKGE001086,SIRT7,SIR2L7,sirtuin 7,17q25.3,protein-coding,/
CWITA001087,TCMBANKGE001087,BTRC,BETA-TRCP; FBW1A; FBXW1; FBXW1A; FWD1; bTrCP; bTrCP1; betaTrCP,beta-transducin repeat containing E3 ubiquitin protein ligase,10q24.32,protein-coding,/
CWITA001088,TCMBANKGE001088,SMAD4,DPC4; JIP; MADH4; MYHRS,SMAD family member 4,18q21.2,protein-coding,/
CWITA001089,TCMBANKGE001089,PARP1,ADPRT; ADPRT 1; ADPRT1; ARTD1; PARP; PARP-1; PPOL; pADPRT-1,poly(ADP-ribose) polymerase 1,1q42.12,protein-coding,Successful target
CWITA001090,TCMBANKGE001090,CYTB,MTCYB,cytochrome b,-,protein-coding,/
CWITA001091,TCMBANKGE001091,ND5,MTND5,"NADH dehydrogenase, subunit 5 (complex I)",-,protein-coding,/
CWITA001092,TCMBANKGE001092,ESRRA,ERR1; ERRa; ERRalpha; ESRL1; NR3B1,estrogen related receptor alpha,11q13.1,protein-coding,Successful target
CWITA001093,TCMBANKGE001093,ND2,MTND2,MTND2,-,protein-coding,/
CWITA001094,TCMBANKGE001094,SIRT3,SIR2L3,sirtuin 3,11p15.5,protein-coding,Research target
CWITA001095,TCMBANKGE001095,OLR1,CLEC8A; LOX1; LOXIN; SCARE1; SLOX1,oxidized low density lipoprotein receptor 1,12p13.2,protein-coding,Discontinued target
CWITA001096,TCMBANKGE001096,TLR4,ARMD10; CD284; TLR-4; TOLL,toll like receptor 4,9q33.1,protein-coding,Clinical Trial target
CWITA001097,TCMBANKGE001097,HIF1A,HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78,hypoxia inducible factor 1 subunit alpha,14q23.2,protein-coding,Clinical Trial target
CWITA001098,TCMBANKGE001098,NFKBIA,EDAID2; IKBA; MAD-3; NFKBI,NFKB inhibitor alpha,14q13.2,protein-coding,/
CWITA001099,TCMBANKGE001099,LRRFIP1,FLAP-1; FLAP1; FLIIAP1; GCF-2; GCF2; HUFI-1; TRIP,LRR binding FLII interacting protein 1,2q37.3,protein-coding,/
CWITA001100,TCMBANKGE001100,MIR155,MIRN155; miRNA155; mir-155,microRNA 155,21q21.3,ncRNA,/
CWITA001101,TCMBANKGE001101,CCL3,G0S19-1; LD78ALPHA; MIP-1-alpha; MIP1A; SCYA3,C-C motif chemokine ligand 3,17q12,protein-coding,Clinical Trial target
CWITA001102,TCMBANKGE001102,MIR21,MIRN21; hsa-mir-21; miR-21; miRNA21,microRNA 21,17q23.1,ncRNA,/
CWITA001103,TCMBANKGE001103,MDM2,ACTFS; HDMX; LSKB; hdm2,MDM2 proto-oncogene,12q15,protein-coding,Research target
CWITA001104,TCMBANKGE001104,TGFB2,G-TSF; LDS4; TGF-beta2,transforming growth factor beta 2,1q41,protein-coding,Clinical Trial target
CWITA001105,TCMBANKGE001105,CS,-,citrate synthase,12q13.3,protein-coding,Research target
CWITA001106,TCMBANKGE001106,MTOR,FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS,mechanistic target of rapamycin kinase,1p36.22,protein-coding,Successful target
CWITA001107,TCMBANKGE001107,NOS3,ECNOS; eNOS,nitric oxide synthase 3,7q36.1,protein-coding,Clinical Trial target
CWITA001108,TCMBANKGE001108,BMP2,BDA2; BMP2A; SSFSC,bone morphogenetic protein 2,20p12.3,protein-coding,Clinical Trial target
CWITA001109,TCMBANKGE001109,ALPP,ALP; ALPI; IAP; PALP; PLAP; PLAP-1,"alkaline phosphatase, placental",2q37.1,protein-coding,/
CWITA001110,TCMBANKGE001110,OGG1,HMMH; HOGG1; MUTM; OGH1,8-oxoguanine DNA glycosylase,3p25.3,protein-coding,Research target
CWITA001111,TCMBANKGE001111,KIT,C-Kit; CD117; MASTC; PBT; SCFR,"KIT proto-oncogene, receptor tyrosine kinase",4q12,protein-coding,Clinical Trial target
CWITA001112,TCMBANKGE001112,PRKAB1,AMPK; HAMPKb,protein kinase AMP-activated non-catalytic subunit beta 1,12q24.23,protein-coding,/
CWITA001113,TCMBANKGE001113,ACTA2,ACTSA,"actin alpha 2, smooth muscle",10q23.31,protein-coding,/
CWITA001114,TCMBANKGE001114,IL6,BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6,interleukin 6,7p15.3,protein-coding,Successful target
CWITA001115,TCMBANKGE001115,Fgf15,FGF19,fibroblast growth factor 15,7|7 F5,protein-coding,/
CWITA001116,TCMBANKGE001116,CYP7A1,CP7A; CYP7; CYPVII,cytochrome P450 family 7 subfamily A member 1,8q12.1,protein-coding,/
CWITA001117,TCMBANKGE001117,PTEN,10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; PTENbeta; TEP1,phosphatase and tensin homolog,10q23.31,protein-coding,Research target
CWITA001118,TCMBANKGE001118,MMP9,CLG4B; GELB; MANDP2; MMP-9,matrix metallopeptidase 9,20q13.12,protein-coding,Research target
CWITA001119,TCMBANKGE001119,S1PR1,CD363; CHEDG1; D1S3362; ECGF1; EDG-1; EDG1; S1P1,sphingosine-1-phosphate receptor 1,1p21.2,protein-coding,Successful target
CWITA001120,TCMBANKGE001120,CAMP,CAP-18; CAP18; CRAMP; FALL-39; FALL39; HSD26; LL37,cathelicidin antimicrobial peptide,3p21.31,protein-coding,Successful target
CWITA001121,TCMBANKGE001121,CEBPA,C/EBP-alpha; CEBP,CCAAT enhancer binding protein alpha,19q13.11,protein-coding,/
CWITA001122,TCMBANKGE001122,AXIN2,AXIL; ODCRCS,axin 2,17q24.1,protein-coding,/
CWITA001123,TCMBANKGE001123,CTNNB1,CTNNB; EVR7; MRD19; NEDSDV; armadillo,catenin beta 1,3p22.1,protein-coding,Successful target
CWITA001124,TCMBANKGE001124,WNT1,BMND16; INT1; OI15,Wnt family member 1,12q13.12,protein-coding,/
CWITA001125,TCMBANKGE001125,IGF1,IGF; IGF-I; IGFI; MGF,insulin like growth factor 1,12q23.2,protein-coding,Clinical Trial target
CWITA001126,TCMBANKGE001126,NFE2L2,HEBP1; IMDDHH; NRF2; Nrf-2,"nuclear factor, erythroid 2 like 2",2q31.2,protein-coding,Clinical Trial target
CWITA001127,TCMBANKGE001127,PRKAA1,AMPK; AMPKa1,protein kinase AMP-activated catalytic subunit alpha 1,5p13.1,protein-coding,/
CWITA001128,TCMBANKGE001128,PRKAA2,AMPK; AMPK2; AMPKa2; PRKAA,protein kinase AMP-activated catalytic subunit alpha 2,1p32.2,protein-coding,/
CWITA001129,TCMBANKGE001129,ARNTL,BMAL1; BMAL1c; JAP3; MOP3; PASD3; TIC; bHLHe5,aryl hydrocarbon receptor nuclear translocator like,11p15.3,protein-coding,/
CWITA001130,TCMBANKGE001130,BAD,BBC2; BCL2L8,BCL2 associated agonist of cell death,11q13.1,protein-coding,/
CWITA001131,TCMBANKGE001131,CASP9,APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56,caspase 9,1p36.21,protein-coding,Clinical Trial target
CWITA001132,TCMBANKGE001132,BAX,BCL2L4,"BCL2 associated X, apoptosis regulator",19q13.33,protein-coding,/
CWITA001133,TCMBANKGE001133,PTK2,FADK; FAK; FAK1; FRNK; PPP1R71; p125FAK; pp125FAK,protein tyrosine kinase 2,8q24.3,protein-coding,Clinical Trial target
CWITA001134,TCMBANKGE001134,IRS1,HIRS-1,insulin receptor substrate 1,2q36.3,protein-coding,Research target
CWITA001135,TCMBANKGE001135,SREBF1,SREBP1; bHLHd1,sterol regulatory element binding transcription factor 1,17p11.2,protein-coding,Research target
CWITA001136,TCMBANKGE001136,MECP2,AUTSX3; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT,methyl-CpG binding protein 2,Xq28,protein-coding,Research target
CWITA001137,TCMBANKGE001137,PPP2CA,NEDLBA; PP2Ac; PP2CA; PP2Calpha; RP-C,protein phosphatase 2 catalytic subunit alpha,5q31.1,protein-coding,Clinical Trial target
CWITA001138,TCMBANKGE001138,LIPE,AOMS4; FPLD6; HSL; LHS,"lipase E, hormone sensitive type",19q13.2,protein-coding,Successful target
CWITA001139,TCMBANKGE001139,SLC6A12,BGT-1; BGT1; GAT2,solute carrier family 6 member 12,12p13.33,protein-coding,Research target
CWITA001140,TCMBANKGE001140,FGF21,-,fibroblast growth factor 21,19q13.33,protein-coding,Clinical Trial target
CWITA001141,TCMBANKGE001141,PPARA,NR1C1; PPAR; PPARalpha; hPPAR,peroxisome proliferator activated receptor alpha,22q13.31,protein-coding,Successful target
CWITA001142,TCMBANKGE001142,CHDH,-,choline dehydrogenase,3p21.1,protein-coding,/
CWITA001143,TCMBANKGE001143,GLO1,GLOD1; GLYI; HEL-S-74,glyoxalase I,6p21.2,protein-coding,Clinical Trial target
CWITA001144,TCMBANKGE001144,CD14,-,CD14 molecule,5q31.3,protein-coding,Clinical Trial target
CWITA001145,TCMBANKGE001145,CDH2,CD325; CDHN; CDw325; NCAD,cadherin 2,18q12.1,protein-coding,Clinical Trial target
CWITA001146,TCMBANKGE001146,SNAI1,SLUGH2; SNA; SNAH; SNAIL; SNAIL1; dJ710H13.1,snail family transcriptional repressor 1,20q13.13,protein-coding,/
CWITA001147,TCMBANKGE001147,CDH1,Arc-1; BCDS1; CD324; CDHE; ECAD; LCAM; UVO,cadherin 1,16q22.1,protein-coding,Research target
CWITA001148,TCMBANKGE001148,VEGFA,MVCD1; VEGF; VPF,vascular endothelial growth factor A,6p21.1,protein-coding,Research target
CWITA001149,TCMBANKGE001149,PPARGC1A,LEM6; PGC-1(alpha); PGC-1alpha; PGC-1v; PGC1; PGC1A; PPARGC1,PPARG coactivator 1 alpha,4p15.2,protein-coding,/
CWITA001150,TCMBANKGE001150,EIF2S1,EIF-2; EIF-2A; EIF-2alpha; EIF2; EIF2A,eukaryotic translation initiation factor 2 subunit alpha,14q23.3,protein-coding,/
CWITA001151,TCMBANKGE001151,GPX4,GPx-4; GSHPx-4; MCSP; PHGPx; SMDS; snGPx; snPHGPx,glutathione peroxidase 4,19p13.3,protein-coding,/
CWITA001152,TCMBANKGE001152,WNT2,INT1L1; IRP,Wnt family member 2,7q31.2,protein-coding,/
CWITA001153,TCMBANKGE001153,EPHB2,BDPLT22; CAPB; DRT; EK5; EPHT3; ERK; Hek5; PCBC; Tyro5,EPH receptor B2,1p36.12,protein-coding,Clinical Trial target
CWITA001154,TCMBANKGE001154,CREB1,CREB; CREB-1,cAMP responsive element binding protein 1,2q33.3,protein-coding,Research target
CWITA001155,TCMBANKGE001155,CASP7,CASP-7; CMH-1; ICE-LAP3; LICE2; MCH3,caspase 7,10q25.3,protein-coding,Clinical Trial target
CWITA001156,TCMBANKGE001156,CASP3,CPP32; CPP32B; SCA-1,caspase 3,4q35.1,protein-coding,Clinical Trial target
CWITA001157,TCMBANKGE001157,SPOCK1,SPOCK; TESTICAN; TIC1,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1",5q31.2,protein-coding,Research target
CWITA001158,TCMBANKGE001158,LEP,LEPD; OB; OBS,leptin,7q32.1,protein-coding,Research target
CWITA001159,TCMBANKGE001159,STAT1,CANDF7; IMD31A; IMD31B; IMD31C; ISGF-3; STAT91,signal transducer and activator of transcription 1,2q32.2,protein-coding,Patented target
CWITA001160,TCMBANKGE001160,CD274,B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1; hPD-L1,CD274 molecule,9p24.1,protein-coding,Successful target
CWITA001161,TCMBANKGE001161,IL2,IL-2; TCGF; lymphokine,interleukin 2,4q27,protein-coding,Successful target
CWITA001162,TCMBANKGE001162,IFNG,IFG; IFI,interferon gamma,12q15,protein-coding,Successful target
CWITA001163,TCMBANKGE001163,CSNK2A2,CK2A2; CK2alpha'; CSNK2A1,casein kinase 2 alpha 2,16q21,protein-coding,Research target
CWITA001164,TCMBANKGE001164,RAF1,CMD1NN; CRAF; NS5; Raf-1; c-Raf,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2,protein-coding,Clinical Trial target
CWITA001165,TCMBANKGE001165,XIAP,API3; BIRC4; IAP-3; ILP1; MIHA; XLP2; hIAP-3; hIAP3,X-linked inhibitor of apoptosis,Xq25,protein-coding,Clinical Trial target
CWITA001166,TCMBANKGE001166,BCL2,Bcl-2; PPP1R50,BCL2 apoptosis regulator,18q21.33,protein-coding,Clinical Trial target
CWITA001167,TCMBANKGE001167,CDC37,P50CDC37,"cell division cycle 37, HSP90 cochaperone",19p13.2,protein-coding,Research target
CWITA001168,TCMBANKGE001168,RIPK1,AIEFL; IMD57; RIP; RIP-1; RIP1,receptor interacting serine/threonine kinase 1,6p25.2,protein-coding,Clinical Trial target
CWITA001169,TCMBANKGE001169,BCL2L1,BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52,BCL2 like 1,20q11.21,protein-coding,Clinical Trial target
CWITA001170,TCMBANKGE001170,CDK4,CMM3; PSK-J3,cyclin dependent kinase 4,12q14.1,protein-coding,Successful target
CWITA001171,TCMBANKGE001171,SRC,ASV; SRC1; THC6; c-SRC; p60-Src,"SRC proto-oncogene, non-receptor tyrosine kinase",20q11.23,protein-coding,Successful target
CWITA001172,TCMBANKGE001172,HSP90AA1,EL52; HEL-S-65p; HSP86; HSP89A; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp103; Hsp89; Hsp90; LAP-2; LAP2,heat shock protein 90 alpha family class A member 1,14q32.31,protein-coding,Successful target
CWITA001173,TCMBANKGE001173,MCL1,BCL2L3; EAT; MCL1-ES; MCL1L; MCL1S; Mcl-1; TM; bcl2-L-3; mcl1/EAT,"MCL1 apoptosis regulator, BCL2 family member",1q21.2,protein-coding,Successful target
CWITA001174,TCMBANKGE001174,COLQ,CMS5; EAD,collagen like tail subunit of asymmetric acetylcholinesterase,3p25.1,protein-coding,/
CWITA001175,TCMBANKGE001175,RBFOX2,FOX2; Fox-2; HNRBP2; HRNBP2; RBM9; RTA; dJ106I20.3; fxh,RNA binding fox-1 homolog 2,22q12.3,protein-coding,/
CWITA001176,TCMBANKGE001176,CAT,-,catalase,11p13,protein-coding,Clinical Trial target
CWITA001177,TCMBANKGE001177,TP53,BCC7; BMFS5; LFS1; P53; TRP53,tumor protein p53,17p13.1,protein-coding,Clinical Trial target
CWITA001178,TCMBANKGE001178,STAT3,ADMIO; ADMIO1; APRF; HIES,signal transducer and activator of transcription 3,17q21.2,protein-coding,Clinical Trial target
CWITA001179,TCMBANKGE001179,SMAD2,JV18; JV18-1; MADH2; MADR2; hMAD-2; hSMAD2,SMAD family member 2,18q21.1,protein-coding,/
CWITA001180,TCMBANKGE001180,SMAD3,HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3,SMAD family member 3,15q22.33,protein-coding,Successful target
CWITA001181,TCMBANKGE001181,TGFB1,CED; DPD1; IBDIMDE; LAP; TGF-beta1; TGFB; TGFbeta,transforming growth factor beta 1,19q13.2,protein-coding,Successful target
CWITA001182,TCMBANKGE001182,SIRT1,SIR2; SIR2L1; SIR2alpha,sirtuin 1,10q21.3,protein-coding,Clinical Trial target
CWITA001183,TCMBANKGE001183,TRPV4,BCYM3; CMT2C; HMSN2C; OTRPC4; SMAL; SPSMA; SSQTL1; TRP12; VRL2; VROAC,transient receptor potential cation channel subfamily V member 4,12q24.11,protein-coding,Clinical Trial target
CWITA001184,TCMBANKGE001184,RELA,CMCU; NFKB3; p65,"RELA proto-oncogene, NF-kB subunit",11q13.1,protein-coding,/
CWITA001185,TCMBANKGE001185,PPARG,CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma,peroxisome proliferator activated receptor gamma,3p25.2,protein-coding,Successful target
CWITA001186,TCMBANKGE001186,IRAK1,IRAK; pelle,interleukin 1 receptor associated kinase 1,Xq28,protein-coding,Patented target
CWITA001187,TCMBANKGE001187,IRAK4,IPD1; IRAK-4; NY-REN-64; REN64,interleukin 1 receptor associated kinase 4,12q12,protein-coding,Clinical Trial target
CWITA001188,TCMBANKGE001188,CXCL10,C7; IFI10; INP10; IP-10; SCYB10; crg-2; gIP-10; mob-1,C-X-C motif chemokine ligand 10,4q21.1,protein-coding,Clinical Trial target
CWITA001189,TCMBANKGE001189,IL1A,IL-1 alpha; IL-1A; IL1; IL1-ALPHA; IL1F1,interleukin 1 alpha,2q14.1,protein-coding,Clinical Trial target
CWITA001190,TCMBANKGE001190,TACR1,NK1R; NKIR; SPR; TAC1R,tachykinin receptor 1,2p12,protein-coding,Successful target
CWITA001191,TCMBANKGE001191,GRIA1,GLUH1; GLUR1; GLURA; GluA1; HBGR1,glutamate ionotropic receptor AMPA type subunit 1,5q33.2,protein-coding,Successful target
CWITA001192,TCMBANKGE001192,HCRT,NRCLP1; OX; PPOX,hypocretin neuropeptide precursor,17q21.2,protein-coding,Research target
CWITA001193,TCMBANKGE001193,GDNF,ATF; ATF1; ATF2; HFB1-GDNF; HSCR3,glial cell derived neurotrophic factor,5p13.2,protein-coding,Clinical Trial target
CWITA001194,TCMBANKGE001194,ADRA2A,ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32,adrenoceptor alpha 2A,10q25.2,protein-coding,Successful target
CWITA001195,TCMBANKGE001195,RXFP3,GPCR135; RLN3R1; RXFPR3; SALPR,relaxin family peptide receptor 3,5p13.2,protein-coding,Research target
CWITA001196,TCMBANKGE001196,RLN3,H3; RXN3; ZINS4; insl7,relaxin 3,19p13.12,protein-coding,/
CWITA001197,TCMBANKGE001197,FOS,AP-1; C-FOS; p55,"Fos proto-oncogene, AP-1 transcription factor subunit",14q24.3,protein-coding,Research target
CWITA001198,TCMBANKGE001198,BECN1,ATG6; VPS30; beclin1,beclin 1,17q21.31,protein-coding,Research target
CWITA001199,TCMBANKGE001199,PDGFRA,CD140A; PDGFR-2; PDGFR2,platelet derived growth factor receptor alpha,4q12,protein-coding,Successful target
CWITA001200,TCMBANKGE001200,STMN1,C1orf215; LAP18; Lag; OP18; PP17; PP19; PR22; SMN,stathmin 1,1p36.11,protein-coding,Research target
CWITA001201,TCMBANKGE001201,MAPK3,ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK,mitogen-activated protein kinase 3,16p11.2,protein-coding,Clinical Trial target
CWITA001202,TCMBANKGE001202,MAPK14,CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA,mitogen-activated protein kinase 14,6p21.31,protein-coding,Clinical Trial target
CWITA001203,TCMBANKGE001203,MAPK1,ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK,mitogen-activated protein kinase 1,22q11.22,protein-coding,Clinical Trial target
CWITA001204,TCMBANKGE001204,ATP2A3,SERCA3,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3,17p13.2,protein-coding,/
CWITA001205,TCMBANKGE001205,DDIT3,AltDDIT3; C/EBPzeta; CEBPZ; CHOP; CHOP-10; CHOP10; GADD153,DNA damage inducible transcript 3,12q13.3,protein-coding,/
CWITA001206,TCMBANKGE001206,RPS13,S13,ribosomal protein S13,11p15.1,protein-coding,/
CWITA001207,TCMBANKGE001207,SNX25,MSTP043; SBBI31,sorting nexin 25,4q35.1,protein-coding,/
CWITA001208,TCMBANKGE001208,TLL2,KIAA0932; MGC133312; MGC133313,tolloid-like 2,10q23-q24,protein-coding,
CWITA001209,TCMBANKGE001209,SIRT3,SIR2L3,sirtuin 3,11p15.5,protein-coding,
CWITA001210,TCMBANKGE001210,NPY6R,NPY1RL; NPY6RP; PP2; Y2B,neuropeptide Y receptor Y6 (pseudogene),5q31.2,pseudo,/
CWITA001211,TCMBANKGE001211,SLFN13,SLFN10; hSLFN13,schlafen family member 13,17q12,protein-coding,/
CWITA001212,TCMBANKGE001212,DCPS,HINTN5; HSL1,"decapping enzyme, scavenger",11q24.2,protein-coding,
CWITA001213,TCMBANKGE001213,S100A12,CAAF1; CAGC; CGRP; ENRAGE; MRP-6; MRP6; p6,S100 calcium binding protein A12,1q21.3,protein-coding,Clinical Trial target
CWITA001214,TCMBANKGE001214,CES5A,CAUXIN; CES4C1; CES5; CES7; HEL126,carboxylesterase 5A,16q12.2,protein-coding,/
CWITA001215,TCMBANKGE001215,POLR3G,C31; RPC32; RPC7,RNA polymerase III subunit G,5q14.3,protein-coding,/
CWITA001216,TCMBANKGE001216,PMP2,CMT1G; FABP8; M-FABP; MP2; P2,peripheral myelin protein 2,8q21.13,protein-coding,/
CWITA001217,TCMBANKGE001217,CALCOCO2,NDP52,calcium binding and coiled-coil domain 2,17q21.32,protein-coding,/
CWITA001218,TCMBANKGE001218,RBM42,-,RNA binding motif protein 42,19q13.12,protein-coding,/
CWITA001219,TCMBANKGE001219,DOK3,DOKL,docking protein 3,5q35.3,protein-coding,/
CWITA001220,TCMBANKGE001220,TAS2R46,T2R46; T2R54,taste 2 receptor member 46,12p13.2,protein-coding,/
CWITA001221,TCMBANKGE001221,CDH10,-,cadherin 10,5p14.2-p14.1,protein-coding,/
CWITA001222,TCMBANKGE001222,RAB11FIP2,Rab11-FIP2; nRip11,RAB11 family interacting protein 2,10q26.11,protein-coding,/
CWITA001223,TCMBANKGE001223,SLC17A5,AST; ISSD; NSD; SD; SIALIN; SIASD; SLD,solute carrier family 17 member 5,6q13,protein-coding,Research target
CWITA001224,TCMBANKGE001224,C4orf33,-,chromosome 4 open reading frame 33,4q28.2,protein-coding,/
CWITA001225,TCMBANKGE001225,CYP3A43,MGC119315; MGC119316,"cytochrome P450, family 3, subfamily A, polypeptide 43",7q21.1,protein-coding,
CWITA001226,TCMBANKGE001226,MED13L,MRFACD; PROSIT240; THRAP2; TRAP240L,mediator complex subunit 13L,12q24.21,protein-coding,/
CWITA001227,TCMBANKGE001227,FER,PPP1R74; TYK3; p94-Fer,FER tyrosine kinase,5q21.3,protein-coding,Research target
CWITA001228,TCMBANKGE001228,RGS13,-,regulator of G protein signaling 13,1q31.2,protein-coding,/
CWITA001229,TCMBANKGE001229,RIOX1,C14orf169; JMJD9; MAPJD; NO66; ROX; URLC2; hsNO66,ribosomal oxygenase 1,14q24.3,protein-coding,/
CWITA001230,TCMBANKGE001230,HOMER1,HOMER; HOMER1A; HOMER1B; HOMER1C; SYN47; Ves-1,homer scaffold protein 1,5q14.1,protein-coding,/
CWITA001231,TCMBANKGE001231,CRHBP,CRF-BP; CRFBP,corticotropin releasing hormone binding protein,5q13.3,protein-coding,Research target
CWITA001232,TCMBANKGE001232,NUDT9,NUDT10,nudix hydrolase 9,4q22.1,protein-coding,/
CWITA001233,TCMBANKGE001233,RNF145,-,ring finger protein 145,5q33.3,protein-coding,/
CWITA001234,TCMBANKGE001234,TIMM9,TIM9; TIM9A,translocase of inner mitochondrial membrane 9,14q23.1,protein-coding,/
CWITA001235,TCMBANKGE001235,NCL,C23; Nsr1,nucleolin,2q37.1,protein-coding,Research target
CWITA001236,TCMBANKGE001236,ACTRT2,ARPM2; ARPT2; Arp-T2; HARPM2,actin related protein T2,1p36.32,protein-coding,/
CWITA001237,TCMBANKGE001237,SQOR,CGI-44; PRO1975; SQR; SQRDL,sulfide quinone oxidoreductase,15q21.1,protein-coding,/
CWITA001238,TCMBANKGE001238,SLC27A2,ACSVL1; FACVL1; FATP2; HsT17226; VLACS; VLCS; hFACVL1,solute carrier family 27 member 2,15q21.2,protein-coding,/
CWITA001239,TCMBANKGE001239,SPRR1B,CORNIFIN; GADD33; SPR-IB; SPRR1,small proline rich protein 1B,1q21.3,protein-coding,/
CWITA001240,TCMBANKGE001240,DAW1,ODA16; WDR69,dynein assembly factor with WD repeats 1,2q36.3,protein-coding,/
CWITA001241,TCMBANKGE001241,ADH7,ADH4,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",4q23-q24,protein-coding,
CWITA001242,TCMBANKGE001242,CREB3L4,AIBZIP; ATCE1; CREB3; CREB4; JAL; hJAL,cAMP responsive element binding protein 3 like 4,1q21.3,protein-coding,/
CWITA001243,TCMBANKGE001243,TTC29,NYD-SP14; SPGF42; TBPP2A,tetratricopeptide repeat domain 29,4q31.22,protein-coding,/
CWITA001244,TCMBANKGE001244,HERC3,-,HECT and RLD domain containing E3 ubiquitin protein ligase 3,4q22.1,protein-coding,/
CWITA001245,TCMBANKGE001245,BCO2,B-DIOX-II; BCDO2,beta-carotene oxygenase 2,11q23.1,protein-coding,/
CWITA001246,TCMBANKGE001246,ACACA,ACAC; ACC; ACC1; ACCA,acetyl-CoA carboxylase alpha,17q21,protein-coding,
CWITA001247,TCMBANKGE001247,GRM1,GPRC1A; GRM1A; MGLUR1; MGLUR1A; mGlu1,"glutamate receptor, metabotropic 1",6q24,protein-coding,
CWITA001248,TCMBANKGE001248,RABGGTB,GGTB,"Rab geranylgeranyltransferase, beta subunit",1p31,protein-coding,
CWITA001249,TCMBANKGE001249,CLN8,C8orf61; EPMR; TLCD6,CLN8 transmembrane ER and ERGIC protein,8p23.3,protein-coding,/
CWITA001250,TCMBANKGE001250,CCNT1,CCNT; CYCT1; HIVE1,cyclin T1,12q13.11-q13.12,protein-coding,/
CWITA001251,TCMBANKGE001251,TRIM40,RNF35,tripartite motif containing 40,6p22.1,protein-coding,/
CWITA001252,TCMBANKGE001252,DMBT1,GP340; SAG; SALSA; muclin,deleted in malignant brain tumors 1,10q26.13,protein-coding,/
CWITA001253,TCMBANKGE001253,GALM,IBD1,galactose mutarotase (aldose 1-epimerase),2p22.1,protein-coding,
CWITA001254,TCMBANKGE001254,PATL1,Pat1b; hPat1b,"PAT1 homolog 1, processing body mRNA decay factor",11q12.1,protein-coding,/
CWITA001255,TCMBANKGE001255,ALG9,CDG1L; DIBD1; GIKANIS; LOH11CR1J,"ALG9 alpha-1,2-mannosyltransferase",11q23.1,protein-coding,/
CWITA001256,TCMBANKGE001256,FABP9,PERF; PERF15; T-FABP; TLBP,fatty acid binding protein 9,8q21.13,protein-coding,/
CWITA001257,TCMBANKGE001257,RET,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1,ret proto-oncogene,10q11.21,protein-coding,Successful target
CWITA001258,TCMBANKGE001258,GLRX,GRX; GRX1; MGC117407,glutaredoxin (thioltransferase),5q14,protein-coding,
CWITA001259,TCMBANKGE001259,INMT-MINDY4,INMT-FAM188B,INMT-MINDY4 readthrough (NMD candidate),7p14.3,ncRNA,/
CWITA001260,TCMBANKGE001260,ATF7IP,AM; ATF-IP; MCAF; MCAF1; p621,activating transcription factor 7 interacting protein,12p13.1,protein-coding,/
CWITA001261,TCMBANKGE001261,LHFPL2,-,LHFPL tetraspan subfamily member 2,5q14.1,protein-coding,/
CWITA001262,TCMBANKGE001262,CPN2,ACBP,carboxypeptidase N subunit 2,3q29,protein-coding,/
CWITA001263,TCMBANKGE001263,ZNF236,ZNF236A; ZNF236B,zinc finger protein 236,18q23,protein-coding,/
CWITA001264,TCMBANKGE001264,NAA38,LSMD1; MAK31; PFAAP2,"N-alpha-acetyltransferase 38, NatC auxiliary subunit",17p13.1,protein-coding,/
CWITA001265,TCMBANKGE001265,MLNR,GPR38; MTLR1,motilin receptor,13q14-q21,protein-coding,
CWITA001266,TCMBANKGE001266,POLR3K,C11; C11-RNP3; My010; RPC10; RPC11; RPC12.5,RNA polymerase III subunit K,16p13.3,protein-coding,/
CWITA001267,TCMBANKGE001267,PRKD2,HSPC187; PKD2; nPKC-D2,protein kinase D2,19q13.32,protein-coding,/
CWITA001268,TCMBANKGE001268,ELOVL3,CIG-30; CIG30; MGC21435,Elovl Fatty Acid Elongase 3,10q24.32,protein-coding,
CWITA001269,TCMBANKGE001269,MCRS1,ICP22BP; INO80Q; MCRS2; MSP58; P78,microspherule protein 1,12q13.12,protein-coding,/
CWITA001270,TCMBANKGE001270,NR2C1,TR2,nuclear receptor subfamily 2 group C member 1,12q22,protein-coding,/
CWITA001271,TCMBANKGE001271,BRAF,BNRAF1; BRAF1; FLJ95109; MGC126806; MGC138284; NS7; RAFB1,v-raf murine sarcoma viral oncogene homolog B1,7q34,protein-coding,
CWITA001272,TCMBANKGE001272,MPG,AAG; ADPG; APNG; CRA36.1; MDG; Mid1; PIG11; PIG16; anpg,N-methylpurine DNA glycosylase,16p13.3,protein-coding,/
CWITA001273,TCMBANKGE001273,PROCR,CCCA; CCD41; EPCR,protein C receptor,20q11.22,protein-coding,/
CWITA001274,TCMBANKGE001274,EFCAB11,C14orf143,EF-hand calcium binding domain 11,14q32.11,protein-coding,/
CWITA001275,TCMBANKGE001275,MLF1,-,myeloid leukemia factor 1,3q25.32,protein-coding,/
CWITA001276,TCMBANKGE001276,NPIPA5,NPIP,nuclear pore complex interacting protein family member A5,16p13.11,protein-coding,/
CWITA001277,TCMBANKGE001277,IFT172,BBS20; NPHP17; RP71; SLB; SRTD10; osm-1; wim,intraflagellar transport 172,2p23.3,protein-coding,/
CWITA001278,TCMBANKGE001278,CERS3,ARCI9; LASS3,ceramide synthase 3,15q26.3,protein-coding,/
CWITA001279,TCMBANKGE001279,LCK,LSK; YT16; p56lck; pp58lck,lymphocyte-specific protein tyrosine kinase,1p34.3,protein-coding,
CWITA001280,TCMBANKGE001280,MB,MGC13548; PVALB,myoglobin,22q13.1,protein-coding,
CWITA001281,TCMBANKGE001281,CCR12P,GPR183P1,"C-C motif chemokine receptor 12, pseudogene",13q32.3,pseudo,/
CWITA001282,TCMBANKGE001282,ACSL6,ACS2; FACL6; LACS 6; LACS2; LACS5,acyl-CoA synthetase long chain family member 6,5q31.1,protein-coding,/
CWITA001283,TCMBANKGE001283,TSSK3,SPOGA3; STK22C; STK22D; TSK3,testis specific serine kinase 3,1p35.1,protein-coding,/
CWITA001284,TCMBANKGE001284,KDELR2,ELP-1; ERD2.2,KDEL endoplasmic reticulum protein retention receptor 2,7p22.1,protein-coding,/
CWITA001285,TCMBANKGE001285,GTF2F1,BTF4; RAP74; TF2F1; TFIIF,general transcription factor IIF subunit 1,19p13.3,protein-coding,/
CWITA001286,TCMBANKGE001286,ZNF594,-,zinc finger protein 594,17p13.2,protein-coding,/
CWITA001287,TCMBANKGE001287,CLEC3B,TN; TNA,C-type lectin domain family 3 member B,3p21.31,protein-coding,/
CWITA001288,TCMBANKGE001288,TIGD2,HEL106,tigger transposable element derived 2,4q22.1,protein-coding,/
CWITA001289,TCMBANKGE001289,DPM2,CDG1U,"dolichyl-phosphate mannosyltransferase subunit 2, regulatory",9q34.11,protein-coding,/
CWITA001290,TCMBANKGE001290,SLC49A4,DIRC2; RCC4,solute carrier family 49 member 4,3q21.1,protein-coding,/
CWITA001291,TCMBANKGE001291,CBR3,SDR21C2; hCBR3,carbonyl reductase 3,21q22.2,protein-coding,
CWITA001292,TCMBANKGE001292,FABP1,FABPL; LNFABP,"fatty acid binding protein 1, liver",2p11,protein-coding,
CWITA001293,TCMBANKGE001293,SLC6A19,B0AT1; HND,solute carrier family 6 member 19,5p15.33,protein-coding,/
CWITA001294,TCMBANKGE001294,SPAG11B,EDDM2B; EP2; EP2C; EP2D; HE2; HE2C; SPAG11; SPAG11A,sperm associated antigen 11B,8p23.1,protein-coding,/
CWITA001295,TCMBANKGE001295,ASPHD1,-,aspartate beta-hydroxylase domain containing 1,16p11.2,protein-coding,/
CWITA001296,TCMBANKGE001296,ALOX12,12-LOX; 12S-LOX; LOG12,"arachidonate 12-lipoxygenase, 12S type",17p13.1,protein-coding,Research target
CWITA001297,TCMBANKGE001297,CNIH1,CNIH; CNIH-1; CNIL; TGAM77,cornichon family AMPA receptor auxiliary protein 1,14q22.2,protein-coding,/
CWITA001298,TCMBANKGE001298,PUS1,MLASA1,pseudouridine synthase 1,12q24.33,protein-coding,/
CWITA001299,TCMBANKGE001299,SNX8,Mvp1,sorting nexin 8,7p22.3,protein-coding,/
CWITA001300,TCMBANKGE001300,INO80B,HMGA1L4; HMGIYL4; IES2; PAP-1BP; PAPA-1; PAPA1; ZNHIT4; hIes2,INO80 complex subunit B,2p13.1,protein-coding,/
CWITA001301,TCMBANKGE001301,DOCK7,EIEE23; ZIR2,dedicator of cytokinesis 7,1p31.3,protein-coding,/
CWITA001302,TCMBANKGE001302,YTHDC1,YT521; YT521-B,YTH domain containing 1,4q13.2,protein-coding,/
CWITA001303,TCMBANKGE001303,SESN1,PA26; SEST1,sestrin 1,6q21,protein-coding,/
CWITA001304,TCMBANKGE001304,ACO2,ACONM; MGC20605; MGC33908,"aconitase 2, mitochondrial",22q11.2-q13.31|22q13.2,protein-coding,
CWITA001305,TCMBANKGE001305,ITGA2B,CD41; CD41B; GP2B; GPIIb; GTA; HPA3,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",17q21.32,protein-coding,
CWITA001306,TCMBANKGE001306,MSMO1,DESP4; ERG25; MCCPD; SC4MOL,methylsterol monooxygenase 1,4q32.3,protein-coding,/
CWITA001307,TCMBANKGE001307,DIPK2A,C3orf58; DIA1; GoPro49; HASF,divergent protein kinase domain 2A,3q24,protein-coding,/
CWITA001308,TCMBANKGE001308,TDRD12,ECAT8,tudor domain containing 12,19q13.11,protein-coding,/
CWITA001309,TCMBANKGE001309,PELP1,MNAR; P160,"proline, glutamate and leucine rich protein 1",17p13.2,protein-coding,/
CWITA001310,TCMBANKGE001310,PPP2R5C,B56G; MGC23064; PR61G,"protein phosphatase 2, regulatory subunit B', gamma",14q32.31,protein-coding,
CWITA001311,TCMBANKGE001311,CAV2,CAV,caveolin 2,7q31.2,protein-coding,/
CWITA001312,TCMBANKGE001312,SUGP2,SFRS14; SRFS14,SURP and G-patch domain containing 2,19p13.11,protein-coding,/
CWITA001313,TCMBANKGE001313,SMURF1,-,SMAD specific E3 ubiquitin protein ligase 1,7q22.1,protein-coding,/
CWITA001314,TCMBANKGE001314,ARF5,-,ADP ribosylation factor 5,7q32.1,protein-coding,/
CWITA001315,TCMBANKGE001315,SLC22A10,OAT5; hOAT5,solute carrier family 22 member 10,11q12.3,protein-coding,/
CWITA001316,TCMBANKGE001316,RTL10,BOP; C22orf29,retrotransposon Gag like 10,22q11.21,protein-coding,/
CWITA001317,TCMBANKGE001317,FPR1,FMLP; FPR,formyl peptide receptor 1,19q13.41,protein-coding,Clinical Trial target
CWITA001318,TCMBANKGE001318,AQP6,AQP2L; KID,aquaporin 6,12q13.12,protein-coding,/
CWITA001319,TCMBANKGE001319,CELF1,BRUNOL2; CUG-BP; CUGBP; CUGBP1; EDEN-BP; NAB50; NAPOR; hNab50,CUGBP Elav-like family member 1,11p11.2,protein-coding,/
CWITA001320,TCMBANKGE001320,ZNF467,EZI; Zfp467,zinc finger protein 467,7q36.1,protein-coding,/
CWITA001321,TCMBANKGE001321,ZBED2,-,zinc finger BED-type containing 2,3q13.13,protein-coding,/
CWITA001322,TCMBANKGE001322,CDKAL1,-,CDK5 regulatory subunit associated protein 1 like 1,6p22.3,protein-coding,/
CWITA001323,TCMBANKGE001323,HPGD,15NPGDH; PGDH; PGDH1; SDR36C1,hydroxyprostaglandin dehydrogenase 15-(NAD),4q34-q35,protein-coding,
CWITA001324,TCMBANKGE001324,H1-5,H1; H1.5; H1B; H1F5; H1s-3; HIST1H1B,"H1.5 linker histone, cluster member",6p22.1,protein-coding,/
CWITA001325,TCMBANKGE001325,FKBP1B,FKBP12.6; FKBP1L; OTK4; PKBP1L; PPIase,FKBP prolyl isomerase 1B,2p23.3,protein-coding,/
CWITA001326,TCMBANKGE001326,SRD5A2,-,steroid 5 alpha-reductase 2,2p23.1,protein-coding,Successful target
CWITA001327,TCMBANKGE001327,PGLYRP2,HMFT0141; PGLYRPL; PGRP-L; PGRPL; TAGL-like; tagL; tagL-alpha; tagl-beta,peptidoglycan recognition protein 2,19p13.12,protein-coding,/
CWITA001328,TCMBANKGE001328,GATD3A,C21orf33; ES1; GATD3; GT335; HES1; KNPH; KNPI,glutamine amidotransferase like class 1 domain containing 3A,21q22.3,protein-coding,/
CWITA001329,TCMBANKGE001329,SYDE1,7h3; SYD1,synapse defective Rho GTPase homolog 1,19p13.12,protein-coding,/
CWITA001330,TCMBANKGE001330,NUDT7,-,nudix hydrolase 7,16q23.1,protein-coding,/
CWITA001331,TCMBANKGE001331,UBE2W,UBC-16; UBC16,ubiquitin conjugating enzyme E2 W,8q21.11,protein-coding,/
CWITA001332,TCMBANKGE001332,XRCC2,FANCU,X-ray repair cross complementing 2,7q36.1,protein-coding,/
CWITA001333,TCMBANKGE001333,ATP6AP1,16A; ATP6IP1; ATP6S1; Ac45; CF2; VATPS1; XAP-3; XAP3,ATPase H+ transporting accessory protein 1,Xq28,protein-coding,/
CWITA001334,TCMBANKGE001334,SGPP1,SPP-1; SPPase1,sphingosine-1-phosphate phosphatase 1,14q23.2,protein-coding,Research target
CWITA001335,TCMBANKGE001335,LRRC10B,-,leucine rich repeat containing 10B,11q12.2,protein-coding,/
CWITA001336,TCMBANKGE001336,POTEC,A26B2; CT104.6; POTE-18; POTE18,POTE ankyrin domain family member C,18p11.21,protein-coding,/
CWITA001337,TCMBANKGE001337,PRKCA,AAG6; MGC129900; MGC129901; PKCNalpha; PKCA; PRKACA,"protein kinase C, alpha",17q22-q23.2,protein-coding,
CWITA001338,TCMBANKGE001338,PARS2,EIEE75; MT-PRORS; proRS,"prolyl-tRNA synthetase 2, mitochondrial",1p32.3,protein-coding,/
CWITA001339,TCMBANKGE001339,ALDH5A1,SSADH; SSDH,aldehyde dehydrogenase 5 family member A1,6p22.3,protein-coding,Successful target
CWITA001340,TCMBANKGE001340,ATG16L2,ATG16B; WDR80,autophagy related 16 like 2,11q13.4,protein-coding,/
CWITA001341,TCMBANKGE001341,RGS2,G0S8,regulator of G protein signaling 2,1q31.2,protein-coding,Research target
CWITA001342,TCMBANKGE001342,TUBB2B,CDCBM7; PMGYSA; bA506K6.1,tubulin beta 2B class IIb,6p25.2,protein-coding,/
CWITA001343,TCMBANKGE001343,UBASH3B,STS-1; STS1; TULA-2; TULA2; p70,ubiquitin associated and SH3 domain containing B,11q24.1,protein-coding,/
CWITA001344,TCMBANKGE001344,VIPR1,HVR1; II; PACAP-R-2; PACAP-R2; RDC1; V1RG; VAPC1; VIP-R-1; VIPR; VIRG; VPAC1; VPAC1R; VPCAP1R,vasoactive intestinal peptide receptor 1,3p22.1,protein-coding,Clinical Trial target
CWITA001345,TCMBANKGE001345,ZNF614,-,zinc finger protein 614,19q13.41,protein-coding,/
CWITA001346,TCMBANKGE001346,FCHO2,-,FCH and mu domain containing endocytic adaptor 2,5q13.2,protein-coding,/
CWITA001347,TCMBANKGE001347,LYPLAL1,Q96AV0,lysophospholipase like 1,1q41,protein-coding,/
CWITA001348,TCMBANKGE001348,PPM1F,CAMKP; CaMKPase; FEM-2; POPX2; hFEM-2,"protein phosphatase, Mg2+/Mn2+ dependent 1F",22q11.22,protein-coding,/
CWITA001349,TCMBANKGE001349,NMT2,-,N-myristoyltransferase 2,10p13,protein-coding,/
CWITA001350,TCMBANKGE001350,CPXM1,CPX1; CPXM,"carboxypeptidase X, M14 family member 1",20p13,protein-coding,/
CWITA001351,TCMBANKGE001351,CCT7,CCTETA; CCTH; NIP7-1; TCP1ETA,chaperonin containing TCP1 subunit 7,2p13.2,protein-coding,/
CWITA001352,TCMBANKGE001352,DIMT1,DIM1; DIMT1L; HSA9761; HUSSY5,DIMT1 rRNA methyltransferase and ribosome maturation factor,5q12.1,protein-coding,/
CWITA001353,TCMBANKGE001353,IRX3,IRX-1; IRXB1,iroquois homeobox 3,16q12.2,protein-coding,/
CWITA001354,TCMBANKGE001354,CXCL13,ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13,C-X-C motif chemokine ligand 13,4q21.1,protein-coding,Research target
CWITA001355,TCMBANKGE001355,GPR137,C11orf4; GPR137A; TM7SF1L1,G protein-coupled receptor 137,11q13.1,protein-coding,Research target
CWITA001356,TCMBANKGE001356,INHA,N,"inhibin, alpha",2q33-q36,protein-coding,
CWITA001357,TCMBANKGE001357,TMEM258,C11orf10; Kud; Kuduk,transmembrane protein 258,11q12.2,protein-coding,/
CWITA001358,TCMBANKGE001358,DDX42,DDX42P; RHELP; RNAHP; SF3B8; SF3b125,DEAD-box helicase 42,17q23.3,protein-coding,/
CWITA001359,TCMBANKGE001359,Skull2,E1; QTL-S1.2,skull morphology 2,1 67.71 cM,unknown,/
CWITA001360,TCMBANKGE001360,GDA,CYPIN; GAH; GUANASE; NEDASIN,guanine deaminase,9q21.13,protein-coding,Research target
CWITA001361,TCMBANKGE001361,CHCHD6,CHCM1; MICOS25; Mic25; PPP1R23,coiled-coil-helix-coiled-coil-helix domain containing 6,3q21.3,protein-coding,/
CWITA001362,TCMBANKGE001362,ZNF460,HZF8; ZNF272,zinc finger protein 460,19q13.43,protein-coding,/
CWITA001363,TCMBANKGE001363,DENND4A,IRLB; MYCPBP,DENN domain containing 4A,15q22.31,protein-coding,/
CWITA001364,TCMBANKGE001364,KATNBL1,C15orf29,katanin regulatory subunit B1 like 1,15q14,protein-coding,/
CWITA001365,TCMBANKGE001365,CALCA,CALC1; CGRP; CGRPNI; CGRP1; CT; KC; MGC126648,calcitonin-related polypeptide alpha,11p15.2,protein-coding,
CWITA001366,TCMBANKGE001366,CXCL9,CMK; Humig; MIG; SCYB9; crg-10,C-X-C_Motif_Chemokine_Ligand_9,4q21.1,protein-coding,
CWITA001367,TCMBANKGE001367,CISD1,C10orf70; MDS029; ZCD1; mitoNEET,CDGSH iron sulfur domain 1,10q21.1,protein-coding,/
CWITA001368,TCMBANKGE001368,RNF144B,IBRDC2; PIR2; bA528A10.3; p53RFP,ring finger protein 144B,6p22.3,protein-coding,/
CWITA001369,TCMBANKGE001369,C2orf42,-,chromosome 2 open reading frame 42,2p13.3,protein-coding,/
CWITA001370,TCMBANKGE001370,RAPGEF4,CAMP-GEFII; CGEF2; EPAC; EPAC 2; EPAC2; Nbla00496,Rap guanine nucleotide exchange factor 4,2q31.1,protein-coding,Research target
CWITA001371,TCMBANKGE001371,KAT6B,GTPTS; MORF; MOZ2; MYST4; ZC2HC6B; qkf; querkopf,lysine acetyltransferase 6B,10q22.2,protein-coding,Research target
CWITA001372,TCMBANKGE001372,WWC2,BOMB,WW and C2 domain containing 2,4q35.1,protein-coding,/
CWITA001373,TCMBANKGE001373,ZSWIM6,AFND; NEDMAGA,zinc finger SWIM-type containing 6,5q12.1,protein-coding,/
CWITA001374,TCMBANKGE001374,MBD4,MED1,"methyl-CpG binding domain 4, DNA glycosylase",3q21.3,protein-coding,/
CWITA001375,TCMBANKGE001375,HELLS,ICF4; LSH; Nbla10143; PASG; SMARCA6,"helicase, lymphoid specific",10q23.33,protein-coding,/
CWITA001376,TCMBANKGE001376,TIGD1,EEYORE,tigger transposable element derived 1,2q37.1,protein-coding,/
CWITA001377,TCMBANKGE001377,TFDP1,DILC; DP1; DRTF1; Dp-1,transcription factor Dp-1,13q34,protein-coding,/
CWITA001378,TCMBANKGE001378,UBE2N,HEL-S-71; UBC13; UBCHBEN; UBC13; UbcH-ben; UbcH13,ubiquitin conjugating enzyme E2 N,12q22,protein-coding,/
CWITA001379,TCMBANKGE001379,AIFM2,AMID; FSP1; PRG3,apoptosis inducing factor mitochondria associated 2,10q22.1,protein-coding,/
CWITA001380,TCMBANKGE001380,SLC43A1,LAT3; PB39; POV1; R00504,solute carrier family 43 member 1,11q12.1,protein-coding,/
CWITA001381,TCMBANKGE001381,PAX4,KPD; MODY9,paired box 4,7q32.1,protein-coding,/
CWITA001382,TCMBANKGE001382,LRCH1,CHDC1; NP81,leucine rich repeats and calponin homology domain containing 1,13q14.13-q14.2,protein-coding,/
CWITA001383,TCMBANKGE001383,ZNF829,-,zinc finger protein 829,19q13.12,protein-coding,/
CWITA001384,TCMBANKGE001384,KRTAP3-1,KAP3.1; KRTAP3.1,keratin associated protein 3-1,17q21.2,protein-coding,/
CWITA001385,TCMBANKGE001385,GSTM4,GSTM4-4; GTM4,glutathione S-transferase mu 4,1p13.3,protein-coding,/
CWITA001386,TCMBANKGE001386,CASTOR3,GATS; STAG3OS,CASTOR family member 3,7q22.1,pseudo,/
CWITA001387,TCMBANKGE001387,TRAPPC2,MIP2A; SEDL; SEDT; TRAPPC2P1; TRS20; ZNF547L; hYP38334,trafficking protein particle complex 2,Xp22.2,protein-coding,/
CWITA001388,TCMBANKGE001388,LCMT1,LCMT; PPMT1,leucine carboxyl methyltransferase 1,16p12.1,protein-coding,
CWITA001389,TCMBANKGE001389,IGSF9B,LINC00947; MIR4697HG,immunoglobulin superfamily member 9B,11q25,protein-coding,/
CWITA001390,TCMBANKGE001390,LPCAT4,AGPAT7; AYTL3; LPAAT-eta; LPEAT2,lysophosphatidylcholine acyltransferase 4,15q14,protein-coding,/
CWITA001391,TCMBANKGE001391,FSD2,SPRYD1,fibronectin type III and SPRY domain containing 2,15q25.2,protein-coding,/
CWITA001392,TCMBANKGE001392,SNX17,-,sorting nexin 17,2p23.3,protein-coding,/
CWITA001393,TCMBANKGE001393,NRCAM,-,neuronal cell adhesion molecule,7q31.1,protein-coding,/
CWITA001394,TCMBANKGE001394,FNIP2,FNIPL; MAPO1,folliculin interacting protein 2,4q32.1,protein-coding,/
CWITA001395,TCMBANKGE001395,NQO1,DHQU; DIA4; DTD; NMOR1; NMORI; QR1,"NAD(P)H dehydrogenase, quinone 1",16q22.1,protein-coding,
CWITA001396,TCMBANKGE001396,DNMT1,AIM; CXXC9; DNMT; FLJ16293; MCMT; MGC104992,DNA (cytosine-5-)-methyltransferase 1,19p13.2,protein-coding,
CWITA001397,TCMBANKGE001397,CASQ1,CASQ; PDIB1; VMCQA,calsequestrin 1,1q23.2,protein-coding,/
CWITA001398,TCMBANKGE001398,CASP10,ALPS2; FLICE2; MCH4,caspase 10,2q33.1,protein-coding,Patented target
CWITA001399,TCMBANKGE001399,DMXL1,-,Dmx like 1,5q23.1,protein-coding,/
CWITA001400,TCMBANKGE001400,KCNQ3,BFNC2; DKFZp686C0248; EBN2; FLJ37386; FLJ38392; KV7.3,"potassium voltage-gated channel, KQT-like subfamily, member 3",8q24,protein-coding,
CWITA001401,TCMBANKGE001401,PCSK7,LPC; PC7; PC8; SPC7,proprotein convertase subtilisin/kexin type 7,11q23.3,protein-coding,Research target
CWITA001402,TCMBANKGE001402,TAF1B,MGC:9349; RAF1B; RAFI63; SL1; TAFI63,"TATA-box binding protein associated factor, RNA polymerase I subunit B",2p25.1,protein-coding,/
CWITA001403,TCMBANKGE001403,COP1,CFAP78; FAP78; RFWD2; RNF200,COP1 E3 ubiquitin ligase,1q25.1-q25.2,protein-coding,/
CWITA001404,TCMBANKGE001404,BTN3A1,BT3.1; BTF5; BTN3.1; CD277,butyrophilin subfamily 3 member A1,6p22.2,protein-coding,/
CWITA001405,TCMBANKGE001405,SPRTN,C1orf124; DVC1; PRO4323; spartan,SprT-like N-terminal domain,1q42.2,protein-coding,/
CWITA001406,TCMBANKGE001406,PBXIP1,HPIP,PBX homeobox interacting protein 1,1q21.3,protein-coding,/
CWITA001407,TCMBANKGE001407,ZC3H6,ZC3HDC6,zinc finger CCCH-type containing 6,2q14.1,protein-coding,/
CWITA001408,TCMBANKGE001408,SMCO4,C11orf75; FN5,single-pass membrane protein with coiled-coil domains 4,11q21,protein-coding,/
CWITA001409,TCMBANKGE001409,ZNF341,HIES3,zinc finger protein 341,20q11.22,protein-coding,/
CWITA001410,TCMBANKGE001410,MYL3,CMH8; MLC-lV/sb; MLC1SB; MLC1V; VLC1; VLCl,myosin light chain 3,3p21.31,protein-coding,/
CWITA001411,TCMBANKGE001411,LARS2,HLASA; LEURS; PRLTS4; mtLeuRS,"leucyl-tRNA synthetase 2, mitochondrial",3p21.31,protein-coding,/
CWITA001412,TCMBANKGE001412,INMT,TEMT,indolethylamine N-methyltransferase,7p14.3,protein-coding,/
CWITA001413,TCMBANKGE001413,TUBB4A,DYT4; TUBB4; beta-5,tubulin beta 4A class IVa,19p13.3,protein-coding,/
CWITA001414,TCMBANKGE001414,DMBX1,MBX; OTX3; PAXB,diencephalon/mesencephalon homeobox 1,1p33,protein-coding,/
CWITA001415,TCMBANKGE001415,PLA2G2E,GIIE_sPLA2; sPLA2N/AIIE,Phospholipase_A2_Group_Iie,1p36.13,protein-coding,
CWITA001416,TCMBANKGE001416,ZNF384,CAGH1; CAGH1A; CIZ; ERDA2; NMP4; NP; TNRC1,zinc finger protein 384,12p13.31,protein-coding,/
CWITA001417,TCMBANKGE001417,HTR1E,5-HT1E,5-hydroxytryptamine receptor 1E,6q14.3,protein-coding,Successful target
CWITA001418,TCMBANKGE001418,SLC6A2,NAT1; NET; NET1; SLC6A5,"solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2",16q12.2,protein-coding,
CWITA001419,TCMBANKGE001419,PHTF2,-,putative homeodomain transcription factor 2,7q11.23-q21.11,protein-coding,/
CWITA001420,TCMBANKGE001420,SLC22A16,CT2; FLIPT2; HEL-S-18; OAT6; OCT6; OKB1; dJ261K5.1,solute carrier family 22 member 16,6q21|6q21-q22.1,protein-coding,Research target
CWITA001421,TCMBANKGE001421,TXNDC9,APACD; PHLP3,thioredoxin domain containing 9,2q11.2,protein-coding,/
CWITA001422,TCMBANKGE001422,IPO11,RanBP11,importin 11,5q12.1,protein-coding,/
CWITA001423,TCMBANKGE001423,UCHL3,UCH-L3,ubiquitin C-terminal hydrolase L3,13q22.2,protein-coding,Research target
CWITA001424,TCMBANKGE001424,ZNF662,-,zinc finger protein 662,3p22.1,protein-coding,/
CWITA001425,TCMBANKGE001425,SCARB1,CD36L1; CLAN1; CLA1; HDLQTL6; MGC138242; SRNBI; SRB1,"scavenger receptor class B, member 1",12q24.31,protein-coding,
CWITA001426,TCMBANKGE001426,ZNF525,-,zinc finger protein 525,19q13.42,protein-coding,/
CWITA001427,TCMBANKGE001427,CHMP1B,C10orf2; C18-ORF2; C18orf2; CHMP1.5; Vps46-2; Vps46B; hVps46-2,charged multivesicular body protein 1B,18p11.21,protein-coding,/
CWITA001428,TCMBANKGE001428,TGM5,MGC141907; TGASE5; TGASEX; TGM6; TGMX; TGX,transglutaminase 5,15q15.2,protein-coding,
CWITA001429,TCMBANKGE001429,HMG20B,BRAF25; BRAF35; HMGX2; HMGXB2; PP7706; SMARCE1r; SOXL; pp8857,high mobility group 20B,19p13.3,protein-coding,/
CWITA001430,TCMBANKGE001430,SENP2,AXAM2; SMT3IP2,SUMO specific peptidase 2,3q27.2,protein-coding,/
CWITA001431,TCMBANKGE001431,RASEF,RAB45,RAS and EF-hand domain containing,9q21.32,protein-coding,/
CWITA001432,TCMBANKGE001432,ALPG,ALPPL; ALPPL2; GCAP,"alkaline phosphatase, germ cell",2q37.1,protein-coding,/
CWITA001433,TCMBANKGE001433,CYP26B1,CYP26A2; DKFZp686G0638; MGC129613; P450RAIN2,"cytochrome P450, family 26, subfamily B, polypeptide 1",2p13.2,protein-coding,
CWITA001434,TCMBANKGE001434,HUS1,hHUS1,HUS1 checkpoint clamp component,7p12.3,protein-coding,/
CWITA001435,TCMBANKGE001435,ELOVL1,CGI-88; IKSHD; Ssc1,ELOVL fatty acid elongase 1,1p34.2,protein-coding,/
CWITA001436,TCMBANKGE001436,Mcpt1,AV080368; Mcp-1,mast cell protease 1,14 C3|14 28.19 cM,protein-coding,/
CWITA001437,TCMBANKGE001437,NME1,AWD; GAAD; NB; NBS; NDKA; NDPK-A; NDPKA; NM23; NM23-H1,NME/NM23 nucleoside diphosphate kinase 1,17q21.33,protein-coding,Research target
CWITA001438,TCMBANKGE001438,HNF4G,NR2A2; NR2A3,hepatocyte nuclear factor 4 gamma,8q21.13,protein-coding,/
CWITA001439,TCMBANKGE001439,METAP1,MAP1A; MetAP1A,methionyl aminopeptidase 1,4q23,protein-coding,Research target
CWITA001440,TCMBANKGE001440,PEG3,PW1; ZKSCAN22; ZNF904; ZSCAN24,paternally expressed 3,19q13.43,protein-coding,/
CWITA001441,TCMBANKGE001441,FBLN2,-,fibulin 2,3p25.1,protein-coding,/
CWITA001442,TCMBANKGE001442,LRRK1,RIPK6; Roco1,leucine rich repeat kinase 1,15q26.3,protein-coding,/
CWITA001443,TCMBANKGE001443,RPL15,DBA12; EC45; L15; RPL10; RPLY10; RPYL10,ribosomal protein L15,3p24.2,protein-coding,Research target
CWITA001444,TCMBANKGE001444,ENOX2,APK1; COVA1; tNOX,ecto-NOX disulfide-thiol exchanger 2,Xq26.1,protein-coding,Research target
CWITA001445,TCMBANKGE001445,DVL1P1,DSH; DVL; DVL-22; DVL1; DVL1L1; DVL4,dishevelled segment polarity protein 1 pseudogene 1,22q11.21|22q11,pseudo,/
CWITA001446,TCMBANKGE001446,KRT85,ECTD4; HB5; Hb-5; K85; KRTHB5; hHb5,keratin 85,12q13.13,protein-coding,/
CWITA001447,TCMBANKGE001447,PPP1R10,CAT53; FB19; PNUTS; PP1R10; R111; p99,protein phosphatase 1 regulatory subunit 10,6p21.33,protein-coding,/
CWITA001448,TCMBANKGE001448,S100P,MIG9,S100 calcium binding protein P,4p16.1,protein-coding,/
CWITA001449,TCMBANKGE001449,PCDH12,DMJDS1; VE-cadherin-2; VECAD2,protocadherin 12,5q31.3,protein-coding,/
CWITA001450,TCMBANKGE001450,ECE1,ECE,endothelin converting enzyme 1,1p36.12,protein-coding,Research target
CWITA001451,TCMBANKGE001451,FOXRED2,ERFAD,FAD dependent oxidoreductase domain containing 2,22q12.3,protein-coding,/
CWITA001452,TCMBANKGE001452,ARHGAP1,CDC42GAP; RHOGAP; RHOGAP1; p50rhoGAP,Rho GTPase activating protein 1,11p11.2,protein-coding,/
CWITA001453,TCMBANKGE001453,LRRTM1,-,leucine rich repeat transmembrane neuronal 1,2p12,protein-coding,/
CWITA001454,TCMBANKGE001454,CLEC14A,C14orf27; CEG1,"C-type lectin domain family 14, member A",14q21.1,protein-coding,
CWITA001455,TCMBANKGE001455,CARTPT,CART,CART prepropeptide,5q13.2,protein-coding,/
CWITA001456,TCMBANKGE001456,PRG4,CACP; HAPO; JCAP; MSF; SZP,proteoglycan 4,1q31.1,protein-coding,Research target
CWITA001457,TCMBANKGE001457,SLC31A2,COPT2; CTR2; hCTR2,solute carrier family 31 member 2,9q32,protein-coding,/
CWITA001458,TCMBANKGE001458,HOOK1,HK1,hook microtubule tethering protein 1,1p32.1,protein-coding,/
CWITA001459,TCMBANKGE001459,ABCF3,EST201864,ATP binding cassette subfamily F member 3,3q27.1,protein-coding,/
CWITA001460,TCMBANKGE001460,RECQL5,RECQ5,RecQ like helicase 5,17q25.1,protein-coding,/
CWITA001461,TCMBANKGE001461,ELP6,C3orf75; TMEM103,elongator acetyltransferase complex subunit 6,3p21.31,protein-coding,/
CWITA001462,TCMBANKGE001462,EFTUD1,FAM42A; FLJ13119; HsT19294; RIA1,elongation factor Tu GTP binding domain containing 1,15q25.2,protein-coding,
CWITA001463,TCMBANKGE001463,WASHC2C,FAM21A; FAM21C; VPEF,WASH complex subunit 2C,10q11.22,protein-coding,/
CWITA001464,TCMBANKGE001464,RASGRP1,CALDAG-GEFI; CALDAG-GEFII; IMD64; RASGRP,RAS guanyl releasing protein 1,15q14,protein-coding,/
CWITA001465,TCMBANKGE001465,AIMP1,EMAP2; EMAPII; HLD3; SCYE1; p43,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,4q24,protein-coding,/
CWITA001466,TCMBANKGE001466,TTLL8,-,tubulin tyrosine ligase like 8,22q13.33,protein-coding,/
CWITA001467,TCMBANKGE001467,LTA4H,-,leukotriene A4 hydrolase,12q23.1,protein-coding,Successful target
CWITA001468,TCMBANKGE001468,PHYKPL,AGXT2L2; PHLU,5-phosphohydroxy-L-lysine phospho-lyase,5q35.3,protein-coding,/
CWITA001469,TCMBANKGE001469,GPR78,-,G protein-coupled receptor 78,4p16.1,protein-coding,/
CWITA001470,TCMBANKGE001470,SLC4A7,DKFZp686H168; NBC2; NBC3; SBC2; SLC4A6,"solute carrier family 4, sodium bicarbonate cotransporter, member 7",3p22,protein-coding,
CWITA001471,TCMBANKGE001471,RWDD2A,RWDD2; dJ747H23.2,RWD domain containing 2A,6q14.1,protein-coding,/
CWITA001472,TCMBANKGE001472,GRK2,ADRBK1; BARK1; BETAN/AARK1,G_Protein-Coupled_Receptor_Kinase_2,11q13.2,protein-coding,
CWITA001473,TCMBANKGE001473,ACTRT1,AIP1; ARIP1; ARPT1; HSD27,actin related protein T1,Xq25,protein-coding,/
CWITA001474,TCMBANKGE001474,AMY1A,AMY1,amylase alpha 1A,1p21.1,protein-coding,/
CWITA001475,TCMBANKGE001475,TRNT1,CCA1; CGI-47; MtCCA; RPEM; SIFD,tRNA nucleotidyl transferase 1,3p26.2,protein-coding,/
CWITA001476,TCMBANKGE001476,MTG1,GTP; GTPBP7,mitochondrial ribosome associated GTPase 1,10q26.3,protein-coding,/
CWITA001477,TCMBANKGE001477,RDH8,PRRDH; SDR28C2,retinol dehydrogenase 8,19p13.2,protein-coding,/
CWITA001478,TCMBANKGE001478,RHOBTB2,DBC2; EIEE64; p83,Rho related BTB domain containing 2,8p21.3,protein-coding,/
CWITA001479,TCMBANKGE001479,STARD4,-,StAR related lipid transfer domain containing 4,5q22.1,protein-coding,/
CWITA001480,TCMBANKGE001480,BNIP3L,BNIP3a; NIX,BCL2 interacting protein 3 like,8p21.2,protein-coding,/
CWITA001481,TCMBANKGE001481,PMAIP1,APR; NOXA,Phorbol-12-Myristate-13-Acetate-Induced_Protein_1,18q21.32,protein-coding,
CWITA001482,TCMBANKGE001482,TNKS,ARTD5; PARP-5a; PARP5A; PARPL; TIN1; TINF1; TNKS1; pART5,tankyrase,8p23.1,protein-coding,Patented target
CWITA001483,TCMBANKGE001483,TSPAN8,CO-029; TM4SF3,tetraspanin 8,12q21.1,protein-coding,/
CWITA001484,TCMBANKGE001484,FEM1A,EPRAP,fem-1 homolog A,19p13.3,protein-coding,/
CWITA001485,TCMBANKGE001485,WARS,GAMMAN2; IFI53; IFP53,tryptophanyl-tRNA synthetase,14q32.31,protein-coding,
CWITA001486,TCMBANKGE001486,Idd6.3,Idd6c,insulin dependent diabetes susceptibility 6.3,-,unknown,/
CWITA001487,TCMBANKGE001487,CYP3A7,CP37; P450NHFLA,"cytochrome P450, family 3, subfamily A, polypeptide 7",7q21-q22.1,protein-coding,
CWITA001488,TCMBANKGE001488,PPM1N,-,"protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)",19q13.32,protein-coding,/
CWITA001489,TCMBANKGE001489,CREB1,CREB; MGC9284,cAMP responsive element binding protein 1,2q34,protein-coding,
CWITA001490,TCMBANKGE001490,TMEM53,NET4,transmembrane protein 53,1p34.1,protein-coding,/
CWITA001491,TCMBANKGE001491,2610507B11Rik,AU022687; D11Bhm178e; D11Bhm179e; E1; Kiaa0100; mKIAA0100,RIKEN cDNA 2610507B11 gene,11 B5|11 46.74 cM,protein-coding,/
CWITA001492,TCMBANKGE001492,MYH13,MyHC-IIL; MyHC-eo,myosin heavy chain 13,17p13.1,protein-coding,/
CWITA001493,TCMBANKGE001493,CTSA,GLB2; GSL; NGBE; PPCA; PPGB,cathepsin A,20q13.12,protein-coding,Clinical Trial target
CWITA001494,TCMBANKGE001494,OAS1,IFIN4; OIAS; OIASI,"2',5'-oligoadenylate synthetase 1, 40/46kDa",12q24.1,protein-coding,
CWITA001495,TCMBANKGE001495,ARHGDIA,GDIA1; HEL-S-47e; NPHS8; RHOGDI; RHOGDI-1,Rho GDP dissociation inhibitor alpha,17q25.3,protein-coding,/
CWITA001496,TCMBANKGE001496,GLT8D1,AD-017; MSTP139,glycosyltransferase 8 domain containing 1,3p21.1,protein-coding,/
CWITA001497,TCMBANKGE001497,SIVA1,CD27BP; SIVA; Siva-1; Siva-2,SIVA1 apoptosis inducing factor,14q32.33,protein-coding,/
CWITA001498,TCMBANKGE001498,KCTD19,-,potassium channel tetramerization domain containing 19,16q22.1,protein-coding,/
CWITA001499,TCMBANKGE001499,ZNF582,-,zinc finger protein 582,19q13.43,protein-coding,/
CWITA001500,TCMBANKGE001500,DHRS11,ARPG836; FLJ39232; MGC4172; SDR24C1,dehydrogenase/reductase (SDR family) member 11,17q12,protein-coding,
CWITA001501,TCMBANKGE001501,XRCC5,KARP-1; KARP1; KU80; KUB2; Ku86; NFIV,X-ray repair cross complementing 5,2q35,protein-coding,Research target
CWITA001502,TCMBANKGE001502,HOXC10,HOX3I,homeobox C10,12q13.13,protein-coding,/
CWITA001503,TCMBANKGE001503,SIRPB2,PTPN1L; PTPNS1L3; dJ776F14.2,signal regulatory protein beta 2,20p13,protein-coding,/
CWITA001504,TCMBANKGE001504,TOP3B,TOP3B1,DNA topoisomerase III beta,22q11.22,protein-coding,/
CWITA001505,TCMBANKGE001505,XDH,XO; XOR,xanthine dehydrogenase,2p23.1,protein-coding,
CWITA001506,TCMBANKGE001506,ADRA1B,ADRA1; ALPHA1BAR,adrenoceptor alpha 1B,5q33.3,protein-coding,Successful target
CWITA001507,TCMBANKGE001507,RNFT2,TMEM118,"ring finger protein, transmembrane 2",12q24.22,protein-coding,/
CWITA001508,TCMBANKGE001508,TNFSF4,CD134L; CD252; GP34; OX-40L; OX4OL; TNLG2B; TXGP1,TNF superfamily member 4,1q25.1,protein-coding,Clinical Trial target
CWITA001509,TCMBANKGE001509,AGO3,EIF2C3,argonaute RISC catalytic component 3,1p34.3,protein-coding,/
CWITA001510,TCMBANKGE001510,WDR5B,-,WD repeat domain 5B,3q21.1,protein-coding,/
CWITA001511,TCMBANKGE001511,MPND,-,MPN domain containing,19p13.3,protein-coding,/
CWITA001512,TCMBANKGE001512,ZNF121,D19S204; ZHC32; ZNF20,zinc finger protein 121,19p13.2,protein-coding,/
CWITA001513,TCMBANKGE001513,TSC22D1,Ptg-2; TGFB1I4; TSC22,TSC22 domain family member 1,13q14.11,protein-coding,/
CWITA001514,TCMBANKGE001514,TLR7,TLR7-like,toll like receptor 7,Xp22.2,protein-coding,Successful target
CWITA001515,TCMBANKGE001515,ADM,AM; PAMP,adrenomedullin,11p15.4,protein-coding,Research target
CWITA001516,TCMBANKGE001516,POLR3A,ADDH; C160; HLD7; RPC1; RPC155; WDRTS; hRPC155,RNA polymerase III subunit A,10q22.3,protein-coding,/
CWITA001517,TCMBANKGE001517,CECR2,-,CECR2 histone acetyl-lysine reader,22q11.1-q11.21,protein-coding,/
CWITA001518,TCMBANKGE001518,BASP1,CAP-23; CAP23; NAP-22; NAP22,brain abundant membrane attached signal protein 1,5p15.1,protein-coding,/
CWITA001519,TCMBANKGE001519,AGPAT2,1-AGPAT2; BSCL; BSCL1; LPAAB; LPAAT-beta,1-acylglycerol-3-phosphate O-acyltransferase 2,9q34.3,protein-coding,Research target
CWITA001520,TCMBANKGE001520,PRKCH,PKC-L; PKCL; PRKCL; nPKC-eta,protein kinase C eta,14q23.1,protein-coding,Research target
CWITA001521,TCMBANKGE001521,SPIRE1,Spir-1,spire type actin nucleation factor 1,18p11.21,protein-coding,/
CWITA001522,TCMBANKGE001522,ALAS2,ALAS-E; ALASE; ANH1; ASB; SIDBA1; XLDPP; XLEPP; XLSA,5'-aminolevulinate synthase 2,Xp11.21,protein-coding,/
CWITA001523,TCMBANKGE001523,EIF2S2,EIF2; EIF2B; EIF2beta; PPP1R67; eIF-2-beta,eukaryotic translation initiation factor 2 subunit beta,20q11.22,protein-coding,/
CWITA001524,TCMBANKGE001524,SKI,SGS; SKV,SKI proto-oncogene,1p36.33-p36.32,protein-coding,/
CWITA001525,TCMBANKGE001525,TNRC6B,-,trinucleotide repeat containing adaptor 6B,22q13.1,protein-coding,/
CWITA001526,TCMBANKGE001526,GFRA3,GDNFR3,GDNF family receptor alpha 3,5q31.2,protein-coding,Clinical Trial target
CWITA001527,TCMBANKGE001527,PDS5A,PIG54; SCC-112; SCC112,PDS5 cohesin associated factor A,4p14,protein-coding,/
CWITA001528,TCMBANKGE001528,DHRS7B,CGI-93; SDR32C1,dehydrogenase/reductase 7B,17p11.2,protein-coding,/
CWITA001529,TCMBANKGE001529,ADGRG7,GPR128,adhesion G protein-coupled receptor G7,3q12.2,protein-coding,/
CWITA001530,TCMBANKGE001530,RARRES1,TIG1,retinoic acid receptor responder (tazarotene induced) 1,3q25.32,protein-coding,
CWITA001531,TCMBANKGE001531,FARSA,CML33; FARSL; FARSLA; FRSA; PheHA,phenylalanyl-tRNA synthetase subunit alpha,19p13.13,protein-coding,/
CWITA001532,TCMBANKGE001532,ERCC1,COFS4; RAD10; UV20,"ERCC excision repair 1, endonuclease non-catalytic subunit",19q13.32,protein-coding,/
CWITA001533,TCMBANKGE001533,CA14,CAXiV,carbonic anhydrase XIV,1q21,protein-coding,
CWITA001534,TCMBANKGE001534,RFPL4AL1,RNF210B,ret finger protein like 4A like 1,19q13.42,protein-coding,/
CWITA001535,TCMBANKGE001535,RAD23A,HHR23A; HR23A,"RAD23 homolog A, nucleotide excision repair protein",19p13.13,protein-coding,/
CWITA001536,TCMBANKGE001536,DLD,DLDD; DLDH; E3; GCSL; LAD; OGDC-E3; PHE3,dihydrolipoamide dehydrogenase,7q31.1,protein-coding,/
CWITA001537,TCMBANKGE001537,Bmca,-,bile mucin accumulation,15 58.05 cM,unknown,/
CWITA001538,TCMBANKGE001538,TRAPPC4,CGI-104; HSPC172; NEDESBA; PTD009; SBDN; SYNBINDIN; TRS23,trafficking protein particle complex 4,11q23.3,protein-coding,/
CWITA001539,TCMBANKGE001539,IFNA6,IFN-alphaK,interferon alpha 6,9p21.3,protein-coding,/
CWITA001540,TCMBANKGE001540,FOLR1,FBP; FOLR; FRalpha,folate receptor alpha,11q13.4,protein-coding,Successful target
CWITA001541,TCMBANKGE001541,ASAP3,ACAP4; CENTB6; DDEFL1; UPLC1,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3",1p36.12,protein-coding,Research target
CWITA001542,TCMBANKGE001542,GTF3C1,TFIIIC; TFIIIC220; TFIIICalpha,general transcription factor IIIC subunit 1,16p12.1,protein-coding,/
CWITA001543,TCMBANKGE001543,GIF,IF; IFMH; INF; TCN3,gastric intrinsic factor (vitamin B synthesis),11q13,protein-coding,
CWITA001544,TCMBANKGE001544,GAL3ST1,CST,galactose-3-O-sulfotransferase 1,22q12.2,protein-coding,/
CWITA001545,TCMBANKGE001545,ADRA2C,ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR,"adrenergic, alpha-2C-, receptor",4p16,protein-coding,
CWITA001546,TCMBANKGE001546,TRMT10A,HEL-S-88; MSSGM; MSSGM1; RG9MTD2; TRM10,tRNA methyltransferase 10A,4q23,protein-coding,/
CWITA001547,TCMBANKGE001547,ALDH2,ALDH-E2; ALDHI; ALDM,aldehyde dehydrogenase 2 family member,12q24.12,protein-coding,Clinical Trial target
CWITA001548,TCMBANKGE001548,FOXA1,HNF3A; TCF3A,forkhead box A1,14q21.1,protein-coding,/
CWITA001549,TCMBANKGE001549,CNTN6,NB3,contactin 6,3p26.3,protein-coding,/
CWITA001550,TCMBANKGE001550,NDE1,HOM-TES-87; LIS4; MHAC; NDE; NUDE; NUDE1,Nude_Neurodevelopment_Protein_1,16p13.11,protein-coding,
CWITA001551,TCMBANKGE001551,DSE,DS-epi1; DSEP; DSEPI; EDSMC2; SART-2; SART2,dermatan sulfate epimerase,6q22.1,protein-coding,/
CWITA001552,TCMBANKGE001552,GGPS1,GGPPS; GGPPS1,geranylgeranyl diphosphate synthase 1,1q42.3,protein-coding,/
CWITA001553,TCMBANKGE001553,FGG,-,fibrinogen gamma chain,4q32.1,protein-coding,Research target
CWITA001554,TCMBANKGE001554,KCNK4,FHEIG; K2p4.1; TRAAK; TRAAK1,potassium two pore domain channel subfamily K member 4,11q13.1,protein-coding,/
CWITA001555,TCMBANKGE001555,RARG,NR1B3; RARC,"retinoic acid receptor, gamma",12q13,protein-coding,
CWITA001556,TCMBANKGE001556,F10,FX; FXA,coagulation factor X,13q34,protein-coding,
CWITA001557,TCMBANKGE001557,XPA,XP1; XPAC,"XPA, DNA damage recognition and repair factor",9q22.33,protein-coding,Research target
CWITA001558,TCMBANKGE001558,HERC6,-,HECT and RLD domain containing E3 ubiquitin protein ligase family member 6,4q22.1,protein-coding,/
CWITA001559,TCMBANKGE001559,INO80E,CCDC95,INO80 complex subunit E,16p11.2,protein-coding,/
CWITA001560,TCMBANKGE001560,GABRA5,MGC138184,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",15q11.2-q12,protein-coding,
CWITA001561,TCMBANKGE001561,LINGO4,DAAT9248; LRRN6D; PRO34002,leucine rich repeat and Ig domain containing 4,1q21.3,protein-coding,/
CWITA001562,TCMBANKGE001562,TXNRD1,GRIMN12; MGC9145; TR; TR1; TRXR1; TXNR,thioredoxin reductase 1,12q23-q24.1,protein-coding,
CWITA001563,TCMBANKGE001563,ABCC4,EST170205; MOATNB; MOATB; MRP4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4",13q32,protein-coding,
CWITA001564,TCMBANKGE001564,HSPA8,HEL-33; HEL-S-72p; HSC54; HSC70; HSC71; HSP71; HSP73; HSPA10; LAP-1; LAP1; NIP71,heat shock protein family A (Hsp70) member 8,11q24.1,protein-coding,Research target
CWITA001565,TCMBANKGE001565,SERPINA4,KAL; KLST; KST; PI-4; PI4; kallistatin,serpin family A member 4,14q32.13,protein-coding,/
CWITA001566,TCMBANKGE001566,PXK,MONAKA; SLOB,PX domain containing serine/threonine kinase like,3p14.3,protein-coding,/
CWITA001567,TCMBANKGE001567,PCDHGA3,PCDH-GAMMA-A3,"protocadherin gamma subfamily A, 3",5q31.3,protein-coding,/
CWITA001568,TCMBANKGE001568,ASNA1,ARSANI; ARSA1; GET3; MGC3821; TRC40,"arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)",19q13.3,protein-coding,
CWITA001569,TCMBANKGE001569,CLK3,PHCLK3; PHCLK3/152,CDC like kinase 3,15q24.1,protein-coding,Research target
CWITA001570,TCMBANKGE001570,RHOQ,ARHQ; HEL-S-42; RASL7A; TC10; TC10A,ras homolog family member Q,2p21,protein-coding,/
CWITA001571,TCMBANKGE001571,CASQ2,PDIB2,calsequestrin 2,1p13.1,protein-coding,/
CWITA001572,TCMBANKGE001572,C4orf46,RCDG1,chromosome 4 open reading frame 46,4q32.1,protein-coding,/
CWITA001573,TCMBANKGE001573,MAT2B,MATNII; MATIIbeta; MGC12237; Nbla02999; SDR23E1; TGR,"methionine adenosyltransferase II, beta",5q34-q35,protein-coding,
CWITA001574,TCMBANKGE001574,FUT10,FUCTX,fucosyltransferase 10,8p12,protein-coding,/
CWITA001575,TCMBANKGE001575,C12orf4,-,chromosome 12 open reading frame 4,12p13.32,protein-coding,/
CWITA001576,TCMBANKGE001576,SAMD7,-,sterile alpha motif domain containing 7,3q26.2,protein-coding,/
CWITA001577,TCMBANKGE001577,DAPK2,DRP-1; DRP1,death associated protein kinase 2,15q22.31,protein-coding,/
CWITA001578,TCMBANKGE001578,TCTEX1D2,SRTD17,Tctex1 domain containing 2,3q29,protein-coding,/
CWITA001579,TCMBANKGE001579,ZNF569,ZAP1; ZNF; Zfp74,zinc finger protein 569,19q13.12,protein-coding,/
CWITA001580,TCMBANKGE001580,FAM210B,5A3; C20orf108; dJ1167H4.1,family with sequence similarity 210 member B,20q13.2,protein-coding,/
CWITA001581,TCMBANKGE001581,AKR1C4,3-alpha-HSD; C11; CDR; CHDR; DD-4; DD4; HAKRA,aldo-keto reductase family 1 member C4,10p15.1,protein-coding,/
CWITA001582,TCMBANKGE001582,CAMK2B,CAM2; CAMK2; CAMKB; CaMKIIbeta; MRD54,calcium/calmodulin dependent protein kinase II beta,7p13,protein-coding,/
CWITA001583,TCMBANKGE001583,ERVK-21,Endo-Rev2; PR; Protease; Proteinase; c12_A; envK1,"endogenous retrovirus group K member 21, envelope",12q14.1,other,/
CWITA001584,TCMBANKGE001584,COL4A6,CXDELq22.3; DELXq22.3; DFNX6,collagen type IV alpha 6 chain,Xq22.3,protein-coding,/
CWITA001585,TCMBANKGE001585,ZFHX3,ATBF1; ATBT; C16orf47; ZFH-3; ZNF927,zinc finger homeobox 3,16q22.2-q22.3,protein-coding,/
CWITA001586,TCMBANKGE001586,PGAP2,CWH43-N; FRAG1; HPMRS3; MRT17; MRT21,post-GPI attachment to proteins 2,11p15.4,protein-coding,/
CWITA001587,TCMBANKGE001587,GGT1,CD224; D22S672; D22S732; GGT; GGT_1; GTG; MGC96892; MGC96904; MGC96963,gamma-glutamyltransferase 1,22q11.23,protein-coding,
CWITA001588,TCMBANKGE001588,IFNA17,IFN-alphaI; IFNA; INFA; LEIF2C1,interferon alpha 17,9p21.3,protein-coding,/
CWITA001589,TCMBANKGE001589,MXRA5,-,matrix remodeling associated 5,Xp22.33,protein-coding,/
CWITA001590,TCMBANKGE001590,CRLS1,C20orf155; CLS; CLS1; GCD10; dJ967N21.6,cardiolipin synthase 1,20p12.3,protein-coding,/
CWITA001591,TCMBANKGE001591,TXNL4B,DLP; Dim2,thioredoxin like 4B,16q22.2,protein-coding,/
CWITA001592,TCMBANKGE001592,RPL36AL,RPL36A,ribosomal protein L36a like,14q21.3,protein-coding,/
CWITA001593,TCMBANKGE001593,EIF3C,EIF3CL; EIF3S8; eIF3-p110,eukaryotic translation initiation factor 3 subunit C,16p11.2,protein-coding,/
CWITA001594,TCMBANKGE001594,ZNF853,-,zinc finger protein 853,7p22.1,protein-coding,/
CWITA001595,TCMBANKGE001595,DNA2,DNA2L; hDNA2,DNA replication helicase/nuclease 2,10q21.3,protein-coding,/
CWITA001596,TCMBANKGE001596,OAT,DKFZp781A11155; GACR; HOGA; OATASE; OKT,ornithine aminotransferase,10q26,protein-coding,
CWITA001597,TCMBANKGE001597,TOP2B,TOPIIB; top2beta,DNA topoisomerase II beta,3p24.2,protein-coding,Successful target
CWITA001598,TCMBANKGE001598,TMA16,C4orf43,translation machinery associated 16 homolog,4q32.2,protein-coding,/
CWITA001599,TCMBANKGE001599,SLC3A1,ATR1; CSNU1; D2H; NBAT; RBAT,solute carrier family 3 member 1,2p21,protein-coding,/
CWITA001600,TCMBANKGE001600,SIRT5,FLJ36950; SIR2L5,sirtuin 5,6p23,protein-coding,
CWITA001601,TCMBANKGE001601,ARPC4,ARC20; P20-ARC,actin related protein 2/3 complex subunit 4,3p25.3,protein-coding,/
CWITA001602,TCMBANKGE001602,SCNN1D,ENaCd; ENaCdelta; SCNED; dNaCh,sodium channel epithelial 1 subunit delta,1p36.33,protein-coding,/
CWITA001603,TCMBANKGE001603,NID2,NID-2,nidogen 2,14q22.1,protein-coding,/
CWITA001604,TCMBANKGE001604,HNRNPF,HNRPF; OK/SW-cl.23; mcs94-1,heterogeneous nuclear ribonucleoprotein F,10q11.21,protein-coding,/
CWITA001605,TCMBANKGE001605,MAF,AYGRP; CCA4; CTRCT21; c-MAF,MAF bZIP transcription factor,16q23.2,protein-coding,/
CWITA001606,TCMBANKGE001606,EPHA2,ARCC2; CTPA; CTPP1; CTRCT6; ECK,EPH receptor A2,1p36.13,protein-coding,Clinical Trial target
CWITA001607,TCMBANKGE001607,FAM222A,C12orf34,family with sequence similarity 222 member A,12q24.11,protein-coding,/
CWITA001608,TCMBANKGE001608,TSSK2,DGS-G; SPOGA2; STK22B; TSK2,testis specific serine kinase 2,22q11.21,protein-coding,Research target
CWITA001609,TCMBANKGE001609,DNAJB14,EGNR9427; PRO34683,DnaJ heat shock protein family (Hsp40) member B14,4q23,protein-coding,/
CWITA001610,TCMBANKGE001610,MAP3K9,MEKK9; MLK1; PRKE1,mitogen-activated protein kinase kinase kinase 9,14q24.2,protein-coding,Clinical Trial target
CWITA001611,TCMBANKGE001611,LMOD1,1D; 64kD; D1; SM-LMOD; SMLMOD,leiomodin 1,1q32.1,protein-coding,/
CWITA001612,TCMBANKGE001612,AOC2,DAO2; RAO; SSAO,amine oxidase copper containing 2,17q21.31,protein-coding,/
CWITA001613,TCMBANKGE001613,ITPR2,IP3R2,"inositol 1,4,5-trisphosphate receptor, type 2",12p11,protein-coding,
CWITA001614,TCMBANKGE001614,CCNG2,-,cyclin G2,4q21.1,protein-coding,/
CWITA001615,TCMBANKGE001615,RRP7A,BK126B4.3; CGI-96; Rrp7,ribosomal RNA processing 7 homolog A,22q13.2,protein-coding,/
CWITA001616,TCMBANKGE001616,GPX5,EGLP; GPx-5; GSHPx-5; HEL-S-75p,glutathione peroxidase 5,6p22.1,protein-coding,/
CWITA001617,TCMBANKGE001617,OVOL1,HOVO1,ovo like transcriptional repressor 1,11q13.1,protein-coding,/
CWITA001618,TCMBANKGE001618,ARL15,ARFRP2,ADP ribosylation factor like GTPase 15,5q11.2,protein-coding,/
CWITA001619,TCMBANKGE001619,ACAD9,MC1DN20; NPD002,acyl-CoA dehydrogenase family member 9,3q21.3,protein-coding,/
CWITA001620,TCMBANKGE001620,TMPRSS6,IRIDA; MT2,transmembrane serine protease 6,22q12.3,protein-coding,Research target
CWITA001621,TCMBANKGE001621,ETV5,ERM,ETS variant transcription factor 5,3q27.2,protein-coding,/
CWITA001622,TCMBANKGE001622,SEMA4C,M-SEMA-F; SEMACL1; SEMAF; SEMAI,semaphorin 4C,2q11.2,protein-coding,/
CWITA001623,TCMBANKGE001623,NSUN4,SHTAP,NOP2/Sun RNA methyltransferase 4,1p33,protein-coding,/
CWITA001624,TCMBANKGE001624,SLC35C1,CDG2C; FUCT1,solute carrier family 35 member C1,11p11.2,protein-coding,/
CWITA001625,TCMBANKGE001625,COX7A1,COX7A; COX7AH; COX7AM,cytochrome c oxidase subunit 7A1,19q13.12,protein-coding,/
CWITA001626,TCMBANKGE001626,TIPIN,-,TIMELESS interacting protein,15q22.31,protein-coding,/
CWITA001627,TCMBANKGE001627,ZNF821,-,zinc finger protein 821,16q22.2,protein-coding,/
CWITA001628,TCMBANKGE001628,TCP11L1,dJ85M6.3,t-complex 11 like 1,11p13,protein-coding,/
CWITA001629,TCMBANKGE001629,SMC3,BAM; BMH; CDLS3; CSPG6; HCAP; SMC3L1,structural maintenance of chromosomes 3,10q25.2,protein-coding,/
CWITA001630,TCMBANKGE001630,HPX,HX,hemopexin,11p15.4,protein-coding,/
CWITA001631,TCMBANKGE001631,VANGL1,KITENIN; LPP2; STB2; STBM2,VANGL planar cell polarity protein 1,1p13.1,protein-coding,Research target
CWITA001632,TCMBANKGE001632,PDE1B,PDE1B1; PDES1B,"phosphodiesterase 1B, calmodulin-dependent",12q13,protein-coding,
CWITA001633,TCMBANKGE001633,PRSS48,ESSPL,serine protease 48,4q31.3,protein-coding,/
CWITA001634,TCMBANKGE001634,NR3C1,GCCR; GCR; GR; GRL,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",5q31.3,protein-coding,
CWITA001635,TCMBANKGE001635,ACOT2,CTE-IA; CTE1A; MTE1; PTE2; PTE2A; ZAP128,acyl-CoA thioesterase 2,14q24.3,protein-coding,/
CWITA001636,TCMBANKGE001636,OLIG2,BHLHB1; OLIGO2; PRKCBP2; RACK17; bHLHe19,oligodendrocyte transcription factor 2,21q22.11,protein-coding,/
CWITA001637,TCMBANKGE001637,EVL,RNB6,Enah/Vasp-like,14q32.2,protein-coding,/
CWITA001638,TCMBANKGE001638,SLC25A18,GC2,"solute carrier family 25 (mitochondrial carrier), member 18",22q11.2,protein-coding,
CWITA001639,TCMBANKGE001639,PPME1,ABDH19; PME-1,protein phosphatase methylesterase 1,11q13.4,protein-coding,Patented target
CWITA001640,TCMBANKGE001640,ENSA,ARPP-19e,endosulfine alpha,1q21.3,protein-coding,Research target
CWITA001641,TCMBANKGE001641,OLFM3,NOE3; NOELIN3; OPTIMEDIN,olfactomedin 3,1p21.1,protein-coding,/
CWITA001642,TCMBANKGE001642,SP9,ZNF990,Sp9 transcription factor,2q31.1,protein-coding,/
CWITA001643,TCMBANKGE001643,DDIT4,Dig2; REDD-1; REDD1,DNA damage inducible transcript 4,10q22.1,protein-coding,Clinical Trial target
CWITA001644,TCMBANKGE001644,MSR1,CD204; SCARA1; SR-A; SR-AI; SR-AII; SR-AIII; SRA; phSR1; phSR2,macrophage scavenger receptor 1,8p22,protein-coding,Research target
CWITA001645,TCMBANKGE001645,GUCA1A,C6orf131; COD3; CORD14; GCAP; GCAP1; GUCA; GUCA1; dJ139D8.6,guanylate cyclase activator 1A (retina),6p21.1,protein-coding,
CWITA001646,TCMBANKGE001646,BLZF1,GOLGIN-45; JEM-1; JEM-1s; JEM1,basic leucine zipper nuclear factor 1,1q24.2,protein-coding,/
CWITA001647,TCMBANKGE001647,PVALB,D22S749,parvalbumin,22q12.3,protein-coding,/
CWITA001648,TCMBANKGE001648,RDH12,FLJ30273; LCA13; LCA3; SDR7C2,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),14q24.1,protein-coding,
CWITA001649,TCMBANKGE001649,OTUB2,C14orf137; OTB2; OTU2,"OTU deubiquitinase, ubiquitin aldehyde binding 2",14q32.12,protein-coding,/
CWITA001650,TCMBANKGE001650,ZNF786,-,zinc finger protein 786,7q36.1,protein-coding,/
CWITA001651,TCMBANKGE001651,LGALS12,GAL12; GRIP1,galectin 12,11q12.3,protein-coding,/
CWITA001652,TCMBANKGE001652,ABCA5,ABC13; EST90625; HTC3,ATP binding cassette subfamily A member 5,17q24.3,protein-coding,/
CWITA001653,TCMBANKGE001653,BSPH1,BSP1; ELSPBP2,binder of sperm protein homolog 1,19q13.33,protein-coding,/
CWITA001654,TCMBANKGE001654,SGCA,50DAG; ADL; DAG2; DMDA2; LGMD2D; LGMDR3; SCARMD1; adhalin,sarcoglycan alpha,17q21.33,protein-coding,Clinical Trial target
CWITA001655,TCMBANKGE001655,AACS,ACSF1; SUR-5,acetoacetyl-CoA synthetase,12q24.31,protein-coding,/
CWITA001656,TCMBANKGE001656,SAT2,SSAT2,spermidine/spermine N1-acetyltransferase family member 2,17p13.1,protein-coding,/
CWITA001657,TCMBANKGE001657,PDF,-,"peptide deformylase, mitochondrial",16q22.1,protein-coding,Successful target
CWITA001658,TCMBANKGE001658,CARS1,CARS; CYSRS; MGC:11246,cysteinyl-tRNA synthetase 1,11p15.4,protein-coding,/
CWITA001659,TCMBANKGE001659,DRD4,D4DR,dopamine receptor D4,11p15.5,protein-coding,
CWITA001660,TCMBANKGE001660,RPLP0,L10E; LP0; P0; PRLP0; RPP0,ribosomal protein lateral stalk subunit P0,12q24.23,protein-coding,/
CWITA001661,TCMBANKGE001661,WIZ,ZNF803,WIZ zinc finger,19p13.12,protein-coding,/
CWITA001662,TCMBANKGE001662,ZSCAN5A,ZNF495; ZSCAN5,zinc finger and SCAN domain containing 5A,19q13.43,protein-coding,/
CWITA001663,TCMBANKGE001663,LRRC4,NAG14; NGL-2,leucine rich repeat containing 4,7q32.1,protein-coding,/
CWITA001664,TCMBANKGE001664,CEACAM7,CGM2,CEA cell adhesion molecule 7,19q13.2,protein-coding,/
CWITA001665,TCMBANKGE001665,PIEZO1,DHS; FAM38A; LMPH3; LMPHM6; Mib,piezo type mechanosensitive ion channel component 1,16q24.3,protein-coding,/
CWITA001666,TCMBANKGE001666,LIN54,CXCDC1; JC8.6; MIP120; TCX1,lin-54 DREAM MuvB core complex component,4q21.22,protein-coding,/
CWITA001667,TCMBANKGE001667,ACOT13,MGC4961; PNASN27; THEM2,acyl-CoA thioesterase 13,6p22.3,protein-coding,
CWITA001668,TCMBANKGE001668,CLBA1,C14orf79,clathrin binding box of aftiphilin containing 1,14q32.33,protein-coding,/
CWITA001669,TCMBANKGE001669,G6PC2,IGRP,glucose-6-phosphatase catalytic subunit 2,2q31.1,protein-coding,Research target
CWITA001670,TCMBANKGE001670,NGEF,ARHGEF27; EPHEXIN,neuronal guanine nucleotide exchange factor,2q37.1,protein-coding,/
CWITA001671,TCMBANKGE001671,MCMDC2,C8orf45,minichromosome maintenance domain containing 2,8q13.1,protein-coding,/
CWITA001672,TCMBANKGE001672,FGF3,HBGF-3; INT2,fibroblast growth factor 3,11q13.3,protein-coding,/
CWITA001673,TCMBANKGE001673,PIM3,pim-3,"Pim-3 proto-oncogene, serine/threonine kinase",22q13.33,protein-coding,Research target
CWITA001674,TCMBANKGE001674,IL17C,CX2; IL-17C,interleukin 17C,16q24.2,protein-coding,/
CWITA001675,TCMBANKGE001675,ZNF225,-,zinc finger protein 225,19q13.31,protein-coding,/
CWITA001676,TCMBANKGE001676,GMPPB,LGMDR19; MDDGA14; MDDGB14; MDDGC14,GDP-mannose pyrophosphorylase B,3p21.31,protein-coding,/
CWITA001677,TCMBANKGE001677,VWA5B1,-,von Willebrand factor A domain containing 5B1,1p36.12,protein-coding,/
CWITA001678,TCMBANKGE001678,NDUFC2,B14.5b; CINB14.5b; HLCN1; NADHDH2,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa",11q14.1,protein-coding,
CWITA001679,TCMBANKGE001679,GNA15,GNA16,G protein subunit alpha 15,19p13.3,protein-coding,/
CWITA001680,TCMBANKGE001680,OLFM4,GC1; GW112; OLM4; OlfD; UNQ362; bA209J19.1; hGC-1; hOLfD,olfactomedin 4,13q14.3,protein-coding,Research target
CWITA001681,TCMBANKGE001681,ELSPBP1,E12; EDDM12; EL149; HE12,epididymal sperm binding protein 1,19q13.33,protein-coding,/
CWITA001682,TCMBANKGE001682,NSUN6,4933414E04Rik; ARL5B-AS1; NOPD1,NOP2/Sun RNA methyltransferase 6,10p12.31,protein-coding,/
CWITA001683,TCMBANKGE001683,MAPK8,JNK; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1,mitogen-activated protein kinase 8,10q11.22,protein-coding,
CWITA001684,TCMBANKGE001684,HSPG2,HSPG; PLC; PRCAN; SJA; SJS; SJS1,Heparan_Sulfate_Proteoglycan_2,1p36.12,protein-coding,
CWITA001685,TCMBANKGE001685,SMO,FZD11; Gx; SMOH,"smoothened, frizzled family receptor",7q32.3,protein-coding,
CWITA001686,TCMBANKGE001686,CTSL,CATL; CTSL1; MEP,cathepsin L,9q21.33,protein-coding,Clinical Trial target
CWITA001687,TCMBANKGE001687,PDE6B,CSNB3; CSNBAD2; GMP-PDEbeta; PDEB; RP40; rd1,phosphodiesterase 6B,4p16.3,protein-coding,/
CWITA001688,TCMBANKGE001688,MACROD2,C20orf133; C2orf133,mono-ADP ribosylhydrolase 2,20p12.1,protein-coding,/
CWITA001689,TCMBANKGE001689,LRRC4B,HSM; LRIG4; NGL-3,leucine rich repeat containing 4B,19q13.33,protein-coding,/
CWITA001690,TCMBANKGE001690,HADHB,ECHB; MSTP029; MTPB; TP-BETA,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta,2p23.3,protein-coding,/
CWITA001691,TCMBANKGE001691,GYS1,GSY; GYS,glycogen synthase 1,19q13.33,protein-coding,/
CWITA001692,TCMBANKGE001692,RDH12,LCA13; RP53; SDR7C2,retinol dehydrogenase 12,14q24.1,protein-coding,/
CWITA001693,TCMBANKGE001693,DOCK8-AS1,C9orf66,DOCK8 antisense RNA 1,9p24.3,ncRNA,/
CWITA001694,TCMBANKGE001694,C21orf91,C21orf14; C21orf38; CSSG1; EURL; YG81,chromosome 21 open reading frame 91,21q21.1,protein-coding,/
CWITA001695,TCMBANKGE001695,C9orf16,EST00098,chromosome 9 open reading frame 16,9q34.11,protein-coding,/
CWITA001696,TCMBANKGE001696,CLCC1,MCLC,chloride channel CLIC like 1,1p13.3,protein-coding,/
CWITA001697,TCMBANKGE001697,MMP1,CLG; CLGN,matrix metallopeptidase 1,11q22.2,protein-coding,Successful target
CWITA001698,TCMBANKGE001698,MICU3,EFHA2,mitochondrial calcium uptake family member 3,8p22,protein-coding,/
CWITA001699,TCMBANKGE001699,DEFA1,DEF1; DEFA2; HNP-1; HP-1; HP1; MRS,defensin alpha 1,8p23.1,protein-coding,/
CWITA001700,TCMBANKGE001700,TFB2M,Hkp1; mtTFB2,"transcription factor B2, mitochondrial",1q44,protein-coding,/
CWITA001701,TCMBANKGE001701,CFC1B,-,"cripto, FRL-1, cryptic family 1B",2q21.1,protein-coding,/
CWITA001702,TCMBANKGE001702,THUMPD3,-,THUMP domain containing 3,3p25.3,protein-coding,/
CWITA001703,TCMBANKGE001703,STING1,ERIS; MITA; MPYS; NET23; SAVI; STING; STING-beta; TMEM173; hMITA; hSTING,stimulator of interferon response cGAMP interactor 1,5q31.2,protein-coding,/
CWITA001704,TCMBANKGE001704,GSDME,DFNA5; ICERE-1,gasdermin E,7p15.3,protein-coding,/
CWITA001705,TCMBANKGE001705,DYNC1I2,DIC74; DNCI2; IC2; NEDMIBA,dynein cytoplasmic 1 intermediate chain 2,2q31.1,protein-coding,/
CWITA001706,TCMBANKGE001706,TM4SF4,ILTMP; il-TMP,transmembrane 4 L six family member 4,3q25.1,protein-coding,/
CWITA001707,TCMBANKGE001707,ZNF649,-,zinc finger protein 649,19q13.41,protein-coding,/
CWITA001708,TCMBANKGE001708,UCK2,DKFZp686M04245; TSA903; UK; UMPK,uridine-cytidine kinase 2,1q23,protein-coding,
CWITA001709,TCMBANKGE001709,CDS1,CDS 1,CDP-diacylglycerol synthase 1,4q21.23,protein-coding,/
CWITA001710,TCMBANKGE001710,AWAT1,DGA2; DGAT2L3,acyl-CoA wax alcohol acyltransferase 1,Xq13.1,protein-coding,/
CWITA001711,TCMBANKGE001711,ALG5,bA421P11.2,ALG5 dolichyl-phosphate beta-glucosyltransferase,13q13.3,protein-coding,/
CWITA001712,TCMBANKGE001712,NLRP12,CLR19.3; FCAS2; NALP12; PAN6; PYPAF7; RNO; RNO2,NLR family pyrin domain containing 12,19q13.42,protein-coding,/
CWITA001713,TCMBANKGE001713,SMG6,C17orf31; EST1A; SMG-6; hSMG5/7a,SMG6 nonsense mediated mRNA decay factor,17p13.3,protein-coding,/
CWITA001714,TCMBANKGE001714,CRB2,FSGS9; VMCKD,crumbs cell polarity complex component 2,9q33.3,protein-coding,/
CWITA001715,TCMBANKGE001715,OGFR,-,opioid growth factor receptor,20q13.33,protein-coding,Clinical Trial target
CWITA001716,TCMBANKGE001716,CIT,CRIK; KIAA0949; STK21,"citron (rho-interacting, serine/threonine kinase 21)",12q24,protein-coding,
CWITA001717,TCMBANKGE001717,NACC2,BEND9; BTBD14; BTBD14A; BTBD31; NAC-2; RBB,NACC family member 2,9q34.3,protein-coding,/
CWITA001718,TCMBANKGE001718,LYSMD1,SB145,LysM domain containing 1,1q21.3,protein-coding,/
CWITA001719,TCMBANKGE001719,NEURL2,C20orf163; OZZ; OZZ-E3,neuralized E3 ubiquitin protein ligase 2,20q13.12,protein-coding,/
CWITA001720,TCMBANKGE001720,ADGRG4,GPR112; PGR17; RP1-299I16,adhesion G protein-coupled receptor G4,Xq26.3,protein-coding,/
CWITA001721,TCMBANKGE001721,ZBTB2,ZNF437,zinc finger and BTB domain containing 2,6q25.1,protein-coding,/
CWITA001722,TCMBANKGE001722,RGS3,C2PA; RGP3,regulator of G protein signaling 3,9q32,protein-coding,/
CWITA001723,TCMBANKGE001723,TPM4,HEL-S-108,tropomyosin 4,19p13.12-p13.11,protein-coding,/
CWITA001724,TCMBANKGE001724,TIMM13,TIM13; TIM13B; TIMM13A; TIMM13B; ppv1,translocase of inner mitochondrial membrane 13,19p13.3,protein-coding,/
CWITA001725,TCMBANKGE001725,SCMH1,Scml3,sex comb on midleg homolog 1 (Drosophila),1p34,protein-coding,
CWITA001726,TCMBANKGE001726,PHKG1,PHKG,phosphorylase kinase catalytic subunit gamma 1,7p11.2,protein-coding,/
CWITA001727,TCMBANKGE001727,HOXC4,HOX3; HOX3E; cp19,homeobox C4,12q13.13,protein-coding,/
CWITA001728,TCMBANKGE001728,RALB,-,RAS like proto-oncogene B,2q14.2,protein-coding,/
CWITA001729,TCMBANKGE001729,NUDT14,UGPP; UGPPase,nudix hydrolase 14,14q32.33,protein-coding,/
CWITA001730,TCMBANKGE001730,ZNF778,-,zinc finger protein 778,16q24.3,protein-coding,/
CWITA001731,TCMBANKGE001731,SOX30,-,SRY-box transcription factor 30,5q33.3,protein-coding,/
CWITA001732,TCMBANKGE001732,ITGAL,CD11A; LFA-1; LFA1A,integrin subunit alpha L,16p11.2,protein-coding,Successful target
CWITA001733,TCMBANKGE001733,ZNF174,ZSCAN8,zinc finger protein 174,16p13.3,protein-coding,/
CWITA001734,TCMBANKGE001734,DNAJC7,DJ11; DJC7; TPR2; TTC2,DnaJ heat shock protein family (Hsp40) member C7,17q21.2,protein-coding,/
CWITA001735,TCMBANKGE001735,PPM1E,CaMKP-N; POPX1; PP2CH; caMKN,"protein phosphatase, Mg2+/Mn2+ dependent 1E",17q22,protein-coding,/
CWITA001736,TCMBANKGE001736,PHF2,CENP-35; GRC5; JHDM1E; KDM7C,PHD finger protein 2,9q22.31,protein-coding,/
CWITA001737,TCMBANKGE001737,PSPH,PSP,phosphoserine phosphatase,7p11.2,protein-coding,
CWITA001738,TCMBANKGE001738,UBQLNL,-,ubiquilin like,11p15.4,protein-coding,/
CWITA001739,TCMBANKGE001739,THBS2,TSP2,thrombospondin 2,6q27,protein-coding,/
CWITA001740,TCMBANKGE001740,Gpi-ps,Gm1840,"glucose-6-phosphate isomerase, pseudogene",8|8 A1.1,pseudo,/
CWITA001741,TCMBANKGE001741,SHC3,N-Shc; NSHC; RAI; SHCC,SHC adaptor protein 3,9q22.1,protein-coding,/
CWITA001742,TCMBANKGE001742,RBP1,CRABPNI; CRBP; CRBP1; CRBPI; RBPC,"retinol binding protein 1, cellular",3q23,protein-coding,
CWITA001743,TCMBANKGE001743,SP8,BTD,Sp8 transcription factor,7p21.1,protein-coding,/
CWITA001744,TCMBANKGE001744,ORM2,AGPNB; AGPNB'; AGP2,orosomucoid 2,9q32,protein-coding,
CWITA001745,TCMBANKGE001745,COMMD8,-,COMM domain containing 8,4p12,protein-coding,/
CWITA001746,TCMBANKGE001746,LCE1B,LEP2; SPRL2A,late cornified envelope 1B,1q21.3,protein-coding,/
CWITA001747,TCMBANKGE001747,CLTB,LCB,clathrin light chain B,5q35.2,protein-coding,/
CWITA001748,TCMBANKGE001748,GLDC,GCE; GCSP; HYGN1,glycine decarboxylase,9p24.1,protein-coding,/
CWITA001749,TCMBANKGE001749,ZNF517,-,zinc finger protein 517,8q24.3,protein-coding,/
CWITA001750,TCMBANKGE001750,IER5,SBBI48,immediate early response 5,1q25.3,protein-coding,/
CWITA001751,TCMBANKGE001751,CKB,B-CK; BCK; CKBB; CPK-B; HEL-211; HEL-S-29,creatine kinase B,14q32.33,protein-coding,/
CWITA001752,TCMBANKGE001752,CMTM3,BNAS2; CKLFSF3,CKLF like MARVEL transmembrane domain containing 3,16q22.1,protein-coding,/
CWITA001753,TCMBANKGE001753,GPX3,GPx-P; GSHPx-3; GSHPx-P,glutathione peroxidase 3,5q33.1,protein-coding,/
CWITA001754,TCMBANKGE001754,STT3B,CDG1X; SIMP; STT3-B,STT3 oligosaccharyltransferase complex catalytic subunit B,3p23,protein-coding,/
CWITA001755,TCMBANKGE001755,MAOB,-,monoamine oxidase B,Xp11.3,protein-coding,Successful target
CWITA001756,TCMBANKGE001756,CNOT6,CCR4; Ccr4a,CCR4-NOT transcription complex subunit 6,5q35.3,protein-coding,/
CWITA001757,TCMBANKGE001757,PSMA7,C6; HSPC; MGC3755; RC6N1; XAPC7,"proteasome (prosome, macropain) subunit, alpha type, 7",20q13.33,protein-coding,
CWITA001758,TCMBANKGE001758,MUSTN1,MUSTANG,"musculoskeletal, embryonic nuclear protein 1",3p21.1,protein-coding,/
CWITA001759,TCMBANKGE001759,STRBP,HEL162; ILF3L; SPNR; p74,spermatid perinuclear RNA binding protein,9q33.3,protein-coding,/
CWITA001760,TCMBANKGE001760,LACTBL1,-,lactamase beta like 1,1p36.12,protein-coding,/
CWITA001761,TCMBANKGE001761,DIAPH3,AN; AUNA1; DIA2; DRF3; NSDAN; diap3; mDia2,diaphanous related formin 3,13q21.2,protein-coding,/
CWITA001762,TCMBANKGE001762,PLPP5,DPPL1; HTPAP; PPAPDC1B,phospholipid phosphatase 5,8p11.23,protein-coding,/
CWITA001763,TCMBANKGE001763,ADGRF3,GPR113; PGR23,adhesion G protein-coupled receptor F3,2p23.3,protein-coding,/
CWITA001764,TCMBANKGE001764,PRXL2B,C1orf93; FAM213B,peroxiredoxin like 2B,1p36.32,protein-coding,/
CWITA001765,TCMBANKGE001765,GBP2,-,guanylate binding protein 2,1p22.2,protein-coding,/
CWITA001766,TCMBANKGE001766,AAR2,C20orf4; CGI-23,AAR2 splicing factor,20q11.23,protein-coding,/
CWITA001767,TCMBANKGE001767,PTPRQ,DFNA73; DFNB84; DFNB84A; PTPGMC1; R-PTP-Q,protein tyrosine phosphatase receptor type Q,12q21.31,protein-coding,/
CWITA001768,TCMBANKGE001768,ASPH,AAH; BAH; CASQ2BP1; HAAH; JCTN; junctin,aspartate beta-hydroxylase,8q12.1,protein-coding,
CWITA001769,TCMBANKGE001769,CDK12,CRK7; CRKR; CRKRS,cyclin dependent kinase 12,17q12,protein-coding,/
CWITA001770,TCMBANKGE001770,AMPD2,PCH9; SPG63,adenosine monophosphate deaminase 2,1p13.3,protein-coding,/
CWITA001771,TCMBANKGE001771,NT5C,DNT; DNT1; P5N2; PNNI; PNNII; UMPH2; cdN; dNTN1,"5', 3'-nucleotidase, cytosolic",17q25.1,protein-coding,
CWITA001772,TCMBANKGE001772,ABCC6,ABC34; ARA; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; PXE; PXE1; URG7,ATP binding cassette subfamily C member 6,16p13.11,protein-coding,/
CWITA001773,TCMBANKGE001773,DNMT3L,-,DNA methyltransferase 3 like,21q22.3,protein-coding,Patented target
CWITA001774,TCMBANKGE001774,SMYD1,BOP; KMT3D; ZMYND18; ZMYND22,SET and MYND domain containing 1,2p11.2,protein-coding,/
CWITA001775,TCMBANKGE001775,EIF2B2,EIF-2Bbeta; EIF2B,eukaryotic translation initiation factor 2B subunit beta,14q24.3,protein-coding,/
CWITA001776,TCMBANKGE001776,CCN5,CT58; CTGF-L; WISP2,cellular communication network factor 5,20q13.12,protein-coding,/
CWITA001777,TCMBANKGE001777,RPRM,REPRIMO,"reprimo, TP53 dependent G2 arrest mediator homolog",2q23.3,protein-coding,/
CWITA001778,TCMBANKGE001778,MIR377,MIRN377; hsa-mir-377; mir-377,microRNA 377,14q32.31,ncRNA,/
CWITA001779,TCMBANKGE001779,CNNM2,ACDP2; HOMG6; HOMGSMR,cyclin and CBS domain divalent metal cation transport mediator 2,10q24.32,protein-coding,/
CWITA001780,TCMBANKGE001780,CPT1A,CPT1; CPT1-L; L-CPT1,carnitine palmitoyltransferase 1A,11q13.3,protein-coding,/
CWITA001781,TCMBANKGE001781,SIT1,SIT; SIT-R,signaling threshold regulating transmembrane adaptor 1,9p13.3,protein-coding,/
CWITA001782,TCMBANKGE001782,EPS8L2,DFNB106; EPS8R2,EPS8 like 2,11p15.5,protein-coding,/
CWITA001783,TCMBANKGE001783,ZNF638,NP220; ZFML; Zfp638,zinc finger protein 638,2p13.3-p13.2,protein-coding,/
CWITA001784,TCMBANKGE001784,SUCLA2,A-BETA; A-SCS; LINC00444; MTDPS5; SCS-betaA,succinate-CoA ligase ADP-forming subunit beta,13q14.2,protein-coding,/
CWITA001785,TCMBANKGE001785,CYP2W1,-,cytochrome P450 family 2 subfamily W member 1,7p22.3,protein-coding,/
CWITA001786,TCMBANKGE001786,KANK1,ANKRD15; CPSQ2; KANK,KN motif and ankyrin repeat domains 1,9p24.3,protein-coding,/
CWITA001787,TCMBANKGE001787,SNAPC5,SNAP19,small nuclear RNA activating complex polypeptide 5,15q22.31,protein-coding,/
CWITA001788,TCMBANKGE001788,ICK,ECO; EJM10; LCK2; MRK,Intestinal_Cell_Kinase,6p12.1,protein-coding,
CWITA001789,TCMBANKGE001789,MSI2,MSI2H,musashi RNA binding protein 2,17q22,protein-coding,Discontinued target
CWITA001790,TCMBANKGE001790,DAZ3,pDP1679,deleted in azoospermia 3,Yq11.23,protein-coding,/
CWITA001791,TCMBANKGE001791,MCOLN1,MG-2; ML1; ML4; MLIV; MST080; MSTP080; TRP-ML1; TRPM-L1; TRPML1,mucolipin 1,19p13.2,protein-coding,Research target
CWITA001792,TCMBANKGE001792,ARPC3,ARC21; p21-Arc,actin related protein 2/3 complex subunit 3,12q24.11,protein-coding,/
CWITA001793,TCMBANKGE001793,ACADVL,ACAD6; LCACD; VLCAD,acyl-CoA dehydrogenase very long chain,17p13.1,protein-coding,/
CWITA001794,TCMBANKGE001794,RAP2A,K-REV; KREV; RAP2; RbBP-30,"RAP2A, member of RAS oncogene family",13q32.1,protein-coding,/
CWITA001795,TCMBANKGE001795,PTPRG,HPTPG; PTPG; R-PTP-GAMMA; RPTPG,protein tyrosine phosphatase receptor type G,3p14.2,protein-coding,/
CWITA001796,TCMBANKGE001796,NPY2R,N,neuropeptide Y receptor Y2,4q31,protein-coding,
CWITA001797,TCMBANKGE001797,TM4SF20,PRO994; SLI5; TCCE518,transmembrane 4 L six family member 20,2q36.3,protein-coding,/
CWITA001798,TCMBANKGE001798,C6orf226,-,chromosome 6 open reading frame 226,6p21.1,protein-coding,/
CWITA001799,TCMBANKGE001799,RBM34,-,RNA binding motif protein 34,1q42.3,protein-coding,/
CWITA001800,TCMBANKGE001800,MAGEA10,CT1.10; MAGE10,MAGE family member A10,Xq28,protein-coding,/
CWITA001801,TCMBANKGE001801,ALG8,CDG1H; PCLD3,"ALG8 alpha-1,3-glucosyltransferase",11q14.1,protein-coding,/
CWITA001802,TCMBANKGE001802,ZRANB3,4933425L19Rik; AH2,zinc finger RANBP2-type containing 3,2q21.3,protein-coding,/
CWITA001803,TCMBANKGE001803,S100A1,S100; S100Nalpha; S100A,S100 calcium binding protein A1,1q21,protein-coding,
CWITA001804,TCMBANKGE001804,SUSD3,-,sushi domain containing 3,9q22.31,protein-coding,/
CWITA001805,TCMBANKGE001805,MTREX,Dob1; KIAA0052; Mtr4; SKIV2L2; fSAP118,Mtr4 exosome RNA helicase,5q11.2,protein-coding,/
CWITA001806,TCMBANKGE001806,DHX34,DDX34; HRH1,DExH-box helicase 34,19q13.32,protein-coding,/
CWITA001807,TCMBANKGE001807,ELOVL7,-,ELOVL fatty acid elongase 7,5q12.1,protein-coding,/
CWITA001808,TCMBANKGE001808,MPEG1,MPG1; MPS1; Mpg-1; P-2,macrophage expressed 1,11q12.1,protein-coding,/
CWITA001809,TCMBANKGE001809,GPSM2,CMCS; DFNB82; LGN; PINS,G protein signaling modulator 2,1p13.3,protein-coding,/
CWITA001810,TCMBANKGE001810,DCLRE1A,PSO2; SNM1; SNM1A,DNA cross-link repair 1A,10q25.3,protein-coding,/
CWITA001811,TCMBANKGE001811,PTHLH,BDE2; HHM; PLP; PTHR; PTHRP,parathyroid hormone like hormone,12p11.22,protein-coding,/
CWITA001812,TCMBANKGE001812,PPP4C,PP-X; PP4; PP4C; PPH3; PPP4; PPX,protein phosphatase 4 catalytic subunit,16p11.2,protein-coding,/
CWITA001813,TCMBANKGE001813,ISLR,HsT17563; Meflin,immunoglobulin superfamily containing leucine rich repeat,15q24.1,protein-coding,/
CWITA001814,TCMBANKGE001814,FAM32A,OTAG-12; OTAG12,family with sequence similarity 32 member A,19p13.11,protein-coding,/
CWITA001815,TCMBANKGE001815,TSG101,TSG10; VPS23,tumor susceptibility 101,11p15.1,protein-coding,Clinical Trial target
CWITA001816,TCMBANKGE001816,HRH1,H1-R; H1R; HH1R; hisH1,histamine receptor H1,3p25.3,protein-coding,Successful target
CWITA001817,TCMBANKGE001817,ZNF559,NBLA00121,zinc finger protein 559,19p13.2,protein-coding,/
CWITA001818,TCMBANKGE001818,NQO2,DHQV; DIA6; NMOR2; QR2,N-ribosyldihydronicotinamide:quinone reductase 2,6p25.2,protein-coding,Successful target
CWITA001819,TCMBANKGE001819,BRF1,BRF; BRF-1; CFDS; GTF3B; HEL-S-76p; TAF3B2; TAF3C; TAFIII90; TF3B90; TFIIIB90; hBRF,BRF1 RNA polymerase III transcription initiation factor subunit,14q32.33,protein-coding,/
CWITA001820,TCMBANKGE001820,METTL26,C16orf13; JFP2,methyltransferase like 26,16p13.3,protein-coding,/
CWITA001821,TCMBANKGE001821,ACSS3,-,acyl-CoA synthetase short chain family member 3,12q21.31,protein-coding,/
CWITA001822,TCMBANKGE001822,DNAJB11,ABBP-2; ABBP2; DJ9; Dj-9; EDJ; ERdj3; ERj3; ERj3p; PKD6; PRO1080; UNQ537,DnaJ heat shock protein family (Hsp40) member B11,3q27.3,protein-coding,/
CWITA001823,TCMBANKGE001823,SORBS1,CAP; FLAF2; R85FL; SH3D5; SH3P12; SORB1,sorbin and SH3 domain containing 1,10q24.1,protein-coding,/
CWITA001824,TCMBANKGE001824,ZNF837,-,zinc finger protein 837,19q13.43,protein-coding,/
CWITA001825,TCMBANKGE001825,CCL8,HC14; MCP-2; MCP2; SCYA10; SCYA8,C-C motif chemokine ligand 8,17q12,protein-coding,/
CWITA001826,TCMBANKGE001826,SDF2L1,-,stromal cell derived factor 2 like 1,22q11.21,protein-coding,/
CWITA001827,TCMBANKGE001827,MYL7,MYL2A; MYLC2A,myosin light chain 7,7p13,protein-coding,/
CWITA001828,TCMBANKGE001828,ABHD17C,FAM108C1,"abhydrolase domain containing 17C, depalmitoylase",15q25.1,protein-coding,/
CWITA001829,TCMBANKGE001829,RPL19,L19,ribosomal protein L19,17q12,protein-coding,/
CWITA001830,TCMBANKGE001830,LSP1,WP34; pp52,lymphocyte specific protein 1,11p15.5,protein-coding,/
CWITA001831,TCMBANKGE001831,PKDCC,RLSDF; SGK493; Vlk,"protein kinase domain containing, cytoplasmic",2p21,protein-coding,/
CWITA001832,TCMBANKGE001832,MRE11,ATLD; HNGS1; MRE11A; MRE11B,"MRE11 homolog, double strand break repair nuclease",11q21,protein-coding,/
CWITA001833,TCMBANKGE001833,GRM3,GLUR3; GPRC1C; MGLUR3; mGlu3,glutamate metabotropic receptor 3,7q21.11-q21.12,protein-coding,Clinical Trial target
CWITA001834,TCMBANKGE001834,PALLD,CGI-151; CGI151; MYN; PNCA1; SIH002,"palladin, cytoskeletal associated protein",4q32.3,protein-coding,/
CWITA001835,TCMBANKGE001835,MTHFD1L,FTHFSDC1; MTC1THFS; dJ292B18.2,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like,6q25.1,protein-coding,/
CWITA001836,TCMBANKGE001836,CCL24,Ckb-6; MPIF-2; MPIF2; SCYA24,C-C motif chemokine ligand 24,7q11.23,protein-coding,/
CWITA001837,TCMBANKGE001837,PPA2,HSPC124; SCFAI; SCFI; SID6-306,inorganic pyrophosphatase 2,4q24,protein-coding,/
CWITA001838,TCMBANKGE001838,WARS1,GAMMA-2; HMN9; IFI53; IFP53; WARS,tryptophanyl-tRNA synthetase 1,14q32.2,protein-coding,/
CWITA001839,TCMBANKGE001839,PRRG4,PRGP4; TMG4,proline rich and Gla domain 4,11p13,protein-coding,/
CWITA001840,TCMBANKGE001840,OGFOD1,TPA1,2-oxoglutarate and iron dependent oxygenase domain containing 1,16q13,protein-coding,/
CWITA001841,TCMBANKGE001841,HIBCH,HIBYLCOAH,3-hydroxyisobutyryl-CoA hydrolase,2q32.2,protein-coding,
CWITA001842,TCMBANKGE001842,PRKAB1,AMPK; HAMPKb; MGC17785,"protein kinase, AMP-activated, beta 1 non-catalytic subunit",12q24.1,protein-coding,
CWITA001843,TCMBANKGE001843,CORO1B,CORONIN-2,coronin 1B,11q13.2,protein-coding,/
CWITA001844,TCMBANKGE001844,TGFBR3,BGCAN; betaglycan,transforming growth factor beta receptor 3,1p22.1,protein-coding,/
CWITA001845,TCMBANKGE001845,IL6,BSF2; HGF; HSF; IFNB2; IL-6,"Interleukin 6 (Interferon, Beta 2)",7p21,protein-coding,
CWITA001846,TCMBANKGE001846,SNRPA,Mud1; U1-A; U1A,small nuclear ribonucleoprotein polypeptide A,19q13.2,protein-coding,/
CWITA001847,TCMBANKGE001847,CMAS,N,cytidine monophosphate N-acetylneuraminic acid synthetase,12p12.1,protein-coding,
CWITA001848,TCMBANKGE001848,MMP13,CLG3; MANDP1,matrix metallopeptidase 13 (collagenase 3),11q22.3,protein-coding,
CWITA001849,TCMBANKGE001849,ST6GALNAC2,SAITL1; SIAT7; SIAT7B; SIATL1; ST6GalNAII; STHM,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2",17q25.1,protein-coding,/
CWITA001850,TCMBANKGE001850,ACSM2B,ACSM2; HXMA; HYST1046,acyl-CoA synthetase medium chain family member 2B,16p12.3,protein-coding,/
CWITA001851,TCMBANKGE001851,ACSS2,ACAS2; ACECS; ACS; ACSA; DKFZp762G026; dJ1161H23.1,acyl-CoA synthetase short-chain family member 2,20q11.22,protein-coding,
CWITA001852,TCMBANKGE001852,RPL18A,L18A,ribosomal protein L18a,19p13.11,protein-coding,/
CWITA001853,TCMBANKGE001853,TMEM141,-,transmembrane protein 141,9q34.3,protein-coding,/
CWITA001854,TCMBANKGE001854,CLEC12A,CD371; CLL-1; CLL1; DCAL-2; MICL,C-type lectin domain family 12 member A,12p13.31,protein-coding,Clinical Trial target
CWITA001855,TCMBANKGE001855,CAVIN2,PS-p68; SDPR; SDR; cavin-2,caveolae associated protein 2,2q32.3,protein-coding,/
CWITA001856,TCMBANKGE001856,LRCH3,-,leucine rich repeats and calponin homology domain containing 3,3q29,protein-coding,/
CWITA001857,TCMBANKGE001857,LOC108021850,E70; SOM,Sox9 enhancer SOM,-,biological-region,/
CWITA001858,TCMBANKGE001858,SLK,LOSK; STK2; bA16H23.1; se20-9,STE20 like kinase,10q24.33-q25.1,protein-coding,Research target
CWITA001859,TCMBANKGE001859,SH3KBP1,AGMX2; CD2BP3; CIN85; GIG10; HSB-1; HSB1; IMD61; MIG18,SH3 domain containing kinase binding protein 1,Xp22.12,protein-coding,/
CWITA001860,TCMBANKGE001860,IGHE,IgE,immunoglobulin heavy constant epsilon,14q32.33,other,/
CWITA001861,TCMBANKGE001861,BDKRB1,B1BKR; B1R; BDKRB2; BKB1R; BKR1; BRADYB1,bradykinin receptor B1,14q32.2,protein-coding,Clinical Trial target
CWITA001862,TCMBANKGE001862,TUBB4B,Beta2; LCAEOD; TUBB2; TUBB2C,tubulin beta 4B class IVb,9q34.3,protein-coding,/
CWITA001863,TCMBANKGE001863,UPK3A,UP3A; UPIII; UPIIIA; UPK3,uroplakin 3A,22q13.31,protein-coding,/
CWITA001864,TCMBANKGE001864,FAM174C,C19orf24,family with sequence similarity 174 member C,19p13.3,protein-coding,/
CWITA001865,TCMBANKGE001865,SLC36A3,PAT3; TRAMD2; tramdorin2,solute carrier family 36 member 3,5q33.1,protein-coding,/
CWITA001866,TCMBANKGE001866,SSTR2,N,somatostatin receptor 2,17q24,protein-coding,
CWITA001867,TCMBANKGE001867,POLR2J,POLR2J1; RPB11; RPB11A; RPB11m; hRPB14,RNA polymerase II subunit J,7q22.1,protein-coding,/
CWITA001868,TCMBANKGE001868,AMD1,ADOMETDC; AMD; DKFZp313L1234; FLJ26964; SAMDC,adenosylmethionine decarboxylase 1,6q21,protein-coding,
CWITA001869,TCMBANKGE001869,TAF5,TAF(II)100; TAF2D; TAFII-100; TAFII100,TATA-box binding protein associated factor 5,10q24.33,protein-coding,/
CWITA001870,TCMBANKGE001870,CCT5,CCT-epsilon; CCTE; HEL-S-69; PNAS-102; TCP-1-epsilon,chaperonin containing TCP1 subunit 5,5p15.2,protein-coding,/
CWITA001871,TCMBANKGE001871,RPGRIP1,CORD13; LCA6; RGI1; RGRIP; RPGRIP; RPGRIP1d,RPGR interacting protein 1,14q11.2,protein-coding,/
CWITA001872,TCMBANKGE001872,PARP9,ARTD9; BAL; BAL1; MGC:7868,poly(ADP-ribose) polymerase family member 9,3q21.1,protein-coding,/
CWITA001873,TCMBANKGE001873,MGAT1,GLCNACNTI; GLCT1; GLYT1; GNTN1; GNTNI; MGAT,"mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase",5q35,protein-coding,
CWITA001874,TCMBANKGE001874,OLFML2B,-,olfactomedin like 2B,1q23.3,protein-coding,/
CWITA001875,TCMBANKGE001875,PDE4DIP,CMYA2; MMGL,phosphodiesterase 4D interacting protein,1q21.2,protein-coding,/
CWITA001876,TCMBANKGE001876,DMP1,ARHP; ARHR; DMP-1,dentin matrix acidic phosphoprotein 1,4q22.1,protein-coding,/
CWITA001877,TCMBANKGE001877,ACE,ACE1; CD143; DCP; DCP1; MGC26566; MVCD3,angiotensin I converting enzyme (peptidyl-dipeptidase A) 1,17q23.3,protein-coding,
CWITA001878,TCMBANKGE001878,SPP2,SPP-24; SPP24,secreted phosphoprotein 2,2q37.1,protein-coding,/
CWITA001879,TCMBANKGE001879,STS,ARSC; ARSC1; ASC; ES; SSDD; XLI,steroid sulfatase,Xp22.31,protein-coding,Successful target
CWITA001880,TCMBANKGE001880,CREB5,CRE-BPA; CREB-5; CREBPA,cAMP responsive element binding protein 5,7p15.1,protein-coding,/
CWITA001881,TCMBANKGE001881,AGGF1,GPATC7; GPATCH7; HSU84971; HUS84971; VG5Q,angiogenic factor with G-patch and FHA domains 1,5q13.3,protein-coding,/
CWITA001882,TCMBANKGE001882,HAO1,GOX; GOX1; HAOX1,hydroxyacid oxidase 1,20p12.3,protein-coding,/
CWITA001883,TCMBANKGE001883,SEMA4F,M-SEMA; PRO2353; S4F; SEMAM; SEMAW; m-Sema-M,ssemaphorin 4F,2p13.1,protein-coding,/
CWITA001884,TCMBANKGE001884,SMC5,SMC5L1,structural maintenance of chromosomes 5,9q21.12,protein-coding,/
CWITA001885,TCMBANKGE001885,DCAF4,WDR21; WDR21A,DDB1 and CUL4 associated factor 4,14q24.2,protein-coding,/
CWITA001886,TCMBANKGE001886,GRIN2D,EB11; NMDAR2D; NR2D,"glutamate receptor, ionotropic, N-methyl D-aspartate 2D",19q13.1-qter,protein-coding,
CWITA001887,TCMBANKGE001887,RERGL,-,RERG like,12p12.3,protein-coding,/
CWITA001888,TCMBANKGE001888,DHX9,DDX9; LKP; NDH2; NDHII; RHA,DExH-box helicase 9,1q25.3,protein-coding,/
CWITA001889,TCMBANKGE001889,GRIK3,EAA5; GLR7; GLUR7; GluR7a,"glutamate receptor, ionotropic, kainate 3",1p34-p33,protein-coding,
CWITA001890,TCMBANKGE001890,ME2,ODS1,malic enzyme 2,18q21.2,protein-coding,/
CWITA001891,TCMBANKGE001891,INCENP,-,inner centromere protein,11q12.3,protein-coding,/
CWITA001892,TCMBANKGE001892,TGFBR1,AAT5; ACVRLK4; ALKN5; ALK5; LDS1A; LDS2A; SKR4; TGFRN1,"transforming growth factor, beta receptor 1",9q22,protein-coding,
CWITA001893,TCMBANKGE001893,PDF,N,peptide deformylase (mitochondrial),16q22.1,protein-coding,
CWITA001894,TCMBANKGE001894,PLP2,A4; A4LSB,proteolipid protein 2,Xp11.23,protein-coding,Research target
CWITA001895,TCMBANKGE001895,GREB1,-,growth regulating estrogen receptor binding 1,2p25.1,protein-coding,/
CWITA001896,TCMBANKGE001896,LPAR6,ARWH1; HYPT8; LAH3; LPA-6; P2RY5; P2Y5,lysophosphatidic acid receptor 6,13q14.2,protein-coding,Research target
CWITA001897,TCMBANKGE001897,SLC10A2,ASBT; IBAT; ISBT; NTCP2; PBAM,solute carrier family 10 member 2,13q33.1,protein-coding,Clinical Trial target
CWITA001898,TCMBANKGE001898,GSTA3,GSTA3N3; GTA3; MGC22232,glutathione S-transferase alpha 3,6p12.1,protein-coding,
CWITA001899,TCMBANKGE001899,GLRX3,GLRX4; GRX3; GRX4; PICOT; TXNL2; TXNL3,glutaredoxin 3,10q26.3,protein-coding,/
CWITA001900,TCMBANKGE001900,HELZ,DHRC; DRHC; HUMORF5,helicase with zinc finger,17q24.2,protein-coding,/
CWITA001901,TCMBANKGE001901,BCO1,BCDO; BCDO1; BCMO; BCMO1; BCO,beta-carotene oxygenase 1,16q23.2,protein-coding,/
CWITA001902,TCMBANKGE001902,ELF3,EPR-1; ERT; ESE-1; ESX,E74 like ETS transcription factor 3,1q32.1,protein-coding,/
CWITA001903,TCMBANKGE001903,SYTL1,JFC1; SLP1,synaptotagmin like 1,1p36.11,protein-coding,/
CWITA001904,TCMBANKGE001904,CNNM4,ACDP4,cyclin and CBS domain divalent metal cation transport mediator 4,2q11.2,protein-coding,/
CWITA001905,TCMBANKGE001905,PPDPF,C20orf149; dJ697K14.9; exdpf,pancreatic progenitor cell differentiation and proliferation factor,20q13.33,protein-coding,/
CWITA001906,TCMBANKGE001906,SLC47A1,FLJ10847; MATE1; MGC64822,"solute carrier family 47, member 1",17p11.2,protein-coding,
CWITA001907,TCMBANKGE001907,CCDC87,-,coiled-coil domain containing 87,11q13.2,protein-coding,/
CWITA001908,TCMBANKGE001908,IMPG1,GP147; IPM150; SPACR; VMD4,interphotoreceptor matrix proteoglycan 1,6q14.1,protein-coding,/
CWITA001909,TCMBANKGE001909,TENT4A,LAK-1; LAK1; PAPD7; POLK; POLS; TRF4; TRF4-1; TRF41; TUTASE5,terminal nucleotidyltransferase 4A,5p15.31,protein-coding,/
CWITA001910,TCMBANKGE001910,CYP2C8,CPC8; CYP2C8DM; CYPIIC8; MP-12/MP-20,cytochrome P450 family 2 subfamily C member 8,10q23.33,protein-coding,/
CWITA001911,TCMBANKGE001911,ZNF554,-,zinc finger protein 554,19p13.3,protein-coding,/
CWITA001912,TCMBANKGE001912,IFNL1,IL-29; IL29,interferon lambda 1,19q13.2,protein-coding,Clinical Trial target
CWITA001913,TCMBANKGE001913,DOP1A,DOP1; DOPEY1; KIAA1117; dJ202D23.2,DOP1 leucine zipper like protein A,6q14.1,protein-coding,/
CWITA001914,TCMBANKGE001914,LYZ,LZM,lysozyme,12q15,protein-coding,
CWITA001915,TCMBANKGE001915,INS-IGF2,INSIGF,INS-IGF2 readthrough,11p15.5,protein-coding,/
CWITA001916,TCMBANKGE001916,TERT,EST2; TCS1; TP2; TRT; hEST2,telomerase reverse transcriptase,5p15.33,protein-coding,
CWITA001917,TCMBANKGE001917,PRRT1,C6orf31; DSPD1; IFITMD7; NG5,proline rich transmembrane protein 1,6p21.32,protein-coding,/
CWITA001918,TCMBANKGE001918,ACCS,ACS; PHACS,1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional),11p11,protein-coding,
CWITA001919,TCMBANKGE001919,GSTM1,GST1; GSTM1N1; GSTM1aN1a; GSTM1bN1b; GTH4; GTM1; HNB; MGC26563; MU; MUN1,glutathione S-transferase mu 1,1p13.3,protein-coding,
CWITA001920,TCMBANKGE001920,ADCY1,AC1,adenylate cyclase 1 (brain),7p13-p12,protein-coding,
CWITA001921,TCMBANKGE001921,IFI44,MTAP44; TLDC5; p44,interferon induced protein 44,1p31.1,protein-coding,/
CWITA001922,TCMBANKGE001922,FA2H,FAAH; FAH1; FAXDC1; SCS7; SPG35,fatty acid 2-hydroxylase,16q23.1,protein-coding,/
CWITA001923,TCMBANKGE001923,NR1I3,CAR; CAR1; MB67; MGC150433; MGC97144; MGC97209,"nuclear receptor subfamily 1, group I, member 3",1q23.3,protein-coding,
CWITA001924,TCMBANKGE001924,COMT,N,catechol-O-methyltransferase,22q11.21-q11.23|22q11.21,protein-coding,
CWITA001925,TCMBANKGE001925,DHRS7,CGI-86; SDR34C1; retDSR4; retSDR4,dehydrogenase/reductase 7,14q23.1,protein-coding,/
CWITA001926,TCMBANKGE001926,PPARG,CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARgamma,peroxisome proliferator-activated receptor gamma,3p25,protein-coding,
CWITA001927,TCMBANKGE001927,PELI1,-,pellino E3 ubiquitin protein ligase 1,2p14,protein-coding,/
CWITA001928,TCMBANKGE001928,SNRPB,CCMS; COD; SNRPB1; Sm-B/B'; SmB/B'; SmB/SmB'; snRNP-B,small nuclear ribonucleoprotein polypeptides B and B1,20p13,protein-coding,/
CWITA001929,TCMBANKGE001929,METTL16,METT10D,methyltransferase like 16,17p13.3,protein-coding,/
CWITA001930,TCMBANKGE001930,PBX1,CAKUHED,PBX homeobox 1,1q23.3,protein-coding,/
CWITA001931,TCMBANKGE001931,ADH5,ADHN3; ADHX; FDH; GSNOR,"alcohol dehydrogenase 5 (class III), chi polypeptide",4q23,protein-coding,
CWITA001932,TCMBANKGE001932,ZNF831,C20orf174,zinc finger protein 831,20q13.32,protein-coding,/
CWITA001933,TCMBANKGE001933,FERMT3,KIND3; MIG-2; MIG2B; UNC112C; URP2; URP2SF,fermitin family member 3,11q13.1,protein-coding,/
CWITA001934,TCMBANKGE001934,ADI1,APL1; ARD; Fe-ARD; HMFT1638; MTCBP1; Ni-ARD; SIPL; mtnD,acireductone dioxygenase 1,2p25.3,protein-coding,/
CWITA001935,TCMBANKGE001935,SLC37A2,pp11662,solute carrier family 37 member 2,11q24.2,protein-coding,/
CWITA001936,TCMBANKGE001936,ZDHHC2,DHHC2; ZNF372,zinc finger DHHC-type palmitoyltransferase 2,8p22,protein-coding,/
CWITA001937,TCMBANKGE001937,ATR,FCTCS; FRP1; MEC1; SCKL; SCKL1,ATR serine/threonine kinase,3q23,protein-coding,Clinical Trial target
CWITA001938,TCMBANKGE001938,SLC35E2B,SLC35E2,solute carrier family 35 member E2B,1p36.33,protein-coding,/
CWITA001939,TCMBANKGE001939,RAB7A,FLJ20819; PRO2706; RAB7,"RAB7A, member RAS oncogene family",3q21.3,protein-coding,
CWITA001940,TCMBANKGE001940,ATXN7L3,-,ataxin 7 like 3,17q21.31,protein-coding,/
CWITA001941,TCMBANKGE001941,SPINT1,HAI; HAI1; MANSC2,"serine peptidase inhibitor, Kunitz type 1",15q15.1,protein-coding,/
CWITA001942,TCMBANKGE001942,LGALS2,HL14,galectin 2,22q13.1,protein-coding,Research target
CWITA001943,TCMBANKGE001943,ADRA1D,ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2,adrenoceptor alpha 1D,20p13,protein-coding,Successful target
CWITA001944,TCMBANKGE001944,BEX2,BEX1; DJ79P11.1,brain expressed X-linked 2,Xq22.2,protein-coding,/
CWITA001945,TCMBANKGE001945,USP44,-,ubiquitin specific peptidase 44,12q22,protein-coding,Research target
CWITA001946,TCMBANKGE001946,U2AF2,U2AF65,U2 small nuclear RNA auxiliary factor 2,19q13.42,protein-coding,/
CWITA001947,TCMBANKGE001947,PEX13,NALD; PBD11A; PBD11B; ZWS,peroxisomal biogenesis factor 13,2p15,protein-coding,/
CWITA001948,TCMBANKGE001948,MRPS10,MRP-S10; PNAS-122,mitochondrial ribosomal protein S10,6p21.1,protein-coding,/
CWITA001949,TCMBANKGE001949,MPC2,BRP44; SLC54A2,mitochondrial pyruvate carrier 2,1q24.2,protein-coding,/
CWITA001950,TCMBANKGE001950,ZNF708,KOX8; ZNF15; ZNF15L1,zinc finger protein 708,19p12,protein-coding,/
CWITA001951,TCMBANKGE001951,HMOX2,HON2,heme oxygenase (decycling) 2,16p13.3,protein-coding,
CWITA001952,TCMBANKGE001952,CNST,C1orf71; PPP1R64,"consortin, connexin sorting protein",1q44,protein-coding,/
CWITA001953,TCMBANKGE001953,TEK,CD202B; GLC3E; TIE-2; TIE2; VMCM; VMCM1,TEK receptor tyrosine kinase,9p21.2,protein-coding,Clinical Trial target
CWITA001954,TCMBANKGE001954,KCNH7,ERG3; HERG3; Kv11.3; MGC45986,"potassium voltage-gated channel, subfamily H (eag-related), member 7",2q24.2,protein-coding,
CWITA001955,TCMBANKGE001955,EEF1A1,CCS-3; CCS3; EE1A1; EEF-1; EEF1A; EF-Tu; EF1A; GRAF-1EF; LENG7; PTI1; eEF1A-1,eukaryotic translation elongation factor 1 alpha 1,6q13,protein-coding,/
CWITA001956,TCMBANKGE001956,TSPYL6,-,TSPY like 6,2p16.2,protein-coding,/
CWITA001957,TCMBANKGE001957,TKFC,DAK; NET45; TKFCD,triokinase and FMN cyclase,11q12.2,protein-coding,/
CWITA001958,TCMBANKGE001958,PROSC,FLJ11861,proline synthetase co-transcribed homolog (bacterial),8p11.2,protein-coding,
CWITA001959,TCMBANKGE001959,B3GAT3,GLCATI; JDSCD; glcUAT-I,"beta-1,3-glucuronyltransferase 3",11q12.3,protein-coding,/
CWITA001960,TCMBANKGE001960,KRR1,HRB2; RIP-1,KRR1 small subunit processome component homolog,12q21.2,protein-coding,/
CWITA001961,TCMBANKGE001961,CASP3,CPP32; CPP32B; SCAN1,"caspase 3, apoptosis-related cysteine peptidase",4q34,protein-coding,
CWITA001962,TCMBANKGE001962,MAT1A,MAT; MATA1; SAMS; SAMS1,"methionine adenosyltransferase I, alpha",10q22,protein-coding,
CWITA001963,TCMBANKGE001963,UBL3,HCG-1; PNSC1,ubiquitin like 3,13q12.3,protein-coding,/
CWITA001964,TCMBANKGE001964,ZNF816-ZNF321P,ZNF816-ZNF321,ZNF816-ZNF321P readthrough,19q13.41,protein-coding,/
CWITA001965,TCMBANKGE001965,HASPIN,GSG2,histone H3 associated protein kinase,17p13.2,protein-coding,/
CWITA001966,TCMBANKGE001966,RASGRF2,GRF2; RAS-GRF2,Ras protein specific guanine nucleotide releasing factor 2,5q14.1,protein-coding,/
CWITA001967,TCMBANKGE001967,F2RL2,PAR-3; PAR3,coagulation factor II thrombin receptor like 2,5q13.3,protein-coding,Research target
CWITA001968,TCMBANKGE001968,LTK,TYK1,leukocyte receptor tyrosine kinase,15q15.1,protein-coding,Research target
CWITA001969,TCMBANKGE001969,UBXN7,UBXD7,UBX domain protein 7,3q29,protein-coding,/
CWITA001970,TCMBANKGE001970,TMEM68,-,transmembrane protein 68,8q12.1,protein-coding,/
CWITA001971,TCMBANKGE001971,MRAS,M-RAs; NS11; R-RAS3; RRAS3,muscle RAS oncogene homolog,3q22.3,protein-coding,/
CWITA001972,TCMBANKGE001972,DDX24,-,DEAD-box helicase 24,14q32.12,protein-coding,/
CWITA001973,TCMBANKGE001973,LANCL3,-,LanC like 3,Xp21.1,protein-coding,/
CWITA001974,TCMBANKGE001974,GIMAP5,HIMAP3; IAN-5; IAN4; IAN4L1; IAN5; IMAP3; IROD,"GTPase, IMAP family member 5",7q36.1,protein-coding,/
CWITA001975,TCMBANKGE001975,SLCO4A1,OATPNE; OATP1; OATP4A1; OATPE; OATPRP1; POAT; SLC21A12,"solute carrier organic anion transporter family, member 4A1",20q13.33,protein-coding,
CWITA001976,TCMBANKGE001976,CSNK1G2,CK1g2,casein kinase 1 gamma 2,19p13.3,protein-coding,Research target
CWITA001977,TCMBANKGE001977,F13A1,F13A,coagulation factor XIII A chain,6p25.1,protein-coding,Patented target
CWITA001978,TCMBANKGE001978,GRM2,GLUR2; GPRC1B; MGLUR2; mGlu2,glutamate metabotropic receptor 2,3p21.2,protein-coding,Clinical Trial target
CWITA001979,TCMBANKGE001979,HDAC9,DKFZp779K1053; HD7; HD7b; HD9; HDAC; HDAC7; HDAC7B; HDAC9B; HDAC9FL; HDRP; KIAA0744; MITR,histone deacetylase 9,7p21.1,protein-coding,
CWITA001980,TCMBANKGE001980,POC1A,PIX2; SOFT; WDR51A,POC1 centriolar protein A,3p21.2,protein-coding,/
CWITA001981,TCMBANKGE001981,HSFX1,LW-1,"heat shock transcription factor family, X-linked 1",Xq28,protein-coding,/
CWITA001982,TCMBANKGE001982,MRPL12,5c5-2; L12mt; MRP-L31/34; MRPL7; MRPL7/L12; RPML12,mitochondrial ribosomal protein L12,17q25.3,protein-coding,/
CWITA001983,TCMBANKGE001983,CPO,MGC138281; MGC138283,carboxypeptidase O,2q33.3,protein-coding,
CWITA001984,TCMBANKGE001984,LHFPL6,LHFP,LHFPL tetraspan subfamily member 6,13q13.3-q14.11,protein-coding,/
CWITA001985,TCMBANKGE001985,CYP2F1,C2F1; CYP2F; CYPIIF1,cytochrome P450 family 2 subfamily F member 1,19q13.2,protein-coding,/
CWITA001986,TCMBANKGE001986,PTPRR,EC-PTP; PCPTP1; PTP-SL; PTPBR7; PTPRQ,protein tyrosine phosphatase receptor type R,12q15,protein-coding,/
CWITA001987,TCMBANKGE001987,SLC16A10,PRO0813; TAT1,"solute carrier family 16, member 10 (aromatic amino acid transporter)",6q21-q22,protein-coding,
CWITA001988,TCMBANKGE001988,ARRDC3,TLIMP,arrestin domain containing 3,5q14.3,protein-coding,/
CWITA001989,TCMBANKGE001989,GPC1,glypican,glypican 1,2q37.3,protein-coding,/
CWITA001990,TCMBANKGE001990,ACP4,ACPT; AI1J,acid phosphatase 4,19q13.33,protein-coding,/
CWITA001991,TCMBANKGE001991,CCND3,-,cyclin D3,6p21.1,protein-coding,Research target
CWITA001992,TCMBANKGE001992,PPIH,CYP-20; CYPH; SnuCyp-20; USA-CYP,peptidylprolyl isomerase H,1p34.2,protein-coding,/
CWITA001993,TCMBANKGE001993,HAGHL,-,hydroxyacylglutathione hydrolase like,16p13.3,protein-coding,/
CWITA001994,TCMBANKGE001994,FBXL19,CXXC11; Fbl19; JHDM1C,F-box and leucine rich repeat protein 19,16p11.2,protein-coding,/
CWITA001995,TCMBANKGE001995,CCL19,CKb11; ELC; MIP-3b; MIP3B; SCYA19,C-C motif chemokine ligand 19,9p13.3,protein-coding,/
CWITA001996,TCMBANKGE001996,BYSL,BYSTIN; Enp1,bystin like,6p21.1,protein-coding,/
CWITA001997,TCMBANKGE001997,GMFG,GMF-GAMMA,glia maturation factor gamma,19q13.2,protein-coding,/
CWITA001998,TCMBANKGE001998,NR0B1,AHC; AHCH; AHX; DAX-1; DAX1; DSS; GTD; HHG; NROB1; SRXY2,nuclear receptor subfamily 0 group B member 1,Xp21.2,protein-coding,Research target
CWITA001999,TCMBANKGE001999,TYMP,ECGF; ECGF1; MEDPS1; MNGIE; MTDPS1; PDECGF; TP; hPDNECGF,thymidine phosphorylase,22q13|22q13.33,protein-coding,
CWITA002000,TCMBANKGE002000,CTLA4,ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12,cytotoxic T-lymphocyte associated protein 4,2q33.2,protein-coding,Successful target
CWITA002001,TCMBANKGE002001,PPP2R3A,PPP2R3; PR130; PR72,protein phosphatase 2 regulatory subunit B''alpha,3q22.2-q22.3,protein-coding,/
CWITA002002,TCMBANKGE002002,SLC32A1,VGAT; VIAAT,"solute carrier family 32 (GABA vesicular transporter), member 1",20q11.23,protein-coding,
CWITA002003,TCMBANKGE002003,Hbb-b1,AA409645; Hbb1; Hbbt1; Hbbt2; MommeD7; beta1,"hemoglobin, beta adult major chain",7 E3|7 54.85 cM,protein-coding,/
CWITA002004,TCMBANKGE002004,H2AZ2,H2A.Z-2; H2AFV; H2AV,H2A.Z variant histone 2,7p13,protein-coding,/
CWITA002005,TCMBANKGE002005,MED10,L6; NUT2; TRG20,mediator complex subunit 10,5p15.31,protein-coding,/
CWITA002006,TCMBANKGE002006,SIK2,LOH11CR1I; QIK; SIK-2; SNF1LK2,salt inducible kinase 2,11q23.1,protein-coding,Research target
CWITA002007,TCMBANKGE002007,EIF2AK1,HCR; HRI; LEMSPAD,eukaryotic translation initiation factor 2 alpha kinase 1,7p22.1,protein-coding,Research target
CWITA002008,TCMBANKGE002008,IL4I1,FIG1; LAAO; LAO,interleukin 4 induced 1,19q13.33,protein-coding,/
CWITA002009,TCMBANKGE002009,PDHX,DLDBP; E3BP; OPDX; PDHXD; PDX1; proX,pyruvate dehydrogenase complex component X,11p13,protein-coding,/
CWITA002010,TCMBANKGE002010,MND1,GAJ,meiotic nuclear divisions 1,4q31.3,protein-coding,/
CWITA002011,TCMBANKGE002011,ZSCAN5B,ZNF371; ZNF495B,zinc finger and SCAN domain containing 5B,19q13.43,protein-coding,/
CWITA002012,TCMBANKGE002012,RBBP6,MY038; P2P-R; PACT; RBQ-1; SNAMA,"RB binding protein 6, ubiquitin ligase",16p12.1,protein-coding,/
CWITA002013,TCMBANKGE002013,WDTC1,ADP; DCAF9,WD and tetratricopeptide repeats 1,1p36.11,protein-coding,/
CWITA002014,TCMBANKGE002014,DOCK9,ZIZ1; ZIZIMIN1,dedicator of cytokinesis 9,13q32.3,protein-coding,/
CWITA002015,TCMBANKGE002015,GLTP,-,glycolipid transfer protein,12q24.11,protein-coding,/
CWITA002016,TCMBANKGE002016,CLPP,DFNB81; PRLTS3,caseinolytic mitochondrial matrix peptidase proteolytic subunit,19p13.3,protein-coding,/
CWITA002017,TCMBANKGE002017,METTL7A,AAM-B; AAMB,methyltransferase like 7A,12q13.12,protein-coding,/
CWITA002018,TCMBANKGE002018,ZMYM6,Buster2; MYM; ZBED7; ZNF198L4; ZNF258,zinc finger MYM-type containing 6,1p34.3,protein-coding,/
CWITA002019,TCMBANKGE002019,DEFB129,C20orf87; DEFB-29; DEFB29; bA530N10.3; hBD-29,defensin beta 129,20p13,protein-coding,/
CWITA002020,TCMBANKGE002020,INPPL1,OPSMD; SHIP2,inositol polyphosphate phosphatase like 1,11q13.4,protein-coding,/
CWITA002021,TCMBANKGE002021,ZNF580,-,zinc finger protein 580,19q13.42,protein-coding,/
CWITA002022,TCMBANKGE002022,XRCC1,RCC; SCAR26,X-ray repair cross complementing 1,19q13.31,protein-coding,/
CWITA002023,TCMBANKGE002023,TUBGCP2,ALP4; GCP-2; GCP2; Grip103; PAMDDFS; SPBC97; SPC97; Spc97p; h103p; hGCP2; hSpc97,tubulin gamma complex associated protein 2,10q26.3,protein-coding,/
CWITA002024,TCMBANKGE002024,PSD3,EFA6D; EFA6R; HCA67,pleckstrin and Sec7 domain containing 3,8p22,protein-coding,/
CWITA002025,TCMBANKGE002025,WBP1,WBP-1,WW domain binding protein 1,2p13.1,protein-coding,/
CWITA002026,TCMBANKGE002026,THAP4,CGI-36; Nb(III); PP238,THAP domain containing 4,2q37.3,protein-coding,/
CWITA002027,TCMBANKGE002027,PACS2,EIEE66; PACS-2; PACS1L,phosphofurin acidic cluster sorting protein 2,14q32.33,protein-coding,/
CWITA002028,TCMBANKGE002028,SLA2,C20orf156; MARS; SLAP-2; SLAP2,Src like adaptor 2,20q11.23,protein-coding,/
CWITA002029,TCMBANKGE002029,EPAS1,ECYT4; HIF2A; HLF; MOP2; PASD2; bHLHe73,endothelial PAS domain protein 1,2p21,protein-coding,Clinical Trial target
CWITA002030,TCMBANKGE002030,PSMB8,D6S216; D6S216E; LMP7; MGC1491; PSMB5i; RING10,"proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)",6p21.3,protein-coding,
CWITA002031,TCMBANKGE002031,TAGLN2,HA1756,transgelin 2,1q23.2,protein-coding,Research target
CWITA002032,TCMBANKGE002032,GPX8,UNQ847,glutathione peroxidase 8 (putative),5q11.2,protein-coding,
CWITA002033,TCMBANKGE002033,MT1M,MT-1M; MT-IM; MT1; MT1K,metallothionein 1M,16q13,protein-coding,/
CWITA002034,TCMBANKGE002034,SELENOK,HSPC030; HSPC297; SELK,selenoprotein K,3p21.1,protein-coding,/
CWITA002035,TCMBANKGE002035,ZNF33B,KOX2; KOX31; ZNF11B,zinc finger protein 33B,10q11.21,protein-coding,/
CWITA002036,TCMBANKGE002036,CLDN18,SFTA5; SFTPJ,claudin 18,3q22.3,protein-coding,Clinical Trial target
CWITA002037,TCMBANKGE002037,AKIP1,BCA3; C11orf17,A-kinase interacting protein 1,11p15.4,protein-coding,/
CWITA002038,TCMBANKGE002038,ABCG5,STSL,"Atp-Binding Cassette, Sub-Family G (White), Member 5",2p21,protein-coding,
CWITA002039,TCMBANKGE002039,TSPO,BPBS; BZRP; DBI; IBP; MBR; PBR; PBS; PKBS; PTBR; mDRC; pk18,translocator protein (18kDa),22q13.31,protein-coding,
CWITA002040,TCMBANKGE002040,FUT8,CDGF; CDGF1,fucosyltransferase 8,14q23.3,protein-coding,/
CWITA002041,TCMBANKGE002041,GRM4,GPRC1D; MGLUR4; mGlu4,glutamate metabotropic receptor 4,6p21.31,protein-coding,Research target
CWITA002042,TCMBANKGE002042,CKAP5,CHTOG; MSPS; TOG; TOGp; ch-TOG,cytoskeleton associated protein 5,11p11.2,protein-coding,/
CWITA002043,TCMBANKGE002043,CTNND2,GT24; NPRAP,catenin delta 2,5p15.2,protein-coding,/
CWITA002044,TCMBANKGE002044,HTN1,HIS1,histatin 1,4q13.3,protein-coding,/
CWITA002045,TCMBANKGE002045,CKMT1A,CKMT1; U-MtCK; mia-CK,"creatine kinase, mitochondrial 1A",15q15.3,protein-coding,/
CWITA002046,TCMBANKGE002046,NDUFB2,AGGG; CI-AGGG,NADH:ubiquinone oxidoreductase subunit B2,7q34,protein-coding,/
CWITA002047,TCMBANKGE002047,COX7A1,COX7A; COX7AH; COX7AM,cytochrome c oxidase subunit VIIa polypeptide 1 (muscle),19q13.1,protein-coding,
CWITA002048,TCMBANKGE002048,GALT,N,galactose-1-phosphate uridylyltransferase,9p13,protein-coding,
CWITA002049,TCMBANKGE002049,PLA2G4B,HsT16992; cPLA2-beta,phospholipase A2 group IVB,15q15.1,protein-coding,/
CWITA002050,TCMBANKGE002050,PDILT,PDIA7,"protein disulfide isomerase like, testis expressed",16p12.3,protein-coding,/
CWITA002051,TCMBANKGE002051,MTNR1A,MELN1ANR; MT1,melatonin receptor 1A,4q35.1,protein-coding,
CWITA002052,TCMBANKGE002052,CIB1,CIB; CIBP; KIP1; PRKDCIP; SIP2-28,calcium and integrin binding 1,15q26.1,protein-coding,/
CWITA002053,TCMBANKGE002053,AICDA,AID; ARP2; CDA2; HEL-S-284; HIGM2,activation induced cytidine deaminase,12p13.31,protein-coding,Clinical Trial target
CWITA002054,TCMBANKGE002054,ABHD10,-,"abhydrolase domain containing 10, depalmitoylase",3q13.2,protein-coding,/
CWITA002055,TCMBANKGE002055,KLK5,KLK-L2; KLKL2; SCTE,kallikrein related peptidase 5,19q13.41,protein-coding,Patented target
CWITA002056,TCMBANKGE002056,GPR137B,TM7SF1,G protein-coupled receptor 137B,1q42.3,protein-coding,/
CWITA002057,TCMBANKGE002057,PSMD12,Rpn5; STISS; p55,"proteasome 26S subunit, non-ATPase 12",17q24.2,protein-coding,/
CWITA002058,TCMBANKGE002058,UQCRC2,MC3DN5; QCR2; UQCR2,ubiquinol-cytochrome c reductase core protein 2,16p12.2,protein-coding,/
CWITA002059,TCMBANKGE002059,VKORC1L1,DKFZp762H0113,"vitamin K epoxide reductase complex, subunit 1-like 1",7q11.21,protein-coding,
CWITA002060,TCMBANKGE002060,PTPRD,HPTP; HPTPD; HPTPDELTA; PTPD; R-PTP-delta; RPTPDELTA,protein tyrosine phosphatase receptor type D,9p24.1-p23,protein-coding,/
CWITA002061,TCMBANKGE002061,SYNE3,C14orf139; C14orf49; KASH3; LINC00341; NCRNA00341; NET53; Nesp3,spectrin repeat containing nuclear envelope family member 3,14q32.13,protein-coding,/
CWITA002062,TCMBANKGE002062,SERPINB6,CAP; DFNB91; MSTP057; PI-6; PI6; PTI; SPI3,serpin family B member 6,6p25.2,protein-coding,/
CWITA002063,TCMBANKGE002063,ABCG2,ABC15; ABCP; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; MGC102821; MRX; MXR; MXR1,"ATP-binding cassette, sub-family G (WHITE), member 2",4q22,protein-coding,
CWITA002064,TCMBANKGE002064,ECI1,DCI,enoyl-CoA delta isomerase 1,16p13.3,protein-coding,/
CWITA002065,TCMBANKGE002065,PRDM2,HUMHOXY1; KMT8; KMT8A; MTB-ZF; RIZ; RIZ1; RIZ2,PR/SET domain 2,1p36.21,protein-coding,/
CWITA002066,TCMBANKGE002066,PAN3,-,poly(A) specific ribonuclease subunit PAN3,13q12.2,protein-coding,/
CWITA002067,TCMBANKGE002067,Adam39,1700056P18Rik,a disintegrin and metallopeptidase domain 39,8|8 A4,protein-coding,/
CWITA002068,TCMBANKGE002068,IFITM2,1-8D; DSPA2c,interferon induced transmembrane protein 2,11p15.5,protein-coding,/
CWITA002069,TCMBANKGE002069,TBC1D30,-,TBC1 domain family member 30,12q14.3,protein-coding,/
CWITA002070,TCMBANKGE002070,SH2D3C,CHAT; NSP3; PRO34088; SHEP1,SH2 domain containing 3C,9q34.11,protein-coding,/
CWITA002071,TCMBANKGE002071,HES2,bHLHb40,hes family bHLH transcription factor 2,1p36.31,protein-coding,/
CWITA002072,TCMBANKGE002072,PHRF1,PPP1R125; RNF221,PHD and ring finger domains 1,11p15.5,protein-coding,/
CWITA002073,TCMBANKGE002073,MEF2A,ADCAD1; RSRFC4; RSRFC9; mef2,myocyte enhancer factor 2A,15q26.3,protein-coding,/
CWITA002074,TCMBANKGE002074,INHBA,EDF; FRP,inhibin subunit beta A,7p14.1,protein-coding,/
CWITA002075,TCMBANKGE002075,IFT57,ESRRBL1; HIPPI; MHS4R2; OFD18,intraflagellar transport 57,3q13.12-q13.13,protein-coding,/
CWITA002076,TCMBANKGE002076,CRP,MGC149895; MGC88244; PTX1,"C-reactive protein, pentraxin-related",1q21-q23,protein-coding,
CWITA002077,TCMBANKGE002077,LUC7L,LUC7B1; Luc7; SR+89; hLuc7B1,LUC7 like,16p13.3,protein-coding,/
CWITA002078,TCMBANKGE002078,PIGP,DCRC; DCRC-S; DSCR5; DSRC; EIEE55; PIG-P,phosphatidylinositol glycan anchor biosynthesis class P,21q22.13,protein-coding,/
CWITA002079,TCMBANKGE002079,ZC3H12C,MCPIP3,zinc finger CCCH-type containing 12C,11q22.3,protein-coding,/
CWITA002080,TCMBANKGE002080,Ea2,Ea-2; H-14; R; R-Z; RHO,erythrocyte antigen 2,-,unknown,/
CWITA002081,TCMBANKGE002081,COA1,C7orf44; MITRAC15,cytochrome c oxidase assembly factor 1 homolog,7p13,protein-coding,/
CWITA002082,TCMBANKGE002082,GABRQ,MGC129629; MGC129630; THETA,"gamma-aminobutyric acid (GABA) receptor, theta",Xq28,protein-coding,
CWITA002083,TCMBANKGE002083,SIGLEC7,AIRM1; CD328; CDw328; DNsiglec; QA79; SIGLECN7; p75; p75/AIRM1,sialic acid binding Ig-like lectin 7,19q13.3,protein-coding,
CWITA002084,TCMBANKGE002084,ITPKC,IP3-3KC; IP3KC,inositol-trisphosphate 3-kinase C,19q13.2,protein-coding,/
CWITA002085,TCMBANKGE002085,CDC123,C10orf7; D123,cell division cycle 123,10p14-p13,protein-coding,/
CWITA002086,TCMBANKGE002086,WNT6,-,Wnt family member 6,2q35,protein-coding,/
CWITA002087,TCMBANKGE002087,ADAM33,C20orf153; DJ964F7.1,ADAM metallopeptidase domain 33,20p13,protein-coding,Research target
CWITA002088,TCMBANKGE002088,GADD45GIP1,CKBBP2; CKbetaBP2; CRIF1; MRP-L59; PLINP; PLINP-1; PRG6; Plinp1,GADD45G interacting protein 1,19p13.13,protein-coding,/
CWITA002089,TCMBANKGE002089,TNMD,BRICD4; CHM1L; TEM,tenomodulin,Xq22.1,protein-coding,/
CWITA002090,TCMBANKGE002090,HOMER3,HOMER-3; VESL3,homer scaffold protein 3,19p13.11,protein-coding,/
CWITA002091,TCMBANKGE002091,GLRA2,GLR,glycine receptor alpha 2,Xp22.2,protein-coding,/
CWITA002092,TCMBANKGE002092,FZD7,FzE3,frizzled class receptor 7,2q33.1,protein-coding,Clinical Trial target
CWITA002093,TCMBANKGE002093,RPL18,DBA18; L18,ribosomal protein L18,19q13.33,protein-coding,/
CWITA002094,TCMBANKGE002094,CAPN3,CANP3; CANPL3; LGMD2; LGMD2A; LGMDD4; LGMDR1; nCL-1; p94,calpain 3,15q15.1,protein-coding,/
CWITA002095,TCMBANKGE002095,HAUS3,C4orf15; IT1; dgt3,HAUS augmin like complex subunit 3,4p16.3,protein-coding,/
CWITA002096,TCMBANKGE002096,EFCAB6,DJBP; HSCBCIP1; dJ185D5.1,EF-hand calcium binding domain 6,22q13.2-q13.31,protein-coding,/
CWITA002097,TCMBANKGE002097,GPR107,GCDRP; LUSTR1; bA138E2.2,G protein-coupled receptor 107,9q34.11,protein-coding,/
CWITA002098,TCMBANKGE002098,NAGLU,CMT2V; MPS-IIIB; MPS3B; NAG; UFHSD,N-acetyl-alpha-glucosaminidase,17q21.2,protein-coding,Successful target
CWITA002099,TCMBANKGE002099,DHRS7C,SDR32C2,dehydrogenase/reductase 7C,17p13.1,protein-coding,/
CWITA002100,TCMBANKGE002100,CEACAM16,CEAL2; DFNA4B; DFNB113,"CEA cell adhesion molecule 16, tectorial membrane component",19q13.31-q13.32,protein-coding,/
CWITA002101,TCMBANKGE002101,TGM3,TGE; UHS2,transglutaminase 3,20p13,protein-coding,/
CWITA002102,TCMBANKGE002102,RUNX1T1,AML1-MTG8; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2,RUNX1 partner transcriptional co-repressor 1,8q21.3,protein-coding,/
CWITA002103,TCMBANKGE002103,MDH1,HEL-S-32; MDH-s; MDHA; MGC:1375; MOR2,malate dehydrogenase 1,2p15,protein-coding,/
CWITA002104,TCMBANKGE002104,UBA5,EIEE44; SCAR24; THIFP1; UBE1DC1,ubiquitin like modifier activating enzyme 5,3q22.1,protein-coding,/
CWITA002105,TCMBANKGE002105,KCNB2,KV2.2,"potassium voltage-gated channel, Shab-related subfamily, member 2",8q13.2,protein-coding,
CWITA002106,TCMBANKGE002106,EFCAB14,KIAA0494,EF-hand calcium binding domain 14,1p33,protein-coding,/
CWITA002107,TCMBANKGE002107,SMIM14,C4orf34,small integral membrane protein 14,4p14,protein-coding,/
CWITA002108,TCMBANKGE002108,CDCP1,CD318; SIMA135; TRASK,CUB domain containing protein 1,3p21.31,protein-coding,/
CWITA002109,TCMBANKGE002109,MTCH1,CGI-64; PIG60; PSAP; SLC25A49,mitochondrial carrier 1,6p21.2,protein-coding,/
CWITA002110,TCMBANKGE002110,VBP1,HIBBJ46; PFD3; PFDN3; VBP-1,VHL binding protein 1,Xq28,protein-coding,/
CWITA002111,TCMBANKGE002111,JPH1,CMT2K; JP-1; JP1,junctophilin 1,8q21.11,protein-coding,/
CWITA002112,TCMBANKGE002112,NCAPD2,CAP-D2; CNAP1; MCPH21; hCAP-D2,non-SMC condensin I complex subunit D2,12p13.31,protein-coding,/
CWITA002113,TCMBANKGE002113,CTSC,CPPI; DPP-I; DPP1; DPPI; HMS; JP; JPD; PALS; PDON1; PLS,cathepsin C,11q14.2,protein-coding,Clinical Trial target
CWITA002114,TCMBANKGE002114,SEPSECS,LP; PCH2D; SLA; SLA/LP,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4p15.2,protein-coding,/
CWITA002115,TCMBANKGE002115,HLA-F,CDA12; HLA-5.4; HLA-CDA12; HLAF,"major histocompatibility complex, class I, F",6p22.1,protein-coding,/
CWITA002116,TCMBANKGE002116,ANKIB1,-,ankyrin repeat and IBR domain containing 1,7q21.2,protein-coding,/
CWITA002117,TCMBANKGE002117,SLC6A8,CRT; CRTR; CT1; MGC87396,"solute carrier family 6 (neurotransmitter transporter, creatine), member 8",Xq28,protein-coding,
CWITA002118,TCMBANKGE002118,GPR176,HB-954,G protein-coupled receptor 176,15q14-q15.1,protein-coding,/
CWITA002119,TCMBANKGE002119,AEN,ISG20L1; pp12744,apoptosis enhancing nuclease,15q26.1,protein-coding,/
CWITA002120,TCMBANKGE002120,TMEM98,TADA1,transmembrane protein 98,17q11.2,protein-coding,/
CWITA002121,TCMBANKGE002121,MTMR11,CRA,myotubularin related protein 11,1q21.2,protein-coding,/
CWITA002122,TCMBANKGE002122,RPL13A,L13A; TSTA1,ribosomal protein L13a,19q13.33,protein-coding,/
CWITA002123,TCMBANKGE002123,NET1,ARHGEF8; NET1A,neuroepithelial cell transforming 1,10p15.1,protein-coding,/
CWITA002124,TCMBANKGE002124,SLC15A3,OCTP; PHT2; PTR3,solute carrier family 15 member 3,11q12.2,protein-coding,Research target
CWITA002125,TCMBANKGE002125,SLC10A7,C4orf13; P7; SSASKS,solute carrier family 10 member 7,4q31.22,protein-coding,/
CWITA002126,TCMBANKGE002126,SRXN1,C20orf139; Npn3; SRX; SRX1,sulfiredoxin 1,20p13,protein-coding,/
CWITA002127,TCMBANKGE002127,PRKCG,MGC57564; PKCNgamma; PKCC; PKCG; SCA14,"protein kinase C, gamma",19q13.4,protein-coding,
CWITA002128,TCMBANKGE002128,NUDC,HNUDC; MNUDC; NPD011,"nuclear distribution C, dynein complex regulator",1p36.11,protein-coding,/
CWITA002129,TCMBANKGE002129,SELENOP,SELP; SEPP; SEPP1; SeP,selenoprotein P,5p12,protein-coding,/
CWITA002130,TCMBANKGE002130,ARHGEF16,GEF16; NBR,Rho guanine nucleotide exchange factor 16,1p36.32,protein-coding,/
CWITA002131,TCMBANKGE002131,ATP5MF,ATP5J2; ATP5JL,ATP synthase membrane subunit f,7q22.1,protein-coding,/
CWITA002132,TCMBANKGE002132,ZNF585A,Zfp27,zinc finger protein 585A,19q13.12,protein-coding,/
CWITA002133,TCMBANKGE002133,HRK,DP5; HARAKIRI,"harakiri, BCL2 interacting protein",12q24.22,protein-coding,/
CWITA002134,TCMBANKGE002134,SCLT1,CAP-1A; CAP1A,sodium channel and clathrin linker 1,4q28.2,protein-coding,/
CWITA002135,TCMBANKGE002135,ACAA2,DSAEC,acetyl-CoA acyltransferase 2,18q21.1,protein-coding,/
CWITA002136,TCMBANKGE002136,GBA,GBA1; GCB; GLUC,glucosylceramidase beta,1q22,protein-coding,Successful target
CWITA002137,TCMBANKGE002137,PSEN1,ACNINV3; AD3; FAD; PS-1; PS1; S182,presenilin 1,14q24.2,protein-coding,Clinical Trial target
CWITA002138,TCMBANKGE002138,S100A6,2A9; 5B10; CABP; CACY; PRA; S10A6,S100 calcium binding protein A6,1q21.3,protein-coding,Research target
CWITA002139,TCMBANKGE002139,FCSK,1110046B12Rik; CDGF2; FUK,fucose kinase,16q22.1,protein-coding,/
CWITA002140,TCMBANKGE002140,GP9,CD42a; GPIX,glycoprotein IX (platelet),3q21.3,protein-coding,
CWITA002141,TCMBANKGE002141,ZNF439,-,zinc finger protein 439,19p13.2,protein-coding,/
CWITA002142,TCMBANKGE002142,TRMT112,HSPC152; HSPC170; TRM112; TRMT11-2; hTrm112,tRNA methyltransferase subunit 11-2,11q13.1,protein-coding,/
CWITA002143,TCMBANKGE002143,KIF19,KIF19A,kinesin family member 19,17q25.1,protein-coding,/
CWITA002144,TCMBANKGE002144,YARS,CMTDIC; TYRRS; YRS; YTS,tyrosyl-tRNA synthetase,1p35.1,protein-coding,
CWITA002145,TCMBANKGE002145,SLC10A2,ASBT; IBAT; ISBT; NTCP2; PBAM,"solute carrier family 10 (sodium/bile acid cotransporter family), member 2",13q33,protein-coding,
CWITA002146,TCMBANKGE002146,MS4A2,APY; ATOPY; FCER1B; FCERI; IGEL; IGER; IGHER; MS4A1,membrane spanning 4-domains A2,11q12.1,protein-coding,/
CWITA002147,TCMBANKGE002147,MCAM,CD146; HEMCAM; METCAM; MUC18; MelCAM,melanoma cell adhesion molecule,11q23.3,protein-coding,Research target
CWITA002148,TCMBANKGE002148,ZNF32,KOX30; ZNF637; Zfp637,zinc finger protein 32,10q11.21,protein-coding,/
CWITA002149,TCMBANKGE002149,Car9,CAIX; Ca9; MN/CA9,carbonic anhydrase 9,4|4 A5,protein-coding,/
CWITA002150,TCMBANKGE002150,RNF39,FAP216; HZF; HZFW; LIRF,ring finger protein 39,6p22.1,protein-coding,/
CWITA002151,TCMBANKGE002151,RPS19,DBA; DBA1; LOH19CR1; S19; eS19,ribosomal protein S19,19q13.2,protein-coding,/
CWITA002152,TCMBANKGE002152,ZSCAN22,HKR2; ZNF50,zinc finger and SCAN domain containing 22,19q13.43,protein-coding,/
CWITA002153,TCMBANKGE002153,TMSB10,MIG12; TB10,thymosin beta 10,2p11.2,protein-coding,/
CWITA002154,TCMBANKGE002154,KCNJ3,GIRK1; KGA; KIR3.1,"potassium inwardly-rectifying channel, subfamily J, member 3",2q24.1,protein-coding,
CWITA002155,TCMBANKGE002155,SLC17A8,DFNA25; VGLUT3,solute carrier family 17 member 8,12q23.1,protein-coding,/
CWITA002156,TCMBANKGE002156,GPR156,GABABL; PGR28,G protein-coupled receptor 156,3q13.33,protein-coding,/
CWITA002157,TCMBANKGE002157,PAFAH1B3,PAFAHG,platelet activating factor acetylhydrolase 1b catalytic subunit 3,19q13.2,protein-coding,/
CWITA002158,TCMBANKGE002158,PARP15,ARTD7; BAL3; pART7,poly(ADP-ribose) polymerase family member 15,3q21.1,protein-coding,/
CWITA002159,TCMBANKGE002159,PDPN,AGGRUS; GP36; GP40; Gp38; HT1A-1; OTS8; PA2.26; T1A; T1A-2; T1A2; TI1A,podoplanin,1p36.21,protein-coding,/
CWITA002160,TCMBANKGE002160,PCOLCE2,PCPE2,procollagen C-endopeptidase enhancer 2,3q23,protein-coding,/
CWITA002161,TCMBANKGE002161,CHCHD1,C10orf34; C2360; MRP-S37,coiled-coil-helix-coiled-coil-helix domain containing 1,10q22.2,protein-coding,/
CWITA002162,TCMBANKGE002162,ADGRE2,CD312; CD97; EMR2; VBU,adhesion G protein-coupled receptor E2,19p13.12,protein-coding,/
CWITA002163,TCMBANKGE002163,ZC2HC1C,C14orf140; FAM164C,zinc finger C2HC-type containing 1C,14q24.3,protein-coding,/
CWITA002164,TCMBANKGE002164,ERLIN1,C10orf69; Erlin-1; KE04; KEO4; SPFH1; SPG62,ER lipid raft associated 1,10q24.31,protein-coding,/
CWITA002165,TCMBANKGE002165,SMTNL2,-,smoothelin like 2,17p13.2,protein-coding,/
CWITA002166,TCMBANKGE002166,EEF1AKMT1,ESP13; N6AMT2,EEF1A lysine methyltransferase 1,13q12.11,protein-coding,/
CWITA002167,TCMBANKGE002167,MTM1,CNM; MTMX; XLMTM,myotubularin 1,Xq28,protein-coding,Research target
CWITA002168,TCMBANKGE002168,CHKB-CPT1B,CHKL-CPT1B; CPT1-M; CPT1B; CPTI-M,CHKB-CPT1B readthrough (NMD candidate),22q13.33,ncRNA,/
CWITA002169,TCMBANKGE002169,DNAJC22,wus,DnaJ heat shock protein family (Hsp40) member C22,12q13.12,protein-coding,/
CWITA002170,TCMBANKGE002170,ICAM4,CD242; LW,intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),19p13.2,protein-coding,/
CWITA002171,TCMBANKGE002171,RALY,HNRPCL2; P542,RALY heterogeneous nuclear ribonucleoprotein,20q11.22,protein-coding,/
CWITA002172,TCMBANKGE002172,COPB2,MCPH19; beta'-COP,COPI coat complex subunit beta 2,3q23,protein-coding,/
CWITA002173,TCMBANKGE002173,REV3L,POLZ; REV3,"REV3 like, DNA directed polymerase zeta catalytic subunit",6q21,protein-coding,/
CWITA002174,TCMBANKGE002174,TRPC1,HTRP-1; TRP1,transient receptor potential cation channel subfamily C member 1,3q23,protein-coding,Research target
CWITA002175,TCMBANKGE002175,COL3A1,EDS4A; EDSVASC; PMGEDSV,collagen type III alpha 1 chain,2q32.2,protein-coding,/
CWITA002176,TCMBANKGE002176,SUPT20H,C13; C13orf19; FAM48A; FP757; P38IP; SPT20,"SPT20 homolog, SAGA complex component",13q13.3,protein-coding,/
CWITA002177,TCMBANKGE002177,MPPED2,239FB; C11orf8,metallophosphoesterase domain containing 2,11p14.1,protein-coding,/
CWITA002178,TCMBANKGE002178,NRP1,BDCA4; CD304; NP1; NRP; VEGF165R,neuropilin 1,10p11.22,protein-coding,Successful target
CWITA002179,TCMBANKGE002179,ZNF322,HCG12; ZNF322A; ZNF388; ZNF489,zinc finger protein 322,6p22.2,protein-coding,/
CWITA002180,TCMBANKGE002180,CEACAM8,CD66b; CD67; CGM6; NCA-95,CEA cell adhesion molecule 8,19q13.2,protein-coding,/
CWITA002181,TCMBANKGE002181,NHLRC2,FINCA,NHL repeat containing 2,10q25.3,protein-coding,/
CWITA002182,TCMBANKGE002182,NEK2,HsPK21; NEK2A; NLK1; PPP1R111; RP67,NIMA related kinase 2,1q32.3,protein-coding,Research target
CWITA002183,TCMBANKGE002183,SLC22A2,2021/10/2,solute carrier family 22 member 2,6q25.3,protein-coding,/
CWITA002184,TCMBANKGE002184,NDUFB6,B17; CI; MGC13675,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa",9p21.1,protein-coding,
CWITA002185,TCMBANKGE002185,BMP5,-,bone morphogenetic protein 5,6p12.1,protein-coding,/
CWITA002186,TCMBANKGE002186,MAGOHB,MGN2; mago; magoh,"mago homolog B, exon junction complex subunit",12p13.2,protein-coding,/
CWITA002187,TCMBANKGE002187,FAAP100,C17orf70,FA core complex associated protein 100,17q25.3,protein-coding,/
CWITA002188,TCMBANKGE002188,FAM83G,PAWS1,family with sequence similarity 83 member G,17p11.2,protein-coding,/
CWITA002189,TCMBANKGE002189,WDR20,DMR,WD repeat domain 20,14q32.31,protein-coding,/
CWITA002190,TCMBANKGE002190,SLC25A24,APC1; SCAMC-1; SCAMC1,solute carrier family 25 member 24,1p13.3,protein-coding,/
CWITA002191,TCMBANKGE002191,TDO2,TDO; TPH2; TRPO,"tryptophan 2,3-dioxygenase",4q31-q32,protein-coding,
CWITA002192,TCMBANKGE002192,PDE7A,HCP1; PDE7,phosphodiesterase 7A,8q13.1,protein-coding,Discontinued target
CWITA002193,TCMBANKGE002193,CEACAM6,CD66c; CEAL; NCA,CEA cell adhesion molecule 6,19q13.2,protein-coding,Research target
CWITA002194,TCMBANKGE002194,DLAT,DLTA; PDCNE2; PDCE2,dihydrolipoamide S-acetyltransferase,11q23.1,protein-coding,
CWITA002195,TCMBANKGE002195,ADH1B,ADH2; HEL-S-117,"alcohol dehydrogenase 1B (class I), beta polypeptide",4q23,protein-coding,/
CWITA002196,TCMBANKGE002196,REPIN1,AP4; RIP60; ZNF464; Zfp464,replication initiator 1,7q36.1,protein-coding,/
CWITA002197,TCMBANKGE002197,TMED2,P24A; RNP24; p24; p24b1; p24beta1,transmembrane p24 trafficking protein 2,12q24.31,protein-coding,/
CWITA002198,TCMBANKGE002198,DEK,D6S231E,DEK proto-oncogene,6p22.3,protein-coding,Research target
CWITA002199,TCMBANKGE002199,SLC30A2,PP12488; TNZD; ZNT2; ZnT-2,solute carrier family 30 member 2,1p36.11,protein-coding,/
CWITA002200,TCMBANKGE002200,TNNI3,CMD1FF; CMD2A; CMH7; MGC116817; RCM1; TNNC1; cTnI,troponin I type 3 (cardiac),19q13.4,protein-coding,
CWITA002201,TCMBANKGE002201,ATP1B1,ATP1B,ATPase Na+/K+ transporting subunit beta 1,1q24.2,protein-coding,/
CWITA002202,TCMBANKGE002202,UQCRQ,QCR8; QPNC; QPC; UQCR7,"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa",5q31.1,protein-coding,
CWITA002203,TCMBANKGE002203,FGR,FLJ43153; MGC75096; SRC2; cNfgr; cNsrc2; p55NFgr; p55cNfgr; p58cNfgr,Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog,1p36.2-p36.1,protein-coding,
CWITA002204,TCMBANKGE002204,TRIP6,OIP-1; OIP1; TRIP-6; TRIP6i2; ZRP-1,thyroid hormone receptor interactor 6,7q22.1,protein-coding,/
CWITA002205,TCMBANKGE002205,ABCA7,ABCA-SSN; ABCX; AD9,ATP binding cassette subfamily A member 7,19p13.3,protein-coding,/
CWITA002206,TCMBANKGE002206,RNF17,Mmip-2; SPATA23; TDRD4,ring finger protein 17,13q12.12,protein-coding,/
CWITA002207,TCMBANKGE002207,PCDH10,OL-PCDH; PCDH19,protocadherin 10,4q28.3,protein-coding,/
CWITA002208,TCMBANKGE002208,POLR1C,AC40; HLD11; RPA39; RPA40; RPA5; RPAC1; RPC40; TCS3,RNA polymerase I and III subunit C,6p21.1,protein-coding,/
CWITA002209,TCMBANKGE002209,TNFRSF9,4-1BB; CD137; CDw137; ILA,TNF receptor superfamily member 9,1p36.23,protein-coding,Clinical Trial target
CWITA002210,TCMBANKGE002210,FAR1,MLSTD2; PFCRD; SDR10E1,fatty acyl-CoA reductase 1,11p15.3,protein-coding,/
CWITA002211,TCMBANKGE002211,SPINK1,PCTT; PSTI; Spink3; TATI; TCP,serine peptidase inhibitor Kazal type 1,5q32,protein-coding,/
CWITA002212,TCMBANKGE002212,PDCD2,RP8; ZMYND7,programmed cell death 2,6q27,protein-coding,Clinical Trial target
CWITA002213,TCMBANKGE002213,TBC1D25,MG81; OATL1,TBC1 domain family member 25,Xp11.23,protein-coding,/
CWITA002214,TCMBANKGE002214,NNMT,N,nicotinamide N-methyltransferase,11q23.1,protein-coding,
CWITA002215,TCMBANKGE002215,AEBP2,-,AE binding protein 2,12p12.3,protein-coding,/
CWITA002216,TCMBANKGE002216,FAM216A,C12orf24; HSU79274,family with sequence similarity 216 member A,12q24.11,protein-coding,/
CWITA002217,TCMBANKGE002217,NRAP,N-RAP,nebulin related anchoring protein,10q25.3,protein-coding,/
CWITA002218,TCMBANKGE002218,GABRG3,-,gamma-aminobutyric acid type A receptor subunit gamma3,15q12,protein-coding,Successful target
CWITA002219,TCMBANKGE002219,CDC34,E2-CDC34; UBC3; UBCH3; UBE2R1,"cell division cycle 34, ubiqiutin conjugating enzyme",19p13.3,protein-coding,/
CWITA002220,TCMBANKGE002220,GRIN2C,NMDAR2C; NR2C,"glutamate receptor, ionotropic, N-methyl D-aspartate 2C",17q25,protein-coding,
CWITA002221,TCMBANKGE002221,TLR3,CD283,Toll-Like Receptor 3,4q35,protein-coding,
CWITA002222,TCMBANKGE002222,IL32,IL-32alpha; IL-32beta; IL-32delta; IL-32gamma; NK4; TAIF; TAIFa; TAIFb; TAIFc; TAIFd,interleukin 32,16p13.3,protein-coding,Research target
CWITA002223,TCMBANKGE002223,CDC25B,N,cell division cycle 25 homolog B (S. pombe),20p13,protein-coding,
CWITA002224,TCMBANKGE002224,U2AF1,FP793; RN; RNU2AF1; U2AF35; U2AFBP,U2 small nuclear RNA auxiliary factor 1,21q22.3,protein-coding,/
CWITA002225,TCMBANKGE002225,BCLAF1,BTF; bK211L9.1,BCL2 associated transcription factor 1,6q23.3,protein-coding,/
CWITA002226,TCMBANKGE002226,SERPINB12,YUKOPIN,serpin family B member 12,18q21.33,protein-coding,/
CWITA002227,TCMBANKGE002227,TDRD9,C14orf75; HIG-1; HLS; NET54; SPGF30; SPNE,tudor domain containing 9,14q32.33,protein-coding,/
CWITA002228,TCMBANKGE002228,LRRN3,FIGLER5; NLRR-3; NLRR3,leucine rich repeat neuronal 3,7q31.1,protein-coding,/
CWITA002229,TCMBANKGE002229,Salpa3,-,serum alkaline phosphatase activity 3,-,unknown,/
CWITA002230,TCMBANKGE002230,USP46,-,ubiquitin specific peptidase 46,4q12,protein-coding,/
CWITA002231,TCMBANKGE002231,Ccl27a,ALP; AW558992; CTACK; CTAK; Ccl27; ESkine; ILC; PESKY; Scya27; Scya27a,chemokine (C-C motif) ligand 27A,4 A5|4 22.08 cM,protein-coding,/
CWITA002232,TCMBANKGE002232,DUSP27,-,"dual specificity phosphatase 27, atypical",1q24.1,protein-coding,/
CWITA002233,TCMBANKGE002233,POLR1G,ASE-1; ASE1; CAST; CD3EAP; PAF49; RPA34,RNA polymerase I subunit G,19q13.32,protein-coding,/
CWITA002234,TCMBANKGE002234,DHX29,DDX29,DExH-box helicase 29,5q11.2,protein-coding,/
CWITA002235,TCMBANKGE002235,FAAH2,AMDD,fatty acid amide hydrolase 2,Xp11.21,protein-coding,Research target
CWITA002236,TCMBANKGE002236,CA6,CANVI; GUSTIN; MGC21256,carbonic anhydrase VI,1p36.2,protein-coding,
CWITA002237,TCMBANKGE002237,SLC20A1,GLVR1; Glvr-1; PIT1; PiT-1,solute carrier family 20 member 1,2q14.1,protein-coding,/
CWITA002238,TCMBANKGE002238,PTPN1,PTP1B,"protein tyrosine phosphatase, non-receptor type 1",20q13.1-q13.2,protein-coding,
CWITA002239,TCMBANKGE002239,H2BW2,H2BFM; H2BM,H2B.W histone 2,Xq22.2,protein-coding,/
CWITA002240,TCMBANKGE002240,FLNB,ABP-278; ABP-280; AOI; FH1; FLN-B; FLN1L; LRS1; SCT; TABP; TAP,filamin B,3p14.3,protein-coding,/
CWITA002241,TCMBANKGE002241,GNAS,AHO; C20orf45; GNAS1; GPSA; GSA; GSP; MGC33735; NESP; PHP1A; PHP1B; PHP1C; POH,GNAS complex locus,20q13.3,protein-coding,
CWITA002242,TCMBANKGE002242,HEY2,CHF1; GRIDLOCK; GRL; HERP1; HESR2; HRT2; bHLHb32,hes related family bHLH transcription factor with YRPW motif 2,6q22.31,protein-coding,/
CWITA002243,TCMBANKGE002243,SLC9A3,DIAR8; NHE-3; NHE3,solute carrier family 9 member A3,5p15.33,protein-coding,Clinical Trial target
CWITA002244,TCMBANKGE002244,IL2,ILN2; TCGF; lymphokine,interleukin 2,4q26-q27,protein-coding,
CWITA002245,TCMBANKGE002245,VTI1A,MMDS3; MVti1; VTI1RP2; Vti1-rp2,vesicle transport through interaction with t-SNAREs 1A,10q25.2,protein-coding,/
CWITA002246,TCMBANKGE002246,CCRL2,ACKR5; CKRX; CRAM; CRAM-A; CRAM-B; HCR,C-C motif chemokine receptor like 2,3p21.31,protein-coding,/
CWITA002247,TCMBANKGE002247,TNFSF9,4-1BB-L; CD137L; TNLG5A,TNF superfamily member 9,19p13.3,protein-coding,/
CWITA002248,TCMBANKGE002248,FAAH,FAAH-1; PSAB,fatty acid amide hydrolase,1p33,protein-coding,/
CWITA002249,TCMBANKGE002249,GYG2,GN-2; GN2,glycogenin 2,Xp22.33,protein-coding,/
CWITA002250,TCMBANKGE002250,GJD2,CX36; GJA9,gap junction protein delta 2,15q14,protein-coding,Research target
CWITA002251,TCMBANKGE002251,COPS3,CSN3; SGN3,COP9 signalosome subunit 3,17p11.2,protein-coding,/
CWITA002252,TCMBANKGE002252,OAS1,E18/E16; IFI-4; OIAS; OIASI,2'-5'-oligoadenylate synthetase 1,12q24.13,protein-coding,/
CWITA002253,TCMBANKGE002253,ARSD,ASD,Arylsulfatase_D,Xp22.33,protein-coding,
CWITA002254,TCMBANKGE002254,SLC19A2,TC1; THMD1; THT1; THTR1; TRMA,solute carrier family 19 member 2,1q24.2,protein-coding,Research target
CWITA002255,TCMBANKGE002255,PDGFRB,CD140B; JTK12; PDGFR; PDGFR1,"platelet-derived growth factor receptor, beta polypeptide",5q33.1,protein-coding,
CWITA002256,TCMBANKGE002256,RHOJ,ARHJ; RASL7B; TC10B; TCL,ras homolog family member J,14q23.2,protein-coding,/
CWITA002257,TCMBANKGE002257,OR10G3,OR14-40,olfactory receptor family 10 subfamily G member 3,14q11.2,protein-coding,/
CWITA002258,TCMBANKGE002258,HTR3C,-,5-hydroxytryptamine receptor 3C,3q27.1,protein-coding,/
CWITA002259,TCMBANKGE002259,TMPO,CMD1T; LAP2; LEMD4; PRO0868; TP,thymopoietin,12q23.1,protein-coding,/
CWITA002260,TCMBANKGE002260,ITIH2,H2P; SHAP,inter-alpha-trypsin inhibitor heavy chain 2,10p14,protein-coding,/
CWITA002261,TCMBANKGE002261,SPAST,ADPSP; FSP2; SPG4,spastin,2p22.3,protein-coding,/
CWITA002262,TCMBANKGE002262,PROKR1,GPR73; GPR73a; PK-R1; PKR1; ZAQ,prokineticin receptor 1,2p13.3,protein-coding,Research target
CWITA002263,TCMBANKGE002263,OTUD1,DUBA7; OTDC1,OTU deubiquitinase 1,10p12.2,protein-coding,/
CWITA002264,TCMBANKGE002264,ACKR3,CMKOR1; CXC-R7; CXCR-7; CXCR7; GPR159; RDC-1; RDC1,atypical chemokine receptor 3,2q37.3,protein-coding,Discontinued target
CWITA002265,TCMBANKGE002265,TIAM1,TIAM-1,TIAM Rac1 associated GEF 1,21q22.11,protein-coding,Research target
CWITA002266,TCMBANKGE002266,RPL13A,L13A; TSTA1,ribosomal protein L13a,19q13.3,protein-coding,
CWITA002267,TCMBANKGE002267,ADAM11,MDC,ADAM metallopeptidase domain 11,17q21.31,protein-coding,/
CWITA002268,TCMBANKGE002268,ZNF418,-,zinc finger protein 418,19q13.43,protein-coding,/
CWITA002269,TCMBANKGE002269,MAP2K6,MAPKK6; MEK6; MKK6; PRKMK6; SAPKK-3; SAPKK3,mitogen-activated protein kinase kinase 6,17q24.3,protein-coding,/
CWITA002270,TCMBANKGE002270,TMED10P1,S31I125; S31III125; TMED10; TMED10P; TMP21; Tmp-21-I; Tmp21-II; p23; p24delta; p24delta1,transmembrane p24 trafficking protein 10 pseudogene 1,8q24.3,pseudo,/
CWITA002271,TCMBANKGE002271,CCR10,GPR2,C-C motif chemokine receptor 10,17q21.2,protein-coding,/
CWITA002272,TCMBANKGE002272,EXTL2,EXTR2,exostosin like glycosyltransferase 2,1p21.2,protein-coding,/
CWITA002273,TCMBANKGE002273,EFCAB9,-,EF-hand calcium binding domain 9,5q35.1,protein-coding,/
CWITA002274,TCMBANKGE002274,LGALS14,CLC2; PPL13,galectin 14,19q13.2,protein-coding,/
CWITA002275,TCMBANKGE002275,DGCR6,-,DiGeorge syndrome critical region gene 6,22q11.21|22q11,protein-coding,/
CWITA002276,TCMBANKGE002276,FBXO30,Fbx30,F-box protein 30,6q24.3,protein-coding,/
CWITA002277,TCMBANKGE002277,IFFO2,-,intermediate filament family orphan 2,1p36.13,protein-coding,/
CWITA002278,TCMBANKGE002278,ABCB10,EST20237; M-ABC2; MTABC2,ATP binding cassette subfamily B member 10,1q42.13,protein-coding,/
CWITA002279,TCMBANKGE002279,TACR1,NK1R; NKIR; SPR; TAC1R,tachykinin receptor 1,2p12,protein-coding,
CWITA002280,TCMBANKGE002280,TRIM16,EBBP,tripartite motif containing 16,17p12,protein-coding,/
CWITA002281,TCMBANKGE002281,GNAI2,GIP; GNAI2B; H_LUCA15.1; H_LUCA16.1,G protein subunit alpha i2,3p21.31,protein-coding,/
CWITA002282,TCMBANKGE002282,FOXF2,FKHL6; FREAC-2; FREAC2,forkhead box F2,6p25.3,protein-coding,/
CWITA002283,TCMBANKGE002283,AKR1A1,ALDR1; ALR; ARM; DD3; MGC12529; MGC1380,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",1p33-p32,protein-coding,
CWITA002284,TCMBANKGE002284,TMEM259,ASBABP1; C19orf6; MBRL; MEMBRALIN; R32184_3,transmembrane protein 259,19p13.3,protein-coding,/
CWITA002285,TCMBANKGE002285,CYP3A7,CP37; CYPIIIA7; P-450(HFL33); P-450111A7; P450-HFLA; P450HLp2,cytochrome P450 family 3 subfamily A member 7,7q22.1,protein-coding,/
CWITA002286,TCMBANKGE002286,CALY,DRD1IP; NSG3,calcyon neuron-specific vesicular protein,10q26.3,protein-coding,
CWITA002287,TCMBANKGE002287,ZFP91,DMS-8; DSM-8; FKSG11; PZF; ZFP-91; ZNF757,"ZFP91 zinc finger protein, atypical E3 ubiquitin ligase",11q12.1,protein-coding,/
CWITA002288,TCMBANKGE002288,OASL,OASL1; OASLd; TRIP-14; TRIP14; p59 OASL; p59-OASL; p59OASL,2'-5'-oligoadenylate synthetase like,12q24.31,protein-coding,/
CWITA002289,TCMBANKGE002289,RBP4,N,"retinol binding protein 4, plasma",10q23-q24,protein-coding,
CWITA002290,TCMBANKGE002290,CDHR3,CDH28,cadherin related family member 3,7q22.3,protein-coding,/
CWITA002291,TCMBANKGE002291,CPSF3,CPSF-73; CPSF73,cleavage and polyadenylation specific factor 3,2p25.1,protein-coding,/
CWITA002292,TCMBANKGE002292,ZNF423,Ebfaz; JBTS19; NPHP14; OAZ; Roaz; ZFP423; Zfp104; hOAZ,zinc finger protein 423,16q12.1,protein-coding,/
CWITA002293,TCMBANKGE002293,PLEKHA6,PEPP-3; PEPP3,pleckstrin homology domain containing A6,1q32.1,protein-coding,/
CWITA002294,TCMBANKGE002294,VARS,G7A; VARS1; VARS2,valyl-tRNA synthetase,6p21.3,protein-coding,
CWITA002295,TCMBANKGE002295,UQCRB,FLJ92016; FLJ97033; QCR7; QPNC; QPC; UQBC; UQBP; UQCR6; UQPC,ubiquinol-cytochrome c reductase binding protein,8q22,protein-coding,
CWITA002296,TCMBANKGE002296,BEST3,VMD2L3,bestrophin 3,12q15,protein-coding,/
CWITA002297,TCMBANKGE002297,CREB3,LUMAN; LZIP; sLZIP,cAMP responsive element binding protein 3,9p13.3,protein-coding,/
CWITA002298,TCMBANKGE002298,KRT6C,K6E; KRT6E; PPKNEFD,keratin 6C,12q13.13,protein-coding,/
CWITA002299,TCMBANKGE002299,ZNF347,ZNF1111,zinc finger protein 347,19q13.42,protein-coding,/
CWITA002300,TCMBANKGE002300,MAPK4,ERK-4; ERK4; PRKM4; p63-MAPK; p63MAPK,mitogen-activated protein kinase 4,18q21.1-q21.2,protein-coding,/
CWITA002301,TCMBANKGE002301,SFRP4,FRP-4; FRPHE; FRZB-2; PYL; sFRP-4,secreted frizzled related protein 4,7p14.1,protein-coding,Research target
CWITA002302,TCMBANKGE002302,MADCAM1,MACAM1,mucosal vascular addressin cell adhesion molecule 1,19p13.3,protein-coding,Clinical Trial target
CWITA002303,TCMBANKGE002303,RAMP1,-,receptor activity modifying protein 1,2q37.3,protein-coding,/
CWITA002304,TCMBANKGE002304,STK32A,YANK1,serine/threonine kinase 32A,5q32,protein-coding,/
CWITA002305,TCMBANKGE002305,SLC25A43,-,solute carrier family 25 member 43,Xq24,protein-coding,/
CWITA002306,TCMBANKGE002306,MED14,CRSP150; CRSP2; CSRP; CXorf4; DRIP150; EXLM1; RGR1; TRAP170,mediator complex subunit 14,Xp11.4,protein-coding,/
CWITA002307,TCMBANKGE002307,LIN7A,LIN-7A; LIN7; MALS-1; MALS1; TIP-33; VELI1,"lin-7 homolog A, crumbs cell polarity complex component",12q21.31,protein-coding,/
CWITA002308,TCMBANKGE002308,SCAPER,IDDRP; MSTP063; ZNF291; Zfp291,S-phase cyclin A associated protein in the ER,15q24.3,protein-coding,/
CWITA002309,TCMBANKGE002309,PPM1B,PP2C-beta; PP2C-beta-X; PP2CB; PP2CBETA; PPC2BETAX,"protein phosphatase, Mg2+/Mn2+ dependent 1B",2p21,protein-coding,/
CWITA002310,TCMBANKGE002310,SEC61A1,HNFJ4; HSEC61; SEC61; SEC61A,SEC61 translocon subunit alpha 1,3q21.3,protein-coding,/
CWITA002311,TCMBANKGE002311,SLC38A4,ATA3; NAT3; PAAT; SNAT4,solute carrier family 38 member 4,12q13.11,protein-coding,Research target
CWITA002312,TCMBANKGE002312,ERICH1,HSPC319,glutamate rich 1,8p23.3,protein-coding,/
CWITA002313,TCMBANKGE002313,FBXL8,FBL8,F-box and leucine rich repeat protein 8,16q22.1,protein-coding,/
CWITA002314,TCMBANKGE002314,MMP24,MMP-24; MMP25; MT-MMP 5; MT-MMP5; MT5-MMP; MT5MMP; MTMMP5,matrix metallopeptidase 24,20q11.22,protein-coding,/
CWITA002315,TCMBANKGE002315,TAOK1,KFC-B; MAP3K16; MARKK; PSK-2; PSK2; TAO1; hKFC-B; hTAOK1,TAO kinase 1,17q11.2,protein-coding,Research target
CWITA002316,TCMBANKGE002316,PTMA,TMSA,prothymosin alpha,2q37.1,protein-coding,/
CWITA002317,TCMBANKGE002317,SFTPC,BRICD6; PSP-C; SFTP2; SMDP2; SP-C; SP5,surfactant protein C,8p21.3,protein-coding,/
CWITA002318,TCMBANKGE002318,CLPB,ANKCLB; HSP78; MEGCANN; MGCA7; SKD3,caseinolytic mitochondrial matrix peptidase chaperone subunit B,11q13.4,protein-coding,/
CWITA002319,TCMBANKGE002319,EVI2A,EVDA; EVI-2A; EVI2,ecotropic viral integration site 2A,17q11.2,protein-coding,/
CWITA002320,TCMBANKGE002320,TPBG,5T4; 5T4AG; M6P1; WAIF1,trophoblast glycoprotein,6q14.1,protein-coding,Clinical Trial target
CWITA002321,TCMBANKGE002321,SSTR1,SRIF-2; SS-1-R; SS1-R; SS1R,somatostatin receptor 1,14q21.1,protein-coding,Successful target
CWITA002322,TCMBANKGE002322,MASP2,MAP19; MASPN2; MASP1P1; sMAP,mannan-binding lectin serine peptidase 2,1p36.3-p36.2,protein-coding,
CWITA002323,TCMBANKGE002323,BICD1,BICD; bic-D 1,BICD cargo adaptor 1,12p11.21,protein-coding,/
CWITA002324,TCMBANKGE002324,KCNJ1,KIR1.1; ROMK; ROMK1,potassium inwardly rectifying channel subfamily J member 1,11q24.3,protein-coding,Patented target
CWITA002325,TCMBANKGE002325,OAZ1,AZI; MGC138338; OAZ,ornithine decarboxylase antizyme 1,19p13.3,protein-coding,
CWITA002326,TCMBANKGE002326,RBM12,HRIHFB2091; SCZD19; SWAN,RNA binding motif protein 12,20q11.22,protein-coding,/
CWITA002327,TCMBANKGE002327,FGD4,CMT4H; FRABP; ZFYVE6,"FYVE, RhoGEF and PH domain containing 4",12p11.21,protein-coding,/
CWITA002328,TCMBANKGE002328,EVI2B,CD361; D17S376; EVDB,ecotropic viral integration site 2B,17q11.2,protein-coding,/
CWITA002329,TCMBANKGE002329,CYP4F12,F22329_1,"cytochrome P450, family 4, subfamily F, polypeptide 12",19p13.1,protein-coding,
CWITA002330,TCMBANKGE002330,C17orf58,-,chromosome 17 open reading frame 58,17q24.2,protein-coding,/
CWITA002331,TCMBANKGE002331,LMNB1,ADLD; LMN; LMN2; LMNB,lamin B1,5q23.2,protein-coding,/
CWITA002332,TCMBANKGE002332,ABCC3,ABC31; DKFZp686E22157; EST90757; MLP2; MOATND; MRP3; cMOAT2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 3",17q22,protein-coding,
CWITA002333,TCMBANKGE002333,HOXB4,HOX-2.6; HOX2; HOX2F,homeobox B4,17q21.32,protein-coding,/
CWITA002334,TCMBANKGE002334,TEP1,TLP1; TP1; TROVE1; VAULT2; p240,telomerase associated protein 1,14q11.2,protein-coding,Research target
CWITA002335,TCMBANKGE002335,EMC9,C14orf122; CGI-112; FAM158A,ER membrane protein complex subunit 9,14q12,protein-coding,/
CWITA002336,TCMBANKGE002336,UQCRB,MC3DN3; QCR7; QP-C; QPC; UQBC; UQBP; UQCR6; UQPC,ubiquinol-cytochrome c reductase binding protein,8q22.1,protein-coding,/
CWITA002337,TCMBANKGE002337,TPM2,AMCD1; DA1; DA2B; DA2B4; HEL-S-273; NEM4; TMSB,tropomyosin 2,9p13.3,protein-coding,/
CWITA002338,TCMBANKGE002338,TM4SF1,H-L6; L6; M3S1; TAAL6,transmembrane 4 L six family member 1,3q25.1,protein-coding,/
CWITA002339,TCMBANKGE002339,GHR,GHBP; GHIP,growth hormone receptor,5p13.1-p12,protein-coding,Clinical Trial target
CWITA002340,TCMBANKGE002340,KLC3,KLC2; KLC2L; KLCt; KNS2B,kinesin light chain 3,19q13.32,protein-coding,/
CWITA002341,TCMBANKGE002341,FADD,GIG3; MORT1,Fas associated via death domain,11q13.3,protein-coding,/
CWITA002342,TCMBANKGE002342,GNAI3,87U6; ARCND1,G protein subunit alpha i3,1p13.3,protein-coding,/
CWITA002343,TCMBANKGE002343,GNB1,MRD42,G protein subunit beta 1,1p36.33,protein-coding,/
CWITA002344,TCMBANKGE002344,HEMK1,HEMK; MPRMC; MTQ1,HemK methyltransferase family member 1,3p21.31,protein-coding,/
CWITA002345,TCMBANKGE002345,ZFY,MGC138710; ZNF911,"zinc finger protein, Y-linked",Yp11.3,protein-coding,
CWITA002346,TCMBANKGE002346,G6PD,G6PD1,glucose-6-phosphate dehydrogenase,Xq28,protein-coding,
CWITA002347,TCMBANKGE002347,RPS25,S25,ribosomal protein S25,11q23.3,protein-coding,/
CWITA002348,TCMBANKGE002348,Ptprs,AL022616; PTP; PTP-NU3; PTPNU-3; PTPsigma; Ptpt9; R-PTP-S; RPTPsigma,"protein tyrosine phosphatase, receptor type, S",17 D|17 29.32 cM,protein-coding,
CWITA002349,TCMBANKGE002349,CRLF3,CREME-9; CREME9; CRLM9; CYTOR4; FRWS; p48.2,cytokine receptor like factor 3,17q11.2,protein-coding,/
CWITA002350,TCMBANKGE002350,SLC26A1,CAON; EDM4; SAT-1; SAT1,solute carrier family 26 member 1,4p16.3,protein-coding,/
CWITA002351,TCMBANKGE002351,CPPED1,CSTP1,calcineurin like phosphoesterase domain containing 1,16p13.12,protein-coding,/
CWITA002352,TCMBANKGE002352,STARD9,KIF16A,StAR related lipid transfer domain containing 9,15q15.2,protein-coding,/
CWITA002353,TCMBANKGE002353,TPSD1,MCP7-LIKE; MCP7L1; MMCP-7L,tryptase delta 1,16p13.3,protein-coding,Research target
CWITA002354,TCMBANKGE002354,RABIF,MSS4; RASGFR3; RASGRF3,RAB interacting factor,1q32.1,protein-coding,/
CWITA002355,TCMBANKGE002355,HAMP,HEPC; HFE2B; LEAP1; PLTR,hepcidin antimicrobial peptide,19q13.12,protein-coding,Research target
CWITA002356,TCMBANKGE002356,CSAD,CSD; FLJ44987; FLJ45500; MGC119354; MGC119355; MGC119357; PCAP,cysteine sulfinic acid decarboxylase,12q13.11-q14.3,protein-coding,
CWITA002357,TCMBANKGE002357,SCN4B,N,"sodium channel, voltage-gated, type IV, beta",11q23.3,protein-coding,
CWITA002358,TCMBANKGE002358,CDK8,K35; MGC126074; MGC126075,cyclin-dependent kinase 8,13q12,protein-coding,
CWITA002359,TCMBANKGE002359,CLDN10,CPETRL3; HELIX; OSP-L; OSPL,claudin 10,13q32.1,protein-coding,/
CWITA002360,TCMBANKGE002360,CDHR1,CORD15; PCDH21; PRCAD; RP65,cadherin related family member 1,10q23.1,protein-coding,/
CWITA002361,TCMBANKGE002361,TK2,MTDPS2; MTTK,"thymidine kinase 2, mitochondrial",16q22-q23.1,protein-coding,
CWITA002362,TCMBANKGE002362,GPR22,-,G protein-coupled receptor 22,7q22.3,protein-coding,/
CWITA002363,TCMBANKGE002363,DHX16,DBP2; DDX16; NMOAS; PRO2014; PRP8; PRPF2; Prp2,DEAH-box helicase 16,6p21.33,protein-coding,/
CWITA002364,TCMBANKGE002364,UPF1,HUPF1; NORF1; RENT1; pNORF1; smg-2,UPF1 RNA helicase and ATPase,19p13.11,protein-coding,/
CWITA002365,TCMBANKGE002365,HSD17B12,KAR; SDR12C1,hydroxysteroid 17-beta dehydrogenase 12,11p11.2,protein-coding,/
CWITA002366,TCMBANKGE002366,KCTD9,BTBD27,potassium channel tetramerization domain containing 9,8p21.2,protein-coding,/
CWITA002367,TCMBANKGE002367,GXYLT2,GLT8D4,glucoside xylosyltransferase 2,3p13,protein-coding,/
CWITA002368,TCMBANKGE002368,TRIB2,C5FW; GS3955; TRB2,tribbles pseudokinase 2,2p24.3,protein-coding,/
CWITA002369,TCMBANKGE002369,RDH5,9cRDH; HSD17B9; RDH1; SDR9C5,retinol dehydrogenase 5,12q13.2,protein-coding,/
CWITA002370,TCMBANKGE002370,DDC,AADC,dopa decarboxylase (aromatic L-amino acid decarboxylase),7p12.2,protein-coding,
CWITA002371,TCMBANKGE002371,SNX13,RGS-PX1,sorting nexin 13,7p21.1,protein-coding,/
CWITA002372,TCMBANKGE002372,IGFBP7,AGM; FSTL2; IBP-7; IGFBP-7; IGFBP-7v; IGFBPRP1; MAC25; PSF; RAMSVPS; TAF,insulin like growth factor binding protein 7,4q12,protein-coding,Research target
CWITA002373,TCMBANKGE002373,CCNDBP1,DIP1; GCIP; HHM,cyclin D1 binding protein 1,15q15.2,protein-coding,/
CWITA002374,TCMBANKGE002374,RPL21,HYPT12; L21,ribosomal protein L21,13q12.2,protein-coding,/
CWITA002375,TCMBANKGE002375,ZNF219,ZFP219,zinc finger protein 219,14q11.2,protein-coding,/
CWITA002376,TCMBANKGE002376,LRRC9,-,leucine rich repeat containing 9,14q23.1,protein-coding,/
CWITA002377,TCMBANKGE002377,CXCR5,BLR1; CD185; MDR15,C-X-C motif chemokine receptor 5,11q23.3,protein-coding,Clinical Trial target
CWITA002378,TCMBANKGE002378,CCDC15,-,coiled-coil domain containing 15,11q24.2,protein-coding,/
CWITA002379,TCMBANKGE002379,LRRC69,-,leucine rich repeat containing 69,8q21.3,protein-coding,/
CWITA002380,TCMBANKGE002380,TRIM74,TRIM50C,tripartite motif containing 74,7q11.23,protein-coding,/
CWITA002381,TCMBANKGE002381,GIP,-,gastric inhibitory polypeptide,17q21.32,protein-coding,Research target
CWITA002382,TCMBANKGE002382,GRIK5,EAA2; GRIK2; KA2,"glutamate receptor, ionotropic, kainate 5",19q13.2,protein-coding,
CWITA002383,TCMBANKGE002383,RLN2,H2; H2-RLX; RLXH2; bA12D24.1.1; bA12D24.1.2,relaxin 2,9p24.1,protein-coding,/
CWITA002384,TCMBANKGE002384,INO80,INO80A; INOC1,INO80 complex ATPase subunit,15q15.1,protein-coding,/
CWITA002385,TCMBANKGE002385,GRID1,KIAA1220,"glutamate receptor, ionotropic, delta 1",10q22,protein-coding,
CWITA002386,TCMBANKGE002386,IKBKB,FLJ33771; FLJ36218; FLJ38368; FLJ40509; IKKNbeta; IKK2; IKKB; MGC131801; NFKBIKB,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta",8p11.2,protein-coding,
CWITA002387,TCMBANKGE002387,RIN3,-,Ras and Rab interactor 3,14q32.12,protein-coding,/
CWITA002388,TCMBANKGE002388,NR3C2,MCR; MLR; MR; NR3C2VIT,nuclear receptor subfamily 3 group C member 2,4q31.23,protein-coding,Successful target
CWITA002389,TCMBANKGE002389,NAALAD2,GCPIII; GPCIII; NAADALASE2; NAALADASE2,N-acetylated alpha-linked acidic dipeptidase 2,11q14.3,protein-coding,Research target
CWITA002390,TCMBANKGE002390,EDN2,ET-2; ET2; PPET2,endothelin 2,1p34.2,protein-coding,Research target
CWITA002391,TCMBANKGE002391,LPAR3,EDG7; Edg-7; GPCR; HOFNH30; LP-A3; LPA3; RP4-678I3,lysophosphatidic acid receptor 3,1p22.3,protein-coding,Clinical Trial target
CWITA002392,TCMBANKGE002392,HIPK2,PRO0593,homeodomain interacting protein kinase 2,7q34,protein-coding,Research target
CWITA002393,TCMBANKGE002393,GRPR,BB2; BB2R,gastrin releasing peptide receptor,Xp22.2,protein-coding,Clinical Trial target
CWITA002394,TCMBANKGE002394,CHD2,EEOC,chromodomain helicase DNA binding protein 2,15q26.1,protein-coding,/
CWITA002395,TCMBANKGE002395,HLA-DOA,HLA-DNA; HLA-DZA; HLADZ,"major histocompatibility complex, class II, DO alpha",6p21.32,protein-coding,/
CWITA002396,TCMBANKGE002396,NDUFA5,B13; CIN13KDNB; CIN13kB; DKFZp781K1356; FLJ12147; NUFM; UQOR13,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa",7q32,protein-coding,
CWITA002397,TCMBANKGE002397,ERO1B,ERO1LB; Ero1beta,Endoplasmic_Reticulum_Oxidoreductase_1_Beta,1q42.3,protein-coding,
CWITA002398,TCMBANKGE002398,RRAGD,RAGD; bA11D8.2.1,Ras related GTP binding D,6q15,protein-coding,/
CWITA002399,TCMBANKGE002399,TAF9,MGC:5067; STAF31/32; TAF2G; TAFII-31; TAFII-32; TAFII31; TAFII32; TAFIID32,TATA-box binding protein associated factor 9,5q13.2,protein-coding,/
CWITA002400,TCMBANKGE002400,AFG3L2,FLJ25993; SCA28,AFG3 ATPase family gene 3-like 2 (S. cerevisiae),18p11,protein-coding,
CWITA002401,TCMBANKGE002401,TRAPPC10,EHOC-1; EHOC1; GT334; TMEM1; TRS130; TRS30,trafficking protein particle complex 10,21q22.3,protein-coding,/
CWITA002402,TCMBANKGE002402,ERCC6L,PICH; RAD26L,"ERCC excision repair 6 like, spindle assembly checkpoint helicase",Xq13.1,protein-coding,/
CWITA002403,TCMBANKGE002403,SETD5,-,SET domain containing 5,3p25.3,protein-coding,/
CWITA002404,TCMBANKGE002404,ANKRD42,PPP1R79; SARP,ankyrin repeat domain 42,11q14.1,protein-coding,/
CWITA002405,TCMBANKGE002405,LAGE3,CVG5; DXS9879E; DXS9951E; ESO3; GAMOS2; ITBA2; Pcc1,L antigen family member 3,Xq28,protein-coding,/
CWITA002406,TCMBANKGE002406,MRGPRF,GPR140; GPR168; MRGF; RTA,MAS related GPR family member F,11q13.3,protein-coding,/
CWITA002407,TCMBANKGE002407,VAMP4,VAMP-4; VAMP24,vesicle associated membrane protein 4,1q24.3,protein-coding,/
CWITA002408,TCMBANKGE002408,RNASE1,MGC12408; RIB1; RNS1,"ribonuclease, RNase A family, 1 (pancreatic)",14q11.2,protein-coding,
CWITA002409,TCMBANKGE002409,RHOC,ARH9; ARHC; H9; RHOH9,ras homolog family member C,1p13.2,protein-coding,/
CWITA002410,TCMBANKGE002410,PITX2,ARP1; ASGD4; Brx1; IDG2; IGDS; IGDS2; IHG2; IRID2; Otlx2; PTX2; RGS; RIEG; RIEG1; RS,paired like homeodomain 2,4q25,protein-coding,/
CWITA002411,TCMBANKGE002411,BCL11B,ATL1; ATL1-alpha; ATL1-beta; ATL1-delta; ATL1-gamma; CTIP-2; CTIP2; IDDFSTA; IMD49; RIT1; ZNF856B; hRIT1-alpha,BAF chromatin remodeling complex subunit BCL11B,14q32.2,protein-coding,/
CWITA002412,TCMBANKGE002412,RNPEPL1,-,arginyl aminopeptidase like 1,2q37.3,protein-coding,/
CWITA002413,TCMBANKGE002413,EFNA4,EFL4; EPLG4; LERK4,ephrin A4,1q21.3,protein-coding,/
CWITA002414,TCMBANKGE002414,TRPM5,LTRPC5; MTR1,transient receptor potential cation channel subfamily M member 5,11p15.5,protein-coding,Research target
CWITA002415,TCMBANKGE002415,ATG13,KIAA0652; PARATARG8,autophagy related 13,11p11.2,protein-coding,/
CWITA002416,TCMBANKGE002416,KNTC1,ROD,kinetochore associated 1,12q24.31,protein-coding,/
CWITA002417,TCMBANKGE002417,KCNA6,HBK2; KV1.6; PPP1R96,potassium voltage-gated channel subfamily A member 6,12p13.32,protein-coding,Research target
CWITA002418,TCMBANKGE002418,DNAJC10,ERdj5; JPDI; MTHr; PDIA19,DnaJ heat shock protein family (Hsp40) member C10,2q32.1,protein-coding,/
CWITA002419,TCMBANKGE002419,CD320,8D6; 8D6A; TCBLR; TCN2R,CD320 molecule,19p13.2,protein-coding,Research target
CWITA002420,TCMBANKGE002420,OPHN1,ARHGAP41; MRX60; OPN1,oligophrenin 1,Xq12,protein-coding,Research target
CWITA002421,TCMBANKGE002421,RWDD3,RSUME,RWD domain containing 3,1p21.3,protein-coding,/
CWITA002422,TCMBANKGE002422,ASRGL1,ALP; ALP1; CRASH; FLJ22316,asparaginase like 1,11q12.3,protein-coding,
CWITA002423,TCMBANKGE002423,XYLT1,DBQD2; PXYLT1; XT-I; XT1; XTI; XYLTI; xylT-I,xylosyltransferase 1,16p12.3,protein-coding,/
CWITA002424,TCMBANKGE002424,STEAP1,PRSS24; STEAP,STEAP family member 1,7q21.13,protein-coding,Clinical Trial target
CWITA002425,TCMBANKGE002425,OTOA,CT108; DFNB22,otoancorin,16p12.2|16p12.2,protein-coding,/
CWITA002426,TCMBANKGE002426,AVPR2,ADHR; DI1; DIR; DIR3; MGC126533; MGC138386; NDI; V2R,arginine vasopressin receptor 2,Xq28,protein-coding,
CWITA002427,TCMBANKGE002427,BUB1,BUB1A; BUB1L; hBUB1,BUB1 mitotic checkpoint serine/threonine kinase,2q13,protein-coding,Research target
CWITA002428,TCMBANKGE002428,PDIA4,ERP70; ERP72; ERp-72,protein disulfide isomerase family A member 4,7q36.1,protein-coding,/
CWITA002429,TCMBANKGE002429,CYP1B1,CP1B; GLC3A; P4501B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",2p21,protein-coding,
CWITA002430,TCMBANKGE002430,POU6F1,BRN5; MPOU; TCFB1,POU class 6 homeobox 1,12q13.13,protein-coding,/
CWITA002431,TCMBANKGE002431,ARID1A,B120; BAF250; BAF250a; BM029; C1orf4; CSS2; ELD; MRD14; OSA1; P270; SMARCF1; hELD; hOSA1,AT-rich interaction domain 1A,1p36.11,protein-coding,/
CWITA002432,TCMBANKGE002432,PSME2,PA28B; PA28beta; REGbeta,proteasome activator subunit 2,14q12,protein-coding,/
CWITA002433,TCMBANKGE002433,MTTP,ABL; MGC149819; MGC149820; MTP,microsomal triglyceride transfer protein,4q24,protein-coding,
CWITA002434,TCMBANKGE002434,GLCCI1,FAM117C; GCTR; GIG18; TSSN1,Glucocorticoid_Induced_1,7p21.3,protein-coding,
CWITA002435,TCMBANKGE002435,UCP3,SLC25A9,uncoupling protein 3,11q13.4,protein-coding,Clinical Trial target
CWITA002436,TCMBANKGE002436,PSMG3,C7orf48; PAC3,proteasome assembly chaperone 3,7p22.3,protein-coding,/
CWITA002437,TCMBANKGE002437,MTRNR2L12,HN12,MT-RNR2 like 12,3q11.2,pseudo,/
CWITA002438,TCMBANKGE002438,N4BP2L1,CG018,NEDD4 binding protein 2 like 1,13q13.1,protein-coding,/
CWITA002439,TCMBANKGE002439,CAPS2,UG0636c06,calcyphosine 2,12q21.1-q21.2,protein-coding,/
CWITA002440,TCMBANKGE002440,TBX3,TBX3-ISO; UMS; XHL,T-box transcription factor 3,12q24.21,protein-coding,/
CWITA002441,TCMBANKGE002441,TMPRSS7,-,transmembrane serine protease 7,3q13.2,protein-coding,/
CWITA002442,TCMBANKGE002442,NT5E,CALJA; CD73; E5NT; NT; NT5; NTE; eN; eNT,5'-nucleotidase ecto,6q14.3,protein-coding,Clinical Trial target
CWITA002443,TCMBANKGE002443,TSPAN19,-,tetraspanin 19,12q21.31,protein-coding,/
CWITA002444,TCMBANKGE002444,CD8B,CD8B1; LEU2; LY3; LYT3; P37,CD8b molecule,2p11.2,protein-coding,/
CWITA002445,TCMBANKGE002445,GHRL,MTLRP,ghrelin and obestatin prepropeptide,3p25.3,protein-coding,Clinical Trial target
CWITA002446,TCMBANKGE002446,AQP3,AQP-3; GIL,aquaporin 3 (Gill blood group),9p13.3,protein-coding,Research target
CWITA002447,TCMBANKGE002447,CRTC2,TORC-2; TORC2,CREB regulated transcription coactivator 2,1q21.3,protein-coding,Research target
CWITA002448,TCMBANKGE002448,TCAIM,C3orf23; TOAG-1; TOAG1,"T cell activation inhibitor, mitochondrial",3p21.31,protein-coding,/
CWITA002449,TCMBANKGE002449,HSD17B4,DBP; MFEN2; MPFN2; SDR8C1,hydroxysteroid (17-beta) dehydrogenase 4,5q21,protein-coding,
CWITA002450,TCMBANKGE002450,FUT6,FCT3A; FT1A; Fuc-TVI; FucT-VI,fucosyltransferase 6,19p13.3,protein-coding,/
CWITA002451,TCMBANKGE002451,PRMT8,HRMT1L3; HRMT1L4,protein arginine methyltransferase 8,12p13.32,protein-coding,/
CWITA002452,TCMBANKGE002452,MYO1G,HA2; HLA-HA2; MHAG,myosin IG,7p13,protein-coding,/
CWITA002453,TCMBANKGE002453,MYO15A,DFNB3; MYO15,myosin XVA,17p11.2,protein-coding,/
CWITA002454,TCMBANKGE002454,RPA2,REPA2; RP-A p32; RP-A p34; RPA32,replication protein A2,1p35.3,protein-coding,/
CWITA002455,TCMBANKGE002455,SEMA4G,-,semaphorin 4G,10q24.31,protein-coding,/
CWITA002456,TCMBANKGE002456,NELFE,D6S45; NELF-E; RD; RDBP; RDP,negative elongation factor complex member E,6p21.33,protein-coding,/
CWITA002457,TCMBANKGE002457,CCDC17,-,coiled-coil domain containing 17,1p34.1,protein-coding,/
CWITA002458,TCMBANKGE002458,CEP57L1,C6orf182; bA487F23.2; cep57R,centrosomal protein 57 like 1,6q21,protein-coding,/
CWITA002459,TCMBANKGE002459,GRHL3,SOM; TFCP2L4; VWS2,grainyhead like transcription factor 3,1p36.11,protein-coding,/
CWITA002460,TCMBANKGE002460,PDE8B,ADSD; FLJ11212; PPNAD3,phosphodiesterase 8B,5q13.3,protein-coding,
CWITA002461,TCMBANKGE002461,PLK1,PLK; STPK13,polo-like kinase 1,16p12.2,protein-coding,
CWITA002462,TCMBANKGE002462,ADPRM,C17orf48; MDS006; NBLA03831,"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent",17p13.1,protein-coding,/
CWITA002463,TCMBANKGE002463,AOC3,HPAO; SSAO; VAP-1; VAP1,amine oxidase copper containing 3,17q21.31,protein-coding,Successful target
CWITA002464,TCMBANKGE002464,TF,DKFZp781D0156; PRO1557; PRO2086,transferrin,3q22.1,protein-coding,
CWITA002465,TCMBANKGE002465,KRT73,IRT6IRS3; K6IRS3; KRT6IRS3,keratin 73,12q13.13,protein-coding,/
CWITA002466,TCMBANKGE002466,HAVCR2,CD366; HAVcr-2; KIM-3; SPTCL; TIM3; TIMD-3; TIMD3; Tim-3,hepatitis A virus cellular receptor 2,5q33.3,protein-coding,/
CWITA002467,TCMBANKGE002467,LIN28B,CSDD2,lin-28 homolog B,6q16.3-q21,protein-coding,/
CWITA002468,TCMBANKGE002468,TUBA3C,TUBA2; TUBA3D; bA408E5.3,"tubulin, alpha 3c",13q11,protein-coding,
CWITA002469,TCMBANKGE002469,DQX1,-,DEAQ-box RNA dependent ATPase 1,2p13.1,protein-coding,/
CWITA002470,TCMBANKGE002470,VAMP3,CEB,vesicle associated membrane protein 3,1p36.23,protein-coding,/
CWITA002471,TCMBANKGE002471,NCOA5,CIA; bA465L10.6,nuclear receptor coactivator 5,20q12-q13.12,protein-coding,
CWITA002472,TCMBANKGE002472,VMA21,MEAX; XMEA,vacuolar ATPase assembly factor VMA21,Xq28,protein-coding,/
CWITA002473,TCMBANKGE002473,DSC2,ARVD11; CDHF2; DG2; DGII/III; DSC3,desmocollin 2,18q12.1,protein-coding,/
CWITA002474,TCMBANKGE002474,ZNF774,-,zinc finger protein 774,15q26.1,protein-coding,/
CWITA002475,TCMBANKGE002475,SDR9C7,ARCI13; RDHS; SDR-O; SDRO,short chain dehydrogenase/reductase family 9C member 7,12q13.3,protein-coding,/
CWITA002476,TCMBANKGE002476,STK17A,DRAK1,serine/threonine kinase 17a,7p13,protein-coding,Research target
CWITA002477,TCMBANKGE002477,PLEKHO1,CKIP-1; CKIP1; JBP; OC120,pleckstrin homology domain containing O1,1q21.2,protein-coding,/
CWITA002478,TCMBANKGE002478,TFAP2B,AP-2B; AP2-B; PDA2,transcription factor AP-2 beta,6p12.3,protein-coding,/
CWITA002479,TCMBANKGE002479,SERPINA7,FLJ17820; TBG,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7",Xq22.2,protein-coding,
CWITA002480,TCMBANKGE002480,MAPK11,P38B; P38BETA2; PRKM11; SAPK2; SAPK2B; p38-2; p38Beta,mitogen-activated protein kinase 11,22q13.33,protein-coding,Clinical Trial target
CWITA002481,TCMBANKGE002481,APOM,G3a; HSPC336; MGC22400; NG20,apolipoprotein M,6p21.33,protein-coding,
CWITA002482,TCMBANKGE002482,NUBPL,C14orf127; IND1; MC1DN21; huInd1,nucleotide binding protein like,14q12,protein-coding,/
CWITA002483,TCMBANKGE002483,HMGN3,PNAS-24; PNAS-25; TRIP7,high mobility group nucleosomal binding domain 3,6q14.1,protein-coding,/
CWITA002484,TCMBANKGE002484,MAP4K2,BL44; GCK; RAB8IP,mitogen-activated protein kinase kinase kinase kinase 2,11q13.1,protein-coding,Patented target
CWITA002485,TCMBANKGE002485,PHEX,HPDR; HPDR1; HYP; HYP1; LXHR; PEX; XLH,phosphate regulating endopeptidase homolog X-linked,Xp22.11,protein-coding,/
CWITA002486,TCMBANKGE002486,ZNF283,HZF19; HZF41,zinc finger protein 283,19q13.31,protein-coding,/
CWITA002487,TCMBANKGE002487,SMPDL3A,ASM3A; ASML3a; yR36GH4.1,sphingomyelin phosphodiesterase acid like 3A,6q22.31,protein-coding,/
CWITA002488,TCMBANKGE002488,MARK4,MARK4L; MARK4S; MARKL1; MARKL1L; PAR-1D,microtubule affinity regulating kinase 4,19q13.32,protein-coding,/
CWITA002489,TCMBANKGE002489,GSTA5,N,glutathione S-transferase alpha 5,6p12.2,protein-coding,
CWITA002490,TCMBANKGE002490,AZU1,AZAMP; AZU; CAP37; HBP; HUMAZUR; NAZC; hHBP,azurocidin 1,19p13.3,protein-coding,/
CWITA002491,TCMBANKGE002491,SLC5A5,NIS; TDH1,solute carrier family 5 member 5,19p13.11,protein-coding,Clinical Trial target
CWITA002492,TCMBANKGE002492,TRPM2,EREG1; KNP3; LTRPC2; LTrpC-2; NUDT9H; NUDT9L1; TRPC7,transient receptor potential cation channel subfamily M member 2,21q22.3,protein-coding,Research target
CWITA002493,TCMBANKGE002493,PGK1,HEL-S-68p; MIG10; PGKA,phosphoglycerate kinase 1,Xq21.1,protein-coding,/
CWITA002494,TCMBANKGE002494,PENK,PE; PENK-A,proenkephalin,8q12.1,protein-coding,/
CWITA002495,TCMBANKGE002495,ENO2,NSE,"enolase 2 (gamma, neuronal)",12p13,protein-coding,
CWITA002496,TCMBANKGE002496,ACTR2,ARP2,actin related protein 2,2p14,protein-coding,/
CWITA002497,TCMBANKGE002497,PISD,DJ858B16; DKFZp566G2246; PSD; PSDC; PSSC; dJ858B16.2,phosphatidylserine decarboxylase,22q12.2,protein-coding,
CWITA002498,TCMBANKGE002498,SLC2A5,GLUT-5; GLUT5,solute carrier family 2 member 5,1p36.23,protein-coding,/
CWITA002499,TCMBANKGE002499,RAB23,HSPC137,"RAB23, member RAS oncogene family",6p12.1-p11.2,protein-coding,/
CWITA002500,TCMBANKGE002500,KCNA6,FLJ25134; HBK2; KV1.6,"potassium voltage-gated channel, shaker-related subfamily, member 6",12p13,protein-coding,
CWITA002501,TCMBANKGE002501,ZIC4,-,Zic family member 4,3q24,protein-coding,/
CWITA002502,TCMBANKGE002502,GCNT4,C2GNT3; LINC01336,glucosaminyl (N-acetyl) transferase 4,5q13.3,protein-coding,/
CWITA002503,TCMBANKGE002503,CRPPA,ISPD; LGMDR20; MDDGA7; MDDGC7; Nip; hISPD,CDP-L-ribitol pyrophosphorylase A,7p21.2,protein-coding,/
CWITA002504,TCMBANKGE002504,ZNF442,-,zinc finger protein 442,19p13.2,protein-coding,/
CWITA002505,TCMBANKGE002505,POLB,MGC125976,"polymerase (DNA directed), beta",8p11.2,protein-coding,
CWITA002506,TCMBANKGE002506,CNNM1,ACDP1; CLP-1,cyclin and CBS domain divalent metal cation transport mediator 1,10q24.2,protein-coding,/
CWITA002507,TCMBANKGE002507,DLK2,DLK-2; EGFL9,delta like non-canonical Notch ligand 2,6p21.1,protein-coding,/
CWITA002508,TCMBANKGE002508,ZNF138,pHZ-32,zinc finger protein 138,7q11.21,protein-coding,/
CWITA002509,TCMBANKGE002509,TNNC2,CFAP85; FAP85,"troponin C2, fast skeletal type",20q13.12,protein-coding,Clinical Trial target
CWITA002510,TCMBANKGE002510,RPL38,L38,ribosomal protein L38,17q25.1,protein-coding,/
CWITA002511,TCMBANKGE002511,PCDHGA5,CDH-GAMMA-A5; ME3; PCDH-GAMMA-A5,"protocadherin gamma subfamily A, 5",5q31.3,protein-coding,/
CWITA002512,TCMBANKGE002512,FASTK,FAST,Fas activated serine/threonine kinase,7q36.1,protein-coding,/
CWITA002513,TCMBANKGE002513,BFAR,BAR; RNF47,bifunctional apoptosis regulator,16p13.12,protein-coding,/
CWITA002514,TCMBANKGE002514,RNF44,-,ring finger protein 44,5q35.2,protein-coding,/
CWITA002515,TCMBANKGE002515,SERPINB3,HsT1196; SCC; SCCAN1; SCCANPD; SCCA1; T4NA,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",18q21.3,protein-coding,
CWITA002516,TCMBANKGE002516,GSTK1,GST; GST 13-13; GST13; GST13-13; GSTK1-1; hGSTK1,glutathione S-transferase kappa 1,7q34,protein-coding,/
CWITA002517,TCMBANKGE002517,LCN1,MGC71975; PMFA; TLC; TP; VEGP,lipocalin 1 (tear prealbumin),9q34,protein-coding,
CWITA002518,TCMBANKGE002518,TBCK,HSPC302; IHPRF3; TBCKL,TBC1 domain containing kinase,4q24,protein-coding,/
CWITA002519,TCMBANKGE002519,ZNF34,KOX32,zinc finger protein 34,8q24.3,protein-coding,/
CWITA002520,TCMBANKGE002520,TCHH,THH; THL; TRHY; UHS3,trichohyalin,1q21.3,protein-coding,/
CWITA002521,TCMBANKGE002521,CACNA1A,APCA; BI; CACNL1A4; CAV2.1; EA2; EIEE42; FHM; HPCA; MHP; MHP1; SCA6,calcium voltage-gated channel subunit alpha1 A,19p13.13,protein-coding,Successful target
CWITA002522,TCMBANKGE002522,COX5A,COX; COXNVA; VA,cytochrome c oxidase subunit Va,15q24.1,protein-coding,
CWITA002523,TCMBANKGE002523,TCF19,SC1; TCF-19,transcription factor 19,6p21.33,protein-coding,/
CWITA002524,TCMBANKGE002524,UNC13B,MUNC13; UNC13; Unc13h2; munc13-2,unc-13 homolog B,9p13.3,protein-coding,Research target
CWITA002525,TCMBANKGE002525,DGKG,DAGK3; DGK-GAMMA,diacylglycerol kinase gamma,3q27.2-q27.3,protein-coding,/
CWITA002526,TCMBANKGE002526,BAP1,HUCEP-13; UCHL2; hucep-6,BRCA1 associated protein 1,3p21.1,protein-coding,Research target
CWITA002527,TCMBANKGE002527,PHYH,LN1; LNAP1; PAHX; PHYH1; RD,phytanoyl-CoA 2-hydroxylase,10p13,protein-coding,
CWITA002528,TCMBANKGE002528,HERPUD1,HERP; Mif1; SUP,homocysteine inducible ER protein with ubiquitin like domain 1,16q13,protein-coding,/
CWITA002529,TCMBANKGE002529,DTL,CDT2; DCAF2; L2DTL; RAMP,denticleless E3 ubiquitin protein ligase homolog,1q32.3,protein-coding,Research target
CWITA002530,TCMBANKGE002530,CERS4,LASS4; Trh1,ceramide synthase 4,19p13.2,protein-coding,/
CWITA002531,TCMBANKGE002531,DYNC2H1,ATD3; DHC1b; DHC2; DNCH2; DYH1B; SRPS2B; SRTD3; hdhc11,dynein cytoplasmic 2 heavy chain 1,11q22.3,protein-coding,/
CWITA002532,TCMBANKGE002532,POLR1F,A43; RPA43; TWISTNB,RNA polymerase I subunit F,7p21.1,protein-coding,/
CWITA002533,TCMBANKGE002533,GRIK1,EAA3; EEA3; GLR5; GLUR5,"glutamate receptor, ionotropic, kainate 1",21q22.11,protein-coding,
CWITA002534,TCMBANKGE002534,CTSG,CATG; CG; MGC23078,cathepsin G,14q11.2,protein-coding,
CWITA002535,TCMBANKGE002535,EEA1,MST105; MSTP105; ZFYVE2,early endosome antigen 1,12q22,protein-coding,
CWITA002536,TCMBANKGE002536,ACHE,ARACHE; NNACHE; YT,acetylcholinesterase,7q22,protein-coding,
CWITA002537,TCMBANKGE002537,TGFB3,ARVD; FLJ16571; TGFNbeta3,"transforming growth factor, beta 3",14q24,protein-coding,
CWITA002538,TCMBANKGE002538,PLAT,DKFZp686I03148; TNPA; TPA,"plasminogen activator, tissue",8p12,protein-coding,
CWITA002539,TCMBANKGE002539,DDX19B,DBP5; DDX19; RNAh,DEAD-box helicase 19B,16q22.1,protein-coding,/
CWITA002540,TCMBANKGE002540,AARS1,AARS; CMT2N; EIEE29,alanyl-tRNA synthetase 1,16q22.1,protein-coding,/
CWITA002541,TCMBANKGE002541,ULBP1,N2DL-1; NKG2DL1; RAET1I,UL16 binding protein 1,6q25.1,protein-coding,/
CWITA002542,TCMBANKGE002542,GYG1,GSD15; GYG,glycogenin 1,3q24,protein-coding,/
CWITA002543,TCMBANKGE002543,DNM2,CMT2M; CMTDI1; CMTDIB; DI-CMTB; DYN2; DYNII; LCCS5,dynamin 2,19p13.2,protein-coding,/
CWITA002544,TCMBANKGE002544,IDI1,IPP1; IPPI1,isopentenyl-diphosphate delta isomerase 1,10p15.3,protein-coding,/
CWITA002545,TCMBANKGE002545,ARL3,ARFL3; JBTS35; RP83,ADP ribosylation factor like GTPase 3,10q24.32,protein-coding,/
CWITA002546,TCMBANKGE002546,PFN1,ALS18,profilin 1,17p13.2,protein-coding,/
CWITA002547,TCMBANKGE002547,PRTG,IGDCC5,protogenin,15q21.3,protein-coding,/
CWITA002548,TCMBANKGE002548,SULT2A1,DHEANST; DHEAS; HST; ST2; ST2A1; ST2A3; STD; hSTa,"sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1",19q13.3,protein-coding,
CWITA002549,TCMBANKGE002549,SNX12,-,sorting nexin 12,Xq13.1,protein-coding,/
CWITA002550,TCMBANKGE002550,NPSR1,ASRT2; GPR154; GPRA; NPSR; PGR14; VRR1,neuropeptide S receptor 1,7p14.3,protein-coding,Patented target
CWITA002551,TCMBANKGE002551,GPAT4,1-AGPAT 6; AGPAT6; LPAAT-zeta; LPAATZ; TSARG7,glycerol-3-phosphate acyltransferase 4,8p11.21,protein-coding,/
CWITA002552,TCMBANKGE002552,BBS2,BBS; RP74,Bardet-Biedl syndrome 2,16q13,protein-coding,/
CWITA002553,TCMBANKGE002553,SLC26A7,SUT2,solute carrier family 26 member 7,8q21.3,protein-coding,/
CWITA002554,TCMBANKGE002554,TMEM123,KCT3; PORIMIN; PORMIN,transmembrane protein 123,11q22.2,protein-coding,/
CWITA002555,TCMBANKGE002555,HSD11B1,11-DH; 11-beta-HSD1; CORTRD2; HDL; HSD11; HSD11B; HSD11L; SDR26C1,hydroxysteroid 11-beta dehydrogenase 1,1q32.2,protein-coding,Clinical Trial target
CWITA002556,TCMBANKGE002556,PDE4A,DPDE2; PDE4; PDE46,"phosphodiesterase 4A, cAMP-specific",19p13.2,protein-coding,
CWITA002557,TCMBANKGE002557,CPA2,-,carboxypeptidase A2,7q32.2,protein-coding,/
CWITA002558,TCMBANKGE002558,COL12A1,BA209D8.1; BTHLM2; COL12A1L; DJ234P15.1; EDSMYP; UCMD2,collagen type XII alpha 1 chain,6q13-q14.1,protein-coding,/
CWITA002559,TCMBANKGE002559,CFH,AHUS1; AMBP1; ARMD4; ARMS1; CFHL3; FH; FHL1; HF; HF1; HF2; HUS,complement factor H,1q31.3,protein-coding,Clinical Trial target
CWITA002560,TCMBANKGE002560,NTSR1,NTR,neurotensin receptor 1,20q13.33,protein-coding,Clinical Trial target
CWITA002561,TCMBANKGE002561,COL9A2,DJ39G22.4; EDM2; MED; STL5,collagen type IX alpha 2 chain,1p34.2,protein-coding,/
CWITA002562,TCMBANKGE002562,DNASE1L2,DNAS1L2,deoxyribonuclease 1 like 2,16p13.3,protein-coding,/
CWITA002563,TCMBANKGE002563,GPR37,EDNRBL; PAELR; hET(B)R-LP,G protein-coupled receptor 37,7q31.33,protein-coding,/
CWITA002564,TCMBANKGE002564,GPR65,TDAG8; hTDAG8,G protein-coupled receptor 65,14q31.3,protein-coding,/
CWITA002565,TCMBANKGE002565,SLC5A7,CHT; CHT1; MGC126299; MGC126300; hCHT,"solute carrier family 5 (choline transporter), member 7",2q12,protein-coding,
CWITA002566,TCMBANKGE002566,TRIB3,C20orf97; NIPK; SINK; SKIP3; TRB3,tribbles pseudokinase 3,20p13,protein-coding,/
CWITA002567,TCMBANKGE002567,OXGR1,GPR80; GPR99; P2RY15; P2Y15; aKGR,oxoglutarate receptor 1,13q32.1,protein-coding,Research target
CWITA002568,TCMBANKGE002568,ALAD,ALADH; PBGS,aminolevulinate dehydratase,9q32,protein-coding,Successful target
CWITA002569,TCMBANKGE002569,KCND3,KCND3L; KCND3S; KSHIVB; KV4.3; MGC142035; MGC142037,"potassium voltage-gated channel, Shal-related subfamily, member 3",1p13.3,protein-coding,
CWITA002570,TCMBANKGE002570,SPO11,CT35; SPATA43; TOPVIA,SPO11 initiator of meiotic double stranded breaks,20q13.31,protein-coding,/
CWITA002571,TCMBANKGE002571,KLF10,EGR-alpha; EGRA; TIEG; TIEG1,Kruppel like factor 10,8q22.3,protein-coding,/
CWITA002572,TCMBANKGE002572,ASB16,-,ankyrin repeat and SOCS box containing 16,17q21.31,protein-coding,/
CWITA002573,TCMBANKGE002573,MICOS10,C1orf151; MINOS1; MIO10; Mic10,mitochondrial contact site and cristae organizing system subunit 10,1p36.13,protein-coding,/
CWITA002574,TCMBANKGE002574,RHBDF1,C16orf8; Dist1; EGFR-RS; gene-89; gene-90; hDist1,rhomboid 5 homolog 1,16p13.3,protein-coding,/
CWITA002575,TCMBANKGE002575,PRPF4,HPRP4; HPRP4P; PRP4; Prp4p; RP70; SNRNP60,pre-mRNA processing factor 4,9q32,protein-coding,/
CWITA002576,TCMBANKGE002576,DYNC1LI1,DLC-A; DNCLI1; LIC1,dynein cytoplasmic 1 light intermediate chain 1,3p22.3,protein-coding,/
CWITA002577,TCMBANKGE002577,NT5M,dNT-2; dNT2; mdN,"5',3'-nucleotidase, mitochondrial",17p11.2,protein-coding,/
CWITA002578,TCMBANKGE002578,RNF213,ALO17; C17orf27; KIAA1618; MYMY2; MYSTR; NET57,ring finger protein 213,17q25.3,protein-coding,/
CWITA002579,TCMBANKGE002579,RNF112,BFP; ZNF179,ring finger protein 112,17p11.2,protein-coding,/
CWITA002580,TCMBANKGE002580,GRAMD4,DIP,GRAM domain containing 4,22q13.31,protein-coding,/
CWITA002581,TCMBANKGE002581,PROP1,CPHD2; PROP-1,PROP paired-like homeobox 1,5q35.3,protein-coding,/
CWITA002582,TCMBANKGE002582,GP9,CD42a; GPIX,glycoprotein IX platelet,3q21.3,protein-coding,/
CWITA002583,TCMBANKGE002583,SLC2A12,GLUT12; GLUT8,solute carrier family 2 member 12,6q23.2,protein-coding,Research target
CWITA002584,TCMBANKGE002584,CHD7,CRG; HH5; IS3; KAL5,chromodomain helicase DNA binding protein 7,8q12.2,protein-coding,/
CWITA002585,TCMBANKGE002585,HYLS1,HLS,HYLS1 centriolar and ciliogenesis associated,11q24.2,protein-coding,/
CWITA002586,TCMBANKGE002586,SLC36A2,PAT2; TRAMD1,solute carrier family 36 member 2,5q33.1,protein-coding,Research target
CWITA002587,TCMBANKGE002587,FAM172A,C5orf21; Toupee,family with sequence similarity 172 member A,5q15,protein-coding,/
CWITA002588,TCMBANKGE002588,KLK1,KLKR; Klk6; hK1,kallikrein 1,19q13.33,protein-coding,Research target
CWITA002589,TCMBANKGE002589,FBP1,FBP,fructose-bisphosphatase 1,9q22.32,protein-coding,/
CWITA002590,TCMBANKGE002590,ZNF48,ZNF553,zinc finger protein 48,16p11.2,protein-coding,/
CWITA002591,TCMBANKGE002591,TKTL2,-,transketolase like 2,4q32.2,protein-coding,/
CWITA002592,TCMBANKGE002592,MRPL50,MRP-L50,mitochondrial ribosomal protein L50,9q31.1,protein-coding,/
CWITA002593,TCMBANKGE002593,GALNT5,GALNAC-T5; GALNACT5,polypeptide N-acetylgalactosaminyltransferase 5,2q24.1,protein-coding,/
CWITA002594,TCMBANKGE002594,SDF2,N,stromal cell-derived factor 2,17q11.2,protein-coding,
CWITA002595,TCMBANKGE002595,PLA2G2D,SPLASH; sPLA2S,"phospholipase A2, group IID",1p36.12,protein-coding,
CWITA002596,TCMBANKGE002596,GNL3L,GNL3B,G protein nucleolar 3 like,Xp11.22,protein-coding,/
CWITA002597,TCMBANKGE002597,ZSWIM8,KIAA0913,zinc finger SWIM-type containing 8,10q22.2,protein-coding,/
CWITA002598,TCMBANKGE002598,ALDH3B2,ALDH8,"aldehyde dehydrogenase 3 family, member B2",11q13,protein-coding,
CWITA002599,TCMBANKGE002599,MTMR8,-,myotubularin related protein 8,Xq11.2,protein-coding,/
CWITA002600,TCMBANKGE002600,FUS,ALS6; ETM4; FUS1; HNRNPP2; POMP75; TLS,FUS RNA binding protein,16p11.2,protein-coding,/
CWITA002601,TCMBANKGE002601,MFSD10,TETRAN; TETTRAN,major facilitator superfamily domain containing 10,4p16.3,protein-coding,/
CWITA002602,TCMBANKGE002602,SEC62,Dtrp1; HTP1; TLOC1; TP-1,"SEC62 homolog, preprotein translocation factor",3q26.2,protein-coding,/
CWITA002603,TCMBANKGE002603,RAD51B,R51H2; RAD51L1; REC2,RAD51 paralog B,14q24.1,protein-coding,/
CWITA002604,TCMBANKGE002604,SSNA1,N14; NA-14; NA14,SS nuclear autoantigen 1,9q34.3,protein-coding,/
CWITA002605,TCMBANKGE002605,IGDCC3,HsT18880; PUNC,immunoglobulin superfamily DCC subclass member 3,15q22.31,protein-coding,/
CWITA002606,TCMBANKGE002606,RUSC2,Iporin; MRT61,RUN and SH3 domain containing 2,9p13.3,protein-coding,/
CWITA002607,TCMBANKGE002607,SLC2A6,GLUT6; GLUT9; HSA011372,solute carrier family 2 member 6,9q34.2,protein-coding,/
CWITA002608,TCMBANKGE002608,PSG2,CEA; PSBG2; PSG1,pregnancy specific beta-1-glycoprotein 2,19q13.31,protein-coding,/
CWITA002609,TCMBANKGE002609,NCOA1,FNSRCN1; KAT13A; MGC129719; MGC129720; RIP160; SRC1; bHLHe42; bHLHe74,nuclear receptor coactivator 1,2p23,protein-coding,
CWITA002610,TCMBANKGE002610,PDGFD,IEGF; MGC26867; SCDGFNB; SCDGFB,platelet derived growth factor D,11q22.3,protein-coding,
CWITA002611,TCMBANKGE002611,PRUNE2,BMCC1; BNIPXL; C9orf65; KIAA0367,prune homolog 2 with BCH domain,9q21.2,protein-coding,/
CWITA002612,TCMBANKGE002612,HDAC5,HD5; NY-CO-9,histone deacetylase 5,17q21.31,protein-coding,Patented target
CWITA002613,TCMBANKGE002613,KRT19,CK19; K19; K1CS,keratin 19,17q21.2,protein-coding,Research target
CWITA002614,TCMBANKGE002614,BLNK,AGM4; BASH; BLNK-S; LY57; SLP-65; SLP65; bca,B cell linker,10q24.1,protein-coding,/
CWITA002615,TCMBANKGE002615,PLB1,PLB; PLB/LIP,phospholipase B1,2p23.2,protein-coding,/
CWITA002616,TCMBANKGE002616,THOC1,HPR1; P84; P84N5,THO complex 1,18p11.32,protein-coding,/
CWITA002617,TCMBANKGE002617,KCNB2,KV2.2,potassium voltage-gated channel subfamily B member 2,8q21.11,protein-coding,Research target
CWITA002618,TCMBANKGE002618,CFL2,NEM7,cofilin 2,14q13.1,protein-coding,/
CWITA002619,TCMBANKGE002619,DNTT,TDT,"deoxynucleotidyltransferase, terminal",10q23-q24,protein-coding,
CWITA002620,TCMBANKGE002620,GFM2,EF-G2mt; EFG2; MRRF2; MST027; MSTP027; RRF; RRF2; RRF2mt; hEFG2; mEF-G 2,GTP dependent ribosome recycling factor mitochondrial 2,5q13.3,protein-coding,/
CWITA002621,TCMBANKGE002621,SLC26A11,-,solute carrier family 26 member 11,17q25.3,protein-coding,/
CWITA002622,TCMBANKGE002622,ZGLP1,GATAD3; GLP-1; GLP1,zinc finger GATA like protein 1,19p13.2,protein-coding,/
CWITA002623,TCMBANKGE002623,PPIAP10,CRP; PPIAL2; PPIP10; dJ823G15.1,peptidylprolyl isomerase A pseudogene 10,20q13.2,pseudo,/
CWITA002624,TCMBANKGE002624,PJA1,PRAJA1; RNF70,praja ring finger ubiquitin ligase 1,Xq13.1,protein-coding,/
CWITA002625,TCMBANKGE002625,CA1,CANI; CAB; Car1,carbonic anhydrase I,8q21.2,protein-coding,
CWITA002626,TCMBANKGE002626,SPIB,SPI-B,Spi-B transcription factor,19q13.33,protein-coding,/
CWITA002627,TCMBANKGE002627,MCC,MCC1,MCC regulator of WNT signaling pathway,5q22.2,protein-coding,/
CWITA002628,TCMBANKGE002628,SLC37A4,G6PT1; G6PT2; G6PT3; GSD1b; GSD1c; GSD1d; PRO0685; TRG-19; TRG19,solute carrier family 37 member 4,11q23.3,protein-coding,Research target
CWITA002629,TCMBANKGE002629,TUBB,M40; MGC117247; MGC16435; OK/SWNcl.56; TUBB1; TUBB5,"tubulin, beta",6p21.33,protein-coding,
CWITA002630,TCMBANKGE002630,P4HA1,P4HA,prolyl 4-hydroxylase subunit alpha 1,10q22.1,protein-coding,Clinical Trial target
CWITA002631,TCMBANKGE002631,CTDNEP1,DULLARD; HSA011916; NET56,CTD nuclear envelope phosphatase 1,17p13.1,protein-coding,/
CWITA002632,TCMBANKGE002632,AKR1C2,AKR1CNpseudo; BABP; DD; DD2; DDH2; FLJ53800; HAKRD; HBAB; MCDR2,"aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)",10p15-p14,protein-coding,
CWITA002633,TCMBANKGE002633,C1orf21,PIG13,chromosome 1 open reading frame 21,1q25.3,protein-coding,/
CWITA002634,TCMBANKGE002634,HK1,HK1Nta; HK1Ntb; HK1Ntc; HKI; HXK1,hexokinase 1,10q22,protein-coding,
CWITA002635,TCMBANKGE002635,PHF20,C20orf104; GLEA2; HCA58; NZF; TDRD20A; TZP,PHD finger protein 20,20q11.22-q11.23,protein-coding,/
CWITA002636,TCMBANKGE002636,ASPM,ASP; Calmbp1; MCPH5,assembly factor for spindle microtubules,1q31.3,protein-coding,/
CWITA002637,TCMBANKGE002637,SLC22A1,HOCT1; OCT1; oct1_cds,"solute carrier family 22 (organic cation transporter), member 1",6q26,protein-coding,
CWITA002638,TCMBANKGE002638,MCHR1,GPR24; MCH1R; MGC32129; SLC1,melanin-concentrating hormone receptor 1,22q13.2,protein-coding,
CWITA002639,TCMBANKGE002639,NUDT13,-,nudix hydrolase 13,10q22.2,protein-coding,/
CWITA002640,TCMBANKGE002640,HNRNPAB,ABBP1; HNRPAB,heterogeneous nuclear ribonucleoprotein A/B,5q35.3,protein-coding,/
CWITA002641,TCMBANKGE002641,SLC30A3,ZNT3,solute carrier family 30 member 3,2p23.3,protein-coding,/
CWITA002642,TCMBANKGE002642,CD151,GP27; MER2; PETA-3; RAPH; SFA1; TSPAN24,CD151 molecule (Raph blood group),11p15.5,protein-coding,/
CWITA002643,TCMBANKGE002643,SGPP2,SPP2; SPPase2,sphingosine-1-phosphate phosphatase 2,2q36.1,protein-coding,/
CWITA002644,TCMBANKGE002644,SENP7,-,SUMO specific peptidase 7,3q12.3,protein-coding,/
CWITA002645,TCMBANKGE002645,ALDH8A1,ALDH12; DJ352A20.2,aldehyde dehydrogenase 8 family member A1,6q23.3,protein-coding,/
CWITA002646,TCMBANKGE002646,ANG,ALS9; HEL168; MGC22466; MGC71966; RNASE4; RNASE5,"angiogenin, ribonuclease, RNase A family, 5",14q11.1-q11.2,protein-coding,
CWITA002647,TCMBANKGE002647,ZNF606,ZNF328,zinc finger protein 606,19q13.43,protein-coding,/
CWITA002648,TCMBANKGE002648,RPL7,L7; humL7-1,ribosomal protein L7,8q21.11,protein-coding,/
CWITA002649,TCMBANKGE002649,CFHR1,CFHL; CFHL1; CFHL1P; CFHR1P; FHR-1; FHR1; H36; H36-1; H36-2; HFL1; HFL2,complement factor H related 1,1q31.3,protein-coding,/
CWITA002650,TCMBANKGE002650,KLRF2,NKp65,killer cell lectin like receptor F2,12p13.31,protein-coding,/
CWITA002651,TCMBANKGE002651,PNPLA8,IPLA2-2; IPLA2G; MMLA; PNPLA-gamma; iPLA2gamma,patatin like phospholipase domain containing 8,7q31.1,protein-coding,/
CWITA002652,TCMBANKGE002652,ATP10D,ATPVD,ATPase phospholipid transporting 10D (putative),4p12,protein-coding,/
CWITA002653,TCMBANKGE002653,GART,AIRS; GARS; GARTF; PAIS; PGFT; PRGS,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase",21q22.11,protein-coding,Clinical Trial target
CWITA002654,TCMBANKGE002654,MXD3,BHLHC13; MAD3; MYX,MAX dimerization protein 3,5q35.3,protein-coding,/
CWITA002655,TCMBANKGE002655,IRX2,IRXA2,iroquois homeobox 2,5p15.33,protein-coding,/
CWITA002656,TCMBANKGE002656,GABRG1,DKFZp686H2042; MGC33838,"gamma-aminobutyric acid (GABA) A receptor, gamma 1",4p12,protein-coding,
CWITA002657,TCMBANKGE002657,GRIN2B,MGC142178; MGC142180; NMDAR2B; NR2B; hNR3,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",12p12,protein-coding,
CWITA002658,TCMBANKGE002658,ARPC5,ARC16; MGC88523; dJ127C7.3; p16NArc,"actin related protein 2/3 complex, subunit 5, 16kDa",1q25.3,protein-coding,
CWITA002659,TCMBANKGE002659,SULT1E1,EST; ESTN1; MGC34459; STE,"sulfotransferase family 1E, estrogen-preferring, member 1",4q13.1,protein-coding,
CWITA002660,TCMBANKGE002660,H2BC18,HIST2H2BF,H2B clustered histone 18,1q21.2,protein-coding,/
CWITA002661,TCMBANKGE002661,FGGY,-,FGGY carbohydrate kinase domain containing,1p32.1,protein-coding,/
CWITA002662,TCMBANKGE002662,BLVRA,BLVR; BVR; BVRA,biliverdin reductase A,7p14-cen,protein-coding,
CWITA002663,TCMBANKGE002663,CHD3,Mi-2a; Mi2-ALPHA; SNIBCPS; ZFH,chromodomain helicase DNA binding protein 3,17p13.1,protein-coding,/
CWITA002664,TCMBANKGE002664,HS3ST1,3OST; 3OST1,heparan sulfate-glucosamine 3-sulfotransferase 1,4p15.33,protein-coding,/
CWITA002665,TCMBANKGE002665,KCNJ8,KIR6.1; uKATPN1,"potassium inwardly-rectifying channel, subfamily J, member 8",12p11.23,protein-coding,
CWITA002666,TCMBANKGE002666,SPC24,SPBC24,SPC24 component of NDC80 kinetochore complex,19p13.2,protein-coding,/
CWITA002667,TCMBANKGE002667,TRIM13,CAR; DLEU5; LEU5; RFP2; RNF77,tripartite motif containing 13,13q14,protein-coding,
CWITA002668,TCMBANKGE002668,LMO4,-,LIM domain only 4,1p22.3,protein-coding,/
CWITA002669,TCMBANKGE002669,TTYH1,-,tweety family member 1,19q13.42,protein-coding,/
CWITA002670,TCMBANKGE002670,NDUFB6,B17; CI,NADH:ubiquinone oxidoreductase subunit B6,9p21.1,protein-coding,/
CWITA002671,TCMBANKGE002671,GRAMD1B,LINC01059,GRAM domain containing 1B,11q24.1,protein-coding,/
CWITA002672,TCMBANKGE002672,GGCX,FLJ26629; VKCFD1,gamma-glutamyl carboxylase,2p12,protein-coding,
CWITA002673,TCMBANKGE002673,UBA1,A1S9; A1S9T; A1ST; AMCX1; CFAP124; GXP1; POC20; SMAX2; UBA1A; UBE1; UBE1X,ubiquitin like modifier activating enzyme 1,Xp11.3,protein-coding,Research target
CWITA002674,TCMBANKGE002674,AKAP11,AKAP-11; AKAP220; PPP1R44; PRKA11,A-kinase anchoring protein 11,13q14.11,protein-coding,/
CWITA002675,TCMBANKGE002675,SPSB3,C16orf31; SSB3,splA/ryanodine receptor domain and SOCS box containing 3,16p13.3,protein-coding,/
CWITA002676,TCMBANKGE002676,SORL1,C11orf32; LR11; LRP9; SORLA; SorLA-1; gp250,sortilin related receptor 1,11q24.1,protein-coding,/
CWITA002677,TCMBANKGE002677,SLC6A8,CCDS1; CRT; CRTR; CT1; CTR5,solute carrier family 6 member 8,Xq28,protein-coding,/
CWITA002678,TCMBANKGE002678,SERHL2,dJ222E13.1,serine hydrolase like 2,22q13.2,protein-coding,/
CWITA002679,TCMBANKGE002679,LAMA2,LAMM; MDC1A,laminin subunit alpha 2,6q22.33,protein-coding,/
CWITA002680,TCMBANKGE002680,SCO2,CEMCOX1; ECGF1; Gliostatin; MYP6; PD-ECGF; SCO1L; TP; TYMP; TdRPase,synthesis of cytochrome C oxidase 2,22q13.33,protein-coding,/
CWITA002681,TCMBANKGE002681,ALDH1A1,ALDC; ALDHNE1; ALDH1; ALDH11; MGC2318; PUMB1; RALDH1,"aldehyde dehydrogenase 1 family, member A1",9q21.13,protein-coding,
CWITA002682,TCMBANKGE002682,ADAMDEC1,M12.219,ADAM like decysin 1,8p21.2,protein-coding,/
CWITA002683,TCMBANKGE002683,RBM24,RNPC6; dJ259A10.1,RNA binding motif protein 24,6p22.3,protein-coding,/
CWITA002684,TCMBANKGE002684,C1orf112,-,chromosome 1 open reading frame 112,1q24.2,protein-coding,/
CWITA002685,TCMBANKGE002685,MYO18A,MAJN; MYSPDZ; SP-R210; SPR210,myosin XVIIIA,17q11.2,protein-coding,/
CWITA002686,TCMBANKGE002686,CEP120,CCDC100; JBTS31; SRTD13,centrosomal protein 120,5q23.2,protein-coding,/
CWITA002687,TCMBANKGE002687,ZBTB34,ZNF918,zinc finger and BTB domain containing 34,9q33.3,protein-coding,/
CWITA002688,TCMBANKGE002688,HTR1F,5-HT-1F; 5-HT1F; 5HT6; HTR1EL; MR77,5-hydroxytryptamine receptor 1F,3p11.2-p11.1,protein-coding,Successful target
CWITA002689,TCMBANKGE002689,RSF1,HBXAP; RSF-1; XAP8; p325,remodeling and spacing factor 1,11q14.1,protein-coding,Research target
CWITA002690,TCMBANKGE002690,FOXJ2,FHX,forkhead box J2,12p13.31,protein-coding,Research target
CWITA002691,TCMBANKGE002691,SPAG6,CFAP194; CT141; FAP194; Repro-SA-1; pf16,sperm associated antigen 6,10p12.2,protein-coding,Research target
CWITA002692,TCMBANKGE002692,RC3H2,MNAB; RNF164,ring finger and CCCH-type domains 2,9q33.2,protein-coding,/
CWITA002693,TCMBANKGE002693,SDHA,CMD1GG; FP; PGL5; SDH1; SDH2; SDHF,succinate dehydrogenase complex flavoprotein subunit A,5p15.33,protein-coding,/
CWITA002694,TCMBANKGE002694,CAMLG,CAML; MGC163197,calcium modulating ligand,5q23,protein-coding,
CWITA002695,TCMBANKGE002695,CHRNA9,HSA243342; MGC142109; MGC142135; NACHRA9,"cholinergic receptor, nicotinic, alpha 9",4p14,protein-coding,
CWITA002696,TCMBANKGE002696,ZIC5,-,Zic family member 5,13q32.3,protein-coding,/
CWITA002697,TCMBANKGE002697,MCM4,CDC21; CDC54; IMD54; NKCD; NKGCD; P1-CDC21; hCdc21,minichromosome maintenance complex component 4,8q11.21,protein-coding,/
CWITA002698,TCMBANKGE002698,PLEKHB2,EVT2,pleckstrin homology domain containing B2,2q21.1,protein-coding,/
CWITA002699,TCMBANKGE002699,TH,DYT14; DYT5b; TYH,tyrosine hydroxylase,11p15.5,protein-coding,Successful target
CWITA002700,TCMBANKGE002700,SLC35A1,CDG2F; CMPST; CST; hCST,solute carrier family 35 member A1,6q15,protein-coding,/
CWITA002701,TCMBANKGE002701,ANAPC15,APC15; C11orf51; HSPC020,anaphase promoting complex subunit 15,11q13.4,protein-coding,/
CWITA002702,TCMBANKGE002702,RBPJL,RBPL; RBPSUHL; SUHL,recombination signal binding protein for immunoglobulin kappa J region like,20q13.12,protein-coding,/
CWITA002703,TCMBANKGE002703,DESI1,D15Wsu75e; DESI2; DJ347H13.4; DeSI-1; FAM152B; POST; PPPDE2,desumoylating isopeptidase 1,22q13.2,protein-coding,/
CWITA002704,TCMBANKGE002704,SPAG9,CT89; HLC-6; HLC4; HLC6; JIP-4; JIP4; JLP; PHET; PIG6,sperm associated antigen 9,17q21.33,protein-coding,/
CWITA002705,TCMBANKGE002705,DNAJB9,ERdj4; MDG-1; MDG1; MST049; MSTP049,DnaJ heat shock protein family (Hsp40) member B9,7q31.1|14q24.2-q24.3,protein-coding,/
CWITA002706,TCMBANKGE002706,CAPZA1,CAPPA1; CAPZ; CAZ1,capping actin protein of muscle Z-line subunit alpha 1,1p13.2,protein-coding,/
CWITA002707,TCMBANKGE002707,THTPA,THTP; THTPASE,thiamine triphosphatase,14q11.2,protein-coding,/
CWITA002708,TCMBANKGE002708,CCL28,CCK1; MEC; SCYA28,C-C motif chemokine ligand 28,5p12,protein-coding,/
CWITA002709,TCMBANKGE002709,RHBDD2,NPD007; RHBDL7,rhomboid domain containing 2,7q11.23,protein-coding,/
CWITA002710,TCMBANKGE002710,EFCAB1,-,EF-hand calcium binding domain 1,8q11.21,protein-coding,/
CWITA002711,TCMBANKGE002711,LSM6,YDR378C,"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated",4q31.22,protein-coding,/
CWITA002712,TCMBANKGE002712,POLD3,P66; P68; PPP1R128,"DNA polymerase delta 3, accessory subunit",11q13.4,protein-coding,/
CWITA002713,TCMBANKGE002713,ADH1C,ADH3,"alcohol dehydrogenase 1C (class I), gamma polypeptide",4q23,protein-coding,
CWITA002714,TCMBANKGE002714,EIF1,A121; EIF-1; EIF1A; ISO1; SUI1,eukaryotic translation initiation factor 1,17q21.2,protein-coding,/
CWITA002715,TCMBANKGE002715,HS3ST3A1,30ST3A1; 3OST3A1,heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1,17p12,protein-coding,
CWITA002716,TCMBANKGE002716,ZNF155,pHZ-96,zinc finger protein 155,19q13.31,protein-coding,/
CWITA002717,TCMBANKGE002717,EMB,GP70,embigin,5q11.1,protein-coding,/
CWITA002718,TCMBANKGE002718,ZNF763,ZNF; ZNF440L,zinc finger protein 763,19p13.2,protein-coding,/
CWITA002719,TCMBANKGE002719,MB21D2,C3orf59,Mab-21 domain containing 2,3q29,protein-coding,/
CWITA002720,TCMBANKGE002720,COX7C,N,cytochrome c oxidase subunit VIIc,5q14,protein-coding,
CWITA002721,TCMBANKGE002721,TMEM109,-,transmembrane protein 109,11q12.2,protein-coding,/
CWITA002722,TCMBANKGE002722,ZNF396,ZSCAN14,zinc finger protein 396,18q12.2,protein-coding,/
CWITA002723,TCMBANKGE002723,PRKACA,MGC102831; MGC48865; PKACA,"protein kinase, cAMP-dependent, catalytic, alpha",19p13.1,protein-coding,
CWITA002724,TCMBANKGE002724,PGPEP1L,-,pyroglutamyl-peptidase I like,15q26.3,protein-coding,/
CWITA002725,TCMBANKGE002725,FBXO31,FBX14; FBXO14; Fbx31; MRT45; pp2386,F-box protein 31,16q24.2,protein-coding,/
CWITA002726,TCMBANKGE002726,AIG1,AIG-1; dJ95L4.1,androgen induced 1,6q24.2,protein-coding,/
CWITA002727,TCMBANKGE002727,ALOXE3,ARCI3; E-LOX; eLOX-3; eLOX3,arachidonate lipoxygenase 3,17p13.1,protein-coding,/
CWITA002728,TCMBANKGE002728,CNTF,HCNTF,ciliary neurotrophic factor,11q12.1,protein-coding,Clinical Trial target
CWITA002729,TCMBANKGE002729,CYP3A4,CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; MGC126680; NFN25; P450C3; P450PCN1,"cytochrome P450, family 3, subfamily A, polypeptide 4",7q21.1,protein-coding,
CWITA002730,TCMBANKGE002730,PTPMT1,DUSP23; MOSP; PLIP; PNAS-129,protein tyrosine phosphatase mitochondrial 1,11p11.2,protein-coding,/
CWITA002731,TCMBANKGE002731,ZBTB7B,CKROX; THPOK; ZBTB15; ZFP-67; ZFP67; ZNF857B; c-KROX; hcKROX,zinc finger and BTB domain containing 7B,1q21.3,protein-coding,/
CWITA002732,TCMBANKGE002732,GZMA,CTLA3; HFSP,granzyme A,5q11.2,protein-coding,/
CWITA002733,TCMBANKGE002733,RPP38,-,ribonuclease P/MRP subunit p38,10p13,protein-coding,/
CWITA002734,TCMBANKGE002734,TAAR2,GPR58; taR-2,trace amine associated receptor 2,6q23.2,protein-coding,/
CWITA002735,TCMBANKGE002735,RPGRIP1L,CORS3; FTM; JBTS7; MKS5; NPHP8; PPP1R134,RPGRIP1 like,16q12.2,protein-coding,/
CWITA002736,TCMBANKGE002736,ADTRP,AIG1L; C6orf105; dJ413H6.1,androgen dependent TFPI regulating protein,6p24.1,protein-coding,/
CWITA002737,TCMBANKGE002737,TMBIM4,CGI-119; GAAP; LFG4; S1R; ZPRO,transmembrane BAX inhibitor motif containing 4,12q14.3,protein-coding,/
CWITA002738,TCMBANKGE002738,MPLKIP,ABHS; C7orf11; ORF20; TTD4,M-phase specific PLK1 interacting protein,7p14.1,protein-coding,/
CWITA002739,TCMBANKGE002739,TRIM49B,-,tripartite motif containing 49B,11p11.12,protein-coding,/
CWITA002740,TCMBANKGE002740,LRCH4,LRN; LRRN1; LRRN4; PP14183,leucine rich repeats and calponin homology domain containing 4,7q22.1,protein-coding,/
CWITA002741,TCMBANKGE002741,IAH1,-,isoamyl acetate hydrolyzing esterase 1 (putative),2p25.1,protein-coding,/
CWITA002742,TCMBANKGE002742,DOCK8,HEL-205; MRD2; ZIR8,dedicator of cytokinesis 8,9p24.3,protein-coding,/
CWITA002743,TCMBANKGE002743,APOL1,APO-L; APOL; APOL-I; FSGS4,apolipoprotein L1,22q12.3,protein-coding,/
CWITA002744,TCMBANKGE002744,CDC42,CDC42Hs; G25K,"cell division cycle 42 (GTP binding protein, 25kDa)",1p36.1,protein-coding,
CWITA002745,TCMBANKGE002745,TANC1,ROLSB; TANC,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1",2q24.2,protein-coding,/
CWITA002746,TCMBANKGE002746,PIGN,MCAHS; MCAHS1; MCD4; MDC4; PIG-N,phosphatidylinositol glycan anchor biosynthesis class N,18q21.33,protein-coding,/
CWITA002747,TCMBANKGE002747,MAP4K4,FLH21957; HEL-S-31; HGK; MEKKK4; NIK,mitogen-activated protein kinase kinase kinase kinase 4,2q11.2,protein-coding,Research target
CWITA002748,TCMBANKGE002748,HSD17B4,DBP; MFE-2; MPF-2; PRLTS1; SDR8C1,hydroxysteroid 17-beta dehydrogenase 4,5q23.1,protein-coding,Research target
CWITA002749,TCMBANKGE002749,PNLIPRP1,PLRP1,pancreatic lipase related protein 1,10q25.3,protein-coding,/
CWITA002750,TCMBANKGE002750,SRSF3,SFRS3; SRp20,serine and arginine rich splicing factor 3,6p21.31-p21.2,protein-coding,/
CWITA002751,TCMBANKGE002751,TMEM106B,HLD16,transmembrane protein 106B,7p21.3,protein-coding,/
CWITA002752,TCMBANKGE002752,MCCC2,MCCB,methylcrotonoyl-CoA carboxylase 2,5q13.2,protein-coding,/
CWITA002753,TCMBANKGE002753,SELP,CD62; CD62P; FLJ45155; GMP140; GRMP; LECAM3; PADGEM; PSEL,"selectin P (granule membrane protein 140kDa, antigen CD62)",1q22-q25,protein-coding,
CWITA002754,TCMBANKGE002754,WIPI1,ATG18; ATG18A; WIPI49,"WD repeat domain, phosphoinositide interacting 1",17q24.2,protein-coding,/
CWITA002755,TCMBANKGE002755,ZNHIT2,C11orf5; FON,zinc finger HIT-type containing 2,11q13.1,protein-coding,/
CWITA002756,TCMBANKGE002756,EML2,ELP70; EMAP-2; EMAP2,EMAP like 2,19q13.32,protein-coding,/
CWITA002757,TCMBANKGE002757,GCLM,GLCLR,"glutamate-cysteine ligase, modifier subunit",1p22.1,protein-coding,
CWITA002758,TCMBANKGE002758,HSPB8,CMT2L; DHMN2; E2IG1; H11; HMN2; HMN2A; HSP22,heat shock protein family B (small) member 8,12q24.23,protein-coding,Research target
CWITA002759,TCMBANKGE002759,C19orf38,HIDE1,chromosome 19 open reading frame 38,19p13.2,protein-coding,/
CWITA002760,TCMBANKGE002760,MFAP5,AAT9; MAGP-2; MAGP2; MFAP-5; MP25,microfibril associated protein 5,12p13.31,protein-coding,/
CWITA002761,TCMBANKGE002761,NAGS,AGAS; ARGA,N-acetylglutamate synthase,17q21.31,protein-coding,/
CWITA002762,TCMBANKGE002762,OCA2,BEY; BEY1; BEY2; BOCA; D15S12; EYCL; EYCL2; EYCL3; HCL3; P; PED; SHEP1,OCA2 melanosomal transmembrane protein,15q12-q13.1,protein-coding,/
CWITA002763,TCMBANKGE002763,RMDN2,BLOCK18; FAM82A; FAM82A1; PRO34163; PYST9371; RMD-2; RMD2; RMD4,regulator of microtubule dynamics 2,2p22.2,protein-coding,/
CWITA002764,TCMBANKGE002764,CCHCR1,C6orf18; HCR; SBP; pg8,coiled-coil alpha-helical rod protein 1,6p21.33,protein-coding,/
CWITA002765,TCMBANKGE002765,RAB4A,HRES-1; HRES-1/RAB4; HRES1; RAB4,"RAB4A, member RAS oncogene family",1q42.13,protein-coding,/
CWITA002766,TCMBANKGE002766,PRKCB,MGC41878; PKCNbeta; PKCB; PRKCB1; PRKCB2,"protein kinase C, beta",16p11.2,protein-coding,
CWITA002767,TCMBANKGE002767,WIPF1,PRPL-2; WAS2; WASPIP; WIP,WAS/WASL interacting protein family member 1,2q31.1,protein-coding,/
CWITA002768,TCMBANKGE002768,NBR1,1A1-3B; IAI3B; M17S2; MIG19,NBR1 autophagy cargo receptor,17q21.31,protein-coding,/
CWITA002769,TCMBANKGE002769,PDE12,2'-PDE; 2-PDE,phosphodiesterase 12,3p14.3,protein-coding,/
CWITA002770,TCMBANKGE002770,GPR75,GPRchr2; WI31133,G protein-coupled receptor 75,2p16.2,protein-coding,/
CWITA002771,TCMBANKGE002771,METAP1D,MAP 1D; MAP1D; MetAP 1D; Metap1l,"methionyl aminopeptidase type 1D, mitochondrial",2q31.1,protein-coding,/
CWITA002772,TCMBANKGE002772,TSNAX,C3PO; TRAX,translin associated factor X,1q42.2,protein-coding,/
CWITA002773,TCMBANKGE002773,ZNF257,BMZF-4; BMZF4,zinc finger protein 257,19p12,protein-coding,/
CWITA002774,TCMBANKGE002774,USP39,65K; CGI-21; HSPC332; SAD1; SNRNP65,ubiquitin specific peptidase 39,2p11.2,protein-coding,/
CWITA002775,TCMBANKGE002775,SLC10A6,MGC129575; MGC129576; SOAT,"solute carrier family 10 (sodium/bile acid cotransporter family), member 6",4q21.3,protein-coding,
CWITA002776,TCMBANKGE002776,PPP1CC,PPN1G; PPP1G,"protein phosphatase 1, catalytic subunit, gamma isozyme",12q24.1-q24.2,protein-coding,
CWITA002777,TCMBANKGE002777,PKLR,PK1; PKL; PKR; PKRL; RPK,"pyruvate kinase, liver and RBC",1q21,protein-coding,
CWITA002778,TCMBANKGE002778,FKBP3,FKBP-25; FKBP-3; FKBP25; PPIase,FKBP prolyl isomerase 3,14q21.2,protein-coding,/
CWITA002779,TCMBANKGE002779,HOPX,CAMEO; HOD; HOP; LAGY; NECC1; OB1; SMAP31; TOTO,HOP homeobox,4q12,protein-coding,/
CWITA002780,TCMBANKGE002780,PLA2G6,CaINPLA2; GVI; INAD1; IPLA2NVIA; NBIA2A; NBIA2B; PARK14; PLA2; PNPLA9; iPLA2,"phospholipase A2, group VI (cytosolic, calcium-independent)",22q13.1,protein-coding,
CWITA002781,TCMBANKGE002781,SLC25A46,HMSN6B,solute carrier family 25 member 46,5q22.1,protein-coding,/
CWITA002782,TCMBANKGE002782,TRIM14,-,tripartite motif containing 14,9q22.33,protein-coding,/
CWITA002783,TCMBANKGE002783,G3BP2,-,G3BP stress granule assembly factor 2,4q21.1,protein-coding,/
CWITA002784,TCMBANKGE002784,SREBF2,SREBP2; bHLHd2,Sterol Regulatory Element Binding Transcription Factor 2,22q13,protein-coding,
CWITA002785,TCMBANKGE002785,SLC34A1,FRTS2; HCINF2; NAPI-3; NPHLOP1; NPT2; NPTIIa; SLC11; SLC17A2,solute carrier family 34 member 1,5q35.3,protein-coding,/
CWITA002786,TCMBANKGE002786,TRIP10,CIP4; HSTP; STOT; STP; TRIP-10,thyroid hormone receptor interactor 10,19p13.3,protein-coding,Research target
CWITA002787,TCMBANKGE002787,ZNF534,KRBO3,zinc finger protein 534,19q13.41,protein-coding,/
CWITA002788,TCMBANKGE002788,GTF3C5,TFIIIC63; TFIIICepsilon; TFiiiC2-63,general transcription factor IIIC subunit 5,9q34.13,protein-coding,/
CWITA002789,TCMBANKGE002789,SCUBE3,CEGF3,"signal peptide, CUB domain and EGF like domain containing 3",6p21.31,protein-coding,/
CWITA002790,TCMBANKGE002790,KLK6,Bssp; Klk7; MGC9355; PRSS18; PRSS9; SP59; hK6,kallikrein-related peptidase 6,19q13.3,protein-coding,
CWITA002791,TCMBANKGE002791,NSDHL,H105E3; SDR31E1; XAP104,NAD(P) dependent steroid dehydrogenase-like,Xq28,protein-coding,
CWITA002792,TCMBANKGE002792,AVP,ADH; ARVP; AVP-NPII; AVRP; VP,Arginine_Vasopressin,20p13,protein-coding,
CWITA002793,TCMBANKGE002793,JUP,CTNNG; DP3; DPIII; PDGB; PKGB,junction plakoglobin,17q21.2,protein-coding,Research target
CWITA002794,TCMBANKGE002794,SPDL1,CCDC99,spindle apparatus coiled-coil protein 1,5q35.1,protein-coding,/
CWITA002795,TCMBANKGE002795,ENOX2,APK1; COVA1; tNOX,ecto-NOX disulfide-thiol exchanger 2,Xq25,protein-coding,
CWITA002796,TCMBANKGE002796,TTC32,-,tetratricopeptide repeat domain 32,2p24.1,protein-coding,/
CWITA002797,TCMBANKGE002797,MGA,MAD5; MXD5,MAX dimerization protein MGA,15q15.1,protein-coding,/
CWITA002798,TCMBANKGE002798,GAMT,CCDS2; HEL-S-20; PIG2; TP53I2,guanidinoacetate N-methyltransferase,19p13.3,protein-coding,/
CWITA002799,TCMBANKGE002799,CD99L2,CD99B; MIC2L1,CD99 molecule like 2,Xq28,protein-coding,/
CWITA002800,TCMBANKGE002800,TRIM28,KAP1; PPP1R157; RNF96; TF1B; TIF1B,tripartite motif containing 28,19q13.43,protein-coding,Research target
CWITA002801,TCMBANKGE002801,ST3GAL4,CGS23; NANTA3; SAT3; SIAT4; SIAT4C; ST-4; ST3GalA.2; ST3GalIV; STZ; gal-NAc6S,"ST3 beta-galactoside alpha-2,3-sialyltransferase 4",11q24.2,protein-coding,/
CWITA002802,TCMBANKGE002802,FILIP1L,DOC-1; DOC1; GIP130; GIP90,filamin A interacting protein 1 like,3q12.1,protein-coding,/
CWITA002803,TCMBANKGE002803,NABP1,OBFC2A; SOSS-B2; SSB2,nucleic acid binding protein 1,2q32.3,protein-coding,/
CWITA002804,TCMBANKGE002804,INTS9,CPSF2L; INT9; RC74,integrator complex subunit 9,8p21.1,protein-coding,/
CWITA002805,TCMBANKGE002805,RNF6,-,ring finger protein 6,13q12.13,protein-coding,Research target
CWITA002806,TCMBANKGE002806,ATP6V1E2,ATP6E1; ATP6EL2; ATP6V1EL2; VMA4,ATPase H+ transporting V1 subunit E2,2p21|2p16-p12,protein-coding,/
CWITA002807,TCMBANKGE002807,PLXNC1,CD232; PLXN-C1; VESPR,plexin C1,12q22,protein-coding,/
CWITA002808,TCMBANKGE002808,COX6C,-,cytochrome c oxidase subunit 6C,8q22.2,protein-coding,/
CWITA002809,TCMBANKGE002809,SNX6,MSTP010; TFAF2,sorting nexin 6,14q13.1,protein-coding,/
CWITA002810,TCMBANKGE002810,FLT3,CD135; FLK2; STK1,fms-related tyrosine kinase 3,13q12,protein-coding,
CWITA002811,TCMBANKGE002811,CABYR,CABYRa; CABYRc; CABYRc/d; CABYRe; CBP86; CT88; FSP-2; FSP2,calcium binding tyrosine phosphorylation regulated,18q11.2,protein-coding,/
CWITA002812,TCMBANKGE002812,CBX8,PC3; RC1,chromobox 8,17q25.3,protein-coding,/
CWITA002813,TCMBANKGE002813,RFFL,CARP-2; CARP2; FRING; RIFIFYLIN; RNF189; RNF34L,ring finger and FYVE like domain containing E3 ubiquitin protein ligase,17q12,protein-coding,/
CWITA002814,TCMBANKGE002814,DGKA,DAGK; DAGK1; DGKNalpha; MGC12821; MGC42356,"diacylglycerol kinase, alpha 80kDa",12q13.3,protein-coding,
CWITA002815,TCMBANKGE002815,KIF20B,CT90; KRMP1; MPHOSPH1; MPP-1; MPP1,kinesin family member 20B,10q23.31,protein-coding,Research target
CWITA002816,TCMBANKGE002816,CNN2,-,calponin 2,19p13.3,protein-coding,/
CWITA002817,TCMBANKGE002817,ZNF461,GIOT-1; GIOT1; HZF28,zinc finger protein 461,19q13.12,protein-coding,/
CWITA002818,TCMBANKGE002818,CCNA2,CCN1; CCNA,cyclin A2,4q25-q31,protein-coding,
CWITA002819,TCMBANKGE002819,RO60,RORNP; SSA2; TROVE2,"Ro60, Y RNA binding protein",1q31.2,protein-coding,/
CWITA002820,TCMBANKGE002820,DARS2,ASPRS; LBSL; MT-ASPRS; mtAspRS,"aspartyl-tRNA synthetase 2, mitochondrial",1q25.1,protein-coding,/
CWITA002821,TCMBANKGE002821,REEP6,C19orf32; DP1L1; REEP6.1; REEP6.2; RP77; TB2L1; Yip2f,receptor accessory protein 6,19p13.3,protein-coding,/
CWITA002822,TCMBANKGE002822,NUDT4,DIPP-2B; DIPP2; DIPP2alpha; DIPP2beta; HDCMB47P; NUDT4B,nudix hydrolase 4,12q22,protein-coding,/
CWITA002823,TCMBANKGE002823,PLGRKT,AD025; C9orf46; MDS030; PLG-RKT; Plg-R(KT),plasminogen receptor with a C-terminal lysine,9p24.1,protein-coding,/
CWITA002824,TCMBANKGE002824,TMEM38B,C9orf87; D4Ertd89e; OI14; TRIC-B; TRICB; bA219P18.1,transmembrane protein 38B,9q31.2,protein-coding,/
CWITA002825,TCMBANKGE002825,CDCA2,PPP1R81; Repo-Man,cell division cycle associated 2,8p21.2,protein-coding,/
CWITA002826,TCMBANKGE002826,ALOX15,15NLOXN1; 15LOXN1,arachidonate 15-lipoxygenase,17p13.3,protein-coding,
CWITA002827,TCMBANKGE002827,TSPAN6,T245; TM4SF6; TSPAN-6,tetraspanin 6,Xq22.1,protein-coding,/
CWITA002828,TCMBANKGE002828,ZFP82,ZNF545,ZFP82 zinc finger protein,19q13.12,protein-coding,/
CWITA002829,TCMBANKGE002829,TNFRSF1A,CD120a; FPF; MGC19588; TBP1; TNFNR; TNFNRNI; TNFNR55; TNFAR; TNFR1; TNFR55; TNFR60; p55; p55NR; p60,"tumor necrosis factor receptor superfamily, member 1A",12p13.2,protein-coding,
CWITA002830,TCMBANKGE002830,PLPP6,PDP1; PPAPDC2; PSDP; bA6J24.6,phospholipid phosphatase 6,9p24.1,protein-coding,/
CWITA002831,TCMBANKGE002831,MYO3B,-,myosin IIIB,2q31.1,protein-coding,/
CWITA002832,TCMBANKGE002832,IL17B,IL-17B; IL-20; NIRF; ZCYTO7,interleukin 17B,5q32,protein-coding,/
CWITA002833,TCMBANKGE002833,MED12,ARC240; CAGH45; FGS1; HOPA; Kto; MED12S; OHDOX; OKS; OPA1; TNRC11; TRAP230,mediator complex subunit 12,Xq13.1,protein-coding,/
CWITA002834,TCMBANKGE002834,HEBP1,HBP; HEBP,heme binding protein 1,12p13.1,protein-coding,/
CWITA002835,TCMBANKGE002835,TFPT,FB1; INO80F; amida,TCF3 fusion partner,19q13.42,protein-coding,/
CWITA002836,TCMBANKGE002836,PDE9A,FLJ90181; HSPDE9A2,phosphodiesterase 9A,21q22.3,protein-coding,
CWITA002837,TCMBANKGE002837,BRWD1,C21orf107; DCAF19; N143; WDR9; WRD9,bromodomain and WD repeat domain containing 1,21q22.2,protein-coding,/
CWITA002838,TCMBANKGE002838,ARF3,-,ADP ribosylation factor 3,12q13.12,protein-coding,/
CWITA002839,TCMBANKGE002839,SMARCA5,ISWI; SNF2H; WCRF135; hISWI; hSNF2H,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5",4q31.21,protein-coding,/
CWITA002840,TCMBANKGE002840,FEM1B,F1A-ALPHA; F1AA; FEM1-beta,fem-1 homolog B,15q23,protein-coding,/
CWITA002841,TCMBANKGE002841,Oaz2-ps,EG668745; Gm9329,"ornithine decarboxylase antizyme 2, pseudogene",3|3 G3,pseudo,/
CWITA002842,TCMBANKGE002842,TAS2R30,T2R30; T2R47; TAS2R47,taste 2 receptor member 30,12p13.2,protein-coding,/
CWITA002843,TCMBANKGE002843,GDF6,BMP-13; BMP13; CDMP2; KFM; KFS; KFS1; KFSL; SGM1; SYNS4,growth differentiation factor 6,8q22.1,protein-coding,/
CWITA002844,TCMBANKGE002844,NBAS,ILFS2; NAG; SOPH,NBAS subunit of NRZ tethering complex,2p24.3,protein-coding,/
CWITA002845,TCMBANKGE002845,ZNF720,-,zinc finger protein 720,16p11.2,protein-coding,/
CWITA002846,TCMBANKGE002846,ARPP19,ARPP-16; ARPP-19; ARPP16; ENSAL,cAMP regulated phosphoprotein 19,15q21.2,protein-coding,/
CWITA002847,TCMBANKGE002847,BTBD11,ABTB2B,BTB domain containing 11,12q23.3,protein-coding,/
CWITA002848,TCMBANKGE002848,ZNF626,-,zinc finger protein 626,19p12,protein-coding,/
CWITA002849,TCMBANKGE002849,AGFG2,HRBL; RABR,ArfGAP with FG repeats 2,7q22.1,protein-coding,/
CWITA002850,TCMBANKGE002850,CCR5,CCNCKRN5; CCCKR5; CD195; CKRN5; CKR5; CMKBR5; FLJ78003; IDDM22,chemokine (C-C motif) receptor 5,3p21.31,protein-coding,
CWITA002851,TCMBANKGE002851,MFRP,CTRP5; MCOP5; NNO2; RD6,membrane frizzled-related protein,11q23.3,protein-coding,/
CWITA002852,TCMBANKGE002852,IFI27L2,FAM14A; ISG12B; TLH29,interferon alpha inducible protein 27 like 2,14q32.12,protein-coding,/
CWITA002853,TCMBANKGE002853,NDUFA3,B9; CI-B9,NADH:ubiquinone oxidoreductase subunit A3,19q13.42,protein-coding,/
CWITA002854,TCMBANKGE002854,ING4,my036; p29ING4,inhibitor of growth family member 4,12p13.31,protein-coding,/
CWITA002855,TCMBANKGE002855,HOXA7,ANTP; HOX1; HOX1.1; HOX1A,homeobox A7,7p15.2,protein-coding,Research target
CWITA002856,TCMBANKGE002856,NPEPL1,bA261P9.2,aminopeptidase like 1,20q13.32,protein-coding,/
CWITA002857,TCMBANKGE002857,PTX3,TNFAIP5; TSG-14,pentraxin 3,3q25.32,protein-coding,/
CWITA002858,TCMBANKGE002858,IKZF2,ANF1A2; HELIOS; ZNF1A2; ZNFN1A2,IKAROS family zinc finger 2,2q34,protein-coding,/
CWITA002859,TCMBANKGE002859,PGGT1B,BGGI; GGTI,"protein geranylgeranyltransferase type I, beta subunit",5q22.3,protein-coding,
CWITA002860,TCMBANKGE002860,EBP,CDPX2; CHO2; CPX; CPXD,emopamil binding protein (sterol isomerase),Xp11.23-p11.22,protein-coding,
CWITA002861,TCMBANKGE002861,SGK3,CISK; SGK2; SGKL,serum/glucocorticoid regulated kinase family member 3,8q13.1,protein-coding,/
CWITA002862,TCMBANKGE002862,RTCB,C22orf28; DJ149A16.6; FAAP; HSPC117,"RNA 2',3'-cyclic phosphate and 5'-OH ligase",22q12.3,protein-coding,/
CWITA002863,TCMBANKGE002863,TMEM243,C7orf23; MM-TRAG; MMTRAG,transmembrane protein 243,7q21.12,protein-coding,/
CWITA002864,TCMBANKGE002864,ZNF521,EHZF; Evi3,zinc finger protein 521,18q11.2,protein-coding,/
CWITA002865,TCMBANKGE002865,TENT5C,FAM46C,terminal nucleotidyltransferase 5C,1p12,protein-coding,/
CWITA002866,TCMBANKGE002866,BPNT1,HEL20; PIP,"3'(2'), 5'-bisphosphate nucleotidase 1",1q41,protein-coding,/
CWITA002867,TCMBANKGE002867,IL7,IL-7,interleukin 7,8q21.13,protein-coding,Clinical Trial target
CWITA002868,TCMBANKGE002868,CALML4,NY-BR-20,calmodulin like 4,15q23,protein-coding,/
CWITA002869,TCMBANKGE002869,NCOA2,GRIP1; KAT13C; MGC138808; NCoAN2; SRC2; TIF2; bHLHe75,nuclear receptor coactivator 2,8q13.3,protein-coding,
CWITA002870,TCMBANKGE002870,EIF3F,EIF3S5; MRT67; eIF3-p47,eukaryotic translation initiation factor 3 subunit F,11p15.4,protein-coding,/
CWITA002871,TCMBANKGE002871,TMEM117,-,transmembrane protein 117,12q12,protein-coding,/
CWITA002872,TCMBANKGE002872,RBP2,CRABPNII; CRBP2; CRBPII; RBPC2,"retinol binding protein 2, cellular",3q23,protein-coding,
CWITA002873,TCMBANKGE002873,NPEPPS,AAP-S; MP100; PSA,aminopeptidase puromycin sensitive,17q21.32,protein-coding,Clinical Trial target
CWITA002874,TCMBANKGE002874,FARSB,FARSLB; FRSB; PheHB; PheRS,"phenylalanyl-tRNA synthetase, beta subunit",2q36.1,protein-coding,
CWITA002875,TCMBANKGE002875,B2M,N,beta-2-microglobulin,15q21-q22.2,protein-coding,
CWITA002876,TCMBANKGE002876,TGM6,SCA35; TGM3L; TGY; dJ734P14.3,transglutaminase 6,20p13,protein-coding,
CWITA002877,TCMBANKGE002877,SUZ12,CHET9; IMMAS; JJAZ1,SUZ12 polycomb repressive complex 2 subunit,17q11.2,protein-coding,/
CWITA002878,TCMBANKGE002878,DNASE2B,DLAD,deoxyribonuclease 2 beta,1p31.1-p22.3,protein-coding,/
CWITA002879,TCMBANKGE002879,HS3ST3A1,3-OST-3A; 3OST3A1,heparan sulfate-glucosamine 3-sulfotransferase 3A1,17p12,protein-coding,/
CWITA002880,TCMBANKGE002880,ZXDC,ZXDL,ZXD family zinc finger C,3q21.3,protein-coding,/
CWITA002881,TCMBANKGE002881,SRBD1,-,S1 RNA binding domain 1,2p21,protein-coding,/
CWITA002882,TCMBANKGE002882,Akap6,AI482140; Akapalpha; Akapbeta; PRKA,A kinase (PRKA) anchor protein 6,12|12 C1,protein-coding,/
CWITA002883,TCMBANKGE002883,SLC4A8,NBC3; NDCBE,solute carrier family 4 member 8,12q13.13,protein-coding,/
CWITA002884,TCMBANKGE002884,RNASEK-C17orf49,BAP18; C17orf49,RNASEK-C17orf49 readthrough,17p13.1,ncRNA,/
CWITA002885,TCMBANKGE002885,SLC7A3,ATRC3; CATN3; CAT3; FLJ14541; MGC20687,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 3",Xq13.1,protein-coding,
CWITA002886,TCMBANKGE002886,ACTR3C,ARP11,actin related protein 3C,7q36.1,protein-coding,/
CWITA002887,TCMBANKGE002887,RBM8A,BOV-1A; BOV-1B; BOV-1C; C1DELq21.1; DEL1q21.1; MDS014; RBM8; RBM8B; TAR; Y14; ZNRP; ZRNP1,Rna_Binding_Motif_Protein_8A,1q21.1,protein-coding,
CWITA002888,TCMBANKGE002888,DDX56,DDX21; DDX26; NOH61,DEAD-box helicase 56,7p13,protein-coding,/
CWITA002889,TCMBANKGE002889,Pgk1-ps3,Pgk-1ps3,"phosphoglycerate kinase 1, pseudogene 3",3 A2|3 5.16 cM,pseudo,/
CWITA002890,TCMBANKGE002890,PYGO1,-,pygopus family PHD finger 1,15q21.3,protein-coding,/
CWITA002891,TCMBANKGE002891,PODXL2,EG; PODLX2,podocalyxin like 2,3q21.3,protein-coding,/
CWITA002892,TCMBANKGE002892,BSN,ZNF231,bassoon presynaptic cytomatrix protein,3p21.31,protein-coding,/
CWITA002893,TCMBANKGE002893,KCNH1,EAG; EAG1; Kv10.1; MGC142269; hNeag,"potassium voltage-gated channel, subfamily H (eag-related), member 1",1q32.2,protein-coding,
CWITA002894,TCMBANKGE002894,RHEBL1,RHEBL1c,RHEB like 1,12q13.12,protein-coding,/
CWITA002895,TCMBANKGE002895,WARS2,TrpRS,"tryptophanyl tRNA synthetase 2, mitochondrial",1p12,protein-coding,
CWITA002896,TCMBANKGE002896,RET,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RETNELE1; RET51,ret proto-oncogene,10q11.2,protein-coding,
CWITA002897,TCMBANKGE002897,UGT1A3,UDPGT; UDPGT 1-3; UGT-1C; UGT1-03; UGT1.3; UGT1A3S; UGT1C,UDP glucuronosyltransferase family 1 member A3,2q37.1,protein-coding,/
CWITA002898,TCMBANKGE002898,CDS2,-,CDP-diacylglycerol synthase 2,20p12.3,protein-coding,/
CWITA002899,TCMBANKGE002899,PAX7,HUP1; MYOSCO; PAX7B; RMS2,paired box 7,1p36.13,protein-coding,/
CWITA002900,TCMBANKGE002900,SLC44A4,C6orf29; CTL4; FLJ14491; NG22,"solute carrier family 44, member 4",6p21.3,protein-coding,
CWITA002901,TCMBANKGE002901,TDO2,HYPTRP; TDO; TO; TPH2; TRPO,"tryptophan 2,3-dioxygenase",4q32.1,protein-coding,Patented target
CWITA002902,TCMBANKGE002902,RCAN1,ADAPT78; CSP1; DSC1; DSCR1; MCIP1; RCN1,regulator of calcineurin 1,21q22.1-q22.2|21q22.12,protein-coding,
CWITA002903,TCMBANKGE002903,DRD2,D2DR; D2R,dopamine receptor D2,11q23,protein-coding,
CWITA002904,TCMBANKGE002904,CTNS,CTNSNLSB; PQLC4,"cystinosis, nephropathic",17p13,protein-coding,
CWITA002905,TCMBANKGE002905,YOD1,DUBA8; OTUD2; PRO0907,YOD1 deubiquitinase,1q32.1,protein-coding,Research target
CWITA002906,TCMBANKGE002906,SLC6A1,GABATHG; GABATR; GAT1,"solute carrier family 6 (neurotransmitter transporter, GABA), member 1",3p25-p24,protein-coding,
CWITA002907,TCMBANKGE002907,POTEJ,POTE2beta,POTE ankyrin domain family member J,2q21.1,protein-coding,/
CWITA002908,TCMBANKGE002908,ALG10,ALG10A; DIE2; KCR1,"ALG10 alpha-1,2-glucosyltransferase",12p11.1,protein-coding,/
CWITA002909,TCMBANKGE002909,VARS1,G7A; NDMSCA; VARS; VARS2,valyl-tRNA synthetase 1,6p21.33,protein-coding,/
CWITA002910,TCMBANKGE002910,CAPZB,CAPB; CAPPB; CAPZ,capping actin protein of muscle Z-line subunit beta,1p36.13,protein-coding,/
CWITA002911,TCMBANKGE002911,RNF5,RING5; RMA1,ring finger protein 5,6p21.32,protein-coding,/
CWITA002912,TCMBANKGE002912,KCND2,KIAA1044; KV4.2; MGC119702; MGC119703; RK5,"potassium voltage-gated channel, Shal-related subfamily, member 2",7q31,protein-coding,
CWITA002913,TCMBANKGE002913,ETS1,ETS-1; EWSR2; c-ets-1; p54,"ETS proto-oncogene 1, transcription factor",11q24.3,protein-coding,Research target
CWITA002914,TCMBANKGE002914,COG5,CDG2I; GOLTC1; GTC90,component of oligomeric golgi complex 5,7q22.3,protein-coding,/
CWITA002915,TCMBANKGE002915,ZFAND5,ZA20D2; ZFAND5A; ZNF216,zinc finger AN1-type containing 5,9q21.13,protein-coding,Research target
CWITA002916,TCMBANKGE002916,STAMBP,AMSH; MICCAP,STAM binding protein,2p13.1,protein-coding,/
CWITA002917,TCMBANKGE002917,ZFP36L2,BRF2; ERF-2; ERF2; RNF162C; TIS11D,ZFP36 ring finger protein like 2,2p21,protein-coding,/
CWITA002918,TCMBANKGE002918,ASIC3,ACCN3; DRASIC; SLNAC1; TNaC1,Acid_Sensing_Ion_Channel_Subunit_3,7q36.1,protein-coding,
CWITA002919,TCMBANKGE002919,RTL8C,CXX1; FAM127A; MAR8C; MART8C; Mar8; Mart8; SIRH5,retrotransposon Gag like 8C,Xq26.3,protein-coding,/
CWITA002920,TCMBANKGE002920,GPNMB,HGFIN; NMB; PLCA3,glycoprotein nmb,7p15.3,protein-coding,Research target
CWITA002921,TCMBANKGE002921,TRIM15,RNF93; ZNF178; ZNFB7,tripartite motif containing 15,6p22.1,protein-coding,/
CWITA002922,TCMBANKGE002922,CERS5,LASS5; Trh4,ceramide synthase 5,12q13.12,protein-coding,/
CWITA002923,TCMBANKGE002923,ARPC1B,ARC41; PLTEID; p40-ARC; p41-ARC,actin related protein 2/3 complex subunit 1B,7q22.1,protein-coding,/
CWITA002924,TCMBANKGE002924,ZNF248,bA162G10.3,zinc finger protein 248,10p11.21,protein-coding,/
CWITA002925,TCMBANKGE002925,PPP2R5C,B56G; B56gamma; PR61G,protein phosphatase 2 regulatory subunit B'gamma,14q32.31,protein-coding,/
CWITA002926,TCMBANKGE002926,SNCG,BCSG1; SR,synuclein gamma,10q23.2,protein-coding,Research target
CWITA002927,TCMBANKGE002927,YES1,HsT441; P61-YES; Yes; c-yes,"YES proto-oncogene 1, Src family tyrosine kinase",18p11.32,protein-coding,Clinical Trial target
CWITA002928,TCMBANKGE002928,RPTOR,KOG1; Mip1,regulatory associated protein of MTOR complex 1,17q25.3,protein-coding,/
CWITA002929,TCMBANKGE002929,ZNF688,-,zinc finger protein 688,16p11.2,protein-coding,/
CWITA002930,TCMBANKGE002930,PKP2,ARVD9,plakophilin 2,12p11.21,protein-coding,/
CWITA002931,TCMBANKGE002931,RSPO4,C20orf182; CRISTIN4,R-spondin 4,20p13,protein-coding,/
CWITA002932,TCMBANKGE002932,HLA-DOB,DOB; HLA_DOB,"major histocompatibility complex, class II, DO beta",6p21.32,protein-coding,/
CWITA002933,TCMBANKGE002933,CR1,C3BR; C4BR; CD35; KN,complement C3b/C4b receptor 1 (Knops blood group),1q32.2,protein-coding,Clinical Trial target
CWITA002934,TCMBANKGE002934,IGSF10,CMF608; FLJ25972,"immunoglobulin superfamily, member 10",3q25.1,protein-coding,
CWITA002935,TCMBANKGE002935,ASPSCR1,ASPCR1; ASPL; ASPS; RCC17; TUG; UBXD9; UBXN9,"ASPSCR1 tether for SLC2A4, UBX domain containing",17q25.3,protein-coding,/
CWITA002936,TCMBANKGE002936,GAL,ETL8; GAL-GMAP; GALN; GLNN; GMAP,galanin and GMAP prepropeptide,11q13.2,protein-coding,Research target
CWITA002937,TCMBANKGE002937,ADH4,ADH-2; HEL-S-4,"alcohol dehydrogenase 4 (class II), pi polypeptide",4q23,protein-coding,/
CWITA002938,TCMBANKGE002938,CCDC63,ODA5,coiled-coil domain containing 63,12q24.11,protein-coding,/
CWITA002939,TCMBANKGE002939,GLOD4,C17orf25; CGI-150; HC71,glyoxalase domain containing 4,17p13.3,protein-coding,/
CWITA002940,TCMBANKGE002940,LIMK2,-,LIM domain kinase 2,22q12.2,protein-coding,Research target
CWITA002941,TCMBANKGE002941,ASB11,-,ankyrin repeat and SOCS box containing 11,Xp22.2,protein-coding,/
CWITA002942,TCMBANKGE002942,QDPR,DHPR; FLJ42391; PKU2; SDR33C1,quinoid dihydropteridine reductase,4p15.31,protein-coding,
CWITA002943,TCMBANKGE002943,OR1J4,HSHTPCRX01; HTPCRX01; OR9-21,olfactory receptor family 1 subfamily J member 4,9q33.2,protein-coding,/
CWITA002944,TCMBANKGE002944,FPGS,-,folylpolyglutamate synthase,9q34.11,protein-coding,/
CWITA002945,TCMBANKGE002945,OPRL1,KORN3; MGC34578; NOCIR; OOR; ORL1,opiate receptor-like 1,20q13.33,protein-coding,
CWITA002946,TCMBANKGE002946,CCDC34,L15; NY-REN-41; RAMA3,coiled-coil domain containing 34,11p14.1,protein-coding,/
CWITA002947,TCMBANKGE002947,ANKRD29,-,ankyrin repeat domain 29,18q11.2,protein-coding,/
CWITA002948,TCMBANKGE002948,RFTN1,MIG2; PIB10; PIG9; RAFTLIN,"raftlin, lipid raft linker 1",3p24.3,protein-coding,/
CWITA002949,TCMBANKGE002949,ENO2,HEL-S-279; NSE,enolase 2,12p13.31,protein-coding,/
CWITA002950,TCMBANKGE002950,ANXA10,ANX14,annexin A10,4q32.3,protein-coding,Research target
CWITA002951,TCMBANKGE002951,ADGRF5,GPR116; KPG_001,adhesion G protein-coupled receptor F5,6p12.3,protein-coding,/
CWITA002952,TCMBANKGE002952,RNF181,HSPC238,ring finger protein 181,2p11.2,protein-coding,/
CWITA002953,TCMBANKGE002953,VPS4A,SKD1; SKD1A; SKD2; VPS4; VPS4-1,vacuolar protein sorting 4 homolog A,16q22.1,protein-coding,/
CWITA002954,TCMBANKGE002954,NKX2-4,NKX2.4; NKX2D,NK2 homeobox 4,20p11.22,protein-coding,/
CWITA002955,TCMBANKGE002955,LRIT2,LRRC22,"leucine rich repeat, Ig-like and transmembrane domains 2",10q23.1,protein-coding,/
CWITA002956,TCMBANKGE002956,ABCG1,ABC8; MGC34313; WHITE1,"ATP-binding cassette, sub-family G (WHITE), member 1",21q22.3,protein-coding,
CWITA002957,TCMBANKGE002957,ARF4,ARF2,ADP ribosylation factor 4,3p14.3,protein-coding,/
CWITA002958,TCMBANKGE002958,AGO4,EIF2C4,argonaute RISC component 4,1p34.3,protein-coding,/
CWITA002959,TCMBANKGE002959,MTRR,MGC129643; MSR; cblE,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5p15.31,protein-coding,
CWITA002960,TCMBANKGE002960,NUP214,CAIN; CAN; IIAE9,nucleoporin 214,9q34.13,protein-coding,/
CWITA002961,TCMBANKGE002961,DYNLL1,DLC1; DLC8; DNCL1; DNCLC1; LC8; LC8a; PIN; hdlc1,dynein light chain LC8-type 1,12q24.31,protein-coding,/
CWITA002962,TCMBANKGE002962,NDUFB11,CI-ESSS; ESSS; MC1DN30; NP17.3; Np15; P17.3,NADH:ubiquinone oxidoreductase subunit B11,Xp11.3,protein-coding,/
CWITA002963,TCMBANKGE002963,ALX1,CART1; FND3; HEL23,ALX homeobox 1,12q21.31,protein-coding,/
CWITA002964,TCMBANKGE002964,XXYLT1,C3orf21,xyloside xylosyltransferase 1,3q29,protein-coding,/
CWITA002965,TCMBANKGE002965,LRRC8B,TA-LRRP; TALRRP,leucine rich repeat containing 8 VRAC subunit B,1p22.2,protein-coding,/
CWITA002966,TCMBANKGE002966,BET1,HBET1,Bet1 golgi vesicular membrane trafficking protein,7q21.3,protein-coding,/
CWITA002967,TCMBANKGE002967,AAAS,AAA; AAASb; ADRACALA; ADRACALIN; ALADIN; GL003,aladin WD repeat nucleoporin,12q13.13,protein-coding,/
CWITA002968,TCMBANKGE002968,GBP1,-,guanylate binding protein 1,1p22.2,protein-coding,/
CWITA002969,TCMBANKGE002969,FCHSD2,NWK; NWK1; SH3MD3,FCH and double SH3 domains 2,11q13.4,protein-coding,/
CWITA002970,TCMBANKGE002970,E2F7,-,E2F transcription factor 7,12q21.2,protein-coding,/
CWITA002971,TCMBANKGE002971,MAN2B2,-,mannosidase alpha class 2B member 2,4p16.1,protein-coding,/
CWITA002972,TCMBANKGE002972,ATP5F1EP2,ATP5EP2,ATP synthase F1 subunit epsilon pseudogene 2,13q12.2,pseudo,/
CWITA002973,TCMBANKGE002973,NFIA,BRMUTD; CTF; NF-I/A; NF1-A; NFI-A; NFI-L,nuclear factor I A,1p31.3,protein-coding,/
CWITA002974,TCMBANKGE002974,UBXN2A,UBXD4,UBX domain protein 2A,2p23.3,protein-coding,/
CWITA002975,TCMBANKGE002975,PGLYRP3,PGLYRPIalpha; PGRP-Ialpha; PGRPIA,peptidoglycan recognition protein 3,1q21.3,protein-coding,/
CWITA002976,TCMBANKGE002976,EPC1,Epl1,enhancer of polycomb homolog 1,10p11.22,protein-coding,/
CWITA002977,TCMBANKGE002977,ANGEL1,Ccr4e; KIAA0759,angel homolog 1,14q24.3,protein-coding,/
CWITA002978,TCMBANKGE002978,RTN4R,NGR; NOGOR,reticulon 4 receptor,22q11.21,protein-coding,Research target
CWITA002979,TCMBANKGE002979,MYL9,LC20; MLC-2C; MLC2; MRLC1; MYRL2,myosin light chain 9,20q11.23,protein-coding,/
CWITA002980,TCMBANKGE002980,CHEK2,CDS1; CHK2; HuCds1; LFS2; PP1425; RAD53; hCds1,checkpoint kinase 2,22q12.1,protein-coding,Clinical Trial target
CWITA002981,TCMBANKGE002981,MAP2K2,FLJ26075; MAPKK2; MEK2; MKK2; PRKMK2,mitogen-activated protein kinase kinase 2,19p13.3,protein-coding,
CWITA002982,TCMBANKGE002982,PTDSS2,PSS2,phosphatidylserine synthase 2,11p15.5,protein-coding,/
CWITA002983,TCMBANKGE002983,CCDC51,MITOK,coiled-coil domain containing 51,3p21.31,protein-coding,/
CWITA002984,TCMBANKGE002984,WNK3,PRKWNK3,WNK lysine deficient protein kinase 3,Xp11.22,protein-coding,Research target
CWITA002985,TCMBANKGE002985,CUL2,-,cullin 2,10p11.21,protein-coding,/
CWITA002986,TCMBANKGE002986,ATP2A1,ATP2A; SERCA1,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1,16p11.2,protein-coding,/
CWITA002987,TCMBANKGE002987,SERPIND1,D22S673; HC2; HCF2; HCII; HLS2; LS2; THPH10,serpin family D member 1,22q11.21,protein-coding,Research target
CWITA002988,TCMBANKGE002988,MPP5,PALS1,membrane palmitoylated protein 5,14q23.3,protein-coding,/
CWITA002989,TCMBANKGE002989,AMT,GCE; GCST; GCVT; NKH,aminomethyltransferase,3p21.2-p21.1,protein-coding,
CWITA002990,TCMBANKGE002990,SHCBP1,PAL,SHC binding and spindle associated 1,16q11.2,protein-coding,Research target
CWITA002991,TCMBANKGE002991,ZNF675,TBZF; TIZ,zinc finger protein 675,19p12,protein-coding,/
CWITA002992,TCMBANKGE002992,TMEFF1,C9orf2; CT120.1; H7365; TR-1,transmembrane protein with EGF like and two follistatin like domains 1,9q31.1,protein-coding,/
CWITA002993,TCMBANKGE002993,ZNF724,ZNF724P,zinc finger protein 724,19p12,protein-coding,/
CWITA002994,TCMBANKGE002994,SLC22A15,FLIPT1; PRO34686,solute carrier family 22 member 15,1p13.1,protein-coding,/
CWITA002995,TCMBANKGE002995,SSUH2,C3orf32; SSU-2; fls485,ssu-2 homolog,3p25.3,protein-coding,/
CWITA002996,TCMBANKGE002996,LRRC70,SLRN,leucine rich repeat containing 70,5q12.1,protein-coding,/
CWITA002997,TCMBANKGE002997,RPE,RPE2-1,ribulose-5-phosphate-3-epimerase,2q34,protein-coding,/
CWITA002998,TCMBANKGE002998,Ppp1r18os,5530401N12Rik,"protein phosphatase 1, regulatory subunit 18, opposite strand",17|17,unknown,/
CWITA002999,TCMBANKGE002999,BRSK1,hSAD1,BR serine/threonine kinase 1,19q13.42,protein-coding,Research target
CWITA003000,TCMBANKGE003000,SGCB,A3b; LGMD2E; LGMDR4; SGC,sarcoglycan beta,4q12,protein-coding,/
CWITA003001,TCMBANKGE003001,DCAF5,BCRG2; BCRP2; D14S1461E; WDR22,DDB1 and CUL4 associated factor 5,14q24.1,protein-coding,/
CWITA003002,TCMBANKGE003002,PLAC8L1,-,PLAC8 like 1,5q32,protein-coding,/
CWITA003003,TCMBANKGE003003,ZNF527,-,zinc finger protein 527,19q13.12,protein-coding,/
CWITA003004,TCMBANKGE003004,PLA2G15,ACS; GXVPLA2; LLPL; LPLA2; LYPLA3,Phospholipase_A2_Group_Xv,16q22.1,protein-coding,
CWITA003005,TCMBANKGE003005,CYP24A1,CP24; CYP24; HCAI; HCINF1; P450-CC24,cytochrome P450 family 24 subfamily A member 1,20q13.2,protein-coding,Clinical Trial target
CWITA003006,TCMBANKGE003006,GUCY2D,CACD1; CG-E; CORD5; CORD6; CSNB1I; CYGD; GUC1A4; GUC2D; LCA; LCA1; RCD2; RETGC-1; ROS-GC1; ROSGC; retGC,"guanylate cyclase 2D, retinal",17p13.1,protein-coding,Successful target
CWITA003007,TCMBANKGE003007,RPL26L1,RPL26P1,ribosomal protein L26 like 1,5q35.1,protein-coding,/
CWITA003008,TCMBANKGE003008,GSK3B,N,glycogen synthase kinase 3 beta,3q13.3,protein-coding,
CWITA003009,TCMBANKGE003009,VPREB3,8HS20; N27C7-2,V-set pre-B cell surrogate light chain 3,22q11.23|22q11,protein-coding,/
CWITA003010,TCMBANKGE003010,CAPN9,GC36; nCL-4,calpain 9,1q42.2,protein-coding,/
CWITA003011,TCMBANKGE003011,BMX,ETK; PSCTK2; PSCTK3,BMX non-receptor tyrosine kinase,Xp22.2,protein-coding,Research target
CWITA003012,TCMBANKGE003012,MPV17,CMT2EE; MTDPS6; SYM1,mitochondrial inner membrane protein MPV17,2p23.3,protein-coding,/
CWITA003013,TCMBANKGE003013,SLC4A4,DKFZp781H1314; HNBC1; KNBC; NBC1; NBC2; SLC4A5; hhNMC; pNBC,"solute carrier family 4, sodium bicarbonate cotransporter, member 4",4q21,protein-coding,
CWITA003014,TCMBANKGE003014,KCNN3,KCa2.3; SK3; SKCA3; ZLS3; hSK3,potassium calcium-activated channel subfamily N member 3,1q21.3,protein-coding,Clinical Trial target
CWITA003015,TCMBANKGE003015,PAXX,C9orf142; XLS,PAXX non-homologous end joining factor,9q34.3,protein-coding,/
CWITA003016,TCMBANKGE003016,TLE3,ESG; ESG3; GRG3; HsT18976,"TLE family member 3, transcriptional corepressor",15q23,protein-coding,/
CWITA003017,TCMBANKGE003017,PLEKHH1,-,"pleckstrin homology, MyTH4 and FERM domain containing H1",14q24.1,protein-coding,/
CWITA003018,TCMBANKGE003018,CIB3,KIP3,calcium and integrin binding family member 3,19p13.11,protein-coding,/
CWITA003019,TCMBANKGE003019,DNAH1,CILD37; DNAHC1; HDHC7; HL-11; HL11; HSRF-1; SPGF18; XLHSRF-1,dynein axonemal heavy chain 1,3p21.1,protein-coding,/
CWITA003020,TCMBANKGE003020,ZNF345,HZF10,zinc finger protein 345,19q13.12,protein-coding,/
CWITA003021,TCMBANKGE003021,PSD4,EFA6B; TIC,pleckstrin and Sec7 domain containing 4,2q14.1,protein-coding,/
CWITA003022,TCMBANKGE003022,SEC14L3,TAP2,Sec14_Like_Lipid_Binding_3,22q12.2,protein-coding,
CWITA003023,TCMBANKGE003023,CYB5RL,-,cytochrome b5 reductase like,1p32.3,protein-coding,/
CWITA003024,TCMBANKGE003024,SLC1A1,DCBXA; EAAC1; EAAT3; SCZD18,solute carrier family 1 member 1,9p24.2,protein-coding,Research target
CWITA003025,TCMBANKGE003025,LRRC63,-,leucine rich repeat containing 63,13q14.13,protein-coding,/
CWITA003026,TCMBANKGE003026,USP31,-,ubiquitin specific peptidase 31,16p12.2,protein-coding,/
CWITA003027,TCMBANKGE003027,ATP8B2,ATPID,ATPase phospholipid transporting 8B2,1q21.3,protein-coding,/
CWITA003028,TCMBANKGE003028,NKX2-8,NKX2.8; NKX2H; Nkx2-9,NK2 homeobox 8,14q13.3,protein-coding,/
CWITA003029,TCMBANKGE003029,WDR77,HKMT1069; MEP-50; MEP50; Nbla10071; p44; p44/Mep50,WD repeat domain 77,1p13.2,protein-coding,/
CWITA003030,TCMBANKGE003030,ZFP36,G0S24; GOS24; NUP475; RNF162A; TIS11; TTP; zfp-36,ZFP36 ring finger protein,19q13.2,protein-coding,/
CWITA003031,TCMBANKGE003031,GGT7,D20S101; GGT4; GGTL3; GGTL5,gamma-glutamyltransferase 7,20q11.22,protein-coding,Research target
CWITA003032,TCMBANKGE003032,SYDE2,-,synapse defective Rho GTPase homolog 2,1p22.3,protein-coding,/
CWITA003033,TCMBANKGE003033,ARL13A,ARL13; dJ341D10.2,ADP ribosylation factor like GTPase 13A,Xq22.1,protein-coding,/
CWITA003034,TCMBANKGE003034,UBXN6,UBXD1; UBXDC2,UBX domain protein 6,19p13.3,protein-coding,/
CWITA003035,TCMBANKGE003035,NR1D2,BD73; EAR-1R; REVERBB; REVERBbeta; RVR,nuclear receptor subfamily 1 group D member 2,3p24.2,protein-coding,/
CWITA003036,TCMBANKGE003036,RNASE3,ECP; RNS3,"ribonuclease, RNase A family, 3",14q24-q31,protein-coding,
CWITA003037,TCMBANKGE003037,IMP4,BXDC4,IMP U3 small nucleolar ribonucleoprotein 4,2q21.1,protein-coding,/
CWITA003038,TCMBANKGE003038,TFPI2,PP5; REF1; TFPI-2,tissue factor pathway inhibitor 2,7q21.3,protein-coding,/
CWITA003039,TCMBANKGE003039,MMP1,CLG; CLGN,matrix metallopeptidase 1 (interstitial collagenase),11q22.3,protein-coding,
CWITA003040,TCMBANKGE003040,BCL2L1,BCLNXL/S; BCL2L; BCLX; BCLXL; BCLXS; BclNX; DKFZp781P2092; bclNxL; bclNxS,BCL2-like 1,20q11.21,protein-coding,
CWITA003041,TCMBANKGE003041,GFER,ALR; ERV1; HERV1; HPO; HPO1; HPO2; HSS,"growth factor, augmenter of liver regeneration",16p13.3,protein-coding,/
CWITA003042,TCMBANKGE003042,ITGA3,CD49C; FRP-2; GAP-B3; GAPB3; ILNEB; MSK18; VCA-2; VL3A; VLA3a,integrin subunit alpha 3,17q21.33,protein-coding,/
CWITA003043,TCMBANKGE003043,HAT1,KAT1,histone acetyltransferase 1,2q31.1,protein-coding,/
CWITA003044,TCMBANKGE003044,UPP1,UDRPASE; UP; UPASE; UPP,uridine phosphorylase 1,7p12.3,protein-coding,
CWITA003045,TCMBANKGE003045,ARL5A,ARFLP5; ARL5,ADP ribosylation factor like GTPase 5A,2q23.3,protein-coding,/
CWITA003046,TCMBANKGE003046,AVP,ADH; ARVP; AVP-NPII; AVRP; VP,arginine vasopressin,20p13,protein-coding,Research target
CWITA003047,TCMBANKGE003047,PARP3,ADPRT3; ADPRTL2; ADPRTL3; IRT1; PADPRTN3,"poly (ADP-ribose) polymerase family, member 3",3p21.31-p21.1,protein-coding,
CWITA003048,TCMBANKGE003048,PPP3CB,CALNA2; CALNB; CNA2; PP2Bbeta,protein phosphatase 3 catalytic subunit beta,10q22.2,protein-coding,/
CWITA003049,TCMBANKGE003049,SULT1C2,ST1C1; ST1C2; SULT1C1; humSULTC2,sulfotransferase family 1C member 2,2q12.3,protein-coding,/
CWITA003050,TCMBANKGE003050,AS3MT,CYT19,arsenite methyltransferase,10q24.32,protein-coding,/
CWITA003051,TCMBANKGE003051,CTSH,ACCN4; ACCN5; CPSB; DKFZp686B24257; MGC1519; minichain,cathepsin H,15q25.1,protein-coding,
CWITA003052,TCMBANKGE003052,GPR137C,TM7SF1L2,G protein-coupled receptor 137C,14q22.1,protein-coding,/
CWITA003053,TCMBANKGE003053,HTR2B,5-HT(2B); 5-HT-2B; 5-HT2B,5-hydroxytryptamine receptor 2B,2q37.1,protein-coding,Successful target
CWITA003054,TCMBANKGE003054,SLC2A11,GLUT10; GLUT11; MGC118830; MGC118833; SLC2A11Na; SLC2A11Nc,"solute carrier family 2 (facilitated glucose transporter), member 11",22q11.2,protein-coding,
CWITA003055,TCMBANKGE003055,CCL21,6Ckine; CKb9; ECL; SCYA21; SLC; TCA4,C-C motif chemokine ligand 21,9p13.3,protein-coding,Research target
CWITA003056,TCMBANKGE003056,GAD2,GAD65,glutamate decarboxylase 2,10p12.1,protein-coding,Clinical Trial target
CWITA003057,TCMBANKGE003057,STX1A,HPC-1; P35-1; STX1; SYN1A,syntaxin 1A,7q11.23,protein-coding,/
CWITA003058,TCMBANKGE003058,CHST13,C4ST3,carbohydrate sulfotransferase 13,3q21.3,protein-coding,/
CWITA003059,TCMBANKGE003059,DHX35,C20orf15; DDX35; KAIA0875,DEAH-box helicase 35,20q11.23-q12,protein-coding,/
CWITA003060,TCMBANKGE003060,SHOC2,SIAA0862; SOC2; SUR8,SHOC2 leucine rich repeat scaffold protein,10q25.2,protein-coding,/
CWITA003061,TCMBANKGE003061,BCL11A,BCL11A-L; BCL11A-S; BCL11A-XL; BCL11a-M; CTIP1; DILOS; EVI9; HBFQTL5; ZNF856,BAF chromatin remodeling complex subunit BCL11A,2p16.1,protein-coding,/
CWITA003062,TCMBANKGE003062,TPX2,C20orf1; C20orf2; DIL-2; DIL2; FLS353; GD:C20orf1; HCA519; HCTP4; REPP86; p100,TPX2 microtubule nucleation factor,20q11.21,protein-coding,Research target
CWITA003063,TCMBANKGE003063,AARD,C8orf85,alanine and arginine rich domain containing protein,8q24.11,protein-coding,/
CWITA003064,TCMBANKGE003064,CSNK2B,CK2B; CK2N; CSK2B; G5A; MGC138222; MGC138224,"casein kinase 2, beta polypeptide",6p21-p12|6p21.3,protein-coding,
CWITA003065,TCMBANKGE003065,NXT1,MTR2; P15,nuclear transport factor 2 like export factor 1,20p11.21,protein-coding,/
CWITA003066,TCMBANKGE003066,CENPA,CENP-A; CenH3,centromere protein A,2p23.3,protein-coding,/
CWITA003067,TCMBANKGE003067,ANKS1B,AIDA; AIDA-1; ANKS2; EB-1; EB1; cajalin-2,ankyrin repeat and sterile alpha motif domain containing 1B,12q23.1,protein-coding,/
CWITA003068,TCMBANKGE003068,ZNF26,HEL-179; KOX20,zinc finger protein 26,12q24.33,protein-coding,/
CWITA003069,TCMBANKGE003069,KCNK13,K2p13.1; THIK-1; THIK1,potassium two pore domain channel subfamily K member 13,14q32.11,protein-coding,/
CWITA003070,TCMBANKGE003070,ST6GALNAC5,SIAT7-E; SIAT7E; ST6GalNAcV,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5",1p31.1,protein-coding,/
CWITA003071,TCMBANKGE003071,P2RY2,HP2U; P2RU1; P2U; P2U1; P2UR; P2Y2; P2Y2R,purinergic receptor P2Y2,11q13.4,protein-coding,Clinical Trial target
CWITA003072,TCMBANKGE003072,KIFC2,-,kinesin family member C2,8q24.3,protein-coding,/
CWITA003073,TCMBANKGE003073,OTULIN,AIPDS; FAM105B; GUM,OTU deubiquitinase with linear linkage specificity,5p15.2,protein-coding,/
CWITA003074,TCMBANKGE003074,CYP51A1,CP51; CYP51; CYPL1; LDM; P450-14DM; P450L1,cytochrome P450 family 51 subfamily A member 1,7q21.2,protein-coding,Clinical Trial target
CWITA003075,TCMBANKGE003075,TTC14,DRDL5813; PRO19630,tetratricopeptide repeat domain 14,3q26.33,protein-coding,/
CWITA003076,TCMBANKGE003076,LCTL,KLG; KLPH,lactase like,15q22.31,protein-coding,/
CWITA003077,TCMBANKGE003077,CCN1,CYR61; GIG1; IGFBP10,cellular communication network factor 1,1p22.3,protein-coding,Research target
CWITA003078,TCMBANKGE003078,CALM1,CALM2; CALM3; CALML2; CAMI; DD132; PHKD; caM,"calmodulin 1 (phosphorylase kinase, delta)",14q24-q31,protein-coding,
CWITA003079,TCMBANKGE003079,CCKBR,CCK-B; CCK2R; GASR,cholecystokinin B receptor,11p15.4,protein-coding,Successful target
CWITA003080,TCMBANKGE003080,CLGN,-,calmegin,4q31.1,protein-coding,/
CWITA003081,TCMBANKGE003081,MPRIP,M-RIP; MRIP; RHOIP3; RIP3; p116Rip,myosin phosphatase Rho interacting protein,17p11.2,protein-coding,/
CWITA003082,TCMBANKGE003082,HDAC3,HD3; KDAC3; RPD3; RPD3-2,histone deacetylase 3,5q31.3,protein-coding,Clinical Trial target
CWITA003083,TCMBANKGE003083,RCOR3,-,REST corepressor 3,1q32.2-q32.3,protein-coding,/
CWITA003084,TCMBANKGE003084,RPS10,DBA9; S10,ribosomal protein S10,6p21.31,protein-coding,/
CWITA003085,TCMBANKGE003085,EDNRA,ETA; ETAR; ETRA,endothelin receptor type A,4q31.22,protein-coding,
CWITA003086,TCMBANKGE003086,Pitx3,Ptx3; ak; aphakia,paired-like homeodomain transcription factor 3,19 C3|19 38.75 cM,protein-coding,/
CWITA003087,TCMBANKGE003087,TYK2,JTK1,tyrosine kinase 2,19p13.2,protein-coding,
CWITA003088,TCMBANKGE003088,TENT5A,C6orf37; FAM46A; OI18; XTP11,terminal nucleotidyltransferase 5A,6q14.1,protein-coding,/
CWITA003089,TCMBANKGE003089,ITPKA,IP3-3KA; IP3KA,inositol-trisphosphate 3-kinase A,15q15.1,protein-coding,/
CWITA003090,TCMBANKGE003090,GNPTAB,GNPTA; ICD,N-Acetylglucosamine-1-Phosphate_Transferase_Subunits_Alpha_And_Beta,12q23.2,protein-coding,
CWITA003091,TCMBANKGE003091,BBOX1,BBH; BBOX; GNBBH; gammaNBBH,"butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1",11p14.2,protein-coding,
CWITA003092,TCMBANKGE003092,HSD11B1L,11-DH3; 11-beta-HSD3; HSD1L; HSD3; SCDR10; SCDR10B; SDR26C2,hydroxysteroid 11-beta dehydrogenase 1 like,19p13.3,protein-coding,/
CWITA003093,TCMBANKGE003093,PTPRK,R-PTP-kappa,protein tyrosine phosphatase receptor type K,6q22.33,protein-coding,/
CWITA003094,TCMBANKGE003094,SLC16A7,MCT2,"solute carrier family 16, member 7 (monocarboxylic acid transporter 2)",12q13,protein-coding,
CWITA003095,TCMBANKGE003095,F2RL1,GPR11; PAR2,F2R like trypsin receptor 1,5q13.3,protein-coding,Patented target
CWITA003096,TCMBANKGE003096,AGAP1,AGAP-1; CENTG2; GGAP1; cnt-g2,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1",2q37.2,protein-coding,/
CWITA003097,TCMBANKGE003097,HOOK3,HK3,hook microtubule tethering protein 3,8p11.21,protein-coding,/
CWITA003098,TCMBANKGE003098,SLC7A4,CATN4; CAT4; HCAT3; MGC129976; MGC129977; VH,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 4",22q11.21,protein-coding,
CWITA003099,TCMBANKGE003099,CD163,M130; MM130; SCARI1,CD163 molecule,12p13.31,protein-coding,Research target
CWITA003100,TCMBANKGE003100,ZNF430,-,zinc finger protein 430,19p12,protein-coding,/
CWITA003101,TCMBANKGE003101,ALKAL2,AUGA; FAM150B; PRO1097; RGPG542,ALK and LTK ligand 2,2p25.3,protein-coding,/
CWITA003102,TCMBANKGE003102,ZBTB14,ZF5; ZFP-161; ZFP-5; ZFP161; ZNF478,zinc finger and BTB domain containing 14,18p11.31,protein-coding,/
CWITA003103,TCMBANKGE003103,ZNF79,pT7,zinc finger protein 79,9q33.3,protein-coding,/
CWITA003104,TCMBANKGE003104,ZNF850,ZNF850P,zinc finger protein 850,19q13.12,protein-coding,/
CWITA003105,TCMBANKGE003105,PARD6A,PAR-6A; PAR6; PAR6C; PAR6alpha; TAX40; TIP-40,par-6 family cell polarity regulator alpha,16q22.1,protein-coding,/
CWITA003106,TCMBANKGE003106,DCUN1D4,-,defective in cullin neddylation 1 domain containing 4,4q12,protein-coding,/
CWITA003107,TCMBANKGE003107,HTR4,5NHT4; 5NHT4R,5-hydroxytryptamine (serotonin) receptor 4,5q31-q33,protein-coding,
CWITA003108,TCMBANKGE003108,ACSM5,-,acyl-CoA synthetase medium chain family member 5,16p12.3,protein-coding,/
CWITA003109,TCMBANKGE003109,PSMB3,HC10NII; MGC4147,"proteasome (prosome, macropain) subunit, beta type, 3",17q12,protein-coding,
CWITA003110,TCMBANKGE003110,PLCE1,NPHS3; PLCE; PPLC,phospholipase C epsilon 1,10q23.33,protein-coding,/
CWITA003111,TCMBANKGE003111,COA6,C1orf31; CEMCOX4,cytochrome c oxidase assembly factor 6,1q42.2,protein-coding,/
CWITA003112,TCMBANKGE003112,RGS8,-,regulator of G protein signaling 8,1q25.3,protein-coding,Research target
CWITA003113,TCMBANKGE003113,CX3CL1,ABCD-3; C3Xkine; CXC3; CXC3C; NTN; NTT; SCYD1; fractalkine; neurotactin,C-X3-C motif chemokine ligand 1,16q21,protein-coding,Research target
CWITA003114,TCMBANKGE003114,ZNF20,KOX13,zinc finger protein 20,19p13.2,protein-coding,/
CWITA003115,TCMBANKGE003115,USP22,USP3L,ubiquitin specific peptidase 22,17p11.2,protein-coding,/
CWITA003116,TCMBANKGE003116,MAP4K3,GLK; MAPKKKK3; MEKKK 3; MEKKK3; RAB8IPL1,mitogen-activated protein kinase kinase kinase kinase 3,2p22.1,protein-coding,Research target
CWITA003117,TCMBANKGE003117,SERGEF,DELGEF; Gnefr,secretion regulating guanine nucleotide exchange factor,11p15.1,protein-coding,/
CWITA003118,TCMBANKGE003118,CA6,CA-VI; GUSTIN,carbonic anhydrase 6,1p36.23,protein-coding,Successful target
CWITA003119,TCMBANKGE003119,GLB1L3,-,galactosidase beta 1 like 3,11q25,protein-coding,/
CWITA003120,TCMBANKGE003120,AP1G2,G2AD,adaptor related protein complex 1 subunit gamma 2,14q11.2,protein-coding,/
CWITA003121,TCMBANKGE003121,SLC10A1,NTCP,"solute carrier family 10 (sodium/bile acid cotransporter family), member 1",14q24.1,protein-coding,
CWITA003122,TCMBANKGE003122,NRP2,NP2; NPN2; PRO2714; VEGF165R2,neuropilin 2,2q33.3,protein-coding,Research target
CWITA003123,TCMBANKGE003123,DYNLT3,RP3; TCTE1L; TCTEX1L,dynein light chain Tctex-type 3,Xp11.4,protein-coding,/
CWITA003124,TCMBANKGE003124,NANOS3,NANOS1L; NOS3; ZC2HC12C,nanos C2HC-type zinc finger 3,19p13.12,protein-coding,/
CWITA003125,TCMBANKGE003125,LRRC4C,NGL-1; NGL1,leucine rich repeat containing 4C,11p12,protein-coding,/
CWITA003126,TCMBANKGE003126,GMPR2,GMPR 2,guanosine monophosphate reductase 2,14q12,protein-coding,/
CWITA003127,TCMBANKGE003127,WDHD1,AND-1; AND1; CHTF4; CTF4,WD repeat and HMG-box DNA binding protein 1,14q22.2-q22.3,protein-coding,/
CWITA003128,TCMBANKGE003128,TUBA1C,MGC10851; MGC14580; TUBA6; bcm948,"tubulin, alpha 1c",12q13.12,protein-coding,
CWITA003129,TCMBANKGE003129,PSMD5,S5B,"proteasome 26S subunit, non-ATPase 5",9q33.2,protein-coding,/
CWITA003130,TCMBANKGE003130,ZNF71,EZFIT,zinc finger protein 71,19q13.43,protein-coding,/
CWITA003131,TCMBANKGE003131,B3GALNT1,B3GALT3; GLCT3; GLOB; Gb4Cer; P; P1; beta3Gal-T3; galT3,"Beta-1,3-N-Acetylgalactosaminyltransferase_1_(Globoside_Blood_Group)",3q26.1,protein-coding,
CWITA003132,TCMBANKGE003132,TMPRSS11D,ASP; HAT,transmembrane serine protease 11D,4q13.2,protein-coding,Research target
CWITA003133,TCMBANKGE003133,ZNF84,HPF2,zinc finger protein 84,12q24.33|map from Rosati ref via FISH [AFS],protein-coding,/
CWITA003134,TCMBANKGE003134,H1-0,H1.0; H10; H1F0; H1FV,H1.0 linker histone,22q13.1,protein-coding,/
CWITA003135,TCMBANKGE003135,PAXBP1,BM020; C21orf66; FSAP105; GCFC; GCFC1,PAX3 and PAX7 binding protein 1,21q22.11,protein-coding,/
CWITA003136,TCMBANKGE003136,HSD17B10,17bNHSD10; ABAD; CAMR; DUPXp11.22; ERAB; HADH2; HCD2; MHBD; MRPP2; MRX17; MRX31; MRXS10; SCHAD; SDR5C1,hydroxysteroid (17-beta) dehydrogenase 10,Xp11.2,protein-coding,
CWITA003137,TCMBANKGE003137,FBXL5,FBL4; FBL5; FLR1,F-box and leucine rich repeat protein 5,4p15.32,protein-coding,/
CWITA003138,TCMBANKGE003138,STAG2,HPE13; MKMS; NEDXCF; SA-2; SA2; SCC3B; bA517O1.1,stromal antigen 2,Xq25,protein-coding,/
CWITA003139,TCMBANKGE003139,CLASP2,-,cytoplasmic linker associated protein 2,3p22.3,protein-coding,/
CWITA003140,TCMBANKGE003140,HNRNPH1,HNRPH; HNRPH1; hnRNPH,heterogeneous nuclear ribonucleoprotein H1,5q35.3,protein-coding,/
CWITA003141,TCMBANKGE003141,ZNF513,HMFT0656; RP58; Zfp513,zinc finger protein 513,2p23.3,protein-coding,/
CWITA003142,TCMBANKGE003142,HTR1B,5NHT1B; 5NHT1DB; HTR1D2; HTR1DB; S12,5-hydroxytryptamine (serotonin) receptor 1B,6q13,protein-coding,
CWITA003143,TCMBANKGE003143,FES,FPS,"FES proto-oncogene, tyrosine kinase",15q26.1,protein-coding,Research target
CWITA003144,TCMBANKGE003144,ZNF787,TIP20,zinc finger protein 787,19q13.43,protein-coding,/
CWITA003145,TCMBANKGE003145,COX6B2,COXVIB2; CT59,cytochrome c oxidase subunit 6B2,19q13.42,protein-coding,/
CWITA003146,TCMBANKGE003146,APOD,N,apolipoprotein D,3q26.2-qter,protein-coding,
CWITA003147,TCMBANKGE003147,SF3B1,Hsh155; MDS; PRP10; PRPF10; SAP155; SF3b155,splicing factor 3b subunit 1,2q33.1,protein-coding,Research target
CWITA003148,TCMBANKGE003148,ZNF641,-,zinc finger protein 641,12q13.11,protein-coding,/
CWITA003149,TCMBANKGE003149,KCNJ9,GIRK3; KIR3.3,"potassium inwardly-rectifying channel, subfamily J, member 9",1q23.2,protein-coding,
CWITA003150,TCMBANKGE003150,PFN4,-,profilin family member 4,2p23.3,protein-coding,/
CWITA003151,TCMBANKGE003151,NPR2,AMDM; ANPRB; ANPb; GUC2B; GUCY2B; NPRB; NPRBi,natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B),9p21-p12,protein-coding,
CWITA003152,TCMBANKGE003152,CSRNP2,C12orf2; C12orf22; FAM130A1; PPP1R72; TAIP-12,cysteine and serine rich nuclear protein 2,12q13.12,protein-coding,/
CWITA003153,TCMBANKGE003153,DMD,BMD; CMD3B; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272; MRX85,dystrophin,Xp21.2-p21.1,protein-coding,Clinical Trial target
CWITA003154,TCMBANKGE003154,ZNF705A,-,zinc finger protein 705A,12p13.31,protein-coding,/
CWITA003155,TCMBANKGE003155,PGLYRP1,PGLYRP; PGRP; PGRP-S; PGRPS; TAG7; TNFSF3L,peptidoglycan recognition protein 1,19q13.32,protein-coding,/
CWITA003156,TCMBANKGE003156,JUN,APN1; AP1; cNJun,jun proto-oncogene,1p32-p31,protein-coding,
CWITA003157,TCMBANKGE003157,CHRM2,HM2,cholinergic receptor muscarinic 2,7q33,protein-coding,Successful target
CWITA003158,TCMBANKGE003158,ORC6,ORC6L,origin recognition complex subunit 6,16q11.2,protein-coding,/
CWITA003159,TCMBANKGE003159,PFKFB4,-,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4",3p21.31,protein-coding,/
CWITA003160,TCMBANKGE003160,COX7C,-,cytochrome c oxidase subunit 7C,5q14.3,protein-coding,/
CWITA003161,TCMBANKGE003161,APEX2,APE2; APEXL2; XTH2; ZGRF2,apurinic/apyrimidinic endodeoxyribonuclease 2,Xp11.21,protein-coding,/
CWITA003162,TCMBANKGE003162,TUT4,PAPD3; TENT3A; ZCCHC11,terminal uridylyl transferase 4,1p32.3,protein-coding,/
CWITA003163,TCMBANKGE003163,PPP2R5A,B56A; B56alpha; PR61A,protein phosphatase 2 regulatory subunit B'alpha,1q32.3,protein-coding,Research target
CWITA003164,TCMBANKGE003164,Api5-ps,Gm18045,"apoptosis inhibitor 5, pseudogene",7|7 A3,pseudo,/
CWITA003165,TCMBANKGE003165,ASAH2B,ASAH2C; ASAH2L; bA449O16.3; bA98I6.3,N-acylsphingosine amidohydrolase 2B,10q11.23,protein-coding,/
CWITA003166,TCMBANKGE003166,TATDN2,-,TatD DNase domain containing 2,3p25.3,protein-coding,/
CWITA003167,TCMBANKGE003167,HDGF,HMG1L2,heparin binding growth factor,1q23.1,protein-coding,Research target
CWITA003168,TCMBANKGE003168,NPTXR,NPR,Neuronal_Pentraxin_Receptor,22q13.1,protein-coding,
CWITA003169,TCMBANKGE003169,EDIL3,DEL1,EGF like repeats and discoidin domains 3,5q14.3,protein-coding,/
CWITA003170,TCMBANKGE003170,TFF2,SML1; SP,trefoil factor 2,21q22.3,protein-coding,
CWITA003171,TCMBANKGE003171,LRRN2,FIGLER7; GAC1; LRANK1; LRRN5,leucine rich repeat neuronal 2,1q32.1,protein-coding,/
CWITA003172,TCMBANKGE003172,IGLL5,IGL; IGLV; VL-MAR,immunoglobulin lambda like polypeptide 5,22q11.22,protein-coding,/
CWITA003173,TCMBANKGE003173,NME2,MGC111212; MGC2212; NDKB; NDPKNB; NDPKB; NM23NH2; NM23B; PUF,"non-metastatic cells 2, protein (NM23B) expressed in",17q21.3,protein-coding,
CWITA003174,TCMBANKGE003174,DPYD,DHP; DHPDHASE; DPD; MGC132008; MGC70799,dihydropyrimidine dehydrogenase,1p22,protein-coding,
CWITA003175,TCMBANKGE003175,SRD5A3,CDG1P; CDG1Q; FLJ13352; SRD5A2L; SRD5A2L1,steroid 5 alpha-reductase 3,4q12,protein-coding,
CWITA003176,TCMBANKGE003176,EPRS,DKFZp313B047; EARS; GLUPRORS; PARS; QARS; QPRS,glutamyl-prolyl-tRNA synthetase,1q41,protein-coding,
CWITA003177,TCMBANKGE003177,YWHAE,14N3N3E; FLJ45465; FLJ53559; KCIPN1; MDCR; MDS,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide",17p13.3,protein-coding,
CWITA003178,TCMBANKGE003178,NDUFA4L2,FLJ26118; NUOMS,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2",12q13.3,protein-coding,
CWITA003179,TCMBANKGE003179,CUL7,3M1; CUL-7; KIAA0076; dJ20C7.5,cullin 7,6p21.1,protein-coding,Research target
CWITA003180,TCMBANKGE003180,HADHA,ECHA; GBP; HADH; LCEH; LCHAD; MGC1728; MTPA; TPNALPHA,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit",2p23,protein-coding,
CWITA003181,TCMBANKGE003181,MECR,CGI-63; DYTOABG; ETR1; FASN2B; NRBF1,mitochondrial trans-2-enoyl-CoA reductase,1p35.3,protein-coding,/
CWITA003182,TCMBANKGE003182,SLC6A14,BMIQ11,"solute carrier family 6 (amino acid transporter), member 14",Xq23-q24,protein-coding,
CWITA003183,TCMBANKGE003183,CAPN11,calpain11,calpain 11,6p21.1,protein-coding,/
CWITA003184,TCMBANKGE003184,LDHAL6A,LDH6A,lactate dehydrogenase A like 6A,11p15.1,protein-coding,/
CWITA003185,TCMBANKGE003185,HERC2,D15F37S1; MRT38; SHEP1; jdf2; p528,HECT and RLD domain containing E3 ubiquitin protein ligase 2,15q13.1,protein-coding,/
CWITA003186,TCMBANKGE003186,ARL1,ARFL1,ADP ribosylation factor like GTPase 1,12q23.2,protein-coding,/
CWITA003187,TCMBANKGE003187,ADIPOR2,ACDCR2; PAQR2,adiponectin receptor 2,12p13.33,protein-coding,/
CWITA003188,TCMBANKGE003188,P4HB,CLCRP1; DSI; ERBA2L; GIT; P4Hbeta; PDI; PDIA1; PHDB; PO4DB; PO4HB; PROHB,prolyl 4-hydroxylase subunit beta,17q25.3,protein-coding,/
CWITA003189,TCMBANKGE003189,MMACHC,cblC,metabolism of cobalamin associated C,1p34.1,protein-coding,/
CWITA003190,TCMBANKGE003190,TGM3,MGC126249; MGC126250; TGE,"transglutaminase 3 (E polypeptide, protein-glutamine-gamma-glutamyltransferase)",20q11.2,protein-coding,
CWITA003191,TCMBANKGE003191,DDAH2,DDAH; DDAHII; G6a; NG30,dimethylarginine dimethylaminohydrolase 2,6p21.3,protein-coding,
CWITA003192,TCMBANKGE003192,IMP3,BRMS2; C15orf12; MRPS4,IMP U3 small nucleolar ribonucleoprotein 3,15q24.2,protein-coding,Research target
CWITA003193,TCMBANKGE003193,MMP8,CLG1; HNC; MMPN8; PMNLNCL,matrix metallopeptidase 8 (neutrophil collagenase),11q22.3,protein-coding,
CWITA003194,TCMBANKGE003194,UBE2A,HHR6A; MRXS30; MRXSN; RAD6A; UBC2,ubiquitin conjugating enzyme E2 A,Xq24,protein-coding,/
CWITA003195,TCMBANKGE003195,PDGFRB,CD140B; IBGC4; IMF1; JTK12; KOGS; PDGFR; PDGFR-1; PDGFR1; PENTT,platelet derived growth factor receptor beta,5q32,protein-coding,Successful target
CWITA003196,TCMBANKGE003196,CDCA7L,JPO2; R1; RAM2,cell division cycle associated 7 like,7p15.3,protein-coding,/
CWITA003197,TCMBANKGE003197,FAM126B,HYCC2,family with sequence similarity 126 member B,2q33.1,protein-coding,/
CWITA003198,TCMBANKGE003198,TRIM25,EFP; RNF147; Z147; ZNF147,tripartite motif containing 25,17q22,protein-coding,/
CWITA003199,TCMBANKGE003199,GNAI1,Gi,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1",7q21,protein-coding,
CWITA003200,TCMBANKGE003200,LRIF1,C1orf103; HBiX1; RIF1,ligand dependent nuclear receptor interacting factor 1,1p13.3,protein-coding,/
CWITA003201,TCMBANKGE003201,ACVR1B,ACTRIB; ACVRLK4; ALK4; SKR2,"activin A receptor, type IB",12q13,protein-coding,
CWITA003202,TCMBANKGE003202,DOCK3,MOCA; NEDIDHA; PBP,dedicator of cytokinesis 3,3p21.2,protein-coding,/
CWITA003203,TCMBANKGE003203,LRRC56,CILD39,leucine rich repeat containing 56,11p15.5,protein-coding,/
CWITA003204,TCMBANKGE003204,RAB8B,-,"RAB8B, member RAS oncogene family",15q22.2,protein-coding,/
CWITA003205,TCMBANKGE003205,WWOX,D16S432E; EIEE28; FOR; FRA16D; HHCMA56; PRO0128; SCAR12; SDR41C1; WOX1,WW domain containing oxidoreductase,16q23.1-q23.2,protein-coding,/
CWITA003206,TCMBANKGE003206,HDHD3,2810435D12Rik; C9orf158,haloacid dehalogenase like hydrolase domain containing 3,9q32,protein-coding,/
CWITA003207,TCMBANKGE003207,MOG,BTN6; BTNL11; MOGIG2; NRCLP7,myelin oligodendrocyte glycoprotein,6p22.1,protein-coding,Research target
CWITA003208,TCMBANKGE003208,DKK1,DKK-1; SK,dickkopf WNT signaling pathway inhibitor 1,10q21.1,protein-coding,Clinical Trial target
CWITA003209,TCMBANKGE003209,KCNAB3,AKR6A9; KCNA3.1B; KCNA3B; KV-BETA-3,potassium voltage-gated channel subfamily A regulatory beta subunit 3,17p13.1,protein-coding,/
CWITA003210,TCMBANKGE003210,POLD1,CDC2; CRCS10; MDPL; POLD,"DNA polymerase delta 1, catalytic subunit",19q13.33,protein-coding,/
CWITA003211,TCMBANKGE003211,NEURL1B,NEURL3; RNF67B; hNeur2; neur2,neuralized E3 ubiquitin protein ligase 1B,5q35.1,protein-coding,/
CWITA003212,TCMBANKGE003212,VWDE,-,von Willebrand factor D and EGF domains,7p21.3,protein-coding,/
CWITA003213,TCMBANKGE003213,SCLY,SCL; hSCL,selenocysteine lyase,2q37.3,protein-coding,/
CWITA003214,TCMBANKGE003214,FTCD,LCHC1,formiminotransferase cyclodeaminase,21q22.3,protein-coding,
CWITA003215,TCMBANKGE003215,PRSS21,ESP-1; ESP1; TEST1; TESTISIN,serine protease 21,16p13.3,protein-coding,/
CWITA003216,TCMBANKGE003216,CDC27,ANAPC3; APC3; CDC27Hs; D0S1430E; D17S978E; H-NUC; HNUC; NUC2,cell division cycle 27,17q21.32,protein-coding,/
CWITA003217,TCMBANKGE003217,CCDC178,C18orf34,coiled-coil domain containing 178,18q12.1,protein-coding,/
CWITA003218,TCMBANKGE003218,NCKIPSD,AF3P21; DIP; DIP1; ORF1; SPIN90; VIP54; WASLBP; WISH,NCK interacting protein with SH3 domain,3p21.31,protein-coding,/
CWITA003219,TCMBANKGE003219,RPS12,S12,ribosomal protein S12,6q23.2,protein-coding,Research target
CWITA003220,TCMBANKGE003220,POF1B,POF; POF2B,POF1B actin binding protein,Xq21.1,protein-coding,/
CWITA003221,TCMBANKGE003221,ENTPD4,LALP70; LAP70; LYSAL1; NTPDase-4; UDPase,ectonucleoside triphosphate diphosphohydrolase 4,8p21.3,protein-coding,/
CWITA003222,TCMBANKGE003222,RBM23,CAPERbeta; PP239; RNPC4,RNA binding motif protein 23,14q11.2,protein-coding,/
CWITA003223,TCMBANKGE003223,EPHA5,CEK7; EHK1; HEK7; TYRO4,EPH receptor A5,4q13.1,protein-coding,
CWITA003224,TCMBANKGE003224,PLD4,C14orf175,phospholipase D family member 4,14q32.33,protein-coding,/
CWITA003225,TCMBANKGE003225,ETV4,E1A-F; E1AF; PEA3; PEAS3,ETS variant transcription factor 4,17q21.31,protein-coding,/
CWITA003226,TCMBANKGE003226,LRRC46,-,leucine rich repeat containing 46,17q21.32,protein-coding,/
CWITA003227,TCMBANKGE003227,H3-3A,H3-3B; H3.3A; H3F3; H3F3A,H3.3 histone A,1q42.12,protein-coding,/
CWITA003228,TCMBANKGE003228,LRP2,DBS; GP330; LRP-2,LDL receptor related protein 2,2q31.1,protein-coding,Research target
CWITA003229,TCMBANKGE003229,Tsti4,-,tail suspension test immobility 4,-,unknown,/
CWITA003230,TCMBANKGE003230,CPS1,CPSASE1; PHN,carbamoyl-phosphate synthase 1,2q34,protein-coding,Successful target
CWITA003231,TCMBANKGE003231,KCNE1,ISK; JLNS; JLNS2; LQT2/5; LQT5; MinK,potassium voltage-gated channel subfamily E regulatory subunit 1,21q22.12,protein-coding,/
CWITA003232,TCMBANKGE003232,DENND2B,HTS1; ST5; p126,DENN domain containing 2B,11p15.4,protein-coding,/
CWITA003233,TCMBANKGE003233,SLC23A1,MGC22361; SLC23A2; SVCT1; YSPL3,"solute carrier family 23 (nucleobase transporters), member 1",5q31.2,protein-coding,
CWITA003234,TCMBANKGE003234,SLC51A,OSTA; OSTalpha,Solute_Carrier_Family_51_Alpha_Subunit,3q29,protein-coding,
CWITA003235,TCMBANKGE003235,AK9,AK 9; AKD1; AKD2; C6orf199; C6orf224; dJ70A9.1,adenylate kinase 9,6q21,protein-coding,/
CWITA003236,TCMBANKGE003236,KLK13,KLK-L4; KLKL4,kallikrein related peptidase 13,19q13.41,protein-coding,/
CWITA003237,TCMBANKGE003237,ADAM23,MDC-3; MDC3,ADAM metallopeptidase domain 23,2q33.3,protein-coding,/
CWITA003238,TCMBANKGE003238,RPL27,DBA16; L27,ribosomal protein L27,17q21.31,protein-coding,/
CWITA003239,TCMBANKGE003239,Pepc,Dip-1; Pep-3; Pep3,peptidase C,1|1,protein-coding,/
CWITA003240,TCMBANKGE003240,SMOX,C20orf16; FLJ20746; MGC1010; PAO; PAOH1; SMO,spermine oxidase,20p13,protein-coding,
CWITA003241,TCMBANKGE003241,GHRHR,GHRFR; GRFR; IGHD1B; IGHD4,growth hormone releasing hormone receptor,7p14.3,protein-coding,Successful target
CWITA003242,TCMBANKGE003242,CHRNA6,CHNRA6,cholinergic receptor nicotinic alpha 6 subunit,8p11.21,protein-coding,/
CWITA003243,TCMBANKGE003243,ACBD6,-,acyl-CoA binding domain containing 6,1q25.2-q25.3,protein-coding,/
CWITA003244,TCMBANKGE003244,BLK,MODY11,"BLK proto-oncogene, Src family tyrosine kinase",8p23.1,protein-coding,Patented target
CWITA003245,TCMBANKGE003245,PDGFB,IBGC5; PDGF-2; PDGF2; SIS; SSV; c-sis,platelet derived growth factor subunit B,22q13.1,protein-coding,Clinical Trial target
CWITA003246,TCMBANKGE003246,TARS3,TARSL2; ThrRS-L,threonyl-tRNA synthetase 3,15q26.3,protein-coding,/
CWITA003247,TCMBANKGE003247,MAPK8IP1,IB1; JIPN1; JIP1; PRKM8IP,mitogen-activated protein kinase 8 interacting protein 1,11p11.2,protein-coding,
CWITA003248,TCMBANKGE003248,SCAND1,RAZ1; SDP1,SCAN domain containing 1,20q11.23,protein-coding,/
CWITA003249,TCMBANKGE003249,KRT7,CK7; K2C7; K7; SCL,keratin 7,12q13.13,protein-coding,/
CWITA003250,TCMBANKGE003250,CD276,4Ig-B7-H3; B7-H3; B7H3; B7RP-2,CD276 molecule,15q24.1,protein-coding,Clinical Trial target
CWITA003251,TCMBANKGE003251,LY96,ESOPN1; MDN2; MD2; lyN96,lymphocyte antigen 96,8q21.11,protein-coding,
CWITA003252,TCMBANKGE003252,HTRA1,ARMD7; CADASIL2; CARASIL; HtrA; L56; ORF480; PRSS11,HtrA serine peptidase 1,10q26.13,protein-coding,Research target
CWITA003253,TCMBANKGE003253,IDH3B,RP46,isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta,20p13,protein-coding,/
CWITA003254,TCMBANKGE003254,RPS18,D6S218E; HKE3; KE-3; KE3; S18,ribosomal protein S18,6p21.32,protein-coding,/
CWITA003255,TCMBANKGE003255,OXCT2,FLJ00030; SCOTT,3-oxoacid CoA transferase 2,1p34,protein-coding,
CWITA003256,TCMBANKGE003256,TMPRSS11A,ECRG1; HATL1; HESP,transmembrane serine protease 11A,4q13.2,protein-coding,/
CWITA003257,TCMBANKGE003257,MRGPRX3,GPCR; MRGX3; SNSR1; SNSR2,MAS related GPR family member X3,11p15.1,protein-coding,/
CWITA003258,TCMBANKGE003258,GRIN2A,NMDAR2A; NR2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",16p13.2,protein-coding,
CWITA003259,TCMBANKGE003259,C7,-,complement C7,5p13.1,protein-coding,/
CWITA003260,TCMBANKGE003260,HBA1,ECYT7; HBA-T3; HBH; METHBA,hemoglobin subunit alpha 1,16p13.3,protein-coding,/
CWITA003261,TCMBANKGE003261,RAB2B,-,"RAB2B, member RAS oncogene family",14q11.2,protein-coding,/
CWITA003262,TCMBANKGE003262,CACNB2,CACNLB2; CAVB2; FLJ23743; MYSB,"calcium channel, voltage-dependent, beta 2 subunit",10p12,protein-coding,
CWITA003263,TCMBANKGE003263,SYCE2,CESC1,synaptonemal complex central element protein 2,19p13.13,protein-coding,/
CWITA003264,TCMBANKGE003264,KREMEN1,ECTD13; KREMEN; KRM1,kringle containing transmembrane protein 1,22q12.1,protein-coding,/
CWITA003265,TCMBANKGE003265,CDCA8,BOR; BOREALIN; DasraB; MESRGP,cell division cycle associated 8,1p34.3,protein-coding,Research target
CWITA003266,TCMBANKGE003266,KCNK9,K2p9.1; KT3.2; TASK-3; TASK3,potassium two pore domain channel subfamily K member 9,8q24.3,protein-coding,Research target
CWITA003267,TCMBANKGE003267,LTB4R2,BLT2; BLTR2; JULF2; KPG_004; LTB4-R 2; LTB4-R2; NOP9,leukotriene B4 receptor 2,14q12,protein-coding,Clinical Trial target
CWITA003268,TCMBANKGE003268,DFFA,DFF-45; DFF1; ICAD,DNA fragmentation factor subunit alpha,1p36.22,protein-coding,Research target
CWITA003269,TCMBANKGE003269,ENDOG,-,endonuclease G,9q34.11,protein-coding,/
CWITA003270,TCMBANKGE003270,IFITM3,1-8U; DSPA2b; IP15,interferon induced transmembrane protein 3,11p15.5,protein-coding,/
CWITA003271,TCMBANKGE003271,RGS4,RGP4; SCZD9,regulator of G protein signaling 4,1q23.3,protein-coding,Research target
CWITA003272,TCMBANKGE003272,TCF3,AGM8; E2A; E47; ITF1; TCF-3; VDIR; bHLHb21; p75,transcription factor 3,19p13.3,protein-coding,Research target
CWITA003273,TCMBANKGE003273,HKDC1,-,hexokinase domain containing 1,10q22.1,protein-coding,/
CWITA003274,TCMBANKGE003274,PYGO2,1190004M21Rik,pygopus family PHD finger 2,1q21.3,protein-coding,/
CWITA003275,TCMBANKGE003275,COL6A5,COL29A1; VWA4,collagen type VI alpha 5 chain,3q22.1,protein-coding,/
CWITA003276,TCMBANKGE003276,BECN1,ATG6; VPS30; beclin1,"beclin 1, autophagy related",17q21,protein-coding,
CWITA003277,TCMBANKGE003277,FBXO25,FBX25,F-box protein 25,8p23.3,protein-coding,/
CWITA003278,TCMBANKGE003278,USP13,ISOT3; IsoT-3,ubiquitin specific peptidase 13,3q26.33,protein-coding,/
CWITA003279,TCMBANKGE003279,SYT7,IPCA-7; IPCA7; PCANAP7; SYT-VII; SYTVII,synaptotagmin 7,11q12.2,protein-coding,/
CWITA003280,TCMBANKGE003280,CSF3R,CD114; GCSFR; SCN7,colony stimulating factor 3 receptor,1p34.3,protein-coding,Successful target
CWITA003281,TCMBANKGE003281,HCFC1R1,HPIP,host cell factor C1 regulator 1,16p13.3,protein-coding,/
CWITA003282,TCMBANKGE003282,NT5C1A,CN-I; CN-IA; CN1; CN1A; CNI,"5'-nucleotidase, cytosolic IA",1p34.2,protein-coding,/
CWITA003283,TCMBANKGE003283,AGPS,ADAP-S; ADAS; ADHAPS; ADPS; ALDHPSY; RCDP3,alkylglycerone phosphate synthase,2q31.2,protein-coding,/
CWITA003284,TCMBANKGE003284,SLC7A3,ATRC3; CAT-3; CAT3,solute carrier family 7 member 3,Xq13.1,protein-coding,/
CWITA003285,TCMBANKGE003285,MPP1,AAG12; DXS552E; EMP55; MRG1; PEMP,membrane palmitoylated protein 1,Xq28,protein-coding,/
CWITA003286,TCMBANKGE003286,GPAT3,AGPAT 10; AGPAT10; AGPAT8; AGPAT9; HMFN0839; LPAAT-theta; MAG1,glycerol-3-phosphate acyltransferase 3,4q21.23,protein-coding,/
CWITA003287,TCMBANKGE003287,UBAP2L,NICE-4; NICE4,ubiquitin associated protein 2 like,1q21.3,protein-coding,/
CWITA003288,TCMBANKGE003288,ORM1,AGPNA; AGP1; ORM,orosomucoid 1,9q31-q32,protein-coding,
CWITA003289,TCMBANKGE003289,ZNF276,CENP-Z; CENPZ; ZADT; ZFP276; ZNF477,zinc finger protein 276,16q24.3,protein-coding,/
CWITA003290,TCMBANKGE003290,WDR47,-,WD repeat domain 47,1p13.3,protein-coding,/
CWITA003291,TCMBANKGE003291,PPP1R16A,MYPT3,protein phosphatase 1 regulatory subunit 16A,8q24.3,protein-coding,/
CWITA003292,TCMBANKGE003292,NFE2L3,NRF3,"nuclear factor, erythroid 2 like 3",7p15.2,protein-coding,/
CWITA003293,TCMBANKGE003293,RIDA,HRSP12; P14.5; PSP; UK114; hp14.5,Reactive_Intermediate_Imine_Deaminase_A_Homolog,8q22.2,protein-coding,
CWITA003294,TCMBANKGE003294,TDP2,AD022; EAP2; EAPII; TTRAP; dJ30M3.3; hTDP2,tyrosyl-DNA phosphodiesterase 2,6p22.3,protein-coding,Research target
CWITA003295,TCMBANKGE003295,GATA2,DCML; IMD21; MONOMAC; NFE1B,GATA binding protein 2,3q21.3,protein-coding,/
CWITA003296,TCMBANKGE003296,PHB2,BAP; BCAP37; Bap37; PNAS-141; REA; hBAP; p22,prohibitin 2,12p13.31,protein-coding,/
CWITA003297,TCMBANKGE003297,STEAP4,STAMP2; SchLAH; TIARP; TNFAIP9,STEAP4 metalloreductase,7q21.12,protein-coding,/
CWITA003298,TCMBANKGE003298,MFSD8,CCMD; CLN7,major facilitator superfamily domain containing 8,4q28.2,protein-coding,/
CWITA003299,TCMBANKGE003299,SLC22A6,FLJ55736; HOAT1; MGC45260; OAT1; PAHT; ROAT1,"solute carrier family 22 (organic anion transporter), member 6",11q12.3,protein-coding,
CWITA003300,TCMBANKGE003300,EIF6,CAB; EIF3A; ITGB4BP; b(2)gcn; eIF-6; p27(BBP); p27BBP,eukaryotic translation initiation factor 6,20q11.22,protein-coding,/
CWITA003301,TCMBANKGE003301,CORIN,ATC2; CRN; Lrp4; PEE5; TMPRSS10,"corin, serine peptidase",4p12,protein-coding,/
CWITA003302,TCMBANKGE003302,MPHOSPH8,HSMPP8; TWA3; mpp8,M-phase phosphoprotein 8,13q12.11,protein-coding,/
CWITA003303,TCMBANKGE003303,ATAD2,ANCCA; CT137; PRO2000,ATPase family AAA domain containing 2,8q24.13,protein-coding,Research target
CWITA003304,TCMBANKGE003304,ADAP1,CENTA1; GCS1L; p42IP4,ArfGAP with dual PH domains 1,7p22.3,protein-coding,/
CWITA003305,TCMBANKGE003305,HBEGF,DTR; DTS; DTSF; HEGFL,heparin binding EGF like growth factor,5q31.3,protein-coding,Clinical Trial target
CWITA003306,TCMBANKGE003306,AMACR,AMACRD; CBAS4; P504S; RACE; RM,alpha-methylacyl-CoA racemase,5p13.2,protein-coding,Research target
CWITA003307,TCMBANKGE003307,HECTD3,-,HECT domain E3 ubiquitin protein ligase 3,1p34.1,protein-coding,/
CWITA003308,TCMBANKGE003308,FASTKD1,-,FAST kinase domains 1,2q31.1,protein-coding,/
CWITA003309,TCMBANKGE003309,KIDINS220,ARMS; SINO,kinase D interacting substrate 220,2p25.1,protein-coding,/
CWITA003310,TCMBANKGE003310,ROPN1L,ASP; RSPH11,rhophilin associated tail protein 1 like,5p15.2,protein-coding,/
CWITA003311,TCMBANKGE003311,KARS,CMTRIB; KARS2; KIAA0070; KRS,lysyl-tRNA synthetase,16q23.1,protein-coding,
CWITA003312,TCMBANKGE003312,HBE1,HBE,hemoglobin subunit epsilon 1,11p15.4,protein-coding,/
CWITA003313,TCMBANKGE003313,SSTR5,SS-5-R,somatostatin receptor 5,16p13.3,protein-coding,Successful target
CWITA003314,TCMBANKGE003314,ELANE,ELA2; GE; HLE; HNE; NE; PMNNE; SCN1,"elastase, neutrophil expressed",19p13.3,protein-coding,
CWITA003315,TCMBANKGE003315,GM2A,GM2NAP; SAPN3,GM2 ganglioside activator,5q33.1,protein-coding,
CWITA003316,TCMBANKGE003316,RALYL,HNRPCL3,RALY RNA binding protein like,8q21.2,protein-coding,/
CWITA003317,TCMBANKGE003317,DPAGT1,ALG7; CDG-Ij; CDG1J; CMS13; CMSTA2; D11S366; DGPT; DPAGT; DPAGT2; G1PT; GPT; UAGT; UGAT,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1,11q23.3,protein-coding,/
CWITA003318,TCMBANKGE003318,SUMO2,HSMT3; SMT3B; SMT3H2; SUMO3; Smt3A,small ubiquitin like modifier 2,17q25.1,protein-coding,/
CWITA003319,TCMBANKGE003319,ZNF200,-,zinc finger protein 200,16p13.3,protein-coding,/
CWITA003320,TCMBANKGE003320,ADCY5,AC5,adenylate cyclase 5,3q13.2-q21,protein-coding,
CWITA003321,TCMBANKGE003321,F5,FVL; PCCF; RPRGL1; THPH2,coagulation factor V,1q24.2,protein-coding,Successful target
CWITA003322,TCMBANKGE003322,NARS2,DFNB94; SLM5; asnRS,"asparaginyl-tRNA synthetase 2, mitochondrial",11q14.1,protein-coding,/
CWITA003323,TCMBANKGE003323,TUBB6,FPVEPD; HsT1601; TUBB-5,tubulin beta 6 class V,18p11.21,protein-coding,/
CWITA003324,TCMBANKGE003324,KIRREL3,KIRRE; MRD4; NEPH2; PRO4502,kirre like nephrin family adhesion molecule 3,11q24.2,protein-coding,/
CWITA003325,TCMBANKGE003325,ZNF382,KS1,zinc finger protein 382,19q13.12,protein-coding,/
CWITA003326,TCMBANKGE003326,MARK2,EMK-1; EMK1; PAR-1; Par-1b; Par1b,microtubule affinity regulating kinase 2,11q13.1,protein-coding,/
CWITA003327,TCMBANKGE003327,LRP12,MIG13A; ST7,LDL receptor related protein 12,8q22.3,protein-coding,/
CWITA003328,TCMBANKGE003328,TAOK2,KIAA0881; MAP3K17; PSK; PSK1; PSK1NBETA; TAO1; TAO2,TAO kinase 2,16p11.2,protein-coding,
CWITA003329,TCMBANKGE003329,GOT1L1,-,glutamic-oxaloacetic transaminase 1 like 1,8p11.23,protein-coding,/
CWITA003330,TCMBANKGE003330,ARF1,PVNH8,ADP ribosylation factor 1,1q42.13,protein-coding,Research target
CWITA003331,TCMBANKGE003331,IL20,IL-20; IL10D; ZCYTO10,interleukin 20,1q32.1,protein-coding,Clinical Trial target
CWITA003332,TCMBANKGE003332,TROAP,TASTIN,trophinin associated protein,12q13.12,protein-coding,/
CWITA003333,TCMBANKGE003333,PYGL,GSD6,glycogen phosphorylase L,14q22.1,protein-coding,/
CWITA003334,TCMBANKGE003334,RYR1,CCO; MHS; MHS1; RYDR; RYR; SKRR,ryanodine receptor 1 (skeletal),19q13.1,protein-coding,
CWITA003335,TCMBANKGE003335,RDX,DFNB24,radixin,11q22.3,protein-coding,/
CWITA003336,TCMBANKGE003336,IKZF4,EOS; ZNFN1A4,IKAROS family zinc finger 4,12q13.2,protein-coding,/
CWITA003337,TCMBANKGE003337,MLPH,SLAC2-A,melanophilin,2q37.3,protein-coding,/
CWITA003338,TCMBANKGE003338,CSF2RB,CD131; CDw131; IL3RB; IL5RB; SMDP5; betaGMR,colony stimulating factor 2 receptor subunit beta,22q12.3,protein-coding,Research target
CWITA003339,TCMBANKGE003339,GABRE,-,gamma-aminobutyric acid type A receptor subunit epsilon,Xq28,protein-coding,Research target
CWITA003340,TCMBANKGE003340,ZNF25,KOX19; Zfp9,zinc finger protein 25,10p11.21,protein-coding,/
CWITA003341,TCMBANKGE003341,VPS35,MEM3; PARK17,VPS35 retromer complex component,16q11.2,protein-coding,/
CWITA003342,TCMBANKGE003342,GATM,AGAT; AT; CCDS3,glycine amidinotransferase,15q21.1,protein-coding,/
CWITA003343,TCMBANKGE003343,OIT3,LZP,oncoprotein induced transcript 3,10q22.1,protein-coding,/
CWITA003344,TCMBANKGE003344,ACTBL2,ACT,actin beta like 2,5q11.2,protein-coding,/
CWITA003345,TCMBANKGE003345,SLC15A4,FP12591; PHT1; PTR4,solute carrier family 15 member 4,12q24.33,protein-coding,Research target
CWITA003346,TCMBANKGE003346,P2RY10P1,GPR121P; P2Y10P1,P2Y receptor family member 10 pseudogene 1,Xq21.1,pseudo,/
CWITA003347,TCMBANKGE003347,CLASP1,MAST1,cytoplasmic linker associated protein 1,2q14.2-q14.3,protein-coding,/
CWITA003348,TCMBANKGE003348,H2BC13,H2B/c; H2BFC; HIST1H2BL; dJ97D16.4,H2B clustered histone 13,6p22.1,protein-coding,/
CWITA003349,TCMBANKGE003349,MRPS33,CGI-139; MRP-S33; PTD003; S33mt,mitochondrial ribosomal protein S33,7q34,protein-coding,/
CWITA003350,TCMBANKGE003350,NCAM2,NCAM21,neural cell adhesion molecule 2,21q21.1,protein-coding,/
CWITA003351,TCMBANKGE003351,EIF2S3B,EIF2S3L; eIF-2gA; eIF2gA,eukaryotic translation initiation factor 2 subunit gamma B,12p13.2,protein-coding,/
CWITA003352,TCMBANKGE003352,HCN2,BCNG-2; BCNG2; HAC-1,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2,19p13.3,protein-coding,Research target
CWITA003353,TCMBANKGE003353,ANKS1A,ANKS1,ankyrin repeat and sterile alpha motif domain containing 1A,6p21.31,protein-coding,/
CWITA003354,TCMBANKGE003354,TFIP11,NTR1; STIP; STIP-1; Spp382; TIP39; bK445C9.6,tuftelin interacting protein 11,22q12.1,protein-coding,/
CWITA003355,TCMBANKGE003355,ORAI2,C7orf19; CBCIP2; MEM142B; TMEM142B,ORAI calcium release-activated calcium modulator 2,7q22.1,protein-coding,/
CWITA003356,TCMBANKGE003356,SEC16A,KIAA0310; SEC16L; p250,"SEC16 homolog A, endoplasmic reticulum export factor",9q34.3,protein-coding,/
CWITA003357,TCMBANKGE003357,MYL5,MYLC2,myosin light chain 5,4p16.3,protein-coding,/
CWITA003358,TCMBANKGE003358,LGALS7,GAL7; LGALS7A,galectin 7,19q13.2,protein-coding,/
CWITA003359,TCMBANKGE003359,TBC1D24,DFNA65; DFNB86; DOORS; EIEE16; EPRPDC; FIME; TLDC6,TBC1 domain family member 24,16p13.3,protein-coding,/
CWITA003360,TCMBANKGE003360,PLA2G3,GIII-SPLA2; SPLA2III; sPLA2-III,phospholipase A2 group III,22q12.2,protein-coding,/
CWITA003361,TCMBANKGE003361,ELK3,ERP; NET; SAP-2; SAP2,"Elk3,_Ets_Transcription_Factor",12q23.1,protein-coding,
CWITA003362,TCMBANKGE003362,PTGR2,DKFZp686P10120; FLJ39091; FLJ99229; PGR2; ZADH1,prostaglandin reductase 2,14q24.3,protein-coding,
CWITA003363,TCMBANKGE003363,ZNF653,E430039K05Rik; ZIP67,zinc finger protein 653,19p13.2,protein-coding,/
CWITA003364,TCMBANKGE003364,CCL25,Ckb15; SCYA25; TECK,C-C motif chemokine ligand 25,19p13.2,protein-coding,/
CWITA003365,TCMBANKGE003365,ALDH9A1,ALDH4; ALDH7; ALDH9; E3; TMABA-DH; TMABADH; TMABALDH,aldehyde dehydrogenase 9 family member A1,1q24.1,protein-coding,/
CWITA003366,TCMBANKGE003366,ACAT2,N,acetyl-CoA acetyltransferase 2,6q25.3,protein-coding,
CWITA003367,TCMBANKGE003367,CAPG,AFCP; HEL-S-66; MCP,"capping actin protein, gelsolin like",2p11.2,protein-coding,/
CWITA003368,TCMBANKGE003368,INTU,CPLANE4; INT; OFD17; PDZD6; PDZK6; SRTD20,inturned planar cell polarity protein,4q28.1,protein-coding,/
CWITA003369,TCMBANKGE003369,MNDA,PYHIN3,myeloid cell nuclear differentiation antigen,1q23.1,protein-coding,/
CWITA003370,TCMBANKGE003370,NDUFB8,ASHI; CI-ASHI; MC1DN32,NADH:ubiquinone oxidoreductase subunit B8,10q24.31,protein-coding,/
CWITA003371,TCMBANKGE003371,ADCYAP1,PACAP,adenylate cyclase activating polypeptide 1,18p11.32,protein-coding,Clinical Trial target
CWITA003372,TCMBANKGE003372,RERG,-,RAS like estrogen regulated growth inhibitor,12p12.3,protein-coding,/
CWITA003373,TCMBANKGE003373,ARSI,ASI; SPG66,arylsulfatase family member I,5q32,protein-coding,/
CWITA003374,TCMBANKGE003374,COL23A1,-,collagen type XXIII alpha 1 chain,5q35.3,protein-coding,/
CWITA003375,TCMBANKGE003375,G2E3,KIAA1333; PHF7B,G2/M-phase specific E3 ubiquitin protein ligase,14q12,protein-coding,/
CWITA003376,TCMBANKGE003376,AXIN1,AXIN; MGC52315,axin 1,16p13.3,protein-coding,
CWITA003377,TCMBANKGE003377,YPEL3,-,yippee like 3,16p11.2,protein-coding,/
CWITA003378,TCMBANKGE003378,IGLL1,14.1; AGM2; CD179b; IGL1; IGL5; IGLJ14.1; IGLL; IGO; IGVPB; VPREB2,immunoglobulin lambda like polypeptide 1,22q11.23,protein-coding,/
CWITA003379,TCMBANKGE003379,ETNPPL,AGXT2L1,ethanolamine-phosphate phospho-lyase,4q25,protein-coding,/
CWITA003380,TCMBANKGE003380,LRRN1,FIGLER3; NLRR-1,leucine rich repeat neuronal 1,3p26.2,protein-coding,/
CWITA003381,TCMBANKGE003381,PDCD4,H731,programmed cell death 4,10q25.2,protein-coding,/
CWITA003382,TCMBANKGE003382,ZNF335,MCPH10; NIF-1; NIF1; NIF2,zinc finger protein 335,20q13.12,protein-coding,/
CWITA003383,TCMBANKGE003383,ACADS,ACAD3; SCAD,acyl-CoA dehydrogenase short chain,12q24.31,protein-coding,/
CWITA003384,TCMBANKGE003384,TTLL12,dJ526I14.2,tubulin tyrosine ligase like 12,22q13.2,protein-coding,/
CWITA003385,TCMBANKGE003385,BAG6,BAG-6; BAT3; D6S52E; G3,BAG cochaperone 6,6p21.33,protein-coding,/
CWITA003386,TCMBANKGE003386,SUPT6H,SPT6; SPT6H; emb-5,"SPT6 homolog, histone chaperone and transcription elongation factor",17q11.2,protein-coding,/
CWITA003387,TCMBANKGE003387,UBE2Q2,-,ubiquitin conjugating enzyme E2 Q2,15q24.2,protein-coding,/
CWITA003388,TCMBANKGE003388,FAM47E,-,family with sequence similarity 47 member E,4q21.1,protein-coding,/
CWITA003389,TCMBANKGE003389,C1S,FLJ44757,"complement component 1, s subcomponent",12p13,protein-coding,
CWITA003390,TCMBANKGE003390,MAP3K2,MEKK2; MEKK2B,mitogen-activated protein kinase kinase kinase 2,2q14.3,protein-coding,
CWITA003391,TCMBANKGE003391,CLEC18C,MRCL; MRCL3,C-type lectin domain family 18 member C,16q22.1,protein-coding,/
CWITA003392,TCMBANKGE003392,DGKB,DAGK2; DGK; DGK-BETA,diacylglycerol kinase beta,7p21.2,protein-coding,/
CWITA003393,TCMBANKGE003393,HCK,JTK9,hemopoietic cell kinase,20q11-q12,protein-coding,
CWITA003394,TCMBANKGE003394,CPA6,CPAH; ETL5; FEB11,carboxypeptidase A6,8q13.2,protein-coding,/
CWITA003395,TCMBANKGE003395,PLXNB3,PLEXB3; PLEXR; PLXN6,plexin B3,Xq28,protein-coding,/
CWITA003396,TCMBANKGE003396,STOM,BND7; EPB7; EPB72,stomatin,9q33.2,protein-coding,/
CWITA003397,TCMBANKGE003397,BCAP29,BAP29,B cell receptor associated protein 29,7q22.3,protein-coding,/
CWITA003398,TCMBANKGE003398,C1orf54,-,chromosome 1 open reading frame 54,1q21.2,protein-coding,/
CWITA003399,TCMBANKGE003399,TAF1D,JOSD3; RAFI41; TAF(I)41; TAFI41,"TATA-box binding protein associated factor, RNA polymerase I subunit D",11q21,protein-coding,/
CWITA003400,TCMBANKGE003400,TGS1,NCOA6IP; PIMT; PIPMT,trimethylguanosine synthase 1,8q12.1,protein-coding,/
CWITA003401,TCMBANKGE003401,APOD,-,apolipoprotein D,3q29,protein-coding,/
CWITA003402,TCMBANKGE003402,UGT3A2,-,UDP glycosyltransferase family 3 member A2,5p13.2,protein-coding,/
CWITA003403,TCMBANKGE003403,DHODH,DHOdehase; POADS; URA1,dihydroorotate dehydrogenase (quinone),16q22.2,protein-coding,Successful target
CWITA003404,TCMBANKGE003404,MANBA,MANB1,mannosidase beta,4q24,protein-coding,/
CWITA003405,TCMBANKGE003405,RNF186,-,ring finger protein 186,1p36.13,protein-coding,/
CWITA003406,TCMBANKGE003406,WDR88,PQWD,WD repeat domain 88,19q13.11,protein-coding,/
CWITA003407,TCMBANKGE003407,CD46,AHUS2; MCP; MIC10; TLX; TRA2.10,CD46 molecule,1q32.2,protein-coding,Research target
CWITA003408,TCMBANKGE003408,HOXD4,HHO.C13; HOX-5.1; HOX4; HOX4B; Hox-4.2,homeobox D4,2q31.1,protein-coding,/
CWITA003409,TCMBANKGE003409,TNS2,C1-TEN; C1TEN; TENC1,tensin 2,12q13.13,protein-coding,/
CWITA003410,TCMBANKGE003410,CALD1,CDM; H-CAD; HCAD; L-CAD; LCAD; NAG22,caldesmon 1,7q33,protein-coding,/
CWITA003411,TCMBANKGE003411,DCAF16,C4orf30,DDB1 and CUL4 associated factor 16,4p15.31,protein-coding,/
CWITA003412,TCMBANKGE003412,CDY2A,CDY; CDY2,chromodomain Y-linked 2A,Yq11.222,protein-coding,/
CWITA003413,TCMBANKGE003413,ERVFRD-1,ERVFRDE1; GLLL6191; HERV-FRD; HERV-W/FRD; UNQ6191; envFRD,"endogenous retrovirus group FRD member 1, envelope",6p24.2,protein-coding,/
CWITA003414,TCMBANKGE003414,TUBAL3,-,tubulin alpha like 3,10p15.1,protein-coding,/
CWITA003415,TCMBANKGE003415,GATA3,HDR; HDRS,GATA binding protein 3,10p14,protein-coding,Research target
CWITA003416,TCMBANKGE003416,USP15,UNPH-2; UNPH4,ubiquitin specific peptidase 15,12q14.1,protein-coding,/
CWITA003417,TCMBANKGE003417,KIAA1522,-,KIAA1522,1p35.1,protein-coding,/
CWITA003418,TCMBANKGE003418,GRM5,GPRC1E; MGLUR5; PPP1R86; mGlu5,glutamate metabotropic receptor 5,11q14.2-q14.3,protein-coding,Clinical Trial target
CWITA003419,TCMBANKGE003419,ANK2,ANK-2; CFAP87; FAP87; LQT4; brank-2,ankyrin 2,4q25-q26,protein-coding,/
CWITA003420,TCMBANKGE003420,GGA1,-,"golgi associated, gamma adaptin ear containing, ARF binding protein 1",22q13.1,protein-coding,/
CWITA003421,TCMBANKGE003421,KLF15,KKLF,Kruppel like factor 15,3q21.3,protein-coding,/
CWITA003422,TCMBANKGE003422,CTNS,CTNS-LSB; PQLC4; SLC66A4,"cystinosin, lysosomal cystine transporter",17p13.2,protein-coding,/
CWITA003423,TCMBANKGE003423,CTTNBP2,C7orf8; CORTBP2; Orf4,cortactin binding protein 2,7q31.31,protein-coding,/
CWITA003424,TCMBANKGE003424,ACMSD,-,aminocarboxymuconate semialdehyde decarboxylase,2q21.3,protein-coding,/
CWITA003425,TCMBANKGE003425,BTN2A1,BK14H9.1; BT2.1; BTF1; BTN2.1; DJ3E1.1,butyrophilin subfamily 2 member A1,6p22.2,protein-coding,/
CWITA003426,TCMBANKGE003426,DNM1,DNM; EIEE31,dynamin 1,9q34.11,protein-coding,/
CWITA003427,TCMBANKGE003427,SNX9,SDP1; SH3PX1; SH3PXD3A; WISP,sorting nexin 9,6q25.3,protein-coding,/
CWITA003428,TCMBANKGE003428,AK2,ADK2,adenylate kinase 2,1p35.1,protein-coding,/
CWITA003429,TCMBANKGE003429,ZKSCAN7,ZFP; ZNF167; ZNF448; ZNF64; ZSCAN39,zinc finger with KRAB and SCAN domains 7,3p21.31,protein-coding,/
CWITA003430,TCMBANKGE003430,UBL4B,-,ubiquitin like 4B,1p13.3,protein-coding,/
CWITA003431,TCMBANKGE003431,PDE11A,FLJ23693; MGC133355; MGC133356; PPNAD2,phosphodiesterase 11A,2q31.2,protein-coding,
CWITA003432,TCMBANKGE003432,ATAD3A,HAYOS; PHRINL,ATPase family AAA domain containing 3A,1p36.33,protein-coding,/
CWITA003433,TCMBANKGE003433,GDPD3,GDE7,glycerophosphodiester phosphodiesterase domain containing 3,16p11.2,protein-coding,/
CWITA003434,TCMBANKGE003434,ATP11C,ATPIG; ATPIQ; HACXL,ATPase phospholipid transporting 11C,Xq27.1,protein-coding,/
CWITA003435,TCMBANKGE003435,HSD3B7,CBAS1; PFIC4; SDR11E3,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7",16p11.2,protein-coding,/
CWITA003436,TCMBANKGE003436,ECH1,HPXEL,enoyl-CoA hydratase 1,19q13.2,protein-coding,/
CWITA003437,TCMBANKGE003437,MTRF1,MRF1; MTTRF1; RF1,mitochondrial translation release factor 1,13q14.11,protein-coding,/
CWITA003438,TCMBANKGE003438,SOAT2,ACACT2; ACAT2; ARGP2,sterol O-acyltransferase 2,12q13.13,protein-coding,Research target
CWITA003439,TCMBANKGE003439,PIH1D1,MOT48; NOP17; Pih1,PIH1 domain containing 1,19q13.33,protein-coding,/
CWITA003440,TCMBANKGE003440,KCNB1,DRK1; Kv2.1,potassium voltage-gated channel subfamily B member 1,20q13.13,protein-coding,Research target
CWITA003441,TCMBANKGE003441,PDSS1,COQ1; COQ10D2; COQ1A; DPS; SPS; TPRT; TPT; TPT 1; hDPS1,decaprenyl diphosphate synthase subunit 1,10p12.1,protein-coding,/
CWITA003442,TCMBANKGE003442,LDHD,DLACD; DLD,lactate dehydrogenase D,16q23.1,protein-coding,/
CWITA003443,TCMBANKGE003443,CDK14,PFTAIRE1; PFTK1,cyclin dependent kinase 14,7q21.13,protein-coding,/
CWITA003444,TCMBANKGE003444,EWSR1,EWS; EWS-FLI1; bK984G1.4,EWS RNA binding protein 1,22q12.2,protein-coding,/
CWITA003445,TCMBANKGE003445,HNF4A,FLJ39654; HNF4; HNF4a7; HNF4a8; HNF4a9; HNF4alpha; MODY; MODY1; NR2A1; NR2A21; TCF; TCF14,"hepatocyte nuclear factor 4, alpha",20q13.12,protein-coding,
CWITA003446,TCMBANKGE003446,PLVAP,DIAR10; FELS; PV-1; PV1; gp68,plasmalemma vesicle associated protein,19p13.11,protein-coding,/
CWITA003447,TCMBANKGE003447,ABCC12,MRP9,ATP binding cassette subfamily C member 12,16q12.1,protein-coding,/
CWITA003448,TCMBANKGE003448,RBM10,DXS8237E; GPATC9; GPATCH9; S1-1; TARPS; ZRANB5,RNA binding motif protein 10,Xp11.3,protein-coding,/
CWITA003449,TCMBANKGE003449,ZNF208,PMIDP; ZNF95,zinc finger protein 208,19p12,protein-coding,/
CWITA003450,TCMBANKGE003450,HINT3,HINT4,histidine triad nucleotide binding protein 3,6q22.32,protein-coding,/
CWITA003451,TCMBANKGE003451,MAP6,MAP6-N; MTAP6; N-STOP; STOP,microtubule associated protein 6,11q13.5,protein-coding,/
CWITA003452,TCMBANKGE003452,UBE3A,ANCR; AS; E6-AP; EPVE6AP; HPVE6A,ubiquitin protein ligase E3A,15q11.2,protein-coding,Research target
CWITA003453,TCMBANKGE003453,AZIN2,ADC; AZI2; AZIB1; ODCN/Ap; ODC1L; ODCp,Antizyme_Inhibitor_2,1p35.1,protein-coding,
CWITA003454,TCMBANKGE003454,CDH26,VR20,cadherin 26,20q13.33,protein-coding,/
CWITA003455,TCMBANKGE003455,ABCA3,ABC-C; ABC3; EST111653; LBM180; SMDP3,ATP binding cassette subfamily A member 3,16p13.3,protein-coding,/
CWITA003456,TCMBANKGE003456,TMEM97,MAC30,transmembrane protein 97,17q11.2,protein-coding,Clinical Trial target
CWITA003457,TCMBANKGE003457,GPR50,H9; Mel1c,G protein-coupled receptor 50,Xq28,protein-coding,/
CWITA003458,TCMBANKGE003458,ALYREF,ALY; ALY/REF; BEF; REF; THOC4,Aly/REF export factor,17q25.3,protein-coding,/
CWITA003459,TCMBANKGE003459,TAS2R50,T2R50; T2R51; TAS2R51,taste 2 receptor member 50,12p13.2,protein-coding,/
CWITA003460,TCMBANKGE003460,FKBP11,FKBP19,FKBP prolyl isomerase 11,12q13.12,protein-coding,/
CWITA003461,TCMBANKGE003461,CYP26C1,FLJ45301,"cytochrome P450, family 26, subfamily C, polypeptide 1",10q23.33,protein-coding,
CWITA003462,TCMBANKGE003462,DGKD,DGKdelta; FLJ26930; KIAA0145; dgkdN2,"diacylglycerol kinase, delta 130kDa",2q37.1,protein-coding,
CWITA003463,TCMBANKGE003463,ALDOA,ALDA; GSD12; MGC10942; MGC17716; MGC17767,"aldolase A, fructose-bisphosphate",16p11.2,protein-coding,
CWITA003464,TCMBANKGE003464,GTPBP8,HSPC135,GTP binding protein 8 (putative),3q13.2,protein-coding,/
CWITA003465,TCMBANKGE003465,TG,AITD3; TGN,thyroglobulin,8q24.22,protein-coding,/
CWITA003466,TCMBANKGE003466,ARHGEF5,GEF5; P60; TIM; TIM1,Rho guanine nucleotide exchange factor 5,7q35,protein-coding,/
CWITA003467,TCMBANKGE003467,SLC35D1,SHNKND; UGTREL7,solute carrier family 35 member D1,1p31.3,protein-coding,/
CWITA003468,TCMBANKGE003468,SMPD3,FLJ22593; MGC138443; NSMASE2,"sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)",16q22.1,protein-coding,
CWITA003469,TCMBANKGE003469,ADGRG6,APG1; DREG; GPR126; LCCS9; PR126; PS1TP2; VIGR,adhesion G protein-coupled receptor G6,6q24.2,protein-coding,/
CWITA003470,TCMBANKGE003470,AP1S3,PSORS15,adaptor related protein complex 1 subunit sigma 3,2q36.1,protein-coding,/
CWITA003471,TCMBANKGE003471,PCYT1B,CCTB; CTB,"phosphate cytidylyltransferase 1, choline, beta",Xp22.11,protein-coding,Clinical Trial target
CWITA003472,TCMBANKGE003472,AADACL4,-,arylacetamide deacetylase like 4,1p36.21,protein-coding,/
CWITA003473,TCMBANKGE003473,CKB,BNCK; CKBB,"creatine kinase, brain",14q32,protein-coding,
CWITA003474,TCMBANKGE003474,GSX2,DMJDS2; GSH2,GS homeobox 2,4q12,protein-coding,/
CWITA003475,TCMBANKGE003475,NUBP2,CFD1; CIAO6; NBP 2; NUBP1,nucleotide binding protein 2,16p13.3,protein-coding,/
CWITA003476,TCMBANKGE003476,OAT,GACR; HOGA; OATASE; OKT,ornithine aminotransferase,10q26.13,protein-coding,Research target
CWITA003477,TCMBANKGE003477,GGCX,VKCFD1,gamma-glutamyl carboxylase,2p11.2,protein-coding,Successful target
CWITA003478,TCMBANKGE003478,SLC7A2,ATRC2; CAT2; HCAT2,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 2",8p22-p21.3,protein-coding,
CWITA003479,TCMBANKGE003479,NEFH,CMT2CC; NFH,neurofilament heavy,22q12.2,protein-coding,/
CWITA003480,TCMBANKGE003480,ACOT4,PTE-Ib; PTE1B; PTE2B,acyl-CoA thioesterase 4,14q24.3,protein-coding,/
CWITA003481,TCMBANKGE003481,GMEB2,GMEB-2; P79PIF; PIF79,glucocorticoid modulatory element binding protein 2,20q13.33,protein-coding,/
CWITA003482,TCMBANKGE003482,LLGL2,HGL; Hugl-2; LGL2,LLGL scribble cell polarity complex component 2,17q25.1,protein-coding,/
CWITA003483,TCMBANKGE003483,TMEM35A,TMEM35,transmembrane protein 35A,Xq22.1,protein-coding,/
CWITA003484,TCMBANKGE003484,ADCYAP1R1,PAC1; PAC1R; PACAPR; PACAPRI,ADCYAP receptor type I,7p14.3,protein-coding,Clinical Trial target
CWITA003485,TCMBANKGE003485,MYO3A,DFNB30,myosin IIIA,10p12.1,protein-coding,/
CWITA003486,TCMBANKGE003486,Mir22hg,2210403K04Rik; mir-22,Mir22 host gene (non-protein coding),11|11 B5,ncRNA,/
CWITA003487,TCMBANKGE003487,GRB2,ASH; EGFRBPNGRB2; Grb3N3; MST084; MSTP084; NCKAP2,growth factor receptor-bound protein 2,17q24-q25,protein-coding,
CWITA003488,TCMBANKGE003488,NCAN,CSPG3; FLJ44681,neurocan,19p12,protein-coding,
CWITA003489,TCMBANKGE003489,SYT11,SYT12; sytXI,synaptotagmin 11,1q22,protein-coding,/
CWITA003490,TCMBANKGE003490,CTDSPL2,HSPC058; HSPC129; SCP4,CTD small phosphatase like 2,15q15.3-q21.1,protein-coding,/
CWITA003491,TCMBANKGE003491,DIS3L2,FAM6A; PRLMNS; hDIS3L2,DIS3 like 3'-5' exoribonuclease 2,2q37.1,protein-coding,/
CWITA003492,TCMBANKGE003492,KIFC3,-,kinesin family member C3,16q21,protein-coding,/
CWITA003493,TCMBANKGE003493,RC3H1,RNF198; ROQUIN,ring finger and CCCH-type domains 1,1q25.1,protein-coding,/
CWITA003494,TCMBANKGE003494,CUTC,CGI-32,cutC copper transporter,10q24.2,protein-coding,/
CWITA003495,TCMBANKGE003495,ZNRF3,BK747E2.3; RNF203,zinc and ring finger 3,22q12.1,protein-coding,/
CWITA003496,TCMBANKGE003496,ATP6,ATPase6; MTATP6,ATP synthase F0 subunit 6,-,protein-coding,/
CWITA003497,TCMBANKGE003497,GFER,ALR; ERV1; HERV1; HPO; HPO1; HPO2; HSS,"growth factor, augmenter of liver regeneration",16p13.3-p13.12,protein-coding,
CWITA003498,TCMBANKGE003498,BTG4,APRO3; PC3B,BTG anti-proliferation factor 4,11q23.1,protein-coding,/
CWITA003499,TCMBANKGE003499,RASSF1,123F2; NORE2A; RASSF1A; RDA32; REH3P21,Ras association domain family member 1,3p21.31,protein-coding,/
CWITA003500,TCMBANKGE003500,LTA4H,N,leukotriene A4 hydrolase,12q22,protein-coding,
CWITA003501,TCMBANKGE003501,SYT8,-,synaptotagmin 8,11p15.5,protein-coding,/
CWITA003502,TCMBANKGE003502,GNRHR,GNRHR1; GRHR; HH7; LHRHR; LRHR,gonadotropin releasing hormone receptor,4q13.2,protein-coding,Successful target
CWITA003503,TCMBANKGE003503,AUTS2,FBRSL2; MRD26,activator of transcription and developmental regulator AUTS2,7q11.22,protein-coding,/
CWITA003504,TCMBANKGE003504,TRHDE,PAP-II; PGPEP2; TRH-DE,thyrotropin releasing hormone degrading enzyme,12q21.1,protein-coding,/
CWITA003505,TCMBANKGE003505,FOXP1,12CC4; HSPC215; MFH; QRF1; hFKH1B,forkhead box P1,3p13,protein-coding,Research target
CWITA003506,TCMBANKGE003506,WHAMM,WHAMM1; WHDC1,"WASP homolog associated with actin, golgi membranes and microtubules",15q25.2,protein-coding,/
CWITA003507,TCMBANKGE003507,CACNA1F,AIED; COD3; COD4; CORDX; CORDX3; CSNB2; CSNB2A; CSNBX2; Cav1.4; JM8; JMC8; OA2,"calcium channel, voltage-dependent, L type, alpha 1F subunit",Xp11.23,protein-coding,
CWITA003508,TCMBANKGE003508,MRPL23,L23MRP; RPL23; RPL23L,mitochondrial ribosomal protein L23,11p15.5,protein-coding,/
CWITA003509,TCMBANKGE003509,KLHL4,DKELCHL; KHL4,kelch like family member 4,Xq21.31,protein-coding,/
CWITA003510,TCMBANKGE003510,SESN3,SEST3,sestrin 3,11q21,protein-coding,/
CWITA003511,TCMBANKGE003511,ZNF485,-,zinc finger protein 485,10q11.21,protein-coding,/
CWITA003512,TCMBANKGE003512,VDR,NR1I1,"vitamin D (1,25- dihydroxyvitamin D3) receptor",12q13.11,protein-coding,
CWITA003513,TCMBANKGE003513,GFPT1,CMS12; CMSTA1; GFA; GFAT; GFAT 1; GFAT1; GFAT1m; GFPT; GFPT1L; MSLG,glutamine--fructose-6-phosphate transaminase 1,2p13.3,protein-coding,/
CWITA003514,TCMBANKGE003514,SLC38A10,PP1744,solute carrier family 38 member 10,17q25.3,protein-coding,/
CWITA003515,TCMBANKGE003515,RHO,CSNBAD1; MGC138309; MGC138311; OPN2; RP4,rhodopsin,3q21-q24,protein-coding,
CWITA003516,TCMBANKGE003516,STX1B,GEFSP9; STX1B1; STX1B2,syntaxin 1B,16p11.2,protein-coding,/
CWITA003517,TCMBANKGE003517,DIRAS1,Di-Ras1; GBTS1; RIG,DIRAS family GTPase 1,19p13.3,protein-coding,/
CWITA003518,TCMBANKGE003518,RYR3,RYR-3,ryanodine receptor 3,15q13.3-q14,protein-coding,/
CWITA003519,TCMBANKGE003519,CENPE,CENP-E; KIF10; MCPH13; PPP1R61,centromere protein E,4q24,protein-coding,Research target
CWITA003520,TCMBANKGE003520,SYNJ2,INPP5H,synaptojanin 2,6q25.3,protein-coding,/
CWITA003521,TCMBANKGE003521,NKPD1,-,NTPase KAP family P-loop domain containing 1,19q13.32,protein-coding,/
CWITA003522,TCMBANKGE003522,NDUFS6,CIN13kA; CIN13kDNA; CI13KDA,"NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)",5p15.33,protein-coding,
CWITA003523,TCMBANKGE003523,EPS8L3,EPS8R3; HYPT5,EPS8 like 3,1p13.3,protein-coding,/
CWITA003524,TCMBANKGE003524,SNORA63,E3; E3-2; RNE3; RNU107; SNORA63A; elF-4AII,"small nucleolar RNA, H/ACA box 63",3q27.3,snoRNA,/
CWITA003525,TCMBANKGE003525,RANBP2,ADANE; ANE1; IIAE3; NUP358; TRP1; TRP2,RAN binding protein 2,2q13,protein-coding,/
CWITA003526,TCMBANKGE003526,AGMO,TMEM195,alkylglycerol monooxygenase,7p21.2,protein-coding,/
CWITA003527,TCMBANKGE003527,SUPT7L,SPT7L; STAF65; STAF65(gamma); STAF65G; SUPT7H,"SPT7 like, STAGA complex subunit gamma",2p23.3,protein-coding,/
CWITA003528,TCMBANKGE003528,NPW,L8; L8C; PPL8; PPNPW,neuropeptide W,16p13.3,protein-coding,/
CWITA003529,TCMBANKGE003529,DUSP12,DUSP1; YVH1,dual specificity phosphatase 12,1q23.3,protein-coding,/
CWITA003530,TCMBANKGE003530,LRRC19,-,leucine rich repeat containing 19,9p21.2,protein-coding,/
CWITA003531,TCMBANKGE003531,ELOA3,ELOA3A; HsT829; TCEB3C; TCEB3L2,elongin A3,18q21.1,protein-coding,/
CWITA003532,TCMBANKGE003532,CLEC18B,MRCL2,C-type lectin domain family 18 member B,16q23.1,protein-coding,/
CWITA003533,TCMBANKGE003533,RBBP7,RbAp46,"RB binding protein 7, chromatin remodeling factor",Xp22.2,protein-coding,/
CWITA003534,TCMBANKGE003534,HMGN2,HMG17,high mobility group nucleosomal binding domain 2,1p36.11,protein-coding,/
CWITA003535,TCMBANKGE003535,RAB6A,RAB6,"Rab6A,_Member_Ras_Oncogene_Family",11q13.4,protein-coding,
CWITA003536,TCMBANKGE003536,GPR18,N,G protein-coupled receptor 18,13q32,protein-coding,
CWITA003537,TCMBANKGE003537,PSKH2,-,protein serine kinase H2,8q21.3,protein-coding,/
CWITA003538,TCMBANKGE003538,NFIL3,E4BP4; IL3BP1; NF-IL3A; NFIL3A,"nuclear factor, interleukin 3 regulated",9q22.31,protein-coding,/
CWITA003539,TCMBANKGE003539,PAH,PH; PKU; PKU1,phenylalanine hydroxylase,12q23.2,protein-coding,Successful target
CWITA003540,TCMBANKGE003540,ZNF701,-,zinc finger protein 701,19q13.41,protein-coding,/
CWITA003541,TCMBANKGE003541,GNGT2,G-GAMMA-8; G-GAMMA-C; GNG8; GNG9; GNGT8,G protein subunit gamma transducin 2,17q21.32,protein-coding,/
CWITA003542,TCMBANKGE003542,ELOA,SIII; SIII p110; TCEB3; TCEB3A,elongin A,1p36.11,protein-coding,/
CWITA003543,TCMBANKGE003543,PPP3R2,PPP3RL,"protein phosphatase 3, regulatory subunit B, beta",9q31.1,protein-coding,
CWITA003544,TCMBANKGE003544,SYNGR3,-,synaptogyrin 3,16p13.3,protein-coding,/
CWITA003545,TCMBANKGE003545,KPNA3,IPOA4; SRP1; SRP1gamma; SRP4; hSRP1,karyopherin subunit alpha 3,13q14.2,protein-coding,/
CWITA003546,TCMBANKGE003546,CARD18,ICEBERG; UNQ5804; pseudo-ICE,caspase recruitment domain family member 18,11q22.3,protein-coding,/
CWITA003547,TCMBANKGE003547,PNMT,MGC34570; PENT; PNMTase,phenylethanolamine N-methyltransferase,17q,protein-coding,
CWITA003548,TCMBANKGE003548,TMSB15A,TMSB15; TMSB15B; TMSL8; TMSNB; Tb15; TbNB,thymosin beta 15a,Xq22.1,protein-coding,/
CWITA003549,TCMBANKGE003549,PKM,CTHBP; HELN/ASN/A30; OIP3; PK3; PKM2; TCB; THBP1,Pyruvate_Kinase_M1/2,15q23,protein-coding,
CWITA003550,TCMBANKGE003550,PROS1,PROS; PS21; PS22; PS23; PS24; PS25; PSA; THPH5; THPH6,protein S,3q11.1,protein-coding,/
CWITA003551,TCMBANKGE003551,PTK7,CCK-4; CCK4,protein tyrosine kinase 7 (inactive),6p21.1,protein-coding,Clinical Trial target
CWITA003552,TCMBANKGE003552,NCAPD3,CAP-D3; CAPD3; MCPH22; hCAP-D3; hHCP-6; hcp-6,non-SMC condensin II complex subunit D3,11q25,protein-coding,/
CWITA003553,TCMBANKGE003553,SNAP25,CMS18; RIC-4; RIC4; SEC9; SNAP; SNAP-25; SUP; bA416N4.2; dJ1068F16.2,synaptosome associated protein 25,20p12.2,protein-coding,Successful target
CWITA003554,TCMBANKGE003554,NEFM,NEF3; NF-M; NFM,neurofilament medium,8p21.2,protein-coding,/
CWITA003555,TCMBANKGE003555,RNF144A,RNF144; UBCE7IP4; hUIP4,ring finger protein 144A,2p25.1,protein-coding,/
CWITA003556,TCMBANKGE003556,COL16A1,447AA; FP1572,collagen type XVI alpha 1 chain,1p35.2,protein-coding,/
CWITA003557,TCMBANKGE003557,HCRT,NRCLP1; OX; PPOX,hypocretin (orexin) neuropeptide precursor,17q21,protein-coding,
CWITA003558,TCMBANKGE003558,CAPZA2,CAPPA2; CAPZ,capping actin protein of muscle Z-line subunit alpha 2,7q31.2,protein-coding,/
CWITA003559,TCMBANKGE003559,AWAT2,ARAT; DC4; DGAT2L4; MFAT; WS,acyl-CoA wax alcohol acyltransferase 2,Xq13.1,protein-coding,/
CWITA003560,TCMBANKGE003560,TAB1,3'-Tab1; MAP3K7IP1,TGF-beta activated kinase 1 (MAP3K7) binding protein 1,22q13.1,protein-coding,/
CWITA003561,TCMBANKGE003561,BCS1L,BCS; BCS1; BJS; FLNMS; GRACILE; Hs.6719; MC3DN1; PTD; h-BCS; h-BCS1,"Bcs1_Homolog,_Ubiquinol-Cytochrome_C_Reductase_Complex_Chaperone",2q35,protein-coding,
CWITA003562,TCMBANKGE003562,DOCK4,-,dedicator of cytokinesis 4,7q31.1,protein-coding,/
CWITA003563,TCMBANKGE003563,MCTS1,MCT-1; MCT1,MCTS1 re-initiation and release factor,Xq24,protein-coding,/
CWITA003564,TCMBANKGE003564,TOR1AIP2,IFRG15; LULL1; NET9,torsin 1A interacting protein 2,1q25.2,protein-coding,/
CWITA003565,TCMBANKGE003565,TGFBR1,AAT5; ACVRLK4; ALK-5; ALK5; ESS1; LDS1; LDS1A; LDS2A; MSSE; SKR4; TBR-i; TBRI; TGFR-1; tbetaR-I,transforming growth factor beta receptor 1,9q22.33,protein-coding,Clinical Trial target
CWITA003566,TCMBANKGE003566,ZNF500,ZKSCAN18; ZSCAN50,zinc finger protein 500,16p13.3,protein-coding,/
CWITA003567,TCMBANKGE003567,EPHA10,-,EPH receptor A10,1p34.3,protein-coding,/
CWITA003568,TCMBANKGE003568,IDH2,D2HGA2; ICDNM; IDH; IDHM; IDP; IDPM; mNADPNIDH,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",15q26.1,protein-coding,
CWITA003569,TCMBANKGE003569,CHCHD3,MICOS19; MINOS3; Mic19; PPP1R22,coiled-coil-helix-coiled-coil-helix domain containing 3,7q32.3-q33,protein-coding,/
CWITA003570,TCMBANKGE003570,CST4,-,cystatin S,20p11.21,protein-coding,/
CWITA003571,TCMBANKGE003571,ECEL1,DA5D; DINE; ECEX; XCE,endothelin converting enzyme like 1,2q37.1,protein-coding,/
CWITA003572,TCMBANKGE003572,MELK,HPK38,maternal embryonic leucine zipper kinase,9p13.2,protein-coding,Clinical Trial target
CWITA003573,TCMBANKGE003573,SNU13,15.5K; FA-1; FA1; NHP2L1; NHPX; OTK27; SNRNP15-5; SPAG12; SSFA1,small nuclear ribonucleoprotein 13,22q13.2,protein-coding,/
CWITA003574,TCMBANKGE003574,H4C1,H4-16; H4C11; H4C12; H4C13; H4C14; H4C15; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4FA; HIST1H4A,H4 clustered histone 1,6p22.2,protein-coding,/
CWITA003575,TCMBANKGE003575,CD1D,CD1A; MGC34622; R3,CD1d molecule,1q22-q23,protein-coding,
CWITA003576,TCMBANKGE003576,VSIG2,2210413P10Rik; CTH; CTXL,V-set and immunoglobulin domain containing 2,11q24.2,protein-coding,/
CWITA003577,TCMBANKGE003577,PLA2G4A,GURDP; PLA2G4; cPLA2; cPLA2-alpha,phospholipase A2 group IVA,1q31.1,protein-coding,Clinical Trial target
CWITA003578,TCMBANKGE003578,RARA,NR1B1; RAR,retinoic acid receptor alpha,17q21.2,protein-coding,Clinical Trial target
CWITA003579,TCMBANKGE003579,IFT80,ATD2; FAP167; SRTD2; WDR56,intraflagellar transport 80,3q25.33,protein-coding,/
CWITA003580,TCMBANKGE003580,PDXP,CIN; PLP; dJ37E16.5,pyridoxal phosphatase,22q13.1,protein-coding,Research target
CWITA003581,TCMBANKGE003581,ACOT7,ACH1; ACT; BACH; CTE-II; LACH; LACH1; hBACH,acyl-CoA thioesterase 7,1p36.31,protein-coding,/
CWITA003582,TCMBANKGE003582,AANAT,DSPS; SNAT,aralkylamine N-acetyltransferase,17q25.1,protein-coding,/
CWITA003583,TCMBANKGE003583,ANKRD27,PP12899; VARP,ankyrin repeat domain 27,19q13.11,protein-coding,/
CWITA003584,TCMBANKGE003584,HCRTR1,OX1R,hypocretin receptor 1,1p35.2,protein-coding,Clinical Trial target
CWITA003585,TCMBANKGE003585,MYL6B,MLC1SA,"myosin, light chain 6B, alkali, smooth muscle and non-muscle",12q13.13,protein-coding,
CWITA003586,TCMBANKGE003586,ZNF259,MGC110983; ZPR1,Zinc Finger Protein 259,11q23.3,protein-coding,
CWITA003587,TCMBANKGE003587,GNA11,FBH; FBH2; FHH2; GNA-11; HHC2; HYPOC2,G protein subunit alpha 11,19p13.3,protein-coding,Research target
CWITA003588,TCMBANKGE003588,RRM2B,MTDPS8A; MTDPS8B; P53R2,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3,protein-coding,/
CWITA003589,TCMBANKGE003589,SCARB2,AMRF; CD36L2; EPM4; HLGP85; LGP85; LIMP-2; LIMPII; SR-BII,scavenger receptor class B member 2,4q21.1,protein-coding,/
CWITA003590,TCMBANKGE003590,SMAD9,MADH6; MADH9; PPH2; SMAD8; SMAD8/9; SMAD8A; SMAD8B,SMAD family member 9,13q13.3,protein-coding,/
CWITA003591,TCMBANKGE003591,SPR,SDR38C1,sepiapterin reductase,2p13.2,protein-coding,/
CWITA003592,TCMBANKGE003592,TAS2R14,T2R14; TRB1,taste 2 receptor member 14,12p13.2,protein-coding,/
CWITA003593,TCMBANKGE003593,NOXRED1,C14orf148,NADP dependent oxidoreductase domain containing 1,14q24.3,protein-coding,/
CWITA003594,TCMBANKGE003594,UPF3B,HUPF3B; MRX62; MRX82; MRXS14; RENT3B; UPF3BP1; UPF3BP2; UPF3BP3; UPF3X; Upf3p-X,UPF3B regulator of nonsense mediated mRNA decay,Xq24,protein-coding,/
CWITA003595,TCMBANKGE003595,RUBCNL,C13orf18; KIAA0226L; PACER,rubicon like autophagy enhancer,13q14.13,protein-coding,/
CWITA003596,TCMBANKGE003596,COTL1,CLP,coactosin like F-actin binding protein 1,16q24.1,protein-coding,/
CWITA003597,TCMBANKGE003597,SFXN1,SLC56A1; TCC,sideroflexin 1,5q35.2,protein-coding,/
CWITA003598,TCMBANKGE003598,RAP2B,-,"RAP2B, member of RAS oncogene family",3q25.2,protein-coding,/
CWITA003599,TCMBANKGE003599,HTRA3,Prsp; Tasp,HtrA serine peptidase 3,4p16.1,protein-coding,/
CWITA003600,TCMBANKGE003600,GALNT7,GALNAC-T7; GalNAcT7,polypeptide N-acetylgalactosaminyltransferase 7,4q34.1,protein-coding,/
CWITA003601,TCMBANKGE003601,CD7,GP40; LEU-9; TP41; Tp40,CD7 molecule,17q25.3,protein-coding,Clinical Trial target
CWITA003602,TCMBANKGE003602,CES2,CE-2; CES2A1; PCE-2; iCE,carboxylesterase 2,16q22.1,protein-coding,/
CWITA003603,TCMBANKGE003603,GNAL,DYT25,G protein subunit alpha L,18p11.21,protein-coding,/
CWITA003604,TCMBANKGE003604,H2BC21,GL105; H2B; H2B.1; H2BE; H2BFQ; H2BGL105; H2BQ; HIST2H2BE,H2B clustered histone 21,1q21.2,protein-coding,/
CWITA003605,TCMBANKGE003605,ISL2,-,ISL LIM homeobox 2,15q24.3,protein-coding,/
CWITA003606,TCMBANKGE003606,LNX2,PDZRN1,ligand of numb-protein X 2,13q12.2,protein-coding,/
CWITA003607,TCMBANKGE003607,PCDHB13,PCDH-BETA13,protocadherin beta 13,5q31.3,protein-coding,/
CWITA003608,TCMBANKGE003608,SLCO3A1,OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; SLC21A11,solute carrier organic anion transporter family member 3A1,15q26.1,protein-coding,Research target
CWITA003609,TCMBANKGE003609,ENOPH1,DKFZp586M0524; E1; FLJ12594; MASA; MST145,enolase-phosphatase 1,4q21.22,protein-coding,
CWITA003610,TCMBANKGE003610,FUT2,B12QTL1; SE; SEC2; Se2; sej,fucosyltransferase 2,19q13.33,protein-coding,/
CWITA003611,TCMBANKGE003611,WDPCP,BBS15; C2orf86; CHDTHP; CPLANE5; FRITZ; FRTZ,WD repeat containing planar cell polarity effector,2p15,protein-coding,/
CWITA003612,TCMBANKGE003612,NME1,AWD; GAAD; NB; NBS; NDKA; NDPKNA; NDPKA; NM23; NM23NH1,"non-metastatic cells 1, protein (NM23A) expressed in",17q21.3,protein-coding,
CWITA003613,TCMBANKGE003613,FAM111B,CANP; POIKTMP,family with sequence similarity 111 member B,11q12.1,protein-coding,/
CWITA003614,TCMBANKGE003614,IGFLR1,TMEM149,IGF like family receptor 1,19q13.12,protein-coding,/
CWITA003615,TCMBANKGE003615,TXNRD2,GCCD5; SELZ; TR; TR-BETA; TR3; TRXR2,thioredoxin reductase 2,22q11.21,protein-coding,/
CWITA003616,TCMBANKGE003616,RSL24D1,C15orf15; HRPNL30Niso; L30; RLP24; RPL24; RPL24L; TVAS3,ribosomal L24 domain containing 1,15q21,protein-coding,
CWITA003617,TCMBANKGE003617,SCN3B,HSA243396; SCNB3,"sodium channel, voltage-gated, type III, beta",11q23.3,protein-coding,
CWITA003618,TCMBANKGE003618,RALGAPA1,GARNL1; GRIPE; NEDHRIT; RalGAPalpha1; TULIP1; p240,Ral GTPase activating protein catalytic subunit alpha 1,14q13.2,protein-coding,/
CWITA003619,TCMBANKGE003619,BEX3,Bex; DXS6984E; HGR74; NADE; NGFRAP1,Brain_Expressed_X-Linked_3,Xq22.2,protein-coding,
CWITA003620,TCMBANKGE003620,TPD52L1,D53; TPD53,TPD52 like 1,6q22.31,protein-coding,/
CWITA003621,TCMBANKGE003621,ACTRT3,ARP-T3; ARPM1,actin related protein T3,3q26.2,protein-coding,/
CWITA003622,TCMBANKGE003622,REXO1,ELOABP1; EloA-BP1; REX1; TCEB3BP1,RNA exonuclease 1 homolog,19p13.3,protein-coding,/
CWITA003623,TCMBANKGE003623,DPY19L1,-,dpy-19 like C-mannosyltransferase 1,7p14.2,protein-coding,/
CWITA003624,TCMBANKGE003624,TPRA1,GPR175; TMEM227; TPRA40,transmembrane protein adipocyte associated 1,3q21.3,protein-coding,/
CWITA003625,TCMBANKGE003625,SLC6A4,5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT,solute carrier family 6 member 4,17q11.2,protein-coding,Successful target
CWITA003626,TCMBANKGE003626,ZNF107,Y8; ZFD25; ZNF588; smap-7,zinc finger protein 107,7q11.21,protein-coding,/
CWITA003627,TCMBANKGE003627,SLC9A8,NHE-8; NHE8,solute carrier family 9 member A8,20q13.13,protein-coding,/
CWITA003628,TCMBANKGE003628,PHF14,-,PHD finger protein 14,7p21.3,protein-coding,/
CWITA003629,TCMBANKGE003629,HIRA,DGCR1; TUP1; TUPLE1,histone cell cycle regulator,22q11.21,protein-coding,/
CWITA003630,TCMBANKGE003630,KATNAL1,-,katanin catalytic subunit A1 like 1,13q12.3,protein-coding,/
CWITA003631,TCMBANKGE003631,DELE1,DELE; KIAA0141,DAP3 binding cell death enhancer 1,5q31.3,protein-coding,/
CWITA003632,TCMBANKGE003632,APPBP2,APP-BP2; HS.84084; PAT1,amyloid beta precursor protein binding protein 2,17q23.2,protein-coding,/
CWITA003633,TCMBANKGE003633,HSPA14,HSP70-4; HSP70L1,heat shock protein family A (Hsp70) member 14,10p13,protein-coding,/
CWITA003634,TCMBANKGE003634,MOB3B,C9orf35; MOB1D; MOBKL2B,MOB kinase activator 3B,9p21.2,protein-coding,/
CWITA003635,TCMBANKGE003635,MAST4,-,microtubule associated serine/threonine kinase family member 4,5q12.3,protein-coding,/
CWITA003636,TCMBANKGE003636,INPP5B,5PTase,inositol polyphosphate-5-phosphatase B,1p34.3,protein-coding,/
CWITA003637,TCMBANKGE003637,PCDHGA8,PCDH-GAMMA-A8,"protocadherin gamma subfamily A, 8",5q31.3,protein-coding,/
CWITA003638,TCMBANKGE003638,APOBEC3F,A3F; ARP8; BK150C2.4.MRNA; KA6,apolipoprotein B mRNA editing enzyme catalytic subunit 3F,22q13.1,protein-coding,/
CWITA003639,TCMBANKGE003639,C19orf48,-,chromosome 19 open reading frame 48,19q13.33,protein-coding,/
CWITA003640,TCMBANKGE003640,PCDHA6,CNR2; CNRN2; CNRS2; CRNR2; PCDH-ALPHA6,protocadherin alpha 6,5q31.3,protein-coding,/
CWITA003641,TCMBANKGE003641,TFAP2C,AP2-GAMMA; ERF1; TFAP2G; hAP-2g,transcription factor AP-2 gamma,20q13.31,protein-coding,/
CWITA003642,TCMBANKGE003642,PIP4K2C,PIP5K2C,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,12q13.3,protein-coding,/
CWITA003643,TCMBANKGE003643,F7,SPCA,coagulation factor VII,13q34,protein-coding,Successful target
CWITA003644,TCMBANKGE003644,IGSF22,IGFN2,immunoglobulin superfamily member 22,11p15.1,protein-coding,/
CWITA003645,TCMBANKGE003645,TSR3,C16orf42,TSR3 ribosome maturation factor,16p13.3,protein-coding,/
CWITA003646,TCMBANKGE003646,HRH2,H2R; HH2R,histamine receptor H2,5q35.2,protein-coding,Successful target
CWITA003647,TCMBANKGE003647,RAB3B,-,"RAB3B, member RAS oncogene family",1p32.3,protein-coding,/
CWITA003648,TCMBANKGE003648,HOXD1,HOX4; HOX4G; Hox-4.7,homeobox D1,2q31.1,protein-coding,/
CWITA003649,TCMBANKGE003649,RDH14,PAN2; SDR7C4,retinol dehydrogenase 14,2p24.2,protein-coding,/
CWITA003650,TCMBANKGE003650,METTL21A,FAM119A; HCA557b; HSPA-KMT,methyltransferase like 21A,2q33.3,protein-coding,/
CWITA003651,TCMBANKGE003651,MUC5B,MG1; MUC-5B; MUC5; MUC9,"mucin 5B, oligomeric mucus/gel-forming",11p15.5,protein-coding,/
CWITA003652,TCMBANKGE003652,PROM2,PROML2,prominin 2,2q11.1,protein-coding,/
CWITA003653,TCMBANKGE003653,CPVL,HVLP,carboxypeptidase vitellogenic like,7p14.3,protein-coding,/
CWITA003654,TCMBANKGE003654,SPTLC2,HSN1C; KIAA0526; LCB2; LCB2A; NSAN1C; SPT2,"serine palmitoyltransferase, long chain base subunit 2",14q24.3,protein-coding,
CWITA003655,TCMBANKGE003655,PTDSS1,LMHD; PSS1; PSSA,phosphatidylserine synthase 1,8q22.1,protein-coding,/
CWITA003656,TCMBANKGE003656,NFAT5,NF-AT5; NFATL1; NFATZ; OREBP; TONEBP,nuclear factor of activated T cells 5,16q22.1,protein-coding,/
CWITA003657,TCMBANKGE003657,OLFM1,AMY; NOE1; NOELIN1; OlfA,olfactomedin 1,9q34.3,protein-coding,/
CWITA003658,TCMBANKGE003658,ATP6V1A,ATP6A1; ATP6V1A1; HO68; VA68; VPP2; Vma1,"ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A",3q13.31,protein-coding,
CWITA003659,TCMBANKGE003659,COBL,-,cordon-bleu WH2 repeat protein,7p12.1,protein-coding,/
CWITA003660,TCMBANKGE003660,TRIML1,RNF209,tripartite motif family like 1,4q35.2,protein-coding,/
CWITA003661,TCMBANKGE003661,ALMS1,ALSS,ALMS1 centrosome and basal body associated protein,2p13.1,protein-coding,/
CWITA003662,TCMBANKGE003662,XRRA1,-,X-ray radiation resistance associated 1,11q13.4,protein-coding,/
CWITA003663,TCMBANKGE003663,VASP,-,vasodilator stimulated phosphoprotein,19q13.32,protein-coding,/
CWITA003664,TCMBANKGE003664,FAM120C,CXorf17; ORF34,family with sequence similarity 120C,Xp11.22,protein-coding,/
CWITA003665,TCMBANKGE003665,SCTR,SR,secretin receptor,2q14.2,protein-coding,/
CWITA003666,TCMBANKGE003666,AHNAK,AHNAKRS; PM227,AHNAK nucleoprotein,11q12.3,protein-coding,/
CWITA003667,TCMBANKGE003667,TNFRSF4,ACT35; CD134; IMD16; OX40; TXGP1L,TNF receptor superfamily member 4,1p36.33,protein-coding,Clinical Trial target
CWITA003668,TCMBANKGE003668,DCK,MGC117410; MGC138632,deoxycytidine kinase,4q13.3-q21.1,protein-coding,
CWITA003669,TCMBANKGE003669,ABO,A3GALNT; A3GALT1; GTB; NAGAT,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",9q34.2,protein-coding,
CWITA003670,TCMBANKGE003670,ABCB6,ABC; LAN; MTABC3; PRP; umat,ATP binding cassette subfamily B member 6 (Langereis blood group),2q35,protein-coding,/
CWITA003671,TCMBANKGE003671,APOBEC3G,A3G; ARCD; ARP-9; ARP9; CEM-15; CEM15; MDS019; bK150C2.7; dJ494G10.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3G,22q13.1,protein-coding,/
CWITA003672,TCMBANKGE003672,CALM1,CALML2; CAM2; CAM3; CAMB; CAMC; CAMI; CAMIII; CPVT4; DD132; LQT14; PHKD; caM,calmodulin 1,14q32.11,protein-coding,/
CWITA003673,TCMBANKGE003673,SLC27A1,ACSVL5; FATP; FATP-1; FATP1,solute carrier family 27 member 1,19p13.11,protein-coding,/
CWITA003674,TCMBANKGE003674,CD63,LAMP-3; ME491; MLA1; OMA81H; TSPAN30,CD63 molecule,12q13.2,protein-coding,/
CWITA003675,TCMBANKGE003675,ZMYND11,BRAM1; BS69; MRD30,zinc finger MYND-type containing 11,10p15.3,protein-coding,/
CWITA003676,TCMBANKGE003676,POLR2F,HRBP14.4; POLRF; RPABC14.4; RPABC2; RPB14.4; RPB6; RPC15,"RNA polymerase II, I and III subunit F",22q13.1,protein-coding,/
CWITA003677,TCMBANKGE003677,UGT1A7,UDPGT; UDPGT_1N7; UGTN1G; UGT1N07; UGT1.7; UGT1G,"UDP glucuronosyltransferase 1 family, polypeptide A7",2q37,protein-coding,
CWITA003678,TCMBANKGE003678,COX19,-,cytochrome c oxidase assembly factor COX19,7p22.3,protein-coding,/
CWITA003679,TCMBANKGE003679,CDK5R1,CDK5P35; CDK5R; MGC33831; NCK5A; p23; p25; p35; p35nck5a,"cyclin-dependent kinase 5, regulatory subunit 1 (p35)",17q11.2,protein-coding,
CWITA003680,TCMBANKGE003680,ADORA2B,ADORA2,adenosine A2b receptor,17p12,protein-coding,Successful target
CWITA003681,TCMBANKGE003681,ZNF281,GZP1; ZBP-99; ZBP99; ZNP-99,zinc finger protein 281,1q32.1,protein-coding,/
CWITA003682,TCMBANKGE003682,TARBP2,LOQS; TRBP; TRBP1; TRBP2,TARBP2 subunit of RISC loading complex,12q13.13,protein-coding,/
CWITA003683,TCMBANKGE003683,PRPF3,HPRP3; HPRP3P; PRP3; Prp3p; RP18; SNRNP90,pre-mRNA processing factor 3,1q21.2,protein-coding,/
CWITA003684,TCMBANKGE003684,MICALL2,JRAB; MICAL-L2,MICAL like 2,7p22.3,protein-coding,/
CWITA003685,TCMBANKGE003685,PRAP1,PRO1195; UPA,proline rich acidic protein 1,10q26.3,protein-coding,/
CWITA003686,TCMBANKGE003686,FANCB,FA2; FAAP90; FAAP95; FAB; FACB,FA complementation group B,Xp22.2,protein-coding,/
CWITA003687,TCMBANKGE003687,UNG,DGU; HIGM4; HIGM5; UDG; UNG1; UNG15; UNG2,uracil DNA glycosylase,12q24.11,protein-coding,/
CWITA003688,TCMBANKGE003688,CACNG1,CACNLG,"calcium channel, voltage-dependent, gamma subunit 1",17q24,protein-coding,
CWITA003689,TCMBANKGE003689,MFAP1,AMP,microfibril associated protein 1,15q15.3,protein-coding,/
CWITA003690,TCMBANKGE003690,EPN2,EHB21,epsin 2,17p11.2,protein-coding,/
CWITA003691,TCMBANKGE003691,HSP90AB1,D6S182; FLJ26984; HSP90NBETA; HSP90B; HSPC2; HSPCB,"heat shock protein 90kDa alpha (cytosolic), class B member 1",6p12,protein-coding,
CWITA003692,TCMBANKGE003692,NDUFB1,CI-MNLL; CI-SGDH; MNLL,NADH:ubiquinone oxidoreductase subunit B1,14q32.12,protein-coding,/
CWITA003693,TCMBANKGE003693,GZMH,CCP-X; CGL-2; CSP-C; CTLA1; CTSGL2,granzyme H,14q12,protein-coding,/
CWITA003694,TCMBANKGE003694,PYGB,GPBB,glycogen phosphorylase B,20p11.21,protein-coding,/
CWITA003695,TCMBANKGE003695,RPS6KA4,MSK2; RSKNB,"ribosomal protein S6 kinase, 90kDa, polypeptide 4",11q11-q13,protein-coding,
CWITA003696,TCMBANKGE003696,ZCWPW1,ZCW1,zinc finger CW-type and PWWP domain containing 1,7q22.1,protein-coding,/
CWITA003697,TCMBANKGE003697,PYCR1,ARCL2B; P5C; P5CR; PIG45; PP222; PRO3; PYCR,pyrroline-5-carboxylate reductase 1,17q25.3,protein-coding,
CWITA003698,TCMBANKGE003698,Pex13-ps,Gm13638,"peroxisomal biogenesis factor 13, pseudogene",2|2 C3,pseudo,/
CWITA003699,TCMBANKGE003699,GSN,ADF; AGEL,gelsolin,9q33.2,protein-coding,Research target
CWITA003700,TCMBANKGE003700,KMT2D,AAD10; ALR; CAGL114; KABUK1; KMS; MLL2; MLL4; TNRC21,Lysine_Methyltransferase_2D,12q13.12,protein-coding,
CWITA003701,TCMBANKGE003701,DDA1,C19orf58; PCIA1,DET1 and DDB1 associated 1,19p13.11,protein-coding,/
CWITA003702,TCMBANKGE003702,TMEM181,GPR178; KIAA1423,transmembrane protein 181,6q25.3,protein-coding,/
CWITA003703,TCMBANKGE003703,SSB,LARP3; La,Sjogren syndrome antigen B (autoantigen La),2q31.1,protein-coding,
CWITA003704,TCMBANKGE003704,PRSS40A,TISP43,serine protease 40A (pseudogene),2q21.1,pseudo,/
CWITA003705,TCMBANKGE003705,EMC1,CAVIPMR; KIAA0090,ER membrane protein complex subunit 1,1p36.13,protein-coding,/
CWITA003706,TCMBANKGE003706,PCDHB10,PCDH-BETA10; PCHB10,protocadherin beta 10,5q31.3,protein-coding,/
CWITA003707,TCMBANKGE003707,MZT1,C13orf37; MOZART1,mitotic spindle organizing protein 1,13q21.33,protein-coding,/
CWITA003708,TCMBANKGE003708,SLC25A30,KMCP1,solute carrier family 25 member 30,13q14.13,protein-coding,/
CWITA003709,TCMBANKGE003709,ALG2,CDG1I; CDGIi; CMS14; CMSTA3; NET38; hALPG2,"ALG2 alpha-1,3/1,6-mannosyltransferase",9q22.33,protein-coding,/
CWITA003710,TCMBANKGE003710,CUEDC1,-,CUE domain containing 1,17q22,protein-coding,/
CWITA003711,TCMBANKGE003711,CGNL1,JACOP; PCING,cingulin like 1,15q21.3,protein-coding,/
CWITA003712,TCMBANKGE003712,VSIG4,CRIg; Z39IG,V-set and immunoglobulin domain containing 4,Xq12,protein-coding,/
CWITA003713,TCMBANKGE003713,ADCYAP1,MGC126852; PACAP,adenylate cyclase activating polypeptide 1 (pituitary),18p11,protein-coding,
CWITA003714,TCMBANKGE003714,ELOVL4,ADMD; CT118; FLJ17667; FLJ92876; STGD2; STGD3,ELOVL fatty acid elongase 4,6q14,protein-coding,
CWITA003715,TCMBANKGE003715,FRMPD1,FRMD2,FERM and PDZ domain containing 1,9p13.2,protein-coding,/
CWITA003716,TCMBANKGE003716,PCCA,-,propionyl-CoA carboxylase subunit alpha,13q32.3,protein-coding,/
CWITA003717,TCMBANKGE003717,CLMN,-,calmin,14q32.13,protein-coding,/
CWITA003718,TCMBANKGE003718,NTSR2,NTR2,neurotensin receptor 2,2p25.1,protein-coding,Research target
CWITA003719,TCMBANKGE003719,BMP6,VGR; VGR1,bone morphogenetic protein 6,6p24.3,protein-coding,/
CWITA003720,TCMBANKGE003720,PCMT1,PIMT,protein-L-isoaspartate (D-aspartate) O-methyltransferase,6q25.1,protein-coding,/
CWITA003721,TCMBANKGE003721,VRK1,PCH1; PCH1A,VRK serine/threonine kinase 1,14q32.2,protein-coding,/
CWITA003722,TCMBANKGE003722,NUDT16L1,SDOS; TIRR,nudix hydrolase 16 like 1,16p13.3,protein-coding,/
CWITA003723,TCMBANKGE003723,RNF122,-,ring finger protein 122,8p12,protein-coding,/
CWITA003724,TCMBANKGE003724,PRMT6,HRMT1L6,protein arginine methyltransferase 6,1p13.3,protein-coding,/
CWITA003725,TCMBANKGE003725,SH3BP5,SAB; SH3BP-5,SH3 domain binding protein 5,3p25.1,protein-coding,/
CWITA003726,TCMBANKGE003726,ABCC8,ABC36; HHF1; HI; HRINS; MRP8; PHHI; SUR; SUR1; TNDM2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",11p15.1,protein-coding,
CWITA003727,TCMBANKGE003727,MIGA1,FAM73A,mitoguardin 1,1p31.1,protein-coding,/
CWITA003728,TCMBANKGE003728,N4BP1,-,NEDD4 binding protein 1,16q12.1,protein-coding,/
CWITA003729,TCMBANKGE003729,BDP1,DFNB112; HSA238520; TAF3B1; TFC5; TFIIIB''; TFIIIB150; TFIIIB90; TFNR,"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB",5q13.2,protein-coding,/
CWITA003730,TCMBANKGE003730,HEPH,CPL,hephaestin,Xq12,protein-coding,/
CWITA003731,TCMBANKGE003731,SNAPC1,PTFgamma; SNAP43,small nuclear RNA activating complex polypeptide 1,14q23.2,protein-coding,/
CWITA003732,TCMBANKGE003732,ERAP1,A-LAP; ALAP; APPILS; ARTS-1; ARTS1; ERAAP; ERAAP1; PILS-AP; PILSAP,endoplasmic reticulum aminopeptidase 1,5q15,protein-coding,Research target
CWITA003733,TCMBANKGE003733,AGXT2,AGT2; BAIBA; DAIBAT,alanine--glyoxylate aminotransferase 2,5p13.2,protein-coding,/
CWITA003734,TCMBANKGE003734,ZNF350,ZBRK1; ZFQR,zinc finger protein 350,19q13.41,protein-coding,/
CWITA003735,TCMBANKGE003735,PARP2,ADPRT2; ADPRTL2; ADPRTL3; PARPN2; pADPRTN2,poly (ADP-ribose) polymerase 2,14q11.2-q12,protein-coding,
CWITA003736,TCMBANKGE003736,NPC1L1,LDLCQ7; NPC11L1; SLC65A2,NPC1 like intracellular cholesterol transporter 1,7p13,protein-coding,Successful target
CWITA003737,TCMBANKGE003737,EI24,EPG4; PIG8; TP53I8,EI24 autophagy associated transmembrane protein,11q24.2,protein-coding,/
CWITA003738,TCMBANKGE003738,DNAJA1,DJ-2; DjA1; HDJ2; HSDJ; HSJ-2; HSJ2; HSPF4; NEDD7; hDJ-2,DnaJ heat shock protein family (Hsp40) member A1,9p21.1,protein-coding,/
CWITA003739,TCMBANKGE003739,PCYT2,ET,"phosphate cytidylyltransferase 2, ethanolamine",17q25.3,protein-coding,
CWITA003740,TCMBANKGE003740,Gng5-ps,Gm15776,"G protein subunit gamma 5, pseudogene",16 B1|16,pseudo,/
CWITA003741,TCMBANKGE003741,NFYC,CBF-C; CBFC; H1TF2A; HAP5; HSM; NF-YC,nuclear transcription factor Y subunit gamma,1p34.2,protein-coding,/
CWITA003742,TCMBANKGE003742,COX6B1,COX6B; COXG; COXVIb1,cytochrome c oxidase subunit 6B1,19q13.12,protein-coding,/
CWITA003743,TCMBANKGE003743,MROH1,HEATR7A,maestro heat like repeat family member 1,8q24.3,protein-coding,/
CWITA003744,TCMBANKGE003744,AGFG1,HRB; RAB; RIP,ArfGAP with FG repeats 1,2q36.3,protein-coding,/
CWITA003745,TCMBANKGE003745,TTYH3,-,tweety family member 3,7p22.3,protein-coding,/
CWITA003746,TCMBANKGE003746,CREBBP,CBP; KAT3A; MKHK1; RSTS; RSTS1,CREB binding protein,16p13.3,protein-coding,Clinical Trial target
CWITA003747,TCMBANKGE003747,RRAGC,GTR2; RAGC; TIB929,Ras related GTP binding C,1p34.3,protein-coding,/
CWITA003748,TCMBANKGE003748,TICRR,C15orf42; SLD3; Treslin,TOPBP1 interacting checkpoint and replication regulator,15q26.1,protein-coding,/
CWITA003749,TCMBANKGE003749,STARD13,ARHGAP37; DLC2; GT650; LINC00464,StAR related lipid transfer domain containing 13,13q13.1-q13.2,protein-coding,/
CWITA003750,TCMBANKGE003750,PARS2,DKFZp727A071; MGC14416; MGC19467; MTNPRORS,"prolyl-tRNA synthetase 2, mitochondrial (putative)",1p32.2,protein-coding,
CWITA003751,TCMBANKGE003751,AK2,ADK2; AK_2,adenylate kinase 2,1p34,protein-coding,
CWITA003752,TCMBANKGE003752,NAA80,FUS-2; FUS2; HsNAAA80; NAT6,"N-alpha-acetyltransferase 80, NatH catalytic subunit",3p21.31,protein-coding,/
CWITA003753,TCMBANKGE003753,CCNB2,HsT17299,cyclin B2,15q22.2,protein-coding,/
CWITA003754,TCMBANKGE003754,TSEN2,PCH2B; SEN2; SEN2L,tRNA splicing endonuclease subunit 2,3p25.2,protein-coding,/
CWITA003755,TCMBANKGE003755,SF3B3,KIAA0017; RSE1; SAP130; SF3b130; STAF130,"splicing factor 3b, subunit 3, 130kDa",16q22.1,protein-coding,
CWITA003756,TCMBANKGE003756,OBSL1,-,obscurin like cytoskeletal adaptor 1,2q35,protein-coding,/
CWITA003757,TCMBANKGE003757,RETSAT,-,retinol saturase,2p11.2,protein-coding,/
CWITA003758,TCMBANKGE003758,SLC2A10,ATORS; ATS; GLUT10,solute carrier family 2 member 10,20q13.12,protein-coding,/
CWITA003759,TCMBANKGE003759,HBQ1,HBQ,hemoglobin subunit theta 1,16p13.3,protein-coding,/
CWITA003760,TCMBANKGE003760,HSD11B2,AME; AME1; HSD11K; HSD2; SDR9C3,hydroxysteroid (11-beta) dehydrogenase 2,16q22,protein-coding,
CWITA003761,TCMBANKGE003761,PLEKHA2,TAPP2,pleckstrin homology domain containing A2,8p11.22,protein-coding,/
CWITA003762,TCMBANKGE003762,KIAA0895,-,KIAA0895,7p14.2,protein-coding,/
CWITA003763,TCMBANKGE003763,CT45A9,CT45-2; CT45A2; CT45A8,cancer/testis antigen family 45 member A9,Xq26.3,protein-coding,/
CWITA003764,TCMBANKGE003764,SLC30A5,ZNT5; ZNTL1; ZTL1; ZnT-5,solute carrier family 30 member 5,5q13.1-q13.2,protein-coding,/
CWITA003765,TCMBANKGE003765,NEU4,-,neuraminidase 4,2q37.3,protein-coding,/
CWITA003766,TCMBANKGE003766,FAM83H,AI3; AI3A,family with sequence similarity 83 member H,8q24.3,protein-coding,/
CWITA003767,TCMBANKGE003767,DECR1,DECR; NADPH; SDR18C1,"2,4-dienoyl CoA reductase 1, mitochondrial",8q21.3,protein-coding,
CWITA003768,TCMBANKGE003768,POU2F1,OCT1; OTF1; oct-1B,POU class 2 homeobox 1,1q24.2,protein-coding,/
CWITA003769,TCMBANKGE003769,GNG8,-,G protein subunit gamma 8,19q13.32,protein-coding,/
CWITA003770,TCMBANKGE003770,KIF1B,CMT2; CMT2A; CMT2A1; HMSNII; KLP; NBLST1,kinesin family member 1B,1p36.22,protein-coding,/
CWITA003771,TCMBANKGE003771,ADNP,ADNP1; HVDAS; MRD28,activity dependent neuroprotector homeobox,20q13.13,protein-coding,/
CWITA003772,TCMBANKGE003772,LBH,-,LBH regulator of WNT signaling pathway,2p23.1,protein-coding,/
CWITA003773,TCMBANKGE003773,EPHA6,EHK-2; EHK2; EK12; EPA6; HEK12; PRO57066,EPH receptor A6,3q11.2,protein-coding,Research target
CWITA003774,TCMBANKGE003774,PGM1,GSD14,phosphoglucomutase 1,1p31,protein-coding,
CWITA003775,TCMBANKGE003775,ARRB1,ARB1; ARR1,arrestin beta 1,11q13.4,protein-coding,Research target
CWITA003776,TCMBANKGE003776,GRB14,-,growth factor receptor bound protein 14,2q24.3,protein-coding,/
CWITA003777,TCMBANKGE003777,TSFM,EFTS; EFTSMT,"Ts translation elongation factor, mitochondrial",12q14.1,protein-coding,/
CWITA003778,TCMBANKGE003778,SGSM3,CIP85; MAP; RABGAP5; RUSC3; RUTBC3; RabGAP-5; rabGAPLP,Small_G_Protein_Signaling_Modulator_3,22q13.1,protein-coding,
CWITA003779,TCMBANKGE003779,ZNF205,RhitH; ZNF210; Zfp13,zinc finger protein 205,16p13.3,protein-coding,/
CWITA003780,TCMBANKGE003780,PRDX2,MGC4104; NKEFB; PRP; PRX2; PRXII; TDPX1; TPX1; TSA,peroxiredoxin 2,19p13.2,protein-coding,
CWITA003781,TCMBANKGE003781,UCHL5,CGI-70; INO80R; UCH-L5; UCH37,ubiquitin C-terminal hydrolase L5,1q31.2,protein-coding,Patented target
CWITA003782,TCMBANKGE003782,JAK1,JAK1A; JAK1B; JTK3,Janus kinase 1,1p32.3-p31.3,protein-coding,
CWITA003783,TCMBANKGE003783,SURF6,RRP14,surfeit 6,9q34.2,protein-coding,/
CWITA003784,TCMBANKGE003784,ABCC11,EWWD; MRP8; WW,"ATP-binding cassette, sub-family C (CFTR/MRP), member 11",16q12.1,protein-coding,
CWITA003785,TCMBANKGE003785,NDUFAB1,ACP; FASN2A; MGC65095; SDAP,"NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa",16p12.2,protein-coding,
CWITA003786,TCMBANKGE003786,FRYL,AF4p12; KIAA0826; MOR2,FRY like transcription coactivator,4p11,protein-coding,/
CWITA003787,TCMBANKGE003787,STX17,-,syntaxin 17,9q31.1,protein-coding,/
CWITA003788,TCMBANKGE003788,Dhfr-rs1,Dhfr-2,"dihydrofolate reductase, related sequence 1",-,pseudo,/
CWITA003789,TCMBANKGE003789,HLA-DQA1,CELIAC1; DQ-A1; DQA1; HLA-DQA,"major histocompatibility complex, class II, DQ alpha 1",6p21.32,protein-coding,Research target
CWITA003790,TCMBANKGE003790,SLC2A10,ATS; GLUT10; MGC126706,"solute carrier family 2 (facilitated glucose transporter), member 10",20q13.1,protein-coding,
CWITA003791,TCMBANKGE003791,PCDHAC1,PCDH-ALPHA-C1,"protocadherin alpha subfamily C, 1",5q31.3,protein-coding,/
CWITA003792,TCMBANKGE003792,SLC25A32,MFT; MFTC; RREI,solute carrier family 25 member 32,8q22.3,protein-coding,/
CWITA003793,TCMBANKGE003793,BPNT2,GPAPP; IMP 3; IMP-3; IMPA3; IMPAD1,"3'(2'), 5'-bisphosphate nucleotidase 2",8q12.1,protein-coding,/
CWITA003794,TCMBANKGE003794,SLC5A2,SGLT2,solute carrier family 5 member 2,16p11.2,protein-coding,Clinical Trial target
CWITA003795,TCMBANKGE003795,NFATC1,MGC138448; NFNATC; NFAT2; NFATc,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1",18q23,protein-coding,
CWITA003796,TCMBANKGE003796,ZNF566,-,zinc finger protein 566,19q13.12,protein-coding,/
CWITA003797,TCMBANKGE003797,LPIN1,PAP1,lipin 1,2p25.1,protein-coding,/
CWITA003798,TCMBANKGE003798,PSAT1,EPIP; NLS2; PSA; PSAT; PSATD,phosphoserine aminotransferase 1,9q21.2,protein-coding,/
CWITA003799,TCMBANKGE003799,CEP97,2810403B08Rik; LRRIQ2,centrosomal protein 97,3q12.3,protein-coding,/
CWITA003800,TCMBANKGE003800,ERVK-24,HERV-K101; PR; Protease; Proteinase; c22_A,endogenous retrovirus group K member 24,22q11.21,other,/
CWITA003801,TCMBANKGE003801,SLIT1,MEGF4; SLIL1; SLIT-1; SLIT3,slit guidance ligand 1,10q24.1,protein-coding,/
CWITA003802,TCMBANKGE003802,CDC42BPA,MRCK; MRCKA; PK428,CDC42 binding protein kinase alpha,1q42.13,protein-coding,Research target
CWITA003803,TCMBANKGE003803,ACER2,ALKCDase2; ASAH3L,alkaline ceramidase 2,9p22.1,protein-coding,/
CWITA003804,TCMBANKGE003804,FGFR2,BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25,fibroblast growth factor receptor 2,10q26.13,protein-coding,Successful target
CWITA003805,TCMBANKGE003805,TRIM22,GPSTAF50; RNF94; STAF50,tripartite motif containing 22,11p15.4,protein-coding,/
CWITA003806,TCMBANKGE003806,SIRT4,SIR2L4,sirtuin 4,12q24.23-q24.31,protein-coding,/
CWITA003807,TCMBANKGE003807,CALCOCO1,Cocoa; PP13275; calphoglin,calcium binding and coiled-coil domain 1,12q13.13,protein-coding,/
CWITA003808,TCMBANKGE003808,SMPD2,ISC1; NSMASE; NSMASE1,sphingomyelin phosphodiesterase 2,6q21,protein-coding,Research target
CWITA003809,TCMBANKGE003809,ZFPM2,DIH3; FOG2; SRXY9; ZC2HC11B; ZNF89B; hFOG-2,"zinc finger protein, FOG family member 2",8q23.1,protein-coding,/
CWITA003810,TCMBANKGE003810,ACBD3,GCP60; GOCAP1; GOLPH1; PAP7,acyl-CoA binding domain containing 3,1q42.12,protein-coding,/
CWITA003811,TCMBANKGE003811,ANGPTL5,-,angiopoietin like 5,11q22.1,protein-coding,/
CWITA003812,TCMBANKGE003812,SLC6A11,GATN3; GAT3; GAT4,"solute carrier family 6 (neurotransmitter transporter, GABA), member 11",3p25.3,protein-coding,
CWITA003813,TCMBANKGE003813,INSR,CD220; HHF5,insulin receptor,19p13.3-p13.2,protein-coding,
CWITA003814,TCMBANKGE003814,ZNF695,SBZF3,zinc finger protein 695,1q44,protein-coding,/
CWITA003815,TCMBANKGE003815,ACBD5,RDLKD,acyl-CoA binding domain containing 5,10p12.1,protein-coding,/
CWITA003816,TCMBANKGE003816,S1PR3,EDG-3; EDG3; LPB3; S1P3,sphingosine-1-phosphate receptor 3,9q22.1,protein-coding,Research target
CWITA003817,TCMBANKGE003817,PIR,-,pirin,Xp22.2,protein-coding,/
CWITA003818,TCMBANKGE003818,DUSP10,MKP-5; MKP5,dual specificity phosphatase 10,1q41,protein-coding,Research target
CWITA003819,TCMBANKGE003819,MCPH1,BRIT1; MCT,microcephalin 1,8p23.1,protein-coding,/
CWITA003820,TCMBANKGE003820,PRSS42P,PRSS42; TESSP2,"serine protease 42, pseudogene",3p21.31,pseudo,/
CWITA003821,TCMBANKGE003821,C9,ARMD15; C9D,complement C9,5p13.1,protein-coding,/
CWITA003822,TCMBANKGE003822,Mod2,Cd243; Mdr; Mdr-1; Mod-2; Mod-2r; Mod-2s; Mod2-r; Mod2-s,"malic enzyme complex, mitochondrial",-,other,/
CWITA003823,TCMBANKGE003823,MMAA,cblA,metabolism of cobalamin associated A,4q31.21,protein-coding,/
CWITA003824,TCMBANKGE003824,PDK3,CMTX6; GS1-358P8.4,pyruvate dehydrogenase kinase 3,Xp22.11,protein-coding,Research target
CWITA003825,TCMBANKGE003825,FUZ,CPLANE3; FY; NTD,Fuzzy_Planar_Cell_Polarity_Protein,19q13.33,protein-coding,
CWITA003826,TCMBANKGE003826,C8G,C8C,complement C8 gamma chain,9q34.3,protein-coding,/
CWITA003827,TCMBANKGE003827,REXO2,CGI-114; REX2; RFN; SFN,RNA exonuclease 2,11q23.2,protein-coding,/
CWITA003828,TCMBANKGE003828,KNCN,Kino; L5,Kinocilin,1p33,protein-coding,
CWITA003829,TCMBANKGE003829,CHRNB2,EFNL3; nAChRB2,cholinergic receptor nicotinic beta 2 subunit,1q21.3,protein-coding,Clinical Trial target
CWITA003830,TCMBANKGE003830,TMEM104,-,transmembrane protein 104,17q25.1,protein-coding,/
CWITA003831,TCMBANKGE003831,PCTP,PC-TP; STARD2,phosphatidylcholine transfer protein,17q22,protein-coding,/
CWITA003832,TCMBANKGE003832,MMP17,MMP-17; MT4-MMP; MT4MMP; MTMMP4,matrix metallopeptidase 17,12q24.33,protein-coding,Research target
CWITA003833,TCMBANKGE003833,SLC44A1,CD92; CDW92; CHTL1; CONATOC; CTL1,solute carrier family 44 member 1,9q31.1-q31.2,protein-coding,/
CWITA003834,TCMBANKGE003834,CNBP,CNBP1; DM2; PROMM; RNF163; ZCCHC22; ZNF9,CCHC-type zinc finger nucleic acid binding protein,3q21.3,protein-coding,/
CWITA003835,TCMBANKGE003835,EPHA7,EHK-3; EHK3; EK11; HEK11,EPH receptor A7,6q16.1,protein-coding,Research target
CWITA003836,TCMBANKGE003836,ZNF845,-,zinc finger protein 845,19q13.42,protein-coding,/
CWITA003837,TCMBANKGE003837,HOXB2,HOX2; HOX2H; Hox-2.8; K8,homeobox B2,17q21.32,protein-coding,/
CWITA003838,TCMBANKGE003838,HSF2BP,MEILB2,heat shock transcription factor 2 binding protein,21q22.3,protein-coding,/
CWITA003839,TCMBANKGE003839,ITCH,ADMFD; AIF4; AIP4; NAPP1,itchy E3 ubiquitin protein ligase,20q11.22,protein-coding,Research target
CWITA003840,TCMBANKGE003840,SLC44A1,CD92; CDW92; CHTL1; CTL1; RP11N287A8.1,"solute carrier family 44, member 1",9q31.2,protein-coding,
CWITA003841,TCMBANKGE003841,KCNA3,HGK5; HLK3; HPCN3; HUKIII; KV1.3; MK3; PCN3,"potassium voltage-gated channel, shaker-related subfamily, member 3",1p13.3,protein-coding,
CWITA003842,TCMBANKGE003842,TTR,CTS; CTS1; HsT2651; PALB; TBPA,transthyretin,18q12.1,protein-coding,
CWITA003843,TCMBANKGE003843,TBC1D9B,GRAMD9B,TBC1 domain family member 9B,5q35.3,protein-coding,/
CWITA003844,TCMBANKGE003844,MOS,MSV,"MOS proto-oncogene, serine/threonine kinase",8q12.1,protein-coding,/
CWITA003845,TCMBANKGE003845,KAZALD1,BONO1; FKSG28; FKSG40; IGFBP-rP10,Kazal type serine peptidase inhibitor domain 1,10q24.31,protein-coding,/
CWITA003846,TCMBANKGE003846,SLC8A1,DKFZp779F0871; FLJ37694; FLJ43417; MGC119581; NCX1,"solute carrier family 8 (sodium/calcium exchanger), member 1",2p23-p22,protein-coding,
CWITA003847,TCMBANKGE003847,PTTG1IP,C21orf1; C21orf3; PBF,PTTG1 interacting protein,21q22.3,protein-coding,/
CWITA003848,TCMBANKGE003848,NUCB2,HEL-S-109; NEFA,nucleobindin 2,11p15.1,protein-coding,/
CWITA003849,TCMBANKGE003849,SRD5A2,MGC138457,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",2p23,protein-coding,
CWITA003850,TCMBANKGE003850,POPDC2,POP2,popeye domain containing 2,3q13.33,protein-coding,/
CWITA003851,TCMBANKGE003851,MAB21L4,C2orf54,mab-21 like 4,2q37.3,protein-coding,/
CWITA003852,TCMBANKGE003852,LY6E,RIG-E; RIGE; SCA-2; SCA2; TSA-1,lymphocyte antigen 6 family member E,8q24.3,protein-coding,/
CWITA003853,TCMBANKGE003853,CDK7,CAK1; CDKN7; MO15; STK1; p39MO15,cyclin-dependent kinase 7,5q12.1,protein-coding,
CWITA003854,TCMBANKGE003854,MADD,DENN; IG20; RAB3GEP,MAP kinase activating death domain,11p11.2,protein-coding,/
CWITA003855,TCMBANKGE003855,ZBTB20,DPZF; HOF; ODA-8S; PRIMS; ZNF288,zinc finger and BTB domain containing 20,3q13.31,protein-coding,/
CWITA003856,TCMBANKGE003856,GPN3,ATPBD1C,GPN-loop GTPase 3,12q24.11,protein-coding,/
CWITA003857,TCMBANKGE003857,NQO2,DHQV; DIA6; NMOR2; QR2,"NAD(P)H dehydrogenase, quinone 2",6pter-q12,protein-coding,
CWITA003858,TCMBANKGE003858,NCLN,NET59,nicalin,19p13.3,protein-coding,/
CWITA003859,TCMBANKGE003859,ZNF879,DKFZp686E2433,zinc finger protein 879,5q35.3,protein-coding,/
CWITA003860,TCMBANKGE003860,PGK2,HEL-S-272; PGKB; PGKPS; dJ417L20.2,phosphoglycerate kinase 2,6p12.3,protein-coding,/
CWITA003861,TCMBANKGE003861,USP43,-,ubiquitin specific peptidase 43,17p13.1,protein-coding,/
CWITA003862,TCMBANKGE003862,PLGLB1,PLGL; PLGP1; PRGB; PRP-B,plasminogen like B1,2p11.2,protein-coding,/
CWITA003863,TCMBANKGE003863,PPP2R5D,B56D; B56delta; MRD35,protein phosphatase 2 regulatory subunit B'delta,6p21.1,protein-coding,/
CWITA003864,TCMBANKGE003864,CDC14B,CDC14B3; Cdc14B1; Cdc14B2; hCDC14B,cell division cycle 14B,9q22.32-q22.33,protein-coding,/
CWITA003865,TCMBANKGE003865,SORD,HEL-S-95n; RDH; SDH; SORD1; XDH,sorbitol dehydrogenase,15q21.1,protein-coding,Research target
CWITA003866,TCMBANKGE003866,ABCA12,ARCI4A; ARCI4B; ICR2B; LI2,ATP binding cassette subfamily A member 12,2q35,protein-coding,/
CWITA003867,TCMBANKGE003867,UBR4,RBAF600; ZUBR1; p600,ubiquitin protein ligase E3 component n-recognin 4,1p36.13,protein-coding,/
CWITA003868,TCMBANKGE003868,ANAPC5,APC5,anaphase promoting complex subunit 5,12q24.31,protein-coding,/
CWITA003869,TCMBANKGE003869,GABBR2,FLJ36928; GABABR2; GPR51; GPRC3B; HG20; HRIHFB2099,"gamma-aminobutyric acid (GABA) B receptor, 2",9q22.1-q22.3,protein-coding,
CWITA003870,TCMBANKGE003870,CYP2J2,CPJ2,"cytochrome P450, family 2, subfamily J, polypeptide 2",1p31.3-p31.2,protein-coding,
CWITA003871,TCMBANKGE003871,KLRB1,CD161; CLEC5B; NKR; NKR-P1; NKR-P1A; NKRP1A; hNKR-P1A,killer cell lectin like receptor B1,12p13.31,protein-coding,/
CWITA003872,TCMBANKGE003872,ZNF426,K-RBP,zinc finger protein 426,19p13.2,protein-coding,/
CWITA003873,TCMBANKGE003873,DOK7,C4orf25; CMS10; CMS1B; FADS3,docking protein 7,4p16.3,protein-coding,/
CWITA003874,TCMBANKGE003874,CXCR6,BONZO; CD186; STRL33; TYMSTR,C-X-C motif chemokine receptor 6,3p21.31,protein-coding,Research target
CWITA003875,TCMBANKGE003875,KCNK9,K2p9.1; KT3.2; MGC138268; MGC138270; TASKN3; TASK3,"potassium channel, subfamily K, member 9",8q24.3,protein-coding,
CWITA003876,TCMBANKGE003876,NME6,IPIA-ALPHA; NDK 6; NM23-H6,NME/NM23 nucleoside diphosphate kinase 6,3p21.31,protein-coding,/
CWITA003877,TCMBANKGE003877,HRSP12,P14.5; PSP; UK114,heat-responsive protein 12,8q22,protein-coding,
CWITA003878,TCMBANKGE003878,ZFY,ZNF911,zinc finger protein Y-linked,Yp11.2,protein-coding,/
CWITA003879,TCMBANKGE003879,VPS37B,-,VPS37B subunit of ESCRT-I,12q24.31,protein-coding,/
CWITA003880,TCMBANKGE003880,ANKEF1,ANKRD5,ankyrin repeat and EF-hand domain containing 1,20p12.2,protein-coding,/
CWITA003881,TCMBANKGE003881,TRIM51,SPRYD5; TRIM51A,tripartite motif-containing 51,11q12.1,protein-coding,/
CWITA003882,TCMBANKGE003882,CCNI2,-,cyclin I family member 2,5q31.1,protein-coding,/
CWITA003883,TCMBANKGE003883,Psme2b,PA28b-p; PA28b2; Psme2-like; Psme2b-ps,"protease (prosome, macropain) activator subunit 2B",11|11 B1.2,protein-coding,/
CWITA003884,TCMBANKGE003884,HPRT1,HGPRT; HPRT,hypoxanthine phosphoribosyltransferase 1,Xq26.1,protein-coding,
CWITA003885,TCMBANKGE003885,SCG2,CHGC; EM66; SN; SgII,secretogranin II,2q36.1,protein-coding,/
CWITA003886,TCMBANKGE003886,CCDC88A,APE; GIRDIN; GIV; GRDN; HkRP1; KIAA1212; PEHO; PEHOL,coiled-coil domain containing 88A,2p16.1,protein-coding,/
CWITA003887,TCMBANKGE003887,CRISPLD2,CRISP11; LCRISP2; LGL1,cysteine rich secretory protein LCCL domain containing 2,16q24.1,protein-coding,/
CWITA003888,TCMBANKGE003888,ZCCHC10,-,zinc finger CCHC-type containing 10,5q31.1,protein-coding,/
CWITA003889,TCMBANKGE003889,FXYD6,-,FXYD domain containing ion transport regulator 6,11q23.3,protein-coding,/
CWITA003890,TCMBANKGE003890,APH1A,6530402N02Rik; APHN1; APHN1A; CGIN78,anterior pharynx defective 1 homolog A (C. elegans),1p36.13-q31.3,protein-coding,
CWITA003891,TCMBANKGE003891,UQCR10,HSPC051; HSPC119; HSPC151; QCR9; UCCR7.2; UCRC,"ubiquinol-cytochrome c reductase, complex III subunit X",22q12.2,protein-coding,/
CWITA003892,TCMBANKGE003892,GLS2,GA; GLS; LGA; MGC71567; hLGA,"glutaminase 2 (liver, mitochondrial)",12q13,protein-coding,
CWITA003893,TCMBANKGE003893,TIAL1,TCBP; TIAR,TIA1 cytotoxic granule associated RNA binding protein like 1,10q26.11,protein-coding,/
CWITA003894,TCMBANKGE003894,STRN3,PPP2R6B; S/G2NA; SG2NA,striatin 3,14q12,protein-coding,/
CWITA003895,TCMBANKGE003895,HEXA,TSD,hexosaminidase subunit alpha,15q23,protein-coding,/
CWITA003896,TCMBANKGE003896,PCP2,GPSM4,Purkinje cell protein 2,19p13.2,protein-coding,/
CWITA003897,TCMBANKGE003897,SYCP2,SCP-2; SCP2; SPGF1,synaptonemal complex protein 2,20q13.33,protein-coding,/
CWITA003898,TCMBANKGE003898,AASDHPPT,AASD-PPT; ACPS; CGI-80; LYS2; LYS5,aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,11q22.3,protein-coding,/
CWITA003899,TCMBANKGE003899,SLC25A15,D13S327; HHH; LNC-HC; ORC1; ORNT1,solute carrier family 25 member 15,13q14.11,protein-coding,/
CWITA003900,TCMBANKGE003900,PPIL1,CGI-124; CYPL1; PPIase; hCyPX,peptidylprolyl isomerase like 1,6p21.2,protein-coding,/
CWITA003901,TCMBANKGE003901,RUFY2,RABIP4R; ZFYVE13,RUN and FYVE domain containing 2,10q21.3,protein-coding,/
CWITA003902,TCMBANKGE003902,PHF19,MTF2L1; PCL3; TDRD19B,PHD finger protein 19,9q33.2,protein-coding,/
CWITA003903,TCMBANKGE003903,CD163L1,CD163B; M160; SCARI2; WC1,CD163 molecule like 1,12p13.31,protein-coding,/
CWITA003904,TCMBANKGE003904,VTN,V75; VN; VNT,vitronectin,17q11.2,protein-coding,/
CWITA003905,TCMBANKGE003905,KRT82,HB2; Hb-2; KRTHB2,keratin 82,12q13.13,protein-coding,/
CWITA003906,TCMBANKGE003906,SH3PXD2A,FISH; SH3MD1; TKS5,SH3 and PX domains 2A,10q24.33,protein-coding,/
CWITA003907,TCMBANKGE003907,SOWAHA,ANKRD43,sosondowah ankyrin repeat domain family member A,5q31.1,protein-coding,/
CWITA003908,TCMBANKGE003908,SLFN5,-,schlafen family member 5,17q12,protein-coding,/
CWITA003909,TCMBANKGE003909,ARFIP2,POR1,ADP ribosylation factor interacting protein 2,11p15.4,protein-coding,/
CWITA003910,TCMBANKGE003910,NPY4R2,CH17-360D5.1; NPY4-R; NPY4R; PP1; PPYR1,neuropeptide Y receptor Y4-2,10q11.22,protein-coding,/
CWITA003911,TCMBANKGE003911,WDR76,CDW14,WD repeat domain 76,15q15.3,protein-coding,/
CWITA003912,TCMBANKGE003912,NAT14,KLP1,N-acetyltransferase 14 (putative),19q13.42,protein-coding,/
CWITA003913,TCMBANKGE003913,HBG2,HBG-T1; TNCY,hemoglobin subunit gamma 2,11p15.4,protein-coding,/
CWITA003914,TCMBANKGE003914,LONRF3,RNF127,LON peptidase N-terminal domain and ring finger 3,Xq24,protein-coding,/
CWITA003915,TCMBANKGE003915,PDHB,DKFZp564K0164; PHE1B,pyruvate dehydrogenase (lipoamide) beta,3p21.1-p14.2,protein-coding,
CWITA003916,TCMBANKGE003916,SYNJ2BP,ARIP2; OMP25,synaptojanin 2 binding protein,14q24.2,protein-coding,/
CWITA003917,TCMBANKGE003917,REXO5,NEF-sp,RNA exonuclease 5,16p12.3,protein-coding,/
CWITA003918,TCMBANKGE003918,E2F3,E2F-3,E2F transcription factor 3,6p22.3,protein-coding,Research target
CWITA003919,TCMBANKGE003919,UBOX5,RNF37; UBCE7IP5; UIP5; hUIP5,U-box domain containing 5,20p13,protein-coding,/
CWITA003920,TCMBANKGE003920,SCPEP1,HSCP1; RISC,serine carboxypeptidase 1,17q22,protein-coding,
CWITA003921,TCMBANKGE003921,FANCF,FAF,FA complementation group F,11p14.3,protein-coding,Research target
CWITA003922,TCMBANKGE003922,TMEFF2,CT120.2; HPP1; TENB2; TPEF; TR; TR-2,transmembrane protein with EGF like and two follistatin like domains 2,2q32.3,protein-coding,/
CWITA003923,TCMBANKGE003923,NREP,C5orf13; D4S114; P311; PRO1873; PTZ17; SEZ17,neuronal regeneration related protein,5q22.1,protein-coding,/
CWITA003924,TCMBANKGE003924,CCND2,KIAK0002; MPPH3,cyclin D2,12p13.32,protein-coding,/
CWITA003925,TCMBANKGE003925,MRPS18C,CGI-134; MRP-S18-1; MRP-S18-c; MRPS18-1; S18mt-c; mrps18-c,mitochondrial ribosomal protein S18C,4q21.23,protein-coding,/
CWITA003926,TCMBANKGE003926,NIPSNAP3A,HSPC299; NIPSNAP4; TASSC,nipsnap homolog 3A,9q31.1,protein-coding,/
CWITA003927,TCMBANKGE003927,SLCO3A1,FLJ40478; OATPND; OATP3A1; OATPD; SLC21A11,"solute carrier organic anion transporter family, member 3A1",15q26,protein-coding,
CWITA003928,TCMBANKGE003928,CLEC4M,CD209L; CD299; DC-SIGN2; DC-SIGNR; DCSIGNR; HP10347; L-SIGN; LSIGN,C-type lectin domain family 4 member M,19p13.2,protein-coding,/
CWITA003929,TCMBANKGE003929,ADH7,ADH4,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",4q23,protein-coding,Research target
CWITA003930,TCMBANKGE003930,GCAT,KBL; MGC23053,glycine C-acetyltransferase,22q13.1,protein-coding,
CWITA003931,TCMBANKGE003931,COX20,FAM36A,cytochrome c oxidase assembly factor COX20,1q44,protein-coding,/
CWITA003932,TCMBANKGE003932,FRK,GTK; PTK5; RAK,fyn-related kinase,6q21-q22.3,protein-coding,
CWITA003933,TCMBANKGE003933,MXD4,MAD4; MST149; MSTP149; bHLHc12,MAX dimerization protein 4,4p16.3,protein-coding,/
CWITA003934,TCMBANKGE003934,HTR2C,5-HT1C; 5-HT2C; 5-HTR2C; 5HTR2C; HTR1C,5-hydroxytryptamine receptor 2C,Xq23,protein-coding,Successful target
CWITA003935,TCMBANKGE003935,HSPA12B,C20orf60,heat shock protein family A (Hsp70) member 12B,20p13,protein-coding,Research target
CWITA003936,TCMBANKGE003936,P2RY8,P2Y8,P2Y receptor family member 8,Xp22.33 and Yp11.2,protein-coding,Research target
CWITA003937,TCMBANKGE003937,CCL8,HC14; MCPN2; MCP2; SCYA10; SCYA8,chemokine (C-C motif) ligand 8,17q11.2,protein-coding,
CWITA003938,TCMBANKGE003938,RTP1,Z3CXXC1,receptor transporter protein 1,3q27.3,protein-coding,/
CWITA003939,TCMBANKGE003939,ATOH8,HATH6; bHLHa21,atonal bHLH transcription factor 8,2p11.2,protein-coding,/
CWITA003940,TCMBANKGE003940,PTN,HARP; HB-GAM; HBBM; HBGF-8; HBGF8; HBNF; HBNF-1; NEGF1; OSF-1,pleiotrophin,7q33,protein-coding,Research target
CWITA003941,TCMBANKGE003941,CAMK2A,CAMKA; KIAA0968,calcium/calmodulin-dependent protein kinase II alpha,5q32,protein-coding,
CWITA003942,TCMBANKGE003942,CLTRN,NX-17; NX17; TMEM27,"collectrin, amino acid transport regulator",Xp22.2,protein-coding,/
CWITA003943,TCMBANKGE003943,RNPS1,E5.1,RNA binding protein with serine rich domain 1,16p13.3,protein-coding,/
CWITA003944,TCMBANKGE003944,MRPL47,CGI-204; L47mt; MRP-L47; NCM1,mitochondrial ribosomal protein L47,3q26.33,protein-coding,/
CWITA003945,TCMBANKGE003945,SLC12A3,FLJ96318; NCCT; TSC,"solute carrier family 12 (sodium/chloride transporters), member 3",16q13,protein-coding,
CWITA003946,TCMBANKGE003946,EEF1E1-BLOC1S5,EEF1E1-MUTED,EEF1E1-BLOC1S5 readthrough (NMD candidate),6p24.3,ncRNA,/
CWITA003947,TCMBANKGE003947,FMO4,FMO2,flavin containing dimethylaniline monoxygenase 4,1q24.3,protein-coding,/
CWITA003948,TCMBANKGE003948,PRLH,PRH; PRRP,prolactin releasing hormone,2q37.3,protein-coding,/
CWITA003949,TCMBANKGE003949,SNRNP70,RNPU1Z; RPU1; SNRP70; Snp1; U1-70K; U170K; U1AP; U1RNP,small nuclear ribonucleoprotein U1 subunit 70,19q13.33,protein-coding,/
CWITA003950,TCMBANKGE003950,IFI6,6-16; FAM14C; G1P3; IFI-6-16; IFI616,interferon alpha inducible protein 6,1p35.3,protein-coding,/
CWITA003951,TCMBANKGE003951,ENAH,ENA; MENA; NDPP1,Enabled Homolog (Drosophila),1q42.12,protein-coding,
CWITA003952,TCMBANKGE003952,ZNF501,ZNF; ZNF52,zinc finger protein 501,3p21.31,protein-coding,/
CWITA003953,TCMBANKGE003953,ZP3,OOMD3; ZP3A; ZP3B; ZPC; Zp-3,zona pellucida glycoprotein 3,7q11.23,protein-coding,/
CWITA003954,TCMBANKGE003954,TMEM45B,-,transmembrane protein 45B,11q24.3,protein-coding,/
CWITA003955,TCMBANKGE003955,MUC2,MLP; MUCN2; SMUC,"mucin 2, oligomeric mucus/gel-forming",11p15.5,protein-coding,
CWITA003956,TCMBANKGE003956,GAK,DNAJ26; DNAJC26,cyclin G associated kinase,4p16.3,protein-coding,/
CWITA003957,TCMBANKGE003957,TRPS1,GC79; LGCR,transcriptional repressor GATA binding 1,8q23.3,protein-coding,/
CWITA003958,TCMBANKGE003958,ISPD,MDDGA7; MDDGC7; Nip; hCG_1745121; hISPD,Isoprenoid_Synthase_Domain_Containing,7p21.2,protein-coding,
CWITA003959,TCMBANKGE003959,SLC5A2,SGLT2,"solute carrier family 5 (sodium/glucose cotransporter), member 2",16p12-p11,protein-coding,
CWITA003960,TCMBANKGE003960,CD82,4F9; C33; GR15; IA4; KAI1; R2; SAR2; ST6; TSPAN27,CD82 molecule,11p11.2,protein-coding,/
CWITA003961,TCMBANKGE003961,CASK,CAGH39; CAMGUK; CMG; FGS4; FLJ22219; FLJ31914; LIN2; MICPCH; TNRC8,calcium/calmodulin-dependent serine protein kinase (MAGUK family),Xp11.4,protein-coding,
CWITA003962,TCMBANKGE003962,TMCO3,C13orf11,transmembrane and coiled-coil domains 3,13q34,protein-coding,/
CWITA003963,TCMBANKGE003963,N4BP2,B3BP,NEDD4 binding protein 2,4p14,protein-coding,/
CWITA003964,TCMBANKGE003964,ARPC3,ARC21; p21NArc,"actin related protein 2/3 complex, subunit 3, 21kDa",12q24.11,protein-coding,
CWITA003965,TCMBANKGE003965,GPX6,GPX5p; GPXP3; GPx-6; GSHPx-6; dJ1186N24; dJ1186N24.1,glutathione peroxidase 6,6p22.1,protein-coding,/
CWITA003966,TCMBANKGE003966,SLC13A2,NADC1; NaCT; NaDCN1; SDCT1,"solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2",17p13.2,protein-coding,
CWITA003967,TCMBANKGE003967,DUT,FLJ20622; dUTPase,deoxyuridine triphosphatase,15q21.1,protein-coding,
CWITA003968,TCMBANKGE003968,SLC8A2,NCX2,solute carrier family 8 member A2,19q13.32,protein-coding,/
CWITA003969,TCMBANKGE003969,RPN1,OST1; RBPH1,ribophorin I,3q21.3,protein-coding,/
CWITA003970,TCMBANKGE003970,SDC1,CD138; SDC; SYND1; syndecan,syndecan 1,2p24.1,protein-coding,Clinical Trial target
CWITA003971,TCMBANKGE003971,DHFRP1,-,dihydrofolate reductase pseudogene 1,18q11.2,pseudo,/
CWITA003972,TCMBANKGE003972,SPECC1,CYTSB; HCMOGT-1; HCMOGT1; NSP,sperm antigen with calponin homology and coiled-coil domains 1,17p11.2,protein-coding,/
CWITA003973,TCMBANKGE003973,SCRIB,CRIB1; SCRB1; SCRIB1; Vartul,scribble planar cell polarity protein,8q24.3,protein-coding,/
CWITA003974,TCMBANKGE003974,FGFRL1,FGFR-5; FGFR5; FHFR,fibroblast growth factor receptor like 1,4p16.3,protein-coding,/
CWITA003975,TCMBANKGE003975,GPR119,GPCR2,G protein-coupled receptor 119,Xq26.1,protein-coding,Successful target
CWITA003976,TCMBANKGE003976,C19orf18,-,chromosome 19 open reading frame 18,19q13.43,protein-coding,/
CWITA003977,TCMBANKGE003977,COL6A6,-,collagen type VI alpha 6 chain,3q22.1,protein-coding,/
CWITA003978,TCMBANKGE003978,GABRR1,-,gamma-aminobutyric acid type A receptor subunit rho1,6q15,protein-coding,Research target
CWITA003979,TCMBANKGE003979,PCDHB1,PCDH-BETA1,protocadherin beta 1,5q31.3,protein-coding,/
CWITA003980,TCMBANKGE003980,MARF1,KIAA0430; LKAP; LMKB; PPP1R34,meiosis regulator and mRNA stability factor 1,16p13.11,protein-coding,/
CWITA003981,TCMBANKGE003981,SLC7A6,LAT-2; LAT3; y+LAT-2,solute carrier family 7 member 6,16q22.1,protein-coding,/
CWITA003982,TCMBANKGE003982,ABCC5,ABC33; DKFZp686C1782; EST277145; MOATNC; MOATC; MRP5; SMRP; pABC11,"ATP-binding cassette, sub-family C (CFTR/MRP), member 5",3q27,protein-coding,
CWITA003983,TCMBANKGE003983,XRN1,2021/9/1,5'-3' exoribonuclease 1,3q23,protein-coding,/
CWITA003984,TCMBANKGE003984,TDP1,-,tyrosyl-DNA phosphodiesterase 1,14q32.11,protein-coding,Patented target
CWITA003985,TCMBANKGE003985,DCC,CRC18; CRCR1; HGPPS2; IGDCC1; MRMV1; NTN1R1,DCC netrin 1 receptor,18q21.2,protein-coding,/
CWITA003986,TCMBANKGE003986,MATN2,-,matrilin 2,8q22.1-q22.2,protein-coding,/
CWITA003987,TCMBANKGE003987,GTPBP10,ObgH2; UG0751c10,GTP binding protein 10,7q21.13,protein-coding,/
CWITA003988,TCMBANKGE003988,DNAJA4,MST104; MSTP104; PRO1472,DnaJ heat shock protein family (Hsp40) member A4,15q25.1,protein-coding,/
CWITA003989,TCMBANKGE003989,FMN1,FMN; LD,formin 1,15q13.3,protein-coding,/
CWITA003990,TCMBANKGE003990,GTF2H5,C6orf175; TFB5; TFIIH; TGF2H5; TTD; TTD-A; TTD3; TTDA; bA120J8.2,general transcription factor IIH subunit 5,6q25.3,protein-coding,/
CWITA003991,TCMBANKGE003991,Ie,-,eye-ear reduction,-,unknown,/
CWITA003992,TCMBANKGE003992,KCNJ1,KIR1.1; ROMK; ROMK1,"potassium inwardly-rectifying channel, subfamily J, member 1",11q24,protein-coding,
CWITA003993,TCMBANKGE003993,ZNF732,-,zinc finger protein 732,4p16.3,protein-coding,/
CWITA003994,TCMBANKGE003994,KCNK18,K2p18.1; MGR13; TRESK; TRESK-2; TRESK2; TRIK,potassium two pore domain channel subfamily K member 18,10q25.3,protein-coding,Research target
CWITA003995,TCMBANKGE003995,ZNF232,ZSCAN11,zinc finger protein 232,17p13.2,protein-coding,/
CWITA003996,TCMBANKGE003996,SPATA5L1,-,spermatogenesis associated 5 like 1,15q21.1,protein-coding,/
CWITA003997,TCMBANKGE003997,PCDHGA6,PCDH-GAMMA-A6,"protocadherin gamma subfamily A, 6",5q31.3,protein-coding,/
CWITA003998,TCMBANKGE003998,GMDS,GMD; SDR3E1,"GDP-mannose 4,6-dehydratase",6p25,protein-coding,
CWITA003999,TCMBANKGE003999,VWC2,PSST739; UNQ739,von Willebrand factor C domain containing 2,7p12.2,protein-coding,/
CWITA004000,TCMBANKGE004000,PPP1R8,ARD-1; ARD1; NIPP-1; NIPP1; PRO2047,protein phosphatase 1 regulatory subunit 8,1p35.3,protein-coding,/
CWITA004001,TCMBANKGE004001,PLEKHJ1,GNRPX,pleckstrin homology domain containing J1,19p13.3,protein-coding,/
CWITA004002,TCMBANKGE004002,CAMKK2,CAMKK; CAMKKB,calcium/calmodulin dependent protein kinase kinase 2,12q24.31,protein-coding,Research target
CWITA004003,TCMBANKGE004003,ODAM,APIN,"odontogenic, ameloblast associated",4q13.3,protein-coding,/
CWITA004004,TCMBANKGE004004,PRKDC,DNA-PKC; DNA-PKcs; DNAPK; DNAPKc; DNPK1; HYRC; HYRC1; IMD26; XRCC7; p350,"protein kinase, DNA-activated, catalytic subunit",8q11.21,protein-coding,Clinical Trial target
CWITA004005,TCMBANKGE004005,ZBTB10,RINZF,zinc finger and BTB domain containing 10,8q21.13,protein-coding,/
CWITA004006,TCMBANKGE004006,RASD1,AGS1; DEXRAS1; MGC:26290,ras related dexamethasone induced 1,17p11.2,protein-coding,/
CWITA004007,TCMBANKGE004007,CLVS1,C6orf212L; CRALBPL; RLBP1L1,clavesin 1,8q12.2-q12.3,protein-coding,/
CWITA004008,TCMBANKGE004008,GRB2,ASH; EGFRBP-GRB2; Grb3-3; MST084; MSTP084; NCKAP2,growth factor receptor bound protein 2,17q25.1,protein-coding,Clinical Trial target
CWITA004009,TCMBANKGE004009,ANXA5,ANX5; ENX2; PP4,annexin A5,4q26-q28|4q27,protein-coding,
CWITA004010,TCMBANKGE004010,DHX58,D11LGP2; D11lgp2e; LGP2; RLR-3,DExH-box helicase 58,17q21.2,protein-coding,/
CWITA004011,TCMBANKGE004011,AZU1,AZAMP; AZU; CAP37; HBP; HUMAZUR; NAZC; hHBP,Azurocidin_1,19p13.3,protein-coding,
CWITA004012,TCMBANKGE004012,SIX6,MCOPCT2; ODRMD; OPTX2; Six9,SIX homeobox 6,14q23.1,protein-coding,/
CWITA004013,TCMBANKGE004013,E4F1,E4F,E4F transcription factor 1,16p13.3,protein-coding,/
CWITA004014,TCMBANKGE004014,LAMA4,CMD1JJ; LAMA3; LAMA4*-1,laminin subunit alpha 4,6q21,protein-coding,/
CWITA004015,TCMBANKGE004015,ULBP2,ALCAN-alpha; N2DL2; NKG2DL2; RAET1H; RAET1L,UL16 binding protein 2,6q25.1,protein-coding,/
CWITA004016,TCMBANKGE004016,GJA4,CX37,gap junction protein alpha 4,1p34.3,protein-coding,Research target
CWITA004017,TCMBANKGE004017,TOP1MT,N,"topoisomerase (DNA) I, mitochondrial",8q24.3,protein-coding,
CWITA004018,TCMBANKGE004018,ABHD14A,DORZ1,abhydrolase domain containing 14A,3p21.2,protein-coding,/
CWITA004019,TCMBANKGE004019,SIGLEC1,CD169; SIGLEC-1; SN,sialic acid binding Ig like lectin 1,20p13,protein-coding,/
CWITA004020,TCMBANKGE004020,CYP20A1,CYP-M,cytochrome P450 family 20 subfamily A member 1,2q33.2,protein-coding,/
CWITA004021,TCMBANKGE004021,FMR1,FMRP; FRAXA; POF; POF1,FMRP translational regulator 1,Xq27.3,protein-coding,/
CWITA004022,TCMBANKGE004022,MCM2,BM28; CCNL1; CDCL1; D3S3194; DFNA70; MITOTIN; cdc19,minichromosome maintenance complex component 2,3q21.3,protein-coding,/
CWITA004023,TCMBANKGE004023,LGALS2,HL14; MGC75071,"lectin, galactoside-binding, soluble, 2",22q12-q13|22q13.1,protein-coding,
CWITA004024,TCMBANKGE004024,RCL1,RNAC; RPCL1,RNA terminal phosphate cyclase like 1,9p24.1,protein-coding,/
CWITA004025,TCMBANKGE004025,GSTA2,GST2; GSTA2N2; GTA2; GTH2; MGC10525,glutathione S-transferase alpha 2,6p12.1,protein-coding,
CWITA004026,TCMBANKGE004026,DCTN2,DCTN50; DYNAMITIN; HEL-S-77; RBP50,dynactin subunit 2,12q13.3,protein-coding,/
CWITA004027,TCMBANKGE004027,RBPMS2,-,"RNA binding protein, mRNA processing factor 2",15q22.31,protein-coding,/
CWITA004028,TCMBANKGE004028,ARL4A,ARL4,ADP ribosylation factor like GTPase 4A,7p21.3,protein-coding,/
CWITA004029,TCMBANKGE004029,SYNC,SYNC1; SYNCOILIN,"syncoilin, intermediate filament protein",1p35.1,protein-coding,/
CWITA004030,TCMBANKGE004030,AVPR1A,AVPR V1a; AVPR1; V1aR,arginine vasopressin receptor 1A,12q14.2,protein-coding,Successful target
CWITA004031,TCMBANKGE004031,SLC13A2,NADC1; NaCT; NaDC-1; SDCT1,solute carrier family 13 member 2,17q11.2,protein-coding,/
CWITA004032,TCMBANKGE004032,MURC,CAVIN4; cavinN4,muscle-related coiled-coil protein,9q31.1,protein-coding,
CWITA004033,TCMBANKGE004033,RIMS1,CORD7; RAB3IP2; RIM; RIM1,regulating synaptic membrane exocytosis 1,6q13,protein-coding,/
CWITA004034,TCMBANKGE004034,PCDHB8,PCDH-BETA8; PCDH3I,protocadherin beta 8,5q31.3,protein-coding,/
CWITA004035,TCMBANKGE004035,NHLRC1,EPM2A; EPM2B; MALIN; bA204B7.2,NHL repeat containing E3 ubiquitin protein ligase 1,6p22.3,protein-coding,/
CWITA004036,TCMBANKGE004036,ACSL1,ACS1; FACL1; FACL2; LACS; LACS1; LACS2,acyl-CoA synthetase long chain family member 1,4q35.1,protein-coding,/
CWITA004037,TCMBANKGE004037,TRPM4,EKVP6; LTrpC4; PFHB1B; TRPM4B; hTRPM4,transient receptor potential cation channel subfamily M member 4,19q13.33,protein-coding,Clinical Trial target
CWITA004038,TCMBANKGE004038,NAXE,AIBP; APOA1BP; PEBEL; YJEFN1,NAD(P)HX epimerase,1q22,protein-coding,/
CWITA004039,TCMBANKGE004039,SIGLEC7,AIRM1; CD328; CDw328; D-siglec; QA79; SIGLEC-7; SIGLEC19P; SIGLECP2; p75; p75/AIRM1,sialic acid binding Ig like lectin 7,19q13.41,protein-coding,/
CWITA004040,TCMBANKGE004040,SAR1B,ANDD; CMRD; GTBPB; SARA2,secretion associated Ras related GTPase 1B,5q31.1,protein-coding,/
CWITA004041,TCMBANKGE004041,SPECC1L,CYTSA; GBBB2; OBLFC1; TBHS,sperm antigen with calponin homology and coiled-coil domains 1 like,22q11.23,protein-coding,/
CWITA004042,TCMBANKGE004042,RORB,NR1F2; RORNBETA; RZRNBETA; RZRB; bA133M9.1,RAR-related orphan receptor B,9q22,protein-coding,
CWITA004043,TCMBANKGE004043,ZNF491,-,zinc finger protein 491,19p13.2,protein-coding,/
CWITA004044,TCMBANKGE004044,DENND1C,FAM31C,DENN domain containing 1C,19p13.3,protein-coding,/
CWITA004045,TCMBANKGE004045,GLO1,GLOD1; GLYI,glyoxalase I,6p21.3-p21.1,protein-coding,
CWITA004046,TCMBANKGE004046,WAPL,FOE; KIAA0261; WAPAL,WAPL cohesin release factor,10q23.2,protein-coding,/
CWITA004047,TCMBANKGE004047,PDE5A,CGB-PDE; CN5A; PDE5,phosphodiesterase 5A,4q26,protein-coding,Successful target
CWITA004048,TCMBANKGE004048,C4BPA,C4BP; PRP,complement component 4 binding protein alpha,1q32.2,protein-coding,/
CWITA004049,TCMBANKGE004049,SMTN,-,smoothelin,22q12.2,protein-coding,/
CWITA004050,TCMBANKGE004050,TRAPPC11,C4orf41; FOIGR; GRY; LGMD2S; LGMDR18,trafficking protein particle complex 11,4q35.1,protein-coding,/
CWITA004051,TCMBANKGE004051,C6orf141,-,chromosome 6 open reading frame 141,6p12.3,protein-coding,/
CWITA004052,TCMBANKGE004052,CCDC47,GK001; MSTP041; THNS,coiled-coil domain containing 47,17q23.3,protein-coding,/
CWITA004053,TCMBANKGE004053,ARF6,-,ADP ribosylation factor 6,14q21.3,protein-coding,/
CWITA004054,TCMBANKGE004054,MKLN1,TWA2,muskelin 1,7q32.3,protein-coding,/
CWITA004055,TCMBANKGE004055,SSTR4,SS-4-R; SS4-R; SS4R,somatostatin receptor 4,20p11.21,protein-coding,Clinical Trial target
CWITA004056,TCMBANKGE004056,PANK2,C20orf48; HARP; HSS; NBIA1; PKAN,pantothenate kinase 2,20p13,protein-coding,/
CWITA004057,TCMBANKGE004057,TFF1,BCEI; D21S21; HP1.A; HPS2; pNRN2; pS2,trefoil factor 1,21q22.3,protein-coding,
CWITA004058,TCMBANKGE004058,UBB,HEL-S-50,ubiquitin B,17p11.2,protein-coding,/
CWITA004059,TCMBANKGE004059,TELO2,CLK2; TEL2; YHFS,telomere maintenance 2,16p13.3,protein-coding,/
CWITA004060,TCMBANKGE004060,ARL5A,ARFLP5; ARL5,ADP-ribosylation factor-like 5A,2q23.3,protein-coding,
CWITA004061,TCMBANKGE004061,KIF13A,RBKIN; bA500C11.2,kinesin family member 13A,6p22.3,protein-coding,/
CWITA004062,TCMBANKGE004062,RFNG,-,RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,17q25.3,protein-coding,/
CWITA004063,TCMBANKGE004063,RUVBL2,CGI-46; ECP-51; ECP51; INO80J; REPTIN; RVB2; TAP54-beta; TIH2; TIP48; TIP49B,RuvB like AAA ATPase 2,19q13.33,protein-coding,/
CWITA004064,TCMBANKGE004064,SLC7A11,CCBR1; xCT,solute carrier family 7 member 11,4q28.3,protein-coding,Research target
CWITA004065,TCMBANKGE004065,PDK1,N,"pyruvate dehydrogenase kinase, isozyme 1",2q31.1,protein-coding,
CWITA004066,TCMBANKGE004066,SARS2,SARS; SARSM; SERS; SYS; SerRS; SerRSmt; mtSerRS,"seryl-tRNA synthetase 2, mitochondrial",19q13.2,protein-coding,/
CWITA004067,TCMBANKGE004067,COPS6,CSN6; MOV34-34KD,COP9 signalosome subunit 6,7q22.1,protein-coding,/
CWITA004068,TCMBANKGE004068,CUL4B,CUL-4B; MRXHF2; MRXS15; MRXSC; SFM2,cullin 4B,Xq24,protein-coding,/
CWITA004069,TCMBANKGE004069,AP4B1,BETA-4; CPSQ5; SPG47,adaptor related protein complex 4 subunit beta 1,1p13.2,protein-coding,/
CWITA004070,TCMBANKGE004070,RPLP1,LP1; P1; RPP1,ribosomal protein lateral stalk subunit P1,15q23,protein-coding,/
CWITA004071,TCMBANKGE004071,IREB2,ACO3; IRE-BP 2; IRE-BP2; IRP2; IRP2AD; NDCAMA,iron responsive element binding protein 2,15q25.1,protein-coding,/
CWITA004072,TCMBANKGE004072,ADCY9,AC9; ACIX,adenylate cyclase 9,16p13.3,protein-coding,/
CWITA004073,TCMBANKGE004073,APP,AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN2,amyloid beta (A4) precursor protein,21q21.2|21q21.3,protein-coding,
CWITA004074,TCMBANKGE004074,INHBE,-,inhibin subunit beta E,12q13.3,protein-coding,/
CWITA004075,TCMBANKGE004075,CLCN3,CLC3; ClC-3,chloride voltage-gated channel 3,4q33,protein-coding,Research target
CWITA004076,TCMBANKGE004076,CD226,DNAM-1; DNAM1; PTA1; TLiSA1,CD226 molecule,18q22.2,protein-coding,/
CWITA004077,TCMBANKGE004077,UQCRQ,MC3DN4; QCR8; QP-C; QPC; UQCR7,ubiquinol-cytochrome c reductase complex III subunit VII,5q31.1,protein-coding,/
CWITA004078,TCMBANKGE004078,SDCBP2,SITAC; SITAC18; ST-2; ST2,syndecan binding protein 2,20p13,protein-coding,/
CWITA004079,TCMBANKGE004079,NDUFA2,B8; CD14; CIB8; MC1DN13,NADH:ubiquinone oxidoreductase subunit A2,5q31.3,protein-coding,/
CWITA004080,TCMBANKGE004080,AFMID,FKF; KF; KFA,arylformamidase,17q25.3,protein-coding,/
CWITA004081,TCMBANKGE004081,PRKCZ,PKCNZETA; PKC2,"protein kinase C, zeta",1p36.33-p36.2,protein-coding,
CWITA004082,TCMBANKGE004082,SNAP23,HsT17016; SNAP-23; SNAP23A; SNAP23B,synaptosome associated protein 23,15q15.1-q15.2,protein-coding,/
CWITA004083,TCMBANKGE004083,SULT1A1,HAST1/HAST2; P-PST; PST; ST1A1; ST1A3; STP; STP1; TSPST1,sulfotransferase family 1A member 1,16p11.2,protein-coding,/
CWITA004084,TCMBANKGE004084,PGAM1,HEL-S-35; PGAM-B; PGAMA,phosphoglycerate mutase 1,10q24.1,protein-coding,/
CWITA004085,TCMBANKGE004085,GFOD1,ADG-90; C6orf114,glucose-fructose oxidoreductase domain containing 1,6p23,protein-coding,/
CWITA004086,TCMBANKGE004086,POLR2B,POL2RB; RPB2; hRPB140,RNA polymerase II subunit B,4q12,protein-coding,/
CWITA004087,TCMBANKGE004087,CWC22,EIF4GL; NCM; fSAPb,CWC22 spliceosome associated protein homolog,2q31.3,protein-coding,/
CWITA004088,TCMBANKGE004088,PABPC4,APP-1; APP1; PABP4; iPABP,poly(A) binding protein cytoplasmic 4,1p34.3,protein-coding,/
CWITA004089,TCMBANKGE004089,ZNF441,-,zinc finger protein 441,19p13.2,protein-coding,/
CWITA004090,TCMBANKGE004090,ASXL2,ASXH2; SHAPNS,ASXL transcriptional regulator 2,2p23.3,protein-coding,/
CWITA004091,TCMBANKGE004091,SV2C,-,synaptic vesicle glycoprotein 2C,5q13.3,protein-coding,/
CWITA004092,TCMBANKGE004092,GGCT,C7orf24; CRF21; GCTG; GGC,gamma-glutamylcyclotransferase,7p14.3,protein-coding,/
CWITA004093,TCMBANKGE004093,APOBEC3C,A3C; APOBEC1L; ARDC2; ARDC4; ARP5; PBI; bK150C2.3,apolipoprotein B mRNA editing enzyme catalytic subunit 3C,22q13.1,protein-coding,/
CWITA004094,TCMBANKGE004094,PROK1,EGVEGF; PK1; PRK1,prokineticin 1,1p13.3,protein-coding,/
CWITA004095,TCMBANKGE004095,CHRNA4,BFNC; EBN; EBN1; FLJ95812; NACHR; NACHRA4; NACRA4,"cholinergic receptor, nicotinic, alpha 4",20q13.2-q13.3,protein-coding,
CWITA004096,TCMBANKGE004096,GUCY2F,CYGF; GC-F; GUC2DL; GUC2F; RETGC-2; ROS-GC2,"guanylate cyclase 2F, retinal",Xq22.3-q23,protein-coding,/
CWITA004097,TCMBANKGE004097,LSM14B,C20orf40; FAM61B; FT005; LSM13; RAP55B; bA11M20.3,LSM family member 14B,20q13.33,protein-coding,/
CWITA004098,TCMBANKGE004098,SRPRA,DP; SRPR; Sralpha,SRP receptor subunit alpha,11q24.2,protein-coding,/
CWITA004099,TCMBANKGE004099,STYXL1,DUSP24; MK-STYX; MKSTYX,serine/threonine/tyrosine interacting like 1,7q11.23,protein-coding,/
CWITA004100,TCMBANKGE004100,F13A1,F13A,"coagulation factor XIII, A1 polypeptide",6p25.3-p24.3,protein-coding,
CWITA004101,TCMBANKGE004101,RPE65,BCO3; LCA2; RP20; mRPE65; p63; rd12; sRPE65,retinoid isomerohydrolase RPE65,1p31.3,protein-coding,Clinical Trial target
CWITA004102,TCMBANKGE004102,ABHD14A-ACY1,-,ABHD14A-ACY1 readthrough,3p21.2,protein-coding,/
CWITA004103,TCMBANKGE004103,SLC2A3,GLUT3,solute carrier family 2 member 3,12p13.31,protein-coding,/
CWITA004104,TCMBANKGE004104,TINAGL1,ARG1; LCN7; LIECG3; TINAGRP,tubulointerstitial nephritis antigen like 1,1p35.2,protein-coding,/
CWITA004105,TCMBANKGE004105,TRIM24,PTC6; RNF82; TF1A; TIF1; TIF1A; TIF1ALPHA; hTIF1,tripartite motif containing 24,7q33-q34,protein-coding,Research target
CWITA004106,TCMBANKGE004106,FRMD4B,6030440G05Rik; GRSP1,FERM domain containing 4B,3p14.1,protein-coding,/
CWITA004107,TCMBANKGE004107,S100A14,BCMP84; S100A15,S100 calcium binding protein A14,1q21.3,protein-coding,/
CWITA004108,TCMBANKGE004108,ZFYVE28,LST2; LYST2; lst-2,zinc finger FYVE-type containing 28,4p16.3,protein-coding,/
CWITA004109,TCMBANKGE004109,TLR7,N,toll-like receptor 7,Xp22.3,protein-coding,
CWITA004110,TCMBANKGE004110,RNH1,RAI; RNH,ribonuclease/angiogenin inhibitor 1,11p15.5,protein-coding,/
CWITA004111,TCMBANKGE004111,PLD2,PLD1C,phospholipase D2,17p13.2,protein-coding,Clinical Trial target
CWITA004112,TCMBANKGE004112,LRFN5,C14orf146; FIGLER8; SALM5,leucine rich repeat and fibronectin type III domain containing 5,14q21.1,protein-coding,/
CWITA004113,TCMBANKGE004113,PHF20L1,CGI-72; TDRD20B; URLC1,PHD finger protein 20 like 1,8q24.22,protein-coding,/
CWITA004114,TCMBANKGE004114,CDKN3,CDI1; CIP2; KAP; KAP1,cyclin dependent kinase inhibitor 3,14q22.2,protein-coding,/
CWITA004115,TCMBANKGE004115,ADAMTS5,ADAMTS11; ADMPN2; FLJ36738,"ADAM metallopeptidase with thrombospondin type 1 motif, 5",21q21.3,protein-coding,
CWITA004116,TCMBANKGE004116,PRDX3,AOP-1; AOP1; HBC189; MER5; PRO1748; SP-22; prx-III,peroxiredoxin 3,10q26.11,protein-coding,/
CWITA004117,TCMBANKGE004117,VGLL2,VGL2; VITO1,vestigial like family member 2,6q22.1,protein-coding,/
CWITA004118,TCMBANKGE004118,PXDN,ASGD7; COPOA; D2S448; D2S448E; MG50; PRG2; PXN; VPO,peroxidasin,2p25.3,protein-coding,/
CWITA004119,TCMBANKGE004119,SORBS2,ARGBP2; PRO0618,sorbin and SH3 domain containing 2,4q35.1,protein-coding,/
CWITA004120,TCMBANKGE004120,IRX5,HMMS; IRX-2a; IRXB2,iroquois homeobox 5,16q12.2,protein-coding,/
CWITA004121,TCMBANKGE004121,PPCS,CMD2C,phosphopantothenoylcysteine synthetase,1p34.2,protein-coding,/
CWITA004122,TCMBANKGE004122,RPL23A,FLJ27455; L23A; MDA20,ribosomal protein L23a,17q11,protein-coding,
CWITA004123,TCMBANKGE004123,ANKRD37,Lrp2bp,ankyrin repeat domain 37,4q35.1,protein-coding,/
CWITA004124,TCMBANKGE004124,CRELD1,AVSD2; CIRRIN,cysteine rich with EGF like domains 1,3p25.3,protein-coding,/
CWITA004125,TCMBANKGE004125,FHIT,AP3Aase; FRA3B,fragile histidine triad diadenosine triphosphatase,3p14.2,protein-coding,Successful target
CWITA004126,TCMBANKGE004126,FERMT1,C20orf42; DTGCU2; KIND1; UNC112A; URP1,fermitin family member 1,20p12.3,protein-coding,/
CWITA004127,TCMBANKGE004127,CSTA,AREI; PSS4; STF1; STFA,cystatin A,3q21.1,protein-coding,/
CWITA004128,TCMBANKGE004128,ZSCAN25,ZNF498,zinc finger and SCAN domain containing 25,7q22.1,protein-coding,/
CWITA004129,TCMBANKGE004129,TSPAN2,NET3; TSN2; TSPAN-2,tetraspanin 2,1p13.2,protein-coding,/
CWITA004130,TCMBANKGE004130,ST6GALNAC4,IV; SIAT3-C; SIAT3C; SIAT7-D; SIAT7D; ST6GALNACIV; ST6GalNAc,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4",9q34.11,protein-coding,/
CWITA004131,TCMBANKGE004131,LPCAT2,AGPAT11; AYTL1; LysoPAFAT,lysophosphatidylcholine acyltransferase 2,16q12.2,protein-coding,/
CWITA004132,TCMBANKGE004132,MLLT3,AF9; YEATS3,MLLT3 super elongation complex subunit,9p21.3,protein-coding,/
CWITA004133,TCMBANKGE004133,KDM6A,KABUK2; UTX; bA386N14.2,lysine demethylase 6A,Xp11.3,protein-coding,/
CWITA004134,TCMBANKGE004134,SFRP1,FRP; FRP-1; FRP1; FrzA; SARP2,Secreted_Frizzled_Related_Protein_1,8p11.21,protein-coding,
CWITA004135,TCMBANKGE004135,HSD11B1,11NDH; 11NbetaNHSD1; HDL; HSD11; HSD11B; HSD11L; MGC13539; SDR26C1,hydroxysteroid (11-beta) dehydrogenase 1,1q32-q41,protein-coding,
CWITA004136,TCMBANKGE004136,SAA2,SAA; SAA1,serum amyloid A2,11p15.1,protein-coding,/
CWITA004137,TCMBANKGE004137,MT4,MT-4; MT-IV; MTIV,metallothionein 4,16q13,protein-coding,/
CWITA004138,TCMBANKGE004138,CELA2A,ELA2A; PEN1,"chymotrypsin-like elastase family, member 2A",1p36.21,protein-coding,
CWITA004139,TCMBANKGE004139,DEGS1,DEGS; DEGS-1; DES1; Des-1; FADS7; HLD18; MIG15; MLD,"delta 4-desaturase, sphingolipid 1",1q42.11,protein-coding,/
CWITA004140,TCMBANKGE004140,LACTB,G24; MRPL56,lactamase beta,15q22.2,protein-coding,/
CWITA004141,TCMBANKGE004141,GALNTL6,GALNACT20; GALNT17; GalNAc-T6L,polypeptide N-acetylgalactosaminyltransferase like 6,4q34.1,protein-coding,/
CWITA004142,TCMBANKGE004142,HELB,DHB; hDHB,DNA helicase B,12q14.3|12q,protein-coding,/
CWITA004143,TCMBANKGE004143,KISS1R,AXOR12; CPPB1; GPR54; HH8; HOT7T175; KISS-1R,KISS1 receptor,19p13.3,protein-coding,Discontinued target
CWITA004144,TCMBANKGE004144,ITPRID2,CS-1; CS1; KRAP; SPAG13; SSFA2,Itpr_Interacting_Domain_Containing_2,2q31.3,protein-coding,
CWITA004145,TCMBANKGE004145,KDM4B,JMJD2B; TDRD14B,lysine demethylase 4B,19p13.3,protein-coding,/
CWITA004146,TCMBANKGE004146,NEDD8,NEDD-8,NEDD8 ubiquitin like modifier,14q12,protein-coding,Clinical Trial target
CWITA004147,TCMBANKGE004147,SLC51B,OSTB; OSTBETA,Solute_Carrier_Family_51_Beta_Subunit,15q22.31,protein-coding,
CWITA004148,TCMBANKGE004148,RALA,RAL,RAS like proto-oncogene A,7p14.1,protein-coding,/
CWITA004149,TCMBANKGE004149,NT5C,DNT; DNT1; HEL74; P5N2; PN-I; PN-II; UMPH2; cdN; dNT-1,"5', 3'-nucleotidase, cytosolic",17q25.1,protein-coding,/
CWITA004150,TCMBANKGE004150,COX6C,N,cytochrome c oxidase subunit VIc,8q22.2,protein-coding,
CWITA004151,TCMBANKGE004151,PRL,GHA1,prolactin,6p22.3,protein-coding,Discontinued target
CWITA004152,TCMBANKGE004152,GABBR2,EIEE59; GABABR2; GPR51; GPRC3B; HG20; HRIHFB2099; NDPLHS,gamma-aminobutyric acid type B receptor subunit 2,9q22.33,protein-coding,/
CWITA004153,TCMBANKGE004153,MED24,ARC100; CRSP100; CRSP4; DRIP100; MED5; THRAP4; TRAP100,mediator complex subunit 24,17q21.1,protein-coding,/
CWITA004154,TCMBANKGE004154,API5,AAC-11; AAC11,apoptosis inhibitor 5,11p12,protein-coding,/
CWITA004155,TCMBANKGE004155,ZNF436,ZNF; Zfp46,zinc finger protein 436,1p36.12,protein-coding,/
CWITA004156,TCMBANKGE004156,PIAS3,ZMIZ5,protein inhibitor of activated STAT 3,1q21.1,protein-coding,/
CWITA004157,TCMBANKGE004157,RXRA,FLJ00280; FLJ00318; FLJ16020; FLJ16733; MGC102720; NR2B1,"retinoid X receptor, alpha",9q34.3,protein-coding,
CWITA004158,TCMBANKGE004158,KCNB1,DRK1; KV2.1; hNDRK1,"potassium voltage-gated channel, Shab-related subfamily, member 1",20q13.2,protein-coding,
CWITA004159,TCMBANKGE004159,TMEM139,-,transmembrane protein 139,7q34,protein-coding,/
CWITA004160,TCMBANKGE004160,MTUS1,ATBP; ATIP; ATIP3; ICIS; MP44; MTSG1,microtubule associated scaffold protein 1,8p22,protein-coding,/
CWITA004161,TCMBANKGE004161,HTATIP2,CC3; SDR44U1; TIP30,HIV-1 Tat interactive protein 2,11p15.1,protein-coding,Research target
CWITA004162,TCMBANKGE004162,SEC16B,LZTR2; PGPR-p117; RGPR; RGPR-p117; SEC16S,"SEC16 homolog B, endoplasmic reticulum export factor",1q25.2,protein-coding,/
CWITA004163,TCMBANKGE004163,TNFSF18,AITRL; GITRL; TL6; TNLG2A; hGITRL,TNF superfamily member 18,1q25.1,protein-coding,/
CWITA004164,TCMBANKGE004164,DNER,UNQ26; bet,delta/notch like EGF repeat containing,2q36.3,protein-coding,/
CWITA004165,TCMBANKGE004165,NAE1,AN116A10.1; APPBP1; ulaN1,NEDD8 activating enzyme E1 subunit 1,16q22,protein-coding,
CWITA004166,TCMBANKGE004166,DDX25,GRTH,DEAD-box helicase 25,11q24.2,protein-coding,/
CWITA004167,TCMBANKGE004167,OARD1,C6orf130; TARG1; dJ34B21.3,O-acyl-ADP-ribose deacylase 1,6p21.1,protein-coding,/
CWITA004168,TCMBANKGE004168,SALL4,DRRS; HSAL4; ZNF797,spalt like transcription factor 4,20q13.2,protein-coding,/
CWITA004169,TCMBANKGE004169,TMEM119,OBIF,transmembrane protein 119,12q23.3,protein-coding,/
CWITA004170,TCMBANKGE004170,MMP10,SLN2; STMY2,matrix metallopeptidase 10 (stromelysin 2),11q22.3,protein-coding,
CWITA004171,TCMBANKGE004171,CPM,-,carboxypeptidase M,12q15,protein-coding,Research target
CWITA004172,TCMBANKGE004172,AHCY,SAHH,adenosylhomocysteinase,20cen-q13.1,protein-coding,
CWITA004173,TCMBANKGE004173,PCDHGB4,CDH20; FIB2; PCDH-GAMMA-B4,"protocadherin gamma subfamily B, 4",5q31.3,protein-coding,/
CWITA004174,TCMBANKGE004174,PPP1R3C,PPP1R5; PTG,protein phosphatase 1 regulatory subunit 3C,10q23.32,protein-coding,/
CWITA004175,TCMBANKGE004175,KIF27,-,kinesin family member 27,9q21.32,protein-coding,/
CWITA004176,TCMBANKGE004176,CYP26C1,FFDD4,cytochrome P450 family 26 subfamily C member 1,10q23.33,protein-coding,/
CWITA004177,TCMBANKGE004177,TNFSF14,CD258; HVEML; LIGHT; LTg,TNF superfamily member 14,19p13.3,protein-coding,Research target
CWITA004178,TCMBANKGE004178,TMEM135,PMP52,transmembrane protein 135,11q14.2,protein-coding,/
CWITA004179,TCMBANKGE004179,SLC19A3,BBGD; THMD2; THTR2; thTr-2,solute carrier family 19 member 3,2q36.3,protein-coding,Research target
CWITA004180,TCMBANKGE004180,CLDN2,-,claudin 2,Xq22.3,protein-coding,/
CWITA004181,TCMBANKGE004181,GLB1,EBP; ELNR1; MPS4B,galactosidase beta 1,3p22.3,protein-coding,Research target
CWITA004182,TCMBANKGE004182,CDCA5,SORORIN,cell division cycle associated 5,11q13.1,protein-coding,/
CWITA004183,TCMBANKGE004183,IVNS1ABP,ARA3; FLARA3; HSPC068; KLHL39; ND1; NS-1; NS1-BP; NS1BP,influenza virus NS1A binding protein,1q25.3,protein-coding,/
CWITA004184,TCMBANKGE004184,NDUFB5,CISGDH; DKFZp686N02262; FLJ30597; MGC111204; MGC12314; SGDH,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa",3q26.33,protein-coding,
CWITA004185,TCMBANKGE004185,ZNF587B,-,zinc finger protein 587B,19q13.43,protein-coding,/
CWITA004186,TCMBANKGE004186,C17orf64,-,chromosome 17 open reading frame 64,17q23.2,protein-coding,/
CWITA004187,TCMBANKGE004187,MSRB2,CBS-1; CBS1; CGI-131; MSRB; PILB,methionine sulfoxide reductase B2,10p12.2,protein-coding,/
CWITA004188,TCMBANKGE004188,CENPK,AF5alpha; CENP-K; FKSG14; P33; Solt,centromere protein K,5q12.3,protein-coding,/
CWITA004189,TCMBANKGE004189,SLC6A7,PROT,"solute carrier family 6 (neurotransmitter transporter, L-proline), member 7",5q31-q32,protein-coding,
CWITA004190,TCMBANKGE004190,GDPD1,GDE4,glycerophosphodiester phosphodiesterase domain containing 1,17q22,protein-coding,/
CWITA004191,TCMBANKGE004191,ABHD15,-,abhydrolase domain containing 15,17q11.2,protein-coding,/
CWITA004192,TCMBANKGE004192,PRB3,G1; PRG,proline rich protein BstNI subfamily 3,12p13.2,protein-coding,/
CWITA004193,TCMBANKGE004193,CDADC1,NYD-SP15; bA103J18.1,cytidine and dCMP deaminase domain containing 1,13q14.2,protein-coding,/
CWITA004194,TCMBANKGE004194,PC,PCB,pyruvate carboxylase,11q13.2,protein-coding,/
CWITA004195,TCMBANKGE004195,SST,SMST,somatostatin,3q28,protein-coding,
CWITA004196,TCMBANKGE004196,CDK20,CCRK; CDCH; P42; PNQALRE,cyclin dependent kinase 20,9q22.1,protein-coding,/
CWITA004197,TCMBANKGE004197,IQSEC2,BRAG1; IQ-ArfGEF; MRX1; MRX18; MRX78,IQ motif and Sec7 domain ArfGEF 2,Xp11.22,protein-coding,/
CWITA004198,TCMBANKGE004198,POLR2K,ABC10-alpha; RPABC4; RPB10alpha; RPB12; RPB7.0; hRPB7.0; hsRPB10a,"RNA polymerase II, I and III subunit K",8q22.2,protein-coding,/
CWITA004199,TCMBANKGE004199,BFSP2,CP47; CP49; CTRCT12; LIFL-L; PHAKOSIN,beaded filament structural protein 2,3q22.1,protein-coding,/
CWITA004200,TCMBANKGE004200,SEC61G,SSS1,Sec61 Gamma Subunit,7p11.2,protein-coding,
CWITA004201,TCMBANKGE004201,PFAS,FGAMS; FGAR-AT; FGARAT; GATD8; PURL,phosphoribosylformylglycinamidine synthase,17p13.1,protein-coding,/
CWITA004202,TCMBANKGE004202,PCDHB14,PCDH-BETA14,protocadherin beta 14,5q31.3,protein-coding,/
CWITA004203,TCMBANKGE004203,TGFBR2,AAT3; FAA3; LDS1B; LDS2; LDS2B; MFS2; RIIC; TAAD2; TBR-ii; TBRII; TGFR-2; TGFbeta-RII,transforming growth factor beta receptor 2,3p24.1,protein-coding,Clinical Trial target
CWITA004204,TCMBANKGE004204,TXNDC16,ERp90; KIAA1344,thioredoxin domain containing 16,14q22.1,protein-coding,/
CWITA004205,TCMBANKGE004205,PLD1,CVDD,phospholipase D1,3q26.31,protein-coding,Research target
CWITA004206,TCMBANKGE004206,PPM1L,PP2C-epsilon; PP2CE; PPM1-LIKE,"protein phosphatase, Mg2+/Mn2+ dependent 1L",3q25.33-q26.1,protein-coding,/
CWITA004207,TCMBANKGE004207,IQCF5,-,IQ motif containing F5,3p21.2,protein-coding,/
CWITA004208,TCMBANKGE004208,AXIN1,AXIN; PPP1R49,axin 1,16p13.3,protein-coding,/
CWITA004209,TCMBANKGE004209,H2BW1,H2BFWT,H2B.W histone 1,Xq22.2,protein-coding,/
CWITA004210,TCMBANKGE004210,TOX3,CAGF9; TNRC9,TOX high mobility group box family member 3,16q12.1,protein-coding,/
CWITA004211,TCMBANKGE004211,GFPT2,FLJ10380; GFAT2,glutamine-fructose-6-phosphate transaminase 2,5q34-q35,protein-coding,
CWITA004212,TCMBANKGE004212,GCNA,ACRC; NAAR1,germ cell nuclear acidic peptidase,Xq13.1,protein-coding,/
CWITA004213,TCMBANKGE004213,GCLC,GCL; GCS; GLCL; GLCLC,"glutamate-cysteine ligase, catalytic subunit",6p12,protein-coding,
CWITA004214,TCMBANKGE004214,BATF3,JDP1; JUNDM1; SNFT,basic leucine zipper ATF-like transcription factor 3,1q32.3,protein-coding,/
CWITA004215,TCMBANKGE004215,MCM6,MCG40308; Mis5; P105MCM,minichromosome maintenance complex component 6,2q21.3,protein-coding,Research target
CWITA004216,TCMBANKGE004216,NKTR,p104,natural killer cell triggering receptor,3p22.1,protein-coding,/
CWITA004217,TCMBANKGE004217,PCDHB12,PCDH-BETA12,protocadherin beta 12,5q31.3,protein-coding,/
CWITA004218,TCMBANKGE004218,RDX,DFNB24,radixin,11q23,protein-coding,
CWITA004219,TCMBANKGE004219,CTSG,CATG; CG,cathepsin G,14q12,protein-coding,Clinical Trial target
CWITA004220,TCMBANKGE004220,KDM4D,JMJD2D,lysine demethylase 4D,11q21,protein-coding,/
CWITA004221,TCMBANKGE004221,ATP6V1C1,ATP6C; ATP6D; VATC; Vma5,ATPase H+ transporting V1 subunit C1,8q22.3,protein-coding,/
CWITA004222,TCMBANKGE004222,DHX8,DDX8; Dhr2; HRH1; PRP22; PRPF22,DEAH-box helicase 8,17q21.31,protein-coding,/
CWITA004223,TCMBANKGE004223,ATF4,CREBN2; CREB2; TAXREB67; TXREB,activating transcription factor 4 (tax-responsive enhancer element B67),22q13.1,protein-coding,
CWITA004224,TCMBANKGE004224,SLC2A11,GLUT10; GLUT11,solute carrier family 2 member 11,22q11.23,protein-coding,/
CWITA004225,TCMBANKGE004225,RPS7,DBA8; S7; eS7,ribosomal protein S7,2p25.3,protein-coding,/
CWITA004226,TCMBANKGE004226,B4GALT4,B4Gal-T4; beta4Gal-T4,"beta-1,4-galactosyltransferase 4",3q13.32,protein-coding,/
CWITA004227,TCMBANKGE004227,ACO1,ACONS; HEL60; IREB1; IREBP; IREBP1; IRP1,aconitase 1,9p21.1,protein-coding,/
CWITA004228,TCMBANKGE004228,SPAG11A,EDDM2A; HE2,sperm associated antigen 11A,8p23.1,protein-coding,/
CWITA004229,TCMBANKGE004229,PRDM9,KMT8B; MEISETZ; MSBP3; PFM6; ZNF899,PR/SET domain 9,5p14.2,protein-coding,/
CWITA004230,TCMBANKGE004230,CIRBP,CIRP,cold inducible RNA binding protein,19p13.3,protein-coding,/
CWITA004231,TCMBANKGE004231,GLE1,CAAHC; CAAHD; GLE1L; LCCS; LCCS1; hGLE1,GLE1 RNA export mediator,9q34.11,protein-coding,/
CWITA004232,TCMBANKGE004232,GDPD2,GDE3; OBDPF,glycerophosphodiester phosphodiesterase domain containing 2,Xq13.1,protein-coding,/
CWITA004233,TCMBANKGE004233,KIRREL1,KIRREL; NEPH1,kirre like nephrin family adhesion molecule 1,1q23.1,protein-coding,/
CWITA004234,TCMBANKGE004234,MCF2L,ARHGEF14; DBS; OST,MCF.2 cell line derived transforming sequence like,13q34,protein-coding,/
CWITA004235,TCMBANKGE004235,SEMA5B,SEMAG; SemG,semaphorin 5B,3q21.1,protein-coding,/
CWITA004236,TCMBANKGE004236,RNASE3,ECP; RAF1; RNS3,ribonuclease A family member 3,14q11.2,protein-coding,/
CWITA004237,TCMBANKGE004237,SLC4A4,HNBC1; KNBC; NBC1; NBC2; NBCe1-A; SLC4A5; hhNMC; kNBC1; pNBC,solute carrier family 4 member 4,4q13.3,protein-coding,/
CWITA004238,TCMBANKGE004238,TTBK1,BDTK,tau tubulin kinase 1,6p21.1,protein-coding,Research target
CWITA004239,TCMBANKGE004239,FZD3,Fz-3,frizzled class receptor 3,8p21.1,protein-coding,/
CWITA004240,TCMBANKGE004240,GLTPD2,-,glycolipid transfer protein domain containing 2,17p13.2,protein-coding,/
CWITA004241,TCMBANKGE004241,F11,FXI; PTA,coagulation factor XI,4q35.2,protein-coding,Clinical Trial target
CWITA004242,TCMBANKGE004242,C19orf33,H2RSP; IMUP; IMUP-1; IMUP-2,chromosome 19 open reading frame 33,19q13.2,protein-coding,/
CWITA004243,TCMBANKGE004243,RPS6KA3,CLS; HUN3; ISPKN1; MAPKAPK1B; MRX19; RSK; RSK2; S6KNalpha3; p90NRSK2; pp90RSK2,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",Xp22.2-p22.1,protein-coding,
CWITA004244,TCMBANKGE004244,WFDC10B,WAP12,WAP four-disulfide core domain 10B,20q13.12,protein-coding,/
CWITA004245,TCMBANKGE004245,H3C15,H3/n; H3/o; H3C13; H3C14; HIST2H3A,H3 clustered histone 15,1q21.2,protein-coding,/
CWITA004246,TCMBANKGE004246,ARMT1,C6orf211,acidic residue methyltransferase 1,6q25.1,protein-coding,/
CWITA004247,TCMBANKGE004247,C14orf28,DRIP-1; DRIP1; c14_5270,chromosome 14 open reading frame 28,14q21.2,protein-coding,/
CWITA004248,TCMBANKGE004248,EGF,HOMG4; URG,epidermal growth factor,4q25,protein-coding,
CWITA004249,TCMBANKGE004249,DHX30,DDX30; NEDMIAL; RETCOR,DExH-box helicase 30,3p21.31,protein-coding,/
CWITA004250,TCMBANKGE004250,LIPF,GL; HGL; HLAL,"lipase F, gastric type",10q23.31,protein-coding,Clinical Trial target
CWITA004251,TCMBANKGE004251,Cluh,1300001I01Rik; Kiaa0664; mKIAA0664,clustered mitochondria (cluA/CLU1) homolog,11 B5|11,protein-coding,/
CWITA004252,TCMBANKGE004252,NME3,DR-nm23; NDPK-C; NDPKC; NM23-H3; NM23H3; c371H6.2,NME/NM23 nucleoside diphosphate kinase 3,16p13.3,protein-coding,/
CWITA004253,TCMBANKGE004253,NPR1,ANPRA; ANPa; GUC2A; GUCY2A; NPRA,natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A),1q21-q22,protein-coding,
CWITA004254,TCMBANKGE004254,CSNK1E,CKIe; CKIepsilon; HCKIE,casein kinase 1 epsilon,22q13.1,protein-coding,Research target
CWITA004255,TCMBANKGE004255,CBFA2T3,ETO2; MTG16; MTGR2; RUNX1T3; ZMYND4,CBFA2/RUNX1 partner transcriptional co-repressor 3,16q24.3,protein-coding,/
CWITA004256,TCMBANKGE004256,DSTYK,CAKUT1; DustyPK; HDCMD38P; RIP5; RIPK5; SPG23,dual serine/threonine and tyrosine protein kinase,1q32.1,protein-coding,/
CWITA004257,TCMBANKGE004257,PSMA5,PSC5; ZETA,proteasome 20S subunit alpha 5,1p13.3,protein-coding,/
CWITA004258,TCMBANKGE004258,APPL2,DIP13B,"adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2",12q23.3,protein-coding,/
CWITA004259,TCMBANKGE004259,CEBPB,C/EBPNbeta; CRP2; IL6DBP; LAP; MGC32080; NFNIL6; TCF5,"CCAAT/enhancer binding protein (C/EBP), beta",20q13.1,protein-coding,
CWITA004260,TCMBANKGE004260,PGAM2,GSD10; PGAM-M; PGAMM,phosphoglycerate mutase 2,7p13,protein-coding,/
CWITA004261,TCMBANKGE004261,MR1,HLALS,"major histocompatibility complex, class I-related",1q25.3,protein-coding,/
CWITA004262,TCMBANKGE004262,INTS1,INT1; NDCAGF; NET28,integrator complex subunit 1,7p22.3,protein-coding,/
CWITA004263,TCMBANKGE004263,TMEM177,-,transmembrane protein 177,2q14.2,protein-coding,/
CWITA004264,TCMBANKGE004264,SLC7A6OS,Iwr1,solute carrier family 7 member 6 opposite strand,16q22.1,protein-coding,/
CWITA004265,TCMBANKGE004265,ARAF,ANRAF; ARAF1; PKS2; RAFA1,v-raf murine sarcoma 3611 viral oncogene homolog,Xp11.4-p11.2,protein-coding,
CWITA004266,TCMBANKGE004266,AR,AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM,androgen receptor,Xq12,protein-coding,Clinical Trial target
CWITA004267,TCMBANKGE004267,REG1A,ICRF; P19; PSP; PSPS; PSPS1; PTP; REG,regenerating family member 1 alpha,2p12,protein-coding,/
CWITA004268,TCMBANKGE004268,FASN,FAS; MGC14367; MGC15706; OAN519; SDR27X1,fatty acid synthase,17q25,protein-coding,
CWITA004269,TCMBANKGE004269,STAU2,39K2; 39K3,staufen double-stranded RNA binding protein 2,8q21.11,protein-coding,/
CWITA004270,TCMBANKGE004270,MAP3K2,MEKK2; MEKK2B,mitogen-activated protein kinase kinase kinase 2,2q14.3,protein-coding,Clinical Trial target
CWITA004271,TCMBANKGE004271,ATP5MD,DAPIT; HCVFTP2; MC5DN6; USMG5; bA792D24.4,ATP synthase membrane subunit DAPIT,10q24.33,protein-coding,/
CWITA004272,TCMBANKGE004272,DVL2,-,dishevelled segment polarity protein 2,17p13.1,protein-coding,/
CWITA004273,TCMBANKGE004273,CSTB,CPI-B; CST6; EPM1; EPM1A; PME; STFB; ULD,cystatin B,21q22.3,protein-coding,/
CWITA004274,TCMBANKGE004274,LRRC3,C21orf102; C21orf30; LRRC3DN,leucine rich repeat containing 3,21q22.3,protein-coding,/
CWITA004275,TCMBANKGE004275,PPP5C,FLJ36922; FLJ55954; PP5; PPP5; PPT,"protein phosphatase 5, catalytic subunit",19q13.3,protein-coding,
CWITA004276,TCMBANKGE004276,SUGT1,SGT1,"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone",13q14.3,protein-coding,Research target
CWITA004277,TCMBANKGE004277,ILVBL,209L8; AHAS; HACL1L; ILV2H,ilvB acetolactate synthase like,19p13.12,protein-coding,/
CWITA004278,TCMBANKGE004278,ZNF670,-,zinc finger protein 670,1q44,protein-coding,/
CWITA004279,TCMBANKGE004279,SEMA5A,SEMAF; semF,semaphorin 5A,5p15.31,protein-coding,/
CWITA004280,TCMBANKGE004280,ARF4,ARF2,ADP-ribosylation factor 4,3p21.2-p21.1,protein-coding,
CWITA004281,TCMBANKGE004281,KLF13,BTEB3; FKLF2; NSLP1; RFLAT-1; RFLAT1,Kruppel like factor 13,15q13.3,protein-coding,/
CWITA004282,TCMBANKGE004282,Plac9b,Gm10393; Plac9,placenta specific 9b,14 A3|14,protein-coding,/
CWITA004283,TCMBANKGE004283,FBN2,CCA; DA9; EOMD,fibrillin 2,5q23.3,protein-coding,/
CWITA004284,TCMBANKGE004284,HCAR3,GPR109B; HCA3; HM74; PUMAG; Puma-g,hydroxycarboxylic acid receptor 3,12q24.31,protein-coding,Clinical Trial target
CWITA004285,TCMBANKGE004285,PYGM,N,"phosphorylase, glycogen, muscle",11q12-q13.2,protein-coding,
CWITA004286,TCMBANKGE004286,PTPN18,BDP1; PTP-HSCF,protein tyrosine phosphatase non-receptor type 18,2q21.1,protein-coding,/
CWITA004287,TCMBANKGE004287,ARHGEF4,ASEF; ASEF1; GEF4; SMIM39; STM6,Rho guanine nucleotide exchange factor 4,2q21.1,protein-coding,/
CWITA004288,TCMBANKGE004288,KIFAP3,FLA3; KAP-1; KAP-3; KAP3; SMAP; Smg-GDS; dJ190I16.1,kinesin associated protein 3,1q24.2,protein-coding,/
CWITA004289,TCMBANKGE004289,TRMT1,MRT68; TRM1,tRNA methyltransferase 1,19p13.13,protein-coding,/
CWITA004290,TCMBANKGE004290,GOLT1A,CGI-141; GOT1; HMFN1187; YMR292W; hGOT1b,golgi transport 1A,1q32.1,protein-coding,/
CWITA004291,TCMBANKGE004291,TK2,MTDPS2; MTTK; PEOB3; SCA31,thymidine kinase 2,16q21,protein-coding,/
CWITA004292,TCMBANKGE004292,GLT6D1,GLTDC1; GT6M7,glycosyltransferase 6 domain containing 1,9q34.3,protein-coding,/
CWITA004293,TCMBANKGE004293,DUSP7,MKPX; PYST2,dual specificity phosphatase 7,3p21.2,protein-coding,/
CWITA004294,TCMBANKGE004294,SPTBN1,ELF; SPTB2; betaSpII,"spectrin, beta, non-erythrocytic 1",2p21,protein-coding,
CWITA004295,TCMBANKGE004295,LAMB3,AI1A; BM600-125KDA; LAM5; LAMNB1,laminin subunit beta 3,1q32.2,protein-coding,Clinical Trial target
CWITA004296,TCMBANKGE004296,PWWP2B,PWWP2; bA432J24.1; pp8607,PWWP domain containing 2B,10q26.3,protein-coding,/
CWITA004297,TCMBANKGE004297,SCAF11,CASP11; SFRS2IP; SIP1; SRRP129; SRSF2IP,SR-related CTD associated factor 11,12q12,protein-coding,/
CWITA004298,TCMBANKGE004298,ATOX1,ATX1; HAH1,antioxidant 1 copper chaperone,5q33.1,protein-coding,/
CWITA004299,TCMBANKGE004299,ANKLE2,KIAA0692; LEMD7; Lem4; MCPH16,ankyrin repeat and LEM domain containing 2,12q24.33,protein-coding,/
CWITA004300,TCMBANKGE004300,KCNA4,HBK4; HK1; HPCN2; HUKII; KCNA4L; KCNA8; KV1.4; PCN2,"potassium voltage-gated channel, shaker-related subfamily, member 4",11p14,protein-coding,
CWITA004301,TCMBANKGE004301,ATP5PD,APT5H; ATP5H; ATPQ,ATP synthase peripheral stalk subunit d,17q25.1,protein-coding,/
CWITA004302,TCMBANKGE004302,LNPEP,CAP; IRAP; P-LAP; PLAP,leucyl and cystinyl aminopeptidase,5q15,protein-coding,Research target
CWITA004303,TCMBANKGE004303,C5orf34,-,chromosome 5 open reading frame 34,5p12,protein-coding,/
CWITA004304,TCMBANKGE004304,TIFA,T2BP; T6BP; TIFAA,TRAF interacting protein with forkhead associated domain,4q25,protein-coding,/
CWITA004305,TCMBANKGE004305,DNTTIP2,ERBP; FCF2; HSU15552; LPTS-RP2; TdIF2,deoxynucleotidyltransferase terminal interacting protein 2,1p22.1,protein-coding,/
CWITA004306,TCMBANKGE004306,RPS16,S16,ribosomal protein S16,19q13.2,protein-coding,/
CWITA004307,TCMBANKGE004307,PDE7B,bA472E5.1,phosphodiesterase 7B,6q23.3,protein-coding,Discontinued target
CWITA004308,TCMBANKGE004308,GPR12,GPCR12; GPCR21; PPP1R84,G protein-coupled receptor 12,13q12.13,protein-coding,Research target
CWITA004309,TCMBANKGE004309,ZNF486,KRBO2,zinc finger protein 486,19p12,protein-coding,/
CWITA004310,TCMBANKGE004310,FAHD1,C16orf36; YISKL,fumarylacetoacetate hydrolase domain containing 1,16p13.3,protein-coding,/
CWITA004311,TCMBANKGE004311,ZNF496,NIZP1; ZFP496; ZKSCAN17; ZSCAN49,zinc finger protein 496,1q44,protein-coding,/
CWITA004312,TCMBANKGE004312,LRRC52,-,leucine rich repeat containing 52,1q24.1,protein-coding,/
CWITA004313,TCMBANKGE004313,INPP5B,5PTase; MGC65156; MGC71303,"inositol polyphosphate-5-phosphatase, 75kDa",1p34,protein-coding,
CWITA004314,TCMBANKGE004314,SBNO2,KIAA0963; SNO; STNO,strawberry notch homolog 2,19p13.3,protein-coding,/
CWITA004315,TCMBANKGE004315,RBX1,BA554C12.1; RNF75; ROC1,ring-box 1,22q13.2,protein-coding,/
CWITA004316,TCMBANKGE004316,ZFP91-CNTF,ZFP91; ZNF757; Zfp-91,ZFP91-CNTF readthrough (NMD candidate),11q12.1,ncRNA,/
CWITA004317,TCMBANKGE004317,RASA4,CAPRI; GAPL,RAS p21 protein activator 4,7q22.1,protein-coding,/
CWITA004318,TCMBANKGE004318,ZNF664,ZFOC1; ZNF176,zinc finger protein 664,12q24.31,protein-coding,/
CWITA004319,TCMBANKGE004319,PUM2,PUMH2; PUML2,pumilio RNA binding family member 2,2p24.1,protein-coding,/
CWITA004320,TCMBANKGE004320,RIPPLY3,DSCR6,ripply transcriptional repressor 3,21q22.13,protein-coding,/
CWITA004321,TCMBANKGE004321,ZFYVE1,DFCP1; PPP1R172; SR3; TAFF1; ZNFN2A1,zinc finger FYVE-type containing 1,14q24.2,protein-coding,/
CWITA004322,TCMBANKGE004322,LRATD2,BCMP101; FAM84B; NSE2,LRAT domain containing 2,8q24.21,protein-coding,/
CWITA004323,TCMBANKGE004323,RRBP1,ES/130; ES130; RRp; hES,ribosome binding protein 1,20p12.1,protein-coding,/
CWITA004324,TCMBANKGE004324,RGR,RP44,retinal G protein coupled receptor,10q23.1,protein-coding,/
CWITA004325,TCMBANKGE004325,NR4A2,HZF-3; NOT; NURR1; RNR1; TINUR,nuclear receptor subfamily 4 group A member 2,2q24.1,protein-coding,Research target
CWITA004326,TCMBANKGE004326,CDC7,CDC7L1; HsCDC7; Hsk1; huCDC7,cell division cycle 7,1p22.1,protein-coding,Clinical Trial target
CWITA004327,TCMBANKGE004327,DNAAF4,CILD25; DYX1; DYX1C1; DYXC1; EKN1; RD,dynein axonemal assembly factor 4,15q21.3,protein-coding,/
CWITA004328,TCMBANKGE004328,ECHS1,SCEH,"enoyl CoA hydratase, short chain, 1, mitochondrial",10q26.2-q26.3,protein-coding,
CWITA004329,TCMBANKGE004329,FGF1,AFGF; ECGF; ECGF-beta; ECGFA; ECGFB; FGF-1; FGF-alpha; FGFA; GLIO703; HBGF-1; HBGF1,fibroblast growth factor 1,5q31.3,protein-coding,Clinical Trial target
CWITA004330,TCMBANKGE004330,VEGFD,FIGF; VEGF-D,vascular endothelial growth factor D,Xp22.2,protein-coding,Discontinued target
CWITA004331,TCMBANKGE004331,HLA-C,D6S204; FLJ27082; HLA-JY3; HLC-C; PSORS1,"Major Histocompatibility Complex, Class I, C",6p21.3,protein-coding,
CWITA004332,TCMBANKGE004332,KIF6,C6orf102; dJ1043E3.1; dJ137F1.4; dJ188D3.1,kinesin family member 6,6p21.2,protein-coding,/
CWITA004333,TCMBANKGE004333,NFKBID,IkBNS; IkappaBNS; TA-NFKBH,NFKB inhibitor delta,19q13.12,protein-coding,/
CWITA004334,TCMBANKGE004334,FBLN7,TM14,fibulin 7,2q13-q14.1,protein-coding,/
CWITA004335,TCMBANKGE004335,PPEF2,PPP7CB,protein phosphatase with EF-hand domain 2,4q21.1,protein-coding,/
CWITA004336,TCMBANKGE004336,KIAA0753,MNR; OFIP,KIAA0753,17p13.1,protein-coding,/
CWITA004337,TCMBANKGE004337,AMPD1,MAD; MADA; MMDD,adenosine monophosphate deaminase 1,1p13.2,protein-coding,/
CWITA004338,TCMBANKGE004338,CLEC3A,CLECSF1,C-type lectin domain family 3 member A,16q23.1,protein-coding,/
CWITA004339,TCMBANKGE004339,RDH14,PAN2; SDR7C4,retinol dehydrogenase 14 (all-trans/9-cis/11-cis),2p24.2,protein-coding,
CWITA004340,TCMBANKGE004340,CMPK1,CK; CMK; CMPK; UMK; UMP-CMPK; UMPK,cytidine/uridine monophosphate kinase 1,1p33,protein-coding,/
CWITA004341,TCMBANKGE004341,COL25A1,AMY; CFEOM5; CLAC; CLAC-P; CLACP,Collagen_Type_Xxv_Alpha_1_Chain,4q25,protein-coding,
CWITA004342,TCMBANKGE004342,RPRD2,HSPC099; KIAA0460,regulation of nuclear pre-mRNA domain containing 2,1q21.2,protein-coding,/
CWITA004343,TCMBANKGE004343,GRIN3B,NR3B,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3B",19p13.3,protein-coding,
CWITA004344,TCMBANKGE004344,CSKMT,CS-KMT; METTL12; U99HG,citrate synthase lysine methyltransferase,11q12.3,protein-coding,/
CWITA004345,TCMBANKGE004345,CKM,CKMM; CPK-M; M-CK,"creatine kinase, M-type",19q13.32,protein-coding,/
CWITA004346,TCMBANKGE004346,TERF2IP,DRIP5; RAP1,TERF2 interacting protein,16q23.1,protein-coding,/
CWITA004347,TCMBANKGE004347,MTHFD1,MTHFC; MTHFD,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",14q24,protein-coding,
CWITA004348,TCMBANKGE004348,POLE2,DPE2,"polymerase (DNA directed), epsilon 2 (p59 subunit)",14q21-q22,protein-coding,
CWITA004349,TCMBANKGE004349,MOB1B,MATS2; MOB4A; MOBKL1A,MOB kinase activator 1B,4q13.3,protein-coding,/
CWITA004350,TCMBANKGE004350,ZBTB8A,BOZF1; ZBTB8; ZNF916A,zinc finger and BTB domain containing 8A,1p35.1,protein-coding,/
CWITA004351,TCMBANKGE004351,PADI4,PAD; PAD4; PADI5; PDI4; PDI5,peptidyl arginine deiminase 4,1p36.13,protein-coding,Research target
CWITA004352,TCMBANKGE004352,ATP6AP2,APT6M8-9; ATP6IP2; ATP6M8-9; ELDF10; HT028; M8-9; MRXE; MRXSH; MSTP009; PRR; RENR; XMRE; XPDS,Atpase_H+_Transporting_Accessory_Protein_2,Xp11.4,protein-coding,
CWITA004353,TCMBANKGE004353,MMD,MMA; MMD1; PAQR11,monocyte to macrophage differentiation associated,17q22,protein-coding,/
CWITA004354,TCMBANKGE004354,PANX1,MRS1; OOMD7; PX1; UNQ2529,pannexin 1,11q21,protein-coding,/
CWITA004355,TCMBANKGE004355,EHMT1,EHMT1-IT1; EUHMTASE1; Eu-HMTase1; FP13812; GLP; GLP1; KLEFS1; KMT1D,euchromatic histone lysine methyltransferase 1,9q34.3,protein-coding,Research target
CWITA004356,TCMBANKGE004356,PSMB4,HN3; HsN3; PROSN26; PROS26,"proteasome (prosome, macropain) subunit, beta type, 4",1q21,protein-coding,
CWITA004357,TCMBANKGE004357,RAD23B,HHR23B; HR23B; P58,"RAD23 homolog B, nucleotide excision repair protein",9q31.2,protein-coding,/
CWITA004358,TCMBANKGE004358,GJB1,CMTX; CMTX1; CX32,gap junction protein beta 1,Xq13.1,protein-coding,Research target
CWITA004359,TCMBANKGE004359,MREG,DSU; WDT2,melanoregulin,2q35,protein-coding,/
CWITA004360,TCMBANKGE004360,VASN,SLITL2,vasorin,16p13.3,protein-coding,/
CWITA004361,TCMBANKGE004361,Gs,-,greasy,-,unknown,/
CWITA004362,TCMBANKGE004362,CETN3,CDC31; CEN3,centrin 3,5q14.3,protein-coding,/
CWITA004363,TCMBANKGE004363,PCCB,-,propionyl-CoA carboxylase subunit beta,3q22.3,protein-coding,/
CWITA004364,TCMBANKGE004364,SLC7A1,ATRC1; CATN1; ERR; HCAT1; REC1L,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 1",13q12-q14,protein-coding,
CWITA004365,TCMBANKGE004365,ANP32A,C15orf1; HPPCn; I1PP2A; LANP; MAPM; PHAP1; PHAPI; PP32,acidic nuclear phosphoprotein 32 family member A,15q23,protein-coding,/
CWITA004366,TCMBANKGE004366,EIF1AY,eIF-4C,eukaryotic translation initiation factor 1A Y-linked,Yq11.223,protein-coding,/
CWITA004367,TCMBANKGE004367,GNPDA2,GNP2; SB52,glucosamine-6-phosphate deaminase 2,4p12,protein-coding,/
CWITA004368,TCMBANKGE004368,IL5RA,CD125; CDw125; HSIL5R3; IL5R,interleukin 5 receptor subunit alpha,3p26.2,protein-coding,Successful target
CWITA004369,TCMBANKGE004369,ZADH2,PRG-3,zinc binding alcohol dehydrogenase domain containing 2,18q22.3,protein-coding,/
CWITA004370,TCMBANKGE004370,SRPK2,FLJ36101; SFRSK2,SRSF protein kinase 2,7q22-q31.1,protein-coding,
CWITA004371,TCMBANKGE004371,CD2,LFA-2; SRBC; T11,CD2 molecule,1p13.1,protein-coding,Clinical Trial target
CWITA004372,TCMBANKGE004372,NECTIN4,EDSS1; LNIR; PRR4; PVRL4; nectin-4,nectin cell adhesion molecule 4,1q23.3,protein-coding,Clinical Trial target
CWITA004373,TCMBANKGE004373,CHD1L,ALC1; CHDL,chromodomain helicase DNA binding protein 1 like,1q21.1,protein-coding,/
CWITA004374,TCMBANKGE004374,RPL9,L9; NPC-A-16,ribosomal protein L9,4p14,protein-coding,/
CWITA004375,TCMBANKGE004375,CDKN1C,BWCR; BWS; KIP2; WBS; p57; p57Kip2,cyclin dependent kinase inhibitor 1C,11p15.4,protein-coding,Research target
CWITA004376,TCMBANKGE004376,TAAR1,TA1; TAR1; TRAR1,trace amine associated receptor 1,6q23.2,protein-coding,Successful target
CWITA004377,TCMBANKGE004377,GINS1,IMD55; PSF1,GINS complex subunit 1,20p11.21,protein-coding,/
CWITA004378,TCMBANKGE004378,CWH43,CWH43-C; PGAP2IP,cell wall biogenesis 43 C-terminal homolog,4p11,protein-coding,/
CWITA004379,TCMBANKGE004379,L3HYPDH,C14orf149,Trans-L-3-Hydroxyproline_Dehydratase,14q23.1,protein-coding,
CWITA004380,TCMBANKGE004380,YBEY,C21orf57,ybeY metalloendoribonuclease,21q22.3,protein-coding,/
CWITA004381,TCMBANKGE004381,NODAL,HTX5,nodal growth differentiation factor,10q22.1,protein-coding,Research target
CWITA004382,TCMBANKGE004382,DNAAF1,CILD13; DAU1; LRRC50; ODA7; swt,dynein axonemal assembly factor 1,16q24.1,protein-coding,/
CWITA004383,TCMBANKGE004383,PNKD,BRP17; DYT8; FKSG19; FPD1; KIPP1184; MR-1; MR-1S; MR1; PDC; PKND1; PNKD1; R1; TAHCCP2,PNKD metallo-beta-lactamase domain containing,2q35,protein-coding,/
CWITA004384,TCMBANKGE004384,EYS,C6orf178; C6orf179; C6orf180; EGFL10; EGFL11; RP25; SPAM; bA166P24.2; bA307F22.3; bA74E24.1; dJ1018A4.2; dJ22I17.2; dJ303F19.1,eyes shut homolog,6q12,protein-coding,/
CWITA004385,TCMBANKGE004385,REPS2,POB1,RALBP1 associated Eps domain containing 2,Xp22.2,protein-coding,/
CWITA004386,TCMBANKGE004386,SLC45A3,IPCA-2; IPCA-6; IPCA-8; IPCA6; PCANAP2; PCANAP6; PCANAP8; PRST,solute carrier family 45 member 3,1q32.1,protein-coding,/
CWITA004387,TCMBANKGE004387,ZNF92,HEL-203; HPF12; HTF12; TF12,zinc finger protein 92,7q11.21,protein-coding,/
CWITA004388,TCMBANKGE004388,RPL8,L8,ribosomal protein L8,8q24.3,protein-coding,/
CWITA004389,TCMBANKGE004389,RHEB,RHEB2,"Ras homolog, mTORC1 binding",7q36.1,protein-coding,/
CWITA004390,TCMBANKGE004390,MARS2,MetRS; mtMetRS,"methionyl-tRNA synthetase 2, mitochondrial",2q33.1,protein-coding,
CWITA004391,TCMBANKGE004391,MTNR1B,FGQTL2; MEL-1B-R; MT2,melatonin receptor 1B,11q14.3,protein-coding,Successful target
CWITA004392,TCMBANKGE004392,ZNF625,-,zinc finger protein 625,19p13.2,protein-coding,/
CWITA004393,TCMBANKGE004393,SCN2A,BFIC3; EIEE11; HBA; HBSCI; HBSCII; NAC2; Na(v)1.2; Nav1.2; SCN2A1; SCN2A2,"sodium channel, voltage-gated, type II, alpha subunit",2q24.3,protein-coding,
CWITA004394,TCMBANKGE004394,SPOCD1,PPP1R146,SPOC domain containing 1,1p35.2,protein-coding,/
CWITA004395,TCMBANKGE004395,CSRNP1,AXUD1; CSRNP-1; FAM130B; TAIP-3; URAX1,cysteine and serine rich nuclear protein 1,3p22.2,protein-coding,/
CWITA004396,TCMBANKGE004396,QRICH2,SPGF35,glutamine rich 2,17q25.1,protein-coding,/
CWITA004397,TCMBANKGE004397,SLC25A31,AAC4; ANT 4; ANT4; SFEC35kDa,solute carrier family 25 member 31,4q28.1,protein-coding,/
CWITA004398,TCMBANKGE004398,CTCF,CFAP108; FAP108; MRD21,CCCTC-binding factor,16q22.1,protein-coding,/
CWITA004399,TCMBANKGE004399,GSTO2,bA127L20.1,glutathione S-transferase omega 2,10q25.1,protein-coding,
CWITA004400,TCMBANKGE004400,PDE1A,HCAM1; HSPDE1A; MGC26303,"phosphodiesterase 1A, calmodulin-dependent",2q32.1,protein-coding,
CWITA004401,TCMBANKGE004401,HHEX,HEX; HMPH; HOX11L-PEN; PRH; PRHX,hematopoietically expressed homeobox,10q23.33,protein-coding,/
CWITA004402,TCMBANKGE004402,SPRED2,Spred-2,sprouty related EVH1 domain containing 2,2p14,protein-coding,/
CWITA004403,TCMBANKGE004403,DGKA,DAGK; DAGK1; DGK-alpha,diacylglycerol kinase alpha,12q13.2,protein-coding,/
CWITA004404,TCMBANKGE004404,RFWD3,FANCW; RNF201,ring finger and WD repeat domain 3,16q23.1,protein-coding,/
CWITA004405,TCMBANKGE004405,IGKV7-3,B1; IGKV73,immunoglobulin kappa variable 7-3 (pseudogene),2p11.2,pseudo,/
CWITA004406,TCMBANKGE004406,CCSER2,FAM190B; Gcap14; KIAA1128; bA486O22.1,coiled-coil serine rich protein 2,10q23.1,protein-coding,/
CWITA004407,TCMBANKGE004407,SOCS6,CIS-4; CIS4; HSPC060; SOCS-4; SOCS-6; SOCS4; SSI4; STAI4; STATI4,suppressor of cytokine signaling 6,18q22.2,protein-coding,/
CWITA004408,TCMBANKGE004408,HCAR2,GPR109A; HCA2; HM74a; HM74b; NIACR1; PUMAG; Puma-g,hydroxycarboxylic acid receptor 2,12q24.31,protein-coding,Successful target
CWITA004409,TCMBANKGE004409,CLC,GAL10; Gal-10; LGALS10; LGALS10A; LPPL_HUMAN,Charcot-Leyden crystal galectin,19q13.2,protein-coding,/
CWITA004410,TCMBANKGE004410,CPOX,COX; CPO; CPX; HCP,coproporphyrinogen oxidase,3q11.2,protein-coding,/
CWITA004411,TCMBANKGE004411,TBCB,CG22; CKAP1; CKAPI,tubulin folding cofactor B,19q13.12,protein-coding,/
CWITA004412,TCMBANKGE004412,TM7SF3,-,transmembrane 7 superfamily member 3,12p11.23,protein-coding,/
CWITA004413,TCMBANKGE004413,EFCAB2,CFAP200; DRC8,EF-hand calcium binding domain 2,1q44,protein-coding,/
CWITA004414,TCMBANKGE004414,FOLR2,BETANHFR; FBP/PLN1; FRNBETA; FRNP3,folate receptor 2 (fetal),11q13.3-q13.5,protein-coding,
CWITA004415,TCMBANKGE004415,CDRT4,-,CMT1A duplicated region transcript 4,17p12,protein-coding,/
CWITA004416,TCMBANKGE004416,CMSS1,C3orf26,cms1 ribosomal small subunit homolog,3q12.1,protein-coding,/
CWITA004417,TCMBANKGE004417,FAXC,C6orf168; dJ273F20,"failed axon connections homolog, metaxin like GST domain containing",6q16.2,protein-coding,/
CWITA004418,TCMBANKGE004418,LMX1A,DFNA7; LMX1; LMX1.1,LIM homeobox transcription factor 1 alpha,1q23.3,protein-coding,/
CWITA004419,TCMBANKGE004419,CITED4,-,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4,1p34.2|1p35-p34,protein-coding,/
CWITA004420,TCMBANKGE004420,CLEC16A,Gop-1; KIAA0350,C-type lectin domain containing 16A,16p13.13,protein-coding,/
CWITA004421,TCMBANKGE004421,KNG1,BDK; BK; HMWK; KNG,kininogen 1,3q27.3,protein-coding,Clinical Trial target
CWITA004422,TCMBANKGE004422,PPP4R4,CFAP14; KIAA1622; PP4R4,protein phosphatase 4 regulatory subunit 4,14q32.12-q32.13,protein-coding,/
CWITA004423,TCMBANKGE004423,DUSP8,C11orf81; HB5; HVH-5; HVH8,dual specificity phosphatase 8,11p15.5,protein-coding,Research target
CWITA004424,TCMBANKGE004424,SIK1,MSK; SIK; SIK-1; SIK1B; SNF1LK,salt inducible kinase 1,21q22.3,protein-coding,Research target
CWITA004425,TCMBANKGE004425,RGS6,GAP; HA117; S914,regulator of G protein signaling 6,14q24.2,protein-coding,Research target
CWITA004426,TCMBANKGE004426,ACOT9,ACATE2; CGI-16; MT-ACT48; MTACT48,acyl-CoA thioesterase 9,Xp22.11,protein-coding,/
CWITA004427,TCMBANKGE004427,AATK,AATYK; AATYK1; LMR1; LMTK1; PPP1R77; p35BP,apoptosis associated tyrosine kinase,17q25.3,protein-coding,/
CWITA004428,TCMBANKGE004428,BMP10,-,bone morphogenetic protein 10,2p13.3,protein-coding,Research target
CWITA004429,TCMBANKGE004429,MISP,C19orf21; MISP1,mitotic spindle positioning,19p13.3,protein-coding,/
CWITA004430,TCMBANKGE004430,BUB3,BUB3L; hBUB3,BUB3 mitotic checkpoint protein,10q26.13,protein-coding,/
CWITA004431,TCMBANKGE004431,WDR41,MSTP048,WD repeat domain 41,5q13.3-q14.1,protein-coding,/
CWITA004432,TCMBANKGE004432,HBD,-,hypophosphatemic bone disease,-,unknown,/
CWITA004433,TCMBANKGE004433,SULT1B1,MGC13356; ST1B1; ST1B2; SULT1B2,"sulfotransferase family, cytosolic, 1B, member 1",4q13.3,protein-coding,
CWITA004434,TCMBANKGE004434,EXOC4,SEC8; SEC8L1; Sec8p,exocyst complex component 4,7q33,protein-coding,/
CWITA004435,TCMBANKGE004435,JADE1,PHF17,jade family PHD finger 1,4q28.2,protein-coding,/
CWITA004436,TCMBANKGE004436,SLC4A1,AE1; BND3; CD233; CHC; DI; EMPB3; EPB3; FR; RTA1A; SAO; SPH4; SW; WD; WD1; WR,solute carrier family 4 member 1 (Diego blood group),17q21.31,protein-coding,/
CWITA004437,TCMBANKGE004437,PYGM,GSD5,"glycogen phosphorylase, muscle associated",11q13.1,protein-coding,Patented target
CWITA004438,TCMBANKGE004438,MIB2,ZZANK1; ZZZ5,mindbomb E3 ubiquitin protein ligase 2,1p36.33,protein-coding,/
CWITA004439,TCMBANKGE004439,ALPPL2,ALPG; ALPPL; GCAP,"alkaline phosphatase, placental-like 2",2q37,protein-coding,
CWITA004440,TCMBANKGE004440,ABCC2,ABC30; CMOAT; DJS; KIAA1010; MRP2; cMRP,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",10q24,protein-coding,
CWITA004441,TCMBANKGE004441,CEP72,-,centrosomal protein 72,5p15.33,protein-coding,/
CWITA004442,TCMBANKGE004442,PADI6,N,"peptidyl arginine deiminase, type VI",1p36.13,protein-coding,
CWITA004443,TCMBANKGE004443,EHHADH,ECHD; LNPBE; LBFP; LBP; MGC120586; PBFE,"enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase",3q26.3-q28,protein-coding,
CWITA004444,TCMBANKGE004444,SRD5A1,S5AR_1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",5p15,protein-coding,
CWITA004445,TCMBANKGE004445,OPN5,GPR136; GRP136; PGR12; TMEM13,opsin 5,6p12.3,protein-coding,/
CWITA004446,TCMBANKGE004446,C7orf26,-,chromosome 7 open reading frame 26,7p22.1,protein-coding,/
CWITA004447,TCMBANKGE004447,ABCA13,-,ATP binding cassette subfamily A member 13,7p12.3,protein-coding,/
CWITA004448,TCMBANKGE004448,EIF2S3,EIF2; EIF2G; EIF2gamma; eIFN2gA,"eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa",Xp22.2-p22.1,protein-coding,
CWITA004449,TCMBANKGE004449,IMPA1,IMP; IMPA,inositol(myo)-1(or 4)-monophosphatase 1,8q21.13-q21.3,protein-coding,
CWITA004450,TCMBANKGE004450,CA4,CAIV; Car4; RP17,carbonic anhydrase 4,17q23.1,protein-coding,Successful target
CWITA004451,TCMBANKGE004451,PPIE,CYP-33; CYP33,peptidylprolyl isomerase E,1p34.2,protein-coding,/
CWITA004452,TCMBANKGE004452,DRAM1,DRAM,DNA damage regulated autophagy modulator 1,12q23.2,protein-coding,/
CWITA004453,TCMBANKGE004453,KCNQ3,BFNC2; EBN2; KV7.3,potassium voltage-gated channel subfamily Q member 3,8q24.22,protein-coding,Clinical Trial target
CWITA004454,TCMBANKGE004454,PDCD6,ALG-2; ALG2; PEF1B,programmed cell death 6,5p15.33,protein-coding,/
CWITA004455,TCMBANKGE004455,APOA4,-,apolipoprotein A4,11q23.3,protein-coding,Research target
CWITA004456,TCMBANKGE004456,RPL37A,L37A,ribosomal protein L37a,2q35,protein-coding,/
CWITA004457,TCMBANKGE004457,UGT2B17,BMND12; UDPGT2B17,UDP glucuronosyltransferase family 2 member B17,4q13.2,protein-coding,/
CWITA004458,TCMBANKGE004458,PRICKLE1,EPM1B; RILP,prickle planar cell polarity protein 1,12q12,protein-coding,/
CWITA004459,TCMBANKGE004459,FAR2,HEL-S-81; MLSTD1; SDR10E2,fatty acyl-CoA reductase 2,12p11.22,protein-coding,/
CWITA004460,TCMBANKGE004460,RASGRF1,CDC25; CDC25L; GNRP; GRF1; GRF55; H-GRF55; PP13187; ras-GRF1,Ras protein specific guanine nucleotide releasing factor 1,15q25.1,protein-coding,/
CWITA004461,TCMBANKGE004461,SHBG,ABP; MGC126834; MGC138391; SBP; TEBG,sex hormone-binding globulin,17p13-p12,protein-coding,
CWITA004462,TCMBANKGE004462,ZNF334,-,zinc finger protein 334,20q13.12,protein-coding,/
CWITA004463,TCMBANKGE004463,STK40,SHIK; SgK495,serine/threonine kinase 40,1p34.3,protein-coding,/
CWITA004464,TCMBANKGE004464,HPT,HPTX; HYPX,hypoparathyroidism,Xq26-q27,N,
CWITA004465,TCMBANKGE004465,FMO3,FMOII; TMAU; dJ127D3.1,flavin containing dimethylaniline monoxygenase 3,1q24.3,protein-coding,/
CWITA004466,TCMBANKGE004466,DAZ2,pDP1678,deleted in azoospermia 2,Yq11.223,protein-coding,/
CWITA004467,TCMBANKGE004467,KAT2A,GCN5; GCN5L2; MGC102791; PCAFNb; hGCN5,K(lysine) acetyltransferase 2A,17q21,protein-coding,
CWITA004468,TCMBANKGE004468,IGF1,IGFNI; IGF1A; IGFI,insulin-like growth factor 1 (somatomedin C),12q23.2,protein-coding,
CWITA004469,TCMBANKGE004469,GNG4,-,G protein subunit gamma 4,1q42.3,protein-coding,/
CWITA004470,TCMBANKGE004470,TXNDC5,ENDOPDI; ERP46; HCC-2; HCC2; PDIA15; STRF8; UNQ364,thioredoxin domain containing 5,6p24.3,protein-coding,/
CWITA004471,TCMBANKGE004471,RTN4,ASY; NI220/250; NOGO; NSP; NSP-CL; Nbla00271; Nbla10545; RTN-X; RTN4-A; RTN4-B1; RTN4-B2; RTN4-C,reticulon 4,2p16.1,protein-coding,Research target
CWITA004472,TCMBANKGE004472,SDHB,FLJ92337; IP; PGL4; SDH; SDH1; SDH2; SDHIP,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",1p36.1-p35,protein-coding,
CWITA004473,TCMBANKGE004473,NAPRT,NAPRT1; PP3856,nicotinate phosphoribosyltransferase,8q24.3,protein-coding,/
CWITA004474,TCMBANKGE004474,ARSH,sulfatase,arylsulfatase family member H,Xp22.33,protein-coding,/
CWITA004475,TCMBANKGE004475,HNRNPL,HNRPL; P/OKcl.14; hnRNP-L,heterogeneous nuclear ribonucleoprotein L,19q13.2,protein-coding,/
CWITA004476,TCMBANKGE004476,FBH1,FBXO18; Fbx18; hFBH1,F-box DNA helicase 1,10p15.1,protein-coding,/
CWITA004477,TCMBANKGE004477,VWA1,WARP,von Willebrand factor A domain containing 1,1p36.33,protein-coding,/
CWITA004478,TCMBANKGE004478,ATG2A,-,autophagy related 2A,11q13.1,protein-coding,/
CWITA004479,TCMBANKGE004479,PPP2R1B,PP2A-Abeta; PR65B,protein phosphatase 2 scaffold subunit Abeta,11q23.1,protein-coding,/
CWITA004480,TCMBANKGE004480,CTNNB1,CTNNB; DKFZp686D02253; FLJ25606; FLJ37923,"catenin (cadherin-associated protein), beta 1, 88kDa",3p21,protein-coding,
CWITA004481,TCMBANKGE004481,WASF1,NEDALVS; SCAR1; WAVE; WAVE1,WASP family member 1,6q21,protein-coding,/
CWITA004482,TCMBANKGE004482,AVL9,KIAA0241,AVL9 cell migration associated,7p14.3,protein-coding,/
CWITA004483,TCMBANKGE004483,METRNL,-,"meteorin like, glial cell differentiation regulator",17q25.3,protein-coding,/
CWITA004484,TCMBANKGE004484,ARHGAP22,RhoGAP2; RhoGap22,Rho GTPase activating protein 22,10q11.22-q11.23,protein-coding,/
CWITA004485,TCMBANKGE004485,TMED4,ERS25; GMP25iso; HNLF; p24a3; p24alpha3,transmembrane p24 trafficking protein 4,7p13,protein-coding,/
CWITA004486,TCMBANKGE004486,USPL1,C13orf22; D13S106E; bA121O19.1,ubiquitin specific peptidase like 1,13q12.3,protein-coding,/
CWITA004487,TCMBANKGE004487,GRB7,-,growth factor receptor bound protein 7,17q12,protein-coding,/
CWITA004488,TCMBANKGE004488,LRTOMT,CFAP111; DFNB63; LRRC51,leucine rich transmembrane and O-methyltransferase domain containing,11q13.4,protein-coding,/
CWITA004489,TCMBANKGE004489,RABGGTA,PTAR3,Rab geranylgeranyltransferase subunit alpha,14q12,protein-coding,/
CWITA004490,TCMBANKGE004490,CHRM2,FLJ43243; HM2; MGC120006; MGC120007,"cholinergic receptor, muscarinic 2",7q31-q35,protein-coding,
CWITA004491,TCMBANKGE004491,SLC12A5,KCC2; KIAA1176,"solute carrier family 12 (potassium/chloride transporter), member 5",20q13.12,protein-coding,
CWITA004492,TCMBANKGE004492,SART1,Ara1; HAF; HOMS1; SART1259; SNRNP110; Snu66,"spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP",11q13.1,protein-coding,/
CWITA004493,TCMBANKGE004493,NOL6,NRAP; UTP22; bA311H10.1,nucleolar protein 6,9p13.3,protein-coding,/
CWITA004494,TCMBANKGE004494,CXCL14,BMAC; BRAK; KEC; KS1; MIP-2g; MIP2G; NJAC; SCYB14,C-X-C motif chemokine ligand 14,5q31.1,protein-coding,/
CWITA004495,TCMBANKGE004495,SLC22A4,DFNB60; OCTN1,solute carrier family 22 member 4,5q31.1,protein-coding,/
CWITA004496,TCMBANKGE004496,CUTA,ACHAP; C6orf82; MGC111154,cutA divalent cation tolerance homolog (E. coli),6p21.32,protein-coding,
CWITA004497,TCMBANKGE004497,SLC6A19,B0AT1; FLJ20680; FLJ34635; HND,"Solute Carrier Family 6 (Neutral Amino Acid Transporter), Member 19",5p15.33,protein-coding,
CWITA004498,TCMBANKGE004498,ABHD12,ABHD12A; BEM46L2; C20orf22; PHARC; dJ965G21.2; hABHD12,"abhydrolase domain containing 12, lysophospholipase",20p11.21,protein-coding,/
CWITA004499,TCMBANKGE004499,HOMER2,ACPD; CPD; DFNA68; HOMER-2; VESL-2,homer scaffold protein 2,15q25.2,protein-coding,/
CWITA004500,TCMBANKGE004500,SECTM1,K12; SECTM,secreted and transmembrane 1,17q25.3,protein-coding,/
CWITA004501,TCMBANKGE004501,GSPT2,ERF3B; GST2,G1 to S phase transition 2,Xp11.22,protein-coding,/
CWITA004502,TCMBANKGE004502,SMOC2,DTDP1; MST117; MSTP117; MSTP140; SMAP2; bA270C4A.1; bA37D8.1; dJ421D16.1,SPARC related modular calcium binding 2,6q27,protein-coding,/
CWITA004503,TCMBANKGE004503,LRRC30,-,leucine rich repeat containing 30,18p11.23,protein-coding,/
CWITA004504,TCMBANKGE004504,UBE2QL1,-,ubiquitin conjugating enzyme E2 Q family like 1,5p15.31,protein-coding,/
CWITA004505,TCMBANKGE004505,OSBPL9,ORP-9; ORP9,oxysterol binding protein like 9,1p32.3,protein-coding,/
CWITA004506,TCMBANKGE004506,SKP1,EMC19; OCP-II; OCP2; SKP1A; TCEB1L; p19A,S-phase kinase associated protein 1,5q31.1,protein-coding,/
CWITA004507,TCMBANKGE004507,SLC2A14,GLUT14; SLC2A3P3,solute carrier family 2 member 14,12p13.31,protein-coding,/
CWITA004508,TCMBANKGE004508,UGT3A1,-,UDP glycosyltransferase family 3 member A1,5p13.2,protein-coding,/
CWITA004509,TCMBANKGE004509,CACNA1B,BIII; CACNL1A5; CACNN; Cav2.2,"calcium channel, voltage-dependent, N type, alpha 1B subunit",9q34,protein-coding,
CWITA004510,TCMBANKGE004510,NLE1,NLE,notchless homolog 1,17q12,protein-coding,/
CWITA004511,TCMBANKGE004511,CHRM4,HM4; M4R,"cholinergic receptor, muscarinic 4",11p12-p11.2,protein-coding,
CWITA004512,TCMBANKGE004512,SLC44A5,CTL5,solute carrier family 44 member 5,1p31.1,protein-coding,/
CWITA004513,TCMBANKGE004513,LIPA,CESD; LAL,"lipase A, lysosomal acid type",10q23.31,protein-coding,Successful target
CWITA004514,TCMBANKGE004514,PLXND1,PLEXD1,plexin D1,3q22.1,protein-coding,/
CWITA004515,TCMBANKGE004515,NXN,NRX; RRS2; TRG-4,nucleoredoxin,17p13.3,protein-coding,/
CWITA004516,TCMBANKGE004516,GCY,STA; TS; TSY,"growth control, Y chromosome influenced",Yq11,unknown,/
CWITA004517,TCMBANKGE004517,FLVCR2,C14orf58; CCT; EPV; FLVCRL14q; MFSD7C; PVHH; SLC49A2,FLVCR heme transporter 2,14q24.3,protein-coding,/
CWITA004518,TCMBANKGE004518,ZNF621,-,zinc finger protein 621,3p22.1,protein-coding,/
CWITA004519,TCMBANKGE004519,SLC26A8,SPGF3; TAT1,solute carrier family 26 member 8,6p21.31,protein-coding,/
CWITA004520,TCMBANKGE004520,CYBRD1,CYB561A2; DCYTB; FRRS3,cytochrome b reductase 1,2q31.1,protein-coding,/
CWITA004521,TCMBANKGE004521,ADGRG2,CBAVDX; EDDM6; GPR64; HE6; TM7LN2,adhesion G protein-coupled receptor G2,Xp22.13,protein-coding,/
CWITA004522,TCMBANKGE004522,TKT,HEL-S-48; HEL107; SDDHD; TK; TKT1,transketolase,3p21.1,protein-coding,Research target
CWITA004523,TCMBANKGE004523,CANX,CNX; IP90; P90,calnexin,5q35.3,protein-coding,/
CWITA004524,TCMBANKGE004524,TRPC7,TRP7,transient receptor potential cation channel subfamily C member 7,5q31.1,protein-coding,Research target
CWITA004525,TCMBANKGE004525,ARID5B,DESRT; MRF-2; MRF2,AT-rich interaction domain 5B,10q21.2,protein-coding,/
CWITA004526,TCMBANKGE004526,NFATC4,NF-AT3; NF-ATC4; NFAT3,nuclear factor of activated T cells 4,14q12,protein-coding,/
CWITA004527,TCMBANKGE004527,MRPL19,L19mt; MRP-L15; MRP-L19; MRPL15; RLX1; RPML15,mitochondrial ribosomal protein L19,2p12,protein-coding,/
CWITA004528,TCMBANKGE004528,ZNF438,bA330O11.1,zinc finger protein 438,10p11.23,protein-coding,/
CWITA004529,TCMBANKGE004529,SYT2,CMS7; MYSPC; SytII,synaptotagmin 2,1q32.1,protein-coding,/
CWITA004530,TCMBANKGE004530,M6PR,CD-M6PR; CD-MPR; MPR 46; MPR-46; MPR46; SMPR,"mannose-6-phosphate receptor, cation dependent",12p13.31,protein-coding,Successful target
CWITA004531,TCMBANKGE004531,RCN2,E6BP; ERC-55; ERC55; TCBP49,reticulocalbin 2,15q24.3,protein-coding,/
CWITA004532,TCMBANKGE004532,AASS,LKR/SDH; LKRSDH; LORSDH,aminoadipate-semialdehyde synthase,7q31.3,protein-coding,
CWITA004533,TCMBANKGE004533,OPRK1,KOR; OPRK,"opioid receptor, kappa 1",8q11.2,protein-coding,
CWITA004534,TCMBANKGE004534,GLRX2,CGI-133; GRX2,glutaredoxin 2,1q31.2,protein-coding,Research target
CWITA004535,TCMBANKGE004535,CRH,CRF,corticotropin releasing hormone,8q13,protein-coding,
CWITA004536,TCMBANKGE004536,SEMA4A,CORD10; RP35; SEMAB; SEMB,semaphorin 4A,1q22,protein-coding,/
CWITA004537,TCMBANKGE004537,PCYT1B,CCTB; CTB,"phosphate cytidylyltransferase 1, choline, beta",Xp22.11,protein-coding,
CWITA004538,TCMBANKGE004538,LORICRIN,LOR,loricrin cornified envelope precursor protein,1q21.3,protein-coding,/
CWITA004539,TCMBANKGE004539,HNMT,HMT; HNMT-S1; HNMT-S2; MRT51,histamine N-methyltransferase,2q22.1,protein-coding,Successful target
CWITA004540,TCMBANKGE004540,FBXL22,Fbl22,F-box and leucine rich repeat protein 22,15q22.31,protein-coding,/
CWITA004541,TCMBANKGE004541,NCBP2,CBC2; CBP20; NIP1; PIG55,nuclear cap binding protein subunit 2,3q29,protein-coding,/
CWITA004542,TCMBANKGE004542,ZNF562,-,zinc finger protein 562,19p13.2,protein-coding,/
CWITA004543,TCMBANKGE004543,TERF1,PIN2; TRBF1; TRF; TRF1; hTRF1-AS; t-TRF1,telomeric repeat binding factor 1,8q21.11,protein-coding,Research target
CWITA004544,TCMBANKGE004544,LGALS1,DKFZp686E23103; GAL1; GBP,"lectin, galactoside-binding, soluble, 1",22q13.1,protein-coding,
CWITA004545,TCMBANKGE004545,CTSA,GLB2; GSL; NGBE; PPCA; PPGB,cathepsin A,20q13.1,protein-coding,
CWITA004546,TCMBANKGE004546,AMOTL1,JEAP,angiomotin like 1,11q21,protein-coding,/
CWITA004547,TCMBANKGE004547,DTX4,RNF155,deltex E3 ubiquitin ligase 4,11q12.1,protein-coding,/
CWITA004548,TCMBANKGE004548,CCR9,CC-CKR-9; CDw199; GPR-9-6; GPR28,C-C motif chemokine receptor 9,3p21.31,protein-coding,Clinical Trial target
CWITA004549,TCMBANKGE004549,RBM25,NET52; RED120; RNPC7; S164; Snu71; fSAP94,RNA binding motif protein 25,14q24.2,protein-coding,/
CWITA004550,TCMBANKGE004550,LRRC20,-,leucine rich repeat containing 20,10q22.1,protein-coding,/
CWITA004551,TCMBANKGE004551,FAM174B,-,family with sequence similarity 174 member B,15q26.1,protein-coding,/
CWITA004552,TCMBANKGE004552,KCNA2,HBK5; HK4; HUKIV; KV1.2; MGC50217; MK2; NGK1; RBK2,"potassium voltage-gated channel, shaker-related subfamily, member 2",1p13,protein-coding,
CWITA004553,TCMBANKGE004553,CYP21A2,CA21H; CAH1; CPS1; CYP21; CYP21B; P450c21B,cytochrome P450 family 21 subfamily A member 2,6p21.33,protein-coding,/
CWITA004554,TCMBANKGE004554,AGPAT3,1-AGPAT 3; LPAAT-GAMMA1; LPAAT3,1-acylglycerol-3-phosphate O-acyltransferase 3,21q22.3,protein-coding,/
CWITA004555,TCMBANKGE004555,CD79A,IGA; MB-1,CD79a molecule,19q13.2,protein-coding,/
CWITA004556,TCMBANKGE004556,LDHAL6A,LDH6A; MGC23940,lactate dehydrogenase A-like 6A,11p15.1,protein-coding,
CWITA004557,TCMBANKGE004557,FGFR2,BEK; BFRN1; CD332; CEK3; CFD1; ECT1; FLJ98662; JWS; KNSAM; KGFR; TK14; TK25,fibroblast growth factor receptor 2,10q26,protein-coding,
CWITA004558,TCMBANKGE004558,ATOX1,ATX1; HAH1; MGC138453; MGC138455,ATX1 antioxidant protein 1 homolog (yeast),5q32,protein-coding,
CWITA004559,TCMBANKGE004559,SOAT1,ACACT; ACAT; ACAT1; RP11N215I23.2; SOAT; STAT,sterol O-acyltransferase 1,1q25,protein-coding,
CWITA004560,TCMBANKGE004560,CMTM6,CKLFSF6; PRO2219,CKLF like MARVEL transmembrane domain containing 6,3p22.3,protein-coding,/
CWITA004561,TCMBANKGE004561,MRPL9,L9mt,mitochondrial ribosomal protein L9,1q21.3,protein-coding,/
CWITA004562,TCMBANKGE004562,CP,CP-2,ceruloplasmin,3q24-q25.1,protein-coding,/
CWITA004563,TCMBANKGE004563,PYROXD2,C10orf33; FP3420; YUEF,pyridine nucleotide-disulphide oxidoreductase domain 2,10q24.2,protein-coding,/
CWITA004564,TCMBANKGE004564,TMEM266,C15orf27; HVRP1; HsHVRP1; hTMEM266,transmembrane protein 266,15q24.2,protein-coding,/
CWITA004565,TCMBANKGE004565,LRG1,HMFT1766; LRG,leucine rich alpha-2-glycoprotein 1,19p13.3,protein-coding,/
CWITA004566,TCMBANKGE004566,CIB2,DFNB48; KIP2; USH1J,calcium and integrin binding family member 2,15q25.1,protein-coding,/
CWITA004567,TCMBANKGE004567,UGT1A9,HLUGP4; LUGP4; UDPGT; UDPGT_1N9; UGTN1I; UGT1N09; UGT1N9; UGT1.9; UGT1AI; UGT1I,"UDP glucuronosyltransferase 1 family, polypeptide A9",2q37,protein-coding,
CWITA004568,TCMBANKGE004568,MAP3K4,MAPKKK4; MEKK 4; MEKK4; MTK1; PRO0412,mitogen-activated protein kinase kinase kinase 4,6q26,protein-coding,Research target
CWITA004569,TCMBANKGE004569,PFDN2,PFD2,prefoldin subunit 2,1q23.3,protein-coding,/
CWITA004570,TCMBANKGE004570,VPS16,hVPS16,VPS16 core subunit of CORVET and HOPS complexes,20p13,protein-coding,/
CWITA004571,TCMBANKGE004571,ACCS,ACS; PHACS,1-aminocyclopropane-1-carboxylate synthase homolog (inactive),11p11.2,protein-coding,/
CWITA004572,TCMBANKGE004572,KLF1,EKLF; EKLF/KLF1,Kruppel like factor 1,19p13.13,protein-coding,/
CWITA004573,TCMBANKGE004573,KCNJ10,BIRK-10; KCNJ13-PEN; KIR1.2; KIR4.1; SESAME,potassium inwardly rectifying channel subfamily J member 10,1q23.2,protein-coding,Successful target
CWITA004574,TCMBANKGE004574,ZSCAN21,NY-REN-21; ZNF38; Zipro1,zinc finger and SCAN domain containing 21,7q22.1,protein-coding,/
CWITA004575,TCMBANKGE004575,UBE2E3,UBCH9; UbcM2,ubiquitin conjugating enzyme E2 E3,2q31.3,protein-coding,/
CWITA004576,TCMBANKGE004576,SLC17A3,GOUT4; NPT4; UAQTL4,solute carrier family 17 member 3,6p22.2,protein-coding,/
CWITA004577,TCMBANKGE004577,HPN,TMPRSS1,hepsin,19q11-q13.2,protein-coding,
CWITA004578,TCMBANKGE004578,PADI2,KIAA0994; PADNH19; PAD2; PDI2,"peptidyl arginine deiminase, type II",1p36.13,protein-coding,
CWITA004579,TCMBANKGE004579,PSMC2,MSS1; Nbla10058; S7,"proteasome 26S subunit, ATPase 2",7q22.1,protein-coding,/
CWITA004580,TCMBANKGE004580,RXRB,DAUDI6; HN2RIIBP; MGC1831; NR2B2; RCoRN1,"retinoid X receptor, beta",6p21.3,protein-coding,
CWITA004581,TCMBANKGE004581,TMEM63A,HLD19; KIAA0792,transmembrane protein 63A,1q42.12,protein-coding,/
CWITA004582,TCMBANKGE004582,LGALS3BP,90K; BTBD17B; CyCAP; M2BP; MAC-2-BP; TANGO10B; gp90,galectin 3 binding protein,17q25.3,protein-coding,/
CWITA004583,TCMBANKGE004583,ACP2,LAP,"acid phosphatase 2, lysosomal",11p11.2|11p12-p11,protein-coding,/
CWITA004584,TCMBANKGE004584,KIF26B,-,kinesin family member 26B,1q44,protein-coding,Research target
CWITA004585,TCMBANKGE004585,CD5,LEU1; T1,CD5 molecule,11q12.2,protein-coding,Research target
CWITA004586,TCMBANKGE004586,CSE1L,CAS; CSE1; XPO2,chromosome segregation 1 like,20q13.13,protein-coding,Research target
CWITA004587,TCMBANKGE004587,SLC25A1,CMS23; CTP; D2L2AD; SEA; SLC20A3,solute carrier family 25 member 1,22q11.21,protein-coding,Research target
CWITA004588,TCMBANKGE004588,ZNF250,ZFP647; ZNF647,zinc finger protein 250,8q24.3,protein-coding,/
CWITA004589,TCMBANKGE004589,SMS,MRSR; SPMSY; SRS; SpS,spermine synthase,Xp22.1,protein-coding,
CWITA004590,TCMBANKGE004590,NLRC5,CLR16.1; NOD27; NOD4,NLR family CARD domain containing 5,16q13,protein-coding,Research target
CWITA004591,TCMBANKGE004591,SLC7A2,ATRC2; CAT2; HCAT2,solute carrier family 7 member 2,8p22,protein-coding,/
CWITA004592,TCMBANKGE004592,SCNN1A,BESC2; ENaCa; ENaCalpha; LIDLS3; SCNEA; SCNN1,sodium channel epithelial 1 subunit alpha,12p13.31,protein-coding,/
CWITA004593,TCMBANKGE004593,MCM3AP,GANP; MAP80; PNRIID; SAC3,minichromosome maintenance complex component 3 associated protein,21q22.3,protein-coding,/
CWITA004594,TCMBANKGE004594,LAIR1,CD305; LAIR-1,leukocyte associated immunoglobulin like receptor 1,19q13.42,protein-coding,/
CWITA004595,TCMBANKGE004595,RBMS1,C2orf12; HCC-4; MSSP; MSSP-1; MSSP-2; MSSP-3; SCR2; YC1,RNA binding motif single stranded interacting protein 1,2q24.2,protein-coding,/
CWITA004596,TCMBANKGE004596,OVGP1,CHIT5; EGP; MUC9; OGP,oviductal glycoprotein 1,1p13.2,protein-coding,/
CWITA004597,TCMBANKGE004597,ATL3,HSN1F,atlastin GTPase 3,11q13.1,protein-coding,/
CWITA004598,TCMBANKGE004598,RUVBL1,ECP-54; ECP54; INO80H; NMP 238; NMP238; PONTIN; Pontin52; RVB1; TIH1; TIP49; TIP49A,RuvB like AAA ATPase 1,3q21.3,protein-coding,/
CWITA004599,TCMBANKGE004599,ATAD2B,-,ATPase family AAA domain containing 2B,2p24.1-p23.3,protein-coding,/
CWITA004600,TCMBANKGE004600,WNT5B,-,Wnt family member 5B,12p13.33,protein-coding,/
CWITA004601,TCMBANKGE004601,DMKN,UNQ729; ZD52F10,dermokine,19q13.12,protein-coding,/
CWITA004602,TCMBANKGE004602,A2M,CPAMD5; DKFZp779B086; S863-7,alpha-2-macroglobulin,12p13.31,protein-coding,
CWITA004603,TCMBANKGE004603,STOML2,HSPC108; SLP-2,stomatin like 2,9p13.3,protein-coding,Research target
CWITA004604,TCMBANKGE004604,BICDL1,BICDR-1; BICDR1; CCDC64; CCDC64A; H_267D11.1,BICD family like cargo adaptor 1,12q24.23,protein-coding,/
CWITA004605,TCMBANKGE004605,EPB41L4B,CG1; EHM2; LULU2,erythrocyte membrane protein band 4.1 like 4B,9q31.3,protein-coding,/
CWITA004606,TCMBANKGE004606,F9,FIX; HEMB; MGC129641; MGC129642; P19; PTC,coagulation factor IX,Xq27.1-q27.2,protein-coding,
CWITA004607,TCMBANKGE004607,RAB28,CORD18,"RAB28, member RAS oncogene family",4p15.33,protein-coding,/
CWITA004608,TCMBANKGE004608,ARHGEF25,GEFT; p63RhoGEF,Rho guanine nucleotide exchange factor 25,12q13.3,protein-coding,/
CWITA004609,TCMBANKGE004609,CCS,-,copper chaperone for superoxide dismutase,11q13.2,protein-coding,/
CWITA004610,TCMBANKGE004610,ARG1,N,"arginase, liver",6q23,protein-coding,
CWITA004611,TCMBANKGE004611,IL24,C49A; FISP; IL10B; MDA7; MOB5; ST16,interleukin 24,1q32.1,protein-coding,Clinical Trial target
CWITA004612,TCMBANKGE004612,BCAN,BEHAB; CSPG7,brevican,1q23.1,protein-coding,/
CWITA004613,TCMBANKGE004613,ITGB3BP,CENP-R; CENPR; HSU37139; NRIF3; TAP20,integrin subunit beta 3 binding protein,1p31.3,protein-coding,/
CWITA004614,TCMBANKGE004614,ASPH,AAH; BAH; CASQ2BP1; FDLAB; HAAH; JCTN; junctin,aspartate beta-hydroxylase,8q12.3,protein-coding,Research target
CWITA004615,TCMBANKGE004615,ZNF433,-,zinc finger protein 433,19p13.2,protein-coding,/
CWITA004616,TCMBANKGE004616,RBM45,DRB1; RB-1,RNA binding motif protein 45,2q31.2,protein-coding,/
CWITA004617,TCMBANKGE004617,TRAFD1,FLN29,TRAF-type zinc finger domain containing 1,12q24.13,protein-coding,/
CWITA004618,TCMBANKGE004618,ACOT6,C14orf42; c14_5530,acyl-CoA thioesterase 6,14q24.3,protein-coding,/
CWITA004619,TCMBANKGE004619,AP2A1,ADTAA; AP2-ALPHA; CLAPA1,adaptor related protein complex 2 subunit alpha 1,19q13.33,protein-coding,/
CWITA004620,TCMBANKGE004620,UBE2B,E2-17kDa; HHR6B; HR6B; RAD6B; UBC2,ubiquitin conjugating enzyme E2 B,5q31.1,protein-coding,/
CWITA004621,TCMBANKGE004621,RPS21,HLDF; S21,ribosomal protein S21,20q13.33,protein-coding,/
CWITA004622,TCMBANKGE004622,TBC1D1,TBC; TBC1,TBC1 domain family member 1,4p14,protein-coding,/
CWITA004623,TCMBANKGE004623,EIF1AX,EIF1A; EIF1AP1; EIF4C; eIF-1A; eIF-4C,eukaryotic translation initiation factor 1A X-linked,Xp22.12,protein-coding,/
CWITA004624,TCMBANKGE004624,FZD4,CD344; EVR1; FEVR; FZD4S; Fz-4; Fz4; FzE4; GPCR; hFz4,frizzled class receptor 4,11q14.2,protein-coding,/
CWITA004625,TCMBANKGE004625,TDRP,C8orf42; Inm01; TDRP1; TDRP2,testis development related protein,8p23.3,protein-coding,/
CWITA004626,TCMBANKGE004626,CDIPT,MGC1328; PIS; PIS1,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,16p11.2,protein-coding,
CWITA004627,TCMBANKGE004627,PEAR1,JEDI; MEGF12,platelet endothelial aggregation receptor 1,1q23.1,protein-coding,/
CWITA004628,TCMBANKGE004628,NIT2,HEL-S-8a,nitrilase family member 2,3q12.2,protein-coding,/
CWITA004629,TCMBANKGE004629,LRRC55,-,leucine rich repeat containing 55,11q12.1,protein-coding,/
CWITA004630,TCMBANKGE004630,TADA1,ADA1; HFI1; STAF42; TADA1L; hADA1,transcriptional adaptor 1,1q24.1,protein-coding,/
CWITA004631,TCMBANKGE004631,GPI,AMF; DKFZp686C13233; GNPI; NLK; PGI; PHI; SAN36; SA36,glucose-6-phosphate isomerase,19q13.1,protein-coding,
CWITA004632,TCMBANKGE004632,LCN12,-,lipocalin 12,9q34.3,protein-coding,/
CWITA004633,TCMBANKGE004633,RBL2,P130; Rb2,RB transcriptional corepressor like 2,16q12.2,protein-coding,/
CWITA004634,TCMBANKGE004634,FAM83D,C20orf129; CHICA; dJ616B8.3,family with sequence similarity 83 member D,20q11.23,protein-coding,Research target
CWITA004635,TCMBANKGE004635,MDC1,NFBD1,mediator of DNA damage checkpoint 1,6p21.33,protein-coding,/
CWITA004636,TCMBANKGE004636,HGS,FLJ11421; FLJ39878; HRS,hepatocyte growth factor-regulated tyrosine kinase substrate,17q25,protein-coding,
CWITA004637,TCMBANKGE004637,IL18R1,CD218a; CDw218a; IL-18R-alpha; IL-18Ralpha; IL-1Rrp; IL18RA; IL18Ralpha2; IL1RRP,interleukin 18 receptor 1,2q12.1,protein-coding,/
CWITA004638,TCMBANKGE004638,HENMT1,C1orf59; HEN1,HEN methyltransferase 1,1p13.3,protein-coding,/
CWITA004639,TCMBANKGE004639,SHPK,CARKL; SHK,sedoheptulokinase,17p13.2,protein-coding,/
CWITA004640,TCMBANKGE004640,F13B,FXIIIB,coagulation factor XIII B chain,1q31.3,protein-coding,Clinical Trial target
CWITA004641,TCMBANKGE004641,CDC37L1,CDC37B; HARC,cell division cycle 37 like 1,9p24.1,protein-coding,/
CWITA004642,TCMBANKGE004642,GPATCH2L,C14orf118,G-patch domain containing 2 like,14q24.3,protein-coding,/
CWITA004643,TCMBANKGE004643,AGPAT5,1AGPAT5; LPAATE,1-acylglycerol-3-phosphate O-acyltransferase 5,8p23.1,protein-coding,/
CWITA004644,TCMBANKGE004644,KMT2A,ALL-1; CXXC7; HRX; HTRX1; MLL; MLL1; MLL1A; TRX1; WDSTS,lysine methyltransferase 2A,11q23.3,protein-coding,Research target
CWITA004645,TCMBANKGE004645,PCYT2,ET; SPG82,"phosphate cytidylyltransferase 2, ethanolamine",17q25.3,protein-coding,/
CWITA004646,TCMBANKGE004646,LIMCH1,LIMCH1A; LMO7B,LIM and calponin homology domains 1,4p13,protein-coding,/
CWITA004647,TCMBANKGE004647,ITPRIPL1,KIAA1754L,ITPRIP like 1,2q11.2,protein-coding,/
CWITA004648,TCMBANKGE004648,SRP68,-,signal recognition particle 68,17q25.1,protein-coding,/
CWITA004649,TCMBANKGE004649,DCHS2,CDH27; CDHJ; CDHR7; PCDH23; PCDHJ,dachsous cadherin-related 2,4q31.3,protein-coding,/
CWITA004650,TCMBANKGE004650,ZNF516,HsT287,zinc finger protein 516,18q23,protein-coding,/
CWITA004651,TCMBANKGE004651,FAM168A,KIAA0280; TCRP1,family with sequence similarity 168 member A,11q13.4,protein-coding,/
CWITA004652,TCMBANKGE004652,CNNM3,ACDP3,cyclin and CBS domain divalent metal cation transport mediator 3,2q11.2,protein-coding,/
CWITA004653,TCMBANKGE004653,HARS1,CMT2W; HARS; HRS; USH3B,histidyl-tRNA synthetase 1,5q31.3,protein-coding,/
CWITA004654,TCMBANKGE004654,TLL2,-,tolloid like 2,10q24.1,protein-coding,/
CWITA004655,TCMBANKGE004655,NADK2,C5orf33; DECRD; MNADK; NADKD1,"NAD kinase 2, mitochondrial",5p13.2,protein-coding,/
CWITA004656,TCMBANKGE004656,ELMO2,CED-12; CED12; Ced-12A; ELMO-2; VMPI,engulfment and cell motility 2,20q13.12,protein-coding,/
CWITA004657,TCMBANKGE004657,CHAD,SLRR4A,chondroadherin,17q21.33,protein-coding,/
CWITA004658,TCMBANKGE004658,PRUNE1,DRES-17; DRES17; H-PRUNE; HTCD37; NMIHBA; PRUNE,prune exopolyphosphatase 1,1q21.3,protein-coding,/
CWITA004659,TCMBANKGE004659,STK17B,DRAK2,serine/threonine kinase 17b,2q32.3,protein-coding,
CWITA004660,TCMBANKGE004660,RBM14,COAA; PSP2; SIP; SYTIP1; TMEM137,Rna_Binding_Motif_Protein_14,11q13.2,protein-coding,
CWITA004661,TCMBANKGE004661,SP110,IFI41; IFI75; IPR1; VODI,SP110 nuclear body protein,2q37.1,protein-coding,/
CWITA004662,TCMBANKGE004662,SLC9B1,NHA1; NHEDC1,solute carrier family 9 member B1,4q24,protein-coding,/
CWITA004663,TCMBANKGE004663,MRPS31,IMOGN38; MRP-S31; S31mt,mitochondrial ribosomal protein S31,13q14.11,protein-coding,/
CWITA004664,TCMBANKGE004664,CDY1,CDY; CDY1A,chromodomain Y-linked 1,Yq11.23,protein-coding,/
CWITA004665,TCMBANKGE004665,SLC29A1,ENT1; MGC1465; MGC3778,"solute carrier family 29 (nucleoside transporters), member 1",6p21.1,protein-coding,
CWITA004666,TCMBANKGE004666,OAS3,p100; p100OAS,2'-5'-oligoadenylate synthetase 3,12q24.13,protein-coding,/
CWITA004667,TCMBANKGE004667,INTS11,CPSF3L; CPSF73L; INT11; RC-68; RC68,integrator complex subunit 11,1p36.33,protein-coding,/
CWITA004668,TCMBANKGE004668,PIM2,-,"Pim-2 proto-oncogene, serine/threonine kinase",Xp11.23,protein-coding,Clinical Trial target
CWITA004669,TCMBANKGE004669,IGF2BP2,IMP-2; IMP2; VICKZ2,insulin like growth factor 2 mRNA binding protein 2,3q27.2,protein-coding,/
CWITA004670,TCMBANKGE004670,CYB5R3,B5R; DIA1,cytochrome b5 reductase 3,22q13.2,protein-coding,/
CWITA004671,TCMBANKGE004671,UBAC1,GBDR1; KPC2; UBADC1,UBA domain containing 1,9q34.3,protein-coding,/
CWITA004672,TCMBANKGE004672,TMEM87A,-,transmembrane protein 87A,15q15.1,protein-coding,/
CWITA004673,TCMBANKGE004673,GRIA4,GLUR4; GLUR4C; GLURD; GluA4,"glutamate receptor, ionotrophic, AMPA 4",11q22,protein-coding,
CWITA004674,TCMBANKGE004674,ARHGAP39,CrGAP; Vilse,Rho GTPase activating protein 39,8q24.3,protein-coding,/
CWITA004675,TCMBANKGE004675,CARD14,BIMP2; CARMA2; PRP; PSORS2; PSS1,caspase recruitment domain family member 14,17q25.3,protein-coding,/
CWITA004676,TCMBANKGE004676,AKR1D1,3o5bred; CBAS2; SRD5B1,"aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)",7q32-q33,protein-coding,
CWITA004677,TCMBANKGE004677,RILP,PP10141,Rab interacting lysosomal protein,17p13.3,protein-coding,/
CWITA004678,TCMBANKGE004678,RFC3,RFC38,replication factor C subunit 3,13q13.2,protein-coding,/
CWITA004679,TCMBANKGE004679,ZIM3,ZNF264; ZNF657,zinc finger imprinted 3,19q13.43,protein-coding,/
CWITA004680,TCMBANKGE004680,LDHAL6B,LDH6B; LDHAL6; LDHL,lactate dehydrogenase A like 6B,15q22.2,protein-coding,/
CWITA004681,TCMBANKGE004681,CCN4,WISP1; WISP1-OT1; WISP1-UT1; WISP1c; WISP1i; WISP1tc,cellular communication network factor 4,8q24.22,protein-coding,/
CWITA004682,TCMBANKGE004682,FAM102A,C9orf132; EEIG1; SYM-3A; bA203J24.7,family with sequence similarity 102 member A,9q34.11,protein-coding,/
CWITA004683,TCMBANKGE004683,BCAR1,CAS; CAS1; CASS1; CRKAS; P130Cas,"BCAR1 scaffold protein, Cas family member",16q23.1,protein-coding,/
CWITA004684,TCMBANKGE004684,KLK6,Bssp; Klk7; PRSS18; PRSS9; SP59; hK6,kallikrein related peptidase 6,19q13.41,protein-coding,Research target
CWITA004685,TCMBANKGE004685,IGSF10,CMF608,immunoglobulin superfamily member 10,3q25.1,protein-coding,/
CWITA004686,TCMBANKGE004686,RBMS2,SCR3,RNA binding motif single stranded interacting protein 2,12q13.3,protein-coding,/
CWITA004687,TCMBANKGE004687,TREM1,CD354; TREM-1,triggering receptor expressed on myeloid cells 1,6p21.1,protein-coding,/
CWITA004688,TCMBANKGE004688,FTHL17,CT38,ferritin heavy chain like 17,Xp21.2,protein-coding,/
CWITA004689,TCMBANKGE004689,NXF1,MEX67; TAP,nuclear RNA export factor 1,11q12.3,protein-coding,/
CWITA004690,TCMBANKGE004690,CXCR4,CD184; D2S201E; FB22; HM89; HSY3RR; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM,chemokine (C-X-C motif) receptor 4,2q21,protein-coding,
CWITA004691,TCMBANKGE004691,PDZK1IP1,DD96; MAP17; SPAP,PDZK1 interacting protein 1,1p33,protein-coding,/
CWITA004692,TCMBANKGE004692,SNRPA,Mud1; U1NA; U1A,small nuclear ribonucleoprotein polypeptide A,19q13.1,protein-coding,
CWITA004693,TCMBANKGE004693,TENT5B,FAM46B,terminal nucleotidyltransferase 5B,1p36.11,protein-coding,/
CWITA004694,TCMBANKGE004694,WDR6,-,WD repeat domain 6,3p21.31,protein-coding,/
CWITA004695,TCMBANKGE004695,ZNF33A,KOX2; KOX31; KOX5; NF11A; ZNF11; ZNF11A; ZNF33; ZZAPK,zinc finger protein 33A,10p11.1,protein-coding,/
CWITA004696,TCMBANKGE004696,MAP4,DKFZp779A1753; MGC8617,microtubule-associated protein 4,3p21,protein-coding,
CWITA004697,TCMBANKGE004697,TTC33,OSRF,tetratricopeptide repeat domain 33,5p13.1,protein-coding,/
CWITA004698,TCMBANKGE004698,ZNF239,HOK-2; MOK2,zinc finger protein 239,10q11.21,protein-coding,/
CWITA004699,TCMBANKGE004699,EBI3,IL-27B; IL27B; IL35B,Epstein-Barr virus induced 3,19p13.3,protein-coding,Research target
CWITA004700,TCMBANKGE004700,HUNK,-,hormonally up-regulated Neu-associated kinase,21q22.11,protein-coding,/
CWITA004701,TCMBANKGE004701,MTFP1,HSPC242; MTP18,mitochondrial fission process 1,22q12.2,protein-coding,/
CWITA004702,TCMBANKGE004702,EEF1AKMT3,FAM119B; METTL21B,EEF1A lysine methyltransferase 3,12q14.1,protein-coding,/
CWITA004703,TCMBANKGE004703,GABRD,EIG10; EJM7; GEFSP5,gamma-aminobutyric acid type A receptor subunit delta,1p36.33,protein-coding,Successful target
CWITA004704,TCMBANKGE004704,SHMT2,GLYA; SHMT,serine hydroxymethyltransferase 2 (mitochondrial),12q12-q14,protein-coding,
CWITA004705,TCMBANKGE004705,ANKRA2,ANKRA,ankyrin repeat family A member 2,5q13.2,protein-coding,/
CWITA004706,TCMBANKGE004706,MOGS,CDG2B; CWH41; DER7; GCS1,mannosyl-oligosaccharide glucosidase,2p13.1,protein-coding,/
CWITA004707,TCMBANKGE004707,KCNE4,MIRP3,potassium voltage-gated channel subfamily E regulatory subunit 4,2q36.1,protein-coding,/
CWITA004708,TCMBANKGE004708,SLC25A19,DNC; MCPHA; MUP1; THMD3; THMD4; TPC,solute carrier family 25 member 19,17q25.1,protein-coding,/
CWITA004709,TCMBANKGE004709,HTR3D,5HT3D,5-hydroxytryptamine receptor 3D,3q27.1,protein-coding,/
CWITA004710,TCMBANKGE004710,ATP2B2,PMCA2; PMCA2a; PMCA2i,ATPase plasma membrane Ca2+ transporting 2,3p25.3,protein-coding,/
CWITA004711,TCMBANKGE004711,SEL1L3,Sel-1L3,SEL1L family member 3,4p15.2,protein-coding,/
CWITA004712,TCMBANKGE004712,AVPR1B,AVPR3,arginine vasopressin receptor 1B,1q32,protein-coding,
CWITA004713,TCMBANKGE004713,STMN2,SCG10; SCGN10,stathmin 2,8q21.13,protein-coding,/
CWITA004714,TCMBANKGE004714,ANKRD7,TSA806,ankyrin repeat domain 7,7q31.31,protein-coding,/
CWITA004715,TCMBANKGE004715,TAFA5,FAM19A5; QLLK5208; TAFA-5; UNQ5208,TAFA chemokine like family member 5,22q13.32,protein-coding,/
CWITA004716,TCMBANKGE004716,CNIH4,CNIH-4; CNIH2; HSPC163,cornichon family AMPA receptor auxiliary protein 4,1q42.11,protein-coding,/
CWITA004717,TCMBANKGE004717,PLIN4,KIAA1881; S3-12,perilipin 4,19p13.3,protein-coding,/
CWITA004718,TCMBANKGE004718,PRPS1,ARTS; CMTX5; DFN2; DFNX1; PPRibP; PRS-I; PRSI,phosphoribosyl pyrophosphate synthetase 1,Xq22.3,protein-coding,/
CWITA004719,TCMBANKGE004719,PIK3R4,VPS15; p150,phosphoinositide-3-kinase regulatory subunit 4,3q22.1,protein-coding,/
CWITA004720,TCMBANKGE004720,P2RX5,LRH-1; P2X5; P2X5R,purinergic receptor P2X 5,17p13.2,protein-coding,/
CWITA004721,TCMBANKGE004721,SPINK13,HBVDNAPTP1; HESPINTOR; LiESP6; SPINK5L3,serine peptidase inhibitor Kazal type 13,5q32,protein-coding,/
CWITA004722,TCMBANKGE004722,RIMS3,NIM3; RIM 3; RIM3,regulating synaptic membrane exocytosis 3,1p34.2,protein-coding,/
CWITA004723,TCMBANKGE004723,AKAP13,AKAP-13; AKAP-Lbc; ARHGEF13; BRX; HA-3; Ht31; LBC; PRKA13; PROTO-LB; PROTO-LBC; c-lbc; p47,A-kinase anchoring protein 13,15q25.3,protein-coding,/
CWITA004724,TCMBANKGE004724,FBN1,ACMICD; ECTOL1; FBN; GPHYSD2; MASS; MFLS; MFS1; OCTD; SGS; SSKS; WMS; WMS2,fibrillin 1,15q21.1,protein-coding,/
CWITA004725,TCMBANKGE004725,TRPV1,DKFZp434K0220; VR1,"transient receptor potential cation channel, subfamily V, member 1",17p13.2,protein-coding,
CWITA004726,TCMBANKGE004726,SLC43A2,LAT4,solute carrier family 43 member 2,17p13.3,protein-coding,/
CWITA004727,TCMBANKGE004727,TRAF3IP2,ACT1; C6orf2; C6orf4; C6orf5; C6orf6; CANDF8; CIKS; PSORS13,TRAF3 interacting protein 2,6q21,protein-coding,/
CWITA004728,TCMBANKGE004728,ACTR8,ARP8; INO80N; hArp8,actin related protein 8,3p21.1,protein-coding,/
CWITA004729,TCMBANKGE004729,ZSCAN5C,ZNF495C; ZSCAN5CP,zinc finger and SCAN domain containing 5C,19q13.43,protein-coding,/
CWITA004730,TCMBANKGE004730,RMI2,BLAP18; C16orf75,RecQ mediated genome instability 2,16p13.13,protein-coding,/
CWITA004731,TCMBANKGE004731,ABCB5,ABCB5alpha; ABCB5beta; EST422562,ATP binding cassette subfamily B member 5,7p21.1,protein-coding,/
CWITA004732,TCMBANKGE004732,TWIST2,AMS; BBRSAY; DERMO1; FFDD3; SETLSS; bHLHa39,Twist_Family_Bhlh_Transcription_Factor_2,2q37.3,protein-coding,
CWITA004733,TCMBANKGE004733,ZNF713,-,zinc finger protein 713,7p11.2,protein-coding,/
CWITA004734,TCMBANKGE004734,PLA2G2F,GIIFsPLA2; sPLA2-IIF,phospholipase A2 group IIF,1p36.12,protein-coding,/
CWITA004735,TCMBANKGE004735,FGF14,FGF-14; FHF-4; FHF4; SCA27,fibroblast growth factor 14,13q33.1,protein-coding,Research target
CWITA004736,TCMBANKGE004736,SERPINA5,PAI-3; PAI3; PCI; PCI-B; PLANH3; PROCI,serpin family A member 5,14q32.13,protein-coding,/
CWITA004737,TCMBANKGE004737,TM4SF19,OCTM4,transmembrane 4 L six family member 19,3q29,protein-coding,/
CWITA004738,TCMBANKGE004738,PEG10,EDR; HB-1; MEF3L; Mar2; Mart2; RGAG3; RTL2; SIRH1,paternally expressed 10,7q21.3,protein-coding,/
CWITA004739,TCMBANKGE004739,RAB14,FBP; RAB-14,"RAB14, member RAS oncogene family",9q33.2,protein-coding,/
CWITA004740,TCMBANKGE004740,CRTAP,CASP; LEPREL3; OI7; P3H5,cartilage associated protein,3p22.3,protein-coding,/
CWITA004741,TCMBANKGE004741,TPM3,CAPM1; CFTD; HEL-189; HEL-S-82p; NEM1; OK/SW-cl.5; TM-5; TM3; TM30; TM30nm; TM5; TPM3nu; TPMsk3; TRK; hscp30,tropomyosin 3,1q21.3,protein-coding,/
CWITA004742,TCMBANKGE004742,GALNT6,GALNAC-T6; GalNAcT6,polypeptide N-acetylgalactosaminyltransferase 6,12q13.13,protein-coding,/
CWITA004743,TCMBANKGE004743,KEL,CD238; ECE3,"Kell blood group, metallo-endopeptidase",7q33,protein-coding,
CWITA004744,TCMBANKGE004744,GTF2H2,BTF2; BTF2P44; T-BTF2P44; TFIIH; p44,general transcription factor IIH subunit 2,5q13.2,protein-coding,/
CWITA004745,TCMBANKGE004745,AADAC,CES5A1; DAC,arylacetamide deacetylase,3q25.1,protein-coding,/
CWITA004746,TCMBANKGE004746,BCR,ALL; BCR1; CML; D22S11; D22S662; FLJ16453; PHL,breakpoint cluster region,22q11|22q11.23,protein-coding,
CWITA004747,TCMBANKGE004747,KAT5,ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; cPLA2,K(lysine) acetyltransferase 5,11q13,protein-coding,
CWITA004748,TCMBANKGE004748,NPFF,FMRFAL,neuropeptide FF-amide peptide precursor,12q13.13,protein-coding,/
CWITA004749,TCMBANKGE004749,SOCS7,NAP4; NCKAP4,suppressor of cytokine signaling 7,17q12,protein-coding,/
CWITA004750,TCMBANKGE004750,HACE1,SPPRS,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,6q16.3,protein-coding,/
CWITA004751,TCMBANKGE004751,GPHN,GEPH; GPH; GPHRYN; HKPX1; MOCODC,gephyrin,14q23.3-q24.1,protein-coding,/
CWITA004752,TCMBANKGE004752,DBR1,-,debranching RNA lariats 1,3q22.3,protein-coding,/
CWITA004753,TCMBANKGE004753,KLF11,FKLF; FKLF1; MODY7; TIEG2; Tieg3,Kruppel like factor 11,2p25.1,protein-coding,/
CWITA004754,TCMBANKGE004754,TOR2A,TORP1,torsin family 2 member A,9q34.11,protein-coding,/
CWITA004755,TCMBANKGE004755,CYP2A6,CPA6; CYP2A; CYP2A3; P450C2A; P450PB,"cytochrome P450, family 2, subfamily A, polypeptide 6",19q13.2,protein-coding,
CWITA004756,TCMBANKGE004756,GYS2,-,glycogen synthase 2,12p12.1,protein-coding,/
CWITA004757,TCMBANKGE004757,HTR6,5-HT6; 5-HT6R,5-hydroxytryptamine receptor 6,1p36.13,protein-coding,Clinical Trial target
CWITA004758,TCMBANKGE004758,ZNF528,-,zinc finger protein 528,19q13.41,protein-coding,/
CWITA004759,TCMBANKGE004759,UBB,FLJ25987; MGC8385; RPS27A; UBA52; UBC,ubiquitin B,17p12-p11.2,protein-coding,
CWITA004760,TCMBANKGE004760,MLF2,NTN4,myeloid leukemia factor 2,12p13.31,protein-coding,/
CWITA004761,TCMBANKGE004761,ARL6,BBS3; RP55,ADP ribosylation factor like GTPase 6,3q11.2,protein-coding,/
CWITA004762,TCMBANKGE004762,RPS9,S9,ribosomal protein S9,19q13.42,protein-coding,/
CWITA004763,TCMBANKGE004763,TGFBRAP1,TRAP-1; TRAP1; VPS3,transforming growth factor beta receptor associated protein 1,2q12.1-q12.2,protein-coding,/
CWITA004764,TCMBANKGE004764,MAP1A,FLJ77111; MAP1L; MTAP1A,microtubule-associated protein 1A,15q15.3,protein-coding,
CWITA004765,TCMBANKGE004765,INTS7,C1orf73; INT7,integrator complex subunit 7,1q32.3,protein-coding,/
CWITA004766,TCMBANKGE004766,IL10RB,CDW210B; CRF2-4; CRFB4; D21S58; D21S66; IL-10R2,interleukin 10 receptor subunit beta,21q22.11,protein-coding,Research target
CWITA004767,TCMBANKGE004767,ITGAE,CD103; HUMINAE,integrin subunit alpha E,17p13.2,protein-coding,Research target
CWITA004768,TCMBANKGE004768,P3H2,LEPREL1; MCVD; MLAT4,prolyl 3-hydroxylase 2,3q28,protein-coding,/
CWITA004769,TCMBANKGE004769,UBE2D2,E2(17)KB2; PUBC1; UBC4; UBC4/5; UBCH4; UBCH5B,ubiquitin conjugating enzyme E2 D2,5q31.2,protein-coding,/
CWITA004770,TCMBANKGE004770,PDHA2,MGC149517; MGC149518; PDHAL,pyruvate dehydrogenase (lipoamide) alpha 2,4q22-q23,protein-coding,
CWITA004771,TCMBANKGE004771,TSC22D2,TILZ4a; TILZ4b; TILZ4c,TSC22 domain family member 2,3q25.1,protein-coding,/
CWITA004772,TCMBANKGE004772,PDIK1L,CLIK1L; STK35L2,PDLIM1 interacting kinase 1 like,1p36.11,protein-coding,/
CWITA004773,TCMBANKGE004773,APRT,AMP; DKFZp686D13177; MGC125856; MGC125857; MGC129961,adenine phosphoribosyltransferase,16q24,protein-coding,
CWITA004774,TCMBANKGE004774,TSPY3,CT78; TSPY; TSPY1; TSPY10,testis specific protein Y-linked 3,Yp11.2,protein-coding,/
CWITA004775,TCMBANKGE004775,TCERG1,CA150; TAF2S; Urn1,transcription elongation regulator 1,5q32,protein-coding,/
CWITA004776,TCMBANKGE004776,PPP1R27,DYSFIP1,protein phosphatase 1 regulatory subunit 27,17q25.3,protein-coding,/
CWITA004777,TCMBANKGE004777,ANKRD6,-,ankyrin repeat domain 6,6q15,protein-coding,/
CWITA004778,TCMBANKGE004778,UGT2B15,HLUG4; UDPGT 2B8; UDPGT2B15; UDPGTH3; UGT2B8,UDP glucuronosyltransferase family 2 member B15,4q13.2,protein-coding,/
CWITA004779,TCMBANKGE004779,KDM2B,CXXC2; FBXL10; Fbl10; JHDM1B; PCCX2,lysine demethylase 2B,12q24.31,protein-coding,/
CWITA004780,TCMBANKGE004780,KCNAB1,AKR6A3; KCNA1B; KV-BETA-1; Kvb1.3; hKvBeta3; hKvb3,potassium voltage-gated channel subfamily A member regulatory beta subunit 1,3q25.31,protein-coding,/
CWITA004781,TCMBANKGE004781,COX5B,COXVB,cytochrome c oxidase subunit Vb,2cen-q13,protein-coding,
CWITA004782,TCMBANKGE004782,FIS1,CGI-135; TTC11,"fission, mitochondrial 1",7q22.1,protein-coding,/
CWITA004783,TCMBANKGE004783,GPX7,CL683; GPX6; GPx-7; GSHPx-7; NPGPx,glutathione peroxidase 7,1p32.3,protein-coding,/
CWITA004784,TCMBANKGE004784,FAHD2A,CGI-105,fumarylacetoacetate hydrolase domain containing 2A,2q11.1,protein-coding,/
CWITA004785,TCMBANKGE004785,PAPOLB,PAPT; TPAP,poly(A) polymerase beta,7p22.1,protein-coding,/
CWITA004786,TCMBANKGE004786,SCGB1A1,CC10; CC16; CCPBP; CCSP; UGB; UP-1; UP1,secretoglobin family 1A member 1,11q12.3,protein-coding,Research target
CWITA004787,TCMBANKGE004787,NUF2,CDCA1; CT106; NUF2R,NUF2 component of NDC80 kinetochore complex,1q23.3,protein-coding,Research target
CWITA004788,TCMBANKGE004788,TSPAN16,TM-8; TM4-B; TM4SF16,tetraspanin 16,19p13.2,protein-coding,/
CWITA004789,TCMBANKGE004789,ACSS1,ACAS2L; ACECS1; AceCS2L,acyl-CoA synthetase short chain family member 1,20p11.21,protein-coding,/
CWITA004790,TCMBANKGE004790,SDHAF1,LYRM8,succinate dehydrogenase complex assembly factor 1,19q13.12,protein-coding,/
CWITA004791,TCMBANKGE004791,GPATCH11,CCDC75; CENP-Y; CENPY,G-patch domain containing 11,2p22.2,protein-coding,/
CWITA004792,TCMBANKGE004792,BICC1,BICC; CYSRD,BicC family RNA binding protein 1,10q21.1,protein-coding,/
CWITA004793,TCMBANKGE004793,WNT5A,hWNT5A,Wnt family member 5A,3p14.3,protein-coding,Research target
CWITA004794,TCMBANKGE004794,OR2L2,HSHTPCRH07; HTPCRH07; OR1-48; OR2L12; OR2L4P,olfactory receptor family 2 subfamily L member 2,1q44,protein-coding,/
CWITA004795,TCMBANKGE004795,TAS2R8,T2R8; TRB5,taste 2 receptor member 8,12p13.2,protein-coding,/
CWITA004796,TCMBANKGE004796,CLDN14,DFNB29,claudin 14,21q22.13,protein-coding,/
CWITA004797,TCMBANKGE004797,TMEM14A,C6orf73; PTD011,transmembrane protein 14A,6p12.2,protein-coding,/
CWITA004798,TCMBANKGE004798,FAHD2B,-,fumarylacetoacetate hydrolase domain containing 2B,2q11.2,protein-coding,/
CWITA004799,TCMBANKGE004799,MXRA7,-,matrix remodeling associated 7,17q25.1,protein-coding,/
CWITA004800,TCMBANKGE004800,FAM13B,ARHGAP49; C5orf5; FAM13B1; KHCHP; N61,family with sequence similarity 13 member B,5q31.2,protein-coding,/
CWITA004801,TCMBANKGE004801,AP3M2,AP47B; CLA20; P47B,adaptor related protein complex 3 subunit mu 2,8p11.21,protein-coding,/
CWITA004802,TCMBANKGE004802,POMGNT1,GNTI.2; GnT I.2; LGMD2O; LGMDR15; MEB; MGAT1.2; RP76; gnT-I.2,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1,protein-coding,/
CWITA004803,TCMBANKGE004803,LYAR,ZC2HC2; ZLYAR,Ly1 antibody reactive,4p16.3,protein-coding,/
CWITA004804,TCMBANKGE004804,SYNDIG1,C20orf39; DSPC2; IFITMD5; TMEM90B,synapse differentiation inducing 1,20p11.21,protein-coding,/
CWITA004805,TCMBANKGE004805,SCGB1D2,LIPB; LPHB; LPNB,secretoglobin family 1D member 2,11q12.3,protein-coding,Research target
CWITA004806,TCMBANKGE004806,TNFRSF19,TAJ; TAJ-alpha; TRADE; TROY,TNF receptor superfamily member 19,13q12.12,protein-coding,/
CWITA004807,TCMBANKGE004807,ADRA1A,ADRA1C; ADRA1L1; ALPHA1AAR,"adrenergic, alpha-1A-, receptor",8p21.2,protein-coding,
CWITA004808,TCMBANKGE004808,PAPOLA,PAP; PAP-alpha,poly(A) polymerase alpha,14q32.2,protein-coding,/
CWITA004809,TCMBANKGE004809,SHOX,GCFX; PHOG; SHOXY; SS,short stature homeobox,Xp22.33 and Yp11.2,protein-coding,/
CWITA004810,TCMBANKGE004810,INVS,INV; NPH2; NPHP2,inversin,9q31.1,protein-coding,/
CWITA004811,TCMBANKGE004811,FYCO1,CATC2; CTRCT18; RUFY3; ZFYVE7,FYVE and coiled-coil domain autophagy adaptor 1,3p21.31,protein-coding,/
CWITA004812,TCMBANKGE004812,RNF139,HRCA1; RCA1; TRC8,ring finger protein 139,8q24.13,protein-coding,/
CWITA004813,TCMBANKGE004813,NKX2-1,BCH; BHC; NK-2; NKX2.1; NKX2A; NMTC1; T/EBP; TEBP; TITF1; TTF-1; TTF1,NK2 homeobox 1,14q13.3,protein-coding,/
CWITA004814,TCMBANKGE004814,FBLIM1,CAL; FBLP-1; FBLP1,filamin binding LIM protein 1,1p36.21,protein-coding,/
CWITA004815,TCMBANKGE004815,SP3,SPR2,Sp3 transcription factor,2q31.1,protein-coding,/
CWITA004816,TCMBANKGE004816,PDIA6,ERP5; P5; TXNDC7,protein disulfide isomerase family A member 6,2p25.1,protein-coding,/
CWITA004817,TCMBANKGE004817,SLC22A1,HOCT1; OCT1; oct1_cds,solute carrier family 22 member 1,6q25.3,protein-coding,/
CWITA004818,TCMBANKGE004818,UQCRC1,D3S3191; QCR1; UQCR1,ubiquinol-cytochrome c reductase core protein 1,3p21.31,protein-coding,/
CWITA004819,TCMBANKGE004819,EEFSEC,EFSEC; SELB,"eukaryotic elongation factor, selenocysteine-tRNA specific",3q21.3,protein-coding,/
CWITA004820,TCMBANKGE004820,UGT2B15,HLUG4; UDPGT_2B8; UDPGT2B15; UDPGTH3; UGT2B8,"UDP glucuronosyltransferase 2 family, polypeptide B15",4q13,protein-coding,
CWITA004821,TCMBANKGE004821,ZSCAN2,ZFP29; ZNF854,zinc finger and SCAN domain containing 2,15q25.2,protein-coding,/
CWITA004822,TCMBANKGE004822,PABPC5,PABP5,poly(A) binding protein cytoplasmic 5,Xq21.31,protein-coding,/
CWITA004823,TCMBANKGE004823,SLC14A2,HUT2; UT-A2; UT2; UTA; UTR; hUT-A6,solute carrier family 14 member 2,18q12.3,protein-coding,/
CWITA004824,TCMBANKGE004824,EIF4A3,DDX48; Fal1; MUK34; NMP265; NUK34; RCPS; eIF-4A-III; eIF4A-III; eIF4AIII,eukaryotic translation initiation factor 4A3,17q25.3,protein-coding,/
CWITA004825,TCMBANKGE004825,ULK2,ATG1B; Unc51.2,unc-51 like autophagy activating kinase 2,17p11.2,protein-coding,/
CWITA004826,TCMBANKGE004826,FLT4,CHTD7; FLT-4; FLT41; LMPH1A; LMPHM1; PCL; VEGFR-3; VEGFR3,fms related receptor tyrosine kinase 4,5q35.3,protein-coding,Clinical Trial target
CWITA004827,TCMBANKGE004827,CARS,CARS1; CYSRS; MGC:11246,cysteinyl-tRNA synthetase,11p15.5,protein-coding,
CWITA004828,TCMBANKGE004828,HRH3,GPCR97; HH3R,histamine receptor H3,20q13.33,protein-coding,Clinical Trial target
CWITA004829,TCMBANKGE004829,S100A3,S100E,S100 calcium binding protein A3,1q21.3,protein-coding,Research target
CWITA004830,TCMBANKGE004830,SKIL,SNO; SnoA; SnoI; SnoN,SKI like proto-oncogene,3q26.2,protein-coding,/
CWITA004831,TCMBANKGE004831,TNIK,MRT54,TRAF2 and NCK interacting kinase,3q26.2-q26.31,protein-coding,Research target
CWITA004832,TCMBANKGE004832,AURKB,AIK2; AIMN1; AIM1; ARK2; AurB; IPL1; STK12; STK5; aurkbNsv1; aurkbNsv2,aurora kinase B,17p13.1,protein-coding,
CWITA004833,TCMBANKGE004833,TRIM72,MG53,tripartite motif containing 72,16p11.2,protein-coding,/
CWITA004834,TCMBANKGE004834,HLA-DRA,HLA-DRA1,"major histocompatibility complex, class II, DR alpha",6p21.32,protein-coding,/
CWITA004835,TCMBANKGE004835,CACNB2,CAB2; CACNLB2; CAVB2; MYSB,calcium voltage-gated channel auxiliary subunit beta 2,10p12.33-p12.31,protein-coding,/
CWITA004836,TCMBANKGE004836,HHAT,MART2; SKI1; Skn,hedgehog acyltransferase,1q32.2,protein-coding,Research target
CWITA004837,TCMBANKGE004837,LRRC58,-,leucine rich repeat containing 58,3q13.33,protein-coding,/
CWITA004838,TCMBANKGE004838,GALNT9,GALNAC-T9; GALNACT9,polypeptide N-acetylgalactosaminyltransferase 9,12q24.33,protein-coding,/
CWITA004839,TCMBANKGE004839,GEM,KIR,GTP binding protein overexpressed in skeletal muscle,8q22.1,protein-coding,Clinical Trial target
CWITA004840,TCMBANKGE004840,Gja3,Cnx46; Cx43; Cx46; Cxnj1; Gja-3,"gap junction protein, alpha 3",14 C3|14 29.82 cM,protein-coding,
CWITA004841,TCMBANKGE004841,NUP133,GAMOS8; NPHS18; hNUP133,nucleoporin 133,1q42.13,protein-coding,/
CWITA004842,TCMBANKGE004842,SRRM2,300-KD; CWF21; Cwc21; HSPC075; SRL300; SRm300,serine/arginine repetitive matrix 2,16p13.3,protein-coding,/
CWITA004843,TCMBANKGE004843,UBE3D,C6orf157; H10BH; UBE2CBP; YJR141W,ubiquitin protein ligase E3D,6q14.1,protein-coding,/
CWITA004844,TCMBANKGE004844,EID1,C15orf3; CRI1; EID-1; IRO45620; PNAS-22; PTD014; RBP21,EP300 interacting inhibitor of differentiation 1,15q21.1,protein-coding,/
CWITA004845,TCMBANKGE004845,POLI,RAD30B; RAD3OB; eta2,DNA polymerase iota,18q21.2,protein-coding,/
CWITA004846,TCMBANKGE004846,GTF2H3,BTF2; P34; TFB4; TFIIH,general transcription factor IIH subunit 3,12q24.31,protein-coding,/
CWITA004847,TCMBANKGE004847,EPHA1,EPH; EPHT; EPHT1,EPH receptor A1,7q34-q35,protein-coding,Research target
CWITA004848,TCMBANKGE004848,CRY2,HCRY2; PHLL2,cryptochrome circadian regulator 2,11p11.2,protein-coding,/
CWITA004849,TCMBANKGE004849,HIC1,ZBTB29; ZNF901; hic-1,HIC ZBTB transcriptional repressor 1,17p13.3,protein-coding,/
CWITA004850,TCMBANKGE004850,BAIAP2L2,-,BAR/IMD domain containing adaptor protein 2 like 2,22q13.1,protein-coding,/
CWITA004851,TCMBANKGE004851,CELSR2,ADGRC2; CDHF10; EGFL2; Flamingo1; MEGF3,cadherin EGF LAG seven-pass G-type receptor 2,1p13.3,protein-coding,/
CWITA004852,TCMBANKGE004852,SLC7A4,CAT-4; CAT4; HCAT3; VH,solute carrier family 7 member 4,22q11.21,protein-coding,/
CWITA004853,TCMBANKGE004853,MRO,B29; C18orf3,maestro,18q21.2,protein-coding,/
CWITA004854,TCMBANKGE004854,RNF2,BAP-1; BAP1; DING; HIPI3; RING1B; RING2,ring finger protein 2,1q25.3,protein-coding,/
CWITA004855,TCMBANKGE004855,PEX16,PBD8A; PBD8B,peroxisomal biogenesis factor 16,11p11.2,protein-coding,/
CWITA004856,TCMBANKGE004856,ALAS1,ALAS; ALAS-H; ALAS3; ALASH; MIG4,5'-aminolevulinate synthase 1,3p21.2,protein-coding,/
CWITA004857,TCMBANKGE004857,MSMO1,DESP4; ERG25; MCCPD; SC4MOL,Methylsterol_Monooxygenase_1,4q32.3,protein-coding,
CWITA004858,TCMBANKGE004858,PLAAT1,A-C1; H-REV107; HRASLS; HRASLS1; HRSL1; HSD28; PLA/AT1; PLAAT-1,phospholipase A and acyltransferase 1,3q29,protein-coding,/
CWITA004859,TCMBANKGE004859,CEL,BAL; BSDL; BSSL; CELL; CEase; FAP; FAPP; LIPA; MODY8,carboxyl ester lipase (bile salt-stimulated lipase),9q34.3,protein-coding,
CWITA004860,TCMBANKGE004860,TMEM107,GRVS638; JBTS29; MKS13; PRO1268,transmembrane protein 107,17p13.1,protein-coding,/
CWITA004861,TCMBANKGE004861,CYP4F12,CYPIVF12; F22329_1,cytochrome P450 family 4 subfamily F member 12,19p13.12,protein-coding,/
CWITA004862,TCMBANKGE004862,QTRT1,FP3235; TGT; TGUT,Queuine_Trna-Ribosyltransferase_Catalytic_Subunit_1,19p13.2,protein-coding,
CWITA004863,TCMBANKGE004863,SLC1A6,EAAT4; MGC33092; MGC43671,"solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",19p13.12,protein-coding,
CWITA004864,TCMBANKGE004864,NTHL1,FAP3; NTH1; OCTS3; hNTH1,nth like DNA glycosylase 1,16p13.3,protein-coding,/
CWITA004865,TCMBANKGE004865,ZNF484,BA526D8.4,zinc finger protein 484,9q22.31,protein-coding,/
CWITA004866,TCMBANKGE004866,BUB1B,BUB1beta; BUBR1; Bub1A; MAD3L; MVA1; SSK1; hBUBR1,BUB1 mitotic checkpoint serine/threonine kinase B,15q15.1,protein-coding,/
CWITA004867,TCMBANKGE004867,RANBP9,BPM-L; BPM90; RANBPM; RanBP7,RAN binding protein 9,6p23,protein-coding,/
CWITA004868,TCMBANKGE004868,ZNF425,-,zinc finger protein 425,7q36.1,protein-coding,/
CWITA004869,TCMBANKGE004869,IMPDH1,DKFZp781N0678; IMPD; IMPD1; LCA11; RP10; sWSS2608,IMP (inosine 5'-monophosphate) dehydrogenase 1,7q31.3-q32,protein-coding,
CWITA004870,TCMBANKGE004870,COMMD10,PTD002,COMM domain containing 10,5q23.1,protein-coding,/
CWITA004871,TCMBANKGE004871,ZFP2,ZNF751; zfp-2,ZFP2 zinc finger protein,5q35.3,protein-coding,/
CWITA004872,TCMBANKGE004872,GAPDHS,GAPD2; GAPDH-2; GAPDS; HEL-S-278; HSD-35,"glyceraldehyde-3-phosphate dehydrogenase, spermatogenic",19q13.12,protein-coding,/
CWITA004873,TCMBANKGE004873,MRPS6,C21orf101; MRP-S6; RPMS6; S6mt,mitochondrial ribosomal protein S6,21q22.11,protein-coding,/
CWITA004874,TCMBANKGE004874,RFPL3S,NCRNA00005; RFPL3-AS; RFPL3-AS1; RFPL3ANT; RFPL3AS,RFPL3 antisense,22q12.3,ncRNA,/
CWITA004875,TCMBANKGE004875,SERPINA9,GCET1; SERPINA11; SERPINA11b,serpin family A member 9,14q32.13,protein-coding,/
CWITA004876,TCMBANKGE004876,EXOC6,EXOC6A; SEC15; SEC15L; SEC15L1; SEC15L3; Sec15p,exocyst complex component 6,10q23.33,protein-coding,/
CWITA004877,TCMBANKGE004877,FKBP14,EDSKMH; EDSKSCL2; FKBP22; IPBP12,FKBP prolyl isomerase 14,7p14.3,protein-coding,/
CWITA004878,TCMBANKGE004878,RFXAP,-,regulatory factor X associated protein,13q13.3,protein-coding,/
CWITA004879,TCMBANKGE004879,WNK1,HSAN2; HSN2; KDP; PPP1R167; PRKWNK1; PSK; p65,WNK lysine deficient protein kinase 1,12p13.33,protein-coding,Research target
CWITA004880,TCMBANKGE004880,FAM117B,ALS2CR13,family with sequence similarity 117 member B,2q33.2,protein-coding,/
CWITA004881,TCMBANKGE004881,SLC26A2,D5S1708; DTD; DTDST; EDM4; MST153; MSTP157,solute carrier family 26 member 2,5q32,protein-coding,/
CWITA004882,TCMBANKGE004882,MRPL37,L2mt; L37mt; MRP-L2; MRP-L37; MRPL2; RPML2,mitochondrial ribosomal protein L37,1p32.3,protein-coding,/
CWITA004883,TCMBANKGE004883,CLEC4A,CD367; CLECSF6; DCIR; DDB27; HDCGC13P; LLIR,C-type lectin domain family 4 member A,12p13.31,protein-coding,/
CWITA004884,TCMBANKGE004884,IRS1,HIRSN1,insulin receptor substrate 1,2q36,protein-coding,
CWITA004885,TCMBANKGE004885,TEX9,-,testis expressed 9,15q21.3,protein-coding,/
CWITA004886,TCMBANKGE004886,HOXB7,HHO.C1; HOX2; HOX2C; Hox-2.3,homeobox B7,17q21.32,protein-coding,/
CWITA004887,TCMBANKGE004887,ZNF449,ZSCAN19,zinc finger protein 449,Xq26.3,protein-coding,/
CWITA004888,TCMBANKGE004888,SLC22A4,MGC34546; MGC40524; OCTN1,"solute carrier family 22 (organic cation/ergothioneine transporter), member 4",5q31.1,protein-coding,
CWITA004889,TCMBANKGE004889,PIK3R2,P85B; p85; p85NBETA,"phosphoinositide-3-kinase, regulatory subunit 2 (beta)",19q13.2-q13.4,protein-coding,
CWITA004890,TCMBANKGE004890,ARHGEF35,ARHGEF5L,Rho guanine nucleotide exchange factor 35,7q35,protein-coding,/
CWITA004891,TCMBANKGE004891,ZNF665,ZFP160L,zinc finger protein 665,19q13.42,protein-coding,/
CWITA004892,TCMBANKGE004892,SLC7A7,LAT3; LPI; MOP-2; Y+LAT1; y+LAT-1,solute carrier family 7 member 7,14q11.2,protein-coding,/
CWITA004893,TCMBANKGE004893,TNK2,ACK; ACK-1; ACK1; p21cdc42Hs,tyrosine kinase non receptor 2,3q29,protein-coding,Research target
CWITA004894,TCMBANKGE004894,AK8,AK 8; C9orf98; DDX31,adenylate kinase 8,9q34.13,protein-coding,/
CWITA004895,TCMBANKGE004895,RGPD8,RANBP2L1; RGP8; RanBP2alpha,RANBP2 like and GRIP domain containing 8,2q14.1,protein-coding,/
CWITA004896,TCMBANKGE004896,RRAS2,NS12; TC21,RAS related 2,11p15.2,protein-coding,/
CWITA004897,TCMBANKGE004897,SLC5A8,AIT; SMCT; SMCT1,solute carrier family 5 member 8,12q23.1-q23.2,protein-coding,/
CWITA004898,TCMBANKGE004898,CREG1,CREG,cellular repressor of E1A stimulated genes 1,1q24.2,protein-coding,/
CWITA004899,TCMBANKGE004899,IL34,C16orf77; IL-34,interleukin 34,16q22.1,protein-coding,/
CWITA004900,TCMBANKGE004900,Mir203,Mirn203; mir-203; mmu-mir-203,microRNA 203,12|12 F1,ncRNA,/
CWITA004901,TCMBANKGE004901,KLHDC8B,CHL,kelch domain containing 8B,3p21.31,protein-coding,/
CWITA004902,TCMBANKGE004902,RIDA,HRSP12; P14.5; PSP; UK114; hp14.5,reactive intermediate imine deaminase A homolog,8q22.2,protein-coding,/
CWITA004903,TCMBANKGE004903,STAM2,Hbp; STAM2A; STAM2B,signal transducing adaptor molecule 2,2q23.3,protein-coding,/
CWITA004904,TCMBANKGE004904,NUP35,MP-44; MP44; NP44; NUP53,nucleoporin 35,2q32.1,protein-coding,/
CWITA004905,TCMBANKGE004905,NECTIN2,CD112; HVEB; PRR2; PVRL2; PVRR2,nectin cell adhesion molecule 2,19q13.32,protein-coding,/
CWITA004906,TCMBANKGE004906,EPHB6,HEP,EPH receptor B6,7q34,protein-coding,Research target
CWITA004907,TCMBANKGE004907,IKBIP,IKIP,IKBKB interacting protein,12q23.1,protein-coding,/
CWITA004908,TCMBANKGE004908,ZNF835,BC37295_3,zinc finger protein 835,19q13.43,protein-coding,/
CWITA004909,TCMBANKGE004909,TFB1M,CGI-75; CGI75; mtTFB; mtTFB1,"transcription factor B1, mitochondrial",6q25.3,protein-coding,/
CWITA004910,TCMBANKGE004910,UTP18,CGI-48; WDR50,UTP18 small subunit processome component,17q21.33,protein-coding,/
CWITA004911,TCMBANKGE004911,GK2,GKP2; GKTA,glycerol kinase 2,4q21.21,protein-coding,/
CWITA004912,TCMBANKGE004912,STAMBPL1,ALMalpha; AMSH-FP; AMSH-LP; bA399O19.2,STAM binding protein like 1,10q23.31,protein-coding,/
CWITA004913,TCMBANKGE004913,TBXA2R,BDPLT13; TXA2-R,thromboxane A2 receptor,19p13.3,protein-coding,Successful target
CWITA004914,TCMBANKGE004914,MDM4,BMFS6; HDMX; MDMX; MRP1,MDM4 regulator of p53,1q32.1,protein-coding,Clinical Trial target
CWITA004915,TCMBANKGE004915,NMNAT2,C1orf15; PNAT2,nicotinamide nucleotide adenylyltransferase 2,1q25.3,protein-coding,/
CWITA004916,TCMBANKGE004916,ESPNL,-,espin like,2q37.3,protein-coding,/
CWITA004917,TCMBANKGE004917,GABRA5,EIEE79,gamma-aminobutyric acid type A receptor subunit alpha5,15q12,protein-coding,Successful target
CWITA004918,TCMBANKGE004918,UGT3A1,FLJ26528; FLJ34658,"UDP glycosyltransferase 3 family, polypeptide A1",5p13.2,protein-coding,
CWITA004919,TCMBANKGE004919,RAD9A,RAD9,RAD9 checkpoint clamp component A,11q13.2,protein-coding,/
CWITA004920,TCMBANKGE004920,CHD4,CHD-4; Mi-2b; Mi2-BETA; SIHIWES,chromodomain helicase DNA binding protein 4,12p13.31,protein-coding,/
CWITA004921,TCMBANKGE004921,HHLA2,B7-H5; B7-H7; B7H7; B7y,HERV-H LTR-associating 2,3q13.13,protein-coding,/
CWITA004922,TCMBANKGE004922,CHAC2,GCG1,ChaC glutathione specific gamma-glutamylcyclotransferase 2,2p16.2,protein-coding,/
CWITA004923,TCMBANKGE004923,CA3,CAIII; Car3,carbonic anhydrase 3,8q21.2,protein-coding,/
CWITA004924,TCMBANKGE004924,COL22A1,-,collagen type XXII alpha 1 chain,8q24.23-q24.3,protein-coding,/
CWITA004925,TCMBANKGE004925,RBBP4,NURF55; RBAP48; lin-53,"RB binding protein 4, chromatin remodeling factor",1p35.1,protein-coding,/
CWITA004926,TCMBANKGE004926,DDX54,DP97,DEAD-box helicase 54,12q24.13,protein-coding,/
CWITA004927,TCMBANKGE004927,CLCF1,BSF-3; BSF3; CISS2; CLC; NNT-1; NNT1; NR6,cardiotrophin like cytokine factor 1,11q13.2,protein-coding,Research target
CWITA004928,TCMBANKGE004928,PHLDB2,LL5b; LL5beta,pleckstrin homology like domain family B member 2,3q13.2,protein-coding,/
CWITA004929,TCMBANKGE004929,THSD4,ADAMTSL-6; ADAMTSL6; FVSY9334; PRO34005,thrombospondin type 1 domain containing 4,15q23,protein-coding,/
CWITA004930,TCMBANKGE004930,LCAT,-,lecithin-cholesterol acyltransferase,16q22.1,protein-coding,Clinical Trial target
CWITA004931,TCMBANKGE004931,RGPD3,RGP3,RANBP2 like and GRIP domain containing 3,2q12.2,protein-coding,/
CWITA004932,TCMBANKGE004932,LRP5L,-,LDL receptor related protein 5 like,22q11.23,protein-coding,/
CWITA004933,TCMBANKGE004933,Symbol,Synonyms,description,map_location,type_of_gene,/
CWITA004934,TCMBANKGE004934,GLYATL1,GATF-C; GNAT,glycine-N-acyltransferase like 1,11q12.1,protein-coding,/
CWITA004935,TCMBANKGE004935,FCGR2A,CD32; CD32A; CDw32; FCG2; FCGR2; FCGR2A1; FcGR; IGFR2,Fc fragment of IgG receptor IIa,1q23.3,protein-coding,Successful target
CWITA004936,TCMBANKGE004936,CCDC59,BR22; HSPC128; TAP26,coiled-coil domain containing 59,12q21.31,protein-coding,/
CWITA004937,TCMBANKGE004937,MRPL24,L24mt; MRP-L18; MRP-L24,mitochondrial ribosomal protein L24,1q23.1,protein-coding,/
CWITA004938,TCMBANKGE004938,BDH1,BDH; SDR9C1,3-hydroxybutyrate dehydrogenase 1,3q29,protein-coding,/
CWITA004939,TCMBANKGE004939,INSM1,IA-1; IA1,INSM transcriptional repressor 1,20p11.23,protein-coding,/
CWITA004940,TCMBANKGE004940,S100A13,N,S100 calcium binding protein A13,1q21,protein-coding,
CWITA004941,TCMBANKGE004941,MRPL42,HSPC204; L31MT; L42MT; MRP-L31; MRP-L42; MRP-S32; MRPL31; MRPS32; PTD007; RPML31; S32MT,mitochondrial ribosomal protein L42,12q22,protein-coding,/
CWITA004942,TCMBANKGE004942,RAB26,V46133,"RAB26, member RAS oncogene family",16p13.3,protein-coding,/
CWITA004943,TCMBANKGE004943,DGKH,DGKeta,diacylglycerol kinase eta,13q14.11,protein-coding,/
CWITA004944,TCMBANKGE004944,DCTN1,DAP-150; DP-150; P135,dynactin subunit 1,2p13.1,protein-coding,/
CWITA004945,TCMBANKGE004945,Ly6c1,AA682074; AA959465; Ly-6C; Ly-6C1; Ly6c,"lymphocyte antigen 6 complex, locus C1",15 D3|15 34.29 cM,protein-coding,/
CWITA004946,TCMBANKGE004946,IGHA2,N,immunoglobulin heavy constant alpha 2 (A2m marker),14q32.33,other,
CWITA004947,TCMBANKGE004947,ESPN,DFNB36; LP2654; USH1M,espin,1p36.31,protein-coding,/
CWITA004948,TCMBANKGE004948,ME2,ODS1,"malic enzyme 2, NAD(+)-dependent, mitochondrial",6p25-p24|18q21,protein-coding,
CWITA004949,TCMBANKGE004949,NLGN3,HNL3,neuroligin 3,Xq13.1,protein-coding,/
CWITA004950,TCMBANKGE004950,TIMM17A,TIM17; TIM17A,translocase of inner mitochondrial membrane 17A,1q32.1,protein-coding,/
CWITA004951,TCMBANKGE004951,TUBB,CDCBM6; CSCSC1; M40; OK/SW-cl.56; TUBB1; TUBB5,tubulin beta class I,6p21.33,protein-coding,/
CWITA004952,TCMBANKGE004952,AKR1C1,2NALPHANHSD; 20NALPHANHSD; C9; DD1; DD1/DD2; DDH; DDH1; HN37; HAKRC; HBAB; MBAB; MGC8954,"aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)",10p15-p14,protein-coding,
CWITA004953,TCMBANKGE004953,ERVW-1,ENV; ENVW; ERVWE1; HERV-7q; HERV-W-ENV; HERV7Q; HERVW; HERVWENV,"Endogenous_Retrovirus_Group_W_Member_1,_Envelope",7q21.2,protein-coding,
CWITA004954,TCMBANKGE004954,ADD2,ADDB,adducin 2,2p13.3,protein-coding,/
CWITA004955,TCMBANKGE004955,CCDC102B,ACY1L; AN; C18orf14; HsT1731,coiled-coil domain containing 102B,18q22.1-q22.2,protein-coding,/
CWITA004956,TCMBANKGE004956,UGP2,EIEE83; SVUGP2; UDPG; UDPGP; UDPGP2; UGP1; UGPP1; UGPP2; pHC379,UDP-glucose pyrophosphorylase 2,2p15,protein-coding,/
CWITA004957,TCMBANKGE004957,SHANK1,SPANK-1; SSTRIP; synamon,SH3 and multiple ankyrin repeat domains 1,19q13.33,protein-coding,/
CWITA004958,TCMBANKGE004958,TMEM268,C9orf91,transmembrane protein 268,9q32,protein-coding,/
CWITA004959,TCMBANKGE004959,PITPNA,MGC99649; PINTPalpha; PITPN; VIB1A,"phosphatidylinositol transfer protein, alpha",17p13.3,protein-coding,
CWITA004960,TCMBANKGE004960,KCNJ16,BIR9; KIR5.1,potassium inwardly rectifying channel subfamily J member 16,17q24.3,protein-coding,/
CWITA004961,TCMBANKGE004961,NACC1,BEND8; BTBD14B; BTBD30; NAC-1; NAC1; NECFM,nucleus accumbens associated 1,19p13.13,protein-coding,Research target
CWITA004962,TCMBANKGE004962,STEAP3,AHMIO2; STMP3; TSAP6; dudlin-2; dudulin-2; pHyde,STEAP3 metalloreductase,2q14.2,protein-coding,/
CWITA004963,TCMBANKGE004963,TWF2,A6RP; A6r; MSTP011; PTK9L,twinfilin actin binding protein 2,3p21.2,protein-coding,/
CWITA004964,TCMBANKGE004964,INKA2,C1orf183; FAM212B,inka box actin regulator 2,1p13.2,protein-coding,/
CWITA004965,TCMBANKGE004965,NPY4R,NPY4-R; PP1; PPYR1; Y4,neuropeptide Y receptor Y4,10q11.22,protein-coding,Clinical Trial target
CWITA004966,TCMBANKGE004966,PLOD2,LH2; TLH,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2",3q24,protein-coding,
CWITA004967,TCMBANKGE004967,PDIA2,PDA2; PDI; PDIP; PDIR,protein disulfide isomerase family A member 2,16p13.3,protein-coding,/
CWITA004968,TCMBANKGE004968,FGF8,AIGF; FGF-8; HBGF-8; HH6; KAL6,fibroblast growth factor 8,10q24.32,protein-coding,Research target
CWITA004969,TCMBANKGE004969,CEP152,MCPH4; MCPH9; SCKL5,centrosomal protein 152,15q21.1,protein-coding,/
CWITA004970,TCMBANKGE004970,CHST3,C6ST; C6ST1; HSD,carbohydrate sulfotransferase 3,10q22.1,protein-coding,/
CWITA004971,TCMBANKGE004971,POU3F4,BRAIN-4; BRN-4; BRN4; DFN3; DFNX2; OCT-9; OTF-9; OTF9,POU class 3 homeobox 4,Xq21.1,protein-coding,/
CWITA004972,TCMBANKGE004972,CYP8B1,CP8B; CYP12,cytochrome P450 family 8 subfamily B member 1,3p22.1,protein-coding,/
CWITA004973,TCMBANKGE004973,VTI1B,VTI1; VTI1-LIKE; VTI1L; VTI2; v-SNARE; vti1-rp1,vesicle transport through interaction with t-SNAREs 1B,14q24.1,protein-coding,/
CWITA004974,TCMBANKGE004974,ESAM,W117m,endothelial cell adhesion molecule,11q24.2,protein-coding,/
CWITA004975,TCMBANKGE004975,TRAF3,CAP-1; CAP1; CD40bp; CRAF1; IIAE5; LAP1; RNF118,TNF receptor associated factor 3,14q32.32,protein-coding,/
CWITA004976,TCMBANKGE004976,ABI3BP,NESHBP; TARSH,ABI family member 3 binding protein,3q12.2,protein-coding,/
CWITA004977,TCMBANKGE004977,VIPR2,C16DUPq36.3; DUP7q36.3; PACAP-R-3; PACAP-R3; VIP-R-2; VPAC2; VPAC2R; VPCAP2R,vasoactive intestinal peptide receptor 2,7q36.3,protein-coding,Clinical Trial target
CWITA004978,TCMBANKGE004978,Appbp2os,D630032N06Rik,"amyloid beta precursor protein (cytoplasmic tail) binding protein 2, opposite strand",11|11 C,ncRNA,/
CWITA004979,TCMBANKGE004979,OBSCN,ARHGEF30; UNC89,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF",1q42.13,protein-coding,/
CWITA004980,TCMBANKGE004980,SCN7A,SCN6A,"sodium channel, voltage-gated, type VII, alpha",2q21-q23,protein-coding,
CWITA004981,TCMBANKGE004981,PCM1,PTC4; RET/PCM-1,pericentriolar material 1,8p22,protein-coding,/
CWITA004982,TCMBANKGE004982,OGA,MEA5; MGEA5; NCOAT,O-GlcNAcase,10q24.32,protein-coding,/
CWITA004983,TCMBANKGE004983,PCMT1,N,protein-L-isoaspartate (D-aspartate) O-methyltransferase,6q24-q25,protein-coding,
CWITA004984,TCMBANKGE004984,NCK2,GRB4; NCKbeta,NCK adaptor protein 2,2q12.2,protein-coding,/
CWITA004985,TCMBANKGE004985,TTLL4,-,tubulin tyrosine ligase like 4,2q35,protein-coding,/
CWITA004986,TCMBANKGE004986,ANG,ALS9; HEL168; RAA1; RNASE4; RNASE5,angiogenin,14q11.2,protein-coding,Research target
CWITA004987,TCMBANKGE004987,MAN2A2,MANA2X,mannosidase alpha class 2A member 2,15q26.1,protein-coding,/
CWITA004988,TCMBANKGE004988,SLC39A9,ZIP-9; ZIP9,solute carrier family 39 member 9,14q24.1,protein-coding,/
CWITA004989,TCMBANKGE004989,Apol7d,Gm15456,apolipoprotein L 7d,1|1 C3,ncRNA,/
CWITA004990,TCMBANKGE004990,RCAN1,ADAPT78; CSP1; DSC1; DSCR1; MCIP1; RCN1,regulator of calcineurin 1,21q22.12,protein-coding,/
CWITA004991,TCMBANKGE004991,CHMP1A,CHMP1; PCH8; PCOLN3; PRSM1; VPS46-1; VPS46A,charged multivesicular body protein 1A,16q24.3,protein-coding,/
CWITA004992,TCMBANKGE004992,HYKK,AGPHD1,hydroxylysine kinase,15q25.1,protein-coding,/
CWITA004993,TCMBANKGE004993,MYO10,-,myosin X,5p15.1,protein-coding,/
CWITA004994,TCMBANKGE004994,XIAP,API3; BIRC4; FLJ26913; IAPN3; ILP1; MIHA; XLP2; hIAPN3; hIAP3,X-linked inhibitor of apoptosis,Xq25,protein-coding,
CWITA004995,TCMBANKGE004995,DUSP2,PAC-1; PAC1,dual specificity phosphatase 2,2q11.2,protein-coding,/
CWITA004996,TCMBANKGE004996,ZNF431,-,zinc finger protein 431,19p12,protein-coding,/
CWITA004997,TCMBANKGE004997,MTIF3,IF3mt,mitochondrial translational initiation factor 3,13q12.2,protein-coding,/
CWITA004998,TCMBANKGE004998,IL22RA1,CRF2-9; IL22R; IL22R1,interleukin 22 receptor subunit alpha 1,1p36.11,protein-coding,/
CWITA004999,TCMBANKGE004999,SLC5A12,SMCT2,solute carrier family 5 member 12,11p14.2,protein-coding,/
CWITA005000,TCMBANKGE005000,PDE11A,PPNAD2,phosphodiesterase 11A,2q31.2,protein-coding,Research target
CWITA005001,TCMBANKGE005001,USP2,UBP41; USP9,ubiquitin specific peptidase 2,11q23.3,protein-coding,Research target
CWITA005002,TCMBANKGE005002,MYCN,MODED; N-myc; NMYC; ODED; bHLHe37,"MYCN proto-oncogene, bHLH transcription factor",2p24.3,protein-coding,Research target
CWITA005003,TCMBANKGE005003,CCNO,CCNU; CILD29; UDG2,cyclin O,5q11.2,protein-coding,/
CWITA005004,TCMBANKGE005004,RRM2,R2; RR2; RR2M,ribonucleotide reductase M2,2p25-p24,protein-coding,
CWITA005005,TCMBANKGE005005,FMR1NB,CT37; NY-SAR-35; NYSAR35,FMR1 neighbor,Xq27.3-q28,protein-coding,/
CWITA005006,TCMBANKGE005006,PAPOLG,-,poly(A) polymerase gamma,2p16.1,protein-coding,/
CWITA005007,TCMBANKGE005007,UPK3B,P35; UP3B; UPIIIB,uroplakin 3B,7q11.23,protein-coding,/
CWITA005008,TCMBANKGE005008,MRPL41,BMRP; MRP-L27; MRPL27; PIG3; RPML27,mitochondrial ribosomal protein L41,9q34.3,protein-coding,/
CWITA005009,TCMBANKGE005009,WDFY3,ALFY; BCHS; MCPH18; ZFYVE25,WD repeat and FYVE domain containing 3,4q21.23,protein-coding,/
CWITA005010,TCMBANKGE005010,ADIPOR1,ACDCR1; CGI-45; CGI45; PAQR1; TESBP1A,adiponectin receptor 1,1q32.1,protein-coding,/
CWITA005011,TCMBANKGE005011,FDPS,FPPS; FPS,farnesyl diphosphate synthase,1q22,protein-coding,
CWITA005012,TCMBANKGE005012,SLC16A6,MCT6; MCT7,"solute carrier family 16, member 6 (monocarboxylic acid transporter 7)",17q24.2,protein-coding,
CWITA005013,TCMBANKGE005013,CRYBA4,CTRCT23; CYRBA4; MCOPCT4,crystallin beta A4,22q12.1,protein-coding,/
CWITA005014,TCMBANKGE005014,FGL2,T49; pT49,fibrinogen like 2,7q11.23,protein-coding,Research target
CWITA005015,TCMBANKGE005015,CASP5,ICE(rel)III; ICEREL-III; ICH-3,caspase 5,11q22.3,protein-coding,Patented target
CWITA005016,TCMBANKGE005016,YJEFN3,-,YjeF N-terminal domain containing 3,19p13.11,protein-coding,/
CWITA005017,TCMBANKGE005017,HNRNPR,HNRPR; hnRNP-R,heterogeneous nuclear ribonucleoprotein R,1p36.12,protein-coding,/
CWITA005018,TCMBANKGE005018,CDR1,CDR; CDR34; CDR62A,cerebellar degeneration related protein 1,Xq27.1,protein-coding,/
CWITA005019,TCMBANKGE005019,RAD51D,BROVCA4; R51H3; RAD51L3; TRAD,RAD51 paralog D,17q12,protein-coding,/
CWITA005020,TCMBANKGE005020,PLA2G4D,cPLA2delta,phospholipase A2 group IVD,15q15.1,protein-coding,/
CWITA005021,TCMBANKGE005021,TRIM47,GOA; RNF100,tripartite motif containing 47,17q25.1,protein-coding,/
CWITA005022,TCMBANKGE005022,SULT1C4,SULT1C; SULT1C2,sulfotransferase family 1C member 4,2q12.3,protein-coding,/
CWITA005023,TCMBANKGE005023,EFCAB7,-,EF-hand calcium binding domain 7,1p31.3,protein-coding,/
CWITA005024,TCMBANKGE005024,GPANK1,ANKRD59; BAT4; D6S54E; G5; GPATCH10,G-patch domain and ankyrin repeats 1,6p21.33,protein-coding,/
CWITA005025,TCMBANKGE005025,GALNT18,GALNACT18; GALNT15; GALNTL4; GalNAc-T15; GalNAc-T18,polypeptide N-acetylgalactosaminyltransferase 18,11p15.4,protein-coding,/
CWITA005026,TCMBANKGE005026,CHORDC1,CHP1,cysteine and histidine rich domain containing 1,11q14.3,protein-coding,/
CWITA005027,TCMBANKGE005027,LYRM7,C5orf31; MC3DN8; MZM1L,LYR motif containing 7,5q23.3-q31.1,protein-coding,/
CWITA005028,TCMBANKGE005028,CARD19,BinCARD; C9orf89,caspase recruitment domain family member 19,9q22.31,protein-coding,/
CWITA005029,TCMBANKGE005029,C20orf27,-,chromosome 20 open reading frame 27,20p13,protein-coding,/
CWITA005030,TCMBANKGE005030,STX3,STX3A,syntaxin 3,11q12.1,protein-coding,/
CWITA005031,TCMBANKGE005031,RIN2,MACS; RASSF4,Ras and Rab interactor 2,20p11.23,protein-coding,/
CWITA005032,TCMBANKGE005032,CADPS2,CAPS2,calcium dependent secretion activator 2,7q31.32,protein-coding,/
CWITA005033,TCMBANKGE005033,IFI44L,C1orf29; GS3686,interferon induced protein 44 like,1p31.1,protein-coding,/
CWITA005034,TCMBANKGE005034,BAG1,BAG-1; HAP; RAP46,BAG cochaperone 1,9p13.3,protein-coding,/
CWITA005035,TCMBANKGE005035,C12orf57,C10; GRCC10,chromosome 12 open reading frame 57,12p13.31,protein-coding,/
CWITA005036,TCMBANKGE005036,ARL4D,ARF4L; ARL6,ADP ribosylation factor like GTPase 4D,17q21.31,protein-coding,/
CWITA005037,TCMBANKGE005037,CALB2,CAB29; CAL2; CR,calbindin 2,16q22.2,protein-coding,/
CWITA005038,TCMBANKGE005038,HBB,CD113t-C; ECYT6; beta-globin,hemoglobin subunit beta,11p15.4,protein-coding,Clinical Trial target
CWITA005039,TCMBANKGE005039,AGAP4,AGAP-4; AGAP-8; AGAP8; CTGLF1; CTGLF5; MRIP2,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 4",10q11.22,protein-coding,/
CWITA005040,TCMBANKGE005040,RABEPK,RAB9P40; bA65N13.1; p40,Rab9 effector protein with kelch motifs,9q33.3,protein-coding,/
CWITA005041,TCMBANKGE005041,CUBN,IFCR; IGS; IGS1; MGA1; gp280,cubilin,10p13,protein-coding,Research target
CWITA005042,TCMBANKGE005042,USP30,-,ubiquitin specific peptidase 30,12q24.11,protein-coding,/
CWITA005043,TCMBANKGE005043,TKTL1,TKR; TKT2,transketolase like 1,Xq28,protein-coding,Research target
CWITA005044,TCMBANKGE005044,STC2,STC-2; STCRP,stanniocalcin 2,5q35.2,protein-coding,Research target
CWITA005045,TCMBANKGE005045,MSN,HEL70; IMD50,moesin,Xq12,protein-coding,/
CWITA005046,TCMBANKGE005046,COX14,C12orf62; PCAG1,cytochrome c oxidase assembly factor COX14,12q13.12,protein-coding,/
CWITA005047,TCMBANKGE005047,GHRH,GHRF; GRF; INN,growth hormone releasing hormone,20q11.23,protein-coding,/
CWITA005048,TCMBANKGE005048,RNASE2,EDN; RNS2,"ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)",14q24-q31,protein-coding,
CWITA005049,TCMBANKGE005049,ZNF696,-,zinc finger protein 696,8q24.3,protein-coding,/
CWITA005050,TCMBANKGE005050,SLC23A2,NBTL1; SLC23A1; SVCT2; YSPL2,solute carrier family 23 member 2,20p13,protein-coding,Successful target
CWITA005051,TCMBANKGE005051,BST1,CD157,bone marrow stromal cell antigen 1,4p15,protein-coding,
CWITA005052,TCMBANKGE005052,ST13,AAG2; FAM10A1; FAM10A4; HIP; HOP; HSPABP; HSPABP1; P48; PRO0786; SNC6,ST13 Hsp70 interacting protein,22q13.2,protein-coding,/
CWITA005053,TCMBANKGE005053,AQP2,AQP-CD; WCH-CD,aquaporin 2,12q13.12,protein-coding,/
CWITA005054,TCMBANKGE005054,HLA-DRB5,-,"major histocompatibility complex, class II, DR beta 5",6p21.32,protein-coding,/
CWITA005055,TCMBANKGE005055,GOSR1,GOLIM2; GOS-28; GOS28; GOS28/P28; GS28; P28,golgi SNAP receptor complex member 1,17q11.2,protein-coding,/
CWITA005056,TCMBANKGE005056,NPBWR2,GPR8,neuropeptides B and W receptor 2,20q13.33,protein-coding,/
CWITA005057,TCMBANKGE005057,B4GALT1,B4GAL-T1; CDG2D; GGTB2; GT1; GTB; beta4Gal-T1,"beta-1,4-galactosyltransferase 1",9p21.1,protein-coding,/
CWITA005058,TCMBANKGE005058,PRRC2C,BAT2-iso; BAT2D1; BAT2L2; XTP2,proline rich coiled-coil 2C,1q24.3,protein-coding,/
CWITA005059,TCMBANKGE005059,ALLC,ALC,allantoicase,2q35,protein-coding,
CWITA005060,TCMBANKGE005060,CD24,CD24A,CD24 molecule,6q21,protein-coding,Research target
CWITA005061,TCMBANKGE005061,ERAP2,FLJ23633; FLJ23701; FLJ23807; L-RAP; LRAP,Endoplasmic Reticulum Aminopeptidase 2,5q15,protein-coding,
CWITA005062,TCMBANKGE005062,CHRNB4,-,cholinergic receptor nicotinic beta 4 subunit,15q25.1,protein-coding,Clinical Trial target
CWITA005063,TCMBANKGE005063,DNAI4,DIC4; WDR78,dynein axonemal intermediate chain 4,1p31.3,protein-coding,/
CWITA005064,TCMBANKGE005064,ABHD5,CGI58; IECN2; NCIE2,"abhydrolase domain containing 5, lysophosphatidic acid acyltransferase",3p21.33,protein-coding,/
CWITA005065,TCMBANKGE005065,MT1A,MGC32848; MT1; MT1S; MTC,metallothionein 1A,16q13,protein-coding,
CWITA005066,TCMBANKGE005066,COMTD1,FLJ23841,catechol-O-methyltransferase domain containing 1,10q22.2,protein-coding,
CWITA005067,TCMBANKGE005067,PLEKHO2,PLEKHQ1; PP1628; pp9099,pleckstrin homology domain containing O2,15q22.31,protein-coding,/
CWITA005068,TCMBANKGE005068,SLC12A9,CCC6; CIP1; WO3.3; hCCC6,solute carrier family 12 member 9,7q22.1,protein-coding,/
CWITA005069,TCMBANKGE005069,PTPN14,CATLPH; PEZ; PTP36,protein tyrosine phosphatase non-receptor type 14,1q32.3-q41,protein-coding,Research target
CWITA005070,TCMBANKGE005070,ITGBL1,OSCP; TIED,integrin subunit beta like 1,13q33.1,protein-coding,/
CWITA005071,TCMBANKGE005071,SLC16A7,MCT2,solute carrier family 16 member 7,12q14.1,protein-coding,/
CWITA005072,TCMBANKGE005072,P2RY6,P2Y6,pyrimidinergic receptor P2Y6,11q13.4,protein-coding,Clinical Trial target
CWITA005073,TCMBANKGE005073,FMO5,-,flavin containing dimethylaniline monoxygenase 5,1q21.1,protein-coding,/
CWITA005074,TCMBANKGE005074,CABP1,CALBRAIN; HCALB_BR,calcium binding protein 1,12q24.31,protein-coding,/
CWITA005075,TCMBANKGE005075,C16orf72,PRO0149,chromosome 16 open reading frame 72,16p13.2,protein-coding,/
CWITA005076,TCMBANKGE005076,CD101,EWI-101; IGSF2; V7,CD101 molecule,1p13.1,protein-coding,/
CWITA005077,TCMBANKGE005077,IGHG1,N,immunoglobulin heavy constant gamma 1 (G1m marker),14q32.33,other,
CWITA005078,TCMBANKGE005078,SLC47A1,MATE1,solute carrier family 47 member 1,17p11.2,protein-coding,Successful target
CWITA005079,TCMBANKGE005079,DUSP13,BEDP; DUSP13A; DUSP13B; MDSP; SKRP4; TMDP,dual specificity phosphatase 13,10q22.2,protein-coding,/
CWITA005080,TCMBANKGE005080,SMG9,C19orf61; F17127_1; HBMS,SMG9 nonsense mediated mRNA decay factor,19q13.31,protein-coding,/
CWITA005081,TCMBANKGE005081,RNF40,BRE1B; RBP95; STARING,ring finger protein 40,16p11.2,protein-coding,/
CWITA005082,TCMBANKGE005082,APOA1,HPALP2; apo(a),apolipoprotein A1,11q23.3,protein-coding,Research target
CWITA005083,TCMBANKGE005083,ACSL3,ACS3; FACL3; PRO2194,acyl-CoA synthetase long-chain family member 3,2q34-q35,protein-coding,
CWITA005084,TCMBANKGE005084,MMP3,CHDS6; MGC126102; MGC126103; MGC126104; MMPN3; SLN1; STMY; STMY1; STR1,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",11q22.3,protein-coding,
CWITA005085,TCMBANKGE005085,TTC39B,C9orf52,tetratricopeptide repeat domain 39B,9p22.3,protein-coding,/
CWITA005086,TCMBANKGE005086,SMIM3,C5orf62; MST150; NID67,small integral membrane protein 3,5q33.1,protein-coding,/
CWITA005087,TCMBANKGE005087,CA5B,CANVB; MGC39962,"carbonic anhydrase VB, mitochondrial",Xp21.1,protein-coding,
CWITA005088,TCMBANKGE005088,ANKRD18A,-,ankyrin repeat domain 18A,9p13.1,protein-coding,/
CWITA005089,TCMBANKGE005089,CARNMT1,C9orf41; UPF0586,carnosine N-methyltransferase 1,9q21.13,protein-coding,/
CWITA005090,TCMBANKGE005090,TUBA8,TUBAL2,"tubulin, alpha 8",22q11.1,protein-coding,
CWITA005091,TCMBANKGE005091,MAX,bHLHd4,MYC associated factor X,14q23.3,protein-coding,/
CWITA005092,TCMBANKGE005092,HNRNPA2B1,HNRNPA2; HNRNPB1; HNRPA2; HNRPA2B1; HNRPB1; IBMPFD2; RNPA2; SNRPB1,heterogeneous nuclear ribonucleoprotein A2/B1,7p15.2,protein-coding,Research target
CWITA005093,TCMBANKGE005093,SLC48A1,HRG-1; HRG1; hHRG-1,solute carrier family 48 member 1,12q13.11,protein-coding,/
CWITA005094,TCMBANKGE005094,ARL9,-,ADP ribosylation factor like GTPase 9,4q12,protein-coding,/
CWITA005095,TCMBANKGE005095,C1QBP,COXPD33; GC1QBP; HABP1; SF2AP32; SF2p32; gC1Q-R; gC1qR; p32,complement C1q binding protein,17p13.2,protein-coding,Research target
CWITA005096,TCMBANKGE005096,PCDH18,PCDH68L,protocadherin 18,4q28.3,protein-coding,/
CWITA005097,TCMBANKGE005097,CNMD,BRICD3; CHM-I; CHM1; LECT1; MYETS1,chondromodulin,13q14.3,protein-coding,/
CWITA005098,TCMBANKGE005098,LRRC73,C6orf154,leucine rich repeat containing 73,6p21.1,protein-coding,/
CWITA005099,TCMBANKGE005099,KMT5B,CGI-85; CGI85; MRD51; SUV420H1,lysine methyltransferase 5B,11q13.2,protein-coding,/
CWITA005100,TCMBANKGE005100,RAB10,-,"RAB10, member RAS oncogene family",2p23.3,protein-coding,/
CWITA005101,TCMBANKGE005101,ZNF593,ZT86,zinc finger protein 593,1p36.11,protein-coding,/
CWITA005102,TCMBANKGE005102,CRYAA,CRYA1; CTRCT9; HSPB4,crystallin alpha A,21q22.3,protein-coding,Research target
CWITA005103,TCMBANKGE005103,MRPL16,L16mt; MRP-L16; PNAS-111,mitochondrial ribosomal protein L16,11q12.1,protein-coding,/
CWITA005104,TCMBANKGE005104,PDPR,PDP3,pyruvate dehydrogenase phosphatase regulatory subunit,16q22.1,protein-coding,/
CWITA005105,TCMBANKGE005105,MIA2,CTAGE5; MEA6; MGEA; MGEA11; MGEA6; TALI,MIA SH3 domain ER export factor 2,14q21.1,protein-coding,/
CWITA005106,TCMBANKGE005106,TSKU,E2IG4; LRRC54; TSK,"tsukushi, small leucine rich proteoglycan",11q13.5,protein-coding,/
CWITA005107,TCMBANKGE005107,ERICH4,C19orf69,glutamate rich 4,19q13.2,protein-coding,/
CWITA005108,TCMBANKGE005108,TOP2A,TOP2; TP2A,topoisomerase (DNA) II alpha 170kDa,17q21-q22,protein-coding,
CWITA005109,TCMBANKGE005109,SDCCAG8,BBS16; CCCAP; CCCAP SLSN7; HSPC085; NPHP10; NY-CO-8; SLSN7; hCCCAP,SHH signaling and ciliogenesis regulator SDCCAG8,1q43-q44,protein-coding,/
CWITA005110,TCMBANKGE005110,GLUL,GLNS; GS; PIG43; PIG59,glutamate-ammonia ligase,1q25.3,protein-coding,Research target
CWITA005111,TCMBANKGE005111,CEP170B,CEP170R; FAM68C; KIAA0284,centrosomal protein 170B,14q32.33,protein-coding,/
CWITA005112,TCMBANKGE005112,INCENP,FLJ31633; MGC111393,inner centromere protein antigens 135/155kDa,11q12.3,protein-coding,
CWITA005113,TCMBANKGE005113,FKBP4,FKBP51; FKBP52; FKBP59; HBI; Hsp56; PPIase; p52,FKBP prolyl isomerase 4,12p13.33,protein-coding,Research target
CWITA005114,TCMBANKGE005114,PDCL,PhLP,phosducin like,9q33.2,protein-coding,/
CWITA005115,TCMBANKGE005115,FIG4,ALS11; BTOP; CMT4J; KIAA0274; SAC3; YVS; dJ249I4.1,FIG4 phosphoinositide 5-phosphatase,6q21,protein-coding,/
CWITA005116,TCMBANKGE005116,RPL23A,L23A; MDA20,ribosomal protein L23a,17q11.2,protein-coding,/
CWITA005117,TCMBANKGE005117,ZNF559-ZNF177,-,ZNF559-ZNF177 readthrough,19p13.2,protein-coding,/
CWITA005118,TCMBANKGE005118,NUDT6,ASFGF2; FGF-AS; FGF2AS; GFG-1; GFG1,nudix hydrolase 6,4q28.1,protein-coding,/
CWITA005119,TCMBANKGE005119,HIPK1,Myak; Nbak2,homeodomain interacting protein kinase 1,1p13.2,protein-coding,/
CWITA005120,TCMBANKGE005120,TRAP1,HSP 75; HSP75; HSP90L; TRAP-1,TNF receptor associated protein 1,16p13.3,protein-coding,/
CWITA005121,TCMBANKGE005121,PKMYT1,MYT1; PPP1R126,"protein kinase, membrane associated tyrosine/threonine 1",16p13.3,protein-coding,Research target
CWITA005122,TCMBANKGE005122,FPR3,FML2_HUMAN; FMLP-R-II; FMLPY; FPRH1; FPRH2; FPRL2; RMLP-R-I,formyl peptide receptor 3,19q13.41,protein-coding,Research target
CWITA005123,TCMBANKGE005123,RPS3,S3,ribosomal protein S3,11q13.4,protein-coding,/
CWITA005124,TCMBANKGE005124,UGT2B4,HLUG25; UDPGT2B4; UDPGTH1; UGT2B11,"UDP glucuronosyltransferase 2 family, polypeptide B4",4q13,protein-coding,
CWITA005125,TCMBANKGE005125,RPUSD3,-,RNA pseudouridine synthase D3,3p25.3,protein-coding,/
CWITA005126,TCMBANKGE005126,ESD,FGH; FLJ11763,esterase D,13q14.1-q14.2,protein-coding,
CWITA005127,TCMBANKGE005127,SLC12A1,BSC1; NKCC2,solute carrier family 12 member 1,15q21.1,protein-coding,Successful target
CWITA005128,TCMBANKGE005128,LRIG2,LIG-2; LIG2; UFS2,leucine rich repeats and immunoglobulin like domains 2,1p13.2,protein-coding,/
CWITA005129,TCMBANKGE005129,DCUN1D3,44M2.4; SCCRO3,defective in cullin neddylation 1 domain containing 3,16p12.3,protein-coding,/
CWITA005130,TCMBANKGE005130,CLIC3,-,chloride intracellular channel 3,9q34.3,protein-coding,/
CWITA005131,TCMBANKGE005131,ALDH1A2,RALDH(II); RALDH2; RALDH2-T,aldehyde dehydrogenase 1 family member A2,15q21.3,protein-coding,/
CWITA005132,TCMBANKGE005132,GRM8,GLUR8; GPRC1H; MGLUR8; mGlu8,glutamate metabotropic receptor 8,7q31.33,protein-coding,Research target
CWITA005133,TCMBANKGE005133,GABRD,EIG10; EJM7; GEFSP5; MGC45284,"gamma-aminobutyric acid (GABA) A receptor, delta",1p|1p36.3,protein-coding,
CWITA005134,TCMBANKGE005134,HPDL,4-HPPD-L; GLOXD1,4-hydroxyphenylpyruvate dioxygenase like,1p34.1,protein-coding,/
CWITA005135,TCMBANKGE005135,C1GALT1C1,C1GALT2; C38H2-L1; COSMC; HSPC067; MST143; TNPS,C1GALT1 specific chaperone 1,Xq24,protein-coding,/
CWITA005136,TCMBANKGE005136,CENPI,CENP-I; FSHPRH1; LRPR1,centromere protein I,Xq22.1,protein-coding,/
CWITA005137,TCMBANKGE005137,MMP11,SLN3; ST3; STMY3,matrix metallopeptidase 11 (stromelysin 3),22q11.2|22q11.23,protein-coding,
CWITA005138,TCMBANKGE005138,IFNB1,IFB; IFF; IFNB; MGC96956,"interferon, beta 1, fibroblast",9p21,protein-coding,
CWITA005139,TCMBANKGE005139,ZNF311,zf31,zinc finger protein 311,6p22.1,protein-coding,/
CWITA005140,TCMBANKGE005140,UBE2G1,E217K; UBC7; UBE2G,ubiquitin conjugating enzyme E2 G1,17p13.2,protein-coding,/
CWITA005141,TCMBANKGE005141,DEFA3,DEF3; HNP-3; HNP3; HP-3; HP3,defensin alpha 3,8p23.1,protein-coding,/
CWITA005142,TCMBANKGE005142,HRH1,H1NR; hisH1,histamine receptor H1,3p25,protein-coding,
CWITA005143,TCMBANKGE005143,FCGR3B,CD16; CD16A; CD16b; FCG3; FCGR3; FCGR3A; FCR-10; FCRIII; FCRIIIb,Fc fragment of IgG receptor IIIb,1q23.3,protein-coding,/
CWITA005144,TCMBANKGE005144,NAT8,ATase2; CCNAT; CML1; GLA; Hcml1; TSC501; TSC510,N-acetyltransferase 8 (putative),2p13.1,protein-coding,/
CWITA005145,TCMBANKGE005145,SDHC,CYB560; CYBL; PGL3; QPS1; SDH3,succinate dehydrogenase complex subunit C,1q23.3,protein-coding,/
CWITA005146,TCMBANKGE005146,RNASEL,PRCA1; RNS4,ribonuclease L,1q25.3,protein-coding,Research target
CWITA005147,TCMBANKGE005147,CEACAM1,BGP; BGP1; BGPI,CEA cell adhesion molecule 1,19q13.2,protein-coding,/
CWITA005148,TCMBANKGE005148,ZNF605,-,zinc finger protein 605,12q24.33,protein-coding,/
CWITA005149,TCMBANKGE005149,CTSV,CATL2; CTSL2; CTSU,cathepsin V,9q22.33,protein-coding,Patented target
CWITA005150,TCMBANKGE005150,TXLNB,C6orf198; LST001; MDP77; dJ522B19.2,taxilin beta,6q24.1,protein-coding,/
CWITA005151,TCMBANKGE005151,SUV39H1,H3-K9-HMTase 1; KMT1A; MG44; SUV39H,suppressor of variegation 3-9 homolog 1,Xp11.23,protein-coding,Research target
CWITA005152,TCMBANKGE005152,BLOC1S3,BLOS3; HPS8; RP,biogenesis of lysosomal organelles complex 1 subunit 3,19q13.32,protein-coding,/
CWITA005153,TCMBANKGE005153,INAVA,C1orf106,innate immunity activator,1q32.1,protein-coding,/
CWITA005154,TCMBANKGE005154,CSN3,CNS10; CSN10; CSNK; KCA,casein kappa,4q13.3,protein-coding,/
CWITA005155,TCMBANKGE005155,ELAC1,D29,elaC ribonuclease Z 1,18q21.2,protein-coding,/
CWITA005156,TCMBANKGE005156,ORAI3,TMEM142C,ORAI calcium release-activated calcium modulator 3,16p11.2,protein-coding,/
CWITA005157,TCMBANKGE005157,NUP50,NPAP60; NPAP60L,nucleoporin 50,22q13.31,protein-coding,/
CWITA005158,TCMBANKGE005158,PFN2,D3S1319E; PFL,profilin 2,3q25.1,protein-coding,
CWITA005159,TCMBANKGE005159,TDRD7,CATC4; PCTAIRE2BP; TRAP,tudor domain containing 7,9q22.33,protein-coding,/
CWITA005160,TCMBANKGE005160,GRM7,FLJ40498; GLUR7; GPRC1G; MGLU7; MGLUR7,"glutamate receptor, metabotropic 7",3p26.1-p25.1,protein-coding,
CWITA005161,TCMBANKGE005161,LRSAM1,CMT2P; RIFLE; TAL,leucine rich repeat and sterile alpha motif containing 1,9q33.3-q34.11,protein-coding,/
CWITA005162,TCMBANKGE005162,GCDH,ACAD5; GCD,glutaryl-CoA dehydrogenase,19p13.2,protein-coding,
CWITA005163,TCMBANKGE005163,HSD17B1,EDH17B2; EDHB17; HSD17; MGC138140; SDR28C1,hydroxysteroid (17-beta) dehydrogenase 1,17q11-q21,protein-coding,
CWITA005164,TCMBANKGE005164,BDH1,BDH; MGC2723; MGC4347; MGC9788; SDR9C1,"3-hydroxybutyrate dehydrogenase, type 1",3q29,protein-coding,
CWITA005165,TCMBANKGE005165,CBARP,BARP; C19orf26; DOS,CACN subunit beta associated regulatory protein,19p13.3,protein-coding,/
CWITA005166,TCMBANKGE005166,GPCPD1,EDI3; GDE5; GDPD6; PREI4,glycerophosphocholine phosphodiesterase 1,20p12.3,protein-coding,/
CWITA005167,TCMBANKGE005167,MPZ,CHM; CHN2; CMT1; CMT1B; CMT2I; CMT2J; CMT4E; CMTDI3; CMTDID; DSS; HMSNIB; MPP; P0,myelin protein zero,1q23.3,protein-coding,/
CWITA005168,TCMBANKGE005168,MARCHF10,MARCH-X; MARCH10; RNF190,membrane associated ring-CH-type finger 10,17q23.2,protein-coding,/
CWITA005169,TCMBANKGE005169,HDLBP,HBP; PRO2900; VGL,high density lipoprotein binding protein,2q37.3,protein-coding,/
CWITA005170,TCMBANKGE005170,GNL1,HSR1,G protein nucleolar 1 (putative),6p21.33,protein-coding,/
CWITA005171,TCMBANKGE005171,BAZ2A,TIP5; WALp3,bromodomain adjacent to zinc finger domain 2A,12q13.3,protein-coding,Research target
CWITA005172,TCMBANKGE005172,NUFIP2,182-FIP; 82-FIP; FIP-82; PIG1,nuclear FMR1 interacting protein 2,17q11.2,protein-coding,/
CWITA005173,TCMBANKGE005173,TNNI2,AMCD2B; DA2B; DA2B1; FSSV; fsTnI,"troponin I2, fast skeletal type",11p15.5,protein-coding,/
CWITA005174,TCMBANKGE005174,PRKD3,EPK2; PKC-NU; PKD3; PRKCN; nPKC-NU,protein kinase D3,2p22.2,protein-coding,/
CWITA005175,TCMBANKGE005175,THAP11,CTG-B43a; CTG-B45d; HRIHFB2206; RONIN,THAP domain containing 11,16q22.1,protein-coding,/
CWITA005176,TCMBANKGE005176,RSPH10B,-,radial spoke head 10 homolog B,7p22.1,protein-coding,/
CWITA005177,TCMBANKGE005177,GRINA,HNRGW; LFG1; NMDARA1; TMBIM3,glutamate ionotropic receptor NMDA type subunit associated protein 1,8q24.3,protein-coding,/
CWITA005178,TCMBANKGE005178,GAL3ST4,GAL3ST-4,galactose-3-O-sulfotransferase 4,7q22.1,protein-coding,/
CWITA005179,TCMBANKGE005179,SLC15A5,-,solute carrier family 15 member 5,12p12.3,protein-coding,/
CWITA005180,TCMBANKGE005180,PLCL1,MGC126580; MGC138190; PLCE; PLCL; PLDL1; PRIP,phospholipase C-like 1,2q33,protein-coding,
CWITA005181,TCMBANKGE005181,SLC4A10,NBCn2; NCBE,"solute carrier family 4, sodium bicarbonate transporter, member 10",2q23-q24,protein-coding,
CWITA005182,TCMBANKGE005182,ISCA1,HBLD2; ISA1; MMDS5; hIscA,iron-sulfur cluster assembly 1,9q21.33,protein-coding,/
CWITA005183,TCMBANKGE005183,CALU,-,calumenin,7q32.1,protein-coding,/
CWITA005184,TCMBANKGE005184,HAAO,3-HAO; HAO; VCRL1; h3HAO,"3-hydroxyanthranilate 3,4-dioxygenase",2p21,protein-coding,Research target
CWITA005185,TCMBANKGE005185,EN2,-,engrailed homeobox 2,7q36.3,protein-coding,/
CWITA005186,TCMBANKGE005186,PPP3R1,CALNB1; CNB; CNB1,"protein phosphatase 3 regulatory subunit B, alpha",2p14,protein-coding,/
CWITA005187,TCMBANKGE005187,Vdac3-ps1,-,"voltage-dependent anion channel 3, pseudogene 1",13|13 A2,pseudo,/
CWITA005188,TCMBANKGE005188,SH3BP4,BOG25; TTP,SH3 domain binding protein 4,2q37.2,protein-coding,/
CWITA005189,TCMBANKGE005189,IYD,C6orf71; DEHAL1; IYD-1; TDH4,iodotyrosine deiodinase,6q25.1,protein-coding,/
CWITA005190,TCMBANKGE005190,USP1,UBP,ubiquitin specific peptidase 1,1p31.3,protein-coding,Research target
CWITA005191,TCMBANKGE005191,PPFIBP1,L2; SGT2; hSGT2; hSgt2p,PPFIA binding protein 1,12p11.23-p11.22,protein-coding,/
CWITA005192,TCMBANKGE005192,FXYD5,DYSAD; HSPC113; IWU1; KCT1; OIT2; PRO6241; RIC,FXYD domain containing ion transport regulator 5,19q13.12,protein-coding,/
CWITA005193,TCMBANKGE005193,SDR42E1,HSPC105,"short chain dehydrogenase/reductase family 42E, member 1",16q23.3,protein-coding,/
CWITA005194,TCMBANKGE005194,KRT37,HA7; K37; KRTHA7,keratin 37,17q21.2,protein-coding,/
CWITA005195,TCMBANKGE005195,UBALD2,FAM100B,UBA like domain containing 2,17q25.1,protein-coding,/
CWITA005196,TCMBANKGE005196,ANKRD20A2P,ANKRD20A2,"ankyrin repeat domain 20 family member A2, pseudogene",9p11.2,pseudo,/
CWITA005197,TCMBANKGE005197,Hsp86-ps1,86kDa; Hsp86-2; Hsp90,"heat shock protein 86, pseudogene 1",-,pseudo,/
CWITA005198,TCMBANKGE005198,AKR1E2,AKR1CL2; AKRDC1; LoopADR; TAKR; hTSP; htAKR,aldo-keto reductase family 1 member E2,10p15.1,protein-coding,/
CWITA005199,TCMBANKGE005199,NEK10,CILD44,NIMA related kinase 10,3p24.1,protein-coding,/
CWITA005200,TCMBANKGE005200,PFN2,D3S1319E; PFL,profilin 2,3q25.1,protein-coding,/
CWITA005201,TCMBANKGE005201,CCDC91,HSD8; p56,coiled-coil domain containing 91,12p11.22,protein-coding,/
CWITA005202,TCMBANKGE005202,LCN9,HEL129,Lipocalin_9,9q34.3,protein-coding,
CWITA005203,TCMBANKGE005203,FOXQ1,HFH1,forkhead box Q1,6p25.3,protein-coding,Research target
CWITA005204,TCMBANKGE005204,TMC6,EV1; EVER1; EVIN1; LAK-4P; TNRC6C-AS1; lnc,transmembrane channel like 6,17q25.3,protein-coding,/
CWITA005205,TCMBANKGE005205,PTGS1,COX1; COX3; PCOX1; PGG/HS; PGHSN1; PGHS1; PHS1; PTGHS,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),9q32-q33.3,protein-coding,
CWITA005206,TCMBANKGE005206,VPS39,TLP; VAM6; hVam6p,VPS39 subunit of HOPS complex,15q15.1,protein-coding,/
CWITA005207,TCMBANKGE005207,NRARP,-,NOTCH regulated ankyrin repeat protein,9q34.3,protein-coding,/
CWITA005208,TCMBANKGE005208,REV1,AIBP80; REV1L,REV1 DNA directed polymerase,2q11.2,protein-coding,/
CWITA005209,TCMBANKGE005209,PHGDH,3-PGDH; 3PGDH; HEL-S-113; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA,phosphoglycerate dehydrogenase,1p12,protein-coding,Research target
CWITA005210,TCMBANKGE005210,GULP1,CED-6; CED6; GULP,GULP PTB domain containing engulfment adaptor 1,2q32.1-q32.2,protein-coding,/
CWITA005211,TCMBANKGE005211,CPNE1,COPN1; CPN1; MGC1142,copine I,20q11.22,protein-coding,
CWITA005212,TCMBANKGE005212,PPP4R2,PP4R2,protein phosphatase 4 regulatory subunit 2,3p13,protein-coding,/
CWITA005213,TCMBANKGE005213,AHR,bHLHe76,aryl hydrocarbon receptor,7p15,protein-coding,
CWITA005214,TCMBANKGE005214,CCNF,FBX1; FBXO1,cyclin F,16p13.3,protein-coding,/
CWITA005215,TCMBANKGE005215,ST6GAL2,SIAT2; ST6GalII,"ST6 beta-galactoside alpha-2,6-sialyltransferase 2",2q12.3,protein-coding,/
CWITA005216,TCMBANKGE005216,RAB15,-,"RAB15, member RAS oncogene family",14q23.3,protein-coding,/
CWITA005217,TCMBANKGE005217,NUP107,NPHS11; NUP84; ODG6; ODG6; GAMOS7,nucleoporin 107,12q15,protein-coding,/
CWITA005218,TCMBANKGE005218,SLC22A16,CT2; FLIPT2; OCT6; OKB1; dJ261K5.1,"solute carrier family 22 (organic cation/carnitine transporter), member 16",6q22.1|6q21-q22.1,protein-coding,
CWITA005219,TCMBANKGE005219,LGALS3,CBP35; GAL3; GALBP; GALIG; L31; LGALS2; MAC2,"lectin, galactoside-binding, soluble, 3",14q22.3,protein-coding,
CWITA005220,TCMBANKGE005220,PPBP,BNTG1; BetaNTG; CTAPNIII; CTAP3; CTAPIII; CXCL7; LANPF4; LDGF; MDGF; NAPN2; PBP; SCAR10; SCYB7; TC1; TC2; TGB; TGB1; THBGB; THBGB1,pro-platelet basic protein (chemokine (C-X-C motif) ligand 7),4q12-q13,protein-coding,
CWITA005221,TCMBANKGE005221,DUSP3,VHR,dual specificity phosphatase 3,17q21.31,protein-coding,/
CWITA005222,TCMBANKGE005222,ZNF101,HZF12,zinc finger protein 101,19p13.11,protein-coding,/
CWITA005223,TCMBANKGE005223,TOPBP1,Dpb11; TOP2BP1,DNA topoisomerase II binding protein 1,3q22.1,protein-coding,/
CWITA005224,TCMBANKGE005224,TLL1,ASD6; TLL,tolloid like 1,4q32.3,protein-coding,/
CWITA005225,TCMBANKGE005225,D9Mgc45e,CD3,"DNA segment, Chr 9, MRC UK Mouse Genome Centre 45 expressed",-,unknown,/
CWITA005226,TCMBANKGE005226,LDHA,GSD11; HEL-S-133P; LDHM; PIG19,lactate dehydrogenase A,11p15.1,protein-coding,Research target
CWITA005227,TCMBANKGE005227,ANKRD10,-,ankyrin repeat domain 10,13q34,protein-coding,/
CWITA005228,TCMBANKGE005228,SHB,bA3J10.2,SH2 domain containing adaptor protein B,9p13.1,protein-coding,/
CWITA005229,TCMBANKGE005229,DPP6,DPL1; DPPX; MRD33; VF2,dipeptidyl peptidase like 6,7q36.2,protein-coding,/
CWITA005230,TCMBANKGE005230,ZNF394,ZKSCAN14; ZSCAN46,zinc finger protein 394,7q22.1,protein-coding,/
CWITA005231,TCMBANKGE005231,NR2C2,TAK1; TR4,nuclear receptor subfamily 2 group C member 2,3p25.1,protein-coding,/
CWITA005232,TCMBANKGE005232,DLG3,MRX; MRX90; NEDLG; PPP1R82; SAP102; XLMR,discs large MAGUK scaffold protein 3,Xq13.1,protein-coding,/
CWITA005233,TCMBANKGE005233,GK5,-,glycerol kinase 5,3q23,protein-coding,/
CWITA005234,TCMBANKGE005234,TMC5,-,transmembrane channel like 5,16p12.3,protein-coding,/
CWITA005235,TCMBANKGE005235,ASPA,ACY2; ASP,aspartoacylase,17p13.3,protein-coding,
CWITA005236,TCMBANKGE005236,DIS3,2810028N01Rik; EXOSC11; KIAA1008; RRP44; dis3p,"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease",13q21.33,protein-coding,/
CWITA005237,TCMBANKGE005237,MED11,HSPC296,mediator complex subunit 11,17p13.2,protein-coding,/
CWITA005238,TCMBANKGE005238,OSGIN1,BDGI; OKL38,oxidative stress induced growth inhibitor 1,16q23.3,protein-coding,/
CWITA005239,TCMBANKGE005239,ARHGDIB,D4; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1; RhoGDI2,Rho GDP dissociation inhibitor beta,12p12.3,protein-coding,/
CWITA005240,TCMBANKGE005240,NUS1,C6orf68; CDG1AA; MGC:7199; MRD55; NgBR; TANGO14,NUS1 dehydrodolichyl diphosphate synthase subunit,6q22.1,protein-coding,/
CWITA005241,TCMBANKGE005241,LHCGR,HHG; LCGR; LGR2; LH/CG-R; LH/CGR; LHR; LHRHR; LSH-R; ULG5,luteinizing hormone/choriogonadotropin receptor,2p16.3,protein-coding,Successful target
CWITA005242,TCMBANKGE005242,SS18L2,KIAA-iso,SS18 like 2,3p22.1,protein-coding,/
CWITA005243,TCMBANKGE005243,RAB33B,SMC2,"RAB33B, member RAS oncogene family",4q31.1,protein-coding,/
CWITA005244,TCMBANKGE005244,DHRS4L1,SDR25C4,Dehydrogenase/Reductase_4_Like_1,14q11.2,protein-coding,
CWITA005245,TCMBANKGE005245,ATP5MC2,ATP5A; ATP5G2,ATP synthase membrane subunit c locus 2,12q13.13,protein-coding,/
CWITA005246,TCMBANKGE005246,XRCC4,N,X-ray repair complementing defective repair in Chinese hamster cells 4,5q14.2,protein-coding,
CWITA005247,TCMBANKGE005247,KRBOX4,ZNF673,KRAB box domain containing 4,Xp11.3,protein-coding,/
CWITA005248,TCMBANKGE005248,ZER1,C9orf60; ZYG; ZYG11BL,zyg-11 related cell cycle regulator,9q34.11,protein-coding,/
CWITA005249,TCMBANKGE005249,ATP6V1B2,ATP6B1B2; ATP6B2; DOOD; HO57; VATB; VPP3; Vma2; ZLS2,ATPase H+ transporting V1 subunit B2,8p21.3,protein-coding,/
CWITA005250,TCMBANKGE005250,PDZD8,PDZK8,PDZ domain containing 8,10q25.3-q26.11,protein-coding,/
CWITA005251,TCMBANKGE005251,DAPK1,DAPK; DKFZp781I035,death-associated protein kinase 1,9q34.1,protein-coding,
CWITA005252,TCMBANKGE005252,CDK18,PCTAIRE; PCTAIRE3; PCTK3,cyclin dependent kinase 18,1q32.1,protein-coding,Research target
CWITA005253,TCMBANKGE005253,ARNT2,WEDAS; bHLHe1,aryl hydrocarbon receptor nuclear translocator 2,15q25.1,protein-coding,/
CWITA005254,TCMBANKGE005254,RHBDF2,RHBDL5; RHBDL6; TEC; TOC; TOCG; iRhom2,rhomboid 5 homolog 2,17q25.1,protein-coding,Research target
CWITA005255,TCMBANKGE005255,RPL23,L23; rpL17,ribosomal protein L23,17q12,protein-coding,/
CWITA005256,TCMBANKGE005256,ATL2,ARL3IP2; ARL6IP2; aip-2; atlastin2,atlastin GTPase 2,2p22.2-p22.1,protein-coding,/
CWITA005257,TCMBANKGE005257,TK1,TK2,thymidine kinase 1,17q25.3,protein-coding,Successful target
CWITA005258,TCMBANKGE005258,RTL8A,CXX1b; FAM127B; MAR8A; SIRH6,retrotransposon Gag like 8A,Xq26.3,protein-coding,/
CWITA005259,TCMBANKGE005259,GPT2,ALT2; GPT 2; MRT49,glutamic--pyruvic transaminase 2,16q11.2,protein-coding,/
CWITA005260,TCMBANKGE005260,GALNTL5,GALNACT19; GALNT15; GalNAc-T5L,polypeptide N-acetylgalactosaminyltransferase like 5,7q36.1,protein-coding,/
CWITA005261,TCMBANKGE005261,CARHSP1,CRHSP-24; CRHSP24; CSDC1,calcium regulated heat stable protein 1,16p13.2,protein-coding,/
CWITA005262,TCMBANKGE005262,ADD3,ADDL; CPSQ3,adducin 3,10q25.1-q25.2,protein-coding,/
CWITA005263,TCMBANKGE005263,SPRR4,-,small proline rich protein 4,1q21.3,protein-coding,/
CWITA005264,TCMBANKGE005264,KLF8,BKLF3; ZNF741,Kruppel like factor 8,Xp11.21,protein-coding,/
CWITA005265,TCMBANKGE005265,GPR17,-,G protein-coupled receptor 17,2q14.3,protein-coding,Research target
CWITA005266,TCMBANKGE005266,ZNF469,BCS; BCS1; Zfp469,zinc finger protein 469,16q24.2,protein-coding,/
CWITA005267,TCMBANKGE005267,SETD1A,EPEDD; KMT2F; Set1; Set1A,"SET domain containing 1A, histone lysine methyltransferase",16p11.2,protein-coding,/
CWITA005268,TCMBANKGE005268,LHCGR,FLJ41504; HHG; LCGR; LGR2; LH/CGNR; LH/CGR; LHR; LHRHR; LSHNR; ULG5,luteinizing hormone/choriogonadotropin receptor,2p21,protein-coding,
CWITA005269,TCMBANKGE005269,CLCN6,CLC-6,chloride voltage-gated channel 6,1p36.22,protein-coding,Research target
CWITA005270,TCMBANKGE005270,SPAG4,CT127; SUN4,sperm associated antigen 4,20q11.22,protein-coding,/
CWITA005271,TCMBANKGE005271,CKS2,CKSHS2,CDC28 protein kinase regulatory subunit 2,9q22.2,protein-coding,/
CWITA005272,TCMBANKGE005272,IMMT,HMP; MICOS60; MINOS2; Mic60; P87; P87/89; P89; PIG4; PIG52,inner membrane mitochondrial protein,2p11.2|2,protein-coding,/
CWITA005273,TCMBANKGE005273,FARS2,COXPD14; FARS1; HSPC320; PheRS; SPG77; mtPheRS,"phenylalanyl-tRNA synthetase 2, mitochondrial",6p25.1,protein-coding,/
CWITA005274,TCMBANKGE005274,GPC3,DGSX; GTR2-2; MXR7; OCI-5; SDYS; SGB; SGBS; SGBS1,glypican 3,Xq26.2,protein-coding,Clinical Trial target
CWITA005275,TCMBANKGE005275,DRD5,DBDR; DRD1B; DRD1L2,Dopamine_Receptor_D5,4p16.1,protein-coding,
CWITA005276,TCMBANKGE005276,ARMC9,ARM; JBTS30; KU-MEL-1; NS21,armadillo repeat containing 9,2q37.1,protein-coding,/
CWITA005277,TCMBANKGE005277,NR2F1,COUPNTFI; EARN3; EAR3; ERBAL3; NR2F2; SVP44; TCFCOUP1; TFCOUP1,"nuclear receptor subfamily 2, group F, member 1",5q14,protein-coding,
CWITA005278,TCMBANKGE005278,TNS4,CTEN; PP14434,tensin 4,17q21.2,protein-coding,Research target
CWITA005279,TCMBANKGE005279,ARHGEF6,COOL2; Cool-2; MRX46; PIXA; alpha-PIX; alphaPIX,Rac/Cdc42 guanine nucleotide exchange factor 6,Xq26.3,protein-coding,/
CWITA005280,TCMBANKGE005280,KIF7,ACLS; AGBK; HLS2; JBTS12; UNQ340,kinesin family member 7,15q26.1,protein-coding,/
CWITA005281,TCMBANKGE005281,ALDH1A3,ALDH1A6; ALDH6; MCOP8; RALDH3,aldehyde dehydrogenase 1 family member A3,15q26.3,protein-coding,/
CWITA005282,TCMBANKGE005282,SEC22A,SEC22L2,"SEC22 homolog A, vesicle trafficking protein",3q21.1,protein-coding,/
CWITA005283,TCMBANKGE005283,CUL3,CUL-3; PHA2E,cullin 3,2q36.2,protein-coding,Research target
CWITA005284,TCMBANKGE005284,NDUFB8,ASHI; CINASHI,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa",10q24.31,protein-coding,
CWITA005285,TCMBANKGE005285,PRPSAP1,PAP39,phosphoribosyl pyrophosphate synthetase associated protein 1,17q25.1,protein-coding,/
CWITA005286,TCMBANKGE005286,NOL9,Grc3; NET6,nucleolar protein 9,1p36.31,protein-coding,/
CWITA005287,TCMBANKGE005287,PRMT2,HRMT1L1,protein arginine methyltransferase 2,21q22.3,protein-coding,/
CWITA005288,TCMBANKGE005288,PDYN,ADCA; PENKB; SCA23,prodynorphin,20p13,protein-coding,/
CWITA005289,TCMBANKGE005289,CLCNKA,CLCK1; ClC-K1; hClC-Ka,chloride voltage-gated channel Ka,1p36.13,protein-coding,Research target
CWITA005290,TCMBANKGE005290,GTF3C4,KAT12; TF3C-delta; TFIII90; TFIIIC290; TFIIIC90; TFIIICDELTA,general transcription factor IIIC subunit 4,9q34.13,protein-coding,/
CWITA005291,TCMBANKGE005291,TAS2R31,T2R31; T2R44; T2R53; TAS2R44,taste 2 receptor member 31,12p13.2,protein-coding,/
CWITA005292,TCMBANKGE005292,TMEM41A,2900010K02Rik,transmembrane protein 41A,3q27.2,protein-coding,/
CWITA005293,TCMBANKGE005293,TXNDC15,BUG; C5orf14; UNQ335,thioredoxin domain containing 15,5q31.1,protein-coding,/
CWITA005294,TCMBANKGE005294,PDE3B,HcGIP1; cGIPDE1,"phosphodiesterase 3B, cGMP-inhibited",11p15.1,protein-coding,
CWITA005295,TCMBANKGE005295,PPP1R9A,NRB1; NRBI; Neurabin-I,protein phosphatase 1 regulatory subunit 9A,7q21.3,protein-coding,/
CWITA005296,TCMBANKGE005296,ARL6IP5,DERP11; GTRAP3-18; HSPC127; JWA; PRAF3; Yip6b; addicsin; hp22; jmx,ADP ribosylation factor like GTPase 6 interacting protein 5,3p14.1,protein-coding,/
CWITA005297,TCMBANKGE005297,SSH1,SSH1L,slingshot protein phosphatase 1,12q24.11,protein-coding,/
CWITA005298,TCMBANKGE005298,FBXO9,FBX9; NY-REN-57; VCIA1; dJ341E18.2,F-box protein 9,6p12.1,protein-coding,/
CWITA005299,TCMBANKGE005299,ATIC,AICAR; AICARFT; FLJ93545; IMPCHASE; PURH,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,2q35,protein-coding,
CWITA005300,TCMBANKGE005300,PLOD1,EDS6; EDSKCL1; LH; LH1; LLH; PLOD,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",1p36.22,protein-coding,Clinical Trial target
CWITA005301,TCMBANKGE005301,GSTM5,GSTM5-5; GTM5,glutathione S-transferase mu 5,1p13.3,protein-coding,/
CWITA005302,TCMBANKGE005302,DVL1,DRS2; DVL; DVL1L1; DVL1P1,dishevelled segment polarity protein 1,1p36.33,protein-coding,/
CWITA005303,TCMBANKGE005303,TAF1A,MGC:17061; RAFI48; SL1; TAFI48,"TATA-box binding protein associated factor, RNA polymerase I subunit A",1q41,protein-coding,/
CWITA005304,TCMBANKGE005304,RDH10,SDR16C4,retinol dehydrogenase 10,8q21.11,protein-coding,/
CWITA005305,TCMBANKGE005305,RPL4,L4,ribosomal protein L4,15q22.31,protein-coding,/
CWITA005306,TCMBANKGE005306,Rab7,Rab7a,"RAB7, member RAS oncogene family",6 D1|6 39.13 cM,protein-coding,/
CWITA005307,TCMBANKGE005307,MAN2C1,MAN6A8; MANA; MANA1,mannosidase alpha class 2C member 1,15q24.2,protein-coding,/
CWITA005308,TCMBANKGE005308,RAD21,CDLS4; HR21; HRAD21; MCD1; MGS; NXP1; SCC1; hHR21,RAD21 cohesin complex component,8q24.11,protein-coding,/
CWITA005309,TCMBANKGE005309,GABBR1,FLJ92613; GABABR1; GABBR1N3; GB1; GPRC3A; dJ271M21.1.1; dJ271M21.1.2,"gamma-aminobutyric acid (GABA) B receptor, 1",6p21.31,protein-coding,
CWITA005310,TCMBANKGE005310,HMCN2,-,hemicentin 2,9q34.11,protein-coding,/
CWITA005311,TCMBANKGE005311,DLC1,ARHGAP7; HP; STARD12; p122-RhoGAP,DLC1 Rho GTPase activating protein,8p22,protein-coding,/
CWITA005312,TCMBANKGE005312,GFRA1,GDNFR; GDNFRA; GFR-ALPHA-1; RET1L; RETL1; TRNR1,GDNF family receptor alpha 1,10q25.3,protein-coding,/
CWITA005313,TCMBANKGE005313,PSMC1,P26S4; S4; p56,"proteasome 26S subunit, ATPase 1",14q32.11,protein-coding,/
CWITA005314,TCMBANKGE005314,SOST,CDD; DAND6; SOST1; VBCH,sclerostin,17q21.31,protein-coding,Clinical Trial target
CWITA005315,TCMBANKGE005315,ST6GALNAC1,HSY11339; SIAT7A; ST6GalNAcI; STYI,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",17q25.1,protein-coding,/
CWITA005316,TCMBANKGE005316,TMPRSS4,CAPH2; MT-SP2; TMPRSS3,transmembrane serine protease 4,11q23.3,protein-coding,/
CWITA005317,TCMBANKGE005317,C4orf48,CHR4_55,chromosome 4 open reading frame 48,4p16.3,protein-coding,/
CWITA005318,TCMBANKGE005318,S100A9,60B8AG; CAGB; CFAG; CGLB; L1AG; LIAG; MAC387; MIF; MRP14; NIF; P14,S100 calcium binding protein A9,1q21.3,protein-coding,Clinical Trial target
CWITA005319,TCMBANKGE005319,ZFP92,ZNF897,ZFP92 zinc finger protein,Xq28,protein-coding,/
CWITA005320,TCMBANKGE005320,WRNIP1,CFAP93; FAP93; WHIP; bA420G6.2,WRN helicase interacting protein 1,6p25.2,protein-coding,/
CWITA005321,TCMBANKGE005321,PSMD11,Rpn6; S9; p44.5,"proteasome 26S subunit, non-ATPase 11",17q11.2,protein-coding,/
CWITA005322,TCMBANKGE005322,TIA1,TIA-1; WDM,TIA1 cytotoxic granule associated RNA binding protein,2p13.3,protein-coding,/
CWITA005323,TCMBANKGE005323,PCDHA3,PCDH-ALPHA3,protocadherin alpha 3,5q31.3,protein-coding,/
CWITA005324,TCMBANKGE005324,COPS8,COP9; CSN8; SGN8,COP9 signalosome subunit 8,2q37.3,protein-coding,/
CWITA005325,TCMBANKGE005325,GPD1L,GPD1-L,glycerol-3-phosphate dehydrogenase 1 like,3p22.3,protein-coding,/
CWITA005326,TCMBANKGE005326,PPM1H,ARHCL1; NERPP-2C; URCC2,"protein phosphatase, Mg2+/Mn2+ dependent 1H",12q14.1-q14.2,protein-coding,/
CWITA005327,TCMBANKGE005327,CNTN5,HNB-2s; NB-2,contactin 5,11q22.1,protein-coding,/
CWITA005328,TCMBANKGE005328,MRI1,M1Pi; MRDI; MTNA; Ypr118w,methylthioribose-1-phosphate isomerase 1,19p13.13,protein-coding,/
CWITA005329,TCMBANKGE005329,HOXA1,BSAS; HOX1; HOX1F,homeobox A1,7p15.2,protein-coding,/
CWITA005330,TCMBANKGE005330,ERCC4,ERCC11; FANCQ; RAD1; XFEPS; XPF,"ERCC excision repair 4, endonuclease catalytic subunit",16p13.12,protein-coding,/
CWITA005331,TCMBANKGE005331,MIA,CD-RAP,MIA SH3 domain containing,19q13.2,protein-coding,Research target
CWITA005332,TCMBANKGE005332,ENO4,C10orf134,enolase 4,10q25.3,protein-coding,/
CWITA005333,TCMBANKGE005333,PIGF,-,phosphatidylinositol glycan anchor biosynthesis class F,2p21,protein-coding,/
CWITA005334,TCMBANKGE005334,OS9,ERLEC2; OS-9,OS9 endoplasmic reticulum lectin,12q13.3-q14.1,protein-coding,/
CWITA005335,TCMBANKGE005335,TAFA4,FAM19A4; TAFA-4,TAFA chemokine like family member 4,3p14.1,protein-coding,/
CWITA005336,TCMBANKGE005336,DNAJC3,ACPHD; ERdj6; HP58; P58; P58IPK; PRKRI; p58(IPK),DnaJ heat shock protein family (Hsp40) member C3,13q32.1,protein-coding,/
CWITA005337,TCMBANKGE005337,ERVK-7,ERVK7; HERV-K(III); HERV-K102; HERV-KIII; PR; Protease; Proteinase,endogenous retrovirus group K member 7,1q22,other,/
CWITA005338,TCMBANKGE005338,VARS2,COXPD20; VALRS; VARS2L; VARSL,"valyl-tRNA synthetase 2, mitochondrial",6p21.33,protein-coding,/
CWITA005339,TCMBANKGE005339,BCR,ALL; BCR1; CML; D22S11; D22S662; PHL,BCR activator of RhoGEF and GTPase,22q11.23,protein-coding,/
CWITA005340,TCMBANKGE005340,BAZ1A,ACF1; WALp1; WCRF180; hACF1,bromodomain adjacent to zinc finger domain 1A,14q13.1-q13.2,protein-coding,/
CWITA005341,TCMBANKGE005341,CEACAM19,CEACM19; CEAL1,CEA cell adhesion molecule 19,19q13.31,protein-coding,/
CWITA005342,TCMBANKGE005342,RNF183,-,ring finger protein 183,9q32,protein-coding,/
CWITA005343,TCMBANKGE005343,LRRC23,LRPB7,leucine rich repeat containing 23,12p13.31,protein-coding,/
CWITA005344,TCMBANKGE005344,QPCT,GCT; QC; sQC,glutaminyl-peptide cyclotransferase,2p22.2,protein-coding,Clinical Trial target
CWITA005345,TCMBANKGE005345,OMD,OSAD; SLRR2C,osteomodulin,9q22.31,protein-coding,/
CWITA005346,TCMBANKGE005346,UBE2M,UBC-RS2; UBC12; hUbc12,ubiquitin conjugating enzyme E2 M,19q13.43,protein-coding,/
CWITA005347,TCMBANKGE005347,GLRA1,MGC138878; MGC138879; STHE,"glycine receptor, alpha 1",5q32,protein-coding,
CWITA005348,TCMBANKGE005348,GLUD1,GDH; GDH1; GLUD; MGC132003,glutamate dehydrogenase 1,10q23.3,protein-coding,
CWITA005349,TCMBANKGE005349,P2RX3,P2X3,purinergic receptor P2X 3,11q12.1,protein-coding,Clinical Trial target
CWITA005350,TCMBANKGE005350,ATP1B4,-,ATPase Na+/K+ transporting family member beta 4,Xq24,protein-coding,/
CWITA005351,TCMBANKGE005351,NEBL,C10orf113; LASP2; LNEBL; bA165O3.1,nebulette,10p12.31,protein-coding,/
CWITA005352,TCMBANKGE005352,VILL,-,villin like,3p22.2,protein-coding,/
CWITA005353,TCMBANKGE005353,NLRC4,AIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; FCAS4; IPAF,NLR family CARD domain containing 4,2p22.3,protein-coding,/
CWITA005354,TCMBANKGE005354,CEBPD,C/EBP-delta; CELF; CRP3; NF-IL6-beta,CCAAT enhancer binding protein delta,8q11.21,protein-coding,/
CWITA005355,TCMBANKGE005355,PADI2,PAD-H19; PAD2; PDI2,peptidyl arginine deiminase 2,1p36.13,protein-coding,/
CWITA005356,TCMBANKGE005356,PCGF1,2010002K04Rik; NSPC1; RNF3A-2; RNF68,polycomb group ring finger 1,2p13.1,protein-coding,/
CWITA005357,TCMBANKGE005357,Lor,AI036317; S77319,loricrin,3 F1|3 40.14 cM,protein-coding,/
CWITA005358,TCMBANKGE005358,CTRB1,CTRB,chymotrypsinogen B1,16q23.1,protein-coding,/
CWITA005359,TCMBANKGE005359,ACAT1,ACAT; MAT; T2; THIL,acetyl-CoA acetyltransferase 1,11q22.3,protein-coding,Clinical Trial target
CWITA005360,TCMBANKGE005360,GABRA4,-,gamma-aminobutyric acid type A receptor subunit alpha4,4p12,protein-coding,/
CWITA005361,TCMBANKGE005361,SLX4IP,C20orf94; bA204H22.1; bA254M13.1; dJ1099D15.3,SLX4 interacting protein,20p12.2,protein-coding,/
CWITA005362,TCMBANKGE005362,C9orf85,-,chromosome 9 open reading frame 85,9q21.13,protein-coding,/
CWITA005363,TCMBANKGE005363,SLC3A2,4F2; 4F2HC; 4T2HC; CD98; CD98HC; MDU1; NACAE,"Solute Carrier Family 3 (Activators Of Dibasic And Neutral Amino Acid Transport), Member 2",11q13,protein-coding,
CWITA005364,TCMBANKGE005364,SLC2A2,GLUT2,solute carrier family 2 member 2,3q26.2,protein-coding,/
CWITA005365,TCMBANKGE005365,PSORS1C2,C6orf17; SPR1,psoriasis susceptibility 1 candidate 2,6p21.33,protein-coding,/
CWITA005366,TCMBANKGE005366,ACSS2,ACAS2; ACECS; ACS; ACSA; AceCS1; dJ1161H23.1,acyl-CoA synthetase short chain family member 2,20q11.22,protein-coding,/
CWITA005367,TCMBANKGE005367,PC,PCB,pyruvate carboxylase,11q13.4-q13.5,protein-coding,
CWITA005368,TCMBANKGE005368,LDB1,CLIM-2; CLIM2; LDB-1; NLI,LIM domain binding 1,10q24.32,protein-coding,/
CWITA005369,TCMBANKGE005369,REN,FLJ10761; HNFJ2,renin,1q32,protein-coding,
CWITA005370,TCMBANKGE005370,PTPRF,BNAH2; LAR,protein tyrosine phosphatase receptor type F,1p34.2,protein-coding,/
CWITA005371,TCMBANKGE005371,ARHGAP11A,GAP (1-12),Rho GTPase activating protein 11A,15q13.3,protein-coding,/
CWITA005372,TCMBANKGE005372,HIP1,HIP-I; ILWEQ; SHON; SHONbeta; SHONgamma,huntingtin interacting protein 1,7q11.23,protein-coding,/
CWITA005373,TCMBANKGE005373,GLYATL1,FLJ26507; FLJ34646; GATFNC; GNAT; MGC15397; MGC15937,glycine-N-acyltransferase-like 1,11q12.1,protein-coding,
CWITA005374,TCMBANKGE005374,ZBTB24,BIF1; ICF2; PATZ2; ZNF450,zinc finger and BTB domain containing 24,6q21,protein-coding,/
CWITA005375,TCMBANKGE005375,ZBTB11,MRT69; ZNF-U69274; ZNF913,zinc finger and BTB domain containing 11,3q12.3,protein-coding,/
CWITA005376,TCMBANKGE005376,SLC30A4,ZNT4; znT-4,solute carrier family 30 member 4,15q21.1|15q21.1,protein-coding,/
CWITA005377,TCMBANKGE005377,PMP22,CIDP; CMT1A; CMT1E; DSS; GAS-3; GAS3; HMSNIA; HNPP; Sp110,peripheral myelin protein 22,17p12,protein-coding,/
CWITA005378,TCMBANKGE005378,KRT20,CD20; CK-20; CK20; K20; KRT21,keratin 20,17q21.2,protein-coding,/
CWITA005379,TCMBANKGE005379,SLC26A6,-,solute carrier family 26 member 6,3p21.31,protein-coding,/
CWITA005380,TCMBANKGE005380,SLC18B1,C6orf192; dJ55C23.6,solute carrier family 18 member B1,6q23.2,protein-coding,/
CWITA005381,TCMBANKGE005381,GPR52,-,G protein-coupled receptor 52,1q25.1,protein-coding,/
CWITA005382,TCMBANKGE005382,NAA60,HAT4; NAT15; NatF; hNaa60,"N-alpha-acetyltransferase 60, NatF catalytic subunit",16p13.3,protein-coding,/
CWITA005383,TCMBANKGE005383,PRR4,LPRP; PROL4,proline rich 4,12p13.2,protein-coding,/
CWITA005384,TCMBANKGE005384,DHX38,DDX38; PRP16; PRPF16; RP84,DEAH-box helicase 38,16q22.2,protein-coding,/
CWITA005385,TCMBANKGE005385,VEZT,VEZATIN,"vezatin, adherens junctions transmembrane protein",12q22,protein-coding,/
CWITA005386,TCMBANKGE005386,SAMD8,HEL-177; SMSr,sterile alpha motif domain containing 8,10q22.2,protein-coding,/
CWITA005387,TCMBANKGE005387,PCDH7,BH-Pcdh; BHPCDH; PPP1R120,protocadherin 7,4p15.1,protein-coding,/
CWITA005388,TCMBANKGE005388,AMMECR1,AMMERC1; MFHIEN,AMMECR nuclear protein 1,Xq23,protein-coding,/
CWITA005389,TCMBANKGE005389,PI4K2B,FLJ11105; PI4KIIB; PIK42B,phosphatidylinositol 4-kinase type 2 beta,4p15.2,protein-coding,
CWITA005390,TCMBANKGE005390,JAKMIP2,JAMIP2; NECC1,janus kinase and microtubule interacting protein 2,5q32,protein-coding,/
CWITA005391,TCMBANKGE005391,CENPX,CENP-X; D9; FAAP10; MHF2; STRA13,centromere protein X,17q25.3,protein-coding,/
CWITA005392,TCMBANKGE005392,MRPS27,MRP-S27; S27mt,mitochondrial ribosomal protein S27,5q13.2,protein-coding,/
CWITA005393,TCMBANKGE005393,SAA4,C-SAA; CSAA,"serum amyloid A4, constitutive",11p15.1,protein-coding,/
CWITA005394,TCMBANKGE005394,Cdc2b,Cdc2,cell division cycle 2 homolog B (S. pombe),-,other,/
CWITA005395,TCMBANKGE005395,SERTAD3,RBT1,SERTA domain containing 3,19q13.2,protein-coding,/
CWITA005396,TCMBANKGE005396,ACADSB,2-MEBCAD; ACAD7; SBCAD,acyl-CoA dehydrogenase short/branched chain,10q26.13,protein-coding,/
CWITA005397,TCMBANKGE005397,WSB2,SBA2,WD repeat and SOCS box containing 2,12q24.23,protein-coding,/
CWITA005398,TCMBANKGE005398,MEOX2,GAX; MOX2,mesenchyme homeobox 2,7p21.2,protein-coding,/
CWITA005399,TCMBANKGE005399,RALGPS2,dJ595C2.1,Ral GEF with PH domain and SH3 binding motif 2,1q25.2,protein-coding,/
CWITA005400,TCMBANKGE005400,ELF4,ELFR; MEF,E74 like ETS transcription factor 4,Xq26.1,protein-coding,/
CWITA005401,TCMBANKGE005401,KCNS3,KV9.3,potassium voltage-gated channel modifier subfamily S member 3,2p24.2,protein-coding,/
CWITA005402,TCMBANKGE005402,CST3,ARMD11; HEL-S-2,cystatin C,20p11.21,protein-coding,/
CWITA005403,TCMBANKGE005403,LASP1,Lasp-1; MLN50,LIM and SH3 protein 1,17q12,protein-coding,Research target
CWITA005404,TCMBANKGE005404,ZNF75D,D8C6; ZKSCAN24; ZNF75; ZNF82; ZSCAN28,zinc finger protein 75D,Xq26.3,protein-coding,/
CWITA005405,TCMBANKGE005405,SNUPN,KPNBL; RNUT1; Snurportin1,snurportin 1,15q24.2,protein-coding,/
CWITA005406,TCMBANKGE005406,CCR1,CD191; CKR-1; CKR1; CMKBR1; HM145; MIP1aR; SCYAR1,C-C motif chemokine receptor 1,3p21.31,protein-coding,Clinical Trial target
CWITA005407,TCMBANKGE005407,WASHC4,KIAA1033; MRT43; SWIP,WASH complex subunit 4,12q23.3,protein-coding,/
CWITA005408,TCMBANKGE005408,MIS18A,B28; C21orf45; C21orf46; FASP1; MIS18alpha; hMis18alpha,MIS18 kinetochore protein A,21q22.11,protein-coding,/
CWITA005409,TCMBANKGE005409,TTN,CMD1G; CMH9; CMPD4; EOMFC; HMERF; LGMD2J; LGMDR10; MYLK5; SALMY; TMD,titin,2q31.2,protein-coding,/
CWITA005410,TCMBANKGE005410,BZW1,BZAP45; Nbla10236,basic leucine zipper and W2 domains 1,2q33.1,protein-coding,/
CWITA005411,TCMBANKGE005411,TMEM26,-,transmembrane protein 26,10q21.2,protein-coding,/
CWITA005412,TCMBANKGE005412,HSD3B1,3BETAHSD; HSD3B; HSDB3; HSDB3A; I; SDR11E1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",1p13.1,protein-coding,
CWITA005413,TCMBANKGE005413,ZNF764,-,zinc finger protein 764,16p11.2,protein-coding,/
CWITA005414,TCMBANKGE005414,HACD3,B-IND1; BIND1; HSPC121; PTPLAD1,3-hydroxyacyl-CoA dehydratase 3,15q22.31,protein-coding,/
CWITA005415,TCMBANKGE005415,GOLGA4,CRPF46; GCP2; GOLG; MU-RMS-40.18; p230,golgin A4,3p22.2,protein-coding,/
CWITA005416,TCMBANKGE005416,GNRHR2,GnRHNIINR,gonadotropin-releasing hormone (type 2) receptor 2,1q12,pseudo,
CWITA005417,TCMBANKGE005417,COASY,DPCK; NBIA6; NBP; PCH12; PPAT; UKR1; pOV-2,Coenzyme A synthase,17q21.2,protein-coding,Research target
CWITA005418,TCMBANKGE005418,EIF2B4,EIF-2B; EIF2B; EIF2Bdelta,eukaryotic translation initiation factor 2B subunit delta,2p23.3,protein-coding,/
CWITA005419,TCMBANKGE005419,HELZ2,PDIP-1; PRIC285,helicase with zinc finger 2,20q13.33,protein-coding,/
CWITA005420,TCMBANKGE005420,MYLPF,HUMMLC2B; MLC2B; MRLC2; MYL11,"myosin light chain, phosphorylatable, fast skeletal muscle",16p11.2,protein-coding,/
CWITA005421,TCMBANKGE005421,BRF2,BRFU; TFIIIB50,BRF2 RNA polymerase III transcription initiation factor subunit,8p11.23,protein-coding,/
CWITA005422,TCMBANKGE005422,CD59,16.3A5; 1F5; EJ16; EJ30; EL32; G344; HRF-20; HRF20; MAC-IP; MACIF; MEM43; MIC11; MIN1; MIN2; MIN3; MIRL; MSK21; p18-20,CD59 molecule (CD59 blood group),11p13,protein-coding,Research target
CWITA005423,TCMBANKGE005423,RIPK2,CARD3; CARDIAK; CCK; GIG30; RICK; RIP2,receptor interacting serine/threonine kinase 2,8q21.3,protein-coding,Clinical Trial target
CWITA005424,TCMBANKGE005424,CDCA7,ICF3; JPO1,cell division cycle associated 7,2q31.1,protein-coding,/
CWITA005425,TCMBANKGE005425,EPB41L1,4.1N; MRD11,erythrocyte membrane protein band 4.1 like 1,20q11.23,protein-coding,/
CWITA005426,TCMBANKGE005426,CEP55,C10orf3; CT111; MARCH; URCC6,centrosomal protein 55,10q23.33,protein-coding,/
CWITA005427,TCMBANKGE005427,CHST6,C-GlcNAc6ST; GST4-beta; MCDC1; glcNAc6ST-5; gn6st-5; hCGn6ST,carbohydrate sulfotransferase 6,16q23.1,protein-coding,/
CWITA005428,TCMBANKGE005428,KCTD13,BACURD1; FKSG86; PDIP1; POLDIP1; hBACURD1,potassium channel tetramerization domain containing 13,16p11.2,protein-coding,/
CWITA005429,TCMBANKGE005429,ALPK3,CMH27; MAK; MIDORI,alpha kinase 3,15q25.3,protein-coding,/
CWITA005430,TCMBANKGE005430,FBXO46,20D7-FC4; FBXO34L; Fbx46,F-box protein 46,19q13.32,protein-coding,/
CWITA005431,TCMBANKGE005431,CDIPT,PIS; PIS1,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,16p11.2,protein-coding,/
CWITA005432,TCMBANKGE005432,LILRA2,CD85H; ILT1; LIR-7; LIR7,leukocyte immunoglobulin like receptor A2,19q13.42,protein-coding,/
CWITA005433,TCMBANKGE005433,ADGRF2,GPR111; PGR20; hGPCR35,adhesion G protein-coupled receptor F2,6p12.3,protein-coding,/
CWITA005434,TCMBANKGE005434,IQCF1,-,IQ motif containing F1,3p21.2,protein-coding,/
CWITA005435,TCMBANKGE005435,GPC2,-,glypican 2,7q22.1,protein-coding,/
CWITA005436,TCMBANKGE005436,CAPNS2,CSS2,calpain small subunit 2,16q12.2,protein-coding,/
CWITA005437,TCMBANKGE005437,TDRD3,-,tudor domain containing 3,13q21.2,protein-coding,/
CWITA005438,TCMBANKGE005438,FAM71B,-,family with sequence similarity 71 member B,5q33.3,protein-coding,/
CWITA005439,TCMBANKGE005439,S100G,CABP; CABP1; CABP9K; CALB3; MGC138379,S100 calcium binding protein G,Xp22.2,protein-coding,
CWITA005440,TCMBANKGE005440,LRRC31,HEL-S-293,leucine rich repeat containing 31,3q26.2,protein-coding,/
CWITA005441,TCMBANKGE005441,KIF20A,MKLP2; RAB6KIFL,kinesin family member 20A,5q31.2,protein-coding,/
CWITA005442,TCMBANKGE005442,PRODH2,HSPOX1; HYPDH,proline dehydrogenase 2,19q13.12,protein-coding,/
CWITA005443,TCMBANKGE005443,DNAJB6,DJ4; DnaJ; HHDJ1; HSJ-2; HSJ2; LGMD1D; LGMD1E; LGMDD1; MRJ; MSJ-1,DnaJ heat shock protein family (Hsp40) member B6,7q36.3,protein-coding,/
CWITA005444,TCMBANKGE005444,FAM136A,-,family with sequence similarity 136 member A,2p13.3,protein-coding,/
CWITA005445,TCMBANKGE005445,ANKRD2,ARPP,ankyrin repeat domain 2,10q24.2,protein-coding,/
CWITA005446,TCMBANKGE005446,UBL5,HUB1,ubiquitin like 5,19p13.2,protein-coding,/
CWITA005447,TCMBANKGE005447,CHADL,SLRR4B,chondroadherin like,22q13.2,protein-coding,/
CWITA005448,TCMBANKGE005448,ILKAP,ILKAP2; ILKAP3; PP2C-DELTA; PPM1O,ILK associated serine/threonine phosphatase,2q37.3,protein-coding,/
CWITA005449,TCMBANKGE005449,XPC,RAD4; XP3; XPCC; p125,"XPC complex subunit, DNA damage recognition and repair factor",3p25.1,protein-coding,/
CWITA005450,TCMBANKGE005450,LFNG,SCDO3,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,7p22.3,protein-coding,/
CWITA005451,TCMBANKGE005451,DAPK3,FLJ36473; ZIP; ZIPK,death-associated protein kinase 3,19p13.3,protein-coding,
CWITA005452,TCMBANKGE005452,ANGPTL1,ANG3; ANGPT3; ARP1; AngY; UNQ162; dJ595C2.2,angiopoietin like 1,1q25.2,protein-coding,/
CWITA005453,TCMBANKGE005453,ADCY7,AC7,adenylate cyclase 7,16q12.1,protein-coding,/
CWITA005454,TCMBANKGE005454,SLC45A4,-,solute carrier family 45 member 4,8q24.3,protein-coding,/
CWITA005455,TCMBANKGE005455,CCBL2,DKFZp547N1117; DKFZp667D0223; KAT3; KATIII; MGC9398; RP4N531M19.2,cysteine conjugate-beta lyase 2,1p22.2,protein-coding,
CWITA005456,TCMBANKGE005456,COL6A3,BTHLM1; DYT27; UCMD1,collagen type VI alpha 3 chain,2q37.3,protein-coding,Research target
CWITA005457,TCMBANKGE005457,C1orf210,TEMP,chromosome 1 open reading frame 210,1p34.2,protein-coding,/
CWITA005458,TCMBANKGE005458,MT3,GIF; GIFB; GRIF; ZnMT3,metallothionein 3,16q13,protein-coding,/
CWITA005459,TCMBANKGE005459,NECTIN3,CD113; CDW113; NECTIN-3; PPR3; PRR3; PVRL3; PVRR3,nectin cell adhesion molecule 3,3q13.13,protein-coding,/
CWITA005460,TCMBANKGE005460,XPR1,IBGC6; SLC53A1; SYG1; X3,xenotropic and polytropic retrovirus receptor 1,1q25.3,protein-coding,/
CWITA005461,TCMBANKGE005461,SLC22A7,MGC24091; MGC45202; NLT; OAT2,"solute carrier family 22 (organic anion transporter), member 7",6p21.1,protein-coding,
CWITA005462,TCMBANKGE005462,PTPRH,R-PTP-H; SAP1,protein tyrosine phosphatase receptor type H,19q13.42,protein-coding,/
CWITA005463,TCMBANKGE005463,PTS,FLJ97081; PTPS,6-pyruvoyltetrahydropterin synthase,11q22.3,protein-coding,
CWITA005464,TCMBANKGE005464,FGF4,HBGFN4; HST; HSTN1; HSTF1; KNFGF; KFGF,fibroblast growth factor 4,11q13.3,protein-coding,
CWITA005465,TCMBANKGE005465,FAM193A,C4orf8; RES4-22,family with sequence similarity 193 member A,4p16.3,protein-coding,/
CWITA005466,TCMBANKGE005466,KLHL11,-,kelch like family member 11,17q21.2,protein-coding,/
CWITA005467,TCMBANKGE005467,SH3TC2,CMT4C; MNMN,SH3 domain and tetratricopeptide repeats 2,5q32,protein-coding,/
CWITA005468,TCMBANKGE005468,DUSP5,DUSP; HVH3,dual specificity phosphatase 5,10q25.2,protein-coding,Research target
CWITA005469,TCMBANKGE005469,WDR17,-,WD repeat domain 17,4q34.2,protein-coding,/
CWITA005470,TCMBANKGE005470,RPL7A,L7A; SURF3; TRUP,ribosomal protein L7a,9q34.2,protein-coding,/
CWITA005471,TCMBANKGE005471,LINGO2,LERN3; LRRN6C,leucine rich repeat and Ig domain containing 2,9p21.2-p21.1,protein-coding,/
CWITA005472,TCMBANKGE005472,IARS,FLJ20736; IARS1; ILERS; ILRS; IRS; PRO0785,isoleucyl-tRNA synthetase,9q21,protein-coding,
CWITA005473,TCMBANKGE005473,ZNF578,-,zinc finger protein 578,19q13.41,protein-coding,/
CWITA005474,TCMBANKGE005474,MAN1B1,ERMAN1; ERManI; MANA-ER; MRT15,mannosidase alpha class 1B member 1,9q34.3,protein-coding,/
CWITA005475,TCMBANKGE005475,IDH3G,H-IDHG,isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma,Xq28,protein-coding,/
CWITA005476,TCMBANKGE005476,CD160,BY55; NK1; NK28,CD160 molecule,1q21.1,protein-coding,Research target
CWITA005477,TCMBANKGE005477,CHRNA5,LNCR2,"cholinergic receptor, nicotinic, alpha 5",15q24,protein-coding,
CWITA005478,TCMBANKGE005478,ASAP1,AMAP1; CENTB4; DDEF1; PAG2; PAP; ZG14P,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1",8q24.21-q24.22,protein-coding,/
CWITA005479,TCMBANKGE005479,ADAT3,FWP005; MRT36; MST121; MSTP121; S863-5; TAD3,adenosine deaminase tRNA specific 3,19p13.3,protein-coding,/
CWITA005480,TCMBANKGE005480,KLHL5,-,kelch like family member 5,4p14,protein-coding,/
CWITA005481,TCMBANKGE005481,IDE,FLJ35968; INSULYSIN,insulin-degrading enzyme,10q23-q25,protein-coding,
CWITA005482,TCMBANKGE005482,BLOC1S6,BLOS6; HPS9; PA; PALLID; PLDN,biogenesis of lysosomal organelles complex 1 subunit 6,15q21.1,protein-coding,/
CWITA005483,TCMBANKGE005483,PPIF,CYP3; CypND; FLJ90798; MGC117207,peptidylprolyl isomerase F,10q22-q23,protein-coding,
CWITA005484,TCMBANKGE005484,ELOB,SIII; TCEB2,elongin B,16p13.3,protein-coding,/
CWITA005485,TCMBANKGE005485,MASTL,GREATWALL; GW; GWL; MAST-L; THC2,microtubule associated serine/threonine kinase like,10p12.1,protein-coding,/
CWITA005486,TCMBANKGE005486,CHIC2,BTL,cysteine rich hydrophobic domain 2,4q12,protein-coding,/
CWITA005487,TCMBANKGE005487,DGKZ,DAGK5; DAGK6; DGK-ZETA; hDGKzeta,diacylglycerol kinase zeta,11p11.2,protein-coding,/
CWITA005488,TCMBANKGE005488,MAP1B,FUTSCH; MAP5; PPP1R102,microtubule associated protein 1B,5q13.2,protein-coding,/
CWITA005489,TCMBANKGE005489,TP53COR1,TRP53COR1; linc-p21; lincRNA-p21,tumor protein p53 pathway corepressor 1,6p21.2,ncRNA,/
CWITA005490,TCMBANKGE005490,CITED1,MSG1,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1,Xq13.1,protein-coding,/
CWITA005491,TCMBANKGE005491,ANKRD45,CT117,ankyrin repeat domain 45,1q25.1,protein-coding,/
CWITA005492,TCMBANKGE005492,FGB,MGC104327; MGC120405,fibrinogen beta chain,4q28,protein-coding,
CWITA005493,TCMBANKGE005493,CCNK,CPR4; IDDHDF,cyclin K,14q32.2,protein-coding,/
CWITA005494,TCMBANKGE005494,CPZ,-,carboxypeptidase Z,4p16.1,protein-coding,/
CWITA005495,TCMBANKGE005495,DRD1,DADR; DRD1A,dopamine receptor D1,5q35.1,protein-coding,
CWITA005496,TCMBANKGE005496,EN2,N,engrailed homeobox 2,7q36,protein-coding,
CWITA005497,TCMBANKGE005497,SAMD9,C7orf5; DRIF1; MIRAGE; NFTC; OEF1; OEF2,sterile alpha motif domain containing 9,7q21.2,protein-coding,/
CWITA005498,TCMBANKGE005498,PTK6,BRK; FLJ42088,PTK6 protein tyrosine kinase 6,20q13.3,protein-coding,
CWITA005499,TCMBANKGE005499,CKS1B,CKS1; PNASN16; PNASN18; ckshs1,CDC28 protein kinase regulatory subunit 1B,1q21.2,protein-coding,
CWITA005500,TCMBANKGE005500,NPR2,AMDM; ANPRB; ANPb; ECDM; GC-B; GCB; GUC2B; GUCY2B; NPRB; NPRBi; SNSK,natriuretic peptide receptor 2,9p13.3,protein-coding,Clinical Trial target
CWITA005501,TCMBANKGE005501,SNRPG,SMG; Sm-G,small nuclear ribonucleoprotein polypeptide G,2p13.3,protein-coding,/
CWITA005502,TCMBANKGE005502,ZNF80,pT17,zinc finger protein 80,3q13.31,protein-coding,/
CWITA005503,TCMBANKGE005503,KCNS1,Kv9.1,potassium voltage-gated channel modifier subfamily S member 1,20q13.12,protein-coding,/
CWITA005504,TCMBANKGE005504,CALN1,CABP8,calneuron 1,7q11.22,protein-coding,/
CWITA005505,TCMBANKGE005505,C19orf25,-,chromosome 19 open reading frame 25,19p13.3,protein-coding,/
CWITA005506,TCMBANKGE005506,IFIT1B,IFIT1L; bA149I23.6,interferon induced protein with tetratricopeptide repeats 1B,10q23.31,protein-coding,/
CWITA005507,TCMBANKGE005507,HPGD,15-PGDH; PGDH; PGDH1; PHOAR1; SDR36C1,15-hydroxyprostaglandin dehydrogenase,4q34.1,protein-coding,/
CWITA005508,TCMBANKGE005508,LPAR5,GPR92; GPR93; KPG_010; LPA5,lysophosphatidic acid receptor 5,12p13.31,protein-coding,Research target
CWITA005509,TCMBANKGE005509,CRISP3,Aeg2; CRISP-3; CRS3; SGP28; dJ442L6.3,cysteine rich secretory protein 3,6p12.3,protein-coding,/
CWITA005510,TCMBANKGE005510,SCML1,-,Scm polycomb group protein like 1,Xp22.13,protein-coding,/
CWITA005511,TCMBANKGE005511,SLC28A1,CNT1; HCNT1; URCTU,solute carrier family 28 member 1,15q25.3,protein-coding,/
CWITA005512,TCMBANKGE005512,FIZ1,ZNF798,FLT3 interacting zinc finger 1,19q13.42,protein-coding,/
CWITA005513,TCMBANKGE005513,FCF1,Bka; C14orf111; CGI-35; UTP24,FCF1 rRNA-processing protein,14q24.3,protein-coding,/
CWITA005514,TCMBANKGE005514,FADS2,D6D; DES6; FADSD6; LLCDL2; SLL0262; TU13,fatty acid desaturase 2,11q12.2,protein-coding,
CWITA005515,TCMBANKGE005515,HNRNPLL,HNRPLL; SRRF,heterogeneous nuclear ribonucleoprotein L like,2p22.1,protein-coding,/
CWITA005516,TCMBANKGE005516,PRSS58,PRSS1; TRY1; TRYX3; UNQ2540,serine protease 58,7q34,protein-coding,/
CWITA005517,TCMBANKGE005517,CALHM5,C6orf188; FAM26E; dJ493F7.3,calcium homeostasis modulator family member 5,6q22.1,protein-coding,/
CWITA005518,TCMBANKGE005518,CACNB3,CAB3; CACNLB3,calcium voltage-gated channel auxiliary subunit beta 3,12q13.12,protein-coding,/
CWITA005519,TCMBANKGE005519,ENTPD1,ATPDase; CD39; NTPDase-1; SPG64,ectonucleoside triphosphate diphosphohydrolase 1,10q24.1,protein-coding,Patented target
CWITA005520,TCMBANKGE005520,PAX8,-,paired box 8,2q14.1,protein-coding,/
CWITA005521,TCMBANKGE005521,YBX1,BP-8; CBF-A; CSDA2; CSDB; DBPB; EFI-A; MDR-NF1; NSEP-1; NSEP1; YB-1; YB1,Y-box binding protein 1,1p34.2,protein-coding,/
CWITA005522,TCMBANKGE005522,SCGB2A2,MGB1; PSBP1; UGB2,secretoglobin family 2A member 2,11q12.3,protein-coding,Research target
CWITA005523,TCMBANKGE005523,GABRA6,MGC116903; MGC116904,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",5q34,protein-coding,
CWITA005524,TCMBANKGE005524,SAMD5,dJ875H10.1,sterile alpha motif domain containing 5,6q24.3,protein-coding,/
CWITA005525,TCMBANKGE005525,SLC25A22,EIEE3; GC-1; GC1; NET44,solute carrier family 25 member 22,11p15.5,protein-coding,/
CWITA005526,TCMBANKGE005526,SMARCD3,BAF60C; CRACD3; Rsc6p,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3",7q36.1,protein-coding,/
CWITA005527,TCMBANKGE005527,PARP16,ARTD15; C15orf30; pART15,poly(ADP-ribose) polymerase family member 16,15q22.31,protein-coding,/
CWITA005528,TCMBANKGE005528,ZW10,HZW10; KNTC1AP,zw10 kinetochore protein,11q23.2,protein-coding,/
CWITA005529,TCMBANKGE005529,DLD,DLDH; E3; GCSL; LAD; PHE3,dihydrolipoamide dehydrogenase,7q31-q32,protein-coding,
CWITA005530,TCMBANKGE005530,HJV,HFE2; HFE2A; JH; RGMC,hemojuvelin BMP co-receptor,1q21.1,protein-coding,/
CWITA005531,TCMBANKGE005531,NDUFS7,CIN20; CIN20KD; FLJ45860; FLJ46880; MGC120002; MY017; PSST,"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)",19p13.3,protein-coding,
CWITA005532,TCMBANKGE005532,NCOA7,ERAP140; ESNA1; NCOA7-AS; Nbla00052; Nbla10993; TLDC4; dJ187J11.3,nuclear receptor coactivator 7,6q22.31-q22.32,protein-coding,/
CWITA005533,TCMBANKGE005533,KANSL3,KIAA1310; NSL3; Rcd1,Kat8_Regulatory_Nsl_Complex_Subunit_3,2q11.2,protein-coding,
CWITA005534,TCMBANKGE005534,BRK1,C3orf10; HSPC300; MDS027; hHBrk1,BRICK1 subunit of SCAR/WAVE actin nucleating complex,3p25.3,protein-coding,/
CWITA005535,TCMBANKGE005535,CHRM1,HM1; M1; M1R,cholinergic receptor muscarinic 1,11q12.3,protein-coding,Successful target
CWITA005536,TCMBANKGE005536,HAGH,GLO2; GLX2; GLXII; HAGH1,hydroxyacylglutathione hydrolase,16p13.3,protein-coding,
CWITA005537,TCMBANKGE005537,NEK1,ALS24; NY-REN-55; SRPS2; SRPS2A; SRTD6,NIMA related kinase 1,4q33,protein-coding,Research target
CWITA005538,TCMBANKGE005538,ATP6V1G3,ATP6G3; Vma10,ATPase H+ transporting V1 subunit G3,1q31.3,protein-coding,/
CWITA005539,TCMBANKGE005539,RPL32,L32; PP9932,ribosomal protein L32,3p25.2,protein-coding,/
CWITA005540,TCMBANKGE005540,ZCCHC7,AIR1; HSPC086,zinc finger CCHC-type containing 7,9p13.2,protein-coding,/
CWITA005541,TCMBANKGE005541,GTF2IRD1,BEN; CREAM1; GTF3; MUSTRD1; RBAP2; WBS; WBSCR11; WBSCR12; hMusTRD1alpha1,GTF2I repeat domain containing 1,7q11.23,protein-coding,/
CWITA005542,TCMBANKGE005542,CST1,-,cystatin SN,20p11.21,protein-coding,/
CWITA005543,TCMBANKGE005543,MPL,CNMPL; CD110; MPLV; TPOR,myeloproliferative leukemia virus oncogene,1p34,protein-coding,
CWITA005544,TCMBANKGE005544,KCNH2,ERG1; HERG; HERG1; Kv11.1; LQT2; SQT1,"potassium voltage-gated channel, subfamily H (eag-related), member 2",7q36.1,protein-coding,
CWITA005545,TCMBANKGE005545,EYA2,EAB1,EYA transcriptional coactivator and phosphatase 2,20q13.12,protein-coding,/
CWITA005546,TCMBANKGE005546,TPK1,HTPK1; PP20; THMD5,thiamin pyrophosphokinase 1,7q35,protein-coding,/
CWITA005547,TCMBANKGE005547,PPL,-,periplakin,16p13.3,protein-coding,/
CWITA005548,TCMBANKGE005548,ACTL6B,ACTL6; BAF53B; EIEE76; IDDSSAD; arpNalpha,actin like 6B,7q22.1,protein-coding,/
CWITA005549,TCMBANKGE005549,FSCN1,FAN1; HSN; SNL; p55,fascin actin-bundling protein 1,7p22.1,protein-coding,Clinical Trial target
CWITA005550,TCMBANKGE005550,GABARAP,ATG8A; GABARAP-a; MM46,GABA type A receptor-associated protein,17p13.1,protein-coding,/
CWITA005551,TCMBANKGE005551,KCNK5,K2p5.1; KCNK5b; TASK-2; TASK2,potassium two pore domain channel subfamily K member 5,6p21.2,protein-coding,/
CWITA005552,TCMBANKGE005552,CERS2,L3; LASS2; SP260; TMSG1,ceramide synthase 2,1q21.3,protein-coding,/
CWITA005553,TCMBANKGE005553,IFNAR1,AVP; IFN-alpha-REC; IFNAR; IFNBR; IFRC,interferon alpha and beta receptor subunit 1,21q22.11,protein-coding,Clinical Trial target
CWITA005554,TCMBANKGE005554,UCK2,TSA903; UK; UMPK,uridine-cytidine kinase 2,1q24.1,protein-coding,/
CWITA005555,TCMBANKGE005555,HTR3A,5NHTN3; 5NHT3A; 5NHT3R; 5HT3R; HTR3,5-hydroxytryptamine (serotonin) receptor 3A,11q23.1,protein-coding,
CWITA005556,TCMBANKGE005556,CAMKMT,C2orf34; CLNMT; CaM KMT; Cam; KMT,calmodulin-lysine N-methyltransferase,2p21,protein-coding,/
CWITA005557,TCMBANKGE005557,LCN2,24p3; MSFI; NGAL; p25,lipocalin 2,9q34.11,protein-coding,Research target
CWITA005558,TCMBANKGE005558,KCNN4,DHS2; IK; IK1; IKCA1; KCA4; KCa3.1; SK4; hIKCa1; hKCa4; hSK4,potassium calcium-activated channel subfamily N member 4,19q13.31,protein-coding,Clinical Trial target
CWITA005559,TCMBANKGE005559,SLC12A8,CCC9,solute carrier family 12 member 8,3q21.2,protein-coding,/
CWITA005560,TCMBANKGE005560,DBT,BCATE2; BCKAD-E2; BCKADE2; BCOADC-E2; E2; E2B,dihydrolipoamide branched chain transacylase E2,1p21.2,protein-coding,/
CWITA005561,TCMBANKGE005561,CCL2,GDCFN2; HC11; HSMCR30; MCAF; MCPN1; MCP1; MGC9434; SCYA2; SMCNCF,chemokine (C-C motif) ligand 2,17q11.2-q12,protein-coding,
CWITA005562,TCMBANKGE005562,USP9X,DFFRX; FAF; FAM; MRX99; MRXS99F,ubiquitin specific peptidase 9 X-linked,Xp11.4,protein-coding,/
CWITA005563,TCMBANKGE005563,INPP1,-,inositol polyphosphate-1-phosphatase,2q32.2,protein-coding,Research target
CWITA005564,TCMBANKGE005564,TRAM2,-,translocation associated membrane protein 2,6p12.2,protein-coding,/
CWITA005565,TCMBANKGE005565,KCNH3,BEC1; ELK2; Kv12.2,potassium voltage-gated channel subfamily H member 3,12q13.12,protein-coding,Research target
CWITA005566,TCMBANKGE005566,SRGAP3,ARHGAP14; MEGAP; SRGAP2; WRP,SLIT-ROBO Rho GTPase activating protein 3,3p25.3,protein-coding,/
CWITA005567,TCMBANKGE005567,MAP3K1,MAPKKK1; MEKK; MEKK 1; MEKK1; SRXY6,mitogen-activated protein kinase kinase kinase 1,5q11.2,protein-coding,Research target
CWITA005568,TCMBANKGE005568,PHOSPHO2,-,"phosphatase, orphan 2",2q31.1,protein-coding,/
CWITA005569,TCMBANKGE005569,PCBD2,DCOH2; DCOHM; PHS2,pterin-4 alpha-carbinolamine dehydratase 2,5q31.1,protein-coding,/
CWITA005570,TCMBANKGE005570,OAZ2,AZ2,ornithine decarboxylase antizyme 2,15q22.31,protein-coding,
CWITA005571,TCMBANKGE005571,CLPB,FLJ13152; HSP78; SKD3,ClpB caseinolytic peptidase B homolog (E. coli),11q13.4,protein-coding,
CWITA005572,TCMBANKGE005572,CNTN2,AXT; FAME5; TAG-1; TAX; TAX1,contactin 2,1q32.1,protein-coding,Research target
CWITA005573,TCMBANKGE005573,EXOC2,SEC5; SEC5L1; Sec5p,exocyst complex component 2,6p25.3,protein-coding,/
CWITA005574,TCMBANKGE005574,RNF150,-,ring finger protein 150,4q31.21,protein-coding,/
CWITA005575,TCMBANKGE005575,GTF2B,TF2B; TFIIB,general transcription factor IIB,1p22.2,protein-coding,/
CWITA005576,TCMBANKGE005576,ZNF600,KR-ZNF1,zinc finger protein 600,19q13.41,protein-coding,/
CWITA005577,TCMBANKGE005577,SEMA3A,COLL1; HH16; Hsema-I; Hsema-III; SEMA1; SEMAD; SEMAIII; SEMAL; SemD; coll-1,semaphorin 3A,7q21.11,protein-coding,/
CWITA005578,TCMBANKGE005578,GPRC6A,GPCR; bA86F4.3,G protein-coupled receptor class C group 6 member A,6q22.1,protein-coding,Research target
CWITA005579,TCMBANKGE005579,CXCR1,CNC; CNCNCKRN1; CD128; CD181; CDw128a; CKRN1; CMKAR1; IL8R1; IL8RA; IL8RBA,chemokine (C-X-C motif) receptor 1,2q35,protein-coding,
CWITA005580,TCMBANKGE005580,GOLIM4,GIMPC; GOLPH4; GPP130; P138,golgi integral membrane protein 4,3q26.2,protein-coding,/
CWITA005581,TCMBANKGE005581,EXOSC1,CGI-108; CSL4; Csl4p; SKI4; Ski4p; p13,exosome component 1,10q24.1,protein-coding,/
CWITA005582,TCMBANKGE005582,NDUFA12,B17.2; DAP13,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12",12q22,protein-coding,
CWITA005583,TCMBANKGE005583,PTGFR,FP; MGC120498; MGC46203,prostaglandin F receptor (FP),1p31.1,protein-coding,
CWITA005584,TCMBANKGE005584,ZNF573,-,zinc finger protein 573,19q13.12,protein-coding,/
CWITA005585,TCMBANKGE005585,PEX6,HMLR2; PAF-2; PAF2; PBD4A; PDB4B; PXAAA1,peroxisomal biogenesis factor 6,6p21.1,protein-coding,/
CWITA005586,TCMBANKGE005586,FAM110B,C8orf72,family with sequence similarity 110 member B,8q12.1,protein-coding,/
CWITA005587,TCMBANKGE005587,BARD1,-,BRCA1 associated RING domain 1,2q35,protein-coding,/
CWITA005588,TCMBANKGE005588,TSPAN9,NET-5; NET5; PP1057,tetraspanin 9,12p13.33-p13.32,protein-coding,/
CWITA005589,TCMBANKGE005589,POLDIP3,PDIP3; PDIP46; SKAR,DNA polymerase delta interacting protein 3,22q13.2,protein-coding,/
CWITA005590,TCMBANKGE005590,YAE1,C7orf36; CIAB2; GK003; YAE1D1,YAE1 maturation factor of ABCE1,7p14.1,protein-coding,/
CWITA005591,TCMBANKGE005591,SERBP1,CGI-55; CHD3IP; HABP4L; PAI-RBP1; PAIRBP1,SERPINE1 mRNA binding protein 1,1p31.3,protein-coding,/
CWITA005592,TCMBANKGE005592,SETD7,KMT7; SET7; SET7/9; SET9,"SET domain containing 7, histone lysine methyltransferase",4q31.1,protein-coding,Research target
CWITA005593,TCMBANKGE005593,TOP2B,TOPIIB; top2beta,topoisomerase (DNA) II beta 180kDa,3p24,protein-coding,
CWITA005594,TCMBANKGE005594,SLAMF7,19A; CD319; CRACC; CS1,Slam_Family_Member_7,1q23.3,protein-coding,
CWITA005595,TCMBANKGE005595,ADPRH,ARH1; hARH1,ADP-ribosylarginine hydrolase,3q13.33,protein-coding,/
CWITA005596,TCMBANKGE005596,OGFOD1,FLJ10826; KIAA1612; TPA1,2-oxoglutarate and iron-dependent oxygenase domain containing 1,16q12.2,protein-coding,
CWITA005597,TCMBANKGE005597,AADAT,KAT2; KATII,aminoadipate aminotransferase,4q33,protein-coding,
CWITA005598,TCMBANKGE005598,HTR4,5-HT4; 5-HT4R,5-hydroxytryptamine receptor 4,5q32,protein-coding,Successful target
CWITA005599,TCMBANKGE005599,CSNK1D,ASPS; CKI-delta; CKId; CKIdelta; FASPS2; HCKID,Casein_Kinase_1_Delta,17q25.3,protein-coding,
CWITA005600,TCMBANKGE005600,CYP2R1,MGC4663,"cytochrome P450, family 2, subfamily R, polypeptide 1",11p15.2,protein-coding,
CWITA005601,TCMBANKGE005601,FAF1,CGI-03; HFAF1s; UBXD12; UBXN3A; hFAF1,Fas associated factor 1,1p32.3,protein-coding,/
CWITA005602,TCMBANKGE005602,ALDOA,ALDA; GSD12; HEL-S-87p,"aldolase, fructose-bisphosphate A",16p11.2,protein-coding,/
CWITA005603,TCMBANKGE005603,PTGFR,FP,prostaglandin F receptor,1p31.1,protein-coding,Successful target
CWITA005604,TCMBANKGE005604,ZNF471,ERP1; Z1971; Zfp78,zinc finger protein 471,19q13.43,protein-coding,/
CWITA005605,TCMBANKGE005605,HPCA,BDR2; DYT2,hippocalcin,1p35.1,protein-coding,/
CWITA005606,TCMBANKGE005606,TMCO6,PRO1580,transmembrane and coiled-coil domains 6,5q31.3,protein-coding,/
CWITA005607,TCMBANKGE005607,ZSWIM5,-,zinc finger SWIM-type containing 5,1p34.1,protein-coding,/
CWITA005608,TCMBANKGE005608,MSANTD1,C4orf44,Myb/SANT DNA binding domain containing 1,4p16.3,protein-coding,/
CWITA005609,TCMBANKGE005609,BLMH,BH; BMH,bleomycin hydrolase,17q11.2,protein-coding,
CWITA005610,TCMBANKGE005610,MYO16,MYAP3; MYR8; Myo16b; NYAP3; PPP1R107,myosin XVI,13q33.3,protein-coding,/
CWITA005611,TCMBANKGE005611,LRRTM2,-,leucine rich repeat transmembrane neuronal 2,5q31.2,protein-coding,/
CWITA005612,TCMBANKGE005612,SLC2A9,GLUT9; GLUTX; UAQTL2; URATv1,"solute carrier family 2 (facilitated glucose transporter), member 9",4p16.1,protein-coding,
CWITA005613,TCMBANKGE005613,NDUFS4,AQDQ; CIN18,"NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)",5q11.1,protein-coding,
CWITA005614,TCMBANKGE005614,KCNK2,K2p2.1; MGC126742; MGC126744; TPKC1; TREK; TREKN1; TREK1; hTREKN1c; hTREKN1e,"potassium channel, subfamily K, member 2",1q41,protein-coding,
CWITA005615,TCMBANKGE005615,HNRNPA3,2610510D13Rik; D10S102; FBRNP; HNRPA3,heterogeneous nuclear ribonucleoprotein A3,2q31.2,protein-coding,/
CWITA005616,TCMBANKGE005616,RPL36A,L36A; L44L; MIG6; RPL44,ribosomal protein L36a,Xq22.1,protein-coding,/
CWITA005617,TCMBANKGE005617,SNAP29,CEDNIK; SNAP-29,synaptosome associated protein 29,22q11.21,protein-coding,/
CWITA005618,TCMBANKGE005618,ACTR3B,ARP11; ARP3BETA,actin related protein 3B,7q36.1-q36.2,protein-coding,/
CWITA005619,TCMBANKGE005619,DIAPH1,DFNA1; DIA1; DRF1; LFHL1; SCBMS; hDIA1,diaphanous related formin 1,5q31.3,protein-coding,/
CWITA005620,TCMBANKGE005620,DBNL,ABP1; HIP-55; HIP55; SH3P7,drebrin like,7p13,protein-coding,/
CWITA005621,TCMBANKGE005621,NARF,IOP2,nuclear prelamin A recognition factor,17q25.3,protein-coding,/
CWITA005622,TCMBANKGE005622,NAPB,SNAP-BETA; SNAPB,NSF attachment protein beta,20p11.21,protein-coding,/
CWITA005623,TCMBANKGE005623,LRWD1,CENP-33; ORCA,leucine rich repeats and WD repeat domain containing 1,7q22.1,protein-coding,/
CWITA005624,TCMBANKGE005624,ZNF365,Su48; UAN; ZNF365D,zinc finger protein 365,10q21.2,protein-coding,/
CWITA005625,TCMBANKGE005625,DIO3,5DIII; D3; DIOIII; TXDI3,iodothyronine deiodinase 3,14q32.31,protein-coding,/
CWITA005626,TCMBANKGE005626,ZBTB42,LCCS6; ZNF925,zinc finger and BTB domain containing 42,14q32.33,protein-coding,/
CWITA005627,TCMBANKGE005627,LTBP3,DASS; GPHYSD3; LTBP-3; LTBP2; STHAG6; pp6425,latent transforming growth factor beta binding protein 3,11q13.1,protein-coding,/
CWITA005628,TCMBANKGE005628,APOE,AD2; LDLCQ5; LPG; MGC1571,Apolipoprotein E,19q13.2,protein-coding,
CWITA005629,TCMBANKGE005629,NMT2,N,N-myristoyltransferase 2,10p13,protein-coding,
CWITA005630,TCMBANKGE005630,DSTN,ACTDP; ADF; HEL32; bA462D18.2,"destrin, actin depolymerizing factor",20p12.1,protein-coding,/
CWITA005631,TCMBANKGE005631,TENM4,Doc4; ETM5; ODZ4; TEN4; TNM4; Ten-M4; ten-4,teneurin transmembrane protein 4,11q14.1,protein-coding,/
CWITA005632,TCMBANKGE005632,PEX14,NAPP2; PBD13A; Pex14p; dJ734G22.2,peroxisomal biogenesis factor 14,1p36.22,protein-coding,/
CWITA005633,TCMBANKGE005633,SRPK3,MSSK-1; MSSK1; STK23,SRSF protein kinase 3,Xq28,protein-coding,/
CWITA005634,TCMBANKGE005634,PPBP,B-TG1; Beta-TG; CTAP-III; CTAP3; CTAPIII; CXCL7; LA-PF4; LDGF; MDGF; NAP-2; PBP; SCYB7; TC1; TC2; TGB; TGB1; THBGB; THBGB1,pro-platelet basic protein,4q13.3,protein-coding,/
CWITA005635,TCMBANKGE005635,LUC7L2,CGI-59; CGI-74; LUC7B2,"LUC7 like 2, pre-mRNA splicing factor",7q34,protein-coding,/
CWITA005636,TCMBANKGE005636,ZNF729,-,zinc finger protein 729,19p12,protein-coding,/
CWITA005637,TCMBANKGE005637,TCEA2,TFIIS,transcription elongation factor A2,20q13.33,protein-coding,/
CWITA005638,TCMBANKGE005638,NOD1,CARD4; CLR7.1; NLRC1,nucleotide binding oligomerization domain containing 1,7p14.3,protein-coding,Research target
CWITA005639,TCMBANKGE005639,PEX5,PBD2A; PBD2B; PTS1-BP; PTS1R; PXR1; RCDP5,peroxisomal biogenesis factor 5,12p13.31,protein-coding,/
CWITA005640,TCMBANKGE005640,PSMD3,P58; RPN3; S3; TSTA2,"proteasome 26S subunit, non-ATPase 3",17q21.1,protein-coding,/
CWITA005641,TCMBANKGE005641,TRIM32,BBS11; HT2A; LGMD2H; LGMDR8; TATIP,tripartite motif containing 32,9q33.1,protein-coding,/
CWITA005642,TCMBANKGE005642,ZNF415,Pact; ZfLp,zinc finger protein 415,19q13.42,protein-coding,/
CWITA005643,TCMBANKGE005643,ZNF611,-,zinc finger protein 611,19q13.41,protein-coding,/
CWITA005644,TCMBANKGE005644,ZNF615,-,zinc finger protein 615,19q13.41,protein-coding,/
CWITA005645,TCMBANKGE005645,PCDHA1,PCDH-ALPHA1,protocadherin alpha 1,5q31.3,protein-coding,/
CWITA005646,TCMBANKGE005646,NEDD4,NEDD4-1; RPF1,NEDD4 E3 ubiquitin protein ligase,15q21.3,protein-coding,Research target
CWITA005647,TCMBANKGE005647,DNAAF2,C14orf104; CILD10; KTU; PF13,dynein axonemal assembly factor 2,14q21.3,protein-coding,/
CWITA005648,TCMBANKGE005648,ACTR6,ARP6; CDA12; HSPC281; MSTP136; hARP6; hARPX,actin related protein 6,12q23.1,protein-coding,/
CWITA005649,TCMBANKGE005649,POLA1,DKFZp686K1672; POLA; p180,"polymerase (DNA directed), alpha 1, catalytic subunit",Xp22.1-p21.3,protein-coding,
CWITA005650,TCMBANKGE005650,POTEH,A26C3; ACTBL1; CT104.7; POTE22,POTE ankyrin domain family member H,22q11.1,protein-coding,/
CWITA005651,TCMBANKGE005651,PDS5B,APRIN; AS3; CG008,PDS5 cohesin associated factor B,13q13.1,protein-coding,/
CWITA005652,TCMBANKGE005652,SDK1,-,sidekick cell adhesion molecule 1,7p22.2,protein-coding,/
CWITA005653,TCMBANKGE005653,GRIN2A,EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2,protein-coding,Successful target
CWITA005654,TCMBANKGE005654,SMG5,EST1B; LPTS-RP1; LPTSRP1; SMG-5,SMG5 nonsense mediated mRNA decay factor,1q22,protein-coding,/
CWITA005655,TCMBANKGE005655,FLG,ATOD2,filaggrin,1q21.3,protein-coding,/
CWITA005656,TCMBANKGE005656,SAMD14,-,sterile alpha motif domain containing 14,17q21.33,protein-coding,/
CWITA005657,TCMBANKGE005657,ANKRD35,-,ankyrin repeat domain 35,1q21.1,protein-coding,/
CWITA005658,TCMBANKGE005658,BIRC6,APOLLON; BRUCE,baculoviral IAP repeat containing 6,2p22.3,protein-coding,/
CWITA005659,TCMBANKGE005659,TMEM150C,TTN3,transmembrane protein 150C,4q21.22,protein-coding,/
CWITA005660,TCMBANKGE005660,CIDEB,-,cell death inducing DFFA like effector b,14q12,protein-coding,/
CWITA005661,TCMBANKGE005661,MSRA,PMSR,methionine sulfoxide reductase A,8p23.1,protein-coding,/
CWITA005662,TCMBANKGE005662,ALB,HSA; PRO0883; PRO0903; PRO1341,albumin,4q13.3,protein-coding,Successful target
CWITA005663,TCMBANKGE005663,Aecp,Acp,vitamin A enhanced cleft palate,-,unknown,/
CWITA005664,TCMBANKGE005664,RAB40B,RAR; SEC4L,"RAB40B, member RAS oncogene family",17q25.3,protein-coding,/
CWITA005665,TCMBANKGE005665,GIN1,GIN-1; TGIN1; ZH2C2,gypsy retrotransposon integrase 1,5q21.1,protein-coding,/
CWITA005666,TCMBANKGE005666,DCN,CSCD; DSPG2; PG40; PGII; PGS2; SLRR1B,decorin,12q21.33,protein-coding,Research target
CWITA005667,TCMBANKGE005667,PPID,CYP-40; CYPD,peptidylprolyl isomerase D,4q32.1,protein-coding,Research target
CWITA005668,TCMBANKGE005668,BEX1,BEX2; HBEX2; HGR74-h,brain expressed X-linked 1,Xq22.1|Xq22,protein-coding,/
CWITA005669,TCMBANKGE005669,EFTUD2,MFDGA; MFDM; SNRNP116; Snrp116; Snu114; U5-116KD,elongation factor Tu GTP binding domain containing 2,17q21.31,protein-coding,/
CWITA005670,TCMBANKGE005670,RASGRP2,CALDAG-GEFI; CDC25L,RAS guanyl releasing protein 2,11q13.1,protein-coding,/
CWITA005671,TCMBANKGE005671,IL11,AGIF; IL-11,interleukin 11,19q13.42,protein-coding,Clinical Trial target
CWITA005672,TCMBANKGE005672,FHOD3,FHOS2; Formactin2,formin homology 2 domain containing 3,18q12.2,protein-coding,/
CWITA005673,TCMBANKGE005673,ABCA8,-,ATP binding cassette subfamily A member 8,17q24.2,protein-coding,/
CWITA005674,TCMBANKGE005674,GPR3,ACCA,G protein-coupled receptor 3,1p36.11,protein-coding,Research target
CWITA005675,TCMBANKGE005675,Polr2k-ps,Gm11526,"polymerase (RNA) II (DNA directed) polypeptide K, pseudogene",11 59.01 cM|11 D,pseudo,/
CWITA005676,TCMBANKGE005676,RBM5,G15; H37; LUCA-15; LUCA15; RMB5,RNA binding motif protein 5,3p21.31,protein-coding,/
CWITA005677,TCMBANKGE005677,GNA13,G13,G protein subunit alpha 13,17q24.1,protein-coding,/
CWITA005678,TCMBANKGE005678,ASS1,ASS; CTLN1,argininosuccinate synthase 1,9q34.1,protein-coding,
CWITA005679,TCMBANKGE005679,SPSB1,SSB-1; SSB1,splA/ryanodine receptor domain and SOCS box containing 1,1p36.22,protein-coding,/
CWITA005680,TCMBANKGE005680,CHAF1B,CAF-1; CAF-IP60; CAF1; CAF1A; CAF1P60; MPHOSPH7; MPP7,chromatin assembly factor 1 subunit B,21q22.12-q22.13,protein-coding,/
CWITA005681,TCMBANKGE005681,FYB1,ADAP; FYB; PRO0823; SLAP-130; SLAP130; THC3,FYN binding protein 1,5p13.1,protein-coding,/
CWITA005682,TCMBANKGE005682,RNF19B,IBRDC3; NKLAM,ring finger protein 19B,1p35.1,protein-coding,/
CWITA005683,TCMBANKGE005683,GSTA1,GST2; GSTA1N1; GTH1; MGC131939,glutathione S-transferase alpha 1,6p12.1,protein-coding,
CWITA005684,TCMBANKGE005684,BICRAL,GLTSCR1L; KIAA0240,BRD4 interacting chromatin remodeling complex associated protein like,6p21.1,protein-coding,/
CWITA005685,TCMBANKGE005685,SPTLC2,HSN1C; LCB2; LCB2A; NSAN1C; SPT2; hLCB2a,serine palmitoyltransferase long chain base subunit 2,14q24.3,protein-coding,/
CWITA005686,TCMBANKGE005686,CYSLTR1,CYSLT1; CYSLT1R; CYSLTR; HMTMF81,cysteinyl leukotriene receptor 1,Xq21.1,protein-coding,Successful target
CWITA005687,TCMBANKGE005687,ST3GAL2,Gal-NAc6S; SIAT4B; ST3GALII; ST3GalA.2,"ST3 beta-galactoside alpha-2,3-sialyltransferase 2",16q22.1,protein-coding,/
CWITA005688,TCMBANKGE005688,ACP1,HAAP; LMW-PTP; LMWPTP,acid phosphatase 1,2p25.3,protein-coding,/
CWITA005689,TCMBANKGE005689,BACE1,ASP2; BACE; FLJ90568; HSPC104; KIAA1149,beta-site APP-cleaving enzyme 1,11q23.2-q23.3,protein-coding,
CWITA005690,TCMBANKGE005690,SLC2A9,GLUT9; GLUTX; UAQTL2; URATv1,solute carrier family 2 member 9,4p16.1,protein-coding,Discontinued target
CWITA005691,TCMBANKGE005691,SULT1B1,ST1B1; ST1B2; SULT1B2,sulfotransferase family 1B member 1,4q13.3,protein-coding,/
CWITA005692,TCMBANKGE005692,TRPV6,ABP/ZF; CAT1; CATL; ECAC2; HRPTTN; HSA277909; LP6728; ZFAB,transient receptor potential cation channel subfamily V member 6,7q34,protein-coding,Clinical Trial target
CWITA005693,TCMBANKGE005693,HHIPL2,KIAA1822L,HHIP like 2,1q41,protein-coding,/
CWITA005694,TCMBANKGE005694,PLA2G2C,UBXN10-AS1,phospholipase A2 group IIC,1p36.12,protein-coding,/
CWITA005695,TCMBANKGE005695,CRACR2B,EFCAB4A,calcium release activated channel regulator 2B,11p15.5,protein-coding,/
CWITA005696,TCMBANKGE005696,POLB,-,DNA polymerase beta,8p11.21,protein-coding,/
CWITA005697,TCMBANKGE005697,NSMCE2,C8orf36; MMS21; NSE2; ZMIZ7,"NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase",8q24.13,protein-coding,/
CWITA005698,TCMBANKGE005698,SDC4,SYND4,syndecan 4,20q13.12,protein-coding,/
CWITA005699,TCMBANKGE005699,RDH16,RODH-4; SDR9C8; hRDH-E,retinol dehydrogenase 16,12q13.3,protein-coding,/
CWITA005700,TCMBANKGE005700,IMPA2,-,inositol monophosphatase 2,18p11.21,protein-coding,Research target
CWITA005701,TCMBANKGE005701,PLCB2,PLC-beta-2,phospholipase C beta 2,15q15.1,protein-coding,/
CWITA005702,TCMBANKGE005702,CHRNA10,-,cholinergic receptor nicotinic alpha 10 subunit,11p15.4,protein-coding,Clinical Trial target
CWITA005703,TCMBANKGE005703,KDM2A,CXXC8; FBL11; FBL7; FBXL11; JHDM1A; LILINA,lysine demethylase 2A,11q13.2,protein-coding,Research target
CWITA005704,TCMBANKGE005704,RASGEF1B,GPIG4,RasGEF domain family member 1B,4q21.21,protein-coding,/
CWITA005705,TCMBANKGE005705,DEFA5,DEF5; HD-5,defensin alpha 5,8p23.1,protein-coding,/
CWITA005706,TCMBANKGE005706,UBE2S,E2-EPF; E2EPF; EPF5,ubiquitin conjugating enzyme E2 S,19q13.42,protein-coding,/
CWITA005707,TCMBANKGE005707,ALDH6A1,MMSADHA; MMSDH,aldehyde dehydrogenase 6 family member A1,14q24.3,protein-coding,/
CWITA005708,TCMBANKGE005708,AMIGO2,ALI1; AMIGO-2; DEGA,adhesion molecule with Ig like domain 2,12q13.11,protein-coding,/
CWITA005709,TCMBANKGE005709,ENPP7,ALK-SMase; E-NPP 7; NPP-7; NPP7,ectonucleotide pyrophosphatase/phosphodiesterase 7,17q25.3,protein-coding,/
CWITA005710,TCMBANKGE005710,OIP5,5730547N13Rik; CT86; LINT-25; MIS18B; MIS18beta; hMIS18beta,Opa interacting protein 5,15q15.1,protein-coding,/
CWITA005711,TCMBANKGE005711,ZNF721,-,zinc finger protein 721,4p16.3,protein-coding,/
CWITA005712,TCMBANKGE005712,DNAJB1,HSPF1; Hdj1; Hsp40; RSPH16B; Sis1,DnaJ heat shock protein family (Hsp40) member B1,19p13.12,protein-coding,Research target
CWITA005713,TCMBANKGE005713,HSD17B6,HSE; RODH; SDR9C6,hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse),12q13,protein-coding,
CWITA005714,TCMBANKGE005714,MRPL44,COXPD16; L44MT; MRP-L44,mitochondrial ribosomal protein L44,2q36.1,protein-coding,/
CWITA005715,TCMBANKGE005715,AFG3L2,SCA28; SPAX5,AFG3 like matrix AAA peptidase subunit 2,18p11.21,protein-coding,/
CWITA005716,TCMBANKGE005716,MPP4,ALS2CR5; DLG6,membrane palmitoylated protein 4,2q33.1,protein-coding,/
CWITA005717,TCMBANKGE005717,COL21A1,COLA1L; FP633,collagen type XXI alpha 1 chain,6p12.1|6p12.3-p11.2,protein-coding,/
CWITA005718,TCMBANKGE005718,CAMK1D,CKLiK; CaMNK1; CaMKID,calcium/calmodulin-dependent protein kinase ID,10p13,protein-coding,
CWITA005719,TCMBANKGE005719,TMEM45A,DERP7; DNAPTP4,transmembrane protein 45A,3q12.2,protein-coding,/
CWITA005720,TCMBANKGE005720,PABPC1L,C20orf119; EPAB; PABPC1L1; dJ1069P2.3,poly(A) binding protein cytoplasmic 1 like,20q13.12,protein-coding,/
CWITA005721,TCMBANKGE005721,QSOX1,Q6; QSCN6,quiescin sulfhydryl oxidase 1,1q25.2,protein-coding,/
CWITA005722,TCMBANKGE005722,AMOTL2,LCCP,angiomotin like 2,3q22.2,protein-coding,/
CWITA005723,TCMBANKGE005723,RPS27A,CEP80; HEL112; S27A; UBA80; UBC; UBCEP1; UBCEP80,ribosomal protein S27a,2p16.1,protein-coding,/
CWITA005724,TCMBANKGE005724,TUBA4A,ALS22; H2-ALPHA; TUBA1,tubulin alpha 4a,2q35,protein-coding,/
CWITA005725,TCMBANKGE005725,AARS2,AARSL; KIAA1270; MTNALARS; MTALARS; bA444E17.1,"alanyl-tRNA synthetase 2, mitochondrial (putative)",6p21.1,protein-coding,
CWITA005726,TCMBANKGE005726,PSMD1,P112; Rpn2; S1,"proteasome 26S subunit, non-ATPase 1",2q37.1,protein-coding,/
CWITA005727,TCMBANKGE005727,SCRG1,SCRG-1,stimulator of chondrogenesis 1,4q34.1,protein-coding,/
CWITA005728,TCMBANKGE005728,BBS12,C4orf24,Bardet-Biedl syndrome 12,4q27,protein-coding,/
CWITA005729,TCMBANKGE005729,ALDH1L2,mtFDH,aldehyde dehydrogenase 1 family member L2,12q23.3,protein-coding,/
CWITA005730,TCMBANKGE005730,Fasl,APT1LG1; CD178; CD95-L; CD95L; Fas-L; Faslg; Tnfsf6; Tnlg1a; gld,"Fas ligand (TNF superfamily, member 6)",1 H2.1|1 69.95 cM,protein-coding,/
CWITA005731,TCMBANKGE005731,CDK2AP2,DOC-1R; p14,cyclin dependent kinase 2 associated protein 2,11q13.2,protein-coding,/
CWITA005732,TCMBANKGE005732,SYN1,MRX50; SYN1a; SYN1b; SYNI,synapsin I,Xp11.3-p11.23,protein-coding,/
CWITA005733,TCMBANKGE005733,PTDSS1,KIAA0024; PSS1; PSSA,phosphatidylserine synthase 1,8q22,protein-coding,
CWITA005734,TCMBANKGE005734,RPS15A,DBA20; S15a,ribosomal protein S15a,16p12.3,protein-coding,/
CWITA005735,TCMBANKGE005735,RAB20,-,"RAB20, member RAS oncogene family",13q34,protein-coding,/
CWITA005736,TCMBANKGE005736,SOX21,SOX25,SRY-box transcription factor 21,13q32.1,protein-coding,/
CWITA005737,TCMBANKGE005737,MYNN,OSZF; SBBIZ1; ZBTB31; ZNF902,myoneurin,3q26.2,protein-coding,/
CWITA005738,TCMBANKGE005738,COA7,C1orf163; RESA1; SCAN3; SELRC1,cytochrome c oxidase assembly factor 7 (putative),1p32.3,protein-coding,/
CWITA005739,TCMBANKGE005739,ACER3,APHC; PHCA; PLDECO,alkaline ceramidase 3,11q13.5,protein-coding,/
CWITA005740,TCMBANKGE005740,TNS3,TEM6; TENS1,tensin 3,7p12.3,protein-coding,/
CWITA005741,TCMBANKGE005741,ZBTB16,PLZF; ZNF145,zinc finger and BTB domain containing 16,11q23.2,protein-coding,/
CWITA005742,TCMBANKGE005742,LGMN,AEP; LGMN1; PRSC1,legumain,14q32.12,protein-coding,Clinical Trial target
CWITA005743,TCMBANKGE005743,NDUFV2,CIN24k,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",18p11.22,protein-coding,
CWITA005744,TCMBANKGE005744,LRFN3,FIGLER1; SALM4,leucine rich repeat and fibronectin type III domain containing 3,19q13.12,protein-coding,/
CWITA005745,TCMBANKGE005745,UAP1,AGX; AGX1; AGX2; SPAG2,UDP-N-acteylglucosamine pyrophosphorylase 1,1q23.3,protein-coding,
CWITA005746,TCMBANKGE005746,XRCC4,SSMED,X-ray repair cross complementing 4,5q14.2,protein-coding,/
CWITA005747,TCMBANKGE005747,CACNA1D,CACH3; CACN4; CACNL1A2; CCHL1A2; Cav1.3; PASNA; SANDD,calcium voltage-gated channel subunit alpha1 D,3p21.1,protein-coding,Clinical Trial target
CWITA005748,TCMBANKGE005748,FRZB,FRE; FRITZ; FRP-3; FRZB-1; FRZB-PEN; FRZB1; FZRB; OS1; SFRP3; SRFP3; hFIZ,frizzled related protein,2q32.1,protein-coding,/
CWITA005749,TCMBANKGE005749,STAU1,PPP1R150; STAU,staufen double-stranded RNA binding protein 1,20q13.13,protein-coding,/
CWITA005750,TCMBANKGE005750,SRC,ASV; SRC1; cNSRC; p60NSrc,v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian),20q12-q13,protein-coding,
CWITA005751,TCMBANKGE005751,PRKCI,DXS1179E; MGC26534; PKCI; nPKCNiota,"protein kinase C, iota",3q26.3,protein-coding,
CWITA005752,TCMBANKGE005752,SLC5A10,SGLT-5; SGLT5,solute carrier family 5 member 10,17p11.2,protein-coding,/
CWITA005753,TCMBANKGE005753,PSMC3,TBP1,"proteasome 26S subunit, ATPase 3",11p11.2,protein-coding,/
CWITA005754,TCMBANKGE005754,SEPSECS,DKFZp434B1417; LP; MGC161491; SLA; SLA/LP,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4p15.2,protein-coding,
CWITA005755,TCMBANKGE005755,HDAC7,HD7; HD7A; HDAC7A,histone deacetylase 7,12q13.11,protein-coding,Patented target
CWITA005756,TCMBANKGE005756,DNAJB4,DNAJW; DjB4; HLJ1,DnaJ heat shock protein family (Hsp40) member B4,1p31.1,protein-coding,/
CWITA005757,TCMBANKGE005757,CYP2A13,CPAD; CYP2A,"cytochrome P450, family 2, subfamily A, polypeptide 13",19q13.2,protein-coding,
CWITA005758,TCMBANKGE005758,KLF17,ZLF393; ZNF393; Zfp393,Kruppel like factor 17,1p34.1,protein-coding,/
CWITA005759,TCMBANKGE005759,STARD7,FAME2; GTT1,StAR related lipid transfer domain containing 7,2q11.2,protein-coding,/
CWITA005760,TCMBANKGE005760,POU5F1,MGC22487; OCT3; OCT4; OTFN3; OTF3; OTF4; OctN3; OctN4,POU class 5 homeobox 1,6p21.31,protein-coding,
CWITA005761,TCMBANKGE005761,ERN1,FLJ30999; IRE1; IRE1P; IRE1a; MGC163277; MGC163279; hIRE1p,endoplasmic reticulum to nucleus signaling 1,17q24.2,protein-coding,
CWITA005762,TCMBANKGE005762,ACACB,ACC2; ACCB; HACC275,acetyl-CoA carboxylase beta,12q24.11,protein-coding,Successful target
CWITA005763,TCMBANKGE005763,LRCH2,dA204F4.4,leucine rich repeats and calponin homology domain containing 2,Xq23,protein-coding,/
CWITA005764,TCMBANKGE005764,MAGI1,AIP-3; AIP3; BAIAP1; BAP-1; BAP1; MAGI-1; MAGI-1b; Magi1d; TNRC19; WWP3,"membrane associated guanylate kinase, WW and PDZ domain containing 1",3p14.1,protein-coding,/
CWITA005765,TCMBANKGE005765,ENTPD7,LALP1,ectonucleoside triphosphate diphosphohydrolase 7,10q24.2,protein-coding,/
CWITA005766,TCMBANKGE005766,PMVK,HUMPMKI; PMK; PMKA; PMKASE; POROK1,phosphomevalonate kinase,1q21.3,protein-coding,Research target
CWITA005767,TCMBANKGE005767,SNIP1,PML1; PMRED,Smad nuclear interacting protein 1,1p34.3,protein-coding,/
CWITA005768,TCMBANKGE005768,SOGA1,C20orf117; KIAA0889; SOGA,"suppressor of glucose, autophagy associated 1",20q11.23,protein-coding,/
CWITA005769,TCMBANKGE005769,Aldoa-ps3,Gm5747,"aldolase A, pseudogene 3",9 E1|9,pseudo,/
CWITA005770,TCMBANKGE005770,RRP9,RNU3IP2; U3-55K,"ribosomal RNA processing 9, U3 small nucleolar RNA binding protein",3p21.2,protein-coding,/
CWITA005771,TCMBANKGE005771,ABCG8,GBD4; MGC142217; STSL,"Atp-Binding Cassette, Sub-Family G (White), Member 8",2p21,protein-coding,
CWITA005772,TCMBANKGE005772,PCCA,N,"propionyl CoA carboxylase, alpha polypeptide",13q32,protein-coding,
CWITA005773,TCMBANKGE005773,RASL10A,RRP22,RAS like family 10 member A,22q12.2,protein-coding,/
CWITA005774,TCMBANKGE005774,GUCY1A2,GC-SA2; GUC1A2,guanylate cyclase 1 soluble subunit alpha 2,11q22.3,protein-coding,/
CWITA005775,TCMBANKGE005775,CCDC117,dJ366L4.1,coiled-coil domain containing 117,22q12.1,protein-coding,/
CWITA005776,TCMBANKGE005776,VSIG10L,-,V-set and immunoglobulin domain containing 10 like,19q13.41,protein-coding,/
CWITA005777,TCMBANKGE005777,AGTR2,AT2; ATGR2; MRX88,angiotensin II receptor type 2,Xq23,protein-coding,Successful target
CWITA005778,TCMBANKGE005778,ACTN1,BDPLT15,actinin alpha 1,14q24.1|14q22-q24,protein-coding,/
CWITA005779,TCMBANKGE005779,ZNF765,-,zinc finger protein 765,19q13.42,protein-coding,/
CWITA005780,TCMBANKGE005780,C15orf62,-,chromosome 15 open reading frame 62,15q15.1,protein-coding,/
CWITA005781,TCMBANKGE005781,CBR1,CBR; SDR21C1; hCBR1,carbonyl reductase 1,21q22.12,protein-coding,Clinical Trial target
CWITA005782,TCMBANKGE005782,NDP,EVR2; FEVR; ND,norrin cystine knot growth factor NDP,Xp11.3,protein-coding,/
CWITA005783,TCMBANKGE005783,GIPC1,C19orf3; GIPC; GLUT1CBP; Hs.6454; IIP-1; NIP; RGS19IP1; SEMCAP; SYNECTIIN; SYNECTIN; TIP-2,GIPC PDZ domain containing family member 1,19p13.12,protein-coding,/
CWITA005784,TCMBANKGE005784,ABCB8,EST328128; MNABC1; MABC1,"ATP-binding cassette, sub-family B (MDR/TAP), member 8",7q36,protein-coding,
CWITA005785,TCMBANKGE005785,SIDT2,CGI-40,SID1 transmembrane family member 2,11q23.3,protein-coding,/
CWITA005786,TCMBANKGE005786,ZNF865,-,zinc finger protein 865,19q13.42,protein-coding,/
CWITA005787,TCMBANKGE005787,BRWD3,BRODL; MRX93,bromodomain and WD repeat domain containing 3,Xq21.1,protein-coding,/
CWITA005788,TCMBANKGE005788,HPD,4-HPPD; 4HPPD; GLOD3; HPPDASE; PPD,4-hydroxyphenylpyruvate dioxygenase,12q24.31,protein-coding,Successful target
CWITA005789,TCMBANKGE005789,MYO1F,-,myosin IF,19p13.2,protein-coding,/
CWITA005790,TCMBANKGE005790,CTSO,CTSO1,cathepsin O,4q32.1,protein-coding,/
CWITA005791,TCMBANKGE005791,H1-3,H1.3; H1D; H1F3; H1s-2; HIST1H1D,"H1.3 linker histone, cluster member",6p22.2,protein-coding,/
CWITA005792,TCMBANKGE005792,NOP10,DKCB1; NOLA3; NOP10P,NOP10 ribonucleoprotein,15q14,protein-coding,/
CWITA005793,TCMBANKGE005793,VLDLR,CAMRQ1; CARMQ1; CHRMQ1; VLDL-R; VLDLRCH,very low density lipoprotein receptor,9p24.2,protein-coding,/
CWITA005794,TCMBANKGE005794,RAE1,Gle2; MIG14; MRNP41; Mnrp41; dJ481F12.3; dJ800J21.1,ribonucleic acid export 1,20q13.31,protein-coding,/
CWITA005795,TCMBANKGE005795,PCDHB2,PCDH-BETA2,protocadherin beta 2,5q31.3,protein-coding,/
CWITA005796,TCMBANKGE005796,SLA,SLA1; SLAP,Src like adaptor,8q24.22,protein-coding,/
CWITA005797,TCMBANKGE005797,ING1,p24ING1c; p33; p33ING1; p33ING1b; p47; p47ING1a,inhibitor of growth family member 1,13q34,protein-coding,/
CWITA005798,TCMBANKGE005798,H2AC21,H2AB; HIST2H2AB,H2A clustered histone 21,1q21.2,protein-coding,/
CWITA005799,TCMBANKGE005799,MMP11,SL-3; ST3; STMY3,matrix metallopeptidase 11,22q11.23,protein-coding,Research target
CWITA005800,TCMBANKGE005800,ADA2,ADGF; CECR1; IDGFL; PAN; SNEDS; VAIHS,adenosine deaminase 2,22q11.1,protein-coding,/
CWITA005801,TCMBANKGE005801,NOD2,ACUG; BLAU; BLAUS; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1; YAOS,Nucleotide_Binding_Oligomerization_Domain_Containing_2,16q12.1,protein-coding,
CWITA005802,TCMBANKGE005802,ARHGAP4,C1; RGC1; RhoGAP4; SrGAP4; p115,Rho GTPase activating protein 4,Xq28,protein-coding,/
CWITA005803,TCMBANKGE005803,ERAL1,CEGA; ERA; ERA-W; ERAL1A; ERAL1B; H-ERA; HERA-A; HERA-B; PRLTS6,Era like 12S mitochondrial rRNA chaperone 1,17q11.2,protein-coding,/
CWITA005804,TCMBANKGE005804,HCN2,BCNGN2; BCNG2; HACN1,hyperpolarization activated cyclic nucleotide-gated potassium channel 2,19p13.3,protein-coding,
CWITA005805,TCMBANKGE005805,MC1R,CMM5; MSH-R; SHEP2,melanocortin 1 receptor,16q24.3,protein-coding,Clinical Trial target
CWITA005806,TCMBANKGE005806,CYP4A11,CP4Y; CYP4A2; CYP4AII; CYPIVA11,cytochrome P450 family 4 subfamily A member 11,1p33,protein-coding,/
CWITA005807,TCMBANKGE005807,NSDHL,H105E3; SDR31E1; XAP104,NAD(P) dependent steroid dehydrogenase-like,Xq28,protein-coding,/
CWITA005808,TCMBANKGE005808,RFC1,A1; CANVAS; MHCBFB; PO-GA; RECC1; RFC; RFC140,replication factor C subunit 1,4p14,protein-coding,/
CWITA005809,TCMBANKGE005809,Hmgb1-ps9,EG619937; Gm6115; Hmg-1RV-B; Hmg1-rs3; Hmgb1-rs3,"high mobility group box 1, pseudogene 9",13|13 D1,pseudo,/
CWITA005810,TCMBANKGE005810,HTT,HD; IT15; LOMARS,huntingtin,4p16.3,protein-coding,Patented target
CWITA005811,TCMBANKGE005811,HSD17B2,EDH17B2; HSD17; SDR9C2,hydroxysteroid 17-beta dehydrogenase 2,16q23.3,protein-coding,/
CWITA005812,TCMBANKGE005812,MAP9,ASAP,microtubule associated protein 9,4q32.1,protein-coding,/
CWITA005813,TCMBANKGE005813,C1orf226,-,chromosome 1 open reading frame 226,1q23.3,protein-coding,/
CWITA005814,TCMBANKGE005814,LHX3,CPHD3; LIM3; M2-LHX3,LIM homeobox 3,9q34.3,protein-coding,/
CWITA005815,TCMBANKGE005815,CYTH3,ARNO3; GRP1; PSCD3,cytohesin 3,7p22.1,protein-coding,
CWITA005816,TCMBANKGE005816,ABTB1,BPOZ; BTB3; BTBD21; EF1ABP; PP2259,ankyrin repeat and BTB domain containing 1,3q21.3,protein-coding,/
CWITA005817,TCMBANKGE005817,MALL,BENE,"mal, T cell differentiation protein like",2q13,protein-coding,/
CWITA005818,TCMBANKGE005818,PNPLA8,IPLA2(GAMMA); IPLA2-2; IPLA2G,Patatin-Like Phospholipase Domain Containing 8,7q31,protein-coding,
CWITA005819,TCMBANKGE005819,TLR8,CD288; MGC119599; MGC119600,toll-like receptor 8,Xp22,protein-coding,
CWITA005820,TCMBANKGE005820,CYB5R3,B5R; DIA1,cytochrome b5 reductase 3,22q13.31-qter|22q13.2-q13.31,protein-coding,
CWITA005821,TCMBANKGE005821,LDHC,CT32; LDH3; LDHX,lactate dehydrogenase C,11p15.1,protein-coding,/
CWITA005822,TCMBANKGE005822,HLA-A,FLJ26655; HLAA,"major histocompatibility complex, class I, A",6p21.3,protein-coding,
CWITA005823,TCMBANKGE005823,ACPP,ACPN3; ACP3; PAP,"acid phosphatase, prostate",3q21-q23,protein-coding,
CWITA005824,TCMBANKGE005824,ZNF780A,ZNF780,zinc finger protein 780A,19q13.2,protein-coding,/
CWITA005825,TCMBANKGE005825,KRT74,ADWH; HTSS2; HYPT3; K6IRS4; KRT5C; KRT6IRS4,keratin 74,12q13.13,protein-coding,/
CWITA005826,TCMBANKGE005826,MUC16,CA125,"mucin 16, cell surface associated",19p13.2,protein-coding,Clinical Trial target
CWITA005827,TCMBANKGE005827,WAS,IMD2; THC; THC1; WASP,Wiskott-Aldrich syndrome (eczema-thrombocytopenia),Xp11.4-p11.21,protein-coding,
CWITA005828,TCMBANKGE005828,NPIPA8,LCR16a9; NPIPA7,nuclear pore complex interacting protein family member A8,16p12.3,protein-coding,/
CWITA005829,TCMBANKGE005829,RAPGEF2,CNrasGEF; NRAPGEP; PDZ-GEF1; PDZGEF1; RA-GEF; RA-GEF-1; RAGEF; Rap-GEP; nRap GEP,Rap guanine nucleotide exchange factor 2,4q32.1,protein-coding,/
CWITA005830,TCMBANKGE005830,PPIA,CYPA; CYPH; MGC117158; MGC12404; MGC23397,peptidylprolyl isomerase A (cyclophilin A),7p13,protein-coding,
CWITA005831,TCMBANKGE005831,H3c7,H3.2-221; H3c13; H3c14; H3c15; H3c2; H3c3; H3c4; H3c6; Hist1; Hist1h3f,H3 clustered histone 7,13 A3.1|13 9.78 cM,protein-coding,/
CWITA005832,TCMBANKGE005832,ERMAP,BTN5; PRO2801; RD; SC,erythroblast membrane associated protein (Scianna blood group),1p34.2,protein-coding,/
CWITA005833,TCMBANKGE005833,UHRF2,NIRF; RNF107; TDRD23; URF2,ubiquitin like with PHD and ring finger domains 2,9p24.1,protein-coding,/
CWITA005834,TCMBANKGE005834,RBKS,RBSK; RK,Ribokinase,2p23.2,protein-coding,
CWITA005835,TCMBANKGE005835,SLC36A1,Dct1; LYAAT1; PAT1; TRAMD3,"solute carrier family 36 (proton/amino acid symporter), member 1",5q33.1,protein-coding,
CWITA005836,TCMBANKGE005836,AGPAT1,1-AGPAT1; G15; LPAAT-alpha; LPAATA,1-acylglycerol-3-phosphate O-acyltransferase 1,6p21.32,protein-coding,Research target
CWITA005837,TCMBANKGE005837,TTC13,-,tetratricopeptide repeat domain 13,1q42.2,protein-coding,/
CWITA005838,TCMBANKGE005838,SLC16A10,MCT10; PRO0813; TAT1,solute carrier family 16 member 10,6q21,protein-coding,/
CWITA005839,TCMBANKGE005839,FCGR2B,CD32; CD32B; FCG2; FCGR2; FCGR2C; FcRII-c; IGFR2,Fc fragment of IgG receptor IIb,1q23.3,protein-coding,Clinical Trial target
CWITA005840,TCMBANKGE005840,DCD,AIDD; DCDN1; DSEP; HCAP; MGC71930; PIF,dermcidin,12q13.1,protein-coding,
CWITA005841,TCMBANKGE005841,ABHD2,HS1-2; LABH2; PHPS1-2,"abhydrolase domain containing 2, acylglycerol lipase",15q26.1,protein-coding,/
CWITA005842,TCMBANKGE005842,ROBO1,DUTT1; SAX3,roundabout guidance receptor 1,3p12.3,protein-coding,Research target
CWITA005843,TCMBANKGE005843,TAP2,ABC18; ABCB3; APT2; D6S217E; PSF-2; PSF2; RING11,"transporter 2, ATP binding cassette subfamily B member",6p21.32,protein-coding,/
CWITA005844,TCMBANKGE005844,GPR149,IEDA; PGR10; R35,G protein-coupled receptor 149,3q25.2,protein-coding,/
CWITA005845,TCMBANKGE005845,GSTT2,-,glutathione S-transferase theta 2 (gene/pseudogene),22q11.23,protein-coding,/
CWITA005846,TCMBANKGE005846,PPP1R14B,PHI-1; PLCB3N; PNG; SOM172,protein phosphatase 1 regulatory inhibitor subunit 14B,11q13.1,protein-coding,/
CWITA005847,TCMBANKGE005847,KCNA2,EIEE32; HBK5; HK4; HUKIV; KV1.2; MK2; NGK1; RBK2,potassium voltage-gated channel subfamily A member 2,1p13.3,protein-coding,Research target
CWITA005848,TCMBANKGE005848,AGTR2,AT2; ATGR2; MRX88,"angiotensin II receptor, type 2",Xq22-q23,protein-coding,
CWITA005849,TCMBANKGE005849,ARL4C,ARL7; LAK,ADP ribosylation factor like GTPase 4C,2q37.1,protein-coding,/
CWITA005850,TCMBANKGE005850,TENT4B,PAPD5; TRF4-2; TUT3,terminal nucleotidyltransferase 4B,16q12.1,protein-coding,/
CWITA005851,TCMBANKGE005851,ALS2,ALS2CR6; ALSJ; IAHSP; PLSJ,alsin Rho guanine nucleotide exchange factor ALS2,2q33.1,protein-coding,/
CWITA005852,TCMBANKGE005852,SEC23B,CDA-II; CDAII; CDAN2; CWS7; HEMPAS; hSec23B,"SEC23 homolog B, COPII coat complex component",20p11.23,protein-coding,/
CWITA005853,TCMBANKGE005853,TRIM59,IFT80L; MRF1; RNF104; TRIM57; TSBF1,tripartite motif containing 59,3q25.33,protein-coding,Research target
CWITA005854,TCMBANKGE005854,TMEM185B,FAM11B,transmembrane protein 185B,2q14.2,protein-coding,/
CWITA005855,TCMBANKGE005855,PRKCE,MGC125656; MGC125657; PKCE; nPKCNepsilon,"protein kinase C, epsilon",2p21,protein-coding,
CWITA005856,TCMBANKGE005856,NEUROD1,BETA2; BHF-1; MODY6; NEUROD; bHLHa3,neuronal differentiation 1,2q31.3,protein-coding,/
CWITA005857,TCMBANKGE005857,Pax3,Pax-3; Sp; Splchl2; splotch,paired box 3,1 C4|1 39.79 cM,protein-coding,/
CWITA005858,TCMBANKGE005858,HNRNPM,CEAR; HNRNPM4; HNRPM; HNRPM4; HTGR1; NAGR1; hnRNP M,heterogeneous nuclear ribonucleoprotein M,19p13.2,protein-coding,/
CWITA005859,TCMBANKGE005859,ZNF497,-,zinc finger protein 497,19q13.43,protein-coding,/
CWITA005860,TCMBANKGE005860,ZNF432,-,zinc finger protein 432,19q13.41,protein-coding,/
CWITA005861,TCMBANKGE005861,TSSK1B,FKSG81; SPOGA4; STK22D; TSK1; TSSK1,testis specific serine kinase 1B,5q22.2,protein-coding,/
CWITA005862,TCMBANKGE005862,COG6,CDG2L; COD2; SHNS,component of oligomeric golgi complex 6,13q14.11,protein-coding,/
CWITA005863,TCMBANKGE005863,MAGEA11,CT1.11; MAGE-11; MAGE11; MAGEA-11,MAGE family member A11,Xq28,protein-coding,/
CWITA005864,TCMBANKGE005864,ZNF230,FDZF2,zinc finger protein 230,19q13.31,protein-coding,/
CWITA005865,TCMBANKGE005865,CAMK4,CaMK IV; CaMK-GR; CaMKIV; caMK,calcium/calmodulin dependent protein kinase IV,5q22.1,protein-coding,/
CWITA005866,TCMBANKGE005866,LDLR,FH; FHC; LDLCQ2,low density lipoprotein receptor,19p13.3,protein-coding,
CWITA005867,TCMBANKGE005867,FBXL2,FBL2; FBL3,F-box and leucine rich repeat protein 2,3p22.3,protein-coding,/
CWITA005868,TCMBANKGE005868,CANT1,DBQD; SCANN1; SCAN1; SHAPY,calcium activated nucleotidase 1,17q25.3,protein-coding,
CWITA005869,TCMBANKGE005869,TMEM176A,GS188; HCA112; MS4B1,transmembrane protein 176A,7q36.1,protein-coding,/
CWITA005870,TCMBANKGE005870,RHOXF1,OTEX; PEPP1,Rhox homeobox family member 1,Xq24,protein-coding,/
CWITA005871,TCMBANKGE005871,CDK16,FLJ16665; PCTAIRE; PCTAIRE1; PCTGAIRE; PCTK1,cyclin-dependent kinase 16,Xp11,protein-coding,
CWITA005872,TCMBANKGE005872,ROR2,BDB; BDB1; NTRKR2,receptor tyrosine kinase like orphan receptor 2,9q22.31,protein-coding,Clinical Trial target
CWITA005873,TCMBANKGE005873,ATP5MC1,ATP5A; ATP5G; ATP5G1,ATP synthase membrane subunit c locus 1,17q21.32,protein-coding,/
CWITA005874,TCMBANKGE005874,DRC3,CFAP134; LRRC48,dynein regulatory complex subunit 3,17p11.2|17p11.2,protein-coding,/
CWITA005875,TCMBANKGE005875,CXCL10,C7; IFI10; INP10; IPN10; SCYB10; crgN2; gIPN10; mobN1,chemokine (C-X-C motif) ligand 10,4q21,protein-coding,
CWITA005876,TCMBANKGE005876,IDH3G,HNIDHG,isocitrate dehydrogenase 3 (NAD+) gamma,Xq28,protein-coding,
CWITA005877,TCMBANKGE005877,CYTH2,ARNO; CTS18; CTS18.1; PSCD2; PSCD2L; SEC7L; Sec7p-L; Sec7p-like; cytohesin-2,cytohesin 2,19q13.33,protein-coding,Research target
CWITA005878,TCMBANKGE005878,COX6B1,COX6B; COXG; COXVIb1,cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous),19q13.1,protein-coding,
CWITA005879,TCMBANKGE005879,CYP4V2,BCD; CYP4AH1,cytochrome P450 family 4 subfamily V member 2,4q35.1-q35.2,protein-coding,/
CWITA005880,TCMBANKGE005880,PDE2A,PDE2A1; PED2A4,"phosphodiesterase 2A, cGMP-stimulated",11q13.4,protein-coding,
CWITA005881,TCMBANKGE005881,FNTA,FPTA; PGGT1A; PTAR2,"farnesyltransferase, CAAX box, alpha",8p11.21,protein-coding,/
CWITA005882,TCMBANKGE005882,OPLAH,5NOpase; DKFZp434H244; OPLA,5-oxoprolinase (ATP-hydrolysing),8q24.3,protein-coding,
CWITA005883,TCMBANKGE005883,CDH20,CDH7L3; Cdh7,cadherin 20,18q21.33,protein-coding,/
CWITA005884,TCMBANKGE005884,MRPS16,CGI-132; COXPD2; MRP-S16; RPMS16,mitochondrial ribosomal protein S16,10q22.2,protein-coding,/
CWITA005885,TCMBANKGE005885,CACNG2,MRD10,calcium voltage-gated channel auxiliary subunit gamma 2,22q12.3,protein-coding,/
CWITA005886,TCMBANKGE005886,PPP2CB,PP2Abeta; PP2CB,protein phosphatase 2 catalytic subunit beta,8p12,protein-coding,/
CWITA005887,TCMBANKGE005887,FAM20C,DMP-4; DMP4; G-CK; GEF-CK; RNS,FAM20C golgi associated secretory pathway kinase,7p22.3,protein-coding,/
CWITA005888,TCMBANKGE005888,GSTM2,GST4; GSTM; GSTM2N2; GTHMUS; MGC117303,glutathione S-transferase mu 2 (muscle),1p13.3,protein-coding,
CWITA005889,TCMBANKGE005889,H2AC11,H2A.1b; H2A/p; H2AC13; H2AC15; H2AC16; H2AC17; H2AFP; H2AG; HIST1H2AG; pH2A/f,H2A clustered histone 11,6p22.1,protein-coding,/
CWITA005890,TCMBANKGE005890,ZNF584,-,zinc finger protein 584,19q13.43,protein-coding,/
CWITA005891,TCMBANKGE005891,HBZ,HBAZ; HBZ-T1; HBZ1,hemoglobin subunit zeta,16p13.3,protein-coding,/
CWITA005892,TCMBANKGE005892,DNAJA3,HCA57; TID1; hTID-1,DnaJ heat shock protein family (Hsp40) member A3,16p13.3,protein-coding,/
CWITA005893,TCMBANKGE005893,MRPL32,HSPC283; L32mt; MRP-L32; bMRP-59b,mitochondrial ribosomal protein L32,7p14.1,protein-coding,/
CWITA005894,TCMBANKGE005894,FGF4,FGF-4; HBGF-4; HST; HST-1; HSTF-1; HSTF1; K-FGF; KFGF,fibroblast growth factor 4,11q13.3,protein-coding,Successful target
CWITA005895,TCMBANKGE005895,NDUFB4,B15; CINB15; MGC5105,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa",3q13.33,protein-coding,
CWITA005896,TCMBANKGE005896,TSPY4,TSPY10; TSPY8,testis specific protein Y-linked 4,Yp11.2,protein-coding,/
CWITA005897,TCMBANKGE005897,SLC25A22,EIEE3; FLJ13044; GC1; NET44,"solute carrier family 25 (mitochondrial carrier: glutamate), member 22",11p15.5,protein-coding,
CWITA005898,TCMBANKGE005898,ABCF1,ABC27; ABC50,ATP binding cassette subfamily F member 1,6p21.33,protein-coding,/
CWITA005899,TCMBANKGE005899,SLC39A8,BIGM103; CDG2N; LZT-Hs6; PP3105; ZIP8,solute carrier family 39 member 8,4q24,protein-coding,/
CWITA005900,TCMBANKGE005900,SELENBP1,EHMTO; HEL-S-134P; LPSB; MTO; SBP56; SP56; hSBP,selenium binding protein 1,1q21.3,protein-coding,/
CWITA005901,TCMBANKGE005901,BRMS1,-,BRMS1 transcriptional repressor and anoikis regulator,11q13.2,protein-coding,/
CWITA005902,TCMBANKGE005902,NAV1,POMFIL3; STEERIN1; UNC53H1,neuron navigator 1,1q32.1,protein-coding,/
CWITA005903,TCMBANKGE005903,ZNF114,-,zinc finger protein 114,19q13.33,protein-coding,/
CWITA005904,TCMBANKGE005904,Ccl21a,6CKBAC2; 6Ckine; ALP; AW987545; CKb9; SCYA21a; SLC; Scya21; Scya21b; Tca4; plt,chemokine (C-C motif) ligand 21A (serine),4 A5|4 22.81 cM,protein-coding,/
CWITA005905,TCMBANKGE005905,ZNF668,-,zinc finger protein 668,16p11.2,protein-coding,/
CWITA005906,TCMBANKGE005906,ZNF699,hang,zinc finger protein 699,19p13.2,protein-coding,/
CWITA005907,TCMBANKGE005907,HSPA8,HSC54; HSC70; HSC71; HSP71; HSP73; HSPA10; LAP1; MGC131511; MGC29929; NIP71,heat shock 70kDa protein 8,11q24.1,protein-coding,
CWITA005908,TCMBANKGE005908,IFI35,IFP35,interferon induced protein 35,17q21.31,protein-coding,/
CWITA005909,TCMBANKGE005909,DMC1,DMC1H; LIM15; dJ199H16.1,DNA meiotic recombinase 1,22q13.1,protein-coding,/
CWITA005910,TCMBANKGE005910,ODC1,ODC,ornithine decarboxylase 1,2p25,protein-coding,
CWITA005911,TCMBANKGE005911,CST8,CRES; CTES5,cystatin 8,20p11.21,protein-coding,/
CWITA005912,TCMBANKGE005912,HOXD3,HOX1D; HOX4; HOX4A; Hox-4.1,homeobox D3,2q31.1,protein-coding,/
CWITA005913,TCMBANKGE005913,MEF2D,-,myocyte enhancer factor 2D,1q22,protein-coding,/
CWITA005914,TCMBANKGE005914,CNTRL,CEP1; CEP110; FAN; bA165P4.1,centriolin,9q33.2,protein-coding,/
CWITA005915,TCMBANKGE005915,HRH2,H2R,histamine receptor H2,5q35.2,protein-coding,
CWITA005916,TCMBANKGE005916,RGS1,1R20; BL34; HEL-S-87; IER1; IR20,regulator of G protein signaling 1,1q31.2,protein-coding,/
CWITA005917,TCMBANKGE005917,ITPA,C20orf37; HLC14N06NP; ITPase; dJ794I6.3,inosine triphosphatase (nucleoside triphosphate pyrophosphatase),20p,protein-coding,
CWITA005918,TCMBANKGE005918,PROC,APC; PC; PROC1,protein C (inactivator of coagulation factors Va and VIIIa),2q13-q14,protein-coding,
CWITA005919,TCMBANKGE005919,EYA3,-,EYA transcriptional coactivator and phosphatase 3,1p35.3,protein-coding,/
CWITA005920,TCMBANKGE005920,ARL17A,ARF1P2; ARL17P1,ADP ribosylation factor like GTPase 17A,17q21.31,protein-coding,/
CWITA005921,TCMBANKGE005921,CALCRL,CGRPR; CRLR; LMPHM8,calcitonin receptor like receptor,2q32.1,protein-coding,Clinical Trial target
CWITA005922,TCMBANKGE005922,LPIN2,-,lipin 2,18p11.31,protein-coding,/
CWITA005923,TCMBANKGE005923,TPH2,ADHD7; NTPH,tryptophan hydroxylase 2,12q21.1,protein-coding,Research target
CWITA005924,TCMBANKGE005924,METTL1,C12orf1; TRM8; TRMT8; YDL201w,methyltransferase like 1,12q14.1,protein-coding,/
CWITA005925,TCMBANKGE005925,TRIP12,MRD49; TRIP-12; TRIPC; ULF,thyroid hormone receptor interactor 12,2q36.3,protein-coding,Research target
CWITA005926,TCMBANKGE005926,ESRRG,DKFZp781L1617; ERR3; ERRgamma; FLJ16023; KIAA0832; NR3B3,estrogen-related receptor gamma,1q41,protein-coding,
CWITA005927,TCMBANKGE005927,ORC1,HSORC1; ORC1L; PARC1,origin recognition complex subunit 1,1p32.3,protein-coding,/
CWITA005928,TCMBANKGE005928,VRK3,-,VRK serine/threonine kinase 3,19q13.33,protein-coding,/
CWITA005929,TCMBANKGE005929,B4GALT3,beta4GalNT3,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3",1q21-q23,protein-coding,
CWITA005930,TCMBANKGE005930,ALKBH1,ABH; ABH1; ALKBH; alkB; hABH,"alkB homolog 1, histone H2A dioxygenase",14q24.3,protein-coding,/
CWITA005931,TCMBANKGE005931,SLC6A6,MGC10619; MGC131729; TAUT,"solute carrier family 6 (neurotransmitter transporter, taurine), member 6",3p25-p24,protein-coding,
CWITA005932,TCMBANKGE005932,PELO,CGI-17; PRO1770,pelota mRNA surveillance and ribosome rescue factor,5q11.2,protein-coding,/
CWITA005933,TCMBANKGE005933,LUM,LDC; SLRR2D,lumican,12q21.33,protein-coding,/
CWITA005934,TCMBANKGE005934,IKBKG,AMCBX1; EDAID1; FIP-3; FIP3; Fip3p; IKK-gamma; IKKAP1; IKKG; IMD33; IP; IP1; IP2; IPD2; NEMO; ZC2HC9,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Xq28,protein-coding,/
CWITA005935,TCMBANKGE005935,SCP2,NLTP; NSL-TP; SCP-2; SCP-CHI; SCP-X; SCPX,sterol carrier protein 2,1p32.3,protein-coding,/
CWITA005936,TCMBANKGE005936,EFHD2,SWS1,EF-hand domain family member D2,1p36.21,protein-coding,/
CWITA005937,TCMBANKGE005937,RSRC2,-,arginine and serine rich coiled-coil 2,12q24.31,protein-coding,/
CWITA005938,TCMBANKGE005938,TRAPPC6B,NEDMEBA; TPC6,trafficking protein particle complex 6B,14q21.1,protein-coding,/
CWITA005939,TCMBANKGE005939,SEC24C,-,"SEC24 homolog C, COPII coat complex component",10q22.2,protein-coding,/
CWITA005940,TCMBANKGE005940,EIF4G1,EIF-4G1; EIF4F; EIF4G; EIF4GI; P220; PARK18,eukaryotic translation initiation factor 4 gamma 1,3q27.1,protein-coding,/
CWITA005941,TCMBANKGE005941,FLNA,ABP-280; ABPX; CSBS; CVD1; FGS2; FLN; FLN-A; FLN1; FMD; MNS; NHBP; OPD; OPD1; OPD2; XLVD; XMVD,filamin A,Xq28,protein-coding,Clinical Trial target
CWITA005942,TCMBANKGE005942,SPATA2L,C16orf76; tamo,spermatogenesis associated 2 like,16q24.3,protein-coding,/
CWITA005943,TCMBANKGE005943,DBH,DBM,dopamine beta-hydroxylase (dopamine beta-monooxygenase),9q34,protein-coding,
CWITA005944,TCMBANKGE005944,MIR148B,MIRN148B|mir-148b,microRNA 148b,12q13.13,ncRNA,/
CWITA005945,TCMBANKGE005945,Ces2d-ps,Gm9756,"carboxylesterase 2D, pseudogene",8|8 D3,pseudo,/
CWITA005946,TCMBANKGE005946,BCAP31,6C6-AG; BAP31; CDM; DDCH; DXS1357E,B cell receptor associated protein 31,Xq28,protein-coding,/
CWITA005947,TCMBANKGE005947,SNCA,MGC110988; NACP; PARK1; PARK4; PD1,"synuclein, alpha (non A4 component of amyloid precursor)",4q21,protein-coding,
CWITA005948,TCMBANKGE005948,CDH5,7B4; CD144; FLJ17376,"cadherin 5, type 2 (vascular endothelium)",16q22.1,protein-coding,
CWITA005949,TCMBANKGE005949,EIF3K,ARG134; EIF3-p28; EIF3S12; HSPC029; M9; MSTP001; PLAC-24; PLAC24; PRO1474; PTD001,eukaryotic translation initiation factor 3 subunit K,19q13.2,protein-coding,/
CWITA005950,TCMBANKGE005950,FRY,13CDNA73; 214K23.2; C13orf14; CG003; bA207N4.2; bA37E23.1,FRY microtubule binding protein,13q13.1,protein-coding,/
CWITA005951,TCMBANKGE005951,ZNF536,-,zinc finger protein 536,19q12,protein-coding,/
CWITA005952,TCMBANKGE005952,SNX30,ATG24A,sorting nexin family member 30,9q32,protein-coding,/
CWITA005953,TCMBANKGE005953,CLASRP,CLASP; SFRS16; SWAP2,CLK4 associating serine/arginine rich protein,19q13.32,protein-coding,/
CWITA005954,TCMBANKGE005954,FNBP1,FBP17,formin binding protein 1,9q34.11,protein-coding,/
CWITA005955,TCMBANKGE005955,GPR132,G2A,G protein-coupled receptor 132,14q32.33,protein-coding,Research target
CWITA005956,TCMBANKGE005956,CPD,GP180,carboxypeptidase D,17q11.2,protein-coding,
CWITA005957,TCMBANKGE005957,VPS72,CFL1; Swc2; TCFL1; YL-1; YL1,vacuolar protein sorting 72 homolog,1q21.3,protein-coding,/
CWITA005958,TCMBANKGE005958,TUB,rd5,tubby homolog (mouse),11p15.5,protein-coding,
CWITA005959,TCMBANKGE005959,STX2,EPIM; EPM; STX2A; STX2B; STX2C,syntaxin 2,12q24.33,protein-coding,/
CWITA005960,TCMBANKGE005960,RORC,IMD42; NR1F3; RORG; RZR-GAMMA; RZRG; TOR,RAR related orphan receptor C,1q21.3,protein-coding,Clinical Trial target
CWITA005961,TCMBANKGE005961,ESR2,ERNBETA; ESRNBETA; ESRB; ESTRB; Erb; NR3A2,estrogen receptor 2 (ER beta),14q23.2,protein-coding,
CWITA005962,TCMBANKGE005962,ALS2CL,RN49018,ALS2 C-terminal like,3p21.31,protein-coding,/
CWITA005963,TCMBANKGE005963,KCNA1,AEMK; EA1; HBK1; HUK1; KV1.1; MBK1; MGC126782; MGC138385; MK1; RBK1,"potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)",12p13.32,protein-coding,
CWITA005964,TCMBANKGE005964,AHCY,SAHH; adoHcyase,adenosylhomocysteinase,20q11.22,protein-coding,Research target
CWITA005965,TCMBANKGE005965,CBLN2,-,cerebellin 2 precursor,18q22.3,protein-coding,/
CWITA005966,TCMBANKGE005966,LRP1,A2MR; APOER; APR; CD91; IGFBP-3R; IGFBP3R; IGFBP3R1; KPA; LRP; LRP1A; TGFBR5,Ldl_Receptor_Related_Protein_1,12q13.3,protein-coding,
CWITA005967,TCMBANKGE005967,MGAM,MG; MGA,maltase-glucoamylase,7q34,protein-coding,Successful target
CWITA005968,TCMBANKGE005968,CCPG1,CPR8,cell cycle progression 1,15q21.3,protein-coding,/
CWITA005969,TCMBANKGE005969,THPO,MGDF; MKCSF; ML; MPLLG; THCYT1; TPO,thrombopoietin,3q27.1,protein-coding,Clinical Trial target
CWITA005970,TCMBANKGE005970,SLC44A2,CTL2; PP1292,solute carrier family 44 member 2,19p13.2,protein-coding,/
CWITA005971,TCMBANKGE005971,ANXA1,ANX1; LPC1,annexin A1,9q12-q21.2|9q21.13,protein-coding,
CWITA005972,TCMBANKGE005972,NPNT,EGFL6L; POEM,nephronectin,4q24,protein-coding,/
CWITA005973,TCMBANKGE005973,da,-,dark,-,unknown,/
CWITA005974,TCMBANKGE005974,UPB1,BUP1,beta-ureidopropionase 1,22q11.23,protein-coding,/
CWITA005975,TCMBANKGE005975,ADORA1,RDC7,adenosine A1 receptor,1q32.1,protein-coding,Successful target
CWITA005976,TCMBANKGE005976,KLF2,LKLF,Kruppel like factor 2,19p13.11,protein-coding,/
CWITA005977,TCMBANKGE005977,ACTN2,CMD1AA; CMH23; MPD6; MYOCOZ,actinin alpha 2,1q43,protein-coding,/
CWITA005978,TCMBANKGE005978,PDGFRL,PDGRL; PRLTS,platelet derived growth factor receptor like,8p22,protein-coding,/
CWITA005979,TCMBANKGE005979,SLC28A2,CNT2; HCNT2; HsT17153; SPNT1,solute carrier family 28 member 2,15q21.1,protein-coding,Research target
CWITA005980,TCMBANKGE005980,NR4A3,CHN; CSMF; MINOR; NOR1; TEC,"nuclear receptor subfamily 4, group A, member 3",9q22,protein-coding,
CWITA005981,TCMBANKGE005981,CGAS,C6orf150; MB21D1; h-cGAS,cyclic GMP-AMP synthase,6q13,protein-coding,/
CWITA005982,TCMBANKGE005982,ZNF451,COASTER; dJ417I1.1,zinc finger protein 451,6p12.1,protein-coding,/
CWITA005983,TCMBANKGE005983,ACOT11,BFIT; STARD14; THEA; THEM1,acyl-CoA thioesterase 11,1p32.3,protein-coding,/
CWITA005984,TCMBANKGE005984,TFR2,HFE3; TFRC2,transferrin receptor 2,7q22.1,protein-coding,/
CWITA005985,TCMBANKGE005985,C3orf62,-,chromosome 3 open reading frame 62,3p21.31,protein-coding,/
CWITA005986,TCMBANKGE005986,CRACD,CRAD; KIAA1211,capping protein inhibiting regulator of actin dynamics,4q12,protein-coding,/
CWITA005987,TCMBANKGE005987,GAS7,-,growth arrest specific 7,17p13.1,protein-coding,/
CWITA005988,TCMBANKGE005988,SLC6A5,GLYTN2; GLYT2; NET1,"solute carrier family 6 (neurotransmitter transporter, glycine), member 5",11p15.1,protein-coding,
CWITA005989,TCMBANKGE005989,TTLL10,TTLL5,tubulin tyrosine ligase like 10,1p36.33,protein-coding,/
CWITA005990,TCMBANKGE005990,TTK,CT96; ESK; MPH1; MPS1; MPS1L1; PYT,TTK protein kinase,6q14.1,protein-coding,Clinical Trial target
CWITA005991,TCMBANKGE005991,MAPK12,ERK3; ERK6; P38GAMMA; PRKM12; SAPKN3; SAPK3,mitogen-activated protein kinase 12,22q13.33,protein-coding,
CWITA005992,TCMBANKGE005992,GALE,SDR1E1,UDP-galactose-4-epimerase,1p36.11,protein-coding,Research target
CWITA005993,TCMBANKGE005993,POGZ,MRD37; WHSUS; ZNF280E; ZNF635; ZNF635m,pogo transposable element derived with ZNF domain,1q21.3,protein-coding,/
CWITA005994,TCMBANKGE005994,SSR2,HSD25; TLAP; TRAP-BETA; TRAPB,signal sequence receptor subunit 2,1q22,protein-coding,/
CWITA005995,TCMBANKGE005995,PALB2,FANCN; PNCA3,partner and localizer of BRCA2,16p12.2,protein-coding,/
CWITA005996,TCMBANKGE005996,CCDC88C,DAPLE; HKRP2; HYC1; KIAA1509; SCA40,coiled-coil domain containing 88C,14q32.11-q32.12,protein-coding,/
CWITA005997,TCMBANKGE005997,STK33,-,serine/threonine kinase 33,11p15.4,protein-coding,Research target
CWITA005998,TCMBANKGE005998,USP4,UNP; Unph,ubiquitin specific peptidase 4,3p21.31,protein-coding,/
CWITA005999,TCMBANKGE005999,HAUS2,C15orf25; CEP27; HsT17025,HAUS augmin like complex subunit 2,15q15.2,protein-coding,/
CWITA006000,TCMBANKGE006000,TMPRSS9,-,transmembrane serine protease 9,19p13.3,protein-coding,/
CWITA006001,TCMBANKGE006001,MPDZ,HYC2; MUPP1,multiple PDZ domain crumbs cell polarity complex component,9p23,protein-coding,/
CWITA006002,TCMBANKGE006002,F12,HAE3; HAEX; HAF,coagulation factor XII,5q35.3,protein-coding,Clinical Trial target
CWITA006003,TCMBANKGE006003,APRT,AMP; APRTD,adenine phosphoribosyltransferase,16q24.3,protein-coding,/
CWITA006004,TCMBANKGE006004,RPL5,L5; MSTP030; PPP1R135; uL18,Ribosomal_Protein_L5,1p22.1,protein-coding,
CWITA006005,TCMBANKGE006005,GATA4,ASD2; TACHD; TOF; VSD1,GATA binding protein 4,8p23.1,protein-coding,Research target
CWITA006006,TCMBANKGE006006,RAG2,RAG-2,recombination activating 2,11p12,protein-coding,/
CWITA006007,TCMBANKGE006007,APOA1,MGC117399,Apolipoprotein A-I,11q23-q24,protein-coding,
CWITA006008,TCMBANKGE006008,MCM3,HCC5; P1-MCM3; P1.h; RLFB,minichromosome maintenance complex component 3,6p12.2,protein-coding,/
CWITA006009,TCMBANKGE006009,GRTP1,TBC1D6,growth hormone regulated TBC protein 1,13q34,protein-coding,/
CWITA006010,TCMBANKGE006010,RETN,ADSF; FIZZ3; RETN1; RSTN; XCP1,resistin,19p13.2,protein-coding,/
CWITA006011,TCMBANKGE006011,ZNF287,ZKSCAN13; ZSCAN45,zinc finger protein 287,17p11.2,protein-coding,/
CWITA006012,TCMBANKGE006012,ALDH1L1,10-FTHFDH; 10-fTHF; FDH; FTHFD,aldehyde dehydrogenase 1 family member L1,3q21.3,protein-coding,/
CWITA006013,TCMBANKGE006013,POTEI,POTE2beta,POTE ankyrin domain family member I,2q21.1,protein-coding,/
CWITA006014,TCMBANKGE006014,SERTAD1,SEI1; TRIP-Br1; TRIPBR1,SERTA domain containing 1,19q13.2,protein-coding,/
CWITA006015,TCMBANKGE006015,AMDHD2,CGI-14,amidohydrolase domain containing 2,16p13.3,protein-coding,/
CWITA006016,TCMBANKGE006016,ADRA1D,ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2,"adrenergic, alpha-1D-, receptor",20p13,protein-coding,
CWITA006017,TCMBANKGE006017,SPAG1,CILD28; CT140; HEL-S-268; HSD-3.8; SP75; TPIS,sperm associated antigen 1,8q22.2,protein-coding,/
CWITA006018,TCMBANKGE006018,ZNF41,MRX89,zinc finger protein 41,Xp11.3,protein-coding,/
CWITA006019,TCMBANKGE006019,ZNF207,BuGZ; hBuGZ,zinc finger protein 207,17q11.2,protein-coding,/
CWITA006020,TCMBANKGE006020,UBC,HMG20,ubiquitin C,12q24.31,protein-coding,Patented target
CWITA006021,TCMBANKGE006021,NAPA,SNAPA,NSF attachment protein alpha,19q13.32-q13.33,protein-coding,/
CWITA006022,TCMBANKGE006022,C2orf69,-,chromosome 2 open reading frame 69,2q33.1,protein-coding,/
CWITA006023,TCMBANKGE006023,CYP51A1,CP51; CYP51; CYPL1; LDM; P450N14DM; P450L1,"cytochrome P450, family 51, subfamily A, polypeptide 1",7q21.2,protein-coding,
CWITA006024,TCMBANKGE006024,KRTAP1-3,KAP1.2; KAP1.3; KAP1.6; KAP1.8A; KAP1.8B; KAP1.9; KRTAP1.3,keratin associated protein 1-3,17q21.2,protein-coding,/
CWITA006025,TCMBANKGE006025,SNRPB2,Msl1; U2B'',small nuclear ribonucleoprotein polypeptide B2,20p12.1,protein-coding,/
CWITA006026,TCMBANKGE006026,KCNA10,Kcn1; Kv1.8,potassium voltage-gated channel subfamily A member 10,1p13.3,protein-coding,Research target
CWITA006027,TCMBANKGE006027,POLL,BETAN; POLKAPPA,DNA polymerase lambda,10q24.32,protein-coding,/
CWITA006028,TCMBANKGE006028,ALX3,FND; FND1,ALX homeobox 3,1p13.3,protein-coding,/
CWITA006029,TCMBANKGE006029,WNK2,NY-CO-43; P/OKcl.13; PRKWNK2; SDCCAG43,WNK lysine deficient protein kinase 2,9q22.31,protein-coding,/
CWITA006030,TCMBANKGE006030,SLC37A3,-,solute carrier family 37 member 3,7q34,protein-coding,/
CWITA006031,TCMBANKGE006031,TGM4,TGP; hTGP,transglutaminase 4,3p21.31,protein-coding,/
CWITA006032,TCMBANKGE006032,SRMS,C20orf148; PTK70; SRM; dJ697K14.1,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,20q13.33,protein-coding,Research target
CWITA006033,TCMBANKGE006033,MTAP,BDMF; DMSFH; DMSMFH; HEL-249; LGMBF; MSAP; c86fus,methylthioadenosine phosphorylase,9p21.3,protein-coding,Research target
CWITA006034,TCMBANKGE006034,PGS1,-,phosphatidylglycerophosphate synthase 1,17q25.3,protein-coding,/
CWITA006035,TCMBANKGE006035,ZNF560,-,zinc finger protein 560,19p13.2,protein-coding,/
CWITA006036,TCMBANKGE006036,IRGM,IFI1; IRGM1; LRG-47; LRG47,immunity related GTPase M,5q33.1,protein-coding,/
CWITA006037,TCMBANKGE006037,MYL1,MLC1F; MLC3F; MYOFTA,myosin light chain 1,2q34,protein-coding,/
CWITA006038,TCMBANKGE006038,SHQ1,GRIM-1; Shq1p,"SHQ1, H/ACA ribonucleoprotein assembly factor",3p13,protein-coding,/
CWITA006039,TCMBANKGE006039,ADORA2A,ADORA2; RDC8; hA2aR,adenosine A2a receptor,22q11.23,protein-coding,
CWITA006040,TCMBANKGE006040,SLC25A20,CAC; CACT,solute carrier family 25 member 20,3p21.31,protein-coding,/
CWITA006041,TCMBANKGE006041,PHC3,EDR3; HPH3,polyhomeotic homolog 3,3q26.2,protein-coding,/
CWITA006042,TCMBANKGE006042,DNAJC2,MPHOSPH11; MPP11; ZRF1; ZUO1,DnaJ heat shock protein family (Hsp40) member C2,7q22.1,protein-coding,/
CWITA006043,TCMBANKGE006043,RAB24,-,"RAB24, member RAS oncogene family",5q35.3,protein-coding,/
CWITA006044,TCMBANKGE006044,ITIH6,ITIH5L; UNQ6369; dJ14O9.1,inter-alpha-trypsin inhibitor heavy chain family member 6,Xp11.22,protein-coding,/
CWITA006045,TCMBANKGE006045,ADRM1,ARM-1; ARM1; GP110,adhesion regulating molecule 1,20q13.33,protein-coding,/
CWITA006046,TCMBANKGE006046,SLC45A2,1A1; AIM1; MATP; OCA4; SHEP5,solute carrier family 45 member 2,5p13.2,protein-coding,/
CWITA006047,TCMBANKGE006047,ZNF655,VIK; VIK-1,zinc finger protein 655,7q22.1,protein-coding,/
CWITA006048,TCMBANKGE006048,KANK3,ANKRD47,KN motif and ankyrin repeat domains 3,19p13.2,protein-coding,/
CWITA006049,TCMBANKGE006049,SLC14A1,HUT11; HsT1341; JK; Jk(b); RACH1; RACH2; UT-B1; UT1; UTE,solute carrier family 14 member 1 (Kidd blood group),18q12.3,protein-coding,Research target
CWITA006050,TCMBANKGE006050,TIMM21,C18orf55; HSPC154; TIM21,translocase of inner mitochondrial membrane 21,18q22.3,protein-coding,/
CWITA006051,TCMBANKGE006051,ALK,CD246; NBLST3,anaplastic lymphoma receptor tyrosine kinase,2p23,protein-coding,
CWITA006052,TCMBANKGE006052,WDR61,REC14; SKI8,WD repeat domain 61,15q25.1,protein-coding,/
CWITA006053,TCMBANKGE006053,NFKB2,LYTN10; LYT10; p52,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),10q24,protein-coding,
CWITA006054,TCMBANKGE006054,AGL,GDE,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1p21.2,protein-coding,/
CWITA006055,TCMBANKGE006055,MCHR1,GPR24; MCH-1R; MCH1R; SLC-1; SLC1,melanin concentrating hormone receptor 1,22q13.2,protein-coding,Clinical Trial target
CWITA006056,TCMBANKGE006056,PLD5,PLDC,phospholipase D family member 5,1q43,protein-coding,/
CWITA006057,TCMBANKGE006057,RNF11,CGI-123; SID1669,ring finger protein 11,1p32.3,protein-coding,/
CWITA006058,TCMBANKGE006058,SELENOW,SEPW1; selW,selenoprotein W,19q13.33,protein-coding,/
CWITA006059,TCMBANKGE006059,CD207,CLEC4K,CD207 molecule,2p13.3,protein-coding,/
CWITA006060,TCMBANKGE006060,GOLGA5,GOLIM5; RFG5; ret-II,golgin A5,14q32.12,protein-coding,/
CWITA006061,TCMBANKGE006061,THBD,AHUS6; BDCA3; CD141; THPH12; THRM; TM,thrombomodulin,20p11.21,protein-coding,Discontinued target
CWITA006062,TCMBANKGE006062,ASB14,-,ankyrin repeat and SOCS box containing 14,3p14.3,protein-coding,/
CWITA006063,TCMBANKGE006063,PMS2,HNPCC4; PMS2CL; PMSL2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),7p22.2,protein-coding,
CWITA006064,TCMBANKGE006064,SLC27A3,ACSVL3; FATP3; VLCS-3,solute carrier family 27 member 3,1q21.3,protein-coding,/
CWITA006065,TCMBANKGE006065,GSX1,GSH1; Gsh-1,GS homeobox 1,13q12.2,protein-coding,/
CWITA006066,TCMBANKGE006066,DNAJC17,-,DnaJ heat shock protein family (Hsp40) member C17,15q15.1,protein-coding,/
CWITA006067,TCMBANKGE006067,ZNF816,ZNF816A,zinc finger protein 816,19q13.41,protein-coding,/
CWITA006068,TCMBANKGE006068,CDX1,-,caudal type homeobox 1,5q32,protein-coding,/
CWITA006069,TCMBANKGE006069,SEL1L,Hrd3; PRO1063; SEL1-LIKE; SEL1L1,SEL1L adaptor subunit of ERAD E3 ubiquitin ligase,14q31.1,protein-coding,/
CWITA006070,TCMBANKGE006070,TBC1D16,-,TBC1 domain family member 16,17q25.3,protein-coding,/
CWITA006071,TCMBANKGE006071,PTPN13,FAP-1; PNP1; PTP-BAS; PTP-BL; PTP1E; PTPL1; PTPLE; hPTP1E,protein tyrosine phosphatase non-receptor type 13,4q21.3,protein-coding,Research target
CWITA006072,TCMBANKGE006072,CLEC6A,CLEC4N; CLECSF10; dectin-2,C-type lectin domain containing 6A,12p13.31,protein-coding,Research target
CWITA006073,TCMBANKGE006073,SNRPE,HYPT11; SME; Sm-E; snRNP-E,small nuclear ribonucleoprotein polypeptide E,1q32.1,protein-coding,/
CWITA006074,TCMBANKGE006074,UGDH,EIEE84; GDH; UDP-GlcDH; UDPGDH; UGD,UDP-glucose 6-dehydrogenase,4p14,protein-coding,/
CWITA006075,TCMBANKGE006075,PRDM10,PFM7; TRIS,PR/SET domain 10,11q24.3,protein-coding,/
CWITA006076,TCMBANKGE006076,CSNK1D,ASPS; CKI-delta; CKId; CKIdelta; FASPS2; HCKID,casein kinase 1 delta,17q25.3,protein-coding,Research target
CWITA006077,TCMBANKGE006077,KLK2,KLK2A2; hGK-1; hK2,kallikrein related peptidase 2,19q13.33,protein-coding,Clinical Trial target
CWITA006078,TCMBANKGE006078,PGBD3,-,piggyBac transposable element derived 3,10q11.23,protein-coding,/
CWITA006079,TCMBANKGE006079,NMUR2,FM-4; FM4; NMU-R2; NMU2R; TGR-1; TGR1,neuromedin U receptor 2,5q33.1,protein-coding,Research target
CWITA006080,TCMBANKGE006080,PRKAG1,AMPKG; MGC8666,"protein kinase, AMP-activated, gamma 1 non-catalytic subunit",12q12-q14,protein-coding,
CWITA006081,TCMBANKGE006081,DIRAS3,ARHI; NOEY2,DIRAS family GTPase 3,1p31.3,protein-coding,/
CWITA006082,TCMBANKGE006082,RPL10L,RPL10_5_1358,ribosomal protein L10 like,14q21.2,protein-coding,/
CWITA006083,TCMBANKGE006083,ABCA5,ABC13; DKFZp451F117; DKFZp779N2435; EST90625; FLJ16381,"ATP-binding cassette, sub-family A (ABC1), member 5",17q24.3,protein-coding,
CWITA006084,TCMBANKGE006084,DLG4,FLJ97752; FLJ98574; PSD95; SAPN90; SAP90,"discs, large homolog 4 (Drosophila)",17p13.1,protein-coding,
CWITA006085,TCMBANKGE006085,RALGPS1,RALGEF2; RALGPS1A,Ral GEF with PH domain and SH3 binding motif 1,9q33.3,protein-coding,/
CWITA006086,TCMBANKGE006086,ERBIN,ERBB2IP; HEL-S-78; LAP2,erbb2 interacting protein,5q12.3,protein-coding,/
CWITA006087,TCMBANKGE006087,FDX1,ADX; FDX; LOH11CR1D,ferredoxin 1,11q22.3,protein-coding,/
CWITA006088,TCMBANKGE006088,CKLF,C32; CKLF1; CKLF2; CKLF3; CKLF4; HSPC224; UCK-1,chemokine like factor,16q21,protein-coding,/
CWITA006089,TCMBANKGE006089,NOVA2,ANOVA; NEDASB; NOVA-2; NOVA3,NOVA alternative splicing regulator 2,19q13.32,protein-coding,/
CWITA006090,TCMBANKGE006090,MSLN,MPF; SMRP,mesothelin,16p13.3,protein-coding,Clinical Trial target
CWITA006091,TCMBANKGE006091,SFRP5,SARP3,secreted frizzled related protein 5,10q24.2,protein-coding,/
CWITA006092,TCMBANKGE006092,MYL12A,MLCB; MRCL3; MRLC3; MYL2B,"myosin, light chain 12A, regulatory, non-sarcomeric",18p11.31,protein-coding,
CWITA006093,TCMBANKGE006093,GAMT,PIG2; TP53I2,guanidinoacetate N-methyltransferase,19p13.3,protein-coding,
CWITA006094,TCMBANKGE006094,CYP2C18,CPCI; CYP2C; CYP2C17; P450-6B/29C; P450IIC17,cytochrome P450 family 2 subfamily C member 18,10q23.33,protein-coding,/
CWITA006095,TCMBANKGE006095,RASA3,GAP1IP4BP; GAPIII,RAS p21 protein activator 3,13q34,protein-coding,/
CWITA006096,TCMBANKGE006096,GALR3,-,galanin receptor 3,22q13.1,protein-coding,/
CWITA006097,TCMBANKGE006097,FLNC,ABP-280; ABP280A; ABPA; ABPL; CMH26; FLN2; MFM5; MPD4; RCM5,filamin C,7q32.1,protein-coding,/
CWITA006098,TCMBANKGE006098,DIAPH2,DIA; DIA2; DRF2; POF; POF2; POF2A,diaphanous related formin 2,Xq21.33,protein-coding,/
CWITA006099,TCMBANKGE006099,VAPA,VAP-33; VAP-A; VAP33; hVAP-33,VAMP associated protein A,18p11.22,protein-coding,/
CWITA006100,TCMBANKGE006100,CSF2RA,CD116; CDw116; CSF2R; CSF2RAX; CSF2RAY; CSF2RX; CSF2RY; GM-CSF-R-alpha; GMCSFR; GMCSFR-alpha; GMR; GMR-alpha; SMDP4; alphaGMR,colony stimulating factor 2 receptor subunit alpha,Xp22.33 and Yp11.2,protein-coding,Successful target
CWITA006101,TCMBANKGE006101,CHRNG,ACHRG; MGC133376,"cholinergic receptor, nicotinic, gamma",2q33-q34,protein-coding,
CWITA006102,TCMBANKGE006102,LIPK,LIPL2; bA186O14.2,lipase family member K,10q23.31,protein-coding,/
CWITA006103,TCMBANKGE006103,Gssos2,Gm14256,"glutathione synthase, opposite strand 2",2 H1|2 77.26 cM,ncRNA,/
CWITA006104,TCMBANKGE006104,SULT1A3,HAST; HAST3; M-PST; ST1A3; ST1A3/ST1A4; ST1A4; ST1A5; STM; TL-PST,sulfotransferase family 1A member 3,16p11.2,protein-coding,/
CWITA006105,TCMBANKGE006105,NMS,-,neuromedin S,2q11.2,protein-coding,/
CWITA006106,TCMBANKGE006106,RSBN1L,-,round spermatid basic protein 1 like,7q11.23,protein-coding,/
CWITA006107,TCMBANKGE006107,ENO1,ENO1L1; HEL-S-17; MPB1; NNE; PPH,Enolase_1,1p36.23,protein-coding,
CWITA006108,TCMBANKGE006108,HINT1,HINT; NMAN; PKCI-1; PRKCNH1,histidine triad nucleotide binding protein 1,5q23.3,protein-coding,/
CWITA006109,TCMBANKGE006109,SYTL5,slp5,synaptotagmin like 5,Xp11.4,protein-coding,/
CWITA006110,TCMBANKGE006110,UBXN10,UBXD3,UBX domain protein 10,1p36.12,protein-coding,/
CWITA006111,TCMBANKGE006111,NDUFS3,CI-30; MC1DN8,NADH:ubiquinone oxidoreductase core subunit S3,11p11.2,protein-coding,/
CWITA006112,TCMBANKGE006112,EPB41L2,4.1-G; 4.1G,erythrocyte membrane protein band 4.1 like 2,6q23.1-q23.2,protein-coding,/
CWITA006113,TCMBANKGE006113,RPL26L1,FLJ46904; RPL26P1,ribosomal protein L26-like 1,5q35.1,protein-coding,
CWITA006114,TCMBANKGE006114,SLC22A10,OAT5; hOAT5,"solute carrier family 22, member 10",11q12.3,protein-coding,
CWITA006115,TCMBANKGE006115,ZNF700,-,zinc finger protein 700,19p13.2,protein-coding,/
CWITA006116,TCMBANKGE006116,POLG2,HP55; MTDPS16; MTPOLB; PEOA4; POLB; POLG-BETA; POLGB,"DNA polymerase gamma 2, accessory subunit",17q23.3,protein-coding,/
CWITA006117,TCMBANKGE006117,SCML4,dJ47M23.1,Scm polycomb group protein like 4,6q21,protein-coding,/
CWITA006118,TCMBANKGE006118,MRRF,MRFF; MTRRF; RRF,mitochondrial ribosome recycling factor,9q33.2,protein-coding,/
CWITA006119,TCMBANKGE006119,SCNN1B,BESC1; ENaCb; ENaCbeta; LIDLS1; SCNEB,sodium channel epithelial 1 subunit beta,16p12.2,protein-coding,/
CWITA006120,TCMBANKGE006120,GGPS1,GGPPS; GGPPS1,geranylgeranyl diphosphate synthase 1,1q43,protein-coding,
CWITA006121,TCMBANKGE006121,BLMH,BH; BMH,bleomycin hydrolase,17q11.2,protein-coding,/
CWITA006122,TCMBANKGE006122,GORASP1,GOLPH5; GRASP65; P65,golgi reassembly stacking protein 1,3p22.2,protein-coding,/
CWITA006123,TCMBANKGE006123,CAMTA2,-,calmodulin binding transcription activator 2,17p13.2,protein-coding,/
CWITA006124,TCMBANKGE006124,AOC3,HPAO; SSAO; VAPN1; VAP1,"amine oxidase, copper containing 3 (vascular adhesion protein 1)",17q21,protein-coding,
CWITA006125,TCMBANKGE006125,FADS6,FP18279,fatty acid desaturase 6,17q25.1,protein-coding,/
CWITA006126,TCMBANKGE006126,SLAMF8,BLAME; CD353; SBBI42,SLAM family member 8,1q23.2,protein-coding,/
CWITA006127,TCMBANKGE006127,ANKRD36,UNQ2430,ankyrin repeat domain 36,2q11.2,protein-coding,/
CWITA006128,TCMBANKGE006128,IFI16,IFNGIP1; PYHIN2,interferon gamma inducible protein 16,1q23.1,protein-coding,/
CWITA006129,TCMBANKGE006129,KIAA0930,C22orf9; LSC3,KIAA0930,22q13.31,protein-coding,/
CWITA006130,TCMBANKGE006130,PDZK1,CAP70; CLAMP; NHERF-3; NHERF3; PDZD1,PDZ domain containing 1,1q21.1,protein-coding,Research target
CWITA006131,TCMBANKGE006131,Ri2,Ri-2,recognition of identity 2,-,unknown,/
CWITA006132,TCMBANKGE006132,HLA-B,AS; HLAB; MGC111087; SPDA1,"major histocompatibility complex, class I, B",6p21.3,protein-coding,
CWITA006133,TCMBANKGE006133,PTPRA,HEPTP; HLPR; HPTPA; HPTPalpha; LRP; PTPA; PTPRL2; R-PTP-alpha; RPTPA,protein tyrosine phosphatase receptor type A,20p13,protein-coding,/
CWITA006134,TCMBANKGE006134,ADD1,ADDA,adducin 1,4p16.3,protein-coding,/
CWITA006135,TCMBANKGE006135,CDH8,Nbla04261,cadherin 8,16q21,protein-coding,/
CWITA006136,TCMBANKGE006136,OPN1SW,BCP; BOP; CBT,"opsin 1, short wave sensitive",7q32.1,protein-coding,/
CWITA006137,TCMBANKGE006137,RPAP1,-,RNA polymerase II associated protein 1,15q15.1,protein-coding,/
CWITA006138,TCMBANKGE006138,COQ6,CGI-10; CGI10; COQ10D6,"coenzyme Q6, monooxygenase",14q24.3,protein-coding,/
CWITA006139,TCMBANKGE006139,MALSU1,C7orf30; mtRsfA,mitochondrial assembly of ribosomal large subunit 1,7p15.3,protein-coding,/
CWITA006140,TCMBANKGE006140,PER2,FASPS; FASPS1,period circadian regulator 2,2q37.3,protein-coding,/
CWITA006141,TCMBANKGE006141,SV2B,HsT19680,synaptic vesicle glycoprotein 2B,15q26.1,protein-coding,/
CWITA006142,TCMBANKGE006142,PSG5,FLNNCAN3; PSG,pregnancy specific beta-1-glycoprotein 5,19q13.2,protein-coding,
CWITA006143,TCMBANKGE006143,ARL6IP6,AIP-6; AIP6; PFAAP1,ADP ribosylation factor like GTPase 6 interacting protein 6,2q23.3,protein-coding,/
CWITA006144,TCMBANKGE006144,GUF1,EF-4; EF4; EIEE40,"GUF1 homolog, GTPase",4p12,protein-coding,/
CWITA006145,TCMBANKGE006145,ARL1,ARFL1,ADP-ribosylation factor-like 1,12q23.2,protein-coding,
CWITA006146,TCMBANKGE006146,NFASC,NEDCPMD; NF; NRCAML,neurofascin,1q32.1,protein-coding,/
CWITA006147,TCMBANKGE006147,EFEMP1,DHRD; DRAD; FBLN3; FBNL; FIBL-3; MLVT; MTLV; S1-5,EGF containing fibulin extracellular matrix protein 1,2p16.1,protein-coding,/
CWITA006148,TCMBANKGE006148,PLOD3,LH3,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3",7q22,protein-coding,
CWITA006149,TCMBANKGE006149,ZMIZ1,MIZ; NEDDFSA; RAI17; TRAFIP10; ZIMP10,zinc finger MIZ-type containing 1,10q22.3,protein-coding,/
CWITA006150,TCMBANKGE006150,RAB40AL,MRXSMP; RAR2; RLGP,RAB40A like,Xq22.1,protein-coding,/
CWITA006151,TCMBANKGE006151,PRX,CMT4F; KIAA1620,periaxin,19q13.2,protein-coding,
CWITA006152,TCMBANKGE006152,RAI14,NORPEG; RAI13,retinoic acid induced 14,5p13.2,protein-coding,/
CWITA006153,TCMBANKGE006153,ATP4A,ATP6A,ATPase H+/K+ transporting subunit alpha,19q13.12,protein-coding,Successful target
CWITA006154,TCMBANKGE006154,CAPRIN2,C1QDC1; EEG-1; EEG1; RNG140,caprin family member 2,12p11.21,protein-coding,/
CWITA006155,TCMBANKGE006155,ZNF398,P51; P71; ZER6,zinc finger protein 398,7q36.1,protein-coding,/
CWITA006156,TCMBANKGE006156,RELN,ETL7; LIS2; PRO1598; RL,reelin,7q22.1,protein-coding,/
CWITA006157,TCMBANKGE006157,PCDH19,EFMR; EIEE9,protocadherin 19,Xq22.1,protein-coding,/
CWITA006158,TCMBANKGE006158,PREP,PE; PEP,prolyl endopeptidase,6q21,protein-coding,Clinical Trial target
CWITA006159,TCMBANKGE006159,MAP1S,BPY2IP1; C19orf5; MAP8; VCY2IP-1; VCY2IP1,microtubule associated protein 1S,19p13.11,protein-coding,/
CWITA006160,TCMBANKGE006160,AZGP1,ZA2G; ZAG,"alpha-2-glycoprotein 1, zinc-binding",7q22.1,protein-coding,Research target
CWITA006161,TCMBANKGE006161,CLEC9A,CD370; DNGR-1; DNGR1; UNQ9341,C-type lectin domain containing 9A,12p13.2,protein-coding,Research target
CWITA006162,TCMBANKGE006162,OTULINL,FAM105A; NET20,OTU deubiquitinase with linear linkage specificity like,5p15.2,protein-coding,/
CWITA006163,TCMBANKGE006163,ITPR2,ANHD; CFAP48; INSP3R2; IP3R2,"inositol 1,4,5-trisphosphate receptor type 2",12p11.23,protein-coding,Research target
CWITA006164,TCMBANKGE006164,GPR21,-,G protein-coupled receptor 21,9q33.2,protein-coding,/
CWITA006165,TCMBANKGE006165,USP18,ISG43; PTORCH2; UBP43,ubiquitin specific peptidase 18,22q11.21,protein-coding,/
CWITA006166,TCMBANKGE006166,CC2D1B,-,coiled-coil and C2 domain containing 1B,1p32.3,protein-coding,/
CWITA006167,TCMBANKGE006167,DOP1B,21orf5; C21orf5; DOPEY2,DOP1 leucine zipper like protein B,21q22.12,protein-coding,/
CWITA006168,TCMBANKGE006168,MROH8,C20orf131; C20orf132,maestro heat like repeat family member 8,20q11.23,protein-coding,/
CWITA006169,TCMBANKGE006169,IFNA14,IFN-alphaH; LEIF2H,interferon alpha 14,9p21.3,protein-coding,/
CWITA006170,TCMBANKGE006170,FTSJ3,EPCS3; SPB1,FtsJ RNA 2'-O-methyltransferase 3,17q23.3,protein-coding,/
CWITA006171,TCMBANKGE006171,DDT,D-DT; DDCT; MIF-2; MIF2,D-dopachrome tautomerase,22q11.23,protein-coding,/
CWITA006172,TCMBANKGE006172,EXT2,SOTV; SSMS,exostosin glycosyltransferase 2,11p11.2,protein-coding,/
CWITA006173,TCMBANKGE006173,TFPI,EPI; LACI; TFI; TFPI1,tissue factor pathway inhibitor,2q32.1,protein-coding,Clinical Trial target
CWITA006174,TCMBANKGE006174,SHLD1,C20orf196; RINN3,shieldin complex subunit 1,20p12.3,protein-coding,/
CWITA006175,TCMBANKGE006175,EBF4,COE4; O/E-4,EBF family member 4,20p13,protein-coding,/
CWITA006176,TCMBANKGE006176,BLOC1S1,BLOS1; BORCS1; GCN5L1; MICoA; RT14,biogenesis of lysosomal organelles complex 1 subunit 1,12q13.2,protein-coding,/
CWITA006177,TCMBANKGE006177,STX6,-,syntaxin 6,1q25.3,protein-coding,/
CWITA006178,TCMBANKGE006178,RRAGB,RAGB; bA465E19.1,Ras related GTP binding B,Xp11.21,protein-coding,/
CWITA006179,TCMBANKGE006179,SRR,ILV1; ISO1,serine racemase,17p13,protein-coding,
CWITA006180,TCMBANKGE006180,TMEM37,PR; PR1,transmembrane protein 37,2q14.2,protein-coding,/
CWITA006181,TCMBANKGE006181,C10orf88,PAAT,chromosome 10 open reading frame 88,10q26.13,protein-coding,/
CWITA006182,TCMBANKGE006182,GDF11,BMP-11; BMP11,growth differentiation factor 11,12q13.2,protein-coding,/
CWITA006183,TCMBANKGE006183,SCAF8,RBM16,SR-related CTD associated factor 8,6q25.2,protein-coding,/
CWITA006184,TCMBANKGE006184,TTC16,-,tetratricopeptide repeat domain 16,9q34.11,protein-coding,/
CWITA006185,TCMBANKGE006185,NDUFA13,B16.6; CDA016; CGI-39; GRIM-19; GRIM19; MC1DN28,NADH:ubiquinone oxidoreductase subunit A13,19p13.11,protein-coding,Clinical Trial target
CWITA006186,TCMBANKGE006186,B4GALT4,B4GalNT4; beta4GalNT4,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4",3q13.3,protein-coding,
CWITA006187,TCMBANKGE006187,KPNA5,IPOA6; SRP6,karyopherin subunit alpha 5,6q22.1,protein-coding,/
CWITA006188,TCMBANKGE006188,PREP,MGC16060; PE; PEP,prolyl endopeptidase,6q22,protein-coding,
CWITA006189,TCMBANKGE006189,FAM20A,AI1G; AIGFS; FP2747,FAM20A golgi associated secretory pathway pseudokinase,17q24.2,protein-coding,/
CWITA006190,TCMBANKGE006190,SPATA7,HEL-S-296; HSD-3.1; HSD3; LCA3,spermatogenesis associated 7,14q31.3,protein-coding,/
CWITA006191,TCMBANKGE006191,TARS,MGC9344; ThrRS,threonyl-tRNA synthetase,5p13.2,protein-coding,
CWITA006192,TCMBANKGE006192,LYPD6B,CT116; LYPD7,LY6/PLAUR domain containing 6B,2q23.2,protein-coding,/
CWITA006193,TCMBANKGE006193,CA12,CA-XII; CAXII; HsT18816; T18816,carbonic anhydrase 12,15q22.2,protein-coding,Successful target
CWITA006194,TCMBANKGE006194,ITGB6,AI1H,integrin subunit beta 6,2q24.2,protein-coding,/
CWITA006195,TCMBANKGE006195,TESMIN,CXCDC2; MTL5; MTLT,testis expressed metallothionein like protein,11q13.3,protein-coding,/
CWITA006196,TCMBANKGE006196,SYNPO2,-,synaptopodin 2,4q26,protein-coding,/
CWITA006197,TCMBANKGE006197,AMD1,ADOMETDC; AMD; SAMDC,adenosylmethionine decarboxylase 1,6q21,protein-coding,Successful target
CWITA006198,TCMBANKGE006198,LZTR1,BTBD29; LZTR-1; NS10; NS2; SWNTS2,leucine zipper like transcription regulator 1,22q11.21|22q11.1-q11.2,protein-coding,/
CWITA006199,TCMBANKGE006199,GLYATL2,BXMAS2N10; GATFNB; MGC24009,glycine-N-acyltransferase-like 2,11q12.1,protein-coding,
CWITA006200,TCMBANKGE006200,LYVE1,CRSBP-1; HAR; LYVE-1; XLKD1,lymphatic vessel endothelial hyaluronan receptor 1,11p15.4,protein-coding,Successful target
CWITA006201,TCMBANKGE006201,NUMB,C14orf41; S171; c14_5527,NUMB endocytic adaptor protein,14q24.2-q24.3,protein-coding,/
CWITA006202,TCMBANKGE006202,FAM89B,LRAP25; MTVR; MTVR1,family with sequence similarity 89 member B,11q13.1,protein-coding,/
CWITA006203,TCMBANKGE006203,YARS2,FLJ13995; MLASA2; MTNTYRRS; TYRRS,"tyrosyl-tRNA synthetase 2, mitochondrial",12p11.21,protein-coding,
CWITA006204,TCMBANKGE006204,XPNPEP2,AEACEI; APP2,X-prolyl aminopeptidase 2,Xq26.1,protein-coding,Research target
CWITA006205,TCMBANKGE006205,UMPS,OPRT,uridine monophosphate synthetase,3q21.2,protein-coding,Research target
CWITA006206,TCMBANKGE006206,TARBP1,TRM3; TRMT3; TRP-185; TRP185,TAR (HIV-1) RNA binding protein 1,1q42.2,protein-coding,/
CWITA006207,TCMBANKGE006207,OR51E2,HPRAJ; OR51E3P; OR52A2; PSGR,olfactory receptor family 51 subfamily E member 2,11p15.4,protein-coding,Research target
CWITA006208,TCMBANKGE006208,SLC6A15,DKFZp761I0921; FLJ10316; MGC87066; NTT73; SBAT1; V7-3; hv7-3,"Solute Carrier Family 6 (Neutral Amino Acid Transporter), Member 15",12q21.3,protein-coding,
CWITA006209,TCMBANKGE006209,ZFAT,AITD3; ZFAT1; ZNF406,zinc finger and AT-hook domain containing,8q24.22,protein-coding,/
CWITA006210,TCMBANKGE006210,CHST15,BRAG; GALNAC4S-6ST,carbohydrate sulfotransferase 15,10q26.13,protein-coding,Research target
CWITA006211,TCMBANKGE006211,MKNK2,GPRK7; MNK2,MAPK interacting serine/threonine kinase 2,19p13.3,protein-coding,Clinical Trial target
CWITA006212,TCMBANKGE006212,SUPT3H,SPT3; SPT3L,"SPT3 homolog, SAGA and STAGA complex component",6p21.1,protein-coding,/
CWITA006213,TCMBANKGE006213,SIN3B,-,SIN3 transcription regulator family member B,19p13.11,protein-coding,/
CWITA006214,TCMBANKGE006214,SPTLC3,C20orf38; FLJ11112; FLJ90790; LCB2B; LCB3; SPT3; SPTLC2L; dJ718P11; dJ718P11.1,"serine palmitoyltransferase, long chain base subunit 3",20p12.1,protein-coding,
CWITA006215,TCMBANKGE006215,NAGS,AGAS; ARGA; MGC133025,N-acetylglutamate synthase,17q21.31,protein-coding,
CWITA006216,TCMBANKGE006216,SETX,ALS4; AOA2; SCAN2; SCAR1; Sen1; bA479K20.2,senataxin,9q34.13,protein-coding,/
CWITA006217,TCMBANKGE006217,TET1,CXXC6; LCX; bA119F7.1,tet methylcytosine dioxygenase 1,10q21.3,protein-coding,/
CWITA006218,TCMBANKGE006218,ANKRD11,ANCO-1; ANCO1; LZ16; T13,ankyrin repeat domain 11,16q24.3,protein-coding,/
CWITA006219,TCMBANKGE006219,SLC13A3,ARLIAK; NADC3; SDCT2,solute carrier family 13 member 3,20q13.12,protein-coding,/
CWITA006220,TCMBANKGE006220,ATP2C2,SPCA2,ATPase secretory pathway Ca2+ transporting 2,16q24.1,protein-coding,/
CWITA006221,TCMBANKGE006221,JPT2,C16orf34; HN1L; L11,Jupiter microtubule associated homolog 2,16p13.3,protein-coding,/
CWITA006222,TCMBANKGE006222,TRMT61B,-,tRNA methyltransferase 61B,2p23.2,protein-coding,/
CWITA006223,TCMBANKGE006223,SFSWAP,SFRS8; SWAP,splicing factor SWAP,12q24.33,protein-coding,/
CWITA006224,TCMBANKGE006224,PTGIR,IP; PRIPR,prostaglandin I2 receptor,19q13.32,protein-coding,Successful target
CWITA006225,TCMBANKGE006225,Agtr1a,1810074K20Rik; AG2S; AI551199; AT1; AT1a; AT2R1; AT2R1A; Agt1ar; Agtr-1a; Agtr1; Angtr-1a,"angiotensin II receptor, type 1a",13 A3.2|13 13.19 cM,protein-coding,/
CWITA006226,TCMBANKGE006226,EIF5A2,EIF-5A2; eIF5AII,eukaryotic translation initiation factor 5A2,3q26.2,protein-coding,Research target
CWITA006227,TCMBANKGE006227,NR2C2AP,TRA16,nuclear receptor 2C2 associated protein,19p13.11,protein-coding,/
CWITA006228,TCMBANKGE006228,DIP2A,C21orf106; DIP2,disco interacting protein 2 homolog A,21q22.3,protein-coding,/
CWITA006229,TCMBANKGE006229,ST6GALNAC3,PRO7177; SIAT7C; ST6GALNACIII; STY,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3",1p31.1,protein-coding,/
CWITA006230,TCMBANKGE006230,NR5A1,AD4BP; ELP; FTZ1; FTZF1; POF7; SFN1; SF1,"nuclear receptor subfamily 5, group A, member 1",9q33,protein-coding,
CWITA006231,TCMBANKGE006231,SLC15A2,FLJ33407; PEPT2,"solute carrier family 15 (H+/peptide transporter), member 2",3q13.33,protein-coding,
CWITA006232,TCMBANKGE006232,HSPB6,HEL55; Hsp20; PPP1R91,heat shock protein family B (small) member 6,19q13.12,protein-coding,/
CWITA006233,TCMBANKGE006233,UGT1A9,HLUGP4; LUGP4; UDPGT; UDPGT 1-9; UGT-1I; UGT1-09; UGT1-9; UGT1.9; UGT1A9S; UGT1AI; UGT1I,UDP glucuronosyltransferase family 1 member A9,2q37.1,protein-coding,/
CWITA006234,TCMBANKGE006234,IGKV1-27,A20; IGKV127,immunoglobulin kappa variable 1-27,2p11.2,other,/
CWITA006235,TCMBANKGE006235,SUCLA2,ANBETA; MTDPS5; SCSNbetaA,"succinate-CoA ligase, ADP-forming, beta subunit",13q12.2-q13.3,protein-coding,
CWITA006236,TCMBANKGE006236,E2F2,E2F-2,E2F transcription factor 2,1p36.12,protein-coding,Research target
CWITA006237,TCMBANKGE006237,PLBD2,P76,phospholipase B domain containing 2,12q24.13,protein-coding,/
CWITA006238,TCMBANKGE006238,PPP3CA,ACCIID; CALN; CALNA; CALNA1; CCN1; CNA1; IECEE; IECEE1; PPP2B,protein phosphatase 3 catalytic subunit alpha,4q24,protein-coding,Successful target
CWITA006239,TCMBANKGE006239,BLVRA,BLVR; BVR; BVRA,biliverdin reductase A,7p13,protein-coding,Successful target
CWITA006240,TCMBANKGE006240,ZNF552,-,zinc finger protein 552,19q13.43,protein-coding,/
CWITA006241,TCMBANKGE006241,NSUN3,MST077; MSTP077,NOP2/Sun RNA methyltransferase 3,3q11.2,protein-coding,/
CWITA006242,TCMBANKGE006242,CD200R1,CD200R; HCRTR2; MOX2R; OX2R,CD200 receptor 1,3q13.2,protein-coding,/
CWITA006243,TCMBANKGE006243,DDR1,CAK; CD167; DDR; EDDR1; HGK2; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE,discoidin domain receptor tyrosine kinase 1,6p21.3,protein-coding,
CWITA006244,TCMBANKGE006244,CDK2,p33(CDK2),cyclin-dependent kinase 2,12q13,protein-coding,
CWITA006245,TCMBANKGE006245,FUBP1,FBP; FUBP,far upstream element (FUSE) binding protein 1,1p31.1,protein-coding,
CWITA006246,TCMBANKGE006246,FGF1,AFGF; ECGF; ECGFNbeta; ECGFA; ECGFB; FGFNalpha; FGFA; GLIO703; HBGF1,fibroblast growth factor 1 (acidic),5q31,protein-coding,
CWITA006247,TCMBANKGE006247,VDAC3,HDNVDAC3,voltage-dependent anion channel 3,8p11.2,protein-coding,
CWITA006248,TCMBANKGE006248,FCER2,BLAST-2; CD23; CD23A; CLEC4J; FCE2; IGEBF,Fc fragment of IgE receptor II,19p13.2,protein-coding,Clinical Trial target
CWITA006249,TCMBANKGE006249,MTCH2,HSPC032; MIMP; SLC25A50,mitochondrial carrier 2,11p11.2,protein-coding,/
CWITA006250,TCMBANKGE006250,ISLR2,LINX,immunoglobulin superfamily containing leucine rich repeat 2,15q24.1,protein-coding,/
CWITA006251,TCMBANKGE006251,ASPSCR1,ASPCR1; ASPL; ASPS; RCC17; TUG; UBXD9; UBXN9,"Aspscr1,_Ubx_Domain_Containing_Tether_For_Slc2A4",17q25.3,protein-coding,
CWITA006252,TCMBANKGE006252,N4BP3,LZTS4,NEDD4 binding protein 3,5q35.3,protein-coding,/
CWITA006253,TCMBANKGE006253,MOGAT2,DGAT2L5; DGAT2L5.; MGAT2; hDC5,monoacylglycerol O-acyltransferase 2,11q13.5,protein-coding,/
CWITA006254,TCMBANKGE006254,FRA10AC1,C10orf4; F26C11.1-like; FRA10A,FRA10A associated CGG repeat 1,10q23.33,protein-coding,/
CWITA006255,TCMBANKGE006255,SP1,-,Sp1 transcription factor,12q13.13,protein-coding,Clinical Trial target
CWITA006256,TCMBANKGE006256,P2RY14,BPR105; GPR105; P2Y14,purinergic receptor P2Y14,3q25.1,protein-coding,Research target
CWITA006257,TCMBANKGE006257,OSTM1,GIPN; GL; HSPC019; OPTB5,osteoclastogenesis associated transmembrane protein 1,6q21,protein-coding,/
CWITA006258,TCMBANKGE006258,PTP4A3,PRL-3; PRL-R; PRL3,protein tyrosine phosphatase 4A3,8q24.3,protein-coding,Research target
CWITA006259,TCMBANKGE006259,NBEA,BCL8B; LYST2,neurobeachin,13q13.3,protein-coding,/
CWITA006260,TCMBANKGE006260,WDR36,GLC1G; TA-WDRP; TAWDRP; UTP21,WD repeat domain 36,5q22.1,protein-coding,/
CWITA006261,TCMBANKGE006261,HDAC10,HD10,histone deacetylase 10,22q13.33,protein-coding,Patented target
CWITA006262,TCMBANKGE006262,CDH16,-,cadherin 16,16q22.1,protein-coding,/
CWITA006263,TCMBANKGE006263,FUOM,C10orf125; FUCU; FucM,fucose mutarotase,10q26.3,protein-coding,/
CWITA006264,TCMBANKGE006264,ISYNA1,INO1; INOS; IPS,inositol-3-phosphate synthase 1,19p13.11,protein-coding,
CWITA006265,TCMBANKGE006265,MYL10,MYLC2PL; PLRLC,myosin light chain 10,7q22.1,protein-coding,/
CWITA006266,TCMBANKGE006266,WDR83OS,ASTERIX; C19orf56; PTD008,WD repeat domain 83 opposite strand,19p13.13,protein-coding,/
CWITA006267,TCMBANKGE006267,CYP27B1,CP2B; CYP1; CYP1alpha; CYP27B; P450c1; PDDR; VDD1; VDDR; VDDRI; VDR,cytochrome P450 family 27 subfamily B member 1,12q14.1,protein-coding,/
CWITA006268,TCMBANKGE006268,DDX59,OFD5; ZNHIT5,DEAD-box helicase 59,1q32.1,protein-coding,/
CWITA006269,TCMBANKGE006269,FRMD4A,CCAFCA; FRMD4; bA295P9.4,FERM domain containing 4A,10p13,protein-coding,/
CWITA006270,TCMBANKGE006270,TRAF1,EBI6; MGC:10353,TNF receptor associated factor 1,9q33.2,protein-coding,/
CWITA006271,TCMBANKGE006271,TMED9,GMP25; HSGP25L2G; p24a2; p24alpha2; p25,transmembrane p24 trafficking protein 9,5q35.3,protein-coding,/
CWITA006272,TCMBANKGE006272,FMO3,FMOII; MGC34400; TMAU; dJ127D3.1,flavin containing monooxygenase 3,1q24.3,protein-coding,
CWITA006273,TCMBANKGE006273,CHKB,CHETK; CHKL; CK; CKB; CKEKB; EK; EKB,choline kinase beta,22q13.33,protein-coding,
CWITA006274,TCMBANKGE006274,CACNB1,CAB1; CACNLB1; CCHLB1; MGC41896,"calcium channel, voltage-dependent, beta 1 subunit",17q21-q22,protein-coding,
CWITA006275,TCMBANKGE006275,LMO1,RBTN1; RHOM1; TTG1,LIM domain only 1,11p15.4,protein-coding,/
CWITA006276,TCMBANKGE006276,ID3,HEIR-1; bHLHb25,"inhibitor of DNA binding 3, HLH protein",1p36.12,protein-coding,/
CWITA006277,TCMBANKGE006277,MARCKSL1,F52; MACMARCKS; MLP; MLP1; MRP,MARCKS like 1,1p35.1,protein-coding,/
CWITA006278,TCMBANKGE006278,PLAGL1,LOT1; ZAC; ZAC1,PLAG1 like zinc finger 1,6q24.2,protein-coding,/
CWITA006279,TCMBANKGE006279,HTR2A,5NHT2A; HTR2,5-hydroxytryptamine (serotonin) receptor 2A,13q14-q21,protein-coding,
CWITA006280,TCMBANKGE006280,RPIA,RPI,ribose 5-phosphate isomerase A,2p11.2,protein-coding,
CWITA006281,TCMBANKGE006281,ALG1L,ALG1L1,ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like,3q21.2,protein-coding,/
CWITA006282,TCMBANKGE006282,CAPN8,nCL-2,calpain 8,1q41,protein-coding,/
CWITA006283,TCMBANKGE006283,ING2,ING1L; p33ING2,inhibitor of growth family member 2,4q35.1,protein-coding,/
CWITA006284,TCMBANKGE006284,ZNF585B,SZFP41; Zfp27,zinc finger protein 585B,19q13.12,protein-coding,/
CWITA006285,TCMBANKGE006285,NARS,ASNRS; NARS1,asparaginyl-tRNA synthetase,18q21.31,protein-coding,
CWITA006286,TCMBANKGE006286,ELF5,ESE2,E74 like ETS transcription factor 5,11p13,protein-coding,/
CWITA006287,TCMBANKGE006287,PHF10,BAF45A; XAP135,PHD finger protein 10,6q27,protein-coding,/
CWITA006288,TCMBANKGE006288,GNG11,GNGT11,G protein subunit gamma 11,7q21.3,protein-coding,/
CWITA006289,TCMBANKGE006289,PTCHD1,AUTSX4,patched domain containing 1,Xp22.11,protein-coding,/
CWITA006290,TCMBANKGE006290,EGFLAM,AGRINL; AGRNL; PIKA,"EGF like, fibronectin type III and laminin G domains",5p13.2-p13.1,protein-coding,/
CWITA006291,TCMBANKGE006291,POLE,CRCS12; FILS; IMAGEI; POLE1,"DNA polymerase epsilon, catalytic subunit",12q24.33,protein-coding,/
CWITA006292,TCMBANKGE006292,CAMK2N1,PRO1489,calcium/calmodulin dependent protein kinase II inhibitor 1,1p36.12,protein-coding,/
CWITA006293,TCMBANKGE006293,CDK10,ALSAS; PISSLRE,cyclin dependent kinase 10,16q24.3,protein-coding,/
CWITA006294,TCMBANKGE006294,NUP153,HNUP153; N153,nucleoporin 153,6p22.3,protein-coding,/
CWITA006295,TCMBANKGE006295,SLC47A2,MATE2; MATE2-B; MATE2-K; MATE2K,solute carrier family 47 member 2,17p11.2,protein-coding,Research target
CWITA006296,TCMBANKGE006296,ADAM19,FKSG34; MADDAM; MLTNB,ADAM metallopeptidase domain 19,5q33.3,protein-coding,/
CWITA006297,TCMBANKGE006297,HLA-DPA1,DP(W3); DP(W4); DPA1; HLA-DP1A; HLA-DPB1; HLADP; HLASB; PLT1,"major histocompatibility complex, class II, DP alpha 1",6p21.32,protein-coding,/
CWITA006298,TCMBANKGE006298,CNR1,CANN6; CBNR; CB1; CB1A; CB1K5; CB1R; CNR,cannabinoid receptor 1 (brain),6q14-q15,protein-coding,
CWITA006299,TCMBANKGE006299,CHDH,N,choline dehydrogenase,3p21.1,protein-coding,
CWITA006300,TCMBANKGE006300,UCKL1,UCK1L; URKL1,uridine-cytidine kinase 1 like 1,20q13.33,protein-coding,/
CWITA006301,TCMBANKGE006301,MYSM1,2A-DUB; 2ADUB; BMFS4,"Myb like, SWIRM and MPN domains 1",1p32.1,protein-coding,/
CWITA006302,TCMBANKGE006302,SPARCL1,MAST 9; MAST9; PIG33; SC1,SPARC like 1,4q22.1,protein-coding,/
CWITA006303,TCMBANKGE006303,MAGEH1,APR-1; APR1; MAGEH,MAGE family member H1,Xp11.21,protein-coding,/
CWITA006304,TCMBANKGE006304,FAM114A1,Noxp20,family with sequence similarity 114 member A1,4p14,protein-coding,/
CWITA006305,TCMBANKGE006305,SLC35E3,BLOV1,solute carrier family 35 member E3,12q15,protein-coding,/
CWITA006306,TCMBANKGE006306,C11orf54,PTD012; PTOD012,chromosome 11 open reading frame 54,11q21,protein-coding,/
CWITA006307,TCMBANKGE006307,Trp53,Tp53; bbl; bfy; bhy; p44; p53,transformation related protein 53,11 B3|11 42.83 cM,protein-coding,/
CWITA006308,TCMBANKGE006308,IMMTP1,IMMTP,inner membrane mitochondrial protein pseudogene 1,21q22.3,pseudo,/
CWITA006309,TCMBANKGE006309,KCNMB1,BKbeta1; K(VCA)beta; SLO-BETA; hbeta1; hslo-beta; k(VCA)beta-1; slo-beta-1,potassium calcium-activated channel subfamily M regulatory beta subunit 1,5q35.1,protein-coding,/
CWITA006310,TCMBANKGE006310,RAPGEF5,GFR; MR-GEF; REPAC,Rap guanine nucleotide exchange factor 5,7p15.3,protein-coding,/
CWITA006311,TCMBANKGE006311,GARS,CMT2D; DSMAV; GlyRS; HMN5; SMAD1,glycyl-tRNA synthetase,7p15,protein-coding,
CWITA006312,TCMBANKGE006312,HOOK2,HK2,hook microtubule tethering protein 2,19p13.13,protein-coding,/
CWITA006313,TCMBANKGE006313,ULBP3,N2DL-3; NKG2DL3; RAET1N,UL16 binding protein 3,6q25.1,protein-coding,/
CWITA006314,TCMBANKGE006314,ENPEP,APA; CD249; gp160,glutamyl aminopeptidase (aminopeptidase A),4q25,protein-coding,
CWITA006315,TCMBANKGE006315,CRIP2,CRIP; CRP2; ESP1,cysteine rich protein 2,14q32.33,protein-coding,/
CWITA006316,TCMBANKGE006316,PRR15L,ATAD4,proline rich 15 like,17q21.32,protein-coding,/
CWITA006317,TCMBANKGE006317,KIF11,EG5; HKSP; KNSL1; MCLMR; TRIP5,kinesin family member 11,10q23.33,protein-coding,Clinical Trial target
CWITA006318,TCMBANKGE006318,GORAB,GO; NTKLBP1; SCYL1BP1,"golgin, RAB6 interacting",1q24.2,protein-coding,/
CWITA006319,TCMBANKGE006319,TTPAL,C20orf121,alpha tocopherol transfer protein like,20q13.12,protein-coding,/
CWITA006320,TCMBANKGE006320,IGFBP4,BP-4; HT29-IGFBP; IBP4; IGFBP-4,insulin like growth factor binding protein 4,17q21.2,protein-coding,/
CWITA006321,TCMBANKGE006321,RARB,HAP; NR1B2; RRB2,"retinoic acid receptor, beta",3p24,protein-coding,
CWITA006322,TCMBANKGE006322,ELMOD2,9830169G11Rik,ELMO domain containing 2,4q31.1,protein-coding,/
CWITA006323,TCMBANKGE006323,SBSN,UNQ698,suprabasin,19q13.12,protein-coding,/
CWITA006324,TCMBANKGE006324,LGALS9,HUAT; LGALS9A; MGC117375; MGC125973; MGC125974,"lectin, galactoside-binding, soluble, 9",17q11.2,protein-coding,
CWITA006325,TCMBANKGE006325,ANGPTL3,ANG-5; ANGPT5; ANL3; FHBL2,angiopoietin like 3,1p31.3,protein-coding,Clinical Trial target
CWITA006326,TCMBANKGE006326,LIG1,MGC117397; MGC130025,"ligase I, DNA, ATP-dependent",19q13.2-q13.3,protein-coding,
CWITA006327,TCMBANKGE006327,MPHOSPH9,MPP-9; MPP9,M-phase phosphoprotein 9,12q24.31,protein-coding,/
CWITA006328,TCMBANKGE006328,CBX6,-,chromobox 6,22q13.1,protein-coding,/
CWITA006329,TCMBANKGE006329,FUT9,Fuc-TIX,fucosyltransferase 9,6q16.1,protein-coding,/
CWITA006330,TCMBANKGE006330,ACTR1B,ARP1B; CTRN2; PC3,actin related protein 1B,2q11.2,protein-coding,/
CWITA006331,TCMBANKGE006331,GAD2,GAD65; MGC161605; MGC161607,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",10p11.23,protein-coding,
CWITA006332,TCMBANKGE006332,PRKAG1,AMPKG,protein kinase AMP-activated non-catalytic subunit gamma 1,12q13.12,protein-coding,/
CWITA006333,TCMBANKGE006333,CA5A,CA5; CA5AD; CAV; CAVA; GS1-21A4.1,carbonic anhydrase 5A,16q24.2,protein-coding,/
CWITA006334,TCMBANKGE006334,GPATCH4,GPATC4,G-patch domain containing 4,1q22-q23.1,protein-coding,/
CWITA006335,TCMBANKGE006335,HMOX1,HON1; HSP32; bK286B10,heme oxygenase (decycling) 1,22q12|22q13.1,protein-coding,
CWITA006336,TCMBANKGE006336,OR52N5,OR11-62; OR52N5Q,olfactory receptor family 52 subfamily N member 5,11p15.4,protein-coding,/
CWITA006337,TCMBANKGE006337,GRK1,GPRK1; RHOK; RK,G protein-coupled receptor kinase 1,13q34,protein-coding,/
CWITA006338,TCMBANKGE006338,CLPS,-,colipase,6p21.31,protein-coding,/
CWITA006339,TCMBANKGE006339,CA2,CA-II; CAC; CAII; Car2; HEL-76; HEL-S-282,carbonic anhydrase 2,8q21.2,protein-coding,Successful target
CWITA006340,TCMBANKGE006340,ENTPD6,CD39L2; IL-6SAG; IL6ST2; NTPDase-6; dJ738P15.3,ectonucleoside triphosphate diphosphohydrolase 6,20p11.21,protein-coding,/
CWITA006341,TCMBANKGE006341,RIF1,-,replication timing regulatory factor 1,2q23.3,protein-coding,/
CWITA006342,TCMBANKGE006342,YLPM1,C14orf170; PPP1R169; ZAP113; ZAP3,YLP motif containing 1,14q24.3,protein-coding,/
CWITA006343,TCMBANKGE006343,GALM,BLOCK25; GALAC4; GLAT; HEL-S-63p; IBD1,galactose mutarotase,2p22.1,protein-coding,/
CWITA006344,TCMBANKGE006344,ADAMTS13,ADAM-TS13; ADAMTS-13; C9orf8; VWFCP; vWF-CP,ADAM metallopeptidase with thrombospondin type 1 motif 13,9q34.2,protein-coding,/
CWITA006345,TCMBANKGE006345,GREM1,C15DUPq; CKTSF1B1; CRAC1; CRCS4; DAND2; DRM; DUP15q; GREMLIN; HMPS; HMPS1; IHG-2; MPSH; PIG2,"gremlin 1, DAN family BMP antagonist",15q13.3,protein-coding,Patented target
CWITA006346,TCMBANKGE006346,CYB5R2,B5R.2,cytochrome b5 reductase 2,11p15.4,protein-coding,/
CWITA006347,TCMBANKGE006347,AP1B1,ADTB1; AP105A; BAM22; CLAPB2; KIDAR,adaptor related protein complex 1 subunit beta 1,22q12.2,protein-coding,/
CWITA006348,TCMBANKGE006348,PPP1R15A,GADD34,protein phosphatase 1 regulatory subunit 15A,19q13.33,protein-coding,/
CWITA006349,TCMBANKGE006349,NDUFB2,AGGG; CINAGGG; MGC70788,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa",7q34,protein-coding,
CWITA006350,TCMBANKGE006350,PCDH11Y,PCDH-PC; PCDH22; PCDHX; PCDHY,protocadherin 11 Y-linked,Yp11.2,protein-coding,/
CWITA006351,TCMBANKGE006351,TLN1,ILWEQ; TLN; talin-1,talin 1,9p13.3,protein-coding,Research target
CWITA006352,TCMBANKGE006352,PROC,APC; PC; PROC1; THPH3; THPH4,"protein C, inactivator of coagulation factors Va and VIIIa",2q14.3,protein-coding,Successful target
CWITA006353,TCMBANKGE006353,RRP12,KIAA0690,ribosomal RNA processing 12 homolog,10q24.1,protein-coding,/
CWITA006354,TCMBANKGE006354,PRSS8,CAP1; PROSTASIN,serine protease 8,16p11.2,protein-coding,Research target
CWITA006355,TCMBANKGE006355,RACK1,GNB2L1; Gnb2-rs1; H12.3; HLC-7; PIG21,receptor for activated C kinase 1,5q35.3,protein-coding,Research target
CWITA006356,TCMBANKGE006356,PM20D1,Cps1,peptidase M20 domain containing 1,1q32.1,protein-coding,/
CWITA006357,TCMBANKGE006357,FEN1,FEN-1; MF1; RAD2,flap structure-specific endonuclease 1,11q12.2,protein-coding,/
CWITA006358,TCMBANKGE006358,CASKIN1,ANKS5A,CASK interacting protein 1,16p13.3,protein-coding,/
CWITA006359,TCMBANKGE006359,SLC45A1,DNB5; IDDNPF; PAST-A,solute carrier family 45 member 1,1p36.23,protein-coding,/
CWITA006360,TCMBANKGE006360,RABGGTA,PTAR3,"Rab geranylgeranyltransferase, alpha subunit",14q11.2,protein-coding,
CWITA006361,TCMBANKGE006361,PATZ1,MAZR; PATZ; RIAZ; ZBTB19; ZNF278; ZSG; dJ400N23,POZ/BTB and AT hook containing zinc finger 1,22q12.2,protein-coding,/
CWITA006362,TCMBANKGE006362,DUSP23,DUSP25; LDP-3; LDP3; MOSP; VHZ,dual specificity phosphatase 23,1q23.2,protein-coding,/
CWITA006363,TCMBANKGE006363,TRIM16L,TRIM70,tripartite motif containing 16 like,17p11.2,protein-coding,/
CWITA006364,TCMBANKGE006364,SLC6A1,GABATHG; GABATR; GAT1; MAE,solute carrier family 6 member 1,3p25.3,protein-coding,Successful target
CWITA006365,TCMBANKGE006365,TYW5,C2orf60; hTYW5,tRNA-yW synthesizing protein 5,2q33.1,protein-coding,/
CWITA006366,TCMBANKGE006366,FABP3,FABP11; HNFABP; MDGI; ONFABP,"fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)",1p33-p32,protein-coding,
CWITA006367,TCMBANKGE006367,SHC2,SCK; SHCB; SLI,SHC adaptor protein 2,19p13.3,protein-coding,/
CWITA006368,TCMBANKGE006368,UGT1A1,BILIQTL1; GNT1; HUG-BR1; UDPGT; UDPGT 1-1; UGT1; UGT1A,UDP glucuronosyltransferase family 1 member A1,2q37.1,protein-coding,/
CWITA006369,TCMBANKGE006369,RASIP1,RAIN,Ras interacting protein 1,19q13.33,protein-coding,/
CWITA006370,TCMBANKGE006370,ZNF98,F7175; ZNF739,zinc finger protein 98,19p12,protein-coding,/
CWITA006371,TCMBANKGE006371,TREH,TRE; TREA; TREHD,trehalase,11q23.3,protein-coding,/
CWITA006372,TCMBANKGE006372,SLC27A6,ACSVL2; FACVL2; FATP6; VLCS-H1,solute carrier family 27 member 6,5q23.3,protein-coding,/
CWITA006373,TCMBANKGE006373,TYW1,RSAFD1; TYW1A; YPL207W,tRNA-yW synthesizing protein 1 homolog,7q11.21,protein-coding,/
CWITA006374,TCMBANKGE006374,RARRES2,HP10433; TIG2,retinoic acid receptor responder 2,7q36.1,protein-coding,/
CWITA006375,TCMBANKGE006375,SLCO1B3,HBLRR; LST-2; LST-3TM13; LST3; OATP-8; OATP1B3; OATP8; SLC21A8,solute carrier organic anion transporter family member 1B3,12p12.2,protein-coding,Research target
CWITA006376,TCMBANKGE006376,ZMYM4,CDIR; MYM; ZNF198L3; ZNF262,zinc finger MYM-type containing 4,1p34.3,protein-coding,/
CWITA006377,TCMBANKGE006377,PAGR1,C16orf53; GAS; PA1,PAXIP1 associated glutamate rich protein 1,16p11.2,protein-coding,/
CWITA006378,TCMBANKGE006378,TENM2,ODZ2; TEN-M2; TEN2; TNM2; ten-2,teneurin transmembrane protein 2,5q34,protein-coding,/
CWITA006379,TCMBANKGE006379,RNF32,FKSG33; HSD15; LMBR2,ring finger protein 32,7q36.3,protein-coding,/
CWITA006380,TCMBANKGE006380,Tlr12,Gm1365; Tlr11,toll-like receptor 12,4|4 D2.2,protein-coding,/
CWITA006381,TCMBANKGE006381,STOML1,SLP-1; STORP; hUNC-24,stomatin like 1,15q24.1,protein-coding,/
CWITA006382,TCMBANKGE006382,DYDC2,-,DPY30 domain containing 2,10q23.1,protein-coding,/
CWITA006383,TCMBANKGE006383,PHF7,HSPC045; HSPC226; NYD-SP6,PHD finger protein 7,3p21.1,protein-coding,/
CWITA006384,TCMBANKGE006384,TAC3,HH10; LncZBTB39; NK3; NKB; NKNB; PRO1155; ZNEUROK1,tachykinin precursor 3,12q13.3,protein-coding,/
CWITA006385,TCMBANKGE006385,METTL18,AsTP2; C1orf156; HPM1,methyltransferase like 18,1q24.2,protein-coding,/
CWITA006386,TCMBANKGE006386,TMEM241,C18orf45; hVVT,transmembrane protein 241,18q11.2,protein-coding,/
CWITA006387,TCMBANKGE006387,SLC35D2,HFRC1; SQV7L; UGTrel8; hfrc,solute carrier family 35 member D2,9q22.32,protein-coding,/
CWITA006388,TCMBANKGE006388,EBF3,COE3; EBF-3; HADDS; O/E-2; OE-2,EBF transcription factor 3,10q26.3,protein-coding,/
CWITA006389,TCMBANKGE006389,BCORL1,BCoR-L1; CXorf10; SHUVER,BCL6 corepressor like 1,Xq26.1,protein-coding,/
CWITA006390,TCMBANKGE006390,SUV39H2,KMT1B,suppressor of variegation 3-9 homolog 2,10p13,protein-coding,/
CWITA006391,TCMBANKGE006391,NCR1,CD335; LY94; NK-p46; NKP46,natural cytotoxicity triggering receptor 1,19q13.42,protein-coding,Research target
CWITA006392,TCMBANKGE006392,TMEM126A,OPA7,transmembrane protein 126A,11q14.1,protein-coding,/
CWITA006393,TCMBANKGE006393,IVD,ACAD2; FLJ12715; FLJ34849,isovaleryl-CoA dehydrogenase,15q14-q15,protein-coding,
CWITA006394,TCMBANKGE006394,UGT1A7,GNT1; UDPGT; UDPGT 1-7; UGT-1A; UGT-1G; UGT1; UGT1-01; UGT1-07; UGT1.1; UGT1.7; UGT1A; UGT1A1; UGT1G; hUG-BR1,UDP glucuronosyltransferase family 1 member A7,2q37.1,protein-coding,/
CWITA006395,TCMBANKGE006395,TMX1,PDIA11; TMX; TXNDC; TXNDC1,thioredoxin related transmembrane protein 1,14q22.1,protein-coding,/
CWITA006396,TCMBANKGE006396,RGS11,RS11,regulator of G protein signaling 11,16p13.3,protein-coding,/
CWITA006397,TCMBANKGE006397,PSPC1,PSP1,paraspeckle component 1,13q12.11,protein-coding,/
CWITA006398,TCMBANKGE006398,RBBP5,RBQ3; SWD1,"RB binding protein 5, histone lysine methyltransferase complex subunit",1q32.1,protein-coding,/
CWITA006399,TCMBANKGE006399,ARPP21,ARPP-21; R3HDM3; RCS; TARPP,cAMP regulated phosphoprotein 21,3p22.3,protein-coding,/
CWITA006400,TCMBANKGE006400,PLG,-,plasminogen,6q26,protein-coding,Successful target
CWITA006401,TCMBANKGE006401,ATP6V1A,ARCL2D; ATP6A1; ATP6V1A1; HO68; IECEE3; VA68; VPP2; Vma1,ATPase H+ transporting V1 subunit A,3q13.31,protein-coding,Research target
CWITA006402,TCMBANKGE006402,NUBP1,CIAO5; NBP; NBP1; NBP35,nucleotide binding protein 1,16p13.13,protein-coding,/
CWITA006403,TCMBANKGE006403,KPNA4,IPOA3; QIP1; SRP3,karyopherin subunit alpha 4,3q25.33,protein-coding,/
CWITA006404,TCMBANKGE006404,UGT1A6,GNT1; HLUGP; HLUGP1; UDPGT; UDPGT 1-6; UGT-1A; UGT-1C; UGT-1E; UGT1; UGT1-01; UGT1-03; UGT1-05; UGT1.1; UGT1.3; UGT1.5; UGT1A; UGT1A1; UGT1A3; UGT1A5; UGT1A6S; UGT1C; UGT1E; UGT1F; hUG-BR1,UDP glucuronosyltransferase family 1 member A6,2q37.1,protein-coding,/
CWITA006405,TCMBANKGE006405,CCL11,SCYA11,C-C motif chemokine ligand 11,17q12,protein-coding,Clinical Trial target
CWITA006406,TCMBANKGE006406,INSL5,PRO182; UNQ156,insulin like 5,1p31.3,protein-coding,/
CWITA006407,TCMBANKGE006407,FLT1,FLT; VEGFR1,fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor),13q12,protein-coding,
CWITA006408,TCMBANKGE006408,SERPINA6,CBG,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6",14q32.1,protein-coding,
CWITA006409,TCMBANKGE006409,AGO2,CASC7; EIF2C2; LINC00980; PPD; Q10,argonaute RISC catalytic component 2,8q24.3,protein-coding,/
CWITA006410,TCMBANKGE006410,ACAT2,-,acetyl-CoA acetyltransferase 2,6q25.3,protein-coding,/
CWITA006411,TCMBANKGE006411,SRGAP1,ARHGAP13; NMTC2,SLIT-ROBO Rho GTPase activating protein 1,12q14.2,protein-coding,/
CWITA006412,TCMBANKGE006412,EEF2,EEFN2; EF2,eukaryotic translation elongation factor 2,19pter-q12,protein-coding,
CWITA006413,TCMBANKGE006413,ALPP,ALP; FLJ61142; PALP; PLAP,"alkaline phosphatase, placental",2q37,protein-coding,
CWITA006414,TCMBANKGE006414,NDUFB9,B22; DKFZp566O173; FLJ22885; LYRM3; UQOR22,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa",8q13.3,protein-coding,
CWITA006415,TCMBANKGE006415,ELOVL2,SSC2,ELOVL fatty acid elongase 2,6p24.2,protein-coding,/
CWITA006416,TCMBANKGE006416,PODNL1,SLRR5B,podocan like 1,19p13.12,protein-coding,/
CWITA006417,TCMBANKGE006417,DLX4,BP1; DLX7; DLX8; DLX9; OFC15,distal-less homeobox 4,17q21.33,protein-coding,/
CWITA006418,TCMBANKGE006418,SLC25A12,AGC1; ARALAR,"solute carrier family 25 (mitochondrial carrier, Aralar), member 12",2q24,protein-coding,
CWITA006419,TCMBANKGE006419,SGK2,H-SGK2; dJ138B7.2,serum/glucocorticoid regulated kinase 2,20q13.12,protein-coding,/
CWITA006420,TCMBANKGE006420,CACNG2,FLJ41437; MGC138502; MGC138504,"calcium channel, voltage-dependent, gamma subunit 2",22q13.1,protein-coding,
CWITA006421,TCMBANKGE006421,LEMD2,CTRCT42; LEM2; NET25; dJ482C21.1,LEM domain nuclear envelope protein 2,6p21.31,protein-coding,/
CWITA006422,TCMBANKGE006422,SGMS2,CDL; SMS2,sphingomyelin synthase 2,4q25,protein-coding,/
CWITA006423,TCMBANKGE006423,MAN1B1,ERMan1; MANANER,"mannosidase, alpha, class 1B, member 1",9q34,protein-coding,
CWITA006424,TCMBANKGE006424,SGSH,HSS; MPS3A; SFMD,N-sulfoglucosamine sulfohydrolase,17q25.3,protein-coding,Clinical Trial target
CWITA006425,TCMBANKGE006425,SLC26A4,DFNB4; EVA; PDS; TDH2B,solute carrier family 26 member 4,7q22.3,protein-coding,Research target
CWITA006426,TCMBANKGE006426,SULT1A3,HAST; HAST3; MNPST; MGC117469; ST1A3/ST1A4; ST1A5; STM; TLNPST,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3",16p11.2,protein-coding,
CWITA006427,TCMBANKGE006427,FBXO3,FBA; FBX3,F-box protein 3,11p13,protein-coding,/
CWITA006428,TCMBANKGE006428,TRIM64C,-,tripartite motif containing 64C,11p11.12,protein-coding,/
CWITA006429,TCMBANKGE006429,MRTO4,C1orf33; MRT4; dJ657E11.4,"MRT4 homolog, ribosome maturation factor",1p36.13,protein-coding,/
CWITA006430,TCMBANKGE006430,RRAGA,FIP-1; FIP1; RAGA,Ras related GTP binding A,9p22.1,protein-coding,/
CWITA006431,TCMBANKGE006431,ZNF66,ZNF66P,zinc finger protein 66,19p12,protein-coding,/
CWITA006432,TCMBANKGE006432,ABAT,FLJ17813; FLJ30272; GABANAT; GABAT; NPD009,4-aminobutyrate aminotransferase,16p13.2,protein-coding,
CWITA006433,TCMBANKGE006433,LRRTM3,-,leucine rich repeat transmembrane neuronal 3,10q21.3,protein-coding,/
CWITA006434,TCMBANKGE006434,GBX2,-,gastrulation brain homeobox 2,2q37.2,protein-coding,/
CWITA006435,TCMBANKGE006435,H2BC4,H2B.1; H2B/l; H2BC10; H2BC6; H2BC7; H2BC8; H2BFL; HIST1H2BC; dJ221C16.3,H2B clustered histone 4,6p22.2,protein-coding,/
CWITA006436,TCMBANKGE006436,PHF21A,BHC80; BM-006; IDDBCS; NEDMS,PHD finger protein 21A,11p11.2,protein-coding,/
CWITA006437,TCMBANKGE006437,SLC25A36,PNC2,solute carrier family 25 member 36,3q23,protein-coding,/
CWITA006438,TCMBANKGE006438,PCSK1,BMIQ12; NEC1; PC1; PC3; SPC3,proprotein convertase subtilisin/kexin type 1,5q15,protein-coding,Research target
CWITA006439,TCMBANKGE006439,CABP7,CALN2,calcium binding protein 7,22q12.2,protein-coding,/
CWITA006440,TCMBANKGE006440,CCNE2,CYCE2,cyclin E2,8q22.1,protein-coding,Research target
CWITA006441,TCMBANKGE006441,KCNC2,KV3.2,potassium voltage-gated channel subfamily C member 2,12q21.1,protein-coding,Research target
CWITA006442,TCMBANKGE006442,MT1G,MT1; MT1K,metallothionein 1G,16q13,protein-coding,/
CWITA006443,TCMBANKGE006443,PLAAT4,HRASLS4; HRSL4; PLA1/2-3; PLAAT-4; RARRES3; RIG1; TIG3,phospholipase A and acyltransferase 4,11q12.3,protein-coding,/
CWITA006444,TCMBANKGE006444,NAGK,GNK; HSA242910,N-acetylglucosamine kinase,2p13.3,protein-coding,/
CWITA006445,TCMBANKGE006445,NPHP3,CFAP31; MKS7; NPH3; RHPD; RHPD1; SLSN3,nephrocystin 3,3q22.1,protein-coding,/
CWITA006446,TCMBANKGE006446,PCDHGB6,PCDH-GAMMA-B6,"protocadherin gamma subfamily B, 6",5q31.3,protein-coding,/
CWITA006447,TCMBANKGE006447,LIPJ,LIPL1; bA425M17.2,lipase family member J,10q23.31,protein-coding,/
CWITA006448,TCMBANKGE006448,HS1BP3,ETM2; HS1-BP3,HCLS1 binding protein 3,2p24.1,protein-coding,/
CWITA006449,TCMBANKGE006449,HDAC2,HD2; RPD3; YAF1,histone deacetylase 2,6q21,protein-coding,
CWITA006450,TCMBANKGE006450,ARMC8,GID5; HSPC056; S863-2; VID28,armadillo repeat containing 8,3q22.3,protein-coding,/
CWITA006451,TCMBANKGE006451,GRK4,GPRK2L; GPRK4; GRK4a; IT11,G protein-coupled receptor kinase 4,4p16.3,protein-coding,/
CWITA006452,TCMBANKGE006452,DNPEP,ASPEP; DAP,aspartyl aminopeptidase,2q35,protein-coding,Clinical Trial target
CWITA006453,TCMBANKGE006453,LGALS4,GAL4; L36LBP,galectin 4,19q13.2,protein-coding,/
CWITA006454,TCMBANKGE006454,PKLR,PK1; PKL; PKRL; RPK,pyruvate kinase L/R,1q22,protein-coding,/
CWITA006455,TCMBANKGE006455,HDAC1,DKFZp686H12203; GONN10; HD1; RPD3; RPD3L1,histone deacetylase 1,1p34,protein-coding,
CWITA006456,TCMBANKGE006456,EPB41L4A,EPB41L4; NBL4,erythrocyte membrane protein band 4.1 like 4A,5q22.1-q22.2,protein-coding,/
CWITA006457,TCMBANKGE006457,SLC7A9,BAT1; CSNU3; FLJ94301,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 9",19q13.1,protein-coding,
CWITA006458,TCMBANKGE006458,SEC61A2,-,SEC61 translocon subunit alpha 2,10p14,protein-coding,/
CWITA006459,TCMBANKGE006459,GPR135,HUMNPIIY20,G protein-coupled receptor 135,14q23.1,protein-coding,/
CWITA006460,TCMBANKGE006460,NPL,C112; C1orf13; NAL; NPL1,N-acetylneuraminate pyruvate lyase,1q25.3,protein-coding,/
CWITA006461,TCMBANKGE006461,CUX1,CASP; CDP; CDP/Cut; CDP1; COY1; CUTL1; CUX; Clox; Cux/CDP; GDDI; GOLIM6; Nbla10317; p100; p110; p200; p75,cut like homeobox 1,7q22.1,protein-coding,/
CWITA006462,TCMBANKGE006462,ANO4,TMEM16D,anoctamin 4,12q23.1,protein-coding,/
CWITA006463,TCMBANKGE006463,PLPP3,Dri42; LPP3; PAP2B; PPAP2B; VCIP,phospholipid phosphatase 3,1p32.2,protein-coding,/
CWITA006464,TCMBANKGE006464,HTR1A,5NHT1A; 5HT1a; ADRB2RL1; ADRBRL1,5-hydroxytryptamine (serotonin) receptor 1A,5q11.2-q13,protein-coding,
CWITA006465,TCMBANKGE006465,SLC9A3R1,EBP50; NHERF; NHERF-1; NHERF1; NPHLOP2,SLC9A3 regulator 1,17q25.1,protein-coding,/
CWITA006466,TCMBANKGE006466,GRIN2D,EB11; EIEE46; GluN2D; NMDAR2D; NR2D,glutamate ionotropic receptor NMDA type subunit 2D,19q13.33,protein-coding,Research target
CWITA006467,TCMBANKGE006467,CES4A,CES6; CES8,carboxylesterase 4A,16q22.1,protein-coding,/
CWITA006468,TCMBANKGE006468,SMPD4,FLJ20297; FLJ20756; KIAA1418; NET13; NSMASEN3; NSMASE3,"sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3)",2q21.1,protein-coding,
CWITA006469,TCMBANKGE006469,ZFHX4,ZFH4; ZHF4,zinc finger homeobox 4,8q21.13,protein-coding,/
CWITA006470,TCMBANKGE006470,MPL,C-MPL; CD110; MPLV; THCYT2; THPOR; TPOR,"MPL proto-oncogene, thrombopoietin receptor",1p34.2,protein-coding,Successful target
CWITA006471,TCMBANKGE006471,GPR4,-,G protein-coupled receptor 4,19q13.32,protein-coding,/
CWITA006472,TCMBANKGE006472,WFIKKN2,GASP-1; WFDC20B; WFIKKNRP; hGASP-1,"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2",17q21.33,protein-coding,/
CWITA006473,TCMBANKGE006473,CD1C,BDCA1; CD1; CD1A; R7,CD1c molecule,1q23.1,protein-coding,/
CWITA006474,TCMBANKGE006474,NAV3,POMFIL1; STEERIN3; unc53H3,neuron navigator 3,12q21.2,protein-coding,/
CWITA006475,TCMBANKGE006475,BTK,AGMX1; AT; ATK; BPK; IMD1; MGC126261; MGC126262; PSCTK1; XLA,Bruton agammaglobulinemia tyrosine kinase,Xq21.33-q22,protein-coding,
CWITA006476,TCMBANKGE006476,NPPA,ANF; ANP; ATFB6; ATRST2; CDD; CDD-ANF; CDP; PND,natriuretic peptide A,1p36.22,protein-coding,/
CWITA006477,TCMBANKGE006477,GRIN3B,GluN3B; NR3B,glutamate ionotropic receptor NMDA type subunit 3B,19p13.3,protein-coding,/
CWITA006478,TCMBANKGE006478,ZNF749,-,zinc finger protein 749,19q13.43,protein-coding,/
CWITA006479,TCMBANKGE006479,ENPP6,NPP6,ectonucleotide pyrophosphatase/phosphodiesterase 6,4q35.1,protein-coding,/
CWITA006480,TCMBANKGE006480,TNFAIP6,TSG-6; TSG6,TNF alpha induced protein 6,2q23.3,protein-coding,/
CWITA006481,TCMBANKGE006481,GPRC5A,GPCR5A; PEIG-1; RAI3; RAIG1; TIG1,G protein-coupled receptor class C group 5 member A,12p13.1,protein-coding,/
CWITA006482,TCMBANKGE006482,INTS3,C1orf193; C1orf60; INT3; SOSS-A; SOSSA,integrator complex subunit 3,1q21.3,protein-coding,/
CWITA006483,TCMBANKGE006483,PSMG4,C6orf86; PAC4; bA506K6.2,proteasome assembly chaperone 4,6p25.2,protein-coding,/
CWITA006484,TCMBANKGE006484,PRSS36,-,serine protease 36,16p11.2,protein-coding,/
CWITA006485,TCMBANKGE006485,S1PR5,EDG8; EdgN8; S1P5; SPPRN1; SPPRN2,sphingosine-1-phosphate receptor 5,19p13.2,protein-coding,
CWITA006486,TCMBANKGE006486,FFAR4,BMIQ10; GPR120; GPR129; GT01; O3FAR1; PGR4,free fatty acid receptor 4,10q23.33,protein-coding,Patented target
CWITA006487,TCMBANKGE006487,PCYOX1,PCL1,prenylcysteine oxidase 1,2p13.3,protein-coding,/
CWITA006488,TCMBANKGE006488,TAS2R5,T2R5,taste 2 receptor member 5,7q34,protein-coding,/
CWITA006489,TCMBANKGE006489,P2RY1,P2Y1; SARCC,purinergic receptor P2Y1,3q25.2,protein-coding,Research target
CWITA006490,TCMBANKGE006490,DCTN3,DCTN-22; DCTN22,dynactin subunit 3,9p13.3,protein-coding,/
CWITA006491,TCMBANKGE006491,NUP62CL,-,nucleoporin 62 C-terminal like,Xq22.3,protein-coding,/
CWITA006492,TCMBANKGE006492,IRF2BP2,CVID14,interferon regulatory factor 2 binding protein 2,1q42.3,protein-coding,/
CWITA006493,TCMBANKGE006493,ANLN,FSGS8; Scraps; scra,anillin actin binding protein,7p14.2,protein-coding,/
CWITA006494,TCMBANKGE006494,PRKCG,PKC-gamma; PKCC; PKCG; PKCI(3); PKCgamma; SCA14,protein kinase C gamma,19q13.42,protein-coding,Successful target
CWITA006495,TCMBANKGE006495,TCN2,D22S676; D22S750; II; TC; TC II; TC-2; TC2; TCII,transcobalamin 2,22q12.2,protein-coding,/
CWITA006496,TCMBANKGE006496,PPP1R16B,ANKRD4; TIMAP,protein phosphatase 1 regulatory subunit 16B,20q11.23,protein-coding,/
CWITA006497,TCMBANKGE006497,CTSB,APPS; CPSB,cathepsin B,8p22,protein-coding,
CWITA006498,TCMBANKGE006498,C11orf96,AG2,chromosome 11 open reading frame 96,11p11.2,protein-coding,/
CWITA006499,TCMBANKGE006499,ALOX5AP,FLAP,arachidonate 5-lipoxygenase activating protein,13q12.3,protein-coding,Discontinued target
CWITA006500,TCMBANKGE006500,PCMTD1,-,protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1,8q11.23,protein-coding,/
CWITA006501,TCMBANKGE006501,NUP58,NUP45; NUPL1; PRO2463,nucleoporin 58,13q12.13,protein-coding,/
CWITA006502,TCMBANKGE006502,CCNG1,CCNG,cyclin G1,5q34,protein-coding,/
CWITA006503,TCMBANKGE006503,POLA2,-,"DNA polymerase alpha 2, accessory subunit",11q13.1,protein-coding,/
CWITA006504,TCMBANKGE006504,ACVR1,ACTRI; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI,"activin A receptor, type I",2q23-q24,protein-coding,
CWITA006505,TCMBANKGE006505,ISCA2,HBLD1; ISA2; MMDS4; c14_5557,iron-sulfur cluster assembly 2,14q24.3,protein-coding,/
CWITA006506,TCMBANKGE006506,TOMM34,HTOM34P; TOM34; URCC3,translocase of outer mitochondrial membrane 34,20q13.12,protein-coding,/
CWITA006507,TCMBANKGE006507,ENC1,CCL28; ENC-1; KLHL35; KLHL37; NRPB; PIG10; TP53I10,ectodermal-neural cortex 1,5q13.3,protein-coding,/
CWITA006508,TCMBANKGE006508,CREBBP,CBP; KAT3A; RSTS,CREB binding protein,16p13.3,protein-coding,
CWITA006509,TCMBANKGE006509,CYP26B1,CYP26A2; P450RAI-2; P450RAI2; RHFCA,cytochrome P450 family 26 subfamily B member 1,2p13.2,protein-coding,/
CWITA006510,TCMBANKGE006510,MSX2,CRS2; FPP; HOX8; MSH; PFM; PFM1,msh homeobox 2,5q35.2,protein-coding,/
CWITA006511,TCMBANKGE006511,PTBP1,HNRNP-I; HNRNPI; HNRPI; PTB; PTB-1; PTB-T; PTB2; PTB3; PTB4; pPTB,polypyrimidine tract binding protein 1,19p13.3,protein-coding,Research target
CWITA006512,TCMBANKGE006512,GART,AIRS; GARS; GARTF; MGC47764; PAIS; PGFT; PRGS,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase",21q22.1|21q22.11,protein-coding,
CWITA006513,TCMBANKGE006513,RIOX2,JMJD10; MDIG; MINA; MINA53; NO52; ROX,ribosomal oxygenase 2,3q11.2,protein-coding,/
CWITA006514,TCMBANKGE006514,OSTF1,OSF; SH3P2; bA235O14.1,osteoclast stimulating factor 1,9q21.13,protein-coding,/
CWITA006515,TCMBANKGE006515,AEBP1,ACLP,AE binding protein 1,7p13,protein-coding,/
CWITA006516,TCMBANKGE006516,AIP,ARA9; FKBP16; FKBP37; PITA1; SMTPHN; XAP-2; XAP2,aryl hydrocarbon receptor interacting protein,11q13.2,protein-coding,/
CWITA006517,TCMBANKGE006517,SLC1A2,EAAT2; EIEE41; GLT-1; HBGT,solute carrier family 1 member 2,11p13,protein-coding,Research target
CWITA006518,TCMBANKGE006518,CTCFL,BORIS; CT27; CTCF-T; HMGB1L1; dJ579F20.2,CCCTC-binding factor like,20q13.31,protein-coding,Research target
CWITA006519,TCMBANKGE006519,FITM1,FIT1,fat storage inducing transmembrane protein 1,14q12,protein-coding,/
CWITA006520,TCMBANKGE006520,MPP2,DLG2,membrane palmitoylated protein 2,17q21.31,protein-coding,/
CWITA006521,TCMBANKGE006521,PTCH2,PTC2,patched 2,1p34.1,protein-coding,/
CWITA006522,TCMBANKGE006522,HLA-C,D6S204; HLA-JY3; HLAC; HLC-C; MHC; PSORS1,"major histocompatibility complex, class I, C",6p21.33,protein-coding,/
CWITA006523,TCMBANKGE006523,TAF1L,TAF(II)210; TAF2A2,TATA-box binding protein associated factor 1 like,9p21.1,protein-coding,/
CWITA006524,TCMBANKGE006524,DSG2,CDHF5; HDGC,desmoglein 2,18q12.1,protein-coding,/
CWITA006525,TCMBANKGE006525,CDC25A,CDC25A2,cell division cycle 25A,3p21.31,protein-coding,Research target
CWITA006526,TCMBANKGE006526,ASCL2,ASH2; HASH2; MASH2; bHLHa45,achaete-scute family bHLH transcription factor 2,11p15.5,protein-coding,/
CWITA006527,TCMBANKGE006527,BCAT2,BCAM; BCATM; BCT2; PP18,"branched chain amino-acid transaminase 2, mitochondrial",19q13,protein-coding,
CWITA006528,TCMBANKGE006528,MYCN,MODED; N-myc; NMYC; ODED; bHLHe37,"V-Myc Myelocytomatosis Viral Related Oncogene, Neuroblastoma Derived (Avian)",2p24.1,protein-coding,
CWITA006529,TCMBANKGE006529,INPP5E,CORS1; CPD4; JBTS1; MORMS; PPI5PIV; pharbin,inositol polyphosphate-5-phosphatase E,9q34.3,protein-coding,/
CWITA006530,TCMBANKGE006530,VTCN1,B7-H4; B7H4; B7S1; B7X; B7h.5; PRO1291; VCTN1,V-set domain containing T cell activation inhibitor 1,1p13.1-p12,protein-coding,Research target
CWITA006531,TCMBANKGE006531,RPS8,S8,ribosomal protein S8,1p34.1,protein-coding,/
CWITA006532,TCMBANKGE006532,CLPS,N,"colipase, pancreatic",6pter-p21.1,protein-coding,
CWITA006533,TCMBANKGE006533,TM4SF5,-,transmembrane 4 L six family member 5,17p13.2,protein-coding,/
CWITA006534,TCMBANKGE006534,DENND10,FAM45A,DENN domain containing 10,10q26.11,protein-coding,/
CWITA006535,TCMBANKGE006535,KCNV1,HNKA; KCNB3; KV2.3; KV8.1,potassium voltage-gated channel modifier subfamily V member 1,8q23.2,protein-coding,/
CWITA006536,TCMBANKGE006536,ECD,GCR2; HSGT1; SGT1,ecdysoneless cell cycle regulator,10q22.2,protein-coding,/
CWITA006537,TCMBANKGE006537,LNX1,LNX; MPDZ; PDZRN2,ligand of numb-protein X 1,4q12,protein-coding,/
CWITA006538,TCMBANKGE006538,CARD6,CINCIN1,caspase recruitment domain family member 6,5p13.1,protein-coding,/
CWITA006539,TCMBANKGE006539,SEMA3G,sem2,semaphorin 3G,3p21.1,protein-coding,/
CWITA006540,TCMBANKGE006540,ESRRA,ERR1; ERRa; ERRalpha; ESRL1; NR3B1,estrogen-related receptor alpha,11q13,protein-coding,
CWITA006541,TCMBANKGE006541,OXNAD1,-,oxidoreductase NAD binding domain containing 1,3p25.1-p24.3,protein-coding,/
CWITA006542,TCMBANKGE006542,Igf1it,Gm19894,"insulin-like growth factor 1, intronic transcript",10|10 43.7 cM,ncRNA,/
CWITA006543,TCMBANKGE006543,KIF13B,GAKIN,kinesin family member 13B,8p12,protein-coding,/
CWITA006544,TCMBANKGE006544,ALDH1L1,10NfTHF; DKFZp781N0997; FDH; FTHFD,"aldehyde dehydrogenase 1 family, member L1",3q21.3,protein-coding,
CWITA006545,TCMBANKGE006545,FCER1G,FCRG,"Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide",1q23,protein-coding,
CWITA006546,TCMBANKGE006546,SEC14L4,TAP3,SEC14 like lipid binding 4,22q12.2,protein-coding,/
CWITA006547,TCMBANKGE006547,CTSK,CTS02; CTSO; CTSO1; CTSO2; MGC23107; PKND; PYCD,cathepsin K,1q21,protein-coding,
CWITA006548,TCMBANKGE006548,COLEC12,CLP1; NSR2; SCARA4; SRCL,collectin subfamily member 12,18p11.32,protein-coding,/
CWITA006549,TCMBANKGE006549,CCDC159,-,coiled-coil domain containing 159,19p13.2,protein-coding,/
CWITA006550,TCMBANKGE006550,CD247,CD3-ZETA; CD3H; CD3Q; CD3Z; IMD25; T3Z; TCRZ,CD247 molecule,1q24.2,protein-coding,/
CWITA006551,TCMBANKGE006551,GLMN,FAP; FAP48; FAP68; FKBPAP; GLML; GVM; VMGLOM,"glomulin, FKBP associated protein",1p22.1,protein-coding,Research target
CWITA006552,TCMBANKGE006552,TPCN1,TPC1,two pore segment channel 1,12q24.13,protein-coding,Research target
CWITA006553,TCMBANKGE006553,PON1,ESA; MVCD5; PON,paraoxonase 1,7q21.3,protein-coding,Research target
CWITA006554,TCMBANKGE006554,RBP7,CRABP4; CRBP4; CRBPIV,retinol binding protein 7,1p36.22,protein-coding,/
CWITA006555,TCMBANKGE006555,APOLD1,VERGE,apolipoprotein L domain containing 1,12p13.1,protein-coding,/
CWITA006556,TCMBANKGE006556,PTH2R,PTHR2,parathyroid hormone 2 receptor,2q34,protein-coding,Clinical Trial target
CWITA006557,TCMBANKGE006557,RIPK4,ANKK2; ANKRD3; CHANDS; DIK; NKRD3; PKK; PPS2; RIP4,receptor interacting serine/threonine kinase 4,21q22.3,protein-coding,Research target
CWITA006558,TCMBANKGE006558,MINPP1,HIPER1; MINPP2; MIPP,multiple inositol-polyphosphate phosphatase 1,10q23.2,protein-coding,/
CWITA006559,TCMBANKGE006559,GYPA,CD235a; GPA; GPErik; GPSAT; HGpMiV; HGpMiXI; HGpSta(C); MN; MNS; PAS-2,glycophorin A (MNS blood group),4q31.21,protein-coding,/
CWITA006560,TCMBANKGE006560,VPS13B,CHS1; COH1,vacuolar protein sorting 13 homolog B,8q22.2,protein-coding,/
CWITA006561,TCMBANKGE006561,CRIM1,CRIM-1; S52,cysteine rich transmembrane BMP regulator 1,2p22.2,protein-coding,/
CWITA006562,TCMBANKGE006562,PDCD5,TFAR19,programmed cell death 5,19q13.11,protein-coding,/
CWITA006563,TCMBANKGE006563,COPE,epsilon-COP,COPI coat complex subunit epsilon,19p13.11,protein-coding,/
CWITA006564,TCMBANKGE006564,PSMB4,HN3; HsN3; PRAAS3; PROS-26; PROS26,proteasome 20S subunit beta 4,1q21.3,protein-coding,/
CWITA006565,TCMBANKGE006565,NPY,PYY4,neuropeptide Y,7p15.3,protein-coding,Research target
CWITA006566,TCMBANKGE006566,TAP1,ABC17; ABCB2; APT1; D6S114E; FLJ26666; FLJ41500; PSF1; RING4; TAP1; 0102N; TAP1N,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)",6p21.3,protein-coding,
CWITA006567,TCMBANKGE006567,ERVK-9,PR; Protease; Proteinase; polymerase,endogenous retrovirus group K member 9,6q14.1,other,/
CWITA006568,TCMBANKGE006568,YRDC,DRIP3; IRIP; SUA5,yrdC N6-threonylcarbamoyltransferase domain containing,1p34.3,protein-coding,/
CWITA006569,TCMBANKGE006569,BHMT,BHMT1,betaine--homocysteine S-methyltransferase,5q13.1-q15,protein-coding,
CWITA006570,TCMBANKGE006570,PIBF1,C13orf24; CEP90; JBTS33; PIBF,progesterone immunomodulatory binding factor 1,13q21.33-q22.1,protein-coding,/
CWITA006571,TCMBANKGE006571,SUPT5H,SPT5; SPT5H; Tat-CT1,"SPT5 homolog, DSIF elongation factor subunit",19q13.2,protein-coding,/
CWITA006572,TCMBANKGE006572,GNLY,D2S69E; LAG-2; LAG2; NKG5; TLA519,granulysin,2p11.2,protein-coding,/
CWITA006573,TCMBANKGE006573,UCHL1,HEL-117; HEL-S-53; NDGOA; PARK5; PGP 9.5; PGP9.5; PGP95; SPG79; Uch-L1,ubiquitin C-terminal hydrolase L1,4p13,protein-coding,Research target
CWITA006574,TCMBANKGE006574,DPEP2,MBD2,dipeptidase 2,16q22.1,protein-coding,/
CWITA006575,TCMBANKGE006575,ABCA1,ABCN1; ABC1; CERP; FLJ14958; HDLDT1; MGC164864; MGC165011; TGD,"ATP-binding cassette, sub-family A (ABC1), member 1",9q31.1,protein-coding,
CWITA006576,TCMBANKGE006576,RRM1,R1; RIR1; RR1,ribonucleotide reductase M1,11p15.5,protein-coding,
CWITA006577,TCMBANKGE006577,GCSH,GCE; NKH,glycine cleavage system protein H,16q23.2,protein-coding,/
CWITA006578,TCMBANKGE006578,DAO,DAAO; DAMOX; MGC35381; OXDA,D-amino-acid oxidase,12q24,protein-coding,
CWITA006579,TCMBANKGE006579,GALNT2,CDG2T; GalNAc-T2,polypeptide N-acetylgalactosaminyltransferase 2,1q42.13,protein-coding,/
CWITA006580,TCMBANKGE006580,MAP4K5,GCKR; KHS; KHS1; MAPKKKK5,mitogen-activated protein kinase kinase kinase kinase 5,14q22.1,protein-coding,/
CWITA006581,TCMBANKGE006581,LCOR,C10orf12; MLR2,ligand dependent nuclear receptor corepressor,10q24.1,protein-coding,/
CWITA006582,TCMBANKGE006582,SDS,SDH,serine dehydratase,12q24.13,protein-coding,
CWITA006583,TCMBANKGE006583,SLC4A5,MGC129662; NBC4,"solute carrier family 4, sodium bicarbonate cotransporter, member 5",2p13,protein-coding,
CWITA006584,TCMBANKGE006584,Rthyd2,-,resistance to thymic deletion 2,-,unknown,/
CWITA006585,TCMBANKGE006585,WDR1,AIP1; HEL-S-52; NORI-1,WD repeat domain 1,4p16.1,protein-coding,/
CWITA006586,TCMBANKGE006586,SLC38A3,G17; NAT1; SN1,"solute carrier family 38, member 3",3p21.3,protein-coding,
CWITA006587,TCMBANKGE006587,MYL12B,MLC-B; MRLC2,myosin light chain 12B,18p11.31,protein-coding,/
CWITA006588,TCMBANKGE006588,BMP15,GDF9B; ODG2; POF4,bone morphogenetic protein 15,Xp11.22,protein-coding,/
CWITA006589,TCMBANKGE006589,MOAP1,MAP-1; PNMA4,modulator of apoptosis 1,14q32.12,protein-coding,/
CWITA006590,TCMBANKGE006590,HNRNPUL2,HNRPUL2; SAF-A2,heterogeneous nuclear ribonucleoprotein U like 2,11q12.3,protein-coding,/
CWITA006591,TCMBANKGE006591,C2CD5,CDP138; KIAA0528,C2 calcium dependent domain containing 5,12p12.1,protein-coding,/
CWITA006592,TCMBANKGE006592,BPHL,BPH-RP; MCNAA; VACVASE,biphenyl hydrolase like,6p25.2,protein-coding,Research target
CWITA006593,TCMBANKGE006593,TBC1D2,PARIS-1; PARIS1; TBC1D2A,TBC1 domain family member 2,9q22.33,protein-coding,/
CWITA006594,TCMBANKGE006594,NEXN,CMH20; NELIN,nexilin F-actin binding protein,1p31.1,protein-coding,/
CWITA006595,TCMBANKGE006595,TOP1MT,-,DNA topoisomerase I mitochondrial,8q24.3,protein-coding,/
CWITA006596,TCMBANKGE006596,DSG3,CDHF6; PVA,desmoglein 3,18q12.1,protein-coding,Research target
CWITA006597,TCMBANKGE006597,CNR2,CB2; CX5,cannabinoid receptor 2 (macrophage),1p36.11,protein-coding,
CWITA006598,TCMBANKGE006598,DCD,AIDD; DCD-1; DSEP; HCAP; PIF,dermcidin,12q13.2,protein-coding,/
CWITA006599,TCMBANKGE006599,USP35,-,ubiquitin specific peptidase 35,11q14.1,protein-coding,/
CWITA006600,TCMBANKGE006600,MYH2,IBM3; MYH2A; MYHSA2; MYHas8; MYPOP; MyHC-2A; MyHC-IIa,myosin heavy chain 2,17p13.1,protein-coding,Research target
CWITA006601,TCMBANKGE006601,C11orf52,-,chromosome 11 open reading frame 52,11q23.1,protein-coding,/
CWITA006602,TCMBANKGE006602,ZNF23,KOX16; ZNF359; ZNF612; Zfp612,zinc finger protein 23,16q22.2,protein-coding,/
CWITA006603,TCMBANKGE006603,NDUFV1,CIN51K; CI51KD; FLJ59059; UQOR1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",11q13,protein-coding,
CWITA006604,TCMBANKGE006604,TCF21,POD1; bHLHa23,transcription factor 21,6q23.2,protein-coding,/
CWITA006605,TCMBANKGE006605,SPOP,BTBD32; NEDMACE; NEDMIDF; NSDVS1; NSDVS2; TEF2,speckle type BTB/POZ protein,17q21.33,protein-coding,/
CWITA006606,TCMBANKGE006606,RBM33,PRR8,RNA binding motif protein 33,7q36.3,protein-coding,/
CWITA006607,TCMBANKGE006607,RNASE4,RAB1; RNS4,ribonuclease A family member 4,14q11.2,protein-coding,/
CWITA006608,TCMBANKGE006608,TMTC1,ARG99; OLF; TMTC1A,transmembrane O-mannosyltransferase targeting cadherins 1,12p11.22,protein-coding,/
CWITA006609,TCMBANKGE006609,RIT1,NS8; RIBB; RIT; ROC1,Ras like without CAAX 1,1q22,protein-coding,/
CWITA006610,TCMBANKGE006610,CTSE,CATE,cathepsin E,1q32.1,protein-coding,Research target
CWITA006611,TCMBANKGE006611,ST8SIA4,PST; PST1; SIAT8D; ST8SIA-IV,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4",5q21.1,protein-coding,Research target
CWITA006612,TCMBANKGE006612,GRIA3,GLURNC; GLURNK3; GLUR3; GLURC; GluA3; MRX94,"glutamate receptor, ionotrophic, AMPA 3",Xq25,protein-coding,
CWITA006613,TCMBANKGE006613,FAM20B,gxk1,FAM20B glycosaminoglycan xylosylkinase,1q25.2,protein-coding,/
CWITA006614,TCMBANKGE006614,OR1D2,OLFR1; OR17-4,olfactory receptor family 1 subfamily D member 2,17p13.3,protein-coding,/
CWITA006615,TCMBANKGE006615,DDHD2,SAMWD1; SPG54; iPLA(1)gamma,DDHD domain containing 2,8p11.23,protein-coding,/
CWITA006616,TCMBANKGE006616,RGS19,GAIP; RGSGAIP,regulator of G protein signaling 19,20q13.33,protein-coding,/
CWITA006617,TCMBANKGE006617,MYH15,-,myosin heavy chain 15,3q13.13,protein-coding,/
CWITA006618,TCMBANKGE006618,SNX3,Grd19; MCOPS8; SDP3,sorting nexin 3,6q21,protein-coding,/
CWITA006619,TCMBANKGE006619,DCUN1D1,DCNL1; DCUN1L1; RP42; SCCRO; SCRO; Tes3,defective in cullin neddylation 1 domain containing 1,3q26.33,protein-coding,/
CWITA006620,TCMBANKGE006620,MAFK,NFE2U; P18,MAF bZIP transcription factor K,7p22.3,protein-coding,/
CWITA006621,TCMBANKGE006621,YWHAE,14-3-3E; HEL2; KCIP-1; MDCR; MDS,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3,protein-coding,/
CWITA006622,TCMBANKGE006622,P2RY11,P2Y11,"purinergic receptor P2Y, G-protein coupled, 11",19p13.2,protein-coding,
CWITA006623,TCMBANKGE006623,VPS53,HCCS1; PCH2E; hVps53L; pp13624,VPS53 subunit of GARP complex,17p13.3,protein-coding,/
CWITA006624,TCMBANKGE006624,RGPD4,RGP4,RANBP2 like and GRIP domain containing 4,2q12.3,protein-coding,/
CWITA006625,TCMBANKGE006625,HEXD,HEXDC,hexosaminidase D,17q25.3,protein-coding,/
CWITA006626,TCMBANKGE006626,ANKRD55,-,ankyrin repeat domain 55,5q11.2,protein-coding,/
CWITA006627,TCMBANKGE006627,RNF26,-,ring finger protein 26,11q23.3,protein-coding,/
CWITA006628,TCMBANKGE006628,TPST2,TANGO13B; TPST-2,tyrosylprotein sulfotransferase 2,22q12.1,protein-coding,/
CWITA006629,TCMBANKGE006629,SPRY2,IGAN3; hSPRY2,sprouty RTK signaling antagonist 2,13q31.1,protein-coding,/
CWITA006630,TCMBANKGE006630,KCNJ10,BIRKN10; KCNJ13NPEN; KIR1.2; KIR4.1; SESAME,"potassium inwardly-rectifying channel, subfamily J, member 10",1q23.2,protein-coding,
CWITA006631,TCMBANKGE006631,PIAS1,DDXBP1; GBP; GU/RH-II; ZMIZ3,protein inhibitor of activated STAT 1,15q23,protein-coding,/
CWITA006632,TCMBANKGE006632,MTOR,FLJ44809; FRAP; FRAP1; FRAP2; RAFT1; RAPT1,mechanistic target of rapamycin (serine/threonine kinase),1p36.2,protein-coding,
CWITA006633,TCMBANKGE006633,PHF12,PF1,PHD finger protein 12,17q11.2,protein-coding,/
CWITA006634,TCMBANKGE006634,LRRC14,LRRC14A,leucine rich repeat containing 14,8q24.3,protein-coding,/
CWITA006635,TCMBANKGE006635,FAM149B1,JBTS36; KIAA0974,family with sequence similarity 149 member B1,10q22.2,protein-coding,/
CWITA006636,TCMBANKGE006636,ANKRD20A4P,ANKRD20A4,"ankyrin repeat domain 20 family member A4, pseudogene",9q13,pseudo,/
CWITA006637,TCMBANKGE006637,SLC12A2,BSC; BSC2; MGC104233; NKCC1,"solute carrier family 12 (sodium/potassium/chloride transporters), member 2",5q23.3,protein-coding,
CWITA006638,TCMBANKGE006638,F11,FXI; MGC141891,coagulation factor XI,4q35,protein-coding,
CWITA006639,TCMBANKGE006639,TIAF1,MAJN; SPR210,TGFB1-induced anti-apoptotic factor 1,17q11.2,protein-coding,/
CWITA006640,TCMBANKGE006640,GUK1,FLJ42686; FLJ43710; GMK,guanylate kinase 1,1q32-q41,protein-coding,
CWITA006641,TCMBANKGE006641,RPLP2,D11S2243E; LP2; P2; RPP2,Ribosomal_Protein_Lateral_Stalk_Subunit_P2,11p15.5,protein-coding,
CWITA006642,TCMBANKGE006642,FYTTD1,UIF,forty-two-three domain containing 1,3q29,protein-coding,/
CWITA006643,TCMBANKGE006643,YWHAZ,14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,8q22.3,protein-coding,/
CWITA006644,TCMBANKGE006644,METTL27,WBSCR27,methyltransferase like 27,7q11.23,protein-coding,/
CWITA006645,TCMBANKGE006645,PIDD1,LRDD; PIDD,p53-induced death domain protein 1,11p15.5,protein-coding,/
CWITA006646,TCMBANKGE006646,TLR1,CD281; TIL; TIL. LPRS5; rsc786,toll like receptor 1,4p14,protein-coding,Patented target
CWITA006647,TCMBANKGE006647,RSC1A1,RS1,regulator of solute carriers 1,1p36.21,protein-coding,/
CWITA006648,TCMBANKGE006648,TM2D1,BBP,TM2 domain containing 1,1p31.3,protein-coding,/
CWITA006649,TCMBANKGE006649,ANO1,DOG1; ORAOV2; TAOS2; TMEM16A,anoctamin 1,11q13.3,protein-coding,Successful target
CWITA006650,TCMBANKGE006650,MMUT,MCM; MUT,methylmalonyl-CoA mutase,6p12.3,protein-coding,/
CWITA006651,TCMBANKGE006651,GABRB1,EIEE45,gamma-aminobutyric acid type A receptor subunit beta1,4p12,protein-coding,/
CWITA006652,TCMBANKGE006652,WARS2,NEMMLAS; TrpRS; mtTrpRS,"tryptophanyl tRNA synthetase 2, mitochondrial",1p12,protein-coding,/
CWITA006653,TCMBANKGE006653,PNKP,AOA4; CMT2B2; EIEE10; MCSZ; PNK,polynucleotide kinase 3'-phosphatase,19q13.33,protein-coding,Research target
CWITA006654,TCMBANKGE006654,ASCL1,ASH1; HASH1; MASH1; bHLHa46,achaete-scute family bHLH transcription factor 1,12q23.2,protein-coding,/
CWITA006655,TCMBANKGE006655,PLXNA3,6.3; HSSEXGENE; PLXN3; PLXN4; XAP-6,plexin A3,Xq28,protein-coding,/
CWITA006656,TCMBANKGE006656,B2M,IMD43,beta-2-microglobulin,15q21.1,protein-coding,Research target
CWITA006657,TCMBANKGE006657,MC2R,ACTHR,melanocortin 2 receptor,18p11.21,protein-coding,Successful target
CWITA006658,TCMBANKGE006658,SECISBP2,SBP2,SECIS binding protein 2,9q22.2,protein-coding,/
CWITA006659,TCMBANKGE006659,ZSCAN16,ZNF392; ZNF435; dJ265C24.3,zinc finger and SCAN domain containing 16,6p22.1,protein-coding,/
CWITA006660,TCMBANKGE006660,NARS2,FLJ23441; SLM5,"asparaginyl-tRNA synthetase 2, mitochondrial (putative)",11q14.1,protein-coding,
CWITA006661,TCMBANKGE006661,PNPLA6,BNHS; LNMS; NTE; NTEMND; OMCS; SPG39; iPLA2delta; sws,patatin like phospholipase domain containing 6,19p13.2,protein-coding,Research target
CWITA006662,TCMBANKGE006662,WDFY1,FENS-1; FENS1; WDF1; ZFYVE17,WD repeat and FYVE domain containing 1,2q36.1,protein-coding,/
CWITA006663,TCMBANKGE006663,GIMAP2,HIMAP2; IAN12; IMAP2,"GTPase, IMAP family member 2",7q36.1,protein-coding,/
CWITA006664,TCMBANKGE006664,PRR14L,C22orf30,proline rich 14 like,22q12.2,protein-coding,/
CWITA006665,TCMBANKGE006665,TXNRD3,TGR; TR2; TR2IT1; TRXR3; TXNRD3IT1; TXNRD3NB; TXNRD3NT1,thioredoxin reductase 3,3q21.3,protein-coding,Research target
CWITA006666,TCMBANKGE006666,INTS6,DBI-1; DDX26; DDX26A; DICE1; HDB; INT6; Notchl2,integrator complex subunit 6,13q14.3,protein-coding,/
CWITA006667,TCMBANKGE006667,GABPB1,BABPB2; E4TF1; E4TF1-47; E4TF1-53; E4TF1B; GABPB; GABPB-1; GABPB2; NRF2B1; NRF2B2,GA binding protein transcription factor subunit beta 1,15q21.2,protein-coding,/
CWITA006668,TCMBANKGE006668,KIF2B,-,kinesin family member 2B,17q22,protein-coding,/
CWITA006669,TCMBANKGE006669,GAS8,CILD33; DRC4; GAS11,growth arrest specific 8,16q24.3,protein-coding,/
CWITA006670,TCMBANKGE006670,DTYMK,CDC8; PP3731; TMPK; TYMK,deoxythymidylate kinase,2q37.3,protein-coding,/
CWITA006671,TCMBANKGE006671,HINT1,FLJ30414; FLJ32340; HINT; PKCIN1; PRKCNH1,histidine triad nucleotide binding protein 1,5q31.2,protein-coding,
CWITA006672,TCMBANKGE006672,MKKS,BBS6; HMCS; KMS; MKS,McKusick-Kaufman syndrome,20p12.2,protein-coding,/
CWITA006673,TCMBANKGE006673,TRIM48,RNF101,tripartite motif containing 48,11q11,protein-coding,/
CWITA006674,TCMBANKGE006674,KYNU,KYNUU; VCRL2,kynureninase,2q22.2,protein-coding,Research target
CWITA006675,TCMBANKGE006675,SSBP3,CSDP; SSDP; SSDP1,single stranded DNA binding protein 3,1p32.3,protein-coding,/
CWITA006676,TCMBANKGE006676,ARHGAP17,MST066; MST110; MSTP038; MSTP066; MSTP110; NADRIN; PP367; PP4534; RICH-1; RICH1; WBP15,Rho GTPase activating protein 17,16p12.1,protein-coding,/
CWITA006677,TCMBANKGE006677,PRR13,TXR1,proline rich 13,12q13.13,protein-coding,/
CWITA006678,TCMBANKGE006678,TMEM158,BBP; RIS1; p40BBP,transmembrane protein 158,3p21.31,protein-coding,/
CWITA006679,TCMBANKGE006679,CYP2U1,P450TEC; SPG49; SPG56,cytochrome P450 family 2 subfamily U member 1,4q25,protein-coding,/
CWITA006680,TCMBANKGE006680,ABRAXAS1,ABRA1; CCDC98; FAM175A,"abraxas 1, BRCA1 A complex subunit",4q21.23,protein-coding,/
CWITA006681,TCMBANKGE006681,CCDC6,D10S170; H4; PTC; TPC; TST1,coiled-coil domain containing 6,10q21.2,protein-coding,/
CWITA006682,TCMBANKGE006682,UMPS,OPRT,uridine monophosphate synthetase,3q13,protein-coding,
CWITA006683,TCMBANKGE006683,CYP1A2,CP12; P3N450; P450(PA),"cytochrome P450, family 1, subfamily A, polypeptide 2",15q24.1,protein-coding,
CWITA006684,TCMBANKGE006684,PCK2,PEPCK; PEPCK-M; PEPCK2,"phosphoenolpyruvate carboxykinase 2, mitochondrial",14q11.2-q12,protein-coding,/
CWITA006685,TCMBANKGE006685,ACTL7B,Tact1,actin like 7B,9q31.3,protein-coding,/
CWITA006686,TCMBANKGE006686,PRDM1,BLIMP1; PRDI-BF1,PR/SET domain 1,6q21,protein-coding,/
CWITA006687,TCMBANKGE006687,MIR374B,MIRN374B|mir-374b,microRNA 374b,Xq13.2,ncRNA,/
CWITA006688,TCMBANKGE006688,LRRC43,-,leucine rich repeat containing 43,12q24.31,protein-coding,/
CWITA006689,TCMBANKGE006689,TMSB4Y,TB4Y,thymosin beta 4 Y-linked,Yq11.221,protein-coding,/
CWITA006690,TCMBANKGE006690,PRSS12,BSSP-3; BSSP3; MRT1,serine protease 12,4q26,protein-coding,Research target
CWITA006691,TCMBANKGE006691,FGFR3,ACH; CD333; CEK2; HSFGFR3EX; JTK4,fibroblast growth factor receptor 3,4p16.3,protein-coding,Clinical Trial target
CWITA006692,TCMBANKGE006692,SF3B5,SF3b10; Ysf3,splicing factor 3b subunit 5,6q24.2,protein-coding,/
CWITA006693,TCMBANKGE006693,TNIP1,ABIN-1; NAF1; VAN; nip40-1,TNFAIP3 interacting protein 1,5q33.1,protein-coding,/
CWITA006694,TCMBANKGE006694,CPNE8,-,copine 8,12q12,protein-coding,/
CWITA006695,TCMBANKGE006695,TMEM126B,HT007; MC1DN29,transmembrane protein 126B,11q14.1,protein-coding,/
CWITA006696,TCMBANKGE006696,PLCB1,EIEE12; PI-PLC; PLC-154; PLC-I; PLC-beta-1; PLC154; PLCB1A; PLCB1B,phospholipase C beta 1,20p12.3,protein-coding,Research target
CWITA006697,TCMBANKGE006697,CARD17,INCA,caspase recruitment domain family member 17,11q22.3,protein-coding,/
CWITA006698,TCMBANKGE006698,RNF165,ARKL2; Ark2C; RNF111L2,ring finger protein 165,18q21.1,protein-coding,/
CWITA006699,TCMBANKGE006699,FGF22,-,fibroblast growth factor 22,19p13.3,protein-coding,/
CWITA006700,TCMBANKGE006700,B4GALT7,EDSP1; EDSSLA; EDSSPD1; XGALT1; XGPT; XGPT1,"beta-1,4-galactosyltransferase 7",5q35.3,protein-coding,/
CWITA006701,TCMBANKGE006701,G6PC3,SCN4; UGRP,glucose-6-phosphatase catalytic subunit 3,17q21.31,protein-coding,/
CWITA006702,TCMBANKGE006702,PPEF1,PP7; PPEF; PPP7C; PPP7CA,protein phosphatase with EF-hand domain 1,Xp22.13,protein-coding,/
CWITA006703,TCMBANKGE006703,STK31,SGK396; TDRD8,serine/threonine kinase 31,7p15.3,protein-coding,/
CWITA006704,TCMBANKGE006704,AMN,PRO1028,amnionless homolog (mouse),14q32.3,protein-coding,
CWITA006705,TCMBANKGE006705,SLC12A7,KCC4,solute carrier family 12 member 7,5p15.33,protein-coding,Research target
CWITA006706,TCMBANKGE006706,GNPNAT1,GNA1; GNPNAT; Gpnat1,glucosamine-phosphate N-acetyltransferase 1,14q22.1,protein-coding,/
CWITA006707,TCMBANKGE006707,TMEM156,-,transmembrane protein 156,4p14,protein-coding,/
CWITA006708,TCMBANKGE006708,RPGR,COD1; CORDX1; CRD; PCDX; RP15; RP3; XLRP3; orf15,retinitis pigmentosa GTPase regulator,Xp11.4,protein-coding,/
CWITA006709,TCMBANKGE006709,SUCLG2,G-SCS; GBETA; GTPSCS,succinate-CoA ligase GDP-forming subunit beta,3p14.1,protein-coding,/
CWITA006710,TCMBANKGE006710,KIF21A,CFEOM1; FEOM1; FEOM3A,kinesin family member 21A,12q12,protein-coding,/
CWITA006711,TCMBANKGE006711,B3GNT5,B3GN-T5; beta3Gn-T5,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5",3q27.1,protein-coding,/
CWITA006712,TCMBANKGE006712,FAM106A,-,family with sequence similarity 106 member A,17p11.2,protein-coding,/
CWITA006713,TCMBANKGE006713,SLC1A7,AAAT; EAAT5,solute carrier family 1 member 7,1p32.3,protein-coding,Research target
CWITA006714,TCMBANKGE006714,LALBA,LYZG,Lactalbumin_Alpha,12q13.11,protein-coding,
CWITA006715,TCMBANKGE006715,DNHD1,C11orf47; CCDC35; DHCD1; DNHD1L,dynein heavy chain domain 1,11p15.4,protein-coding,/
CWITA006716,TCMBANKGE006716,TNFRSF12A,CD266; FN14; TWEAKR,TNF receptor superfamily member 12A,16p13.3,protein-coding,Clinical Trial target
CWITA006717,TCMBANKGE006717,QSER1,-,glutamine and serine rich 1,11p13,protein-coding,/
CWITA006718,TCMBANKGE006718,AIRE,AIRE1; APECED; APS1; APSI; PGA1,autoimmune regulator,21q22.3,protein-coding,/
CWITA006719,TCMBANKGE006719,SOAT2,ACACT2; ACAT2; ARGP2; MGC116732,sterol O-acyltransferase 2,12q13.13,protein-coding,
CWITA006720,TCMBANKGE006720,SLC28A3,CNT3,solute carrier family 28 member 3,9q21.32-q21.33,protein-coding,/
CWITA006721,TCMBANKGE006721,EARS2,KIAA1970; MSE1,"glutamyl-tRNA synthetase 2, mitochondrial (putative)",16p12.2,protein-coding,
CWITA006722,TCMBANKGE006722,FBXO28,CENP-30; Fbx28,F-box protein 28,1q42.11,protein-coding,/
CWITA006723,TCMBANKGE006723,POLR3D,BN51T; C53; RPC4; RPC53; TSBN51,RNA polymerase III subunit D,8p21.3,protein-coding,/
CWITA006724,TCMBANKGE006724,REN,HNFJ2,renin,1q32.1,protein-coding,Successful target
CWITA006725,TCMBANKGE006725,AFAP1,AFAP; AFAP-110; AFAP110,actin filament associated protein 1,4p16.1,protein-coding,/
CWITA006726,TCMBANKGE006726,SFXN2,SLC56A2,sideroflexin 2,10q24.32,protein-coding,/
CWITA006727,TCMBANKGE006727,COL15A1,-,collagen type XV alpha 1 chain,9q22.33,protein-coding,/
CWITA006728,TCMBANKGE006728,CILP,CILP-1; HsT18872,cartilage intermediate layer protein,15q22.31,protein-coding,/
CWITA006729,TCMBANKGE006729,RANBP1,HTF9A,RAN binding protein 1,22q11.21,protein-coding,/
CWITA006730,TCMBANKGE006730,GNG13,G(gamma)13; h2-35,G protein subunit gamma 13,16p13.3,protein-coding,/
CWITA006731,TCMBANKGE006731,TIAM2,STEF; TIAM-2,TIAM Rac1 associated GEF 2,6q25.2-q25.3,protein-coding,/
CWITA006732,TCMBANKGE006732,CCNI,CCNI1; CYC1; CYI,cyclin I,4q21.1,protein-coding,/
CWITA006733,TCMBANKGE006733,PVR,CD155; HVED; NECL5; Necl-5; PVS; TAGE4,PVR cell adhesion molecule,19q13.31,protein-coding,/
CWITA006734,TCMBANKGE006734,CDH19,CDH7; CDH7L2,cadherin 19,18q22.1,protein-coding,/
CWITA006735,TCMBANKGE006735,SULT1A2,HAST4; P-PST; P-PST 2; ST1A2; STP2; TSPST2,sulfotransferase family 1A member 2,16p11.2,protein-coding,/
CWITA006736,TCMBANKGE006736,BCL2L2,BCL-W; BCL2-L-2; BCLW; PPP1R51,BCL2 like 2,14q11.2,protein-coding,Clinical Trial target
CWITA006737,TCMBANKGE006737,SORD,SORD1,sorbitol dehydrogenase,15q15.3,protein-coding,
CWITA006738,TCMBANKGE006738,CCDC58,-,coiled-coil domain containing 58,3q21.1,protein-coding,/
CWITA006739,TCMBANKGE006739,ZNF362,RN; lin-29,zinc finger protein 362,1p35.1,protein-coding,/
CWITA006740,TCMBANKGE006740,CACNA1B,BIII; CACNL1A5; CACNN; Cav2.2; DYT23; NEDNEH,calcium voltage-gated channel subunit alpha1 B,9q34.3,protein-coding,Successful target
CWITA006741,TCMBANKGE006741,EPHA4,EK8; HEK8; SEK; TYRO1,EPH receptor A4,2q36.1,protein-coding,Research target
CWITA006742,TCMBANKGE006742,NFYB,CBF-A; CBF-B; HAP3; NF-YB,nuclear transcription factor Y subunit beta,12q23.3,protein-coding,/
CWITA006743,TCMBANKGE006743,SUN2,UNC84B,Sad1 and UNC84 domain containing 2,22q13.1,protein-coding,/
CWITA006744,TCMBANKGE006744,SCAF4,SFRS15; SRA4,SR-related CTD associated factor 4,21q22.11,protein-coding,/
CWITA006745,TCMBANKGE006745,SLC25A37,HT015; MFRN; MFRN1; MSC; MSCP; PRO1278; PRO1584; PRO2217,solute carrier family 25 member 37,8p21.2,protein-coding,/
CWITA006746,TCMBANKGE006746,DDAH2,DDAH; DDAHII; G6a; HEL-S-277; NG30,dimethylarginine dimethylaminohydrolase 2,6p21.33,protein-coding,/
CWITA006747,TCMBANKGE006747,AK8,C9orf98; DDX31; FLJ32704; FLJ36014; RP11N143F18.1,adenylate kinase 8,9q34.13,protein-coding,
CWITA006748,TCMBANKGE006748,IL16,LCF; NIL16; PRIL16; prIL-16,interleukin 16,15q25.1,protein-coding,Research target
CWITA006749,TCMBANKGE006749,TMC4,-,transmembrane channel like 4,19q13.42,protein-coding,/
CWITA006750,TCMBANKGE006750,IL21,CVID11; IL-21; Za11,interleukin 21,4q27,protein-coding,Clinical Trial target
CWITA006751,TCMBANKGE006751,TNFAIP2,B94; EXOC3L3,TNF alpha induced protein 2,14q32.32,protein-coding,/
CWITA006752,TCMBANKGE006752,TAF10,TAF2A; TAF2H; TAFII30,TATA-box binding protein associated factor 10,11p15.4,protein-coding,/
CWITA006753,TCMBANKGE006753,NHSL1,C6orf63,NHS like 1,6q24.1,protein-coding,/
CWITA006754,TCMBANKGE006754,ZNF214,BAZ-1; BAZ1,zinc finger protein 214,11p15.4,protein-coding,/
CWITA006755,TCMBANKGE006755,GPR27,SREB1,G protein-coupled receptor 27,3p13,protein-coding,/
CWITA006756,TCMBANKGE006756,CADM1,BL2; IGSF4; IGSF4A; NECL2; Necl-2; RA175; ST17; SYNCAM; TSLC1; sTSLC-1; sgIGSF; synCAM1,cell adhesion molecule 1,11q23.3,protein-coding,/
CWITA006757,TCMBANKGE006757,TNFRSF6B,DCR3; DJ583P15.1.1; M68; M68E; TR6,TNF receptor superfamily member 6b,20q13.33,protein-coding,/
CWITA006758,TCMBANKGE006758,ACADM,ACAD1; FLJ18227; FLJ93013; FLJ99884; MCAD; MCADH,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",1p31,protein-coding,
CWITA006759,TCMBANKGE006759,CENPV,3110013H01Rik; CENP-V; PRR6; p30,centromere protein V,17p11.2,protein-coding,/
CWITA006760,TCMBANKGE006760,QPRT,HEL-S-90n; QPRTase,quinolinate phosphoribosyltransferase,16p11.2,protein-coding,/
CWITA006761,TCMBANKGE006761,RDH5,FLJ39337; FLJ97089; HSD17B9; RDH1; SDR9C5,retinol dehydrogenase 5 (11-cis/9-cis),12q13-q14,protein-coding,
CWITA006762,TCMBANKGE006762,NT5C3A,NT5C3; P5'N-1; P5N-1; PN-I; POMP; PSN1; UMPH; UMPH1; cN-III; hUMP1; p36,"5'-nucleotidase, cytosolic IIIA",7p14.3,protein-coding,/
CWITA006763,TCMBANKGE006763,ZNF440,-,zinc finger protein 440,19p13.2,protein-coding,/
CWITA006764,TCMBANKGE006764,TRIM35,HLS5; MAIR,tripartite motif containing 35,8p21.2,protein-coding,/
CWITA006765,TCMBANKGE006765,ZNF514,-,zinc finger protein 514,2q11.1,protein-coding,/
CWITA006766,TCMBANKGE006766,PPAT,ATASE; GPAT; PRAT,phosphoribosyl pyrophosphate amidotransferase,4q12,protein-coding,Successful target
CWITA006767,TCMBANKGE006767,CDH18,CDH14; CDH14L; CDH24,cadherin 18,5p14.3,protein-coding,/
CWITA006768,TCMBANKGE006768,EPS8,DFNB102,epidermal growth factor receptor pathway substrate 8,12p12.3,protein-coding,/
CWITA006769,TCMBANKGE006769,UHMK1,KIS; KIST; P-CIP2,U2AF homology motif kinase 1,1q23.3,protein-coding,/
CWITA006770,TCMBANKGE006770,CLPX,EPP2,caseinolytic mitochondrial matrix peptidase chaperone subunit X,15q22.31,protein-coding,/
CWITA006771,TCMBANKGE006771,FAM209A,C20orf106; dJ1153D9.3,family with sequence similarity 209 member A,20q13.31,protein-coding,/
CWITA006772,TCMBANKGE006772,KIAA0040,-,KIAA0040,1q25.1,protein-coding,/
CWITA006773,TCMBANKGE006773,AGBL1,CCP4; FECD8,ATP/GTP binding protein like 1,15q25.3,protein-coding,/
CWITA006774,TCMBANKGE006774,BTG1,APRO2,BTG anti-proliferation factor 1,12q21.33,protein-coding,Research target
CWITA006775,TCMBANKGE006775,GOLGA8A,CFAP286; FAP286; GM88; GOLGA8B,golgin A8 family member A,15q14,protein-coding,/
CWITA006776,TCMBANKGE006776,CDK9,C-2k; CDC2L4; CTK1; PITALRE; TAK,cyclin dependent kinase 9,9q34.11,protein-coding,Clinical Trial target
CWITA006777,TCMBANKGE006777,Amd-ps3,-,"S-adenosylmethionine decarboxylase, pseudogene 3",18|18 E1,pseudo,/
CWITA006778,TCMBANKGE006778,PLEC,EBS1; EBSMD; EBSND; EBSO; EBSOG; EBSPA; HD1; LGMD2Q; LGMDR17; PCN; PLEC1; PLEC1b; PLTN,plectin,8q24.3,protein-coding,/
CWITA006779,TCMBANKGE006779,DHRS4L2,FLJ11525; MGC905; SDR25C3,dehydrogenase/reductase (SDR family) member 4 like 2,14q11.2,protein-coding,
CWITA006780,TCMBANKGE006780,MIPOL1,CCDC193,mirror-image polydactyly 1,14q13.3-q21.1,protein-coding,/
CWITA006781,TCMBANKGE006781,TMEM42,-,transmembrane protein 42,3p21.31,protein-coding,/
CWITA006782,TCMBANKGE006782,PNMA8B,PNMAL2,PNMA family member 8B,19q13.32,protein-coding,/
CWITA006783,TCMBANKGE006783,ZNF800,-,zinc finger protein 800,7q31.33,protein-coding,/
CWITA006784,TCMBANKGE006784,SEMA4B,SEMAC; SemC,semaphorin 4B,15q26.1,protein-coding,/
CWITA006785,TCMBANKGE006785,KRT80,KB20,keratin 80,12q13.13,protein-coding,/
CWITA006786,TCMBANKGE006786,GPBAR1,BG37; GPCR19; GPR131; MN/ABAR; TGR5,G_Protein-Coupled_Bile_Acid_Receptor_1,2q35,protein-coding,
CWITA006787,TCMBANKGE006787,DTWD1,MDS009,DTW domain containing 1,15q21.2,protein-coding,/
CWITA006788,TCMBANKGE006788,DCTPP1,CDA03; RS21C6; XTP3TPA,dCTP pyrophosphatase 1,16p11.2,protein-coding,/
CWITA006789,TCMBANKGE006789,UBE2T,FANCT; HSPC150; PIG50,ubiquitin conjugating enzyme E2 T,1q32.1,protein-coding,Clinical Trial target
CWITA006790,TCMBANKGE006790,CEMIP2,TMEM2,cell migration inducing hyaluronidase 2,9q21.13,protein-coding,/
CWITA006791,TCMBANKGE006791,C6orf132,bA7K24.2,chromosome 6 open reading frame 132,6p21.1,protein-coding,/
CWITA006792,TCMBANKGE006792,TRAK2,ALS2CR3; CALS-C; GRIF-1; GRIF1; MILT2; OIP98,trafficking kinesin protein 2,2q33.1,protein-coding,/
CWITA006793,TCMBANKGE006793,MAP1LC3C,ATG8J; LC3C,microtubule associated protein 1 light chain 3 gamma,1q43,protein-coding,/
CWITA006794,TCMBANKGE006794,SNAPC3,PTFbeta; SNAP50,small nuclear RNA activating complex polypeptide 3,9p22.3,protein-coding,/
CWITA006795,TCMBANKGE006795,HYI,HT036,hydroxypyruvate isomerase (putative),1p34.2,protein-coding,/
CWITA006796,TCMBANKGE006796,KBTBD2,BKLHD1,kelch repeat and BTB domain containing 2,7p14.3,protein-coding,/
CWITA006797,TCMBANKGE006797,LAT,LAT1; pp36,linker for activation of T cells,16p11.2,protein-coding,
CWITA006798,TCMBANKGE006798,ACY1,ACY-1; ACY1D; HEL-S-5,aminoacylase 1,3p21.2,protein-coding,/
CWITA006799,TCMBANKGE006799,KIF17,KIF17B; KIF3X; KLP-2; OSM-3,kinesin family member 17,1p36.12,protein-coding,/
CWITA006800,TCMBANKGE006800,NAP1L1,NAP1; NAP1L; NRP,nucleosome assembly protein 1 like 1,12q21.2,protein-coding,/
CWITA006801,TCMBANKGE006801,DDOST,AGER1; CDG1R; GATD6; OKSWcl45; OST; OST48; WBP1,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit,1p36.12,protein-coding,/
CWITA006802,TCMBANKGE006802,ZNF143,SBF; STAF; pHZ-1,zinc finger protein 143,11p15.4,protein-coding,/
CWITA006803,TCMBANKGE006803,OVCH1,OVCH,ovochymase 1,12p11.22,protein-coding,/
CWITA006804,TCMBANKGE006804,TMPRSS12,CT151,transmembrane serine protease 12,12q13.12,protein-coding,/
CWITA006805,TCMBANKGE006805,MED15,ARC105; CAG7A; CTG7A; PCQAP; TIG-1; TIG1; TNRC7,mediator complex subunit 15,22q11.21,protein-coding,/
CWITA006806,TCMBANKGE006806,FUT4,CD15; ELFT; FCT3A; FUC-TIV; FUTIV; LeX; SSEA-1,fucosyltransferase 4,11q21,protein-coding,Successful target
CWITA006807,TCMBANKGE006807,TMOD2,N-TMOD; NTMOD,tropomodulin 2,15q21.2,protein-coding,/
CWITA006808,TCMBANKGE006808,CMA1,CYH; MCT1; chymase,chymase 1,14q12,protein-coding,Clinical Trial target
CWITA006809,TCMBANKGE006809,GSTK1,GST; GST_13N13; GST13; GST13N13; GSTK1N1; hGSTK1,glutathione S-transferase kappa 1,7q35,protein-coding,
CWITA006810,TCMBANKGE006810,RBM14,COAA; PSP2; SIP; SYTIP1; TMEM137,RNA binding motif protein 14,11q13.2,protein-coding,/
CWITA006811,TCMBANKGE006811,PPP1R35,C7orf47,protein phosphatase 1 regulatory subunit 35,7q22.1,protein-coding,/
CWITA006812,TCMBANKGE006812,PAN2,USP52,poly(A) specific ribonuclease subunit PAN2,12q13.3,protein-coding,/
CWITA006813,TCMBANKGE006813,TET2,KIAA1546; MDS,tet methylcytosine dioxygenase 2,4q24,protein-coding,/
CWITA006814,TCMBANKGE006814,FAM86C1P,FAM86C; FAM86C1,"family with sequence similarity 86 member C1, pseudogene",11q13.4,protein-coding,/
CWITA006815,TCMBANKGE006815,ARG2,-,arginase 2,14q24.1,protein-coding,Clinical Trial target
CWITA006816,TCMBANKGE006816,GLYATL2,BXMAS2-10; GATF-B,glycine-N-acyltransferase like 2,11q12.1,protein-coding,/
CWITA006817,TCMBANKGE006817,PCDH11X,PCDH-X; PCDH-Y; PCDH11; PCDH11Y; PCDH22; PCDHX; PPP1R119,protocadherin 11 X-linked,Xq21.31,protein-coding,/
CWITA006818,TCMBANKGE006818,HCN4,SSS2,hyperpolarization activated cyclic nucleotide gated potassium channel 4,15q24.1,protein-coding,Research target
CWITA006819,TCMBANKGE006819,IFNA7,IFN-alphaJ; IFNA-J,interferon alpha 7,9p21.3,protein-coding,/
CWITA006820,TCMBANKGE006820,UGT8,CGT; UGT4,UDP glycosyltransferase 8,4q26,protein-coding,/
CWITA006821,TCMBANKGE006821,CBX3,HECH; HP1-GAMMA; HP1Hs-gamma,chromobox 3,7p15.2,protein-coding,/
CWITA006822,TCMBANKGE006822,HHIP,HIP,hedgehog interacting protein,4q31.21,protein-coding,/
CWITA006823,TCMBANKGE006823,HOXA5,HOX1; HOX1.3; HOX1C,homeobox A5,7p15.2,protein-coding,Research target
CWITA006824,TCMBANKGE006824,RXFP1,LGR7; RXFPR1,relaxin family peptide receptor 1,4q32.1,protein-coding,Clinical Trial target
CWITA006825,TCMBANKGE006825,HEY1,BHLHb31; CHF2; HERP2; HESR1; HRT-1; NERP2; OAF1; hHRT1,hes related family bHLH transcription factor with YRPW motif 1,8q21.13,protein-coding,/
CWITA006826,TCMBANKGE006826,C18orf54,LAS2,chromosome 18 open reading frame 54,18q21.2,protein-coding,/
CWITA006827,TCMBANKGE006827,CLINT1,CLINT; ENTH; EPN4; EPNR,clathrin interactor 1,5q33.3,protein-coding,/
CWITA006828,TCMBANKGE006828,YES1,HsT441; P61NYES; Yes; cNyes,v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1,18p11.31-p11.21,protein-coding,
CWITA006829,TCMBANKGE006829,CSRP2,CRP2; LMO5; SmLIM,cysteine and glycine rich protein 2,12q21.2,protein-coding,/
CWITA006830,TCMBANKGE006830,KRT12,K12,keratin 12,17q12,protein-coding,
CWITA006831,TCMBANKGE006831,SLC9A9,AUTS16; NHE9,solute carrier family 9 member A9,3q24,protein-coding,/
CWITA006832,TCMBANKGE006832,IGHG3,IgG3,immunoglobulin heavy constant gamma 3 (G3m marker),14q32.33,other,/
CWITA006833,TCMBANKGE006833,CCDC74B,-,coiled-coil domain containing 74B,2q21.1,protein-coding,/
CWITA006834,TCMBANKGE006834,FTL,LFTD; NBIA3,ferritin light chain,19q13.33,protein-coding,/
CWITA006835,TCMBANKGE006835,ZNF586,-,zinc finger protein 586,19q13.43,protein-coding,/
CWITA006836,TCMBANKGE006836,TWNK,ATXN8; C10orf2; IOSCA; MTDPS7; PEO; PEO1; PEOA3; PRLTS5; SANDO; SCA8; TWINL,twinkle mtDNA helicase,10q24.31,protein-coding,/
CWITA006837,TCMBANKGE006837,TST,MGC19578; RDS,thiosulfate sulfurtransferase (rhodanese),22q13.1,protein-coding,
CWITA006838,TCMBANKGE006838,VRK2,-,VRK serine/threonine kinase 2,2p16.1,protein-coding,/
CWITA006839,TCMBANKGE006839,THOC2,CXorf3; MRX12; MRX35; THO2; dJ506G2.1; hTREX120,THO complex 2,Xq25,protein-coding,/
CWITA006840,TCMBANKGE006840,SERPINA12,OL-64,serpin family A member 12,14q32.13,protein-coding,/
CWITA006841,TCMBANKGE006841,RBM46,CT68,RNA binding motif protein 46,4q32.1,protein-coding,/
CWITA006842,TCMBANKGE006842,PPAT,ATASE; GPAT; PRAT,phosphoribosyl pyrophosphate amidotransferase,4q12,protein-coding,
CWITA006843,TCMBANKGE006843,NOTCH2NLB,N2N; NOTCH2NL; NOTCH2NLA,notch 2 N-terminal like B,1q21.2,protein-coding,/
CWITA006844,TCMBANKGE006844,MYO5C,-,myosin VC,15q21.2,protein-coding,/
CWITA006845,TCMBANKGE006845,ARHGEF26,CSGEF; HMFN1864; SGEF,Rho guanine nucleotide exchange factor 26,3q25.2,protein-coding,/
CWITA006846,TCMBANKGE006846,PLAGL2,ZNF900,PLAG1 like zinc finger 2,20q11.21,protein-coding,/
CWITA006847,TCMBANKGE006847,PDE1C,Hcam3,"phosphodiesterase 1C, calmodulin-dependent 70kDa",7p14.3,protein-coding,
CWITA006848,TCMBANKGE006848,MFSD14B,HIATL1,major facilitator superfamily domain containing 14B,9q22.32,protein-coding,/
CWITA006849,TCMBANKGE006849,FBN3,-,fibrillin 3,19p13.2,protein-coding,/
CWITA006850,TCMBANKGE006850,HTR3E,5NHT3c1; MGC120035; MGC120036; MGC120037,"5-hydroxytryptamine (serotonin) receptor 3, family member E",3q27.1,protein-coding,
CWITA006851,TCMBANKGE006851,MLNR,GPR38; MTLR1,motilin receptor,13q14.2,protein-coding,Clinical Trial target
CWITA006852,TCMBANKGE006852,SLC2A7,GLUT-7; GLUT7; hGLUT7,solute carrier family 2 member 7,1p36.23,protein-coding,/
CWITA006853,TCMBANKGE006853,GABRG3,N,"gamma-aminobutyric acid (GABA) A receptor, gamma 3",15q12,protein-coding,
CWITA006854,TCMBANKGE006854,MAPK8IP2,IB-2; IB2; JIP2; PRKM8IPL,mitogen-activated protein kinase 8 interacting protein 2,22q13.33,protein-coding,/
CWITA006855,TCMBANKGE006855,BCL6,BCL5; BCL6A; LAZ3; ZBTB27; ZNF51,BCL6 transcription repressor,3q27.3,protein-coding,Research target
CWITA006856,TCMBANKGE006856,NOG,SYM1; SYNS1; SYNS1A,noggin,17q22,protein-coding,/
CWITA006857,TCMBANKGE006857,CHRNA1,ACHRA; ACHRD; CHRNA; CMS2A; FCCMS; SCCMS,"cholinergic receptor, nicotinic, alpha 1 (muscle)",2q24-q32,protein-coding,
CWITA006858,TCMBANKGE006858,LRRC1,LANO; dJ523E19.1,leucine rich repeat containing 1,6p12.1,protein-coding,/
CWITA006859,TCMBANKGE006859,HIPK3,DYRK6; FIST3; PKY; YAK1,homeodomain interacting protein kinase 3,11p13,protein-coding,/
CWITA006860,TCMBANKGE006860,CYP2C9,CPC9; CYP2C; CYP2C10; CYPIIC9; MGC149605; MGC88320; P450IIC9,"cytochrome P450, family 2, subfamily C, polypeptide 9",10q24,protein-coding,
CWITA006861,TCMBANKGE006861,APOBEC3B,A3B; APOBEC1L; ARCD3; ARP4; DJ742C19.2; PHRBNL; bK150C2.2,apolipoprotein B mRNA editing enzyme catalytic subunit 3B,22q13.1,protein-coding,/
CWITA006862,TCMBANKGE006862,PTGDR,AS1; ASRT1; DP; DP1; MGC49004,prostaglandin D2 receptor (DP),14q22.1,protein-coding,
CWITA006863,TCMBANKGE006863,VCAM1,CD106; DKFZp779G2333; INCAMN100; MGC99561,vascular cell adhesion molecule 1,1p32-p31,protein-coding,
CWITA006864,TCMBANKGE006864,CHAT,CHOACTASE; CMS1A; CMS1A2,choline O-acetyltransferase,10q11.2,protein-coding,
CWITA006865,TCMBANKGE006865,GLIS2,NKL; NPHP7,GLIS family zinc finger 2,16p13.3,protein-coding,/
CWITA006866,TCMBANKGE006866,HSD11B2,AME; AME1; HSD11K; HSD2; SDR9C3,hydroxysteroid 11-beta dehydrogenase 2,16q22.1,protein-coding,Clinical Trial target
CWITA006867,TCMBANKGE006867,RLN1,H1; H1RLX; RLXH1; bA12D24.3.1; bA12D24.3.2,relaxin 1,9p24.1,protein-coding,/
CWITA006868,TCMBANKGE006868,POLE3,CHARAC17; CHRAC17; YBL1; p17,"polymerase (DNA directed), epsilon 3 (p17 subunit)",9q33,protein-coding,
CWITA006869,TCMBANKGE006869,PTGER3,EP3; EP3-I; EP3-II; EP3-III; EP3-IV; EP3-VI; EP3e; PGE2-R; lnc003875,prostaglandin E receptor 3,1p31.1,protein-coding,Clinical Trial target
CWITA006870,TCMBANKGE006870,GAD1,FLJ45882; GAD; SCP,"glutamate decarboxylase 1 (brain, 67kDa)",2q31,protein-coding,
CWITA006871,TCMBANKGE006871,PLA2R1,CLEC13C; PLA2-R; PLA2G1R; PLA2IR; PLA2R,phospholipase A2 receptor 1,2q24.2,protein-coding,Patented target
CWITA006872,TCMBANKGE006872,CPNE1,COPN1; CPN1,copine 1,20q11.22,protein-coding,/
CWITA006873,TCMBANKGE006873,CNOT1,AD-005; CDC39; HPE12; NOT1; NOT1H,CCR4-NOT transcription complex subunit 1,16q21,protein-coding,/
CWITA006874,TCMBANKGE006874,SNX11,-,sorting nexin 11,17q21.32,protein-coding,/
CWITA006875,TCMBANKGE006875,Lprq3,-,lipoprotein QTL 3,1 76.73 cM,unknown,/
CWITA006876,TCMBANKGE006876,DMGDH,DMGDHD; ME2GLYDH,dimethylglycine dehydrogenase,5q14.1,protein-coding,/
CWITA006877,TCMBANKGE006877,MLH1,COCA2; FCC2; HNPCC; HNPCC2; hMLH1,mutL homolog 1,3p22.2,protein-coding,Research target
CWITA006878,TCMBANKGE006878,PSMD13,HSPC027; Rpn9; S11; p40.5,"proteasome 26S subunit, non-ATPase 13",11p15.5,protein-coding,/
CWITA006879,TCMBANKGE006879,KRT33A,HA3I; Ha-3I; K33A; KRTHA3A; Krt1-3; hHa3-I,keratin 33A,17q21.2,protein-coding,/
CWITA006880,TCMBANKGE006880,PBX2,G17; HOX12; PBX2MHC,PBX homeobox 2,6p21.32,protein-coding,/
CWITA006881,TCMBANKGE006881,SLC25A20,CAC; CACT,"solute carrier family 25 (carnitine/acylcarnitine translocase), member 20",3p21.31,protein-coding,
CWITA006882,TCMBANKGE006882,NARS1,ASNRS; NARS,asparaginyl-tRNA synthetase 1,18q21.31,protein-coding,/
CWITA006883,TCMBANKGE006883,MTF2,M96; PCL2; TDRD19A; dJ976O13.2,metal response element binding transcription factor 2,1p22.1,protein-coding,/
CWITA006884,TCMBANKGE006884,MYO7A,DFNA11; DFNB2; MYOVIIA; MYU7A; NSRD2; USH1B,myosin VIIA,11q13.5,protein-coding,/
CWITA006885,TCMBANKGE006885,APOH,B2G1; B2GP1; BG,apolipoprotein H,17q24.2,protein-coding,Discontinued target
CWITA006886,TCMBANKGE006886,ADH1A,ADH1,"alcohol dehydrogenase 1A (class I), alpha polypeptide",4q23,protein-coding,Successful target
CWITA006887,TCMBANKGE006887,Rps29-ps,Gm15757,"ribosomal protein S29, pseudogene",5|5 74.94 cM,pseudo,/
CWITA006888,TCMBANKGE006888,ZNF782,-,zinc finger protein 782,9q22.33,protein-coding,/
CWITA006889,TCMBANKGE006889,FECH,EPP; EPP1; FCE,ferrochelatase,18q21.31,protein-coding,Successful target
CWITA006890,TCMBANKGE006890,SLC2A8,GLUT8; GLUTX1,"solute carrier family 2 (facilitated glucose transporter), member 8",9q33.3,protein-coding,
CWITA006891,TCMBANKGE006891,SLCO6A1,CT48; GST; OATP-I; OATP6A1; OATPY,solute carrier organic anion transporter family member 6A1,5q21.1,protein-coding,/
CWITA006892,TCMBANKGE006892,RAB27B,C25KG,"RAB27B, member RAS oncogene family",18q21.2,protein-coding,/
CWITA006893,TCMBANKGE006893,PEPC,-,peptidase C,1q25,protein-coding,/
CWITA006894,TCMBANKGE006894,BRD7,BP75; CELTIX1; NAG4,bromodomain containing 7,16q12.1,protein-coding,Research target
CWITA006895,TCMBANKGE006895,LRRC26,CAPC; bA350O14.10,leucine rich repeat containing 26,9q34.3,protein-coding,/
CWITA006896,TCMBANKGE006896,NKX2-3,CSX3; NK2.3; NKX2.3; NKX2C; NKX4-3,NK2 homeobox 3,10q24.2,protein-coding,/
CWITA006897,TCMBANKGE006897,GFUS,FX; P35B; SDR4E1; TSTA3,GDP-L-fucose synthase,8q24.3,protein-coding,/
CWITA006898,TCMBANKGE006898,NELL2,NRP2,neural EGFL like 2,12q12,protein-coding,/
CWITA006899,TCMBANKGE006899,TBL1X,CHNG8; EBI; SMAP55; TBL1,transducin beta like 1 X-linked,Xp22.31-p22.2,protein-coding,/
CWITA006900,TCMBANKGE006900,HSPA1L,HSP70-1L; HSP70-HOM; HSP70T; hum70t,heat shock protein family A (Hsp70) member 1 like,6p21.33,protein-coding,/
CWITA006901,TCMBANKGE006901,FREM3,-,FRAS1 related extracellular matrix 3,4q31.21,protein-coding,/
CWITA006902,TCMBANKGE006902,PGGHG,ATHL1,protein-glucosylgalactosylhydroxylysine glucosidase,11p15.5,protein-coding,/
CWITA006903,TCMBANKGE006903,G6pdx,G28A; G6pd; Gpdx,glucose-6-phosphate dehydrogenase X-linked,X A7.3|X 38.0 cM,protein-coding,/
CWITA006904,TCMBANKGE006904,MBTPS1,PCSK8; S1P; SEDKF; SKI-1,"membrane bound transcription factor peptidase, site 1",16q23.3-q24.1,protein-coding,Research target
CWITA006905,TCMBANKGE006905,LRRN4,C20orf75; NLRR-4; NLRR4; dJ1056H1.1,leucine rich repeat neuronal 4,20p12.3,protein-coding,/
CWITA006906,TCMBANKGE006906,CYP11A1,CYP11A; P450SCC,"cytochrome P450, family 11, subfamily A, polypeptide 1",15q23-q24,protein-coding,
CWITA006907,TCMBANKGE006907,AKR1A1,ALDR1; ALR; ARM; DD3; HEL-S-6,aldo-keto reductase family 1 member A1,1p34.1,protein-coding,/
CWITA006908,TCMBANKGE006908,TUBB1,N,"tubulin, beta 1",20q13.32,protein-coding,
CWITA006909,TCMBANKGE006909,GRM1,GPRC1A; MGLU1; MGLUR1; PPP1R85; SCA44; SCAR13,glutamate metabotropic receptor 1,6q24.3,protein-coding,Discontinued target
CWITA006910,TCMBANKGE006910,ELOVL3,CIG-30; CIG30,ELOVL fatty acid elongase 3,10q24.32,protein-coding,/
CWITA006911,TCMBANKGE006911,GABRA2,EIEE78,gamma-aminobutyric acid type A receptor subunit alpha2,4p12,protein-coding,Successful target
CWITA006912,TCMBANKGE006912,CHODL,C21orf68; MT75; PRED12,chondrolectin,21q21.1,protein-coding,/
CWITA006913,TCMBANKGE006913,HEATR5B,-,HEAT repeat containing 5B,2p22.2,protein-coding,/
CWITA006914,TCMBANKGE006914,DCDC2,DCDC2A; DFNB66; NPHP19; NSC; RU2; RU2S,doublecortin domain containing 2,6p22.3,protein-coding,/
CWITA006915,TCMBANKGE006915,MC5R,MC2,melanocortin 5 receptor,18p11.21,protein-coding,Clinical Trial target
CWITA006916,TCMBANKGE006916,SLC19A2,TC1; THT1; THTR1; TRMA,"solute carrier family 19 (thiamine transporter), member 2",1q23.3,protein-coding,
CWITA006917,TCMBANKGE006917,OXA1L,OXA1,OXA1L mitochondrial inner membrane protein,14q11.2,protein-coding,/
CWITA006918,TCMBANKGE006918,TOB2,APRO5; TOB4; TOBL; TROB2,"transducer of ERBB2, 2",22q13.2,protein-coding,/
CWITA006919,TCMBANKGE006919,GPX3,GPxNP; GSHPxN3; GSHPxNP,glutathione peroxidase 3 (plasma),5q23,protein-coding,
CWITA006920,TCMBANKGE006920,CA3,CAIII; Car3; FLJ36434,"carbonic anhydrase III, muscle specific",8q21.2,protein-coding,
CWITA006921,TCMBANKGE006921,PTPRJ,CD148; DEP1; HPTPeta; R-PTP-ETA; SCC1,protein tyrosine phosphatase receptor type J,11p11.2,protein-coding,Research target
CWITA006922,TCMBANKGE006922,YWHAB,GW128; HEL-S-1; HS1; KCIP-1; YWHAA,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,20q13.12,protein-coding,/
CWITA006923,TCMBANKGE006923,MTFR2,DUFD1; FAM54A,mitochondrial fission regulator 2,6q23.3,protein-coding,/
CWITA006924,TCMBANKGE006924,ZNF502,-,zinc finger protein 502,3p21.31,protein-coding,/
CWITA006925,TCMBANKGE006925,NPEPPS,AAP-S; MP100; PSA,Aminopeptidase Puromycin Sensitive,17q21,protein-coding,
CWITA006926,TCMBANKGE006926,ADH5,ADH-3; ADHX; FALDH; FDH; GSH-FDH; GSNOR; HEL-S-60p,"alcohol dehydrogenase 5 (class III), chi polypeptide",4q23,protein-coding,/
CWITA006927,TCMBANKGE006927,PDE6A,CGPRNA; PDEA; RP43,"phosphodiesterase 6A, cGMP-specific, rod, alpha",5q31.2-q34,protein-coding,
CWITA006928,TCMBANKGE006928,CTRL,CTRL1,chymotrypsin like,16q22.1,protein-coding,/
CWITA006929,TCMBANKGE006929,ARVCF,-,ARVCF delta catenin family member,22q11.21,protein-coding,/
CWITA006930,TCMBANKGE006930,PDXDC1,KIAA0251; LP8165,pyridoxal-dependent decarboxylase domain containing 1,16p13.11,protein-coding,
CWITA006931,TCMBANKGE006931,ZNF106,SH3BP3; ZFP106; ZNF474,zinc finger protein 106,15q15.1,protein-coding,/
CWITA006932,TCMBANKGE006932,HTR1E,5NHT1E,5-hydroxytryptamine (serotonin) receptor 1E,6q14-q15,protein-coding,
CWITA006933,TCMBANKGE006933,DHRS4L2,SDR25C3,dehydrogenase/reductase 4 like 2,14q11.2,protein-coding,/
CWITA006934,TCMBANKGE006934,TPMT,TPMTD,thiopurine S-methyltransferase,6p22.3,protein-coding,/
CWITA006935,TCMBANKGE006935,ATP7B,PWD; WC1; WD; WND,"ATPase, Cu++ transporting, beta polypeptide",13q14.3,protein-coding,
CWITA006936,TCMBANKGE006936,ARHGAP19,-,Rho GTPase activating protein 19,10q24.1,protein-coding,/
CWITA006937,TCMBANKGE006937,BST1,CD157,bone marrow stromal cell antigen 1,4p15.32,protein-coding,/
CWITA006938,TCMBANKGE006938,RPL36,L36,ribosomal protein L36,19p13.3,protein-coding,/
CWITA006939,TCMBANKGE006939,LMF1,C16orf26; HMFN1876; JFP11; TMEM112; TMEM112A,lipase maturation factor 1,16p13.3,protein-coding,/
CWITA006940,TCMBANKGE006940,PIN1,DOD; UBL5,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1",19p13,protein-coding,
CWITA006941,TCMBANKGE006941,IGSF3,EWI-3; LCDD; V8,immunoglobulin superfamily member 3,1p13.1,protein-coding,/
CWITA006942,TCMBANKGE006942,MRPS15,DC37; MPR-S15; RPMS15; S15mt,mitochondrial ribosomal protein S15,1p34.3,protein-coding,/
CWITA006943,TCMBANKGE006943,CHRM3,EGBRS; HM3; PBS,cholinergic receptor muscarinic 3,1q43,protein-coding,Successful target
CWITA006944,TCMBANKGE006944,SLC38A9,URLC11,solute carrier family 38 member 9,5q11.2,protein-coding,/
CWITA006945,TCMBANKGE006945,AARS2,AARSL; COXPD8; LKENP; MT-ALARS; MTALARS,"alanyl-tRNA synthetase 2, mitochondrial",6p21.1,protein-coding,/
CWITA006946,TCMBANKGE006946,C1QTNF5,CTRP5; MFRP,C1q and TNF related 5,11q23.3,protein-coding,/
CWITA006947,TCMBANKGE006947,CDK5R2,NCK5AI; P39; p39nck5ai,cyclin dependent kinase 5 regulatory subunit 2,2q35,protein-coding,/
CWITA006948,TCMBANKGE006948,EPS15,AF-1P; AF1P; MLLT5,epidermal growth factor receptor pathway substrate 15,1p32.3,protein-coding,/
CWITA006949,TCMBANKGE006949,PARP4,ADPRTL1; ARTD4; PARP-4; PARPL; PH5P; VAULT3; VPARP; VWA5C; p193,poly(ADP-ribose) polymerase family member 4,13q12.12,protein-coding,/
CWITA006950,TCMBANKGE006950,CA14,CAXiV,carbonic anhydrase 14,1q21.2,protein-coding,Successful target
CWITA006951,TCMBANKGE006951,PA2G4,EBP1; HG4-1; p38-2G4,proliferation-associated 2G4,12q13.2,protein-coding,/
CWITA006952,TCMBANKGE006952,ETFRF1,LYRM5,electron transfer flavoprotein regulatory factor 1,12p12.1,protein-coding,/
CWITA006953,TCMBANKGE006953,FOLR1,FBP; FOLR,folate receptor 1 (adult),11q13.3-q14.1,protein-coding,
CWITA006954,TCMBANKGE006954,VPS26A,HB58; Hbeta58; PEP8A; VPS26,"VPS26, retromer complex component A",10q22.1,protein-coding,/
CWITA006955,TCMBANKGE006955,MBNL3,CHCR; MBLX; MBLX39; MBXL,muscleblind like splicing regulator 3,Xq26.2,protein-coding,/
CWITA006956,TCMBANKGE006956,NONO,MRXS34; NMT55; NRB54; P54; P54NRB; PPP1R114,non-POU domain containing octamer binding,Xq13.1,protein-coding,/
CWITA006957,TCMBANKGE006957,SLC16A4,MCT4; MCT5,solute carrier family 16 member 4,1p13.3,protein-coding,/
CWITA006958,TCMBANKGE006958,SLC16A1,FLJ36745; HHF7; MCT; MCT1; MGC44475,"solute carrier family 16, member 1 (monocarboxylic acid transporter 1)",1p12,protein-coding,
CWITA006959,TCMBANKGE006959,SLC16A3,MCT 3; MCT 4; MCT-3; MCT-4; MCT3; MCT4,solute carrier family 16 member 3,17q25.3,protein-coding,Research target
CWITA006960,TCMBANKGE006960,ZNF783,-,zinc finger family member 783,7q36.1,protein-coding,/
CWITA006961,TCMBANKGE006961,F2,PT; RPRGL2; THPH1,"coagulation factor II, thrombin",11p11.2,protein-coding,Successful target
CWITA006962,TCMBANKGE006962,TMEM11,C17orf35; PM1; PMI,transmembrane protein 11,17p11.2,protein-coding,/
CWITA006963,TCMBANKGE006963,PAGE4,CT16.7; GAGE-9; GAGEC1; JM-27; JM27; PAGE-1; PAGE-4,PAGE family member 4,Xp11.23,protein-coding,/
CWITA006964,TCMBANKGE006964,PRTFDC1,HHGP,phosphoribosyl transferase domain containing 1,10p12.1,protein-coding,/
CWITA006965,TCMBANKGE006965,ZNF331,RITA; ZNF361; ZNF463,zinc finger protein 331,19q13.42,protein-coding,/
CWITA006966,TCMBANKGE006966,TRAPPC4,HSPC172; PTD009; SBDN; SYNBINDIN; TRS23,trafficking protein particle complex 4,11q23.3,protein-coding,
CWITA006967,TCMBANKGE006967,PSMA3,HC8; PSC3,proteasome 20S subunit alpha 3,14q23.1,protein-coding,/
CWITA006968,TCMBANKGE006968,FAAH,FAAHN1; MGC102823; MGC138146,fatty acid amide hydrolase,1p35-p34,protein-coding,
CWITA006969,TCMBANKGE006969,PCBD1,DCOH; PCBD; PCD; PHS,pterin-4 alpha-carbinolamine dehydratase 1,10q22.1,protein-coding,/
CWITA006970,TCMBANKGE006970,EFNB2,EPLG5; HTKL; Htk-L; LERK5,ephrin B2,13q33.3,protein-coding,/
CWITA006971,TCMBANKGE006971,AP3S2,AP3S3; sigma3b,adaptor related protein complex 3 subunit sigma 2,15q26.1,protein-coding,/
CWITA006972,TCMBANKGE006972,FGF13,FGF-13; FGF2; FHF-2; FHF2; LINC00889,fibroblast growth factor 13,Xq26.3-q27.1,protein-coding,/
CWITA006973,TCMBANKGE006973,DKK4,DKK-4,dickkopf WNT signaling pathway inhibitor 4,8p11.21,protein-coding,/
CWITA006974,TCMBANKGE006974,MBOAT4,FKSG89; GOAT; OACT4,membrane bound O-acyltransferase domain containing 4,8p12,protein-coding,Patented target
CWITA006975,TCMBANKGE006975,THBS1,THBS; THBS-1; TSP; TSP-1; TSP1,thrombospondin 1,15q14,protein-coding,Clinical Trial target
CWITA006976,TCMBANKGE006976,PIAS4,PIAS-gamma; PIASY; Piasg; ZMIZ6,protein inhibitor of activated STAT 4,19p13.3,protein-coding,/
CWITA006977,TCMBANKGE006977,RNFT1,PTD016,"ring finger protein, transmembrane 1",17q23.1,protein-coding,/
CWITA006978,TCMBANKGE006978,ZNF570,-,zinc finger protein 570,19q13.12,protein-coding,/
CWITA006979,TCMBANKGE006979,CCAR1,-,cell division cycle and apoptosis regulator 1,10q21.3,protein-coding,/
CWITA006980,TCMBANKGE006980,CENPN,BM039; C16orf60; CENP-N; ICEN32,centromere protein N,16q23.2,protein-coding,/
CWITA006981,TCMBANKGE006981,SIN3A,WITKOS,SIN3 transcription regulator family member A,15q24.2,protein-coding,/
CWITA006982,TCMBANKGE006982,ARID2,BAF200; CSS6; p200,AT-rich interaction domain 2,12q12,protein-coding,/
CWITA006983,TCMBANKGE006983,CCDC167,C6orf129; HSPC265,coiled-coil domain containing 167,6p21.2,protein-coding,/
CWITA006984,TCMBANKGE006984,C1orf50,-,chromosome 1 open reading frame 50,1p34.2,protein-coding,/
CWITA006985,TCMBANKGE006985,RASL11A,-,RAS like family 11 member A,13q12.2,protein-coding,/
CWITA006986,TCMBANKGE006986,DAP3,DAP-3; MRP-S29; MRPS29; S29mt; bMRP-10,death associated protein 3,1q22,protein-coding,/
CWITA006987,TCMBANKGE006987,MTR,HMAG; MS; cblG,5-methyltetrahydrofolate-homocysteine methyltransferase,1q43,protein-coding,Research target
CWITA006988,TCMBANKGE006988,ITPR1,DKFZp313E1334; DKFZp313N1434; INSP3R1; IP3R; IP3R1; SCA15; SCA16,"inositol 1,4,5-trisphosphate receptor, type 1",3p26.1,protein-coding,
CWITA006989,TCMBANKGE006989,ASPDH,-,aspartate dehydrogenase domain containing,19q13.33,protein-coding,/
CWITA006990,TCMBANKGE006990,TXNDC2,SPTRX; SPTRX1,thioredoxin domain containing 2,18p11.22,protein-coding,/
CWITA006991,TCMBANKGE006991,PDSS2,C6orf210; COQ10D3; COQ1B; DLP1; bA59I9.3; hDLP1,decaprenyl diphosphate synthase subunit 2,6q21,protein-coding,/
CWITA006992,TCMBANKGE006992,ZFX,ZNF926,zinc finger protein X-linked,Xp22.11,protein-coding,/
CWITA006993,TCMBANKGE006993,AHRR,AHH; AHHR; bHLHe77,aryl-hydrocarbon receptor repressor,5p15.33,protein-coding,/
CWITA006994,TCMBANKGE006994,ZBTB40,ZNF923,zinc finger and BTB domain containing 40,1p36.12,protein-coding,/
CWITA006995,TCMBANKGE006995,ITPK1,ITRPK1,inositol-tetrakisphosphate 1-kinase,14q32.12,protein-coding,/
CWITA006996,TCMBANKGE006996,CFC1,CFC1B; CRYPTIC; DTGA2; HTX2,"cripto, FRL-1, cryptic family 1",2q21.1,protein-coding,/
CWITA006997,TCMBANKGE006997,HSD17B7,PRAP; SDR37C1,hydroxysteroid 17-beta dehydrogenase 7,1q23.3,protein-coding,/
CWITA006998,TCMBANKGE006998,IFNG,IFG; IFI,"interferon, gamma",12q14,protein-coding,
CWITA006999,TCMBANKGE006999,SP6,EPFN; EPIPROFIN; KLF14,Sp6 transcription factor,17q21.32,protein-coding,/
CWITA007000,TCMBANKGE007000,ZNF577,-,zinc finger protein 577,19q13.41,protein-coding,/
CWITA007001,TCMBANKGE007001,DKKL1,CT34; SGY; SGY-1; SGY1,dickkopf like acrosomal protein 1,19q13.33,protein-coding,/
CWITA007002,TCMBANKGE007002,PAPSS2,ATPSK2; BCYM4; SK2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,10q23.2-q23.31,protein-coding,/
CWITA007003,TCMBANKGE007003,ZC3H15,HT010; LEREPO4; MSTP012,zinc finger CCCH-type containing 15,2q32.1,protein-coding,/
CWITA007004,TCMBANKGE007004,MYO9A,CMS24,myosin IXA,15q23,protein-coding,/
CWITA007005,TCMBANKGE007005,APBB1IP,INAG1; PREL1; RARP1; RIAM,amyloid beta precursor protein binding family B member 1 interacting protein,10p12.1,protein-coding,/
CWITA007006,TCMBANKGE007006,ENPP3,B10; CD203c; NPP3; PD-IBETA; PDNP3,ectonucleotide pyrophosphatase/phosphodiesterase 3,6q23.2,protein-coding,Clinical Trial target
CWITA007007,TCMBANKGE007007,IFNA16,IFN-alpha-16; IFN-alphaO,interferon alpha 16,9p21.3,protein-coding,/
CWITA007008,TCMBANKGE007008,TUBB3,CFEOM3A; TUBB4; betaN4,"tubulin, beta 3",16q24.3,protein-coding,
CWITA007009,TCMBANKGE007009,F8,AHF; DXS1253E; F8B; F8C; FVIII; HEMA,coagulation factor VIII,Xq28,protein-coding,Successful target
CWITA007010,TCMBANKGE007010,TMEM50B,C21orf4; HCVP7TP3,transmembrane protein 50B,21q22.11,protein-coding,/
CWITA007011,TCMBANKGE007011,CFAP52,WDR16; WDRPUH,cilia and flagella associated protein 52,17p13.1,protein-coding,/
CWITA007012,TCMBANKGE007012,CHTF8,CTF8; DERPC,chromosome transmission fidelity factor 8,16q22.1,protein-coding,/
CWITA007013,TCMBANKGE007013,ZNF692,AREBP; Zfp692,zinc finger protein 692,1q44,protein-coding,/
CWITA007014,TCMBANKGE007014,ATP6V0C,ATP6C; ATP6L; ATPL; VATL; VPPC; Vma3,ATPase H+ transporting V0 subunit c,16p13.3,protein-coding,/
CWITA007015,TCMBANKGE007015,ZNF480,-,zinc finger protein 480,19q13.41,protein-coding,/
CWITA007016,TCMBANKGE007016,ZKSCAN3,ZF47; ZFP306; ZNF306; ZNF309; ZSCAN13; ZSCAN35; Zfp47; dJ874C20.1; dJ874C20.1.; zfp-47,zinc finger with KRAB and SCAN domains 3,6p22.1,protein-coding,/
CWITA007017,TCMBANKGE007017,TAF5L,PAF65B,TATA-box binding protein associated factor 5 like,1q42.13,protein-coding,/
CWITA007018,TCMBANKGE007018,RPL26,DBA11; L26,ribosomal protein L26,17p13.1,protein-coding,/
CWITA007019,TCMBANKGE007019,MRTFA,BSAC; MAL; MKL; MKL1; MRTF-A,myocardin related transcription factor A,22q13.1-q13.2,protein-coding,/
CWITA007020,TCMBANKGE007020,UQCRH,QCR6; UQCR8,ubiquinol-cytochrome c reductase hinge protein,1p33,protein-coding,/
CWITA007021,TCMBANKGE007021,ACAD10,-,acyl-CoA dehydrogenase family member 10,12q24.12,protein-coding,/
CWITA007022,TCMBANKGE007022,COPG1,COPG,COPI coat complex subunit gamma 1,3q21.3,protein-coding,/
CWITA007023,TCMBANKGE007023,GOPC,CAL; FIG; GOPC1; PIST; dJ94G16.2,golgi associated PDZ and coiled-coil motif containing,6q22.1,protein-coding,/
CWITA007024,TCMBANKGE007024,SLC29A3,ENT3; HCLAP; HJCD; PHID,solute carrier family 29 member 3,10q22.1,protein-coding,/
CWITA007025,TCMBANKGE007025,ORMDL3,-,ORMDL sphingolipid biosynthesis regulator 3,17q21.1,protein-coding,/
CWITA007026,TCMBANKGE007026,CBR4,SDR45C1,carbonyl reductase 4,4q32.3,protein-coding,/
CWITA007027,TCMBANKGE007027,ERVK-19,HERV-K(C19); P1.8; PR; Protease; Proteinase; envK3; polymerase,"endogenous retrovirus group K member 19, envelope",19q11,other,/
CWITA007028,TCMBANKGE007028,KIF21B,-,kinesin family member 21B,1q32.1,protein-coding,/
CWITA007029,TCMBANKGE007029,RABGEF1,RABEX5; RAP1; rabex-5,RAB guanine nucleotide exchange factor 1,7q11.21,protein-coding,/
CWITA007030,TCMBANKGE007030,PCDHA8,PCDH-ALPHA8,protocadherin alpha 8,5q31.3,protein-coding,/
CWITA007031,TCMBANKGE007031,ITGA1,CD49a; VLA1,integrin subunit alpha 1,5q11.2,protein-coding,Clinical Trial target
CWITA007032,TCMBANKGE007032,ZNF157,HZF22,zinc finger protein 157,Xp11.3,protein-coding,/
CWITA007033,TCMBANKGE007033,PAPLN,PPN,"papilin, proteoglycan like sulfated glycoprotein",14q24.2,protein-coding,/
CWITA007034,TCMBANKGE007034,MRPL14,L14mt; L32mt; MRP-L14; MRP-L32; MRPL32; RMPL32; RPML32,mitochondrial ribosomal protein L14,6p21.1,protein-coding,/
CWITA007035,TCMBANKGE007035,SLC25A10,DIC,"solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10",17q25.3,protein-coding,
CWITA007036,TCMBANKGE007036,KCNQ5,Kv7.5; MRD46,potassium voltage-gated channel subfamily Q member 5,6q13,protein-coding,Research target
CWITA007037,TCMBANKGE007037,PSMB1,HC5; PMSB1; PSC5,proteasome 20S subunit beta 1,6q27,protein-coding,/
CWITA007038,TCMBANKGE007038,SDS,SDH,serine dehydratase,12q24.13,protein-coding,/
CWITA007039,TCMBANKGE007039,CYRIB,BM-009; CYRI; CYRI-B; FAM49B; L1,CYFIP related Rac1 interactor B,8q24.21,protein-coding,/
CWITA007040,TCMBANKGE007040,ADCY3,AC-III; AC3; BMIQ19,adenylate cyclase 3,2p23.3,protein-coding,/
CWITA007041,TCMBANKGE007041,RAC2,EN-7; Gx; HSPC022; p21-Rac2,Rac family small GTPase 2,22q13.1,protein-coding,/
CWITA007042,TCMBANKGE007042,C15orf48,COXFA4L3; FOAP-11; MIR147BHG; NMES1,chromosome 15 open reading frame 48,15q21.1,protein-coding,/
CWITA007043,TCMBANKGE007043,ZFAND6,AWP1; ZA20D3; ZFAND5B,zinc finger AN1-type containing 6,15q25.1,protein-coding,/
CWITA007044,TCMBANKGE007044,DNAJC6,DJC6; PARK19,DnaJ heat shock protein family (Hsp40) member C6,1p31.3,protein-coding,/
CWITA007045,TCMBANKGE007045,PRKX,PKX1,protein kinase X-linked,Xp22.33,protein-coding,/
CWITA007046,TCMBANKGE007046,AP2S1,AP17; CLAPS2; FBH3; FBHOk; HHC3,adaptor related protein complex 2 subunit sigma 1,19q13.32,protein-coding,/
CWITA007047,TCMBANKGE007047,LEAP2,LEAP-2,liver enriched antimicrobial peptide 2,5q31.1,protein-coding,/
CWITA007048,TCMBANKGE007048,TINF2,DKCA3; TIN2,TERF1 interacting nuclear factor 2,14q12,protein-coding,/
CWITA007049,TCMBANKGE007049,ATP5ME,ATP5I; ATP5K,ATP synthase membrane subunit e,4p16.3,protein-coding,/
CWITA007050,TCMBANKGE007050,TRIM11,BIA1; RNF92,tripartite motif containing 11,1q42.13,protein-coding,/
CWITA007051,TCMBANKGE007051,ZNF592,CAMOS; SCAR5,zinc finger protein 592,15q25.3,protein-coding,/
CWITA007052,TCMBANKGE007052,NDUFA11,B14.7; CINB14.7; FLJ76501,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa",19p13.3,protein-coding,
CWITA007053,TCMBANKGE007053,IFIT3,CIG-49; GARG-49; IFI60; IFIT4; IRG2; ISG60; P60; RIG-G; cig41,interferon induced protein with tetratricopeptide repeats 3,10q23.31,protein-coding,/
CWITA007054,TCMBANKGE007054,C8B,C82,complement C8 beta chain,1p32.2,protein-coding,/
CWITA007055,TCMBANKGE007055,PGGT1B,BGGI; GGTI,protein geranylgeranyltransferase type I subunit beta,5q22.3,protein-coding,Clinical Trial target
CWITA007056,TCMBANKGE007056,NME8,CILD6; HEL-S-99; NM23-H8; SPTRX2; TXNDC3; sptrx-2,NME/NM23 family member 8,7p14.1,protein-coding,/
CWITA007057,TCMBANKGE007057,ZRSR2P1,U2AF1-RS1; U2AF1L1; U2AF1P; U2AF1RS1; U2AFBPL; ZC3H21; ZRSR1,ZRSR2 pseudogene 1,5q22.2,pseudo,/
CWITA007058,TCMBANKGE007058,GPR37L1,ET(B)R-LP-2; ETBR-LP-2; ETBRLP2,G protein-coupled receptor 37 like 1,1q32.1,protein-coding,/
CWITA007059,TCMBANKGE007059,PYCRL,FLJ13852,pyrroline-5-carboxylate reductase-like,8q24.3,protein-coding,
CWITA007060,TCMBANKGE007060,ZNF419,ZAPHIR; ZNF419A,zinc finger protein 419,19q13.43,protein-coding,/
CWITA007061,TCMBANKGE007061,ZNF625-ZNF20,-,ZNF625-ZNF20 readthrough (NMD candidate),19p13.2,ncRNA,/
CWITA007062,TCMBANKGE007062,S100A7,PSOR1; S100A7c,S100 calcium binding protein A7,1q21.3,protein-coding,/
CWITA007063,TCMBANKGE007063,UGT2B7,UDPGT_2B9; UDPGT2B7; UDPGTH2; UGT2B9,"UDP glucuronosyltransferase 2 family, polypeptide B7",4q13,protein-coding,
CWITA007064,TCMBANKGE007064,UTY,KDM6AL; KDM6C; UTY1,"ubiquitously transcribed tetratricopeptide repeat containing, Y-linked",Yq11.221,protein-coding,/
CWITA007065,TCMBANKGE007065,IGHV1-2,IGHV12; V35,Immunoglobulin_Heavy_Variable_1-2,14q32.33,other,
CWITA007066,TCMBANKGE007066,ZNF85,HPF4; HTF1,zinc finger protein 85,19p12,protein-coding,/
CWITA007067,TCMBANKGE007067,TOLLIP,IL-1RAcPIP,toll interacting protein,11p15.5,protein-coding,/
CWITA007068,TCMBANKGE007068,TDRD15,-,tudor domain containing 15,2p24.1,protein-coding,/
CWITA007069,TCMBANKGE007069,STXBP3,MUNC18-3; MUNC18C; PSP; UNC-18C,syntaxin binding protein 3,1p13.3,protein-coding,/
CWITA007070,TCMBANKGE007070,EFR3A,-,EFR3 homolog A,8q24.22,protein-coding,/
CWITA007071,TCMBANKGE007071,PRDM6,KMT8C; PDA3; PRISM,PR/SET domain 6,5q23.2,protein-coding,/
CWITA007072,TCMBANKGE007072,TGFB1I1,ARA55; HIC-5; HIC5; TSC-5,transforming growth factor beta 1 induced transcript 1,16p11.2,protein-coding,/
CWITA007073,TCMBANKGE007073,RTCA,RPC; RTC1; RTCD1,RNA 3'-terminal phosphate cyclase,1p21.2,protein-coding,/
CWITA007074,TCMBANKGE007074,NDRG1,CAP43; CMT4D; DRG-1; DRG1; GC4; HMSNL; NDR1; NMSL; PROXY1; RIT42; RTP; TARG1; TDD5,N-myc downstream regulated 1,8q24.22,protein-coding,/
CWITA007075,TCMBANKGE007075,FASTKD2,COXPD44; KIAA0971,FAST kinase domains 2,2q33.3,protein-coding,/
CWITA007076,TCMBANKGE007076,KIF4B,-,kinesin family member 4B,5q33.2,protein-coding,/
CWITA007077,TCMBANKGE007077,PSIP1,DFS70; LEDGF; PAIP; PSIP2; p52; p75,PC4 and SFRS1 interacting protein 1,9p22.3,protein-coding,Research target
CWITA007078,TCMBANKGE007078,SRSF9,SFRS9; SRp30c,serine and arginine rich splicing factor 9,12q24.31,protein-coding,/
CWITA007079,TCMBANKGE007079,FAM222B,C17orf63,family with sequence similarity 222 member B,17q11.2,protein-coding,/
CWITA007080,TCMBANKGE007080,PSTPIP1,CD2BP1; CD2BP1L; CD2BP1S; H-PIP; PAPAS; PSTPIP,proline-serine-threonine phosphatase interacting protein 1,15q24.3,protein-coding,/
CWITA007081,TCMBANKGE007081,THRB,ERBANBETA; ERBA2; GRTH; MGC126109; MGC126110; NR1A2; PRTH; THR1; THRB1; THRB2,"thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)",3p24.2,protein-coding,
CWITA007082,TCMBANKGE007082,Mapk6-ps1,-,"mitogen-activated protein kinase 6, pseudogene 1",-,pseudo,/
CWITA007083,TCMBANKGE007083,TRMT11,C6orf75; MDS024; TRM11; TRMT11-1,tRNA methyltransferase 11 homolog,6q22.32,protein-coding,/
CWITA007084,TCMBANKGE007084,SLC1A4,ASCT1; SATT; SPATCCM,solute carrier family 1 member 4,2p14,protein-coding,/
CWITA007085,TCMBANKGE007085,SEC11C,SEC11L3; SPC21; SPCS4C,"SEC11 homolog C, signal peptidase complex subunit",18q21.32,protein-coding,/
CWITA007086,TCMBANKGE007086,ANO6,BDPLT7; SCTS; TMEM16F,anoctamin 6,12q12,protein-coding,/
CWITA007087,TCMBANKGE007087,ARIH2OS,C3orf71,ARIH2 opposite strand lncRNA,3p21.31,ncRNA,/
CWITA007088,TCMBANKGE007088,LARP4B,KIAA0217; LARP5,La ribonucleoprotein 4B,10p15.3,protein-coding,/
CWITA007089,TCMBANKGE007089,HK1,HK; HK1-ta; HK1-tb; HK1-tc; HKD; HKI; HMSNR; HXK1; NEDVIBA; RP79; hexokinase,hexokinase 1,10q22.1,protein-coding,/
CWITA007090,TCMBANKGE007090,NDUFS5,CIN15k; CI15K,"NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)",1p34.2-p33,protein-coding,
CWITA007091,TCMBANKGE007091,WWC3,BM042,WWC family member 3,Xp22.2,protein-coding,/
CWITA007092,TCMBANKGE007092,SLAMF1,CD150; CDw150; SLAM,signaling lymphocytic activation molecule family member 1,1q23.3,protein-coding,/
CWITA007093,TCMBANKGE007093,HELQ,HEL308,"helicase, POLQ like",4q21.23,protein-coding,/
CWITA007094,TCMBANKGE007094,ZNF146,OZF,zinc finger protein 146,19q13.12,protein-coding,Research target
CWITA007095,TCMBANKGE007095,HCFC2,HCF-2; HCF2,host cell factor C2,12q23.3,protein-coding,/
CWITA007096,TCMBANKGE007096,LTN1,C21orf10; C21orf98; RNF160; ZNF294,listerin E3 ubiquitin protein ligase 1,21q21.3,protein-coding,/
CWITA007097,TCMBANKGE007097,TPI1,MGC88108; TPI,triosephosphate isomerase 1,12p13,protein-coding,
CWITA007098,TCMBANKGE007098,BRSK2,C11orf7; PEN11B; SAD1; SADA; STK29,BR serine/threonine kinase 2,11p15.5,protein-coding,Research target
CWITA007099,TCMBANKGE007099,HAUS4,C14orf94,HAUS augmin like complex subunit 4,14q11.2,protein-coding,/
CWITA007100,TCMBANKGE007100,IFIT1,C56; G10P1; IFI-56; IFI-56K; IFI56; IFIT-1; IFNAI1; ISG56; P56; RNM561,interferon induced protein with tetratricopeptide repeats 1,10q23.31,protein-coding,/
CWITA007101,TCMBANKGE007101,CBR1,CBR; SDR21C1; hCBR1,carbonyl reductase 1,21q22.13,protein-coding,
CWITA007102,TCMBANKGE007102,TAF3,TAF140; TAFII-140; TAFII140,TATA-box binding protein associated factor 3,10p14,protein-coding,/
CWITA007103,TCMBANKGE007103,MGAT5,GNT-V; GNT-VA; MGAT5A; glcNAc-T V,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase",2q21.2-q21.3,protein-coding,/
CWITA007104,TCMBANKGE007104,DAZL,DAZH; DAZL1; DAZLA; SPGYLA,deleted in azoospermia like,3p24.3,protein-coding,/
CWITA007105,TCMBANKGE007105,PDXK,C21orf124; C21orf97; HEL-S-1a; HMSN6C; PKH; PNK; PRED79,pyridoxal kinase,21q22.3,protein-coding,Research target
CWITA007106,TCMBANKGE007106,PARM1,Cipar1; DKFZP564O0823; PARM-1; WSC4,prostate androgen-regulated mucin-like protein 1,4q13.3,protein-coding,/
CWITA007107,TCMBANKGE007107,NPFFR2,GPR74; HLWAR77; NPFF2; NPGPR,neuropeptide FF receptor 2,4q13.3,protein-coding,Research target
CWITA007108,TCMBANKGE007108,MRPL17,L17mt; LIP2; MRP-L17; MRP-L26; RPL17L; RPML26,mitochondrial ribosomal protein L17,11p15.4,protein-coding,/
CWITA007109,TCMBANKGE007109,TRIM31,C6orf13; HCG1; HCGI; RNF,tripartite motif containing 31,6p22.1,protein-coding,/
CWITA007110,TCMBANKGE007110,INF2,C14orf151; C14orf173; CMTDIE; FSGS5; pp9484,inverted formin 2,14q32.33,protein-coding,/
CWITA007111,TCMBANKGE007111,NEUROG3,Atoh5; Math4B; NGN-3; bHLHa7; ngn3,neurogenin 3,10q22.1,protein-coding,/
CWITA007112,TCMBANKGE007112,ZNF581,HSPC189,zinc finger protein 581,19q13.42,protein-coding,/
CWITA007113,TCMBANKGE007113,HDAC4,AHO3; BDMR; HA6116; HD4; HDAC-4; HDAC-A; HDACA,histone deacetylase 4,2q37.3,protein-coding,Clinical Trial target
CWITA007114,TCMBANKGE007114,NAE1,A-116A10.1; APPBP1; HPP1; ula-1,NEDD8 activating enzyme E1 subunit 1,16q22.1,protein-coding,/
CWITA007115,TCMBANKGE007115,FAM107A,DRR1; TU3A,family with sequence similarity 107 member A,3p14.3-p14.2,protein-coding,/
CWITA007116,TCMBANKGE007116,TGM2,GNALPHANh; GNAH; TG2; TGC,"transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)",20q12,protein-coding,
CWITA007117,TCMBANKGE007117,CPSF7,CFIm59,cleavage and polyadenylation specific factor 7,11q12.2,protein-coding,/
CWITA007118,TCMBANKGE007118,LDHAL6B,LDH6B; LDHAL6; LDHL,lactate dehydrogenase A-like 6B,15q22.2,protein-coding,
CWITA007119,TCMBANKGE007119,DUSP15,C20orf57; VHY,dual specificity phosphatase 15,20q11.21,protein-coding,/
CWITA007120,TCMBANKGE007120,PACSIN2,SDPII,protein kinase C and casein kinase substrate in neurons 2,22q13.2,protein-coding,/
CWITA007121,TCMBANKGE007121,XPO1,CRM-1; CRM1; emb; exp1,exportin 1,2p15,protein-coding,Clinical Trial target
CWITA007122,TCMBANKGE007122,SALL1,HEL-S-89; HSAL1; Sal-1; TBS; ZNF794,spalt like transcription factor 1,16q12.1,protein-coding,/
CWITA007123,TCMBANKGE007123,GLIPR2,C9orf19; GAPR-1; GAPR1,GLI pathogenesis related 2,9p13.3,protein-coding,/
CWITA007124,TCMBANKGE007124,UBE4A,E4; UBOX2; UFD2,ubiquitination factor E4A,11q23.3,protein-coding,/
CWITA007125,TCMBANKGE007125,VPS13C,PARK23,vacuolar protein sorting 13 homolog C,15q22.2,protein-coding,/
CWITA007126,TCMBANKGE007126,H2BC5,H2B.1B; H2B/a; H2B/b; H2B/g; H2B/h; H2B/k; H2B/l; H2BFA; H2BFB; H2BFG; H2BFH; H2BFK; H2BFL; HIRIP2; HIST1H2BC; HIST1H2BD; HIST1H2BE; HIST1H2BF; HIST1H2BG; HIST1H2BI; dJ221C16.6,H2B clustered histone 5,6p22.2,protein-coding,/
CWITA007127,TCMBANKGE007127,GCNT2,CCAT; CTRCT13; GCNT2C; GCNT5; IGNT; II; NACGT1; NAGCT1; ULG3; bA360O19.2; bA421M1.1,glucosaminyl (N-acetyl) transferase 2 (I blood group),6p24.3-p24.2,protein-coding,/
CWITA007128,TCMBANKGE007128,PLA2G2A,MOM1; PLA2; PLA2B; PLA2L; PLA2S; PLAS1; sPLA2,"phospholipase A2, group IIA (platelets, synovial fluid)",1p35,protein-coding,
CWITA007129,TCMBANKGE007129,PFKFB2,PFK-2/FBPase-2,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2",1q32.1,protein-coding,Research target
CWITA007130,TCMBANKGE007130,BCOR,ANOP2; MAA2; MCOPS2,BCL6 corepressor,Xp11.4,protein-coding,/
CWITA007131,TCMBANKGE007131,ITPKB,IP3-3KB; IP3K; IP3K-B; IP3KB; PIG37,inositol-trisphosphate 3-kinase B,1q42.12,protein-coding,/
CWITA007132,TCMBANKGE007132,BANK1,BANK,B cell scaffold protein with ankyrin repeats 1,4q24,protein-coding,/
CWITA007133,TCMBANKGE007133,NAA30,C14orf35; MAK3; Mak3p; NAT12; NAT12P,"N-alpha-acetyltransferase 30, NatC catalytic subunit",14q22.3,protein-coding,/
CWITA007134,TCMBANKGE007134,FKBP2,FKBP-13; FKBP13; PPIase,FKBP prolyl isomerase 2,11q13.1,protein-coding,/
CWITA007135,TCMBANKGE007135,RAB44,RASD3; RASL13; dJ431A14.3,"RAB44, member RAS oncogene family",6p21.2,protein-coding,/
CWITA007136,TCMBANKGE007136,GPR45,PSP24; PSP24(ALPHA); PSP24A,G protein-coupled receptor 45,2q12.1,protein-coding,/
CWITA007137,TCMBANKGE007137,SERPINB5,PI5; maspin,serpin family B member 5,18q21.33,protein-coding,Research target
CWITA007138,TCMBANKGE007138,ICA1,ICA69; ICAp69,islet cell autoantigen 1,7p21.3,protein-coding,Research target
CWITA007139,TCMBANKGE007139,PHC2,EDR2; HPH2; PH2,polyhomeotic homolog 2,1p35.1,protein-coding,/
CWITA007140,TCMBANKGE007140,PCBP1,HEL-S-85; HNRPE1; HNRPX; hnRNP-E1; hnRNP-X,poly(rC) binding protein 1,2p13.3,protein-coding,/
CWITA007141,TCMBANKGE007141,MTHFR,-,methylenetetrahydrofolate reductase,1p36.22,protein-coding,Research target
CWITA007142,TCMBANKGE007142,SERINC1,TDE1L; TDE2; TMS-2; TMS2,serine incorporator 1,6q22.31,protein-coding,/
CWITA007143,TCMBANKGE007143,MYOG,MYF4; bHLHc3; myf-4,myogenin,1q32.1,protein-coding,/
CWITA007144,TCMBANKGE007144,TP53I11,PIG11,tumor protein p53 inducible protein 11,11p11.2,protein-coding,/
CWITA007145,TCMBANKGE007145,GGT6,-,gamma-glutamyltransferase 6,17p13.2,protein-coding,/
CWITA007146,TCMBANKGE007146,R3HDM2,CAG6; PR01365,R3H domain containing 2,12q13.3,protein-coding,/
CWITA007147,TCMBANKGE007147,PITPNM1,DRES9; NIR2; PITPNM; RDGB; RDGB1; RDGBA; RDGBA1; Rd9,phosphatidylinositol transfer protein membrane associated 1,11q13.2,protein-coding,/
CWITA007148,TCMBANKGE007148,BDKRB2,B2R; BK-2; BK2; BKR2; BRB2,bradykinin receptor B2,14q32.2,protein-coding,Successful target
CWITA007149,TCMBANKGE007149,PDLIM2,MYSTIQUE; SLIM,PDZ and LIM domain 2,8p21.3,protein-coding,/
CWITA007150,TCMBANKGE007150,LRRC18,UNQ933; UNQ9338; VKGE9338,leucine rich repeat containing 18,10q11.23,protein-coding,/
CWITA007151,TCMBANKGE007151,TIMP2,CSC-21K; DDC8,TIMP metallopeptidase inhibitor 2,17q25.3,protein-coding,/
CWITA007152,TCMBANKGE007152,CLPTM1,-,CLPTM1 regulator of GABA type A receptor forward trafficking,19q13.32,protein-coding,/
CWITA007153,TCMBANKGE007153,NDUFS8,CI-23k; CI23KD; MC1DN2; TYKY,NADH:ubiquinone oxidoreductase core subunit S8,11q13.2,protein-coding,/
CWITA007154,TCMBANKGE007154,KPNB1,IMB1; IPO1; IPOB; Impnb; NTF97,karyopherin subunit beta 1,17q21.32,protein-coding,Research target
CWITA007155,TCMBANKGE007155,ZNF512,-,zinc finger protein 512,2p23.3,protein-coding,/
CWITA007156,TCMBANKGE007156,IGHD,-,immunoglobulin heavy constant delta,14q32.33,other,/
CWITA007157,TCMBANKGE007157,ZNF575,-,zinc finger protein 575,19q13.31,protein-coding,/
CWITA007158,TCMBANKGE007158,TCTE1,D6S46; DRC5; FAP155,t-complex-associated-testis-expressed 1,6p21.1,protein-coding,/
CWITA007159,TCMBANKGE007159,ORM2,AGP-B; AGP-B'; AGP2,orosomucoid 2,9q32,protein-coding,/
CWITA007160,TCMBANKGE007160,NT5C3B,NT5C3L; cN-IIIB,"5'-nucleotidase, cytosolic IIIB",17q21.2,protein-coding,/
CWITA007161,TCMBANKGE007161,PCDHA13,CNR5; CNRN5; CNRS5; CRNR5; PCDH-ALPHA13,protocadherin alpha 13,5q31.3,protein-coding,/
CWITA007162,TCMBANKGE007162,SLC39A3,ZIP-3; ZIP3,solute carrier family 39 member 3,19p13.3,protein-coding,/
CWITA007163,TCMBANKGE007163,NUP205,C7orf14; NPHS13,nucleoporin 205,7q33,protein-coding,/
CWITA007164,TCMBANKGE007164,MAN2B1,LAMAN; MANB,mannosidase alpha class 2B member 1,19p13.13,protein-coding,/
CWITA007165,TCMBANKGE007165,VKORC1,EDTP308; FLJ00289; IMAGE3455200; MGC2694; MST134; MST576; VKCFD2; VKOR,"vitamin K epoxide reductase complex, subunit 1",16p11.2,protein-coding,
CWITA007166,TCMBANKGE007166,COL27A1,STLS,collagen type XXVII alpha 1 chain,9q32,protein-coding,/
CWITA007167,TCMBANKGE007167,LIG4,LIG4S,DNA ligase 4,13q33.3,protein-coding,/
CWITA007168,TCMBANKGE007168,KRT72,K6IRS2; K6irs; KRT6; KRT6IRS2,keratin 72,12q13.13,protein-coding,/
CWITA007169,TCMBANKGE007169,VCX3A,VCX-8r; VCX-A; VCX3; VCX8R; VCXA,variable charge X-linked 3A,Xp22.31,protein-coding,/
CWITA007170,TCMBANKGE007170,CD302,BIMLEC; CLEC13A; DCL-1; DCL1,CD302 molecule,2q24.2,protein-coding,/
CWITA007171,TCMBANKGE007171,CRBN,MRT2; MRT2A,cereblon,3p26.2,protein-coding,Clinical Trial target
CWITA007172,TCMBANKGE007172,RNASE1,RAC1; RIB1; RNS1,"ribonuclease A family member 1, pancreatic",14q11.2,protein-coding,/
CWITA007173,TCMBANKGE007173,ANO7,D-TMPP; DTMPP; IPCA-5; IPCA5; NGEP; PCANAP5; PCANAP5L; TMEM16G,anoctamin 7,2q37.3,protein-coding,Research target
CWITA007174,TCMBANKGE007174,FADS3,CYB5RP; LLCDL3,fatty acid desaturase 3,11q12.2,protein-coding,/
CWITA007175,TCMBANKGE007175,FCN2,EBP-37; FCNL; P35; ficolin-2,ficolin 2,9q34.3,protein-coding,/
CWITA007176,TCMBANKGE007176,GCAT,KBL,glycine C-acetyltransferase,22q13.1,protein-coding,/
CWITA007177,TCMBANKGE007177,SGTB,SGT2,small glutamine rich tetratricopeptide repeat containing beta,5q12.3,protein-coding,/
CWITA007178,TCMBANKGE007178,SERAC1,-,serine active site containing 1,6q25.3,protein-coding,/
CWITA007179,TCMBANKGE007179,CPXM2,CPX2; UNQ676,"carboxypeptidase X, M14 family member 2",10q26.13,protein-coding,/
CWITA007180,TCMBANKGE007180,EGLN2,EIT-6; EIT6; HIF-PH1; HIFPH1; HPH-1; HPH-3; PHD1,egl-9 family hypoxia inducible factor 2,19q13.2,protein-coding,Clinical Trial target
CWITA007181,TCMBANKGE007181,WNK4,PHA2B; PRKWNK4,WNK lysine deficient protein kinase 4,17q21.2,protein-coding,/
CWITA007182,TCMBANKGE007182,EN1,-,engrailed homeobox 1,2q14.2,protein-coding,/
CWITA007183,TCMBANKGE007183,GCNT7,C20orf105; dJ1153D9.2; gcnt,glucosaminyl (N-acetyl) transferase family member 7,20q13.31,protein-coding,/
CWITA007184,TCMBANKGE007184,MSX1,ECTD3; HOX7; HYD1; STHAG1,msh homeobox 1,4p16.2,protein-coding,/
CWITA007185,TCMBANKGE007185,ASMT,ASMTY; HIOMT; HIOMTY,acetylserotonin O-methyltransferase,Xp22.33 and Yp11.2,protein-coding,/
CWITA007186,TCMBANKGE007186,NTS,NMN-125; NN; NT; NT/N; NTS1,neurotensin,12q21.31,protein-coding,/
CWITA007187,TCMBANKGE007187,KDM5D,HY; HYA; JARID1D; KIAA0234; SMCY,lysine (K)-specific demethylase 5D,Yq11|Yq11,protein-coding,
CWITA007188,TCMBANKGE007188,SULT1A1,HAST1/HAST2; MGC131921; MGC5163; PNPST; PST; ST1A1; ST1A3; STP; STP1; TSPST1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",16p12.1,protein-coding,
CWITA007189,TCMBANKGE007189,UBA1,A1S9; A1S9T; A1ST; AMCX1; GXP1; MGC4781; POC20; SMAX2; UBA1A; UBE1; UBE1X,ubiquitin-like modifier activating enzyme 1,Xp11.23,protein-coding,
CWITA007190,TCMBANKGE007190,MGAM,MG; MGA,maltase-glucoamylase (alpha-glucosidase),7q34,protein-coding,
CWITA007191,TCMBANKGE007191,RAPGEF6,KIA001LB; PDZ-GEF2; PDZGEF2; RA-GEF-2; RAGEF2,Rap guanine nucleotide exchange factor 6,5q31.1,protein-coding,/
CWITA007192,TCMBANKGE007192,EMP3,YMP,epithelial membrane protein 3,19q13.33,protein-coding,/
CWITA007193,TCMBANKGE007193,STK35,CLIK1; STK35L1,serine/threonine kinase 35,20p13,protein-coding,/
CWITA007194,TCMBANKGE007194,ADRBK2,BARK2; GRK3,"adrenergic, beta, receptor kinase 2",22q11|22q12.1,protein-coding,
CWITA007195,TCMBANKGE007195,IQCD,4933433C09Rik; CFAP84; DRC10,IQ motif containing D,12q24.13,protein-coding,/
CWITA007196,TCMBANKGE007196,ZDHHC14,NEW1CP,zinc finger DHHC-type palmitoyltransferase 14,6q25.3,protein-coding,/
CWITA007197,TCMBANKGE007197,KIAA1549,RP86,KIAA1549,7q34,protein-coding,/
CWITA007198,TCMBANKGE007198,KMT2B,CXXC10; DYT28; HRX2; MLL1B; MLL2; MLL4; TRX2; WBP-7; WBP7,lysine methyltransferase 2B,19q13.12,protein-coding,/
CWITA007199,TCMBANKGE007199,TMLHE,AUTSX6; BBOX2; TMLD; TMLH; TMLHED; XAP130,"trimethyllysine hydroxylase, epsilon",Xq28,protein-coding,/
CWITA007200,TCMBANKGE007200,PDCD7,ES18; HES18,programmed cell death 7,15q22.31,protein-coding,/
CWITA007201,TCMBANKGE007201,BCS1L,BCS; BCS1; BJS; FLNMS; GRACILE; Hs.6719; MC3DN1; PTD; h-BCS; h-BCS1,"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone",2q35,protein-coding,/
CWITA007202,TCMBANKGE007202,CETP,BPIFF; HDLCQ10,cholesteryl ester transfer protein,16q13,protein-coding,Clinical Trial target
CWITA007203,TCMBANKGE007203,SLC38A6,NAT-1; SNAT6,solute carrier family 38 member 6,14q23.1,protein-coding,/
CWITA007204,TCMBANKGE007204,Frs3os,4930417B13Rik; Gm14873,"fibroblast growth factor receptor substrate 3, opposite strand",17|17 C,ncRNA,/
CWITA007205,TCMBANKGE007205,HAO2,GIG16; HAOX2,hydroxyacid oxidase 2,1p12,protein-coding,/
CWITA007206,TCMBANKGE007206,UBXN1,2B28; SAKS1; UBXD10,UBX domain protein 1,11q12.3,protein-coding,/
CWITA007207,TCMBANKGE007207,ERG28,C14orf1; NET51,ergosterol biosynthesis 28 homolog,14q24.3,protein-coding,/
CWITA007208,TCMBANKGE007208,BIVM,-,"basic, immunoglobulin-like variable motif containing",13q33.1,protein-coding,/
CWITA007209,TCMBANKGE007209,FAH,-,fumarylacetoacetate hydrolase,15q25.1,protein-coding,/
CWITA007210,TCMBANKGE007210,SULF1,SULF-1,sulfatase 1,8q13.2-q13.3,protein-coding,/
CWITA007211,TCMBANKGE007211,CARD10,BIMP1; CARMA3,caspase recruitment domain family member 10,22q13.1,protein-coding,/
CWITA007212,TCMBANKGE007212,CNTLN,C9orf101; C9orf39; bA340N12.1,centlein,9p22.2,protein-coding,Research target
CWITA007213,TCMBANKGE007213,BRD3,ORFX; RING3L,bromodomain containing 3,9q34.2,protein-coding,Clinical Trial target
CWITA007214,TCMBANKGE007214,GRIA4,GLUR4; GLUR4C; GLURD; GluA4; NEDSGA,glutamate ionotropic receptor AMPA type subunit 4,11q22.3,protein-coding,Successful target
CWITA007215,TCMBANKGE007215,EIF2B1,EIF2B; EIF2BA,eukaryotic translation initiation factor 2B subunit alpha,12q24.31,protein-coding,/
CWITA007216,TCMBANKGE007216,OTOGL,C12orf64; DFNB84B,otogelin like,12q21.31,protein-coding,/
CWITA007217,TCMBANKGE007217,FCAR,CD89; CTB-61M7.2; FcalphaRI,Fc fragment of IgA receptor,19q13.42,protein-coding,Discontinued target
CWITA007218,TCMBANKGE007218,PRSS53,POL3S; UNQ308,serine protease 53,16p11.2,protein-coding,/
CWITA007219,TCMBANKGE007219,ACTL6A,ACTL6; ARPN-BETA; Arp4; BAF53A; INO80K,actin like 6A,3q26.33,protein-coding,/
CWITA007220,TCMBANKGE007220,PF4V1,CXCL4L1; CXCL4V1; PF4-ALT; PF4A; SCYB4V1,platelet factor 4 variant 1,4q13.3,protein-coding,/
CWITA007221,TCMBANKGE007221,PPIH,CYPN20; CYPH; MGC5016; SnuCypN20; USANCYP,peptidylprolyl isomerase H (cyclophilin H),1p34.1,protein-coding,
CWITA007222,TCMBANKGE007222,CYB561A3,CYBASC3; LCYTB,cytochrome b561 family member A3,11q12.2,protein-coding,/
CWITA007223,TCMBANKGE007223,RBM15,OTT; OTT1; SPEN,RNA binding motif protein 15,1p13.3,protein-coding,/
CWITA007224,TCMBANKGE007224,GNAI1,Gi,G protein subunit alpha i1,7q21.11,protein-coding,/
CWITA007225,TCMBANKGE007225,HNRNPA1,ALS19; ALS20; HNRPA1; HNRPA1L3; IBMPFD3; UP 1; hnRNP A1; hnRNP-A1,heterogeneous nuclear ribonucleoprotein A1,12q13.13,protein-coding,Research target
CWITA007226,TCMBANKGE007226,RHBDD3,C22orf3; HS984G1A; PTAG,rhomboid domain containing 3,22q12.2,protein-coding,/
CWITA007227,TCMBANKGE007227,PTPN4,PTPMEG; PTPMEG1,"protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)",2q14.2,protein-coding,
CWITA007228,TCMBANKGE007228,ANAPC11,APC11; Apc11p; HSPC214,anaphase promoting complex subunit 11,17q25.3,protein-coding,/
CWITA007229,TCMBANKGE007229,ZNF420,APAK,zinc finger protein 420,19q13.12,protein-coding,/
CWITA007230,TCMBANKGE007230,FXN,CyaY; FA; FARR; FRDA; X25,frataxin,9q21.11,protein-coding,/
CWITA007231,TCMBANKGE007231,PTGER2,EP2,"prostaglandin E receptor 2 (subtype EP2), 53kDa",14q22,protein-coding,
CWITA007232,TCMBANKGE007232,ACTL7A,-,actin like 7A,9q31.3,protein-coding,/
CWITA007233,TCMBANKGE007233,NSG2,CALY3; HMP19,neuronal vesicle trafficking associated 2,5q35.2,protein-coding,/
CWITA007234,TCMBANKGE007234,CACNG4,-,calcium voltage-gated channel auxiliary subunit gamma 4,17q24.2,protein-coding,/
CWITA007235,TCMBANKGE007235,PLPP1,LLP1a; LPP1; PAP-2a; PAP2; PPAP2A,phospholipid phosphatase 1,5q11.2,protein-coding,/
CWITA007236,TCMBANKGE007236,NISCH,I-1; IR1; IRAS; hIRAS,nischarin,3p21.1,protein-coding,Research target
CWITA007237,TCMBANKGE007237,BCL2L12,-,BCL2 like 12,19q13.33,protein-coding,/
CWITA007238,TCMBANKGE007238,HOXD11,HOX4; HOX4F,homeobox D11,2q31.1,protein-coding,/
CWITA007239,TCMBANKGE007239,RFXANK,ANKRA1; BLS; F14150_1; RFX-B,regulatory factor X associated ankyrin containing protein,19p13.11,protein-coding,/
CWITA007240,TCMBANKGE007240,GINS2,HSPC037; PSF2; Pfs2,GINS complex subunit 2,16q24.1,protein-coding,/
CWITA007241,TCMBANKGE007241,OSGEPL1,OSGEPL; Qri7,O-sialoglycoprotein endopeptidase like 1,2q32.2,protein-coding,/
CWITA007242,TCMBANKGE007242,DEPDC1B,BRCC3; XTP1,DEP domain containing 1B,5q12.1,protein-coding,/
CWITA007243,TCMBANKGE007243,DEDD2,FLAME-3; FLAME3,death effector domain containing 2,19q13.2,protein-coding,/
CWITA007244,TCMBANKGE007244,ABRACL,C6orf115; Costars; HSPC280; PRO2013,ABRA C-terminal like,6q24.1,protein-coding,/
CWITA007245,TCMBANKGE007245,EDF1,CFAP280; EDF-1; MBF1,endothelial differentiation related factor 1,9q34.3,protein-coding,/
CWITA007246,TCMBANKGE007246,ZNF99,C19orf9; F8281,zinc finger protein 99,19p12,protein-coding,/
CWITA007247,TCMBANKGE007247,BBS10,C12orf58,Bardet-Biedl syndrome 10,12q21.2,protein-coding,/
CWITA007248,TCMBANKGE007248,PGR-AS1,AT1; AT2; AT3,PGR antisense RNA 1,11q22.1,ncRNA,/
CWITA007249,TCMBANKGE007249,ZNF507,Zfp507,zinc finger protein 507,19q13.11,protein-coding,/
CWITA007250,TCMBANKGE007250,C3orf14,HT021,chromosome 3 open reading frame 14,3p14.2,protein-coding,/
CWITA007251,TCMBANKGE007251,PPP2R2A,B55A; B55ALPHA; PR52A; PR55A; PR55alpha,protein phosphatase 2 regulatory subunit Balpha,8p21.2,protein-coding,/
CWITA007252,TCMBANKGE007252,IL22,IL-21; IL-22; IL-D110; IL-TIF; ILTIF; TIFIL-23; TIFa; zcyto18,interleukin 22,12q15,protein-coding,Clinical Trial target
CWITA007253,TCMBANKGE007253,ITGB8,-,integrin subunit beta 8,7p21.1,protein-coding,Research target
CWITA007254,TCMBANKGE007254,DDI2,-,DNA damage inducible 1 homolog 2,1p36.21,protein-coding,/
CWITA007255,TCMBANKGE007255,ZNF416,-,zinc finger protein 416,19q13.43,protein-coding,/
CWITA007256,TCMBANKGE007256,RAB3GAP1,P130; RAB3GAP; RAB3GAP130; WARBM1,RAB3 GTPase activating protein catalytic subunit 1,2q21.3,protein-coding,/
CWITA007257,TCMBANKGE007257,RING1,RING1A; RNF1,ring finger protein 1,6p21.32,protein-coding,/
CWITA007258,TCMBANKGE007258,RARS2,ArgRS; DALRD2; PCH6; PRO1992; RARSL,"arginyl-tRNA synthetase 2, mitochondrial",6q15,protein-coding,/
CWITA007259,TCMBANKGE007259,SAT1,DC21; KFSD; KFSDX; SAT; SSAT; SSAT-1,spermidine/spermine N1-acetyltransferase 1,Xp22.11,protein-coding,/
CWITA007260,TCMBANKGE007260,ALDH1B1,ALDH5; ALDHX; MGC2230,"aldehyde dehydrogenase 1 family, member B1",9p11.1,protein-coding,
CWITA007261,TCMBANKGE007261,TTC27,-,tetratricopeptide repeat domain 27,2p22.3,protein-coding,/
CWITA007262,TCMBANKGE007262,DMTF1,DMP1; DMTF; MRUL; hDMP1,cyclin D binding myb like transcription factor 1,7q21.12,protein-coding,/
CWITA007263,TCMBANKGE007263,IQGAP3,-,IQ motif containing GTPase activating protein 3,1q22,protein-coding,/
CWITA007264,TCMBANKGE007264,P2RX6,P2RXL1; P2X6; P2XM,purinergic receptor P2X 6,22q11.21,protein-coding,/
CWITA007265,TCMBANKGE007265,P3H1,GROS1; LEPRE1; OI8,Prolyl_3-Hydroxylase_1,1p34.2,protein-coding,
CWITA007266,TCMBANKGE007266,PRKCQ,MGC126514; MGC141919; PRKCT; nPKCNtheta,"protein kinase C, theta",10p15,protein-coding,
CWITA007267,TCMBANKGE007267,ANKRD63,-,ankyrin repeat domain 63,15q15.1,protein-coding,/
CWITA007268,TCMBANKGE007268,XPOT,XPO3,exportin for tRNA,12q14.2,protein-coding,/
CWITA007269,TCMBANKGE007269,CGB8,-,chorionic gonadotropin subunit beta 8,19q13.33,protein-coding,/
CWITA007270,TCMBANKGE007270,KRTAP5-7,KRTAP5-3; KRTAP5.7,Keratin_Associated_Protein_5-7,11q13.4,protein-coding,
CWITA007271,TCMBANKGE007271,SCOC,HRIHFB2072; SCOCO; UNC-69,short coiled-coil protein,4q31.1,protein-coding,/
CWITA007272,TCMBANKGE007272,NXNL2,C9orf121; RDCVF2; RdCVF2L,nucleoredoxin like 2,9q22.1,protein-coding,/
CWITA007273,TCMBANKGE007273,HSP90AA1,FLJ31884; HSP86; HSP89A; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp89; Hsp90; LAP2,"heat shock protein 90kDa alpha (cytosolic), class A member 1",14q32.33,protein-coding,
CWITA007274,TCMBANKGE007274,GNAT3,GDCA,G protein subunit alpha transducin 3,7q21.11,protein-coding,/
CWITA007275,TCMBANKGE007275,ATP8B4,ATPIM,ATPase phospholipid transporting 8B4 (putative),15q21.2,protein-coding,/
CWITA007276,TCMBANKGE007276,ESR1,DKFZp686N23123; ER; ESR; ESRA; Era; NR3A1,estrogen receptor 1,6q25.1,protein-coding,
CWITA007277,TCMBANKGE007277,TSPAN1,NET1; TM4C; TM4SF,tetraspanin 1,1p34.1,protein-coding,/
CWITA007278,TCMBANKGE007278,SCT,-,secretin,11p15.5,protein-coding,Successful target
CWITA007279,TCMBANKGE007279,R3HDM1,R3HDM,R3H domain containing 1,2q21.3,protein-coding,/
CWITA007280,TCMBANKGE007280,BGLT3,BGL3; LINC01083; lncRNA-BGL3,Beta_Globin_Locus_Transcript_3,11p15.4,ncRNA,
CWITA007281,TCMBANKGE007281,PIK3C3,MGC61518; VPS34; hVps34,"phosphoinositide-3-kinase, class 3",18q12.3,protein-coding,
CWITA007282,TCMBANKGE007282,GABRA6,-,gamma-aminobutyric acid type A receptor subunit alpha6,5q34,protein-coding,/
CWITA007283,TCMBANKGE007283,ELAPOR1,EIG121; KIAA1324,endosome-lysosome associated apoptosis and autophagy regulator 1,1p13.3,protein-coding,/
CWITA007284,TCMBANKGE007284,MECOM,AML1-EVI-1; EVI1; KMT8E; MDS1; MDS1-EVI1; PRDM3; RUSAT2,MDS1 and EVI1 complex locus,3q26.2,protein-coding,/
CWITA007285,TCMBANKGE007285,A1BG,A1B; ABG; GAB; HYST2477,alpha-1-B glycoprotein,19q13.43,protein-coding,/
CWITA007286,TCMBANKGE007286,LRRC66,-,leucine rich repeat containing 66,4q12,protein-coding,/
CWITA007287,TCMBANKGE007287,SCN9A,ETHA; FEB3B; NENNA; NENA; Nav1.7; PN1,"sodium channel, voltage-gated, type IX, alpha subunit",2q24,protein-coding,
CWITA007288,TCMBANKGE007288,PUS7,IDDABS,pseudouridine synthase 7,7q22.3,protein-coding,/
CWITA007289,TCMBANKGE007289,CHD1,CHD-1; PILBOS,chromodomain helicase DNA binding protein 1,5q15-q21.1,protein-coding,/
CWITA007290,TCMBANKGE007290,CSRP1,CRP; CRP1; CSRP; CYRP; D1S181E; HEL-141; HEL-S-286,cysteine and glycine rich protein 1,1q32.1,protein-coding,/
CWITA007291,TCMBANKGE007291,UBE2V1,CIR1; CROC-1; CROC1; UBE2V; UEV-1; UEV1; UEV1A,ubiquitin conjugating enzyme E2 V1,20q13.13,protein-coding,/
CWITA007292,TCMBANKGE007292,CMC4,C6.1B; MTCP1; MTCP1B; MTCP1NB; p8; p8MTCP1,C-X9-C motif containing 4,Xq28,protein-coding,/
CWITA007293,TCMBANKGE007293,CYLC2,-,cylicin 2,9q31.1,protein-coding,/
CWITA007294,TCMBANKGE007294,ANGPTL6,AGF; ARP5,angiopoietin like 6,19p13.2,protein-coding,/
CWITA007295,TCMBANKGE007295,UGT2A3,-,UDP glucuronosyltransferase family 2 member A3,4q13.2,protein-coding,/
CWITA007296,TCMBANKGE007296,PLAC8,C15; DGIC; PNAS-144; onzin,placenta associated 8,4q21.22,protein-coding,/
CWITA007297,TCMBANKGE007297,SRP19,-,signal recognition particle 19,5q22.2,protein-coding,/
CWITA007298,TCMBANKGE007298,TOR1A,DQ2; DYT1,torsin family 1 member A,9q34.11,protein-coding,Research target
CWITA007299,TCMBANKGE007299,DYNC1LI2,DNCLI2; LIC2,dynein cytoplasmic 1 light intermediate chain 2,16q22.1,protein-coding,/
CWITA007300,TCMBANKGE007300,COMMD4,-,COMM domain containing 4,15q24.2,protein-coding,/
CWITA007301,TCMBANKGE007301,LHX2,LH2; hLhx2,LIM homeobox 2,9q33.3,protein-coding,/
CWITA007302,TCMBANKGE007302,HM13,H13; IMP1; IMPAS; IMPASN1; MSTP086; PSENL3; PSL3; SPP; dJ324O17.1,histocompatibility (minor) 13,20q11.21,protein-coding,
CWITA007303,TCMBANKGE007303,UBC,HMG20,ubiquitin C,12q24.3,protein-coding,
CWITA007304,TCMBANKGE007304,PPP2R3B,NYREN8; PPP2R3L; PPP2R3LY; PR48; PR70,protein phosphatase 2 regulatory subunit B''beta,Xp22.33 and Yp11.31,protein-coding,/
CWITA007305,TCMBANKGE007305,HSPB11,C1orf41; FAP232; HSPCO34; IFT25; PP25,heat shock protein family B (small) member 11,1p32.3,protein-coding,/
CWITA007306,TCMBANKGE007306,CYBA,p22NPHOX,"cytochrome b-245, alpha polypeptide",16q24,protein-coding,
CWITA007307,TCMBANKGE007307,NFIC,CTF; CTF5; NF-I; NFI,nuclear factor I C,19p13.3,protein-coding,/
CWITA007308,TCMBANKGE007308,TNFRSF21,BM-018; CD358; DR6,TNF receptor superfamily member 21,6p12.3,protein-coding,Research target
CWITA007309,TCMBANKGE007309,CHL1,CALL; L1CAM2,cell adhesion molecule L1 like,3p26.3,protein-coding,/
CWITA007310,TCMBANKGE007310,MNAT1,CAP35; MAT1; RNF66; TFB3,MNAT1 component of CDK activating kinase,14q23.1,protein-coding,/
CWITA007311,TCMBANKGE007311,SPR,SDR38C1,"sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)",2p14-p12,protein-coding,
CWITA007312,TCMBANKGE007312,CXCL1,FSP; GRO1; GROa; MGSA; MGSA-a; NAP-3; SCYB1,C-X-C_Motif_Chemokine_Ligand_1,4q13.3,protein-coding,
CWITA007313,TCMBANKGE007313,GMPS,GATD7,guanine monophosphate synthase,3q25.31,protein-coding,Research target
CWITA007314,TCMBANKGE007314,GPR101,GPCR6; PAGH2; PITA2,G protein-coupled receptor 101,Xq26.3,protein-coding,Research target
CWITA007315,TCMBANKGE007315,TPR,N,translocated promoter region (to activated MET oncogene),1q25,protein-coding,
CWITA007316,TCMBANKGE007316,FGFR4,CD334; JTK2; MGC20292; TKF,fibroblast growth factor receptor 4,5q35.1-qter,protein-coding,
CWITA007317,TCMBANKGE007317,FANCC,FA3; FAC; FACC,FA complementation group C,9q22.32,protein-coding,/
CWITA007318,TCMBANKGE007318,CKMT2,SMTCK,"creatine kinase, mitochondrial 2",5q14.1,protein-coding,/
CWITA007319,TCMBANKGE007319,MBNL2,MBLL; MBLL39; PRO2032,muscleblind like splicing regulator 2,13q32.1,protein-coding,Research target
CWITA007320,TCMBANKGE007320,ATP23,KUB3; XRCC6BP1,ATP23 metallopeptidase and ATP synthase assembly factor homolog,12q14.1,protein-coding,/
CWITA007321,TCMBANKGE007321,PRODH,HSPOX2; PIG6; POX; PRODH1; PRODH2; TP53I6,proline dehydrogenase 1,22q11.21,protein-coding,/
CWITA007322,TCMBANKGE007322,TH,DYT14; DYT5b; TYH,tyrosine hydroxylase,11p15.5,protein-coding,
CWITA007323,TCMBANKGE007323,IFITM1,9-27; CD225; DSPA2a; IFI17; LEU13,interferon induced transmembrane protein 1,11p15.5,protein-coding,/
CWITA007324,TCMBANKGE007324,FANCG,FAG; XRCC9,FA complementation group G,9p13.3,protein-coding,/
CWITA007325,TCMBANKGE007325,SEC14L5,PRELID4B,SEC14 like lipid binding 5,16p13.3,protein-coding,/
CWITA007326,TCMBANKGE007326,POLR2G,RPB19; RPB7; hRPB19; hsRPB7,RNA polymerase II subunit G,11q12.3,protein-coding,Research target
CWITA007327,TCMBANKGE007327,UROS,UROIIIS,uroporphyrinogen III synthase,10q26.2,protein-coding,/
CWITA007328,TCMBANKGE007328,PAX6,AN; AN1; AN2; ASGD5; D11S812E; FVH1; MGDA; WAGR,paired box 6,11p13,protein-coding,/
CWITA007329,TCMBANKGE007329,ASS1,ASS; CTLN1,argininosuccinate synthase 1,9q34.11,protein-coding,/
CWITA007330,TCMBANKGE007330,ARL16,-,ADP ribosylation factor like GTPase 16,17q25.3,protein-coding,/
CWITA007331,TCMBANKGE007331,CALHM2,FAM26B,calcium homeostasis modulator family member 2,10q24.33,protein-coding,/
CWITA007332,TCMBANKGE007332,FPGT-TNNI3K,CARK; TNNI3K,FPGT-TNNI3K readthrough,1p31.1,protein-coding,/
CWITA007333,TCMBANKGE007333,HNRNPK,AUKS; CSBP; HNRPK; TUNP,heterogeneous nuclear ribonucleoprotein K,9q21.32,protein-coding,/
CWITA007334,TCMBANKGE007334,GUCA1C,GCAP3,guanylate cyclase activator 1C,3q13.13,protein-coding,/
CWITA007335,TCMBANKGE007335,CPQ,LDP; PGCP,Carboxypeptidase_Q,8q22.1,protein-coding,
CWITA007336,TCMBANKGE007336,ZNF292,Nbla00365; ZFP292; ZN-16; Zn-15; bA393I2.3,zinc finger protein 292,6q14.3,protein-coding,/
CWITA007337,TCMBANKGE007337,NAT9,"EBSP, hNATL",N-acetyltransferase 9 (putative),17q25.1,protein-coding,/
CWITA007338,TCMBANKGE007338,HINT2,HIT-17,histidine triad nucleotide binding protein 2,9p13.3,protein-coding,/
CWITA007339,TCMBANKGE007339,MPZL1,MPZL1b; PZR; PZR1b; PZRa; PZRb,myelin protein zero like 1,1q24.2,protein-coding,/
CWITA007340,TCMBANKGE007340,SC5D,ERG3; S5DES; SC5DL,sterol-C5-desaturase,11q23.3-q24.1,protein-coding,/
CWITA007341,TCMBANKGE007341,KIF22,A-328A3.2; KID; KNSL4; OBP; OBP-1; OBP-2; SEMDJL2,kinesin family member 22,16p11.2,protein-coding,/
CWITA007342,TCMBANKGE007342,TAS1R2,GPR71; T1R2; TR2,taste 1 receptor member 2,1p36.13,protein-coding,/
CWITA007343,TCMBANKGE007343,NEK4,NRK2; STK2; pp12301,NIMA related kinase 4,3p21.1,protein-coding,/
CWITA007344,TCMBANKGE007344,MGME1,C20orf72; DDK1; MTDPS11; bA504H3.4,mitochondrial genome maintenance exonuclease 1,20p11.23,protein-coding,/
CWITA007345,TCMBANKGE007345,FMC1-LUC7L2,C7orf55; C7orf55-LUC7L2; FMC1,FMC1-LUC7L2 readthrough,7q34,protein-coding,/
CWITA007346,TCMBANKGE007346,CHUK,IKBKA; IKKNalpha; IKK1; IKKA; NFKBIKA; TCF16,conserved helix-loop-helix ubiquitous kinase,10q24-q25,protein-coding,
CWITA007347,TCMBANKGE007347,PDK2,PDHK2,"pyruvate dehydrogenase kinase, isozyme 2",17q21.33,protein-coding,
CWITA007348,TCMBANKGE007348,LRRC17,P37NB,leucine rich repeat containing 17,7q22.1,protein-coding,/
CWITA007349,TCMBANKGE007349,CBX4,NBP16; PC2,chromobox 4,17q25.3,protein-coding,/
CWITA007350,TCMBANKGE007350,PCLAF,KIAA0101; L5; NS5ATP9; OEATC; OEATC-1; OEATC1; PAF; PAF15; p15(PAF); p15/PAF; p15PAF,Pcna_Clamp_Associated_Factor,15q22.31,protein-coding,
CWITA007351,TCMBANKGE007351,RPS29,DBA13; S29; uS14,ribosomal protein S29,14q21.3,protein-coding,/
CWITA007352,TCMBANKGE007352,SCN4B,ATFB17; LQT10; Navbeta4,sodium voltage-gated channel beta subunit 4,11q23.3,protein-coding,/
CWITA007353,TCMBANKGE007353,ITGB2,CD18; LAD; LCAMB; LFAN1; MACN1; MF17; MFI7,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",21q22.3,protein-coding,
CWITA007354,TCMBANKGE007354,PP2D1,C3orf48,protein phosphatase 2C like domain containing 1,3p24.3,protein-coding,/
CWITA007355,TCMBANKGE007355,MTNR1A,MEL-1A-R; MT1,melatonin receptor 1A,4q35.2,protein-coding,Successful target
CWITA007356,TCMBANKGE007356,TOMM7,TOM7,translocase of outer mitochondrial membrane 7,7p15.3,protein-coding,/
CWITA007357,TCMBANKGE007357,DLGAP5,DLG7; HURP,DLG associated protein 5,14q22.3,protein-coding,/
CWITA007358,TCMBANKGE007358,EDC3,LSM16; MRT50; YJDC; YJEFN2; hYjeF_N2-15q23,enhancer of mRNA decapping 3,15q24.1,protein-coding,/
CWITA007359,TCMBANKGE007359,MTPAP,PAPD1; SPAX4; TENT6,mitochondrial poly(A) polymerase,10p11.23,protein-coding,/
CWITA007360,TCMBANKGE007360,GRID2IP,DELPHILIN,Grid2 interacting protein,7p22.1,protein-coding,/
CWITA007361,TCMBANKGE007361,C1R,EDSPD1,complement C1r,12p13.31,protein-coding,/
CWITA007362,TCMBANKGE007362,SLC6A11,GAT-3; GAT3; GAT4,solute carrier family 6 member 11,3p25.3,protein-coding,Clinical Trial target
CWITA007363,TCMBANKGE007363,PEX11A,PEX11-ALPHA; PMP28; hsPEX11p,peroxisomal biogenesis factor 11 alpha,15q26.1,protein-coding,/
CWITA007364,TCMBANKGE007364,Tstap198-15,-,tissue specific transplantation antigen P198-15,-,other,/
CWITA007365,TCMBANKGE007365,IGFALS,ACLSD; ALS,insulin like growth factor binding protein acid labile subunit,16p13.3,protein-coding,/
CWITA007366,TCMBANKGE007366,GPER1,CEPR; CMKRL2; DRY12; FEGN/A1; GPCRN/ABr; GPER; GPR30; LERGU; LERGU2; LyGPR; mER,G_Protein-Coupled_Estrogen_Receptor_1,7p22.3,protein-coding,
CWITA007367,TCMBANKGE007367,RRP1B,KIAA0179; NNP1L; Nnp1; PPP1R136; RRP1,ribosomal RNA processing 1B,21q22.3,protein-coding,/
CWITA007368,TCMBANKGE007368,GSTP1,DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI,glutathione S-transferase pi 1,11q13.2,protein-coding,Clinical Trial target
CWITA007369,TCMBANKGE007369,SLC16A4,MCT4; MCT5,"solute carrier family 16, member 4 (monocarboxylic acid transporter 5)",1p13.3,protein-coding,
CWITA007370,TCMBANKGE007370,WWC1,HBEBP3; HBEBP36; KIBRA; MEMRYQTL; PPP1R168,WW and C2 domain containing 1,5q34,protein-coding,/
CWITA007371,TCMBANKGE007371,SNX2,TRG-9,sorting nexin 2,5q23.2,protein-coding,/
CWITA007372,TCMBANKGE007372,S100A2,CAN19; S100L,S100 calcium binding protein A2,1q21.3,protein-coding,/
CWITA007373,TCMBANKGE007373,NUP155,ATFB15; N155,nucleoporin 155,5p13.2,protein-coding,/
CWITA007374,TCMBANKGE007374,CYP27A1,CP27; CTX; CYP27,"cytochrome P450, family 27, subfamily A, polypeptide 1",2q33-qter,protein-coding,
CWITA007375,TCMBANKGE007375,POLK,DINB1; DINP; POLQ,DNA polymerase kappa,5q13.3,protein-coding,/
CWITA007376,TCMBANKGE007376,SMARCA1,ISWI; NURF140; SNF2L; SNF2L1; SNF2LB; SNF2LT; SWI; SWI2; hSNF2L,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",Xq25-q26.1,protein-coding,/
CWITA007377,TCMBANKGE007377,GLB1L2,MST114; MSTP114,galactosidase beta 1 like 2,11q25,protein-coding,/
CWITA007378,TCMBANKGE007378,SLC22A3,EMT; EMTH; OCT3,"solute carrier family 22 (extraneuronal monoamine transporter), member 3",6q25.3,protein-coding,
CWITA007379,TCMBANKGE007379,SOX1,-,SRY-box transcription factor 1,13q34,protein-coding,/
CWITA007380,TCMBANKGE007380,NEU2,SIAL2,Neuraminidase_2,2q37.1,protein-coding,
CWITA007381,TCMBANKGE007381,CSPG5,NGC,chondroitin sulfate proteoglycan 5,3p21.31,protein-coding,/
CWITA007382,TCMBANKGE007382,EIF3A,EIF3; EIF3S10; P167; TIF32; eIF3-p170; eIF3-theta; p180; p185,eukaryotic translation initiation factor 3 subunit A,10q26.11,protein-coding,/
CWITA007383,TCMBANKGE007383,FST,FS,follistatin,5q11.2,protein-coding,Research target
CWITA007384,TCMBANKGE007384,LVRN,APQ; AQPEP; TAQPEP,laeverin,5q23.1,protein-coding,/
CWITA007385,TCMBANKGE007385,NRAS,ALPS4; CMNS; N-ras; NCMS; NRAS1; NS6,"NRAS proto-oncogene, GTPase",1p13.2,protein-coding,Clinical Trial target
CWITA007386,TCMBANKGE007386,RAB19,RAB19B,"RAB19, member RAS oncogene family",7q34,protein-coding,/
CWITA007387,TCMBANKGE007387,GALNT12,CRCS1; GalNAc-T12,polypeptide N-acetylgalactosaminyltransferase 12,9q22.33,protein-coding,/
CWITA007388,TCMBANKGE007388,CDK13,CDC2L; CDC2L5; CHDFIDD; CHED; hCDK13,cyclin dependent kinase 13,7p14.1,protein-coding,/
CWITA007389,TCMBANKGE007389,DPYD,DHP; DHPDHASE; DPD,dihydropyrimidine dehydrogenase,1p21.3,protein-coding,Successful target
CWITA007390,TCMBANKGE007390,GOT1,GIG18,"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",10q24.1-q25.1,protein-coding,
CWITA007391,TCMBANKGE007391,MCTP1,-,multiple C2 and transmembrane domain containing 1,5q15,protein-coding,/
CWITA007392,TCMBANKGE007392,KCNN2,KCa2.2; SK2; SKCA2; SKCa 2; hSK2,potassium calcium-activated channel subfamily N member 2,5q22.3,protein-coding,Clinical Trial target
CWITA007393,TCMBANKGE007393,CAPSL,-,calcyphosine like,5p13.2,protein-coding,/
CWITA007394,TCMBANKGE007394,B3GNT3,B3GAL-T8; B3GN-T3; B3GNT-3; HP10328; TMEM3; beta3Gn-T3,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3",19p13.11,protein-coding,/
CWITA007395,TCMBANKGE007395,H2-Ab1,AI845868; Abeta; H-2Ab; H2-Ab; I-Abeta; IAb; Ia-2; Ia2; Rmcs1,"histocompatibility 2, class II antigen A, beta 1",17 B1|17 17.98 cM,protein-coding,/
CWITA007396,TCMBANKGE007396,ART1,ART2; CD296; MGC133217; RT6,ADP-ribosyltransferase 1,11p15,protein-coding,
CWITA007397,TCMBANKGE007397,SH2B3,IDDM20; LNK,SH2B adaptor protein 3,12q24.12,protein-coding,Research target
CWITA007398,TCMBANKGE007398,RPL8,L8,ribosomal protein L8,8q24.3,protein-coding,
CWITA007399,TCMBANKGE007399,SATB2,GLSS,SATB homeobox 2,2q33.1,protein-coding,/
CWITA007400,TCMBANKGE007400,MTSS2,ABBA; ABBA-1; ABBA1; MTSS1L,MTSS I-BAR domain containing 2,16q22.1,protein-coding,/
CWITA007401,TCMBANKGE007401,ADH1A,ADH1,"alcohol dehydrogenase 1A (class I), alpha polypeptide",4q23,protein-coding,
CWITA007402,TCMBANKGE007402,SLCO2A1,MATR1; OATP2A1; PGT; SLC21A2,"solute carrier organic anion transporter family, member 2A1",3q21,protein-coding,
CWITA007403,TCMBANKGE007403,APOF,Apo-F; LTIP,apolipoprotein F,12q13.3,protein-coding,/
CWITA007404,TCMBANKGE007404,KCNG4,KV6.3; KV6.4,potassium voltage-gated channel modifier subfamily G member 4,16q24.1,protein-coding,/
CWITA007405,TCMBANKGE007405,MAPT,DDPAC; FLJ31424; FTDPN17; MAPTL; MGC138549; MSTD; MTBT1; MTBT2; PPND; TAU,microtubule-associated protein tau,17q21.1,protein-coding,
CWITA007406,TCMBANKGE007406,LEFTY2,EBAF; LEFTA; LEFTYA; TGFB4,left-right determination factor 2,1q42.12,protein-coding,/
CWITA007407,TCMBANKGE007407,MDH1B,RP11-95H11,malate dehydrogenase 1B,2q33.3,protein-coding,/
CWITA007408,TCMBANKGE007408,CTSD,CLN10; CPSD; MGC2311,cathepsin D,11p15.5,protein-coding,
CWITA007409,TCMBANKGE007409,ITSN1,ITSN; SH3D1A; SH3P17,intersectin 1,21q22.11,protein-coding,/
CWITA007410,TCMBANKGE007410,LRRC53,-,leucine rich repeat containing 53,1p31.1,protein-coding,/
CWITA007411,TCMBANKGE007411,Csn,-,"casein gene family, alpha, beta, gamma, delta/epsilon, kappa",-,other,/
CWITA007412,TCMBANKGE007412,PTPRM,PTPRL1; R-PTP-MU; RPTPM; RPTPU; hR-PTPu,protein tyrosine phosphatase receptor type M,18p11.23,protein-coding,/
CWITA007413,TCMBANKGE007413,REEP5,C5orf18; D5S346; DP1; POB16; TB2; YOP1; Yip2e,receptor accessory protein 5,5q22.2,protein-coding,/
CWITA007414,TCMBANKGE007414,KLKB1,KLK3; PKK; PKKD; PPK,kallikrein B1,4q35.2,protein-coding,Clinical Trial target
CWITA007415,TCMBANKGE007415,ZNF697,-,zinc finger protein 697,1p12,protein-coding,/
CWITA007416,TCMBANKGE007416,LARS1,HSPC192; ILFS1; LARS; LEURS; LEUS; LFIS; LRS; PIG44; RNTLS; hr025Cl,leucyl-tRNA synthetase 1,5q32,protein-coding,/
CWITA007417,TCMBANKGE007417,HSP90B1,ECGP; GP96; GRP94; HEL-S-125m; HEL35; TRA1,heat shock protein 90 beta family member 1,12q23.3,protein-coding,Clinical Trial target
CWITA007418,TCMBANKGE007418,GP6,BDPLT11; GPIV; GPVI,glycoprotein VI platelet,19q13.42,protein-coding,Clinical Trial target
CWITA007419,TCMBANKGE007419,ZBTB38,CIBZ; PPP1R171; ZNF921,zinc finger and BTB domain containing 38,3q23,protein-coding,/
CWITA007420,TCMBANKGE007420,HMGXB3,HMGX3; SMF,HMG-box containing 3,5q32,protein-coding,/
CWITA007421,TCMBANKGE007421,LRRC47,-,leucine rich repeat containing 47,1p36.32,protein-coding,/
CWITA007422,TCMBANKGE007422,ORM1,AGP-A; AGP1; HEL-S-153w; ORM,orosomucoid 1,9q32,protein-coding,/
CWITA007423,TCMBANKGE007423,ANKRD23,DARP; MARP3,ankyrin repeat domain 23,2q11.2,protein-coding,/
CWITA007424,TCMBANKGE007424,AGBL3,CCP3,ATP/GTP binding protein like 3,7q33,protein-coding,/
CWITA007425,TCMBANKGE007425,UBE3B,BPIDS; KOS,ubiquitin protein ligase E3B,12q24.11,protein-coding,/
CWITA007426,TCMBANKGE007426,CST2,-,cystatin SA,20p11.21,protein-coding,/
CWITA007427,TCMBANKGE007427,TNPO2,IPO3; KPNB2B; TRN2,transportin 2,19p13.13,protein-coding,/
CWITA007428,TCMBANKGE007428,ADCY1,AC1; DFNB44,adenylate cyclase 1,7p12.3,protein-coding,Successful target
CWITA007429,TCMBANKGE007429,MYBBP1A,P160; PAP2; Pol5,MYB binding protein 1a,17p13.2,protein-coding,/
CWITA007430,TCMBANKGE007430,PSMB7,Z,proteasome 20S subunit beta 7,9q33.3,protein-coding,Patented target
CWITA007431,TCMBANKGE007431,RFC2,RFC40,replication factor C subunit 2,7q11.23,protein-coding,/
CWITA007432,TCMBANKGE007432,PTGES2,C9orf15; GBF-1; GBF1; PGES2; mPGES-2,prostaglandin E synthase 2,9q34.11,protein-coding,/
CWITA007433,TCMBANKGE007433,SQOR,CGI-44; PRO1975; SQR; SQRDL,Sulfide_Quinone_Oxidoreductase,15q21.1,protein-coding,
CWITA007434,TCMBANKGE007434,EBF2,COE2; EBF-2; O/E-3; OE-3,EBF transcription factor 2,8p21.2,protein-coding,/
CWITA007435,TCMBANKGE007435,SNX4,ATG24B,sorting nexin 4,3q21.2,protein-coding,/
CWITA007436,TCMBANKGE007436,ZNF148,BERF-1; BFCOL1; GDACCF; HT-BETA; ZBP-89; ZFP148; pHZ-52,zinc finger protein 148,3q21.2,protein-coding,/
CWITA007437,TCMBANKGE007437,SNTB2,D16S2531E; EST25263; SNT2B2; SNT3; SNTL,syntrophin beta 2,16q22.1,protein-coding,/
CWITA007438,TCMBANKGE007438,UBE3C,HECTH2,ubiquitin protein ligase E3C,7q36.3,protein-coding,/
CWITA007439,TCMBANKGE007439,CD58,LFA-3; LFA3; ag3,CD58 molecule,1p13.1,protein-coding,Successful target
CWITA007440,TCMBANKGE007440,FGF20,FGF-20; RHDA2,fibroblast growth factor 20,8p22,protein-coding,/
CWITA007441,TCMBANKGE007441,KLB,BKL,klotho beta,4p14,protein-coding,Clinical Trial target
CWITA007442,TCMBANKGE007442,NOTCH4,INT3,notch receptor 4,6p21.32,protein-coding,Clinical Trial target
CWITA007443,TCMBANKGE007443,HIC2,HRG22; ZBTB30; ZNF907,HIC ZBTB transcriptional repressor 2,22q11.21,protein-coding,/
CWITA007444,TCMBANKGE007444,GNRHR,GNRHR1; GRHR; LHRHR; LRHR,gonadotropin-releasing hormone receptor,4q21.2,protein-coding,
CWITA007445,TCMBANKGE007445,LEF1,DKFZp586H0919; FLJ46390; TCF1ALPHA,lymphoid enhancer-binding factor 1,4q23-q25,protein-coding,
CWITA007446,TCMBANKGE007446,SHMT2,GLYA; HEL-S-51e; SHMT,serine hydroxymethyltransferase 2,12q13.3,protein-coding,/
CWITA007447,TCMBANKGE007447,FAM89A,C1orf153,family with sequence similarity 89 member A,1q42.2,protein-coding,/
CWITA007448,TCMBANKGE007448,SSR4,CDG1Y; TRAPD,signal sequence receptor subunit 4,Xq28,protein-coding,/
CWITA007449,TCMBANKGE007449,FABP4,ANFABP; AFABP; ALBP; aP2,"fatty acid binding protein 4, adipocyte",8q21,protein-coding,
CWITA007450,TCMBANKGE007450,MRPL11,CGI-113; L11MT; MRP-L11,mitochondrial ribosomal protein L11,11q13.2,protein-coding,/
CWITA007451,TCMBANKGE007451,MRPL18,HSPC071; L18mt; MRP-L18,mitochondrial ribosomal protein L18,6q25.3,protein-coding,/
CWITA007452,TCMBANKGE007452,DST,BP240; BPA; BPAG1; CATX-15; CATX15; D6S1101; DMH; DT; EBSB2; HSAN6; MACF2,dystonin,6p12.1,protein-coding,/
CWITA007453,TCMBANKGE007453,FMNL2,FHOD2,formin like 2,2q23.3,protein-coding,/
CWITA007454,TCMBANKGE007454,APCS,MGC88159; PTX2; SAP,"amyloid P component, serum",1q21-q23,protein-coding,
CWITA007455,TCMBANKGE007455,KCNJ15,IRKK; KIR1.3; KIR4.2; MGC13584,"potassium inwardly-rectifying channel, subfamily J, member 15",21q22.2,protein-coding,
CWITA007456,TCMBANKGE007456,ADGRE1,EMR1; TM7LN3,adhesion G protein-coupled receptor E1,19p13.3-p13.2,protein-coding,/
CWITA007457,TCMBANKGE007457,ZNF875,HKR1,zinc finger protein 875,19q13.12,protein-coding,/
CWITA007458,TCMBANKGE007458,ERBB4,HER4; MGC138404; p180erbB4,v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian),2q33.3-q34,protein-coding,
CWITA007459,TCMBANKGE007459,DBH,DBM; ORTHYP1,dopamine beta-hydroxylase,9q34.2,protein-coding,Clinical Trial target
CWITA007460,TCMBANKGE007460,L3HYPDH,C14orf149,trans-L-3-hydroxyproline dehydratase,14q23.1,protein-coding,/
CWITA007461,TCMBANKGE007461,POLR2C,RPB3; RPB31; hRPB33; hsRPB3,RNA polymerase II subunit C,16q21,protein-coding,/
CWITA007462,TCMBANKGE007462,IKZF5,PEGASUS; ZNFN1A5,IKAROS family zinc finger 5,10q26.13,protein-coding,/
CWITA007463,TCMBANKGE007463,SHPRH,bA545I5.2,SNF2 histone linker PHD RING helicase,6q24.3,protein-coding,/
CWITA007464,TCMBANKGE007464,UBE2I,C358B7.1; P18; UBC9,ubiquitin conjugating enzyme E2 I,16p13.3,protein-coding,/
CWITA007465,TCMBANKGE007465,DENND11,KIAA1147; LCHN; PRO2561,DENN domain containing 11,7q34,protein-coding,/
CWITA007466,TCMBANKGE007466,FUCA1,FUCA,alpha-L-fucosidase 1,1p36.11,protein-coding,/
CWITA007467,TCMBANKGE007467,FOXI1,FKH10; FKHL10; FREAC-6; FREAC6; HFH-3; HFH3,forkhead box I1,5q35.1,protein-coding,/
CWITA007468,TCMBANKGE007468,GLRX5,C14orf87; FLB4739; GRX5; PR01238; PRO1238; PRSA; SIDBA3; SPAHGC,glutaredoxin 5,14q32.13,protein-coding,/
CWITA007469,TCMBANKGE007469,HOXA4,HOX1; HOX1D,homeobox A4,7p15.2,protein-coding,/
CWITA007470,TCMBANKGE007470,SLC24A1,CSNB1D; HsT17412; NCKX; NCKX1; RODX,solute carrier family 24 member 1,15q22.31,protein-coding,/
CWITA007471,TCMBANKGE007471,PLPBP,EPVB6D; PROSC,pyridoxal phosphate binding protein,8p11.23,protein-coding,/
CWITA007472,TCMBANKGE007472,NUDT15,MTH2; NUDT15D,nudix hydrolase 15,13q14.2,protein-coding,/
CWITA007473,TCMBANKGE007473,TRANK1,LBA1,tetratricopeptide repeat and ankyrin repeat containing 1,3p22.2,protein-coding,/
CWITA007474,TCMBANKGE007474,MMACHC,DKFZp564I122; FLJ25671; RP11N291L19.3; cblC,"methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria",1p34.1,protein-coding,
CWITA007475,TCMBANKGE007475,RRNAD1,C1orf66; CGI-41; METTL25B,ribosomal RNA adenine dimethylase domain containing 1,1q23.1,protein-coding,/
CWITA007476,TCMBANKGE007476,TEC,-,transient erythroblastopenia of childhood,19q13.2,unknown,Patented target
CWITA007477,TCMBANKGE007477,NPAS2,MOP4; PASD4; bHLHe9,neuronal PAS domain protein 2,2q11.2,protein-coding,/
CWITA007478,TCMBANKGE007478,MX1,IFI-78K; IFI78; MX; MxA; lncMX1-215,MX dynamin like GTPase 1,21q22.3,protein-coding,/
CWITA007479,TCMBANKGE007479,ZBTB45,ZNF499,zinc finger and BTB domain containing 45,19q13.43,protein-coding,/
CWITA007480,TCMBANKGE007480,SF3B6,CGI-110; HSPC175; Ht006; P14; SAP14; SAP14a; SF3B14; SF3B14a,splicing factor 3b subunit 6,2p23.3,protein-coding,/
CWITA007481,TCMBANKGE007481,ZBTB47,ZNF651,zinc finger and BTB domain containing 47,3p22.1,protein-coding,/
CWITA007482,TCMBANKGE007482,BCL2L10,BCL-B; Boo; Diva; bcl2-L-10,BCL2 like 10,15q21.2,protein-coding,/
CWITA007483,TCMBANKGE007483,PFKL,ATP-PFK; PFK-B; PFK-L,"phosphofructokinase, liver type",21q22.3,protein-coding,/
CWITA007484,TCMBANKGE007484,CMA1,CYH; MCT1; MGC119890; MGC119891; chymase,"chymase 1, mast cell",14q11.2,protein-coding,
CWITA007485,TCMBANKGE007485,TRAPPC6A,MGC2650; TRS33,trafficking protein particle complex 6A,19q13.32,protein-coding,
CWITA007486,TCMBANKGE007486,LCN2,24p3; MSFI; NGAL,lipocalin 2,9q34,protein-coding,
CWITA007487,TCMBANKGE007487,VHL,HRCA1; RCA1; VHL1; pVHL,von Hippel-Lindau tumor suppressor,3p25.3,protein-coding,Patented target
CWITA007488,TCMBANKGE007488,MDM2,HDMX; MGC5370; MGC71221; hdm2,Mdm2 p53 binding protein homolog (mouse),12q14.3-q15,protein-coding,
CWITA007489,TCMBANKGE007489,PGRMC1,HPR6.6; MPR,progesterone receptor membrane component 1,Xq22-q24,protein-coding,
CWITA007490,TCMBANKGE007490,NME2,NDKB; NDPK-B; NDPKB; NM23-H2; NM23B; PUF,NME/NM23 nucleoside diphosphate kinase 2,17q21.33,protein-coding,/
CWITA007491,TCMBANKGE007491,RTCA,RPC; RTC1; RTCD1,Rna_3'-Terminal_Phosphate_Cyclase,1p21.2,protein-coding,
CWITA007492,TCMBANKGE007492,GLT1D1,-,glycosyltransferase 1 domain containing 1,12q24.33,protein-coding,/
CWITA007493,TCMBANKGE007493,NMB,-,neuromedin B,15q25.2,protein-coding,/
CWITA007494,TCMBANKGE007494,ATP9A,ATPIIA,ATPase phospholipid transporting 9A (putative),20q13.2,protein-coding,/
CWITA007495,TCMBANKGE007495,RPL10,AUTSX5; DXS648; DXS648E; L10; MRXS35; NOV; QM,ribosomal protein L10,Xq28,protein-coding,/
CWITA007496,TCMBANKGE007496,GPR161,RE2,G protein-coupled receptor 161,1q24.2,protein-coding,/
CWITA007497,TCMBANKGE007497,SLC16A5,MCT5; MCT6,"solute carrier family 16, member 5 (monocarboxylic acid transporter 6)",17q25.1,protein-coding,
CWITA007498,TCMBANKGE007498,PCDHB4,PCDH-BETA4,protocadherin beta 4,5q31.3,protein-coding,/
CWITA007499,TCMBANKGE007499,FKBPL,DIR1; FKBP4; NG7; WISP39,FKBP prolyl isomerase like,6p21.32,protein-coding,/
CWITA007500,TCMBANKGE007500,MXI1,MAD2; MXD2; MXI; bHLHc11,"MAX interactor 1, dimerization protein",10q25.2,protein-coding,/
CWITA007501,TCMBANKGE007501,LARGE1,LARGE; MDC1D; MDDGA6; MDDGB6,LARGE xylosyl- and glucuronyltransferase 1,22q12.3,protein-coding,/
CWITA007502,TCMBANKGE007502,SLC25A29,C14orf69; CACL; FLJ38975,"solute carrier family 25, member 29",14q32.2,protein-coding,
CWITA007503,TCMBANKGE007503,HABP2,FSAP; HABP; HGFAL; NMTC5; PHBP,hyaluronan binding protein 2,10q25.3,protein-coding,/
CWITA007504,TCMBANKGE007504,HSD3B1,3BETAHSD; HSD3B; HSDB3; HSDB3A; SDR11E1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",1p12,protein-coding,/
CWITA007505,TCMBANKGE007505,MPP3,DLG3,membrane palmitoylated protein 3,17q21.31,protein-coding,/
CWITA007506,TCMBANKGE007506,CTSZ,CTSX,cathepsin Z,20q13.32,protein-coding,/
CWITA007507,TCMBANKGE007507,PAX2,FSGS7; PAPRS,paired box 2,10q24.31,protein-coding,/
CWITA007508,TCMBANKGE007508,FBXO5,EMI1; FBX5; Fbxo31,F-box protein 5,6q25.2,protein-coding,/
CWITA007509,TCMBANKGE007509,KRT5,CK5; DDD; DDD1; EBS2; K5; KRT5A,keratin 5,12q13.13,protein-coding,/
CWITA007510,TCMBANKGE007510,NCAPG2,3KS; CAP-G2; CAPG2; LUZP5; MTB; hCAP-G2,non-SMC condensin II complex subunit G2,7q36.3,protein-coding,/
CWITA007511,TCMBANKGE007511,ATP5F1A,ATP5A; ATP5A1; ATP5AL2; ATPM; COXPD22; HEL-S-123m; MC5DN4; MOM2; OMR; ORM; hATP1,ATP synthase F1 subunit alpha,18q21.1,protein-coding,/
CWITA007512,TCMBANKGE007512,MUC4,ASGP; HSA276359; MUC-4,"mucin 4, cell surface associated",3q29,protein-coding,/
CWITA007513,TCMBANKGE007513,GNS,G6S,glucosamine (N-acetyl)-6-sulfatase,12q14.3,protein-coding,/
CWITA007514,TCMBANKGE007514,XPNPEP1,APP1; SAMP; XPNPEP; XPNPEPL; XPNPEPL1,X-prolyl aminopeptidase 1,10q25.1,protein-coding,/
CWITA007515,TCMBANKGE007515,DIDO1,BYE1; C20orf158; DATF-1; DATF1; DIDO2; DIDO3; DIO-1; DIO1; dJ885L7.8,death inducer-obliterator 1,20q13.33,protein-coding,/
CWITA007516,TCMBANKGE007516,TRAV8-2,TCRAV1S5; TCRAV8S2; TRAV82,T cell receptor alpha variable 8-2,14q11.2,other,/
CWITA007517,TCMBANKGE007517,S100A13,-,S100 calcium binding protein A13,1q21.3,protein-coding,/
CWITA007518,TCMBANKGE007518,MCCC1,DKFZp686B20267; FLJ25545; MCCNB; MCCA,methylcrotonoyl-CoA carboxylase 1 (alpha),3q27,protein-coding,
CWITA007519,TCMBANKGE007519,CH25H,C25H,cholesterol 25-hydroxylase,10q23.31,protein-coding,/
CWITA007520,TCMBANKGE007520,TPO,MSA; TDH2A; TPX,thyroid peroxidase,2p25,protein-coding,
CWITA007521,TCMBANKGE007521,SOD1,ALS; ALS1; IPOA; SOD; hSod1; homodimer,"superoxide dismutase 1, soluble",21q22.1|21q22.11,protein-coding,
CWITA007522,TCMBANKGE007522,NEIL2,NEH2; NEI2,nei like DNA glycosylase 2,8p23.1,protein-coding,/
CWITA007523,TCMBANKGE007523,TRO,MAGE-d3; MAGED3,trophinin,Xp11.21,protein-coding,/
CWITA007524,TCMBANKGE007524,PLPPR4,LPPR4; LPR4; PHP1; PRG-1; PRG1,phospholipid phosphatase related 4,1p21.3-p21.2,protein-coding,/
CWITA007525,TCMBANKGE007525,DPH2,DPH2L2,diphthamide biosynthesis 2,1p34.1,protein-coding,/
CWITA007526,TCMBANKGE007526,Mir16-1,Mirn16; Mirn16-1; miR-16; mir-16-1,microRNA 16-1,14|14 D1,ncRNA,/
CWITA007527,TCMBANKGE007527,BAMBI,NMA,BMP and activin membrane bound inhibitor,10p12.1,protein-coding,/
CWITA007528,TCMBANKGE007528,DYRK1A,DYRK; DYRK1; HP86; MNB; MNBH,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,21q22.13,protein-coding,
CWITA007529,TCMBANKGE007529,CDC20,CDC20A; bA276H19.3; p55CDC,cell division cycle 20,1p34.2,protein-coding,/
CWITA007530,TCMBANKGE007530,HLA-DPB1,DPB1; HLA-DP; HLA-DP1B; HLA-DPB,"major histocompatibility complex, class II, DP beta 1",6p21.32,protein-coding,/
CWITA007531,TCMBANKGE007531,CYP24A1,CP24; CYP24; MGC126273; MGC126274; P450NCC24,"cytochrome P450, family 24, subfamily A, polypeptide 1",20q13,protein-coding,
CWITA007532,TCMBANKGE007532,TRIM44,AN3; DIPB; HSA249128; MC7,tripartite motif containing 44,11p13,protein-coding,/
CWITA007533,TCMBANKGE007533,LEFTY1,LEFTB; LEFTYB,left-right determination factor 1,1q42.12,protein-coding,/
CWITA007534,TCMBANKGE007534,PAEP,GD; GdA; GdF; GdS; PAEG; PEP; PP14; ZIF-1,progestagen associated endometrial protein,9q34.3,protein-coding,/
CWITA007535,TCMBANKGE007535,CDR2L,HUMPPA,cerebellar degeneration related protein 2 like,17q25.1,protein-coding,/
CWITA007536,TCMBANKGE007536,FCRL3,CD307c; FCRH3; IFGP3; IRTA3; SPAP2,Fc receptor like 3,1q23.1,protein-coding,/
CWITA007537,TCMBANKGE007537,P2RY10,LYPSR2; P2Y10,P2Y receptor family member 10,Xq21.1,protein-coding,Research target
CWITA007538,TCMBANKGE007538,GPR34,LYPSR1,G protein-coupled receptor 34,Xp11.4,protein-coding,Research target
CWITA007539,TCMBANKGE007539,AQR,IBP160; fSAP164,aquarius intron-binding spliceosomal factor,15q14,protein-coding,/
CWITA007540,TCMBANKGE007540,ATMIN,ASCIZ; ZNF822,ATM interactor,16q23.2,protein-coding,/
CWITA007541,TCMBANKGE007541,ZNF784,-,zinc finger protein 784,19q13.42,protein-coding,/
CWITA007542,TCMBANKGE007542,P2RY2,HP2U; MGC20088; MGC40010; P2RU1; P2U; P2U1; P2UR; P2Y2; P2Y2R,"purinergic receptor P2Y, G-protein coupled, 2",11q13.5-q14.1,protein-coding,
CWITA007543,TCMBANKGE007543,INSR,CD220; HHF5,insulin receptor,19p13.2,protein-coding,Successful target
CWITA007544,TCMBANKGE007544,FAM98A,-,family with sequence similarity 98 member A,2p22.3,protein-coding,/
CWITA007545,TCMBANKGE007545,ATP6V1C1,ATP6C; ATP6D; FLJ20057; VATC; Vma5,"ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1",8q22.3,protein-coding,
CWITA007546,TCMBANKGE007546,RABL2B,-,"RAB, member of RAS oncogene family like 2B",22q13.33,protein-coding,/
CWITA007547,TCMBANKGE007547,BRD2,BRD2-IT1; D6S113E; FSH; FSRG1; NAT; O27.1.1; RING3; RNF3,bromodomain containing 2,6p21.32,protein-coding,Clinical Trial target
CWITA007548,TCMBANKGE007548,THSD7A,-,thrombospondin type 1 domain containing 7A,7p21.3,protein-coding,/
CWITA007549,TCMBANKGE007549,WNT5A,hWNT5A,"Wingless-Type Mmtv Integration Site Family, Member 5A",3p21-p14,protein-coding,
CWITA007550,TCMBANKGE007550,H3P30,p42,H3 histone pseudogene 30,9p21.3,pseudo,/
CWITA007551,TCMBANKGE007551,SMYD5,NN8-4AG; RAI15; RRG1; ZMYND23,SMYD family member 5,2p13.2,protein-coding,/
CWITA007552,TCMBANKGE007552,SELENOM,SELM; SEPM,selenoprotein M,22q12.2,protein-coding,/
CWITA007553,TCMBANKGE007553,FBRSL1,-,fibrosin like 1,12q24.33,protein-coding,/
CWITA007554,TCMBANKGE007554,PANX2,PX2; hPANX2,pannexin 2,22q13.33,protein-coding,/
CWITA007555,TCMBANKGE007555,MRPL3,COXPD9; MRL3; RPML3,mitochondrial ribosomal protein L3,3q22.1,protein-coding,/
CWITA007556,TCMBANKGE007556,SUCLG2,GBETA,"succinate-CoA ligase, GDP-forming, beta subunit",3p14.1,protein-coding,
CWITA007557,TCMBANKGE007557,NEU3,SIAL3,neuraminidase 3,11q13.4,protein-coding,/
CWITA007558,TCMBANKGE007558,SAP18,2HOR0202; SAP18P,Sin3A associated protein 18,13q12.11,protein-coding,/
CWITA007559,TCMBANKGE007559,SRF,MCM1,serum response factor,6p21.1,protein-coding,/
CWITA007560,TCMBANKGE007560,AFG1L,AFG1; LACE1; c222389,AFG1 like ATPase,6q21,protein-coding,/
CWITA007561,TCMBANKGE007561,PSMA7,C6; HEL-S-276; HSPC; RC6-1; XAPC7,proteasome 20S subunit alpha 7,20q13.33,protein-coding,/
CWITA007562,TCMBANKGE007562,ADM2,AM2; dJ579N16.4,adrenomedullin 2,22q13.33,protein-coding,Research target
CWITA007563,TCMBANKGE007563,DIRAS2,Di-Ras2,DIRAS family GTPase 2,9q22.2,protein-coding,/
CWITA007564,TCMBANKGE007564,CHRNB1,ACHRB; CHRNB; CMS1D; CMS2A; CMS2C; SCCMS,cholinergic receptor nicotinic beta 1 subunit,17p13.1,protein-coding,/
CWITA007565,TCMBANKGE007565,ADAMTS9,-,ADAM metallopeptidase with thrombospondin type 1 motif 9,3p14.1,protein-coding,/
CWITA007566,TCMBANKGE007566,RAB9A,RAB9,"RAB9A, member RAS oncogene family",Xp22.2,protein-coding,Successful target
CWITA007567,TCMBANKGE007567,FLT4,FLT41; LMPH1A; PCL; VEGFR3,fms-related tyrosine kinase 4,5q35.3,protein-coding,
CWITA007568,TCMBANKGE007568,SLC7A10,ASC1; HASC-1; asc-1,solute carrier family 7 member 10,19q13.11,protein-coding,/
CWITA007569,TCMBANKGE007569,CSGALNACT2,CHGN2; ChGn-2; GALNACT-2; GALNACT2; PRO0082; beta4GalNAcT,chondroitin sulfate N-acetylgalactosaminyltransferase 2,10q11.21,protein-coding,/
CWITA007570,TCMBANKGE007570,EXOSC8,CIP3; EAP2; OIP2; PCH1C; RRP43; Rrp43p; bA421P11.3; p9,exosome component 8,13q13.3,protein-coding,/
CWITA007571,TCMBANKGE007571,NTF4,GLC10; GLC1O; NT-4; NT-4/5; NT-5; NT4; NT5; NTF5,neurotrophin 4,19q13.33,protein-coding,Research target
CWITA007572,TCMBANKGE007572,IGSF8,CD316; CD81P3; EWI-2; EWI2; KCT-4; LIR-D1; PGRL,immunoglobulin superfamily member 8,1q23.2,protein-coding,/
CWITA007573,TCMBANKGE007573,REEP2,C5orf19; SGC32445; SPG72; Yip2d,receptor accessory protein 2,5q31.2,protein-coding,/
CWITA007574,TCMBANKGE007574,CSNK1G3,N,"casein kinase 1, gamma 3",5q23,protein-coding,
CWITA007575,TCMBANKGE007575,FKBP10,BRKS1; FKBP65; OI11; OI6; PPIASE; hFKBP65,FKBP prolyl isomerase 10,17q21.2,protein-coding,/
CWITA007576,TCMBANKGE007576,MYH7,CMD1S; CMH1; DKFZp451F047; MGC138376; MGC138378; MPD1; MYHCB; SPMD; SPMM,"myosin, heavy chain 7, cardiac muscle, beta",14q12,protein-coding,
CWITA007577,TCMBANKGE007577,EFNB3,EFL6; EPLG8; LERK8,ephrin B3,17p13.1,protein-coding,/
CWITA007578,TCMBANKGE007578,GNPDA1,GNP1; GNPDA; GNPI; GPI; HLN,glucosamine-6-phosphate deaminase 1,5q31.3,protein-coding,/
CWITA007579,TCMBANKGE007579,SDHC,CYB560; CYBL; PGL3; QPS1; SDH3,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",1q23.3,protein-coding,
CWITA007580,TCMBANKGE007580,ZNF197,D3S1363E; P18; VHLaK; ZKSCAN9; ZNF166; ZNF20; ZSCAN41,zinc finger protein 197,3p21.31,protein-coding,/
CWITA007581,TCMBANKGE007581,KRT7,CK7; K2C7; K7; MGC129731; MGC3625; SCL,keratin 7,12q13.13,protein-coding,
CWITA007582,TCMBANKGE007582,ELMO1,CED-12; CED12; ELMO-1,engulfment and cell motility 1,7p14.2-p14.1,protein-coding,/
CWITA007583,TCMBANKGE007583,CLEC2A,INPE5792; KACL; PILAR; UNQ5792,C-type lectin domain family 2 member A,12p13.31,protein-coding,/
CWITA007584,TCMBANKGE007584,KCNJ6,BIR1; GIRKN2; GIRK2; KATPN2; KATP2; KCNJ7; KIR3.2; MGC126596; hiGIRK2,"potassium inwardly-rectifying channel, subfamily J, member 6",21q22.1|21q22.1,protein-coding,
CWITA007585,TCMBANKGE007585,ATP5MC3,ATP5G3; P3,ATP synthase membrane subunit c locus 3,2q31.1,protein-coding,/
CWITA007586,TCMBANKGE007586,ZBTB48,HKR3; TZAP; ZNF855; pp9964,zinc finger and BTB domain containing 48,1p36.31,protein-coding,/
CWITA007587,TCMBANKGE007587,PDE3A,CGINPDE,"phosphodiesterase 3A, cGMP-inhibited",12p12,protein-coding,
CWITA007588,TCMBANKGE007588,ARID4B,BCAA; BRCAA1; RBBP1L1; RBP1L1; SAP180,AT-rich interaction domain 4B,1q42.3,protein-coding,/
CWITA007589,TCMBANKGE007589,ATP5F1B,ATP5B; ATPMB; ATPSB; HEL-S-271,ATP synthase F1 subunit beta,12q13.3,protein-coding,/
CWITA007590,TCMBANKGE007590,CALML5,CLSP,calmodulin like 5,10p15.1,protein-coding,/
CWITA007591,TCMBANKGE007591,ECI2,ACBD2; DRS1; HCA88; KIAA0536; PECI; dJ1013A10.3,enoyl-CoA delta isomerase 2,6p24.3,protein-coding,
CWITA007592,TCMBANKGE007592,MRPL36,BRIP1; L36mt; MRP-L36; PRPL36; RPMJ,mitochondrial ribosomal protein L36,5p15.33,protein-coding,/
CWITA007593,TCMBANKGE007593,AJUBA,JUB,ajuba LIM protein,14q11.2,protein-coding,/
CWITA007594,TCMBANKGE007594,ACE2,ACEH; DKFZp434A014,angiotensin I converting enzyme (peptidyl-dipeptidase A) 2,Xp22,protein-coding,
CWITA007595,TCMBANKGE007595,ZNF189,-,zinc finger protein 189,9q31.1,protein-coding,/
CWITA007596,TCMBANKGE007596,ZNF12,GIOT-3; HZF11; KOX3; ZNF325,zinc finger protein 12,7p22.1,protein-coding,/
CWITA007597,TCMBANKGE007597,NOX3,GP91-3; MOX-2,NADPH oxidase 3,6q25.3,protein-coding,/
CWITA007598,TCMBANKGE007598,SMCO2,C12orf70,single-pass membrane protein with coiled-coil domains 2,12p11.23,protein-coding,/
CWITA007599,TCMBANKGE007599,ATP5F1E,ATP5E; ATPE; MC5DN3,ATP synthase F1 subunit epsilon,20q13.32,protein-coding,/
CWITA007600,TCMBANKGE007600,SNAPC4,PTFalpha; SNAP190,small nuclear RNA activating complex polypeptide 4,9q34.3,protein-coding,/
CWITA007601,TCMBANKGE007601,UBE2H,E2-20K; GID3; UBC8; UBCH; UBCH2,ubiquitin conjugating enzyme E2 H,7q32.2,protein-coding,/
CWITA007602,TCMBANKGE007602,MMP7,MMP-7; MPSL1; PUMP-1,matrix metallopeptidase 7,11q22.2,protein-coding,Successful target
CWITA007603,TCMBANKGE007603,PRPF18,PRP18; hPrp18,pre-mRNA processing factor 18,10p13,protein-coding,/
CWITA007604,TCMBANKGE007604,ABCB1,ABC20; CD243; CLCS; GP170; MDR1; MGC163296; PNGP; PGY1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",7q21.12,protein-coding,
CWITA007605,TCMBANKGE007605,ZNF681,-,zinc finger protein 681,19p12,protein-coding,/
CWITA007606,TCMBANKGE007606,NAP1L4,NAP1L4b; NAP2; NAP2L; hNAP2,nucleosome assembly protein 1 like 4,11p15.4,protein-coding,/
CWITA007607,TCMBANKGE007607,MYO1H,-,myosin IH,12q24.11,protein-coding,/
CWITA007608,TCMBANKGE007608,MNT,MAD6; MXD6; ROX; bHLHd3; lncRNA-HAL,MAX network transcriptional repressor,17p13.3,protein-coding,/
CWITA007609,TCMBANKGE007609,PNRC2,-,proline rich nuclear receptor coactivator 2,1p36.11,protein-coding,/
CWITA007610,TCMBANKGE007610,PDE8B,ADSD; PPNAD3,phosphodiesterase 8B,5q13.3,protein-coding,/
CWITA007611,TCMBANKGE007611,ALDH16A1,-,aldehyde dehydrogenase 16 family member A1,19q13.33,protein-coding,/
CWITA007612,TCMBANKGE007612,SYNCRIP,GRY-RBP; GRYRBP; HNRNPQ; HNRPQ1; NSAP1; PP68; hnRNP-Q,synaptotagmin binding cytoplasmic RNA interacting protein,6q14.3,protein-coding,/
CWITA007613,TCMBANKGE007613,POU4F1,BRN3A; Oct-T1; RDC-1; brn-3A,POU class 4 homeobox 1,13q31.1,protein-coding,/
CWITA007614,TCMBANKGE007614,PHF1,MTF2L2; PCL1; PHF2; TDRD19C; hPHF1,PHD finger protein 1,6p21.32,protein-coding,/
CWITA007615,TCMBANKGE007615,SLC5A3,BCW2; SMIT; SMIT1; SMIT2,solute carrier family 5 member 3,21q22.11,protein-coding,/
CWITA007616,TCMBANKGE007616,Prt6,Prt-6,pancreatic proteinase 6,-,protein-coding,/
CWITA007617,TCMBANKGE007617,DOCK1,DOCK180; ced5,dedicator of cytokinesis 1,10q26.2,protein-coding,/
CWITA007618,TCMBANKGE007618,GATAD1,CMD2B; ODAG; RG083M05.2,GATA zinc finger domain containing 1,7q21.2,protein-coding,/
CWITA007619,TCMBANKGE007619,GYG1,GSD15; GYG,glycogenin 1,3q24-q25.1,protein-coding,
CWITA007620,TCMBANKGE007620,NAALADL2,-,N-acetylated alpha-linked acidic dipeptidase like 2,3q26.31,protein-coding,/
CWITA007621,TCMBANKGE007621,SSX2IP,ADIP; hMsd1,SSX family member 2 interacting protein,1p22.3,protein-coding,Research target
CWITA007622,TCMBANKGE007622,NENF,CIR2; SCIRP10; SPUF,neudesin neurotrophic factor,1q32.3,protein-coding,/
CWITA007623,TCMBANKGE007623,SLC15A1,HPECT1; HPEPT1; PEPT1,"solute carrier family 15 (oligopeptide transporter), member 1",13q33-q34,protein-coding,
CWITA007624,TCMBANKGE007624,CD28,Tp44,CD28 molecule,2q33.2,protein-coding,Successful target
CWITA007625,TCMBANKGE007625,TRIM64B,-,tripartite motif containing 64B,11q14.3,protein-coding,/
CWITA007626,TCMBANKGE007626,GLRX2,GRX2; bA101E13.1,glutaredoxin 2,1q31.2-q31.3,protein-coding,
CWITA007627,TCMBANKGE007627,PAG1,CBP; PAG,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,8q21.13,protein-coding,/
CWITA007628,TCMBANKGE007628,DOCK5,-,dedicator of cytokinesis 5,8p21.2,protein-coding,/
CWITA007629,TCMBANKGE007629,PRXL2C,AAED1; C9orf21,peroxiredoxin like 2C,9q22.33,protein-coding,/
CWITA007630,TCMBANKGE007630,CHAF1A,CAF-1; CAF1; CAF1B; CAF1P150; P150,chromatin assembly factor 1 subunit A,19p13.3,protein-coding,/
CWITA007631,TCMBANKGE007631,CACYBP,GIG5; PNAS-107; S100A6BP; SIP,calcyclin binding protein,1q25.1,protein-coding,/
CWITA007632,TCMBANKGE007632,IRAK2,IRAK-2,interleukin 1 receptor associated kinase 2,3p25.3,protein-coding,/
CWITA007633,TCMBANKGE007633,SEC13,D3S1231E; SEC13L1; SEC13R; npp-20,"SEC13 homolog, nuclear pore and COPII coat complex component",3p25.3,protein-coding,/
CWITA007634,TCMBANKGE007634,ZNF546,ZNF49,zinc finger protein 546,19q13.2,protein-coding,/
CWITA007635,TCMBANKGE007635,NMUR1,(FM-3); FM-3; FM3; GPC-R; GPR66; NMU1R,neuromedin U receptor 1,2q37.1,protein-coding,Research target
CWITA007636,TCMBANKGE007636,FADS1,D5D; FADS6; FADSD5; LLCDL1; TU12,fatty acid desaturase 1,11q12.2,protein-coding,/
CWITA007637,TCMBANKGE007637,NDUFA9,CC6; CIN39k; CI39k; MGC111043; NDUFS2L; SDR22E1,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa",12p13.3,protein-coding,
CWITA007638,TCMBANKGE007638,IDH3B,FLJ11043; HNIDHB; MGC903; RP46,isocitrate dehydrogenase 3 (NAD+) beta,20p13,protein-coding,
CWITA007639,TCMBANKGE007639,TTC24,-,tetratricopeptide repeat domain 24,1q22,protein-coding,/
CWITA007640,TCMBANKGE007640,RAB4B,-,"RAB4B, member RAS oncogene family",19q13.2,protein-coding,/
CWITA007641,TCMBANKGE007641,RNF10,RIE2,ring finger protein 10,12q24.31,protein-coding,/
CWITA007642,TCMBANKGE007642,SCARF1,SREC; SREC-I; SREC1,scavenger receptor class F member 1,17p13.3,protein-coding,/
CWITA007643,TCMBANKGE007643,PEMT,PEAMT; PEMPT; PEMT2; PLMT; PNMT,phosphatidylethanolamine N-methyltransferase,17p11.2,protein-coding,Research target
CWITA007644,TCMBANKGE007644,FOLR2,BETA-HFR; FBP; FBP/PL-1; FOLR1; FR-BETA; FR-P3; FRbeta,folate receptor beta,11q13.4,protein-coding,Research target
CWITA007645,TCMBANKGE007645,GUK1,GMK,guanylate kinase 1,1q42.13,protein-coding,/
CWITA007646,TCMBANKGE007646,DPT,TRAMP,dermatopontin,1q24.2,protein-coding,/
CWITA007647,TCMBANKGE007647,ZNF571,HSPC059,zinc finger protein 571,19q13.12,protein-coding,/
CWITA007648,TCMBANKGE007648,SLC6A5,GLYT-2; GLYT2; HKPX3; NET1,solute carrier family 6 member 5,11p15.1,protein-coding,Research target
CWITA007649,TCMBANKGE007649,IPO4,Imp4,importin 4,14q12,protein-coding,/
CWITA007650,TCMBANKGE007650,FUT7,FucT-VII,fucosyltransferase 7,9q34.3,protein-coding,/
CWITA007651,TCMBANKGE007651,NOTCH2,AGS2; HJCYS; hN2,notch receptor 2,1p12,protein-coding,Clinical Trial target
CWITA007652,TCMBANKGE007652,STRN,PPP2R6A; SG2NA; STRN1,striatin,2p22.2,protein-coding,/
CWITA007653,TCMBANKGE007653,FIBCD1,-,fibrinogen C domain containing 1,9q34.12,protein-coding,/
CWITA007654,TCMBANKGE007654,PICK1,PICK; PRKCABP,protein interacting with PRKCA 1,22q13.1,protein-coding,/
CWITA007655,TCMBANKGE007655,IL1B,ILN1; IL1NBETA; IL1F2,"interleukin 1, beta",2q14,protein-coding,
CWITA007656,TCMBANKGE007656,FSHR,FSHR1; FSHRO; LGR1; ODG1,follicle stimulating hormone receptor,2p16.3,protein-coding,Successful target
CWITA007657,TCMBANKGE007657,CHRM1,HM1; M1; M1R; MGC30125,"cholinergic receptor, muscarinic 1",11q13,protein-coding,
CWITA007658,TCMBANKGE007658,MACIR,C5orf30,macrophage immunometabolism regulator,5q21.1,protein-coding,/
CWITA007659,TCMBANKGE007659,CHMP2A,BC-2; BC2; CHMP2; VPS2; VPS2A,charged multivesicular body protein 2A,19q13.43,protein-coding,/
CWITA007660,TCMBANKGE007660,AIMP1,EMAP2; EMAPII; SCYE1; p43,Aminoacyl Trna Synthetase Complex-Interacting Multifunctional Protein 1,4q24,protein-coding,
CWITA007661,TCMBANKGE007661,GPATCH8,GPATC8; KIAA0553,G-patch domain containing 8,17q21.31,protein-coding,/
CWITA007662,TCMBANKGE007662,CHRNB4,N,"cholinergic receptor, nicotinic, beta 4",15q24,protein-coding,
CWITA007663,TCMBANKGE007663,ABLIM3,HMFN1661,actin binding LIM protein family member 3,5q32,protein-coding,/
CWITA007664,TCMBANKGE007664,DDX60,-,DExD/H-box helicase 60,4q32.3,protein-coding,/
CWITA007665,TCMBANKGE007665,SPTAN1,EIEE5; NEAS; SPTA2,"spectrin alpha, non-erythrocytic 1",9q34.11,protein-coding,/
CWITA007666,TCMBANKGE007666,EHBP1L1,-,EH domain binding protein 1 like 1,11q13.1,protein-coding,/
CWITA007667,TCMBANKGE007667,HAL,HIS; HSTD,histidine ammonia-lyase,12q22-q24.1,protein-coding,
CWITA007668,TCMBANKGE007668,EIF2S3,EIF2; EIF2G; EIF2gamma; MEHMO; MRXSBRK; eIF-2gA,eukaryotic translation initiation factor 2 subunit gamma,Xp22.11,protein-coding,/
CWITA007669,TCMBANKGE007669,ZNF823,HSZFP36,zinc finger protein 823,19p13.2,protein-coding,/
CWITA007670,TCMBANKGE007670,CAPN12,-,calpain 12,19q13.2,protein-coding,/
CWITA007671,TCMBANKGE007671,HECTD1,EULIR,HECT domain E3 ubiquitin protein ligase 1,14q12,protein-coding,/
CWITA007672,TCMBANKGE007672,NAGA,D22S674; GALB,"N-acetylgalactosaminidase, alpha-",22q13-qter|22q11,protein-coding,
CWITA007673,TCMBANKGE007673,GSTT2,GSTT2B; MGC182032,glutathione S-transferase theta 2,22q11.2|22q11.23,protein-coding,
CWITA007674,TCMBANKGE007674,MAK16,MAK16L; RBM13,MAK16 homolog,8p12,protein-coding,/
CWITA007675,TCMBANKGE007675,GRIK2,EAA4; GLR6; GLUK6; GLUR6; MGC74427; MRT6,"glutamate receptor, ionotropic, kainate 2",6q16.3-q21,protein-coding,
CWITA007676,TCMBANKGE007676,PCDHGC5,PCDH-GAMMA-C5,"protocadherin gamma subfamily C, 5",5q31.3,protein-coding,/
CWITA007677,TCMBANKGE007677,UHRF1BP1L,SHIP164,UHRF1 binding protein 1 like,12q23.1,protein-coding,/
CWITA007678,TCMBANKGE007678,TUG1,LINC00080; NCRNA00080; TI-227H,taurine up-regulated 1,22q12.2,ncRNA,/
CWITA007679,TCMBANKGE007679,C1orf116,SARG,chromosome 1 open reading frame 116,1q32.1,protein-coding,/
CWITA007680,TCMBANKGE007680,S1PR4,EDG6; LPC1; S1P4; SLP4,sphingosine-1-phosphate receptor 4,19p13.3,protein-coding,Research target
CWITA007681,TCMBANKGE007681,ENPEP,APA; CD249; gp160,glutamyl aminopeptidase,4q25,protein-coding,Clinical Trial target
CWITA007682,TCMBANKGE007682,KCNC4,C1orf30; HKSHIIIC; KSHIIIC; KV3.4; MGC126818,"potassium voltage-gated channel, Shaw-related subfamily, member 4",1p21,protein-coding,
CWITA007683,TCMBANKGE007683,WBP2,DFNB107; GRAMD6; WBP-2,WW domain binding protein 2,17q25.1,protein-coding,/
CWITA007684,TCMBANKGE007684,LGALS9C,Gal-9B; LGALS9B,galectin 9C,17p11.2,protein-coding,/
CWITA007685,TCMBANKGE007685,TUBA3E,-,tubulin alpha 3e,2q21.1,protein-coding,/
CWITA007686,TCMBANKGE007686,FNIP1,-,folliculin interacting protein 1,5q31.1,protein-coding,/
CWITA007687,TCMBANKGE007687,TTF1,TTF-1; TTF-I,transcription termination factor 1,9q34.13,protein-coding,/
CWITA007688,TCMBANKGE007688,C11orf91,-,chromosome 11 open reading frame 91,11p13,protein-coding,/
CWITA007689,TCMBANKGE007689,SMPD1,ASM; ASMASE; NPD,"sphingomyelin phosphodiesterase 1, acid lysosomal",11p15.4-p15.1,protein-coding,
CWITA007690,TCMBANKGE007690,FKBP7,FKBP23; PPIase,FKBP prolyl isomerase 7,2q31.2,protein-coding,/
CWITA007691,TCMBANKGE007691,TRIM36,ANPH; HAPRIN; RBCC728; RNF98,tripartite motif containing 36,5q22.3,protein-coding,/
CWITA007692,TCMBANKGE007692,GSTM1,GST1; GSTM1-1; GSTM1a-1a; GSTM1b-1b; GTH4; GTM1; H-B; MU; MU-1,glutathione S-transferase mu 1,1p13.3,protein-coding,/
CWITA007693,TCMBANKGE007693,RDH8,PRRDH; SDR28C2,retinol dehydrogenase 8 (all-trans),19p13.2,protein-coding,
CWITA007694,TCMBANKGE007694,COPS4,CSN4; SGN4,COP9 signalosome subunit 4,4q21.22,protein-coding,/
CWITA007695,TCMBANKGE007695,SPANXB1,B1; CT11.2; SPANX-B; SPANXB; SPANXB2; SPANXF1; SPANXF2,SPANX family member B1,Xq27.1,protein-coding,/
CWITA007696,TCMBANKGE007696,EPHA2,ARCC2; ECK,EPH receptor A2,1p36,protein-coding,
CWITA007697,TCMBANKGE007697,PSMG1,C21LRP; DSCR2; LRPC21; PAC-1; PAC1,proteasome assembly chaperone 1,21q22.2,protein-coding,/
CWITA007698,TCMBANKGE007698,KIAA0586,JBTS23; SRTD14; Talpid3,KIAA0586,14q23.1,protein-coding,/
CWITA007699,TCMBANKGE007699,VKORC1L1,-,vitamin K epoxide reductase complex subunit 1 like 1,7q11.21,protein-coding,/
CWITA007700,TCMBANKGE007700,HMSD,ACC-6; ACC6; C18orf53; HSMD-v,histocompatibility minor serpin domain containing,18q22.1,protein-coding,/
CWITA007701,TCMBANKGE007701,RASAL2,NGAP,RAS protein activator like 2,1q25.2,protein-coding,/
CWITA007702,TCMBANKGE007702,PRICKLE2,EPM5,prickle planar cell polarity protein 2,3p14.1,protein-coding,/
CWITA007703,TCMBANKGE007703,NFKBIZ,IKBZ; INAP; MAIL,NFKB inhibitor zeta,3q12.3,protein-coding,/
CWITA007704,TCMBANKGE007704,MORC4,ZCW4; ZCWCC2; dJ75H8.2,MORC family CW-type zinc finger 4,Xq22.3,protein-coding,/
CWITA007705,TCMBANKGE007705,CYP46A1,CP46; CYP46,cytochrome P450 family 46 subfamily A member 1,14q32.2,protein-coding,Discontinued target
CWITA007706,TCMBANKGE007706,COX17,-,cytochrome c oxidase copper chaperone COX17,3q13.33,protein-coding,Research target
CWITA007707,TCMBANKGE007707,PNPLA4,DXS1283E; GS2; iPLA2eta,patatin like phospholipase domain containing 4,Xp22.31,protein-coding,/
CWITA007708,TCMBANKGE007708,PLXNA4,FAYV2820; PLEXA4; PLXNA4A; PLXNA4B; PRO34003,plexin A4,7q32.3,protein-coding,/
CWITA007709,TCMBANKGE007709,SERPINC1,AT3; AT3D; ATIII; ATIII-R2; ATIII-T1; ATIII-T2; THPH7,serpin family C member 1,1q25.1,protein-coding,Successful target
CWITA007710,TCMBANKGE007710,NDUFB9,B22; CI-B22; LYRM3; MC1DN24; UQOR22,NADH:ubiquinone oxidoreductase subunit B9,8q24.13,protein-coding,/
CWITA007711,TCMBANKGE007711,TOMM70,TOMM70A; Tom70,translocase of outer mitochondrial membrane 70,3q12.2,protein-coding,/
CWITA007712,TCMBANKGE007712,CCKBR,CCKNB; CCK2R; GASR,cholecystokinin B receptor,11p15.4,protein-coding,
CWITA007713,TCMBANKGE007713,LPAR1,EDG2; GPR26; Gpcr26; LPA1; Mrec1.3; VZG1; edg-2; rec.1.3; vzg-1,lysophosphatidic acid receptor 1,9q31.3,protein-coding,Clinical Trial target
CWITA007714,TCMBANKGE007714,ZNF654,-,zinc finger protein 654,3p11.1,protein-coding,/
CWITA007715,TCMBANKGE007715,SCAMP3,C1orf3,secretory carrier membrane protein 3,1q22,protein-coding,/
CWITA007716,TCMBANKGE007716,BRDT,BRD6; CT9; SPGF21,bromodomain testis associated,1p22.1,protein-coding,Clinical Trial target
CWITA007717,TCMBANKGE007717,PVALB,D22S749; MGC116759,parvalbumin,22q12-q13.1|22q13.1,protein-coding,
CWITA007718,TCMBANKGE007718,TK1,TK2,"thymidine kinase 1, soluble",17q23.2-q25.3,protein-coding,
CWITA007719,TCMBANKGE007719,PLAG1,PSA; SGPA; ZNF912,PLAG1 zinc finger,8q12.1,protein-coding,/
CWITA007720,TCMBANKGE007720,ALDH1A2,MGC26444; RALDH(II); RALDH2; RALDH2NT,"aldehyde dehydrogenase 1 family, member A2",15q21.3,protein-coding,
CWITA007721,TCMBANKGE007721,C5,C5D; C5a; C5b; CPAMD4; ECLZB,complement C5,9q33.2,protein-coding,Successful target
CWITA007722,TCMBANKGE007722,TAF4B,SPGF13; TAF2C2; TAFII105,TATA-box binding protein associated factor 4b,18q11.2,protein-coding,/
CWITA007723,TCMBANKGE007723,DOK4,IRS-5; IRS5,docking protein 4,16q21,protein-coding,/
CWITA007724,TCMBANKGE007724,KCNJ12,FLJ14167; IRK2; KCNJN1; Kir2.2; Kir2.2v; hIRK; hIRK1; hkir2.2x; kcnj12x,"potassium inwardly-rectifying channel, subfamily J, member 12",17p11.2,protein-coding,
CWITA007725,TCMBANKGE007725,CIP2A,KIAA1524; p90,cellular inhibitor of PP2A,3q13.13,protein-coding,/
CWITA007726,TCMBANKGE007726,SRSF5,HRS; SFRS5; SRP40,serine and arginine rich splicing factor 5,14q24.1,protein-coding,/
CWITA007727,TCMBANKGE007727,NR2E1,TLL; TLX; XTLL,nuclear receptor subfamily 2 group E member 1,6q21,protein-coding,/
CWITA007728,TCMBANKGE007728,OAF,NS5ATP13TP2,out at first homolog,11q23.3,protein-coding,/
CWITA007729,TCMBANKGE007729,TTLL3,HOTTL,tubulin tyrosine ligase like 3,3p25.3,protein-coding,/
CWITA007730,TCMBANKGE007730,H3C14,H3; H3.2; H3/M; H3C13; H3C15; H3F2; H3FM; H3FN; HIST2H3C,H3 clustered histone 14,1q21.2,protein-coding,/
CWITA007731,TCMBANKGE007731,CLN5,-,CLN5 intracellular trafficking protein,13q22.3,protein-coding,/
CWITA007732,TCMBANKGE007732,COX4I2,COX4; COX4-2; COX4B; COX4L2; COXIV-2; dJ857M17.2,cytochrome c oxidase subunit 4I2,20q11.21,protein-coding,/
CWITA007733,TCMBANKGE007733,TLK1,PKU-beta,tousled like kinase 1,2q31.1,protein-coding,/
CWITA007734,TCMBANKGE007734,GLYAT,ACGNAT; CAT; GAT,glycine-N-acyltransferase,11q12.1,protein-coding,/
CWITA007735,TCMBANKGE007735,NR5A2,B1F; B1F2; CPF; FTF; FTZ-F1; FTZ-F1beta; LRH-1; LRH1; hB1F-2,nuclear receptor subfamily 5 group A member 2,1q32.1,protein-coding,Research target
CWITA007736,TCMBANKGE007736,PCDHA10,CNR8; CNRN8; CNRS8; CRNR8; PCDH-ALPHA10,protocadherin alpha 10,5q31.3,protein-coding,/
CWITA007737,TCMBANKGE007737,CAPN13,-,calpain 13,2p23.1,protein-coding,/
CWITA007738,TCMBANKGE007738,BRPF1,BR140; IDDDFP,bromodomain and PHD finger containing 1,3p25.3,protein-coding,Research target
CWITA007739,TCMBANKGE007739,ELK3,ERP; NET; SAP-2; SAP2,ETS transcription factor ELK3,12q23.1,protein-coding,Research target
CWITA007740,TCMBANKGE007740,CFTR,ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNRNCFTR; dJ760C5.1,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",7q31.2,protein-coding,
CWITA007741,TCMBANKGE007741,MIF,GIF; GLIF; MMIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),22q11.23,protein-coding,
CWITA007742,TCMBANKGE007742,HSPB3,DHMN2C; HMN2C; HSPL27,heat shock protein family B (small) member 3,5q11.2,protein-coding,Clinical Trial target
CWITA007743,TCMBANKGE007743,COMMD3,BUP; C10orf8,COMM domain containing 3,10p12.2,protein-coding,/
CWITA007744,TCMBANKGE007744,MRPS12,MPR-S12; MT-RPS12; RPMS12; RPS12; RPSM12,mitochondrial ribosomal protein S12,19q13.2,protein-coding,/
CWITA007745,TCMBANKGE007745,GUCY1B1,GC-S-beta-1; GC-SB3; GUC1B3; GUCB3; GUCSB3; GUCY1B3,guanylate cyclase 1 soluble subunit beta 1,4q32.1,protein-coding,Clinical Trial target
CWITA007746,TCMBANKGE007746,PPP2R2C,B55-GAMMA; B55gamma; IMYPNO; IMYPNO1; PR52; PR55G,protein phosphatase 2 regulatory subunit Bgamma,4p16.1,protein-coding,/
CWITA007747,TCMBANKGE007747,UBE2F-SCLY,-,UBE2F-SCLY readthrough (NMD candidate),2q37.3,ncRNA,/
CWITA007748,TCMBANKGE007748,EVL,RNB6,Enah/Vasp-Like,14q32.2,protein-coding,
CWITA007749,TCMBANKGE007749,MT2A,MT2,metallothionein 2A,16q13,protein-coding,
CWITA007750,TCMBANKGE007750,CHN2,ARHGAP3; BCH; CHN2-3; RHOGAP3,chimerin 2,7p14.3,protein-coding,Research target
CWITA007751,TCMBANKGE007751,RNASET2,RNASE6PL; bA514O12.3,ribonuclease T2,6q27,protein-coding,/
CWITA007752,TCMBANKGE007752,GPC5,-,glypican 5,13q31.3,protein-coding,/
CWITA007753,TCMBANKGE007753,HIF3A,HIF-3A; HIF3-alpha-1; IPAS; MOP7; PASD7; bHLHe17,hypoxia inducible factor 3 subunit alpha,19q13.32,protein-coding,/
CWITA007754,TCMBANKGE007754,TXNDC11,EFP1,thioredoxin domain containing 11,16p13.13,protein-coding,/
CWITA007755,TCMBANKGE007755,MRPL2,CGI-22; MRP-L14; RPML14,mitochondrial ribosomal protein L2,6p21.1,protein-coding,/
CWITA007756,TCMBANKGE007756,ASNS,TS11,asparagine synthetase (glutamine-hydrolyzing),7q21.3,protein-coding,
CWITA007757,TCMBANKGE007757,USP29,HOM-TES-84/86,ubiquitin specific peptidase 29,19q13.43,protein-coding,/
CWITA007758,TCMBANKGE007758,EPHX2,CEH; SEH,"epoxide hydrolase 2, cytoplasmic",8p21,protein-coding,
CWITA007759,TCMBANKGE007759,MFSD2A,MCPH15; MFSD2; NLS1,major facilitator superfamily domain containing 2A,1p34.2,protein-coding,/
CWITA007760,TCMBANKGE007760,RBSN,Rabenosyn-5; ZFYVE20,"rabenosyn, RAB effector",3p25.1,protein-coding,/
CWITA007761,TCMBANKGE007761,SRSF6,B52; HEL-S-91; SFRS6; SRP55,serine and arginine rich splicing factor 6,20q13.11,protein-coding,/
CWITA007762,TCMBANKGE007762,PFKFB1,F6PK; HL2K; MGC116715; MGC116717; PFRX,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1",Xp11.21,protein-coding,
CWITA007763,TCMBANKGE007763,HDC,-,histidine decarboxylase,15q21.2,protein-coding,Clinical Trial target
CWITA007764,TCMBANKGE007764,MAPKAP1,JC310; MIP1; SIN1; SIN1b; SIN1g,MAPK associated protein 1,9q33.3,protein-coding,Clinical Trial target
CWITA007765,TCMBANKGE007765,TPRKB,CGI-121; CGI121; GAMOS5,TP53RK binding protein,2p13.1,protein-coding,/
CWITA007766,TCMBANKGE007766,F3,CD142; FLJ17960; TF; TFA,"coagulation factor III (thromboplastin, tissue factor)",1p22-p21,protein-coding,
CWITA007767,TCMBANKGE007767,ZBTB46,BTBD4; BZEL; RINZF; ZNF340; dJ583P15.7; dJ583P15.8,zinc finger and BTB domain containing 46,20q13.33,protein-coding,/
CWITA007768,TCMBANKGE007768,ZFAND3,TEX27,zinc finger AN1-type containing 3,6p21.2,protein-coding,/
CWITA007769,TCMBANKGE007769,Bsp,-,black spleen,-,unknown,/
CWITA007770,TCMBANKGE007770,PHOX2B,CCHS; NBLST2; NBPhox; PMX2B,paired like homeobox 2B,4p13,protein-coding,/
CWITA007771,TCMBANKGE007771,PARP8,ARTD16; pART16,poly(ADP-ribose) polymerase family member 8,5q11.1,protein-coding,/
CWITA007772,TCMBANKGE007772,FFAR1,FFA1R; GPCR40; GPR40,free fatty acid receptor 1,19q13.12,protein-coding,Clinical Trial target
CWITA007773,TCMBANKGE007773,PLXNB2,MM1; Nbla00445; PLEXB2; dJ402G11.3,plexin B2,22q13.33,protein-coding,/
CWITA007774,TCMBANKGE007774,MRPL30,L28MT; L30MT; MRP-L28; MRP-L30; MRPL28; MRPL28M; RPML28,mitochondrial ribosomal protein L30,2q11.2,protein-coding,/
CWITA007775,TCMBANKGE007775,BCL9,LGS,BCL9 transcription coactivator,1q21.2,protein-coding,/
CWITA007776,TCMBANKGE007776,H3,H-3,histocompatibility 3,-,protein-coding,/
CWITA007777,TCMBANKGE007777,VIPAS39,C14orf133; SPE-39; SPE39; VIPAR; VPS16B; hSPE-39,"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog",14q24.3,protein-coding,/
CWITA007778,TCMBANKGE007778,LGALSL,GRP; HSPC159,galectin like,2p14,protein-coding,/
CWITA007779,TCMBANKGE007779,MAP6D1,MAPO6D1; SL21,MAP6 domain containing 1,3q27.1,protein-coding,/
CWITA007780,TCMBANKGE007780,KCNIP1,KCHIP1; VABP,potassium voltage-gated channel interacting protein 1,5q35.1,protein-coding,/
CWITA007781,TCMBANKGE007781,ZNF462,WSKA; ZFPIP; Zfp462,zinc finger protein 462,9q31.2,protein-coding,/
CWITA007782,TCMBANKGE007782,SEMA3C,SEMAE; SemE,semaphorin 3C,7q21.11,protein-coding,/
CWITA007783,TCMBANKGE007783,ZNF131,ZBTB35; pHZ-10,zinc finger protein 131,5p12,protein-coding,/
CWITA007784,TCMBANKGE007784,LGR6,GPCR; VTS20631,leucine rich repeat containing G protein-coupled receptor 6,1q32.1,protein-coding,/
CWITA007785,TCMBANKGE007785,PSMD10,dJ889N15.2; p28; p28(GANK),"proteasome 26S subunit, non-ATPase 10",Xq22.3,protein-coding,Research target
CWITA007786,TCMBANKGE007786,ADH4,ADHN2,"alcohol dehydrogenase 4 (class II), pi polypeptide",4q21-q24|4q22,protein-coding,
CWITA007787,TCMBANKGE007787,ZNF354B,KID2,zinc finger protein 354B,5q35.3,protein-coding,/
CWITA007788,TCMBANKGE007788,MATK,CHK; CTK; HHYLTK; HYL; HYLTK; Lsk,megakaryocyte-associated tyrosine kinase,19p13.3,protein-coding,/
CWITA007789,TCMBANKGE007789,TAS1R2,GPR71; T1R2; TR2,Taste_1_Receptor_Member_2,1p36.13,protein-coding,
CWITA007790,TCMBANKGE007790,ZNF479,HKr19; KR19,zinc finger protein 479,7p11.2,protein-coding,/
CWITA007791,TCMBANKGE007791,APOBEC3A,A3A; ARP3; PHRBN; bK150C2.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3A,22q13.1,protein-coding,/
CWITA007792,TCMBANKGE007792,EPHA5,CEK7; EHK-1; EHK1; EK7; HEK7; TYRO4,EPH receptor A5,4q13.1-q13.2,protein-coding,Research target
CWITA007793,TCMBANKGE007793,AOX1,AO; AOH1,aldehyde oxidase 1,2q33,protein-coding,
CWITA007794,TCMBANKGE007794,NRBP2,TRG16; pp9320,nuclear receptor binding protein 2,8q24.3,protein-coding,/
CWITA007795,TCMBANKGE007795,SCHIP1,SCHIP-1,schwannomin interacting protein 1,3q25.32-q25.33,protein-coding,/
CWITA007796,TCMBANKGE007796,AMPH,AMPH1,amphiphysin,7p14.1,protein-coding,/
CWITA007797,TCMBANKGE007797,KITLG,DCUA; DFNA69; FPH2; FPHH; KL-1; Kitl; MGF; SCF; SF; SHEP7; SLF,KIT ligand,12q21.32,protein-coding,Research target
CWITA007798,TCMBANKGE007798,SPAM1,HEL-S-96n; HYA1; HYAL1; HYAL3; HYAL5; PH-20; PH20; SPAG15,sperm adhesion molecule 1,7q31.32,protein-coding,/
CWITA007799,TCMBANKGE007799,FLT3,CD135; FLK-2; FLK2; STK1,fms related receptor tyrosine kinase 3,13q12.2,protein-coding,Successful target
CWITA007800,TCMBANKGE007800,OSR1,ODD,odd-skipped related transcription factor 1,2p24.1,protein-coding,/
CWITA007801,TCMBANKGE007801,ITIH1,H1P; IATIH; IGHEP1; ITI-HC1; ITIH; SHAP,inter-alpha-trypsin inhibitor heavy chain 1,3p21.1,protein-coding,/
CWITA007802,TCMBANKGE007802,CPA4,CPA3,carboxypeptidase A4,7q32.2,protein-coding,/
CWITA007803,TCMBANKGE007803,HAUS1,CCDC5; HEI-C; HEIC; HsT1461,HAUS augmin like complex subunit 1,18q21.1,protein-coding,/
CWITA007804,TCMBANKGE007804,TMEM163,DC29; SV31,transmembrane protein 163,2q21.3,protein-coding,/
CWITA007805,TCMBANKGE007805,ZNF726,ZNF92P3,zinc finger protein 726,19p12,protein-coding,/
CWITA007806,TCMBANKGE007806,FAM214A,KIAA1370,family with sequence similarity 214 member A,15q21.2-q21.3,protein-coding,/
CWITA007807,TCMBANKGE007807,ARX,CT121; EIEE1; ISSX; MRX29; MRX32; MRX33; MRX36; MRX38; MRX43; MRX54; MRX76; MRX87; MRXS1; PRTS,aristaless related homeobox,Xp21.3,protein-coding,/
CWITA007808,TCMBANKGE007808,CAVIN3,HSRBC; PRKCDBP; SRBC; cavin-3,caveolae associated protein 3,11p15.4,protein-coding,/
CWITA007809,TCMBANKGE007809,DNPH1,C6orf108; RCL; dJ330M21.3,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,6p21.1,protein-coding,/
CWITA007810,TCMBANKGE007810,ANAPC7,APC7,anaphase promoting complex subunit 7,12q24.11,protein-coding,/
CWITA007811,TCMBANKGE007811,CSTF1,CstF-50; CstFp50,cleavage stimulation factor subunit 1,20q13.2-q13.31,protein-coding,/
CWITA007812,TCMBANKGE007812,ZBTB39,ZNF922,zinc finger and BTB domain containing 39,12q13.3,protein-coding,/
CWITA007813,TCMBANKGE007813,MTR,FLJ33168; FLJ43216; FLJ45386; MS; cblG,5-methyltetrahydrofolate-homocysteine methyltransferase,1q43,protein-coding,
CWITA007814,TCMBANKGE007814,BGLAP,BGP; OC,bone gamma-carboxyglutamate (gla) protein,1q25-q31,protein-coding,
CWITA007815,TCMBANKGE007815,PCDHB7,PCDH-BETA7,protocadherin beta 7,5q31.3,protein-coding,/
CWITA007816,TCMBANKGE007816,UVRAG,DHTX; VPS38; p63,UV radiation resistance associated,11q13.5,protein-coding,/
CWITA007817,TCMBANKGE007817,SLC2A13,HMIT,solute carrier family 2 member 13,12q12,protein-coding,/
CWITA007818,TCMBANKGE007818,RSKR,SGK494,ribosomal protein S6 kinase related,17q11.2,protein-coding,/
CWITA007819,TCMBANKGE007819,HGD,AKU; HGO,"homogentisate 1,2-dioxygenase",3q13.33,protein-coding,/
CWITA007820,TCMBANKGE007820,RAB2A,LHX; RAB2,"RAB2A, member RAS oncogene family",8q12.1-q12.2,protein-coding,/
CWITA007821,TCMBANKGE007821,GABRB2,MGC119386; MGC119388; MGC119389,"gamma-aminobutyric acid (GABA) A receptor, beta 2",5q34,protein-coding,
CWITA007822,TCMBANKGE007822,HPGDS,GSTS; PGDS,hematopoietic prostaglandin D synthase,4q22.3,protein-coding,
CWITA007823,TCMBANKGE007823,MMP23A,MIFR; MIFR-1; MMP21,matrix metallopeptidase 23A (pseudogene),1p36.33,pseudo,/
CWITA007824,TCMBANKGE007824,ZNF263,FPM315; ZKSCAN12; ZSCAN44,zinc finger protein 263,16p13.3,protein-coding,/
CWITA007825,TCMBANKGE007825,RPL27A,L27A,ribosomal protein L27a,11p15.4,protein-coding,/
CWITA007826,TCMBANKGE007826,MPI,CDG1B; PMI; PMI1,mannose phosphate isomerase,15q24.1,protein-coding,/
CWITA007827,TCMBANKGE007827,ZNF644,BM-005; MYP21; NatF; ZEP-2,zinc finger protein 644,1p22.2,protein-coding,/
CWITA007828,TCMBANKGE007828,FGG,N,fibrinogen gamma chain,4q28,protein-coding,
CWITA007829,TCMBANKGE007829,POLH,RAD30; RAD30A; XP-V; XPV,DNA polymerase eta,6p21.1,protein-coding,/
CWITA007830,TCMBANKGE007830,NR0B2,SHP; SHP1,nuclear receptor subfamily 0 group B member 2,1p36.11,protein-coding,Research target
CWITA007831,TCMBANKGE007831,ZNF771,DSC43,zinc finger protein 771,16p11.2,protein-coding,/
CWITA007832,TCMBANKGE007832,COPS2,ALIEN; CSN2; SGN2; TRIP15,COP9 signalosome subunit 2,15q21.1,protein-coding,/
CWITA007833,TCMBANKGE007833,MARS,FLJ35667; METRS; MRS; MTRNS,methionyl-tRNA synthetase,12q13.2,protein-coding,
CWITA007834,TCMBANKGE007834,ACY1,ACYN1; ACY1D,aminoacylase 1,3p21.1,protein-coding,
CWITA007835,TCMBANKGE007835,GCH1,DYT14; DYT5; DYT5a; GCH; GTPNCHN1; GTPCH1; HPABH4B,GTP cyclohydrolase 1,14q22.1-q22.2,protein-coding,
CWITA007836,TCMBANKGE007836,SELL,CD62L; LAM1; LECAM1; LEU8; LNHR; LSEL; LYAM1; PLNHR; TQ1,selectin L,1q24.2,protein-coding,Clinical Trial target
CWITA007837,TCMBANKGE007837,RPA3,REPA3; RP-A p14,replication protein A3,7p21.3,protein-coding,/
CWITA007838,TCMBANKGE007838,LRRC3B,LRP15,leucine rich repeat containing 3B,3p24.1,protein-coding,/
CWITA007839,TCMBANKGE007839,PLAAT3,AdPLA; H-REV107; H-REV107-1; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; PLA2G16; PLAAT-3,phospholipase A and acyltransferase 3,11q12.3-q13.1,protein-coding,/
CWITA007840,TCMBANKGE007840,BCL6B,BAZF; ZBTB28; ZNF62,BCL6B transcription repressor,17p13.1,protein-coding,/
CWITA007841,TCMBANKGE007841,INSRR,IRR,insulin receptor related receptor,1q23.1,protein-coding,/
CWITA007842,TCMBANKGE007842,ZNF267,HZF2,zinc finger protein 267,16p11.2,protein-coding,/
CWITA007843,TCMBANKGE007843,PSMB9,LMP2; PRAAS3; PSMB6i; RING12; beta1i,proteasome 20S subunit beta 9,6p21.32,protein-coding,Patented target
CWITA007844,TCMBANKGE007844,SASH1,CAPOK; DUH1; SH3D6A; dJ323M4.1,SAM and SH3 domain containing 1,6q24.3-q25.1,protein-coding,/
CWITA007845,TCMBANKGE007845,MYH4,MYH2B; MyHC-2B; MyHC-IIb,myosin heavy chain 4,17p13.1,protein-coding,/
CWITA007846,TCMBANKGE007846,HAL,HIS; HSTD,histidine ammonia-lyase,12q23.1,protein-coding,Research target
CWITA007847,TCMBANKGE007847,HDDC2,C6orf74; CGI-130; NS5ATP2; dJ167O5.2,HD domain containing 2,6q22.31,protein-coding,/
CWITA007848,TCMBANKGE007848,ATF1,EWSNATF1; FUS/ATFN1; TREB36,activating transcription factor 1,12q13,protein-coding,
CWITA007849,TCMBANKGE007849,Skull4,E3; L3; QTL-S3.1,skull morphology 4,3 32.25 cM,unknown,/
CWITA007850,TCMBANKGE007850,CFL1,CFL; HEL-S-15; cofilin,cofilin 1,11q13.1,protein-coding,/
CWITA007851,TCMBANKGE007851,DCPS,ARS; DCS1; HINT-5; HINT5; HSL1; HSPC015,"decapping enzyme, scavenger",11q24.2,protein-coding,Clinical Trial target
CWITA007852,TCMBANKGE007852,SHROOM3,APXL3; MSTP013; SHRM; ShrmL,shroom family member 3,4q21.1,protein-coding,/
CWITA007853,TCMBANKGE007853,EOGT,AER61; AOS4; C3orf64; EOGT1,EGF domain specific O-linked N-acetylglucosamine transferase,3p14.1,protein-coding,/
CWITA007854,TCMBANKGE007854,NOP9,C14orf21,NOP9 nucleolar protein,14q12,protein-coding,/
CWITA007855,TCMBANKGE007855,FCAMR,CD351; FCA/MR; FKSG87,Fc fragment of IgA and IgM receptor,1q32.1,protein-coding,/
CWITA007856,TCMBANKGE007856,UROC1,HMFN0320; UROCD,urocanate hydratase 1,3q21.3,protein-coding,/
CWITA007857,TCMBANKGE007857,NDUFA13,B16.6; CDA016; FLJ58045; FLJ59191; GRIMN19; GRIM19,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13",19p13.2,protein-coding,
CWITA007858,TCMBANKGE007858,GZMK,TRYP2,granzyme K,5q11.2,protein-coding,/
CWITA007859,TCMBANKGE007859,CAT,MGC138422; MGC138424,catalase,11p13,protein-coding,
CWITA007860,TCMBANKGE007860,ST7L,FAM4B; ST7R; STLR,suppression of tumorigenicity 7 like,1p13.2,protein-coding,/
CWITA007861,TCMBANKGE007861,PAPSS1,ATPSK1; PAPSS; SK1,3'-phosphoadenosine 5'-phosphosulfate synthase 1,4q25,protein-coding,/
CWITA007862,TCMBANKGE007862,IL13RA1,CD213A1; CT19; IL-13Ra; NR4,interleukin 13 receptor subunit alpha 1,Xq24,protein-coding,Research target
CWITA007863,TCMBANKGE007863,FBXO17,FBG4; FBX26; FBXO26; Fbx17,F-box protein 17,19q13.2,protein-coding,/
CWITA007864,TCMBANKGE007864,ACACB,ACC2; ACCB; HACC275,acetyl-CoA carboxylase beta,12q24.11,protein-coding,
CWITA007865,TCMBANKGE007865,LRRC7,DENSIN,leucine rich repeat containing 7,1p31.1,protein-coding,/
CWITA007866,TCMBANKGE007866,SAG,RP47; S-AG,S-antigen visual arrestin,2q37.1,protein-coding,/
CWITA007867,TCMBANKGE007867,CYP17A1,CPT7; CYP17; P450C17; S17AH,"cytochrome P450, family 17, subfamily A, polypeptide 1",10q24.3,protein-coding,
CWITA007868,TCMBANKGE007868,HMGCS2,-,3-hydroxy-3-methylglutaryl-CoA synthase 2,1p12,protein-coding,Research target
CWITA007869,TCMBANKGE007869,CCSAP,C1orf96; CSAP,"centriole, cilia and spindle associated protein",1q42.13,protein-coding,/
CWITA007870,TCMBANKGE007870,ASB10,GLC1F,ankyrin repeat and SOCS box containing 10,7q36.1,protein-coding,/
CWITA007871,TCMBANKGE007871,ZNF404,-,zinc finger protein 404,19q13.31,protein-coding,/
CWITA007872,TCMBANKGE007872,TNFSF13B,BAFF; BLYS; CD257; DTL; TALL-1; TALL1; THANK; TNFSF20; TNLG7A; ZTNF4,TNF superfamily member 13b,13q33.3,protein-coding,Successful target
CWITA007873,TCMBANKGE007873,VSNL1,HLP3; HPCAL3; HUVISL1; VILIP; VILIP-1,visinin like 1,2p24.2,protein-coding,/
CWITA007874,TCMBANKGE007874,TRIM73,TRIM50B,tripartite motif containing 73,7q11.23,protein-coding,/
CWITA007875,TCMBANKGE007875,ACP7,PAPL; PAPL1,"acid phosphatase 7, tartrate resistant (putative)",19q13.2,protein-coding,/
CWITA007876,TCMBANKGE007876,ZNF304,-,zinc finger protein 304,19q13.43,protein-coding,/
CWITA007877,TCMBANKGE007877,TSPAN4,NAG-2; NAG2; TETRASPAN; TM4SF7; TSPAN-4,tetraspanin 4,11p15.5,protein-coding,/
CWITA007878,TCMBANKGE007878,ZNF317,-,zinc finger protein 317,19p13.2,protein-coding,/
CWITA007879,TCMBANKGE007879,BMPR1A,10q23del; ACVRLK3; ALK3; CD292; SKR5,bone morphogenetic protein receptor type 1A,10q23.2,protein-coding,/
CWITA007880,TCMBANKGE007880,GABRB1,N,"gamma-aminobutyric acid (GABA) A receptor, beta 1",4p12,protein-coding,
CWITA007881,TCMBANKGE007881,SAPCD2,C9orf140; p42.3,suppressor APC domain containing 2,9q34.3,protein-coding,/
CWITA007882,TCMBANKGE007882,MED7,ARC34; CRSP33; CRSP9,mediator complex subunit 7,5q33.3,protein-coding,/
CWITA007883,TCMBANKGE007883,MCEE,GLOD2,methylmalonyl-CoA epimerase,2p13.3,protein-coding,/
CWITA007884,TCMBANKGE007884,GPR68,AI2A6; GPR12A; OGR1,G protein-coupled receptor 68,14q32.11,protein-coding,/
CWITA007885,TCMBANKGE007885,GABRP,-,gamma-aminobutyric acid type A receptor subunit pi,5q35.1,protein-coding,Research target
CWITA007886,TCMBANKGE007886,HLA-G,MHC-G,"major histocompatibility complex, class I, G",6p22.1,protein-coding,/
CWITA007887,TCMBANKGE007887,SNX3,Grd19; MCOPS8; MGC17570; SDP3,sorting nexin 3,6q21,protein-coding,
CWITA007888,TCMBANKGE007888,MDH1,MDHNs; MDHA; MGC:1375; MOR2,"malate dehydrogenase 1, NAD (soluble)",2p13.3,protein-coding,
CWITA007889,TCMBANKGE007889,CLEC4G,DTTR431; LP2698; LSECtin; UNQ431,C-type lectin domain family 4 member G,19p13.2,protein-coding,/
CWITA007890,TCMBANKGE007890,HSF2,HSF 2; HSTF 2,heat shock transcription factor 2,6q22.31,protein-coding,/
CWITA007891,TCMBANKGE007891,LRRIQ4,LRRC64,leucine rich repeats and IQ motif containing 4,3q26.2,protein-coding,/
CWITA007892,TCMBANKGE007892,SLC1A7,AAAT; EAAT5; FLJ36602,"solute carrier family 1 (glutamate transporter), member 7",1p32.3,protein-coding,
CWITA007893,TCMBANKGE007893,KDM5B,CT31; JARID1B; MRT65; PLU-1; PLU1; PPP1R98; PUT1; RBBP2H1A; RBP2-H1,lysine demethylase 5B,1q32.1,protein-coding,Research target
CWITA007894,TCMBANKGE007894,CRIPT,HSPC139; SSMDF,CXXC repeat containing interactor of PDZ3 domain,2p21,protein-coding,/
CWITA007895,TCMBANKGE007895,GLUD2,GDH2; GLUDP1,glutamate dehydrogenase 2,Xq24-q25,protein-coding,
CWITA007896,TCMBANKGE007896,AVPR2,ADHR; DI1; DIR; DIR3; NDI; V2R,arginine vasopressin receptor 2,Xq28,protein-coding,Successful target
CWITA007897,TCMBANKGE007897,EBAG9,EB9; PDAF,estrogen receptor binding site associated antigen 9,8q23.2,protein-coding,/
CWITA007898,TCMBANKGE007898,DENND1A,FAM31A; KIAA1608,DENN domain containing 1A,9q33.3,protein-coding,/
CWITA007899,TCMBANKGE007899,FST,FS,follistatin,5q11.2,protein-coding,
CWITA007900,TCMBANKGE007900,RPS28,DBA15; S28; eS28,ribosomal protein S28,19p13.2,protein-coding,/
CWITA007901,TCMBANKGE007901,KIF15,HKLP2; KLP2; KNSL7; NY-BR-62,kinesin family member 15,3p21.31,protein-coding,/
CWITA007902,TCMBANKGE007902,GET4,C7orf20; CEE; CGI-20; TRC35,guided entry of tail-anchored proteins factor 4,7p22.3,protein-coding,/
CWITA007903,TCMBANKGE007903,COQ7,CAT5; CLK-1; CLK1; COQ10D8,"coenzyme Q7, hydroxylase",16p12.3,protein-coding,/
CWITA007904,TCMBANKGE007904,AK4,AK3; AK3L1; AK3L2; MGC166959,adenylate kinase 4,1p31.3,protein-coding,
CWITA007905,TCMBANKGE007905,KRT81,HB1; Hb-1; KRTHB1; MLN137; ghHkb1; hHAKB2-1,keratin 81,12q13.13,protein-coding,/
CWITA007906,TCMBANKGE007906,RRS1,-,ribosome biogenesis regulator 1 homolog,8q13.1,protein-coding,/
CWITA007907,TCMBANKGE007907,HHLA3,-,HERV-H LTR-associating 3,1p31.1,ncRNA,/
CWITA007908,TCMBANKGE007908,TMEM140,-,transmembrane protein 140,7q33,protein-coding,/
CWITA007909,TCMBANKGE007909,ADGRD1,GPR133; PGR25,Adhesion_G_Protein-Coupled_Receptor_D1,12q24.33,protein-coding,
CWITA007910,TCMBANKGE007910,CENPH,-,centromere protein H,5q13.2,protein-coding,/
CWITA007911,TCMBANKGE007911,HADHA,ECHA; GBP; HADH; LCEH; LCHAD; MTPA; TP-ALPHA,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha,2p23.3,protein-coding,/
CWITA007912,TCMBANKGE007912,MOSPD2,-,motile sperm domain containing 2,Xp22.2,protein-coding,/
CWITA007913,TCMBANKGE007913,PGC,PEPC; PGII,progastricsin,6p21.1,protein-coding,Research target
CWITA007914,TCMBANKGE007914,ATF6B,CREB-RP; CREBL1; G13,activating transcription factor 6 beta,6p21.32,protein-coding,/
CWITA007915,TCMBANKGE007915,ATG9A,APG9L1; MGD3208; mATG9,autophagy related 9A,2q35,protein-coding,/
CWITA007916,TCMBANKGE007916,TAS2R1,T2R1; TRB7,taste 2 receptor member 1,5p15.31,protein-coding,/
CWITA007917,TCMBANKGE007917,IDUA,IDA; MPS1; MPSI,alpha-L-iduronidase,4p16.3,protein-coding,/
CWITA007918,TCMBANKGE007918,DDR1,CAK; CD167; DDR; EDDR1; HGK2; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE,discoidin domain receptor tyrosine kinase 1,6p21.33,protein-coding,Research target
CWITA007919,TCMBANKGE007919,USP3,SIH003; UBP,ubiquitin specific peptidase 3,15q22.31,protein-coding,/
CWITA007920,TCMBANKGE007920,DHTKD1,AMOXAD; CMT2Q,dehydrogenase E1 and transketolase domain containing 1,10p14,protein-coding,/
CWITA007921,TCMBANKGE007921,CNOT7,CAF-1; CAF1; Caf1a; hCAF-1,CCR4-NOT transcription complex subunit 7,8p22,protein-coding,/
CWITA007922,TCMBANKGE007922,CGB3,CGB; CGB5; CGB7; CGB8; hCGB,chorionic gonadotropin subunit beta 3,19q13.33,protein-coding,Clinical Trial target
CWITA007923,TCMBANKGE007923,TRAPPC5,MGC52424; TRS31,trafficking protein particle complex 5,19p13.2,protein-coding,
CWITA007924,TCMBANKGE007924,PKIA,PRKACN1,cAMP-dependent protein kinase inhibitor alpha,8q21.13,protein-coding,/
CWITA007925,TCMBANKGE007925,PNMA1,MA1,PNMA family member 1,14q24.3,protein-coding,/
CWITA007926,TCMBANKGE007926,PTPRE,DKFZp313F1310; FLJ57799; FLJ58245; HPTPE; PTPE; RNPTPNEPSILON,"protein tyrosine phosphatase, receptor type, E",10q26,protein-coding,
CWITA007927,TCMBANKGE007927,UQCR11,0710008D09Rik; QCR10; UQCR,"ubiquinol-cytochrome c reductase, complex III subunit XI",19p13.3,protein-coding,/
CWITA007928,TCMBANKGE007928,MLXIP,MIR; MONDOA; bHLHe36,MLX interacting protein,12q24.31,protein-coding,/
CWITA007929,TCMBANKGE007929,EPHB4,HTK; MYK1; TYRO11,EPH receptor B4,7q22,protein-coding,
CWITA007930,TCMBANKGE007930,CCNB1IP1,C14orf18; HEI10,cyclin B1 interacting protein 1,14q11.2,protein-coding,/
CWITA007931,TCMBANKGE007931,FTCD,LCHC1,formimidoyltransferase cyclodeaminase,21q22.3,protein-coding,/
CWITA007932,TCMBANKGE007932,KCNG2,KCNF2; KV6.2,potassium voltage-gated channel modifier subfamily G member 2,18q23,protein-coding,/
CWITA007933,TCMBANKGE007933,SLC1A4,ASCT1; SATT,"solute carrier family 1 (glutamate/neutral amino acid transporter), member 4",2p15-p13,protein-coding,
CWITA007934,TCMBANKGE007934,SLC13A1,NAS1; NaSiN1,"solute carrier family 13 (sodium/sulfate symporters), member 1",7q31-q32,protein-coding,
CWITA007935,TCMBANKGE007935,SLC6A13,GAT-2; GAT2; GAT3,solute carrier family 6 member 13,12p13.33,protein-coding,/
CWITA007936,TCMBANKGE007936,TLR9,CD289,toll-like receptor 9,3p21.3,protein-coding,
CWITA007937,TCMBANKGE007937,CLCN2,CICN2; CLC2; ECA2; ECA3; EGI11; EGI3; EGMA; EJM6; EJM8,chloride channel 2,3q27-q28,protein-coding,
CWITA007938,TCMBANKGE007938,SERPINE1,PAI; PAIN1; PAI1; PLANH1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",7q21.3-q22,protein-coding,
CWITA007939,TCMBANKGE007939,PEX2,PAF1; PBD5A; PBD5B; PMP3; PMP35; PXMP3; RNF72; ZWS3,peroxisomal biogenesis factor 2,8q21.13,protein-coding,/
CWITA007940,TCMBANKGE007940,BCKDHB,BCKDE1B; BCKDH E1-beta; E1B,branched chain keto acid dehydrogenase E1 subunit beta,6q14.1,protein-coding,/
CWITA007941,TCMBANKGE007941,ATP6V1F,ATP6S14; VATF; Vma7,ATPase H+ transporting V1 subunit F,7q32.1,protein-coding,/
CWITA007942,TCMBANKGE007942,OSBP2,HLM; ORP-4; ORP4; OSBPL1; OSBPL4,oxysterol binding protein 2,22q12.2,protein-coding,/
CWITA007943,TCMBANKGE007943,IFT81,CDV-1; CDV-1R; CDV1; CDV1R; DV1; SRTD19,intraflagellar transport 81,12q24.11,protein-coding,/
CWITA007944,TCMBANKGE007944,FAXDC2,C5orf4,Fatty Acid Hydroxylase Domain Containing 2,5q33.2,protein-coding,
CWITA007945,TCMBANKGE007945,HIPK4,-,homeodomain interacting protein kinase 4,19q13.2,protein-coding,/
CWITA007946,TCMBANKGE007946,ZNF14,GIOT-4; KOX6,zinc finger protein 14,19p13.11,protein-coding,/
CWITA007947,TCMBANKGE007947,PTPRO,GLEPP1; NPHS6; PTP-OC; PTP-U2; PTPROT; PTPU2; R-PTP-O,protein tyrosine phosphatase receptor type O,12p12.3|12p13-p12,protein-coding,/
CWITA007948,TCMBANKGE007948,CASK,CAGH39; CAMGUK; CMG; FGS4; LIN2; MICPCH; MRXSNA; TNRC8; hCASK,calcium/calmodulin dependent serine protein kinase,Xp11.4,protein-coding,/
CWITA007949,TCMBANKGE007949,CNOT8,CAF1; CALIF; Caf1b; POP2; hCAF1,CCR4-NOT transcription complex subunit 8,5q33.2,protein-coding,/
CWITA007950,TCMBANKGE007950,RBP3,D10S64; D10S65; D10S66; IRBP; RBPI,"retinol binding protein 3, interstitial",10q11.2,protein-coding,
CWITA007951,TCMBANKGE007951,ACTR1A,ARP1; Arp1A; CTRN1,actin related protein 1A,10q24.32,protein-coding,/
CWITA007952,TCMBANKGE007952,GPR173,SREB3,G protein-coupled receptor 173,Xp11.22,protein-coding,/
CWITA007953,TCMBANKGE007953,XYLB,-,xylulokinase,3p22.2,protein-coding,/
CWITA007954,TCMBANKGE007954,SI,MGC131621; MGC131622,sucrase-isomaltase (alpha-glucosidase),3q25.2-q26.2,protein-coding,
CWITA007955,TCMBANKGE007955,NIT1,-,nitrilase 1,1q23.3,protein-coding,/
CWITA007956,TCMBANKGE007956,AUH,-,AU RNA binding methylglutaconyl-CoA hydratase,9q22.31,protein-coding,/
CWITA007957,TCMBANKGE007957,PRDM16,CMD1LL; KMT8F; LVNC8; MEL1; PFM13,PR/SET domain 16,1p36.32,protein-coding,/
CWITA007958,TCMBANKGE007958,SPTLC1,HSAN1; HSN1; LBC1; LCB1; SPT1; SPTI,serine palmitoyltransferase long chain base subunit 1,9q22.31,protein-coding,/
CWITA007959,TCMBANKGE007959,PTPN12,PTP-PEST; PTPG1,protein tyrosine phosphatase non-receptor type 12,7q11.23,protein-coding,/
CWITA007960,TCMBANKGE007960,ABI2,ABI-2; ABI2B; AIP-1; AIP1; AblBP3; SSH3BP2; argBP1; argBPIA; argBPIB,abl interactor 2,2q33.2,protein-coding,/
CWITA007961,TCMBANKGE007961,Naip3,Birc1c; EG667838; Mitf; Naip-rs5; pORF1; pORF2,"NLR family, apoptosis inhibitory protein 3",13 D1|13 53.13 cM,pseudo,/
CWITA007962,TCMBANKGE007962,HSPBAP1,PASS1,HSPB1 associated protein 1,3q21.1,protein-coding,/
CWITA007963,TCMBANKGE007963,GPR26,-,G protein-coupled receptor 26,10q26.13,protein-coding,/
CWITA007964,TCMBANKGE007964,PRDX5,ACR1; AOEB166; B166; MGC117264; MGC142283; MGC142285; PLP; PMP20; PRDX6; PRXV,peroxiredoxin 5,11q13,protein-coding,
CWITA007965,TCMBANKGE007965,FAM3A,2.19; DLD; DXS560S; XAP-7,FAM3 metabolism regulating signaling molecule A,Xq28,protein-coding,/
CWITA007966,TCMBANKGE007966,LETM2,SLC55A2,leucine zipper and EF-hand containing transmembrane protein 2,8p11.23,protein-coding,/
CWITA007967,TCMBANKGE007967,AOPEP,AP-O; APO; C90RF3; C9orf3; ONPEP,aminopeptidase O (putative),9q22.32,protein-coding,/
CWITA007968,TCMBANKGE007968,PLK4,MCCRP2; SAK; STK18,polo like kinase 4,4q28.1,protein-coding,Research target
CWITA007969,TCMBANKGE007969,LACTB2,CGI-83,lactamase beta 2,8q13.3,protein-coding,/
CWITA007970,TCMBANKGE007970,LYN,FLJ26625; JTK8,v-yes-1 Yamaguchi sarcoma viral related oncogene homolog,8q13,protein-coding,
CWITA007971,TCMBANKGE007971,COX4I1,COX4; COX4N1; COXIV; FLJ23483; MGC72016,cytochrome c oxidase subunit IV isoform 1,16q24.1,protein-coding,
CWITA007972,TCMBANKGE007972,TMEM60,C7orf35; DC32,transmembrane protein 60,7q11.23,protein-coding,/
CWITA007973,TCMBANKGE007973,NDUFB3,B12,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa",2q31.3,protein-coding,
CWITA007974,TCMBANKGE007974,SERPINC1,AT3; ATIII; MGC22579,"serpin peptidase inhibitor, clade C (antithrombin), member 1",1q23-q25.1,protein-coding,
CWITA007975,TCMBANKGE007975,GLCCI1,FAM117C; GCTR; GIG18; TSSN1,glucocorticoid induced 1,7p21.3,protein-coding,/
CWITA007976,TCMBANKGE007976,CBLB,Cbl-b; Nbla00127; RNF56,Cbl proto-oncogene B,3q13.11,protein-coding,Research target
CWITA007977,TCMBANKGE007977,CENPQ,C6orf139; CENP-Q,centromere protein Q,6p12.3,protein-coding,/
CWITA007978,TCMBANKGE007978,TOM1L2,-,target of myb1 like 2 membrane trafficking protein,17p11.2,protein-coding,/
CWITA007979,TCMBANKGE007979,NDEL1,EOPA; MITAP1; NDE1L1; NDE2; NUDEL,nudE neurodevelopment protein 1 like 1,17p13.1,protein-coding,/
CWITA007980,TCMBANKGE007980,CKM,CKMM; MNCK,"creatine kinase, muscle",19q13.2-q13.3,protein-coding,
CWITA007981,TCMBANKGE007981,RMND5A,CTLH; GID2; GID2A; RMD5; p44CTLH,required for meiotic nuclear division 5 homolog A,2p11.2,protein-coding,/
CWITA007982,TCMBANKGE007982,TRBC1,BV05S1J2.2; MGC88817; TCRBC1,T cell receptor beta constant 1,7q34,other,
CWITA007983,TCMBANKGE007983,AP5M1,C14orf108; MUDENG; Mu5; MuD,adaptor related protein complex 5 subunit mu 1,14q22.3,protein-coding,/
CWITA007984,TCMBANKGE007984,PNCK,BSTK3; CaMK1b,pregnancy up-regulated nonubiquitous CaM kinase,Xq28,protein-coding,/
CWITA007985,TCMBANKGE007985,GPR18,-,G protein-coupled receptor 18,13q32.3,protein-coding,Research target
CWITA007986,TCMBANKGE007986,C3orf38,-,chromosome 3 open reading frame 38,3p11.1,protein-coding,/
CWITA007987,TCMBANKGE007987,CYP4Z1,CYP4A20,cytochrome P450 family 4 subfamily Z member 1,1p33,protein-coding,/
CWITA007988,TCMBANKGE007988,SLC22A11,OAT4; hOAT4,solute carrier family 22 member 11,11q13.1,protein-coding,/
CWITA007989,TCMBANKGE007989,CNIH3,CNIH-3,cornichon family AMPA receptor auxiliary protein 3,1q42.12,protein-coding,/
CWITA007990,TCMBANKGE007990,TMEM217,C6orf128; dJ355M6.2,transmembrane protein 217,6p21.2,protein-coding,/
CWITA007991,TCMBANKGE007991,LRRC2,-,leucine rich repeat containing 2,3p21.31,protein-coding,/
CWITA007992,TCMBANKGE007992,SAP30L,NS4ATP2,SAP30 like,5q33.2,protein-coding,/
CWITA007993,TCMBANKGE007993,RAB1A,RAB1; YPT1,"RAB1A, member RAS oncogene family",2p14,protein-coding,/
CWITA007994,TCMBANKGE007994,ZNF596,-,zinc finger protein 596,8p23.3,protein-coding,/
CWITA007995,TCMBANKGE007995,C19orf73,-,chromosome 19 open reading frame 73,19q13.33,protein-coding,/
CWITA007996,TCMBANKGE007996,KCNK7,K2p7.1; TWIK3,potassium two pore domain channel subfamily K member 7,11q13.1,protein-coding,/
CWITA007997,TCMBANKGE007997,OCRL,Dent-2; INPP5F; LOCR; NPHL2; OCRL-1; OCRL1,OCRL inositol polyphosphate-5-phosphatase,Xq26.1,protein-coding,/
CWITA007998,TCMBANKGE007998,TSPO,BPBS; BZRP; DBI; IBP; MBR; PBR; PBS; PKBS; PTBR; mDRC; pk18,translocator protein,22q13.2,protein-coding,Successful target
CWITA007999,TCMBANKGE007999,HCAR1,FKSG80; GPR104; GPR81; HCA1; LACR1; TA-GPCR; TAGPCR,hydroxycarboxylic acid receptor 1,12q24.31,protein-coding,Research target
CWITA008000,TCMBANKGE008000,ZNF443,ZK1,zinc finger protein 443,19p13.2,protein-coding,/
CWITA008001,TCMBANKGE008001,MIB1,DIP-1; DIP1; LVNC7; MIB; ZZANK2; ZZZ6,mindbomb E3 ubiquitin protein ligase 1,18q11.2,protein-coding,/
CWITA008002,TCMBANKGE008002,DUSP9,MKP-4; MKP4,dual specificity phosphatase 9,Xq28,protein-coding,Research target
CWITA008003,TCMBANKGE008003,SRSF10,FUSIP1; FUSIP2; NSSR; PPP1R149; SFRS13; SFRS13A; SRp38; SRrp40; TASR; TASR1; TASR2,serine and arginine rich splicing factor 10,1p36.11,protein-coding,/
CWITA008004,TCMBANKGE008004,ASPN,OS3; PLAP-1; PLAP1; SLRR1C,asporin,9q22.31,protein-coding,/
CWITA008005,TCMBANKGE008005,CHP2,-,calcineurin like EF-hand protein 2,16p12.2,protein-coding,/
CWITA008006,TCMBANKGE008006,ZC3HAV1L,C7orf39,"zinc finger CCCH-type containing, antiviral 1 like",7q34,protein-coding,/
CWITA008007,TCMBANKGE008007,CA10,CA-RPX; CARPX; HUCEP-15,carbonic anhydrase 10,17q21.33-q22,protein-coding,/
CWITA008008,TCMBANKGE008008,RGPD1,RGP1; RGPD2; RanBP2L2; ranBP2L6,RANBP2 like and GRIP domain containing 1,2p11.2,protein-coding,/
CWITA008009,TCMBANKGE008009,SDR39U1,C14orf124; HCDI,short chain dehydrogenase/reductase family 39U member 1,14q12,protein-coding,/
CWITA008010,TCMBANKGE008010,RPS27L,-,ribosomal protein S27 like,15q22.2,protein-coding,/
CWITA008011,TCMBANKGE008011,HTR2A,5-HT2A; HTR2,5-hydroxytryptamine receptor 2A,13q14.2,protein-coding,Successful target
CWITA008012,TCMBANKGE008012,MAP2,MAP-2; MAP2A; MAP2B; MAP2C,microtubule associated protein 2,2q34,protein-coding,/
CWITA008013,TCMBANKGE008013,TLCD1,-,TLC domain containing 1,17q11.2,protein-coding,/
CWITA008014,TCMBANKGE008014,TAF9B,DN-7; DN7; TAF9L; TAFII31L; TFIID-31,TATA-box binding protein associated factor 9b,Xq21.1,protein-coding,/
CWITA008015,TCMBANKGE008015,ATP1A3,DYT12; MGC13276; RDP,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",19q13.31,protein-coding,
CWITA008016,TCMBANKGE008016,KPNA2,IPOA1; QIP2; RCH1; SRP1-alpha; SRP1alpha,karyopherin subunit alpha 2,17q24.2,protein-coding,/
CWITA008017,TCMBANKGE008017,SYNC,MGC149625; MGC149626; SYNC1; SYNCOILIN,"syncoilin, intermediate filament protein",1p35.1,protein-coding,
CWITA008018,TCMBANKGE008018,MGST1,GST12; MGC14525; MGST; MGSTNI,microsomal glutathione S-transferase 1,12p12.3-p12.1,protein-coding,
CWITA008019,TCMBANKGE008019,INA,NEF5; NF-66; TXBP-1,internexin neuronal intermediate filament protein alpha,10q24.33,protein-coding,/
CWITA008020,TCMBANKGE008020,ST6GALNAC6,SIAT7-F; SIAT7F; ST6GALNACVI,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6",9q34.11,protein-coding,/
CWITA008021,TCMBANKGE008021,YBX3,CSDA; CSDA1; DBPA; ZONAB,Y-box binding protein 3,12p13.2,protein-coding,/
CWITA008022,TCMBANKGE008022,AKR1C3,DD3; DDX; HA1753; HAKRB; HAKRe; HSD17B5; PGFS; hluPGFS,aldo-keto reductase family 1 member C3,10p15.1,protein-coding,Successful target
CWITA008023,TCMBANKGE008023,LBP,BPIFD2,lipopolysaccharide binding protein,20q11.23,protein-coding,Research target
CWITA008024,TCMBANKGE008024,FICD,HIP13; HYPE; UNQ3041,FIC domain protein adenylyltransferase,12q23.3,protein-coding,/
CWITA008025,TCMBANKGE008025,UBA7,D8; UBA1B; UBE1L; UBE2,ubiquitin like modifier activating enzyme 7,3p21.31,protein-coding,/
CWITA008026,TCMBANKGE008026,H2AC6,H2A/l; H2AFL; HIST1H2AC; dJ221C16.4,H2A clustered histone 6,6p22.2,protein-coding,/
CWITA008027,TCMBANKGE008027,SLC6A4,5NHTT; 5NHTTLPR; 5HTT; HTT; OCD1; SERT; hSERT,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4",17q11.2,protein-coding,
CWITA008028,TCMBANKGE008028,ZBED1,ALTE; DREF; TRAMP; hDREF,zinc finger BED-type containing 1,Xp22.33 and Yp11.2,protein-coding,/
CWITA008029,TCMBANKGE008029,TCF7L1,TCF-3; TCF3,transcription factor 7 like 1,2p11.2,protein-coding,/
CWITA008030,TCMBANKGE008030,MORF4L2,MORFL2; MRGX,mortality factor 4 like 2,Xq22.2,protein-coding,/
CWITA008031,TCMBANKGE008031,CHEK1,CHK1,CHK1 checkpoint homolog (S. pombe),11q24.2,protein-coding,
CWITA008032,TCMBANKGE008032,ETFB,FP585; MADD,electron transfer flavoprotein subunit beta,19q13.41,protein-coding,/
CWITA008033,TCMBANKGE008033,ADAM12,ADAM12-OT1; CAR10; MCMP; MCMPMltna; MLTN; MLTNA,ADAM metallopeptidase domain 12,10q26.2,protein-coding,/
CWITA008034,TCMBANKGE008034,PHLDA1,DT1P1B11; PHRIP; TDAG51,pleckstrin homology like domain family A member 1,12q21.2,protein-coding,/
CWITA008035,TCMBANKGE008035,ZNF544,-,zinc finger protein 544,19q13.43,protein-coding,/
CWITA008036,TCMBANKGE008036,PHYH,LN1; LNAP1; PAHX; PHYH1; RD,phytanoyl-CoA 2-hydroxylase,10p13,protein-coding,/
CWITA008037,TCMBANKGE008037,TAS2R43,T2R43; T2R52,taste 2 receptor member 43,12p13.2,protein-coding,/
CWITA008038,TCMBANKGE008038,ACTR3,ARP3,actin related protein 3,2q14.1,protein-coding,/
CWITA008039,TCMBANKGE008039,ABCD3,ABC43; CBAS5; PMP70; PXMP1; ZWS2,ATP binding cassette subfamily D member 3,1p21.3,protein-coding,/
CWITA008040,TCMBANKGE008040,CLDN6,-,claudin 6,16p13.3,protein-coding,/
CWITA008041,TCMBANKGE008041,METTL7B,ALDI,methyltransferase like 7B,12q13.2,protein-coding,/
CWITA008042,TCMBANKGE008042,AREL1,FIEL1; KIAA0317,apoptosis resistant E3 ubiquitin protein ligase 1,14q24.3,protein-coding,/
CWITA008043,TCMBANKGE008043,WNT7B,-,Wnt family member 7B,22q13.31,protein-coding,/
CWITA008044,TCMBANKGE008044,PSMA4,HC9; HsT17706; PSC9,proteasome 20S subunit alpha 4,15q25.1,protein-coding,/
CWITA008045,TCMBANKGE008045,AKAP9,AKAP-9; AKAP350; AKAP450; CG-NAP; HYPERION; LQT11; MU-RMS-40.16A; PPP1R45; PRKA9; YOTIAO,A-kinase anchoring protein 9,7q21.2,protein-coding,/
CWITA008046,TCMBANKGE008046,RGN,GNL; HEL-S-41; RC; SMP30,regucalcin,Xp11.3,protein-coding,/
CWITA008047,TCMBANKGE008047,PON3,N,paraoxonase 3,7q21.3,protein-coding,
CWITA008048,TCMBANKGE008048,SLC5A7,CHT; CHT1; CMS20; HMN7A,solute carrier family 5 member 7,2q12.3,protein-coding,Research target
CWITA008049,TCMBANKGE008049,PAH,PH; PKU; PKU1,phenylalanine hydroxylase,12q22-q24.2,protein-coding,
CWITA008050,TCMBANKGE008050,ASTE1,HT001,asteroid homolog 1,3q22.1,protein-coding,/
CWITA008051,TCMBANKGE008051,CYP2R1,-,cytochrome P450 family 2 subfamily R member 1,11p15.2,protein-coding,/
CWITA008052,TCMBANKGE008052,LCTL,FLJ33279; KLG; KLPH,lactase-like,15q22.31,protein-coding,
CWITA008053,TCMBANKGE008053,ARHGAP44,NPC-A-10; RICH2,Rho GTPase activating protein 44,17p12,protein-coding,/
CWITA008054,TCMBANKGE008054,FAM149A,MST119; MSTP119,family with sequence similarity 149 member A,4q35.1,protein-coding,/
CWITA008055,TCMBANKGE008055,ECHDC1,HEL-S-76; MMCD; dJ351K20.2,ethylmalonyl-CoA decarboxylase 1,6q22.33,protein-coding,/
CWITA008056,TCMBANKGE008056,ADRA2C,ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR,adrenoceptor alpha 2C,4p16.3,protein-coding,Successful target
CWITA008057,TCMBANKGE008057,ZCCHC2,C18orf49,zinc finger CCHC-type containing 2,18q21.33,protein-coding,/
CWITA008058,TCMBANKGE008058,SH3RF1,POSH; RNF142; SH3MD2,SH3 domain containing ring finger 1,4q32.3-q33,protein-coding,/
CWITA008059,TCMBANKGE008059,RNF14,ARA54; HFB30; HRIHFB2038; TRIAD2,ring finger protein 14,5q31.3,protein-coding,/
CWITA008060,TCMBANKGE008060,SLC30A8,ZNT8; ZnT-8,solute carrier family 30 member 8,8q24.11,protein-coding,Research target
CWITA008061,TCMBANKGE008061,TRIM66,C11orf29; TIF1D; TIF1DELTA,tripartite motif containing 66,11p15.4,protein-coding,/
CWITA008062,TCMBANKGE008062,DLL3,SCDO1,delta like canonical Notch ligand 3,19q13.2,protein-coding,Clinical Trial target
CWITA008063,TCMBANKGE008063,TMEM201,Ima1; NET5; SAMP1,transmembrane protein 201,1p36.22,protein-coding,/
CWITA008064,TCMBANKGE008064,SPRR2D,-,small proline rich protein 2D,1q21.3,protein-coding,/
CWITA008065,TCMBANKGE008065,COL11A1,CO11A1; COLL6; DFNA37; STL2,collagen type XI alpha 1 chain,1p21.1,protein-coding,/
CWITA008066,TCMBANKGE008066,CACNA1I,Cav3.3; KIAA1120,"calcium channel, voltage-dependent, T type, alpha 1I subunit",22q13.1,protein-coding,
CWITA008067,TCMBANKGE008067,SLC41A2,SLC41A1-L1,solute carrier family 41 member 2,12q23.3,protein-coding,/
CWITA008068,TCMBANKGE008068,PRTN3,ACPA; AGP7; C-ANCA; CANCA; MBN; MBT; NP-4; NP4; P29; PR-3; PR3,proteinase 3,19p13.3,protein-coding,Clinical Trial target
CWITA008069,TCMBANKGE008069,TREX2,-,three prime repair exonuclease 2,Xq28,protein-coding,/
CWITA008070,TCMBANKGE008070,TTPA,ATTP; AVED; TTP1; alphaTTP,alpha tocopherol transfer protein,8q12.3,protein-coding,/
CWITA008071,TCMBANKGE008071,BLM,BS; MGC126616; MGC131618; MGC131620; RECQ2; RECQL2; RECQL3,"Bloom syndrome, RecQ helicase-like",15q26.1,protein-coding,
CWITA008072,TCMBANKGE008072,VAMP2,NEDHAHM; SYB2; VAMP-2,vesicle associated membrane protein 2,17p13.1,protein-coding,/
CWITA008073,TCMBANKGE008073,STIM2,-,stromal interaction molecule 2,4p15.2,protein-coding,/
CWITA008074,TCMBANKGE008074,BAG4,BAG-4; SODD,BAG cochaperone 4,8p11.23,protein-coding,/
CWITA008075,TCMBANKGE008075,WDR74,Nsa1,WD repeat domain 74,11q12.3,protein-coding,/
CWITA008076,TCMBANKGE008076,SSR3,TRAPG,signal sequence receptor subunit 3,3q25.31,protein-coding,/
CWITA008077,TCMBANKGE008077,AKR1C2,AKR1C-pseudo; BABP; DD; DD-2; DD/BABP; DD2; DDH2; HAKRD; HBAB; MCDR2; SRXY8; TDD,aldo-keto reductase family 1 member C2,10p15.1,protein-coding,/
CWITA008078,TCMBANKGE008078,FOXK2,ILF; ILF-1; ILF1; nGTBP,forkhead box K2,17q25.3,protein-coding,/
CWITA008079,TCMBANKGE008079,UBQLN4,A1U; A1Up; C1orf6; CIP75; UBIN,ubiquilin 4,1q22,protein-coding,/
CWITA008080,TCMBANKGE008080,SLC1A3,EA6; EAAT1; FLJ25094; GLAST; GLAST1,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",5p13,protein-coding,
CWITA008081,TCMBANKGE008081,FBP2,-,fructose-bisphosphatase 2,9q22.32,protein-coding,/
CWITA008082,TCMBANKGE008082,Aspt1,-,aspartate transaminase trait 1,-,unknown,/
CWITA008083,TCMBANKGE008083,RBM4B,RBM30; RBM4L; ZCCHC15; ZCCHC21B; ZCRB3B,RNA binding motif protein 4B,11q13.2,protein-coding,/
CWITA008084,TCMBANKGE008084,MFN1,hfzo1; hfzo2,mitofusin 1,3q26.33,protein-coding,/
CWITA008085,TCMBANKGE008085,CNTN3,BIG-1; PANG; PCS,contactin 3,3p12.3,protein-coding,/
CWITA008086,TCMBANKGE008086,ZBTB41,FRBZ1; ZNF924,zinc finger and BTB domain containing 41,1q31.3,protein-coding,/
CWITA008087,TCMBANKGE008087,ADARB2,ADAR3; RED2,adenosine deaminase RNA specific B2 (inactive),10p15.3,protein-coding,/
CWITA008088,TCMBANKGE008088,KAZN,C1orf196; KAZ,"kazrin, periplakin interacting protein",1p36.21,protein-coding,/
CWITA008089,TCMBANKGE008089,IMMP2L,IMMP2L-IT1; IMP2; IMP2-LIKE,inner mitochondrial membrane peptidase subunit 2,7q31.1,protein-coding,/
CWITA008090,TCMBANKGE008090,ZNF100,-,zinc finger protein 100,19p12,protein-coding,/
CWITA008091,TCMBANKGE008091,GUCY2C,GUC2C; STAR,guanylate cyclase 2C (heat stable enterotoxin receptor),12p12,protein-coding,
CWITA008092,TCMBANKGE008092,CEP135,CEP4; KIAA0635; MCPH8,centrosomal protein 135,4q12,protein-coding,/
CWITA008093,TCMBANKGE008093,MICAL2,MICAL-2; MICAL2PV1; MICAL2PV2,"microtubule associated monooxygenase, calponin and LIM domain containing 2",11p15.3,protein-coding,/
CWITA008094,TCMBANKGE008094,RUNDC3B,RPIB9; RPIP9,RUN domain containing 3B,7q21.12,protein-coding,/
CWITA008095,TCMBANKGE008095,CEP128,C14orf145; C14orf61; LEDP/132,centrosomal protein 128,14q31.1,protein-coding,/
CWITA008096,TCMBANKGE008096,KBTBD6,-,kelch repeat and BTB domain containing 6,13q14.11,protein-coding,/
CWITA008097,TCMBANKGE008097,LRRC40,dJ677H15.1,leucine rich repeat containing 40,1p31.1,protein-coding,/
CWITA008098,TCMBANKGE008098,LCN9,HEL129,lipocalin 9,9q34.3,protein-coding,/
CWITA008099,TCMBANKGE008099,BMP1,OI13; PCOLC; PCP; PCP2; TLD,Bone_Morphogenetic_Protein_1,8p21.3,protein-coding,
CWITA008100,TCMBANKGE008100,CHD6,CHD-6; CHD5; RIGB,chromodomain helicase DNA binding protein 6,20q12,protein-coding,/
CWITA008101,TCMBANKGE008101,MRPL54,L54mt; MRP-L54,mitochondrial ribosomal protein L54,19p13.3,protein-coding,/
CWITA008102,TCMBANKGE008102,FZD5,C2orf31; HFZ5,frizzled class receptor 5,2q33.3,protein-coding,/
CWITA008103,TCMBANKGE008103,RAB9A,RAB9,"RAB9A, member RAS oncogene family",Xp22.2,protein-coding,
CWITA008104,TCMBANKGE008104,PSCA,PRO232,prostate stem cell antigen,8q24.3,protein-coding,Clinical Trial target
CWITA008105,TCMBANKGE008105,AVEN,PDCD12,apoptosis and caspase activation inhibitor,15q14,protein-coding,/
CWITA008106,TCMBANKGE008106,SLC10A6,SOAT,solute carrier family 10 member 6,4q21.3,protein-coding,/
CWITA008107,TCMBANKGE008107,S100A1,S100; S100-alpha; S100A,S100 calcium binding protein A1,1q21.3,protein-coding,/
CWITA008108,TCMBANKGE008108,NPIPA3,-,nuclear pore complex interacting protein family member A3,16p13.11,protein-coding,/
CWITA008109,TCMBANKGE008109,BAG1,HAP; RAP46,BCL2-associated athanogene,9p12,protein-coding,
CWITA008110,TCMBANKGE008110,HSFY1,HSF2L; HSFY,heat shock transcription factor Y-linked 1,Yq11.222,protein-coding,/
CWITA008111,TCMBANKGE008111,AMN1,-,antagonist of mitotic exit network 1 homolog,12p11.21,protein-coding,/
CWITA008112,TCMBANKGE008112,NYNRIN,CGIN1; KIAA1305,NYN domain and retroviral integrase containing,14q12,protein-coding,/
CWITA008113,TCMBANKGE008113,CD74,DHLAG; HLADG; II; Ia-GAMMA; p33,CD74 molecule,5q33.1,protein-coding,Research target
CWITA008114,TCMBANKGE008114,SLC36A4,PAT4,solute carrier family 36 member 4,11q21,protein-coding,/
CWITA008115,TCMBANKGE008115,ATP13A3,AFURS1,ATPase 13A3,3q29,protein-coding,/
CWITA008116,TCMBANKGE008116,LILRB1,CD85J; ILT-2; ILT2; LIR-1; LIR1; MIR-7; MIR7; PIR-B; PIRB,leukocyte immunoglobulin like receptor B1,19q13.42,protein-coding,/
CWITA008117,TCMBANKGE008117,TAF13,MRT60; TAF(II)18; TAF2K; TAFII-18; TAFII18,TATA-box binding protein associated factor 13,1p13.3,protein-coding,/
CWITA008118,TCMBANKGE008118,RPP21,C6orf135; CAT60,ribonuclease P/MRP subunit p21,6p22.1,protein-coding,/
CWITA008119,TCMBANKGE008119,SLCO4A1,OATP-E; OATP1; OATP4A1; OATPE; OATPRP1; POAT; SLC21A12,solute carrier organic anion transporter family member 4A1,20q13.33,protein-coding,Research target
CWITA008120,TCMBANKGE008120,CENPM,C22orf18; CENP-M; PANE1,centromere protein M,22q13.2,protein-coding,/
CWITA008121,TCMBANKGE008121,CDH13,CDHH; P105,cadherin 13,16q23.3,protein-coding,/
CWITA008122,TCMBANKGE008122,C11orf49,-,chromosome 11 open reading frame 49,11p11.2,protein-coding,/
CWITA008123,TCMBANKGE008123,RNF4,RES4-26; SLX5; SNURF,ring finger protein 4,4p16.3,protein-coding,/
CWITA008124,TCMBANKGE008124,ADRA2B,ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR,adrenoceptor alpha 2B,2q11.2,protein-coding,Successful target
CWITA008125,TCMBANKGE008125,DONSON,B17; C21orf60; MIMIS; MISSLA,DNA replication fork stabilization factor DONSON,21q22.11,protein-coding,/
CWITA008126,TCMBANKGE008126,TPI1,HEL-S-49; TIM; TPI; TPID,triosephosphate isomerase 1,12p13.31,protein-coding,/
CWITA008127,TCMBANKGE008127,TMEM150A,TM6P1; TMEM150; TTN1,transmembrane protein 150A,2p11.2,protein-coding,/
CWITA008128,TCMBANKGE008128,DARS1,DARS; HBSL; aspRS,aspartyl-tRNA synthetase 1,2q21.3,protein-coding,/
CWITA008129,TCMBANKGE008129,SCN1B,GEFSP1,"sodium channel, voltage-gated, type I, beta",19q13.1,protein-coding,
CWITA008130,TCMBANKGE008130,RINT1,ILFS3; RINT-1,RAD50 interactor 1,7q22.3,protein-coding,/
CWITA008131,TCMBANKGE008131,PPIB,B; CYP-S1; CYPB; HEL-S-39; OI9; SCYLP,peptidylprolyl isomerase B,15q22.31,protein-coding,Successful target
CWITA008132,TCMBANKGE008132,TMBIM1,LFG3; MST100; MSTP100; PP1201; RECS1,transmembrane BAX inhibitor motif containing 1,2q35,protein-coding,/
CWITA008133,TCMBANKGE008133,KRT78,CK-78; K5B; K78; Kb40,keratin 78,12q13.13,protein-coding,/
CWITA008134,TCMBANKGE008134,BCKDK,BCKDKD; BDK,branched chain keto acid dehydrogenase kinase,16p11.2,protein-coding,/
CWITA008135,TCMBANKGE008135,IMMP1L,IMMP1; IMP1; IMP1-LIKE,inner mitochondrial membrane peptidase subunit 1,11p13,protein-coding,/
CWITA008136,TCMBANKGE008136,LNP1,NP3,leukemia NUP98 fusion partner 1,3q12.2,protein-coding,/
CWITA008137,TCMBANKGE008137,ATP6V0B,ATP6F; HATPL; VMA16,ATPase H+ transporting V0 subunit b,1p34.1,protein-coding,/
CWITA008138,TCMBANKGE008138,DDX60L,-,DExD/H-box 60 like,4q32.3,protein-coding,/
CWITA008139,TCMBANKGE008139,MLN,-,motilin,6p21.31,protein-coding,/
CWITA008140,TCMBANKGE008140,MVK,LRBP; MK; MVLK; POROK3,mevalonate kinase,12q24.11,protein-coding,Research target
CWITA008141,TCMBANKGE008141,SUPT16H,CDC68; FACTP140; SPT16; SPT16/CDC68,"SPT16 homolog, facilitates chromatin remodeling subunit",14q11.2,protein-coding,/
CWITA008142,TCMBANKGE008142,LRRC3C,-,leucine rich repeat containing 3C,17q21.1,protein-coding,/
CWITA008143,TCMBANKGE008143,BCAM,AU; CD239; LU; MSK19,basal cell adhesion molecule (Lutheran blood group),19q13.32,protein-coding,/
CWITA008144,TCMBANKGE008144,PRKRA,DYT16; HSD14; PACT; RAX,protein activator of interferon induced protein kinase EIF2AK2,2q31.2,protein-coding,/
CWITA008145,TCMBANKGE008145,EIF3F,EIF3S5; eIF3Np47,"eukaryotic translation initiation factor 3, subunit F",11p15.4,protein-coding,
CWITA008146,TCMBANKGE008146,NCAPH2,CAPH2,non-SMC condensin II complex subunit H2,22q13.33,protein-coding,/
CWITA008147,TCMBANKGE008147,POLE,DKFZp434F222; FLJ21434; POLE1,"polymerase (DNA directed), epsilon",12q24.3,protein-coding,
CWITA008148,TCMBANKGE008148,COX10,-,cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10,17p12,protein-coding,/
CWITA008149,TCMBANKGE008149,SYNM,DMN; SYN,synemin,15q26.3,protein-coding,/
CWITA008150,TCMBANKGE008150,YPEL2,FKSG4,yippee like 2,17q22,protein-coding,/
CWITA008151,TCMBANKGE008151,SPARC,BM-40; OI17; ON; ONT,secreted protein acidic and cysteine rich,5q33.1,protein-coding,Research target
CWITA008152,TCMBANKGE008152,ASAH2,BCDase; HNAC1; LCDase; N-CDase; NCDase,N-acylsphingosine amidohydrolase 2,10q11.23,protein-coding,/
CWITA008153,TCMBANKGE008153,GSC,SAMS,goosecoid homeobox,14q32.13,protein-coding,/
CWITA008154,TCMBANKGE008154,GATC,15E1.2; COXPD42,glutamyl-tRNA amidotransferase subunit C,12q24.31,protein-coding,/
CWITA008155,TCMBANKGE008155,PPRC1,PRC,PPARG related coactivator 1,10q24.32,protein-coding,/
CWITA008156,TCMBANKGE008156,IGHG2,DKFZp686I04196,immunoglobulin heavy constant gamma 2 (G2m marker),14q32.33,other,
CWITA008157,TCMBANKGE008157,FPGT,GFPP,fucose-1-phosphate guanylyltransferase,1p31.1,protein-coding,/
CWITA008158,TCMBANKGE008158,MRPS9,MRP-S9; RPMS9; S9mt,mitochondrial ribosomal protein S9,2q12.1,protein-coding,/
CWITA008159,TCMBANKGE008159,HNF1A,HNFN1A; HNF1; IDDM20; LFB1; MODY3; TCFN1; TCF1,HNF1 homeobox A,12q22-qter|12q24.2,protein-coding,
CWITA008160,TCMBANKGE008160,TNFRSF13B,CD267; CVID; CVID2; IGAD2; RYZN; TACI; TNFRSF14B,TNF receptor superfamily member 13B,17p11.2,protein-coding,Clinical Trial target
CWITA008161,TCMBANKGE008161,TRAF3IP3,T3JAM,TRAF3 interacting protein 3,1q32.2,protein-coding,/
CWITA008162,TCMBANKGE008162,ZAP70,FLJ17670; FLJ17679; SRK; STD; TZK; ZAPN70,zeta-chain (TCR) associated protein kinase 70kDa,2q12,protein-coding,
CWITA008163,TCMBANKGE008163,GRIN3A,GluN3A; NMDAR-L; NMDAR3A; NR3A,glutamate ionotropic receptor NMDA type subunit 3A,9q31.1,protein-coding,/
CWITA008164,TCMBANKGE008164,TGFBI,BIGH3; CDB1; CDG2; CDGG1; CSD; CSD1; CSD2; CSD3; EBMD; LCD1,transforming growth factor beta induced,5q31.1,protein-coding,/
CWITA008165,TCMBANKGE008165,GNB4,CMTD1F,G protein subunit beta 4,3q26.33,protein-coding,/
CWITA008166,TCMBANKGE008166,AGRN,AGRIN; CMS8; CMSPPD,agrin,1p36.33,protein-coding,/
CWITA008167,TCMBANKGE008167,LSR,ILDR3; LISCH7,lipolysis stimulated lipoprotein receptor,19q13.12,protein-coding,/
CWITA008168,TCMBANKGE008168,CSNK2A1,CK2A1; CKII,"casein kinase 2, alpha 1 polypeptide",20p13,protein-coding,
CWITA008169,TCMBANKGE008169,EBPL,EBRP,EBP like,13q14.2,protein-coding,/
CWITA008170,TCMBANKGE008170,AGO1,EIF2C; EIF2C1; GERP95; Q99; hAgo1,argonaute RISC component 1,1p34.3,protein-coding,/
CWITA008171,TCMBANKGE008171,CAMK2D,CAMKD; DKFZp686G23119; DKFZp686I2288; MGC44911,calcium/calmodulin-dependent protein kinase II delta,4q26,protein-coding,
CWITA008172,TCMBANKGE008172,MAOA,BRNRS; MAO-A,monoamine oxidase A,Xp11.3,protein-coding,Successful target
CWITA008173,TCMBANKGE008173,RNF130,G1RZFP; GOLIATH; GP,ring finger protein 130,5q35.3,protein-coding,/
CWITA008174,TCMBANKGE008174,SPSB4,SSB-4; SSB4,splA/ryanodine receptor domain and SOCS box containing 4,3q23,protein-coding,/
CWITA008175,TCMBANKGE008175,PMS1,HNPCC3; MLH2; PMSL1; hPMS1,"PMS1 homolog 1, mismatch repair system component",2q32.2,protein-coding,Research target
CWITA008176,TCMBANKGE008176,CROT,COT,carnitine O-octanoyltransferase,7q21.1,protein-coding,
CWITA008177,TCMBANKGE008177,REXO4,REX4; XPMC2; XPMC2H,"REX4 homolog, 3'-5' exonuclease",9q34.2,protein-coding,/
CWITA008178,TCMBANKGE008178,SULT1E1,EST; EST-1; ST1E1; STE,sulfotransferase family 1E member 1,4q13.3,protein-coding,/
CWITA008179,TCMBANKGE008179,BMPER,CRIM3; CV-2; CV2,BMP binding endothelial regulator,7p14.3,protein-coding,/
CWITA008180,TCMBANKGE008180,PREX1,P-REX1,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1",20q13.13,protein-coding,/
CWITA008181,TCMBANKGE008181,CHST11,C4ST; C4ST-1; C4ST1; HSA269537; OCBMD,carbohydrate sulfotransferase 11,12q23.3,protein-coding,/
CWITA008182,TCMBANKGE008182,SCN5A,CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1,"sodium channel, voltage-gated, type V, alpha subunit",3p21,protein-coding,
CWITA008183,TCMBANKGE008183,ACE,ACE1; CD143; DCP; DCP1,angiotensin I converting enzyme,17q23.3,protein-coding,/
CWITA008184,TCMBANKGE008184,FAM218A,C4orf39; TRIM61-AS1,family with sequence similarity 218 member A,4q32.3,ncRNA,/
CWITA008185,TCMBANKGE008185,KLRC2,CD159c; NKG2-C; NKG2C,killer cell lectin like receptor C2,12p13.2,protein-coding,/
CWITA008186,TCMBANKGE008186,SMYD4,ZMYND21,SET and MYND domain containing 4,17p13.3,protein-coding,/
CWITA008187,TCMBANKGE008187,SNTB1,59-DAP; A1B; BSYN2; DAPA1B; SNT2; SNT2B1; TIP-43,syntrophin beta 1,8q24.12,protein-coding,/
CWITA008188,TCMBANKGE008188,PTH,PTH1,parathyroid hormone,11p15.3-p15.1,protein-coding,
CWITA008189,TCMBANKGE008189,USP9Y,DFFRY; SPGFY2,ubiquitin specific peptidase 9 Y-linked,Yq11.221,protein-coding,/
CWITA008190,TCMBANKGE008190,CMTM7,CKLFSF7,CKLF like MARVEL transmembrane domain containing 7,3p22.3,protein-coding,/
CWITA008191,TCMBANKGE008191,FAM219A,C9orf25,family with sequence similarity 219 member A,9p13.3,protein-coding,/
CWITA008192,TCMBANKGE008192,CRYBB2,CCA2; CRYB2; CRYB2A; CTRCT3; D22S665,crystallin beta B2,22q11.23,protein-coding,/
CWITA008193,TCMBANKGE008193,NOC3L,AD24; C10orf117; FAD24,NOC3 like DNA replication regulator,10q23.33,protein-coding,/
CWITA008194,TCMBANKGE008194,NR2F1,BBOAS; BBSOAS; COUP-TFI; COUPTF1; EAR-3; EAR3; ERBAL3; SVP44; TCFCOUP1; TFCOUP1,nuclear receptor subfamily 2 group F member 1,5q15,protein-coding,/
CWITA008195,TCMBANKGE008195,UPK1A,TSPAN21; UP1A; UPIA; UPKA,uroplakin 1A,19q13.12,protein-coding,/
CWITA008196,TCMBANKGE008196,KCNG1,K13; KCNG; KV6.1; kH2,potassium voltage-gated channel modifier subfamily G member 1,20q13.13,protein-coding,/
CWITA008197,TCMBANKGE008197,LRRCC1,CLERC; CLERK; SAP2; VFL1,leucine rich repeat and coiled-coil centrosomal protein 1,8q21.2,protein-coding,/
CWITA008198,TCMBANKGE008198,S100A16,AAG13; DT1P1A7; S100F,S100 calcium binding protein A16,1q21.3,protein-coding,/
CWITA008199,TCMBANKGE008199,KCND1,KV4.1,"potassium voltage-gated channel, Shal-related subfamily, member 1",Xp11.23,protein-coding,
CWITA008200,TCMBANKGE008200,EXOC3,SEC6; SEC6L1; Sec6p,exocyst complex component 3,5p15.33,protein-coding,/
CWITA008201,TCMBANKGE008201,TRDMT1,DMNT2; DNMT2; MHSAIIP; PUMET; RNMT1,tRNA aspartic acid methyltransferase 1,10p13,protein-coding,/
CWITA008202,TCMBANKGE008202,GAS2L3,G2L3,growth arrest specific 2 like 3,12q23.1,protein-coding,/
CWITA008203,TCMBANKGE008203,ZNF273,HZF9,zinc finger protein 273,7q11.21,protein-coding,/
CWITA008204,TCMBANKGE008204,ARL2,ARFL2,ADP ribosylation factor like GTPase 2,11q13.1,protein-coding,Research target
CWITA008205,TCMBANKGE008205,ZNF583,-,zinc finger protein 583,19q13.43,protein-coding,/
CWITA008206,TCMBANKGE008206,NTF3,HDNF; NGF-2; NGF2; NT-3; NT3,neurotrophin 3,12p13.31,protein-coding,Discontinued target
CWITA008207,TCMBANKGE008207,SLC25A21,MTDPS18; ODC; ODC1,solute carrier family 25 member 21,14q13.3,protein-coding,/
CWITA008208,TCMBANKGE008208,RRAS,R-Ras,RAS related,19q13.33,protein-coding,/
CWITA008209,TCMBANKGE008209,LHX6,LHX6.1,LIM homeobox 6,9q33.2,protein-coding,/
CWITA008210,TCMBANKGE008210,CD9,BTCCN1; DRAPN27; FLJ99568; MIC3; MRPN1; TSPANN29; TSPAN29,CD9 molecule,12p13.3,protein-coding,
CWITA008211,TCMBANKGE008211,MMAB,ATR; CFAP23; cblB; cob,metabolism of cobalamin associated B,12q24.11,protein-coding,/
CWITA008212,TCMBANKGE008212,FXYD1,PLM,FXYD domain containing ion transport regulator 1,19q13.12,protein-coding,/
CWITA008213,TCMBANKGE008213,MYO9B,CELIAC4; MYR5,myosin IXB,19p13.11,protein-coding,/
CWITA008214,TCMBANKGE008214,APTX,AOA; AOA1; AXA1; EAOH; EOAHA; FHA-HIT,aprataxin,9p21.1,protein-coding,/
CWITA008215,TCMBANKGE008215,PPFIA2,-,PTPRF interacting protein alpha 2,12q21.31,protein-coding,/
CWITA008216,TCMBANKGE008216,RANBP3,-,RAN binding protein 3,19p13.3,protein-coding,/
CWITA008217,TCMBANKGE008217,MYH14,DFNA4; DKFZp667A1311; FLJ13881; FLJ43092; KIAA2034; MHC16; MYH17; NMHC_IINC; NMHCNIINC; myosin,"myosin, heavy chain 14, non-muscle",19q13.33,protein-coding,
CWITA008218,TCMBANKGE008218,NSMF,HH9; NELF,NMDA receptor synaptonuclear signaling and neuronal migration factor,9q34.3,protein-coding,/
CWITA008219,TCMBANKGE008219,PPT2,C6orf8; G14; PPT-2,palmitoyl-protein thioesterase 2,6p21.32,protein-coding,/
CWITA008220,TCMBANKGE008220,RAC3,-,Rac family small GTPase 3,17q25.3,protein-coding,Research target
CWITA008221,TCMBANKGE008221,CAD,N,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",2p22-p21,protein-coding,
CWITA008222,TCMBANKGE008222,PTPN7,BPTP-4; HEPTP; LC-PTP; LPTP; PTPNI,protein tyrosine phosphatase non-receptor type 7,1q32.1,protein-coding,/
CWITA008223,TCMBANKGE008223,ITIH4,GP120; H4P; IHRP; ITI-HC4; ITIHL1; PK-120; PK120,inter-alpha-trypsin inhibitor heavy chain 4,3p21.1,protein-coding,/
CWITA008224,TCMBANKGE008224,GSTO1,DKFZp686H13163; GSTTLp28; P28,glutathione S-transferase omega 1,10q25.1,protein-coding,
CWITA008225,TCMBANKGE008225,COL1A2,EDSARTH2; EDSCV; OI4,collagen type I alpha 2 chain,7q21.3,protein-coding,Clinical Trial target
CWITA008226,TCMBANKGE008226,SLC10A3,DXS253E; P3,solute carrier family 10 member 3,Xq28,protein-coding,/
CWITA008227,TCMBANKGE008227,MAGED2,11B6; BARTS5; BCG-1; BCG1; HCA10; MAGE-D2,MAGE family member D2,Xp11.21,protein-coding,/
CWITA008228,TCMBANKGE008228,CNTN1,F3; GP135; MYPCN,contactin 1,12q12,protein-coding,Research target
CWITA008229,TCMBANKGE008229,SYBU,GOLSYN; OCSYN; SNPHL,syntabulin,8q23.2,protein-coding,/
CWITA008230,TCMBANKGE008230,GSTO2,GSTO 2-2; bA127L20.1,glutathione S-transferase omega 2,10q25.1,protein-coding,/
CWITA008231,TCMBANKGE008231,ECM2,-,extracellular matrix protein 2,9q22.31,protein-coding,/
CWITA008232,TCMBANKGE008232,RUFY1,RABIP4; ZFYVE12,RUN and FYVE domain containing 1,5q35.3,protein-coding,/
CWITA008233,TCMBANKGE008233,ARL11,ARLTS1,ADP ribosylation factor like GTPase 11,13q14.2,protein-coding,/
CWITA008234,TCMBANKGE008234,ZNF124,HZF-16; HZF16; ZK7,zinc finger protein 124,1q44,protein-coding,/
CWITA008235,TCMBANKGE008235,CACUL1,C10orf46; CAC1,CDK2 associated cullin domain 1,10q26.11,protein-coding,/
CWITA008236,TCMBANKGE008236,SLC16A8,MCT3; REMP,Solute_Carrier_Family_16_Member_8,22q13.1,protein-coding,
CWITA008237,TCMBANKGE008237,MCM5,CDC46; MGORS8; P1-CDC46,minichromosome maintenance complex component 5,22q12.3,protein-coding,/
CWITA008238,TCMBANKGE008238,GAA,LYAG,"glucosidase, alpha; acid",17q25.2-q25.3,protein-coding,
CWITA008239,TCMBANKGE008239,CRABP1,CRABP; CRABP-I; CRABPI; RBP5,cellular retinoic acid binding protein 1,15q25.1,protein-coding,/
CWITA008240,TCMBANKGE008240,MSH2,COCA1; FCC1; HNPCC; HNPCC1; LCFS2; hMSH2,mutS homolog 2,2p21-p16.3,protein-coding,Research target
CWITA008241,TCMBANKGE008241,TUBA1B,KNALPHAN1,"tubulin, alpha 1b",12q13.12,protein-coding,
CWITA008242,TCMBANKGE008242,GDPD4,GDE6,glycerophosphodiester phosphodiesterase domain containing 4,11q13.5,protein-coding,/
CWITA008243,TCMBANKGE008243,ZNF296,ZFP296; ZNF342,zinc finger protein 296,19q13.32,protein-coding,/
CWITA008244,TCMBANKGE008244,DSC3,CDHF3; DSC; DSC1; DSC2; DSC4; HT-CP,desmocollin 3,18q12.1,protein-coding,/
CWITA008245,TCMBANKGE008245,SFPQ,POMP100; PPP1R140; PSF,splicing factor proline and glutamine rich,1p34.3,protein-coding,/
CWITA008246,TCMBANKGE008246,ADGRF1,GPR110; KPG_012; PGR19; hGPCR36,adhesion G protein-coupled receptor F1,6p12.3|6,protein-coding,/
CWITA008247,TCMBANKGE008247,PRKAR2A,PKR2; PRKAR2,protein kinase cAMP-dependent type II regulatory subunit alpha,3p21.31,protein-coding,/
CWITA008248,TCMBANKGE008248,RGS17,RGS-17; RGSZ2; hRGS17,regulator of G protein signaling 17,6q25.2,protein-coding,/
CWITA008249,TCMBANKGE008249,SRCAP,DOMO1; EAF1; FLHS; SWR1,Snf2 related CREBBP activator protein,16p11.2,protein-coding,/
CWITA008250,TCMBANKGE008250,FABP7,BNFABP; BLBP; DKFZp547J2313; FABPB; MRG,"fatty acid binding protein 7, brain",6q22-q23,protein-coding,
CWITA008251,TCMBANKGE008251,HIBCH,HIBYLCOAH,3-hydroxyisobutyryl-CoA hydrolase,2q32.2,protein-coding,/
CWITA008252,TCMBANKGE008252,ZNF302,HSD16; MST154; MSTP154; ZNF135L; ZNF140L; ZNF327,zinc finger protein 302,19q13.11,protein-coding,/
CWITA008253,TCMBANKGE008253,SEMA4D,A8; BB18; C9orf164; CD100; COLL4; GR3; M-sema-G; SEMAJ; coll-4,semaphorin 4D,9q22.2,protein-coding,Clinical Trial target
CWITA008254,TCMBANKGE008254,UGT1A1,BILIQTL1; GNT1; HUGNBR1; UDPGT; UDPGT_1N1; UGT1; UGT1A,"UDP glucuronosyltransferase 1 family, polypeptide A1",2q37,protein-coding,
CWITA008255,TCMBANKGE008255,GPR6,-,G protein-coupled receptor 6,6q21,protein-coding,/
CWITA008256,TCMBANKGE008256,TRAF3IP1,FAP116; IFT54; MIP-T3; MIPT3; SLSN9,TRAF3 interacting protein 1,2q37.3,protein-coding,/
CWITA008257,TCMBANKGE008257,TRIM7,GNIP; RNF90,tripartite motif containing 7,5q35.3,protein-coding,/
CWITA008258,TCMBANKGE008258,CCDC92,-,coiled-coil domain containing 92,12q24.31,protein-coding,/
CWITA008259,TCMBANKGE008259,SCGB1D2,LIPB; LPHB; LPNB,Secretoglobin_Family_1D_Member_2,11q12.3,protein-coding,
CWITA008260,TCMBANKGE008260,ESM1,endocan,endothelial cell specific molecule 1,5q11.2,protein-coding,/
CWITA008261,TCMBANKGE008261,PSAP,GLBA; SAP1; SAP2,prosaposin,10q22.1,protein-coding,/
CWITA008262,TCMBANKGE008262,GLRB,N,"glycine receptor, beta",4q31.3,protein-coding,
CWITA008263,TCMBANKGE008263,FEZF1,FEZ; HH22; ZNF312B,FEZ family zinc finger 1,7q31.32,protein-coding,/
CWITA008264,TCMBANKGE008264,PBK,CT84; HEL164; Nori-3; SPK; TOPK,PDZ binding kinase,8p21.1,protein-coding,Research target
CWITA008265,TCMBANKGE008265,EID3,NS4EB; NSE4B; NSMCE4B,EP300 interacting inhibitor of differentiation 3,12q23.3,protein-coding,/
CWITA008266,TCMBANKGE008266,ZNF407,-,zinc finger protein 407,18q22.3,protein-coding,/
CWITA008267,TCMBANKGE008267,RGS14,-,regulator of G protein signaling 14,5q35.3,protein-coding,/
CWITA008268,TCMBANKGE008268,PITRM1,MP1; PreP,pitrilysin metallopeptidase 1,10p15.2,protein-coding,/
CWITA008269,TCMBANKGE008269,TUBA8,CDCBM8; TUBAL2,tubulin alpha 8,22q11.21,protein-coding,/
CWITA008270,TCMBANKGE008270,MST1,D3F15S2; DNF15S2; HGFL; MSP; NF15S2,macrophage stimulating 1,3p21.31,protein-coding,/
CWITA008271,TCMBANKGE008271,CLEC4E,CLECSF9; MINCLE,"C-type lectin domain family 4, member E",12p13.31,protein-coding,
CWITA008272,TCMBANKGE008272,GPR62,GPCR8; KPG_005,G protein-coupled receptor 62,3p21.2,protein-coding,/
CWITA008273,TCMBANKGE008273,BTG3,ANA; ANA/BTG3; APRO4; TOB5; TOB55; TOFA,BTG anti-proliferation factor 3,21q21.1,protein-coding,/
CWITA008274,TCMBANKGE008274,RBM39,CAPER; CAPERalpha; FSAP59; HCC1; RNPC2,RNA binding motif protein 39,20q11.22,protein-coding,/
CWITA008275,TCMBANKGE008275,HIP1R,HIP12; HIP3; ILWEQ,huntingtin interacting protein 1 related,12q24.31,protein-coding,/
CWITA008276,TCMBANKGE008276,BRI3,I3,brain protein I3,7q21.3,protein-coding,/
CWITA008277,TCMBANKGE008277,APOC2,APO-CII; APOC-II,apolipoprotein C2,19q13.32,protein-coding,/
CWITA008278,TCMBANKGE008278,COL4A4,ATS2; BFH; CA44,collagen type IV alpha 4 chain,2q36.3,protein-coding,/
CWITA008279,TCMBANKGE008279,AASDHPPT,AASD-PPT; ACPS; CGI-80; LYS2; LYS5,Aminoadipate-Semialdehyde_Dehydrogenase-Phosphopantetheinyl_Transferase,11q22.3,protein-coding,
CWITA008280,TCMBANKGE008280,GRPEL2,Mt-GrpE#2,"GrpE like 2, mitochondrial",5q32,protein-coding,/
CWITA008281,TCMBANKGE008281,UNKL,C16orf28; ZC3H5L; ZC3HDC5L,unk like zinc finger,16p13.3,protein-coding,/
CWITA008282,TCMBANKGE008282,FLYWCH2,-,FLYWCH family member 2,16p13.3,protein-coding,/
CWITA008283,TCMBANKGE008283,MARCO,SCARA2; SR-A6,macrophage receptor with collagenous structure,2q14.2,protein-coding,/
CWITA008284,TCMBANKGE008284,RAC2,ENN7; Gx; HSPC022,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)",22q13.1,protein-coding,
CWITA008285,TCMBANKGE008285,ART4,ARTC4; CD297; DO; DO/ART4; DOK1,ADP-ribosyltransferase 4 (Dombrock blood group),12p12.3,protein-coding,/
CWITA008286,TCMBANKGE008286,NOC2L,NET15; NET7; NIR; PPP1R112,NOC2 like nucleolar associated transcriptional repressor,1p36.33,protein-coding,/
CWITA008287,TCMBANKGE008287,DCUN1D5,SCCRO5,defective in cullin neddylation 1 domain containing 5,11q22.3,protein-coding,/
CWITA008288,TCMBANKGE008288,MOCS2,MCBPE; MOCO1; MOCODB; MPTS,molybdenum cofactor synthesis 2,5q11.2,protein-coding,/
CWITA008289,TCMBANKGE008289,CAPN1,CANP; CANP1; CANPL1; muCANP; muCL,"calpain 1, (mu/I) large subunit",11q13,protein-coding,
CWITA008290,TCMBANKGE008290,PPP3CA,CALN; CALNA; CALNA1; CCN1; CNA1; PPP2B,"protein phosphatase 3, catalytic subunit, alpha isozyme",4q24,protein-coding,
CWITA008291,TCMBANKGE008291,AK3,AK3L1; AK6; AKL3L; AKL3L1; FIX,adenylate kinase 3,9p24.1,protein-coding,/
CWITA008292,TCMBANKGE008292,PITX1,BFT; CCF; LBNBG; POTX; PTX1,paired like homeodomain 1,5q31.1,protein-coding,/
CWITA008293,TCMBANKGE008293,GANAB,G2AN; GLUII; KIAA0088,"glucosidase, alpha; neutral AB",11q12.3,protein-coding,
CWITA008294,TCMBANKGE008294,BHLHB9,GASP3; p60TRP,basic helix-loop-helix family member b9,Xq22.1,protein-coding,/
CWITA008295,TCMBANKGE008295,MAP3K21,MLK4; dJ862P8.3,mitogen-activated protein kinase kinase kinase 21,1q42.2,protein-coding,Research target
CWITA008296,TCMBANKGE008296,CRELD2,-,cysteine rich with EGF like domains 2,22q13.33,protein-coding,/
CWITA008297,TCMBANKGE008297,SOX3,GHDX; MRGH; PHP; PHPX; SOXB,SRY-box transcription factor 3,Xq27.1,protein-coding,/
CWITA008298,TCMBANKGE008298,DTYMK,CDC8; FLJ44192; MGC198617; PP3731; TMPK; TYMK,deoxythymidylate kinase (thymidylate kinase),2q37.3,protein-coding,
CWITA008299,TCMBANKGE008299,OCM,OCM1; OM; ONCM,oncomodulin,7p22.1,protein-coding,/
CWITA008300,TCMBANKGE008300,FKBP6,FKBP36,FKBP prolyl isomerase 6,7q11.23,protein-coding,/
CWITA008301,TCMBANKGE008301,NPY,PYY4,neuropeptide Y,7p15.1,protein-coding,
CWITA008302,TCMBANKGE008302,MACROD1,LRP16,mono-ADP ribosylhydrolase 1,11q13.1,protein-coding,/
CWITA008303,TCMBANKGE008303,DEGS2,C14orf66; DES2; FADS8,"delta 4-desaturase, sphingolipid 2",14q32.2,protein-coding,/
CWITA008304,TCMBANKGE008304,DCAKD,-,dephospho-CoA kinase domain containing,17q21.31,protein-coding,/
CWITA008305,TCMBANKGE008305,GFI1,GFI-1; GFI1A; SCN2; ZNF163,growth factor independent 1 transcriptional repressor,1p22.1,protein-coding,/
CWITA008306,TCMBANKGE008306,PLG,DKFZp779M0222,plasminogen,6q26,protein-coding,
CWITA008307,TCMBANKGE008307,UCKL1,UCK1NLIKE; UCK1L; URKL1,uridine-cytidine kinase 1-like 1,20q13.33,protein-coding,
CWITA008308,TCMBANKGE008308,ERN2,IRE1-BETA; IRE1b; IRE2p; hIRE2p,endoplasmic reticulum to nucleus signaling 2,16p12.2,protein-coding,/
CWITA008309,TCMBANKGE008309,ALKBH2,ABH2; FLJ99103; MGC90512,"alkB, alkylation repair homolog 2 (E. coli)",12q24.11,protein-coding,
CWITA008310,TCMBANKGE008310,baf,-,b-associated fitness,-,unknown,/
CWITA008311,TCMBANKGE008311,QRFPR,AQ27; GPR103; SP9155,pyroglutamylated RFamide peptide receptor,4q27,protein-coding,/
CWITA008312,TCMBANKGE008312,CKAP4,CLIMP-63; CLIMP63; ERGIC-63; p63,cytoskeleton associated protein 4,12q23.3,protein-coding,/
CWITA008313,TCMBANKGE008313,SRP54,SCN8,signal recognition particle 54,14q13.2,protein-coding,/
CWITA008314,TCMBANKGE008314,IKZF3,AIO; AIOLOS; ZNFN1A3,IKAROS family zinc finger 3,17q12-q21.1,protein-coding,/
CWITA008315,TCMBANKGE008315,SLC9A3R2,E3KARP; NHE3RF2; NHERF-2; NHERF2; OCTS2; SIP-1; SIP1; TKA-1,SLC9A3 regulator 2,16p13.3,protein-coding,/
CWITA008316,TCMBANKGE008316,CLSPN,-,claspin,1p34.3,protein-coding,/
CWITA008317,TCMBANKGE008317,MAOA,N,monoamine oxidase A,Xp11.3,protein-coding,
CWITA008318,TCMBANKGE008318,VWA8,KIAA0564; P7BP2,von Willebrand factor A domain containing 8,13q14.11,protein-coding,/
CWITA008319,TCMBANKGE008319,THUMPD1,Tan1,THUMP domain containing 1,16p12.3,protein-coding,/
CWITA008320,TCMBANKGE008320,ARHGEF1,GEF1; IMD62; LBCL2; LSC; P115-RHOGEF; SUB1.5,Rho guanine nucleotide exchange factor 1,19q13.2,protein-coding,/
CWITA008321,TCMBANKGE008321,PDE6H,ACHM6; RCD3,phosphodiesterase 6H,12p12.3,protein-coding,/
CWITA008322,TCMBANKGE008322,WIPI2,ATG18B; Atg21; CGI-50; IDDSSA; WIPI-2,"WD repeat domain, phosphoinositide interacting 2",7p22.1,protein-coding,/
CWITA008323,TCMBANKGE008323,NRXN3,C14orf60,neurexin 3,14q24.3-q31.1,protein-coding,/
CWITA008324,TCMBANKGE008324,ZKSCAN1,KOX18; PHZ-37; ZNF139; ZNF36; ZSCAN33,zinc finger with KRAB and SCAN domains 1,7q22.1,protein-coding,/
CWITA008325,TCMBANKGE008325,NCAPH,BRRN1; CAP-H; CAPH; MCPH23,non-SMC condensin I complex subunit H,2q11.2,protein-coding,/
CWITA008326,TCMBANKGE008326,GGH,GH,gamma-glutamyl hydrolase,8q12.3,protein-coding,Research target
CWITA008327,TCMBANKGE008327,KCNQ4,DFNA2; DFNA2A; KV7.4,potassium voltage-gated channel subfamily Q member 4,1p34.2,protein-coding,Research target
CWITA008328,TCMBANKGE008328,PDP1,PDH; PDP; PDPC; PPM2A; PPM2C,pyruvate dehyrogenase phosphatase catalytic subunit 1,8q22.1,protein-coding,/
CWITA008329,TCMBANKGE008329,HSD17B3,EDH17B3; SDR12C2,hydroxysteroid 17-beta dehydrogenase 3,9q22.32,protein-coding,/
CWITA008330,TCMBANKGE008330,CROT,COT,carnitine O-octanoyltransferase,7q21.12,protein-coding,/
CWITA008331,TCMBANKGE008331,DUSP28,DUSP26; VHP,dual specificity phosphatase 28,2q37.3,protein-coding,/
CWITA008332,TCMBANKGE008332,KLHL21,-,kelch like family member 21,1p36.31,protein-coding,/
CWITA008333,TCMBANKGE008333,PDP2,PDPC 2; PPM2B; PPM2C2,pyruvate dehyrogenase phosphatase catalytic subunit 2,16q22.1,protein-coding,/
CWITA008334,TCMBANKGE008334,MBD5,MRD1,methyl-CpG binding domain protein 5,2q23.1,protein-coding,/
CWITA008335,TCMBANKGE008335,MOK,RAGE; RAGE-1; RAGE1; STK30,MOK protein kinase,14q32.31,protein-coding,/
CWITA008336,TCMBANKGE008336,CD200,MOX1; MOX2; MRC; OX-2,CD200 molecule,3q13.2,protein-coding,Clinical Trial target
CWITA008337,TCMBANKGE008337,INSL3,RLF; RLNL; ley-I-L,insulin like 3,19p13.11,protein-coding,/
CWITA008338,TCMBANKGE008338,HLA-DRB4,DR4; DRB4; HLA-DR4B; HLA-DRB4*,"major histocompatibility complex, class II, DR beta 4",6p21.3,protein-coding,/
CWITA008339,TCMBANKGE008339,MPV17L,M-LPH; MLPH1; MLPH2; MPV17L1,MPV17 mitochondrial inner membrane protein like,16p13.11,protein-coding,/
CWITA008340,TCMBANKGE008340,ADAM15,MDC15,ADAM metallopeptidase domain 15,1q21.3,protein-coding,/
CWITA008341,TCMBANKGE008341,ZNF506,-,zinc finger protein 506,19p13.11,protein-coding,/
CWITA008342,TCMBANKGE008342,KBTBD8,TA-KRP; TAKRP,kelch repeat and BTB domain containing 8,3p14.1,protein-coding,/
CWITA008343,TCMBANKGE008343,JMY,WHAMM2; WHDC1L3,"junction mediating and regulatory protein, p53 cofactor",5q14.1,protein-coding,/
CWITA008344,TCMBANKGE008344,TBC1D22A,C22orf4; HSC79E021,TBC1 domain family member 22A,22q13.31,protein-coding,/
CWITA008345,TCMBANKGE008345,SPANXD,CT11.3; CT11.4; SPANX-C; SPANX-D; SPANX-E; SPANXC; SPANXE; dJ171K16.1,SPANX family member D,Xq27.2,protein-coding,/
CWITA008346,TCMBANKGE008346,SULT4A1,BR-STL-1; BRSTL1; DJ388M5.3; NST; SULTX3; hBR-STL-1,sulfotransferase family 4A member 1,22q13.31,protein-coding,/
CWITA008347,TCMBANKGE008347,EIF3I,EIF3S2; PRO2242; TRIP-1; TRIP1; eIF3-beta; eIF3-p36,eukaryotic translation initiation factor 3 subunit I,1p35.2,protein-coding,/
CWITA008348,TCMBANKGE008348,ZNF354C,KID3,zinc finger protein 354C,5q35.3,protein-coding,/
CWITA008349,TCMBANKGE008349,LRRC37A3,LRRC37; LRRC37A,leucine rich repeat containing 37 member A3,17q24.1,protein-coding,/
CWITA008350,TCMBANKGE008350,IRS4,CHNG9; IRS-4; PY160,insulin receptor substrate 4,Xq22.3,protein-coding,/
CWITA008351,TCMBANKGE008351,ZBTB8OS,ARCH; ARCH2,zinc finger and BTB domain containing 8 opposite strand,1p35.1,protein-coding,/
CWITA008352,TCMBANKGE008352,MEGF8,C19orf49; CRPT2; EGFL4; SBP1,multiple EGF like domains 8,19q13.2,protein-coding,/
CWITA008353,TCMBANKGE008353,pr,-,porcine tail,-,unknown,/
CWITA008354,TCMBANKGE008354,PIK3CB,DKFZp779K1237; MGC133043; P110BETA; PI3K; PI3KBETA; PIK3C1,"phosphoinositide-3-kinase, catalytic, beta polypeptide",3q22.3,protein-coding,
CWITA008355,TCMBANKGE008355,TSPAN12,EVR5; NET-2; NET2; TM4SF12,tetraspanin 12,7q31.31,protein-coding,/
CWITA008356,TCMBANKGE008356,NDUFA3,B9,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa",19q13.42,protein-coding,
CWITA008357,TCMBANKGE008357,CLEC1B,1810061I13Rik; CLEC2; CLEC2B; PRO1384; QDED721,C-type lectin domain family 1 member B,12p13.31-p13.2,protein-coding,/
CWITA008358,TCMBANKGE008358,NETO2,BTCL2; NEOT2,neuropilin and tolloid like 2,16q12.1,protein-coding,/
CWITA008359,TCMBANKGE008359,CA8,CA-RP; CA-VIII; CALS; CAMRQ3; CARP,carbonic anhydrase 8,8q12.1,protein-coding,/
CWITA008360,TCMBANKGE008360,ACTA1,ACTA; ASMA; CFTD; CFTD1; CFTDM; MPFD; NEM1; NEM2; NEM3,"actin, alpha 1, skeletal muscle",1q42.13,protein-coding,
CWITA008361,TCMBANKGE008361,ADGRL3,CIRL3; CL3; LEC3; LPHN3,adhesion G protein-coupled receptor L3,4q13.1,protein-coding,Research target
CWITA008362,TCMBANKGE008362,PTGR2,HEL-S-298; PGR2; ZADH1,prostaglandin reductase 2,14q24.3,protein-coding,/
CWITA008363,TCMBANKGE008363,SLC37A1,G3PP,solute carrier family 37 member 1,21q22.3,protein-coding,/
CWITA008364,TCMBANKGE008364,SRSF1,ASF; SF2; SF2p33; SFRS1; SRp30a,serine and arginine rich splicing factor 1,17q22,protein-coding,/
CWITA008365,TCMBANKGE008365,SMAP1,SMAP-1,small ArfGAP 1,6q13,protein-coding,/
CWITA008366,TCMBANKGE008366,RPS6KA4,MSK2; RSK-B; S6K-alpha-4,ribosomal protein S6 kinase A4,11q13.1,protein-coding,/
CWITA008367,TCMBANKGE008367,Cox20b,Cox20-ps; Gm15683,cytochrome c oxidase assembly protein 20B,7|7 E2,pseudo,/
CWITA008368,TCMBANKGE008368,PNPLA3,ADPN; C22orf20; iPLA(2)epsilon,patatin like phospholipase domain containing 3,22q13.31,protein-coding,/
CWITA008369,TCMBANKGE008369,ARHGAP15,BM046,Rho GTPase activating protein 15,2q22.2-q22.3,protein-coding,/
CWITA008370,TCMBANKGE008370,SLCO5A1,OATP-J; OATP-RP4; OATP5A1; OATPJ; OATPRP4; SLC21A15,solute carrier organic anion transporter family member 5A1,8q13.3,protein-coding,/
CWITA008371,TCMBANKGE008371,NPTX2,NARP; NP-II; NP2,neuronal pentraxin 2,7q22.1,protein-coding,Clinical Trial target
CWITA008372,TCMBANKGE008372,ADK,AK,adenosine kinase,10q22|10q11-q24,protein-coding,
CWITA008373,TCMBANKGE008373,JAK3,JAKN3; JAK3_HUMAN; JAKL; LNJAK; LJAK,Janus kinase 3,19p13.1,protein-coding,
CWITA008374,TCMBANKGE008374,FUT11,FUCTXI,fucosyltransferase 11,10q22.2,protein-coding,/
CWITA008375,TCMBANKGE008375,CSPP1,CSPP; CSPP-L; JBTS21,centrosome and spindle pole associated protein 1,8q13.1-q13.2,protein-coding,/
CWITA008376,TCMBANKGE008376,SNRNP27,27K; RY1,small nuclear ribonucleoprotein U4/U6.U5 subunit 27,2p13.3,protein-coding,/
CWITA008377,TCMBANKGE008377,ELP5,C17orf81; DERP6; HSPC002; MST071; MSTP071,elongator acetyltransferase complex subunit 5,17p13.1,protein-coding,/
CWITA008378,TCMBANKGE008378,RGPD5,BS-63; BS63; HEL161; RGP5,RANBP2 like and GRIP domain containing 5,2q13,protein-coding,/
CWITA008379,TCMBANKGE008379,FGFR4,CD334; JTK2; TKF,fibroblast growth factor receptor 4,5q35.2,protein-coding,Clinical Trial target
CWITA008380,TCMBANKGE008380,IRF5,SLEB10,interferon regulatory factor 5,7q32.1,protein-coding,/
CWITA008381,TCMBANKGE008381,CEP44,KIAA1712; PS1TP3,centrosomal protein 44,4q34.1,protein-coding,/
CWITA008382,TCMBANKGE008382,CILK1,ECO; EJM10; ICK; LCK2; MRK; hICK,ciliogenesis associated kinase 1,6p12.1,protein-coding,/
CWITA008383,TCMBANKGE008383,NUCB1,CALNUC; NUC,Nucleobindin_1,19q13.33,protein-coding,
CWITA008384,TCMBANKGE008384,CTSS,FLJ50259; MGC3886,cathepsin S,1q21,protein-coding,
CWITA008385,TCMBANKGE008385,MAP3K8,AURA2; COT; EST; ESTF; MEKK8; TPL2; Tpl-2; c-COT,mitogen-activated protein kinase kinase kinase 8,10p11.23,protein-coding,Research target
CWITA008386,TCMBANKGE008386,SLC12A5,EIEE34; EIG14; KCC2; hKCC2,solute carrier family 12 member 5,20q13.12,protein-coding,Research target
CWITA008387,TCMBANKGE008387,THRSP,LPGP1; Lpgp; S14; SPOT14; THRP,thyroid hormone responsive,11q14.1,protein-coding,/
CWITA008388,TCMBANKGE008388,ASB7,-,ankyrin repeat and SOCS box containing 7,15q26.3,protein-coding,/
CWITA008389,TCMBANKGE008389,ARIH1,ARI; HARI; HHARI; UBCH7BP,ariadne RBR E3 ubiquitin protein ligase 1,15q24.1,protein-coding,/
CWITA008390,TCMBANKGE008390,CYP2D6,CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; MGC120389; MGC120390; P450NDB1; P450C2D; P450DB1,"cytochrome P450, family 2, subfamily D, polypeptide 6",22q13.1,protein-coding,
CWITA008391,TCMBANKGE008391,STARD5,-,StAR related lipid transfer domain containing 5,15q25.1,protein-coding,/
CWITA008392,TCMBANKGE008392,HARS2,HARSL; HARSR; HO3; HisRS; PRLTS2,"histidyl-tRNA synthetase 2, mitochondrial",5q31.3,protein-coding,/
CWITA008393,TCMBANKGE008393,GRN,CLN11; GEP; GP88; PCDGF; PEPI; PGRN,granulin precursor,17q21.31,protein-coding,Research target
CWITA008394,TCMBANKGE008394,VAV2,VAV-2,vav guanine nucleotide exchange factor 2,9q34.2,protein-coding,/
CWITA008395,TCMBANKGE008395,SURF2,SURF-2,surfeit 2,9q34.2,protein-coding,/
CWITA008396,TCMBANKGE008396,POLR1H,A12.2; HTEX-6; HTEX6; Rpa12; TCTEX6; TEX6; ZNRD1; ZR14; hZR14; tctex-6,RNA polymerase I subunit H,6p22.1,protein-coding,/
CWITA008397,TCMBANKGE008397,MMP27,MMP-27,matrix metallopeptidase 27,11q22.2,protein-coding,/
CWITA008398,TCMBANKGE008398,AMPD3,-,adenosine monophosphate deaminase 3,11p15.4,protein-coding,/
CWITA008399,TCMBANKGE008399,RPL41,L41,ribosomal protein L41,12q13.2,protein-coding,/
CWITA008400,TCMBANKGE008400,BCL3,BCL4; D19S37,BCL3 transcription coactivator,19q13.32,protein-coding,/
CWITA008401,TCMBANKGE008401,DAZ4,pDP1680; pDP1681,deleted in azoospermia 4,Yq11.23,protein-coding,/
CWITA008402,TCMBANKGE008402,PDE8A,FLJ16150; HsT19550,phosphodiesterase 8A,15q25.3,protein-coding,
CWITA008403,TCMBANKGE008403,POTEB2,POTE-15; POTEB,POTE ankyrin domain family member B2,15q11.2,protein-coding,/
CWITA008404,TCMBANKGE008404,HMX1,H6; NKX5-3,H6 family homeobox 1,4p16.1,protein-coding,/
CWITA008405,TCMBANKGE008405,NTPCR,C1orf57; HCR-NTPase; THEP1,"nucleoside-triphosphatase, cancer-related",1q42.2,protein-coding,/
CWITA008406,TCMBANKGE008406,KRT83,EKVP5; HB3; Hb-3; KRTHB3; MNLIX,keratin 83,12q13.13,protein-coding,/
CWITA008407,TCMBANKGE008407,EPHA8,EEK; EK3; HEK3,EPH receptor A8,1p36.12,protein-coding,Research target
CWITA008408,TCMBANKGE008408,FAM81A,-,family with sequence similarity 81 member A,15q22.2,protein-coding,/
CWITA008409,TCMBANKGE008409,UQCRFS1,MC3DN10; RIP1; RIS1; RISP; UQCR5,"ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1",19q12,protein-coding,/
CWITA008410,TCMBANKGE008410,LY6G6E,C6orf22; G6e,lymphocyte antigen 6 family member G6E,6p21.33,pseudo,/
CWITA008411,TCMBANKGE008411,PHKG2,GSD9C,phosphorylase kinase catalytic subunit gamma 2,16p11.2,protein-coding,Research target
CWITA008412,TCMBANKGE008412,CACNA1G,Ca(V)T.1; Cav3.1; MGC117234; NBR13,"calcium channel, voltage-dependent, T type, alpha 1G subunit",17q22,protein-coding,
CWITA008413,TCMBANKGE008413,DGKE,AHUS7; DAGK5; DAGK6; DGK; NPHS7,diacylglycerol kinase epsilon,17q22,protein-coding,/
CWITA008414,TCMBANKGE008414,CALML3,CLP,calmodulin like 3,10p15.1,protein-coding,/
CWITA008415,TCMBANKGE008415,ZNF737,ZNF102,zinc finger protein 737,19p12,protein-coding,/
CWITA008416,TCMBANKGE008416,GLYAT,ACGNAT; CAT; GAT,glycine-N-acyltransferase,11q12.1,protein-coding,
CWITA008417,TCMBANKGE008417,GPSM1,AGS3,G protein signaling modulator 1,9q34.3,protein-coding,/
CWITA008418,TCMBANKGE008418,ALG11,CDG1P; GT8,"ALG11 alpha-1,2-mannosyltransferase",13q14.3,protein-coding,/
CWITA008419,TCMBANKGE008419,GLUL,GLNS; GS; PIG43; PIG59,glutamate-ammonia ligase,1q31,protein-coding,
CWITA008420,TCMBANKGE008420,SUMO3,SMT3A; SMT3H1; SUMO-3; Smt3B,small ubiquitin like modifier 3,21q22.3,protein-coding,/
CWITA008421,TCMBANKGE008421,STUB1,CHIP; HSPABP2; NY-CO-7; SCA48; SCAR16; SDCCAG7; UBOX1,STIP1 homology and U-box containing protein 1,16p13.3,protein-coding,/
CWITA008422,TCMBANKGE008422,KCNA7,HAK6; KV1.7,potassium voltage-gated channel subfamily A member 7,19q13.33,protein-coding,Research target
CWITA008423,TCMBANKGE008423,CAPN15,SOLH,calpain 15,16p13.3,protein-coding,/
CWITA008424,TCMBANKGE008424,THNSL1,FLJ22002; TSH1,threonine synthase-like 1 (S. cerevisiae),10p12.1,protein-coding,
CWITA008425,TCMBANKGE008425,TMTC4,-,transmembrane O-mannosyltransferase targeting cadherins 4,13q32.3,protein-coding,/
CWITA008426,TCMBANKGE008426,CTRB2,-,chymotrypsinogen B2,16q23.1,protein-coding,/
CWITA008427,TCMBANKGE008427,TULP3,TUBL3,TUB like protein 3,12p13.33,protein-coding,/
CWITA008428,TCMBANKGE008428,PCDHGB1,PCDH-GAMMA-B1,"protocadherin gamma subfamily B, 1",5q31.3,protein-coding,/
CWITA008429,TCMBANKGE008429,CACNA1F,AIED; COD3; COD4; CORDX; CORDX3; CSNB2; CSNB2A; CSNBX2; Cav1.4; Cav1.4alpha1; JM8; JMC8; OA2,calcium voltage-gated channel subunit alpha1 F,Xp11.23,protein-coding,Research target
CWITA008430,TCMBANKGE008430,FRMD5,-,FERM domain containing 5,15q15.3,protein-coding,/
CWITA008431,TCMBANKGE008431,OSMR,IL-31R-beta; IL-31RB; OSMRB; OSMRbeta; PLCA1,oncostatin M receptor,5p13.1,protein-coding,Research target
CWITA008432,TCMBANKGE008432,FARSB,FARSLB; FRSB; HSPC173; NEDBLLA; PheHB; PheRS; RILDBC,phenylalanyl-tRNA synthetase subunit beta,2q36.1,protein-coding,/
CWITA008433,TCMBANKGE008433,RASD2,Rhes; TEM2,RASD family member 2,22q12.3,protein-coding,/
CWITA008434,TCMBANKGE008434,MEOX1,KFS2; MOX1,mesenchyme homeobox 1,17q21.31,protein-coding,/
CWITA008435,TCMBANKGE008435,AMZ1,-,archaelysin family metallopeptidase 1,7p22.3,protein-coding,/
CWITA008436,TCMBANKGE008436,SH3GL2,CNSA2; EEN-B1; SH3D2A; SH3P4,"SH3 domain containing GRB2 like 2, endophilin A1",9p22.2,protein-coding,/
CWITA008437,TCMBANKGE008437,PALM2AKAP2,AKAP-2; AKAP-KL; AKAP2; AKAPKL; MISP2; PALM2; PALM2-AKAP2; PRKA2,PALM2 and AKAP2 fusion,9q31.3,protein-coding,/
CWITA008438,TCMBANKGE008438,C12orf45,-,chromosome 12 open reading frame 45,12q23.3,protein-coding,/
CWITA008439,TCMBANKGE008439,KTN1,CG1; KNT; MU-RMS-40.19,kinectin 1,14q22.3,protein-coding,/
CWITA008440,TCMBANKGE008440,HMMR,CD168; IHABP; RHAMM,hyaluronan mediated motility receptor,5q34,protein-coding,/
CWITA008441,TCMBANKGE008441,DDX27,DRS1; Drs1p; HSPC259; PP3241; RHLP; dJ686N3.1,DEAD-box helicase 27,20q13.13,protein-coding,/
CWITA008442,TCMBANKGE008442,NFIX,CTF; MRSHSS; NF-I/X; NF1-X; NF1A; SOTOS2,nuclear factor I X,19p13.13,protein-coding,/
CWITA008443,TCMBANKGE008443,TSHZ2,C20orf17; OVC10-2; TSH2; ZABC2; ZNF218,teashirt zinc finger homeobox 2,20q13.2,protein-coding,/
CWITA008444,TCMBANKGE008444,SLC2A4RG,GEF; HDBP-1; HDBP1; Si-1-2; Si-1-2-19,SLC2A4 regulator,20q13.33,protein-coding,/
CWITA008445,TCMBANKGE008445,ITGA11,HsT18964,integrin subunit alpha 11,15q23,protein-coding,Research target
CWITA008446,TCMBANKGE008446,MIDN,-,midnolin,19p13.3,protein-coding,/
CWITA008447,TCMBANKGE008447,POTEB,A26B1; CT104.5; POTE-15; POTE15; POTEB2,POTE ankyrin domain family member B,15q11.2,protein-coding,/
CWITA008448,TCMBANKGE008448,GRIK5,EAA2; GRIK2; GluK5; KA2,glutamate ionotropic receptor kainate type subunit 5,19q13.2,protein-coding,Research target
CWITA008449,TCMBANKGE008449,BPHL,BPHNRP; MCNAA; MGC125930; MGC41865; VACVASE,biphenyl hydrolase-like (serine hydrolase),6p25,protein-coding,
CWITA008450,TCMBANKGE008450,TACR3,MGC148060; MGC148061; NKN3R; NK3R; NKR; TAC3RL,tachykinin receptor 3,4q25,protein-coding,
CWITA008451,TCMBANKGE008451,TAX1BP3,TIP-1; TIP1,Tax1 binding protein 3,17p13.2,protein-coding,/
CWITA008452,TCMBANKGE008452,GFM1,COXPD1; EFG; EFG1; EFGM; EGF1; GFM; hEFG1; mtEF-G1,G elongation factor mitochondrial 1,3q25.32,protein-coding,/
CWITA008453,TCMBANKGE008453,DPRX,-,divergent-paired related homeobox,19q13.42,protein-coding,/
CWITA008454,TCMBANKGE008454,PRIMA1,PRIMA,proline rich membrane anchor 1,14q32.12,protein-coding,/
CWITA008455,TCMBANKGE008455,CKS1B,CKS1; PNAS-16; PNAS-18; ckshs1,CDC28 protein kinase regulatory subunit 1B,1q21.3,protein-coding,/
CWITA008456,TCMBANKGE008456,ORC2,ORC2L,origin recognition complex subunit 2,2q33.1,protein-coding,/
CWITA008457,TCMBANKGE008457,CDK16,PCTAIRE; PCTAIRE1; PCTGAIRE; PCTK1,cyclin dependent kinase 16,Xp11.3,protein-coding,/
CWITA008458,TCMBANKGE008458,CHM,DXS540; GGTA; HSD-32; REP-1; TCD,CHM Rab escort protein,Xq21.2,protein-coding,/
CWITA008459,TCMBANKGE008459,TMEM87B,-,transmembrane protein 87B,2q13,protein-coding,/
CWITA008460,TCMBANKGE008460,ZNF587,ZF6,zinc finger protein 587,19q13.43,protein-coding,/
CWITA008461,TCMBANKGE008461,PISD,DJ858B16; LIBF; PSD; PSDC; PSSC; dJ858B16.2,phosphatidylserine decarboxylase,22q12.2,protein-coding,/
CWITA008462,TCMBANKGE008462,MOXD1,MOX; PRO5780; dJ248E1.1,monooxygenase DBH like 1,6q23.2,protein-coding,/
CWITA008463,TCMBANKGE008463,CDKN2C,INK4C; p18; p18-INK4C,cyclin dependent kinase inhibitor 2C,1p32.3,protein-coding,Research target
CWITA008464,TCMBANKGE008464,RBP1,CRABP-I; CRBP; CRBP1; CRBPI; RBPC,retinol binding protein 1,3q23,protein-coding,/
CWITA008465,TCMBANKGE008465,NIPBL,CDLS; CDLS1; IDN3; IDN3-B; Scc2,NIPBL cohesin loading factor,5p13.2,protein-coding,/
CWITA008466,TCMBANKGE008466,RECQL,RECQL1; RecQ1,RecQ like helicase,12p12.1,protein-coding,/
CWITA008467,TCMBANKGE008467,CDK19,CDC2L6; CDK11; bA346C16.3,cyclin dependent kinase 19,6q21,protein-coding,/
CWITA008468,TCMBANKGE008468,FBXW9,Fbw9; MEC-15,F-box and WD repeat domain containing 9,19p13.13,protein-coding,/
CWITA008469,TCMBANKGE008469,SRARP,C1orf64; ERRF,steroid receptor associated and regulated protein,1p36.13,protein-coding,/
CWITA008470,TCMBANKGE008470,UTP3,CRL1; CRLZ1; SAS10,UTP3 small subunit processome component,4q13.3,protein-coding,/
CWITA008471,TCMBANKGE008471,ZBTB4,KAISO-L1; ZNF903,zinc finger and BTB domain containing 4,17p13.1,protein-coding,/
CWITA008472,TCMBANKGE008472,RPL5,L5; MSTP030; PPP1R135; uL18,ribosomal protein L5,1p22.1,protein-coding,/
CWITA008473,TCMBANKGE008473,GPHA2,A2; GPA2; ZSIG51,glycoprotein hormone subunit alpha 2,11q13.1,protein-coding,/
CWITA008474,TCMBANKGE008474,CA1,CA-I; CAB; Car1; HEL-S-11,carbonic anhydrase 1,8q21.2,protein-coding,Successful target
CWITA008475,TCMBANKGE008475,TMEM44,-,transmembrane protein 44,3q29,protein-coding,/
CWITA008476,TCMBANKGE008476,C16orf89,-,chromosome 16 open reading frame 89,16p13.3,protein-coding,/
CWITA008477,TCMBANKGE008477,MBL2,COLEC1; HSMBPC; MBL; MBP; MBP1; MGC116832; MGC116833,"mannose-binding lectin (protein C) 2, soluble",10q11.2,protein-coding,
CWITA008478,TCMBANKGE008478,ZNF564,-,zinc finger protein 564,19p13.2,protein-coding,/
CWITA008479,TCMBANKGE008479,PICALM,CALM; CLTH; LAP,phosphatidylinositol binding clathrin assembly protein,11q14.2,protein-coding,/
CWITA008480,TCMBANKGE008480,ICAM5,TLCN; TLN,intercellular adhesion molecule 5,19p13.2,protein-coding,/
CWITA008481,TCMBANKGE008481,VWF,F8VWF; VWD,von Willebrand factor,12p13.31,protein-coding,Clinical Trial target
CWITA008482,TCMBANKGE008482,HOXB9,HOX-2.5; HOX2; HOX2E,homeobox B9,17q21.32,protein-coding,/
CWITA008483,TCMBANKGE008483,EQTN,AFAF; C9orf11; SPACA8,equatorin,9p21.2,protein-coding,/
CWITA008484,TCMBANKGE008484,IFNA10,IFN-alphaC,interferon alpha 10,9p21.3,protein-coding,/
CWITA008485,TCMBANKGE008485,PYCR3,PYCRL,pyrroline-5-carboxylate reductase 3,8q24.3,protein-coding,/
CWITA008486,TCMBANKGE008486,PLXDC1,TEM3; TEM7,plexin domain containing 1,17q12,protein-coding,Research target
CWITA008487,TCMBANKGE008487,SLC6A7,PROT,solute carrier family 6 member 7,5q32,protein-coding,Research target
CWITA008488,TCMBANKGE008488,RNF103-CHMP3,CGI149; CHMP3; NEDF; RNF103-VPS24; VPS24; hVps24,RNF103-CHMP3 readthrough,2p11.2,protein-coding,/
CWITA008489,TCMBANKGE008489,MGST2,GST2; MGST-II,microsomal glutathione S-transferase 2,4q31.1,protein-coding,/
CWITA008490,TCMBANKGE008490,RNF19A,RNF19,"ring finger protein 19A, RBR E3 ubiquitin protein ligase",8q22.2,protein-coding,/
CWITA008491,TCMBANKGE008491,ME1,HUMNDME; MES,"malic enzyme 1, NADP(+)-dependent, cytosolic",6q12,protein-coding,
CWITA008492,TCMBANKGE008492,PDPK1,PDK1; PDPK2; PDPK2P; PRO0461,3-phosphoinositide dependent protein kinase 1,16p13.3,protein-coding,Clinical Trial target
CWITA008493,TCMBANKGE008493,GSTM3,GST5; GSTB; GSTM3N3; GTM3; MGC3310; MGC3704,glutathione S-transferase mu 3 (brain),1p13.3,protein-coding,
CWITA008494,TCMBANKGE008494,MAP7D1,PARCC1; RPRC1,MAP7 domain containing 1,1p34.3,protein-coding,/
CWITA008495,TCMBANKGE008495,MOCOS,HMCS; MCS; MOS,molybdenum cofactor sulfurase,18q12.2,protein-coding,/
CWITA008496,TCMBANKGE008496,NAPSA,KAP; Kdap; NAP1; NAPA; SNAPA,napsin A aspartic peptidase,19q13.33,protein-coding,/
CWITA008497,TCMBANKGE008497,PARD6G,PAR-6G; PAR6gamma,par-6 family cell polarity regulator gamma,18q23,protein-coding,/
CWITA008498,TCMBANKGE008498,TASP1,C20orf13; dJ585I14.2,taspase 1,20p12.1,protein-coding,/
CWITA008499,TCMBANKGE008499,CAST,BS-17; PLACK,calpastatin,5q15,protein-coding,/
CWITA008500,TCMBANKGE008500,CCDC62,CT109; ERAP75; TSP-NY,coiled-coil domain containing 62,12q24.31,protein-coding,/
CWITA008501,TCMBANKGE008501,ACP3,5'-NT; ACP-3; ACPP; TM-PAP,acid phosphatase 3,3q22.1,protein-coding,/
CWITA008502,TCMBANKGE008502,MAP4,-,microtubule associated protein 4,3p21.31,protein-coding,Research target
CWITA008503,TCMBANKGE008503,ASL,ASAL,argininosuccinate lyase,7q11.21,protein-coding,/
CWITA008504,TCMBANKGE008504,PSMA2,HC3; MU; PMSA2; PSC2,proteasome 20S subunit alpha 2,7p14.1,protein-coding,/
CWITA008505,TCMBANKGE008505,KCNJ12,IRK-2; IRK2; KCNJN1; Kir2.2; Kir2.2v; hIRK; hIRK1; hkir2.2x; kcnj12x,potassium inwardly rectifying channel subfamily J member 12,17p11.2,protein-coding,/
CWITA008506,TCMBANKGE008506,BTF3L4,-,basic transcription factor 3 like 4,1p32.3,protein-coding,/
CWITA008507,TCMBANKGE008507,ANGPT4,ANG3; ANG4,angiopoietin 4,20p13,protein-coding,/
CWITA008508,TCMBANKGE008508,GANAB,G2AN; GIIA; GLUII; PKD3,glucosidase II alpha subunit,11q12.3,protein-coding,/
CWITA008509,TCMBANKGE008509,GOLGA3,GCP170; MEA-2,golgin A3,12q24.33,protein-coding,/
CWITA008510,TCMBANKGE008510,KCNJ11,BIR; HHF2; IKATP; KIR6.2; MGC133230; PHHI; TNDM3,"potassium inwardly-rectifying channel, subfamily J, member 11",11p15.1,protein-coding,
CWITA008511,TCMBANKGE008511,RBMX,HNRNPG; HNRPG; MRXS11; RBMXP1; RBMXRT; RNMX; hnRNP-G,RNA binding motif protein X-linked,Xq26.3,protein-coding,/
CWITA008512,TCMBANKGE008512,ENO3,GSD13; MSE,"enolase 3 (beta, muscle)",17pter-p11,protein-coding,
CWITA008513,TCMBANKGE008513,SGK1,SGK,serum/glucocorticoid regulated kinase 1,6q23,protein-coding,
CWITA008514,TCMBANKGE008514,THRA,AR7; CHNG6; EAR7; ERB-T-1; ERBA; ERBA1; NR1A1; THRA1; THRA2; c-ERBA-1,thyroid hormone receptor alpha,17q21.1,protein-coding,Successful target
CWITA008515,TCMBANKGE008515,MAP2K3,MAPKK3; MEK3; MKK3; PRKMK3; SAPKK-2; SAPKK2,mitogen-activated protein kinase kinase 3,17p11.2,protein-coding,/
CWITA008516,TCMBANKGE008516,CYP4A22,-,cytochrome P450 family 4 subfamily A member 22,1p33,protein-coding,/
CWITA008517,TCMBANKGE008517,ISOC2,-,isochorismatase domain containing 2,19q13.42,protein-coding,/
CWITA008518,TCMBANKGE008518,PARP11,ARTD11; C12orf6; MIB006,poly(ADP-ribose) polymerase family member 11,12p13.32,protein-coding,/
CWITA008519,TCMBANKGE008519,CTRC,CLCR; ELA4,chymotrypsin C,1p36.21,protein-coding,Research target
CWITA008520,TCMBANKGE008520,PPWD1,-,peptidylprolyl isomerase domain and WD repeat containing 1,5q12.3,protein-coding,/
CWITA008521,TCMBANKGE008521,GALNS,GALNAC6S; GAS; GalN6S; MPS4A,galactosamine (N-acetyl)-6-sulfatase,16q24.3,protein-coding,Successful target
CWITA008522,TCMBANKGE008522,SLCO1B1,LSTN1; LST1; MGC133282; OATPNC; OATP1B1; OATP2; OATPC; SLC21A6,"solute carrier organic anion transporter family, member 1B1",12p,protein-coding,
CWITA008523,TCMBANKGE008523,MYO7B,-,myosin VIIB,2q14.3,protein-coding,/
CWITA008524,TCMBANKGE008524,ZNF202,ZKSCAN10; ZSCAN42,zinc finger protein 202,11q24.1,protein-coding,Research target
CWITA008525,TCMBANKGE008525,MRAP2,C6orf117; bA51G5.2,melanocortin 2 receptor accessory protein 2,6q14.2,protein-coding,/
CWITA008526,TCMBANKGE008526,NMT1,NMT,N-myristoyltransferase 1,17q21.31,protein-coding,
CWITA008527,TCMBANKGE008527,THAP2,-,THAP domain containing 2,12q21.1,protein-coding,/
CWITA008528,TCMBANKGE008528,DLL1,DELTA1; DL1; Delta; NEDBAS,delta like canonical Notch ligand 1,6q27,protein-coding,Research target
CWITA008529,TCMBANKGE008529,GDNF,ATF1; ATF2; HFB1-GDNF; HSCR3,Glial Cell Derived Neurotrophic Factor,5p13.1-p12,protein-coding,
CWITA008530,TCMBANKGE008530,DLG1,DLGH1; SAP-97; SAP97; hdlg,discs large MAGUK scaffold protein 1,3q29,protein-coding,/
CWITA008531,TCMBANKGE008531,ASCC1,ASC1p50; CGI-18; SMABF2; p50,activating signal cointegrator 1 complex subunit 1,10q22.1,protein-coding,/
CWITA008532,TCMBANKGE008532,ASB2,ASB-2,ankyrin repeat and SOCS box containing 2,14q32.12,protein-coding,/
CWITA008533,TCMBANKGE008533,APLP2,APLP-2; APPH; APPL2; CDEBP,amyloid beta precursor like protein 2,11q24.3,protein-coding,/
CWITA008534,TCMBANKGE008534,CNP,CNP1,"2',3'-cyclic nucleotide 3' phosphodiesterase",17q21.2,protein-coding,Research target
CWITA008535,TCMBANKGE008535,TRPC5OS,TRPC5-AS1,TRPC5 opposite strand,Xq23,protein-coding,/
CWITA008536,TCMBANKGE008536,MTAP,MSAP; c86fus,methylthioadenosine phosphorylase,9p21,protein-coding,
CWITA008537,TCMBANKGE008537,TMEM65,-,transmembrane protein 65,8q24.13,protein-coding,/
CWITA008538,TCMBANKGE008538,GABPB2,GABPB-2,GA binding protein transcription factor subunit beta 2,1q21.3,protein-coding,/
CWITA008539,TCMBANKGE008539,MRPS18A,HumanS18b; MRP-S18-3; MRP-S18-a; MRPS18-3; S18bmt; S18mt-a,mitochondrial ribosomal protein S18A,6p21.1,protein-coding,/
CWITA008540,TCMBANKGE008540,P4HA2,N,"prolyl 4-hydroxylase, alpha polypeptide II",5q31,protein-coding,
CWITA008541,TCMBANKGE008541,CSN2,CASB,casein beta,4q13.3,protein-coding,/
CWITA008542,TCMBANKGE008542,MON1B,HSRG1; SAND2; SRG1,"MON1 homolog B, secretory trafficking associated",16q23.1,protein-coding,/
CWITA008543,TCMBANKGE008543,PARP3,ADPRT3; ADPRTL2; ADPRTL3; ARTD3; IRT1; PADPRT-3,poly(ADP-ribose) polymerase family member 3,3p21.2,protein-coding,Patented target
CWITA008544,TCMBANKGE008544,Kcnmb4os2,4933400F03Rik,"potassium large conductance calcium-activated channel, subfamily M, beta member 4, opposite strand 2",10|10 D2,ncRNA,/
CWITA008545,TCMBANKGE008545,ZNF524,-,zinc finger protein 524,19q13.42,protein-coding,/
CWITA008546,TCMBANKGE008546,DNAJA2,CPR3; DJ3; DJA2; DNAJ; DNJ3; HIRIP4; PRO3015; RDJ2,DnaJ heat shock protein family (Hsp40) member A2,16q11.2,protein-coding,/
CWITA008547,TCMBANKGE008547,PSENEN,MSTP064; PENN2; PEN2,presenilin enhancer 2 homolog (C. elegans),19q13.12,protein-coding,
CWITA008548,TCMBANKGE008548,ZNF385B,ZNF533,zinc finger protein 385B,2q31.2-q31.3,protein-coding,/
CWITA008549,TCMBANKGE008549,EXO1,HEX1; hExoI,exonuclease 1,1q43,protein-coding,/
CWITA008550,TCMBANKGE008550,RRH,-,retinal pigment epithelium-derived rhodopsin homolog,4q25,protein-coding,/
CWITA008551,TCMBANKGE008551,TMED10,P24(DELTA); S31I125; S31III125; TMP21; Tmp-21-I; p23; p24d1,transmembrane p24 trafficking protein 10,14q24.3,protein-coding,/
CWITA008552,TCMBANKGE008552,TECTA,DFNA12; DFNA8; DFNB21,tectorin alpha,11q23.3,protein-coding,/
CWITA008553,TCMBANKGE008553,STXBP6,HSPC156; amisyn,syntaxin binding protein 6,14q12,protein-coding,/
CWITA008554,TCMBANKGE008554,NISCH,FLJ14425; FLJ40413; FLJ90519; IN1; IRAS; KIAA0975,nischarin,3p21.1,protein-coding,
CWITA008555,TCMBANKGE008555,PHYHD1,-,phytanoyl-CoA dioxygenase domain containing 1,9q34.11,protein-coding,/
CWITA008556,TCMBANKGE008556,SCNN1D,ENaCd; ENaCdelta; MGC149710; MGC149711; SCNED; dNaCh,"sodium channel, nonvoltage-gated 1, delta",1p36.3-p36.2,protein-coding,
CWITA008557,TCMBANKGE008557,PRR5L,PROTOR2,proline rich 5 like,11p13-p12,protein-coding,/
CWITA008558,TCMBANKGE008558,Mipepos,Gm15919,"mitochondrial intermediate peptidase, opposite strand",14 D1|14 31.94 cM,ncRNA,/
CWITA008559,TCMBANKGE008559,GJB2,BAPS; CX26; DFNA3; DFNA3A; DFNB1; DFNB1A; HID; KID; NSRD1; PPK,gap junction protein beta 2,13q12.11,protein-coding,Research target
CWITA008560,TCMBANKGE008560,ABCC1,ABC29; ABCC; DKFZp686N04233; DKFZp781G125; GSNX; MRP; MRP1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",16p13.1,protein-coding,
CWITA008561,TCMBANKGE008561,RASL11B,-,RAS like family 11 member B,4q12,protein-coding,/
CWITA008562,TCMBANKGE008562,PTGER1,EP1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",19p13.1,protein-coding,
CWITA008563,TCMBANKGE008563,SYTL4,SLP4,synaptotagmin like 4,Xq22.1,protein-coding,/
CWITA008564,TCMBANKGE008564,SLC13A3,NADC3; SDCT2,"solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3",20q12-q13.1,protein-coding,
CWITA008565,TCMBANKGE008565,ACOD1,CAD; IRG1,aconitate decarboxylase 1,13q22.3,protein-coding,/
CWITA008566,TCMBANKGE008566,PNP,NP; PRO1837; PUNP,purine nucleoside phosphorylase,14q11.2,protein-coding,Clinical Trial target
CWITA008567,TCMBANKGE008567,TCOF1,MFD1; TCS; TCS1; treacle,treacle ribosome biogenesis factor 1,5q32-q33.1,protein-coding,/
CWITA008568,TCMBANKGE008568,SERPINB9,CAP-3; CAP3; PI-9; PI9,serpin family B member 9,6p25.2,protein-coding,/
CWITA008569,TCMBANKGE008569,RNASEH1,H1RNA; PEOB2; RNH1,ribonuclease H1,2p25.3,protein-coding,/
CWITA008570,TCMBANKGE008570,PIPOX,LPIPOX,pipecolic acid and sarcosine oxidase,17q11.2,protein-coding,/
CWITA008571,TCMBANKGE008571,SRSF2,PR264; SC-35; SC35; SFRS2; SFRS2A; SRp30b,serine and arginine rich splicing factor 2,17q25.1,protein-coding,/
CWITA008572,TCMBANKGE008572,PSMB6,DELTA; LMPY; Y,proteasome 20S subunit beta 6,17p13.2,protein-coding,Patented target
CWITA008573,TCMBANKGE008573,PSMB10,FLJ00366; LMP10; MECL1; MGC1665; beta2i,"proteasome (prosome, macropain) subunit, beta type, 10",16q22.1,protein-coding,
CWITA008574,TCMBANKGE008574,LOXL4,LOXC,lysyl oxidase like 4,10q24.2,protein-coding,/
CWITA008575,TCMBANKGE008575,C1RL,C1RL1; C1RLP; C1r-LP; CLSPa,complement C1r subcomponent like,12p13.31,protein-coding,/
CWITA008576,TCMBANKGE008576,SEPHS1,SELD; SPS; SPS1,selenophosphate synthetase 1,10p13,protein-coding,/
CWITA008577,TCMBANKGE008577,TYW3,C1orf171,tRNA-yW synthesizing protein 3 homolog,1p31.1,protein-coding,/
CWITA008578,TCMBANKGE008578,POLM,Pol Mu; Tdt-N,DNA polymerase mu,7p13,protein-coding,/
CWITA008579,TCMBANKGE008579,CUX2,CDP2; CUTL2; EIEE67,cut like homeobox 2,12q24.11-q24.12,protein-coding,/
CWITA008580,TCMBANKGE008580,ETNK1,EKI; EKI 1; EKI1; Nbla10396,ethanolamine kinase 1,12p12.1,protein-coding,/
CWITA008581,TCMBANKGE008581,IST1,CHMP8; OLC1,IST1 factor associated with ESCRT-III,16q22.2,protein-coding,/
CWITA008582,TCMBANKGE008582,FAM111A,GCLEB; KCS2,family with sequence similarity 111 member A,11q12.1,protein-coding,/
CWITA008583,TCMBANKGE008583,SCGB2A1,LPHC; LPNC; MGB2; UGB3,secretoglobin family 2A member 1,11q12.3,protein-coding,/
CWITA008584,TCMBANKGE008584,CTNND1,BCDS2; CAS; CTNND; P120CAS; P120CTN; p120; p120(CAS); p120(CTN),catenin delta 1,11q12.1,protein-coding,/
CWITA008585,TCMBANKGE008585,NRIP1,CAKUT3; RIP140,nuclear receptor interacting protein 1,21q11.2-q21.1,protein-coding,/
CWITA008586,TCMBANKGE008586,FLOT2,ECS-1; ECS1; ESA; ESA1; M17S1,flotillin 2,17q11.2,protein-coding,/
CWITA008587,TCMBANKGE008587,ZNF597,HIT-4,zinc finger protein 597,16p13.3,protein-coding,/
CWITA008588,TCMBANKGE008588,GPR88,COCPMR; STRG,G protein-coupled receptor 88,1p21.2,protein-coding,Research target
CWITA008589,TCMBANKGE008589,ALKBH2,ABH2,"alkB homolog 2, alpha-ketoglutarate dependent dioxygenase",12q24.11,protein-coding,/
CWITA008590,TCMBANKGE008590,ADAM28,ADAM_28; ADAM23; MDCNL; MDCNLm; MDCNLs; MDCL; eMDC_II; eMDCII,ADAM metallopeptidase domain 28,8p21.2,protein-coding,
CWITA008591,TCMBANKGE008591,PBRM1,BAF180; PB1,Polybromo_1,3p21.1,protein-coding,
CWITA008592,TCMBANKGE008592,RGPD2,NUP358; RANBP2L2; RGP2,RANBP2 like and GRIP domain containing 2,2p11.2,protein-coding,/
CWITA008593,TCMBANKGE008593,TACC3,ERIC-1; ERIC1; Tacc4; maskin,transforming acidic coiled-coil containing protein 3,4p16.3,protein-coding,Research target
CWITA008594,TCMBANKGE008594,CACNA1C,CACH2; CACN2; CACNL1A1; CCHL1A1; CaV1.2; MGC120730; TS,"calcium channel, voltage-dependent, L type, alpha 1C subunit",12p13.3,protein-coding,
CWITA008595,TCMBANKGE008595,MANSC1,9130403P13Rik; LOH12CR3,MANSC domain containing 1,12p13.2,protein-coding,/
CWITA008596,TCMBANKGE008596,ZFP30,ZNF745,ZFP30 zinc finger protein,19q13.12,protein-coding,/
CWITA008597,TCMBANKGE008597,HDAC11,HD11,histone deacetylase 11,3p25.1,protein-coding,Patented target
CWITA008598,TCMBANKGE008598,DHFR2,DHFRL1; DHFRP4,dihydrofolate reductase 2,3q11.2,protein-coding,/
CWITA008599,TCMBANKGE008599,ARAF,A-RAF; ARAF1; PKS2; RAFA1,"A-Raf proto-oncogene, serine/threonine kinase",Xp11.3,protein-coding,Clinical Trial target
CWITA008600,TCMBANKGE008600,TCF20,AR1; DDVIBA; SPBP; TCF-20,transcription factor 20,22q13.2|22q13.3,protein-coding,/
CWITA008601,TCMBANKGE008601,PRKCD,MAY1; MGC49908; PKCD; nPKCNdelta,"protein kinase C, delta",3p21.31,protein-coding,
CWITA008602,TCMBANKGE008602,KLF6,BCD1; CBA1; COPEB; CPBP; GBF; PAC1; ST12; ZF9,Kruppel like factor 6,10p15.2,protein-coding,/
CWITA008603,TCMBANKGE008603,UQCR10,HSPC051; HSPC151; QCR9; UCCR7.2; UCRC,"ubiquinol-cytochrome c reductase, complex III subunit X",22cen-q12.3,protein-coding,
CWITA008604,TCMBANKGE008604,NOBOX,OG-2; OG2; OG2X; POF5; TCAG_12042,NOBOX oogenesis homeobox,7q35,protein-coding,/
CWITA008605,TCMBANKGE008605,ZNF770,PRO1914,zinc finger protein 770,15q14,protein-coding,/
CWITA008606,TCMBANKGE008606,GCK,FGQTL3; GK; GLK; HHF3; HK4; HKIV; HXKP; LGLK; MODY2,glucokinase (hexokinase 4),7p15.3-p15.1,protein-coding,
CWITA008607,TCMBANKGE008607,SCN11A,NAV1.9; NaN; SCN12A; SNSN2,"sodium channel, voltage-gated, type XI, alpha subunit",3p22.2,protein-coding,
CWITA008608,TCMBANKGE008608,RXFP2,GPR106; GREAT; INSL3R; LGR8; LGR8.1; RXFPR2,relaxin family peptide receptor 2,13q13.1,protein-coding,/
CWITA008609,TCMBANKGE008609,MED27,CRAP34; CRSP34; CRSP8; MED3; TRAP37,mediator complex subunit 27,9q34.13,protein-coding,/
CWITA008610,TCMBANKGE008610,RNASEH2B,AGS2; DLEU8,ribonuclease H2 subunit B,13q14.3,protein-coding,/
CWITA008611,TCMBANKGE008611,EAF2,BM040; TRAITS; U19,ELL associated factor 2,3q13.33,protein-coding,/
CWITA008612,TCMBANKGE008612,KRT23,CK23; HAIK1; K23,keratin 23,17q21.2,protein-coding,/
CWITA008613,TCMBANKGE008613,LAIR2,CD306,leukocyte associated immunoglobulin like receptor 2,19q13.42,protein-coding,/
CWITA008614,TCMBANKGE008614,SH2D2A,F2771; SCAP; TSAD; VRAP,SH2 domain containing 2A,1q23.1,protein-coding,/
CWITA008615,TCMBANKGE008615,IL6R,CD126; IL-6R-1; IL-6RA; IL6Q; IL6RA; IL6RQ; gp80,interleukin 6 receptor,1q21.3,protein-coding,/
CWITA008616,TCMBANKGE008616,LDOC1,BCUR1; Mar7; Mart7; RTL7; SIRH7,LDOC1 regulator of NFKB signaling,Xq27.1,protein-coding,/
CWITA008617,TCMBANKGE008617,ADCY10,HCA2; HEL-S-7a; SAC; SACI; Sacy; hsAC,adenylate cyclase 10,1q24.2,protein-coding,/
CWITA008618,TCMBANKGE008618,ZC3HC1,HSPC216; NIPA,zinc finger C3HC-type containing 1,7q32.2,protein-coding,/
CWITA008619,TCMBANKGE008619,ORMDL2,HSPC160; MST095; MSTP095; adoplin-2,ORMDL sphingolipid biosynthesis regulator 2,12q13.2,protein-coding,/
CWITA008620,TCMBANKGE008620,ZNF766,-,zinc finger protein 766,19q13.41,protein-coding,/
CWITA008621,TCMBANKGE008621,TYMS,HST422; TMS; TS,thymidylate synthetase,18p11.32,protein-coding,Research target
CWITA008622,TCMBANKGE008622,WNT7A,Wnt-7a,Wnt family member 7A,3p25.1,protein-coding,Research target
CWITA008623,TCMBANKGE008623,CYP27B1,CP2B; CYP1; CYP1alpha; CYP27B; P450c1; PDDR; VDD1; VDDR; VDDRI; VDR,"cytochrome P450, family 27, subfamily B, polypeptide 1",12q13.1-q13.3,protein-coding,
CWITA008624,TCMBANKGE008624,DHCR7,SLOS,7-dehydrocholesterol reductase,11q13.4,protein-coding,
CWITA008625,TCMBANKGE008625,TONSL,IKBR; NFKBIL2; SEMDSP,"tonsoku like, DNA repair protein",8q24.3,protein-coding,/
CWITA008626,TCMBANKGE008626,PWP1,IEF-SSP-9502,"PWP1 homolog, endonuclein",12q23.3,protein-coding,/
CWITA008627,TCMBANKGE008627,CEP170,FAM68A; KAB; KIAA0470,centrosomal protein 170,1q43,protein-coding,/
CWITA008628,TCMBANKGE008628,MEA1,HYS; MEA,male-enhanced antigen 1,6p21.1,protein-coding,/
CWITA008629,TCMBANKGE008629,Adh6b,Adh5b,alcohol dehydrogenase 6B (class V),3|3 G3,protein-coding,/
CWITA008630,TCMBANKGE008630,SH3BGR,21-GARP,SH3 domain binding glutamate rich protein,21q22.2,protein-coding,/
CWITA008631,TCMBANKGE008631,RHBDL2,RRP2,rhomboid like 2,1p34.3,protein-coding,/
CWITA008632,TCMBANKGE008632,ARL14,ARF7,ADP ribosylation factor like GTPase 14,3q25.33,protein-coding,/
CWITA008633,TCMBANKGE008633,SLC46A2,Ly110; TSCOT,solute carrier family 46 member 2,9q32,protein-coding,/
CWITA008634,TCMBANKGE008634,FOXC1,ARA; ASGD3; FKHL7; FREAC-3; FREAC3; IGDA; IHG1; IRID1; RIEG3,forkhead box C1,6p25.3,protein-coding,Research target
CWITA008635,TCMBANKGE008635,SIX2,-,SIX homeobox 2,2p21,protein-coding,/
CWITA008636,TCMBANKGE008636,DDX41,ABS; MPLPF,DEAD-box helicase 41,5q35.3,protein-coding,/
CWITA008637,TCMBANKGE008637,PRSS45P,PRSS45; TESPL; TESSP5,"serine protease 45, pseudogene",3p21.31,pseudo,/
CWITA008638,TCMBANKGE008638,IPCEF1,PIP3-E,interaction protein for cytohesin exchange factors 1,6q25.2,protein-coding,/
CWITA008639,TCMBANKGE008639,GSTP1,DFN7; FAEES3; GST3; GSTP; PI,glutathione S-transferase pi 1,11q13,protein-coding,
CWITA008640,TCMBANKGE008640,P2RY4,NRU; P2P; P2Y4; UNR,pyrimidinergic receptor P2Y4,Xq13.1,protein-coding,Discontinued target
CWITA008641,TCMBANKGE008641,HSD17B13,HMFN0376; NIIL497; SCDR9; SDR16C3,hydroxysteroid 17-beta dehydrogenase 13,4q22.1,protein-coding,/
CWITA008642,TCMBANKGE008642,IL36RN,FIL1; FIL1(DELTA); FIL1D; IL-36Ra; IL1F5; IL1HY1; IL1L1; IL1RP3; IL36RA; PSORP; PSORS14,interleukin 36 receptor antagonist,2q14.1,protein-coding,/
CWITA008643,TCMBANKGE008643,ZNF268,HZF3,zinc finger protein 268,12q24.33,protein-coding,/
CWITA008644,TCMBANKGE008644,CLK1,CLK; CLK/STY; STY,CDC like kinase 1,2q33.1,protein-coding,Patented target
CWITA008645,TCMBANKGE008645,PMPCB,Beta-MPP; MPP11; MPPB; MPPP52; P-52,"peptidase, mitochondrial processing subunit beta",7q22.1,protein-coding,/
CWITA008646,TCMBANKGE008646,PLPP2,LPP2; PAP-2c; PAP2-g; PPAP2C,phospholipid phosphatase 2,19p13.3,protein-coding,/
CWITA008647,TCMBANKGE008647,GSTA2,GST2; GSTA2-2; GTA2; GTH2,glutathione S-transferase alpha 2,6p12.2,protein-coding,Research target
CWITA008648,TCMBANKGE008648,HMGCLL1,bA418P12.1; er-cHL,3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1,6p12.1,protein-coding,/
CWITA008649,TCMBANKGE008649,INSIG1,CL6,insulin induced gene 1,7q36.3,protein-coding,/
CWITA008650,TCMBANKGE008650,FKBP1A,FKBP-12; FKBP-1A; FKBP1; FKBP12; PKC12; PKCI2; PPIASE,FKBP prolyl isomerase 1A,20p13,protein-coding,Successful target
CWITA008651,TCMBANKGE008651,NTN4,PRO3091,netrin 4,12q22,protein-coding,/
CWITA008652,TCMBANKGE008652,SEC14L6,-,SEC14 like lipid binding 6,22q12.2,protein-coding,/
CWITA008653,TCMBANKGE008653,GDI1,1A; GDIL; MRX41; MRX48; OPHN2; RABGD1A; RABGDIA; XAP-4,GDP dissociation inhibitor 1,Xq28,protein-coding,/
CWITA008654,TCMBANKGE008654,MUCL1,SBEM,mucin like 1,12q13.2,protein-coding,/
CWITA008655,TCMBANKGE008655,NUDT19,RP2,nudix hydrolase 19,19q13.11,protein-coding,/
CWITA008656,TCMBANKGE008656,DAD1,OST2,defender against cell death 1,14q11.2,protein-coding,/
CWITA008657,TCMBANKGE008657,PPP3CC,CALNA3; CNA3; PP2Bgamma,protein phosphatase 3 catalytic subunit gamma,8p21.3,protein-coding,/
CWITA008658,TCMBANKGE008658,DEFB104A,BD-4; DEFB-4; DEFB104; DEFB4; hBD-4,defensin beta 104A,8p23.1,protein-coding,/
CWITA008659,TCMBANKGE008659,SMCHD1,BAMS; FSHD2,structural maintenance of chromosomes flexible hinge domain containing 1,18p11.32,protein-coding,/
CWITA008660,TCMBANKGE008660,ALCAM,CD166; MEMD,activated leukocyte cell adhesion molecule,3q13.11,protein-coding,Research target
CWITA008661,TCMBANKGE008661,RESF1,C12orf35; GET; KIAA1551; UTA2-1,retroelement silencing factor 1,12p11.21,protein-coding,/
CWITA008662,TCMBANKGE008662,ZNF35,HF.10; HF10; Zfp105,zinc finger protein 35,3p21.31,protein-coding,/
CWITA008663,TCMBANKGE008663,PLD1,N,"phospholipase D1, phosphatidylcholine-specific",3q26,protein-coding,
CWITA008664,TCMBANKGE008664,TSPYL5,-,TSPY like 5,8q22.1,protein-coding,/
CWITA008665,TCMBANKGE008665,ZNF286A,ZNF286,zinc finger protein 286A,17p12,protein-coding,/
CWITA008666,TCMBANKGE008666,DROSHA,ETOHI2; HSA242976; RANSE3L; RN3; RNASE3L; RNASEN,drosha ribonuclease III,5p13.3,protein-coding,/
CWITA008667,TCMBANKGE008667,FLT3LG,FL; FLG3L; FLT3L,fms related receptor tyrosine kinase 3 ligand,19q13.33,protein-coding,/
CWITA008668,TCMBANKGE008668,ZP1,HEL163; OOMD; OOMD1,zona pellucida glycoprotein 1,11q12.2,protein-coding,/
CWITA008669,TCMBANKGE008669,SERPINA5,PAIN3; PAI3; PCI; PLANH3; PROCI,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5",14q32.1,protein-coding,
CWITA008670,TCMBANKGE008670,PIP4K2A,PI5P4KA; PIP5K2A; PIP5KII-alpha; PIP5KIIA; PIPK,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,10p12.2,protein-coding,/
CWITA008671,TCMBANKGE008671,PDE6G,DKFZp686C0587; MGC125749; PDEG; RP57,"phosphodiesterase 6G, cGMP-specific, rod, gamma",17q25,protein-coding,
CWITA008672,TCMBANKGE008672,SRPX2,BPP; CBPS; PMGX; RESDX; SRPUL,sushi repeat containing protein X-linked 2,Xq22.1,protein-coding,/
CWITA008673,TCMBANKGE008673,AMHR2,AMHR; MISR2; MISRII; MRII,"anti-Mullerian hormone receptor, type II",12q13,protein-coding,
CWITA008674,TCMBANKGE008674,MS4A4A,4SPAN1; CD20-L1; CD20L1; HDCME31P; MS4A4; MS4A7,membrane spanning 4-domains A4A,11q12.2,protein-coding,/
CWITA008675,TCMBANKGE008675,SLC15A2,PEPT2,solute carrier family 15 member 2,3q13.33,protein-coding,Research target
CWITA008676,TCMBANKGE008676,ANKRD30B,NY-BR-1.1,ankyrin repeat domain 30B,18p11.21,protein-coding,/
CWITA008677,TCMBANKGE008677,AK5,AK6,adenylate kinase 5,1p31.1,protein-coding,/
CWITA008678,TCMBANKGE008678,NAPEPLD,C7orf18; FMP30; NAPE-PLD,N-acyl phosphatidylethanolamine phospholipase D,7q22.1,protein-coding,Research target
CWITA008679,TCMBANKGE008679,EFNB1,CFND; CFNS; EFB1; EFL3; EPLG2; Elk-L; LERK2,ephrin B1,Xq13.1,protein-coding,/
CWITA008680,TCMBANKGE008680,DTD1,C20orf88; DTD; DUE-B; DUEB; HARS2; pqn-68,D-aminoacyl-tRNA deacylase 1,20p11.23,protein-coding,/
CWITA008681,TCMBANKGE008681,RNF126,-,ring finger protein 126,19p13.3,protein-coding,/
CWITA008682,TCMBANKGE008682,C3orf33,AC3-33,chromosome 3 open reading frame 33,3q25.31,protein-coding,/
CWITA008683,TCMBANKGE008683,PARP12,ARTD12; MST109; MSTP109; ZC3H1; ZC3HDC1,poly(ADP-ribose) polymerase family member 12,7q34,protein-coding,/
CWITA008684,TCMBANKGE008684,SSTR1,SRIFN2,somatostatin receptor 1,14q13,protein-coding,
CWITA008685,TCMBANKGE008685,PCNX3,PCNXL3,pecanex 3,11q13.1,protein-coding,/
CWITA008686,TCMBANKGE008686,CDC25B,-,cell division cycle 25B,20p13,protein-coding,Clinical Trial target
CWITA008687,TCMBANKGE008687,SERPIND1,D22S673; HC2; HCF2; HCII; HLS2; LS2,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",22q11.2|22q11.21,protein-coding,
CWITA008688,TCMBANKGE008688,NOCT,CCR4L; CCRN4L; Ccr4c; NOC,nocturnin,4q31.1,protein-coding,/
CWITA008689,TCMBANKGE008689,Myhc,-,"myosin heavy chain, cardiac muscle complex",-,other,/
CWITA008690,TCMBANKGE008690,ACAA1,ACAA; PTHIO; THIO,Acetyl-Coa_Acyltransferase_1,3p22.2,protein-coding,
CWITA008691,TCMBANKGE008691,PSMC5,S8; SUG-1; SUG1; TBP10; TRIP1; p45; p45/SUG,"proteasome 26S subunit, ATPase 5",17q23.3,protein-coding,/
CWITA008692,TCMBANKGE008692,UROD,PCT; UPD,uroporphyrinogen decarboxylase,1p34.1,protein-coding,/
CWITA008693,TCMBANKGE008693,EFHD1,MST133; MSTP133; PP3051; SWS2,EF-hand domain family member D1,2q37.1,protein-coding,/
CWITA008694,TCMBANKGE008694,ZXDB,ZNF905; dJ83L6.1,zinc finger X-linked duplicated B,Xp11.21,protein-coding,/
CWITA008695,TCMBANKGE008695,KMT5A,PR-Set7; PR/SET07; SET07; SET8; SETD8,lysine methyltransferase 5A,12q24.31,protein-coding,Research target
CWITA008696,TCMBANKGE008696,IMPDH1,IMPD; IMPD1; IMPDH-I; LCA11; RP10; sWSS2608,inosine monophosphate dehydrogenase 1,7q32.1,protein-coding,Successful target
CWITA008697,TCMBANKGE008697,Sms-ps,Gm14680; SPMSY; Sms,"spermine synthase, pseudogene",X A6|X,pseudo,/
CWITA008698,TCMBANKGE008698,CSF1R,CNFMS; CD115; CSFR; FIM2; FMS,colony stimulating factor 1 receptor,5q32,protein-coding,
CWITA008699,TCMBANKGE008699,SLC25A17,PMP34,solute carrier family 25 member 17,22q13.2,protein-coding,/
CWITA008700,TCMBANKGE008700,CHRNA2,-,cholinergic receptor nicotinic alpha 2 subunit,8p21.2,protein-coding,Successful target
CWITA008701,TCMBANKGE008701,NFATC2IP,ESC2; NIP45; RAD60,nuclear factor of activated T cells 2 interacting protein,16p11.2,protein-coding,/
CWITA008702,TCMBANKGE008702,OPRM1,LMOR; M-OR-1; MOP; MOR; MOR1; OPRM,opioid receptor mu 1,6q25.2,protein-coding,Successful target
CWITA008703,TCMBANKGE008703,ASB18,ASB-18,ankyrin repeat and SOCS box containing 18,2q37.2,protein-coding,/
CWITA008704,TCMBANKGE008704,POLN,POL4P,DNA polymerase nu,4p16.3,protein-coding,/
CWITA008705,TCMBANKGE008705,TATDN1,CDA11,TatD DNase domain containing 1,8q24.13,protein-coding,/
CWITA008706,TCMBANKGE008706,PSAPL1,-,prosaposin like 1,4p16.1,protein-coding,/
CWITA008707,TCMBANKGE008707,KLK12,KLK-L5; KLKL5,kallikrein related peptidase 12,19q13.41,protein-coding,/
CWITA008708,TCMBANKGE008708,PPP3R1,CALNB1; CNB; CNB1,"protein phosphatase 3, regulatory subunit B, alpha",2p15,protein-coding,
CWITA008709,TCMBANKGE008709,COL6A1,BTHLM1; OPLL; UCHMD1,collagen type VI alpha 1 chain,21q22.3,protein-coding,/
CWITA008710,TCMBANKGE008710,TCTN1,JBTS13; TECT1,tectonic family member 1,12q24.11,protein-coding,/
CWITA008711,TCMBANKGE008711,WDR89,C14orf150; MSTP050,WD repeat domain 89,14q23.2,protein-coding,/
CWITA008712,TCMBANKGE008712,NDUFS3,CIN30,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)",11p11.11,protein-coding,
CWITA008713,TCMBANKGE008713,POLE4,YHHQ1; p12,"polymerase (DNA-directed), epsilon 4 (p12 subunit)",2p12,protein-coding,
CWITA008714,TCMBANKGE008714,ACO2,ACONM; HEL-S-284; ICRD; OCA8; OPA9,aconitase 2,22q13.2,protein-coding,Research target
CWITA008715,TCMBANKGE008715,PSMB9,LMP2; MGC70470; PSMB6i; RING12; beta1i,"proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2)",6p21.3,protein-coding,
CWITA008716,TCMBANKGE008716,ZNF750,ZFP750,zinc finger protein 750,17q25.3,protein-coding,/
CWITA008717,TCMBANKGE008717,PLP1,GPM6C; HLD1; MMPL; PLP; PLP/DM20; PMD; SPG2,proteolipid protein 1,Xq22.2,protein-coding,/
CWITA008718,TCMBANKGE008718,PRSS3,MTG; PRSS4; T9; TRY3; TRY4,serine protease 3,9p13.3,protein-coding,/
CWITA008719,TCMBANKGE008719,USP40,-,ubiquitin specific peptidase 40,2q37.1,protein-coding,/
CWITA008720,TCMBANKGE008720,SF3B3,RSE1; SAP130; SF3b130; STAF130,splicing factor 3b subunit 3,16q22.1,protein-coding,/
CWITA008721,TCMBANKGE008721,SLCO2A1,MATR1; OATP2A1; PGT; PHOAR2; SLC21A2,solute carrier organic anion transporter family member 2A1,3q22.1-q22.2,protein-coding,Patented target
CWITA008722,TCMBANKGE008722,APC,BTPS2; DESMD; DP2; DP2.5; DP3; GS; PPP1R46,APC regulator of WNT signaling pathway,5q22.2,protein-coding,/
CWITA008723,TCMBANKGE008723,PDE10A,ADSD2; HSPDE10A; IOLOD; LINC00473; PDE10A19,phosphodiesterase 10A,6q27,protein-coding,Clinical Trial target
CWITA008724,TCMBANKGE008724,CDYL,CDYL1,chromodomain Y like,6p25.1,protein-coding,/
CWITA008725,TCMBANKGE008725,SLC9A1,APNH; FLJ42224; NHE1,"solute carrier family 9 (sodium/hydrogen exchanger), member 1",1p36.1-p35,protein-coding,
CWITA008726,TCMBANKGE008726,C1orf162,-,chromosome 1 open reading frame 162,1p13.2,protein-coding,/
CWITA008727,TCMBANKGE008727,ZNF776,-,zinc finger protein 776,19q13.43,protein-coding,/
CWITA008728,TCMBANKGE008728,PBRM1,BAF180; PB1,polybromo 1,3p21.1,protein-coding,Research target
CWITA008729,TCMBANKGE008729,PKP4,p0071,plakophilin 4,2q24.1,protein-coding,/
CWITA008730,TCMBANKGE008730,SNX18,SH3PX2; SH3PXD3B; SNAG1,sorting nexin 18,5q11.2,protein-coding,/
CWITA008731,TCMBANKGE008731,WNT9B,WNT14B; WNT15,Wnt family member 9B,17q21.32,protein-coding,/
CWITA008732,TCMBANKGE008732,RNGTT,CAP1A; HCE; HCE1; hCAP,RNA guanylyltransferase and 5'-phosphatase,6q15,protein-coding,/
CWITA008733,TCMBANKGE008733,TAS2R9,T2R9; TRB6,taste 2 receptor member 9,12p13.2,protein-coding,/
CWITA008734,TCMBANKGE008734,OSBPL5,OBPH1; ORP5,oxysterol binding protein like 5,11p15.4,protein-coding,/
CWITA008735,TCMBANKGE008735,WDR19,ATD5; CED4; DYF-2; FAP66; IFT144; NPHP13; ORF26; Oseg6; PWDMP; SRTD5,WD repeat domain 19,4p14,protein-coding,/
CWITA008736,TCMBANKGE008736,RALGDS,RGDS; RGF; RalGEF,ral guanine nucleotide dissociation stimulator,9q34.13-q34.2,protein-coding,/
CWITA008737,TCMBANKGE008737,VAT1,VATI,vesicle amine transport 1,17q21.31,protein-coding,/
CWITA008738,TCMBANKGE008738,KRBOX1,-,KRAB box domain containing 1,3p22.1,protein-coding,/
CWITA008739,TCMBANKGE008739,ENPP1,ARHR2; M6S1; NPP1; NPPS; PCN1; PCA1; PDNP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q22-q23,protein-coding,
CWITA008740,TCMBANKGE008740,ZNF672,-,zinc finger protein 672,1q44,protein-coding,/
CWITA008741,TCMBANKGE008741,POLE2,DPE2,"DNA polymerase epsilon 2, accessory subunit",14q21.3,protein-coding,/
CWITA008742,TCMBANKGE008742,UGT2B28,-,UDP glucuronosyltransferase family 2 member B28,4q13.2,protein-coding,/
CWITA008743,TCMBANKGE008743,OPRK1,K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK,opioid receptor kappa 1,8q11.23,protein-coding,Successful target
CWITA008744,TCMBANKGE008744,CPA1,CPA,carboxypeptidase A1 (pancreatic),7q32,protein-coding,
CWITA008745,TCMBANKGE008745,GTF2H4,P52; TFB2; TFIIH,general transcription factor IIH subunit 4,6p21.33,protein-coding,/
CWITA008746,TCMBANKGE008746,ATP7A,DSMAX; MK; MNK; SMAX3,ATPase copper transporting alpha,Xq21.1,protein-coding,/
CWITA008747,TCMBANKGE008747,ACYP2,ACYM; ACYP,acylphosphatase 2,2p16.2,protein-coding,/
CWITA008748,TCMBANKGE008748,SMIM20,C4orf52; MITRAC7; PNX,small integral membrane protein 20,4p15.2,protein-coding,/
CWITA008749,TCMBANKGE008749,PIP5K1A,-,phosphatidylinositol-4-phosphate 5-kinase type 1 alpha,1q21.3,protein-coding,Research target
CWITA008750,TCMBANKGE008750,CAPN7,CALPAIN7; PALBH,calpain 7,3p25.1,protein-coding,/
CWITA008751,TCMBANKGE008751,ZNF788P,ZNF788,"zinc finger family member 788, pseudogene",19p13.2,protein-coding,/
CWITA008752,TCMBANKGE008752,ENPP4,NPP4,ectonucleotide pyrophosphatase/phosphodiesterase 4,6p21.1,protein-coding,/
CWITA008753,TCMBANKGE008753,TPP2,TPP-2; TPP-II; TPPII,tripeptidyl peptidase 2,13q33.1,protein-coding,Discontinued target
CWITA008754,TCMBANKGE008754,H3P10,p16,H3 histone pseudogene 10,3p24.2,pseudo,/
CWITA008755,TCMBANKGE008755,RNF113A,Cwc24; RNF113; TTD5; ZNF183,ring finger protein 113A,Xq24,protein-coding,/
CWITA008756,TCMBANKGE008756,CTSF,CATSF,cathepsin F,11q13,protein-coding,
CWITA008757,TCMBANKGE008757,SMARCC2,BAF170; CRACC2; CSS8; Rsc8,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2",12q13.2,protein-coding,/
CWITA008758,TCMBANKGE008758,MAGEB4,CT3.6,MAGE family member B4,Xp21.2,protein-coding,/
CWITA008759,TCMBANKGE008759,ALPL,APNTNAP; APTNAP; FLJ40094; FLJ93059; HOPS; MGC161443; MGC167935; TNAP; TNSALP,"alkaline phosphatase, liver/bone/kidney",1p36.12,protein-coding,
CWITA008760,TCMBANKGE008760,TAF1,BA2R; CCG1; CCGS; DYT3; DYT3/TAF1; KAT4; MRXS33; N-TAF1; NSCL2; OF; P250; TAF(II)250; TAF2A; TAFII-250; TAFII250; XDP,TATA-box binding protein associated factor 1,Xq13.1,protein-coding,/
CWITA008761,TCMBANKGE008761,ICAM1,BB2; CD54; P3.58,Intercellular Adhesion Molecule 1,19p13.3-p13.2,protein-coding,
CWITA008762,TCMBANKGE008762,LPA,AK38; APOA; LP,"lipoprotein, Lp(a)",6q26,protein-coding,
CWITA008763,TCMBANKGE008763,IL6ST,CD130; CDW130; GP130; HIES4; IL-6RB; sGP130,interleukin 6 signal transducer,5q11.2,protein-coding,/
CWITA008764,TCMBANKGE008764,MSH4,-,mutS homolog 4,1p31.1,protein-coding,/
CWITA008765,TCMBANKGE008765,Gma3,Gm-3; Gm3,granulocyte macrophage antigen 3,-,unknown,/
CWITA008766,TCMBANKGE008766,NIF3L1,ALS2CR1; CALS-7; MDS015,NGG1 interacting factor 3 like 1,2q33.1,protein-coding,/
CWITA008767,TCMBANKGE008767,TRAPPC3,BET3,trafficking protein particle complex 3,1p34.3,protein-coding,/
CWITA008768,TCMBANKGE008768,CCDC50,C3orf6; DFNA44; YMER,coiled-coil domain containing 50,3q28,protein-coding,/
CWITA008769,TCMBANKGE008769,LRRD1,-,leucine rich repeats and death domain containing 1,7q21.2,protein-coding,/
CWITA008770,TCMBANKGE008770,COL20A1,-,collagen type XX alpha 1 chain,20q13.33,protein-coding,/
CWITA008771,TCMBANKGE008771,PIGM,GPI-MT-I,phosphatidylinositol glycan anchor biosynthesis class M,1q23.2,protein-coding,/
CWITA008772,TCMBANKGE008772,S100G,CABP; CABP1; CABP9K; CALB3,S100 calcium binding protein G,Xp22.2,protein-coding,Research target
CWITA008773,TCMBANKGE008773,MDM1,-,Mdm1 nuclear protein,12q15,protein-coding,/
CWITA008774,TCMBANKGE008774,STMN4,RB3,stathmin 4,8p21.2,protein-coding,/
CWITA008775,TCMBANKGE008775,VIL1,D2S1471; VIL,villin 1,2q35,protein-coding,/
CWITA008776,TCMBANKGE008776,PARVA,CH-ILKBP; MXRA2,parvin alpha,11p15.3,protein-coding,/
CWITA008777,TCMBANKGE008777,EDRF1,C10orf137,erythroid differentiation regulatory factor 1,10q26.2,protein-coding,/
CWITA008778,TCMBANKGE008778,DBN1,D0S117E,drebrin 1,5q35.3,protein-coding,/
CWITA008779,TCMBANKGE008779,OR5D18,OR11-143,olfactory receptor family 5 subfamily D member 18,11q12.1,protein-coding,/
CWITA008780,TCMBANKGE008780,PSMA5,FLJ42315; MGC117302; MGC125802; MGC125803; MGC125804; PSC5; ZETA,"proteasome (prosome, macropain) subunit, alpha type, 5",1p13,protein-coding,
CWITA008781,TCMBANKGE008781,UBN2,-,ubinuclein 2,7q34,protein-coding,/
CWITA008782,TCMBANKGE008782,TBX2,VETD,T-box transcription factor 2,17q23.2,protein-coding,/
CWITA008783,TCMBANKGE008783,CLECL1,DCAL-1; DCAL1,C-type lectin like 1,12p13.31,protein-coding,/
CWITA008784,TCMBANKGE008784,HSD17B2,EDH17B2; HSD17; SDR9C2,hydroxysteroid (17-beta) dehydrogenase 2,16q24.1-q24.2,protein-coding,
CWITA008785,TCMBANKGE008785,PCDHGA2,PCDH-GAMMA-A2,"protocadherin gamma subfamily A, 2",5q31.3,protein-coding,/
CWITA008786,TCMBANKGE008786,CRAT,CAT; CAT1; NBIA8,carnitine O-acetyltransferase,9q34.11,protein-coding,Discontinued target
CWITA008787,TCMBANKGE008787,OMG,OMGP,oligodendrocyte myelin glycoprotein,17q11.2,protein-coding,/
CWITA008788,TCMBANKGE008788,VDAC2,FLJ23841; POR,voltage-dependent anion channel 2,10q22,protein-coding,
CWITA008789,TCMBANKGE008789,DHX32,DDX32; DHLP1,DEAH-box helicase 32 (putative),10q26.2,protein-coding,/
CWITA008790,TCMBANKGE008790,RIBC1,2610028I09Rik,RIB43A domain with coiled-coils 1,Xp11.22,protein-coding,/
CWITA008791,TCMBANKGE008791,ZNF677,-,zinc finger protein 677,19q13.42,protein-coding,/
CWITA008792,TCMBANKGE008792,CEP85L,C6orf204; LIS10; NY-BR-15; bA57K17.2,centrosomal protein 85 like,6q22.31,protein-coding,/
CWITA008793,TCMBANKGE008793,DGKG,DAGK3; DGKNGAMMA; MGC104993; MGC133330,"diacylglycerol kinase, gamma 90kDa",3q27.2-q27.3,protein-coding,
CWITA008794,TCMBANKGE008794,BRINP2,DBCCR1L2; FAM5B,BMP/retinoic acid inducible neural specific 2,1q25.2,protein-coding,/
CWITA008795,TCMBANKGE008795,Rafar,-,retinoic acid induced forelimb autopod reduction,11 52.22 cM,unknown,/
CWITA008796,TCMBANKGE008796,HSD17B6,HSE; RODH; SDR9C6,hydroxysteroid 17-beta dehydrogenase 6,12q13.3,protein-coding,/
CWITA008797,TCMBANKGE008797,TMEM222,C1orf160,transmembrane protein 222,1p36.11,protein-coding,/
CWITA008798,TCMBANKGE008798,CYP4A11,CP4Y; CYP4A2; CYP4AII,"cytochrome P450, family 4, subfamily A, polypeptide 11",1p33,protein-coding,
CWITA008799,TCMBANKGE008799,DGAT2,ARAT; GS1999FULL; HMFN1045,diacylglycerol O-acyltransferase 2,11q13.5,protein-coding,Successful target
CWITA008800,TCMBANKGE008800,ATP2B1,PMCA1; PMCA1kb,ATPase plasma membrane Ca2+ transporting 1,12q21.33,protein-coding,/
CWITA008801,TCMBANKGE008801,NAV2,HELAD1; POMFIL2; RAINB1; STEERIN2; UNC53H2,neuron navigator 2,11p15.1,protein-coding,/
CWITA008802,TCMBANKGE008802,TSLP,-,thymic stromal lymphopoietin,5q22.1,protein-coding,Clinical Trial target
CWITA008803,TCMBANKGE008803,PHOSPHO1,-,phosphoethanolamine/phosphocholine phosphatase 1,17q21.32,protein-coding,/
CWITA008804,TCMBANKGE008804,IPO13,IMP13; KAP13; LGL2; RANBP13,importin 13,1p34.1,protein-coding,/
CWITA008805,TCMBANKGE008805,BPGM,DPGM; ECYT8,bisphosphoglycerate mutase,7q33,protein-coding,/
CWITA008806,TCMBANKGE008806,RCBTB1,CLLD7; CLLL7; GLP; RDEOA,RCC1 and BTB domain containing protein 1,13q14.2,protein-coding,/
CWITA008807,TCMBANKGE008807,RBKS,RBSK; RK,ribokinase,2p23.2,protein-coding,/
CWITA008808,TCMBANKGE008808,SEC24B,SEC24,"SEC24 homolog B, COPII coat complex component",4q25,protein-coding,/
CWITA008809,TCMBANKGE008809,C6orf15,STG,chromosome 6 open reading frame 15,6p21.33,protein-coding,/
CWITA008810,TCMBANKGE008810,CYP2C18,CPCI; CYP2C; CYP2C17; DKFZp686I24235; P450N6B/29C; P450IIC17,"cytochrome P450, family 2, subfamily C, polypeptide 18",10q24,protein-coding,
CWITA008811,TCMBANKGE008811,CCL16,CKb12; HCC-4; ILINCK; LCC-1; LEC; LMC; Mtn-1; NCC-4; NCC4; SCYA16; SCYL4,C-C motif chemokine ligand 16,17q12,protein-coding,/
CWITA008812,TCMBANKGE008812,TMEM19,-,transmembrane protein 19,12q21.1,protein-coding,/
CWITA008813,TCMBANKGE008813,MTHFR,N,methylenetetrahydrofolate reductase (NAD(P)H),1p36.3,protein-coding,
CWITA008814,TCMBANKGE008814,BRD8,SMAP; SMAP2; p120,bromodomain containing 8,5q31.2,protein-coding,/
CWITA008815,TCMBANKGE008815,ABCC5,ABC33; EST277145; MOAT-C; MOATC; MRP5; SMRP; pABC11,ATP binding cassette subfamily C member 5,3q27.1,protein-coding,/
CWITA008816,TCMBANKGE008816,AHSA2P,AHA1; AHSA2; Hch1,"activator of HSP90 ATPase homolog 2, pseudogene",2p15,pseudo,/
CWITA008817,TCMBANKGE008817,NXT2,P15-2,nuclear transport factor 2 like export factor 2,Xq23,protein-coding,/
CWITA008818,TCMBANKGE008818,TTC37,KIAA0372; Ski3; THES,tetratricopeptide repeat domain 37,5q15,protein-coding,/
CWITA008819,TCMBANKGE008819,PCDHA4,CNR1; CNRN1; CRNR1; PCDH-ALPHA4,protocadherin alpha 4,5q31.3,protein-coding,/
CWITA008820,TCMBANKGE008820,CBX5,HEL25; HP1; HP1A,chromobox 5,12q13.13,protein-coding,/
CWITA008821,TCMBANKGE008821,AIFM3,AIFL,apoptosis inducing factor mitochondria associated 3,22q11.21,protein-coding,/
CWITA008822,TCMBANKGE008822,GNE,DMRV; GLCNE; IBM2; NM; Uae1,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,9p13.3,protein-coding,Clinical Trial target
CWITA008823,TCMBANKGE008823,VAMP8,EDB; VAMP-8,vesicle associated membrane protein 8,2p11.2,protein-coding,/
CWITA008824,TCMBANKGE008824,NOXO1,MGC20258; P41NOX; P41NOXA; P41NOXB; P41NOXC; SH3PXD5; SNX28,NADPH oxidase organizer 1,16p13.3,protein-coding,
CWITA008825,TCMBANKGE008825,LTBP4,ARCL1C; LTBP-4; LTBP4L; LTBP4S,latent transforming growth factor beta binding protein 4,19q13.2,protein-coding,/
CWITA008826,TCMBANKGE008826,LBR,C14SR; DHCR14B; LMN2R; PHA; PHASK; TDRD18,lamin B receptor,1q42.12,protein-coding,/
CWITA008827,TCMBANKGE008827,CNPY3,CAG4A; EIEE60; ERDA5; PRAT4A; TNRC5,canopy FGF signaling regulator 3,6p21.1,protein-coding,/
CWITA008828,TCMBANKGE008828,AMPD1,MAD; MADA,adenosine monophosphate deaminase 1,1p13,protein-coding,
CWITA008829,TCMBANKGE008829,SURF4,ERV29,surfeit 4,9q34.2,protein-coding,/
CWITA008830,TCMBANKGE008830,JAK3,JAK-3; JAK3_HUMAN; JAKL; L-JAK; LJAK,Janus kinase 3,19p13.11,protein-coding,Successful target
CWITA008831,TCMBANKGE008831,DNASE1L1,DNAS1L1; DNASEX; DNL1L; G4.8; XIB,deoxyribonuclease 1 like 1,Xq28,protein-coding,/
CWITA008832,TCMBANKGE008832,SLC2A3,FLJ90380; GLUT3,"solute carrier family 2 (facilitated glucose transporter), member 3",12p13.3,protein-coding,
CWITA008833,TCMBANKGE008833,VPS36,C13orf9; CGI-145; EAP45,vacuolar protein sorting 36 homolog,13q14.3,protein-coding,/
CWITA008834,TCMBANKGE008834,COX11,COX11P,cytochrome c oxidase copper chaperone COX11,17q22,protein-coding,/
CWITA008835,TCMBANKGE008835,IPPK,C9orf12; INSP5K2; IP5K; IPK1; bA476B13.1,inositol-pentakisphosphate 2-kinase,9q22.31,protein-coding,/
CWITA008836,TCMBANKGE008836,MLLT11,AF1Q,MLLT11 transcription factor 7 cofactor,1q21.3,protein-coding,/
CWITA008837,TCMBANKGE008837,ITGAX,CD11C; SLEB6,integrin subunit alpha X,16p11.2,protein-coding,/
CWITA008838,TCMBANKGE008838,GOLM1,C9orf155; GOLPH2; GP73; HEL46; PSEC0257; bA379P1.3,golgi membrane protein 1,9q21.33,protein-coding,/
CWITA008839,TCMBANKGE008839,NT5DC2,-,5'-nucleotidase domain containing 2,3p21.1,protein-coding,/
CWITA008840,TCMBANKGE008840,THRA,AR7; EAR7; ERBNTN1; ERBA; ERBA1; MGC000261; MGC43240; NR1A1; THRA1; THRA2; cNERBAN1,"thyroid hormone receptor, alpha",17q11.2,protein-coding,
CWITA008841,TCMBANKGE008841,TCEA3,TFIIS; TFIIS.H,transcription elongation factor A3,1p36.12,protein-coding,/
CWITA008842,TCMBANKGE008842,CCDC130,-,coiled-coil domain containing 130,19p13.13,protein-coding,/
CWITA008843,TCMBANKGE008843,EEF1A1,CCSN3; CCS3; EE1A1; EEFN1; EEF1A; EFNTu; EF1A; FLJ25721; GRAFN1EF; HNGC:16303; LENG7; MGC102687; MGC131894; MGC16224; PTI1; eEF1AN1,eukaryotic translation elongation factor 1 alpha 1,6q14.1,protein-coding,
CWITA008844,TCMBANKGE008844,GMPR,GMPR1,guanosine monophosphate reductase,6p23,protein-coding,
CWITA008845,TCMBANKGE008845,GALR1,GALNR; GALNR1,galanin receptor 1,18q23,protein-coding,Research target
CWITA008846,TCMBANKGE008846,GSE1,CRHSP24; KIAA0182,Gse1 coiled-coil protein,16q24.1,protein-coding,/
CWITA008847,TCMBANKGE008847,GIMAP1,HIMAP1; IAN2; IMAP1; IMAP38,"GTPase, IMAP family member 1",7q36.1,protein-coding,/
CWITA008848,TCMBANKGE008848,UBE4B,E4; HDNB1; UBOX3; UFD2; UFD2A,ubiquitination factor E4B,1p36.22,protein-coding,/
CWITA008849,TCMBANKGE008849,SLC39A11,C17orf26; ZIP-11; ZIP11,solute carrier family 39 member 11,17q24.3-q25.1,protein-coding,/
CWITA008850,TCMBANKGE008850,TAS2R4,T2R4,taste 2 receptor member 4,7q34,protein-coding,/
CWITA008851,TCMBANKGE008851,PSMA1,HC2; MGC14542; MGC14575; MGC14751; MGC1667; MGC21459; MGC22853; MGC23915; NU; PROS30,"proteasome (prosome, macropain) subunit, alpha type, 1",11p15.1,protein-coding,
CWITA008852,TCMBANKGE008852,KCMF1,DEBT91; FIGC; PCMF; ZZZ1,potassium channel modulatory factor 1,2p11.2,protein-coding,/
CWITA008853,TCMBANKGE008853,RPP25L,C9orf23; bA296L22.5,ribonuclease P/MRP subunit p25 like,9p13.3,protein-coding,/
CWITA008854,TCMBANKGE008854,PBLD,HEL-S-306; MAWBP; MAWDBP,phenazine biosynthesis like protein domain containing,10q21.3,protein-coding,/
CWITA008855,TCMBANKGE008855,PDE6C,ACHM5; COD4; PDEA2,phosphodiesterase 6C,10q23.33,protein-coding,/
CWITA008856,TCMBANKGE008856,STS,ARSC; ARSC1; ASC; ES; SSDD; XLI,"steroid sulfatase (microsomal), isozyme S",Xp22.32,protein-coding,
CWITA008857,TCMBANKGE008857,LPL,HDLCQ11; LIPD,lipoprotein lipase,8p21.3,protein-coding,Successful target
CWITA008858,TCMBANKGE008858,KPNA1,IPOA5; NPI-1; RCH2; SRP1,karyopherin subunit alpha 1,3q21.1,protein-coding,/
CWITA008859,TCMBANKGE008859,TRIM23,ARD1; ARFD1; RNF46,tripartite motif containing 23,5q12.3,protein-coding,/
CWITA008860,TCMBANKGE008860,NDUFA2,B8; CD14; CIB8,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa",5q31,protein-coding,
CWITA008861,TCMBANKGE008861,EXOSC10,PM-Scl; PM/Scl-100; PMSCL; PMSCL2; RRP6; Rrp6p; p2; p3; p4,exosome component 10,1p36.22,protein-coding,/
CWITA008862,TCMBANKGE008862,KIF3C,-,kinesin family member 3C,2p23.3,protein-coding,/
CWITA008863,TCMBANKGE008863,GABRR2,-,gamma-aminobutyric acid type A receptor subunit rho2,6q15,protein-coding,Research target
CWITA008864,TCMBANKGE008864,CYB5B,CYB5-M; CYPB5M; OMB5,cytochrome b5 type B,16q22.1,protein-coding,/
CWITA008865,TCMBANKGE008865,FOLH1,FGCP; FOLH; GCP2; GCPII; NAALAD1; NAALAdase; PSM; PSMA; mGCP,folate hydrolase 1,11p11.12,protein-coding,Successful target
CWITA008866,TCMBANKGE008866,RAB8B,FLJ38125,"RAB8B, member RAS oncogene family",15q22.2,protein-coding,
CWITA008867,TCMBANKGE008867,ACADS,ACAD3; SCAD,"acyl-CoA dehydrogenase, C-2 to C-3 short chain",12q24.31,protein-coding,
CWITA008868,TCMBANKGE008868,PCDHGA9,PCDH-GAMMA-A9,"protocadherin gamma subfamily A, 9",5q31.3,protein-coding,/
CWITA008869,TCMBANKGE008869,ASMT,ASMTY; HIOMT; HIOMTY,acetylserotonin O-methyltransferase,Xp22.3_or_Yp11.3,protein-coding,
CWITA008870,TCMBANKGE008870,NLN,AGTBP; EP24.16; MEP; MOP,neurolysin,5q12.3,protein-coding,/
CWITA008871,TCMBANKGE008871,SLC23A1,SLC23A2; SVCT1; YSPL3,solute carrier family 23 member 1,5q31.2,protein-coding,Successful target
CWITA008872,TCMBANKGE008872,STYK1,NOK; SuRTK106,serine/threonine/tyrosine kinase 1,12p13.2,protein-coding,Research target
CWITA008873,TCMBANKGE008873,SBDS,CGI-97; SDS; SWDS,SBDS ribosome maturation factor,7q11.21,protein-coding,/
CWITA008874,TCMBANKGE008874,TXNRD2,SELZ; TR; TRNBETA; TR3; TRXR2,thioredoxin reductase 2,22q11.21,protein-coding,
CWITA008875,TCMBANKGE008875,CDCA3,GRCC8; TOME-1,cell division cycle associated 3,12p13.31,protein-coding,/
CWITA008876,TCMBANKGE008876,PROX1,-,prospero homeobox 1,1q32.3,protein-coding,/
CWITA008877,TCMBANKGE008877,PANK4,-,pantothenate kinase 4 (inactive),1p36.32,protein-coding,/
CWITA008878,TCMBANKGE008878,TAS2R13,T2R13; TRB3,taste 2 receptor member 13,12p13.2,protein-coding,/
CWITA008879,TCMBANKGE008879,MAGED1,DLXIN-1; NRAGE,MAGE family member D1,Xp11.22,protein-coding,/
CWITA008880,TCMBANKGE008880,C4A,C4; C4A2; C4A3; C4A4; C4A6; C4AD; C4S; CO4; CPAMD2; RG,complement C4A (Rodgers blood group),6p21.33,protein-coding,/
CWITA008881,TCMBANKGE008881,PTPRS,PTPSIGMA,"protein tyrosine phosphatase, receptor type, S",19p13.3,protein-coding,
CWITA008882,TCMBANKGE008882,CBX2,CDCA6; M33; SRXY5,chromobox 2,17q25.3,protein-coding,/
CWITA008883,TCMBANKGE008883,SOD2,IPOB; MNSOD; MVCD6,"superoxide dismutase 2, mitochondrial",6q25.3,protein-coding,
CWITA008884,TCMBANKGE008884,PRSS37,TRYX2,serine protease 37,7q34,protein-coding,/
CWITA008885,TCMBANKGE008885,RPL12,L12,ribosomal protein L12,9q33.3,protein-coding,/
CWITA008886,TCMBANKGE008886,KCNA5,ATFB7; HCK1; HK2; HPCN1; KV1.5; MGC117058; MGC117059; PCN1,"potassium voltage-gated channel, shaker-related subfamily, member 5",12p13,protein-coding,
CWITA008887,TCMBANKGE008887,BMERB1,C16orf45; MINP,bMERB domain containing 1,16p13.11,protein-coding,/
CWITA008888,TCMBANKGE008888,CHI3L1,ASRT7; CGP-39; GP-39; GP39; HC-gp39; HCGP-3P; YK-40; YKL-40; YKL40; YYL-40; hCGP-39,chitinase 3 like 1,1q32.1,protein-coding,/
CWITA008889,TCMBANKGE008889,PCDHGB3,PCDH-GAMMA-B3,"protocadherin gamma subfamily B, 3",5q31.3,protein-coding,/
CWITA008890,TCMBANKGE008890,USE1,D12; MDS032; P31; SLT1,unconventional SNARE in the ER 1,19p13.11,protein-coding,/
CWITA008891,TCMBANKGE008891,ODC1,ODC,ornithine decarboxylase 1,2p25.1,protein-coding,Successful target
CWITA008892,TCMBANKGE008892,DENND2D,-,DENN domain containing 2D,1p13.3-p13.2,protein-coding,/
CWITA008893,TCMBANKGE008893,TAT,-,tyrosine aminotransferase,16q22.2,protein-coding,/
CWITA008894,TCMBANKGE008894,NANOS1,EC_Rep1a; NOS-1; NOS1; SPGF12; ZC2HC12A,nanos C2HC-type zinc finger 1,10q26.11,protein-coding,/
CWITA008895,TCMBANKGE008895,PRKACG,BDPLT19; KAPG; PKACg,protein kinase cAMP-activated catalytic subunit gamma,9q21.11,protein-coding,/
CWITA008896,TCMBANKGE008896,BLVRB,BVRB; FLR; HEL-S-10; SDR43U1,biliverdin reductase B,19q13.2,protein-coding,/
CWITA008897,TCMBANKGE008897,DESI2,C1orf121; CGI-146; DESI; DESI1; DeSI-2; FAM152A; PNAS-4; PPPDE1,desumoylating isopeptidase 2,1q44,protein-coding,/
CWITA008898,TCMBANKGE008898,AR,AIS; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM,androgen receptor,Xq12,protein-coding,
CWITA008899,TCMBANKGE008899,IDS,ID2S; MPS2; SIDS,iduronate 2-sulfatase,Xq28,protein-coding,Successful target
CWITA008900,TCMBANKGE008900,Gluchos2,-,glucose homeostasis QTL 2,11 7.3 cM,unknown,/
CWITA008901,TCMBANKGE008901,TBXAS1,CYP5; CYP5A1; FLJ52771; GHOSAL; THAS; TS; TXAS; TXS,thromboxane A synthase 1 (platelet),7q34-q35,protein-coding,
CWITA008902,TCMBANKGE008902,FGFBP3,C10orf13; FGF-BP3,fibroblast growth factor binding protein 3,10q23.32,protein-coding,/
CWITA008903,TCMBANKGE008903,CPSF4,CPSF30; NAR; NEB-1; NEB1,cleavage and polyadenylation specific factor 4,7q22.1,protein-coding,/
CWITA008904,TCMBANKGE008904,SLC51A,OSTA; OSTalpha,solute carrier family 51 subunit alpha,3q29,protein-coding,/
CWITA008905,TCMBANKGE008905,FXYD2,ATP1G1; HOMG2,FXYD domain containing ion transport regulator 2,11q23.3,protein-coding,/
CWITA008906,TCMBANKGE008906,Hsp86-ps2,86kDa; Hsp86-3; Hsp90,"heat shock protein 86, pseudogene 2",-,pseudo,/
CWITA008907,TCMBANKGE008907,GGA2,VEAR,"golgi associated, gamma adaptin ear containing, ARF binding protein 2",16p12.2,protein-coding,/
CWITA008908,TCMBANKGE008908,NDST1,HSST; MRT46; NST1,N-deacetylase and N-sulfotransferase 1,5q33.1,protein-coding,/
CWITA008909,TCMBANKGE008909,STAT2,IMD44; ISGF-3; P113; STAT113,signal transducer and activator of transcription 2,12q13.3,protein-coding,/
CWITA008910,TCMBANKGE008910,MPC1,BRP44L; CGI-129; MPYCD; SLC54A1,mitochondrial pyruvate carrier 1,6q27,protein-coding,/
CWITA008911,TCMBANKGE008911,UBE2R2,CDC34B; E2-CDC34B; UBC3B,ubiquitin conjugating enzyme E2 R2,9p13.3,protein-coding,/
CWITA008912,TCMBANKGE008912,ZNF627,-,zinc finger protein 627,19p13.2,protein-coding,/
CWITA008913,TCMBANKGE008913,NECAP2,-,NECAP endocytosis associated 2,1p36.13,protein-coding,/
CWITA008914,TCMBANKGE008914,F8A1,DXS522E; F8A; HAP40,coagulation factor VIII associated 1,Xq28,protein-coding,/
CWITA008915,TCMBANKGE008915,RNLS,C10orf59; RENALASE,"renalase, FAD dependent amine oxidase",10q23.31,protein-coding,/
CWITA008916,TCMBANKGE008916,cac,cat,recessive cataract,-,unknown,/
CWITA008917,TCMBANKGE008917,KCNK2,K2p2.1; TPKC1; TREK; TREK-1; TREK1; hTREK-1c; hTREK-1e,potassium two pore domain channel subfamily K member 2,1q41,protein-coding,/
CWITA008918,TCMBANKGE008918,PNPLA5,GS2L; dJ388M5; dJ388M5.4,patatin like phospholipase domain containing 5,22q13.31,protein-coding,/
CWITA008919,TCMBANKGE008919,DCT,TRP-2; TYRP2,dopachrome tautomerase,13q32.1,protein-coding,/
CWITA008920,TCMBANKGE008920,ALKBH8,ABH8; MRT71; TRM9; TRMT9; TRMT9A,"alkB homolog 8, tRNA methyltransferase",11q22.3,protein-coding,/
CWITA008921,TCMBANKGE008921,RXRA,NR2B1,retinoid X receptor alpha,9q34.2,protein-coding,Successful target
CWITA008922,TCMBANKGE008922,GMCL2,GCL; GMCL1L; GMCL1P1,"germ cell-less 2, spermatogenesis associated",5q35.3,protein-coding,/
CWITA008923,TCMBANKGE008923,HLF,-,"HLF transcription factor, PAR bZIP family member",17q22,protein-coding,/
CWITA008924,TCMBANKGE008924,CHAC1,-,ChaC glutathione specific gamma-glutamylcyclotransferase 1,15q15.1,protein-coding,/
CWITA008925,TCMBANKGE008925,GABRR2,N,"gamma-aminobutyric acid (GABA) receptor, rho 2",6q14-q21|6q13-q16.3,protein-coding,
CWITA008926,TCMBANKGE008926,FBXO7,FBX; FBX07; FBX7; PARK15; PKPS,F-box protein 7,22q12.3,protein-coding,/
CWITA008927,TCMBANKGE008927,KAT2A,GCN5; GCN5L2; PCAF-b; hGCN5,lysine acetyltransferase 2A,17q21.2,protein-coding,/
CWITA008928,TCMBANKGE008928,GLRA4,-,glycine receptor alpha 4 (pseudogene),Xq22.2,pseudo,/
CWITA008929,TCMBANKGE008929,EFNA3,EFL2; EPLG3; Ehk1-L; LERK3,ephrin A3,1q21.3,protein-coding,/
CWITA008930,TCMBANKGE008930,PNN,DRS; DRSP; SDK3; memA,"pinin, desmosome associated protein",14q21.1,protein-coding,/
CWITA008931,TCMBANKGE008931,SEMA6A,HT018; SEMA; SEMA6A1; SEMAQ; VIA,semaphorin 6A,5q23.1,protein-coding,/
CWITA008932,TCMBANKGE008932,WWP1,AIP5; Tiul1; hSDRP1,WW domain containing E3 ubiquitin protein ligase 1,8q21.3,protein-coding,Research target
CWITA008933,TCMBANKGE008933,KCTD1,C18orf5,potassium channel tetramerization domain containing 1,18q11.2,protein-coding,/
CWITA008934,TCMBANKGE008934,UBAP1L,UBAP-1L,ubiquitin associated protein 1 like,15q22.31,protein-coding,/
CWITA008935,TCMBANKGE008935,XG,PBDX,Xg glycoprotein (Xg blood group),Xp22.33,protein-coding,/
CWITA008936,TCMBANKGE008936,IFT122,CED; CED1; FAP80; SPG; WDR10; WDR10p; WDR140,intraflagellar transport 122,3q21.3-q22.1,protein-coding,/
CWITA008937,TCMBANKGE008937,ELSPBP1,E12; EDDM12; HE12,epididymal sperm binding protein 1,19q13.33,protein-coding,
CWITA008938,TCMBANKGE008938,CPT1A,CPT1; CPT1NL; LNCPT1,carnitine palmitoyltransferase 1A (liver),11q13.2,protein-coding,
CWITA008939,TCMBANKGE008939,ALYREF,ALY; ALY/REF; BEF; REF; THOC4,Aly/Ref_Export_Factor,17q25.3,protein-coding,
CWITA008940,TCMBANKGE008940,CDA,CDD,cytidine deaminase,1p36.2-p35,protein-coding,
CWITA008941,TCMBANKGE008941,CRIP1,CRHP; CRIP; CRP-1; CRP1,cysteine rich protein 1,14q32.33,protein-coding,/
CWITA008942,TCMBANKGE008942,QARS,GLNRS; PRO2195,glutaminyl-tRNA synthetase,3p21.31,protein-coding,
CWITA008943,TCMBANKGE008943,GPR55,N,G protein-coupled receptor 55,2q37,protein-coding,
CWITA008944,TCMBANKGE008944,CACNA1H,CACNA1HB; Cav3.2; ECA6; EIG6; HALD4,calcium voltage-gated channel subunit alpha1 H,16p13.3,protein-coding,Successful target
CWITA008945,TCMBANKGE008945,TEAD4,EFTR-2; RTEF1; TCF13L1; TEF-3; TEF3; TEFR-1; hRTEF-1B,TEA domain transcription factor 4,12p13.33,protein-coding,/
CWITA008946,TCMBANKGE008946,BLM,BS; MGRISCE1; RECQ2; RECQL2; RECQL3,BLM RecQ like helicase,15q26.1,protein-coding,/
CWITA008947,TCMBANKGE008947,MRPL35,L35mt; MRP-L35,mitochondrial ribosomal protein L35,2p11.2,protein-coding,/
CWITA008948,TCMBANKGE008948,VPS41,HVPS41; HVSP41; hVps41p,VPS41 subunit of HOPS complex,7p14.1,protein-coding,/
CWITA008949,TCMBANKGE008949,GRK7,GPRK7,G protein-coupled receptor kinase 7,3q23,protein-coding,/
CWITA008950,TCMBANKGE008950,FSTL3,FLRG; FSRP,follistatin like 3,19p13.3,protein-coding,Research target
CWITA008951,TCMBANKGE008951,CHRNA2,N,"cholinergic receptor, nicotinic, alpha 2 (neuronal)",8p21,protein-coding,
CWITA008952,TCMBANKGE008952,MAOB,MGC26382,monoamine oxidase B,Xp11.23,protein-coding,
CWITA008953,TCMBANKGE008953,ODF3L2,C19orf19,outer dense fiber of sperm tails 3 like 2,19p13.3,protein-coding,/
CWITA008954,TCMBANKGE008954,ZSCAN31,ZNF20-Lp; ZNF310P; ZNF323,zinc finger and SCAN domain containing 31,6p22.1|6p22.3-p22.1,protein-coding,/
CWITA008955,TCMBANKGE008955,LENG8,pp13842,leukocyte receptor cluster member 8,19q13.42,protein-coding,/
CWITA008956,TCMBANKGE008956,ILRUN,C6orf106; FP852; dJ391O22.4,inflammation and lipid regulator with UBA-like and NBR1-like domains,6p21.31,protein-coding,/
CWITA008957,TCMBANKGE008957,KCNH8,ELK; ELK1; Kv12.1; elk3,potassium voltage-gated channel subfamily H member 8,3p24.3,protein-coding,/
CWITA008958,TCMBANKGE008958,KCNJ15,IRKK; KIR1.3; KIR4.2,potassium inwardly rectifying channel subfamily J member 15,21q22.13-q22.2,protein-coding,/
CWITA008959,TCMBANKGE008959,LCLAT1,1AGPAT8; AGPAT8; ALCAT1; HSRG1849; LYCAT; UNQ1849,lysocardiolipin acyltransferase 1,2p23.1,protein-coding,/
CWITA008960,TCMBANKGE008960,CDK5RAP2,C48; Cep215; MCPH3,CDK5 regulatory subunit associated protein 2,9q33.2,protein-coding,/
CWITA008961,TCMBANKGE008961,THNSL2,SOFAT; THS2; TSH2,threonine synthase like 2,2p11.2,protein-coding,/
CWITA008962,TCMBANKGE008962,BHLHE22,BHLHB5; Beta3; Beta3a; CAGL85; TNRC20,basic helix-loop-helix family member e22,8q12.3,protein-coding,/
CWITA008963,TCMBANKGE008963,SLC10A5,P5,solute carrier family 10 member 5,8q21.13,protein-coding,/
CWITA008964,TCMBANKGE008964,NCF4,CGD3; NCF; P40PHOX; SH3PXD4,neutrophil cytosolic factor 4,22q12.3,protein-coding,/
CWITA008965,TCMBANKGE008965,CPEB4,CPE-BP4; hCPEB-4,cytoplasmic polyadenylation element binding protein 4,5q35.2,protein-coding,/
CWITA008966,TCMBANKGE008966,FZD6,FZ-6; FZ6; HFZ6; NDNC1; NDNC10,frizzled class receptor 6,8q22.3,protein-coding,/
CWITA008967,TCMBANKGE008967,SH2D5,-,SH2 domain containing 5,1p36.12,protein-coding,/
CWITA008968,TCMBANKGE008968,DOCK10,DRIP2; Nbla10300; ZIZ3,dedicator of cytokinesis 10,2q36.2,protein-coding,/
CWITA008969,TCMBANKGE008969,IAPP,DAP; IAP,islet amyloid polypeptide,12p12.1,protein-coding,Research target
CWITA008970,TCMBANKGE008970,MYBL1,A-MYB; AMYB,MYB proto-oncogene like 1,8q13.1,protein-coding,/
CWITA008971,TCMBANKGE008971,CARMIL1,CARMIL; CARMIL1a; LRRC16; LRRC16A; dJ501N12.1; dJ501N12.5,capping protein regulator and myosin 1 linker 1,6p22.2,protein-coding,/
CWITA008972,TCMBANKGE008972,ACSM1,BUCS1; MACS1,acyl-CoA synthetase medium chain family member 1,16p12.3,protein-coding,/
CWITA008973,TCMBANKGE008973,TRMT12,TRM12; TYW2,tRNA methyltransferase 12 homolog,8q24.13,protein-coding,/
CWITA008974,TCMBANKGE008974,CORO2B,CLIPINC,coronin 2B,15q23,protein-coding,/
CWITA008975,TCMBANKGE008975,CAPN14,-,calpain 14,2p23.1,protein-coding,/
CWITA008976,TCMBANKGE008976,DDX23,PRPF28; SNRNP100; U5-100K; U5-100KD; prp28,DEAD-box helicase 23,12q13.12,protein-coding,/
CWITA008977,TCMBANKGE008977,SPRY1,hSPRY1,sprouty RTK signaling antagonist 1,4q28.1,protein-coding,Research target
CWITA008978,TCMBANKGE008978,ESS2,DGCR13; DGCR14; DGS-H; DGS-I; DGSH; DGSI; ES2; ESS-2; Es2el; bis1,ess-2 splicing factor homolog,22q11.21|22q11.2,protein-coding,/
CWITA008979,TCMBANKGE008979,MAPKAPK3,3PK; MAPKAP3,mitogen-activated protein kinase-activated protein kinase 3,3p21.3,protein-coding,
CWITA008980,TCMBANKGE008980,POR,CPR; CYPOR; DKFZp686G04235; FLJ26468; P450R,P450 (cytochrome) oxidoreductase,7q11.2,protein-coding,
CWITA008981,TCMBANKGE008981,ZNF142,HA4654; NEDISHM; pHZ-49,zinc finger protein 142,2q35,protein-coding,/
CWITA008982,TCMBANKGE008982,ACSL1,ACS1; FACL1; FACL2; LACS; LACS1; LACS2,acyl-CoA synthetase long-chain family member 1,4q35,protein-coding,
CWITA008983,TCMBANKGE008983,NEDD9,CAS-L; CAS2; CASL; CASS2; HEF1,"neural precursor cell expressed, developmentally down-regulated 9",6p24.2,protein-coding,Research target
CWITA008984,TCMBANKGE008984,BCL7B,-,BAF chromatin remodeling complex subunit BCL7B,7q11.23,protein-coding,/
CWITA008985,TCMBANKGE008985,ANTKMT,ANT-KMT; C16orf24; FAM173A,adenine nucleotide translocase lysine methyltransferase,16p13.3,protein-coding,/
CWITA008986,TCMBANKGE008986,SLC16A11,MCT 11; MCT11,solute carrier family 16 member 11,17p13.1,protein-coding,/
CWITA008987,TCMBANKGE008987,SOBP,JXC1; MRAMS,sine oculis binding protein homolog,6q21,protein-coding,/
CWITA008988,TCMBANKGE008988,TMEM30A,C6orf67; CDC50A,transmembrane protein 30A,6q14.1,protein-coding,/
CWITA008989,TCMBANKGE008989,PRKAG3,AMPKG3,Protein_Kinase_Amp-Activated_Non-Catalytic_Subunit_Gamma_3,2q35,protein-coding,
CWITA008990,TCMBANKGE008990,MCM7,CDC47; MCM2; P1.1-MCM3; P1CDC47; P85MCM; PNAS146; PPP1R104,minichromosome maintenance complex component 7,7q22.1,protein-coding,Research target
CWITA008991,TCMBANKGE008991,ATG10,APG10; APG10L; pp12616,autophagy related 10,5q14.1-q14.2,protein-coding,/
CWITA008992,TCMBANKGE008992,NUDCD1,CML66; OVA66,NudC domain containing 1,8q23.1,protein-coding,/
CWITA008993,TCMBANKGE008993,IQSEC1,ARF-GEP100; ARFGEP100; BRAG2; GEP100; IDDSSBA,IQ motif and Sec7 domain ArfGEF 1,3p25.2-p25.1,protein-coding,/
CWITA008994,TCMBANKGE008994,LAD1,LadA,ladinin 1,1q32.1,protein-coding,/
CWITA008995,TCMBANKGE008995,EXD3,Nbr; mut-7,exonuclease 3'-5' domain containing 3,9q34.3,protein-coding,/
CWITA008996,TCMBANKGE008996,FAN1,KIAA1018; KMIN; MTMR15; hFAN1,FANCD2 and FANCI associated nuclease 1,15q13.3,protein-coding,/
CWITA008997,TCMBANKGE008997,NUDT1,MTH1,nudix hydrolase 1,7p22.3,protein-coding,/
CWITA008998,TCMBANKGE008998,ACADSB,2NMEBCAD; ACAD7; SBCAD,"acyl-CoA dehydrogenase, short/branched chain",10q26.13,protein-coding,
CWITA008999,TCMBANKGE008999,ASCC2,ASC1p100; p100,activating signal cointegrator 1 complex subunit 2,22q12.2,protein-coding,/
CWITA009000,TCMBANKGE009000,THNSL1,TSH1,threonine synthase like 1,10p12.1,protein-coding,/
CWITA009001,TCMBANKGE009001,GNMT,N,glycine N-methyltransferase,6p12,protein-coding,
CWITA009002,TCMBANKGE009002,IQGAP2,-,IQ motif containing GTPase activating protein 2,5q13.3,protein-coding,/
CWITA009003,TCMBANKGE009003,FOXA3,FKHH3; HNF3G; TCF3G,forkhead box A3,19q13.32,protein-coding,/
CWITA009004,TCMBANKGE009004,KRTAP9-9,KAP9.5; KAP9.9; KRTAP9-5; KRTAP9.9,keratin associated protein 9-9,17q21.2,protein-coding,/
CWITA009005,TCMBANKGE009005,CYP26A1,CP26; CYP26; P450RAI; P450RAI1,"cytochrome P450, family 26, subfamily A, polypeptide 1",10q23-q24,protein-coding,
CWITA009006,TCMBANKGE009006,C2orf81,hCG40743,chromosome 2 open reading frame 81,2p13.1,protein-coding,/
CWITA009007,TCMBANKGE009007,LAPTM5,CLAST6,lysosomal protein transmembrane 5,1p35.2,protein-coding,/
CWITA009008,TCMBANKGE009008,F11R,CD321; JAM; JAM1; JAMA; JCAM; KAT; PAM-1,F11 receptor,1q23.3,protein-coding,Research target
CWITA009009,TCMBANKGE009009,CAP1,CAP; CAP1-PEN,cyclase associated actin cytoskeleton regulatory protein 1,1p34.2,protein-coding,/
CWITA009010,TCMBANKGE009010,HPN,TMPRSS1,hepsin,19q13.11,protein-coding,Research target
CWITA009011,TCMBANKGE009011,MERTK,MER; MGC133349; RP38; cNmer,c-mer proto-oncogene tyrosine kinase,2q14.1,protein-coding,
CWITA009012,TCMBANKGE009012,ACAA1,ACAA; PTHIO; THIO,acetyl-CoA acyltransferase 1,3p22.2,protein-coding,/
CWITA009013,TCMBANKGE009013,PRKAG3,AMPKG3,protein kinase AMP-activated non-catalytic subunit gamma 3,2q35,protein-coding,/
CWITA009014,TCMBANKGE009014,MS4A1,B1; Bp35; CD20; CVID5; LEU-16; MS4A2; S7,membrane spanning 4-domains A1,11q12.2,protein-coding,Successful target
CWITA009015,TCMBANKGE009015,ABRA,STARS,actin binding Rho activating protein,8q23.1,protein-coding,/
CWITA009016,TCMBANKGE009016,SYN1,SYN1a; SYN1b; SYNI,synapsin I,Xp11.23,protein-coding,
CWITA009017,TCMBANKGE009017,ZNF532,-,zinc finger protein 532,18q21.32,protein-coding,/
CWITA009018,TCMBANKGE009018,RPS23,BTDD; MABAS; MCINS; PAMAS; S23; uS12,ribosomal protein S23,5q14.2,protein-coding,/
CWITA009019,TCMBANKGE009019,BCKDHA,BCKDE1A; FLJ45695; MSU; MSUD1; OVD1A,"Branched Chain Keto Acid Dehydrogenase E1, Alpha Polypeptide",19q13.1-q13.2,protein-coding,
CWITA009020,TCMBANKGE009020,CAMKV,1G5; VACAMKL,CaM kinase like vesicle associated,3p21.31,protein-coding,/
CWITA009021,TCMBANKGE009021,HLA-DQB1,CELIAC1; HLA-DQB; IDDM1,"major histocompatibility complex, class II, DQ beta 1",6p21.32,protein-coding,/
CWITA009022,TCMBANKGE009022,KLK9,KLK-L3; KLKL3,kallikrein related peptidase 9,19q13.41,protein-coding,/
CWITA009023,TCMBANKGE009023,PGAM2,GSD10; MGC88743; PGAMNM; PGAMM,phosphoglycerate mutase 2 (muscle),7p13-p12,protein-coding,
CWITA009024,TCMBANKGE009024,SLC52A1,GPCR42; GPR172B; PAR2; RBFVD; RFT1; RFVT1; hRFT1; huPAR-2,solute carrier family 52 member 1,17p13.2,protein-coding,/
CWITA009025,TCMBANKGE009025,CHRNB2,EFNL3; nAChRB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",1q21.3,protein-coding,
CWITA009026,TCMBANKGE009026,KCNC3,KSHIIID; KV3.3; SCA13,potassium voltage-gated channel subfamily C member 3,19q13.33,protein-coding,Research target
CWITA009027,TCMBANKGE009027,ABCB5,ABCB5alpha; ABCB5beta; EST422562,"ATP-binding cassette, sub-family B (MDR/TAP), member 5",7p21.1,protein-coding,
CWITA009028,TCMBANKGE009028,GPT,AAT1; ALT1; GPT1,glutamic-pyruvate transaminase (alanine aminotransferase),8q24.3,protein-coding,
CWITA009029,TCMBANKGE009029,ACTL9,HSD21,actin like 9,19p13.2,protein-coding,/
CWITA009030,TCMBANKGE009030,SERTAD4,DJ667H12.2,SERTA domain containing 4,1q32.2,protein-coding,/
CWITA009031,TCMBANKGE009031,PLA2G4E,-,phospholipase A2 group IVE,15q15.1,protein-coding,/
CWITA009032,TCMBANKGE009032,TAAR6,TA4; TAR4; TAR6; TRAR4; taR-4; taR-6,trace amine associated receptor 6,6q23.2,protein-coding,/
CWITA009033,TCMBANKGE009033,ABCB7,ABC7; ASAT; Atm1p; EST140535,ATP binding cassette subfamily B member 7,Xq13.3,protein-coding,/
CWITA009034,TCMBANKGE009034,FANCL,FAAP43; PHF9; POG,FA complementation group L,2p16.1,protein-coding,/
CWITA009035,TCMBANKGE009035,TAF8,II; TAF; TAF(II)43; TAFII-43; TAFII43; TBN,TATA-box binding protein associated factor 8,6p21.1,protein-coding,/
CWITA009036,TCMBANKGE009036,GPR19,-,G protein-coupled receptor 19,12p13.1,protein-coding,/
CWITA009037,TCMBANKGE009037,RUSC1,NESCA,RUN and SH3 domain containing 1,1q22,protein-coding,/
CWITA009038,TCMBANKGE009038,CPA1,CPA,carboxypeptidase A1,7q32.2,protein-coding,Research target
CWITA009039,TCMBANKGE009039,HBA1,CD31; MGC126895; MGC126897,"hemoglobin, alpha 1",16p13.3,protein-coding,
CWITA009040,TCMBANKGE009040,GRIA2,GLUR2; GLURB; GluA2; GluRNK2; HBGR2,"glutamate receptor, ionotropic, AMPA 2",4q32-q33,protein-coding,
CWITA009041,TCMBANKGE009041,ZNF492,ZNF115,zinc finger protein 492,19p12,protein-coding,/
CWITA009042,TCMBANKGE009042,ALDH3B1,ALDH4; ALDH7; FLJ26433; FLJ34710,"aldehyde dehydrogenase 3 family, member B1",11q13,protein-coding,
CWITA009043,TCMBANKGE009043,MIS18BP1,C14orf106; HSA242977; KNL2; M18BP1,MIS18 binding protein 1,14q21.2,protein-coding,/
CWITA009044,TCMBANKGE009044,NKIRAS2,KBRAS2; kappaB-Ras2,NFKB inhibitor interacting Ras like 2,17q21.2,protein-coding,/
CWITA009045,TCMBANKGE009045,TRAPPC6A,TRS33,trafficking protein particle complex 6A,19q13.32,protein-coding,/
CWITA009046,TCMBANKGE009046,ALDH7A1,ATQ1; EPD; PDE,aldehyde dehydrogenase 7 family member A1,5q23.2,protein-coding,/
CWITA009047,TCMBANKGE009047,CA11,CA-RP; CA-RP II; CA-XI; CARP-2; CARPX1,carbonic anhydrase 11,19q13.33,protein-coding,/
CWITA009048,TCMBANKGE009048,PTPN22,LYP; LYP1; LYP2; PEP; PTPN22.5; PTPN22.6; PTPN8,protein tyrosine phosphatase non-receptor type 22,1p13.2,protein-coding,/
CWITA009049,TCMBANKGE009049,SLC22A5,CDSP; FLJ46769; OCTN2; OCTN2VT,"solute carrier family 22 (organic cation/carnitine transporter), member 5",5q31,protein-coding,
CWITA009050,TCMBANKGE009050,NDUFS8,CIN23k; CI23KD; TYKY,"NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)",11q13,protein-coding,
CWITA009051,TCMBANKGE009051,PAICS,ADE2; ADE2H1; AIRC; PAIS,phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase,4q12,protein-coding,/
CWITA009052,TCMBANKGE009052,BHMT2,-,betaine--homocysteine S-methyltransferase 2,5q14.1,protein-coding,/
CWITA009053,TCMBANKGE009053,ACVR2A,ACTRII; ACVR2,activin A receptor type 2A,2q22.3-q23.1,protein-coding,Clinical Trial target
CWITA009054,TCMBANKGE009054,KCNK10,K2p10.1; PPP1R97; TREK-2; TREK2,potassium two pore domain channel subfamily K member 10,14q31.3,protein-coding,/
CWITA009055,TCMBANKGE009055,KIF11,EG5; HKSP; KNSL1; TRIP5,kinesin family member 11,10q24.1,protein-coding,
CWITA009056,TCMBANKGE009056,SLC6A15,NTT73; SBAT1; V7-3; hv7-3,solute carrier family 6 member 15,12q21.31,protein-coding,/
CWITA009057,TCMBANKGE009057,SIGMAR1,FLJ25585; MGC3851; OPRS1; SRNBP1; SRBP,sigma non-opioid intracellular receptor 1,9p13.3,protein-coding,
CWITA009058,TCMBANKGE009058,PIK3CA,MGC142161; MGC142163; PI3K; p110Nalpha,"phosphoinositide-3-kinase, catalytic, alpha polypeptide",3q26.3,protein-coding,
CWITA009059,TCMBANKGE009059,TMEM86B,-,transmembrane protein 86B,19q13.42,protein-coding,/
CWITA009060,TCMBANKGE009060,PCDHB11,ME2; PCDH-BETA11,protocadherin beta 11,5q31.3,protein-coding,/
CWITA009061,TCMBANKGE009061,PRPF40A,FBP-11; FBP11; FLAF1; FNBP3; HIP-10; HIP10; HYPA; NY-REN-6; Prp40,pre-mRNA processing factor 40 homolog A,2q23.3,protein-coding,/
CWITA009062,TCMBANKGE009062,GZF1,JLSM; ZBTB23; ZNF336,GDNF inducible zinc finger protein 1,20p11.21,protein-coding,/
CWITA009063,TCMBANKGE009063,ZBTB9,ZNF919,zinc finger and BTB domain containing 9,6p21.32,protein-coding,/
CWITA009064,TCMBANKGE009064,HTR1D,5NHT1D; HT1DA; HTR1DA; HTRL; RDC4,5-hydroxytryptamine (serotonin) receptor 1D,1p36.3-p34.3,protein-coding,
CWITA009065,TCMBANKGE009065,CRABP1,CRABP; CRABPNI; CRABPI; RBP5,cellular retinoic acid binding protein 1,15q24,protein-coding,
CWITA009066,TCMBANKGE009066,URM1,C9orf74,ubiquitin related modifier 1,9q34.11,protein-coding,/
CWITA009067,TCMBANKGE009067,SERINC2,FKSG84; PRO0899; TDE2; TDE2L,serine incorporator 2,1p35.2,protein-coding,/
CWITA009068,TCMBANKGE009068,PRKD1,CHDED; PKC-MU; PKCM; PKD; PRKCM,protein kinase D1,14q12,protein-coding,Research target
CWITA009069,TCMBANKGE009069,RPRD1A,HsT3101; P15RS,regulation of nuclear pre-mRNA domain containing 1A,18q12.2,protein-coding,/
CWITA009070,TCMBANKGE009070,PTP4A1,HH72; PRL-1; PRL1; PTP(CAAX1); PTPCAAX1,protein tyrosine phosphatase 4A1,6q12,protein-coding,Research target
CWITA009071,TCMBANKGE009071,BLVRB,BVRB; FLR; MGC117413; SDR43U1,biliverdin reductase B (flavin reductase (NADPH)),19q13.1-q13.2,protein-coding,
CWITA009072,TCMBANKGE009072,HEATR1,BAP28; UTP10,HEAT repeat containing 1,1q43,protein-coding,/
CWITA009073,TCMBANKGE009073,PTPRC,B220; CD45; CD45R; GP180; L-CA; LCA; LY5; T200,protein tyrosine phosphatase receptor type C,1q31.3-q32.1,protein-coding,Clinical Trial target
CWITA009074,TCMBANKGE009074,EBP,CDPX2; CHO2; CPX; CPXD; MEND,EBP cholestenol delta-isomerase,Xp11.23,protein-coding,Clinical Trial target
CWITA009075,TCMBANKGE009075,EFNA2,ELF-1; EPLG6; HEK7-L; LERK-6; LERK6,ephrin A2,19p13.3,protein-coding,/
CWITA009076,TCMBANKGE009076,ARHGEF18,P114-RhoGEF; RP78; SA-RhoGEF; p114RhoGEF,Rho/Rac guanine nucleotide exchange factor 18,19p13.2,protein-coding,/
CWITA009077,TCMBANKGE009077,SAAL1,SPACIA1,serum amyloid A like 1,11p15.1,protein-coding,/
CWITA009078,TCMBANKGE009078,AP4S1,AP47B; CLA20; CLAPS4; CPSQ6; SPG52,adaptor related protein complex 4 subunit sigma 1,14q12,protein-coding,/
CWITA009079,TCMBANKGE009079,IGSF6,DORA,immunoglobulin superfamily member 6,16p12.2,protein-coding,/
CWITA009080,TCMBANKGE009080,PMM2,CDG1; CDG1a; CDGS; PMI; PMI1; PMM 2,phosphomannomutase 2,16p13.2,protein-coding,/
CWITA009081,TCMBANKGE009081,TNNC2,N,troponin C type 2 (fast),20q12-q13.11,protein-coding,
CWITA009082,TCMBANKGE009082,HSPA4L,APG-1; HSPH3; Osp94,heat shock protein family A (Hsp70) member 4 like,4q28.1,protein-coding,/
CWITA009083,TCMBANKGE009083,APEH,AARE; ACPH; APH; D3F15S2; D3S48E; DNF15S2; OPH,acylaminoacyl-peptide hydrolase,3p21.31,protein-coding,Research target
CWITA009084,TCMBANKGE009084,CES3,ES31,carboxylesterase 3,16q22.1,protein-coding,/
CWITA009085,TCMBANKGE009085,OXR1,CHEGDD; Nbla00307; TLDC3,oxidation resistance 1,8q23.1,protein-coding,/
CWITA009086,TCMBANKGE009086,NAP1L2,BPX,nucleosome assembly protein 1 like 2,Xq13.2,protein-coding,/
CWITA009087,TCMBANKGE009087,DDO,DASOX; DDO-1; DDO-2; FLJ45203,D-Aspartate Oxidase,6q21,protein-coding,
CWITA009088,TCMBANKGE009088,KNL1,AF15Q14; CASC5; CT29; D40; MCPH4; PPP1R55; Spc7; hKNL-1; hSpc105,kinetochore scaffold 1,15q15.1,protein-coding,/
CWITA009089,TCMBANKGE009089,EXT1,EXT; LGCR; LGS; TRPS2; TTV,exostosin glycosyltransferase 1,8q24.11,protein-coding,/
CWITA009090,TCMBANKGE009090,OXCT1,OXCT; SCOT,3-oxoacid CoA transferase 1,5p13.1,protein-coding,
CWITA009091,TCMBANKGE009091,SDR16C5,EPHD-2; RDH#2; RDH-E2; RDHE2; retSDR2,short chain dehydrogenase/reductase family 16C member 5,8q12.1,protein-coding,/
CWITA009092,TCMBANKGE009092,F9,F9 p22; FIX; HEMB; P19; PTC; THPH8,coagulation factor IX,Xq27.1,protein-coding,Successful target
CWITA009093,TCMBANKGE009093,FAM209B,C20orf107; dJ1153D9.4,family with sequence similarity 209 member B,20q13.31,protein-coding,/
CWITA009094,TCMBANKGE009094,H2BC15,H2B/d; H2BFD; HIST1H2BN,H2B clustered histone 15,6p22.1,protein-coding,/
CWITA009095,TCMBANKGE009095,BHMT2,FLJ20001,betaine--homocysteine S-methyltransferase 2,5q13,protein-coding,
CWITA009096,TCMBANKGE009096,FLNA,ABP-280; ABPX; CSBS; CVD1; FGS2; FLN; FLN-A; FLN1; FMD; MNS; NHBP; OPD; OPD1; OPD2; XLVD; XMVD,Filamin_A,Xq28,protein-coding,
CWITA009097,TCMBANKGE009097,TMPRSS13,MSP; MSPL; MSPS; TMPRSS11,transmembrane serine protease 13,11q23.3,protein-coding,/
CWITA009098,TCMBANKGE009098,CDH11,CAD11; CDHOB; ESWS; OB; OSF-4,cadherin 11,16q21,protein-coding,Clinical Trial target
CWITA009099,TCMBANKGE009099,LRRC39,-,leucine rich repeat containing 39,1p21.2,protein-coding,/
CWITA009100,TCMBANKGE009100,TACSTD2,EGP-1; EGP1; GA733-1; GA7331; GP50; M1S1; TROP2,tumor associated calcium signal transducer 2,1p32.1,protein-coding,/
CWITA009101,TCMBANKGE009101,QSOX2,QSCN6L1; SOXN,quiescin sulfhydryl oxidase 2,9q34.3,protein-coding,/
CWITA009102,TCMBANKGE009102,CYSLTR2,CYSLT2; CYSLT2R; HG57; HPN321; KPG_011; hGPCR21,cysteinyl leukotriene receptor 2,13q14.2,protein-coding,
CWITA009103,TCMBANKGE009103,SNRPD1,HsT2456; SMD1; SNRPD; Sm-D1,small nuclear ribonucleoprotein D1 polypeptide,18q11.2,protein-coding,/
CWITA009104,TCMBANKGE009104,SWAP70,HSPC321; SWAP-70,switching B cell complex subunit SWAP70,11p15.4,protein-coding,/
CWITA009105,TCMBANKGE009105,CHRNB3,-,cholinergic receptor nicotinic beta 3 subunit,8p11.21,protein-coding,/
CWITA009106,TCMBANKGE009106,TTLL9,C20orf125,tubulin tyrosine ligase like 9,20q11.21,protein-coding,/
CWITA009107,TCMBANKGE009107,ACY3,ACY-3; HCBP1,aminoacylase 3,11q13.2,protein-coding,/
CWITA009108,TCMBANKGE009108,CEPT1,DKFZp313G0615; MGC45223,choline/ethanolamine phosphotransferase 1,1p13.3,protein-coding,
CWITA009109,TCMBANKGE009109,DDX21,GUA; GURDB; RH-II/GU; RH-II/GuA,DExD-box helicase 21,10q22.1,protein-coding,/
CWITA009110,TCMBANKGE009110,HPS5,AIBP63; BLOC2S2,HPS5 biogenesis of lysosomal organelles complex 2 subunit 2,11p15.1,protein-coding,/
CWITA009111,TCMBANKGE009111,HIF1AN,DKFZp762F1811; FIH1; FLJ20615; FLJ22027,"hypoxia inducible factor 1, alpha subunit inhibitor",10q24,protein-coding,
CWITA009112,TCMBANKGE009112,KCNN4,IK1; IKCA1; KCA4; KCa3.1; SK4; hIKCa1; hKCa4; hSK4,"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4",19q13.2,protein-coding,
CWITA009113,TCMBANKGE009113,GUCA1A,C6orf131; COD3; CORD14; GCAP; GCAP1; GUCA; GUCA1,guanylate cyclase activator 1A,6p21.1,protein-coding,/
CWITA009114,TCMBANKGE009114,TPPP3,CGI-38; TPPP/p20; p20; p25gamma,tubulin polymerization promoting protein family member 3,16q22.1,protein-coding,/
CWITA009115,TCMBANKGE009115,ACTR2,ARP2,ARP2 actin-related protein 2 homolog (yeast),2p14,protein-coding,
CWITA009116,TCMBANKGE009116,SAT1,DC21; KFSD; KFSDX; SAT; SSAT; SSATN1,spermidine/spermine N1-acetyltransferase 1,Xp22.1,protein-coding,
CWITA009117,TCMBANKGE009117,EMP2,XMP,epithelial membrane protein 2,16p13.13,protein-coding,/
CWITA009118,TCMBANKGE009118,MYLK2,KMLC; MLCK; MLCK2; skMLCK,myosin light chain kinase 2,20q13.31,protein-coding,
CWITA009119,TCMBANKGE009119,ME1,HUMNDME; MES,malic enzyme 1,6q14.2,protein-coding,/
CWITA009120,TCMBANKGE009120,LRP11,MANSC3; bA350J20.3,LDL receptor related protein 11,6q25.1,protein-coding,/
CWITA009121,TCMBANKGE009121,SLC22A11,MGC34282; OAT4; hOAT4,"solute carrier family 22 (organic anion/urate transporter), member 11",11q13.1,protein-coding,
CWITA009122,TCMBANKGE009122,MCFD2,F5F8D; F5F8D2; LMAN1IP; SDNSF,"multiple coagulation factor deficiency 2, ER cargo receptor complex subunit",2p21,protein-coding,/
CWITA009123,TCMBANKGE009123,SIPA1L3,CTRCT45; SPAL3; SPAR3,signal induced proliferation associated 1 like 3,19q13.13-q13.2,protein-coding,/
CWITA009124,TCMBANKGE009124,EIF5,EIF-5; EIF-5A,eukaryotic translation initiation factor 5,14q32.32,protein-coding,/
CWITA009125,TCMBANKGE009125,MCEMP1,C19orf59,mast cell expressed membrane protein 1,19p13.2,protein-coding,/
CWITA009126,TCMBANKGE009126,RPL37,DKFZp686G1699; L37; MGC99572,ribosomal protein L37,5p13,protein-coding,
CWITA009127,TCMBANKGE009127,BCL2A1,ACC-1; ACC-2; ACC1; ACC2; BCL2L5; BFL1; GRS; HBPA1,BCL2 related protein A1,15q25.1,protein-coding,Research target
CWITA009128,TCMBANKGE009128,CCL1,I-309; P500; SCYA1; SISe; TCA3,C-C motif chemokine ligand 1,17q12,protein-coding,/
CWITA009129,TCMBANKGE009129,TFF2,SML1; SP,trefoil factor 2,21q22.3,protein-coding,/
CWITA009130,TCMBANKGE009130,SLC38A11,AVT2,solute carrier family 38 member 11,2q24.3,protein-coding,/
CWITA009131,TCMBANKGE009131,EIF1B,GC20,eukaryotic translation initiation factor 1B,3p22.1,protein-coding,/
CWITA009132,TCMBANKGE009132,GLB1L,-,galactosidase beta 1 like,2q35,protein-coding,/
CWITA009133,TCMBANKGE009133,GDF9,POF14,growth differentiation factor 9,5q31.1,protein-coding,/
CWITA009134,TCMBANKGE009134,TPSB2,TPS2; tryptaseB; tryptaseC,tryptase beta 2 (gene/pseudogene),16p13.3,protein-coding,
CWITA009135,TCMBANKGE009135,ZNF211,C2H2-25; CH2H2-25; ZNF-25,zinc finger protein 211,19q13.43,protein-coding,/
CWITA009136,TCMBANKGE009136,MAP3K7CL,C21orf7; HC21ORF7; TAK1L; TAKL; TAKL-1; TAKL-2; TAKL-4,MAP3K7 C-terminal like,21q21.3,protein-coding,/
CWITA009137,TCMBANKGE009137,ZNF3,A8-51; HF.12; KOX25; PP838; Zfp113,zinc finger protein 3,7q22.1,protein-coding,/
CWITA009138,TCMBANKGE009138,HSPE1,CPN10; EPF; GROES; HSP10,heat shock protein family E (Hsp10) member 1,2q33.1,protein-coding,Clinical Trial target
CWITA009139,TCMBANKGE009139,TP73,P73,tumor protein p73,1p36.32,protein-coding,/
CWITA009140,TCMBANKGE009140,ZNF804A,C2orf10,zinc finger protein 804A,2q32.1,protein-coding,/
CWITA009141,TCMBANKGE009141,PRSS1,DKFZp779A0837; FLJ57296; MGC120175; MGC149362; TRP1; TRY1; TRY4; TRYP1,"protease, serine, 1 (trypsin 1)",7q32-qter|7q34,protein-coding,
CWITA009142,TCMBANKGE009142,SMARCA5,ISWI; SNF2H; WCRF135; hISWI; hSNF2H,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5",4q31.1-q31.2,protein-coding,
CWITA009143,TCMBANKGE009143,GLRA1,HKPX1; STHE,glycine receptor alpha 1,5q33.1,protein-coding,Successful target
CWITA009144,TCMBANKGE009144,LILRB3,CD85A; HL9; ILT-5; ILT5; LILRA6; LIR-3; LIR3; PIR-B; PIRB,leukocyte immunoglobulin like receptor B3,19q13.42,protein-coding,/
CWITA009145,TCMBANKGE009145,BAAT,BACAT; BAT; FLJ20300; MGC104432,bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase),9q22.3,protein-coding,
CWITA009146,TCMBANKGE009146,MED20,PRO0213; SRB2; TRFP,mediator complex subunit 20,6p21.1,protein-coding,/
CWITA009147,TCMBANKGE009147,IDO1,IDO; IDON1; INDO,"indoleamine 2,3-dioxygenase 1",8p12-p11,protein-coding,
CWITA009148,TCMBANKGE009148,FGR,SRC2; c-fgr; c-src2; p55-Fgr; p55c-fgr; p58-Fgr; p58c-fgr,"FGR proto-oncogene, Src family tyrosine kinase",1p35.3,protein-coding,Research target
CWITA009149,TCMBANKGE009149,AK7,AK 7; CFAP75; FAP75; SPGF27,adenylate kinase 7,14q32.2,protein-coding,/
CWITA009150,TCMBANKGE009150,ALAS2,ALASNE; ALASE; ANH1; ASB; FLJ93603; XLDPP; XLSA,"aminolevulinate, delta-, synthase 2",Xp11.21,protein-coding,
CWITA009151,TCMBANKGE009151,ZNF280C,SUHW3; ZNF633; ZPET,zinc finger protein 280C,Xq26.1,protein-coding,/
CWITA009152,TCMBANKGE009152,MMS22L,C6orf167; dJ39B17.2,"MMS22 like, DNA repair protein",6q16.1,protein-coding,/
CWITA009153,TCMBANKGE009153,FOXN3,C14orf116; CHES1; PRO1635,forkhead box N3,14q31.3-q32.11,protein-coding,/
CWITA009154,TCMBANKGE009154,ARFGAP2,IRZ; NBLA10535; ZFP289; ZNF289,ADP ribosylation factor GTPase activating protein 2,11p11.2,protein-coding,/
CWITA009155,TCMBANKGE009155,CHRNA5,LNCR2,cholinergic receptor nicotinic alpha 5 subunit,15q25.1,protein-coding,Research target
CWITA009156,TCMBANKGE009156,IGFBP5,IBP5,insulin like growth factor binding protein 5,2q35,protein-coding,Research target
CWITA009157,TCMBANKGE009157,ATL1,AD-FSP; FSP1; GBP3; HSN1D; SPG3; SPG3A; atlastin1,atlastin GTPase 1,14q22.1,protein-coding,/
CWITA009158,TCMBANKGE009158,ATG14,ATG14L; BARKOR; KIAA0831,autophagy related 14,14q22.3,protein-coding,/
CWITA009159,TCMBANKGE009159,RHOU,ARHU; CDC42L1; G28K; WRCH1; hG28K,ras homolog family member U,1q42.13,protein-coding,/
CWITA009160,TCMBANKGE009160,SYT16,CHR14SYT; SYT14L; Strep14; syt14r,synaptotagmin 16,14q23.2,protein-coding,/
CWITA009161,TCMBANKGE009161,LMAN2,C5orf8; GP36B; VIP36,"lectin, mannose binding 2",5q35.3,protein-coding,/
CWITA009162,TCMBANKGE009162,CDK17,PCTAIRE2; PCTK2,cyclin dependent kinase 17,12q23.1,protein-coding,/
CWITA009163,TCMBANKGE009163,LDHA,GSD11; LDH1; LDHM,lactate dehydrogenase A,11p15.4,protein-coding,
CWITA009164,TCMBANKGE009164,SH3D19,EBP; EVE1; Eve-1; Kryn; SH3P19,SH3 domain containing 19,4q31.3,protein-coding,/
CWITA009165,TCMBANKGE009165,TLX2,HOX11L1; NCX,T cell leukemia homeobox 2,2p13.1,protein-coding,/
CWITA009166,TCMBANKGE009166,CYP21A2,CA21H; CAH1; CPS1; CYP21; CYP21B; MGC150536; MGC150537; P450c21B,"cytochrome P450, family 21, subfamily A, polypeptide 2",6p21.3,protein-coding,
CWITA009167,TCMBANKGE009167,RGS21,-,regulator of G protein signaling 21,1q31.2,protein-coding,/
CWITA009168,TCMBANKGE009168,TNF,DIF; TNFNalpha; TNFA; TNFSF2,tumor necrosis factor,6p21.3,protein-coding,
CWITA009169,TCMBANKGE009169,GANC,FLJ40082; MGC138256,"glucosidase, alpha; neutral C",15q15.2,protein-coding,
CWITA009170,TCMBANKGE009170,DDX1,DBP-RB; UKVH5d,DEAD-box helicase 1,2p24.3,protein-coding,/
CWITA009171,TCMBANKGE009171,REEP1,C2orf23; HMN5B; SPG31; Yip2a,receptor accessory protein 1,2p11.2,protein-coding,/
CWITA009172,TCMBANKGE009172,TCFL5,CHA; E2BP-1; Figlb; SOSF1; bHLHe82,transcription factor like 5,20q13.33,protein-coding,/
CWITA009173,TCMBANKGE009173,BTNL8,BTN9.2,butyrophilin like 8,5q35.3,protein-coding,/
CWITA009174,TCMBANKGE009174,CARD8,CARDINAL; DACAR; DAKAR; NDPP; NDPP1; TUCAN,caspase recruitment domain family member 8,19q13.33,protein-coding,/
CWITA009175,TCMBANKGE009175,TCL1B,SYN-1; TML1,TCL1 family AKT coactivator B,14q32.13,protein-coding,/
CWITA009176,TCMBANKGE009176,VGF,SCG7; SgVII,VGF nerve growth factor inducible,7q22.1,protein-coding,/
CWITA009177,TCMBANKGE009177,CTHRC1,-,collagen triple helix repeat containing 1,8q22.3,protein-coding,/
CWITA009178,TCMBANKGE009178,RBM38,HSRNASEB; RNPC1; SEB4B; SEB4D; dJ800J21.2,RNA binding motif protein 38,20q13.31,protein-coding,/
CWITA009179,TCMBANKGE009179,COX8A,COX; COX8; COX8N2; COX8L; VIII; VIIINL,cytochrome c oxidase subunit VIIIA (ubiquitous),11q12-q13,protein-coding,
CWITA009180,TCMBANKGE009180,RAB12,-,"RAB12, member RAS oncogene family",18p11.22,protein-coding,/
CWITA009181,TCMBANKGE009181,L3MBTL1,H-L(3)MBT; L3MBTL; ZC2HC3; dJ138B7.3,L3MBTL histone methyl-lysine binding protein 1,20q13.12,protein-coding,/
CWITA009182,TCMBANKGE009182,SFTPB,PSP-B; SFTB3; SFTP3; SMDP1; SP-B,surfactant protein B,2p11.2,protein-coding,/
CWITA009183,TCMBANKGE009183,GCSH,GCE; NKH,glycine cleavage system protein H (aminomethyl carrier),16q23.2,protein-coding,
CWITA009184,TCMBANKGE009184,NSD2,KMT3F; KMT3G; MMSET; REIIBP; TRX5; WHS; WHSC1,nuclear receptor binding SET domain protein 2,4p16.3,protein-coding,/
CWITA009185,TCMBANKGE009185,MEFV,FMF; MEF; TRIM20,"MEFV innate immuity regulator, pyrin",16p13.3,protein-coding,/
CWITA009186,TCMBANKGE009186,PADI3,MGC126307; MGC126308; PAD3; PDI3,"peptidyl arginine deiminase, type III",1p36.13,protein-coding,
CWITA009187,TCMBANKGE009187,GCGR,GGR; GL-R,glucagon receptor,17q25.3,protein-coding,Clinical Trial target
CWITA009188,TCMBANKGE009188,COG8,CDG2H; DOR1,component of oligomeric golgi complex 8,16q22.1,protein-coding,/
CWITA009189,TCMBANKGE009189,TRIM49C,TRIM49L2,tripartite motif containing 49C,11q14.3,protein-coding,/
CWITA009190,TCMBANKGE009190,ALDH1A3,ALDH1A6; ALDH6; RALDH3,"aldehyde dehydrogenase 1 family, member A3",15q26.3,protein-coding,
CWITA009191,TCMBANKGE009191,EEF1AKMT2,C10orf138; Efm4; METTL10,EEF1A lysine methyltransferase 2,10q26.13,protein-coding,/
CWITA009192,TCMBANKGE009192,KIR3DL3,CD158Z; KIR3DL7; KIR44; KIRC1,"killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3",19q13.42,protein-coding,/
CWITA009193,TCMBANKGE009193,Serpina1c,Pi3; Pi6; Skalp; Spi1-3; Spi1-6; Wap3,"serine (or cysteine) peptidase inhibitor, clade A, member 1C",12 E|12 52.98 cM,protein-coding,/
CWITA009194,TCMBANKGE009194,KSR2,-,kinase suppressor of ras 2,12q24.22-q24.23,protein-coding,/
CWITA009195,TCMBANKGE009195,MME,CALLA; CD10; DKFZp686O16152; MGC126681; MGC126707; NEP; SFE,membrane metallo-endopeptidase,3q25.1-q25.2,protein-coding,
CWITA009196,TCMBANKGE009196,EPHB4,CMAVM2; HFASD; HTK; LMPHM7; MYK1; TYRO11,EPH receptor B4,7q22.1,protein-coding,Clinical Trial target
CWITA009197,TCMBANKGE009197,DAP,-,death associated protein,5p15.2,protein-coding,/
CWITA009198,TCMBANKGE009198,DENND5A,EIEE49; RAB6IP1,DENN domain containing 5A,11p15.4,protein-coding,/
CWITA009199,TCMBANKGE009199,NUDT10,APS2; DIPP3-alpha; DIPP3a,nudix hydrolase 10,Xp11.22,protein-coding,/
CWITA009200,TCMBANKGE009200,B4GALT5,B4Gal-T5; BETA4-GALT-IV; beta4Gal-T5; beta4GalT-V; gt-V,"beta-1,4-galactosyltransferase 5",20q13.13,protein-coding,/
CWITA009201,TCMBANKGE009201,P4HA1,P4HA,"prolyl 4-hydroxylase, alpha polypeptide I",10q21.3-q23.1,protein-coding,
CWITA009202,TCMBANKGE009202,CR1L,-,complement C3b/C4b receptor 1 like,1q32.2,protein-coding,/
CWITA009203,TCMBANKGE009203,SNX10,OPTB8,sorting nexin 10,7p15.2,protein-coding,/
CWITA009204,TCMBANKGE009204,MBTPS2,BRESEK; IFAP; KFSD; KFSDX; OI19; OLMSX; S2P,"membrane bound transcription factor peptidase, site 2",Xp22.12,protein-coding,/
CWITA009205,TCMBANKGE009205,XK,KX; NA; NAC; X1k; XKR1,X-Linked_Kx_Blood_Group,Xp21.1,protein-coding,
CWITA009206,TCMBANKGE009206,HEATR3,SYO1,HEAT repeat containing 3,16q12.1,protein-coding,/
CWITA009207,TCMBANKGE009207,DLG2,PPP1R58; PSD-93; PSD93; chapsyn-110,discs large MAGUK scaffold protein 2,11q14.1,protein-coding,/
CWITA009208,TCMBANKGE009208,TNFSF8,CD153; CD30L; CD30LG; TNLG3A,TNF superfamily member 8,9q32-q33.1,protein-coding,/
CWITA009209,TCMBANKGE009209,RPS2,LLREP3; S2,ribosomal protein S2,16p13.3,protein-coding,/
CWITA009210,TCMBANKGE009210,KRT15,CK15; K15; K1CO,keratin 15,17q21.2,protein-coding,/
CWITA009211,TCMBANKGE009211,PUM1,HSPUM; PUMH; PUMH1; PUML1; SCA47,pumilio RNA binding family member 1,1p35.2,protein-coding,/
CWITA009212,TCMBANKGE009212,PEF1,ABP32; PEF1A,penta-EF-hand domain containing 1,1p35.2,protein-coding,/
CWITA009213,TCMBANKGE009213,TAFA3,FAM19A3; TAFA-3,TAFA chemokine like family member 3,1p13.2,protein-coding,/
CWITA009214,TCMBANKGE009214,KCNJ5,CIR; GIRK4; KATP1; KIR3.4; LQT13,potassium inwardly rectifying channel subfamily J member 5,11q24.3,protein-coding,Clinical Trial target
CWITA009215,TCMBANKGE009215,IER3IP1,HSPC039; MEDS; PRO2309,immediate early response 3 interacting protein 1,18q21.1,protein-coding,/
CWITA009216,TCMBANKGE009216,CACNA2D1,CACNA2; CACNL2A; CCHL2A; LINC01112; lncRNA-N3,calcium voltage-gated channel auxiliary subunit alpha2delta 1,7q21.11,protein-coding,Successful target
CWITA009217,TCMBANKGE009217,LMO2,LMO-2; RBTN2; RBTNL1; RHOM2; TTG2,LIM domain only 2,11p13,protein-coding,Research target
CWITA009218,TCMBANKGE009218,ALDH5A1,SSADH; SSDH,"aldehyde dehydrogenase 5 family, member A1",6p22,protein-coding,
CWITA009219,TCMBANKGE009219,NDRG4,BDM1; SMAP-8; SMAP8,NDRG family member 4,16q21,protein-coding,/
CWITA009220,TCMBANKGE009220,SLC39A1,ZIP1; ZIRTL,solute carrier family 39 member 1,1q21.3,protein-coding,/
CWITA009221,TCMBANKGE009221,MATN3,DIPOA; EDM5; HOA; OADIP; OS2,matrilin 3,2p24.1,protein-coding,/
CWITA009222,TCMBANKGE009222,UBR7,C14orf130,ubiquitin protein ligase E3 component n-recognin 7,14q32.12,protein-coding,/
CWITA009223,TCMBANKGE009223,Dpml,-,dopamine loss,-,unknown,/
CWITA009224,TCMBANKGE009224,ATP5MPL,6.8PL; C14orf2; MLQ; MP68; PLPM,ATP synthase membrane subunit 6.8PL,14q32.33,protein-coding,/
CWITA009225,TCMBANKGE009225,RXRG,NR2B3; RXRC,"retinoid X receptor, gamma",1q22-q23,protein-coding,
CWITA009226,TCMBANKGE009226,FABP5,E-FABP; EFABP; KFABP; PA-FABP; PAFABP,fatty acid binding protein 5,8q21.13,protein-coding,Patented target
CWITA009227,TCMBANKGE009227,SELE,CD62E; ELAM; ELAM1; ESEL; LECAM2,selectin E,1q22-q25,protein-coding,
CWITA009228,TCMBANKGE009228,GPR151,GALR4; GALRL; GPCR; GPCR-2037; PGR7,G protein-coupled receptor 151,5q32,protein-coding,/
CWITA009229,TCMBANKGE009229,MSC,ABF-1; ABF1; MYOR; bHLHa22,musculin,8q13.3,protein-coding,/
CWITA009230,TCMBANKGE009230,UNC5CL,MUXA; ZUD,unc-5 family C-terminal like,6p21.1,protein-coding,/
CWITA009231,TCMBANKGE009231,MBD6,-,methyl-CpG binding domain protein 6,12q13.3,protein-coding,/
CWITA009232,TCMBANKGE009232,CHRNA3,LNCR2; MGC104879; NACHRA3; PAOD2,"cholinergic receptor, nicotinic, alpha 3",15q24,protein-coding,
CWITA009233,TCMBANKGE009233,DNLZ,C9orf151; HEP; HEP1; TIMM15; ZIM17; bA413M3.2,DNL-type zinc finger,9q34.3,protein-coding,/
CWITA009234,TCMBANKGE009234,COL7A1,EBD1; EBDCT; EBR1; NDNC8,collagen type VII alpha 1 chain,3p21.31,protein-coding,Research target
CWITA009235,TCMBANKGE009235,PCK1,MGC22652; PEPCKNC; PEPCK1; PEPCKC,phosphoenolpyruvate carboxykinase 1 (soluble),20q13.31,protein-coding,
CWITA009236,TCMBANKGE009236,SLC5A1,D22S675; NAGT; SGLT1,solute carrier family 5 member 1,22q12.3,protein-coding,Clinical Trial target
CWITA009237,TCMBANKGE009237,PIGK,GPI8; NEDHCAS,phosphatidylinositol glycan anchor biosynthesis class K,1p31.1,protein-coding,/
CWITA009238,TCMBANKGE009238,PSMC3IP,GT198; HOP2; HUMGT198A; ODG3; TBPIP,PSMC3 interacting protein,17q21.2,protein-coding,/
CWITA009239,TCMBANKGE009239,SRD5A3,CDG1P; CDG1Q; KRIZI; SRD5A2L; SRD5A2L1,steroid 5 alpha-reductase 3,4q12,protein-coding,/
CWITA009240,TCMBANKGE009240,SULT2B1,HSST2,"sulfotransferase family, cytosolic, 2B, member 1",19q13.3,protein-coding,
CWITA009241,TCMBANKGE009241,TRRAP,DEDDFA; DFNA75; PAF350/400; PAF400; STAF40; TR-AP; Tra1,transformation/transcription domain associated protein,7q22.1,protein-coding,/
CWITA009242,TCMBANKGE009242,ASB6,-,ankyrin repeat and SOCS box containing 6,9q34.11,protein-coding,/
CWITA009243,TCMBANKGE009243,IQCH,NYDSP5,IQ motif containing H,15q23,protein-coding,/
CWITA009244,TCMBANKGE009244,CTDSP1,NIF3; NLI-IF; NLIIF; SCP1,CTD small phosphatase 1,2q35,protein-coding,/
CWITA009245,TCMBANKGE009245,NOXO1,P41NOX; P41NOXA; P41NOXB; P41NOXC; SH3PXD5; SNX28,NADPH oxidase organizer 1,16p13.3,protein-coding,/
CWITA009246,TCMBANKGE009246,ASL,ASAL,argininosuccinate lyase,7cen-q11.2,protein-coding,
CWITA009247,TCMBANKGE009247,RUVBL2,ECP51; INO80J; REPTIN; RVB2; TIH2; TIP48; TIP49B,RuvB-like 2 (E. coli),19q13.3,protein-coding,
CWITA009248,TCMBANKGE009248,TNIP3,ABIN-3; LIND,TNFAIP3 interacting protein 3,4q27,protein-coding,/
CWITA009249,TCMBANKGE009249,FAM169A,SLAP75,family with sequence similarity 169 member A,5q13.3,protein-coding,/
CWITA009250,TCMBANKGE009250,ASNS,ASNSD; TS11,asparagine synthetase (glutamine-hydrolyzing),7q21.3,protein-coding,/
CWITA009251,TCMBANKGE009251,PRSS50,CT20; TSP50,serine protease 50,3p21.31,protein-coding,/
CWITA009252,TCMBANKGE009252,PNMT,PENT; PNMTase,phenylethanolamine N-methyltransferase,17q12,protein-coding,Research target
CWITA009253,TCMBANKGE009253,GPR139,GPRg1; PGR3,G protein-coupled receptor 139,16p12.3,protein-coding,Clinical Trial target
CWITA009254,TCMBANKGE009254,ARPC1A,Arc40; HEL-68; HEL-S-307; SOP2Hs; SOP2L,actin related protein 2/3 complex subunit 1A,7q22.1,protein-coding,/
CWITA009255,TCMBANKGE009255,COQ2,CL640; COQ10D1; MSA1; PHB:PPT,"coenzyme Q2, polyprenyltransferase",4q21.22-q21.23,protein-coding,/
CWITA009256,TCMBANKGE009256,SLC6A2,NAT1; NET; NET1; SLC6A5,solute carrier family 6 member 2,16q12.2,protein-coding,Successful target
CWITA009257,TCMBANKGE009257,PUS10,CCDC139; DOBI; Hup10,pseudouridine synthase 10,2p16.1-p15,protein-coding,/
CWITA009258,TCMBANKGE009258,CYP2B6,CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; IIB1; P450,"cytochrome P450, family 2, subfamily B, polypeptide 6",19q13.2,protein-coding,
CWITA009259,TCMBANKGE009259,ATXN7L2,-,ataxin 7 like 2,1p13.3,protein-coding,/
CWITA009260,TCMBANKGE009260,WDSUB1,UBOX6; WDSAM1,"WD repeat, sterile alpha motif and U-box domain containing 1",2q24.2,protein-coding,/
CWITA009261,TCMBANKGE009261,SLC27A4,ACSVL4; FATP4; IPS,solute carrier family 27 member 4,9q34.11,protein-coding,Research target
CWITA009262,TCMBANKGE009262,ZSCAN12,ZFP96; ZNF29K1; ZNF305; ZNF96; dJ29K1.2,zinc finger and SCAN domain containing 12,6p22.1,protein-coding,/
CWITA009263,TCMBANKGE009263,IL12RB2,-,interleukin 12 receptor subunit beta 2,1p31.3,protein-coding,Research target
CWITA009264,TCMBANKGE009264,RPSA,37LRP; 67LR; ICAS; LAMBR; LAMR1; LBP; LBP/p40; LRP; LRP/LR; NEM/1CHD4; SA; lamR; p40,ribosomal protein SA,3p22.1,protein-coding,Patented target
CWITA009265,TCMBANKGE009265,MEIS2,CPCMR; HsT18361; MRG1,Meis homeobox 2,15q14,protein-coding,/
CWITA009266,TCMBANKGE009266,JDP2,JUNDM2,Jun dimerization protein 2,14q24.3,protein-coding,/
CWITA009267,TCMBANKGE009267,GRB10,GRB-IR; Grb-10; IRBP; MEG1; RSS,growth factor receptor bound protein 10,7p12.1,protein-coding,/
CWITA009268,TCMBANKGE009268,CTC1,AAF-132; AAF132; C17orf68; CRMCC; tmp494178,CST telomere replication complex component 1,17p13.1,protein-coding,/
CWITA009269,TCMBANKGE009269,CYCS,CYC; HCS; THC4,"cytochrome c, somatic",7p15.3,protein-coding,
CWITA009270,TCMBANKGE009270,ADORA1,RDC7,adenosine A1 receptor,1q32.1,protein-coding,
CWITA009271,TCMBANKGE009271,TULP4,TUSP,TUB like protein 4,6q25.3,protein-coding,/
CWITA009272,TCMBANKGE009272,TCEAL9,WBP5; WEX6,transcription elongation factor A like 9,Xq22.2,protein-coding,/
CWITA009273,TCMBANKGE009273,SLC1A5,AAAT; ASCT2; ATBO; M7V1; M7VS1; R16; RDRC,solute carrier family 1 member 5,19q13.32,protein-coding,Research target
CWITA009274,TCMBANKGE009274,TGIF1,HPE4; TGIF,TGFB induced factor homeobox 1,18p11.31,protein-coding,/
CWITA009275,TCMBANKGE009275,CYP27C1,-,cytochrome P450 family 27 subfamily C member 1,2q14.3,protein-coding,/
CWITA009276,TCMBANKGE009276,TSBP1,C6orf10; TSBP,testis expressed basic protein 1,6p21.32,protein-coding,/
CWITA009277,TCMBANKGE009277,DRGX,DRG11; PRRXL1,dorsal root ganglia homeobox,10q11.23,protein-coding,/
CWITA009278,TCMBANKGE009278,POLE3,CHARAC17; CHRAC17; CHRAC2; YBL1; p17,"DNA polymerase epsilon 3, accessory subunit",9q32,protein-coding,/
CWITA009279,TCMBANKGE009279,PLEKHF2,EAPF; PHAFIN2; ZFYVE18,pleckstrin homology and FYVE domain containing 2,8q22.1,protein-coding,/
CWITA009280,TCMBANKGE009280,HTR2B,5NHT(2B); 5NHT2B,5-hydroxytryptamine (serotonin) receptor 2B,2q36.3-q37.1,protein-coding,
CWITA009281,TCMBANKGE009281,UBE2J1,CGI-76; HSPC153; HSPC205; HSU93243; NCUBE-1; NCUBE1; UBC6; UBC6E; Ubc6p,ubiquitin conjugating enzyme E2 J1,6q15,protein-coding,/
CWITA009282,TCMBANKGE009282,NNT,MGC126502; MGC126503,nicotinamide nucleotide transhydrogenase,5p12,protein-coding,
CWITA009283,TCMBANKGE009283,SACS,ARSACS; DNAJC29; PPP1R138; SPAX6,sacsin molecular chaperone,13q12.12,protein-coding,/
CWITA009284,TCMBANKGE009284,MDH2,MNMDH; MDH; MGC:3559; MOR1,"malate dehydrogenase 2, NAD (mitochondrial)",7cen-q22,protein-coding,
CWITA009285,TCMBANKGE009285,NMNAT1,LCA9; NMNAT; PNAT1,nicotinamide nucleotide adenylyltransferase 1,1p36.22,protein-coding,/
CWITA009286,TCMBANKGE009286,SETDB1,ESET; H3-K9-HMTase4; KG1T; KMT1E; TDRD21,SET domain bifurcated histone lysine methyltransferase 1,1q21.3,protein-coding,/
CWITA009287,TCMBANKGE009287,CSH1,CS-1; CSA; CSMT; GHB3; PL; hCS-1; hCS-A,chorionic somatomammotropin hormone 1,17q23.3,protein-coding,/
CWITA009288,TCMBANKGE009288,ERC1,Cast2; ELKS; ERC-1; RAB6IP2,ELKS/RAB6-interacting/CAST family member 1,12p13.33,protein-coding,/
CWITA009289,TCMBANKGE009289,TMEM71,-,transmembrane protein 71,8q24.22,protein-coding,/
CWITA009290,TCMBANKGE009290,KHDC4,BLOM7; KIAA0907; SNORA80EHG,"KH domain containing 4, pre-mRNA splicing factor",1q22,protein-coding,/
CWITA009291,TCMBANKGE009291,CDKL1,KKIALRE; P42,cyclin dependent kinase like 1,14q21.3,protein-coding,Research target
CWITA009292,TCMBANKGE009292,TNFRSF10B,CD262; DR5; KILLER; KILLER/DR5; TRAIL-R2; TRAILR2; TRICK2; TRICK2A; TRICK2B; TRICKB; ZTNFR9,"Tumor Necrosis Factor Receptor Superfamily, Member 10B",8p22-p21,protein-coding,
CWITA009293,TCMBANKGE009293,PLEKHA7,-,pleckstrin homology domain containing A7,11p15.2-p15.1,protein-coding,/
CWITA009294,TCMBANKGE009294,HTR3A,5-HT-3; 5-HT3A; 5-HT3R; 5HT3R; HTR3,5-hydroxytryptamine receptor 3A,11q23.2,protein-coding,Successful target
CWITA009295,TCMBANKGE009295,ZNF529,-,zinc finger protein 529,19q13.12,protein-coding,/
CWITA009296,TCMBANKGE009296,ESCO2,2410004I17Rik; EFO2; EFO2p; RBS; hEFO2,establishment of sister chromatid cohesion N-acetyltransferase 2,8p21.1,protein-coding,/
CWITA009297,TCMBANKGE009297,GML,LY6DL,glycosylphosphatidylinositol anchored molecule like,8q24.3,protein-coding,/
CWITA009298,TCMBANKGE009298,HLA-DMA,D6S222E; DMA; HLADM; RING6,"major histocompatibility complex, class II, DM alpha",6p21.32,protein-coding,/
CWITA009299,TCMBANKGE009299,SMG8,C17orf71,SMG8 nonsense mediated mRNA decay factor,17q22,protein-coding,/
CWITA009300,TCMBANKGE009300,THBS4,TSP-4; TSP4,thrombospondin 4,5q14.1,protein-coding,/
CWITA009301,TCMBANKGE009301,ARRDC4,-,arrestin domain containing 4,15q26.2,protein-coding,/
CWITA009302,TCMBANKGE009302,PPOX,PPO; V290M; VP,protoporphyrinogen oxidase,1q23.3,protein-coding,Successful target
CWITA009303,TCMBANKGE009303,RNF125,TNORS; TRAC-1; TRAC1,ring finger protein 125,18q12.1,protein-coding,/
CWITA009304,TCMBANKGE009304,FDFT1,DGPT; ERG9; SQS; SQSD; SS,farnesyl-diphosphate farnesyltransferase 1,8p23.1,protein-coding,Discontinued target
CWITA009305,TCMBANKGE009305,RPL36A-HNRNPH2,-,RPL36A-HNRNPH2 readthrough,Xq22.1,protein-coding,/
CWITA009306,TCMBANKGE009306,ACVRL1,ACVRLK1; ALKN1; ALK1; HHT; HHT2; ORW2; SKR3; TSRNI,activin A receptor type II-like 1,12q11-q14,protein-coding,
CWITA009307,TCMBANKGE009307,ERVK-18,HERV-K18; PR; Protease; Proteinase; c1_C; env,endogenous retrovirus group K member 18,1q23.3,other,/
CWITA009308,TCMBANKGE009308,RPL11,DBA7; GIG34; L11; uL5,ribosomal protein L11,1p36.11,protein-coding,/
CWITA009309,TCMBANKGE009309,ERVK-8,ERVK8; HERV-K115; PR; Protease; Proteinase; envK6,"endogenous retrovirus group K member 8, envelope",8p23.1,other,/
CWITA009310,TCMBANKGE009310,CELA2A,AOMS4; ELA2A; PE-1,chymotrypsin like elastase 2A,1p36.21,protein-coding,/
CWITA009311,TCMBANKGE009311,SP5,-,Sp5 transcription factor,2q31.1,protein-coding,/
CWITA009312,TCMBANKGE009312,THOC6,WDR58; fSAP35,THO complex 6,16p13.3,protein-coding,/
CWITA009313,TCMBANKGE009313,CERT1,CERT; CERTL; COL4A3BP; GPBP; MRD34; STARD11,ceramide transporter 1,5q13.3,protein-coding,/
CWITA009314,TCMBANKGE009314,NDST1,HSST; NST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,5q33.1,protein-coding,
CWITA009315,TCMBANKGE009315,SNORA73A,E1; E1-7; E1b; RNE1; RNU17A; U17A,"small nucleolar RNA, H/ACA box 73A",1p35.3,snoRNA,/
CWITA009316,TCMBANKGE009316,KRT6B,CK-6B; CK6B; K6B; KRTL1; PC2; PC4,keratin 6B,12q13.13,protein-coding,/
CWITA009317,TCMBANKGE009317,PSMB7,Z,"proteasome (prosome, macropain) subunit, beta type, 7",9q34.11-q34.12,protein-coding,
CWITA009318,TCMBANKGE009318,HS2ST1,dJ604K5.2,heparan sulfate 2-O-sulfotransferase 1,1p22.3,protein-coding,/
CWITA009319,TCMBANKGE009319,GPR61,BALGR; GPCR3,G protein-coupled receptor 61,1p13.3,protein-coding,/
CWITA009320,TCMBANKGE009320,KLC2,-,kinesin light chain 2,11q13.2,protein-coding,/
CWITA009321,TCMBANKGE009321,DUSP21,LMWDSP21,dual specificity phosphatase 21,Xp11.3,protein-coding,/
CWITA009322,TCMBANKGE009322,IL3RA,CD123; IL3R; IL3RAY; IL3RX; IL3RY; hIL-3Ra,interleukin 3 receptor subunit alpha,Xp22.33 and Yp11.2,protein-coding,Successful target
CWITA009323,TCMBANKGE009323,FGF5,HBGF-5; Smag-82; TCMGLY,fibroblast growth factor 5,4q21.21,protein-coding,/
CWITA009324,TCMBANKGE009324,ABCA6,EST155051,ATP binding cassette subfamily A member 6,17q24.2-q24.3,protein-coding,/
CWITA009325,TCMBANKGE009325,PARP2,ADPRT2; ADPRTL2; ADPRTL3; ARTD2; PARP-2; pADPRT-2,poly(ADP-ribose) polymerase 2,14q11.2,protein-coding,Patented target
CWITA009326,TCMBANKGE009326,KYAT1,CCBL1; GTK; KAT1; KATI,Kynurenine_Aminotransferase_1,9q34.11,protein-coding,
CWITA009327,TCMBANKGE009327,GSTO1,GSTO 1-1; GSTTLp28; HEL-S-21; P28; SPG-R,glutathione S-transferase omega 1,10q25.1,protein-coding,Research target
CWITA009328,TCMBANKGE009328,PNPLA7,C9orf111; NTE-R1; NTEL1,patatin like phospholipase domain containing 7,9q34.3,protein-coding,/
CWITA009329,TCMBANKGE009329,FCN3,FCNH; HAKA1,ficolin 3,1p36.11,protein-coding,/
CWITA009330,TCMBANKGE009330,PTGER3,EP3; EP3NI; EP3NII; EP3NIII; EP3NIV; EP3e; MGC141828; MGC141829; MGC27302,prostaglandin E receptor 3 (subtype EP3),1p31.2,protein-coding,
CWITA009331,TCMBANKGE009331,ZC3HAV1,ARTD13; FLB6421; PARP13; ZAP; ZC3H2; ZC3HDC2,"zinc finger CCCH-type containing, antiviral 1",7q34,protein-coding,/
CWITA009332,TCMBANKGE009332,COQ10B,-,coenzyme Q10B,2q33.1,protein-coding,/
CWITA009333,TCMBANKGE009333,TUBA1B,K-ALPHA-1,tubulin alpha 1b,12q13.12,protein-coding,/
CWITA009334,TCMBANKGE009334,SDC2,CD362; HSPG; HSPG1; SYND2,syndecan 2,8q22.1,protein-coding,Research target
CWITA009335,TCMBANKGE009335,MICAL1,MICAL; MICAL-1; NICAL,"microtubule associated monooxygenase, calponin and LIM domain containing 1",6q21,protein-coding,/
CWITA009336,TCMBANKGE009336,HIBADH,NS5ATP1,3-hydroxyisobutyrate dehydrogenase,7p15.2,protein-coding,/
CWITA009337,TCMBANKGE009337,FTSJ1,CDLIV; JM23; MRX44; MRX9; SPB1; TRMT7,FtsJ RNA 2'-O-methyltransferase 1,Xp11.23,protein-coding,/
CWITA009338,TCMBANKGE009338,RHOG,ARHG,ras homolog family member G,11p15.4,protein-coding,/
CWITA009339,TCMBANKGE009339,BCHE,CHE1; E1,butyrylcholinesterase,3q26.1-q26.2,protein-coding,
CWITA009340,TCMBANKGE009340,STX8,CARB,syntaxin 8,17p13.1,protein-coding,/
CWITA009341,TCMBANKGE009341,PACS1,MRD17; SHMS,phosphofurin acidic cluster sorting protein 1,11q13.1-q13.2,protein-coding,/
CWITA009342,TCMBANKGE009342,F10,FX; FXA,coagulation factor X,13q34,protein-coding,Successful target
CWITA009343,TCMBANKGE009343,CABP2,DFNB93,calcium binding protein 2,11q13.2,protein-coding,/
CWITA009344,TCMBANKGE009344,SYCE1L,MRP2,synaptonemal complex central element protein 1 like,16q23.1,protein-coding,/
CWITA009345,TCMBANKGE009345,CRYZ,DKFZp779E0834; FLJ41475,"crystallin, zeta (quinone reductase)",1p31-p22,protein-coding,
CWITA009346,TCMBANKGE009346,TAS2R20,T2R20; T2R49; T2R56; TAS2R49,taste 2 receptor member 20,12p13.2,protein-coding,/
CWITA009347,TCMBANKGE009347,YY2,ZNF631,YY2 transcription factor,Xp22.12,protein-coding,/
CWITA009348,TCMBANKGE009348,ELP4,AN; AN2; C11orf19; PAX6NEB; PAXNEB; dJ68P15A.1; hELP4,elongator acetyltransferase complex subunit 4,11p13,protein-coding,/
CWITA009349,TCMBANKGE009349,ANPEP,APN; CD13; GP150; LAP1; P150; PEPN,alanyl (membrane) aminopeptidase,15q25-q26,protein-coding,
CWITA009350,TCMBANKGE009350,RHBDD1,RHBDL4; RRP4,rhomboid domain containing 1,2q36.3,protein-coding,/
CWITA009351,TCMBANKGE009351,FZD2,Fz2; OMOD2; fz-2; fzE2; hFz2,frizzled class receptor 2,17q21.31,protein-coding,/
CWITA009352,TCMBANKGE009352,SPART,SPG20; TAHCCP1,spartin,13q13.3,protein-coding,/
CWITA009353,TCMBANKGE009353,ACTB,PS1TP5BP1,"actin, beta",7p22,protein-coding,
CWITA009354,TCMBANKGE009354,PIGA,GPI3; MCAHS2; PIG-A; PNH1,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2,protein-coding,/
CWITA009355,TCMBANKGE009355,ACOXL,-,acyl-CoA oxidase like,2q13,protein-coding,/
CWITA009356,TCMBANKGE009356,CA7,CA-VII; CAVII,carbonic anhydrase 7,16q22.1,protein-coding,Patented target
CWITA009357,TCMBANKGE009357,CCT3,CCT-gamma; CCTG; PIG48; TCP-1-gamma; TRIC5,chaperonin containing TCP1 subunit 3,1q22,protein-coding,/
CWITA009358,TCMBANKGE009358,MMP15,MMP-15; MT2-MMP; MT2MMP; MTMMP2; SMCP-2,matrix metallopeptidase 15,16q21,protein-coding,Research target
CWITA009359,TCMBANKGE009359,VCAN,CSPG2; ERVR; GHAP; PG-M; WGN; WGN1,versican,5q14.2-q14.3,protein-coding,/
CWITA009360,TCMBANKGE009360,KBTBD11,KLHDC7C,kelch repeat and BTB domain containing 11,8p23.3,protein-coding,/
CWITA009361,TCMBANKGE009361,GPT,AAT1; ALT1; GPT1,glutamic--pyruvic transaminase,8q24.3,protein-coding,/
CWITA009362,TCMBANKGE009362,ASPRV1,MUNO; SASP; SASPase; Taps,aspartic peptidase retroviral like 1,2p13.3,protein-coding,/
CWITA009363,TCMBANKGE009363,RNF41,FLRF; NRDP1; SBBI03,ring finger protein 41,12q13.3,protein-coding,/
CWITA009364,TCMBANKGE009364,TEFM,C17orf42,"transcription elongation factor, mitochondrial",17q11.2,protein-coding,/
CWITA009365,TCMBANKGE009365,SNX27,MRT1; MY014,sorting nexin 27,1q21.3,protein-coding,/
CWITA009366,TCMBANKGE009366,FBN2,CCA; DA9; EOMD,Fibrillin_2,5q23.3,protein-coding,
CWITA009367,TCMBANKGE009367,DDB1,DDBA; UV-DDB1; XAP1; XPCE; XPE; XPE-BF,damage specific DNA binding protein 1,11q12.2,protein-coding,/
CWITA009368,TCMBANKGE009368,USF1,FCHL; FCHL1; HYPLIP1; MLTF; MLTFI; UEF; bHLHb11,upstream transcription factor 1,1q23.3,protein-coding,/
CWITA009369,TCMBANKGE009369,PPP2R5E,B56E; B56epsilon,protein phosphatase 2 regulatory subunit B'epsilon,14q23.2,protein-coding,/
CWITA009370,TCMBANKGE009370,LYPLA1,APT-1; APT1; LPL-I; LPL1; hAPT1,lysophospholipase 1,8q11.23,protein-coding,/
CWITA009371,TCMBANKGE009371,PCLAF,KIAA0101; L5; NS5ATP9; OEATC; OEATC-1; OEATC1; PAF; PAF15; p15(PAF); p15/PAF; p15PAF,PCNA clamp associated factor,15q22.31,protein-coding,/
CWITA009372,TCMBANKGE009372,GALC,-,galactosylceramidase,14q31.3,protein-coding,Research target
CWITA009373,TCMBANKGE009373,MMP8,CLG1; HNC; MMP-8; PMNL-CL,matrix metallopeptidase 8,11q22.2,protein-coding,Clinical Trial target
CWITA009374,TCMBANKGE009374,PCDHA12,PCDH-ALPHA12,protocadherin alpha 12,5q31.3,protein-coding,/
CWITA009375,TCMBANKGE009375,IFI27L1,FAM14B; ISG12C,interferon alpha inducible protein 27 like 1,14q32.12,protein-coding,/
CWITA009376,TCMBANKGE009376,IRGC,CINEMA; IRGC1; Iigp5; R30953_1,"immunity-related GTPase family, cinema",19q13.31,protein-coding,
CWITA009377,TCMBANKGE009377,SCN3A,KIAA1356; NAC3; Nav1.3,"sodium channel, voltage-gated, type III, alpha subunit",2q24,protein-coding,
CWITA009378,TCMBANKGE009378,ZAK,AZK; MLK7; MLT; MLTK; MRK; mlklak; pk,sterile alpha motif and leucine zipper containing kinase AZK,2q24.2,protein-coding,
CWITA009379,TCMBANKGE009379,LAMP5,BAD-LAMP; BADLAMP; C20orf103; LAMP-5; UNC-46,lysosomal associated membrane protein family member 5,20p12.2,protein-coding,/
CWITA009380,TCMBANKGE009380,C8G,C8C; MGC142186,"complement component 8, gamma polypeptide",9q34.3,protein-coding,
CWITA009381,TCMBANKGE009381,RARS1,ArgRS; DALRD1; HLD9; RARS,arginyl-tRNA synthetase 1,5q34,protein-coding,/
CWITA009382,TCMBANKGE009382,ZBTB44,BTBD15; HSPC063; ZNF851,zinc finger and BTB domain containing 44,11q24.3,protein-coding,/
CWITA009383,TCMBANKGE009383,KCNJ2,ATFB9; HHBIRK1; HHIRK1; IRK1; KIR2.1; LQT7; SQT3,potassium inwardly rectifying channel subfamily J member 2,17q24.3,protein-coding,Research target
CWITA009384,TCMBANKGE009384,CYB561D2,101F6; TSP10; XXcos-LUCA11.4,cytochrome b561 family member D2,3p21.31,protein-coding,/
CWITA009385,TCMBANKGE009385,CD200R1L,CD200R2; CD200RLa,CD200 receptor 1 like,3q13.2,protein-coding,/
CWITA009386,TCMBANKGE009386,AAMP,-,angio associated migratory cell protein,2q35,protein-coding,/
CWITA009387,TCMBANKGE009387,TAS2R19,MSTP058; T2R19; T2R23; T2R48; TAS2R23; TAS2R48,taste 2 receptor member 19,12p13.2,protein-coding,/
CWITA009388,TCMBANKGE009388,UNC5B,UNC5H2; p53RDL1,unc-5 netrin receptor B,10q22.1,protein-coding,/
CWITA009389,TCMBANKGE009389,LYZ,LYZF1; LZM,lysozyme,12q15,protein-coding,Research target
CWITA009390,TCMBANKGE009390,NDUFAF5,C20orf7; MC1DN16; bA526K24.2; dJ842G6.1,NADH:ubiquinone oxidoreductase complex assembly factor 5,20p12.1,protein-coding,/
CWITA009391,TCMBANKGE009391,ARHGEF39,C9orf100,Rho guanine nucleotide exchange factor 39,9p13.3,protein-coding,/
CWITA009392,TCMBANKGE009392,ZNF682,BC39498_3,zinc finger protein 682,19p12,protein-coding,/
CWITA009393,TCMBANKGE009393,ADCY4,AC4,adenylate cyclase 4,14q12,protein-coding,/
CWITA009394,TCMBANKGE009394,CBY1,C22orf2; CBY; Chibby1; HS508I15A; PGEA1; PIGEA-14; PIGEA14; arb1,"chibby family member 1, beta catenin antagonist",22q13.1,protein-coding,/
CWITA009395,TCMBANKGE009395,SLC7A8,LAT2; LPINPC1,"solute carrier family 7 (amino acid transporter, L-type), member 8",14q11.2,protein-coding,
CWITA009396,TCMBANKGE009396,COL9A3,DJ885L7.4.1; EDM3; IDD; MED,collagen type IX alpha 3 chain,20q13.33,protein-coding,/
CWITA009397,TCMBANKGE009397,DAB2,DOC-2; DOC2,DAB adaptor protein 2,5p13.1,protein-coding,/
CWITA009398,TCMBANKGE009398,SLC40A1,FPN1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3,solute carrier family 40 member 1,2q32.2,protein-coding,Clinical Trial target
CWITA009399,TCMBANKGE009399,TEDC1,C14orf80,tubulin epsilon and delta complex 1,14q32.33,protein-coding,/
CWITA009400,TCMBANKGE009400,GNAS,AHO; C20orf45; GNAS1; GPSA; GSA; GSP; NESP; PITA3; POH; SCG6; SgVI,GNAS complex locus,20q13.32,protein-coding,/
CWITA009401,TCMBANKGE009401,ERP44,PDIA10; TXNDC4,endoplasmic reticulum protein 44,9q31.1,protein-coding,/
CWITA009402,TCMBANKGE009402,KIF3A,FLA10; KLP-20,kinesin family member 3A,5q31.1,protein-coding,/
CWITA009403,TCMBANKGE009403,KCNF1,IK8; KCNF; KV5.1; kH1,potassium voltage-gated channel modifier subfamily F member 1,2p25.1,protein-coding,/
CWITA009404,TCMBANKGE009404,PTAFR,PAFR,platelet-activating factor receptor,1p35-p34.3,protein-coding,
CWITA009405,TCMBANKGE009405,KRT6A,CK-6C; CK-6E; CK6A; CK6C; CK6D; K6A; K6C; K6D; KRT6C; KRT6D; PC3,keratin 6A,12q13.13,protein-coding,Clinical Trial target
CWITA009406,TCMBANKGE009406,SEC61G,SSS1,SEC61 translocon subunit gamma,7p11.2,protein-coding,/
CWITA009407,TCMBANKGE009407,TYK2,IMD35; JTK1,tyrosine kinase 2,19p13.2,protein-coding,Clinical Trial target
CWITA009408,TCMBANKGE009408,FGFR3,ACH; CD333; CEK2; HSFGFR3EX; JTK4,fibroblast growth factor receptor 3,4p16.3,protein-coding,
CWITA009409,TCMBANKGE009409,COL4A1,BSVD; BSVD1; COL4A1s; PADMAL; RATOR,collagen type IV alpha 1 chain,13q34,protein-coding,/
CWITA009410,TCMBANKGE009410,NPR1,ANPRA; ANPa; GUC2A; GUCY2A; NPRA,natriuretic peptide receptor 1,1q21.3,protein-coding,Successful target
CWITA009411,TCMBANKGE009411,SKA1,C18orf24,spindle and kinetochore associated complex subunit 1,18q21.1,protein-coding,/
CWITA009412,TCMBANKGE009412,C6,-,complement C6,5p13.1,protein-coding,/
CWITA009413,TCMBANKGE009413,ZNF251,-,zinc finger protein 251,8q24.3,protein-coding,/
CWITA009414,TCMBANKGE009414,NMRAL2P,NMRAL1P1,"NmrA like redox sensor 2, pseudogene",3q27.2,pseudo,/
CWITA009415,TCMBANKGE009415,SUPT4H1,SPT4; SPT4H; SUPT4H; Supt4a,"SPT4 homolog, DSIF elongation factor subunit",17q22,protein-coding,/
CWITA009416,TCMBANKGE009416,GTF2E2,FE; TF2E2; TFIIE-B; TTD6,general transcription factor IIE subunit 2,8p12,protein-coding,/
CWITA009417,TCMBANKGE009417,PPFIBP2,Cclp1,PPFIA binding protein 2,11p15.4,protein-coding,/
CWITA009418,TCMBANKGE009418,C17orf75,NJMU-R1; SRI2,chromosome 17 open reading frame 75,17q11.2,protein-coding,/
CWITA009419,TCMBANKGE009419,PIGB,EIEE80; GPI-MT-III; PIG-B,phosphatidylinositol glycan anchor biosynthesis class B,15q21.3,protein-coding,/
CWITA009420,TCMBANKGE009420,F2RL3,PAR4,F2R like thrombin or trypsin receptor 3,19p13.11,protein-coding,Research target
CWITA009421,TCMBANKGE009421,PPIG,CARSNCyp; CYP; MGC133241; SCAF10; SRCyp,peptidylprolyl isomerase G (cyclophilin G),2q31.1,protein-coding,
CWITA009422,TCMBANKGE009422,PJA2,Neurodap1; RNF131,praja ring finger ubiquitin ligase 2,5q21.3,protein-coding,/
CWITA009423,TCMBANKGE009423,USP54,C10orf29; bA137L10.3; bA137L10.4,ubiquitin specific peptidase 54,10q22.2,protein-coding,/
CWITA009424,TCMBANKGE009424,IL4I1,FIG1,interleukin 4 induced 1,19q13.3-q13.4,protein-coding,
CWITA009425,TCMBANKGE009425,SYT5,-,synaptotagmin 5,19q13.42|11p,protein-coding,/
CWITA009426,TCMBANKGE009426,RMND1,C6orf96; COXPD11; RMD1; bA351K16; bA351K16.3,required for meiotic nuclear division 1 homolog,6q25.1,protein-coding,/
CWITA009427,TCMBANKGE009427,ATP8A1,ATPASEII; ATPIA; ATPP2; MGC130042; MGC130043; MGC26327,"ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1",4p13,protein-coding,
CWITA009428,TCMBANKGE009428,RBM41,-,RNA binding motif protein 41,Xq22.3,protein-coding,/
CWITA009429,TCMBANKGE009429,CRISPLD1,CRISP-10; CRISP10; LCRISP1,cysteine rich secretory protein LCCL domain containing 1,8q21.13,protein-coding,/
CWITA009430,TCMBANKGE009430,SDHD,CBT1; PGL; PGL1; SDH4,"succinate dehydrogenase complex, subunit D, integral membrane protein",11q23,protein-coding,
CWITA009431,TCMBANKGE009431,BNIP1,NIP1; SEC20; TRG-8,BCL2 interacting protein 1,5q35.1,protein-coding,/
CWITA009432,TCMBANKGE009432,SLC39A14,HCIN; HMNDYT2; LZT-Hs4; NET34; ZIP14; cig19,solute carrier family 39 member 14,8p21.3,protein-coding,/
CWITA009433,TCMBANKGE009433,GABRE,N,"gamma-aminobutyric acid (GABA) A receptor, epsilon",Xq28,protein-coding,
CWITA009434,TCMBANKGE009434,SNX1,HsT17379; VPS5,sorting nexin 1,15q22.31,protein-coding,/
CWITA009435,TCMBANKGE009435,PPP1R12A,GUBS; M130; MBS; MYPT1,protein phosphatase 1 regulatory subunit 12A,12q21.2-q21.31,protein-coding,/
CWITA009436,TCMBANKGE009436,SLC41A3,SLC41A1-L2,solute carrier family 41 member 3,3q21.2-q21.3,protein-coding,/
CWITA009437,TCMBANKGE009437,SHMT1,CSHMT; MGC15229; MGC24556; SHMT,serine hydroxymethyltransferase 1 (soluble),17p11.2,protein-coding,
CWITA009438,TCMBANKGE009438,PTGDS,L-PGDS; LPGDS; PDS; PGD2; PGDS; PGDS2,prostaglandin D2 synthase,9q34.3,protein-coding,/
CWITA009439,TCMBANKGE009439,FCRLA,FCRL; FCRL1; FCRLM1; FCRLX; FCRLb; FCRLc1; FCRLc2; FCRLd; FCRLe; FCRX; FREB,Fc receptor like A,1q23.3,protein-coding,/
CWITA009440,TCMBANKGE009440,PGAP1,Bst1; ISPD3024; MRT42; SPG67,post-GPI attachment to proteins inositol deacylase 1,2q33.1,protein-coding,/
CWITA009441,TCMBANKGE009441,Far2os1,Gm16583,"fatty acyl CoA reductase 2, opposite strand 1",6|6 78.49 cM,ncRNA,/
CWITA009442,TCMBANKGE009442,Hsp84-2,84kDa; Hsp90; hsp2,"heat shock protein, 2",-,other,/
CWITA009443,TCMBANKGE009443,GPKOW,GPATC5; GPATCH5; Mos2; Spp2; T54,G-patch domain and KOW motifs,Xp11.23,protein-coding,/
CWITA009444,TCMBANKGE009444,CENPP,CENP-P,centromere protein P,9q22.31,protein-coding,/
CWITA009445,TCMBANKGE009445,BIRC5,API4; EPRN1,baculoviral IAP repeat containing 5,17q25,protein-coding,
CWITA009446,TCMBANKGE009446,DHRS12,SDR40C1,dehydrogenase/reductase 12,13q14.3,protein-coding,/
CWITA009447,TCMBANKGE009447,DDX4,VASA,DEAD-box helicase 4,5q11.2,protein-coding,/
CWITA009448,TCMBANKGE009448,DDX10,Dbp4; HRH-J8,DEAD-box helicase 10,11q22.3,protein-coding,/
CWITA009449,TCMBANKGE009449,AMY2A,AMY2; AMY2B; PA,"amylase, alpha 2A (pancreatic)",1p21,protein-coding,
CWITA009450,TCMBANKGE009450,TBL1Y,DFNY2; TBL1,transducin beta like 1 Y-linked,Yp11.2,protein-coding,/
CWITA009451,TCMBANKGE009451,AKR7A2,AFAR; AFAR1; AFB1-AR1; AKR7,aldo-keto reductase family 7 member A2,1p36.13,protein-coding,/
CWITA009452,TCMBANKGE009452,MGAT4A,GNT-IV; GNT-IVA; GnT-4a,"alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A",2q11.2,protein-coding,/
CWITA009453,TCMBANKGE009453,CYREN,C7orf49; MRI; MRI-2,cell cycle regulator of NHEJ,7q33,protein-coding,/
CWITA009454,TCMBANKGE009454,TP53BP2,53BP2; ASPP2; BBP; P53BP2; PPP1R13A,tumor protein p53 binding protein 2,1q41,protein-coding,/
CWITA009455,TCMBANKGE009455,CHRM5,HM5,cholinergic receptor muscarinic 5,15q14,protein-coding,Successful target
CWITA009456,TCMBANKGE009456,PNRC1,B4-2; PNAS-145; PROL2; PRR2,proline rich nuclear receptor coactivator 1,6q15,protein-coding,/
CWITA009457,TCMBANKGE009457,HRH3,GPCR97; HH3R,histamine receptor H3,20q13.33,protein-coding,
CWITA009458,TCMBANKGE009458,MST1R,CD136; CDw136; NPCA3; PTK8; RON; SEA,macrophage stimulating 1 receptor,3p21.31,protein-coding,Clinical Trial target
CWITA009459,TCMBANKGE009459,TMTC3,LIS8; SMILE,transmembrane O-mannosyltransferase targeting cadherins 3,12q21.32,protein-coding,/
CWITA009460,TCMBANKGE009460,PLOD3,LH3,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",7q22.1,protein-coding,/
CWITA009461,TCMBANKGE009461,GALT,-,galactose-1-phosphate uridylyltransferase,9p13.3,protein-coding,/
CWITA009462,TCMBANKGE009462,ANXA7,ANX7; SNX; SYNEXIN,annexin A7,10q22.2,protein-coding,/
CWITA009463,TCMBANKGE009463,PLEKHA4,PEPP1,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4",19q13.33,protein-coding,
CWITA009464,TCMBANKGE009464,EFL1,EFTUD1; FAM42A; HsT19294; RIA1; SDS2,Elongation_Factor_Like_Gtpase_1,15q25.2,protein-coding,
CWITA009465,TCMBANKGE009465,SENP1,SuPr-2,SUMO specific peptidase 1,12q13.11,protein-coding,Research target
CWITA009466,TCMBANKGE009466,SARS2,FLJ20450; SARS; SARSM; SERS; SYS; SerRS; SerRSmt; mtSerRS,"Seryl-Trna Synthetase 2, Mitochondrial",19q13.2,protein-coding,
CWITA009467,TCMBANKGE009467,TNFSF11,CD254; ODF; OPGL; OPTB2; RANKL; TRANCE; hRANKL2; sOdf,"tumor necrosis factor (ligand) superfamily, member 11",13q14,protein-coding,
CWITA009468,TCMBANKGE009468,DXO,DOM3L; DOM3Z; NG6; RAI1,decapping exoribonuclease,6p21.33,protein-coding,/
CWITA009469,TCMBANKGE009469,DGUOK,MTDPS3; NCPH; PEOB4; dGK,deoxyguanosine kinase,2p13.1,protein-coding,/
CWITA009470,TCMBANKGE009470,THAP10,-,THAP domain containing 10,15q23,protein-coding,/
CWITA009471,TCMBANKGE009471,LNPEP,CAP; IRAP; P-LAP; PLAP,Leucyl/Cystinyl Aminopeptidase,5q15,protein-coding,
CWITA009472,TCMBANKGE009472,AKR1B10,AKR1B11; AKR1B12; ALDRLn; ARL-1; ARL1; HIS; HSI,aldo-keto reductase family 1 member B10,7q33,protein-coding,/
CWITA009473,TCMBANKGE009473,NR0B1,AHC; AHCH; AHX; DAXN1; DAX1; DSS; GTD; HHG; NROB1,"nuclear receptor subfamily 0, group B, member 1",Xp21.3,protein-coding,
CWITA009474,TCMBANKGE009474,RAB1B,-,"RAB1B, member RAS oncogene family",11q13.2,protein-coding,/
CWITA009475,TCMBANKGE009475,NAB1,-,NGFI-A binding protein 1,2q32.2,protein-coding,/
CWITA009476,TCMBANKGE009476,NPY5R,NPY5-R; NPYR5; NPYY5-R,neuropeptide Y receptor Y5,4q32.2,protein-coding,Discontinued target
CWITA009477,TCMBANKGE009477,KIF18A,MS-KIF18A; PPP1R99,kinesin family member 18A,11p14.1,protein-coding,/
CWITA009478,TCMBANKGE009478,MYO5B,-,myosin VB,18q21.1,protein-coding,/
CWITA009479,TCMBANKGE009479,ITPR3,IP3R; IP3R3,"inositol 1,4,5-trisphosphate receptor type 3",6p21.31,protein-coding,Research target
CWITA009480,TCMBANKGE009480,SCG3,SGIII,secretogranin III,15q21.2,protein-coding,Research target
CWITA009481,TCMBANKGE009481,GFOD2,-,glucose-fructose oxidoreductase domain containing 2,16q22.1,protein-coding,/
CWITA009482,TCMBANKGE009482,CD40LG,CD154; CD40L; HIGM1; IGM; IMD3; T-BAM; TNFSF5; TRAP; gp39; hCD40L,CD40 ligand,Xq26.3,protein-coding,Research target
CWITA009483,TCMBANKGE009483,BHLHE41,BHLHB3; DEC2; FNSS1; SHARP1; hDEC2,basic helix-loop-helix family member e41,12p12.1,protein-coding,/
CWITA009484,TCMBANKGE009484,INTS13,ASUN; C12orf11; GCT1; Mat89Bb; NET48; SPATA30,integrator complex subunit 13,12p11.23,protein-coding,/
CWITA009485,TCMBANKGE009485,KCNT2,EIEE57; KCa4.2; SLICK; SLO2.1,potassium sodium-activated channel subfamily T member 2,1q31.3,protein-coding,Clinical Trial target
CWITA009486,TCMBANKGE009486,CHMP5,C9orf83; CGI-34; HSPC177; PNAS-2; SNF7DC2; Vps60,charged multivesicular body protein 5,9p13.3,protein-coding,/
CWITA009487,TCMBANKGE009487,THEM6,C8orf55; DSCD75,thioesterase superfamily member 6,8q24.3,protein-coding,/
CWITA009488,TCMBANKGE009488,AURKA,AIK; ARK1; AURA; AURORA2; BTAK; MGC34538; STK15; STK6; STK7,aurora kinase A,20q13,protein-coding,
CWITA009489,TCMBANKGE009489,ARHGEF28,RGNEF; RIP2; p190RHOGEF,Rho guanine nucleotide exchange factor 28,5q13.2,protein-coding,/
CWITA009490,TCMBANKGE009490,TPK1,HTPK1; PP20,thiamin pyrophosphokinase 1,7q34-q35,protein-coding,
CWITA009491,TCMBANKGE009491,CEP19,C3orf34; MOSPGF,centrosomal protein 19,3q29,protein-coding,/
CWITA009492,TCMBANKGE009492,HOXA10,HOX1; HOX1.8; HOX1H; PL,homeobox A10,7p15.2,protein-coding,/
CWITA009493,TCMBANKGE009493,IGSF1,CHTE; IGCD1; IGDC1; INHBP; PGSF2; p120,immunoglobulin superfamily member 1,Xq26.1,protein-coding,/
CWITA009494,TCMBANKGE009494,ARID3B,BDP; DRIL2,AT-rich interaction domain 3B,15q24.1,protein-coding,/
CWITA009495,TCMBANKGE009495,MASP1,3MC1; CRARF; CRARF1; MAP1; MASP; MASP3; MAp44; PRSS5; RaRF,mannan binding lectin serine peptidase 1,3q27.3,protein-coding,/
CWITA009496,TCMBANKGE009496,C11orf68,BLES03; P5326,chromosome 11 open reading frame 68,11q13.1,protein-coding,/
CWITA009497,TCMBANKGE009497,EFCAB8,-,EF-hand calcium binding domain 8,20q11.21,protein-coding,/
CWITA009498,TCMBANKGE009498,ASPA,ACY2; ASP,aspartoacylase,17p13.2,protein-coding,/
CWITA009499,TCMBANKGE009499,GINS3,PSF3,GINS complex subunit 3,16q21,protein-coding,/
CWITA009500,TCMBANKGE009500,ZC2HC1A,C8orf70; CGI-62; FAM164A,zinc finger C2HC-type containing 1A,8q21.13,protein-coding,/
CWITA009501,TCMBANKGE009501,LIME1,LIME; dJ583P15.4,Lck interacting transmembrane adaptor 1,20q13.33,protein-coding,/
CWITA009502,TCMBANKGE009502,AQP11,AQPX1,aquaporin 11,11q14.1,protein-coding,/
CWITA009503,TCMBANKGE009503,GALNT15,GALNACT15; GALNT13; GALNT7; GALNTL2; PIH5; pp-GalNAc-T15,polypeptide N-acetylgalactosaminyltransferase 15,3p25.1,protein-coding,/
CWITA009504,TCMBANKGE009504,SND1,TDRD11; Tudor-SN; p100,staphylococcal nuclease and tudor domain containing 1,7q32.1,protein-coding,/
CWITA009505,TCMBANKGE009505,ERMP1,FXNA; KIAA1815; bA207C16.3,endoplasmic reticulum metallopeptidase 1,9p24.1,protein-coding,/
CWITA009506,TCMBANKGE009506,ENAH,ENA; MENA; NDPP1,ENAH actin regulator,1q42.12,protein-coding,Research target
CWITA009507,TCMBANKGE009507,Rdh18-ps,Rdh18,"retinol dehydrogenase 18, pseudogene",10|10 D3,pseudo,/
CWITA009508,TCMBANKGE009508,S100P,MIG9,S100 calcium binding protein P,4p16,protein-coding,
CWITA009509,TCMBANKGE009509,NPIPB4,61E3.4,nuclear pore complex interacting protein family member B4,16p12.2,protein-coding,/
CWITA009510,TCMBANKGE009510,PODXL,Gp200; PC; PCLP; PCLP-1,podocalyxin like,7q32.3,protein-coding,/
CWITA009511,TCMBANKGE009511,CAMK1D,CKLiK; CaM-K1; CaMKID,calcium/calmodulin dependent protein kinase ID,10p13,protein-coding,/
CWITA009512,TCMBANKGE009512,TMEM47,BCMP1; TM4SF10; VAB-9,transmembrane protein 47,Xp21.1,protein-coding,/
CWITA009513,TCMBANKGE009513,PCDHGC3,PC43; PCDH-GAMMA-C3; PCDH2,"protocadherin gamma subfamily C, 3",5q31.3,protein-coding,/
CWITA009514,TCMBANKGE009514,MMP7,MMPN7; MPSL1; PUMPN1,"matrix metallopeptidase 7 (matrilysin, uterine)",11q21-q22,protein-coding,
CWITA009515,TCMBANKGE009515,NRG2,DON1; HRG2; NTAK,neuregulin 2,5q31.2,protein-coding,/
CWITA009516,TCMBANKGE009516,COQ3,DHHBMT; DHHBMTASE; UG0215E05; bA9819.1,"coenzyme Q3, methyltransferase",6q16.2,protein-coding,/
CWITA009517,TCMBANKGE009517,GCNT3,C2/4GnT; C24GNT; C2GNT2; C2GNTM; GNTM,"glucosaminyl (N-acetyl) transferase 3, mucin type",15q22.2,protein-coding,/
CWITA009518,TCMBANKGE009518,TAP1,ABC17; ABCB2; APT1; D6S114E; PSF-1; PSF1; RING4; TAP1*0102N; TAP1N,"transporter 1, ATP binding cassette subfamily B member",6p21.32,protein-coding,Research target
CWITA009519,TCMBANKGE009519,EVI5,EVI-5; NB4S,ecotropic viral integration site 5,1p22.1,protein-coding,/
CWITA009520,TCMBANKGE009520,GRM8,FLJ41058; GLUR8; GPRC1H; MGC126724; MGLUR8; mGlu8,"glutamate receptor, metabotropic 8",7q31.3-q32.1,protein-coding,
CWITA009521,TCMBANKGE009521,PDE4B,DKFZp686F2182; DPDE4; MGC126529; PDE4B5; PDEIVB,"phosphodiesterase 4B, cAMP-specific",1p31,protein-coding,
CWITA009522,TCMBANKGE009522,MEGF9,EGFL5,multiple EGF like domains 9,9q33.2,protein-coding,/
CWITA009523,TCMBANKGE009523,Lrdg2,-,light induced retinal degeneration 2,4 74.75 cM,unknown,/
CWITA009524,TCMBANKGE009524,NOP58,HSPC120; NOP5; NOP5/NOP58,NOP58 ribonucleoprotein,2q33.1,protein-coding,/
CWITA009525,TCMBANKGE009525,PI4K2A,PI4KII; PIK42A,phosphatidylinositol 4-kinase type 2 alpha,10q24.2,protein-coding,/
CWITA009526,TCMBANKGE009526,PMEPA1,STAG1; TMEPAI,"prostate transmembrane protein, androgen induced 1",20q13.31,protein-coding,/
CWITA009527,TCMBANKGE009527,GADL1,ADC; CSADC; HuADC; HuCSADC,glutamate decarboxylase like 1,3p24.1-p23,protein-coding,/
CWITA009528,TCMBANKGE009528,CSNK1G2,CK1g2,"casein kinase 1, gamma 2",19p13.3,protein-coding,
CWITA009529,TCMBANKGE009529,SELENOT,SELT,selenoprotein T,3q25.1,protein-coding,/
CWITA009530,TCMBANKGE009530,GLRB,HKPX2,glycine receptor beta,4q32.1,protein-coding,/
CWITA009531,TCMBANKGE009531,HRAS,CNBAS/HAS; CNHNRAS; CNHANRAS1; CTLO; HNRASIDX; HAMSV; HRAS1; KNRAS; NNRAS; RASH1,v-Ha-ras Harvey rat sarcoma viral oncogene homolog,11p15.5,protein-coding,
CWITA009532,TCMBANKGE009532,ABCA17P,ABCA17,"ATP binding cassette subfamily A member 17, pseudogene",16p13.3,pseudo,/
CWITA009533,TCMBANKGE009533,OLFM1,AMY; NOE1; NOELIN1; OlfA,Olfactomedin_1,9q34.3,protein-coding,
CWITA009534,TCMBANKGE009534,SLC18A2,MGC120477; MGC120478; MGC26538; SVAT; SVMT; VAT2; VMAT2,"solute carrier family 18 (vesicular monoamine), member 2",10q25,protein-coding,
CWITA009535,TCMBANKGE009535,USP47,TRFP,ubiquitin specific peptidase 47,11p15.3,protein-coding,/
CWITA009536,TCMBANKGE009536,GALNT13,GalNAc-T13,polypeptide N-acetylgalactosaminyltransferase 13,2q23.3-q24.1,protein-coding,/
CWITA009537,TCMBANKGE009537,ISL1,ISLET1; Isl-1,ISL LIM homeobox 1,5q11.1,protein-coding,/
CWITA009538,TCMBANKGE009538,SMIM11A,C21orf51; FAM165B; SMIM11; SMIM11B,small integral membrane protein 11A,21q22.11-q22.12,protein-coding,/
CWITA009539,TCMBANKGE009539,KCNK6,FLJ12282; K2p6.1; KCNK8; TOSS; TWIKN2; TWIK2,"potassium channel, subfamily K, member 6",19q13.1,protein-coding,
CWITA009540,TCMBANKGE009540,ITGB4,CD104; GP150,integrin subunit beta 4,17q25.1,protein-coding,/
CWITA009541,TCMBANKGE009541,TRIT1,COXPD35; GRO1; IPPT; IPT; IPTase; MOD5; hGRO1,tRNA isopentenyltransferase 1,1p34.2,protein-coding,/
CWITA009542,TCMBANKGE009542,TXNDC12,AG1; AGR1; ERP16; ERP18; ERP19; PDIA16; TLP19; hAG-1; hTLP19,thioredoxin domain containing 12,1p32.3,protein-coding,Research target
CWITA009543,TCMBANKGE009543,LTA,LT; TNFB; TNFSF1; TNLG1E,lymphotoxin alpha,6p21.33,protein-coding,Clinical Trial target
CWITA009544,TCMBANKGE009544,DIP2C,KIAA0934,disco interacting protein 2 homolog C,10p15.3,protein-coding,/
CWITA009545,TCMBANKGE009545,ERAS,HRAS2; HRASP,ES cell expressed Ras,Xp11.23,protein-coding,/
CWITA009546,TCMBANKGE009546,NOXA1,NY-CO-31; SDCCAG31; p51NOX,NADPH oxidase activator 1,9q34.3,protein-coding,/
CWITA009547,TCMBANKGE009547,PDK3,N,"pyruvate dehydrogenase kinase, isozyme 3",Xp22.11,protein-coding,
CWITA009548,TCMBANKGE009548,UTP20,1A6/DRIM; DRIM,UTP20 small subunit processome component,12q23.2,protein-coding,/
CWITA009549,TCMBANKGE009549,ERC2,CAST; CAST1; ELKSL; SPBC110; Spc110,ELKS/RAB6-interacting/CAST family member 2,3p14.3,protein-coding,/
CWITA009550,TCMBANKGE009550,PDXK,C21orf124; C21orf97; DKFZp566A071; FLJ31940; FLJ37311; MGC15873; MGC31754; MGC52346; PKH; PNK,"pyridoxal (pyridoxine, vitamin B6) kinase",21q22.3,protein-coding,
CWITA009551,TCMBANKGE009551,FAM50A,9F; DXS9928E; HXC-26; HXC26; XAP5,family with sequence similarity 50 member A,Xq28,protein-coding,/
CWITA009552,TCMBANKGE009552,SFTPA2,COLEC5; PSAP; PSP-A; PSPA; SFTP1; SFTPA2B; SP-2A; SP-A; SPA2; SPAII,surfactant protein A2,10q22.3,protein-coding,/
CWITA009553,TCMBANKGE009553,SGSM2,RUTBC1,small G protein signaling modulator 2,17p13.3,protein-coding,/
CWITA009554,TCMBANKGE009554,COX6A2,COX6AH; COXVIAH,cytochrome c oxidase subunit 6A2,16p11.2,protein-coding,/
CWITA009555,TCMBANKGE009555,SPOCK2,testican-2,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2",10q22.1,protein-coding,/
CWITA009556,TCMBANKGE009556,NCF2,NCF-2; NOXA2; P67-PHOX; P67PHOX,neutrophil cytosolic factor 2,1q25.3,protein-coding,/
CWITA009557,TCMBANKGE009557,PTPRCAP,CD45-AP; LPAP,protein tyrosine phosphatase receptor type C associated protein,11q13.2,protein-coding,/
CWITA009558,TCMBANKGE009558,EED,COGIS; HEED; WAIT1,embryonic ectoderm development,11q14.2,protein-coding,Clinical Trial target
CWITA009559,TCMBANKGE009559,CD99,HBA71; MIC2; MIC2X; MIC2Y; MSK5X,CD99 molecule (Xg blood group),Xp22.33 and Yp11.2,protein-coding,/
CWITA009560,TCMBANKGE009560,ING5,p28ING5,inhibitor of growth family member 5,2q37.3,protein-coding,/
CWITA009561,TCMBANKGE009561,WNT9A,WNT14,Wnt family member 9A,1q42.13,protein-coding,/
CWITA009562,TCMBANKGE009562,C5AR1,C5A; C5AR; C5R1; CD88,complement C5a receptor 1,19q13.32,protein-coding,Clinical Trial target
CWITA009563,TCMBANKGE009563,OSBPL11,ORP-11; ORP11; OSBP12; TCCCIA00292,oxysterol binding protein like 11,3q21.2,protein-coding,/
CWITA009564,TCMBANKGE009564,MTHFD2L,-,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like,4q13.3,protein-coding,/
CWITA009565,TCMBANKGE009565,CACNA1H,CACNA1HB; Cav3.2; ECA6; EIG6; FLJ90484,"calcium channel, voltage-dependent, T type, alpha 1H subunit",16p13.3,protein-coding,
CWITA009566,TCMBANKGE009566,PANK1,PANK,pantothenate kinase 1,10q23.31,protein-coding,/
CWITA009567,TCMBANKGE009567,NEURL1,NEUR1; NEURL; RNF67; bA416N2.1; neu; neu-1,neuralized E3 ubiquitin protein ligase 1,10q24.33,protein-coding,/
CWITA009568,TCMBANKGE009568,SBF2,CMT4B2; DENND7B; MTMR13,SET binding factor 2,11p15.4,protein-coding,/
CWITA009569,TCMBANKGE009569,NFYA,CBF-A; CBF-B; HAP2; NF-YA,nuclear transcription factor Y subunit alpha,6p21.1,protein-coding,/
CWITA009570,TCMBANKGE009570,LPA,AK38; APOA; LP,lipoprotein(a),6q25.3-q26,protein-coding,Clinical Trial target
CWITA009571,TCMBANKGE009571,SDE2,C1orf55; dJ671D7.1,SDE2 telomere maintenance homolog,1q42.12,protein-coding,/
CWITA009572,TCMBANKGE009572,RALBP1,RIP1; RLIP1; RLIP76,ralA binding protein 1,18p11.3,protein-coding,
CWITA009573,TCMBANKGE009573,FBXL17,FBXO13; Fbl17; Fbx13,F-box and leucine rich repeat protein 17,5q21.3,protein-coding,/
CWITA009574,TCMBANKGE009574,ZNF689,TIPUH1,zinc finger protein 689,16p11.2,protein-coding,/
CWITA009575,TCMBANKGE009575,ATP6V0D2,ATP6D2; VMA6,ATPase H+ transporting V0 subunit d2,8q21.3,protein-coding,/
CWITA009576,TCMBANKGE009576,NRL,D14S46E; NRL-MAF; RP27,neural retina leucine zipper,14q11.2-q12,protein-coding,/
CWITA009577,TCMBANKGE009577,Gm2a-rs1,-,"GM2 ganglioside activator protein, related sequence 1",-,pseudo,/
CWITA009578,TCMBANKGE009578,UGT8,CGT; UGT4,Udp_Glycosyltransferase_8,4q26,protein-coding,
CWITA009579,TCMBANKGE009579,OTUD6B,CGI-77; DUBA-5; DUBA5; IDDFSDA,OTU deubiquitinase 6B,8q21.3,protein-coding,/
CWITA009580,TCMBANKGE009580,SERPINB2,HsT1201; PAI; PAI-2; PAI2; PLANH2,serpin family B member 2,18q21.33-q22.1,protein-coding,/
CWITA009581,TCMBANKGE009581,Cars,CA3; Cars1,cysteinyl-tRNA synthetase,7 F5|7 88.25 cM,protein-coding,/
CWITA009582,TCMBANKGE009582,EHBP1,HPC12; NACSIN,EH domain binding protein 1,2p15,protein-coding,/
CWITA009583,TCMBANKGE009583,FAM24B,-,family with sequence similarity 24 member B,10q26.13,protein-coding,/
CWITA009584,TCMBANKGE009584,TMPRSS11F,HATL4,transmembrane serine protease 11F,4q13.2,protein-coding,/
CWITA009585,TCMBANKGE009585,ENTPD8,E-NTPDase; GLSR2492; NTPDase-8; UNQ2492,ectonucleoside triphosphate diphosphohydrolase 8,9q34.3,protein-coding,/
CWITA009586,TCMBANKGE009586,CNN1,HEL-S-14; SMCC; Sm-Calp,calponin 1,19p13.2,protein-coding,/
CWITA009587,TCMBANKGE009587,GAS1,-,growth arrest specific 1,9q21.33,protein-coding,/
CWITA009588,TCMBANKGE009588,SNAP47,C1orf142; ESFI5812; HEL-S-290; HEL170; SNAP-47; SVAP1,synaptosome associated protein 47,1q42.13,protein-coding,/
CWITA009589,TCMBANKGE009589,ARHGAP5,GFI2; RhoGAP5; p190-B; p190BRhoGAP,Rho GTPase activating protein 5,14q12,protein-coding,/
CWITA009590,TCMBANKGE009590,TAS2R39,T2R39; T2R57,taste 2 receptor member 39,7q34,protein-coding,/
CWITA009591,TCMBANKGE009591,PRDM13,MU-MB-20.220; PFM10,PR/SET domain 13,6q16.2,protein-coding,/
CWITA009592,TCMBANKGE009592,ZFP69,ZFP69A; ZKSCAN23A; ZNF642; ZSCAN54A,ZFP69 zinc finger protein,1p34.2,protein-coding,/
CWITA009593,TCMBANKGE009593,PGBD1,HUCEP-4; SCAND4; dJ874C20.4,piggyBac transposable element derived 1,6p22.1,protein-coding,/
CWITA009594,TCMBANKGE009594,PRLR,hPRLrI,prolactin receptor,5p13.2,protein-coding,
CWITA009595,TCMBANKGE009595,RGMB,DRAGON,repulsive guidance molecule BMP co-receptor b,5q15,protein-coding,/
CWITA009596,TCMBANKGE009596,MROH9,ARMC11; C1orf129,maestro heat like repeat family member 9,1q24.3,protein-coding,/
CWITA009597,TCMBANKGE009597,ZNF628,ZEC; Zfp628,zinc finger protein 628,19q13.42,protein-coding,/
CWITA009598,TCMBANKGE009598,PRH2,PRP-1/PRP-2; Pr; pr1/Pr2,proline rich protein HaeIII subfamily 2,12p13.2,protein-coding,/
CWITA009599,TCMBANKGE009599,ITM2B,ABRI; BRI; BRI2; BRICD2B; E25B; E3-16; FBD; RDGCA; imBRI2,integral membrane protein 2B,13q14.2,protein-coding,/
CWITA009600,TCMBANKGE009600,NCOR1,N-CoR; N-CoR1; PPP1R109; TRAC1; hN-CoR,nuclear receptor corepressor 1,17p12-p11.2,protein-coding,/
CWITA009601,TCMBANKGE009601,RPS4X,CCG2; DXS306; RPS4; S4; SCAR; SCR10,ribosomal protein S4 X-linked,Xq13.1,protein-coding,/
CWITA009602,TCMBANKGE009602,SERPINB4,LEUPIN; PI11; SCCA-2; SCCA1; SCCA2,serpin family B member 4,18q21.33,protein-coding,/
CWITA009603,TCMBANKGE009603,COBLL1,COBLR1,cordon-bleu WH2 repeat protein like 1,2q24.3,protein-coding,/
CWITA009604,TCMBANKGE009604,NPPB,BNP,natriuretic peptide B,1p36.22,protein-coding,Research target
CWITA009605,TCMBANKGE009605,SRI,CP-22; CP22; SCN; V19,sorcin,7q21.12,protein-coding,/
CWITA009606,TCMBANKGE009606,ADM5,AM5; C19orf76,adrenomedullin 5 (putative),19q13.33,protein-coding,/
CWITA009607,TCMBANKGE009607,CTIF,Gm672; KIAA0427,cap binding complex dependent translation initiation factor,18q21.1,protein-coding,/
CWITA009608,TCMBANKGE009608,WEE1,DKFZp686I18166; FLJ16446; WEE1A; WEE1hu,WEE1 homolog (S. pombe),11p15.3-p15.1,protein-coding,
CWITA009609,TCMBANKGE009609,PRG2,BMPG; MBP; MBP1; proMBP,"proteoglycan 2, pro eosinophil major basic protein",11q12.1,protein-coding,/
CWITA009610,TCMBANKGE009610,MIIP,IIP45,migration and invasion inhibitory protein,1p36.22,protein-coding,/
CWITA009611,TCMBANKGE009611,Ifi206,EG240921; Gm4955; Pyblhin-C,interferon activated gene 206,1|1 H3,protein-coding,/
CWITA009612,TCMBANKGE009612,ANKRD60,C20orf86; bA196N14.3,ankyrin repeat domain 60,20q13.32,protein-coding,/
CWITA009613,TCMBANKGE009613,ZKSCAN5,ZFP-95; ZFP95; ZNF914; ZSCAN37,zinc finger with KRAB and SCAN domains 5,7q22.1,protein-coding,/
CWITA009614,TCMBANKGE009614,PPM1A,PP2C-ALPHA; PP2CA; PP2Calpha,"protein phosphatase, Mg2+/Mn2+ dependent 1A",14q23.1,protein-coding,Clinical Trial target
CWITA009615,TCMBANKGE009615,PTGER1,EP1,prostaglandin E receptor 1,19p13.12,protein-coding,Clinical Trial target
CWITA009616,TCMBANKGE009616,SLC22A18,BWR1A; BWSCR1A; HET; IMPT1; ITM; ORCTL2; SLC22A1L; TSSC5; p45-BWR1A,solute carrier family 22 member 18,11p15.4,protein-coding,/
CWITA009617,TCMBANKGE009617,GREM2,CKTSF1B2; DAND3; PRDC; STHAG9,"gremlin 2, DAN family BMP antagonist",1q43,protein-coding,/
CWITA009618,TCMBANKGE009618,WDFY4,C10orf64,WDFY family member 4,10q11.23,protein-coding,/
CWITA009619,TCMBANKGE009619,NUP85,FROUNT; NPHS17; Nup75,nucleoporin 85,17q25.1,protein-coding,/
CWITA009620,TCMBANKGE009620,MAP4K3,GLK; MAPKKKK3; MEKKK_3; MEKKK3; RAB8IPL1,Mitogen-Activated_Protein_Kinase_Kinase_Kinase_Kinase_3,2p22.1,protein-coding,
CWITA009621,TCMBANKGE009621,LPGAT1,FAM34A; FAM34A1; NET8,lysophosphatidylglycerol acyltransferase 1,1q32.3,protein-coding,/
CWITA009622,TCMBANKGE009622,LIFR,CD118; LIF-R; SJS2; STWS; SWS,LIF receptor subunit alpha,5p13.1,protein-coding,Clinical Trial target
CWITA009623,TCMBANKGE009623,KLHDC7A,-,kelch domain containing 7A,1p36.13,protein-coding,/
CWITA009624,TCMBANKGE009624,EHD2,PAST2,EH domain containing 2,19q13.33,protein-coding,/
CWITA009625,TCMBANKGE009625,MAP2,DKFZp686I2148; MAP2A; MAP2B; MAP2C,microtubule-associated protein 2,2q34-q35,protein-coding,
CWITA009626,TCMBANKGE009626,HOXC5,CP11; HOX3; HOX3D,homeobox C5,12q13.13,protein-coding,/
CWITA009627,TCMBANKGE009627,TYMS,HST422; MGC88736; TMS; TS,thymidylate synthetase,18p11.32,protein-coding,
CWITA009628,TCMBANKGE009628,CHRNE,ACHRE; CMS1D; CMS1E; CMS2A; CMS4A; CMS4B; CMS4C; FCCMS; SCCMS,cholinergic receptor nicotinic epsilon subunit,17p13.2,protein-coding,/
CWITA009629,TCMBANKGE009629,PPIL4,HDCME13P,peptidylprolyl isomerase like 4,6q25.1,protein-coding,/
CWITA009630,TCMBANKGE009630,ADRB1,ADRB1R; B1AR; BETA1AR; RHR,"adrenergic, beta-1-, receptor",10q24-q26,protein-coding,
CWITA009631,TCMBANKGE009631,GRK3,ADRBK2; BARK2,G protein-coupled receptor kinase 3,22q12.1,protein-coding,Research target
CWITA009632,TCMBANKGE009632,GABRA4,N,"gamma-aminobutyric acid (GABA) A receptor, alpha 4",4p12,protein-coding,
CWITA009633,TCMBANKGE009633,RAN,ARA24; Gsp1; TC4,"RAN, member RAS oncogene family",12q24.33,protein-coding,/
CWITA009634,TCMBANKGE009634,PPT1,CLN1; INCL; PPT,palmitoyl-protein thioesterase 1,1p32,protein-coding,
CWITA009635,TCMBANKGE009635,ZNF618,FP13169; NEDD10,zinc finger protein 618,9q32,protein-coding,/
CWITA009636,TCMBANKGE009636,MGAT2,CDG2A; CDGS2; GLCNACTII; GNT-II; GNT2,"alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",14q21.3,protein-coding,Patented target
CWITA009637,TCMBANKGE009637,ZBTB32,FAXF; FAZF; Rog; TZFP; ZNF538,zinc finger and BTB domain containing 32,19q13.12,protein-coding,/
CWITA009638,TCMBANKGE009638,AMY2B,AMY2; AMY3; HXA,amylase alpha 2B,1p21.1,protein-coding,/
CWITA009639,TCMBANKGE009639,ZNF226,-,zinc finger protein 226,19q13.31,protein-coding,/
CWITA009640,TCMBANKGE009640,ASCC3,ASC1p200; HELIC1; RNAH,activating signal cointegrator 1 complex subunit 3,6q16.3,protein-coding,/
CWITA009641,TCMBANKGE009641,NR1H3,LXRNa; LXRA; RLDN1,"nuclear receptor subfamily 1, group H, member 3",11p11.2,protein-coding,
CWITA009642,TCMBANKGE009642,FAM9C,TEX39C,family with sequence similarity 9 member C,Xp22.2,protein-coding,/
CWITA009643,TCMBANKGE009643,UACA,NUCLING,uveal autoantigen with coiled-coil domains and ankyrin repeats,15q23,protein-coding,/
CWITA009644,TCMBANKGE009644,HMGB4,dJ1007G16.5,high mobility group box 4,1p35.1,protein-coding,/
CWITA009645,TCMBANKGE009645,DOK1,P62DOK; pp62,docking protein 1,2p13.1,protein-coding,/
CWITA009646,TCMBANKGE009646,PUS7L,-,pseudouridine synthase 7 like,12q12,protein-coding,/
CWITA009647,TCMBANKGE009647,ZFP90,FIK; NK10; ZNF756; zfp-90,ZFP90 zinc finger protein,16q22.1,protein-coding,/
CWITA009648,TCMBANKGE009648,G0S2,-,G0/G1 switch 2,1q32.2,protein-coding,/
CWITA009649,TCMBANKGE009649,ZNF10,KOX1,zinc finger protein 10,12q24.33,protein-coding,/
CWITA009650,TCMBANKGE009650,ST3GAL3,EIEE15; MRT12; SIAT6; ST3GALII; ST3Gal III; ST3GalIII; ST3N,"ST3 beta-galactoside alpha-2,3-sialyltransferase 3",1p34.1,protein-coding,/
CWITA009651,TCMBANKGE009651,CCNL1,ANIA6A; BM-001; PRO1073; ania-6a,cyclin L1,3q25.31,protein-coding,/
CWITA009652,TCMBANKGE009652,FAM241A,C4orf32,family with sequence similarity 241 member A,4q25,protein-coding,/
CWITA009653,TCMBANKGE009653,TFAP4,AP-4; bHLHc41,transcription factor AP-4,16p13.3,protein-coding,/
CWITA009654,TCMBANKGE009654,SLC13A1,NAS1; NaSi-1,solute carrier family 13 member 1,7q31.32,protein-coding,/
CWITA009655,TCMBANKGE009655,RSL24D1,C15orf15; HRP-L30-iso; L30; RLP24; RPL24; RPL24L; TVAS3,ribosomal L24 domain containing 1,15q21.3,protein-coding,/
CWITA009656,TCMBANKGE009656,UGT1A3,UDPGT_1N3; UGT1C,"UDP glucuronosyltransferase 1 family, polypeptide A3",2q37,protein-coding,
CWITA009657,TCMBANKGE009657,SLC7A14,PPP1R142,solute carrier family 7 member 14,3q26.2,protein-coding,/
CWITA009658,TCMBANKGE009658,ATP12A,ATP1AL1; H-K-ATPase; HK,ATPase H+/K+ transporting non-gastric alpha2 subunit,13q12.12|13q12.1-q12.3,protein-coding,/
CWITA009659,TCMBANKGE009659,PADI1,HPAD10; PAD1; PDI; PDI1,peptidyl arginine deiminase 1,1p36.13,protein-coding,/
CWITA009660,TCMBANKGE009660,ADGRL1,CIRL1; CL1; LEC2; LPHN1,adhesion G protein-coupled receptor L1,19p13.12,protein-coding,Research target
CWITA009661,TCMBANKGE009661,DGUOK,MTDPS3; dGK,deoxyguanosine kinase,2p13,protein-coding,
CWITA009662,TCMBANKGE009662,AHCYL1,DCAL; IRBIT; PPP1R78; PRO0233; XPVKONA,adenosylhomocysteinase like 1,1p13.3,protein-coding,/
CWITA009663,TCMBANKGE009663,KIAA0895L,-,KIAA0895 like,16q22.1,protein-coding,/
CWITA009664,TCMBANKGE009664,RNF111,ARK; hRNF111,ring finger protein 111,15q22.1-q22.2,protein-coding,/
CWITA009665,TCMBANKGE009665,SYNPO,-,synaptopodin,5q33.1,protein-coding,/
CWITA009666,TCMBANKGE009666,SLC36A1,Dct1; LYAAT1; PAT1; TRAMD3,solute carrier family 36 member 1,5q33.1,protein-coding,Research target
CWITA009667,TCMBANKGE009667,PRG3,MBP2; MBPH,"proteoglycan 3, pro eosinophil major basic protein 2",11q12.1,protein-coding,/
CWITA009668,TCMBANKGE009668,SLC25A6,AAC3; ANT; ANT 2; ANT 3; ANT3; ANT3Y,solute carrier family 25 member 6,Xp22.33 and Yp11.2,protein-coding,/
CWITA009669,TCMBANKGE009669,MARK3,CTAK1; KP78; PAR1A; Par-1a; VIPB,microtubule affinity regulating kinase 3,14q32.32-q32.33,protein-coding,Clinical Trial target
CWITA009670,TCMBANKGE009670,CELSR1,ADGRC1; CDHF9; FMI2; HFMI2; ME2,cadherin EGF LAG seven-pass G-type receptor 1,22q13.31,protein-coding,/
CWITA009671,TCMBANKGE009671,TTC12,CILD45; TPARM,tetratricopeptide repeat domain 12,11q23.2,protein-coding,/
CWITA009672,TCMBANKGE009672,CAMK1G,CLICKIII; VWS1; dJ272L16.1,calcium/calmodulin-dependent protein kinase IG,1q32-q41,protein-coding,
CWITA009673,TCMBANKGE009673,LOXL1,LOL; LOXL,lysyl oxidase like 1,15q24.1,protein-coding,/
CWITA009674,TCMBANKGE009674,ATP5F1C,ATP5C; ATP5C1; ATP5CL1,ATP synthase F1 subunit gamma,10p14,protein-coding,/
CWITA009675,TCMBANKGE009675,EPM2A,EPM2; MELF,"EPM2A glucan phosphatase, laforin",6q24.3,protein-coding,/
CWITA009676,TCMBANKGE009676,IRGC,CINEMA; IFGGE; IRGC1; Iigp5; R30953_1,immunity related GTPase cinema,19q13.31,protein-coding,/
CWITA009677,TCMBANKGE009677,SLCO4C1,OATP-H; OATP-M1; OATP4C1; OATPX; PRO2176; SLC21A20,solute carrier organic anion transporter family member 4C1,5q21.1,protein-coding,Successful target
CWITA009678,TCMBANKGE009678,HLTF,HIP116; HIP116A; HLTF1; RNF80; SMARCA3; SNF2L3; ZBU1,helicase like transcription factor,3q24,protein-coding,/
CWITA009679,TCMBANKGE009679,BTD,-,biotinidase,3p25.1,protein-coding,/
CWITA009680,TCMBANKGE009680,DNAJC19,PAM18; TIM14; TIMM14,DnaJ heat shock protein family (Hsp40) member C19,3q26.33,protein-coding,/
CWITA009681,TCMBANKGE009681,FAM207A,C21orf70; PRED56,family with sequence similarity 207 member A,21q22.3,protein-coding,/
CWITA009682,TCMBANKGE009682,ARMC6,R30923_1,armadillo repeat containing 6,19p13.11,protein-coding,/
CWITA009683,TCMBANKGE009683,KLK15,ACO; HSRNASPH,kallikrein related peptidase 15,19q13.33,protein-coding,/
CWITA009684,TCMBANKGE009684,CNGB1,CNCG2; CNCG3L; CNCG4; CNG4; CNGB1B; GAR1; GARP; GARP2; RCNC2; RCNCb; RCNCbeta; RP45,cyclic nucleotide gated channel subunit beta 1,16q21,protein-coding,/
CWITA009685,TCMBANKGE009685,CYBC1,C17orf62; Eros,cytochrome b-245 chaperone 1,17q25.3,protein-coding,/
CWITA009686,TCMBANKGE009686,ALDH3B2,ALDH8,aldehyde dehydrogenase 3 family member B2,11q13.2,protein-coding,/
CWITA009687,TCMBANKGE009687,DYRK4,-,dual specificity tyrosine phosphorylation regulated kinase 4,12p13.32,protein-coding,Research target
CWITA009688,TCMBANKGE009688,MT1A,MT-1A; MT-IA; MT1; MT1S; MTC,metallothionein 1A,16q13,protein-coding,/
CWITA009689,TCMBANKGE009689,SDC3,SDCN; SYND3,syndecan 3,1p35.2,protein-coding,/
CWITA009690,TCMBANKGE009690,FAM177A1,C14orf24,family with sequence similarity 177 member A1,14q13.2,protein-coding,/
CWITA009691,TCMBANKGE009691,UNCX,UNCX4.1,UNC homeobox,7p22.3,protein-coding,/
CWITA009692,TCMBANKGE009692,DHX36,DDX36; G4R1; MLEL1; RHAU,DEAH-box helicase 36,3q25.2,protein-coding,/
CWITA009693,TCMBANKGE009693,MMP21,HTX7; MMP-21,matrix metallopeptidase 21,10q26.2,protein-coding,Research target
CWITA009694,TCMBANKGE009694,ANAPC1,APC1; MCPR; TSG24,anaphase promoting complex subunit 1,2q13,protein-coding,/
CWITA009695,TCMBANKGE009695,PFKFB4,N,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4",3p22-p21,protein-coding,
CWITA009696,TCMBANKGE009696,ADSS,ADEH; MGC20404,adenylosuccinate synthase,1cen-q12,protein-coding,
CWITA009697,TCMBANKGE009697,FERMT2,KIND2; MIG2; PLEKHC1; UNC112; UNC112B; mig-2,fermitin family member 2,14q22.1,protein-coding,/
CWITA009698,TCMBANKGE009698,DEPTOR,DEP.6; DEPDC6,DEP domain containing MTOR interacting protein,8q24.12,protein-coding,Research target
CWITA009699,TCMBANKGE009699,NPAS1,MOP5; PASD5; bHLHe11,neuronal PAS domain protein 1,19q13.32,protein-coding,/
CWITA009700,TCMBANKGE009700,KLK7,PRSS6; SCCE; hK7,kallikrein-related peptidase 7,19q13.41,protein-coding,
CWITA009701,TCMBANKGE009701,TOR3A,ADIR; ADIR2,torsin family 3 member A,1q25.2,protein-coding,/
CWITA009702,TCMBANKGE009702,USF2,FIP; bHLHb12,"upstream transcription factor 2, c-fos interacting",19q13.12,protein-coding,/
CWITA009703,TCMBANKGE009703,SLC38A8,FVH2,solute carrier family 38 member 8,16q23.3,protein-coding,/
CWITA009704,TCMBANKGE009704,ANGPTL8,C19orf80; PRO1185; PVPA599; RIFL; TD26,angiopoietin like 8,19p13.2,protein-coding,/
CWITA009705,TCMBANKGE009705,SF3A2,PRP11; PRPF11; SAP62; SF3a66,splicing factor 3a subunit 2,19p13.3,protein-coding,/
CWITA009706,TCMBANKGE009706,UBAP2,UBAP-2,ubiquitin associated protein 2,9p13.3,protein-coding,/
CWITA009707,TCMBANKGE009707,GALR2,GAL2-R; GALNR2; GALR-2,galanin receptor 2,17q25.1,protein-coding,Research target
CWITA009708,TCMBANKGE009708,BPIFB2,BPIL1; C20orf184; LPLUNC2; RYSR; dJ726C3.2,BPI fold containing family B member 2,20q11.21,protein-coding,/
CWITA009709,TCMBANKGE009709,MUT,MCM,methylmalonyl CoA mutase,6p12.3,protein-coding,
CWITA009710,TCMBANKGE009710,ITPRIP,DANGER; KIAA1754; bA127L20; bA127L20.2,"inositol 1,4,5-trisphosphate receptor interacting protein",10q25.1,protein-coding,/
CWITA009711,TCMBANKGE009711,MYLIP,IDOL; MIR,myosin regulatory light chain interacting protein,6p22.3,protein-coding,/
CWITA009712,TCMBANKGE009712,TOX2,C20orf100; GCX-1; GCX1; dJ1108D11.2; dJ495O3.1,TOX high mobility group box family member 2,20q13.12,protein-coding,/
CWITA009713,TCMBANKGE009713,CDHR5,MLPCDH; MU-PCDH; MUCDHL; MUPCDH,cadherin related family member 5,11p15.5,protein-coding,/
CWITA009714,TCMBANKGE009714,SPTLC3,C20orf38; LCB 3; LCB2B; LCB3; SPT 3; SPT3; SPTLC2L; dJ718P11; dJ718P11.1; hLCB2b,serine palmitoyltransferase long chain base subunit 3,20p12.1,protein-coding,/
CWITA009715,TCMBANKGE009715,MYO1A,BBMI; DFNA48; MIHC; MYHL,myosin IA,12q13.3,protein-coding,/
CWITA009716,TCMBANKGE009716,CTBP1,BARS; MGC104684,C-terminal binding protein 1,4p16,protein-coding,
CWITA009717,TCMBANKGE009717,OSTN,MUSCLIN,osteocrin,3q28,protein-coding,/
CWITA009718,TCMBANKGE009718,SLFN11,SLFN8/9,schlafen family member 11,17q12,protein-coding,/
CWITA009719,TCMBANKGE009719,CLEC12B,UNQ5782,C-type lectin domain family 12 member B,12p13.2,protein-coding,/
CWITA009720,TCMBANKGE009720,KCNC3,KSHIIID; KV3.3; SCA13,"potassium voltage-gated channel, Shaw-related subfamily, member 3",19q13.33,protein-coding,
CWITA009721,TCMBANKGE009721,OSBPL1A,ORP-1; ORP1; OSBPL1B,oxysterol binding protein like 1A,18q11.2,protein-coding,/
CWITA009722,TCMBANKGE009722,ZNF620,-,zinc finger protein 620,3p22.1,protein-coding,/
CWITA009723,TCMBANKGE009723,ZNF367,AFF29; CDC14B; ZFF29,zinc finger protein 367,9q22.32|9q22.32,protein-coding,/
CWITA009724,TCMBANKGE009724,TMEM256,C17orf61,transmembrane protein 256,17p13.1,protein-coding,/
CWITA009725,TCMBANKGE009725,PRPS2,PRSII,phosphoribosyl pyrophosphate synthetase 2,Xp22.2,protein-coding,/
CWITA009726,TCMBANKGE009726,ERG,erg-3; p55,ETS transcription factor ERG,21q22.2,protein-coding,/
CWITA009727,TCMBANKGE009727,ITGA2B,BDPLT16; BDPLT2; CD41; CD41B; GP2B; GPIIb; GT; GTA; HPA3; PPP1R93,integrin subunit alpha 2b,17q21.31,protein-coding,/
CWITA009728,TCMBANKGE009728,EVA1A,FAM176A; TMEM166,"eva-1 homolog A, regulator of programmed cell death",2p12,protein-coding,/
CWITA009729,TCMBANKGE009729,NLK,-,nemo like kinase,17q11.2,protein-coding,/
CWITA009730,TCMBANKGE009730,MAF,MGC71685; cNMAF,v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian),16q22-q23,protein-coding,
CWITA009731,TCMBANKGE009731,GRM5,GPRC1E; MGLUR5; mGlu5,"glutamate receptor, metabotropic 5",11q14.3,protein-coding,
CWITA009732,TCMBANKGE009732,CENPS,APITD1; CENP-S; FAAP16; MHF1,centromere protein S,1p36.22,protein-coding,/
CWITA009733,TCMBANKGE009733,ZNF260,OZRF1; PEX1; ZFP260,zinc finger protein 260,19q13.12,protein-coding,/
CWITA009734,TCMBANKGE009734,MC1R,CMM5; MGC14337; MSHNR; SHEP2,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),16q24.3,protein-coding,
CWITA009735,TCMBANKGE009735,PUF60,FIR; RoBPI; SIAHBP1; VRJS,poly(U) binding splicing factor 60,8q24.3,protein-coding,/
CWITA009736,TCMBANKGE009736,SLC25A48,-,solute carrier family 25 member 48,5q31.1,protein-coding,/
CWITA009737,TCMBANKGE009737,EXOSC9,PCH1D; PM/Scl-75; PMSCL1; RRP45; Rrp45p; p5; p6,exosome component 9,4q27,protein-coding,/
CWITA009738,TCMBANKGE009738,C3,AHUS5; ARMD9; ASP; CPAMD1,complement component 3,19p13.3-p13.2,protein-coding,
CWITA009739,TCMBANKGE009739,ADGRE3,EMR3,adhesion G protein-coupled receptor E3,19p13.12,protein-coding,/
CWITA009740,TCMBANKGE009740,PER3,FASPS3; GIG13,period circadian regulator 3,1p36.23,protein-coding,/
CWITA009741,TCMBANKGE009741,HOXB5,HHO.C10; HOX2; HOX2A; HU-1; Hox2.1,homeobox B5,17q21.32,protein-coding,/
CWITA009742,TCMBANKGE009742,HLA-DRB1,DRB1; HLA-DR1B; HLA-DRB; SS1,"major histocompatibility complex, class II, DR beta 1",6p21.32,protein-coding,Clinical Trial target
CWITA009743,TCMBANKGE009743,TRNP1,C1orf225; TNRP; TRNP,TMF1 regulated nuclear protein 1,1p36.11,protein-coding,/
CWITA009744,TCMBANKGE009744,OLA1,DOC45; GBP45; GTBP9; GTPBP9; PTD004,Obg like ATPase 1,2q31.1,protein-coding,/
CWITA009745,TCMBANKGE009745,TSSC4,-,tumor suppressing subtransferable candidate 4,11p15.5,protein-coding,/
CWITA009746,TCMBANKGE009746,NDUFB4,B15; CI-B15,NADH:ubiquinone oxidoreductase subunit B4,3q13.33,protein-coding,/
CWITA009747,TCMBANKGE009747,TCTA,-,T cell leukemia translocation altered,3p21.31,protein-coding,/
CWITA009748,TCMBANKGE009748,BAZ1B,WBSCR10; WBSCR9; WSTF,bromodomain adjacent to zinc finger domain 1B,7q11.23,protein-coding,/
CWITA009749,TCMBANKGE009749,NDUFAB1,ACP; ACP1; FASN2A; SDAP,NADH:ubiquinone oxidoreductase subunit AB1,16p12.2,protein-coding,/
CWITA009750,TCMBANKGE009750,MRPS7,COXPD34; MRP-S; MRP-S7; RP-S7; RPMS7; S7mt; bMRP27a,mitochondrial ribosomal protein S7,17q25.1,protein-coding,/
CWITA009751,TCMBANKGE009751,KLC1,KLC; KNS2; KNS2A,kinesin light chain 1,14q32.33,protein-coding,/
CWITA009752,TCMBANKGE009752,BTBD9,dJ322I12.1,BTB domain containing 9,6p21.2,protein-coding,/
CWITA009753,TCMBANKGE009753,KCNIP3,CSEN; DREAM; KCHIP3,potassium voltage-gated channel interacting protein 3,2q11.1,protein-coding,/
CWITA009754,TCMBANKGE009754,S100A11,MLN70; S100C,S100 calcium binding protein A11,1q21,protein-coding,
CWITA009755,TCMBANKGE009755,SOCS5,CIS6; CISH6; Cish5; SOCS-5,suppressor of cytokine signaling 5,2p21,protein-coding,/
CWITA009756,TCMBANKGE009756,MAPK6,ERK3; HsT17250; PRKM6; p97MAPK,mitogen-activated protein kinase 6,15q21.2,protein-coding,/
CWITA009757,TCMBANKGE009757,CLP1,HEAB; hClp1,cleavage factor polyribonucleotide kinase subunit 1,11q12.1,protein-coding,/
CWITA009758,TCMBANKGE009758,PDE3A,CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB,phosphodiesterase 3A,12p12.2,protein-coding,Successful target
CWITA009759,TCMBANKGE009759,PCNX4,C14orf135; FBP2; PCNXL4,pecanex 4,14q23.1,protein-coding,/
CWITA009760,TCMBANKGE009760,BCL2L14,BCLG,BCL2 like 14,12p13.2,protein-coding,/
CWITA009761,TCMBANKGE009761,GUCY1A1,GC-S-alpha-1; GC-SA3; GCS-alpha-3; GUC1A3; GUCA3; GUCSA3; GUCY1A3; MYMY6,guanylate cyclase 1 soluble subunit alpha 1,4q32.1,protein-coding,/
CWITA009762,TCMBANKGE009762,OXT,OT; OT-NPI; OXT-NPI,oxytocin/neurophysin I prepropeptide,20p13,protein-coding,/
CWITA009763,TCMBANKGE009763,MRPL22,HSPC158; L22mt; MRP-L22; MRP-L25; RPML25,mitochondrial ribosomal protein L22,5q33.2,protein-coding,/
CWITA009764,TCMBANKGE009764,CALB1,CALB; D-28K,calbindin 1,8q21.3,protein-coding,/
CWITA009765,TCMBANKGE009765,PTGER4,EP4; EP4R; MGC126583,prostaglandin E receptor 4 (subtype EP4),5p13.1,protein-coding,
CWITA009766,TCMBANKGE009766,SLC7A8,LAT2; LPI-PC1,solute carrier family 7 member 8,14q11.2,protein-coding,/
CWITA009767,TCMBANKGE009767,IMMT,HMP; MINOS2; Mic60; P87; P87/89; P89; PIG4; PIG52,Inner_Membrane_Mitochondrial_Protein,2p11.2;2,protein-coding,
CWITA009768,TCMBANKGE009768,LMO3,RBTN3; RBTNL2; RHOM3; Rhom-3,LIM domain only 3,12p12.3,protein-coding,/
CWITA009769,TCMBANKGE009769,RREB1,FINB; HNT; LZ321; RREB-1; Zep-1,ras responsive element binding protein 1,6p24.3,protein-coding,/
CWITA009770,TCMBANKGE009770,TYR,CMM8; OCA1A; OCAIA; SHEP3,tyrosinase (oculocutaneous albinism IA),11q14-q21,protein-coding,
CWITA009771,TCMBANKGE009771,GAP43,B-50; GAP-43; PP46,growth associated protein 43,3q13.31,protein-coding,Research target
CWITA009772,TCMBANKGE009772,EIF4H,WBSCR1; WSCR1; eIF-4H,eukaryotic translation initiation factor 4H,7q11.23,protein-coding,/
CWITA009773,TCMBANKGE009773,PROK2,BV8; HH4; KAL4; MIT1; PK2,prokineticin 2,3p13,protein-coding,/
CWITA009774,TCMBANKGE009774,MSH3,DUP; FAP4; MRP1,mutS homolog 3,5q14.1,protein-coding,/
CWITA009775,TCMBANKGE009775,CD3D,CD3-DELTA; IMD19; T3D,CD3d molecule,11q23.3,protein-coding,/
CWITA009776,TCMBANKGE009776,CAPN6,CANPX; CAPNX; CalpM; DJ914P14.1,calpain 6,Xq23,protein-coding,/
CWITA009777,TCMBANKGE009777,CSNK1G3,CKI-gamma 3; CSNK1G3L,casein kinase 1 gamma 3,5q23.2,protein-coding,Research target
CWITA009778,TCMBANKGE009778,KLK11,PRSS20; TLSP,kallikrein related peptidase 11,19q13.41,protein-coding,/
CWITA009779,TCMBANKGE009779,PTH2,TIP39,parathyroid hormone 2,19q13.33,protein-coding,/
CWITA009780,TCMBANKGE009780,SULT2B1,ARCI14; HSST2,sulfotransferase family 2B member 1,19q13.33,protein-coding,/
CWITA009781,TCMBANKGE009781,NUDT21,CFIM25; CPSF5,nudix hydrolase 21,16q13,protein-coding,/
CWITA009782,TCMBANKGE009782,IMPDH2,IMPD2; IMPDHNII,IMP (inosine 5'-monophosphate) dehydrogenase 2,3p21.2,protein-coding,
CWITA009783,TCMBANKGE009783,NUCKS1,JC7; NUCKS,nuclear casein kinase and cyclin dependent kinase substrate 1,1q32.1,protein-coding,/
CWITA009784,TCMBANKGE009784,CIAO2B,CGI-128; CIA2B; FAM96B; MIP18,cytosolic iron-sulfur assembly component 2B,16q22.1,protein-coding,/
CWITA009785,TCMBANKGE009785,CLYBL,CLB,citramalyl-CoA lyase,13q32.3,protein-coding,/
CWITA009786,TCMBANKGE009786,KIF4A,KIF4; KIF4G1; MRX100,kinesin family member 4A,Xq13.1,protein-coding,/
CWITA009787,TCMBANKGE009787,ACCSL,-,1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like,11p11.2,protein-coding,/
CWITA009788,TCMBANKGE009788,LSM4,GRP; YER112W,"LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated",19p13.11,protein-coding,/
CWITA009789,TCMBANKGE009789,RAD54L,HR54; RAD54A; hHR54; hRAD54,RAD54 like,1p34.1,protein-coding,/
CWITA009790,TCMBANKGE009790,PTCD3,MRP-S39,pentatricopeptide repeat domain 3,2p11.2,protein-coding,/
CWITA009791,TCMBANKGE009791,TFPI,EPI; LACI; TFI; TFPI1,Tissue_Factor_Pathway_Inhibitor,2q32.1,protein-coding,
CWITA009792,TCMBANKGE009792,HNRNPH2,FTP3; HNRPH'; HNRPH2; MRXSB; NRPH2; hnRNPH',heterogeneous nuclear ribonucleoprotein H2,Xq22.1,protein-coding,/
CWITA009793,TCMBANKGE009793,FRMD6,C14orf31; EX1; Willin; c14_5320,FERM domain containing 6,14q22.1,protein-coding,/
CWITA009794,TCMBANKGE009794,PPCDC,MDS018; PPC-DC; coaC,phosphopantothenoylcysteine decarboxylase,15q24.2,protein-coding,/
CWITA009795,TCMBANKGE009795,PTK2B,CADTK; CAKB; FADK2; FAK2; PKB; PTK; PYK2; RAFTK,PTK2B protein tyrosine kinase 2 beta,8p21.1,protein-coding,
CWITA009796,TCMBANKGE009796,USH2A,RP39; US2; USH2; dJ1111A8.1,usherin,1q41,protein-coding,/
CWITA009797,TCMBANKGE009797,KLRC1,CD159A; NKG2; NKG2A,killer cell lectin like receptor C1,12p13.2,protein-coding,Clinical Trial target
CWITA009798,TCMBANKGE009798,ZFP41,ZNF753; zfp-41,ZFP41 zinc finger protein,8q24.3,protein-coding,/
CWITA009799,TCMBANKGE009799,NXF5,-,nuclear RNA export factor 5,Xq22.1,protein-coding,/
CWITA009800,TCMBANKGE009800,RPIA,RPI; RPIAD,ribose 5-phosphate isomerase A,2p11.2,protein-coding,/
CWITA009801,TCMBANKGE009801,OR51E1,D-GPCR; DGPCR; GPR136; GPR164; OR51E1P; OR52A3P; POGR; PSGR2,olfactory receptor family 51 subfamily E member 1,11p15.4,protein-coding,/
CWITA009802,TCMBANKGE009802,DHFR,DHFRP1; DYR,dihydrofolate reductase,5q14.1,protein-coding,Successful target
CWITA009803,TCMBANKGE009803,CLEC1A,CLEC-1; CLEC1,C-type lectin domain family 1 member A,12p13.2,protein-coding,/
CWITA009804,TCMBANKGE009804,ZFP69B,ZKSCAN23B; ZNF643; ZSCAN54B,ZFP69 zinc finger protein B,1p34.2,protein-coding,/
CWITA009805,TCMBANKGE009805,NME7,CFAP67; MN23H7; NDK 7; NDK7; nm23-H7,NME/NM23 family member 7,1q24.2,protein-coding,/
CWITA009806,TCMBANKGE009806,PRSS55,CT153; T-SP1; TSP1; UNQ9391,serine protease 55,8p23.1,protein-coding,/
CWITA009807,TCMBANKGE009807,Atp5k-ps2,Atp5k-rs2; Gm14337,"ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit E, pseudogene 2",2|2 H4,pseudo,/
CWITA009808,TCMBANKGE009808,SPAG7,ACRP; FSA-1,sperm associated antigen 7,17p13.2,protein-coding,/
CWITA009809,TCMBANKGE009809,STIL,MCPH7; SIL,STIL centriolar assembly protein,1p33,protein-coding,/
CWITA009810,TCMBANKGE009810,NAA10,ARD1; ARD1A; ARD1P; DXS707; MCOPS1; NATD; OGDNS; TE2; hARD1,"N-alpha-acetyltransferase 10, NatA catalytic subunit",Xq28,protein-coding,/
CWITA009811,TCMBANKGE009811,UFD1,UFD1L,ubiquitin recognition factor in ER associated degradation 1,22q11.21,protein-coding,/
CWITA009812,TCMBANKGE009812,CCDC116,-,coiled-coil domain containing 116,22q11.21,protein-coding,/
CWITA009813,TCMBANKGE009813,PAIP1,-,poly(A) binding protein interacting protein 1,5p12,protein-coding,/
CWITA009814,TCMBANKGE009814,HNRNPCL1,HNRPCL1,heterogeneous nuclear ribonucleoprotein C like 1,1p36.21,protein-coding,/
CWITA009815,TCMBANKGE009815,LIM2,CTRCT19; MP17; MP19,lens intrinsic membrane protein 2,19q13.41,protein-coding,/
CWITA009816,TCMBANKGE009816,ZNF860,-,zinc finger protein 860,3p23-p22.3,protein-coding,/
CWITA009817,TCMBANKGE009817,GALE,FLJ95174; FLJ97302; SDR1E1,UDP-galactose-4-epimerase,1p36-p35,protein-coding,
CWITA009818,TCMBANKGE009818,PGRMC1,Dap1; HPR6.6; IZA; MPR,progesterone receptor membrane component 1,Xq24,protein-coding,Research target
CWITA009819,TCMBANKGE009819,MYH10,NMMHC-IIB; NMMHCB,myosin heavy chain 10,17p13.1,protein-coding,/
CWITA009820,TCMBANKGE009820,IGDCC4,DDM36; NOPE,immunoglobulin superfamily DCC subclass member 4,15q22.31,protein-coding,/
CWITA009821,TCMBANKGE009821,ZNF519,HsT2362,zinc finger protein 519,18p11.21,protein-coding,/
CWITA009822,TCMBANKGE009822,ZNF814,-,zinc finger protein 814,19q13.43,protein-coding,/
CWITA009823,TCMBANKGE009823,EEA1,MST105; MSTP105; ZFYVE2,early endosome antigen 1,12q22,protein-coding,/
CWITA009824,TCMBANKGE009824,HCAR3,GPR109B; HCA3; HM74; PUMAG; PumaNg,hydroxycarboxylic acid receptor 3,12q24.31,protein-coding,
CWITA009825,TCMBANKGE009825,CTLA4,ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12,Cytotoxic_T-Lymphocyte_Associated_Protein_4,2q33.2,protein-coding,
CWITA009826,TCMBANKGE009826,CHD1,DKFZp686E2337,chromodomain helicase DNA binding protein 1,5q15-q21,protein-coding,
CWITA009827,TCMBANKGE009827,GFRA4,-,GDNF family receptor alpha 4,20p13,protein-coding,/
CWITA009828,TCMBANKGE009828,GSC2,GSCL,goosecoid homeobox 2,22q11.21,protein-coding,/
CWITA009829,TCMBANKGE009829,APOL6,APOL-VI; APOLVI,apolipoprotein L6,22q12.3,protein-coding,/
CWITA009830,TCMBANKGE009830,SCMH1,Scml3,Scm polycomb group protein homolog 1,1p34.2,protein-coding,/
CWITA009831,TCMBANKGE009831,PRSS54,CT67; KLKBL4,serine protease 54,16q21,protein-coding,/
CWITA009832,TCMBANKGE009832,ZNF852,-,zinc finger protein 852,3p21.31,protein-coding,/
CWITA009833,TCMBANKGE009833,PIPOX,LPIPOX,pipecolic acid oxidase,17q11.2,protein-coding,
CWITA009834,TCMBANKGE009834,RAD54L2,ARIP4; HSPC325; SRISNF2L,RAD54 like 2,3p21.2,protein-coding,/
CWITA009835,TCMBANKGE009835,ATP1B2,AMOG,ATPase Na+/K+ transporting subunit beta 2,17p13.1,protein-coding,/
CWITA009836,TCMBANKGE009836,AVPR1B,AVPR3; V1bR,arginine vasopressin receptor 1B,1q32.1,protein-coding,Successful target
CWITA009837,TCMBANKGE009837,B4GALT2,B4GalNT2; B4GalNT3; beta4GalNT2,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2",1p34-p33,protein-coding,
CWITA009838,TCMBANKGE009838,MTFMT,COXPD15; FMT1; MC1DN27,mitochondrial methionyl-tRNA formyltransferase,15q22.31,protein-coding,/
CWITA009839,TCMBANKGE009839,IDH1,IDCD; IDH; IDP; IDPC; PICD,"isocitrate dehydrogenase 1 (NADP+), soluble",2q33.3,protein-coding,
CWITA009840,TCMBANKGE009840,SLC25A4,AAC1; ANT; ANT1; PEO2; PEO3; T1,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",4q35,protein-coding,
CWITA009841,TCMBANKGE009841,PSMD4,AF; AF-1; ASF; MCB1; Rpn10; S5A; pUB-R5,"proteasome 26S subunit, non-ATPase 4",1q21.3,protein-coding,/
CWITA009842,TCMBANKGE009842,FDPS,FPPS; FPS; POROK9,farnesyl diphosphate synthase,1q22,protein-coding,Successful target
CWITA009843,TCMBANKGE009843,SLC46A1,FLJ39875; HCP1; MGC9564; PCFT,"solute carrier family 46 (folate transporter), member 1",17q11.2,protein-coding,
CWITA009844,TCMBANKGE009844,SLC17A2,NPT3,solute carrier family 17 member 2,6p22.2,protein-coding,/
CWITA009845,TCMBANKGE009845,CYP11B1,CPN1; CYP11B; DKFZp686B05283; FHI; FLJ36771; P450C11,"cytochrome P450, family 11, subfamily B, polypeptide 1",8q21,protein-coding,
CWITA009846,TCMBANKGE009846,PARP1,ADPRT; ADPRT_1; ADPRT1; PARP; PARPN1; PPOL; pADPRTN1,poly (ADP-ribose) polymerase 1,1q41-q42,protein-coding,
CWITA009847,TCMBANKGE009847,TESK1,-,testis associated actin remodelling kinase 1,9p13.3,protein-coding,Research target
CWITA009848,TCMBANKGE009848,ARSD,ASD,arylsulfatase D,Xp22.33,protein-coding,/
CWITA009849,TCMBANKGE009849,SSTR3,N,somatostatin receptor 3,22q13.1,protein-coding,
CWITA009850,TCMBANKGE009850,TMEM128,-,transmembrane protein 128,4p16.3,protein-coding,/
CWITA009851,TCMBANKGE009851,FAP,DPPIV; FAPA; FAPalpha; SIMP,fibroblast activation protein alpha,2q24.2,protein-coding,Clinical Trial target
CWITA009852,TCMBANKGE009852,SSC4D,S4D-SRCRB; SRCRB-S4D; SRCRB4D,scavenger receptor cysteine rich family member with 4 domains,7q11.23,protein-coding,/
CWITA009853,TCMBANKGE009853,SHISAL1,KIAA1644,shisa like 1,22q13.31,protein-coding,/
CWITA009854,TCMBANKGE009854,HIF1A,HIFN1alpha; HIF1; HIF1NALPHA; MOP1; PASD8; bHLHe78,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",14q23.2,protein-coding,
CWITA009855,TCMBANKGE009855,AS3MT,CYT19,arsenic (+3 oxidation state) methyltransferase,10q24.32,protein-coding,
CWITA009856,TCMBANKGE009856,DPEP1,MBD1; MDP; RDP,dipeptidase 1 (renal),16q24.3,protein-coding,
CWITA009857,TCMBANKGE009857,THRB,C-ERBA-2; C-ERBA-BETA; ERBA2; GRTH; NR1A2; PRTH; THR1; THRB1; THRB2,thyroid hormone receptor beta,3p24.2,protein-coding,Successful target
CWITA009858,TCMBANKGE009858,SLC25A45,-,solute carrier family 25 member 45,11q13.1,protein-coding,/
CWITA009859,TCMBANKGE009859,HOXA11,HOX1; HOX1I; RUSAT1,homeobox A11,7p15.2,protein-coding,Research target
CWITA009860,TCMBANKGE009860,SAMD3,-,sterile alpha motif domain containing 3,6q23.1,protein-coding,/
CWITA009861,TCMBANKGE009861,TEKT4,-,tektin 4,2q11.1,protein-coding,/
CWITA009862,TCMBANKGE009862,UQCR11,0710008D09Rik; QCR10; UQCR,"ubiquinol-cytochrome c reductase, complex III subunit XI",19p13.3,protein-coding,
CWITA009863,TCMBANKGE009863,MTRR,MSR; cblE,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5p15.31,protein-coding,/
CWITA009864,TCMBANKGE009864,CLEC18A,MRCL; MRCL1; MRLP2,C-type lectin domain family 18 member A,16q22.1,protein-coding,/
CWITA009865,TCMBANKGE009865,NCEH1,AADACL1; NCEH,neutral cholesterol ester hydrolase 1,3q26.31,protein-coding,/
CWITA009866,TCMBANKGE009866,RANBP6,-,RAN binding protein 6,9p24.1,protein-coding,/
CWITA009867,TCMBANKGE009867,TAF2,CIF150; MRT40; TAF2B; TAFII150,TATA-box binding protein associated factor 2,8q24.12,protein-coding,Research target
CWITA009868,TCMBANKGE009868,APBA1,D9S411E; LIN10; MINT1; X11; X11A; X11ALPHA,amyloid beta precursor protein binding family A member 1,9q21.12,protein-coding,/
CWITA009869,TCMBANKGE009869,GNAQ,CMC1; G-ALPHA-q; GAQ; SWS,G protein subunit alpha q,9q21.2,protein-coding,Research target
CWITA009870,TCMBANKGE009870,PGA3,-,pepsinogen A3,11q12.2,protein-coding,/
CWITA009871,TCMBANKGE009871,GRM6,CSNB1B; GPRC1F; MGLUR6; mGlu6,glutamate metabotropic receptor 6,5q35.3,protein-coding,Research target
CWITA009872,TCMBANKGE009872,PDHA1,PDHA; PDHAD; PDHCE1A; PHE1A,pyruvate dehydrogenase E1 subunit alpha 1,Xp22.12,protein-coding,/
CWITA009873,TCMBANKGE009873,SYK,DKFZp313N1010; FLJ25043; FLJ37489,spleen tyrosine kinase,9q22,protein-coding,
CWITA009874,TCMBANKGE009874,CDKN2B,CDK4I; INK4B; MTS2; P15; TP15; p15INK4b,cyclin dependent kinase inhibitor 2B,9p21.3,protein-coding,/
CWITA009875,TCMBANKGE009875,PIP,GCDFP-15; GCDFP15; GPIP4,prolactin induced protein,7q34,protein-coding,/
CWITA009876,TCMBANKGE009876,HMBS,PBG-D; PBGD; PORC; UPS,hydroxymethylbilane synthase,11q23.3,protein-coding,Clinical Trial target
CWITA009877,TCMBANKGE009877,GPC4,K-glypican; KPTS,glypican 4,Xq26.2,protein-coding,/
CWITA009878,TCMBANKGE009878,ZNF165,CT53; LD65; ZSCAN7,zinc finger protein 165,6p22.1,protein-coding,/
CWITA009879,TCMBANKGE009879,POC5,C5orf37,POC5 centriolar protein,5q13.3,protein-coding,/
CWITA009880,TCMBANKGE009880,ZNF217,ZABC1,zinc finger protein 217,20q13.2,protein-coding,Research target
CWITA009881,TCMBANKGE009881,ALDH1B1,ALDH5; ALDHX,aldehyde dehydrogenase 1 family member B1,9p13.1,protein-coding,/
CWITA009882,TCMBANKGE009882,IFNLR1,CRF2/12; IFNLR; IL-28R1; IL28RA; LICR2,interferon lambda receptor 1,1p36.11,protein-coding,/
CWITA009883,TCMBANKGE009883,ZNF572,-,zinc finger protein 572,8q24.13,protein-coding,/
CWITA009884,TCMBANKGE009884,ATP5B,ATPMB; ATPSB; MGC5231,"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",12q13.13,protein-coding,
CWITA009885,TCMBANKGE009885,ATP5IF1,ATPI; ATPIF1; ATPIP; IP,ATP synthase inhibitory factor subunit 1,1p35.3,protein-coding,/
CWITA009886,TCMBANKGE009886,OR11A1,6M1-18; OR11A2; dJ994E9.6; hs6M1-18,olfactory receptor family 11 subfamily A member 1,6p22.1,protein-coding,/
CWITA009887,TCMBANKGE009887,PFN1,N,profilin 1,17p13.3,protein-coding,
CWITA009888,TCMBANKGE009888,CCL26,IMAC; MIP-4a; MIP-4alpha; SCYA26; TSC-1,C-C motif chemokine ligand 26,7q11.23,protein-coding,/
CWITA009889,TCMBANKGE009889,CYP2S1,CYPIIS1,cytochrome P450 family 2 subfamily S member 1,19q13.2,protein-coding,/
CWITA009890,TCMBANKGE009890,CPNE2,COPN2; CPN2,copine 2,16q13,protein-coding,/
CWITA009891,TCMBANKGE009891,SLC5A8,AIT; SMCT; SMCT1,Solute_Carrier_Family_5_Member_8,12q23.1N/Aq23.2,protein-coding,
CWITA009892,TCMBANKGE009892,C9orf152,bA470J20.2,chromosome 9 open reading frame 152,9q31.3,protein-coding,/
CWITA009893,TCMBANKGE009893,GNG12,-,G protein subunit gamma 12,1p31.3,protein-coding,/
CWITA009894,TCMBANKGE009894,GSTM4,GSTM4N4; GTM4; MGC131945; MGC9247,glutathione S-transferase mu 4,1p13.3,protein-coding,
CWITA009895,TCMBANKGE009895,ALDOC,ALDC,"aldolase, fructose-bisphosphate C",17q11.2,protein-coding,/
CWITA009896,TCMBANKGE009896,EEF1E1,AIMP3; P18,eukaryotic translation elongation factor 1 epsilon 1,6p24.3,protein-coding,/
CWITA009897,TCMBANKGE009897,NKX2-2,NKX2.2; NKX2B,NK2 homeobox 2,20p11.22,protein-coding,/
CWITA009898,TCMBANKGE009898,ONECUT3,OC3,one cut homeobox 3,19p13.3,protein-coding,/
CWITA009899,TCMBANKGE009899,PLS1,DFNA76,plastin 1,3q23,protein-coding,/
CWITA009900,TCMBANKGE009900,HMGCL,HL,3-hydroxymethyl-3-methylglutaryl-CoA lyase,1p36.1-p35,protein-coding,
CWITA009901,TCMBANKGE009901,P3H1,GROS1; LEPRE1; OI8,prolyl 3-hydroxylase 1,1p34.2,protein-coding,/
CWITA009902,TCMBANKGE009902,A2ML1,CPAMD9; OMS; p170,alpha-2-macroglobulin like 1,12p13.31,protein-coding,/
CWITA009903,TCMBANKGE009903,MAP7,E-MAP-115; EMAP115,microtubule associated protein 7,6q23.3,protein-coding,/
CWITA009904,TCMBANKGE009904,PSMA6,IOTA; PROS27; p27K,proteasome 20S subunit alpha 6,14q13.2,protein-coding,/
CWITA009905,TCMBANKGE009905,SLC30A9,BILAPES; C4orf1; GAC63; HUEL; ZNT9,solute carrier family 30 member 9,4p13,protein-coding,/
CWITA009906,TCMBANKGE009906,KLRG1,2F1; CLEC15A; MAFA; MAFA-2F1; MAFA-L; MAFA-LIKE,killer cell lectin like receptor G1,12p13.31,protein-coding,/
CWITA009907,TCMBANKGE009907,SMARCAL1,HARP; HHARP,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1",2q35,protein-coding,/
CWITA009908,TCMBANKGE009908,PRPF4B,PR4H; PRP4; PRP4H; PRP4K; dJ1013A10.1,pre-mRNA processing factor 4B,6p25.2,protein-coding,/
CWITA009909,TCMBANKGE009909,TRMT1L,C1orf25; MST070; MSTP070; TRM1L; bG120K12.3,tRNA methyltransferase 1 like,1q25.3,protein-coding,/
CWITA009910,TCMBANKGE009910,ANKRD16,-,ankyrin repeat domain 16,10p15.1,protein-coding,/
CWITA009911,TCMBANKGE009911,BICRA,GLTSCR1,BRD4 interacting chromatin remodeling complex associated protein,19q13.33,protein-coding,/
CWITA009912,TCMBANKGE009912,SSTR3,SS-3-R; SS3-R; SS3R; SSR-28,somatostatin receptor 3,22q13.1,protein-coding,Successful target
CWITA009913,TCMBANKGE009913,ARHGAP26,GRAF; GRAF1; OPHN1L; OPHN1L1,Rho GTPase activating protein 26,5q31.3,protein-coding,/
CWITA009914,TCMBANKGE009914,IFT88,D13S1056E; DAF19; TG737; TTC10; hTg737,intraflagellar transport 88,13q12.11,protein-coding,/
CWITA009915,TCMBANKGE009915,Tas2r140,T2R40; T2r34; TRB3; TRB5; Tas2r13; Tas2r137; Tas2r40; Tas2r8; mTRB3; mt2r64,"taste receptor, type 2, member 140",6 G1|6 64.03 cM,protein-coding,/
CWITA009916,TCMBANKGE009916,HSD3B2,HSD3B; HSDB; SDR11E2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",1p13.1,protein-coding,
CWITA009917,TCMBANKGE009917,ELK4,SAP1,ETS transcription factor ELK4,1q32.1,protein-coding,/
CWITA009918,TCMBANKGE009918,H3P37,H3F3AP2; H3F3CP; p47,H3 histone pseudogene 37,14q11.2,pseudo,/
CWITA009919,TCMBANKGE009919,DPH5,AD-018; CGI-30; HSPC143; NPD015,diphthamide biosynthesis 5,1p21.2,protein-coding,/
CWITA009920,TCMBANKGE009920,SP140L,-,SP140 nuclear body protein like,2q37.1,protein-coding,/
CWITA009921,TCMBANKGE009921,DLX6,-,distal-less homeobox 6,7q21.3,protein-coding,/
CWITA009922,TCMBANKGE009922,GABRG2,CAE2; ECA2; EIEE74; FEB8; GEFSP3,gamma-aminobutyric acid type A receptor subunit gamma2,5q34,protein-coding,Successful target
CWITA009923,TCMBANKGE009923,VDAC2,POR,voltage dependent anion channel 2,10q22.2,protein-coding,Research target
CWITA009924,TCMBANKGE009924,ADCY8,AC8; ADCY3; HBAC1,adenylate cyclase 8,8q24.22,protein-coding,/
CWITA009925,TCMBANKGE009925,KCNMB2,MGC22431,"potassium large conductance calcium-activated channel, subfamily M, beta member 2",3q26.32,protein-coding,
CWITA009926,TCMBANKGE009926,AP1S1,AP19; CLAPS1; EKV3; MEDNIK; SIGMA1A,adaptor related protein complex 1 subunit sigma 1,7q22.1,protein-coding,/
CWITA009927,TCMBANKGE009927,AAMDC,C11orf67; CK067; PTD015,adipogenesis associated Mth938 domain containing,11q14.1,protein-coding,/
CWITA009928,TCMBANKGE009928,RADIL,RASIP2,Rap associating with DIL domain,7p22.1,protein-coding,/
CWITA009929,TCMBANKGE009929,SPNS2,DFNB115; SLC62A2,sphingolipid transporter 2,17p13.2,protein-coding,/
CWITA009930,TCMBANKGE009930,FANK1,HSD13,fibronectin type III and ankyrin repeat domains 1,10q26.2,protein-coding,/
CWITA009931,TCMBANKGE009931,ADPGK,2610017G09Rik; ADP-GK,ADP dependent glucokinase,15q24.1,protein-coding,/
CWITA009932,TCMBANKGE009932,XAB2,HCNP; HCRN; NTC90; SYF1,XPA binding protein 2,19p13.2,protein-coding,/
CWITA009933,TCMBANKGE009933,TPSAB1,TPS1; TPS2; TPSB1; TPSB2; Tryptase-2,tryptase alpha/beta 1,16p13.3,protein-coding,Successful target
CWITA009934,TCMBANKGE009934,SGCD,35DAG; CMD1L; DAGD; LGMDR6; SG-delta; SGCDP; SGD,sarcoglycan delta,5q33.2-q33.3,protein-coding,/
CWITA009935,TCMBANKGE009935,ZNF45,KOX5; ZNF13,zinc finger protein 45,19q13.31,protein-coding,/
CWITA009936,TCMBANKGE009936,CALML6,CAGLP,calmodulin like 6,1p36.33,protein-coding,/
CWITA009937,TCMBANKGE009937,CYP1A1,AHH; AHRR; CP11; CYP1; P1N450; P450NC; P450DX,"cytochrome P450, family 1, subfamily A, polypeptide 1",15q24.1,protein-coding,
CWITA009938,TCMBANKGE009938,MAGI2,ACVRIP1; AIP-1; AIP1; ARIP1; MAGI-2; NPHS15; SSCAM,"membrane associated guanylate kinase, WW and PDZ domain containing 2",7q21.11,protein-coding,/
CWITA009939,TCMBANKGE009939,SLC1A6,EAAT4,solute carrier family 1 member 6,19p13.12,protein-coding,Research target
CWITA009940,TCMBANKGE009940,PARL,PRO2207; PSARL; PSARL1; PSENIP2; RHBDS1,presenilin associated rhomboid like,3q27.1,protein-coding,/
CWITA009941,TCMBANKGE009941,SLC2A1,DYT17; DYT18; GLUT; GLUT1; GLUT1DS; MGC141895; MGC141896; PED,"solute carrier family 2 (facilitated glucose transporter), member 1",1p34.2,protein-coding,
CWITA009942,TCMBANKGE009942,TAS2R16,BGLPT; T2R16,taste 2 receptor member 16,7q31.32|7q31,protein-coding,/
CWITA009943,TCMBANKGE009943,UBA6,E1-L2; MOP-4; UBE1L2,ubiquitin like modifier activating enzyme 6,4q13.2,protein-coding,/
CWITA009944,TCMBANKGE009944,SYT10,-,synaptotagmin 10,12p11.1,protein-coding,/
CWITA009945,TCMBANKGE009945,KDM6B,JMJD3; NEDCFSA,lysine demethylase 6B,17p13.1,protein-coding,Research target
CWITA009946,TCMBANKGE009946,EFHC1,EJM1; POC9; RIB72; dJ304B14.2,EF-hand domain containing 1,6p12.2,protein-coding,/
CWITA009947,TCMBANKGE009947,TRDMT1,DMNT2; DNMT2; MHSAIIP; PUMET; RNMT1,tRNA aspartic acid methyltransferase 1,10p15.1,protein-coding,
CWITA009948,TCMBANKGE009948,CCL5,D17S136E; MGC17164; RANTES; SCYA5; SISd; TCP228,chemokine (C-C motif) ligand 5,17q11.2-q12,protein-coding,
CWITA009949,TCMBANKGE009949,GLTP,N,glycolipid transfer protein,12q24.11,protein-coding,
CWITA009950,TCMBANKGE009950,PDXDC1,LP8165,pyridoxal dependent decarboxylase domain containing 1,16p13.11,protein-coding,/
CWITA009951,TCMBANKGE009951,CACNA1S,CACNL1A3; CCHL1A3; Cav1.1; HOKPP; HOKPP1; MHS5; TTPP1; hypoPP,calcium voltage-gated channel subunit alpha1 S,1q32.1,protein-coding,Research target
CWITA009952,TCMBANKGE009952,TRIM49,RNF18; TRIM49A; TRIM49L2,tripartite motif containing 49,11q14.3,protein-coding,/
CWITA009953,TCMBANKGE009953,NEB,NEB177D; NEM2,nebulin,2q23.3,protein-coding,/
CWITA009954,TCMBANKGE009954,ZNF337,-,zinc finger protein 337,20p11.21,protein-coding,/
CWITA009955,TCMBANKGE009955,CA7,CAVII,carbonic anhydrase VII,16q22.1,protein-coding,
CWITA009956,TCMBANKGE009956,LITAF,PIG7; SIMPLE; TP53I7,lipopolysaccharide induced TNF factor,16p13.13,protein-coding,/
CWITA009957,TCMBANKGE009957,GNA14,-,G protein subunit alpha 14,9q21.2,protein-coding,/
CWITA009958,TCMBANKGE009958,NPB,L7; PPL7; PPNPB,neuropeptide B,17q25.3,protein-coding,/
CWITA009959,TCMBANKGE009959,SLC22A24,NET46,solute carrier family 22 member 24,11q12.3,protein-coding,/
CWITA009960,TCMBANKGE009960,RBM19,Mrd1,RNA binding motif protein 19,12q24.13-q24.21,protein-coding,/
CWITA009961,TCMBANKGE009961,RPS6KA6,PP90RSK4; RSK-4; RSK4; S6K-alpha-6; p90RSK6,ribosomal protein S6 kinase A6,Xq21.1,protein-coding,Research target
CWITA009962,TCMBANKGE009962,PSG4,PSBG-4; PSBG-9; PSG9,pregnancy specific beta-1-glycoprotein 4,19q13.31,protein-coding,/
CWITA009963,TCMBANKGE009963,PRNP,ASCR; CD230; CJD; GSS; MGC26679; PRIP; PrP; PrP27N30; PrP33N35C; PrPc; prion,prion protein,20p13,protein-coding,
CWITA009964,TCMBANKGE009964,MSANTD3,C9orf30; L8,Myb/SANT DNA binding domain containing 3,9q31.1,protein-coding,/
CWITA009965,TCMBANKGE009965,TP53I3,PIG3,tumor protein p53 inducible protein 3,2p23.3,protein-coding,/
CWITA009966,TCMBANKGE009966,ACAN,AGC1; AGCAN; CSPG1; CSPGCP; MSK16; SEDK; SSOAOD,aggrecan,15q26.1,protein-coding,/
CWITA009967,TCMBANKGE009967,DSG4,CDGF13; CDHF13; HYPT6; LAH,desmoglein 4,18q12.1,protein-coding,/
CWITA009968,TCMBANKGE009968,NPC2,EDDM1; HE1,NPC intracellular cholesterol transporter 2,14q24.3,protein-coding,/
CWITA009969,TCMBANKGE009969,ERVK-25,PR; Protease; Proteinase; c11_A,endogenous retrovirus group K member 25,11q22.1,other,/
CWITA009970,TCMBANKGE009970,PPP1CB,HEL-S-80p; MP; NSLH2; PP-1B; PP1B; PP1beta; PP1c; PPP1CD; PPP1beta,protein phosphatase 1 catalytic subunit beta,2p23.2,protein-coding,/
CWITA009971,TCMBANKGE009971,ZNF836,-,zinc finger protein 836,19q13.41,protein-coding,/
CWITA009972,TCMBANKGE009972,ANKRD30BL,ANKRD30BP3; NCRNA00164,ankyrin repeat domain 30B like,2q21.2,protein-coding,/
CWITA009973,TCMBANKGE009973,ZNF277,NRIF4; ZNF277P,zinc finger protein 277,7q31.1,protein-coding,/
CWITA009974,TCMBANKGE009974,CLOCK,KAT13D; bHLHe8,clock circadian regulator,4q12,protein-coding,/
CWITA009975,TCMBANKGE009975,LAMC2,B2T; BM600; CSF; EBR2; EBR2A; LAMB2T; LAMNB2,laminin subunit gamma 2,1q25.3,protein-coding,Research target
CWITA009976,TCMBANKGE009976,TRIM34,IFP1; RNF21,tripartite motif containing 34,11p15.4,protein-coding,/
CWITA009977,TCMBANKGE009977,SPTBN2,GTRAP41; SCA5; SCAR14,"spectrin beta, non-erythrocytic 2",11q13.2,protein-coding,/
CWITA009978,TCMBANKGE009978,FAM204A,C10orf84; bA319I23.1,family with sequence similarity 204 member A,10q26.11,protein-coding,/
CWITA009979,TCMBANKGE009979,PRKAR1B,PRKAR1,protein kinase cAMP-dependent type I regulatory subunit beta,7p22.3,protein-coding,/
CWITA009980,TCMBANKGE009980,AP3B1,ADTB3; ADTB3A; HPS; HPS2; PE,adaptor related protein complex 3 subunit beta 1,5q14.1,protein-coding,/
CWITA009981,TCMBANKGE009981,GRM7,GLUR7; GPRC1G; MGLU7; MGLUR7; PPP1R87,glutamate metabotropic receptor 7,3p26.1,protein-coding,Research target
CWITA009982,TCMBANKGE009982,PREPL,CMS22,prolyl endopeptidase like,2p21,protein-coding,Research target
CWITA009983,TCMBANKGE009983,TRAPPC3,BET3,trafficking protein particle complex 3,1p34.3,protein-coding,
CWITA009984,TCMBANKGE009984,B9D1,B9; EPPB9; JBTS27; MKS9; MKSR-1; MKSR1,B9 domain containing 1,17p11.2,protein-coding,/
CWITA009985,TCMBANKGE009985,P2RX4,P2X4; P2X4R,purinergic receptor P2X 4,12q24.31,protein-coding,Clinical Trial target
CWITA009986,TCMBANKGE009986,WDR45,JM5; NBIA4; NBIA5; WDRX1; WIPI-4; WIPI4,WD repeat domain 45,Xp11.23,protein-coding,/
CWITA009987,TCMBANKGE009987,PCNA,MGC8367,proliferating cell nuclear antigen,20pter-p12,protein-coding,
CWITA009988,TCMBANKGE009988,SLC22A9,HOAT4; OAT4; OAT7; UST3H; ust3,solute carrier family 22 member 9,11q12.3,protein-coding,/
CWITA009989,TCMBANKGE009989,ZNF707,-,zinc finger protein 707,8q24.3,protein-coding,/
CWITA009990,TCMBANKGE009990,TSPAN3,TM4-A; TM4SF8; TSPAN-3,tetraspanin 3,15q24.3,protein-coding,/
CWITA009991,TCMBANKGE009991,Il1,Il-1,interleukin 1 complex,-,other,/
CWITA009992,TCMBANKGE009992,ABCC8,ABC36; HHF1; HI; HRINS; MRP8; PHHI; PNDM3; SUR; SUR1; SUR1delta2; TNDM2,ATP binding cassette subfamily C member 8,11p15.1,protein-coding,Successful target
CWITA009993,TCMBANKGE009993,SERPINA7,TBG; TBGQTL,serpin family A member 7,Xq22.3,protein-coding,/
CWITA009994,TCMBANKGE009994,MBD2,DMTase; NY-CO-41,methyl-CpG binding domain protein 2,18q21.2,protein-coding,/
CWITA009995,TCMBANKGE009995,ACTG1,ACT; ACTG; DFNA20; DFNA26; HEL-176,actin gamma 1,17q25.3,protein-coding,Research target
CWITA009996,TCMBANKGE009996,UQCRFS1,RIP1; RIS1; RISP; UQCR5,"ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1",19q12,protein-coding,
CWITA009997,TCMBANKGE009997,PER1,PER; RIGUI; hPER,period circadian regulator 1,17p13.1,protein-coding,/
CWITA009998,TCMBANKGE009998,MMAB,ATR; MGC20496; cblB; cob,methylmalonic aciduria (cobalamin deficiency) cblB type,12q24,protein-coding,
CWITA009999,TCMBANKGE009999,FZD8,FZ-8; hFZ8,frizzled class receptor 8,10p11.21,protein-coding,/
CWITA010000,TCMBANKGE010000,SLC29A2,DER12; ENT2; HNP36,solute carrier family 29 member 2,11q13.2,protein-coding,/
CWITA010001,TCMBANKGE010001,KRAS,CNKNRAS; KNRAS2A; KNRAS2B; KNRAS4A; KNRAS4B; KINRAS; KRAS1; KRAS2; NS; NS3; RASK2,v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,12p12.1,protein-coding,
CWITA010002,TCMBANKGE010002,MBOAT1,LPEAT1; LPLAT; LPLAT 1; LPSAT; OACT1; dJ434O11.1,membrane bound O-acyltransferase domain containing 1,6p22.3,protein-coding,/
CWITA010003,TCMBANKGE010003,ANKRD18B,bA255A11.3; bA255A11.5,ankyrin repeat domain 18B,9p13.3,protein-coding,/
CWITA010004,TCMBANKGE010004,VGLL1,TDU; VGL1,vestigial like family member 1,Xq26.3,protein-coding,/
CWITA010005,TCMBANKGE010005,REG1B,PSPS2; REGH; REGI-BETA; REGL,regenerating family member 1 beta,2p12,protein-coding,/
CWITA010006,TCMBANKGE010006,EIF4A2,BM-010; DDX2B; EIF4A; EIF4F; eIF-4A-II; eIF4A-II,eukaryotic translation initiation factor 4A2,3q27.3,protein-coding,/
CWITA010007,TCMBANKGE010007,TP53RK,BUD32; C20orf64; GAMOS4; Nori-2; Nori-2p; PRPK; TPRKB; dJ101A2,TP53 regulating kinase,20q13.12,protein-coding,/
CWITA010008,TCMBANKGE010008,PRMT1,ANM1; HCP1; HRMT1L2; IR1B4,protein arginine methyltransferase 1,19q13.3,protein-coding,
CWITA010009,TCMBANKGE010009,ALAS1,ALAS; ALAS3; ALASH; MIG4,"aminolevulinate, delta-, synthase 1",3p21.1,protein-coding,
CWITA010010,TCMBANKGE010010,ZWINT,HZwint-1; KNTC2AP; SIP30; ZWINT1,ZW10 interacting kinetochore protein,10q21.1,protein-coding,Research target
CWITA010011,TCMBANKGE010011,HEXB,ENCN1AS,hexosaminidase B (beta polypeptide),5q13,protein-coding,
CWITA010012,TCMBANKGE010012,PMP2,FABP8; MNFABP; MP2; P2,peripheral myelin protein 2,8q21.3-q22.1,protein-coding,
CWITA010013,TCMBANKGE010013,USP25,USP21,ubiquitin specific peptidase 25,21q21.1,protein-coding,/
CWITA010014,TCMBANKGE010014,PPP1R3B,GL; PPP1R4; PTG,protein phosphatase 1 regulatory subunit 3B,8p23.1,protein-coding,/
CWITA010015,TCMBANKGE010015,RLBP1,CRALBP,retinaldehyde binding protein 1,15q26.1,protein-coding,/
CWITA010016,TCMBANKGE010016,OXTR,OTNR,oxytocin receptor,3p25,protein-coding,
CWITA010017,TCMBANKGE010017,FAAP24,C19orf40,FA core complex associated protein 24,19q13.11,protein-coding,/
CWITA010018,TCMBANKGE010018,ADGRG3,GPR97; PB99; PGR26,adhesion G protein-coupled receptor G3,16q21,protein-coding,/
CWITA010019,TCMBANKGE010019,FYN,MGC45350; SLK; SYN,"FYN oncogene related to SRC, FGR, YES",6q21,protein-coding,
CWITA010020,TCMBANKGE010020,TSTA3,FX; P35B; SDR4E1,tissue specific transplantation antigen P35B,8q24.3,protein-coding,
CWITA010021,TCMBANKGE010021,CHGB,SCG1,chromogranin B,20p12.3,protein-coding,/
CWITA010022,TCMBANKGE010022,SERINC3,AIGP1; DIFF33; SBBI99; TDE; TDE1; TMS-1,serine incorporator 3,20q13.12,protein-coding,/
CWITA010023,TCMBANKGE010023,HCFC1,CFF; HCF; HCF-1; HCF1; HFC1; MRX3; PPP1R89; VCAF,host cell factor C1,Xq28,protein-coding,/
CWITA010024,TCMBANKGE010024,COQ2,CL640; FLJ13014; FLJ26072,"Coenzyme Q2 Homolog, Prenyltransferase (Yeast)",4q21.23,protein-coding,
CWITA010025,TCMBANKGE010025,CEP192,PPP1R62,centrosomal protein 192,18p11.21,protein-coding,/
CWITA010026,TCMBANKGE010026,CD1B,CD1; CD1A; R1,CD1b molecule,1q23.1,protein-coding,/
CWITA010027,TCMBANKGE010027,TAT,N,tyrosine aminotransferase,16q22.1,protein-coding,
CWITA010028,TCMBANKGE010028,NXPE3,FAM55C; MST115; MSTP115,neurexophilin and PC-esterase domain family member 3,3q12.3,protein-coding,/
CWITA010029,TCMBANKGE010029,NAP1L3,MB20; NPL3,nucleosome assembly protein 1 like 3,Xq21.32,protein-coding,/
CWITA010030,TCMBANKGE010030,VCL,CMD1W; CMH15; HEL114; MV; MVCL,vinculin,10q22.2,protein-coding,/
CWITA010031,TCMBANKGE010031,AHCYL2,ADOHCYASE3; IRBIT2,adenosylhomocysteinase like 2,7q32.1,protein-coding,/
CWITA010032,TCMBANKGE010032,UBR5,DD5; EDD; EDD1; HYD,ubiquitin protein ligase E3 component n-recognin 5,8q22.3,protein-coding,/
CWITA010033,TCMBANKGE010033,ZNF558,-,zinc finger protein 558,19p13.2,protein-coding,/
CWITA010034,TCMBANKGE010034,ANKH,ANK; CCAL2; CMDJ; CPPDD; HANK; MANK; SLC62A1,ANKH inorganic pyrophosphate transport regulator,5p15.2,protein-coding,/
CWITA010035,TCMBANKGE010035,SLC25A12,AGC1; ARALAR; EIEE39,solute carrier family 25 member 12,2q31.1,protein-coding,/
CWITA010036,TCMBANKGE010036,AHSG,A2HS; AHS; APMR1; FETUA; HSGA,alpha 2-HS glycoprotein,3q27.3,protein-coding,Clinical Trial target
CWITA010037,TCMBANKGE010037,FBXO6,FBG2; FBS2; FBX6; Fbx6b,F-box protein 6,1p36.22,protein-coding,/
CWITA010038,TCMBANKGE010038,DNPEP,ASPEP; DAP,aspartyl aminopeptidase,2q35,protein-coding,
CWITA010039,TCMBANKGE010039,TMEM9B,C11orf15,TMEM9 domain family member B,11p15.4,protein-coding,/
CWITA010040,TCMBANKGE010040,TSPYL4,dJ486I3.2,TSPY like 4,6q22.1,protein-coding,/
CWITA010041,TCMBANKGE010041,CDH6,CAD6; KCAD,cadherin 6,5p13.3,protein-coding,/
CWITA010042,TCMBANKGE010042,RPL35A,DBA5; L35A; eL33,ribosomal protein L35a,3q29,protein-coding,/
CWITA010043,TCMBANKGE010043,PPIF,CYP3; CyP-M; Cyp-D; CypD,peptidylprolyl isomerase F,10q22.3,protein-coding,Research target
CWITA010044,TCMBANKGE010044,CREBZF,SMILE; ZF,CREB/ATF bZIP transcription factor,11q14.1,protein-coding,/
CWITA010045,TCMBANKGE010045,HAO1,GOX; GOX1; HAOX1; MGC142225; MGC142227,hydroxyacid oxidase (glycolate oxidase) 1,20p12,protein-coding,
CWITA010046,TCMBANKGE010046,TAS1R1,GM148; GPR70; T1R1; TR1,taste 1 receptor member 1,1p36.31,protein-coding,/
CWITA010047,TCMBANKGE010047,TUBGCP6,GCP-6; GCP6; MCCRP; MCCRP1; MCPHCR,tubulin gamma complex associated protein 6,22q13.33,protein-coding,/
CWITA010048,TCMBANKGE010048,PSMA8,PSMA7L,proteasome 20S subunit alpha 8,18q11.2,protein-coding,/
CWITA010049,TCMBANKGE010049,LIPF,GL; HGL; HLAL; MGC138477; MGC142271,"lipase, gastric",10q23.31,protein-coding,
CWITA010050,TCMBANKGE010050,C3orf52,TTMP,chromosome 3 open reading frame 52,3q13.2,protein-coding,/
CWITA010051,TCMBANKGE010051,KDM4E,JMJD2E; KDM4DL; KDM5E,lysine demethylase 4E,11q21,protein-coding,Patented target
CWITA010052,TCMBANKGE010052,H3P40,p50,H3 histone pseudogene 40,15q26.2,pseudo,/
CWITA010053,TCMBANKGE010053,RGS20,RGSZ1; ZGAP1; g(z)GAP; gz-GAP,regulator of G protein signaling 20,8q11.23,protein-coding,/
CWITA010054,TCMBANKGE010054,KIRREL2,FILTRIN; NEPH3; NLG1,kirre like nephrin family adhesion molecule 2,19q13.12,protein-coding,/
CWITA010055,TCMBANKGE010055,CHST5,I-GlcNAc-6-ST; I-GlcNAc6ST; glcNAc6ST-3; gn6st-3; hIGn6ST,carbohydrate sulfotransferase 5,16q23.1,protein-coding,Research target
CWITA010056,TCMBANKGE010056,ZNF233,-,zinc finger protein 233,19q13.31,protein-coding,/
CWITA010057,TCMBANKGE010057,TSHZ3,TSH3; ZNF537,teashirt zinc finger homeobox 3,19q12,protein-coding,/
CWITA010058,TCMBANKGE010058,MAP4K1,HPK1,mitogen-activated protein kinase kinase kinase kinase 1,19q13.2,protein-coding,Research target
CWITA010059,TCMBANKGE010059,NADSYN1,FLJ10631; FLJ36703; FLJ40627,NAD synthetase 1,11q13.4,protein-coding,
CWITA010060,TCMBANKGE010060,POMC,ACTH; CLIP; LPH; MSH; NPP; POC,proopiomelanocortin,2p23.3,protein-coding,
CWITA010061,TCMBANKGE010061,ZNF736,-,zinc finger protein 736,7q11.21,protein-coding,/
CWITA010062,TCMBANKGE010062,NFU1,CGI-33; HIRIP; HIRIP5; MMDS1; NIFUC; Nfu; NifU,NFU1 iron-sulfur cluster scaffold,2p13.3,protein-coding,/
CWITA010063,TCMBANKGE010063,CNOT2,CDC36; HSPC131; IDNADFS; NOT2; NOT2H,CCR4-NOT transcription complex subunit 2,12q15,protein-coding,/
CWITA010064,TCMBANKGE010064,ANKRD12,ANCO-2; ANCO1; GAC-1; Nbla00144,ankyrin repeat domain 12,18p11.22,protein-coding,/
CWITA010065,TCMBANKGE010065,SEC14L4,TAP3,SEC14-like 4 (S. cerevisiae),22q12.2,protein-coding,
CWITA010066,TCMBANKGE010066,FKBP8,FKBP38; FKBPr38,FKBP prolyl isomerase 8,19p13.11,protein-coding,/
CWITA010067,TCMBANKGE010067,NALCN,CLIFAHDD; CanIon; IHPRF; IHPRF1; INNFD; VGCNL1; bA430M15.1,"sodium leak channel, non-selective",13q32.3-q33.1,protein-coding,/
CWITA010068,TCMBANKGE010068,NSUN7,-,NOP2/Sun RNA methyltransferase family member 7,4p14,protein-coding,/
CWITA010069,TCMBANKGE010069,SNX14,RGS-PX2; SCAR20,sorting nexin 14,6q14.3,protein-coding,/
CWITA010070,TCMBANKGE010070,AKTIP,FT1; FTS,AKT interacting protein,16q12.2,protein-coding,/
CWITA010071,TCMBANKGE010071,PCDHGB2,PCDH-GAMMA-B2,"protocadherin gamma subfamily B, 2",5q31.3,protein-coding,/
CWITA010072,TCMBANKGE010072,SERPINB3,HsT1196; SCC; SCCA-1; SCCA-PD; SCCA1; SSCA1; T4-A,serpin family B member 3,18q21.33,protein-coding,Research target
CWITA010073,TCMBANKGE010073,IL12B,CLMF; CLMF2; ILN12B; NKSF; NKSF2,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)",5q31.1-q33.1,protein-coding,
CWITA010074,TCMBANKGE010074,PPP1CA,MGC15877; MGC1674; PPN1A; PP1alpha; PPP1A,"protein phosphatase 1, catalytic subunit, alpha isozyme",11q13,protein-coding,
CWITA010075,TCMBANKGE010075,CPQ,LDP; PGCP,carboxypeptidase Q,8q22.1,protein-coding,/
CWITA010076,TCMBANKGE010076,PCDHB15,PCDH-BETA15,protocadherin beta 15,5q31.3,protein-coding,/
CWITA010077,TCMBANKGE010077,RAPGEFL1,Link-GEFII,Rap guanine nucleotide exchange factor like 1,17q21.1,protein-coding,/
CWITA010078,TCMBANKGE010078,PWWP2A,MST101,PWWP domain containing 2A,5q33.3,protein-coding,/
CWITA010079,TCMBANKGE010079,ADSS1,ADSSL1; MPD5,adenylosuccinate synthase 1,14q32.33,protein-coding,/
CWITA010080,TCMBANKGE010080,PXDC1,C6orf145,PX domain containing 1,6p25.2,protein-coding,/
CWITA010081,TCMBANKGE010081,KCNK16,K2p16.1; TALK-1; TALK1,potassium two pore domain channel subfamily K member 16,6p21.2,protein-coding,/
CWITA010082,TCMBANKGE010082,BBS5,-,Bardet-Biedl syndrome 5,2q31.1,protein-coding,/
CWITA010083,TCMBANKGE010083,PLEKHA8,FAPP2,pleckstrin homology domain containing A8,7p14.3,protein-coding,/
CWITA010084,TCMBANKGE010084,HP1BP3,HP1-BP74; HP1BP74,heterochromatin protein 1 binding protein 3,1p36.12,protein-coding,/
CWITA010085,TCMBANKGE010085,C1orf198,-,chromosome 1 open reading frame 198,1q42.2,protein-coding,/
CWITA010086,TCMBANKGE010086,LRFN2,FIGLER2; KIAA1246; SALM1,leucine rich repeat and fibronectin type III domain containing 2,6p21.2-p21.1,protein-coding,/
CWITA010087,TCMBANKGE010087,TFRC,CD71; IMD46; T9; TFR; TFR1; TR; TRFR; p90,transferrin receptor,3q29,protein-coding,Research target
CWITA010088,TCMBANKGE010088,GCFC2,C2orf3; DNABF; GCF; TCF9,GC-rich sequence DNA-binding factor 2,2p12,protein-coding,/
CWITA010089,TCMBANKGE010089,CDT1,DUP; RIS2,chromatin licensing and DNA replication factor 1,16q24.3,protein-coding,/
CWITA010090,TCMBANKGE010090,NFATC2,NFAT1; NFATP,nuclear factor of activated T cells 2,20q13.2,protein-coding,/
CWITA010091,TCMBANKGE010091,GNB2,-,G protein subunit beta 2,7q22.1,protein-coding,/
CWITA010092,TCMBANKGE010092,GSTT2B,GSTT2P,glutathione S-transferase theta 2B,22q11.23,protein-coding,/
CWITA010093,TCMBANKGE010093,GYPB,CD235b; GPB; GYP; GYPA; MNS; PAS-3; SS,glycophorin B (MNS blood group),4q31.21,protein-coding,/
CWITA010094,TCMBANKGE010094,COMTD1,-,catechol-O-methyltransferase domain containing 1,10q22.2,protein-coding,/
CWITA010095,TCMBANKGE010095,ALDH2,ALDHNE2; ALDHI; ALDM; MGC1806,aldehyde dehydrogenase 2 family (mitochondrial),12q24.2,protein-coding,
CWITA010096,TCMBANKGE010096,CARD16,COP; COP1; PSEUDO-ICE,caspase recruitment domain family member 16,11q22.3,protein-coding,/
CWITA010097,TCMBANKGE010097,BRPF3,-,bromodomain and PHD finger containing 3,6p21.31,protein-coding,Research target
CWITA010098,TCMBANKGE010098,Sbp,AV082137; AV082259; p25,spermine binding protein,17|17 A3.3,protein-coding,/
CWITA010099,TCMBANKGE010099,ZDHHC17,DHHC-17; HIP14; HIP3; HSPC294; HYPH,zinc finger DHHC-type palmitoyltransferase 17,12q21.2,protein-coding,/
CWITA010100,TCMBANKGE010100,PHF3,-,PHD finger protein 3,6q12,protein-coding,/
CWITA010101,TCMBANKGE010101,SNRPA1,Lea1; U2A',small nuclear ribonucleoprotein polypeptide A',15q26.3,protein-coding,/
CWITA010102,TCMBANKGE010102,WSCD1,-,WSC domain containing 1,17p13.2,protein-coding,/
CWITA010103,TCMBANKGE010103,OPTN,ALS12; FIP2; GLC1E; HIP7; HYPL; NRP; TFIIIA-INTP,optineurin,10p13,protein-coding,/
CWITA010104,TCMBANKGE010104,LYPLA2,APT-2; APT2; DJ886K2.4,lysophospholipase 2,1p36.11,protein-coding,/
CWITA010105,TCMBANKGE010105,PLXNB1,PLEXIN-B1; PLXN5; SEP,plexin B1,3p21.31,protein-coding,/
CWITA010106,TCMBANKGE010106,HSD17B11,17-BETA-HSD11; 17-BETA-HSDXI; 17BHSD11; DHRS8; PAN1B; RETSDR2; SDR16C2,hydroxysteroid 17-beta dehydrogenase 11,4q22.1,protein-coding,/
CWITA010107,TCMBANKGE010107,PLA2G2D,PLA2IID; SPLASH; sPLA2-IID; sPLA2S,phospholipase A2 group IID,1p36.12,protein-coding,/
CWITA010108,TCMBANKGE010108,PIK3R1,GRB1; p85; p85NALPHA,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",5q13.1,protein-coding,
CWITA010109,TCMBANKGE010109,MORC3,NXP2; ZCW5; ZCWCC3,MORC family CW-type zinc finger 3,21q22.12,protein-coding,/
CWITA010110,TCMBANKGE010110,C2orf49,asw,chromosome 2 open reading frame 49,2q12.2,protein-coding,/
CWITA010111,TCMBANKGE010111,LRRC32,D11S833E; GARP,leucine rich repeat containing 32,11q13.5,protein-coding,/
CWITA010112,TCMBANKGE010112,ADAP2,CENTA2; HSA272195; cent-b,ArfGAP with dual PH domains 2,17q11.2,protein-coding,/
CWITA010113,TCMBANKGE010113,KIF3B,FLA8; HH0048; KLP-11,kinesin family member 3B,20q11.21,protein-coding,/
CWITA010114,TCMBANKGE010114,PALMD,C1orf11; PALML,palmdelphin,1p21.2,protein-coding,Research target
CWITA010115,TCMBANKGE010115,NDUFA1,CI-MWFE; MC1DN12; MWFE; ZNF183,NADH:ubiquinone oxidoreductase subunit A1,Xq24,protein-coding,/
CWITA010116,TCMBANKGE010116,ZBTB26,ZNF481; bioref,zinc finger and BTB domain containing 26,9q33.2,protein-coding,/
CWITA010117,TCMBANKGE010117,DDX18,Has1; MrDb,DEAD-box helicase 18,2q14.1,protein-coding,/
CWITA010118,TCMBANKGE010118,PPIL6,PPIase; RSPH12; bA425D10.6; dJ919F19.1,peptidylprolyl isomerase like 6,6q21,protein-coding,/
CWITA010119,TCMBANKGE010119,DOK5,C20orf180; IRS-6; IRS6,docking protein 5,20q13.2,protein-coding,/
CWITA010120,TCMBANKGE010120,BCAS1,AIBC1; NABC1; PMES-2,brain enriched myelin associated protein 1,20q13.2,protein-coding,/
CWITA010121,TCMBANKGE010121,PPIG,CARS-Cyp; CYP; SCAF10; SRCyp,peptidylprolyl isomerase G,2q31.1,protein-coding,/
CWITA010122,TCMBANKGE010122,PIP5K1B,MSS4; STM7,phosphatidylinositol-4-phosphate 5-kinase type 1 beta,9q21.11,protein-coding,/
CWITA010123,TCMBANKGE010123,PCP4,PEP-19,Purkinje cell protein 4,21q22.2,protein-coding,/
CWITA010124,TCMBANKGE010124,DHRS1,SDR19C1,dehydrogenase/reductase 1,14q12,protein-coding,/
CWITA010125,TCMBANKGE010125,ACR,-,acrosin,22q13.33,protein-coding,Research target
CWITA010126,TCMBANKGE010126,IL15RA,CD215,interleukin 15 receptor subunit alpha,10p15.1,protein-coding,Clinical Trial target
CWITA010127,TCMBANKGE010127,WNT10A,OODD; SSPS; STHAG4,Wnt family member 10A,2q35,protein-coding,/
CWITA010128,TCMBANKGE010128,RRM2B,DKFZp686M05248; MGC102856; MGC42116; MTDPS8A; MTDPS8B; P53R2,ribonucleotide reductase M2 B (TP53 inducible),8q23.1,protein-coding,
CWITA010129,TCMBANKGE010129,TSEN34,LENG5; PCH2C; SEN34; SEN34L,tRNA splicing endonuclease subunit 34,19q13.42,protein-coding,/
CWITA010130,TCMBANKGE010130,BBOX1,BBH; BBOX; G-BBH; gamma-BBH,gamma-butyrobetaine hydroxylase 1,11p14.2,protein-coding,/
CWITA010131,TCMBANKGE010131,YPEL5,CGI-127,yippee like 5,2p23.1,protein-coding,/
CWITA010132,TCMBANKGE010132,KCNMB4,-,potassium calcium-activated channel subfamily M regulatory beta subunit 4,12q15,protein-coding,Clinical Trial target
CWITA010133,TCMBANKGE010133,MYL4,ALC1; AMLC; GT1; PRO1957,myosin light chain 4,17q21.32,protein-coding,/
CWITA010134,TCMBANKGE010134,MYH11,AAT4; FAA4; SMHC; SMMHC,myosin heavy chain 11,16p13.11,protein-coding,/
CWITA010135,TCMBANKGE010135,NOS2,HEPNNOS; INOS; NOS; NOS2A,"nitric oxide synthase 2, inducible",17q11.2-q12,protein-coding,
CWITA010136,TCMBANKGE010136,PEBP1,HCNP; HCNPpp; HEL-210; HEL-S-34; HEL-S-96; PBP; PEBP; PEBP-1; RKIP,phosphatidylethanolamine binding protein 1,12q24.23,protein-coding,Research target
CWITA010137,TCMBANKGE010137,GSTA4,DKFZp686D21185; GSTA4N4; GTA4,glutathione S-transferase alpha 4,6p12.1,protein-coding,
CWITA010138,TCMBANKGE010138,SLC30A10,HMDPC; HMNDYT1; ZNT10; ZNT8; ZRC1; ZnT-10,solute carrier family 30 member 10,1q41,protein-coding,/
CWITA010139,TCMBANKGE010139,MMP26,-,matrix metallopeptidase 26,11p15.4,protein-coding,/
CWITA010140,TCMBANKGE010140,FANCI,KIAA1794,FA complementation group I,15q26.1,protein-coding,/
CWITA010141,TCMBANKGE010141,ZNF610,-,zinc finger protein 610,19q13.41,protein-coding,/
CWITA010142,TCMBANKGE010142,ZG16B,EECP; HRPE773; JCLN2; PAUF; PRO1567,zymogen granule protein 16B,16p13.3,protein-coding,/
CWITA010143,TCMBANKGE010143,RGS7,-,regulator of G protein signaling 7,1q43|1q23.1,protein-coding,/
CWITA010144,TCMBANKGE010144,POLR2M,GCOM1; GRINL1A; Gdown; Gdown1,RNA polymerase II subunit M,15q21.3,protein-coding,/
CWITA010145,TCMBANKGE010145,RHOBTB3,-,Rho related BTB domain containing 3,5q15,protein-coding,/
CWITA010146,TCMBANKGE010146,PDLIM5,ENH; ENH1; L9; LIM,PDZ and LIM domain 5,4q22.3,protein-coding,/
CWITA010147,TCMBANKGE010147,ABCC9,ABC37; CMD1O; FLJ36852; SUR2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",12p12.1,protein-coding,
CWITA010148,TCMBANKGE010148,CKAP2L,-,cytoskeleton associated protein 2 like,2q14.1,protein-coding,/
CWITA010149,TCMBANKGE010149,MAD1L1,MAD1; PIG9; TP53I9; TXBP181,mitotic arrest deficient 1 like 1,7p22.3,protein-coding,Research target
CWITA010150,TCMBANKGE010150,MMP20,AI2A2; MMPN20,matrix metallopeptidase 20,11q22.3,protein-coding,
CWITA010151,TCMBANKGE010151,DCAF6,1200006M05Rik; ARCAP; IQWD1; MSTP055; NRIP; PC326,DDB1 and CUL4 associated factor 6,1q24.2,protein-coding,/
CWITA010152,TCMBANKGE010152,DYRK3,DYRK5; RED; REDK; hYAK3-2,dual specificity tyrosine phosphorylation regulated kinase 3,1q32.1,protein-coding,Patented target
CWITA010153,TCMBANKGE010153,H2AC7,H2A.3; H2A/g; H2AFG; HIST1H2AD,H2A clustered histone 7,6p22.2,protein-coding,/
CWITA010154,TCMBANKGE010154,SEC24A,-,"SEC24 homolog A, COPII coat complex component",5q31.1,protein-coding,/
CWITA010155,TCMBANKGE010155,TRPV3,VRL3,"transient receptor potential cation channel, subfamily V, member 3",17p13.2,protein-coding,
CWITA010156,TCMBANKGE010156,SCNN1A,BESC2; ENaCa; ENaCalpha; FLJ21883; SCNEA; SCNN1,"sodium channel, nonvoltage-gated 1 alpha",12p13,protein-coding,
CWITA010157,TCMBANKGE010157,TEAD3,DTEF-1; ETFR-1; TEAD-3; TEAD5; TEF-5; TEF5,TEA domain transcription factor 3,6p21.31,protein-coding,/
CWITA010158,TCMBANKGE010158,ESF1,ABTAP; C20orf6; HDCMC28P; bA526K24.1,ESF1 nucleolar pre-rRNA processing protein homolog,20p12.1,protein-coding,/
CWITA010159,TCMBANKGE010159,TCP1,CCT-alpha; CCT1; CCTa; D6S230E; TCP-1-alpha,t-complex 1,6q25.3,protein-coding,/
CWITA010160,TCMBANKGE010160,ACSF3,-,acyl-CoA synthetase family member 3,16q24.3,protein-coding,/
CWITA010161,TCMBANKGE010161,RBBP9,BOG; RBBP10,"RB binding protein 9, serine hydrolase",20p11.23,protein-coding,Research target
CWITA010162,TCMBANKGE010162,PIK3CG,PI3CG; PI3K; PI3Kgamma; PIK3,"phosphoinositide-3-kinase, catalytic, gamma polypeptide",7q22.3,protein-coding,
CWITA010163,TCMBANKGE010163,GATB,HSPC199; PET112; PET112L,Glutamyl-Trna_Amidotransferase_Subunit_B,4q31.3,protein-coding,
CWITA010164,TCMBANKGE010164,CEP89,CCDC123; CEP123,centrosomal protein 89,19q13.11,protein-coding,/
CWITA010165,TCMBANKGE010165,GABRB2,ICEE2,gamma-aminobutyric acid type A receptor subunit beta2,5q34,protein-coding,Successful target
CWITA010166,TCMBANKGE010166,TYMP,ECGF; ECGF1; MEDPS1; MNGIE; MTDPS1; PDECGF; TP; hPD-ECGF,thymidine phosphorylase,22q13.33,protein-coding,Successful target
CWITA010167,TCMBANKGE010167,TLR6,CD286,toll like receptor 6,4p14,protein-coding,Clinical Trial target
CWITA010168,TCMBANKGE010168,PRRG1,PRGP1,proline rich and Gla domain 1,Xp21.1,protein-coding,/
CWITA010169,TCMBANKGE010169,KDM4C,GASC1; JHDM3C; JMJD2C; TDRD14C,lysine demethylase 4C,9p24.1,protein-coding,Patented target
CWITA010170,TCMBANKGE010170,NDUFA6,B14; CINB14; LYRM6; NADHB14,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa",22q13.2,protein-coding,
CWITA010171,TCMBANKGE010171,CA13,CAXIII,carbonic anhydrase 13,8q21.2,protein-coding,/
CWITA010172,TCMBANKGE010172,ATP2A1,ATP2A; SERCA1,"ATPase, Ca++ transporting, cardiac muscle, fast twitch 1",16p12.1,protein-coding,
CWITA010173,TCMBANKGE010173,HS3ST5,3-OST-5; 3OST5; HS3OST5; NBLA04021,heparan sulfate-glucosamine 3-sulfotransferase 5,6q21-q22.1,protein-coding,/
CWITA010174,TCMBANKGE010174,CNBD2,C20orf152; CNMPD1,cyclic nucleotide binding domain containing 2,20q11.23,protein-coding,/
CWITA010175,TCMBANKGE010175,POT1,CMM10; GLM9; HPOT1,protection of telomeres 1,7q31.33,protein-coding,/
CWITA010176,TCMBANKGE010176,ACOT8,HNAACTE; NAP1; PTE-1; PTE-2; PTE1; PTE2; hACTE-III; hTE,acyl-CoA thioesterase 8,20q13.12,protein-coding,/
CWITA010177,TCMBANKGE010177,DCP2,NUDT20,decapping mRNA 2,5q22.2,protein-coding,/
CWITA010178,TCMBANKGE010178,STK4,KRS2; MST1; YSK3,serine/threonine kinase 4,20q13.12,protein-coding,Research target
CWITA010179,TCMBANKGE010179,WRAP53,DKCB3; TCAB1; WDR79,WD repeat containing antisense to TP53,17p13.1,protein-coding,/
CWITA010180,TCMBANKGE010180,PCGF5,RNF159,polycomb group ring finger 5,10q23.32,protein-coding,/
CWITA010181,TCMBANKGE010181,ENOSF1,FUCD; RTS; TYMSAS,enolase superfamily member 1,18p11.32,protein-coding,/
CWITA010182,TCMBANKGE010182,RPL14,CAG-ISL-7; CTG-B33; L14; RL14; hRL14,ribosomal protein L14,3p22.1,protein-coding,/
CWITA010183,TCMBANKGE010183,CAB39L,MO25-BETA; MO2L; bA103J18.3,calcium binding protein 39 like,13q14.2,protein-coding,/
CWITA010184,TCMBANKGE010184,NFKBIB,IKBB; TRIP9,NFKB inhibitor beta,19q13.2,protein-coding,/
CWITA010185,TCMBANKGE010185,SCLY,SCL; hSCL,selenocysteine lyase,2q37.3,protein-coding,
CWITA010186,TCMBANKGE010186,RARB,HAP; MCOPS12; NR1B2; RARbeta1; RRB2,retinoic acid receptor beta,3p24.2,protein-coding,Successful target
CWITA010187,TCMBANKGE010187,RPL15,EC45; FLJ26304; L15; MGC88603; RPL10; RPLY10; RPYL10,ribosomal protein L15,3p24.2,protein-coding,
CWITA010188,TCMBANKGE010188,MITD1,-,microtubule interacting and trafficking domain containing 1,2q11.2,protein-coding,/
CWITA010189,TCMBANKGE010189,L1CAM,CAML1; CD171; HSAS; HSAS1; MASA; MIC5; NNCAMNL1; NNCAML1; NCAMNL1; S10; SPG1,L1 cell adhesion molecule,Xq28,protein-coding,
CWITA010190,TCMBANKGE010190,NUAK2,SNARK,NUAK family kinase 2,1q32.1,protein-coding,Research target
CWITA010191,TCMBANKGE010191,DNAJC1,DNAJL1; ERdj1; HTJ1; MTJ1,DnaJ heat shock protein family (Hsp40) member C1,10p12.31,protein-coding,/
CWITA010192,TCMBANKGE010192,DEPDC7,TR2; dJ85M6.4,DEP domain containing 7,11p13,protein-coding,/
CWITA010193,TCMBANKGE010193,CRYL1,GDH; HEL30; gul3DH; lambda-CRY,crystallin lambda 1,13q12.11,protein-coding,/
CWITA010194,TCMBANKGE010194,GRIN3A,FLJ45414; NMDARNL; NR3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",9q31.1,protein-coding,
CWITA010195,TCMBANKGE010195,MKX,C10orf48; IFRX; IRXL1,mohawk homeobox,10p12.1,protein-coding,/
CWITA010196,TCMBANKGE010196,NUDT9,MGC3037; NUDT10,nudix (nucleoside diphosphate linked moiety X)-type motif 9,4q22.1,protein-coding,
CWITA010197,TCMBANKGE010197,SLC9A6,MRSA; NHE6,Solute_Carrier_Family_9_Member_A6,Xq26.3,protein-coding,
CWITA010198,TCMBANKGE010198,ZMAT3,PAG608; WIG-1; WIG1,zinc finger matrin-type 3,3q26.32,protein-coding,/
CWITA010199,TCMBANKGE010199,ARID1B,6A3-5; BAF250B; BRIGHT; CSS1; DAN15; ELD/OSA1; MRD12; OSA2; P250R,AT-rich interaction domain 1B,6q25.3,protein-coding,/
CWITA010200,TCMBANKGE010200,ALKBH4,ABH4,"alkB homolog 4, lysine demethylase",7q22.1,protein-coding,/
CWITA010201,TCMBANKGE010201,TIRAP,BACTS1; Mal; MyD88-2; wyatt,TIR domain containing adaptor protein,11q24.2,protein-coding,Patented target
CWITA010202,TCMBANKGE010202,RETNLB,FIZZ1; FIZZ2; HXCP2; RELM-beta; RELMb; RELMbeta; XCP2,resistin like beta,3q13.13,protein-coding,/
CWITA010203,TCMBANKGE010203,PRSS3,MTG; PRSS4; T9; TRY3; TRY4,"protease, serine, 3",9p11.2,protein-coding,
CWITA010204,TCMBANKGE010204,PRKAR2B,PRKAR2; RIINBETA,"protein kinase, cAMP-dependent, regulatory, type II, beta",7q22,protein-coding,
CWITA010205,TCMBANKGE010205,CMBL,JS-1,carboxymethylenebutenolidase homolog,5p15.2,protein-coding,/
CWITA010206,TCMBANKGE010206,EIF4E,CBP; EIF4E1; EIF4EL1; EIF4F; MGC111573,eukaryotic translation initiation factor 4E,4q21-q25,protein-coding,
CWITA010207,TCMBANKGE010207,RABGAP1,GAPCENA; TBC1D11,RAB GTPase activating protein 1,9q33.2-q33.3,protein-coding,/
CWITA010208,TCMBANKGE010208,SUCLG1,GALPHA; MTDPS9; SUCLA1,succinate-CoA ligase GDP/ADP-forming subunit alpha,2p11.2,protein-coding,/
CWITA010209,TCMBANKGE010209,PRDM14,PFM11,PR/SET domain 14,8q13.3,protein-coding,/
CWITA010210,TCMBANKGE010210,S1PR5,EDG8; Edg-8; S1P5; SPPR-1; SPPR-2,sphingosine-1-phosphate receptor 5,19p13.2,protein-coding,Clinical Trial target
CWITA010211,TCMBANKGE010211,LRFN4,FIGLER6; SALM3; SALM3.,leucine rich repeat and fibronectin type III domain containing 4,11q13.2,protein-coding,/
CWITA010212,TCMBANKGE010212,PSMB8,ALDD; D6S216; D6S216E; JMP; LMP7; NKJO; PRAAS1; PSMB5i; RING10,proteasome 20S subunit beta 8,6p21.32,protein-coding,Patented target
CWITA010213,TCMBANKGE010213,HERC5,CEB1; CEBP1,HECT and RLD domain containing E3 ubiquitin protein ligase 5,4q22.1,protein-coding,/
CWITA010214,TCMBANKGE010214,MAP11,C7orf43; MCPH25; TRAPPC14,microtubule associated protein 11,7q22.1,protein-coding,/
CWITA010215,TCMBANKGE010215,ZNF354A,EZNF; HEL104; HKL1; KID-1; KID1; TCF17,zinc finger protein 354A,5q35.3,protein-coding,/
CWITA010216,TCMBANKGE010216,PCBD1,DCOH; PCBD; PCD; PHS,pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha,10q22,protein-coding,
CWITA010217,TCMBANKGE010217,KLHL9,-,kelch like family member 9,9p21.3,protein-coding,/
CWITA010218,TCMBANKGE010218,CENPL,C1orf155; CENP-L; dJ383J4.3,centromere protein L,1q25.1,protein-coding,/
CWITA010219,TCMBANKGE010219,KCTD3,NY-REN-45,potassium channel tetramerization domain containing 3,1q41,protein-coding,/
CWITA010220,TCMBANKGE010220,SLC4A8,DKFZp761B2318; FLJ46462; NBC3; NDCBE,"solute carrier family 4, sodium bicarbonate cotransporter, member 8",12q13.13,protein-coding,
CWITA010221,TCMBANKGE010221,BCKDHA,BCKDE1A; MSU; MSUD1; OVD1A,branched chain keto acid dehydrogenase E1 subunit alpha,19q13.2,protein-coding,/
CWITA010222,TCMBANKGE010222,INS,IDDM2; ILPR; IRDN; MODY10,insulin,11p15.5,protein-coding,
CWITA010223,TCMBANKGE010223,NPIPB5,-,nuclear pore complex interacting protein family member B5,16p12.2,protein-coding,/
CWITA010224,TCMBANKGE010224,Gzmn,GrN,granzyme N,14 C3|14 28.19 cM,protein-coding,/
CWITA010225,TCMBANKGE010225,PABPC1,PAB1; PABP; PABP1; PABPC2; PABPL1,poly(A) binding protein cytoplasmic 1,8q22.3,protein-coding,/
CWITA010226,TCMBANKGE010226,PCDHA11,CNR7; CNRN7; CNRS7; CRNR7; PCDH-ALPHA11,protocadherin alpha 11,5q31.3,protein-coding,/
CWITA010227,TCMBANKGE010227,SERPINB5,PI5; maspin,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",18q21.3,protein-coding,
CWITA010228,TCMBANKGE010228,GPRC5A,GPCR5A; RAI3; RAIG1,"G protein-coupled receptor, family C, group 5, member A",12p13-p12.3,protein-coding,
CWITA010229,TCMBANKGE010229,CYBB,CGD; GP91N1; GP91NPHOX; GP91PHOX; NOX2; p91NPHOX,"cytochrome b-245, beta polypeptide",Xp21.1,protein-coding,
CWITA010230,TCMBANKGE010230,CALR,CRT; FLJ26680; RO; SSA; cC1qR,calreticulin,19p13.3-p13.2,protein-coding,
CWITA010231,TCMBANKGE010231,BABAM2,BRCC4; BRCC45; BRE,BRISC and BRCA1 A complex member 2,2p23.2,protein-coding,/
CWITA010232,TCMBANKGE010232,MEDAG,AWMS3; C13orf33; MEDA-4; MEDA4; hAWMS3,mesenteric estrogen dependent adipogenesis,13q12.3,protein-coding,/
CWITA010233,TCMBANKGE010233,ACYP2,ACYM; ACYP,"acylphosphatase 2, muscle type",2p16.2,protein-coding,
CWITA010234,TCMBANKGE010234,CXCL6,CKA-3; GCP-2; GCP2; SCYB6,C-X-C motif chemokine ligand 6,4q13.3,protein-coding,/
CWITA010235,TCMBANKGE010235,AGXT,AGT; AGT1; AGXT1; PH1; SPAT; SPT; TLH6,alanine--glyoxylate and serine--pyruvate aminotransferase,2q37.3,protein-coding,Research target
CWITA010236,TCMBANKGE010236,SVEP1,C9orf13; CCP22; POLYDOM; SEL-OB; SELOB,"sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1",9q31.3,protein-coding,/
CWITA010237,TCMBANKGE010237,BPIFA2,C20orf70; PSP; SPLUNC2; bA49G10.1,BPI fold containing family A member 2,20q11.21,protein-coding,/
CWITA010238,TCMBANKGE010238,IL5,EDF; ILN5; TRF,"interleukin 5 (colony-stimulating factor, eosinophil)",5q31.1,protein-coding,
CWITA010239,TCMBANKGE010239,PHLDA2,BRW1C; BWR1C; HLDA2; IPL; TSSC3,pleckstrin homology like domain family A member 2,11p15.4,protein-coding,/
CWITA010240,TCMBANKGE010240,UGT1A4,HUGNBR2; UDPGT; UDPGT_1N4; UGTN1D; UGT1N04; UGT1.4; UGT1D,"UDP glucuronosyltransferase 1 family, polypeptide A4",2q37,protein-coding,
CWITA010241,TCMBANKGE010241,ATP5MG,ATP5JG; ATP5L,ATP synthase membrane subunit g,11q23.3,protein-coding,/
CWITA010242,TCMBANKGE010242,NOMO3,Nomo,NODAL modulator 3,16p13.11,protein-coding,/
CWITA010243,TCMBANKGE010243,HNF4G,NR2A2; NR2A3,"hepatocyte nuclear factor 4, gamma",8q21.11,protein-coding,
CWITA010244,TCMBANKGE010244,CD2BP2,FWP010; LIN1; PPP1R59; Snu40; U5-52K,CD2 cytoplasmic tail binding protein 2,16p11.2,protein-coding,/
CWITA010245,TCMBANKGE010245,ZNF483,ZKSCAN16; ZSCAN48,zinc finger protein 483,9q31.3,protein-coding,/
CWITA010246,TCMBANKGE010246,SQLE,-,squalene epoxidase,8q24.13,protein-coding,Successful target
CWITA010247,TCMBANKGE010247,KRT71,HYPT13; K6IRS1; KRT6IRS; KRT6IRS1,keratin 71,12q13.13,protein-coding,/
CWITA010248,TCMBANKGE010248,LGALS8,Gal-8; PCTA-1; PCTA1; Po66-CBP,galectin 8,1q43,protein-coding,/
CWITA010249,TCMBANKGE010249,SPIRE2,MGC117166; SpirN2,spire homolog 2 (Drosophila),16q24,protein-coding,
CWITA010250,TCMBANKGE010250,COPS7A,CSN7; CSN7A; SGN7a,COP9 signalosome subunit 7A,12p13.31,protein-coding,/
CWITA010251,TCMBANKGE010251,MVB12B,C9orf28; FAM125B,multivesicular body subunit 12B,9q33.3,protein-coding,/
CWITA010252,TCMBANKGE010252,HMGCL,HL,3-hydroxy-3-methylglutaryl-CoA lyase,1p36.11,protein-coding,/
CWITA010253,TCMBANKGE010253,CPT2,CPT1; CPTASE,carnitine palmitoyltransferase 2,1p32,protein-coding,
CWITA010254,TCMBANKGE010254,RIC3,AYST720; FLJ11608; PRO1385,resistance to inhibitors of cholinesterase 3 homolog (C. elegans),11p15.4,protein-coding,
CWITA010255,TCMBANKGE010255,ERO1A,ERO1-L; ERO1-L-alpha; ERO1-alpha; ERO1L; ERO1LA; Ero1alpha,endoplasmic reticulum oxidoreductase 1 alpha,14q22.1,protein-coding,/
CWITA010256,TCMBANKGE010256,NCOA5,CIA; bA465L10.6,nuclear receptor coactivator 5,20q13.12,protein-coding,/
CWITA010257,TCMBANKGE010257,Hsdr1,Alf; hsdr-1,hepatocyte specific developmental regulation 1,-,unknown,/
CWITA010258,TCMBANKGE010258,FOXE1,FKHL15; FOXE2; HFKH4; HFKL5; NMTC4; TITF2; TTF-2; TTF2,forkhead box E1,9q22.33,protein-coding,/
CWITA010259,TCMBANKGE010259,NACAD,-,NAC alpha domain containing,7p13,protein-coding,/
CWITA010260,TCMBANKGE010260,RHNO1,C12orf32; HKMT1188; RHINO,RAD9-HUS1-RAD1 interacting nuclear orphan 1,12p13.33,protein-coding,/
CWITA010261,TCMBANKGE010261,C15orf39,-,chromosome 15 open reading frame 39,15q24.2,protein-coding,/
CWITA010262,TCMBANKGE010262,RUFY3,RIPX; SINGAR1; ZFYVE30,RUN and FYVE domain containing 3,4q13.3,protein-coding,/
CWITA010263,TCMBANKGE010263,WAS,IMD2; SCNX; THC; THC1; WASP; WASPA,WASP actin nucleation promoting factor,Xp11.23,protein-coding,Clinical Trial target
CWITA010264,TCMBANKGE010264,DEF8,-,differentially expressed in FDCP 8 homolog,16q24.3,protein-coding,/
CWITA010265,TCMBANKGE010265,ISG20,CD25; HEM45,interferon stimulated exonuclease gene 20,15q26.1,protein-coding,/
CWITA010266,TCMBANKGE010266,PLEKHF1,APPD; LAPF; PHAFIN1; ZFYVE15,pleckstrin homology and FYVE domain containing 1,19q12,protein-coding,/
CWITA010267,TCMBANKGE010267,NRROS,ELLP3030; GARPL1; LRRC33; SENEBAC; UNQ3030,negative regulator of reactive oxygen species,3q29,protein-coding,/
CWITA010268,TCMBANKGE010268,SLF2,C10orf6; FAM178A,SMC5-SMC6 complex localization factor 2,10q24.31,protein-coding,/
CWITA010269,TCMBANKGE010269,RANGAP1,Fug1; RANGAP; SD,Ran GTPase activating protein 1,22q13.2,protein-coding,/
CWITA010270,TCMBANKGE010270,APEX1,APE; APE1; APEN; APEX; APX; HAP1; REF1,apurinic/apyrimidinic endodeoxyribonuclease 1,14q11.2,protein-coding,Clinical Trial target
CWITA010271,TCMBANKGE010271,NHS,CTRCT40; CXN; SCML1,NHS actin remodeling regulator,Xp22.2-p22.13,protein-coding,/
CWITA010272,TCMBANKGE010272,CLEC5A,CLECSF5; MDL-1; MDL1,C-type lectin domain containing 5A,7q34,protein-coding,/
CWITA010273,TCMBANKGE010273,REST,DFNA27; GINGF5; HGF5; NRSF; WT6; XBR,RE1 silencing transcription factor,4q12,protein-coding,/
CWITA010274,TCMBANKGE010274,KARS1,CMTRIB; DFNB89; KARS; KARS2; KRS,lysyl-tRNA synthetase 1,16q23.1,protein-coding,/
CWITA010275,TCMBANKGE010275,ZNF780B,ZNF779,zinc finger protein 780B,19q13.2,protein-coding,/
CWITA010276,TCMBANKGE010276,FAM83B,C6orf143,family with sequence similarity 83 member B,6p12.1,protein-coding,Research target
CWITA010277,TCMBANKGE010277,CYP2D6,CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1,cytochrome P450 family 2 subfamily D member 6,22q13.2,protein-coding,Successful target
CWITA010278,TCMBANKGE010278,SDSL,SDH 2; SDS-RS1; TDH; cSDH,serine dehydratase like,12q24.13,protein-coding,/
CWITA010279,TCMBANKGE010279,UBE2K,E2-25K; HIP2; HYPG; LIG; UBC1,ubiquitin conjugating enzyme E2 K,4p14,protein-coding,/
CWITA010280,TCMBANKGE010280,ITSN2,PRO2015; SH3D1B; SH3P18; SWA; SWAP,intersectin 2,2p23.3,protein-coding,/
CWITA010281,TCMBANKGE010281,UBE2Z,HOYS7; USE1,ubiquitin conjugating enzyme E2 Z,17q21.32,protein-coding,/
CWITA010282,TCMBANKGE010282,PIK3C2A,CPK; OCSKD; PI3-K-C2(ALPHA); PI3-K-C2A; PI3K-C2-alpha; PI3K-C2alpha,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,11p15.1,protein-coding,/
CWITA010283,TCMBANKGE010283,CDH7,CDH7L1,cadherin 7,18q22.1,protein-coding,/
CWITA010284,TCMBANKGE010284,ITPA,C20orf37; HLC14-06-P; ITPase; My049; NTPase; dJ794I6.3,inosine triphosphatase,20p13,protein-coding,/
CWITA010285,TCMBANKGE010285,A2M,A2MD; CPAMD5; FWP007; S863-7,alpha-2-macroglobulin,12p13.31,protein-coding,/
CWITA010286,TCMBANKGE010286,CHML,REP2,CHM like Rab escort protein,1q43,protein-coding,/
CWITA010287,TCMBANKGE010287,TAOK2,MAP3K17; PSK; PSK1; PSK1-BETA; TAO1; TAO2,TAO kinase 2,16p11.2,protein-coding,/
CWITA010288,TCMBANKGE010288,HAUS6,Dgt6; FAM29A,HAUS augmin like complex subunit 6,9p22.1,protein-coding,/
CWITA010289,TCMBANKGE010289,TM9SF4,dJ836N17.2,transmembrane 9 superfamily member 4,20q11.21,protein-coding,/
CWITA010290,TCMBANKGE010290,DARS,DKFZp781B11202; MGC111579,aspartyl-tRNA synthetase,2q21.3,protein-coding,
CWITA010291,TCMBANKGE010291,NEU1,FLJ93471; NANH; NEU; SIAL1,sialidase 1 (lysosomal sialidase),6p21.3,protein-coding,
CWITA010292,TCMBANKGE010292,ZNF678,-,zinc finger protein 678,1q42.13,protein-coding,/
CWITA010293,TCMBANKGE010293,SETBP1,MRD29; SEB,SET binding protein 1,18q12.3,protein-coding,/
CWITA010294,TCMBANKGE010294,TREML2,C6orf76; TLT-2; TLT2; dJ238O23.1,triggering receptor expressed on myeloid cells like 2,6p21.1,protein-coding,/
CWITA010295,TCMBANKGE010295,MRGPRD,MRGD; TGR7,MAS related GPR family member D,11q13.3,protein-coding,/
CWITA010296,TCMBANKGE010296,GRAMD2B,GRAMD3; NS3TP2,GRAM domain containing 2B,5q23.2,protein-coding,/
CWITA010297,TCMBANKGE010297,COL10A1,-,collagen type X alpha 1 chain,6q22.1,protein-coding,/
CWITA010298,TCMBANKGE010298,ENPP5,NPP-5; NPP5,ectonucleotide pyrophosphatase/phosphodiesterase family member 5,6p21.1,protein-coding,/
CWITA010299,TCMBANKGE010299,CES1,ACAT; CEH; CES2; HMSE; HMSE1; MGC117365; PCEN1; SES1; TGH,carboxylesterase 1,16q22.2,protein-coding,
CWITA010300,TCMBANKGE010300,CLIC2,CLCNL2; CLIC2b; MRXS32; XAP121,chloride intracellular channel 2,Xq28,protein-coding,/
CWITA010301,TCMBANKGE010301,PRPF38B,NET1,pre-mRNA processing factor 38B,1p13.3,protein-coding,/
CWITA010302,TCMBANKGE010302,FNDC3B,FAD104; PRO4979; YVTM2421,fibronectin type III domain containing 3B,3q26.31,protein-coding,/
CWITA010303,TCMBANKGE010303,RPL3L,-,ribosomal protein L3 like,16p13.3,protein-coding,/
CWITA010304,TCMBANKGE010304,ADAMTS1,C3-C5; METH1,ADAM metallopeptidase with thrombospondin type 1 motif 1,21q21.3,protein-coding,Research target
CWITA010305,TCMBANKGE010305,LRP8,APOER2; HSZ75190; LRP-8; MCI1,LDL receptor related protein 8,1p32.3,protein-coding,/
CWITA010306,TCMBANKGE010306,FSHB,HH24,follicle stimulating hormone subunit beta,11p14.1,protein-coding,Clinical Trial target
CWITA010307,TCMBANKGE010307,SYT17,Syt-17; sytXVII,synaptotagmin 17,16p12.3,protein-coding,/
CWITA010308,TCMBANKGE010308,COLGALT2,C1orf17; ColGalT 2; GLT25D2,collagen beta(1-O)galactosyltransferase 2,1q25.3,protein-coding,/
CWITA010309,TCMBANKGE010309,CEL,BAL; BSDL; BSSL; CELL; CEase; FAP; FAPP; LIPA; MODY8,carboxyl ester lipase,9q34.13,protein-coding,Clinical Trial target
CWITA010310,TCMBANKGE010310,SYVN1,DER3; HRD1,synoviolin 1,11q13.1,protein-coding,Research target
CWITA010311,TCMBANKGE010311,MSRB2,CBSN1; CBS1; MGC26104; MSRB; PILB,methionine sulfoxide reductase B2,10p12,protein-coding,
CWITA010312,TCMBANKGE010312,EPYC,DSPG3; PGLB; Pg-Lb; SLRR3B,epiphycan,12q21.33,protein-coding,/
CWITA010313,TCMBANKGE010313,AADACL3,-,arylacetamide deacetylase like 3,1p36.21,protein-coding,/
CWITA010314,TCMBANKGE010314,MTNR1B,FGQTL2; MELN1BNR; MT2,melatonin receptor 1B,11q21-q22,protein-coding,
CWITA010315,TCMBANKGE010315,GDF1,CERS1; CHTD6; DORV; DTGA3; LAG1; LASS1; RAI; UOG1,growth differentiation factor 1,19p13.11,protein-coding,/
CWITA010316,TCMBANKGE010316,PPIL3,CYPJ,peptidylprolyl isomerase like 3,2q33.1,protein-coding,/
CWITA010317,TCMBANKGE010317,TUBG1,GCPN1; TUBG; TUBGCP1,"tubulin, gamma 1",17q21,protein-coding,
CWITA010318,TCMBANKGE010318,Hdac1-ps,EG15181; Gm10093; Gm1824; HD1; Hdac1; RPD3,"histone deacetylase 1, pseudogene",17 E3|17,pseudo,/
CWITA010319,TCMBANKGE010319,MTHFD2,NMDMC,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase",2p13.1,protein-coding,/
CWITA010320,TCMBANKGE010320,BMPR1B,ALK-6; ALK6; AMDD; BDA1D; BDA2; CDw293,bone morphogenetic protein receptor type 1B,4q22.3,protein-coding,/
CWITA010321,TCMBANKGE010321,ZMYND8,PRKCBP1; PRO2893; RACK7,zinc finger MYND-type containing 8,20q13.12,protein-coding,/
CWITA010322,TCMBANKGE010322,SLC44A3,CTL3; MGC45474,"solute carrier family 44, member 3",1p21.3,protein-coding,
CWITA010323,TCMBANKGE010323,SLC7A13,AGT-1; AGT1; XAT2,solute carrier family 7 member 13,8q21.3,protein-coding,/
CWITA010324,TCMBANKGE010324,ZNF254,BMZF-5; HD-ZNF1; ZNF539; ZNF91L,zinc finger protein 254,19p12,protein-coding,/
CWITA010325,TCMBANKGE010325,MYO1E,FSGS6; HuncM-IC; MYO1C,myosin IE,15q22.2,protein-coding,/
CWITA010326,TCMBANKGE010326,TMEM192,-,transmembrane protein 192,4q32.3,protein-coding,/
CWITA010327,TCMBANKGE010327,EMD,EDMD; LEMD5; STA,emerin,Xq28,protein-coding,/
CWITA010328,TCMBANKGE010328,AGXT2,AGT2; DAIBAT,alanine--glyoxylate aminotransferase 2,5p13,protein-coding,
CWITA010329,TCMBANKGE010329,PRKAR2B,PRKAR2; RII-BETA,protein kinase cAMP-dependent type II regulatory subunit beta,7q22.3,protein-coding,Research target
CWITA010330,TCMBANKGE010330,SH3BGRL3,HEL-S-297; SH3BP-1; TIP-B1,SH3 domain binding glutamate rich protein like 3,1p36.11,protein-coding,/
CWITA010331,TCMBANKGE010331,NKX2-6,CSX2; CTHM; NKX2F; NKX4-2,NK2 homeobox 6,8p21.2,protein-coding,/
CWITA010332,TCMBANKGE010332,SRM,PAPT; SPDSY; SPS1; SRML1,spermidine synthase,1p36-p22,protein-coding,
CWITA010333,TCMBANKGE010333,C2orf68,HCRCN81,chromosome 2 open reading frame 68,2p11.2,protein-coding,/
CWITA010334,TCMBANKGE010334,RPRD1B,C20orf77; CREPT; K-H; Kub5-Hera; NET60; dJ1057B20.2,regulation of nuclear pre-mRNA domain containing 1B,20q11.23,protein-coding,/
CWITA010335,TCMBANKGE010335,KCNJ9,GIRK3; KIR3.3,potassium inwardly rectifying channel subfamily J member 9,1q23.2,protein-coding,Research target
CWITA010336,TCMBANKGE010336,UBE2E2,UBCH8,ubiquitin conjugating enzyme E2 E2,3p24.3,protein-coding,Research target
CWITA010337,TCMBANKGE010337,SOCS4,SOCS7,suppressor of cytokine signaling 4,14q22.3,protein-coding,/
CWITA010338,TCMBANKGE010338,FRAT1,-,FRAT regulator of WNT signaling pathway 1,10q24.1,protein-coding,/
CWITA010339,TCMBANKGE010339,CLEC4E,CLECSF9; MINCLE,C-type lectin domain family 4 member E,12p13.31,protein-coding,/
CWITA010340,TCMBANKGE010340,CIAO3,HPRN; IOP1; LET1L; NAR1; NARFL; PRN,cytosolic iron-sulfur assembly component 3,16p13.3,protein-coding,/
CWITA010341,TCMBANKGE010341,ANO5,GDD1; LGMD2L; LGMDR12; TMEM16E,anoctamin 5,11p14.3,protein-coding,/
CWITA010342,TCMBANKGE010342,FAM13A,ARHGAP48; FAM13A1,family with sequence similarity 13 member A,4q22.1,protein-coding,/
CWITA010343,TCMBANKGE010343,TRHR,CHNG7; TRH-R,thyrotropin releasing hormone receptor,8q23.1,protein-coding,Successful target
CWITA010344,TCMBANKGE010344,CPED1,C7orf58,cadherin like and PC-esterase domain containing 1,7q31.31,protein-coding,/
CWITA010345,TCMBANKGE010345,KLK14,KLK-L6,kallikrein related peptidase 14,19q13.41,protein-coding,Patented target
CWITA010346,TCMBANKGE010346,PCDHGA1,PCDH-GAMMA-A1,"protocadherin gamma subfamily A, 1",5q31.3,protein-coding,/
CWITA010347,TCMBANKGE010347,CACNB3,CAB3; CACNLB3; FLJ58949,"calcium channel, voltage-dependent, beta 3 subunit",12q13,protein-coding,
CWITA010348,TCMBANKGE010348,RAB40A,RAR2; RAR2A,"RAB40A, member RAS oncogene family",Xq22.2,protein-coding,/
CWITA010349,TCMBANKGE010349,SULF2,HSULF-2,sulfatase 2,20q13.12,protein-coding,/
CWITA010350,TCMBANKGE010350,CCR7,BLR2; CC-CKR-7; CCR-7; CD197; CDw197; CMKBR7; EBI1,C-C motif chemokine receptor 7,17q21.2,protein-coding,Research target
CWITA010351,TCMBANKGE010351,UPF2,HUPF2; RENT2; smg-3,UPF2 regulator of nonsense mediated mRNA decay,10p14,protein-coding,/
CWITA010352,TCMBANKGE010352,LRTM1,HT017,leucine rich repeats and transmembrane domains 1,3p14.3,protein-coding,/
CWITA010353,TCMBANKGE010353,BBS4,-,Bardet-Biedl syndrome 4,15q24.1,protein-coding,/
CWITA010354,TCMBANKGE010354,PPP2CA,PP2Ac; PP2CA; PP2Calpha; RPNC,"protein phosphatase 2, catalytic subunit, alpha isozyme",5q31.1,protein-coding,
CWITA010355,TCMBANKGE010355,RPL3,ASC-1; L3; TARBP-B,ribosomal protein L3,22q13.1,protein-coding,/
CWITA010356,TCMBANKGE010356,LRP1B,LRP-1B; LRP-DIT; LRPDIT,LDL receptor related protein 1B,2q22.1-q22.2,protein-coding,/
CWITA010357,TCMBANKGE010357,ZNF319,ZFP319,zinc finger protein 319,16q21,protein-coding,/
CWITA010358,TCMBANKGE010358,MUC15,MUC-15; PAS3; PASIII,"mucin 15, cell surface associated",11p14.2,protein-coding,Research target
CWITA010359,TCMBANKGE010359,DMPK,DM; DM1; DM1PK; DMK; MDPK; MT-PK,DM1 protein kinase,19q13.32,protein-coding,Clinical Trial target
CWITA010360,TCMBANKGE010360,ZNF846,-,zinc finger protein 846,19p13.2,protein-coding,/
CWITA010361,TCMBANKGE010361,BANF1,BAF; BCRP1; D14S1460; NGPS,BAF nuclear assembly factor 1,11q13.1,protein-coding,/
CWITA010362,TCMBANKGE010362,SCPEP1,HSCP1; RISC,serine carboxypeptidase 1,17q22,protein-coding,/
CWITA010363,TCMBANKGE010363,UHRF1BP1,C6orf107; ICBP90; dJ349A12.1,UHRF1 binding protein 1,6p21.31,protein-coding,/
CWITA010364,TCMBANKGE010364,TMEM138,HSPC196,transmembrane protein 138,11q12.2,protein-coding,/
CWITA010365,TCMBANKGE010365,SCN2B,N,"sodium channel, voltage-gated, type II, beta",11q23,protein-coding,
CWITA010366,TCMBANKGE010366,DLGAP4,DAP-4; DAP4; DLP4; SAPAP-4; SAPAP4,DLG associated protein 4,20q11.23,protein-coding,/
CWITA010367,TCMBANKGE010367,PRR7,-,"proline rich 7, synaptic",5q35.3,protein-coding,/
CWITA010368,TCMBANKGE010368,RRP8,KIAA0409; NML,ribosomal RNA processing 8,11p15.4,protein-coding,/
CWITA010369,TCMBANKGE010369,ZNF320,ZFPL,zinc finger protein 320,19q13.41,protein-coding,/
CWITA010370,TCMBANKGE010370,NECTIN1,CD111; CLPED1; ED4; HIgR; HV1S; HVEC; OFC7; PRR; PRR1; PVRL1; PVRR; PVRR1; SK-12; nectin-1,Nectin_Cell_Adhesion_Molecule_1,11q23.3,protein-coding,
CWITA010371,TCMBANKGE010371,PTRH1,C9orf115; PTH1,peptidyl-tRNA hydrolase 1 homolog,9q34.11,protein-coding,/
CWITA010372,TCMBANKGE010372,BACE2,AEPLC; ALP56; ASP1; ASP21; BAE2; CDA13; CEAP1; DRAP,beta-secretase 2,21q22.2-q22.3,protein-coding,Clinical Trial target
CWITA010373,TCMBANKGE010373,CDC20B,G6VTS76519,cell division cycle 20B,5q11.2,protein-coding,/
CWITA010374,TCMBANKGE010374,ACTL10,C20orf134; dJ63M2.2,actin like 10,20q11.22,protein-coding,/
CWITA010375,TCMBANKGE010375,RPP40,RNASEP1; bA428J1.3,ribonuclease P/MRP subunit p40,6p25.1,protein-coding,/
CWITA010376,TCMBANKGE010376,KDM5A,RBBP-2; RBBP2; RBP2,lysine demethylase 5A,12p13.33,protein-coding,Research target
CWITA010377,TCMBANKGE010377,GNG10,-,G protein subunit gamma 10,9q31.3,protein-coding,/
CWITA010378,TCMBANKGE010378,RBM4,LARK; RBM4A; ZCCHC21; ZCRB3A,RNA binding motif protein 4,11q13.2,protein-coding,/
CWITA010379,TCMBANKGE010379,ZBTB22,BING1; ZBTB22A; ZNF297; ZNF297A; fru; fruitless,zinc finger and BTB domain containing 22,6p21.32,protein-coding,/
CWITA010380,TCMBANKGE010380,OSGEP,GAMOS3; GCPL1; KAE1; OSGEP1; PRSMG1; TCS3,O-sialoglycoprotein endopeptidase,14q11.2,protein-coding,/
CWITA010381,TCMBANKGE010381,KCNA1,AEMK; EA1; HBK1; HUK1; KV1.1; MBK1; MK1; RBK1,potassium voltage-gated channel subfamily A member 1,12p13.32,protein-coding,Research target
CWITA010382,TCMBANKGE010382,ATP5F1D,ATP5D; MC5DN5,ATP synthase F1 subunit delta,19p13.3,protein-coding,/
CWITA010383,TCMBANKGE010383,CCDC126,-,coiled-coil domain containing 126,7p15.3,protein-coding,/
CWITA010384,TCMBANKGE010384,NEK11,-,NIMA related kinase 11,3q22.1,protein-coding,/
CWITA010385,TCMBANKGE010385,CNTN4,AXCAM; BIG-2,contactin 4,3p26.3-p26.2,protein-coding,/
CWITA010386,TCMBANKGE010386,HLCS,HCS,holocarboxylase synthetase,21q22.13,protein-coding,/
CWITA010387,TCMBANKGE010387,NKX3-2,BAPX1; NKX3.2; NKX3B; SMMD,NK3 homeobox 2,4p15.33,protein-coding,/
CWITA010388,TCMBANKGE010388,PPARD,FAAR; NR1C2; NUC1; NUCI; NUCII; PPARB,peroxisome proliferator activated receptor delta,6p21.31,protein-coding,Clinical Trial target
CWITA010389,TCMBANKGE010389,MGST1,GST12; MGST; MGST-I,microsomal glutathione S-transferase 1,12p12.3,protein-coding,/
CWITA010390,TCMBANKGE010390,KIF2A,CDCBM3; HK2; KIF2,kinesin family member 2A,5q12.1,protein-coding,/
CWITA010391,TCMBANKGE010391,COX7B,N,cytochrome c oxidase subunit VIIb,Xq21.1,protein-coding,
CWITA010392,TCMBANKGE010392,RTKN2,PLEKHK1; bA531F24.1,rhotekin 2,10q21.2,protein-coding,/
CWITA010393,TCMBANKGE010393,EXOSC3,CGI-102; PCH1B; RRP40; Rrp40p; bA3J10.7; hRrp-40; p10,exosome component 3,9p13.2,protein-coding,/
CWITA010394,TCMBANKGE010394,HNRNPH3,2H9; HNRPH3,heterogeneous nuclear ribonucleoprotein H3,10q21.3,protein-coding,/
CWITA010395,TCMBANKGE010395,XPO4,exp4,exportin 4,13q12.11,protein-coding,/
CWITA010396,TCMBANKGE010396,TMPRSS11E,DESC1; TMPRSS11E2,transmembrane serine protease 11E,4q13.2,protein-coding,/
CWITA010397,TCMBANKGE010397,GJA1,CX43; DFNB38; GJAL; HSS; ODDD,"gap junction protein, alpha 1, 43kDa",6q21-q23.2,protein-coding,
CWITA010398,TCMBANKGE010398,MCHR2,GPR145; GPRv17; MCH-2R; MCH-R2; MCH2; MCH2R; MCHR-2; SLT,melanin concentrating hormone receptor 2,6q16.2,protein-coding,Research target
CWITA010399,TCMBANKGE010399,MOCOS,FLJ20733; HMCS; MCS; MOS,molybdenum cofactor sulfurase,18q12,protein-coding,
CWITA010400,TCMBANKGE010400,REG3A,HIP; HIP/PAP; INGAP; PAP; PAP-H; PAP1; PBCGF; REG-III; REG3,regenerating family member 3 alpha,2p12,protein-coding,Clinical Trial target
CWITA010401,TCMBANKGE010401,PLIN2,ADFP; ADRP,perilipin 2,9p22.1,protein-coding,/
CWITA010402,TCMBANKGE010402,NF1,NFNS; VRNF; WSS,neurofibromin 1,17q11.2,protein-coding,/
CWITA010403,TCMBANKGE010403,ISX,Pix-1; RAXLX,intestine specific homeobox,22q12.3,protein-coding,/
CWITA010404,TCMBANKGE010404,PWP2,EHOC-17; PWP2H; UTP1,PWP2 small subunit processome component,21q22.3,protein-coding,/
CWITA010405,TCMBANKGE010405,DUSP18,DSP18; DUSP20; LMWDSP20,dual specificity phosphatase 18,22q12.2,protein-coding,/
CWITA010406,TCMBANKGE010406,OR1S2,OR11-231,olfactory receptor family 1 subfamily S member 2,11q12.1,protein-coding,/
CWITA010407,TCMBANKGE010407,NCKAP1,HEM2; NAP1; NAP125; p125Nap1,NCK associated protein 1,2q32.1,protein-coding,/
CWITA010408,TCMBANKGE010408,EIF4EBP2,4EBP2; PHASII,eukaryotic translation initiation factor 4E binding protein 2,10q22.1,protein-coding,Clinical Trial target
CWITA010409,TCMBANKGE010409,SV2A,KIAA0736; SV2,synaptic vesicle glycoprotein 2A,1q21.2,protein-coding,
CWITA010410,TCMBANKGE010410,SMYD2,HSKM-B; KMT3C; ZMYND14,SET and MYND domain containing 2,1q32.3,protein-coding,Research target
CWITA010411,TCMBANKGE010411,MGST3,GST-III,microsomal glutathione S-transferase 3,1q24.1,protein-coding,/
CWITA010412,TCMBANKGE010412,MARK1,MARK; Par-1c; Par1c,microtubule affinity regulating kinase 1,1q41,protein-coding,/
CWITA010413,TCMBANKGE010413,ARL8A,ARL10B; GIE2,ADP ribosylation factor like GTPase 8A,1q32.1,protein-coding,/
CWITA010414,TCMBANKGE010414,SPSB2,GRCC9; SSB2,splA/ryanodine receptor domain and SOCS box containing 2,12p13.31,protein-coding,/
CWITA010415,TCMBANKGE010415,TBPL1,MGC:8389; MGC:9620; STUD; TLF; TLP; TRF2,TATA-box binding protein like 1,6q23.2,protein-coding,/
CWITA010416,TCMBANKGE010416,PSMD2,P97; RPN1; S2; TRAP2,"proteasome 26S subunit, non-ATPase 2",3q27.1,protein-coding,/
CWITA010417,TCMBANKGE010417,EXOSC5,RRP41B; RRP46; Rrp46p; hRrp46p; p12B,exosome component 5,19q13.2,protein-coding,/
CWITA010418,TCMBANKGE010418,NASP,FLB7527; HMDRA1; PRO1999,nuclear autoantigenic sperm protein,1p34.1,protein-coding,/
CWITA010419,TCMBANKGE010419,FUT5,FUC-TV,fucosyltransferase 5,19p13.3,protein-coding,/
CWITA010420,TCMBANKGE010420,ASF1B,CIA-II,anti-silencing function 1B histone chaperone,19p13.12,protein-coding,/
CWITA010421,TCMBANKGE010421,MPHOSPH10,CT90; MPP10; MPP10P; PPP1R106,M-phase phosphoprotein 10,2p13.3,protein-coding,/
CWITA010422,TCMBANKGE010422,COMMD1,C2orf5; MURR1,copper metabolism domain containing 1,2p15,protein-coding,/
CWITA010423,TCMBANKGE010423,C18orf32,-,chromosome 18 open reading frame 32,18q21.1,protein-coding,/
CWITA010424,TCMBANKGE010424,CTNNBIP1,ICAT,catenin beta interacting protein 1,1p36.22,protein-coding,/
CWITA010425,TCMBANKGE010425,FLRT3,HH21,fibronectin leucine rich transmembrane protein 3,20p12.1,protein-coding,/
CWITA010426,TCMBANKGE010426,TMEM208,HSPC171,transmembrane protein 208,16q22.1,protein-coding,/
CWITA010427,TCMBANKGE010427,PGAP3,AGLA546; CAB2; PERLD1; PP1498; hCOS16,post-GPI attachment to proteins phospholipase 3,17q12,protein-coding,/
CWITA010428,TCMBANKGE010428,ZNF24,KOX17; RSG-A; ZNF191; ZSCAN3; Zfp191,zinc finger protein 24,18q12.2,protein-coding,/
CWITA010429,TCMBANKGE010429,NTRK3,GP145-TrkC; TRKC; gp145(trkC),neurotrophic receptor tyrosine kinase 3,15q25.3,protein-coding,Successful target
CWITA010430,TCMBANKGE010430,LIN7C,LIN-7-C; LIN-7C; MALS-3; MALS3; VELI3,"lin-7 homolog C, crumbs cell polarity complex component",11p14.1,protein-coding,/
CWITA010431,TCMBANKGE010431,UTS2B,U2B; URP; UTS2D,urotensin 2B,3q28,protein-coding,/
CWITA010432,TCMBANKGE010432,FMO2,FMO1B1,flavin containing dimethylaniline monoxygenase 2,1q24.3,protein-coding,/
CWITA010433,TCMBANKGE010433,CSF1R,BANDDOS; C-FMS; CD115; CSF-1R; CSFR; FIM2; FMS; HDLS; M-CSF-R,colony stimulating factor 1 receptor,5q32,protein-coding,Research target
CWITA010434,TCMBANKGE010434,FAM124A,-,family with sequence similarity 124 member A,13q14.3,protein-coding,/
CWITA010435,TCMBANKGE010435,COL17A1,BA16H23.2; BP180; BPA-2; BPAG2; ERED; LAD-1,collagen type XVII alpha 1 chain,10q25.1,protein-coding,/
CWITA010436,TCMBANKGE010436,NEIL1,FLJ22402; FPG1; NEI1; hFPG1,nei endonuclease VIII-like 1 (E. coli),15q24.2,protein-coding,
CWITA010437,TCMBANKGE010437,ENTPD2,CD39L1; NTPDase-2,ectonucleoside triphosphate diphosphohydrolase 2,9q34.3,protein-coding,/
CWITA010438,TCMBANKGE010438,MEGF6,EGFL3,multiple EGF like domains 6,1p36.32,protein-coding,/
CWITA010439,TCMBANKGE010439,ZNF324,ZF5128; ZNF324A,zinc finger protein 324,19q13.43,protein-coding,/
CWITA010440,TCMBANKGE010440,ALG14,CMS15,ALG14 UDP-N-acetylglucosaminyltransferase subunit,1p21.3,protein-coding,/
CWITA010441,TCMBANKGE010441,ZSCAN23,ZNF390; ZNF453; dJ29K1.3; dJ29K1.3.1,zinc finger and SCAN domain containing 23,6p22.1,protein-coding,/
CWITA010442,TCMBANKGE010442,SETD2,HBP231; HIF-1; HIP-1; HSPC069; HYPB; KMT3A; LLS; SET2; p231HBP,"SET domain containing 2, histone lysine methyltransferase",3p21.31,protein-coding,Research target
CWITA010443,TCMBANKGE010443,DYRK1B,AOMS3; MIRK,dual specificity tyrosine phosphorylation regulated kinase 1B,19q13.2,protein-coding,Patented target
CWITA010444,TCMBANKGE010444,BORCS7-ASMT,C10orf32-AS3MT; C10orf32-ASMT,BORCS7-ASMT readthrough (NMD candidate),10q24.32,ncRNA,/
CWITA010445,TCMBANKGE010445,LMAN1,ERGIC-53; ERGIC53; F5F8D; FMFD1; MCFD1; MR60; gp58,"lectin, mannose binding 1",18q21.32,protein-coding,/
CWITA010446,TCMBANKGE010446,NUMA1,NMP-22; NUMA,nuclear mitotic apparatus protein 1,11q13.4,protein-coding,/
CWITA010447,TCMBANKGE010447,RHOA,ARH12; ARHA; RHO12; RHOH12,"ras homolog gene family, member A",3p21.3,protein-coding,
CWITA010448,TCMBANKGE010448,RAD51C,BROVCA3; FANCO; R51H3; RAD51L2,RAD51 paralog C,17q22,protein-coding,/
CWITA010449,TCMBANKGE010449,ENDOD1,-,endonuclease domain containing 1,11q21,protein-coding,/
CWITA010450,TCMBANKGE010450,CHSY1,CHSY; CSS1; ChSy-1; TPBS,chondroitin sulfate synthase 1,15q26.3,protein-coding,/
CWITA010451,TCMBANKGE010451,ZNF134,pHZ-15,zinc finger protein 134,19q13.43,protein-coding,/
CWITA010452,TCMBANKGE010452,LAMP3,CD208; DC LAMP; DC-LAMP; DCLAMP; LAMP; LAMP-3; TSC403,lysosomal associated membrane protein 3,3q27.1,protein-coding,/
CWITA010453,TCMBANKGE010453,PGM2L1,BM32A; PMMLP,phosphoglucomutase 2 like 1,11q13.4,protein-coding,/
CWITA010454,TCMBANKGE010454,NOP56,NOL5A; SCA36,NOP56 ribonucleoprotein,20p13,protein-coding,/
CWITA010455,TCMBANKGE010455,PLEK,P47,pleckstrin,2p14,protein-coding,/
CWITA010456,TCMBANKGE010456,ZZEF1,ZZZ4,zinc finger ZZ-type and EF-hand domain containing 1,17p13.2,protein-coding,/
CWITA010457,TCMBANKGE010457,MUSK,CMS9; FADS; FADS1,muscle associated receptor tyrosine kinase,9q31.3,protein-coding,Research target
CWITA010458,TCMBANKGE010458,TNRC6C,-,trinucleotide repeat containing adaptor 6C,17q25.3,protein-coding,/
CWITA010459,TCMBANKGE010459,IQCG,CFAP122; DRC9,IQ motif containing G,3q29,protein-coding,/
CWITA010460,TCMBANKGE010460,PTGFRN,CD315; CD9P-1; EWI-F; FPRP; SMAP-6,prostaglandin F2 receptor inhibitor,1p13.1,protein-coding,/
CWITA010461,TCMBANKGE010461,MSH6,GTBP; GTMBP; HNPCC5; HSAP; p160,mutS homolog 6,2p16.3,protein-coding,/
CWITA010462,TCMBANKGE010462,ALOX12B,12R-LOX; ARCI2,"arachidonate 12-lipoxygenase, 12R type",17p13.1,protein-coding,/
CWITA010463,TCMBANKGE010463,ANKRD26,THC2; bA145E8.1,ankyrin repeat domain 26,10p12.1,protein-coding,/
CWITA010464,TCMBANKGE010464,TGM1,ICR2; KTG; LI; LI1; TGASE; TGK,"transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase)",14q11.2,protein-coding,
CWITA010465,TCMBANKGE010465,ATP8A1,ATPASEII; ATPIA; ATPP2,ATPase phospholipid transporting 8A1,4p13,protein-coding,/
CWITA010466,TCMBANKGE010466,ASB15,-,ankyrin repeat and SOCS box containing 15,7q31.32,protein-coding,/
CWITA010467,TCMBANKGE010467,MC4R,BMIQ20,melanocortin 4 receptor,18q21.32,protein-coding,Successful target
CWITA010468,TCMBANKGE010468,RPL22L1,-,ribosomal protein L22 like 1,3q26.2,protein-coding,/
CWITA010469,TCMBANKGE010469,C1S,EDSPD2,complement C1s,12p13.31,protein-coding,Successful target
CWITA010470,TCMBANKGE010470,UBE2E1,UBCH6,ubiquitin conjugating enzyme E2 E1,3p24.2,protein-coding,/
CWITA010471,TCMBANKGE010471,ZNF547,MIP-2A; SEDLP1; TRAPPC2.19; TRAPPC2B; TRAPPC2P1,zinc finger protein 547,19q13.43,protein-coding,/
CWITA010472,TCMBANKGE010472,SNORD94,U94,"small nucleolar RNA, C/D box 94",2p11.2,snoRNA,/
CWITA010473,TCMBANKGE010473,NLRP7,CLR19.4; HYDM; NALP7; NOD12; PAN7; PYPAF3,NLR family pyrin domain containing 7,19q13.42,protein-coding,/
CWITA010474,TCMBANKGE010474,CLN3,BTN1; BTS; JNCL,"CLN3 lysosomal/endosomal transmembrane protein, battenin",16p12.1,protein-coding,/
CWITA010475,TCMBANKGE010475,NPCA1,NPC1,Nasopharyngeal carcinoma 1,4p15.1-q12,unknown,/
CWITA010476,TCMBANKGE010476,TMX3,PDIA13; TXNDC10,thioredoxin related transmembrane protein 3,18q22.1,protein-coding,/
CWITA010477,TCMBANKGE010477,CHRNB1,ACHRB; CHRNB; CMS1D; CMS2A; FLJ57107; SCCMS,"cholinergic receptor, nicotinic, beta 1 (muscle)",17p13.1,protein-coding,
CWITA010478,TCMBANKGE010478,SHMT1,CSHMT; SHMT,serine hydroxymethyltransferase 1,17p11.2,protein-coding,/
CWITA010479,TCMBANKGE010479,SPECC1L-ADORA2A,-,SPECC1L-ADORA2A readthrough (NMD candidate),22q11.23,ncRNA,/
CWITA010480,TCMBANKGE010480,REX1BD,C19orf60,required for excision 1-B domain containing,19p13.11,protein-coding,/
CWITA010481,TCMBANKGE010481,ATP8B1,ATPIC; BRIC; FIC1; ICP1; PFIC; PFIC1,ATPase phospholipid transporting 8B1,18q21.31,protein-coding,/
CWITA010482,TCMBANKGE010482,C3AR1,AZ3B; C3AR; HNFAG09,complement C3a receptor 1,12p13.31,protein-coding,Research target
CWITA010483,TCMBANKGE010483,CAB39,CGI-66; MO25,calcium binding protein 39,2q37.1,protein-coding,/
CWITA010484,TCMBANKGE010484,CPB1,CPB; PASP; PCPB,carboxypeptidase B1,3q24,protein-coding,Research target
CWITA010485,TCMBANKGE010485,PPP2R3C,C14orf10; G4-1; G5pr; GDRM; SPGF36,protein phosphatase 2 regulatory subunit B''gamma,14q13.2,protein-coding,/
CWITA010486,TCMBANKGE010486,SLC1A2,EAAT2; GLTN1,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",11p13-p12,protein-coding,
CWITA010487,TCMBANKGE010487,CHRNA1,ACHRA; ACHRD; CHRNA; CMS1A; CMS1B; CMS2A; FCCMS; SCCMS,cholinergic receptor nicotinic alpha 1 subunit,2q31.1,protein-coding,Successful target
CWITA010488,TCMBANKGE010488,ZNF215,BAZ-2; BAZ2; ZKSCAN11; ZSCAN43,zinc finger protein 215,11p15.4,protein-coding,/
CWITA010489,TCMBANKGE010489,CGN,-,cingulin,1q21.3,protein-coding,/
CWITA010490,TCMBANKGE010490,MAN2A1,AMan II; GOLIM7; MANA2; MANII,mannosidase alpha class 2A member 1,5q21.3,protein-coding,Discontinued target
CWITA010491,TCMBANKGE010491,DDAH1,DDAH; FLJ21264; FLJ25539,dimethylarginine dimethylaminohydrolase 1,1p22,protein-coding,
CWITA010492,TCMBANKGE010492,SLC25A3,OK/SW-cl.48; PHC; PTP,solute carrier family 25 member 3,12q23.1,protein-coding,/
CWITA010493,TCMBANKGE010493,TMED8,FAM15B,transmembrane p24 trafficking protein family member 8,14q24.3,protein-coding,/
CWITA010494,TCMBANKGE010494,Cd59a,AA987121; Cd59; protectin,CD59a antigen,2 E2|2 54.53 cM,protein-coding,/
CWITA010495,TCMBANKGE010495,NAT8L,CML3; NACED; NAT8-LIKE,N-acetyltransferase 8 like,4p16.3,protein-coding,/
CWITA010496,TCMBANKGE010496,ARHGEF11,GTRAP48; PDZ-RHOGEF,Rho guanine nucleotide exchange factor 11,1q23.1,protein-coding,/
CWITA010497,TCMBANKGE010497,CITED2,ASD8; MRG-1; MRG1; P35SRJ; VSD2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,6q24.1,protein-coding,/
CWITA010498,TCMBANKGE010498,ATF6,ATF6A,activating transcription factor 6,1q22-q23,protein-coding,
CWITA010499,TCMBANKGE010499,RYK,D3S3195; JTK5; JTK5A; RYK1,receptor like tyrosine kinase,3q22.2,protein-coding,/
CWITA010500,TCMBANKGE010500,PTBP2,PTBLP; brPTB; nPTB,polypyrimidine tract binding protein 2,1p21.3,protein-coding,/
CWITA010501,TCMBANKGE010501,TUBG2,-,tubulin gamma 2,17q21.2,protein-coding,/
CWITA010502,TCMBANKGE010502,SET,2PP2A; I2PP2A; IGAAD; IPP2A2; MRD58; PHAPII; TAF-I; TAF-IBETA,SET nuclear proto-oncogene,9q34.11,protein-coding,/
CWITA010503,TCMBANKGE010503,KLK3,APS; KLK2A1; PSA; hK3,kallikrein-related peptidase 3,19q13.41,protein-coding,
CWITA010504,TCMBANKGE010504,UAP1,AGX; AGX1; AGX2; SPAG2,UDP-N-acetylglucosamine pyrophosphorylase 1,1q23.3,protein-coding,/
CWITA010505,TCMBANKGE010505,LRBA,BGL; CDC4L; CVID8; LAB300; LBA,LPS responsive beige-like anchor protein,4q31.3,protein-coding,/
CWITA010506,TCMBANKGE010506,ZBTB33,ZNF-kaiso; ZNF348,zinc finger and BTB domain containing 33,Xq24,protein-coding,/
CWITA010507,TCMBANKGE010507,STX11,FHL4; HLH4; HPLH4,syntaxin 11,6q24.2,protein-coding,/
CWITA010508,TCMBANKGE010508,SLC13A4,NAS2; SUT-1; SUT1,solute carrier family 13 member 4,7q33,protein-coding,/
CWITA010509,TCMBANKGE010509,KCNAB2,AKR6A5; HKvbeta2; HKvbeta2.1; HKvbeta2.2; KCNA2B; KV-BETA-2,potassium voltage-gated channel subfamily A regulatory beta subunit 2,1p36.31,protein-coding,/
CWITA010510,TCMBANKGE010510,PRSS27,CAPH2; MPN,serine protease 27,16p13.3,protein-coding,/
CWITA010511,TCMBANKGE010511,YIPF3,C6orf109; FinGER3; KLIP1; dJ337H4.3,Yip1 domain family member 3,6p21.1,protein-coding,/
CWITA010512,TCMBANKGE010512,FAIM2,LFG; LFG2; NGP35; NMP35; TMBIM2,Fas apoptotic inhibitory molecule 2,12q13.12,protein-coding,/
CWITA010513,TCMBANKGE010513,TM2D3,BLP2,TM2 domain containing 3,15q26.3,protein-coding,/
CWITA010514,TCMBANKGE010514,ARHGAP35,GRF-1; GRLF1; P190-A; P190A; p190ARhoGAP; p190RhoGAP,Rho GTPase activating protein 35,19q13.32,protein-coding,/
CWITA010515,TCMBANKGE010515,ABCF2,ABC28; EST133090; HUSSY-18; HUSSY18,ATP binding cassette subfamily F member 2,7q36.1,protein-coding,/
CWITA010516,TCMBANKGE010516,TTC39C,C18orf17; HsT2697,tetratricopeptide repeat domain 39C,18q11.2,protein-coding,/
CWITA010517,TCMBANKGE010517,ZNF714,-,zinc finger protein 714,19p12,protein-coding,/
CWITA010518,TCMBANKGE010518,TAS2R7,T2R7; TRB4,taste 2 receptor member 7,12p13.2,protein-coding,/
CWITA010519,TCMBANKGE010519,NPIPA7,NPIPA8,nuclear pore complex interacting protein family member A7,16p13.11,protein-coding,/
CWITA010520,TCMBANKGE010520,CRLF1,CISS; CISS1; CLF; CLF-1; NR6; zcytor5,cytokine receptor like factor 1,19p13.11,protein-coding,Research target
CWITA010521,TCMBANKGE010521,SLC5A11,KST1; RKST1; SGLT6; SMIT2,solute carrier family 5 member 11,16p12.1,protein-coding,/
CWITA010522,TCMBANKGE010522,EHHADH,ECHD; FRTS3; L-PBE; LBFP; LBP; PBFE,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,3q27.2,protein-coding,/
CWITA010523,TCMBANKGE010523,MFSD4A,MFSD4; UNQ3064,major facilitator superfamily domain containing 4A,1q32.1,protein-coding,/
CWITA010524,TCMBANKGE010524,BAG5,BAG-5,BAG cochaperone 5,14q32.33,protein-coding,/
CWITA010525,TCMBANKGE010525,HOXA6,HOX1; HOX1.2; HOX1B,homeobox A6,7p15.2,protein-coding,/
CWITA010526,TCMBANKGE010526,GABRA3,MGC33793,"gamma-aminobutyric acid (GABA) A receptor, alpha 3",Xq28,protein-coding,
CWITA010527,TCMBANKGE010527,ARRB2,ARB2; ARR2; BARR2,arrestin beta 2,17p13.2,protein-coding,Research target
CWITA010528,TCMBANKGE010528,LIPJ,FLJ11218; LIPL1; bA425M17.2,"lipase, family member J",10q23.31,protein-coding,
CWITA010529,TCMBANKGE010529,PLEKHG5,CMTRIC; DSMA4; GEF720; Syx; Tech,pleckstrin homology and RhoGEF domain containing G5,1p36.31,protein-coding,/
CWITA010530,TCMBANKGE010530,CCDC170,C6orf97; bA282P11.1,coiled-coil domain containing 170,6q25.1,protein-coding,/
CWITA010531,TCMBANKGE010531,PLPP4,DPPL2; PPAPDC1; PPAPDC1A,phospholipid phosphatase 4,10q26.12,protein-coding,/
CWITA010532,TCMBANKGE010532,MAP3K9,MEKK9; MLK1; PRKE1,mitogen-activated protein kinase kinase kinase 9,14q24.3-q31,protein-coding,
CWITA010533,TCMBANKGE010533,EVA1B,C1orf78; FAM176B,eva-1 homolog B,1p34.3,protein-coding,/
CWITA010534,TCMBANKGE010534,ITGA10,PRO827,integrin subunit alpha 10,1q21.1,protein-coding,/
CWITA010535,TCMBANKGE010535,TTC4,CNS1,tetratricopeptide repeat domain 4,1p32.3,protein-coding,/
CWITA010536,TCMBANKGE010536,HNRNPD,AUF1; AUF1A; HNRPD; P37; hnRNPD0,heterogeneous nuclear ribonucleoprotein D,4q21.22,protein-coding,/
CWITA010537,TCMBANKGE010537,SMC2,CAP-E; CAPE; SMC-2; SMC2L1,structural maintenance of chromosomes 2,9q31.1,protein-coding,Research target
CWITA010538,TCMBANKGE010538,CTDSP1,NLIIF; SCP1,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1",2q35,protein-coding,
CWITA010539,TCMBANKGE010539,PTOV1,ACID2; PTOV-1,PTOV1 extended AT-hook containing adaptor protein,19q13.33,protein-coding,/
CWITA010540,TCMBANKGE010540,ITK,EMT; LYK; MGC126257; MGC126258; PSCTK2,IL2-inducible T-cell kinase,5q31-q32,protein-coding,
CWITA010541,TCMBANKGE010541,MYOCD,MGBL; MYCD,myocardin,17p12,protein-coding,/
CWITA010542,TCMBANKGE010542,RND3,ARHE; Rho8; RhoE; memB,Rho family GTPase 3,2q23.3,protein-coding,
CWITA010543,TCMBANKGE010543,SGO1,CAID; NY-BR-85; SGO; SGOL1,shugoshin 1,3p24.3,protein-coding,Research target
CWITA010544,TCMBANKGE010544,ALPK2,HAK,alpha kinase 2,18q21.31-q21.32,protein-coding,/
CWITA010545,TCMBANKGE010545,BDKRB2,B2R; BKN2; BK2; BKR2; BRB2; DKFZp686O088,bradykinin receptor B2,14q32.1-q32.2,protein-coding,
CWITA010546,TCMBANKGE010546,SIAH3,-,siah E3 ubiquitin protein ligase family member 3,13q14.13,protein-coding,/
CWITA010547,TCMBANKGE010547,GFPT2,GFAT; GFAT 2; GFAT2,glutamine-fructose-6-phosphate transaminase 2,5q35.3,protein-coding,/
CWITA010548,TCMBANKGE010548,TTC9,TTC9A,tetratricopeptide repeat domain 9,14q24.2,protein-coding,/
CWITA010549,TCMBANKGE010549,TNPO1,IPO2; KPNB2; MIP; MIP1; TRN,transportin 1,5q13.2,protein-coding,/
CWITA010550,TCMBANKGE010550,PDK4,FLJ40832,"pyruvate dehydrogenase kinase, isozyme 4",7q21.3,protein-coding,
CWITA010551,TCMBANKGE010551,NES,Nbla00170,nestin,1q23.1,protein-coding,Research target
CWITA010552,TCMBANKGE010552,PLEKHG4,ARHGEF44; PRTPHN1; SCA4,pleckstrin homology and RhoGEF domain containing G4,16q22.1,protein-coding,/
CWITA010553,TCMBANKGE010553,PRRC1,-,proline rich coiled-coil 1,5q23.2,protein-coding,/
CWITA010554,TCMBANKGE010554,PRKRIP1,C114; KRBOX3,PRKR interacting protein 1,7q22.1,protein-coding,/
CWITA010555,TCMBANKGE010555,FBP1,FBP,"fructose-1,6-bisphosphatase 1",9q22.3,protein-coding,
CWITA010556,TCMBANKGE010556,IGFN1,EEF1A2BP1,immunoglobulin like and fibronectin type III domain containing 1,1q32.1,protein-coding,/
CWITA010557,TCMBANKGE010557,CPLANE2,C1orf89; RSG1,ciliogenesis and planar polarity effector 2,1p36.13,protein-coding,/
CWITA010558,TCMBANKGE010558,NYX,CLRP; CSNB1; CSNB1A; CSNB4; NBM1,nyctalopin,Xp11.4,protein-coding,/
CWITA010559,TCMBANKGE010559,AMZ2,-,archaelysin family metallopeptidase 2,17q24.2,protein-coding,/
CWITA010560,TCMBANKGE010560,RAB40C,RARL; RASL8C,"RAB40C, member RAS oncogene family",16p13.3,protein-coding,/
CWITA010561,TCMBANKGE010561,ZNF740,Zfp740,zinc finger protein 740,12q13.13,protein-coding,/
CWITA010562,TCMBANKGE010562,GRID2,MGC117022; MGC117023; MGC117024,"glutamate receptor, ionotropic, delta 2",4q22,protein-coding,
CWITA010563,TCMBANKGE010563,RSRC1,BM-011; MRT70; SFRS21; SRrp53,arginine and serine rich coiled-coil 1,3q25.32,protein-coding,/
CWITA010564,TCMBANKGE010564,PKIA,PRKACN1,"protein kinase (cAMP-dependent, catalytic) inhibitor alpha",8q21.12,protein-coding,
CWITA010565,TCMBANKGE010565,MAN2A1,GOLIM7; MANA2; MANII,"mannosidase, alpha, class 2A, member 1",5q21-q22,protein-coding,
CWITA010566,TCMBANKGE010566,ZDHHC23,DHHC-23; NIDD,zinc finger DHHC-type palmitoyltransferase 23,3q13.31,protein-coding,/
CWITA010567,TCMBANKGE010567,PIK3R3,DKFZp686P05226; FLJ41892; p55; p55NGAMMA,"phosphoinositide-3-kinase, regulatory subunit 3 (gamma)",1p34.1,protein-coding,
CWITA010568,TCMBANKGE010568,FNBP1L,C1orf39; TOCA1,formin binding protein 1 like,1p22.1,protein-coding,/
CWITA010569,TCMBANKGE010569,Pirb,Gp91; LIR-3; Lilrb3; PIR-B,paired Ig-like receptor B,7 A1|7 2.14 cM,protein-coding,/
CWITA010570,TCMBANKGE010570,PYCR2,FLJ54750; P5CR2,"pyrroline-5-carboxylate reductase family, member 2",1q42.12,protein-coding,
CWITA010571,TCMBANKGE010571,MTIF2,-,mitochondrial translational initiation factor 2,2p16.1,protein-coding,/
CWITA010572,TCMBANKGE010572,TST,RDS,thiosulfate sulfurtransferase,22q12.3,protein-coding,/
CWITA010573,TCMBANKGE010573,PLSCR4,TRA1,phospholipid scramblase 4,3q24,protein-coding,/
CWITA010574,TCMBANKGE010574,CTU1,ATPBD3; NCS6,cytosolic thiouridylase subunit 1,19q13.41,protein-coding,/
CWITA010575,TCMBANKGE010575,TBC1D14,-,TBC1 domain family member 14,4p16.1,protein-coding,/
CWITA010576,TCMBANKGE010576,MDN1,Rea1,midasin AAA ATPase 1,6q15,protein-coding,/
CWITA010577,TCMBANKGE010577,FCGR1A,CD64; CD64A; FCRI; IGFR1,Fc fragment of IgG receptor Ia,1q21.2,protein-coding,Research target
CWITA010578,TCMBANKGE010578,MFSD5,hsMOT2,major facilitator superfamily domain containing 5,12q13.13,protein-coding,/
CWITA010579,TCMBANKGE010579,NPY1R,NPY1-R; NPYR,neuropeptide Y receptor Y1,4q32.2,protein-coding,Clinical Trial target
CWITA010580,TCMBANKGE010580,GPX7,CL683; FLJ14777; GPX6; GPxN7; GSHPxN7; NPGPx,glutathione peroxidase 7,1p32,protein-coding,
CWITA010581,TCMBANKGE010581,PRDM12,HSAN8; PFM9,PR/SET domain 12,9q34.12,protein-coding,/
CWITA010582,TCMBANKGE010582,MASP2,MAP19; MASP-2; MASP1P1; sMAP,mannan binding lectin serine peptidase 2,1p36.22,protein-coding,Clinical Trial target
CWITA010583,TCMBANKGE010583,SMN2,BCD541; C-BCD541; GEMIN1; SMNC; TDRD16B,"survival of motor neuron 2, centromeric",5q13.2,protein-coding,/
CWITA010584,TCMBANKGE010584,ARID4A,RBBP-1; RBBP1; RBP-1; RBP1,AT-rich interaction domain 4A,14q23.1,protein-coding,/
CWITA010585,TCMBANKGE010585,MICU1,CALC; CBARA1; EFHA3; MPXPS; ara CALC,mitochondrial calcium uptake 1,10q22.1,protein-coding,/
CWITA010586,TCMBANKGE010586,RBBP8,COM1; CTIP; JWDS; RIM; SAE2; SCKL2,"RB binding protein 8, endonuclease",18q11.2,protein-coding,/
CWITA010587,TCMBANKGE010587,MTPN,GCDP; V-1,myotrophin,7q33,protein-coding,/
CWITA010588,TCMBANKGE010588,ZNF548,-,zinc finger protein 548,19q13.43,protein-coding,/
CWITA010589,TCMBANKGE010589,SLC16A6,MCT6; MCT7,solute carrier family 16 member 6,17q24.2,protein-coding,/
CWITA010590,TCMBANKGE010590,TRIM27,RFP; RNF76,tripartite motif containing 27,6p22.1,protein-coding,Research target
CWITA010591,TCMBANKGE010591,SLC28A3,CNT3,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 3",9q22.2,protein-coding,
CWITA010592,TCMBANKGE010592,PTDSS2,FLJ46373; PSS2,phosphatidylserine synthase 2,11p15.5,protein-coding,
CWITA010593,TCMBANKGE010593,DHX33,DDX33,DEAH-box helicase 33,17p13.2,protein-coding,/
CWITA010594,TCMBANKGE010594,FJX1,-,four-jointed box kinase 1,11p13,protein-coding,/
CWITA010595,TCMBANKGE010595,ALDOB,ALDB; ALDO2,"aldolase B, fructose-bisphosphate",9q21.3-q22.2,protein-coding,
CWITA010596,TCMBANKGE010596,KLRC3,NKG2-E; NKG2E,killer cell lectin like receptor C3,12p13.2,protein-coding,/
CWITA010597,TCMBANKGE010597,MGRN1,RNF156,mahogunin ring finger 1,16p13.3,protein-coding,/
CWITA010598,TCMBANKGE010598,WNT4,SERKAL; WNT-4,Wnt family member 4,1p36.12,protein-coding,/
CWITA010599,TCMBANKGE010599,POLA2,FLJ21662; FLJ37250,"polymerase (DNA directed), alpha 2 (70kD subunit)",11q13.1,protein-coding,
CWITA010600,TCMBANKGE010600,MEAF6,C1orf149; CENP-28; EAF6; NY-SAR-91,MYST/Esa1 associated factor 6,1p34.3,protein-coding,/
CWITA010601,TCMBANKGE010601,KHNYN,KIAA0323,KH and NYN domain containing,14q12,protein-coding,/
CWITA010602,TCMBANKGE010602,EIF3B,EIF3-ETA; EIF3-P110; EIF3-P116; EIF3S9; PRT1,eukaryotic translation initiation factor 3 subunit B,7p22.3,protein-coding,/
CWITA010603,TCMBANKGE010603,FAM53B,KIAA0140; bA12J10.2; smp,family with sequence similarity 53 member B,10q26.13,protein-coding,/
CWITA010604,TCMBANKGE010604,BPY2,BPY2A; VCY2; VCY2A,basic charge Y-linked 2,Yq11.223,protein-coding,/
CWITA010605,TCMBANKGE010605,ZNF410,APA-1; APA1,zinc finger protein 410,14q24.3,protein-coding,/
CWITA010606,TCMBANKGE010606,HOXB1,HCFP3; HOX2; HOX2I; Hox-2.9,homeobox B1,17q21.32,protein-coding,/
CWITA010607,TCMBANKGE010607,LEF1,LEF-1; TCF10; TCF1ALPHA; TCF7L3,lymphoid enhancer binding factor 1,4q25,protein-coding,/
CWITA010608,TCMBANKGE010608,MTERF3,CGI-12; MTERFD1,mitochondrial transcription termination factor 3,8q22.1,protein-coding,/
CWITA010609,TCMBANKGE010609,UBQLN2,ALS15; CHAP1; DSK2; HRIHFB2157; N4BP4; PLIC2,ubiquilin 2,Xp11.21,protein-coding,/
CWITA010610,TCMBANKGE010610,NEK6,SID6-1512,NIMA related kinase 6,9q33.3,protein-coding,Research target
CWITA010611,TCMBANKGE010611,ERGIC3,C20orf47; C2orf47; CGI-54; Erv46; NY-BR-84; PRO0989; SDBCAG84; dJ477O4.2,ERGIC and golgi 3,20q11.22,protein-coding,/
CWITA010612,TCMBANKGE010612,SUOX,-,sulfite oxidase,12q13.2,protein-coding,/
CWITA010613,TCMBANKGE010613,PTTG1,EAP1; HPTTG; PTTG; TUTR1,"PTTG1 regulator of sister chromatid separation, securin",5q33.3,protein-coding,/
CWITA010614,TCMBANKGE010614,SFTPD,COLEC7; PSP-D; SFTP4; SP-D,surfactant protein D,10q22.3,protein-coding,Research target
CWITA010615,TCMBANKGE010615,LMAN2L,MRT52; VIPL,"lectin, mannose binding 2 like",2q11.2,protein-coding,/
CWITA010616,TCMBANKGE010616,SLC7A7,LAT3; LPI; MOPN2; Y+LAT1; y+LATN1,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 7",14q11.2,protein-coding,
CWITA010617,TCMBANKGE010617,KCNK1,DPK; HOHO; K2P1; K2p1.1; KCNO1; TWIK-1; TWIK1,potassium two pore domain channel subfamily K member 1,1q42.2,protein-coding,/
CWITA010618,TCMBANKGE010618,LSM7,YNL147W,"LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated",19p13.3,protein-coding,/
CWITA010619,TCMBANKGE010619,CD164,DFNA66; MGC-24; MGC-24v; MUC-24; endolyn,CD164 molecule,6q21,protein-coding,/
CWITA010620,TCMBANKGE010620,SMARCC1,BAF155; CRACC1; Rsc8; SRG3; SWI3,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1",3p21.31,protein-coding,/
CWITA010621,TCMBANKGE010621,AGTPBP1,CCP1; CONDCA; NNA1,ATP/GTP binding protein 1,9q21.33,protein-coding,/
CWITA010622,TCMBANKGE010622,MYT1,C20orf36; MTF1; MYTI; NZF2; PLPB1; ZC2H2C1; ZC2HC4A,myelin transcription factor 1,20q13.33,protein-coding,/
CWITA010623,TCMBANKGE010623,IPO8,RANBP8,importin 8,12p11.21,protein-coding,/
CWITA010624,TCMBANKGE010624,SLC2A8,GLUT8; GLUTX1,solute carrier family 2 member 8,9q33.3,protein-coding,/
CWITA010625,TCMBANKGE010625,SAMD9L,ATXPC; C7orf6; DRIF2; UEF1,sterile alpha motif domain containing 9 like,7q21.2,protein-coding,/
CWITA010626,TCMBANKGE010626,RAVER1,-,"ribonucleoprotein, PTB binding 1",19p13.2,protein-coding,/
CWITA010627,TCMBANKGE010627,ARSG,USH4,arylsulfatase G,17q24.2,protein-coding,/
CWITA010628,TCMBANKGE010628,ST3GAL6,SIAT10; ST3GALVI,"ST3 beta-galactoside alpha-2,3-sialyltransferase 6",3q12.1,protein-coding,/
CWITA010629,TCMBANKGE010629,POLR2I,RPB9; hRPB14.5,RNA polymerase II subunit I,19q13.12,protein-coding,/
CWITA010630,TCMBANKGE010630,TREM1,TREMN1,triggering receptor expressed on myeloid cells 1,6p21.1,protein-coding,
CWITA010631,TCMBANKGE010631,TUBB3,CDCBM; CDCBM1; CFEOM3; CFEOM3A; FEOM3; TUBB4; beta-4,tubulin beta 3 class III,16q24.3,protein-coding,/
CWITA010632,TCMBANKGE010632,MGST2,FLJ27438; GST2; MGC14097; MGSTNII,microsomal glutathione S-transferase 2,4q28.3,protein-coding,
CWITA010633,TCMBANKGE010633,PPFIA4,-,PTPRF interacting protein alpha 4,1q32.1,protein-coding,/
CWITA010634,TCMBANKGE010634,C12orf75,AGD3; OCC-1; OCC1,chromosome 12 open reading frame 75,12q23.3,protein-coding,/
CWITA010635,TCMBANKGE010635,PAQR9,-,progestin and adipoQ receptor family member 9,3q23,protein-coding,/
CWITA010636,TCMBANKGE010636,CSNK1G1,N,"casein kinase 1, gamma 1",15q22.1-q22.31,protein-coding,
CWITA010637,TCMBANKGE010637,AGTRAP,ATRAP,angiotensin II receptor associated protein,1p36.22,protein-coding,/
CWITA010638,TCMBANKGE010638,BTBD2,-,BTB domain containing 2,19p13.3,protein-coding,/
CWITA010639,TCMBANKGE010639,ZFP28,mkr5,ZFP28 zinc finger protein,19q13.43,protein-coding,/
CWITA010640,TCMBANKGE010640,SEC14L2,C22orf6; KIAA1186; KIAA1658; MGC65053; SPF; TAP; TAP1,SEC14-like 2 (S. cerevisiae),22q12.2,protein-coding,
CWITA010641,TCMBANKGE010641,TRIM43,TRIM43A,tripartite motif containing 43,2q11.1,protein-coding,/
CWITA010642,TCMBANKGE010642,CDC42EP1,BORG5; CEP1; MSE55,CDC42 effector protein 1,22q13.1,protein-coding,/
CWITA010643,TCMBANKGE010643,PPP1CA,PP-1A; PP1A; PP1alpha; PPP1A,protein phosphatase 1 catalytic subunit alpha,11q13.2,protein-coding,Successful target
CWITA010644,TCMBANKGE010644,LPL,HDLCQ11; LIPD,lipoprotein lipase,8p22,protein-coding,
CWITA010645,TCMBANKGE010645,TAF7,TAF2F; TAFII55,TATA-box binding protein associated factor 7,5q31.3,protein-coding,/
CWITA010646,TCMBANKGE010646,DNTTIP1,C20orf167; Tdif1; dJ447F3.4,deoxynucleotidyltransferase terminal interacting protein 1,20q13.12,protein-coding,/
CWITA010647,TCMBANKGE010647,IL13RA2,CD213A2; CT19; IL-13R; IL13BP,interleukin 13 receptor subunit alpha 2,Xq23,protein-coding,Clinical Trial target
CWITA010648,TCMBANKGE010648,PIK3R3,p55; p55-GAMMA; p55PIK,phosphoinositide-3-kinase regulatory subunit 3,1p34.1,protein-coding,/
CWITA010649,TCMBANKGE010649,RHOV,ARHV; CHP; WRCH2,ras homolog family member V,15q15.1,protein-coding,/
CWITA010650,TCMBANKGE010650,RAB42,-,"RAB42, member RAS oncogene family",1p35.3,protein-coding,/
CWITA010651,TCMBANKGE010651,FEZ2,HUM3CL,fasciculation and elongation protein zeta 2,2p22.2,protein-coding,/
CWITA010652,TCMBANKGE010652,PDHB,PDHBD; PDHE1-B; PDHE1B; PHE1B,pyruvate dehydrogenase E1 subunit beta,3p14.3,protein-coding,/
CWITA010653,TCMBANKGE010653,FLI1,BDPLT21; EWSR2; SIC-1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3,protein-coding,/
CWITA010654,TCMBANKGE010654,SPEN,HIAA0929; MINT; RBM15C; SHARP,spen family transcriptional repressor,1p36.21-p36.13,protein-coding,/
CWITA010655,TCMBANKGE010655,TANC2,ROLSA; rols,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2",17q23.2-q23.3,protein-coding,/
CWITA010656,TCMBANKGE010656,PTPN5,PTPSTEP; STEP; STEP61,protein tyrosine phosphatase non-receptor type 5,11p15.1,protein-coding,/
CWITA010657,TCMBANKGE010657,PRKG1,AAT8; PKG; PKG1; PRKG1B; PRKGR1B; cGK; cGK 1; cGK1; cGKI; cGKI-BETA; cGKI-alpha,protein kinase cGMP-dependent 1,10q11.23-q21.1,protein-coding,Research target
CWITA010658,TCMBANKGE010658,CRY1,DSPD; PHLL1,cryptochrome circadian regulator 1,12q23.3,protein-coding,Research target
CWITA010659,TCMBANKGE010659,PLEKHA3,FAPP1,pleckstrin homology domain containing A3,2q31.2,protein-coding,/
CWITA010660,TCMBANKGE010660,GPX1,GSHPX1; MGC14399; MGC88245,glutathione peroxidase 1,3p21.3,protein-coding,
CWITA010661,TCMBANKGE010661,MRPL4,CGI-28; L4mt,mitochondrial ribosomal protein L4,19p13.2,protein-coding,/
CWITA010662,TCMBANKGE010662,AZGP1,ZA2G; ZAG,"alpha-2-glycoprotein 1, zinc-binding",7q22.1,protein-coding,
CWITA010663,TCMBANKGE010663,MT1E,MT-1E; MT-IE; MT1; MTD,metallothionein 1E,16q13,protein-coding,/
CWITA010664,TCMBANKGE010664,FXYD3,MAT8; PLML,FXYD domain containing ion transport regulator 3,19q13.12,protein-coding,/
CWITA010665,TCMBANKGE010665,CD9,BTCC-1; DRAP-27; MIC3; MRP-1; TSPAN-29; TSPAN29,CD9 molecule,12p13.31,protein-coding,Research target
CWITA010666,TCMBANKGE010666,ZNF652,-,zinc finger protein 652,17q21.32-q21.33,protein-coding,/
CWITA010667,TCMBANKGE010667,SLC6A9,DKFZp547A1118; GLYT1,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",1p33,protein-coding,
CWITA010668,TCMBANKGE010668,EGLN3,FLJ21620; HIFPH3; MGC125998; MGC125999; PHD3,egl nine homolog 3 (C. elegans),14q13.1,protein-coding,
CWITA010669,TCMBANKGE010669,CASR,CAR; EIG8; FHH; FIH; GPRC2A; HHC; HHC1; MGC138441; NSHPT; PCAR1,calcium-sensing receptor,3q13,protein-coding,
CWITA010670,TCMBANKGE010670,KCNJ8,KIR6.1; uKATP-1,potassium inwardly rectifying channel subfamily J member 8,12p12.1,protein-coding,/
CWITA010671,TCMBANKGE010671,IRX4,IRXA3,iroquois homeobox 4,5p15.33,protein-coding,/
CWITA010672,TCMBANKGE010672,alp,-,"alopecia, recessive",-,unknown,/
CWITA010673,TCMBANKGE010673,ASPG,C14orf76; GPA/WT; LYSOLP,asparaginase,14q32.33,protein-coding,/
CWITA010674,TCMBANKGE010674,Il11ra1,AI314697; GP130; Il-11ra; Il11ra; Il11ra2; NR1,"interleukin 11 receptor, alpha chain 1",4 A5|4 21.94 cM,protein-coding,/
CWITA010675,TCMBANKGE010675,DYSF,FER1L1; LGMD2B; LGMDR2; MMD1,dysferlin,2p13.2,protein-coding,Research target
CWITA010676,TCMBANKGE010676,C8orf33,-,chromosome 8 open reading frame 33,8q24.3,protein-coding,/
CWITA010677,TCMBANKGE010677,ACVR2B,ACTRIIB; ActR-IIB; HTX4,activin A receptor type 2B,3p22.2,protein-coding,Research target
CWITA010678,TCMBANKGE010678,CDK15,ALS2CR7; PFTK2,cyclin-dependent kinase 15,2q33.2,protein-coding,
CWITA010679,TCMBANKGE010679,DENR,DRP; DRP1; SMAP-3,density regulated re-initiation and release factor,12q24.31,protein-coding,/
CWITA010680,TCMBANKGE010680,RXFP4,GPCR142; GPR100; RLN3R2; RXFPR4,relaxin family peptide/INSL5 receptor 4,1q22,protein-coding,/
CWITA010681,TCMBANKGE010681,CAAP1,C9orf82; CAAP,caspase activity and apoptosis inhibitor 1,9p21.2,protein-coding,/
CWITA010682,TCMBANKGE010682,THYN1,HSPC144; MDS012; MY105; THY28; THY28KD,thymocyte nuclear protein 1,11q25,protein-coding,/
CWITA010683,TCMBANKGE010683,MAZ,PUR1; Pur-1; SAF-1; SAF-2; SAF-3; ZF87; ZNF801; Zif87,MYC associated zinc finger protein,16p11.2,protein-coding,Research target
CWITA010684,TCMBANKGE010684,LYSMD2,-,LysM domain containing 2,15q21.2,protein-coding,/
CWITA010685,TCMBANKGE010685,PRPF6,ANT-1; ANT1; C20orf14; Prp6; RP60; SNRNP102; TOM; U5-102K; hPrp6,pre-mRNA processing factor 6,20q13.33,protein-coding,/
CWITA010686,TCMBANKGE010686,GUCD1,C22orf13; LLN4,guanylyl cyclase domain containing 1,22q11.23,protein-coding,/
CWITA010687,TCMBANKGE010687,DYNC2I2,CFAP133; DIC5; FAP133; SRTD11; WDR34; bA216B9.3,dynein 2 intermediate chain 2,9q34.11,protein-coding,/
CWITA010688,TCMBANKGE010688,FABP2,FABPI; INFABP; MGC133132,"fatty acid binding protein 2, intestinal",4q28-q31,protein-coding,
CWITA010689,TCMBANKGE010689,HMG20A,HMGX1; HMGXB1,high mobility group 20A,15q24.3,protein-coding,/
CWITA010690,TCMBANKGE010690,PLXNA2,OCT; PLXN2,plexin A2,1q32.2,protein-coding,/
CWITA010691,TCMBANKGE010691,LSS,FLJ25486; FLJ35015; FLJ39450; FLJ46393; OSC,"lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)",21q22.3,protein-coding,
CWITA010692,TCMBANKGE010692,KAT5,ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2,lysine acetyltransferase 5,11q13.1,protein-coding,/
CWITA010693,TCMBANKGE010693,ZFR,SPG71; ZFR1,zinc finger RNA binding protein,5p13.3,protein-coding,/
CWITA010694,TCMBANKGE010694,TSPY2,TSPYQ1,testis specific protein Y-linked 2,Yp11.2,protein-coding,/
CWITA010695,TCMBANKGE010695,ADARB1,ADAR2; DRABA2; DRADA2; NEDHYMS; RED1,adenosine deaminase RNA specific B1,21q22.3,protein-coding,/
CWITA010696,TCMBANKGE010696,COQ9,C16orf49; COQ10D5,coenzyme Q9,16q21,protein-coding,/
CWITA010697,TCMBANKGE010697,Npcd,Cbx6-Nptxr,neuronal pentraxin chromo domain,15|15 E1,protein-coding,/
CWITA010698,TCMBANKGE010698,UGT1A6,GNT1; HLUGP; HLUGP1; MGC29860; UDPGT; UDPGT_1N6; UGT1; UGT1A6S; UGT1F,"UDP glucuronosyltransferase 1 family, polypeptide A6",2q37,protein-coding,
CWITA010699,TCMBANKGE010699,NFIB,CTF; HMGIC/NFIB; MACID; NF-I/B; NF1-B; NFI-B; NFI-RED; NFIB2; NFIB3,nuclear factor I B,9p23-p22.3,protein-coding,/
CWITA010700,TCMBANKGE010700,MFAP3L,NYD-sp9,microfibril associated protein 3 like,4q33,protein-coding,/
CWITA010701,TCMBANKGE010701,VCX2,VCX-2r; VCX2R; VCXB,variable charge X-linked 2,Xp22.31,protein-coding,/
CWITA010702,TCMBANKGE010702,FCER1A,FCE1A; FcERI,"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide",1q23,protein-coding,
CWITA010703,TCMBANKGE010703,DAXX,BING2; DAP6; EAP1; SMIM40,death domain associated protein,6p21.32,protein-coding,/
CWITA010704,TCMBANKGE010704,Sod1m,Msod1,"superoxide dismutase 1, soluble, modifier",-,unknown,/
CWITA010705,TCMBANKGE010705,MRTFB,MKL2; MRTF-B; NPD001,myocardin related transcription factor B,16p13.12,protein-coding,/
CWITA010706,TCMBANKGE010706,OXCT2,FKSG25; SCOTT,3-oxoacid CoA-transferase 2,1p34.2,protein-coding,/
CWITA010707,TCMBANKGE010707,SEL1L2,C20orf50; sel-1L2,SEL1L2 adaptor subunit of ERAD E3 ligase,20p12.1,protein-coding,/
CWITA010708,TCMBANKGE010708,PRSS33,EOS,serine protease 33,16p13.3,protein-coding,/
CWITA010709,TCMBANKGE010709,CNPY2,HP10390; MSAP; TMEM4; ZSIG9,canopy FGF signaling regulator 2,12q13.3,protein-coding,/
CWITA010710,TCMBANKGE010710,CALR3,CMH19; CRT2; CT93,calreticulin 3,19p13.11,protein-coding,/
CWITA010711,TCMBANKGE010711,ABCC9,ABC37; ATFB12; CANTU; CMD1O; SUR2,ATP binding cassette subfamily C member 9,12p12.1,protein-coding,Successful target
CWITA010712,TCMBANKGE010712,MME,CALLA; CD10; CMT2T; NEP; SCA43; SFE,membrane metalloendopeptidase,3q25.2,protein-coding,Clinical Trial target
CWITA010713,TCMBANKGE010713,RAP1GAP,RAP1GA1; RAP1GAP1; RAP1GAPII; RAPGAP,RAP1 GTPase activating protein,1p36.12,protein-coding,/
CWITA010714,TCMBANKGE010714,FGF18,FGF-18; ZFGF5,fibroblast growth factor 18,5q35.1,protein-coding,Clinical Trial target
CWITA010715,TCMBANKGE010715,MALT1,IMD12; MLT; MLT1; PCASP1,MALT1 paracaspase,18q21.32,protein-coding,/
CWITA010716,TCMBANKGE010716,AMBP,A1M; EDC1; HCP; HI30; IATIL; ITI; ITIL; ITILC; UTI,alpha-1-microglobulin/bikunin precursor,9q32,protein-coding,/
CWITA010717,TCMBANKGE010717,TUBA1C,TUBA6; bcm948,tubulin alpha 1c,12q13.12,protein-coding,/
CWITA010718,TCMBANKGE010718,ECI1,DCI,enoyl-CoA delta isomerase 1,16p13.3,protein-coding,
CWITA010719,TCMBANKGE010719,AKAP17A,721P; AKAP-17A; CCDC133; CXYorf3; DXYS155E; PRKA17A; SFRS17A; XE7; XE7Y,A-kinase anchoring protein 17A,Xp22.33 and Yp11.2,protein-coding,/
CWITA010720,TCMBANKGE010720,LMBRD1,C6orf209; LMBD1; MAHCF; NESI,LMBR1 domain containing 1,6q13,protein-coding,/
CWITA010721,TCMBANKGE010721,MAP2K1,MAPKK1; MEK1; MKK1; PRKMK1,mitogen-activated protein kinase kinase 1,15q22.1-q22.33,protein-coding,
CWITA010722,TCMBANKGE010722,BRI3BP,BNAS1; HCCR-1; HCCR-2; HCCRBP-1; HCCRBP-3; KG19,BRI3 binding protein,12q24.31,protein-coding,/
CWITA010723,TCMBANKGE010723,HSF5,HSF 5; HSTF 5,heat shock transcription factor 5,17q22,protein-coding,/
CWITA010724,TCMBANKGE010724,GRIK3,EAA5; GLR7; GLUR7; GluK3; GluR7a,glutamate ionotropic receptor kainate type subunit 3,1p34.3,protein-coding,Research target
CWITA010725,TCMBANKGE010725,ZNF212,C2H2-150; ZNF182; ZNFC150,zinc finger protein 212,7q36.1,protein-coding,/
CWITA010726,TCMBANKGE010726,SHISA2,C13orf13; PRO28631; TMEM46; WGAR9166; bA398O19.2; hShisa,shisa family member 2,13q12.13,protein-coding,/
CWITA010727,TCMBANKGE010727,DAZAP1,-,DAZ associated protein 1,19p13.3,protein-coding,/
CWITA010728,TCMBANKGE010728,MBD1,CXXC3; PCM1; RFT,methyl-CpG binding domain protein 1,18q21.1,protein-coding,/
CWITA010729,TCMBANKGE010729,OSGIN2,C8orf1; hT41,oxidative stress induced growth inhibitor family member 2,8q21.3,protein-coding,/
CWITA010730,TCMBANKGE010730,DRD3,D3DR; ETM1; FET1; MGC149204; MGC149205,dopamine receptor D3,3q13.3,protein-coding,
CWITA010731,TCMBANKGE010731,MYO1B,MMI-alpha; MMIa; MYH-1c; myr1,myosin IB,2q32.3,protein-coding,/
CWITA010732,TCMBANKGE010732,RRP1,D21S2056E; NNP-1; NOP52; RRP1A,ribosomal RNA processing 1,21q22.3,protein-coding,/
CWITA010733,TCMBANKGE010733,RBM3,IS1-RNPL; RNPL,RNA binding motif protein 3,Xp11.23,protein-coding,/
CWITA010734,TCMBANKGE010734,TUBB1,-,tubulin beta 1 class VI,20q13.32,protein-coding,Clinical Trial target
CWITA010735,TCMBANKGE010735,HERPUD2,-,HERPUD family member 2,7p14.2,protein-coding,/
CWITA010736,TCMBANKGE010736,SPATA20,HEL-S-98; SSP411; Tisp78,spermatogenesis associated 20,17q21.33,protein-coding,/
CWITA010737,TCMBANKGE010737,MMEL1,MMEL2; NEP2; NEPII; NL1; NL2; SEP,membrane metalloendopeptidase like 1,1p36.32,protein-coding,/
CWITA010738,TCMBANKGE010738,SCD5,ACOD4; FADS4; HSCD5; SCD2; SCD4,stearoyl-CoA desaturase 5,4q21.22,protein-coding,/
CWITA010739,TCMBANKGE010739,TFF1,BCEI; D21S21; HP1.A; HPS2; pNR-2; pS2,trefoil factor 1,21q22.3,protein-coding,Clinical Trial target
CWITA010740,TCMBANKGE010740,SMIM19,C8orf40,small integral membrane protein 19,8p11.21,protein-coding,/
CWITA010741,TCMBANKGE010741,GDF3,KFS3; MCOP7; MCOPCB6,growth differentiation factor 3,12p13.31,protein-coding,/
CWITA010742,TCMBANKGE010742,RIOK3,SUDD,RIO kinase 3,18q11.2,protein-coding,/
CWITA010743,TCMBANKGE010743,MYLK4,SgK085,myosin light chain kinase family member 4,6p25.2,protein-coding,/
CWITA010744,TCMBANKGE010744,RAP2C,-,"RAP2C, member of RAS oncogene family",Xq26.2,protein-coding,/
CWITA010745,TCMBANKGE010745,PRELP,MST161; MSTP161; SLRR2A,proline and arginine rich end leucine rich repeat protein,1q32.1,protein-coding,/
CWITA010746,TCMBANKGE010746,ASXL1,BOPS; MDS,ASXL transcriptional regulator 1,20q11.21,protein-coding,/
CWITA010747,TCMBANKGE010747,ZNF710,-,zinc finger protein 710,15q26.1,protein-coding,/
CWITA010748,TCMBANKGE010748,PYGB,MGC9213,"phosphorylase, glycogen; brain",20p11.2-p11.1,protein-coding,
CWITA010749,TCMBANKGE010749,TSGA10,CEP4L; CT79; SPGF26,testis specific 10,2q11.2,protein-coding,/
CWITA010750,TCMBANKGE010750,SFRP2,FRP-2; SARP1; SDF-5,secreted frizzled related protein 2,4q31.3,protein-coding,/
CWITA010751,TCMBANKGE010751,EVPLL,-,envoplakin like,17p11.2,protein-coding,/
CWITA010752,TCMBANKGE010752,NT5C2,GMP; NT5B; PNT5; SPG45; SPG65; cN-II,"5'-nucleotidase, cytosolic II",10q24.32-q24.33,protein-coding,/
CWITA010753,TCMBANKGE010753,SKP1,EMC19; MGC34403; OCPNII; OCP2; SKP1A; TCEB1L; p19A,S-phase kinase-associated protein 1,5q31,protein-coding,
CWITA010754,TCMBANKGE010754,TC2N,C14orf47; C2CD1; MTAC2D1; Tac2-N,"tandem C2 domains, nuclear",14q32.12,protein-coding,/
CWITA010755,TCMBANKGE010755,TUBB2B,DKFZp566F223; FLJ98847; MGC8685; bA506K6.1,"tubulin, beta 2B",6p25,protein-coding,
CWITA010756,TCMBANKGE010756,CPT2,CPT1; CPTASE; IIAE4,carnitine palmitoyltransferase 2,1p32.3,protein-coding,/
CWITA010757,TCMBANKGE010757,SPA17,CT22; SP17; SP17-1,sperm autoantigenic protein 17,11q24.2,protein-coding,/
CWITA010758,TCMBANKGE010758,BMT2,C7orf60; SAMTOR,base methyltransferase of 25S rRNA 2 homolog,7q31.1,protein-coding,/
CWITA010759,TCMBANKGE010759,H6PD,CORTRD1; G6PDH; GDH; H6PDH,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,1p36.22,protein-coding,/
CWITA010760,TCMBANKGE010760,SREBF1,SREBPN1c; SREBP1; bHLHd1,sterol regulatory element binding transcription factor 1,17p11.2,protein-coding,
CWITA010761,TCMBANKGE010761,LCN1,PMFA; TLC; TP; VEGP,lipocalin 1,9q34.3,protein-coding,/
CWITA010762,TCMBANKGE010762,KLHL29,KBTBD9,kelch like family member 29,2p24.1,protein-coding,/
CWITA010763,TCMBANKGE010763,RTN4IP1,NIMP; OPA10,reticulon 4 interacting protein 1,6q21,protein-coding,/
CWITA010764,TCMBANKGE010764,PCDH9,-,protocadherin 9,13q21.32,protein-coding,/
CWITA010765,TCMBANKGE010765,HSPA2,HSP70-2; HSP70-3,heat shock protein family A (Hsp70) member 2,14q23.3,protein-coding,/
CWITA010766,TCMBANKGE010766,LARP1,LARP; Lar1; Lhp1,"La ribonucleoprotein 1, translational regulator",5q33.2,protein-coding,/
CWITA010767,TCMBANKGE010767,BMF,-,Bcl2 modifying factor,15q15.1,protein-coding,/
CWITA010768,TCMBANKGE010768,TCEA1,GTF2S; SII; TCEA; TF2S; TFIIS,transcription elongation factor A1,8q11.23,protein-coding,/
CWITA010769,TCMBANKGE010769,DIXDC1,CCD1,DIX domain containing 1,11q23.1,protein-coding,/
CWITA010770,TCMBANKGE010770,PCSK2,NEC 2; NEC-2; NEC2; PC2; SPC2,proprotein convertase subtilisin/kexin type 2,20p12.1,protein-coding,Research target
CWITA010771,TCMBANKGE010771,ARL6IP4,SFRS20; SR-25; SRp25; SRrp37,ADP ribosylation factor like GTPase 6 interacting protein 4,12q24.31,protein-coding,/
CWITA010772,TCMBANKGE010772,GATAD2B,MRD18; P66beta; p68,GATA zinc finger domain containing 2B,1q21.3,protein-coding,/
CWITA010773,TCMBANKGE010773,NUP160,NPHS19,nucleoporin 160,11p11.2,protein-coding,/
CWITA010774,TCMBANKGE010774,ZNF397,ZNF47; ZSCAN15,zinc finger protein 397,18q12.2,protein-coding,/
CWITA010775,TCMBANKGE010775,PCDH15,CDHR15; DFNB23; USH1F,protocadherin related 15,10q21.1,protein-coding,/
CWITA010776,TCMBANKGE010776,PRCP,HUMPCP; PCP,prolylcarboxypeptidase,11q14.1,protein-coding,Patented target
CWITA010777,TCMBANKGE010777,DISC1,C1orf136; SCZD9,DISC1 scaffold protein,1q42.2,protein-coding,/
CWITA010778,TCMBANKGE010778,ARMCX5,GASP5,armadillo repeat containing X-linked 5,Xq22.1,protein-coding,/
CWITA010779,TCMBANKGE010779,MN1,CEBALID; MGCR; MGCR1; MGCR1-PEN; dJ353E16.2,"MN1 proto-oncogene, transcriptional regulator",22q12.1,protein-coding,/
CWITA010780,TCMBANKGE010780,FAM193B,IRIZIO,family with sequence similarity 193 member B,5q35.3,protein-coding,/
CWITA010781,TCMBANKGE010781,BRCA2,BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; GLM3; PNCA2; XRCC11,BRCA2 DNA repair associated,13q13.1,protein-coding,Research target
CWITA010782,TCMBANKGE010782,IGF2BP3,CT98; IMP-3; IMP3; KOC; KOC1; VICKZ3,insulin like growth factor 2 mRNA binding protein 3,7p15.3,protein-coding,/
CWITA010783,TCMBANKGE010783,TPD52,D52; N8L; PC-1; PrLZ; hD52,tumor protein D52,8q21.13,protein-coding,/
CWITA010784,TCMBANKGE010784,SURF1,CMT4K,SURF1 cytochrome c oxidase assembly factor,9q34.2,protein-coding,/
CWITA010785,TCMBANKGE010785,BATF,B-ATF; BATF1; SFA-2; SFA2,basic leucine zipper ATF-like transcription factor,14q24.3,protein-coding,/
CWITA010786,TCMBANKGE010786,AADACL2,-,arylacetamide deacetylase like 2,3q25.1,protein-coding,/
CWITA010787,TCMBANKGE010787,CHIT1,CHI3; CHIT; CHITD,chitinase 1,1q32.1,protein-coding,Research target
CWITA010788,TCMBANKGE010788,ATP6V1B1,ATP6B1; RTA1B; VATB; VMA2; VPP3,ATPase H+ transporting V1 subunit B1,2p13.3,protein-coding,/
CWITA010789,TCMBANKGE010789,HNF1A,HNF-1A; HNF1; HNF4A; IDDM20; LFB1; MODY3; TCF-1; TCF1,HNF1 homeobox A,12q24.31,protein-coding,Clinical Trial target
CWITA010790,TCMBANKGE010790,PGM1,CDG1T; GSD14,phosphoglucomutase 1,1p31.3,protein-coding,/
CWITA010791,TCMBANKGE010791,MVD,FP17780; MDDase; MPD; POROK7,mevalonate diphosphate decarboxylase,16q24.2,protein-coding,Research target
CWITA010792,TCMBANKGE010792,CABP5,CABP3,calcium binding protein 5,19q13.33,protein-coding,/
CWITA010793,TCMBANKGE010793,CLC,GAL10; GalN10; LGALS10; LGALS10A; LPPL_HUMAN; MGC149659,Charcot-Leyden crystal protein,19q13.1,protein-coding,
CWITA010794,TCMBANKGE010794,ABHD17A,C19orf27; FAM108A1,"abhydrolase domain containing 17A, depalmitoylase",19p13.3,protein-coding,/
CWITA010795,TCMBANKGE010795,CSMD2,dJ1007G16.1; dJ1007G16.2; dJ947L8.1,CUB and Sushi multiple domains 2,1p35.1,protein-coding,/
CWITA010796,TCMBANKGE010796,FADS1,D5D; FADS6; FADSD5; FLJ38956; FLJ90273; LLCDL1; TU12,fatty acid desaturase 1,11q12.2-q13.1,protein-coding,
CWITA010797,TCMBANKGE010797,PFKFB1,F6PK; HL2K; PFRX,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1",Xp11.21,protein-coding,/
CWITA010798,TCMBANKGE010798,FOXK1,FOXK1L,forkhead box K1,7p22.1,protein-coding,/
CWITA010799,TCMBANKGE010799,CALY,DRD1IP; NSG3,calcyon neuron specific vesicular protein,10q26.3,protein-coding,Discontinued target
CWITA010800,TCMBANKGE010800,GPR85,SREB; SREB2,G protein-coupled receptor 85,7q31.1,protein-coding,Research target
CWITA010801,TCMBANKGE010801,UGT2B10,UDPGT2B10,UDP glucuronosyltransferase family 2 member B10,4q13.2,protein-coding,/
CWITA010802,TCMBANKGE010802,KDM3A,JHDM2A; JHMD2A; JMJD1; JMJD1A; TSGA,lysine demethylase 3A,2p11.2,protein-coding,Research target
CWITA010803,TCMBANKGE010803,EPS15L1,EPS15R,epidermal growth factor receptor pathway substrate 15 like 1,19p13.11,protein-coding,/
CWITA010804,TCMBANKGE010804,PRKAG2,AAKG; AAKG2; CMH6; H91620p; WPWS,protein kinase AMP-activated non-catalytic subunit gamma 2,7q36.1,protein-coding,/
CWITA010805,TCMBANKGE010805,UBE2F,NCE2,ubiquitin conjugating enzyme E2 F (putative),2q37.3,protein-coding,/
CWITA010806,TCMBANKGE010806,WDR3,DIP2; UTP12,WD repeat domain 3,1p12,protein-coding,/
CWITA010807,TCMBANKGE010807,EBF1,COE1; EBF; O/E-1; OLF1,EBF transcription factor 1,5q33.3,protein-coding,/
CWITA010808,TCMBANKGE010808,STK26,MASK; MST4,serine/threonine kinase 26,Xq26.2,protein-coding,/
CWITA010809,TCMBANKGE010809,ABCB4,ABC21; GBD1; ICP3; MDR2; MDR2/3; MDR3; PFIC-3; PGY3,ATP binding cassette subfamily B member 4,7q21.12,protein-coding,Discontinued target
CWITA010810,TCMBANKGE010810,STK10,LOK; PRO2729,serine/threonine kinase 10,5q35.1,protein-coding,/
CWITA010811,TCMBANKGE010811,SP100,lysp100b,SP100 nuclear antigen,2q37.1,protein-coding,/
CWITA010812,TCMBANKGE010812,ALG3,CDG1D; CDGS4; CDGS6; D16Ertd36e; NOT56L; Not56; not,"ALG3 alpha-1,3- mannosyltransferase",3q27.1,protein-coding,/
CWITA010813,TCMBANKGE010813,CRKL,-,"CRK like proto-oncogene, adaptor protein",22q11.21,protein-coding,/
CWITA010814,TCMBANKGE010814,IER5L,bA247A12.2,immediate early response 5 like,9q34.11,protein-coding,/
CWITA010815,TCMBANKGE010815,AP1M2,AP1-mu2; HSMU1B; MU-1B; MU1B; mu2,adaptor related protein complex 1 subunit mu 2,19p13.2,protein-coding,/
CWITA010816,TCMBANKGE010816,CYTIP,B3-1; CASP; CYBR; CYTHIP; HE; PSCDBP,cytohesin 1 interacting protein,2q24.1,protein-coding,/
CWITA010817,TCMBANKGE010817,CXCL17,DMC; Dcip1; UNQ473; VCC-1; VCC1,C-X-C motif chemokine ligand 17,19q13.2,protein-coding,/
CWITA010818,TCMBANKGE010818,MAPK8IP1,IB1; JIP-1; JIP1; PRKM8IP,mitogen-activated protein kinase 8 interacting protein 1,11p11.2,protein-coding,Patented target
CWITA010819,TCMBANKGE010819,TRMT2A,HTF9C,tRNA methyltransferase 2 homolog A,22q11.21,protein-coding,/
CWITA010820,TCMBANKGE010820,ECE1,ECE,endothelin converting enzyme 1,1p36.1,protein-coding,
CWITA010821,TCMBANKGE010821,MAP1A,MAP1L; MTAP1A,microtubule associated protein 1A,15q15.3,protein-coding,/
CWITA010822,TCMBANKGE010822,IPP,KLHL27,intracisternal A particle-promoted polypeptide,1p34.1,protein-coding,/
CWITA010823,TCMBANKGE010823,TPST1,TANGO13A,tyrosylprotein sulfotransferase 1,7q11.21,protein-coding,/
CWITA010824,TCMBANKGE010824,NUP37,MCPH24; p37,nucleoporin 37,12q23.2,protein-coding,/
CWITA010825,TCMBANKGE010825,NUP98,ADIR2; NUP196; NUP96; Nup98-96,nucleoporin 98 and 96 precursor,11p15.4,protein-coding,/
CWITA010826,TCMBANKGE010826,ARMC2,SPGF38; bA787I22.1,armadillo repeat containing 2,6q21,protein-coding,/
CWITA010827,TCMBANKGE010827,CHN1,ARHGAP2; CHN; DURS2; NC; RHOGAP2,chimerin 1,2q31.1,protein-coding,/
CWITA010828,TCMBANKGE010828,IGHD2-15,D2; IGHD215,immunoglobulin heavy diversity 2-15,14q32.33,other,/
CWITA010829,TCMBANKGE010829,PEBP4,CORK-1; CORK1; GWTM1933; HEL-S-300; PEBP-4; PRO4408; hPEBP4,phosphatidylethanolamine binding protein 4,8p21.3,protein-coding,/
CWITA010830,TCMBANKGE010830,DRAP1,NC2-alpha,DR1 associated protein 1,11q13.1,protein-coding,/
CWITA010831,TCMBANKGE010831,BAAT,BACAT; BAT,bile acid-CoA:amino acid N-acyltransferase,9q31.1,protein-coding,/
CWITA010832,TCMBANKGE010832,SPEG,APEG-1; APEG1; BPEG; CNM5; MYLK6; SPEGalpha; SPEGbeta,striated muscle enriched protein kinase,2q35,protein-coding,/
CWITA010833,TCMBANKGE010833,ITPKA,IP3N3KA; IP3KA,inositol-trisphosphate 3-kinase A,15q15.1,protein-coding,
CWITA010834,TCMBANKGE010834,CASKIN2,ANKS5B,CASK interacting protein 2,17q25.1,protein-coding,/
CWITA010835,TCMBANKGE010835,SLC2A2,GLUT2,"solute carrier family 2 (facilitated glucose transporter), member 2",3q26.1-q26.2,protein-coding,
CWITA010836,TCMBANKGE010836,SLC2A4,GLUT4,"solute carrier family 2 (facilitated glucose transporter), member 4",17p13,protein-coding,
CWITA010837,TCMBANKGE010837,FABP6,I-15P; I-BABP; I-BALB; I-BAP; ILBP; ILBP3; ILLBP,fatty acid binding protein 6,5q33.3,protein-coding,/
CWITA010838,TCMBANKGE010838,GPLD1,GPIPLD; GPIPLDM; PIGPLD; PIGPLD1; PLD,glycosylphosphatidylinositol specific phospholipase D1,6p22.3,protein-coding,/
CWITA010839,TCMBANKGE010839,SAR1A,SAR1; SARA1; Sara; masra2,secretion associated Ras related GTPase 1A,10q22.1,protein-coding,/
CWITA010840,TCMBANKGE010840,ADH6,ADH-5,alcohol dehydrogenase 6 (class V),4q23,protein-coding,/
CWITA010841,TCMBANKGE010841,ACVRL1,ACVRLK1; ALK-1; ALK1; HHT; HHT2; ORW2; SKR3; TSR-I,activin A receptor like type 1,12q13.13,protein-coding,Clinical Trial target
CWITA010842,TCMBANKGE010842,TSPAN7,A15; CCG-B7; CD231; DXS1692E; MRX58; MXS1; TALLA-1; TM4SF2; TM4SF2b,tetraspanin 7,Xp11.4,protein-coding,Research target
CWITA010843,TCMBANKGE010843,ALDH18A1,ADCL3; ARCL3A; GSAS; P5CS; PYCS; SPG9; SPG9A; SPG9B,aldehyde dehydrogenase 18 family member A1,10q24.1,protein-coding,/
CWITA010844,TCMBANKGE010844,ST8SIA1,GD3S; SIAT8; SIAT8-A; SIAT8A; ST8SiaI,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1",12p12.1,protein-coding,/
CWITA010845,TCMBANKGE010845,MGAT1,GLCNAC-TI; GLCT1; GLYT1; GNT-1; GNT-I; GnTI; MGAT,"alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",5q35.3,protein-coding,Research target
CWITA010846,TCMBANKGE010846,WASHC3,CCDC53; CGI-116,WASH complex subunit 3,12q23.2,protein-coding,/
CWITA010847,TCMBANKGE010847,CIC,MRD45,capicua transcriptional repressor,19q13.2,protein-coding,/
CWITA010848,TCMBANKGE010848,PAFAH1B1,LIS1; LIS2; MDCR; MDS; NudF; PAFAH,platelet activating factor acetylhydrolase 1b regulatory subunit 1,17p13.3,protein-coding,/
CWITA010849,TCMBANKGE010849,PCDHA7,CNR4; CNRN4; CNRS4; CRNR4; PCDH-ALPHA7,protocadherin alpha 7,5q31.3,protein-coding,/
CWITA010850,TCMBANKGE010850,TEAD1,AA; NTEF-1; REF1; TCF-13; TCF13; TEAD-1; TEF-1,TEA domain transcription factor 1,11p15.3,protein-coding,/
CWITA010851,TCMBANKGE010851,TXNL1,HEL-S-114; TRP32; TXL-1; TXNL; Txl,thioredoxin like 1,18q21.31,protein-coding,/
CWITA010852,TCMBANKGE010852,DGAT1,ARAT; ARGP1; DGAT; DIAR7,diacylglycerol O-acyltransferase 1,8q24.3,protein-coding,Patented target
CWITA010853,TCMBANKGE010853,GPX2,GINGPx; GPRP; GSHPXNGI; GSHPxN2,glutathione peroxidase 2 (gastrointestinal),14q24.1,protein-coding,
CWITA010854,TCMBANKGE010854,TAAR8,GPR102; TA5; TAR5; TRAR5; TaR-5; TaR-8,trace amine associated receptor 8,6q23.2,protein-coding,/
CWITA010855,TCMBANKGE010855,UPP2,UDRPASE2; UP2; UPASE2,uridine phosphorylase 2,2q24.1,protein-coding,
CWITA010856,TCMBANKGE010856,ILF2,NF45; PRO3063,interleukin enhancer binding factor 2,1q21.3,protein-coding,/
CWITA010857,TCMBANKGE010857,Aprt-ps,-,"adenine phosphoribosyl transferase, pseudogene",8 B3.3|8 34.43 cM,pseudo,/
CWITA010858,TCMBANKGE010858,DPH5,CGIN30; HSPC143; MGC61450; NPD015,DPH5 homolog (S. cerevisiae),1p21.2,protein-coding,
CWITA010859,TCMBANKGE010859,FMO1,-,flavin containing dimethylaniline monoxygenase 1,1q24.3,protein-coding,/
CWITA010860,TCMBANKGE010860,PI3,ESI; SKALP; WAP3; WFDC14; cementoin,peptidase inhibitor 3,20q13.12,protein-coding,/
CWITA010861,TCMBANKGE010861,SLCO1A2,OATP; OATPNA; OATP1A2; SLC21A3,"solute carrier organic anion transporter family, member 1A2",12p12,protein-coding,
CWITA010862,TCMBANKGE010862,CHRND,ACHRD; CMS2A; CMS3A; CMS3B; CMS3C; FCCMS; SCCMS,cholinergic receptor nicotinic delta subunit,2q37.1,protein-coding,/
CWITA010863,TCMBANKGE010863,MYO18B,KFS4,myosin XVIIIB,22q12.1,protein-coding,/
CWITA010864,TCMBANKGE010864,SFTPA1,COLEC4; PSAP; PSP-A; PSPA; SFTP1; SFTPA1B; SP-A; SP-A1; SP-A1 beta; SP-A1 delta; SP-A1 epsilon; SP-A1 gamma; SPA; SPA1,surfactant protein A1,10q22.3,protein-coding,/
CWITA010865,TCMBANKGE010865,SFT2D2,UNQ512; dJ747L4.C1.2,SFT2 domain containing 2,1q24.2,protein-coding,/
CWITA010866,TCMBANKGE010866,Igbp1,AI115586; AI662457; AW208785; C81413; Pc52; Tap42; p52,immunoglobulin (CD79A) binding protein 1,X|X C3,protein-coding,/
CWITA010867,TCMBANKGE010867,ALKBH7,ABH7; SPATA11; UNQ6002,alkB homolog 7,19p13.3,protein-coding,/
CWITA010868,TCMBANKGE010868,GPD1,FLJ26652,glycerol-3-phosphate dehydrogenase 1 (soluble),12q12-q13,protein-coding,
CWITA010869,TCMBANKGE010869,SLC39A13,EDSSPD3; LZT-Hs9; SCDEDS; ZIP13,solute carrier family 39 member 13,11p11.2,protein-coding,/
CWITA010870,TCMBANKGE010870,ART1,ART2; ARTC1; CD296; RT6,ADP-ribosyltransferase 1,11p15.4,protein-coding,/
CWITA010871,TCMBANKGE010871,B4GALT2,B4Gal-T2; B4Gal-T3; beta4Gal-T2,"beta-1,4-galactosyltransferase 2",1p34.1,protein-coding,/
CWITA010872,TCMBANKGE010872,KCNK15,K2p15.1; KCNK11; KCNK14; KT3.3; TASK-5; TASK5; dJ781B1.1,potassium two pore domain channel subfamily K member 15,20q13.12,protein-coding,/
CWITA010873,TCMBANKGE010873,HUWE1,ARF-BP1; HECTH9; HSPC272; Ib772; LASU1; MRXST; MULE; URE-B1; UREB1,"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1",Xp11.22,protein-coding,/
CWITA010874,TCMBANKGE010874,GGTLC1,GGTL6; GGTLA3; GGTLA4; dJ831C21.1; dJ831C21.2,gamma-glutamyltransferase light chain 1,20p11.21,protein-coding,/
CWITA010875,TCMBANKGE010875,SELENOI,EPT1; SELI; SEPI; SPG81,selenoprotein I,2p23.3,protein-coding,/
CWITA010876,TCMBANKGE010876,PROZ,PZ,"protein Z, vitamin K-dependent plasma glycoprotein",13q34,protein-coding,
CWITA010877,TCMBANKGE010877,CYB5R1,B5R.1; B5R1; NQO3A2; humb5R2,cytochrome b5 reductase 1,1p36.13-q41,protein-coding,
CWITA010878,TCMBANKGE010878,PPIC,CYPC; MGC3673,peptidylprolyl isomerase C (cyclophilin C),5q23.2,protein-coding,
CWITA010879,TCMBANKGE010879,HSPH1,HSP105; HSP105A; HSP105B; NY-CO-25,heat shock protein family H (Hsp110) member 1,13q12.3,protein-coding,/
CWITA010880,TCMBANKGE010880,MAN1A1,HUMM3; HUMM9; MAN9,mannosidase alpha class 1A member 1,6q22.31,protein-coding,/
CWITA010881,TCMBANKGE010881,UXS1,SDR6E1; UGD,UDP-glucuronate decarboxylase 1,2q12.2,protein-coding,/
CWITA010882,TCMBANKGE010882,TLR10,CD290,toll like receptor 10,4p14,protein-coding,/
CWITA010883,TCMBANKGE010883,TTL,MGC46235,Tubulin Tyrosine Ligase,2q13,protein-coding,
CWITA010884,TCMBANKGE010884,ADH1B,ADH2; DKFZp686C06125,"alcohol dehydrogenase 1B (class I), beta polypeptide",4q23,protein-coding,
CWITA010885,TCMBANKGE010885,AQP9,AQP-9; HsT17287; SSC1; T17287,aquaporin 9,15q21.3,protein-coding,Research target
CWITA010886,TCMBANKGE010886,IGKV3D-7,IGKV3D7; L25,immunoglobulin kappa variable 3D-7,2p11.2,other,/
CWITA010887,TCMBANKGE010887,NTRK1,DKFZp781I14186; MTC; TRK; TRK1; TRKA; TrkNA; p140NTrkA,"neurotrophic tyrosine kinase, receptor, type 1",1q21-q22,protein-coding,
CWITA010888,TCMBANKGE010888,FAM9A,TEX39A,family with sequence similarity 9 member A,Xp22.31,protein-coding,/
CWITA010889,TCMBANKGE010889,SENP6,SSP1; SUSP1,SUMO specific peptidase 6,6q14.1,protein-coding,/
CWITA010890,TCMBANKGE010890,SCFD2,STXBP1L1,sec1 family domain containing 2,4q12,protein-coding,/
CWITA010891,TCMBANKGE010891,ZNF408,EVR6; RP72,zinc finger protein 408,11p11.2,protein-coding,/
CWITA010892,TCMBANKGE010892,CCBE1,HKLLS1,collagen and calcium binding EGF domains 1,18q21.32,protein-coding,/
CWITA010893,TCMBANKGE010893,NDUFS7,CI-20; CI-20KD; MC1DN3; MY017; PSST,NADH:ubiquinone oxidoreductase core subunit S7,19p13.3,protein-coding,/
CWITA010894,TCMBANKGE010894,LCP2,SLP-76; SLP76,lymphocyte cytosolic protein 2,5q35.1,protein-coding,/
CWITA010895,TCMBANKGE010895,BCAS3,GAOB1; MAAB,BCAS3 microtubule associated cell migration factor,17q23.2,protein-coding,/
CWITA010896,TCMBANKGE010896,NUP93,NIC96,nucleoporin 93,16q13,protein-coding,/
CWITA010897,TCMBANKGE010897,NEK2,HsPK21; NEK2A; NLK1,NIMA (never in mitosis gene a)-related kinase 2,1q32.2-q41,protein-coding,
CWITA010898,TCMBANKGE010898,CPSF2,CPSF100,cleavage and polyadenylation specific factor 2,14q32.12,protein-coding,/
CWITA010899,TCMBANKGE010899,CREB3L2,BBF2H7,cAMP responsive element binding protein 3 like 2,7q33,protein-coding,/
CWITA010900,TCMBANKGE010900,SYNGR1,-,synaptogyrin 1,22q13.1,protein-coding,/
CWITA010901,TCMBANKGE010901,MSRB1,HSPC270; SELR; SELX; SEPX1; SepR,methionine sulfoxide reductase B1,16p13.3,protein-coding,Research target
CWITA010902,TCMBANKGE010902,RPS3A,FTE1; MFTL; S3A,ribosomal protein S3A,4q31.3,protein-coding,/
CWITA010903,TCMBANKGE010903,KIF1C,LTXS1; SATX2; SAX2; SPAX2; SPG58,kinesin family member 1C,17p13.2,protein-coding,/
CWITA010904,TCMBANKGE010904,ZNF608,NY-REN-36,zinc finger protein 608,5q23.2,protein-coding,/
CWITA010905,TCMBANKGE010905,ANPEP,APN; CD13; GP150; LAP1; P150; PEPN,"alanyl aminopeptidase, membrane",15q26.1,protein-coding,Clinical Trial target
CWITA010906,TCMBANKGE010906,ATP5PO,ATP5O; ATPO; HMC08D05; OSCP,ATP synthase peripheral stalk subunit OSCP,21q22.11,protein-coding,/
CWITA010907,TCMBANKGE010907,PROKR2,GPR73L1; GPR73b; GPRg2; HH3; KAL3; PKR2; dJ680N4.3,prokineticin receptor 2,20p12.3,protein-coding,Research target
CWITA010908,TCMBANKGE010908,ELP1,DYS; FD; IKAP; IKBKAP; IKI3; TOT1,elongator complex protein 1,9q31.3,protein-coding,/
CWITA010909,TCMBANKGE010909,GIGYF2,GYF2; PARK11; PERQ2; PERQ3; TNRC15,GRB10 interacting GYF protein 2,2q37.1,protein-coding,/
CWITA010910,TCMBANKGE010910,ACTR10,ACTR11; Arp10; Arp11; HARP11,actin related protein 10,14q23.1,protein-coding,/
CWITA010911,TCMBANKGE010911,SPRED1,LGSS; NFLS; PPP1R147; hSpred1; spred-1,sprouty related EVH1 domain containing 1,15q14,protein-coding,/
CWITA010912,TCMBANKGE010912,IMPA1,IMP; IMPA; MRT59,inositol monophosphatase 1,8q21.13,protein-coding,/
CWITA010913,TCMBANKGE010913,BRIP1,BACH1; FANCJ; OF,BRCA1 interacting protein C-terminal helicase 1,17q23.2,protein-coding,Research target
CWITA010914,TCMBANKGE010914,MED21,SRB7; SURB7; hSrb7,mediator complex subunit 21,12p11.23,protein-coding,/
CWITA010915,TCMBANKGE010915,YKT6,-,YKT6 v-SNARE homolog,7p13,protein-coding,/
CWITA010916,TCMBANKGE010916,CCNE1,CCNE; pCCNE1,cyclin E1,19q12,protein-coding,Research target
CWITA010917,TCMBANKGE010917,ZNF768,-,zinc finger protein 768,16p11.2,protein-coding,/
CWITA010918,TCMBANKGE010918,ESRRB,DFNB35; ERR beta-2; ERR2; ERRb; ERRbeta2; ESRL2; NR3B2,estrogen related receptor beta,14q24.3,protein-coding,Research target
CWITA010919,TCMBANKGE010919,FAM151A,C1orf179,family with sequence similarity 151 member A,-,protein-coding,/
CWITA010920,TCMBANKGE010920,ZNF728,-,zinc finger protein 728,19p12,protein-coding,/
CWITA010921,TCMBANKGE010921,LCMT2,FLJ51321; KIAA0547; MGC9534; PPM2; TYW4,leucine carboxyl methyltransferase 2,15q15.3,protein-coding,
CWITA010922,TCMBANKGE010922,RPS6,S6,ribosomal protein S6,9p22.1,protein-coding,/
CWITA010923,TCMBANKGE010923,PATJ,Cipp; INADL; InaD-like; hINADL,PATJ crumbs cell polarity complex component,1p31.3,protein-coding,/
CWITA010924,TCMBANKGE010924,HSD3B2,HSD3B; HSDB; SDR11E2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",1p12,protein-coding,/
CWITA010925,TCMBANKGE010925,ZIC3,HTX; HTX1; VACTERLX; ZNF203,Zic family member 3,Xq26.3,protein-coding,/
CWITA010926,TCMBANKGE010926,ACY3,ACYN3; HCBP1; MGC9740,aspartoacylase (aminocyclase) 3,11q13.2,protein-coding,
CWITA010927,TCMBANKGE010927,MCAT,FASN2C; MCT; MGC47838; MT; NET62; fabD,malonyl CoA:ACP acyltransferase (mitochondrial),22q13.31,protein-coding,
CWITA010928,TCMBANKGE010928,CYP4B1,CYPIVB1; P-450HP,cytochrome P450 family 4 subfamily B member 1,1p33,protein-coding,/
CWITA010929,TCMBANKGE010929,DHODH,DHOdehase; POADS; URA1,dihydroorotate dehydrogenase,16q22,protein-coding,
CWITA010930,TCMBANKGE010930,ACOT12,CACH-1; Cach; STARD15; THEAL,acyl-CoA thioesterase 12,5q14.1,protein-coding,/
CWITA010931,TCMBANKGE010931,HSPA12A,-,heat shock protein family A (Hsp70) member 12A,10q25.3,protein-coding,/
CWITA010932,TCMBANKGE010932,OPRD1,OPRD,"opioid receptor, delta 1",1p36.1-p34.3,protein-coding,
CWITA010933,TCMBANKGE010933,THUMPD2,C2orf8,THUMP domain containing 2,2p22.1|2p22-p21,protein-coding,/
CWITA010934,TCMBANKGE010934,ST8SIA2,HsT19690; SIAT8-B; SIAT8B; ST8SIA-II; ST8SiaII; STX,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",15q26.1,protein-coding,/
CWITA010935,TCMBANKGE010935,FAM161B,C14orf44; c14_5547,FAM161 centrosomal protein B,14q24.3,protein-coding,/
CWITA010936,TCMBANKGE010936,PRR14,-,proline rich 14,16p11.2,protein-coding,/
CWITA010937,TCMBANKGE010937,ASAP2,AMAP2; CENTB3; DDEF2; PAG3; PAP; Pap-alpha; SHAG1,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2",2p25.1|2p24,protein-coding,/
CWITA010938,TCMBANKGE010938,SP4,HF1B; SPR-1,Sp4 transcription factor,7p15.3,protein-coding,/
CWITA010939,TCMBANKGE010939,LRFN1,SALM2,leucine rich repeat and fibronectin type III domain containing 1,19q13.2,protein-coding,/
CWITA010940,TCMBANKGE010940,ANKHD1,MASK; MASK1; PP2500; VBARP,ankyrin repeat and KH domain containing 1,5q31.3,protein-coding,/
CWITA010941,TCMBANKGE010941,NFKBIE,IKBE,NFKB inhibitor epsilon,6p21.1,protein-coding,/
CWITA010942,TCMBANKGE010942,SLC25A5,2F1; AAC2; ANT2; T2; T3,solute carrier family 25 member 5,Xq24,protein-coding,/
CWITA010943,TCMBANKGE010943,BRS3,BB3; BB3R; BBR3,bombesin receptor subtype 3,Xq26.3,protein-coding,Research target
CWITA010944,TCMBANKGE010944,NME5,NM23-H5; NM23H5; RSPH23,NME/NM23 family member 5,5q31.2,protein-coding,/
CWITA010945,TCMBANKGE010945,FAM171A1,APCN; C10orf38,family with sequence similarity 171 member A1,10p13,protein-coding,/
CWITA010946,TCMBANKGE010946,PSMA2,HC3; MU; PMSA2; PSC2,"proteasome (prosome, macropain) subunit, alpha type, 2",7p13,protein-coding,
CWITA010947,TCMBANKGE010947,SEC11A,1810012E07Rik; SEC11L1; SPC18; SPCS4A; sid2895,"SEC11 homolog A, signal peptidase complex subunit",15q25.2-q25.3,protein-coding,/
CWITA010948,TCMBANKGE010948,SARDH,BPR-2; DMGDHL1; SAR; SARD; SDH,sarcosine dehydrogenase,9q34.2,protein-coding,/
CWITA010949,TCMBANKGE010949,CENPF,CENF; CILD31; PRO1779; STROMS; hcp-1,centromere protein F,1q41,protein-coding,/
CWITA010950,TCMBANKGE010950,ZNF28,KOX24,zinc finger protein 28,19q13.41,protein-coding,/
CWITA010951,TCMBANKGE010951,KCNC4,C1orf30; HKSHIIIC; KSHIIIC; KV3.4,potassium voltage-gated channel subfamily C member 4,1p13.3,protein-coding,Research target
CWITA010952,TCMBANKGE010952,GAPDHS,GAPD2; GAPDHN2; GAPDS; HSDN35,"glyceraldehyde-3-phosphate dehydrogenase, spermatogenic",19q13.12,protein-coding,
CWITA010953,TCMBANKGE010953,GRIP1,FRASRS3; GRIP,glutamate receptor interacting protein 1,12q14.3,protein-coding,/
CWITA010954,TCMBANKGE010954,OAS2,-,2'-5'-oligoadenylate synthetase 2,12q24.13,protein-coding,/
CWITA010955,TCMBANKGE010955,ZDHHC21,DHHC-21; DHHC21; DNZ1; HSPC097,zinc finger DHHC-type palmitoyltransferase 21,9p22.3,protein-coding,/
CWITA010956,TCMBANKGE010956,EGR4,AT133; NGFI-C; NGFIC; PAT133,early growth response 4,2p13.2,protein-coding,/
CWITA010957,TCMBANKGE010957,CEP164,NPHP15,centrosomal protein 164,11q23.3,protein-coding,/
CWITA010958,TCMBANKGE010958,ZNF563,-,zinc finger protein 563,19p13.2,protein-coding,/
CWITA010959,TCMBANKGE010959,CTPS1,CTPS; GATD5; IMD24,CTP synthase 1,1p34.2,protein-coding,Clinical Trial target
CWITA010960,TCMBANKGE010960,SLC5A4,DJ90G24.4; SAAT1; SGLT3,solute carrier family 5 member 4,22q12.3,protein-coding,Clinical Trial target
CWITA010961,TCMBANKGE010961,KCNA3,HGK5; HLK3; HPCN3; HUKIII; KV1.3; MK3; PCN3,potassium voltage-gated channel subfamily A member 3,1p13.3,protein-coding,Clinical Trial target
CWITA010962,TCMBANKGE010962,TMC7,-,transmembrane channel like 7,16p12.3,protein-coding,/
CWITA010963,TCMBANKGE010963,LRAT,LCA14; MGC33103,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),4q32.1,protein-coding,
CWITA010964,TCMBANKGE010964,PTPN4,MEG; PTPMEG; PTPMEG1,protein tyrosine phosphatase non-receptor type 4,2q14.2,protein-coding,/
CWITA010965,TCMBANKGE010965,TRPM6,CHAK2; HMGX; HOMG; HOMG1; HSH,transient receptor potential cation channel subfamily M member 6,9q21.13,protein-coding,Research target
CWITA010966,TCMBANKGE010966,FAIM,FAIM1,Fas apoptotic inhibitory molecule,3q22.3,protein-coding,/
CWITA010967,TCMBANKGE010967,FLAD1,FAD1; FADS; LSMFLAD; PP591,flavin adenine dinucleotide synthetase 1,1q21.3,protein-coding,/
CWITA010968,TCMBANKGE010968,SPATS2L,DNAPTP6; SGNP,spermatogenesis associated serine rich 2 like,2q33.1,protein-coding,/
CWITA010969,TCMBANKGE010969,LRP1,A2MR; APOER; APR; CD91; IGFBP-3R; IGFBP3R; IGFBP3R1; KPA; LRP; LRP1A; TGFBR5,LDL receptor related protein 1,12q13.3,protein-coding,Research target
CWITA010970,TCMBANKGE010970,OLAH,AURA1; SAST; TE2; THEDC1,oleoyl-ACP hydrolase,10p13,protein-coding,/
CWITA010971,TCMBANKGE010971,FABP2,FABPI; I-FABP,fatty acid binding protein 2,4q26,protein-coding,/
CWITA010972,TCMBANKGE010972,PDHA1,PDHA; PDHCE1A; PHE1A,pyruvate dehydrogenase (lipoamide) alpha 1,Xp22.1,protein-coding,
CWITA010973,TCMBANKGE010973,EPCAM,DIAR5; EGP-2; EGP314; EGP40; ESA; HNPCC8; KS1/4; KSA; M4S1; MIC18; MK-1; TACSTD1; TROP1,epithelial cell adhesion molecule,2p21,protein-coding,Clinical Trial target
CWITA010974,TCMBANKGE010974,TMEM267,C5orf28,transmembrane protein 267,5p12,protein-coding,/
CWITA010975,TCMBANKGE010975,MIOX,ALDRL6,myo-inositol oxygenase,22q13.33,protein-coding,/
CWITA010976,TCMBANKGE010976,LIF,CDF; DIA; HILDA; MLPLI,LIF interleukin 6 family cytokine,22q12.2,protein-coding,Research target
CWITA010977,TCMBANKGE010977,P4HTM,EGLN4; HIFPH4; P4HNTM; PHN4; PH4; PHD4,"prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)",3p21.31,protein-coding,
CWITA010978,TCMBANKGE010978,CRYBB3,CATCN2; CRYB3; CTRCT22,crystallin beta B3,22q11.23,protein-coding,/
CWITA010979,TCMBANKGE010979,TBXAS1,BDPLT14; CYP5; CYP5A1; GHOSAL; THAS; TS; TXAS; TXS,thromboxane A synthase 1,7q34,protein-coding,Clinical Trial target
CWITA010980,TCMBANKGE010980,FGA,Fib2,fibrinogen alpha chain,4q31.3,protein-coding,/
CWITA010981,TCMBANKGE010981,SYT15,CHR10SYT; sytXV,synaptotagmin 15,10q11.22,protein-coding,/
CWITA010982,TCMBANKGE010982,PHF8,JHDM1F; KDM7B; MRXSSD; ZNF422,PHD finger protein 8,Xp11.22,protein-coding,Research target
CWITA010983,TCMBANKGE010983,TRIM58,BIA2,tripartite motif containing 58,1q44,protein-coding,/
CWITA010984,TCMBANKGE010984,DPYSL4,CRMP3; DRP-4; ULIP4,dihydropyrimidinase like 4,10q26.3,protein-coding,/
CWITA010985,TCMBANKGE010985,PELI3,-,pellino E3 ubiquitin protein ligase family member 3,11q13.2,protein-coding,/
CWITA010986,TCMBANKGE010986,SMPD4,NEDMABA; NEDMEBA; NET13; NSMASE-3; NSMASE3; SKNY,sphingomyelin phosphodiesterase 4,2q21.1,protein-coding,Discontinued target
CWITA010987,TCMBANKGE010987,RUSF1,C16orf58; RUS,RUS family member 1,16p11.2,protein-coding,/
CWITA010988,TCMBANKGE010988,ARL5B,ARL8,ADP ribosylation factor like GTPase 5B,10p12.31,protein-coding,/
CWITA010989,TCMBANKGE010989,ZG16,JCLN; JCLN1; ZG16A,zymogen granule protein 16,16p11.2,protein-coding,/
CWITA010990,TCMBANKGE010990,ADGRG5,GPR114; PGR27,adhesion G protein-coupled receptor G5,16q21,protein-coding,/
CWITA010991,TCMBANKGE010991,LCK,IMD22; LSK; YT16; p56lck; pp58lck,"LCK proto-oncogene, Src family tyrosine kinase",1p35.2,protein-coding,Successful target
CWITA010992,TCMBANKGE010992,CEACAM3,CD66D; CEA; CGM1; W264; W282,CEA cell adhesion molecule 3,19q13.2,protein-coding,Successful target
CWITA010993,TCMBANKGE010993,CTPS2,-,CTP synthase 2,Xp22.2,protein-coding,/
CWITA010994,TCMBANKGE010994,SRPK2,SFRSK2,SRSF protein kinase 2,7q22.3,protein-coding,Research target
CWITA010995,TCMBANKGE010995,GUSB,BG; MPS7,glucuronidase beta,7q11.21,protein-coding,Successful target
CWITA010996,TCMBANKGE010996,TRIM61,RNF35,tripartite motif containing 61,4q32.3,protein-coding,/
CWITA010997,TCMBANKGE010997,AMHR2,AMHR; MISR2; MISRII; MRII,anti-Mullerian hormone receptor type 2,12q13.13,protein-coding,Research target
CWITA010998,TCMBANKGE010998,TBL1XR1,C21; DC42; IRA1; MRD41; TBLR1,TBL1X receptor 1,3q26.32,protein-coding,Research target
CWITA010999,TCMBANKGE010999,DDX6,FLJ36338; HLR2; P54; RCK,DEAD (Asp-Glu-Ala-Asp) box polypeptide 6,11q23.3,protein-coding,
CWITA011000,TCMBANKGE011000,COX5B,COXVB,cytochrome c oxidase subunit 5B,2q11.2,protein-coding,/
CWITA011001,TCMBANKGE011001,KERA,CNA2; KTN; SLRR2B,keratocan,12q21.33,protein-coding,/
CWITA011002,TCMBANKGE011002,IKZF1,CVID13; Hs.54452; IK1; IKAROS; LYF1; LyF-1; PPP1R92; PRO0758; ZNFN1A1,IKAROS family zinc finger 1,7p12.2,protein-coding,/
CWITA011003,TCMBANKGE011003,RFX3,-,regulatory factor X3,9p24.2,protein-coding,/
CWITA011004,TCMBANKGE011004,FAM3C,GS3786; ILEI,FAM3 metabolism regulating signaling molecule C,7q31.31,protein-coding,/
CWITA011005,TCMBANKGE011005,LRRC49,PGs4,leucine rich repeat containing 49,15q23,protein-coding,/
CWITA011006,TCMBANKGE011006,TOP1,TOPI,topoisomerase (DNA) I,20q12-q13.1,protein-coding,
CWITA011007,TCMBANKGE011007,OXSM,CEM1; FASN2D; KASI; KS,"3-oxoacyl-ACP synthase, mitochondrial",3p24.2,protein-coding,Research target
CWITA011008,TCMBANKGE011008,PCDHGA11,PCDH-GAMMA-A11,"protocadherin gamma subfamily A, 11",5q31.3,protein-coding,/
CWITA011009,TCMBANKGE011009,BMP7,OP-1,bone morphogenetic protein 7,20q13.31,protein-coding,/
CWITA011010,TCMBANKGE011010,RUNX1,AML1; AML1-EVI-1; AMLCR1; CBF2alpha; CBFA2; EVI-1; PEBP2aB; PEBP2alpha,RUNX family transcription factor 1,21q22.12,protein-coding,Research target
CWITA011011,TCMBANKGE011011,DHRSX,CXorf11; DHRS5X; DHRS5Y; DHRSXY; DHRSY; SDR46C1; SDR7C6,dehydrogenase/reductase X-linked,Xp22.33 and Yp11.2,protein-coding,/
CWITA011012,TCMBANKGE011012,AMT,GCE; GCST; GCVT; NKH,aminomethyltransferase,3p21.31,protein-coding,/
CWITA011013,TCMBANKGE011013,PDE4C,DPDE1; MGC126222,"phosphodiesterase 4C, cAMP-specific",19p13.11,protein-coding,
CWITA011014,TCMBANKGE011014,RAD51AP1,PIR51,RAD51 associated protein 1,12p13.32,protein-coding,/
CWITA011015,TCMBANKGE011015,LRGUK,CFAP246,leucine rich repeats and guanylate kinase domain containing,7q33,protein-coding,/
CWITA011016,TCMBANKGE011016,HTR1F,5-HT-1F; 5-HT1F; 5HT6; HTR1EL; MR77,5-hydroxytryptamine (serotonin) receptor 1F,3p12,protein-coding,
CWITA011017,TCMBANKGE011017,RUNDC3A,RAP2IP; RPIP-8; RPIP8,RUN domain containing 3A,17q21.31,protein-coding,/
CWITA011018,TCMBANKGE011018,UST,2OST,uronyl 2-sulfotransferase,6q25.1,protein-coding,/
CWITA011019,TCMBANKGE011019,KCNJ3,GIRK1; KGA; KIR3.1,potassium inwardly rectifying channel subfamily J member 3,2q24.1,protein-coding,Research target
CWITA011020,TCMBANKGE011020,FHL1,FCMSU; FHL-1; FHL1A; FHL1B; FLH1A; KYOT; RBMX1A; RBMX1B; SLIM; SLIM-1; SLIM1; SLIMMER; XMPMA,four and a half LIM domains 1,Xq26.3,protein-coding,Research target
CWITA011021,TCMBANKGE011021,TRIM69,HSD-34; HSD34; RNF36; Trif,tripartite motif containing 69,15q21.1,protein-coding,/
CWITA011022,TCMBANKGE011022,PRX,CMT4F,periaxin,19q13.2,protein-coding,/
CWITA011023,TCMBANKGE011023,CLCN4,CLC4; ClC-4; ClC-4A; MRX15; MRX49; MRXSRC,chloride voltage-gated channel 4,Xp22.2,protein-coding,/
CWITA011024,TCMBANKGE011024,FABP7,B-FABP; BLBP; FABPB; MRG,fatty acid binding protein 7,6q22.31,protein-coding,/
CWITA011025,TCMBANKGE011025,KIT,CNKit; CD117; PBT; SCFR,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,4q11-q12,protein-coding,
CWITA011026,TCMBANKGE011026,TCF7,TCF-1,transcription factor 7,5q31.1,protein-coding,/
CWITA011027,TCMBANKGE011027,GRK2,ADRBK1; BARK1; BETA-ARK1,G protein-coupled receptor kinase 2,11q13.2,protein-coding,Research target
CWITA011028,TCMBANKGE011028,IRF7,IMD39; IRF-7; IRF-7H; IRF7A; IRF7B; IRF7C; IRF7H,interferon regulatory factor 7,11p15.5,protein-coding,/
CWITA011029,TCMBANKGE011029,DCK,-,deoxycytidine kinase,4q13.3,protein-coding,Research target
CWITA011030,TCMBANKGE011030,PAM16,CGI-136; MAGMAS; SMDMDM; TIM16; TIMM16,presequence translocase associated motor 16,16p13.3,protein-coding,/
CWITA011031,TCMBANKGE011031,CYP2C9,CPC9; CYP2C; CYP2C10; CYPIIC9; P450IIC9,cytochrome P450 family 2 subfamily C member 9,10q23.33,protein-coding,Successful target
CWITA011032,TCMBANKGE011032,SETMAR,METNASE; Mar1,SET domain and mariner transposase fusion gene,3p26.1,protein-coding,/
CWITA011033,TCMBANKGE011033,NDUFB7,B18; CINB18; MGC2480,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa",19p13.12,protein-coding,
CWITA011034,TCMBANKGE011034,COL5A3,-,collagen type V alpha 3 chain,19p13.2,protein-coding,/
CWITA011035,TCMBANKGE011035,DIP2B,-,disco interacting protein 2 homolog B,12q13.12,protein-coding,/
CWITA011036,TCMBANKGE011036,SRP72,BMFF; BMFS1; HEL103,signal recognition particle 72,4q12,protein-coding,/
CWITA011037,TCMBANKGE011037,ZNF526,-,zinc finger protein 526,19q13.2,protein-coding,/
CWITA011038,TCMBANKGE011038,GAS2,GAS-2,growth arrest specific 2,11p14.3,protein-coding,/
CWITA011039,TCMBANKGE011039,LRRC41,MUF1; PP7759,leucine rich repeat containing 41,1p34.1-p33,protein-coding,/
CWITA011040,TCMBANKGE011040,TACR3,HH11; NK-3R; NK3; NK3R; NKR; TAC3R; TAC3RL,tachykinin receptor 3,4q24,protein-coding,Clinical Trial target
CWITA011041,TCMBANKGE011041,LONRF1,RNF191,LON peptidase N-terminal domain and ring finger 1,8p23.1,protein-coding,/
CWITA011042,TCMBANKGE011042,PARD3B,ALS2CR19; PAR3B; PAR3L; PAR3beta,par-3 family cell polarity regulator beta,2q33.3,protein-coding,/
CWITA011043,TCMBANKGE011043,NELFA,NELF-A; P/OKcl.15; WHSC2,negative elongation factor complex member A,4p16.3,protein-coding,/
CWITA011044,TCMBANKGE011044,ZNF629,ZNF; ZNF65,zinc finger protein 629,16p11.2,protein-coding,/
CWITA011045,TCMBANKGE011045,TMIGD3,AD026,transmembrane and immunoglobulin domain containing 3,1p13.2,protein-coding,/
CWITA011046,TCMBANKGE011046,MLST8,GBL; GbetaL; LST8; POP3; WAT1,"MTOR associated protein, LST8 homolog",16p13.3,protein-coding,/
CWITA011047,TCMBANKGE011047,PDE4D,DKFZp686M11213; DPDE3; FLJ97311; HSPDE4D; PDE4DN2; STRK1,"phosphodiesterase 4D, cAMP-specific",5q12,protein-coding,
CWITA011048,TCMBANKGE011048,ARPC4,ARC20; MGC13544; P20NARC,"actin related protein 2/3 complex, subunit 4, 20kDa",3p25.3,protein-coding,
CWITA011049,TCMBANKGE011049,TAB2,CHTD2; MAP3K7IP2; TAB-2,TGF-beta activated kinase 1 (MAP3K7) binding protein 2,6q25.1,protein-coding,/
CWITA011050,TCMBANKGE011050,DIS3L,DIS3L1,DIS3 like exosome 3'-5' exoribonuclease,15q22.31,protein-coding,/
CWITA011051,TCMBANKGE011051,ZNF550,-,zinc finger protein 550,19q13.43,protein-coding,/
CWITA011052,TCMBANKGE011052,SLC44A4,C6orf29; CTL4; DFNA72; NG22; TPPT; hTPPT1,solute carrier family 44 member 4,6p21.33,protein-coding,Clinical Trial target
CWITA011053,TCMBANKGE011053,PTCHD4,C6orf138; PTCH53; dJ402H5.2,patched domain containing 4,6p12.3,protein-coding,/
CWITA011054,TCMBANKGE011054,KCNIP4,CALP; KCHIP4,potassium voltage-gated channel interacting protein 4,4p15.31-p15.2,protein-coding,/
CWITA011055,TCMBANKGE011055,IPO9,Imp9,importin 9,1q32.1,protein-coding,/
CWITA011056,TCMBANKGE011056,BSCL2,GNG3LG; HMN5; PELD; SPG17,"BSCL2 lipid droplet biogenesis associated, seipin",11q12.3,protein-coding,/
CWITA011057,TCMBANKGE011057,PUM3,HA-8; HLA-HA8; KIAA0020; PEN; PUF-A; PUF6; XTP5,pumilio RNA binding family member 3,9p24.2,protein-coding,/
CWITA011058,TCMBANKGE011058,CLEC2L,-,C-type lectin domain family 2 member L,7q34,protein-coding,/
CWITA011059,TCMBANKGE011059,GIPR,PGQTL2,gastric inhibitory polypeptide receptor,19q13.32,protein-coding,Clinical Trial target
CWITA011060,TCMBANKGE011060,PTH1R,EKNS; PFE; PTHR; PTHR1,parathyroid hormone 1 receptor,3p21.31,protein-coding,Successful target
CWITA011061,TCMBANKGE011061,GRIK1,EAA3; EEA3; GLR5; GLUR5; GluK1; gluR-5,glutamate ionotropic receptor kainate type subunit 1,21q21.3,protein-coding,Successful target
CWITA011062,TCMBANKGE011062,SLC25A13,ARALAR2; CITRIN; CTLN2,"solute carrier family 25, member 13 (citrin)",7q21.3,protein-coding,
CWITA011063,TCMBANKGE011063,SPAG16,PF20; WDR29,sperm associated antigen 16,2q34,protein-coding,/
CWITA011064,TCMBANKGE011064,HES5,bHLHb38,hes family bHLH transcription factor 5,1p36.32,protein-coding,/
CWITA011065,TCMBANKGE011065,STUM,C1orf95,"stum, mechanosensory transduction mediator homolog",1q42.12,protein-coding,/
CWITA011066,TCMBANKGE011066,SLC16A12,CJMG; CRT2; CTRCT47; MCT12,solute carrier family 16 member 12,10q23.31,protein-coding,/
CWITA011067,TCMBANKGE011067,MAFB,DURS3; KRML; MCTO,MAF bZIP transcription factor B,20q12,protein-coding,/
CWITA011068,TCMBANKGE011068,KCNH6,ERG2; HERG2; Kv11.2,"potassium voltage-gated channel, subfamily H (eag-related), member 6",17q23.3,protein-coding,
CWITA011069,TCMBANKGE011069,DPYSL3,CRMP-4; CRMP4; DRP-3; DRP3; LCRMP; ULIP; ULIP-1,dihydropyrimidinase like 3,5q32,protein-coding,/
CWITA011070,TCMBANKGE011070,COX7A2L,COX7AR; COX7RP; EB1; SIG81,cytochrome c oxidase subunit 7A2 like,2p21,protein-coding,/
CWITA011071,TCMBANKGE011071,RARG,NR1B3; RARC,retinoic acid receptor gamma,12q13.13,protein-coding,Successful target
CWITA011072,TCMBANKGE011072,CACNA1C,CACH2; CACN2; CACNL1A1; CCHL1A1; CaV1.2; LQT8; TS; TS. LQT8,calcium voltage-gated channel subunit alpha1 C,12p13.33,protein-coding,Successful target
CWITA011073,TCMBANKGE011073,ACSBG1,BG; BG1; BGM; GR-LACS; LPD,Acyl-Coa_Synthetase_Bubblegum_Family_Member_1,15q25.1,protein-coding,
CWITA011074,TCMBANKGE011074,RNPEP,AP-B; APB,arginyl aminopeptidase,1q32.1,protein-coding,Research target
CWITA011075,TCMBANKGE011075,ITGA6,CD49f; ITGA6B; VLA-6,integrin subunit alpha 6,2q31.1,protein-coding,Research target
CWITA011076,TCMBANKGE011076,BLOC1S2,BLOS2; BORCS2; CEAP; CEAP11,biogenesis of lysosomal organelles complex 1 subunit 2,10q24.31,protein-coding,/
CWITA011077,TCMBANKGE011077,UGT2B11,-,UDP glucuronosyltransferase family 2 member B11,4q13.2,protein-coding,/
CWITA011078,TCMBANKGE011078,SMARCD1,BAF60A; CRACD1; CSS11; Rsc6p,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1",12q13.12,protein-coding,/
CWITA011079,TCMBANKGE011079,PRSS1,TRP1; TRY1; TRY4; TRYP1,serine protease 1,7q34,protein-coding,Successful target
CWITA011080,TCMBANKGE011080,AFTPH,Nbla10388,aftiphilin,2p14,protein-coding,/
CWITA011081,TCMBANKGE011081,NT5C2,GMP; NT5B; PNT5; cNNII,"5'-nucleotidase, cytosolic II",10q24.32,protein-coding,
CWITA011082,TCMBANKGE011082,METTL9,CGI-81; DREV; DREV1; PAP1,methyltransferase like 9,16p12.2,protein-coding,/
CWITA011083,TCMBANKGE011083,LAMA3,BM600; E170; LAMNA; LOCS,laminin subunit alpha 3,18q11.2,protein-coding,/
CWITA011084,TCMBANKGE011084,PZP,CPAMD6,PZP alpha-2-macroglobulin like,12p13.31,protein-coding,/
CWITA011085,TCMBANKGE011085,MEF2C,C5DELq14.3; DEL5q14.3,myocyte enhancer factor 2C,5q14.3,protein-coding,/
CWITA011086,TCMBANKGE011086,ACSL3,ACS3; FACL3; LACS 3; LACS3; PRO2194,acyl-CoA synthetase long chain family member 3,2q36.1,protein-coding,/
CWITA011087,TCMBANKGE011087,RALA,MGC48949; RAL,v-ral simian leukemia viral oncogene homolog A (ras related),7p15-p13,protein-coding,
CWITA011088,TCMBANKGE011088,SFR1,C10orf78; MEI5; MEIR5; bA373N18.1,SWI5 dependent homologous recombination repair protein 1,10q25.1,protein-coding,/
CWITA011089,TCMBANKGE011089,TMEM131L,KIAA0922,transmembrane 131 like,4q31.3,protein-coding,/
CWITA011090,TCMBANKGE011090,QRFP,26RFa; P518,pyroglutamylated RFamide peptide,9q34.12,protein-coding,/
CWITA011091,TCMBANKGE011091,PCCB,DKFZp451E113,"propionyl CoA carboxylase, beta polypeptide",3q21-q22,protein-coding,
CWITA011092,TCMBANKGE011092,SLC9A2,NHE2,solute carrier family 9 member A2,2q12.1,protein-coding,/
CWITA011093,TCMBANKGE011093,INHBA,EDF; FRP,Inhibin_Subunit_Beta_A,7p14.1,protein-coding,
CWITA011094,TCMBANKGE011094,TRIM6-TRIM34,IFP1; RNF21; RNF89; TRIM34; TRIM6,TRIM6-TRIM34 readthrough,11p15.4,protein-coding,/
CWITA011095,TCMBANKGE011095,CRADD,MRT34; RAIDD,CASP2 and RIPK1 domain containing adaptor with death domain,12q22,protein-coding,/
CWITA011096,TCMBANKGE011096,CLDN9,-,claudin 9,16p13.3,protein-coding,/
CWITA011097,TCMBANKGE011097,ASB13,-,ankyrin repeat and SOCS box containing 13,10p15.1,protein-coding,/
CWITA011098,TCMBANKGE011098,NR2F2,ARP-1; ARP1; CHTD4; COUPTF2; COUPTFB; COUPTFII; NF-E3; SVP40; TFCOUP2,nuclear receptor subfamily 2 group F member 2,15q26.2,protein-coding,/
CWITA011099,TCMBANKGE011099,HRCT1,LGLL338; PRO537; UNQ338,histidine rich carboxyl terminus 1,9p13.3,protein-coding,/
CWITA011100,TCMBANKGE011100,BHLHA15,BHLHB8; MIST1,basic helix-loop-helix family member a15,7q21.3,protein-coding,/
CWITA011101,TCMBANKGE011101,EVC,DWF-1; EVC1; EVCL,EvC ciliary complex subunit 1,4p16.2,protein-coding,/
CWITA011102,TCMBANKGE011102,SLC25A10,DIC,solute carrier family 25 member 10,17q25.3,protein-coding,/
CWITA011103,TCMBANKGE011103,VANGL2,KIAA1215; LPP1; LTAP; MGC119403; MGC119404; STB1; STBM; STBM1,"Vang-Like 2 (Van Gogh, Drosophila)",1q22-q23,protein-coding,
CWITA011104,TCMBANKGE011104,TRAM1,PNAS8; TRAM; TRAMP,translocation associated membrane protein 1,8q13.3,protein-coding,/
CWITA011105,TCMBANKGE011105,ST8SIA3,SIAT8C; ST8SiaIII,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3",18q21.31,protein-coding,/
CWITA011106,TCMBANKGE011106,TAS2R40,GPR60; T2R40; T2R58,taste 2 receptor member 40,7q34,protein-coding,/
CWITA011107,TCMBANKGE011107,PGP,AUM; G3PP; PGPase,phosphoglycolate phosphatase,16p13.3,protein-coding,/
CWITA011108,TCMBANKGE011108,PCSK4,PC4; SPC5,proprotein convertase subtilisin/kexin type 4,19p13.3,protein-coding,Research target
CWITA011109,TCMBANKGE011109,TUBD1,TUBD,tubulin delta 1,17q23.1,protein-coding,/
CWITA011110,TCMBANKGE011110,UBE2D4,HBUCE1,ubiquitin conjugating enzyme E2 D4 (putative),7p13,protein-coding,/
CWITA011111,TCMBANKGE011111,ATF7,ATFA; MGC57182,activating transcription factor 7,12q13,protein-coding,
CWITA011112,TCMBANKGE011112,DOCK2,IMD40,dedicator of cytokinesis 2,5q35.1,protein-coding,/
CWITA011113,TCMBANKGE011113,CDC23,ANAPC8; APC8; CUT23,cell division cycle 23,5q31.2,protein-coding,/
CWITA011114,TCMBANKGE011114,MFSD1,SMAP4,major facilitator superfamily domain containing 1,3q25.32,protein-coding,/
CWITA011115,TCMBANKGE011115,RHEB,MGC111559; RHEB2,Ras homolog enriched in brain,7q36,protein-coding,
CWITA011116,TCMBANKGE011116,C4BPB,C4BP,complement component 4 binding protein beta,1q32.1,protein-coding,/
CWITA011117,TCMBANKGE011117,CDKN2AIP,CARF,CDKN2A interacting protein,4q35.1,protein-coding,/
CWITA011118,TCMBANKGE011118,CACNA2D2,CACNA2D; CASVDD,calcium voltage-gated channel auxiliary subunit alpha2delta 2,3p21.31,protein-coding,Research target
CWITA011119,TCMBANKGE011119,SLC6A3,DAT; DAT1,"solute carrier family 6 (neurotransmitter transporter, dopamine), member 3",5p15.3,protein-coding,
CWITA011120,TCMBANKGE011120,RASA2,GAP1M,RAS p21 protein activator 2,3q23,protein-coding,/
CWITA011121,TCMBANKGE011121,APBA3,MGC:15815; X11L2; mint3,amyloid beta precursor protein binding family A member 3,19p13.3,protein-coding,/
CWITA011122,TCMBANKGE011122,CCDC198,C14orf105,coiled-coil domain containing 198,14q22.3,protein-coding,/
CWITA011123,TCMBANKGE011123,NMNAT1,NMNAT; PNAT1,nicotinamide nucleotide adenylyltransferase 1,1p36.22,protein-coding,
CWITA011124,TCMBANKGE011124,WDR70,-,WD repeat domain 70,5p13.2,protein-coding,/
CWITA011125,TCMBANKGE011125,ZIC1,BAIDCS; CRS6; ZIC; ZNF201,Zic family member 1,3q24,protein-coding,/
CWITA011126,TCMBANKGE011126,CTBS,CTB,chitobiase,1p22.3,protein-coding,/
CWITA011127,TCMBANKGE011127,FPGS,N,folylpolyglutamate synthase,9q34.1,protein-coding,
CWITA011128,TCMBANKGE011128,IP6K2,IHPK2; InsP6K2; PIUS,inositol hexakisphosphate kinase 2,3p21.31,protein-coding,/
CWITA011129,TCMBANKGE011129,GH1,GH; GH-N; GHB5; GHN; IGHD1A; IGHD1B; IGHD2; hGH-N,growth hormone 1,17q23.3,protein-coding,Clinical Trial target
CWITA011130,TCMBANKGE011130,ZNF154,pHZ-92,zinc finger protein 154,19q13.43,protein-coding,/
CWITA011131,TCMBANKGE011131,RAB11A,YL8,"RAB11A, member RAS oncogene family",15q22.31,protein-coding,/
CWITA011132,TCMBANKGE011132,TAS2R3,T2R3,taste 2 receptor member 3,7q34,protein-coding,/
CWITA011133,TCMBANKGE011133,ABL2,ABLL; ARG,"ABL proto-oncogene 2, non-receptor tyrosine kinase",1q25.2,protein-coding,Research target
CWITA011134,TCMBANKGE011134,PGK1,MGC117307; MGC142128; MGC8947; MIG10; PGKA,phosphoglycerate kinase 1,Xq13,protein-coding,
CWITA011135,TCMBANKGE011135,ZNF827,-,zinc finger protein 827,4q31.21-q31.22,protein-coding,/
CWITA011136,TCMBANKGE011136,TUT1,PAPD2; RBM21; STARPAP; TENT1; TUTase; URLC6,"terminal uridylyl transferase 1, U6 snRNA-specific",11q12.3,protein-coding,/
CWITA011137,TCMBANKGE011137,RFPL3,RNF120,ret finger protein like 3,22q12.3,protein-coding,/
CWITA011138,TCMBANKGE011138,Plast4,-,plasma plant sterol 4,-,unknown,/
CWITA011139,TCMBANKGE011139,ZBTB12,Bat9; C6orf46; D6S59E; G10; NG35,zinc finger and BTB domain containing 12,6p21.33,protein-coding,/
CWITA011140,TCMBANKGE011140,ARHGEF19,WGEF,Rho guanine nucleotide exchange factor 19,1p36.13,protein-coding,/
CWITA011141,TCMBANKGE011141,GSS,GSHS; HEL-S-64p; HEL-S-88n,glutathione synthetase,20q11.22,protein-coding,Research target
CWITA011142,TCMBANKGE011142,USH1C,AIE-75; DFNB18; DFNB18A; NY-CO-37; NY-CO-38; PDZ-45; PDZ-73; PDZ-73/NY-CO-38; PDZ73; PDZD7C; ush1cpst,USH1 protein network component harmonin,11p15.1,protein-coding,/
CWITA011143,TCMBANKGE011143,CHIA,AMCASE; CHIT2; TSA1902,chitinase acidic,1p13.2,protein-coding,Research target
CWITA011144,TCMBANKGE011144,ZNF607,-,zinc finger protein 607,19q13.12,protein-coding,/
CWITA011145,TCMBANKGE011145,NSD1,ARA267; KMT3B; SOTOS; SOTOS1; STO,nuclear receptor binding SET domain protein 1,5q35.3,protein-coding,Research target
CWITA011146,TCMBANKGE011146,CNTNAP3,CASPR3; CNTNAP3A,contactin associated protein family member 3,9p12,protein-coding,/
CWITA011147,TCMBANKGE011147,HERC4,-,HECT and RLD domain containing E3 ubiquitin protein ligase 4,10q21.3,protein-coding,/
CWITA011148,TCMBANKGE011148,PDPK1,MGC20087; MGC35290; PDK1; PRO0461,3-phosphoinositide dependent protein kinase-1,16p13.3,protein-coding,
CWITA011149,TCMBANKGE011149,EIF5B,IF2,eukaryotic translation initiation factor 5B,2q11.2,protein-coding,/
CWITA011150,TCMBANKGE011150,RAD18,RNF73,RAD18 E3 ubiquitin protein ligase,3p25.3,protein-coding,/
CWITA011151,TCMBANKGE011151,CEBPG,GPE1BP; IG/EBP-1,CCAAT enhancer binding protein gamma,19q13.11,protein-coding,/
CWITA011152,TCMBANKGE011152,HERC1,MDFPMR; p532; p619,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,15q22.31,protein-coding,/
CWITA011153,TCMBANKGE011153,P4HB,DSI; ERBA2L; GIT; P4Hbeta; PDI; PDIA1; PHDB; PO4DB; PO4HB; PROHB,"prolyl 4-hydroxylase, beta polypeptide",17q25,protein-coding,
CWITA011154,TCMBANKGE011154,GLP2R,-,glucagon like peptide 2 receptor,17p13.1,protein-coding,Successful target
CWITA011155,TCMBANKGE011155,ANKRD28,CFAP79; FAP79; PITK; PPP1R65,ankyrin repeat domain 28,3p25.1,protein-coding,/
CWITA011156,TCMBANKGE011156,PRLHR,GPR10; GR3; PrRPR,prolactin releasing hormone receptor,10q26.11,protein-coding,/
CWITA011157,TCMBANKGE011157,RAD9B,-,RAD9 checkpoint clamp component B,12q24.11,protein-coding,/
CWITA011158,TCMBANKGE011158,ACSM6,C10orf129; bA310E22.3,acyl-CoA synthetase medium chain family member 6,10q23.33,protein-coding,/
CWITA011159,TCMBANKGE011159,USP34,-,ubiquitin specific peptidase 34,2p15,protein-coding,/
CWITA011160,TCMBANKGE011160,CLSTN1,ALC-ALPHA; CDHR12; CST-1; CSTN1; PIK3CD; XB31alpha; alcalpha1; alcalpha2,calsyntenin 1,1p36.22,protein-coding,/
CWITA011161,TCMBANKGE011161,ANKS6,ANKRD14; NPHP16; PKDR1; SAMD6,ankyrin repeat and sterile alpha motif domain containing 6,9q22.33,protein-coding,/
CWITA011162,TCMBANKGE011162,OR7A5,HTPCR2,olfactory receptor family 7 subfamily A member 5,19p13.12,protein-coding,/
CWITA011163,TCMBANKGE011163,MYO5A,GS1; MYH12; MYO5; MYR12,myosin VA,15q21.2,protein-coding,/
CWITA011164,TCMBANKGE011164,GLUD1,GDH; GDH1; GLUD,glutamate dehydrogenase 1,10q23.2,protein-coding,/
CWITA011165,TCMBANKGE011165,C20orf194,-,chromosome 20 open reading frame 194,20p13,protein-coding,/
CWITA011166,TCMBANKGE011166,KMO,dJ317G22.1,kynurenine 3-monooxygenase,1q43,protein-coding,Patented target
CWITA011167,TCMBANKGE011167,NSRP1,CCDC55; HSPC095; NSrp70,nuclear speckle splicing regulatory protein 1,17q11.2,protein-coding,/
CWITA011168,TCMBANKGE011168,TCF12,CRS3; HEB; HTF4; HsT17266; TCF-12; bHLHb20; p64,transcription factor 12,15q21.3,protein-coding,/
CWITA011169,TCMBANKGE011169,PRSS38,MPN2,serine protease 38,1q42.13,protein-coding,/
CWITA011170,TCMBANKGE011170,PSMD14,PAD1; POH1; RPN11,"proteasome 26S subunit, non-ATPase 14",2q24.2,protein-coding,/
CWITA011171,TCMBANKGE011171,YWHAH,YWHA1,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,22q12.3,protein-coding,Research target
CWITA011172,TCMBANKGE011172,MLH3,HNPCC7,mutL homolog 3,14q24.3,protein-coding,/
CWITA011173,TCMBANKGE011173,FAM3B,2-21; C21orf11; C21orf76; ORF9; PANDER; PRED44,FAM3 metabolism regulating signaling molecule B,21q22.3,protein-coding,/
CWITA011174,TCMBANKGE011174,ARAP3,CENTD3; DRAG1,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",5q31.3,protein-coding,/
CWITA011175,TCMBANKGE011175,ST7,ETS7q; FAM4A; FAM4A1; HELG; RAY1; SEN4; TSG7,suppression of tumorigenicity 7,7q31.2,protein-coding,/
CWITA011176,TCMBANKGE011176,SATL1,-,spermidine/spermine N1-acetyl transferase like 1,Xq21.1,protein-coding,/
CWITA011177,TCMBANKGE011177,DNAJC15,DNAJD1; HSD18; MCJ,DnaJ heat shock protein family (Hsp40) member C15,13q14.11,protein-coding,/
CWITA011178,TCMBANKGE011178,COL4A5,ASLN; ATS; ATS1; CA54,collagen type IV alpha 5 chain,Xq22.3,protein-coding,/
CWITA011179,TCMBANKGE011179,FCER1G,FCRG,Fc fragment of IgE receptor Ig,1q23.3,protein-coding,Successful target
CWITA011180,TCMBANKGE011180,CSTF2T,CstF-64T,cleavage stimulation factor subunit 2 tau variant,10q21.1,protein-coding,/
CWITA011181,TCMBANKGE011181,Topbp1-ps1,Gm28059,"topoisomerase (DNA) II binding protein 1, pseudogene 1",7 B3|7,pseudo,/
CWITA011182,TCMBANKGE011182,ITGB2,CD18; LAD; LCAMB; LFA-1; MAC-1; MF17; MFI7,integrin subunit beta 2,21q22.3,protein-coding,Discontinued target
CWITA011183,TCMBANKGE011183,TTLL3,DKFZp434B103; DKFZp686D076; FLJ13898; HOTTL; MGC120529; MGC120530; MGC120532,"tubulin tyrosine ligase-like family, member 3",3p25.3,protein-coding,
CWITA011184,TCMBANKGE011184,FAM98B,-,family with sequence similarity 98 member B,15q14,protein-coding,/
CWITA011185,TCMBANKGE011185,TESC,CHP3; TSC,tescalcin,12q24.22,protein-coding,/
CWITA011186,TCMBANKGE011186,CHRNA3,BAIPRCK; LNCR2; NACHRA3; PAOD2,cholinergic receptor nicotinic alpha 3 subunit,15q25.1,protein-coding,/
CWITA011187,TCMBANKGE011187,POC1B-GALNT4,GALNT4; GalNAc-T4,POC1B-GALNT4 readthrough,12q21.33,protein-coding,/
CWITA011188,TCMBANKGE011188,LARS2,KIAA0028; LEURS; MGC26121,"leucyl-tRNA synthetase 2, mitochondrial",3p21.3,protein-coding,
CWITA011189,TCMBANKGE011189,ADAMTS6,ADAM-TS 6; ADAM-TS6; ADAMTS-6,ADAM metallopeptidase with thrombospondin type 1 motif 6,5q12.3,protein-coding,/
CWITA011190,TCMBANKGE011190,BAZ2B,WALp4,bromodomain adjacent to zinc finger domain 2B,2q24.2,protein-coding,Research target
CWITA011191,TCMBANKGE011191,Ptges3-ps,Gm9769,"prostaglandin E synthase 3, pseudogene",6|6 C3,pseudo,/
CWITA011192,TCMBANKGE011192,CANT1,DBQD; DBQD1; EDM7; SCAN-1; SCAN1; SHAPY,calcium activated nucleotidase 1,17q25.3,protein-coding,/
CWITA011193,TCMBANKGE011193,RPS27,DBA17; MPS-1; MPS1; S27,ribosomal protein S27,1q21.3,protein-coding,/
CWITA011194,TCMBANKGE011194,DPP10,DPL2; DPPY; DPRP-3; DPRP3,dipeptidyl peptidase like 10,2q14.1,protein-coding,Research target
CWITA011195,TCMBANKGE011195,ZNF468,-,zinc finger protein 468,19q13.41,protein-coding,/
CWITA011196,TCMBANKGE011196,CPEB2,CPE-BP2; CPEB-2; hCPEB-2,cytoplasmic polyadenylation element binding protein 2,4p15.32,protein-coding,/
CWITA011197,TCMBANKGE011197,PLIN3,M6PRBP1; PP17; TIP47,perilipin 3,19p13.3,protein-coding,/
CWITA011198,TCMBANKGE011198,FAM217B,C20orf177; dJ551D2.5,family with sequence similarity 217 member B,20q13.33,protein-coding,/
CWITA011199,TCMBANKGE011199,ALDH3A2,ALDH10; DKFZp686E23276; FALDH; FLJ20851; SLS,"aldehyde dehydrogenase 3 family, member A2",17p11.2,protein-coding,
CWITA011200,TCMBANKGE011200,ADAM10,AD10; AD18; CD156c; CDw156; HsT18717; MADM; RAK; kuz,ADAM metallopeptidase domain 10,15q21.3,protein-coding,Research target
CWITA011201,TCMBANKGE011201,CENPC,CENP-C; CENPC1; MIF2; hcp-4,centromere protein C,4q13.2,protein-coding,/
CWITA011202,TCMBANKGE011202,ZBTB49,ZNF509,zinc finger and BTB domain containing 49,4p16.3,protein-coding,/
CWITA011203,TCMBANKGE011203,RPL34,L34,ribosomal protein L34,4q25,protein-coding,/
CWITA011204,TCMBANKGE011204,ACP1,HAAP; MGC111030; MGC3499,"acid phosphatase 1, soluble",2p25,protein-coding,
CWITA011205,TCMBANKGE011205,SLC39A7,D6S115E; D6S2244E; H2-KE4; HKE4; KE4; RING5; ZIP7,solute carrier family 39 member 7,6p21.32,protein-coding,/
CWITA011206,TCMBANKGE011206,CLDN7,CEPTRL2; CLDN-7; CPETRL2; Hs.84359; claudin-1,claudin 7,17p13.1,protein-coding,/
CWITA011207,TCMBANKGE011207,NGB,-,neuroglobin,14q24.3,protein-coding,/
CWITA011208,TCMBANKGE011208,IARS2,FLJ10326; ILERS,"isoleucyl-tRNA synthetase 2, mitochondrial",1q41,protein-coding,
CWITA011209,TCMBANKGE011209,Car3,BB219044; Ca3; Car-3,carbonic anhydrase 3,3 A1|3 3.22 cM,protein-coding,/
CWITA011210,TCMBANKGE011210,SLC18A1,CGAT; VAT1; VMAT1,"solute carrier family 18 (vesicular monoamine), member 1",8p21.3,protein-coding,
CWITA011211,TCMBANKGE011211,NMRAL1,HSCARG; SDR48A1,NmrA like redox sensor 1,16p13.3,protein-coding,/
CWITA011212,TCMBANKGE011212,Cea,-,carcinoembryonic antigen gene family,-,other,/
CWITA011213,TCMBANKGE011213,P2RY12,ADPG-R; BDPLT8; HORK3; P2T(AC); P2Y(12)R; P2Y(AC); P2Y(ADP); P2Y(cyc); P2Y12; SP1999,purinergic receptor P2Y12,3q25.1,protein-coding,Successful target
CWITA011214,TCMBANKGE011214,DAO,DAAO; DAMOX; OXDA,D-amino acid oxidase,12q24.11,protein-coding,Clinical Trial target
CWITA011215,TCMBANKGE011215,ALDH4A1,ALDH4; P5CD; P5CDh,aldehyde dehydrogenase 4 family member A1,1p36.13,protein-coding,/
CWITA011216,TCMBANKGE011216,ALDOB,ALDB; ALDO2,"aldolase, fructose-bisphosphate B",9q31.1,protein-coding,/
CWITA011217,TCMBANKGE011217,CD79B,AGM6; B29; IGB,CD79b molecule,17q23.3,protein-coding,Clinical Trial target
CWITA011218,TCMBANKGE011218,KISS1,HH13; KiSS-1,KiSS-1 metastasis suppressor,1q32.1,protein-coding,Clinical Trial target
CWITA011219,TCMBANKGE011219,PIKFYVE,CFD; FAB1; HEL37; PIP5K; PIP5K3; ZFYVE29,"phosphoinositide kinase, FYVE-type zinc finger containing",2q34,protein-coding,Clinical Trial target
CWITA011220,TCMBANKGE011220,CIITA,C2TA; CIITAIV; MHC2TA; NLRA,class II major histocompatibility complex transactivator,16p13.13,protein-coding,/
CWITA011221,TCMBANKGE011221,SCN10A,FEPS2; Nav1.8; PN3; SNS; hPN3,Sodium_Voltage-Gated_Channel_Alpha_Subunit_10,3p22.2,protein-coding,
CWITA011222,TCMBANKGE011222,CPS1,CPSASE1,"carbamoyl-phosphate synthase 1, mitochondrial",2q35,protein-coding,
CWITA011223,TCMBANKGE011223,CCDC14,-,coiled-coil domain containing 14,3q21.1,protein-coding,/
CWITA011224,TCMBANKGE011224,HSPA6,HSP70B',heat shock protein family A (Hsp70) member 6,1q23.3,protein-coding,/
CWITA011225,TCMBANKGE011225,FFAR1,FFA1R; GPCR40; GPR40,free fatty acid receptor 1,19q13.1,protein-coding,
CWITA011226,TCMBANKGE011226,KCND3,BRGDA9; KCND3L; KCND3S; KSHIVB; KV4.3; SCA19; SCA22,potassium voltage-gated channel subfamily D member 3,1p13.2,protein-coding,Successful target
CWITA011227,TCMBANKGE011227,CDC16,ANAPC6; APC6; CDC16Hs; CUT9,cell division cycle 16,13q34,protein-coding,/
CWITA011228,TCMBANKGE011228,TPM1,C15orf13; CMD1Y; CMH3; HEL-S-265; HTM-alpha; LVNC9; TMSA,tropomyosin 1,15q22.2,protein-coding,/
CWITA011229,TCMBANKGE011229,NDUFA10,CIN42KD; CIN42k; FLJ21923; MGC5103,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa",2q37.3,protein-coding,
CWITA011230,TCMBANKGE011230,CAMK2D,CAMKD,calcium/calmodulin dependent protein kinase II delta,4q26,protein-coding,/
CWITA011231,TCMBANKGE011231,CST7,CMAP,cystatin F,20p11.21,protein-coding,/
CWITA011232,TCMBANKGE011232,XPO6,EXP6; RANBP20,exportin 6,16p12.1,protein-coding,/
CWITA011233,TCMBANKGE011233,KBTBD7,-,kelch repeat and BTB domain containing 7,13q14.11,protein-coding,/
CWITA011234,TCMBANKGE011234,ART3,ARTC3,ADP-ribosyltransferase 3,4q21.1|4p15.1-p14,protein-coding,/
CWITA011235,TCMBANKGE011235,SLC8A1,NCX1,solute carrier family 8 member A1,2p22.1,protein-coding,Research target
CWITA011236,TCMBANKGE011236,MEPCE,BCDIN3,methylphosphate capping enzyme,7q22.1,protein-coding,/
CWITA011237,TCMBANKGE011237,HADH,HAD; HADH1; HADHSC; HCDH; HHF4; MSCHAD; SCHAD,hydroxyacyl-CoA dehydrogenase,4q25,protein-coding,/
CWITA011238,TCMBANKGE011238,SPC25,AD024; SPBC25; hSpc25,SPC25 component of NDC80 kinetochore complex,2q24.3,protein-coding,/
CWITA011239,TCMBANKGE011239,MAP3K8,AURA2; COT; EST; ESTF; MEKK8; TPL2; Tpl-2; c-COT,Mitogen-Activated_Protein_Kinase_Kinase_Kinase_8,10p11.23,protein-coding,
CWITA011240,TCMBANKGE011240,SEC14L3,TAP2,SEC14 like lipid binding 3,22q12.2,protein-coding,/
CWITA011241,TCMBANKGE011241,SERF2,4F5REL; FAM2C; H4F5REL; HsT17089,small EDRK-rich factor 2,15q15.3,protein-coding,/
CWITA011242,TCMBANKGE011242,UPRT,FUR1; UPP,uracil phosphoribosyltransferase homolog,Xq13.3,protein-coding,/
CWITA011243,TCMBANKGE011243,VN1R4,V1RL4,vomeronasal 1 receptor 4,19q13.42,protein-coding,/
CWITA011244,TCMBANKGE011244,ATP6V0D1,ATP6D; ATP6DV; P39; VATX; VMA6; VPATPD,ATPase H+ transporting V0 subunit d1,16q22.1,protein-coding,/
CWITA011245,TCMBANKGE011245,SPRED3,Eve-3; spred-3,sprouty related EVH1 domain containing 3,19q13.2,protein-coding,/
CWITA011246,TCMBANKGE011246,DPM1,CDGIE; MPDS,"dolichyl-phosphate mannosyltransferase subunit 1, catalytic",20q13.13,protein-coding,/
CWITA011247,TCMBANKGE011247,RAB11B,H-YPT3; NDAGSCW,"RAB11B, member RAS oncogene family",19p13.2,protein-coding,/
CWITA011248,TCMBANKGE011248,Ciaaq1,Ciaa1,collagen induced arthritis autoantibody QTL 1,7 31.44 cM,unknown,/
CWITA011249,TCMBANKGE011249,TSN,BCLF-1; C3PO; RCHF1; REHF-1; TBRBP; TRSLN,translin,2q14.3,protein-coding,/
CWITA011250,TCMBANKGE011250,MELTF,CD228; MAP97; MFI2; MTF1; MTf,melanotransferrin,3q29,protein-coding,/
CWITA011251,TCMBANKGE011251,GAREM1,C18orf11; FAM59A; GAREM; Gm944,GRB2 associated regulator of MAPK1 subtype 1,18q12.1,protein-coding,/
CWITA011252,TCMBANKGE011252,EIF4G2,AAG1; DAP5; NAT1; P97,eukaryotic translation initiation factor 4 gamma 2,11p15.4,protein-coding,/
CWITA011253,TCMBANKGE011253,SMIM8,C6orf162; dJ102H19.2,small integral membrane protein 8,6q15,protein-coding,/
CWITA011254,TCMBANKGE011254,ATP1A2,FHM2; MHP2,ATPase Na+/K+ transporting subunit alpha 2,1q23.2,protein-coding,Research target
CWITA011255,TCMBANKGE011255,KMT5C,SUV420H2; Suv4-20h2,lysine methyltransferase 5C,19q13.42,protein-coding,/
CWITA011256,TCMBANKGE011256,GALK1,GALK; GK1; HEL-S-19,galactokinase 1,17q25.1,protein-coding,/
CWITA011257,TCMBANKGE011257,PCDH8,ARCADLIN; PAPC,protocadherin 8,13q14.3,protein-coding,/
CWITA011258,TCMBANKGE011258,MYOF,FER1L3,myoferlin,10q23.33,protein-coding,/
CWITA011259,TCMBANKGE011259,ULK4,FAM7C1; REC01035,unc-51 like kinase 4,3p22.1,protein-coding,/
CWITA011260,TCMBANKGE011260,GPR63,PSP24(beta); PSP24B,G protein-coupled receptor 63,6q16.1,protein-coding,Research target
CWITA011261,TCMBANKGE011261,RPL7L1,dJ475N16.4,ribosomal protein L7 like 1,6p21.1,protein-coding,/
CWITA011262,TCMBANKGE011262,FUBP1,FBP; FUBP; hDH V,far upstream element binding protein 1,1p31.1,protein-coding,/
CWITA011263,TCMBANKGE011263,SLC22A8,MGC24086; OAT3,"solute carrier family 22 (organic anion transporter), member 8",11q11,protein-coding,
CWITA011264,TCMBANKGE011264,FBLN5,ADCL2; ARCL1A; ARMD3; DANCE; EVEC; FIBL-5; HNARMD; UP50,fibulin 5,14q32.12,protein-coding,/
CWITA011265,TCMBANKGE011265,RLBP1,CRALBP; MGC3663,retinaldehyde binding protein 1,15q26,protein-coding,
CWITA011266,TCMBANKGE011266,NRM,NRM29,nurim,6p21.33,protein-coding,/
CWITA011267,TCMBANKGE011267,NR6A1,CT150; GCNF; GCNF1; NR61; RTR; hGCNF; hRTR,nuclear receptor subfamily 6 group A member 1,9q33.3,protein-coding,/
CWITA011268,TCMBANKGE011268,TRAIP,RNF206; SCKL9; TRIP,TRAF interacting protein,3p21.31,protein-coding,/
CWITA011269,TCMBANKGE011269,ACVR1,ACTRI; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI,activin A receptor type 1,2q24.1,protein-coding,Patented target
CWITA011270,TCMBANKGE011270,SERTAD2,Sei-2; TRIP-Br2; TRIPBR2,SERTA domain containing 2,2p14,protein-coding,/
CWITA011271,TCMBANKGE011271,IL20RB,DIRS1; FNDC6; IL-20R2,interleukin 20 receptor subunit beta,3q22.3,protein-coding,/
CWITA011272,TCMBANKGE011272,EGFL7,NEU1; VE-STATIN; ZNEU1,EGF like domain multiple 7,9q34.3,protein-coding,Clinical Trial target
CWITA011273,TCMBANKGE011273,GJA9,CX58; CX59; GJA10,gap junction protein alpha 9,1p34.3,protein-coding,Research target
CWITA011274,TCMBANKGE011274,ATAD3B,AAA-TOB3; TOB3,ATPase family AAA domain containing 3B,1p36.33,protein-coding,/
CWITA011275,TCMBANKGE011275,DET1,-,DET1 partner of COP1 E3 ubiquitin ligase,15q26.1,protein-coding,/
CWITA011276,TCMBANKGE011276,KDM8,JMJD5,lysine demethylase 8,16p12.1,protein-coding,/
CWITA011277,TCMBANKGE011277,PVR,CD155; FLJ25946; HVED; NECL5; NeclN5; PVS; TAGE4,poliovirus receptor,19q13.2,protein-coding,
CWITA011278,TCMBANKGE011278,PPARGC1B,ERRL1; PERC; PGC-1(beta); PGC1B,PPARG coactivator 1 beta,5q32,protein-coding,Research target
CWITA011279,TCMBANKGE011279,NRXN1,Hs.22998; PTHSL2; SCZD17,neurexin 1,2p16.3,protein-coding,/
CWITA011280,TCMBANKGE011280,USP5,ISOT,ubiquitin specific peptidase 5,12p13.31,protein-coding,Research target
CWITA011281,TCMBANKGE011281,P4HA2,MYP25,prolyl 4-hydroxylase subunit alpha 2,5q31.1,protein-coding,/
CWITA011282,TCMBANKGE011282,UPK2,UP2; UPII,uroplakin 2,11q23.3,protein-coding,/
CWITA011283,TCMBANKGE011283,LRRC8D,LRRC5,leucine rich repeat containing 8 VRAC subunit D,1p22.2,protein-coding,/
CWITA011284,TCMBANKGE011284,ADAT1,HADAT1,adenosine deaminase tRNA specific 1,16q23.1,protein-coding,/
CWITA011285,TCMBANKGE011285,NAGK,GNK; HSA242910,N-acetylglucosamine kinase,2p13.3,protein-coding,
CWITA011286,TCMBANKGE011286,ACSL4,ACS4; FACL4; LACS4; MRX63; MRX68,acyl-CoA synthetase long-chain family member 4,Xq22.3-q23,protein-coding,
CWITA011287,TCMBANKGE011287,CFB,AHUS4; ARMD14; BF; BFD; CFAB; CFBD; FB; FBI12; GBG; H2-Bf; PBF2,complement factor B,6p21.33,protein-coding,Discontinued target
CWITA011288,TCMBANKGE011288,MTFR1,CHPPR; FAM54A2,mitochondrial fission regulator 1,8q13.1,protein-coding,/
CWITA011289,TCMBANKGE011289,NKAIN1,FAM77C,sodium/potassium transporting ATPase interacting 1,1p35.2,protein-coding,/
CWITA011290,TCMBANKGE011290,TBXT,SAVA; T; TFT,T-box transcription factor T,6q27,protein-coding,/
CWITA011291,TCMBANKGE011291,DCTD,MGC111062,dCMP deaminase,4q35.1,protein-coding,
CWITA011292,TCMBANKGE011292,ZNF383,HSD17; Zfp383,zinc finger protein 383,19q13.12,protein-coding,/
CWITA011293,TCMBANKGE011293,RDH11,ARSDR1; CGI82; HCBP12; MDT1; PSDR1; RALR1; RDJCSS; SCALD; SDR7C1,retinol dehydrogenase 11,14q24.1,protein-coding,/
CWITA011294,TCMBANKGE011294,SLC14A2,FLJ16167; HUT2; MGC119566; MGC119567; UTNA2; UT2; UTA; UTR; hUTNA6,"solute carrier family 14 (urea transporter), member 2",18q12.1-q21.1,protein-coding,
CWITA011295,TCMBANKGE011295,MANEA,ENDO; hEndo,mannosidase endo-alpha,6q16.1,protein-coding,/
CWITA011296,TCMBANKGE011296,LRRC8E,-,leucine rich repeat containing 8 VRAC subunit E,19p13.2,protein-coding,/
CWITA011297,TCMBANKGE011297,LAMTOR5,HBXIP; XIP,"late endosomal/lysosomal adaptor, MAPK and MTOR activator 5",1p13.3,protein-coding,/
CWITA011298,TCMBANKGE011298,PABPN1,OPMD; PAB2; PABII; PABP-2; PABP2,poly(A) binding protein nuclear 1,14q11.2,protein-coding,/
CWITA011299,TCMBANKGE011299,UGT2B7,UDPGT 2B7; UDPGT 2B9; UDPGT2B7; UDPGTH2; UDPGTh-2; UGT2B9,UDP glucuronosyltransferase family 2 member B7,4q13.2,protein-coding,/
CWITA011300,TCMBANKGE011300,DHRS13,SDR7C5,dehydrogenase/reductase 13,17q11.2,protein-coding,/
CWITA011301,TCMBANKGE011301,TMEM170B,-,transmembrane protein 170B,6p24.2,protein-coding,/
CWITA011302,TCMBANKGE011302,ZBED9,Buster4; SCAND3; ZFP38-L; ZNF305P2; ZNF452; dJ1186N24.3,zinc finger BED-type containing 9,6p22.1,protein-coding,/
CWITA011303,TCMBANKGE011303,RNF138,HSD-4; NARF; STRIN; hNARF,ring finger protein 138,18q12.1,protein-coding,/
CWITA011304,TCMBANKGE011304,SORBS3,SCAM-1; SCAM1; SH3D4,sorbin and SH3 domain containing 3,8p21.3,protein-coding,/
CWITA011305,TCMBANKGE011305,TCEANC2,C1orf83,transcription elongation factor A N-terminal and central domain containing 2,1p32.3,protein-coding,/
CWITA011306,TCMBANKGE011306,FDXR,ADXR,ferredoxin reductase,17q24-q25,protein-coding,
CWITA011307,TCMBANKGE011307,UQCRC2,QCR2; UQCR2,ubiquinol-cytochrome c reductase core protein II,16p12,protein-coding,
CWITA011308,TCMBANKGE011308,Cfmq2,-,cystic fibrosis modifier QTL 2,9 17.8 cM,unknown,/
CWITA011309,TCMBANKGE011309,REPS1,NBIA7; RALBP1,RALBP1 associated Eps domain containing 1,6q24.1,protein-coding,/
CWITA011310,TCMBANKGE011310,SEC24D,CLCRP2,"SEC24 homolog D, COPII coat complex component",4q26,protein-coding,/
CWITA011311,TCMBANKGE011311,C1orf105,-,chromosome 1 open reading frame 105,1q24.3,protein-coding,/
CWITA011312,TCMBANKGE011312,FIBP,FGFIBP; FIBP-1; TROFAS,FGF1 intracellular binding protein,11q13.1,protein-coding,/
CWITA011313,TCMBANKGE011313,STAG3,-,stromal antigen 3,7q22.1,protein-coding,/
CWITA011314,TCMBANKGE011314,SLC41A1,MgtE,solute carrier family 41 member 1,1q32.1,protein-coding,/
CWITA011315,TCMBANKGE011315,SKAP2,PRAP; RA70; SAPS; SCAP2; SKAP-HOM; SKAP55R,src kinase associated phosphoprotein 2,7p15.2,protein-coding,/
CWITA011316,TCMBANKGE011316,TCN2,D22S676; D22S750; II; TC; TC_II; TCN2; TC2; TCII,transcobalamin II,22q12.2,protein-coding,
CWITA011317,TCMBANKGE011317,ATP13A1,ATP13A; CGI-152,ATPase 13A1,19p13.11,protein-coding,/
CWITA011318,TCMBANKGE011318,NCS1,FLUP; FREQ,neuronal calcium sensor 1,9q34.11,protein-coding,/
CWITA011319,TCMBANKGE011319,CSTF2,CstF-64,cleavage stimulation factor subunit 2,Xq22.1,protein-coding,/
CWITA011320,TCMBANKGE011320,SPCS2,-,signal peptidase complex subunit 2,11q13.4,protein-coding,/
CWITA011321,TCMBANKGE011321,HM13,H13; IMP1; IMPAS; IMPAS-1; MSTP086; PSENL3; PSL3; SPP; SPPL1,histocompatibility minor 13,20q11.21,protein-coding,/
CWITA011322,TCMBANKGE011322,TAS2R41,T2R41; T2R59,taste 2 receptor member 41,7q35,protein-coding,/
CWITA011323,TCMBANKGE011323,TEK,CD202B; TIEN2; TIE2; VMCM; VMCM1,"TEK tyrosine kinase, endothelial",9p21,protein-coding,
CWITA011324,TCMBANKGE011324,IRAK3,ASRT5; IRAKM,interleukin 1 receptor associated kinase 3,12q14.3,protein-coding,Research target
CWITA011325,TCMBANKGE011325,CYP4F22,ARCI5; INLNE; LI3,cytochrome P450 family 4 subfamily F member 22,19p13.12,protein-coding,/
CWITA011326,TCMBANKGE011326,CHTF18,C16orf41; C321D2.2; C321D2.3; C321D2.4; CHL12; Ctf18; RUVBL,chromosome transmission fidelity factor 18,16p13.3,protein-coding,/
CWITA011327,TCMBANKGE011327,TCF25,FKSG26; Hulp1; NULP1; PRO2620; hKIAA1049,transcription factor 25,16q24.3,protein-coding,/
CWITA011328,TCMBANKGE011328,KCNA10,Kcn1; Kv1.8,"potassium voltage-gated channel, shaker-related subfamily, member 10",1p13.1,protein-coding,
CWITA011329,TCMBANKGE011329,RPL23,L23; MGC111167; MGC117346; MGC72008; rpL17,ribosomal protein L23,17q,protein-coding,
CWITA011330,TCMBANKGE011330,MAGOH,MAGOH1; MAGOHA,"mago homolog, exon junction complex subunit",1p32.3,protein-coding,/
CWITA011331,TCMBANKGE011331,NFS1,IscS; NIFS,NFS1 nitrogen fixation 1 homolog (S. cerevisiae),20q11.22,protein-coding,
CWITA011332,TCMBANKGE011332,CPT1C,CATL1; CPT1-B; CPT1P; CPTI-B; CPTIC; SPG73,carnitine palmitoyltransferase 1C,19q13.33,protein-coding,/
CWITA011333,TCMBANKGE011333,GASK1B,AD021; AD036; C4orf18; ENED; FAM198B,golgi associated kinase 1B,4q32.1,protein-coding,/
CWITA011334,TCMBANKGE011334,CSF3,C17orf33; CSF3OS; GCSF,colony stimulating factor 3,17q21.1,protein-coding,Successful target
CWITA011335,TCMBANKGE011335,CCDC121,-,coiled-coil domain containing 121,2p23.3,protein-coding,/
CWITA011336,TCMBANKGE011336,URAD,PRHOXNB,ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase,13q12.2,protein-coding,/
CWITA011337,TCMBANKGE011337,PRKDC,DNANPKcs; DNAPK; DNPK1; HYRC; HYRC1; XRCC7; p350,"protein kinase, DNA-activated, catalytic polypeptide",8q11,protein-coding,
CWITA011338,TCMBANKGE011338,MIOS,MIO; Sea4; Yulink,meiosis regulator for oocyte development,7p21.3,protein-coding,/
CWITA011339,TCMBANKGE011339,TRIM29,ATDC,tripartite motif containing 29,11q23.3,protein-coding,/
CWITA011340,TCMBANKGE011340,ATF1,EWS-ATF1; FUS/ATF-1; TREB36,activating transcription factor 1,12q13.12,protein-coding,/
CWITA011341,TCMBANKGE011341,ADRA2A,ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32,"adrenergic, alpha-2A-, receptor",10q24-q26,protein-coding,
CWITA011342,TCMBANKGE011342,NGF,Beta-NGF; HSAN5; NGFB,nerve growth factor,1p13.2,protein-coding,Clinical Trial target
CWITA011343,TCMBANKGE011343,TRAPPC3L,BET3L; bA259P20.2,trafficking protein particle complex 3 like,6q22.1,protein-coding,/
CWITA011344,TCMBANKGE011344,HUS1B,-,HUS1 checkpoint clamp component B,6p25.3,protein-coding,/
CWITA011345,TCMBANKGE011345,AKIRIN1,C1orf108; STRF2,akirin 1,1p34.3,protein-coding,/
CWITA011346,TCMBANKGE011346,CTPS1,CTPS; GATD5; IMD24,Ctp_Synthase_1,1p34.2,protein-coding,
CWITA011347,TCMBANKGE011347,AGPAT4,1-AGPAT4; LPAAT-delta; dJ473J16.2,1-acylglycerol-3-phosphate O-acyltransferase 4,6q26,protein-coding,/
CWITA011348,TCMBANKGE011348,IGF2R,CD222; CI-M6PR; CIMPR; M6P-R; M6P/IGF2R; MPR 300; MPR1; MPR300; MPRI,insulin like growth factor 2 receptor,6q25.3,protein-coding,Clinical Trial target
CWITA011349,TCMBANKGE011349,SLC31A1,COPT1; CTR1,solute carrier family 31 member 1,9q32,protein-coding,/
CWITA011350,TCMBANKGE011350,NIPSNAP1,-,nipsnap homolog 1,22q12.2,protein-coding,/
CWITA011351,TCMBANKGE011351,CMPK1,CMK; CMPK; UMK; UMPNCMPK; UMPK,"cytidine monophosphate (UMP-CMP) kinase 1, cytosolic",1p32,protein-coding,
CWITA011352,TCMBANKGE011352,Slco1a6,4930422F19Rik; AI790453; Oatp-5; Oatp5; Slc21a13,"solute carrier organic anion transporter family, member 1a6",6|6 G2,protein-coding,/
CWITA011353,TCMBANKGE011353,GINS4,SLD5,GINS complex subunit 4,8p11.21,protein-coding,/
CWITA011354,TCMBANKGE011354,NFATC3,NF-AT4c; NFAT4; NFATX,nuclear factor of activated T cells 3,16q22.1,protein-coding,/
CWITA011355,TCMBANKGE011355,SORCS2,-,sortilin related VPS10 domain containing receptor 2,4p16.1,protein-coding,/
CWITA011356,TCMBANKGE011356,NDOR1,CIAE1; NR1; bA350O14.9,NADPH dependent diflavin oxidoreductase 1,9q34.3,protein-coding,/
CWITA011357,TCMBANKGE011357,THOP1,EP24.15; MEPD_HUMAN; MP78; TOP,thimet oligopeptidase 1,19p13.3,protein-coding,/
CWITA011358,TCMBANKGE011358,TUBB2A,CDCBM5; TUBB; TUBB2,tubulin beta 2A class IIa,6p25.2,protein-coding,Successful target
CWITA011359,TCMBANKGE011359,REM2,-,RRAD and GEM like GTPase 2,14q11.2,protein-coding,/
CWITA011360,TCMBANKGE011360,SETD4,C21orf18; C21orf27,SET domain containing 4,21q22.12,protein-coding,/
CWITA011361,TCMBANKGE011361,HTR3D,5HT3D; MGC119636; MGC119637,5-hydroxytryptamine (serotonin) receptor 3 family member D,3q27.1,protein-coding,
CWITA011362,TCMBANKGE011362,HOXA13,HOX1; HOX1J,homeobox A13,7p15.2,protein-coding,Research target
CWITA011363,TCMBANKGE011363,DDC,AADC,dopa decarboxylase,7p12.2-p12.1,protein-coding,Successful target
CWITA011364,TCMBANKGE011364,GDF15,GDF-15; MIC-1; MIC1; NAG-1; PDF; PLAB; PTGFB,growth differentiation factor 15,19p13.11,protein-coding,Research target
CWITA011365,TCMBANKGE011365,RND1,ARHS; RHO6; RHOS,Rho family GTPase 1,12q13.12,protein-coding,/
CWITA011366,TCMBANKGE011366,MAL,MVP17; VIP17,"mal, T cell differentiation protein",2q11.1,protein-coding,/
CWITA011367,TCMBANKGE011367,RAB43,RAB11B; RAB41,"RAB43, member RAS oncogene family",3q21.3,protein-coding,/
CWITA011368,TCMBANKGE011368,IFFO1,HOM-TES-103; IFFO,intermediate filament family orphan 1,12p13.31,protein-coding,/
CWITA011369,TCMBANKGE011369,PSKH1,-,protein serine kinase H1,16q22.1,protein-coding,/
CWITA011370,TCMBANKGE011370,SEC14L1,PRELID4A; SEC14L,SEC14 like lipid binding 1,17q25.2-q25.3,protein-coding,/
CWITA011371,TCMBANKGE011371,REG4,GISP; REG-IV; RELP,regenerating family member 4,1p12,protein-coding,Research target
CWITA011372,TCMBANKGE011372,ANTXR2,CMG-2; CMG2; HFS; ISH; JHF,ANTXR cell adhesion molecule 2,4q21.21,protein-coding,/
CWITA011373,TCMBANKGE011373,TPH1,MGC119994; TPRH; TRPH,tryptophan hydroxylase 1,11p15.3-p14,protein-coding,
CWITA011374,TCMBANKGE011374,ACAD11,ACAD-11,acyl-CoA dehydrogenase family member 11,3q22.1,protein-coding,/
CWITA011375,TCMBANKGE011375,RPL35,DBA19; L35,ribosomal protein L35,9q33.3,protein-coding,/
CWITA011376,TCMBANKGE011376,STK16,KRCT; MPSK; PKL12; PSK; TSF1; hPSK,serine/threonine kinase 16,2q35,protein-coding,Research target
CWITA011377,TCMBANKGE011377,TRPV5,CAT2; ECAC1; OTRPC3,transient receptor potential cation channel subfamily V member 5,7q34,protein-coding,/
CWITA011378,TCMBANKGE011378,MYH7,CMD1S; CMH1; MPD1; MYHCB; SPMD; SPMM,myosin heavy chain 7,14q11.2,protein-coding,Clinical Trial target
CWITA011379,TCMBANKGE011379,AVPR1A,AVPR1,arginine vasopressin receptor 1A,12q14-q15,protein-coding,
CWITA011380,TCMBANKGE011380,CLEC11A,CLECSF3; LSLCL; P47; SCGF,C-type lectin domain containing 11A,19q13.33,protein-coding,/
CWITA011381,TCMBANKGE011381,PARG,PARG99,poly(ADP-ribose) glycohydrolase,10q11.23,protein-coding,Research target
CWITA011382,TCMBANKGE011382,CDC42EP2,BORG1; CEP2,CDC42 effector protein 2,11q13.1,protein-coding,/
CWITA011383,TCMBANKGE011383,PHIP,BRWD2; CHUJANS; DCAF14; DIDOD; WDR11; ndrp,pleckstrin homology domain interacting protein,6q14.1,protein-coding,/
CWITA011384,TCMBANKGE011384,DNAJB2,CMT2T; DSMA5; HSJ-1; HSJ1; HSPF3,DnaJ heat shock protein family (Hsp40) member B2,2q35,protein-coding,/
CWITA011385,TCMBANKGE011385,APLNR,AGTRL1; APJ; APJR; HG11,apelin receptor,11q12.1,protein-coding,Clinical Trial target
CWITA011386,TCMBANKGE011386,HSD17B8,D6S2245E; FABG; FABGL; H2NKE6; HKE6; KE6; RING2; SDR30C1; dJ1033B10.9,hydroxysteroid (17-beta) dehydrogenase 8,6p21.3,protein-coding,
CWITA011387,TCMBANKGE011387,CYGB,HGB; STAP,cytoglobin,17q25.1,protein-coding,/
CWITA011388,TCMBANKGE011388,FXR2,FMR1L2; FXR2P,FMR1 autosomal homolog 2,17p13.1,protein-coding,/
CWITA011389,TCMBANKGE011389,CFAP251,CaM-IP4; SPGF33; WDR66,cilia and flagella associated protein 251,12q24.31,protein-coding,/
CWITA011390,TCMBANKGE011390,IL17RC,CANDF9; IL17-RL; IL17RL,interleukin 17 receptor C,3p25.3|3p25.3-p24.1,protein-coding,/
CWITA011391,TCMBANKGE011391,STMN4,MGC111012; RB3,stathmin-like 4,8p21.2,protein-coding,
CWITA011392,TCMBANKGE011392,POTEE,A26C1; A26C1A; CT104.2; POTE-2; POTE2; POTE2gamma,POTE ankyrin domain family member E,2q21.1,protein-coding,/
CWITA011393,TCMBANKGE011393,PSME3,HEL-S-283; Ki; PA28-gamma; PA28G; PA28gamma; REG-GAMMA,proteasome activator subunit 3,17q21.31,protein-coding,/
CWITA011394,TCMBANKGE011394,PSMB5,LMPX; MB1; MGC104214; X,"proteasome (prosome, macropain) subunit, beta type, 5",14q11.2,protein-coding,
CWITA011395,TCMBANKGE011395,CLK2,-,CDC like kinase 2,1q22,protein-coding,Patented target
CWITA011396,TCMBANKGE011396,FOXD3,AIS1; Genesis; HFH2; VAMAS2,forkhead box D3,1p31.3,protein-coding,/
CWITA011397,TCMBANKGE011397,KYAT3,CCBL2; KAT3; KATIII,kynurenine aminotransferase 3,1p22.2,protein-coding,/
CWITA011398,TCMBANKGE011398,ATP5PF,ATP5; ATP5A; ATP5J; ATPM; CF6; F6,ATP synthase peripheral stalk subunit F6,21q21.3,protein-coding,/
CWITA011399,TCMBANKGE011399,DTD2,ATD; C14orf126,D-aminoacyl-tRNA deacylase 2,14q12,protein-coding,/
CWITA011400,TCMBANKGE011400,DPM3,CDG1O,"dolichyl-phosphate mannosyltransferase subunit 3, regulatory",1q22,protein-coding,/
CWITA011401,TCMBANKGE011401,S1PR2,AGR16; DFNB68; EDG-5; EDG5; Gpcr13; H218; LPB2; S1P2,sphingosine-1-phosphate receptor 2,19p13.2,protein-coding,Research target
CWITA011402,TCMBANKGE011402,TP53INP1,SIP; TP53DINP1; TP53INP1A; TP53INP1B; Teap; p53DINP1,tumor protein p53 inducible nuclear protein 1,8q22.1,protein-coding,/
CWITA011403,TCMBANKGE011403,LRRIQ3,LRRC44,leucine rich repeats and IQ motif containing 3,1p31.1,protein-coding,/
CWITA011404,TCMBANKGE011404,CHD8,AUTS18; HELSNF1,chromodomain helicase DNA binding protein 8,14q11.2,protein-coding,/
CWITA011405,TCMBANKGE011405,RAB5IF,C20orf24; PNAS-11; RCAF1; RIP5,RAB5 interacting factor,20q11.23,protein-coding,/
CWITA011406,TCMBANKGE011406,OAZ3,AZ3; OAZNt; TISP15,ornithine decarboxylase antizyme 3,1q21.3,protein-coding,
CWITA011407,TCMBANKGE011407,PDGFA,PDGF-A; PDGF1,platelet derived growth factor subunit A,7p22.3,protein-coding,Clinical Trial target
CWITA011408,TCMBANKGE011408,NCF4,MGC3810; NCF; P40PHOX; SH3PXD4,"neutrophil cytosolic factor 4, 40kDa",22q13.1,protein-coding,
CWITA011409,TCMBANKGE011409,KCNK17,K2p17.1; TALK-2; TALK2; TASK-4; TASK4,potassium two pore domain channel subfamily K member 17,6p21.2,protein-coding,/
CWITA011410,TCMBANKGE011410,NRF1,ALPHA-PAL,nuclear respiratory factor 1,7q32.2,protein-coding,/
CWITA011411,TCMBANKGE011411,ZNF280A,3'OY11.1; SUHW1; ZNF280; ZNF636,zinc finger protein 280A,22q11.22,protein-coding,/
CWITA011412,TCMBANKGE011412,LHX5,-,LIM homeobox 5,12q24.13,protein-coding,/
CWITA011413,TCMBANKGE011413,PHF6,BFLS; BORJ; CENP-31,PHD finger protein 6,Xq26.2,protein-coding,/
CWITA011414,TCMBANKGE011414,SLC31A1,COPT1; CTR1; MGC75487; hCTR1,"solute carrier family 31 (copper transporters), member 1",9q31-q32,protein-coding,
CWITA011415,TCMBANKGE011415,ASIC1,ACCN2; ASIC; BNaC2,acid sensing ion channel subunit 1,12q13.12,protein-coding,Successful target
CWITA011416,TCMBANKGE011416,CABLES2,C20orf150; dJ908M14.2; ik3-2,Cdk5 and Abl enzyme substrate 2,20q13.33,protein-coding,/
CWITA011417,TCMBANKGE011417,FGA,Fib2; MGC119422; MGC119423; MGC119425,fibrinogen alpha chain,4q28,protein-coding,
CWITA011418,TCMBANKGE011418,PYCR1,ARCL2B; ARCL3B; P5C; P5CR; PIG45; PP222; PRO3; PYCR,pyrroline-5-carboxylate reductase 1,17q25.3,protein-coding,/
CWITA011419,TCMBANKGE011419,DPF3,BAF45C; CERD4,double PHD fingers 3,14q24.2,protein-coding,/
CWITA011420,TCMBANKGE011420,INPP4B,-,inositol polyphosphate-4-phosphatase type II B,4q31.21,protein-coding,/
CWITA011421,TCMBANKGE011421,RAB38,NY-MEL-1; rrGTPbp,"RAB38, member RAS oncogene family",11q14.2,protein-coding,/
CWITA011422,TCMBANKGE011422,TEF,-,"TEF transcription factor, PAR bZIP family member",22q13.2,protein-coding,/
CWITA011423,TCMBANKGE011423,GPAA1,GAA1; GPIBD15; hGAA1,glycosylphosphatidylinositol anchor attachment 1,8q24.3,protein-coding,/
CWITA011424,TCMBANKGE011424,IFT43,C14orf179; CED3; RP81; SRTD18,intraflagellar transport 43,14q24.3,protein-coding,/
CWITA011425,TCMBANKGE011425,SLC18A1,CGAT; VAT1; VMAT1,solute carrier family 18 member A1,8p21.3,protein-coding,/
CWITA011426,TCMBANKGE011426,GMPS,N,guanine monphosphate synthetase,3q24,protein-coding,
CWITA011427,TCMBANKGE011427,PSMB2,HC7-I,proteasome 20S subunit beta 2,1p34.3,protein-coding,/
CWITA011428,TCMBANKGE011428,GPX5,N,glutathione peroxidase 5 (epididymal androgen-related protein),6p22.1,protein-coding,
CWITA011429,TCMBANKGE011429,PFKP,ATP-PFK; PFK-C; PFK-P; PFKF,"phosphofructokinase, platelet",10p15.2,protein-coding,/
CWITA011430,TCMBANKGE011430,SEC63,DNAJC23; ERdj2; PCLD2; PRO2507; SEC63L,"SEC63 homolog, protein translocation regulator",6q21,protein-coding,/
CWITA011431,TCMBANKGE011431,FAM234B,KIAA1467,family with sequence similarity 234 member B,12p13.1,protein-coding,/
CWITA011432,TCMBANKGE011432,BOLA1,CGI-143,bolA family member 1,1q21.2,protein-coding,/
CWITA011433,TCMBANKGE011433,MED26,CRSP7; CRSP70,mediator complex subunit 26,19p13.11,protein-coding,/
CWITA011434,TCMBANKGE011434,THY1,CD90; CDw90,Thy-1 cell surface antigen,11q23.3,protein-coding,/
CWITA011435,TCMBANKGE011435,PSAT1,EPIP; MGC1460; PSA; PSAT,phosphoserine aminotransferase 1,9q21.2,protein-coding,
CWITA011436,TCMBANKGE011436,FANCM,FAAP250; KIAA1596; POF15; SPGF28,FA complementation group M,14q21.2,protein-coding,/
CWITA011437,TCMBANKGE011437,CA12,CAXII; FLJ20151; HsT18816,carbonic anhydrase XII,15q22,protein-coding,
CWITA011438,TCMBANKGE011438,OTC,OCTD,ornithine carbamoyltransferase,Xp11.4,protein-coding,/
CWITA011439,TCMBANKGE011439,CSNK2B,CK2B; CK2N; CSK2B; Ckb1; Ckb2; G5A; POBINDS,casein kinase 2 beta,6p21.33,protein-coding,/
CWITA011440,TCMBANKGE011440,CAMSAP3,KIAA1543; NEZHA; PPP1R80,calmodulin regulated spectrin associated protein family member 3,19p13.2,protein-coding,/
CWITA011441,TCMBANKGE011441,NAP1L5,DRLM,nucleosome assembly protein 1 like 5,4q22.1|4q21-q22,protein-coding,/
CWITA011442,TCMBANKGE011442,HMGB3,HMG-2a; HMG-4; HMG2A; HMG4,high mobility group box 3,Xq28,protein-coding,/
CWITA011443,TCMBANKGE011443,GTPBP6,PGPL,GTP binding protein 6 (putative),Xp22.33 and Yp11.31,protein-coding,/
CWITA011444,TCMBANKGE011444,TAOK3,DPK; JIK; MAP3K18; hKFC-A,TAO kinase 3,12q24.23,protein-coding,Research target
CWITA011445,TCMBANKGE011445,PAQR8,C6orf33; LMPB1; MPRB,progestin and adipoQ receptor family member 8,6p12.2,protein-coding,/
CWITA011446,TCMBANKGE011446,RNF103,HKF-1; KF-1; KF1; ZFP-103; ZFP103,ring finger protein 103,2p11.2,protein-coding,/
CWITA011447,TCMBANKGE011447,TDRD6,CT41.2; NY-CO-45; SPATA36; TDR2; bA446F17.4,tudor domain containing 6,6p12.3,protein-coding,/
CWITA011448,TCMBANKGE011448,ARHGEF15,ARGEF15; E5; Ephexin5; Vsm-RhoGEF,Rho guanine nucleotide exchange factor 15,17p13.1,protein-coding,/
CWITA011449,TCMBANKGE011449,KLF9,BTEB; BTEB1,Kruppel like factor 9,9q21.12,protein-coding,/
CWITA011450,TCMBANKGE011450,NDC80,HEC; HEC1; HsHec1; KNTC2; TID3; hsNDC80,NDC80 kinetochore complex component,18p11.32,protein-coding,/
CWITA011451,TCMBANKGE011451,PPP2R1A,MGC786; PP2ANAalpha; PP2AAALPHA; PR65A,"protein phosphatase 2, regulatory subunit A, alpha",19q13.41,protein-coding,
CWITA011452,TCMBANKGE011452,ARHGAP45,HA-1; HLA-HA1; HMHA1,Rho GTPase activating protein 45,19p13.3,protein-coding,/
CWITA011453,TCMBANKGE011453,Olfr143,K18; MOR170-6,olfactory receptor 143,9|9 A5.1,protein-coding,/
CWITA011454,TCMBANKGE011454,CLMP,ACAM; ASAM; CSBM; CSBS,CXADR like membrane protein,11q24.1,protein-coding,/
CWITA011455,TCMBANKGE011455,RGL3,-,ral guanine nucleotide dissociation stimulator like 3,19p13.2,protein-coding,/
CWITA011456,TCMBANKGE011456,ARFGEF1,ARFGEP1; BIG1; P200,ADP ribosylation factor guanine nucleotide exchange factor 1,8q13.2,protein-coding,/
CWITA011457,TCMBANKGE011457,KCNJ5,CIR; GIRK4; KATP1; KIR3.4; LQT13,"potassium inwardly-rectifying channel, subfamily J, member 5",11q24,protein-coding,
CWITA011458,TCMBANKGE011458,CLIP2,CLIP; CLIP-115; CYLN2; WBSCR3; WBSCR4; WSCR3; WSCR4,CAP-Gly domain containing linker protein 2,7q11.23,protein-coding,/
CWITA011459,TCMBANKGE011459,GTF2A1L,ALF,general transcription factor IIA subunit 1 like,2p16.3,protein-coding,/
CWITA011460,TCMBANKGE011460,PIGH,GPI-H,phosphatidylinositol glycan anchor biosynthesis class H,14q24.1,protein-coding,/
CWITA011461,TCMBANKGE011461,NADSYN1,VCRL3,NAD synthetase 1,11q13.4,protein-coding,/
CWITA011462,TCMBANKGE011462,ATP1A1,MGC3285; MGC51750,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",1p21,protein-coding,
CWITA011463,TCMBANKGE011463,COLEC11,3MC2; CL-K1-I; CL-K1-II; CL-K1-IIa; CL-K1-IIb; CLK1,collectin subfamily member 11,2p25.3,protein-coding,/
CWITA011464,TCMBANKGE011464,FABP3,FABP11; H-FABP; M-FABP; MDGI; O-FABP,fatty acid binding protein 3,1p35.2,protein-coding,/
CWITA011465,TCMBANKGE011465,HTR3B,5-HT3B,5-hydroxytryptamine receptor 3B,11q23.2,protein-coding,Discontinued target
CWITA011466,TCMBANKGE011466,KLK1,KLKR; Klk6; hK1,kallikrein 1,19q13.3,protein-coding,
CWITA011467,TCMBANKGE011467,OLIG3,Bhlhb7; bHLHe20,oligodendrocyte transcription factor 3,6q23.3,protein-coding,/
CWITA011468,TCMBANKGE011468,DLG4,MRD62; PSD95; SAP-90; SAP90,discs large MAGUK scaffold protein 4,17p13.1,protein-coding,Clinical Trial target
CWITA011469,TCMBANKGE011469,DAPK1,DAPK; ROCO3,death associated protein kinase 1,9q21.33,protein-coding,/
CWITA011470,TCMBANKGE011470,CMTM1,CKLFH; CKLFH1; CKLFSF1,CKLF like MARVEL transmembrane domain containing 1,16q21,protein-coding,/
CWITA011471,TCMBANKGE011471,ZNF77,pT1,zinc finger protein 77,19p13.3,protein-coding,/
CWITA011472,TCMBANKGE011472,PIMREG,CATS; FAM64A; RCS1,PICALM interacting mitotic regulator,17p13.2,protein-coding,/
CWITA011473,TCMBANKGE011473,CCL13,CKb10; MCP-4; NCC-1; NCC1; SCYA13; SCYL1,C-C motif chemokine ligand 13,17q12,protein-coding,/
CWITA011474,TCMBANKGE011474,NUP88,FADS4,nucleoporin 88,17p13.2,protein-coding,/
CWITA011475,TCMBANKGE011475,F7,N,coagulation factor VII (serum prothrombin conversion accelerator),13q34,protein-coding,
CWITA011476,TCMBANKGE011476,SRSF11,NET2; SFRS11; dJ677H15.2; p54,serine and arginine rich splicing factor 11,1p31.1,protein-coding,/
CWITA011477,TCMBANKGE011477,PPM1K,BDP; MSUDMV; PP2Ckappa; PP2Cm; PTMP; UG0882E07,"protein phosphatase, Mg2+/Mn2+ dependent 1K",4q22.1,protein-coding,/
CWITA011478,TCMBANKGE011478,EMC3,POB; TMEM111,ER membrane protein complex subunit 3,3p25.3,protein-coding,/
CWITA011479,TCMBANKGE011479,ZKSCAN2,ZNF694; ZSCAN31; ZSCAN34,zinc finger with KRAB and SCAN domains 2,16p12.1,protein-coding,/
CWITA011480,TCMBANKGE011480,ISCU,2310020H20Rik; HML; ISU2; NIFU; NIFUN; hnifU,iron-sulfur cluster assembly enzyme,12q23.3,protein-coding,/
CWITA011481,TCMBANKGE011481,ZNF576,-,zinc finger protein 576,19q13.31,protein-coding,/
CWITA011482,TCMBANKGE011482,CSNK1G1,CK1gamma1,casein kinase 1 gamma 1,15q22.31,protein-coding,Research target
CWITA011483,TCMBANKGE011483,IMPDH2,IMPD2; IMPDH-II,inosine monophosphate dehydrogenase 2,3p21.31,protein-coding,Successful target
CWITA011484,TCMBANKGE011484,ASGR1,ASGPR; ASGPR1; CLEC4H1; HL-1,asialoglycoprotein receptor 1,17p13.1,protein-coding,Clinical Trial target
CWITA011485,TCMBANKGE011485,KCNJ4,HIR; HIRK2; HRK1; IRK-3; IRK3; Kir2.3,potassium inwardly rectifying channel subfamily J member 4,22q13.1,protein-coding,Research target
CWITA011486,TCMBANKGE011486,LRTM2,-,leucine rich repeats and transmembrane domains 2,12p13.33,protein-coding,/
CWITA011487,TCMBANKGE011487,SLC6A16,NT5; NTT5,solute carrier family 6 member 16,19q13.33,protein-coding,/
CWITA011488,TCMBANKGE011488,SIPA1L1,E6TP1; SPAR1,signal induced proliferation associated 1 like 1,14q24.2,protein-coding,/
CWITA011489,TCMBANKGE011489,TP53,FLJ92943; LFS1; P53; TRP53,tumor protein p53,17p13.1,protein-coding,
CWITA011490,TCMBANKGE011490,RNF215,-,ring finger protein 215,22q12.2,protein-coding,/
CWITA011491,TCMBANKGE011491,GSTA5,-,glutathione S-transferase alpha 5,6p12.2,protein-coding,/
CWITA011492,TCMBANKGE011492,ANXA6,ANX6; CBP68; CPB-II; p68; p70,annexin A6,5q33.1,protein-coding,/
CWITA011493,TCMBANKGE011493,HDHD5,CECR5,haloacid dehalogenase like hydrolase domain containing 5,22q11.1,protein-coding,/
CWITA011494,TCMBANKGE011494,CBLN4,CBLNL1,cerebellin 4 precursor,20q13.2,protein-coding,/
CWITA011495,TCMBANKGE011495,NUDT5,YSA1; YSA1H; YSAH1; hNUDT5,nudix hydrolase 5,10p14,protein-coding,/
CWITA011496,TCMBANKGE011496,PSMA6,IOTA; MGC22756; MGC2333; MGC23846; PROS27; p27K,"proteasome (prosome, macropain) subunit, alpha type, 6",14q13,protein-coding,
CWITA011497,TCMBANKGE011497,SOX5,L-SOX5; L-SOX5B; L-SOX5F; LAMSHF,SRY-box transcription factor 5,12p12.1,protein-coding,Research target
CWITA011498,TCMBANKGE011498,GBGT1,A3GALNT; FS; UNQ2513,"globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)",9q34.2,protein-coding,/
CWITA011499,TCMBANKGE011499,RPL6,L6; SHUJUN-2; TAXREB107; TXREB1,ribosomal protein L6,12q24.13,protein-coding,/
CWITA011500,TCMBANKGE011500,TNFAIP8,GG2-1; MDC-3.13; NDED; SCC-S2; SCCS2,TNF alpha induced protein 8,5q23.1,protein-coding,/
CWITA011501,TCMBANKGE011501,DUSP11,PIR1,dual specificity phosphatase 11,2p13.1,protein-coding,/
CWITA011502,TCMBANKGE011502,KAT7,HBO1; HBOA; MYST2; ZC2HC7,lysine acetyltransferase 7,17q21.33,protein-coding,/
CWITA011503,TCMBANKGE011503,PARD6B,PAR6B,par-6 family cell polarity regulator beta,20q13.13,protein-coding,/
CWITA011504,TCMBANKGE011504,SMG1,61E3.4; ATX; LIP,SMG1 nonsense mediated mRNA decay associated PI3K related kinase,16p12.3,protein-coding,/
CWITA011505,TCMBANKGE011505,TAC4,EK; HK-1; HK1; PPT-C,tachykinin precursor 4,17q21.33,protein-coding,/
CWITA011506,TCMBANKGE011506,GRK6,GPRK6,G protein-coupled receptor kinase 6,5q35.3,protein-coding,/
CWITA011507,TCMBANKGE011507,CLEC19A,-,C-type lectin domain containing 19A,16p12.3,protein-coding,/
CWITA011508,TCMBANKGE011508,PDCD11,ALG-4; ALG4; NFBP; RRP5,programmed cell death 11,10q24.33,protein-coding,/
CWITA011509,TCMBANKGE011509,GNG5,-,G protein subunit gamma 5,1p22.3,protein-coding,/
CWITA011510,TCMBANKGE011510,CRAT,CAT1,carnitine O-acetyltransferase,9q34.1,protein-coding,
CWITA011511,TCMBANKGE011511,PKN3,UTDP4-1,protein kinase N3,9q34.11,protein-coding,Clinical Trial target
CWITA011512,TCMBANKGE011512,KCNQ2,BFNC; BFNS1; EBN; EBN1; EIEE7; ENB1; HNSPC; KCNA11; KV7.2; KVEBN1,"potassium voltage-gated channel, KQT-like subfamily, member 2",20q13.3,protein-coding,
CWITA011513,TCMBANKGE011513,PALM,PALM1,paralemmin,19p13.3,protein-coding,/
CWITA011514,TCMBANKGE011514,OTC,MGC129967; MGC129968; MGC138856; OCTD,ornithine carbamoyltransferase,Xp21.1,protein-coding,
CWITA011515,TCMBANKGE011515,FSTL5,-,follistatin like 5,4q32.2,protein-coding,/
CWITA011516,TCMBANKGE011516,SLC30A6,MST103; MSTP103; ZNT6,solute carrier family 30 member 6,2p22.3,protein-coding,/
CWITA011517,TCMBANKGE011517,H2AC20,H2A; H2A-GL101; H2A/q; H2AFQ; HIST2H2AC,H2A clustered histone 20,1q21.2,protein-coding,/
CWITA011518,TCMBANKGE011518,TLE4,BCE-1; BCE1; E(spI); E(spl); ESG; ESG4; GRG4; Grg-4,"TLE family member 4, transcriptional corepressor",9q21.31,protein-coding,/
CWITA011519,TCMBANKGE011519,CYP2B7P,CYP2B; CYP2B7; CYP2B7P1,"cytochrome P450 family 2 subfamily B member 7, pseudogene",19q13.2,pseudo,/
CWITA011520,TCMBANKGE011520,RORA,DKFZp686M2414; MGC119326; MGC119329; NR1F1; ROR1; ROR2; ROR3; RZRNALPHA; RZRA,RAR-related orphan receptor A,15q22.2,protein-coding,
CWITA011521,TCMBANKGE011521,CLEC7A,BGR; CANDF4; CD369; CLECSF12; DECTIN1; SCARE2,C-type lectin domain containing 7A,12p13.2,protein-coding,/
CWITA011522,TCMBANKGE011522,PDZD2,AIPC; PAPIN; PDZK3; PIN1,PDZ domain containing 2,5p13.3,protein-coding,/
CWITA011523,TCMBANKGE011523,HPRT1,HGPRT; HPRT,hypoxanthine phosphoribosyltransferase 1,Xq26.2-q26.3,protein-coding,/
CWITA011524,TCMBANKGE011524,UGT1A8,UDPGT; UDPGT_1N8; UGTN1H; UGT1N08; UGT1.8; UGT1A8S; UGT1H,"UDP glucuronosyltransferase 1 family, polypeptide A8",2q37,protein-coding,
CWITA011525,TCMBANKGE011525,KIF9,-,kinesin family member 9,3p21.31,protein-coding,/
CWITA011526,TCMBANKGE011526,MYL12A,HEL-S-24; MLC-2B; MLCB; MRCL3; MRLC3; MYL2B,myosin light chain 12A,18p11.31,protein-coding,/
CWITA011527,TCMBANKGE011527,SLC35G2,TMEM22,solute carrier family 35 member G2,3q22.3,protein-coding,/
CWITA011528,TCMBANKGE011528,BBX,ARTC1; HBP2; HSPC339; MDS001,BBX high mobility group box domain containing,3q13.12,protein-coding,/
CWITA011529,TCMBANKGE011529,PSMB5,LMPX; MB1; X,proteasome 20S subunit beta 5,14q11.2,protein-coding,Patented target
CWITA011530,TCMBANKGE011530,RAPSN,CMS11; CMS4C; FADS; FADS2; RAPSYN; RNF205,receptor associated protein of the synapse,11p11.2,protein-coding,/
CWITA011531,TCMBANKGE011531,ABR,MDB,ABR activator of RhoGEF and GTPase,17p13.3,protein-coding,/
CWITA011532,TCMBANKGE011532,NCAN,CSPG3,neurocan,19p13.11,protein-coding,/
CWITA011533,TCMBANKGE011533,H3C1,H3/A; H3C10; H3C11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FA; HIST1H3A,H3 clustered histone 1,6p22.2,protein-coding,/
CWITA011534,TCMBANKGE011534,DUPD1,DUSP27; FMDSP,dual specificity phosphatase and pro isomerase domain containing 1,10q22.2,protein-coding,/
CWITA011535,TCMBANKGE011535,CAMKK1,CAMKKA,calcium/calmodulin dependent protein kinase kinase 1,17p13.2,protein-coding,Research target
CWITA011536,TCMBANKGE011536,NINJ1,NIN1; NINJURIN,ninjurin 1,9q22.31,protein-coding,/
CWITA011537,TCMBANKGE011537,PTGIR,IP; MGC102830; PRIPR,prostaglandin I2 (prostacyclin) receptor (IP),19q13.3,protein-coding,
CWITA011538,TCMBANKGE011538,ABCA9,EST640918,ATP binding cassette subfamily A member 9,17q24.2,protein-coding,/
CWITA011539,TCMBANKGE011539,TEX19,-,testis expressed 19,17q25.3,protein-coding,/
CWITA011540,TCMBANKGE011540,MIXL1,MILD1; MIX; MIXL,Mix paired-like homeobox,1q42.12,protein-coding,/
CWITA011541,TCMBANKGE011541,SSBP1,Mt-SSB; SOSS-B1; SSBP; mtSSB,single stranded DNA binding protein 1,7q34,protein-coding,/
CWITA011542,TCMBANKGE011542,MBOAT7,BB1; LENG4; LPIAT; LPLAT; LRC4; MBOA7; MRT57; OACT7; hMBOA-7,membrane bound O-acyltransferase domain containing 7,19q13.42,protein-coding,/
CWITA011543,TCMBANKGE011543,HMGCS1,HMGCS,3-hydroxy-3-methylglutaryl-CoA synthase 1,5p12,protein-coding,Research target
CWITA011544,TCMBANKGE011544,IGHG1,-,immunoglobulin heavy constant gamma 1 (G1m marker),14q32.33,other,/
CWITA011545,TCMBANKGE011545,Ndufc2,1810004I06Rik; 2010300P09Rik; G1; R75094,NADH:ubiquinone oxidoreductase subunit C2,7|7 E1,protein-coding,/
CWITA011546,TCMBANKGE011546,CKAP2,LB1; TMAP; se20-10,cytoskeleton associated protein 2,13q14.3,protein-coding,/
CWITA011547,TCMBANKGE011547,APOC3,APOCIII,apolipoprotein C3,11q23.3,protein-coding,Clinical Trial target
CWITA011548,TCMBANKGE011548,ZNF414,ZFP414,zinc finger protein 414,19p13.2,protein-coding,/
CWITA011549,TCMBANKGE011549,PTPN20,CT126; PTPN20A; PTPN20B; bA142I17.1; bA42B19.1,protein tyrosine phosphatase non-receptor type 20,10q11.22,protein-coding,/
CWITA011550,TCMBANKGE011550,PRKAR1A,CAR; CNC; CNC1; DKFZp779L0468; MGC17251; PKR1; PPNAD1; PRKAR1; TSE1,"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)",17q23-q24,protein-coding,
CWITA011551,TCMBANKGE011551,GPR39,-,G protein-coupled receptor 39,2q21.2,protein-coding,Research target
CWITA011552,TCMBANKGE011552,PSAP,FLJ00245; GLBA; MGC110993; SAP1,prosaposin,10q21-q22,protein-coding,
CWITA011553,TCMBANKGE011553,ATXN7L1,ATXN7L4,ataxin 7 like 1,7q22.3,protein-coding,/
CWITA011554,TCMBANKGE011554,ASB9,-,ankyrin repeat and SOCS box containing 9,Xp22.2,protein-coding,/
CWITA011555,TCMBANKGE011555,TAF12,TAF2J; TAFII20,TATA-box binding protein associated factor 12,1p35.3,protein-coding,/
CWITA011556,TCMBANKGE011556,DBI,ACBD1; ACBP; CCKNRP; EP; MGC70414,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",2q12-q21,protein-coding,
CWITA011557,TCMBANKGE011557,ATP5A1,ATP5A; ATP5AL2; ATPM; MOM2; OMR; ORM; hATP1,"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle",18q21,protein-coding,
CWITA011558,TCMBANKGE011558,FAM174A,HGS_RE408; NS5ATP6; TMEM157; UNQ1912,family with sequence similarity 174 member A,5q21.1,protein-coding,/
CWITA011559,TCMBANKGE011559,CPD,GP180,carboxypeptidase D,17q11.2,protein-coding,/
CWITA011560,TCMBANKGE011560,FDX2,FDX1L; MEOAL,ferredoxin 2,19p13.2,protein-coding,/
CWITA011561,TCMBANKGE011561,MOCS3,UBA4,molybdenum cofactor synthesis 3,20q13.13,protein-coding,/
CWITA011562,TCMBANKGE011562,GLS2,GA; GLS; LGA; hLGA,glutaminase 2,12q13.3,protein-coding,/
CWITA011563,TCMBANKGE011563,NOVA1,Nova-1,NOVA alternative splicing regulator 1,14q12,protein-coding,/
CWITA011564,TCMBANKGE011564,SKIDA1,C10orf140; DLN-1,SKI/DACH domain containing 1,10p12.31,protein-coding,/
CWITA011565,TCMBANKGE011565,PPP1R21,CCDC128; KLRAQ1,protein phosphatase 1 regulatory subunit 21,2p16.3,protein-coding,/
CWITA011566,TCMBANKGE011566,COCH,COCH-5B2; COCH5B2; DFNA9; DFNB110,cochlin,14q12,protein-coding,/
CWITA011567,TCMBANKGE011567,RFPL4A,RFPL4; RNF210,ret finger protein like 4A,19q13.42,protein-coding,/
CWITA011568,TCMBANKGE011568,SLC17A4,KAIA2138,solute carrier family 17 member 4,6p22.2,protein-coding,/
CWITA011569,TCMBANKGE011569,HTR3B,5N/AHT3B,5-Hydroxytryptamine_Receptor_3B,11q23.2,protein-coding,
CWITA011570,TCMBANKGE011570,ITGAL,CD11A; LFAN1; LFA1A,"integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",16p11.2,protein-coding,
CWITA011571,TCMBANKGE011571,Pvcan3,-,protection against vaginal candidiasis 3,18 18.17 cM,unknown,/
CWITA011572,TCMBANKGE011572,MBLAC2,-,metallo-beta-lactamase domain containing 2,5q14.3,protein-coding,/
CWITA011573,TCMBANKGE011573,TTC7B,TTC7L1; c14_5685,tetratricopeptide repeat domain 7B,14q32.11,protein-coding,/
CWITA011574,TCMBANKGE011574,GALK2,GK2,galactokinase 2,15q21.1-q21.2,protein-coding,/
CWITA011575,TCMBANKGE011575,ZBTB21,ZNF295,zinc finger and BTB domain containing 21,21q22.3,protein-coding,/
CWITA011576,TCMBANKGE011576,NINJ2,-,ninjurin 2,12p13.33,protein-coding,/
CWITA011577,TCMBANKGE011577,NFXL1,CDZFP; HOZFP; OZFP; URCC5,"nuclear transcription factor, X-box binding like 1",4p12,protein-coding,/
CWITA011578,TCMBANKGE011578,NCAPG,CAPG; CHCG; NY-MEL-3; YCG1,non-SMC condensin I complex subunit G,4p15.31,protein-coding,/
CWITA011579,TCMBANKGE011579,LRP2,DBS; GP330,low density lipoprotein receptor-related protein 2,2q24-q31,protein-coding,
CWITA011580,TCMBANKGE011580,SPATA18,Mieap; SPETEX1,spermatogenesis associated 18,4q12,protein-coding,/
CWITA011581,TCMBANKGE011581,DNAH5,CILD3; DNAHC5; HL1; KTGNR; PCD,dynein axonemal heavy chain 5,5p15.2,protein-coding,/
CWITA011582,TCMBANKGE011582,PSMA1,HC2; HEL-S-275; NU; PROS30,proteasome 20S subunit alpha 1,11p15.2,protein-coding,/
CWITA011583,TCMBANKGE011583,OLFML3,HNOEL-iso; OLF44,olfactomedin like 3,1p13.2,protein-coding,/
CWITA011584,TCMBANKGE011584,OGDH,AKGDH; E1k; OGDC,oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),7p14-p13,protein-coding,
CWITA011585,TCMBANKGE011585,CNGA4,CNCA2; CNG-4; CNG4; CNG5; CNGB2; OCNC2; OCNCBETA; OCNCb,cyclic nucleotide gated channel subunit alpha 4,11p15.4,protein-coding,/
CWITA011586,TCMBANKGE011586,NME4,NDPK-D; NM23H4; nm23-H4,NME/NM23 nucleoside diphosphate kinase 4,16p13.3,protein-coding,/
CWITA011587,TCMBANKGE011587,HPF1,C4orf27,histone PARylation factor 1,4q33,protein-coding,/
CWITA011588,TCMBANKGE011588,HNF4A,FRTS4; HNF4; HNF4a7; HNF4a8; HNF4a9; HNF4alpha; MODY; MODY1; NR2A1; NR2A21; TCF; TCF14,hepatocyte nuclear factor 4 alpha,20q13.12,protein-coding,Research target
CWITA011589,TCMBANKGE011589,Ywhaq-ps3,Gm11226,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta, pseudogene 3",4 C2|4 35.92 cM,pseudo,/
CWITA011590,TCMBANKGE011590,GLIPR1,CRISP7; GLIPR; RTVP1,GLI pathogenesis related 1,12q21.2,protein-coding,Clinical Trial target
CWITA011591,TCMBANKGE011591,APCDD1,B7323; DRAPC1; FP7019; HHS; HTS; HYPT1,APC down-regulated 1,18p11.22,protein-coding,/
CWITA011592,TCMBANKGE011592,NUTF2,NTF-2; NTF2; PP15,nuclear transport factor 2,16q22.1,protein-coding,/
CWITA011593,TCMBANKGE011593,TDGF1,CR; CR-1; CRGF; CRIPTO,teratocarcinoma-derived growth factor 1,3p21.31,protein-coding,Clinical Trial target
CWITA011594,TCMBANKGE011594,COIL,CLN80; p80-coilin,coilin,17q22,protein-coding,/
CWITA011595,TCMBANKGE011595,SRA1,SRA; SRAP; STRAA1; pp7684,steroid receptor RNA activator 1,5q31.3,protein-coding,/
CWITA011596,TCMBANKGE011596,RBP5,CRBPNIII; CRBP3; CRBPIII,"retinol binding protein 5, cellular",12p13.31,protein-coding,
CWITA011597,TCMBANKGE011597,KLF16,BTEB4; DRRF; NSLP2,Kruppel like factor 16,19p13.3,protein-coding,/
CWITA011598,TCMBANKGE011598,CS,N,citrate synthase,12q13.2,protein-coding,
CWITA011599,TCMBANKGE011599,OR5H6,OR3-11,olfactory receptor family 5 subfamily H member 6,3q11.2,protein-coding,/
CWITA011600,TCMBANKGE011600,GCKR,FGQTL5; GKRP,glucokinase regulator,2p23.3,protein-coding,/
CWITA011601,TCMBANKGE011601,PLA1A,PS-PLA1; PSPLA1,phospholipase A1 member A,3q13.33,protein-coding,/
CWITA011602,TCMBANKGE011602,DENND1B,C1ORF18; C1orf218; FAM31B,DENN domain containing 1B,1q31.3,protein-coding,/
CWITA011603,TCMBANKGE011603,CARS2,DKFZp667A2315; DKFZp686G08243; FLJ12118; FLJ42514,"cysteinyl-tRNA synthetase 2, mitochondrial (putative)",13q34,protein-coding,
CWITA011604,TCMBANKGE011604,PDE4C,DPDE1; PDE21,phosphodiesterase 4C,19p13.11,protein-coding,Research target
CWITA011605,TCMBANKGE011605,KRT34,HA4; Ha-4; KRTHA4; hHa4,keratin 34,17q21.2,protein-coding,/
CWITA011606,TCMBANKGE011606,AQP7,AQP7L; AQPap; GLYCQTL,aquaporin 7,9p13.3,protein-coding,Research target
CWITA011607,TCMBANKGE011607,LARP6,ACHN,"La ribonucleoprotein 6, translational regulator",15q23,protein-coding,/
CWITA011608,TCMBANKGE011608,STAB1,CLEVER-1; FEEL-1; FELE-1; FEX1; SCARH2; STAB-1,stabilin 1,3p21.1,protein-coding,Research target
CWITA011609,TCMBANKGE011609,HABP4,IHABP-4; IHABP4; Ki-1/57; SERBP1L,hyaluronan binding protein 4,9q22.32,protein-coding,/
CWITA011610,TCMBANKGE011610,PYM1,PYM; WIBG,"PYM homolog 1, exon junction complex associated factor",12q13.2,protein-coding,/
CWITA011611,TCMBANKGE011611,STAR,STARD1,steroidogenic acute regulatory protein,8p11.23,protein-coding,Research target
CWITA011612,TCMBANKGE011612,RFPL1,RNF78,ret finger protein like 1,22q12.2,protein-coding,/
CWITA011613,TCMBANKGE011613,CA2,CANII; CAII; Car2,carbonic anhydrase II,8q22,protein-coding,
CWITA011614,TCMBANKGE011614,IDI2,IPPI2,isopentenyl-diphosphate delta isomerase 2,10p15.3,protein-coding,/
CWITA011615,TCMBANKGE011615,NAT2,AAC2; NAT-2; PNAT,N-acetyltransferase 2,8p22,protein-coding,/
CWITA011616,TCMBANKGE011616,ZSCAN18,ZNF447,zinc finger and SCAN domain containing 18,19q13.43,protein-coding,/
CWITA011617,TCMBANKGE011617,IK,CSA2; RED; RER,IK cytokine,5q31.3,protein-coding,/
CWITA011618,TCMBANKGE011618,EIF3L,EIF3EIP; EIF3S11; EIF3S6IP; HSPC021; HSPC025; MSTP005,eukaryotic translation initiation factor 3 subunit L,22q13.1,protein-coding,/
CWITA011619,TCMBANKGE011619,RTN1,NSP,reticulon 1,14q23.1,protein-coding,/
CWITA011620,TCMBANKGE011620,EXOC3L4,C14orf73,exocyst complex component 3 like 4,14q32.32,protein-coding,/
CWITA011621,TCMBANKGE011621,APOA5,APOAV; RAP3,apolipoprotein A5,11q23.3,protein-coding,/
CWITA011622,TCMBANKGE011622,GABRG2,CAE2; ECA2; GEFSP3,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",5q34,protein-coding,
CWITA011623,TCMBANKGE011623,WNT3,INT4; TETAMS,Wnt family member 3,17q21.31-q21.32,protein-coding,/
CWITA011624,TCMBANKGE011624,TMEM200A,KIAA1913; TTMA; TTMC,transmembrane protein 200A,6q23.1,protein-coding,/
CWITA011625,TCMBANKGE011625,ADGB,C6orf103; CAPN16,androglobin,6q24.3,protein-coding,/
CWITA011626,TCMBANKGE011626,TPPP2,C14orf8; CT152; P18; p25beta,tubulin polymerization promoting protein family member 2,14q11.2,protein-coding,/
CWITA011627,TCMBANKGE011627,COL4A2,BSVD2; ICH; POREN2,collagen type IV alpha 2 chain,13q34,protein-coding,/
CWITA011628,TCMBANKGE011628,TRABD2A,C2orf89; TIKI1,TraB domain containing 2A,2p11.2,protein-coding,/
CWITA011629,TCMBANKGE011629,PHOSPHO1,N,"phosphatase, orphan 1",17q21.32,protein-coding,
CWITA011630,TCMBANKGE011630,FAXDC2,C5orf4,fatty acid hydroxylase domain containing 2,5q33.2,protein-coding,/
CWITA011631,TCMBANKGE011631,ZNF543,-,zinc finger protein 543,19q13.43,protein-coding,/
CWITA011632,TCMBANKGE011632,PTGIS,CYP8; CYP8A1; MGC126858; MGC126860; PGIS; PTGI,prostaglandin I2 (prostacyclin) synthase,20q13.13,protein-coding,
CWITA011633,TCMBANKGE011633,MRPL34,L34mt,mitochondrial ribosomal protein L34,19p13.11,protein-coding,/
CWITA011634,TCMBANKGE011634,CDH3,CDHP; HJMD; PCAD,cadherin 3,16q22.1,protein-coding,Clinical Trial target
CWITA011635,TCMBANKGE011635,TMEM59L,BSMAP; C19orf4,transmembrane protein 59 like,19p13.11,protein-coding,/
CWITA011636,TCMBANKGE011636,HTR6,5NHT6; 5NHT6R,5-hydroxytryptamine (serotonin) receptor 6,1p36-p35,protein-coding,
CWITA011637,TCMBANKGE011637,ZNF223,-,zinc finger protein 223,19q13.31,protein-coding,/
CWITA011638,TCMBANKGE011638,TAS2R42,T2R24; T2R42; T2R55; TAS2R55,taste 2 receptor member 42,12p13.2,protein-coding,/
CWITA011639,TCMBANKGE011639,SLC35G3,AMAC1; TMEM21A,solute carrier family 35 member G3,17q12,protein-coding,/
CWITA011640,TCMBANKGE011640,SGCG,35DAG; A4; DAGA4; DMDA; DMDA1; LGMD2C; LGMDR5; MAM; SCARMD2; SCG3; gamma-SG,sarcoglycan gamma,13q12.12,protein-coding,Research target
CWITA011641,TCMBANKGE011641,C9orf40,-,chromosome 9 open reading frame 40,9q21.13,protein-coding,/
CWITA011642,TCMBANKGE011642,ALDH18A1,GSAS; MGC117316; P5CS; PYCS,"aldehyde dehydrogenase 18 family, member A1",10q24.3,protein-coding,
CWITA011643,TCMBANKGE011643,SMAP2,SMAP1L,small ArfGAP2,1p34.2,protein-coding,/
CWITA011644,TCMBANKGE011644,NIM1K,NIM1,NIM1 serine/threonine protein kinase,5p12,protein-coding,/
CWITA011645,TCMBANKGE011645,HBM,HBAP2; HBK,hemoglobin subunit mu,16p13.3,protein-coding,/
CWITA011646,TCMBANKGE011646,TCIM,C8orf4; TC-1; TC1,transcriptional and immune response regulator,8p11.21,protein-coding,/
CWITA011647,TCMBANKGE011647,GPRC5B,RAIG-2; RAIG2,G protein-coupled receptor class C group 5 member B,16p12.3,protein-coding,/
CWITA011648,TCMBANKGE011648,PLA2G12B,FKSG71; GXIIB; GXIIIsPLA2; PLA2G13; sPLA2-GXIIB,phospholipase A2 group XIIB,10q22.1,protein-coding,/
CWITA011649,TCMBANKGE011649,SYT4,HsT1192,synaptotagmin 4,18q12.3,protein-coding,/
CWITA011650,TCMBANKGE011650,SCUBE2,CEGB1; CEGF1; CEGP1; scube/You,"signal peptide, CUB domain and EGF like domain containing 2",11p15.4,protein-coding,Research target
CWITA011651,TCMBANKGE011651,ZNF195,HRF1; ZNFP104,zinc finger protein 195,11p15.4,protein-coding,/
CWITA011652,TCMBANKGE011652,ZNF395,HDBP-2; HDBP2; HDRF-2; PBF; PRF-1; PRF1; Si-1-8-14,zinc finger protein 395,8p21.1,protein-coding,/
CWITA011653,TCMBANKGE011653,CCBL1,FLJ95217; GTK; KAT1; KATI; MGC29624,"cysteine conjugate-beta lyase, cytoplasmic",9q34.11,protein-coding,
CWITA011654,TCMBANKGE011654,NPS,-,neuropeptide S,10q26.2,protein-coding,/
CWITA011655,TCMBANKGE011655,TNFRSF14,ATAR; CD270; HVEA; HVEM; LIGHTR; TR2,TNF receptor superfamily member 14,1p36.32,protein-coding,Research target
CWITA011656,TCMBANKGE011656,NEIL3,FGP2; FPG2; NEI3; ZGRF3; hFPG2; hNEI3,nei like DNA glycosylase 3,4q34.3,protein-coding,/
CWITA011657,TCMBANKGE011657,PES1,NOP7; PES,pescadillo ribosomal biogenesis factor 1,22q12.2,protein-coding,/
CWITA011658,TCMBANKGE011658,PODN,PCAN; SLRR5A,podocan,1p32.3,protein-coding,/
CWITA011659,TCMBANKGE011659,NTNG2,LHLL9381; Lmnt2; NEDBASH; NTNG1; bA479K20.1,netrin G2,9q34.13,protein-coding,/
CWITA011660,TCMBANKGE011660,ZNF785,ZNF688,zinc finger protein 785,16p11.2,protein-coding,/
CWITA011661,TCMBANKGE011661,TOB1,APRO5; APRO6; PIG49; TOB; TROB; TROB1,"transducer of ERBB2, 1",17q21.33,protein-coding,/
CWITA011662,TCMBANKGE011662,COG7,CDG2E,component of oligomeric golgi complex 7,16p12.2,protein-coding,/
CWITA011663,TCMBANKGE011663,CHRFAM7A,CHRNA7; CHRNA7NDR1; DN10; MGC120482; MGC120483,"CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion",15q13.1,protein-coding,
CWITA011664,TCMBANKGE011664,UBE2U,-,ubiquitin conjugating enzyme E2 U,1p31.3,protein-coding,/
CWITA011665,TCMBANKGE011665,PHLDA3,TIH1,pleckstrin homology like domain family A member 3,1q32.1,protein-coding,/
CWITA011666,TCMBANKGE011666,GPD2,GDH2; GPDM; mGPDH,glycerol-3-phosphate dehydrogenase 2,2q24.1,protein-coding,/
CWITA011667,TCMBANKGE011667,ACOX1,ACOX; MGC1198; PALMCOX; SCOX,"acyl-CoA oxidase 1, palmitoyl",17q24-q25|17q25.1,protein-coding,
CWITA011668,TCMBANKGE011668,RAP1A,C21KG; G-22K; KREV-1; KREV1; RAP1; SMGP21,"RAP1A, member of RAS oncogene family",1p13.2,protein-coding,/
CWITA011669,TCMBANKGE011669,L2HGDH,C14orf160; L2HGA,L-2-hydroxyglutarate dehydrogenase,14q21.3,protein-coding,/
CWITA011670,TCMBANKGE011670,ATP2C1,ATP2C1A; BCPM; HHD; PMR1; SPCA1; hSPCA1,ATPase secretory pathway Ca2+ transporting 1,3q22.1,protein-coding,/
CWITA011671,TCMBANKGE011671,FABP12,-,fatty acid binding protein 12,8q21.13,protein-coding,/
CWITA011672,TCMBANKGE011672,CPAMD8,ASGD8; K-CAP; VIP,C3 and PZP like alpha-2-macroglobulin domain containing 8,19p13.11,protein-coding,/
CWITA011673,TCMBANKGE011673,PSMB10,LMP10; MECL1; beta2i,proteasome 20S subunit beta 10,16q22.1,protein-coding,Patented target
CWITA011674,TCMBANKGE011674,ERRFI1,GENE-33; MIG-6; MIG6; RALT,ERBB receptor feedback inhibitor 1,1p36.23,protein-coding,/
CWITA011675,TCMBANKGE011675,CRBN,DKFZp781K0715; MGC27358; MRT2A,cereblon,3p26.2,protein-coding,
CWITA011676,TCMBANKGE011676,NDUFA1,CINMWFE; MWFE; ZNF183,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa",Xq24,protein-coding,
CWITA011677,TCMBANKGE011677,WDR5,BIG-3; CFAP89; SWD3,WD repeat domain 5,9q34.2,protein-coding,Research target
CWITA011678,TCMBANKGE011678,ZFP1,ZNF475,ZFP1 zinc finger protein,16q23.1,protein-coding,/
CWITA011679,TCMBANKGE011679,TSR2,DBA14; DT1P1A10; WGG1,TSR2 ribosome maturation factor,Xp11.22,protein-coding,/
CWITA011680,TCMBANKGE011680,RELT,AI3C; TNFRSF19L; TRLT,RELT TNF receptor,11q13.4,protein-coding,/
CWITA011681,TCMBANKGE011681,CXCL16,CXCLG16; SR-PSOX; SRPSOX,C-X-C motif chemokine ligand 16,17p13.2,protein-coding,/
CWITA011682,TCMBANKGE011682,HSD17B1,17-beta-HSD; 20-alpha-HSD; E2DH; EDH17B2; EDHB17; HSD17; SDR28C1,hydroxysteroid 17-beta dehydrogenase 1,17q21.2,protein-coding,Clinical Trial target
CWITA011683,TCMBANKGE011683,ARHGEF12,LARG; PRO2792,Rho guanine nucleotide exchange factor 12,11q23.3,protein-coding,/
CWITA011684,TCMBANKGE011684,TAS1R3,T1R3,taste 1 receptor member 3,1p36.33,protein-coding,/
CWITA011685,TCMBANKGE011685,ZNF705G,-,zinc finger protein 705G,8p23.1,protein-coding,/
CWITA011686,TCMBANKGE011686,TUT7,PAPD6; TENT3B; ZCCHC6,terminal uridylyl transferase 7,9q21.33,protein-coding,/
CWITA011687,TCMBANKGE011687,S100A2,CAN19; MGC111539; S100L,S100 calcium binding protein A2,1q21,protein-coding,
CWITA011688,TCMBANKGE011688,S100A10,42C; ANX2L; ANX2LG; CAL1L; CLP11; Ca[1]; GP11; P11; p10,S100 calcium binding protein A10,1q21.3,protein-coding,/
CWITA011689,TCMBANKGE011689,EPN1,N,epsin 1,19q13.42,protein-coding,
CWITA011690,TCMBANKGE011690,CDC42EP4,BORG4; CEP4; KAIA1777,CDC42 effector protein 4,17q25.1,protein-coding,/
CWITA011691,TCMBANKGE011691,THOC5,C22orf19; Fmip; PK1.3; fSAP79,THO complex 5,22q12.2,protein-coding,/
CWITA011692,TCMBANKGE011692,MRPS11,HCC-2; MRP-S11; S11mt,mitochondrial ribosomal protein S11,15q25.3,protein-coding,/
CWITA011693,TCMBANKGE011693,ACAN,AGC1; AGCAN; CSPG1; CSPGCP; MSK16; SEDK,aggrecan,15q26.1,protein-coding,
CWITA011694,TCMBANKGE011694,DLX2,TES-1; TES1,distal-less homeobox 2,2q31.1,protein-coding,/
CWITA011695,TCMBANKGE011695,PCYT1A,CCTA; CT; CTA; CTPCT; PCYT1; SMDCRD,"phosphate cytidylyltransferase 1, choline, alpha",3q29,protein-coding,/
CWITA011696,TCMBANKGE011696,TRPM8,LTRPC6; MGC2849; TRPP8,"transient receptor potential cation channel, subfamily M, member 8",2q37.1,protein-coding,
CWITA011697,TCMBANKGE011697,ABCA2,ABC2; IDPOGSA,ATP binding cassette subfamily A member 2,9q34.3,protein-coding,/
CWITA011698,TCMBANKGE011698,ITGA5,CD49e; FNRA; VLA-5; VLA5A,integrin subunit alpha 5,12q13.13,protein-coding,Clinical Trial target
CWITA011699,TCMBANKGE011699,UGT1A5,UDPGT; UDPGT 1-5; UGT1E,UDP glucuronosyltransferase family 1 member A5,2q37.1,protein-coding,/
CWITA011700,TCMBANKGE011700,GPR142,GPRg1b; PGR2,G protein-coupled receptor 142,17q25.1,protein-coding,/
CWITA011701,TCMBANKGE011701,KIF23,CHO1; KNSL5; MKLP-1; MKLP1,kinesin family member 23,15q23,protein-coding,/
CWITA011702,TCMBANKGE011702,TNFRSF8,CD30; D1S166E; Ki-1,TNF receptor superfamily member 8,1p36.22,protein-coding,Successful target
CWITA011703,TCMBANKGE011703,MESP1,bHLHc5,mesoderm posterior bHLH transcription factor 1,15q26.1,protein-coding,/
CWITA011704,TCMBANKGE011704,HSPA5,BIP; FLJ26106; GRP78; MIF2,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",9q33.3,protein-coding,
CWITA011705,TCMBANKGE011705,EZH1,KMT6B,enhancer of zeste 1 polycomb repressive complex 2 subunit,17q21.2,protein-coding,Clinical Trial target
CWITA011706,TCMBANKGE011706,VMP1,EPG3; TANGO5; TMEM49,vacuole membrane protein 1,17q23.1,protein-coding,/
CWITA011707,TCMBANKGE011707,IL1RAP,C3orf13; IL-1RAcP; IL1R3,interleukin 1 receptor accessory protein,3q28,protein-coding,Research target
CWITA011708,TCMBANKGE011708,ZNF556,-,zinc finger protein 556,19p13.3,protein-coding,/
CWITA011709,TCMBANKGE011709,MAP3K11,MEKK11; MLK-3; MLK3; PTK1; SPRK,mitogen-activated protein kinase kinase kinase 11,11q13.1,protein-coding,Research target
CWITA011710,TCMBANKGE011710,CDK1,CDC2; CDC28A; DKFZp686L20222; MGC111195; P34CDC2,cyclin-dependent kinase 1,10q21.1,protein-coding,
CWITA011711,TCMBANKGE011711,CD72,CD72b; LYB2,CD72 molecule,9p13.3,protein-coding,/
CWITA011712,TCMBANKGE011712,SPACA4,SAMP14,sperm acrosome associated 4,19q13.33,protein-coding,/
CWITA011713,TCMBANKGE011713,DARS2,ASPRS; FLJ10514; LBSL; MTNASPRS; RP3N383J4.2,"aspartyl-tRNA synthetase 2, mitochondrial",1q25.1,protein-coding,
CWITA011714,TCMBANKGE011714,CD70,CD27-L; CD27L; CD27LG; LPFS3; TNFSF7; TNLG8A,CD70 molecule,19p13.3,protein-coding,Clinical Trial target
CWITA011715,TCMBANKGE011715,PEX3,PBD10A; PBD10B; TRG18,peroxisomal biogenesis factor 3,6q24.2,protein-coding,/
CWITA011716,TCMBANKGE011716,FARP1,CDEP; FARP1-IT1; PLEKHC2; PPP1R75,"FERM, ARH/RhoGEF and pleckstrin domain protein 1",13q32.2,protein-coding,/
CWITA011717,TCMBANKGE011717,POLR2J3,POLR2J2; RPB11b1; RPB11b2,RNA polymerase II subunit J3,7q22.1,protein-coding,/
CWITA011718,TCMBANKGE011718,SLC29A1,ENT1,solute carrier family 29 member 1 (Augustine blood group),6p21.1,protein-coding,Successful target
CWITA011719,TCMBANKGE011719,ASB12,-,ankyrin repeat and SOCS box containing 12,Xq11.2,protein-coding,/
CWITA011720,TCMBANKGE011720,FNDC1,AGS8; FNDC2; MEL4B3; bA243O10.1; dJ322A24.1,fibronectin type III domain containing 1,6q25.3,protein-coding,Research target
CWITA011721,TCMBANKGE011721,DEDD,CASP8IP1; DEDD1; DEFT; FLDED1; KE05,death effector domain containing,1q23.3,protein-coding,/
CWITA011722,TCMBANKGE011722,VEGFA,MGC70609; MVCD1; VEGF; VPF,vascular endothelial growth factor A,6p12,protein-coding,
CWITA011723,TCMBANKGE011723,DHCR7,SLOS,7-dehydrocholesterol reductase,11q13.4,protein-coding,/
CWITA011724,TCMBANKGE011724,RASAL1,RASAL,RAS protein activator like 1,12q24.13,protein-coding,/
CWITA011725,TCMBANKGE011725,FLRT2,-,fibronectin leucine rich transmembrane protein 2,14q31.3,protein-coding,/
CWITA011726,TCMBANKGE011726,SLC25A33,BMSC-MCP; PNC1,solute carrier family 25 member 33,1p36.22,protein-coding,/
CWITA011727,TCMBANKGE011727,EXOC5,HSEC10; PRO1912; SEC10; SEC10L1; SEC10P,exocyst complex component 5,14q22.3,protein-coding,/
CWITA011728,TCMBANKGE011728,C2orf72,-,chromosome 2 open reading frame 72,2q37.1,protein-coding,/
CWITA011729,TCMBANKGE011729,RNASEH2A,AGS4; JUNB; RNASEHI; RNHIA; RNHL; THSD8,ribonuclease H2 subunit A,19p13.13,protein-coding,/
CWITA011730,TCMBANKGE011730,POMGNT2,AGO61; C3orf39; GTDC2; MDDGA8; MDDGC8,"protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)",3p22.1,protein-coding,/
CWITA011731,TCMBANKGE011731,FRRS1,SDFR2; SDR2,ferric chelate reductase 1,1p21.2,protein-coding,/
CWITA011732,TCMBANKGE011732,SOCS2,CIS2; Cish2; SOCS-2; SSI-2; SSI2; STATI2,suppressor of cytokine signaling 2,12q22,protein-coding,/
CWITA011733,TCMBANKGE011733,JAG2,HJ2; SER2,jagged canonical Notch ligand 2,14q32.33,protein-coding,Research target
CWITA011734,TCMBANKGE011734,HOGA1,C10orf65; DHDPS2; DHDPSL; HP3; NPL2,4-hydroxy-2-oxoglutarate aldolase 1,10q24.2,protein-coding,/
CWITA011735,TCMBANKGE011735,CCDC80,CL2; DRO1; LINC01279; SSG1; URB; okuribin,coiled-coil domain containing 80,3q13.2,protein-coding,/
CWITA011736,TCMBANKGE011736,ITGA5,CD49e; FNRA; VLA5A,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",12q11-q13,protein-coding,
CWITA011737,TCMBANKGE011737,HOXC8,HOX3; HOX3A,homeobox C8,12q13.13,protein-coding,/
CWITA011738,TCMBANKGE011738,HJURP,FAKTS; URLC9; hFLEG1,Holliday junction recognition protein,2q37.1,protein-coding,/
CWITA011739,TCMBANKGE011739,CTF1,CT-1; CT1,cardiotrophin 1,16p11.2,protein-coding,Clinical Trial target
CWITA011740,TCMBANKGE011740,TNP1,TP1,transition protein 1,2q35,protein-coding,/
CWITA011741,TCMBANKGE011741,ZNF773,ZNF419B,zinc finger protein 773,19q13.43,protein-coding,/
CWITA011742,TCMBANKGE011742,CBS,HIP4,cystathionine-beta-synthase,21q22.3,protein-coding,
CWITA011743,TCMBANKGE011743,Art2b,ART2.2; ARTC2; Art; Ly92b; Rt-6; Rt6; Rt6-2,ADP-ribosyltransferase 2b,7 E2|7 54.61 cM,protein-coding,/
CWITA011744,TCMBANKGE011744,CPO,-,carboxypeptidase O,2q33.3,protein-coding,/
CWITA011745,TCMBANKGE011745,HDC,MGC163399,histidine decarboxylase,15q21-q22,protein-coding,
CWITA011746,TCMBANKGE011746,QPCT,GCT; QC; sQC,glutaminyl-peptide cyclotransferase,2p22.2,protein-coding,
CWITA011747,TCMBANKGE011747,MATR3,ALS21; MPD2; VCPDM,matrin 3,5q31.2,protein-coding,/
CWITA011748,TCMBANKGE011748,LMCD1,-,LIM and cysteine rich domains 1,3p25.3,protein-coding,/
CWITA011749,TCMBANKGE011749,GRHPR,GLXR; GLYD; PH2,glyoxylate and hydroxypyruvate reductase,9p13.2,protein-coding,/
CWITA011750,TCMBANKGE011750,PLA2G1B,MGC119834; MGC119835; PLA2; PLA2A; PPLA2,"phospholipase A2, group IB (pancreas)",12q23-q24.1,protein-coding,
CWITA011751,TCMBANKGE011751,NINL,NLP,ninein like,20p11.21,protein-coding,/
CWITA011752,TCMBANKGE011752,ADCY2,AC2; HBAC2,adenylate cyclase 2,5p15.31,protein-coding,Research target
CWITA011753,TCMBANKGE011753,DUT,dUTPase,deoxyuridine triphosphatase,15q21.1,protein-coding,Clinical Trial target
CWITA011754,TCMBANKGE011754,SUCNR1,GPR91,succinate receptor 1,3q25.1,protein-coding,
CWITA011755,TCMBANKGE011755,TLR2,CD282; TIL4,toll-like receptor 2,4q32,protein-coding,
CWITA011756,TCMBANKGE011756,GAB2,-,GRB2 associated binding protein 2,11q14.1,protein-coding,/
CWITA011757,TCMBANKGE011757,ADGRA2,GPR124; TEM5,adhesion G protein-coupled receptor A2,8p11.23,protein-coding,/
CWITA011758,TCMBANKGE011758,EVA1C,B18; B19; C21orf63; C21orf64; FAM176C; PRED34; SUE21,eva-1 homolog C,21q22.11,protein-coding,/
CWITA011759,TCMBANKGE011759,ZFP62,ZET; ZNF755,ZFP62 zinc finger protein,5q35.3,protein-coding,/
CWITA011760,TCMBANKGE011760,RFPL2,RNF79,ret finger protein like 2,22q12.3,protein-coding,/
CWITA011761,TCMBANKGE011761,MBP,-,myelin basic protein,18q23,protein-coding,Clinical Trial target
CWITA011762,TCMBANKGE011762,ZDHHC7,DHHC7; SERZ-B; SERZ1; ZNF370,zinc finger DHHC-type palmitoyltransferase 7,16q24.1,protein-coding,/
CWITA011763,TCMBANKGE011763,ZNF57,ZNF424,zinc finger protein 57,19p13.3,protein-coding,/
CWITA011764,TCMBANKGE011764,POLR3B,C128; HLD8; INMAP; RPC2,RNA polymerase III subunit B,12q23.3,protein-coding,/
CWITA011765,TCMBANKGE011765,SDSL,SDH_2; SDSNRS1; TDH,serine dehydratase-like,12q24.13,protein-coding,
CWITA011766,TCMBANKGE011766,HDAC8,HD8; HDACL1; RPD3,histone deacetylase 8,Xq13,protein-coding,
CWITA011767,TCMBANKGE011767,HNMT,HMT; HNMTNS1; HNMTNS2,histamine N-methyltransferase,2q22.1,protein-coding,
CWITA011768,TCMBANKGE011768,FAH,FLJ51912,fumarylacetoacetate hydrolase (fumarylacetoacetase),15q23-q25,protein-coding,
CWITA011769,TCMBANKGE011769,C4orf36,-,chromosome 4 open reading frame 36,4q21.3,protein-coding,/
CWITA011770,TCMBANKGE011770,NGLY1,CDDG; CDG1V; PNG-1; PNG1; PNGase,N-glycanase 1,3p24.2,protein-coding,/
CWITA011771,TCMBANKGE011771,CUL1,-,cullin 1,7q36.1,protein-coding,/
CWITA011772,TCMBANKGE011772,HSD17B11,17BHSD11; DHRS8; PAN1B; RETSDR2; SDR16C2,hydroxysteroid (17-beta) dehydrogenase 11,4q22.1,protein-coding,
CWITA011773,TCMBANKGE011773,LYRM4,C6orf149; CGI-203; COXPD19; ISD11,LYR motif containing 4,6p25.1,protein-coding,/
CWITA011774,TCMBANKGE011774,Egfros,E230015J15Rik,"epidermal growth factor receptor, opposite strand",11|11,ncRNA,/
CWITA011775,TCMBANKGE011775,OPN4,MOP,opsin 4,10q23.2,protein-coding,/
CWITA011776,TCMBANKGE011776,EIF4E,AUTS19; CBP; EIF4E1; EIF4EL1; EIF4F; eIF-4E,eukaryotic translation initiation factor 4E,4q23,protein-coding,Research target
CWITA011777,TCMBANKGE011777,RGS10,-,regulator of G protein signaling 10,10q26.11,protein-coding,/
CWITA011778,TCMBANKGE011778,Ccnb2-ps,Gm9486,"cyclin B2, pseudogene",8 B3.3|8,pseudo,/
CWITA011779,TCMBANKGE011779,C16orf87,-,chromosome 16 open reading frame 87,16q11.2,protein-coding,/
CWITA011780,TCMBANKGE011780,TLR8,CD288,toll like receptor 8,Xp22.2,protein-coding,Clinical Trial target
CWITA011781,TCMBANKGE011781,BCKDK,N,branched chain ketoacid dehydrogenase kinase,16p11.2,protein-coding,
CWITA011782,TCMBANKGE011782,NSUN2,MISU; MRT5; SAKI; TRM4,NOP2/Sun RNA methyltransferase 2,5p15.31,protein-coding,/
CWITA011783,TCMBANKGE011783,HECTD2,-,HECT domain E3 ubiquitin protein ligase 2,10q23.32,protein-coding,/
CWITA011784,TCMBANKGE011784,DCUN1D2,C13orf17,defective in cullin neddylation 1 domain containing 2,13q34,protein-coding,/
CWITA011785,TCMBANKGE011785,ESX1,ESX1L; ESXR1,ESX homeobox 1,Xq22.2,protein-coding,/
CWITA011786,TCMBANKGE011786,MAPK10,FLJ12099; FLJ33785; JNK3; JNK3A; MGC50974; PRKM10; p493F12; p54bSAPK,mitogen-activated protein kinase 10,4q22.1-q23,protein-coding,
CWITA011787,TCMBANKGE011787,TECR,GPSN2; MRT14; SC2; TER,"trans-2,3-enoyl-CoA reductase",19p13.12,protein-coding,/
CWITA011788,TCMBANKGE011788,SCN1A,EIEE6; FEB3; FEB3A; FHM3; GEFSP2; HBSCI; NAC1; Nav1.1; SCN1; SMEI,"sodium channel, voltage-gated, type I, alpha subunit",2q24.3,protein-coding,
CWITA011789,TCMBANKGE011789,NUDCD2,NudCL2,NudC domain containing 2,5q34,protein-coding,/
CWITA011790,TCMBANKGE011790,ITIH5,ITI-HC5; PP14776,inter-alpha-trypsin inhibitor heavy chain 5,10p14,protein-coding,/
CWITA011791,TCMBANKGE011791,POPDC3,LGMDR26; POP3; bA355M14.1,popeye domain containing 3,6q21,protein-coding,/
CWITA011792,TCMBANKGE011792,RGL1,RGL,ral guanine nucleotide dissociation stimulator like 1,1q25.3,protein-coding,/
CWITA011793,TCMBANKGE011793,DHRS4,CR; FLJ11008; NRDR; PHCR; PSCD; SCADNSRL; SDRNSRL; SDR25C1; SDR25C2,dehydrogenase/reductase (SDR family) member 4,14q11.2,protein-coding,
CWITA011794,TCMBANKGE011794,PRMT3,HRMT1L3,protein arginine methyltransferase 3,11p15.1,protein-coding,Research target
CWITA011795,TCMBANKGE011795,ALX4,CRS5; FND2,ALX homeobox 4,11p11.2,protein-coding,/
CWITA011796,TCMBANKGE011796,NRIP1,FLJ77253; RIP140,nuclear receptor interacting protein 1,21q11.2,protein-coding,
CWITA011797,TCMBANKGE011797,LAP3,HEL-S-106; LAP; LAPEP; PEPS,leucine aminopeptidase 3,4p15.32,protein-coding,/
CWITA011798,TCMBANKGE011798,ADGRD1,GPR133; PGR25,adhesion G protein-coupled receptor D1,12q24.33,protein-coding,/
CWITA011799,TCMBANKGE011799,PDE4B,DPDE4; PDEIVB,phosphodiesterase 4B,1p31.3,protein-coding,Clinical Trial target
CWITA011800,TCMBANKGE011800,CRYM,DFNA40; THBP,crystallin mu,16p12.2,protein-coding,/
CWITA011801,TCMBANKGE011801,CDKN2D,INK4D; p19; p19-INK4D,cyclin dependent kinase inhibitor 2D,19p13.2,protein-coding,/
CWITA011802,TCMBANKGE011802,ACVR1C,ACVRLK7; ALK7,activin A receptor type 1C,2q24.1,protein-coding,/
CWITA011803,TCMBANKGE011803,HTR7,5-HT7,5-hydroxytryptamine receptor 7,10q23.31,protein-coding,Clinical Trial target
CWITA011804,TCMBANKGE011804,FAM49B,BM-009; L1,Family_With_Sequence_Similarity_49_Member_B,8q24.21,protein-coding,
CWITA011805,TCMBANKGE011805,KCNH1,EAG; EAG1; Kv10.1; TMBTS; ZLS1; h-eag; hEAG; hEAG1,potassium voltage-gated channel subfamily H member 1,1q32.2,protein-coding,Research target
CWITA011806,TCMBANKGE011806,ATP7A,DSMAX; FLJ17790; MK; MNK; SMAX3,"ATPase, Cu++ transporting, alpha polypeptide",Xq21.1,protein-coding,
CWITA011807,TCMBANKGE011807,B3GALT5,"B3GalT-V; B3GalTx; B3T5; GLCT5; beta-1,3-GalTase 5; beta-3-Gx-T5; beta3Gal-T5","beta-1,3-galactosyltransferase 5",21q22.2,protein-coding,/
CWITA011808,TCMBANKGE011808,RNF8,hRNF8,ring finger protein 8,6p21.2,protein-coding,/
CWITA011809,TCMBANKGE011809,PSRC1,DDA3; FP3214,proline and serine rich coiled-coil 1,1p13.3,protein-coding,/
CWITA011810,TCMBANKGE011810,PIEZO2,C18orf30; C18orf58; DA3; DA5; DAIPT; FAM38B; FAM38B2; HsT748; HsT771; MWKS,piezo type mechanosensitive ion channel component 2,18p11.22-p11.21,protein-coding,/
CWITA011811,TCMBANKGE011811,ACTL8,CT57,actin like 8,1p36.13,protein-coding,/
CWITA011812,TCMBANKGE011812,XAF1,BIRC4BP; HSXIAPAF1; XIAPAF1,XIAP associated factor 1,17p13.1,protein-coding,/
CWITA011813,TCMBANKGE011813,NEUROD2,EIEE72; NDRF; bHLHa1,neuronal differentiation 2,17q12,protein-coding,/
CWITA011814,TCMBANKGE011814,SLC22A14,OCTL2; OCTL4; ORCTL4,solute carrier family 22 member 14,3p22.2,protein-coding,/
CWITA011815,TCMBANKGE011815,ANKRD9,-,ankyrin repeat domain 9,14q32.31,protein-coding,/
CWITA011816,TCMBANKGE011816,REXO1L1P,GOR; REXO1L1,"Rexo1_Like_1,_Pseudogene",8q21.2,pseudo,
CWITA011817,TCMBANKGE011817,LDLRAP1,ARH; ARH1; ARH2; FHCB1; FHCB2; FHCL4,low density lipoprotein receptor adaptor protein 1,1p36.11,protein-coding,/
CWITA011818,TCMBANKGE011818,KRBA2,-,KRAB-A domain containing 2,17p13.1,protein-coding,/
CWITA011819,TCMBANKGE011819,NDUFB3,B12; CI-B12; MC1DN25,NADH:ubiquinone oxidoreductase subunit B3,2q33.1,protein-coding,/
CWITA011820,TCMBANKGE011820,TUBE1,TUBE; dJ142L7.2,tubulin epsilon 1,6q21,protein-coding,/
CWITA011821,TCMBANKGE011821,TRAF7,CAFDADD; RFWD1; RNF119,TNF receptor associated factor 7,16p13.3,protein-coding,/
CWITA011822,TCMBANKGE011822,NBPF3,AE2,NBPF member 3,1p36.12,protein-coding,/
CWITA011823,TCMBANKGE011823,GRK3,ADRBK2; BARK2,G_Protein-Coupled_Receptor_Kinase_3,22q12.1,protein-coding,
CWITA011824,TCMBANKGE011824,ZNF671,-,zinc finger protein 671,19q13.43,protein-coding,/
CWITA011825,TCMBANKGE011825,RGS18,RGS13,regulator of G protein signaling 18,1q31.2,protein-coding,/
CWITA011826,TCMBANKGE011826,SLC22A23,C6orf85,solute carrier family 22 member 23,6p25.2,protein-coding,/
CWITA011827,TCMBANKGE011827,KCNK3,K2p3.1; OAT1; PPH4; TASK; TASK-1; TASK1; TBAK1,potassium two pore domain channel subfamily K member 3,2p23.3,protein-coding,Clinical Trial target
CWITA011828,TCMBANKGE011828,PTPN21,PTPD1; PTPRL10,protein tyrosine phosphatase non-receptor type 21,14q31.3,protein-coding,/
CWITA011829,TCMBANKGE011829,PTPRT,RPTPrho,protein tyrosine phosphatase receptor type T,20q12-q13.11,protein-coding,/
CWITA011830,TCMBANKGE011830,RPL39,L39; RPL39P42; RPL39_23_1806,ribosomal protein L39,Xq24,protein-coding,/
CWITA011831,TCMBANKGE011831,EFNA1,B61; ECKLG; EFL1; EPLG1; GMAN; LERK-1; LERK1; TNFAIP4,ephrin A1,1q22,protein-coding,/
CWITA011832,TCMBANKGE011832,EFNA5,AF1; EFL5; EPLG7; GLC1M; LERK7; RAGS,ephrin A5,5q21.3,protein-coding,/
CWITA011833,TCMBANKGE011833,LRRC10,HRLRRP; LRRC10A,leucine rich repeat containing 10,12q15,protein-coding,/
CWITA011834,TCMBANKGE011834,VWA7,C6orf27; G7c; NG37,von Willebrand factor A domain containing 7,6p21.33,protein-coding,/
CWITA011835,TCMBANKGE011835,PRELID2,-,PRELI domain containing 2,5q32,protein-coding,/
CWITA011836,TCMBANKGE011836,WDR43,NET12; UTP5,WD repeat domain 43,2p23.2,protein-coding,/
CWITA011837,TCMBANKGE011837,HMGCR,LDLCQ3,3-hydroxy-3-methylglutaryl-CoA reductase,5q13.3-q14,protein-coding,
CWITA011838,TCMBANKGE011838,SRPK1,SFRSK1,SRSF protein kinase 1,6p21.31,protein-coding,Research target
CWITA011839,TCMBANKGE011839,CLK4,-,CDC like kinase 4,5q35.3,protein-coding,Research target
CWITA011840,TCMBANKGE011840,ZNF253,BMZF-1; BMZF1; ZNF411,zinc finger protein 253,19p13.11,protein-coding,/
CWITA011841,TCMBANKGE011841,IGFBP6,IBP6,insulin like growth factor binding protein 6,12q13.13,protein-coding,Research target
CWITA011842,TCMBANKGE011842,SNAPIN,BLOC1S7; BLOS7; BORCS3; SNAPAP,SNAP associated protein,1q21.3,protein-coding,/
CWITA011843,TCMBANKGE011843,NOM1,C7orf3; PPP1R113; SGD1,nucleolar protein with MIF4G domain 1,7q36.3,protein-coding,/
CWITA011844,TCMBANKGE011844,TRADD,Hs.89862,TNFRSF1A associated via death domain,16q22.1,protein-coding,/
CWITA011845,TCMBANKGE011845,ISG20,CD25; HEM45,interferon stimulated exonuclease gene 20kDa,15q26,protein-coding,
CWITA011846,TCMBANKGE011846,POLD2,-,"DNA polymerase delta 2, accessory subunit",7p13,protein-coding,/
CWITA011847,TCMBANKGE011847,CPT1B,CPT1-M; CPT1M; CPTI; CPTI-M; M-CPT1; MCCPT1; MCPT1,carnitine palmitoyltransferase 1B,22q13.33,protein-coding,Successful target
CWITA011848,TCMBANKGE011848,ZNF22,HKR-T1; KOX15; ZNF422; Zfp422,zinc finger protein 22,10q11.21,protein-coding,/
CWITA011849,TCMBANKGE011849,CAPNS1,CALPAIN4; CANP; CANPS; CAPN4; CDPS; CSS1,calpain small subunit 1,19q13.12,protein-coding,/
CWITA011850,TCMBANKGE011850,DEFA6,DEF6; HD-6,defensin alpha 6,8p23.1,protein-coding,/
CWITA011851,TCMBANKGE011851,SEMA3E,M-SEMAH; M-SemaK; SEMAH; coll-5,semaphorin 3E,7q21.11,protein-coding,/
CWITA011852,TCMBANKGE011852,SLC6A17,MRT48; NTT4,solute carrier family 6 member 17,1p13.3,protein-coding,Research target
CWITA011853,TCMBANKGE011853,WDR54,-,WD repeat domain 54,2p13.1,protein-coding,/
CWITA011854,TCMBANKGE011854,EPB41L5,BE37; LULU; LULU1; YMO1; YRT,erythrocyte membrane protein band 4.1 like 5,2q14.2,protein-coding,/
CWITA011855,TCMBANKGE011855,MPP7,-,membrane palmitoylated protein 7,10p12.1,protein-coding,/
CWITA011856,TCMBANKGE011856,Gja6,A530015O12Rik; Cnx33; Cx33; Cxnk2; Gja-6,"gap junction protein, alpha 6",X F4|X 73.95 cM,protein-coding,/
CWITA011857,TCMBANKGE011857,RNF38,-,ring finger protein 38,9p13.2,protein-coding,/
CWITA011858,TCMBANKGE011858,GGH,GH,"gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)",8q12.3,protein-coding,
CWITA011859,TCMBANKGE011859,CFI,AHUS3; ARMD13; C3BINA; C3b-INA; FI; IF; KAF,complement factor I,4q25,protein-coding,Research target
CWITA011860,TCMBANKGE011860,NPBWR1,GPR7,neuropeptides B and W receptor 1,8q11.23,protein-coding,/
CWITA011861,TCMBANKGE011861,EXOSC2,RRP4; Rrp4p; SHRF; hRrp4p; p7,exosome component 2,9q34.12,protein-coding,/
CWITA011862,TCMBANKGE011862,PRKACB,PKA C-beta; PKACB,protein kinase cAMP-activated catalytic subunit beta,1p31.1,protein-coding,/
CWITA011863,TCMBANKGE011863,CETN1,CEN1; CETN,centrin 1,18p11.32,protein-coding,/
CWITA011864,TCMBANKGE011864,TGM1,ARCI1; ICR2; KTG; LI; LI1; TGASE; TGK,transglutaminase 1,14q12,protein-coding,/
CWITA011865,TCMBANKGE011865,ANXA11,ALS23; ANX11; CAP-50; CAP50,annexin A11,10q22.3,protein-coding,/
CWITA011866,TCMBANKGE011866,FTMT,MTF,ferritin mitochondrial,5q23.1,protein-coding,/
CWITA011867,TCMBANKGE011867,RSPO2,CRISTIN2; HHRRD; TETAMS2,R-spondin 2,8q23.1,protein-coding,/
CWITA011868,TCMBANKGE011868,TTC17,-,tetratricopeptide repeat domain 17,11p12-p11.2,protein-coding,/
CWITA011869,TCMBANKGE011869,ZNF781,-,zinc finger protein 781,19q13.12,protein-coding,/
CWITA011870,TCMBANKGE011870,RABL6,C9orf86; PARF; RBEL1; pp8875,"RAB, member RAS oncogene family like 6",9q34.3,protein-coding,/
CWITA011871,TCMBANKGE011871,SAT2,SSAT2,spermidine/spermine N1-acetyltransferase family member 2,17p13.1,protein-coding,
CWITA011872,TCMBANKGE011872,CDH23,CDHR23; PITA5; USH1D,cadherin related 23,10q22.1,protein-coding,/
CWITA011873,TCMBANKGE011873,FIGNL1,-,fidgetin like 1,7p12.2,protein-coding,/
CWITA011874,TCMBANKGE011874,PHF11,APY; BCAP; IGEL; IGER; IGHER; NY-REN-34; NYREN34,PHD finger protein 11,13q14.2,protein-coding,/
CWITA011875,TCMBANKGE011875,ZBTB5,-,zinc finger and BTB domain containing 5,9p13.2,protein-coding,/
CWITA011876,TCMBANKGE011876,BROX,C1orf58,BRO1 domain and CAAX motif containing,1q41,protein-coding,/
CWITA011877,TCMBANKGE011877,CAVIN1,CAVIN; CGL4; FKSG13; PTRF; cavin-1,caveolae associated protein 1,17q21.2,protein-coding,/
CWITA011878,TCMBANKGE011878,GPR162,A-2; GRCA,G protein-coupled receptor 162,12p13.31,protein-coding,/
CWITA011879,TCMBANKGE011879,AGBL5,CCP5; RP75,ATP/GTP binding protein like 5,2p23.3,protein-coding,/
CWITA011880,TCMBANKGE011880,ANKRD52,ANKRD33,ankyrin repeat domain 52,12q13.3,protein-coding,/
CWITA011881,TCMBANKGE011881,NPM1,B23; NPM,nucleophosmin 1,5q35.1,protein-coding,Clinical Trial target
CWITA011882,TCMBANKGE011882,EHMT2,BAT8; C6orf30; G9A; GAT8; KMT1C; NG36,euchromatic histone lysine methyltransferase 2,6p21.33,protein-coding,Research target
CWITA011883,TCMBANKGE011883,KLHDC10,slim,kelch domain containing 10,7q32.2,protein-coding,/
CWITA011884,TCMBANKGE011884,DKC1,CBF5; DKC; DKCX; NAP57; NOLA4; XAP101,dyskerin pseudouridine synthase 1,Xq28,protein-coding,/
CWITA011885,TCMBANKGE011885,CCDC142,-,coiled-coil domain containing 142,2p13.1,protein-coding,/
CWITA011886,TCMBANKGE011886,TDRD1,CT41.1,tudor domain containing 1,10q25.3,protein-coding,/
CWITA011887,TCMBANKGE011887,TAF6,ALYUS; MGC:8964; TAF(II)70; TAF(II)80; TAF2E; TAFII-70; TAFII-80; TAFII70; TAFII80; TAFII85,TATA-box binding protein associated factor 6,7q22.1,protein-coding,/
CWITA011888,TCMBANKGE011888,PPIC,CYPC,peptidylprolyl isomerase C,5q23.2,protein-coding,/
CWITA011889,TCMBANKGE011889,ADGRB3,BAI3,adhesion G protein-coupled receptor B3,6q12-q13,protein-coding,/
CWITA011890,TCMBANKGE011890,CABP4,CRSD; CSNB2B,calcium binding protein 4,11q13.2,protein-coding,/
CWITA011891,TCMBANKGE011891,PPIAL4F,-,peptidylprolyl isomerase A like 4F,1q21.1,protein-coding,/
CWITA011892,TCMBANKGE011892,NPIPA2,NPIP; NPIPA1,nuclear pore complex interacting protein family member A2,16p13.11,protein-coding,/
CWITA011893,TCMBANKGE011893,KLHL14,-,kelch like family member 14,18q12.1,protein-coding,/
CWITA011894,TCMBANKGE011894,GM2A,GM2-AP; SAP-3,GM2 ganglioside activator,5q33.1,protein-coding,Clinical Trial target
CWITA011895,TCMBANKGE011895,DLG5,LP-DLG; P-DLG5; PDLG,discs large MAGUK scaffold protein 5,10q22.3,protein-coding,/
CWITA011896,TCMBANKGE011896,PKIB,PRKACN2,cAMP-dependent protein kinase inhibitor beta,6q22.31,protein-coding,/
CWITA011897,TCMBANKGE011897,CELA3B,CBPP; ELA3B,chymotrypsin like elastase 3B,1p36.12,protein-coding,/
CWITA011898,TCMBANKGE011898,TLN2,ILWEQ,talin 2,15q22.2,protein-coding,/
CWITA011899,TCMBANKGE011899,Hvmt1,-,heavy metal tolerance protein 1,-,protein-coding,/
CWITA011900,TCMBANKGE011900,SSRP1,FACT; FACT80; T160,structure specific recognition protein 1,11q12.1,protein-coding,Clinical Trial target
CWITA011901,TCMBANKGE011901,AQP5,AQP-5; PPKB,aquaporin 5,12q13.12,protein-coding,/
CWITA011902,TCMBANKGE011902,CYHR1,CHRP,cysteine and histidine rich 1,8q24.3,protein-coding,/
CWITA011903,TCMBANKGE011903,CHRNA6,CHNRA6,"cholinergic receptor, nicotinic, alpha 6",8p11.21,protein-coding,
CWITA011904,TCMBANKGE011904,PDE2A,CGS-PDE; PDE2A1; PED2A4; cGSPDE,phosphodiesterase 2A,11q13.4,protein-coding,Clinical Trial target
CWITA011905,TCMBANKGE011905,RGS5,MST092; MST106; MST129; MSTP032; MSTP092; MSTP106; MSTP129,regulator of G protein signaling 5,1q23.3,protein-coding,/
CWITA011906,TCMBANKGE011906,RAB11FIP1,NOEL1A; RCP; rab11-FIP1,RAB11 family interacting protein 1,8p11.23,protein-coding,/
CWITA011907,TCMBANKGE011907,MFSD3,-,major facilitator superfamily domain containing 3,8q24.3,protein-coding,/
CWITA011908,TCMBANKGE011908,TAS2R10,T2R10; TRB2,taste 2 receptor member 10,12p13.2,protein-coding,/
CWITA011909,TCMBANKGE011909,SUOX,N,sulfite oxidase,12q13.2,protein-coding,
CWITA011910,TCMBANKGE011910,MNX1,HB9; HLXB9; HOXHB9; SCRA1,motor neuron and pancreas homeobox 1,7q36.3,protein-coding,/
CWITA011911,TCMBANKGE011911,RAB22A,-,"RAB22A, member RAS oncogene family",20q13.32,protein-coding,Research target
CWITA011912,TCMBANKGE011912,ARL3,ARFL3,ADP-ribosylation factor-like 3,10q23.3,protein-coding,
CWITA011913,TCMBANKGE011913,EEF1D,EF-1D; EF1D; FP1047,eukaryotic translation elongation factor 1 delta,8q24.3,protein-coding,/
CWITA011914,TCMBANKGE011914,INPP5K,MDCCAID; PPS; SKIP,inositol polyphosphate-5-phosphatase K,17p13.3,protein-coding,/
CWITA011915,TCMBANKGE011915,APBB1,FE65; MGC:9072; RIR,amyloid beta precursor protein binding family B member 1,11p15.4,protein-coding,/
CWITA011916,TCMBANKGE011916,UEVLD,ATTP; UEV3,UEV and lactate/malate dehyrogenase domains,11p15.1,protein-coding,/
CWITA011917,TCMBANKGE011917,ZSWIM2,MEX; ZZZ2,zinc finger SWIM-type containing 2,2q32.1,protein-coding,/
CWITA011918,TCMBANKGE011918,PPP1R15B,CREP; MSSGM2,protein phosphatase 1 regulatory subunit 15B,1q32.1,protein-coding,/
CWITA011919,TCMBANKGE011919,ARHGAP27,CAMGAP1; PP905; SH3D20; SH3P20,Rho GTPase activating protein 27,17q21.31,protein-coding,/
CWITA011920,TCMBANKGE011920,MIR130A,MIRN130A|miRNA130A|mir-130a,microRNA 130a,11q12.1,ncRNA,/
CWITA011921,TCMBANKGE011921,MFSD11,ET,major facilitator superfamily domain containing 11,17q25.1-q25.2,protein-coding,/
CWITA011922,TCMBANKGE011922,RABGAP1L,HHL; TBC1D18,RAB GTPase activating protein 1 like,1q25.1,protein-coding,/
CWITA011923,TCMBANKGE011923,CHRM4,HM4; M4R,cholinergic receptor muscarinic 4,11p11.2,protein-coding,Successful target
CWITA011924,TCMBANKGE011924,CAMP,CAPN18; CAP18; CRAMP; FALLN39; FALL39; LL37,cathelicidin antimicrobial peptide,3p21.3,protein-coding,
CWITA011925,TCMBANKGE011925,TLR4,ARMD10; CD284; TOLL; hToll,toll-like receptor 4,9q33.1,protein-coding,
CWITA011926,TCMBANKGE011926,CXCL11,H174; I-TAC; IP-9; IP9; SCYB11; SCYB9B; b-R1,C-X-C motif chemokine ligand 11,4q21.1,protein-coding,Research target
CWITA011927,TCMBANKGE011927,CBR3,HEL-S-25; SDR21C2; hCBR3,carbonyl reductase 3,21q22.12,protein-coding,/
CWITA011928,TCMBANKGE011928,CCR8,CC-CKR-8; CCR-8; CDw198; CKRL1; CMKBR8; CMKBRL2; CY6; GPRCY6; TER1,C-C motif chemokine receptor 8,3p22.1,protein-coding,Discontinued target
CWITA011929,TCMBANKGE011929,PLSCR3,-,phospholipid scramblase 3,17p13.1,protein-coding,/
CWITA011930,TCMBANKGE011930,PM20D2,ACY1L2,peptidase M20 domain containing 2,6q15,protein-coding,/
CWITA011931,TCMBANKGE011931,CASP1,ICE; IL1BC; P45,"caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)",11q23,protein-coding,
CWITA011932,TCMBANKGE011932,RPL10L,FLJ27353; RPL10_5_1358,ribosomal protein L10-like,14q13-q21,protein-coding,
CWITA011933,TCMBANKGE011933,CCDC81,-,coiled-coil domain containing 81,11q14.2,protein-coding,/
CWITA011934,TCMBANKGE011934,LYST,CHS; CHS1,lysosomal trafficking regulator,1q42.3,protein-coding,/
CWITA011935,TCMBANKGE011935,RRAD,RAD; RAD1; REM3,"RRAD, Ras related glycolysis inhibitor and calcium channel regulator",16q22.1,protein-coding,/
CWITA011936,TCMBANKGE011936,PTGDR2,CD294; CRTH2; DL1R; DP2; GPR44,Prostaglandin_D2_Receptor_2,11q12.2,protein-coding,
CWITA011937,TCMBANKGE011937,LIPN,ARCI8; LI4; LIPL4; bA186O14.3,lipase family member N,10q23.31,protein-coding,/
CWITA011938,TCMBANKGE011938,CARMIL2,CARMIL2b; IMD58; LRRC16C; RLTPR,capping protein regulator and myosin 1 linker 2,16q22.1,protein-coding,/
CWITA011939,TCMBANKGE011939,Acc,-,anterior capsular cataract,-,unknown,/
CWITA011940,TCMBANKGE011940,SPTBN4,CMND; NEDHND; QV; SPNB4; SPTBN3,"spectrin beta, non-erythrocytic 4",19q13.2,protein-coding,/
CWITA011941,TCMBANKGE011941,VPS13A,CHAC; CHOREIN,vacuolar protein sorting 13 homolog A,9q21.2,protein-coding,/
CWITA011942,TCMBANKGE011942,BNIP2,BNIP-2; NIP2,BCL2 interacting protein 2,15q22.2,protein-coding,/
CWITA011943,TCMBANKGE011943,MAP1LC3B2,ATG8G,microtubule associated protein 1 light chain 3 beta 2,12q24.22,protein-coding,/
CWITA011944,TCMBANKGE011944,ALDH7A1,ATQ1; EPD; FLJ11738; FLJ92814; PDE,"aldehyde dehydrogenase 7 family, member A1",5q31,protein-coding,
CWITA011945,TCMBANKGE011945,FAM162A,C3orf28; E2IG5; HGTD-P,family with sequence similarity 162 member A,3q21.1,protein-coding,/
CWITA011946,TCMBANKGE011946,ZNF169,-,zinc finger protein 169,9q22.32,protein-coding,/
CWITA011947,TCMBANKGE011947,AQP1,AQP-CHIP; CHIP28; CO,aquaporin 1 (Colton blood group),7p14.3,protein-coding,Research target
CWITA011948,TCMBANKGE011948,GLRA3,-,glycine receptor alpha 3,4q34.1,protein-coding,/
CWITA011949,TCMBANKGE011949,PYCR2,HLD10; P5CR2,pyrroline-5-carboxylate reductase 2,1q42.12,protein-coding,/
CWITA011950,TCMBANKGE011950,ZNF221,-,zinc finger protein 221,19q13.31,protein-coding,/
CWITA011951,TCMBANKGE011951,KIF1A,ATSV; C2orf20; HSN2C; MRD9; NESCAVS; SPG30; UNC104,kinesin family member 1A,2q37.3,protein-coding,/
CWITA011952,TCMBANKGE011952,GGT2,GGT; GGT 2,gamma-glutamyltransferase 2,22q11.21,protein-coding,/
CWITA011953,TCMBANKGE011953,MEN1,MEAI; SCG2,menin 1,11q13.1,protein-coding,/
CWITA011954,TCMBANKGE011954,TARDBP,ALS10; TDP-43,TAR DNA binding protein,1p36.22,protein-coding,Clinical Trial target
CWITA011955,TCMBANKGE011955,GALNT14,GALNT15; GalNac-T10; GalNac-T14,polypeptide N-acetylgalactosaminyltransferase 14,2p23.1,protein-coding,/
CWITA011956,TCMBANKGE011956,SMIM29,C6orf1; LBH,small integral membrane protein 29,6p21.31,protein-coding,/
CWITA011957,TCMBANKGE011957,PLEKHB1,KPL1; PHR1; PHRET1,pleckstrin homology domain containing B1,11q13.4,protein-coding,/
CWITA011958,TCMBANKGE011958,HLCS,HCS,holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase),21q22.1|21q22.13,protein-coding,
CWITA011959,TCMBANKGE011959,SYTL3,SLP3,synaptotagmin like 3,6q25.3,protein-coding,/
CWITA011960,TCMBANKGE011960,ENO3,GSD13; MSE,enolase 3,17p13.2,protein-coding,/
CWITA011961,TCMBANKGE011961,OCA2,BEY; BEY1; BEY2; BOCA; D15S12; EYCL; EYCL2; EYCL3; HCL3; P; PED; SHEP1,Oca2_Melanosomal_Transmembrane_Protein,15q12-q13.1,protein-coding,
CWITA011962,TCMBANKGE011962,HOXA2,HOX1K; MCOHI,homeobox A2,7p15.2,protein-coding,/
CWITA011963,TCMBANKGE011963,RBP4,MCOPCB10; RDCCAS,retinol binding protein 4,10q23.33,protein-coding,Research target
CWITA011964,TCMBANKGE011964,KLHDC2,HCLP-1; HCLP1; LCP,kelch domain containing 2,14q21.3,protein-coding,/
CWITA011965,TCMBANKGE011965,GPX8,EPLA847; GPx-8; GSHPx-8; UNQ847,glutathione peroxidase 8 (putative),5q11.2,protein-coding,/
CWITA011966,TCMBANKGE011966,ASZ1,ALP1; ANKL1; C7orf7; CT1.19; GASZ; Orf3,"ankyrin repeat, SAM and basic leucine zipper domain containing 1",7q31.2,protein-coding,/
CWITA011967,TCMBANKGE011967,BST2,CD317; TETHERIN,bone marrow stromal cell antigen 2,19p13.11,protein-coding,Research target
CWITA011968,TCMBANKGE011968,LHX8,LHX7,LIM homeobox 8,1p31.1,protein-coding,/
CWITA011969,TCMBANKGE011969,AKAP12,AKAP250; SSeCKS,A-kinase anchoring protein 12,6q25.1,protein-coding,/
CWITA011970,TCMBANKGE011970,SNX24,PRO1284; SBBI31,sorting nexin 24,5q23.2,protein-coding,/
CWITA011971,TCMBANKGE011971,PIGR,-,polymeric immunoglobulin receptor,1q32.1,protein-coding,/
CWITA011972,TCMBANKGE011972,ARSA,MLD,arylsulfatase A,22q13.31-qter|22q13.33,protein-coding,
CWITA011973,TCMBANKGE011973,SLC39A6,LIV-1; ZIP6,solute carrier family 39 member 6,18q12.2,protein-coding,Clinical Trial target
CWITA011974,TCMBANKGE011974,AGR3,AG-3; AG3; BCMP11; HAG3; PDIA18; hAG-3,"anterior gradient 3, protein disulphide isomerase family member",7p21.1,protein-coding,/
CWITA011975,TCMBANKGE011975,CHRNE,ACHRE; CMS1D; CMS1E; CMS2A; FCCMS; SCCMS,"cholinergic receptor, nicotinic, epsilon",17p13.2,protein-coding,
CWITA011976,TCMBANKGE011976,CLDN16,HOMG3; PCLN1,claudin 16,3q28,protein-coding,/
CWITA011977,TCMBANKGE011977,BRMS1L,BRMS1,BRMS1 like transcriptional repressor,14q13.2,protein-coding,/
CWITA011978,TCMBANKGE011978,CDV3,H41,CDV3 homolog,3q22.1,protein-coding,/
CWITA011979,TCMBANKGE011979,CHD9,AD013; CHD-9; CReMM; KISH2; PRIC320,chromodomain helicase DNA binding protein 9,16q12.2,protein-coding,/
CWITA011980,TCMBANKGE011980,CD300A,CLM-8; CMRF-35-H9; CMRF-35H; CMRF35-H; CMRF35-H9; CMRF35H; CMRF35H9; IGSF12; IRC1; IRC1/IRC2; IRC2; IRp60,CD300a molecule,17q25.1,protein-coding,Research target
CWITA011981,TCMBANKGE011981,PDE3B,HcGIP1; cGIPDE1,phosphodiesterase 3B,11p15.2,protein-coding,Research target
CWITA011982,TCMBANKGE011982,FXN,CyaY; FA; FARR; FRDA; X25,Frataxin,9q21.11,protein-coding,
CWITA011983,TCMBANKGE011983,TXNDC12,AG1; AGR1; ERP18; ERP19; PDIA16; TLP19; hAGN1,thioredoxin domain containing 12 (endoplasmic reticulum),1p32.3,protein-coding,
CWITA011984,TCMBANKGE011984,Eh,-,hairy ears,-,unknown,/
CWITA011985,TCMBANKGE011985,NOS1,IHPS1; NNNOS; NCNNOS; NOS; bNOS; nNOS,nitric oxide synthase 1 (neuronal),12q24.2-q24.31,protein-coding,
CWITA011986,TCMBANKGE011986,SOX18,HLTRS; HLTS,SRY-box transcription factor 18,20q13.33,protein-coding,/
CWITA011987,TCMBANKGE011987,TP63,AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L,tumor protein p63,3q28,protein-coding,/
CWITA011988,TCMBANKGE011988,UPF3A,HUPF3A; RENT3A; UPF3,UPF3A regulator of nonsense mediated mRNA decay,13q34,protein-coding,/
CWITA011989,TCMBANKGE011989,FAM83F,-,family with sequence similarity 83 member F,22q13.1,protein-coding,/
CWITA011990,TCMBANKGE011990,CEACAM5,CD66e; CEA,CEA cell adhesion molecule 5,19q13.2,protein-coding,Clinical Trial target
CWITA011991,TCMBANKGE011991,EIF2A,CDA02; EIF-2A; MST089; MSTP004; MSTP089,eukaryotic translation initiation factor 2A,3q25.1,protein-coding,/
CWITA011992,TCMBANKGE011992,RNF141,RFP141; ZFP26; ZNF230,ring finger protein 141,11p15.4|11p15,protein-coding,/
CWITA011993,TCMBANKGE011993,BCL9L,B9L; BCL9-2; DLNB11,BCL9 like,11q23.3,protein-coding,/
CWITA011994,TCMBANKGE011994,TMEM237,ALS2CR4; JBTS14,transmembrane protein 237,2q33.1,protein-coding,/
CWITA011995,TCMBANKGE011995,MET,AUTS9; HGFR; RCCP2; cNMet,met proto-oncogene (hepatocyte growth factor receptor),7q31,protein-coding,
CWITA011996,TCMBANKGE011996,LRRTM4,-,leucine rich repeat transmembrane neuronal 4,2p12,protein-coding,/
CWITA011997,TCMBANKGE011997,LRMDA,C10orf11; CDA017,leucine rich melanocyte differentiation associated,10q22.2-q22.3,protein-coding,/
CWITA011998,TCMBANKGE011998,USB1,C16orf57; HVSL1; Mpn1; PN; hUsb1,U6 snRNA biogenesis phosphodiesterase 1,16q21,protein-coding,/
CWITA011999,TCMBANKGE011999,PEPD,PROLIDASE,peptidase D,19q13.11,protein-coding,Research target
CWITA012000,TCMBANKGE012000,PRRX2,PMX2; PRX2,paired related homeobox 2,9q34.11,protein-coding,/
CWITA012001,TCMBANKGE012001,VWA5A,BCSC-1; BCSC1; LOH11CR2A,von Willebrand factor A domain containing 5A,11q24.2,protein-coding,/
CWITA012002,TCMBANKGE012002,TMEM178A,TMEM178,transmembrane protein 178A,2p22.1,protein-coding,/
CWITA012003,TCMBANKGE012003,KCNC1,EPM7; KV3.1; KV4; NGK2,potassium voltage-gated channel subfamily C member 1,11p15.1,protein-coding,Research target
CWITA012004,TCMBANKGE012004,NUDT11,APS1; ASP1; DIPP3b; DIPP3beta; hDIPP3beta,nudix hydrolase 11,Xp11.22,protein-coding,/
CWITA012005,TCMBANKGE012005,ZNF91,HPF7; HTF10,zinc finger protein 91,19p12,protein-coding,/
CWITA012006,TCMBANKGE012006,MED18,SRB5; p28b,mediator complex subunit 18,1p35.3,protein-coding,/
CWITA012007,TCMBANKGE012007,PARN,DAN; DKCB6; PFBMFT4,poly(A)-specific ribonuclease,16p13.12,protein-coding,/
CWITA012008,TCMBANKGE012008,DMXL2,DFNA71; EIEE81; PEPNS; RC3,Dmx like 2,15q21.2,protein-coding,/
CWITA012009,TCMBANKGE012009,TGIF2,-,TGFB induced factor homeobox 2,20q11.23,protein-coding,/
CWITA012010,TCMBANKGE012010,LAMC1,LAMB2,laminin subunit gamma 1,1q25.3,protein-coding,/
CWITA012011,TCMBANKGE012011,C4B,C4B1; C4B12; C4B2; C4B3; C4B5; C4BD; C4B_2; C4F; CH; CO4; CPAMD3,complement C4B (Chido blood group),6p21.33,protein-coding,/
CWITA012012,TCMBANKGE012012,SH3GL1,CNSA1; EEN; SH3D2B; SH3P8,"SH3 domain containing GRB2 like 1, endophilin A2",19p13.3,protein-coding,Research target
CWITA012013,TCMBANKGE012013,ZNF330,HSA6591; NOA36,zinc finger protein 330,4q31.21,protein-coding,/
CWITA012014,TCMBANKGE012014,NDUFS2,CIN49,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)",1q23,protein-coding,
CWITA012015,TCMBANKGE012015,FNTB,FPTB; MGC31935,"farnesyltransferase, CAAX box, beta",14q23-q24,protein-coding,
CWITA012016,TCMBANKGE012016,GPX6,GPX5p; GPXP3; GPxN6; GSHPxN6; dJ1186N24; dJ1186N24.1,glutathione peroxidase 6 (olfactory),6p22.1,protein-coding,
CWITA012017,TCMBANKGE012017,KCNJ14,IRK4; KIAA1942; KIR2.4; MGC46111,"potassium inwardly-rectifying channel, subfamily J, member 14",19q13,protein-coding,
CWITA012018,TCMBANKGE012018,SNW1,Bx42; FUN20; NCOA-62; PRPF45; Prp45; SKIIP; SKIP; SKIP1,SNW domain containing 1,14q24.3,protein-coding,/
CWITA012019,TCMBANKGE012019,COG4,CDG2J; COD1; SWILS,component of oligomeric golgi complex 4,16q22.1,protein-coding,/
CWITA012020,TCMBANKGE012020,KANK4,ANKRD38; dJ1078M7.1,KN motif and ankyrin repeat domains 4,1p31.3,protein-coding,/
CWITA012021,TCMBANKGE012021,MRPS26,C20orf193; GI008; MRP-S13; MRP-S26; MRPS13; NY-BR-87; RPMS13; dJ534B8.3,mitochondrial ribosomal protein S26,20p13,protein-coding,/
CWITA012022,TCMBANKGE012022,CACNB4,CAB4; CACNLB4; EA5; EIG9; EJM; EJM4; EJM6,calcium voltage-gated channel auxiliary subunit beta 4,2q23.3,protein-coding,/
CWITA012023,TCMBANKGE012023,ZNF135,ZNF61; ZNF78L1; pHZ-17; pT3,zinc finger protein 135,19q13.43,protein-coding,/
CWITA012024,TCMBANKGE012024,KIF2C,KNSL6; MCAK,kinesin family member 2C,1p34.1,protein-coding,
CWITA012025,TCMBANKGE012025,GRK5,FP2025; GPRK5,G protein-coupled receptor kinase 5,10q26.11,protein-coding,Research target
CWITA012026,TCMBANKGE012026,LGALS9,HUAT; LGALS9A,galectin 9,17q11.2,protein-coding,/
CWITA012027,TCMBANKGE012027,CORO7-PAM16,CORO7; Coronin-7; Crn7,CORO7-PAM16 readthrough,16p13.3,protein-coding,/
CWITA012028,TCMBANKGE012028,PIK3C2G,PI3K-C2-gamma; PI3K-C2GAMMA,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,12p12.3,protein-coding,/
CWITA012029,TCMBANKGE012029,TSPAN31,SAS,tetraspanin 31,12q14.1,protein-coding,/
CWITA012030,TCMBANKGE012030,ZBED3,-,zinc finger BED-type containing 3,5q13.3,protein-coding,/
CWITA012031,TCMBANKGE012031,RAB8A,MEL; RAB8,"RAB8A, member RAS oncogene family",19p13.11,protein-coding,/
CWITA012032,TCMBANKGE012032,SERPINA6,CBG,serpin family A member 6,14q32.13,protein-coding,Successful target
CWITA012033,TCMBANKGE012033,RAP2A,KNREV; KREV; RAP2; RbBPN30,"RAP2A, member of RAS oncogene family",13q34,protein-coding,
CWITA012034,TCMBANKGE012034,FADS2,D6D; DES6; FADSD6; LLCDL2; SLL0262; TU13,fatty acid desaturase 2,11q12.2,protein-coding,Research target
CWITA012035,TCMBANKGE012035,SETDB2,C13orf4; CLLD8; CLLL8; KMT1F,SET domain bifurcated histone lysine methyltransferase 2,13q14.2,protein-coding,/
CWITA012036,TCMBANKGE012036,RP1,DCDC4A; ORP1,RP1 axonemal microtubule associated,8q11.23-q12.1,protein-coding,/
CWITA012037,TCMBANKGE012037,LRRC8A,AGM5; LRRC8; SWELL1,leucine rich repeat containing 8 VRAC subunit A,9q34.11,protein-coding,/
CWITA012038,TCMBANKGE012038,Gnf4,-,growth and fatness 4,2 62.49 cM,unknown,/
CWITA012039,TCMBANKGE012039,ACSM3,SA; SAH,acyl-CoA synthetase medium chain family member 3,16p12.3,protein-coding,/
CWITA012040,TCMBANKGE012040,NDUFS1,CIN75Kd; CIN75k; MGC26839; PRO1304,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",2q33-q34,protein-coding,
CWITA012041,TCMBANKGE012041,DUSP26,DSP-4; DUSP24; LDP-4; LDP4; MKP-8; MKP8; NATA1; NEAP; SKRP3,dual specificity phosphatase 26,8p12,protein-coding,/
CWITA012042,TCMBANKGE012042,SIL1,BAP; MSS; ULG5,SIL1 nucleotide exchange factor,5q31.2,protein-coding,/
CWITA012043,TCMBANKGE012043,RTL1,HUR1; MART1; Mar1; PEG11; SIRH2,retrotransposon Gag like 1,14q32.2,protein-coding,/
CWITA012044,TCMBANKGE012044,THBD,AHUS6; BDCA3; CD141; THRM; TM,thrombomodulin,20p11.2,protein-coding,
CWITA012045,TCMBANKGE012045,CLCA2,CACC; CACC3; CLCRG2; CaCC-3,chloride channel accessory 2,1p22.3,protein-coding,/
CWITA012046,TCMBANKGE012046,ARSA,ASA; MLD,arylsulfatase A,22q13.33,protein-coding,Clinical Trial target
CWITA012047,TCMBANKGE012047,KRTAP5-2,KRTAP5-8; KRTAP5.2,keratin associated protein 5-2,11p15.5,protein-coding,/
CWITA012048,TCMBANKGE012048,HLA-B,AS; B-4901; HLAB,"major histocompatibility complex, class I, B",6p21.33,protein-coding,Clinical Trial target
CWITA012049,TCMBANKGE012049,UFM1,BM-002; C13orf20; HLD14,ubiquitin fold modifier 1,13q13.3,protein-coding,/
CWITA012050,TCMBANKGE012050,SLC2A6,GLUT6; GLUT9; HSA011372,"solute carrier family 2 (facilitated glucose transporter), member 6",9q34,protein-coding,
CWITA012051,TCMBANKGE012051,UTP25,C1orf107; DEF; DIEXF; DJ434O14.5,"Utp25,_Small_Subunit_Processor_Component",1q32.2,protein-coding,
CWITA012052,TCMBANKGE012052,BCAT1,BCATC; BCT1; DKFZp686E12175; ECA39; MECA39; PNAS121; PP18,"branched chain amino-acid transaminase 1, cytosolic",12p12.1,protein-coding,
CWITA012053,TCMBANKGE012053,PSMD8,HEL-S-91n; HIP6; HYPF; Nin1p; Rpn12; S14; p31,"proteasome 26S subunit, non-ATPase 8",19q13.2,protein-coding,/
CWITA012054,TCMBANKGE012054,RASSF9,P-CIP1; PAMCI; PCIP1,Ras association domain family member 9,12q21.31,protein-coding,/
CWITA012055,TCMBANKGE012055,SMPX,Chisel; Csl; DFN6; DFNX4,small muscle protein X-linked,Xp22.12,protein-coding,/
CWITA012056,TCMBANKGE012056,ACSBG1,BG; BG1; BGM; GR-LACS; LPD,acyl-CoA synthetase bubblegum family member 1,15q25.1,protein-coding,/
CWITA012057,TCMBANKGE012057,BOLL,BOULE,"boule homolog, RNA binding protein",2q33.1,protein-coding,/
CWITA012058,TCMBANKGE012058,KCNH4,BEC2; ELK1; Kv12.3,potassium voltage-gated channel subfamily H member 4,17q21.2,protein-coding,/
CWITA012059,TCMBANKGE012059,FREM2,CRYPTOP; FRASRS2,FRAS1 related extracellular matrix 2,13q13.3,protein-coding,/
CWITA012060,TCMBANKGE012060,GALNT8,GALNAC-T8,polypeptide N-acetylgalactosaminyltransferase 8,12p13.32,protein-coding,/
CWITA012061,TCMBANKGE012061,CNN3,-,calponin 3,1p21.3,protein-coding,/
CWITA012062,TCMBANKGE012062,PRKG2,PKG2; PRKGR2; cGK2; cGKII,protein kinase cGMP-dependent 2,4q21.21,protein-coding,Research target
CWITA012063,TCMBANKGE012063,APAF1,APAFN1; CED4; DKFZp781B1145,apoptotic peptidase activating factor 1,12q23,protein-coding,
CWITA012064,TCMBANKGE012064,GTSE1,B99,G2 and S-phase expressed 1,22q13.31,protein-coding,/
CWITA012065,TCMBANKGE012065,ERP27,C12orf46; PDIA8,endoplasmic reticulum protein 27,12p12.3,protein-coding,/
CWITA012066,TCMBANKGE012066,ADGRA1,GPR123,adhesion G protein-coupled receptor A1,10q26.3,protein-coding,/
CWITA012067,TCMBANKGE012067,INO80D,-,INO80 complex subunit D,2q33.3,protein-coding,/
CWITA012068,TCMBANKGE012068,WDR44,RAB11BP; RPH11; SYM-4,WD repeat domain 44,Xq24,protein-coding,/
CWITA012069,TCMBANKGE012069,SLC25A2,ORC2; ORNT2,solute carrier family 25 member 2,5q31.3,protein-coding,/
CWITA012070,TCMBANKGE012070,E2F6,E2F-6,E2F transcription factor 6,2p25.1,protein-coding,/
CWITA012071,TCMBANKGE012071,OSBPL8,MST120; MSTP120; ORP8; OSBP10,oxysterol binding protein like 8,12q21.2,protein-coding,/
CWITA012072,TCMBANKGE012072,OR4K13,OR14-27,olfactory receptor family 4 subfamily K member 13,14q11.2,protein-coding,/
CWITA012073,TCMBANKGE012073,HILPDA,C7orf68; HIG-2; HIG2,hypoxia inducible lipid droplet associated,7q32.1,protein-coding,/
CWITA012074,TCMBANKGE012074,SLC39A4,AEZ; AWMS2; ZIP4,solute carrier family 39 member 4,8q24.3,protein-coding,/
CWITA012075,TCMBANKGE012075,OCIAD2,-,OCIA domain containing 2,4p11,protein-coding,/
CWITA012076,TCMBANKGE012076,SPRY4,HH17,sprouty RTK signaling antagonist 4,5q31.3,protein-coding,/
CWITA012077,TCMBANKGE012077,HSD17B7,MGC12523; MGC75018; PRAP; SDR37C1,hydroxysteroid (17-beta) dehydrogenase 7,1q23,protein-coding,
CWITA012078,TCMBANKGE012078,FBLN1,FBLN; FIBL1,fibulin 1,22q13.31,protein-coding,/
CWITA012079,TCMBANKGE012079,PTPN9,MEG2; PTPMEG2,protein tyrosine phosphatase non-receptor type 9,15q24.2,protein-coding,/
CWITA012080,TCMBANKGE012080,PCDHGB7,ME6; PCDH-GAMMA-B7,"protocadherin gamma subfamily B, 7",5q31.3,protein-coding,/
CWITA012081,TCMBANKGE012081,ZNF213,CR53; ZKSCAN21; ZSCAN53,zinc finger protein 213,16p13.3,protein-coding,/
CWITA012082,TCMBANKGE012082,SDHAF2,C11orf79; PGL2; SDH5,succinate dehydrogenase complex assembly factor 2,11q12.2,protein-coding,/
CWITA012083,TCMBANKGE012083,PKN1,DBK; PAK-1; PAK1; PKN; PKN-ALPHA; PRK1; PRKCL1,protein kinase N1,19p13.12,protein-coding,Research target
CWITA012084,TCMBANKGE012084,LGALS9B,-,galectin 9B,17p11.2,protein-coding,/
CWITA012085,TCMBANKGE012085,ABCC6,ABC34; ARA; EST349056; MLP1; MOATE; MRP6; PXE; PXE1; URG7,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",16p13.1,protein-coding,
CWITA012086,TCMBANKGE012086,SLC26A10,-,solute carrier family 26 member 10,12q13.3,pseudo,/
CWITA012087,TCMBANKGE012087,VEZF1,DB1; ZNF161,vascular endothelial zinc finger 1,17q22,protein-coding,/
CWITA012088,TCMBANKGE012088,PNPO,FLJ10535; PDXPO,pyridoxamine 5'-phosphate oxidase,17q21.32,protein-coding,
CWITA012089,TCMBANKGE012089,SFT2D3,-,SFT2 domain containing 3,2q14.3,protein-coding,/
CWITA012090,TCMBANKGE012090,BCL2,BclN2,B-cell CLL/lymphoma 2,18q21.33|18q21.3,protein-coding,
CWITA012091,TCMBANKGE012091,PCDHB6,PCDH-BETA6,protocadherin beta 6,5q31.3,protein-coding,/
CWITA012092,TCMBANKGE012092,KPNA6,IPOA7,karyopherin subunit alpha 6,1p35.2,protein-coding,/
CWITA012093,TCMBANKGE012093,ARF1,N,ADP-ribosylation factor 1,1q42,protein-coding,
CWITA012094,TCMBANKGE012094,PRKCZ,PKC-ZETA; PKC2,protein kinase C zeta,1p36.33,protein-coding,Research target
CWITA012095,TCMBANKGE012095,ZNF679,-,zinc finger protein 679,7q11.21,protein-coding,/
CWITA012096,TCMBANKGE012096,NIN,SCKL7,ninein,14q22.1,protein-coding,/
CWITA012097,TCMBANKGE012097,FLRT1,SPG68,fibronectin leucine rich transmembrane protein 1,11q13.1,protein-coding,/
CWITA012098,TCMBANKGE012098,RETSAT,FLJ20296,"retinol saturase (all-trans-retinol 13,14-reductase)",2p11.2,protein-coding,
CWITA012099,TCMBANKGE012099,ADAL,HsMAPDA,adenosine deaminase like,15q15.3,protein-coding,/
CWITA012100,TCMBANKGE012100,HCK,JTK9; p59Hck; p61Hck,"HCK proto-oncogene, Src family tyrosine kinase",20q11.21,protein-coding,Research target
CWITA012101,TCMBANKGE012101,GOT1,AST1; ASTQTL1; GIG18; cAspAT; cCAT,glutamic-oxaloacetic transaminase 1,10q24.2,protein-coding,Research target
CWITA012102,TCMBANKGE012102,VPS28,-,VPS28 subunit of ESCRT-I,8q24.3,protein-coding,/
CWITA012103,TCMBANKGE012103,CLCN2,CIC-2; CLC2; ECA2; ECA3; EGI11; EGI3; EGMA; EJM6; EJM8; HALD2; LKPAT; clC-2,chloride voltage-gated channel 2,3q27.1,protein-coding,Successful target
CWITA012104,TCMBANKGE012104,FECH,EPP; FCE,ferrochelatase,18q21.3,protein-coding,
CWITA012105,TCMBANKGE012105,ABHD14B,CIB; HEL-S-299,abhydrolase domain containing 14B,3p21.2,protein-coding,/
CWITA012106,TCMBANKGE012106,TRAPPC1,BET5; MUM2,trafficking protein particle complex 1,17p13.1,protein-coding,/
CWITA012107,TCMBANKGE012107,CFP,BFD; PFC; PFD; PROPERDIN,complement factor properdin,Xp11.23,protein-coding,Research target
CWITA012108,TCMBANKGE012108,ZFAND4,ANUBL1,zinc finger AN1-type containing 4,10q11.22,protein-coding,/
CWITA012109,TCMBANKGE012109,PRMT5,HRMT1L5; HSL7; IBP72; JBP1; SKB1; SKB1Hs,protein arginine methyltransferase 5,14q11.2,protein-coding,Clinical Trial target
CWITA012110,TCMBANKGE012110,ACOX3,-,"acyl-CoA oxidase 3, pristanoyl",4p16.1,protein-coding,/
CWITA012111,TCMBANKGE012111,NEDD4L,NEDD4-2; NEDD4.2; PVNH7; RSP5; hNEDD4-2,NEDD4 like E3 ubiquitin protein ligase,18q21.31,protein-coding,/
CWITA012112,TCMBANKGE012112,KCND1,KV4.1,potassium voltage-gated channel subfamily D member 1,Xp11.23,protein-coding,Research target
CWITA012113,TCMBANKGE012113,SLC7A5,4F2LC; CD98; D16S469E; E16; LAT1; MPE16,solute carrier family 7 member 5,16q24.2,protein-coding,Research target
CWITA012114,TCMBANKGE012114,FAM135A,KIAA1411,family with sequence similarity 135 member A,6q13,protein-coding,/
CWITA012115,TCMBANKGE012115,PGRMC2,DG6; PMBP,progesterone receptor membrane component 2,4q28.2,protein-coding,/
CWITA012116,TCMBANKGE012116,A4GALT,A14GALT; A4GALT1; Gb3S; P(k); P1; P1PK; PK,"alpha 1,4-galactosyltransferase (P blood group)",22q13.2,protein-coding,/
CWITA012117,TCMBANKGE012117,GOLGA2,GM130,golgin A2,9q34.11,protein-coding,/
CWITA012118,TCMBANKGE012118,TMPRSS2,PRSS10,transmembrane serine protease 2,21q22.3,protein-coding,Research target
CWITA012119,TCMBANKGE012119,ZFYVE19,ANCHR; MPFYVE,zinc finger FYVE-type containing 19,15q15.1,protein-coding,/
CWITA012120,TCMBANKGE012120,SHC4,RaLP; SHCD,SHC adaptor protein 4,15q21.1,protein-coding,/
CWITA012121,TCMBANKGE012121,CASC3,BTZ; MLN51,CASC3 exon junction complex subunit,17q21.1,protein-coding,/
CWITA012122,TCMBANKGE012122,NAALADL1,I100; NAALADASEL,N-acetylated alpha-linked acidic dipeptidase like 1,11q13.1,protein-coding,/
CWITA012123,TCMBANKGE012123,HPCAL1,BDR1; HLP2; VILIP-3,hippocalcin like 1,2p25.1,protein-coding,/
CWITA012124,TCMBANKGE012124,STAT5B,STAT5,signal transducer and activator of transcription 5B,17q11.2,protein-coding,
CWITA012125,TCMBANKGE012125,HADH,HAD; HADH1; HADHSC; HCDH; HHF4; MGC8392; MSCHAD; SCHAD,hydroxyacyl-CoA dehydrogenase,4q22-q26,protein-coding,
CWITA012126,TCMBANKGE012126,ZCCHC24,C10orf56; Z3CXXC8,zinc finger CCHC-type containing 24,10q22.3,protein-coding,/
CWITA012127,TCMBANKGE012127,NIPSNAP3B,FP944; NIPSNAP3; SNAP1,nipsnap homolog 3B,9q31.1,protein-coding,/
CWITA012128,TCMBANKGE012128,IFIH1,AGS7; Hlcd; IDDM19; MDA-5; MDA5; RLR-2; SGMRT1,interferon induced with helicase C domain 1,2q24.2,protein-coding,/
CWITA012129,TCMBANKGE012129,ATP11B,ATPIF; ATPIR,ATPase phospholipid transporting 11B (putative),3q26.33,protein-coding,/
CWITA012130,TCMBANKGE012130,ZNF417,-,zinc finger protein 417,19q13.43,protein-coding,/
CWITA012131,TCMBANKGE012131,NAMPT,1110035O14Rik; PBEF; PBEF1; VF; VISFATIN,nicotinamide phosphoribosyltransferase,7q22.3,protein-coding,Clinical Trial target
CWITA012132,TCMBANKGE012132,MMP12,HME; ME; MGC138506; MME; MMPN12,matrix metallopeptidase 12 (macrophage elastase),11q22.3,protein-coding,
CWITA012133,TCMBANKGE012133,HCN1,BCNG-1; BCNG1; EIEE24; GEFSP10; HAC-2,hyperpolarization activated cyclic nucleotide gated potassium channel 1,5p12,protein-coding,Research target
CWITA012134,TCMBANKGE012134,NPR3,ANP-C; ANPR-C; ANPRC; C5orf23; GUCY2B; NPR-C; NPRC,natriuretic peptide receptor 3,5p13.3,protein-coding,Clinical Trial target
CWITA012135,TCMBANKGE012135,GNB5,GB5; IDDCA; LADCI; gbeta5,G protein subunit beta 5,15q21.2,protein-coding,/
CWITA012136,TCMBANKGE012136,TRIM26,AFP; RNF95; ZNF173,tripartite motif containing 26,6p22.1,protein-coding,/
CWITA012137,TCMBANKGE012137,DNAJC12,HPANBH4; JDP1,DnaJ heat shock protein family (Hsp40) member C12,10q21.3,protein-coding,/
CWITA012138,TCMBANKGE012138,ZNF711,CMPX1; MRX65; MRX97; ZNF4; ZNF5; ZNF6; Zfp711; dJ75N13.1,zinc finger protein 711,Xq21.1,protein-coding,/
CWITA012139,TCMBANKGE012139,BMP1,OI13; PCOLC; PCP; PCP2; TLD,bone morphogenetic protein 1,8p21.3,protein-coding,Research target
CWITA012140,TCMBANKGE012140,SMC4,CAP-C; CAPC; SMC-4; SMC4L1,structural maintenance of chromosomes 4,3q25.33,protein-coding,/
CWITA012141,TCMBANKGE012141,RPF2,BXDC1; bA397G5.4,ribosome production factor 2 homolog,6q21,protein-coding,/
CWITA012142,TCMBANKGE012142,GDE1,363E6.2; MIR16,glycerophosphodiester phosphodiesterase 1,16p12.3,protein-coding,/
CWITA012143,TCMBANKGE012143,MT1X,MT-1l; MT1,metallothionein 1X,16q13,protein-coding,/
CWITA012144,TCMBANKGE012144,RDH13,DKFZp313H0740; FLJ39479; SDR7C3,retinol dehydrogenase 13 (all-trans/9-cis),19q13.42,protein-coding,
CWITA012145,TCMBANKGE012145,CDO1,CDO-I,cysteine dioxygenase type 1,5q22.3,protein-coding,/
CWITA012146,TCMBANKGE012146,GXYLT1,GLT8D3,glucoside xylosyltransferase 1,12q12,protein-coding,/
CWITA012147,TCMBANKGE012147,PGLYRP4,PGLYRPIbeta; PGRP-Ibeta; PGRPIB; SBBI67,peptidoglycan recognition protein 4,1q21.3,protein-coding,/
CWITA012148,TCMBANKGE012148,LSM6,YDR378C,"LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)",4q31.22,protein-coding,
CWITA012149,TCMBANKGE012149,RAB11A,MGC1490; YL8,"RAB11A, member RAS oncogene family",15q22.31,protein-coding,
CWITA012150,TCMBANKGE012150,SLF1,ANKRD32; BRCTD1; BRCTx,SMC5-SMC6 complex localization factor 1,5q15,protein-coding,/
CWITA012151,TCMBANKGE012151,CLVS2,C6orf212; C6orf213; RLBP1L2; bA160A10.4,clavesin 2,6q22.31,protein-coding,/
CWITA012152,TCMBANKGE012152,PPARD,FAAR; MGC3931; NR1C2; NUC1; NUCI; NUCII; PPARB,peroxisome proliferator-activated receptor delta,6p21.2,protein-coding,
CWITA012153,TCMBANKGE012153,BMS1,ACC; BMS1L,BMS1 ribosome biogenesis factor,10q11.21,protein-coding,/
CWITA012154,TCMBANKGE012154,BORA,C13orf34,BORA aurora kinase A activator,13q21.33,protein-coding,/
CWITA012155,TCMBANKGE012155,SLC6A3,DAT; DAT1; PKDYS; PKDYS1,solute carrier family 6 member 3,5p15.33,protein-coding,Successful target
CWITA012156,TCMBANKGE012156,EMILIN3,C20orf130; EMILIN5; dJ620E11.4,elastin microfibril interfacer 3,20q12,protein-coding,/
CWITA012157,TCMBANKGE012157,TRIM17,RBCC; RNF16; terf,tripartite motif containing 17,1q42.13,protein-coding,/
CWITA012158,TCMBANKGE012158,ACRBP,CT23; OY-TES-1; SP32,acrosin binding protein,12p13.31,protein-coding,/
CWITA012159,TCMBANKGE012159,ZNF493,-,zinc finger protein 493,19p12,protein-coding,/
CWITA012160,TCMBANKGE012160,MTFMT,FMT1,mitochondrial methionyl-tRNA formyltransferase,15q22.31,protein-coding,
CWITA012161,TCMBANKGE012161,TGM7,TGMZ,transglutaminase 7,15q15.2,protein-coding,
CWITA012162,TCMBANKGE012162,SETD6,-,"SET domain containing 6, protein lysine methyltransferase",16q21,protein-coding,/
CWITA012163,TCMBANKGE012163,HOXD8,HOX4; HOX4E; HOX5.4,homeobox D8,2q31.1,protein-coding,/
CWITA012164,TCMBANKGE012164,STRA6,MCOPCB8; MCOPS9; PP14296,signaling receptor and transporter of retinol STRA6,15q24.1,protein-coding,/
CWITA012165,TCMBANKGE012165,CCDC138,-,coiled-coil domain containing 138,2q13,protein-coding,/
CWITA012166,TCMBANKGE012166,HACD2,PTPLB,3-hydroxyacyl-CoA dehydratase 2,3q21.1,protein-coding,/
CWITA012167,TCMBANKGE012167,CUL4A,-,cullin 4A,13q34,protein-coding,/
CWITA012168,TCMBANKGE012168,SREBF2,SREBP-2; SREBP2; bHLHd2,sterol regulatory element binding transcription factor 2,22q13.2,protein-coding,Research target
CWITA012169,TCMBANKGE012169,ARF6,DKFZp564M0264,ADP-ribosylation factor 6,14q21.3,protein-coding,
CWITA012170,TCMBANKGE012170,TMEM168,-,transmembrane protein 168,7q31.1,protein-coding,/
CWITA012171,TCMBANKGE012171,GABBR1,GABABR1; GABBR1-3; GB1; GPRC3A,gamma-aminobutyric acid type B receptor subunit 1,6p22.1,protein-coding,/
CWITA012172,TCMBANKGE012172,LAMB2,LAMS; NPHS5,laminin subunit beta 2,3p21.31,protein-coding,/
CWITA012173,TCMBANKGE012173,LRRCC1,CLERC; CLERK; SAP2; VFL1,Leucine_Rich_Repeat_And_Coiled-Coil_Centrosomal_Protein_1,8q21.2,protein-coding,
CWITA012174,TCMBANKGE012174,CLPP,N,"ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli)",19p13.3,protein-coding,
CWITA012175,TCMBANKGE012175,MAPKAPK3,3PK; MAPKAP-K3; MAPKAP3; MAPKAPK-3; MDPT3; MK-3; MK3,MAPK activated protein kinase 3,3p21.2,protein-coding,Research target
CWITA012176,TCMBANKGE012176,PLBD1,-,phospholipase B domain containing 1,12p13.1,protein-coding,/
CWITA012177,TCMBANKGE012177,RAP1B,K-REV; RAL1B,"RAP1B, member of RAS oncogene family",12q15,protein-coding,/
CWITA012178,TCMBANKGE012178,CHKA,CHK; CK; CKI; EK,choline kinase alpha,11q13.2,protein-coding,
CWITA012179,TCMBANKGE012179,ZMYM5,HSPC050; MYM; ZNF198L1; ZNF237,zinc finger MYM-type containing 5,13q12.11,protein-coding,/
CWITA012180,TCMBANKGE012180,SLC2A5,GLUT5,"solute carrier family 2 (facilitated glucose/fructose transporter), member 5",1p36.2,protein-coding,
CWITA012181,TCMBANKGE012181,LMX1B,LMX1.2; NPS1,LIM homeobox transcription factor 1 beta,9q33.3,protein-coding,/
CWITA012182,TCMBANKGE012182,HES6,C-HAIRY1; HES-6; bHLHb41; bHLHc23,hes family bHLH transcription factor 6,2q37.3,protein-coding,/
CWITA012183,TCMBANKGE012183,STOX2,-,storkhead box 2,4q35.1,protein-coding,/
CWITA012184,TCMBANKGE012184,PPTC7,TA-PP2C; TAPP2C,protein phosphatase targeting COQ7,12q24.11,protein-coding,/
CWITA012185,TCMBANKGE012185,PCYT1A,CCTA; CT; CTA; CTPCT; PCYT1,"phosphate cytidylyltransferase 1, choline, alpha",3q29,protein-coding,
CWITA012186,TCMBANKGE012186,POU2F3,Epoc-1; OCT-11; OCT11; OTF-11; PLA-1; PLA1; Skn-1a,POU class 2 homeobox 3,11q23.3,protein-coding,/
CWITA012187,TCMBANKGE012187,GDF7,BMP12,growth differentiation factor 7,2p24.1,protein-coding,/
CWITA012188,TCMBANKGE012188,FUT3,CD174; FT3B; FucT-III; LE; Les,fucosyltransferase 3 (Lewis blood group),19p13.3,protein-coding,Clinical Trial target
CWITA012189,TCMBANKGE012189,NTAN1,PNAA; PNAD,N-terminal asparagine amidase,16p13.11,protein-coding,/
CWITA012190,TCMBANKGE012190,STX16,SYN16,syntaxin 16,20q13.32,protein-coding,/
CWITA012191,TCMBANKGE012191,KCTD6,KCASH3,potassium channel tetramerization domain containing 6,3p14.3,protein-coding,/
CWITA012192,TCMBANKGE012192,ZNF862,-,zinc finger protein 862,7q36.1,protein-coding,/
CWITA012193,TCMBANKGE012193,CDK5RAP1,C20orf34; C42; CGI-05; HSPC167,CDK5 regulatory subunit associated protein 1,20q11.21,protein-coding,/
CWITA012194,TCMBANKGE012194,STIP1,HEL-S-94n; HOP; IEF-SSP-3521; P60; STI1; STI1L,stress induced phosphoprotein 1,11q13.1,protein-coding,/
CWITA012195,TCMBANKGE012195,KIF5A,ALS25; D12S1889; MY050; NEIMY; NKHC; SPG10,kinesin family member 5A,12q13.3,protein-coding,Research target
CWITA012196,TCMBANKGE012196,ATRX,JMS; MRX52; RAD54; RAD54L; XH2; XNP; ZNF-HX,ATRX chromatin remodeler,Xq21.1,protein-coding,/
CWITA012197,TCMBANKGE012197,PTGDR,AS1; ASRT1; DP; DP1; PTGDR1,prostaglandin D2 receptor,14q22.1,protein-coding,Clinical Trial target
CWITA012198,TCMBANKGE012198,IRF2BP1,-,interferon regulatory factor 2 binding protein 1,19q13.32,protein-coding,/
CWITA012199,TCMBANKGE012199,BIRC8,ILP-2; ILP2; RNF136; hILP2,baculoviral IAP repeat containing 8,19q13.42,pseudo,/
CWITA012200,TCMBANKGE012200,NSD3,KMT3F; KMT3G; WHISTLE; WHSC1L1; pp14328,nuclear receptor binding SET domain protein 3,8p11.23,protein-coding,/
CWITA012201,TCMBANKGE012201,DFFB,CAD; CPAN; DFF-40; DFF2; DFF40,DNA fragmentation factor subunit beta,1p36.32,protein-coding,Research target
CWITA012202,TCMBANKGE012202,GPI,AMF; GNPI; NLK; PGI; PHI; SA-36; SA36,glucose-6-phosphate isomerase,19q13.11,protein-coding,Research target
CWITA012203,TCMBANKGE012203,FH,FMRD; HLRCC; HsFH; LRCC; MCL; MCUL1,fumarate hydratase,1q43,protein-coding,/
CWITA012204,TCMBANKGE012204,ACAD8,ACAD-8; ARC42; IBDH,acyl-CoA dehydrogenase family member 8,11q25,protein-coding,/
CWITA012205,TCMBANKGE012205,RFC5,RFC36,replication factor C subunit 5,12q24.23,protein-coding,/
CWITA012206,TCMBANKGE012206,ZNF93,HPF34; HTF34; TF34; ZNF505,zinc finger protein 93,19p12,protein-coding,/
CWITA012207,TCMBANKGE012207,NDUFB1,CINMNLL; CINSGDH; MNLL,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa",14q32.12,protein-coding,
CWITA012208,TCMBANKGE012208,AASS,LKR/SDH; LKRSDH; LORSDH,aminoadipate-semialdehyde synthase,7q31.32,protein-coding,/
CWITA012209,TCMBANKGE012209,ITM2C,BRI3; BRICD2C; E25; E25C; ITM3,integral membrane protein 2C,2q37.1,protein-coding,/
CWITA012210,TCMBANKGE012210,ADGRA3,GPR125; PGR21; TEM5L,adhesion G protein-coupled receptor A3,4p15.2,protein-coding,/
CWITA012211,TCMBANKGE012211,HMGB1,DKFZp686A04236; HMG1; HMG3; SBPN1,high mobility group box 1,13q12,protein-coding,
CWITA012212,TCMBANKGE012212,CLDN3,C7orf1; CPE-R2; CPETR2; HRVP1; RVP1,claudin 3,7q11.23,protein-coding,/
CWITA012213,TCMBANKGE012213,TRPM1,CSNB1C; LTRPC1; MLSN1,transient receptor potential cation channel subfamily M member 1,15q13.3,protein-coding,Research target
CWITA012214,TCMBANKGE012214,NEUROG1,AKA; Math4C; NEUROD3; bHLHa6; ngn1,neurogenin 1,5q31.1,protein-coding,/
CWITA012215,TCMBANKGE012215,FBXO45,Fbx45,F-box protein 45,3q29,protein-coding,/
CWITA012216,TCMBANKGE012216,SERPINA1,A1A; A1AT; AAT; MGC23330; MGC9222; PI; PI1; PRO2275; alpha1AT,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",14q32.1,protein-coding,
CWITA012217,TCMBANKGE012217,MSI1,-,musashi RNA binding protein 1,12q24.31,protein-coding,Research target
CWITA012218,TCMBANKGE012218,NUP43,bA350J20.1; p42,nucleoporin 43,6q25.1,protein-coding,/
CWITA012219,TCMBANKGE012219,CACNA2D4,RCD4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,12p13.33,protein-coding,/
CWITA012220,TCMBANKGE012220,TTC31,-,tetratricopeptide repeat domain 31,2p13.1,protein-coding,/
CWITA012221,TCMBANKGE012221,SULT1C3,ST1C3,sulfotransferase family 1C member 3,2q12.3,protein-coding,/
CWITA012222,TCMBANKGE012222,IFNA13,-,interferon alpha 13,9p21.3,protein-coding,/
CWITA012223,TCMBANKGE012223,RLIM,MRX61; NY-REN-43; RNF12; TOKAS,"ring finger protein, LIM domain interacting",Xq13.2,protein-coding,/
CWITA012224,TCMBANKGE012224,VDR,NR1I1; PPP1R163,vitamin D receptor,12q13.11,protein-coding,Successful target
CWITA012225,TCMBANKGE012225,PKP3,-,plakophilin 3,11p15.5,protein-coding,/
CWITA012226,TCMBANKGE012226,NSF,SKD2,N-ethylmaleimide-sensitive factor,17q21,protein-coding,
CWITA012227,TCMBANKGE012227,GCDH,ACAD5; GCD,glutaryl-CoA dehydrogenase,19p13.13,protein-coding,/
CWITA012228,TCMBANKGE012228,DGCR8,C22orf12; DGCRK6; Gy1; pasha,DGCR8 microprocessor complex subunit,22q11.21,protein-coding,/
CWITA012229,TCMBANKGE012229,URB2,KIAA0133; NET10; NPA2,URB2 ribosome biogenesis homolog,1q42.13,protein-coding,/
CWITA012230,TCMBANKGE012230,CNDP1,CN1; CPGL2; HsT2308,carnosine dipeptidase 1,18q22.3,protein-coding,/
CWITA012231,TCMBANKGE012231,UBD,FAT10; GABBR1; UBD-3,ubiquitin D,6p22.1,protein-coding,/
CWITA012232,TCMBANKGE012232,CDC14A,DFNB105; DFNB32; DFNB35; cdc14; hCDC14,cell division cycle 14A,1p21.2,protein-coding,/
CWITA012233,TCMBANKGE012233,KCNK3,K2p3.1; OAT1; TASK; TASKN1; TBAK1,"potassium channel, subfamily K, member 3",2p23,protein-coding,
CWITA012234,TCMBANKGE012234,P2RY11,P2Y11,purinergic receptor P2Y11,19p13.2,protein-coding,Discontinued target
CWITA012235,TCMBANKGE012235,NDUFB5,CISGDH; SGDH,NADH:ubiquinone oxidoreductase subunit B5,3q26.33,protein-coding,/
CWITA012236,TCMBANKGE012236,CXXC1,2410002I16Rik; 5830420C16Rik; CFP1; CGBP; HsT2645; PCCX1; PHF18; SPP1; ZCGPC1; hCGBP,CXXC finger protein 1,18q21.1,protein-coding,/
CWITA012237,TCMBANKGE012237,SMG7,C1orf16; EST1C; SGA56M,SMG7 nonsense mediated mRNA decay factor,1q25.3,protein-coding,/
CWITA012238,TCMBANKGE012238,CLIC6,CLIC1L,chloride intracellular channel 6,21q22.12,protein-coding,/
CWITA012239,TCMBANKGE012239,SMARCA2,BAF190; BRM; NCBRS; SNF2; SNF2L2; SNF2LA; SWI2; Sth1p; hBRM; hSNF2a,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",9p24.3,protein-coding,/
CWITA012240,TCMBANKGE012240,SELENOS,AD-015; ADO15; SBBI8; SELS; SEPS1; VIMP,selenoprotein S,15q26.3,protein-coding,/
CWITA012241,TCMBANKGE012241,APLP1,APLP,amyloid beta precursor like protein 1,19q13.12,protein-coding,/
CWITA012242,TCMBANKGE012242,ALG1,CDG1K; HMAT1; HMT-1; HMT1; MT-1; Mat-1; hMat-1,ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase,16p13.3,protein-coding,/
CWITA012243,TCMBANKGE012243,RNF135,L13; MMFD; REUL; Riplet,ring finger protein 135,17q11.2,protein-coding,/
CWITA012244,TCMBANKGE012244,DTNA,D18S892E; DRP3; DTN; DTN-A; LVNC1,dystrobrevin alpha,18q12.1,protein-coding,/
CWITA012245,TCMBANKGE012245,ACOX1,ACOX; PALMCOX; SCOX,acyl-CoA oxidase 1,17q25.1,protein-coding,/
CWITA012246,TCMBANKGE012246,TLR9,CD289,toll like receptor 9,3p21.2,protein-coding,Clinical Trial target
CWITA012247,TCMBANKGE012247,DCAF1,RIP; VPRBP,DDB1 and CUL4 associated factor 1,3p21.2,protein-coding,/
CWITA012248,TCMBANKGE012248,PDLIM7,LMP1; LMP3,PDZ and LIM domain 7,5q35.3,protein-coding,/
CWITA012249,TCMBANKGE012249,DLST,DLTS; KGD2; PGL7,dihydrolipoamide S-succinyltransferase,14q24.3,protein-coding,/
CWITA012250,TCMBANKGE012250,FARS2,FARS1; HSPC320; PheRS; dJ520B18.2,"phenylalanyl-tRNA synthetase 2, mitochondrial",6p25.1,protein-coding,
CWITA012251,TCMBANKGE012251,CDK4,CMM3; MGC14458; PSKNJ3,cyclin-dependent kinase 4,12q14,protein-coding,
CWITA012252,TCMBANKGE012252,OPCML,IGLON1; OBCAM; OPCM,opioid binding protein/cell adhesion molecule like,11q25,protein-coding,/
CWITA012253,TCMBANKGE012253,M6PR,CDNMPR; FLJ32994; MPR_46; MPRN46; MPR46; SMPR,mannose-6-phosphate receptor (cation dependent),12p13,protein-coding,
CWITA012254,TCMBANKGE012254,NFKBIA,IKBA; MADN3; NFKBI,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",14q13,protein-coding,
CWITA012255,TCMBANKGE012255,ABCA10,EST698739,ATP binding cassette subfamily A member 10,17q24.3,protein-coding,/
CWITA012256,TCMBANKGE012256,CHRM3,HM3,"cholinergic receptor, muscarinic 3",1q43,protein-coding,
CWITA012257,TCMBANKGE012257,CAPS,CAPS1,calcyphosine,19p13.3,protein-coding,/
CWITA012258,TCMBANKGE012258,AKR1C3,DD3; DDX; HA1753; HAKRB; HAKRe; HSD17B5; KIAA0119; PGFS; hluPGFS,"aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)",10p15-p14,protein-coding,
CWITA012259,TCMBANKGE012259,SH2D1A,DSHP; EBVS; IMD5; LYP; MTCP1; SAP; SAP/SH2D1A; XLP; XLPD; XLPD1,SH2 domain containing 1A,Xq25,protein-coding,/
CWITA012260,TCMBANKGE012260,TF,HEL-S-71p; PRO1557; PRO2086; TFQTL1,transferrin,3q22.1,protein-coding,Research target
CWITA012261,TCMBANKGE012261,DBP,DABP; taxREB302,D-box binding PAR bZIP transcription factor,19q13.33,protein-coding,/
CWITA012262,TCMBANKGE012262,OR10K1,OR1-6,olfactory receptor family 10 subfamily K member 1,1q23.1,protein-coding,/
CWITA012263,TCMBANKGE012263,ASB5,ASB-5,ankyrin repeat and SOCS box containing 5,4q34.2,protein-coding,/
CWITA012264,TCMBANKGE012264,THAP7,-,THAP domain containing 7,22q11.21,protein-coding,/
CWITA012265,TCMBANKGE012265,SLC25A40,MCFP,solute carrier family 25 member 40,7q21.12,protein-coding,/
CWITA012266,TCMBANKGE012266,CTH,MGC9471,cystathionase (cystathionine gamma-lyase),1p31.1,protein-coding,
CWITA012267,TCMBANKGE012267,EIF2B3,EIF-2B; EIF2Bgamma,eukaryotic translation initiation factor 2B subunit gamma,1p34.1,protein-coding,/
CWITA012268,TCMBANKGE012268,VDAC1,MGC111064; PORIN; VDACN1,voltage-dependent anion channel 1,5q31,protein-coding,
CWITA012269,TCMBANKGE012269,CPA3,MC-CPA,carboxypeptidase A3,3q24,protein-coding,/
CWITA012270,TCMBANKGE012270,SYNE2,EDMD5; KASH2; NUA; NUANCE; Nesp2; Nesprin-2; SYNE-2; TROPH,spectrin repeat containing nuclear envelope protein 2,14q23.2,protein-coding,/
CWITA012271,TCMBANKGE012271,ALDH4A1,ALDH4; DKFZp779M035; P5CD; P5CDh,"aldehyde dehydrogenase 4 family, member A1",1p36,protein-coding,
CWITA012272,TCMBANKGE012272,CELA1,ELA1,chymotrypsin like elastase 1,12q13.13,protein-coding,Successful target
CWITA012273,TCMBANKGE012273,DHRS3,RDH17; Rsdr1; SDR1; SDR16C1; retSDR1,dehydrogenase/reductase (SDR family) member 3,1p36.1,protein-coding,
CWITA012274,TCMBANKGE012274,Reg1,PSP; PTP,regenerating islet-derived 1,6 C3|6 34.77 cM,protein-coding,/
CWITA012275,TCMBANKGE012275,GANC,-,"glucosidase alpha, neutral C",15q15.1,protein-coding,/
CWITA012276,TCMBANKGE012276,TRA2A,AWMS1; HSU53209,transformer 2 alpha homolog,7p15.3,protein-coding,/
CWITA012277,TCMBANKGE012277,MMP25,MMP-25; MMP20; MMP20A; MMPL1; MT-MMP 6; MT-MMP6; MT6-MMP; MT6MMP; MTMMP6,matrix metallopeptidase 25,16p13.3,protein-coding,/
CWITA012278,TCMBANKGE012278,ELOC,SIII; TCEB1,elongin C,8q21.11,protein-coding,/
CWITA012279,TCMBANKGE012279,KRTAP5-8,KRTAP5-2; KRTAP5.8; UHSKerB,Keratin_Associated_Protein_5-8,11q13.4,protein-coding,
CWITA012280,TCMBANKGE012280,MS4A13,-,membrane spanning 4-domains A13,11q12.2,protein-coding,/
CWITA012281,TCMBANKGE012281,ZNF76,D6S229E; ZNF523; Zfp523,zinc finger protein 76,6p21.31,protein-coding,/
CWITA012282,TCMBANKGE012282,EDNRB,ABCDS; ETNB; ETNBR; ETB; ETBR; ETRB; HSCR; HSCR2; WS4A,endothelin receptor type B,13q22,protein-coding,
CWITA012283,TCMBANKGE012283,GNRH2,GnRH-II; LH-RHII,gonadotropin releasing hormone 2,20p13,protein-coding,/
CWITA012284,TCMBANKGE012284,GDF5,BDA1C; BMP-14; BMP14; CDMP1; DUPANS; LAP-4; LAP4; OS5; SYM1B; SYNS2,growth differentiation factor 5,20q11.22,protein-coding,Clinical Trial target
CWITA012285,TCMBANKGE012285,HECTD4,C12ord51; C12orf51; HEEL; POTAGE,HECT domain E3 ubiquitin protein ligase 4,12q24.13,protein-coding,/
CWITA012286,TCMBANKGE012286,WIF1,WIF-1,WNT inhibitory factor 1,12q14.3,protein-coding,/
CWITA012287,TCMBANKGE012287,RAX2,ARMD6; CORD11; QRX; RAXL1,retina and anterior neural fold homeobox 2,19p13.3,protein-coding,/
CWITA012288,TCMBANKGE012288,B3GALT4,BETA3GALT4; GALT2; GALT4,"beta-1,3-galactosyltransferase 4",6p21.32,protein-coding,/
CWITA012289,TCMBANKGE012289,ZNF648,-,zinc finger protein 648,1q25.3,protein-coding,/
CWITA012290,TCMBANKGE012290,LMO7,FBX20; FBXO20; LMO7b; LOMP,LIM domain 7,13q22.2,protein-coding,/
CWITA012291,TCMBANKGE012291,POLD4,POLDS; p12,"DNA polymerase delta 4, accessory subunit",11q13.2,protein-coding,/
CWITA012292,TCMBANKGE012292,CDC5L,CDC5; CDC5-LIKE; CEF1; PCDC5RP; dJ319D22.1,cell division cycle 5 like,6p21.1,protein-coding,/
CWITA012293,TCMBANKGE012293,CMIP,TCMIP,c-Maf inducing protein,16q23.2-q23.3,protein-coding,/
CWITA012294,TCMBANKGE012294,FKBP1C,-,FKBP prolyl isomerase 1C,6q12,pseudo,/
CWITA012295,TCMBANKGE012295,SLC39A2,6A1; ETI-1; ZIP-2; ZIP2,solute carrier family 39 member 2,14q11.2,protein-coding,/
CWITA012296,TCMBANKGE012296,PAQR5,MPRG,progestin and adipoQ receptor family member 5,15q23,protein-coding,/
CWITA012297,TCMBANKGE012297,KIF1A,ATSV; C2orf20; DKFZp686I2094; FLJ30229; HUNCN104; MGC133285; MGC133286; UNC104,kinesin family member 1A,2q37.3,protein-coding,
CWITA012298,TCMBANKGE012298,GABRR1,MGC163216,"gamma-aminobutyric acid (GABA) receptor, rho 1",6q14-q21|6q13-q16.3,protein-coding,
CWITA012299,TCMBANKGE012299,PRKAA2,AMPK; AMPK2; PRKAA,"protein kinase, AMP-activated, alpha 2 catalytic subunit",1p31,protein-coding,
CWITA012300,TCMBANKGE012300,SLC8A3,NCX3,solute carrier family 8 member A3,14q24.2,protein-coding,/
CWITA012301,TCMBANKGE012301,SUSD4,PRO222,sushi domain containing 4,1q41,protein-coding,/
CWITA012302,TCMBANKGE012302,PRDM5,BCS2; PFM2,PR/SET domain 5,4q27,protein-coding,/
CWITA012303,TCMBANKGE012303,NMNAT3,PNATN3; PNAT3,nicotinamide nucleotide adenylyltransferase 3,3q23,protein-coding,
CWITA012304,TCMBANKGE012304,NAPG,GAMMASNAP,NSF attachment protein gamma,18p11.22,protein-coding,/
CWITA012305,TCMBANKGE012305,SLC25A15,D13S327; HHH; ORC1; ORNT1,solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15,13q14,protein-coding,
CWITA012306,TCMBANKGE012306,HSPB7,cvHSP,heat shock protein family B (small) member 7,1p36.13,protein-coding,/
CWITA012307,TCMBANKGE012307,ZNF366,DC-SCRIPT; DCSCRIPT,zinc finger protein 366,5q13.2|5q13.2,protein-coding,/
CWITA012308,TCMBANKGE012308,OGFRL1,dJ331H24.1,opioid growth factor receptor like 1,6q13,protein-coding,/
CWITA012309,TCMBANKGE012309,YME1L1,FTSH; MEG4; OPA11; PAMP; YME1L,YME1 like 1 ATPase,10p12.1,protein-coding,/
CWITA012310,TCMBANKGE012310,SLC10A4,P4,solute carrier family 10 member 4,4p11,protein-coding,/
CWITA012311,TCMBANKGE012311,RELA,MGC131774; NFKB3; p65,v-rel reticuloendotheliosis viral oncogene homolog A (avian),11q13,protein-coding,
CWITA012312,TCMBANKGE012312,RPL39L,L39-2; RPL39L1,ribosomal protein L39 like,3q27.3,protein-coding,/
CWITA012313,TCMBANKGE012313,PTPRN2,IA-2beta; IAR; ICAAR; PTPRP; R-PTP-N2,protein tyrosine phosphatase receptor type N2,7q36.3,protein-coding,/
CWITA012314,TCMBANKGE012314,OPRPN,BPLP; PRL1; PROL1; opiorphin,opiorphin prepropeptide,4q13.3,protein-coding,/
CWITA012315,TCMBANKGE012315,ARL5B,ARL8,ADP-ribosylation factor-like 5B,10p12.31,protein-coding,
CWITA012316,TCMBANKGE012316,PDCD10,CCM3; TFAR15,programmed cell death 10,3q26.1,protein-coding,/
CWITA012317,TCMBANKGE012317,CDRT1,C170RF1; C17ORF1; C17ORF1A; FBXW10B; FBXW10P1; HREP; SM25H2,CMT1A duplicated region transcript 1,17p12,protein-coding,/
CWITA012318,TCMBANKGE012318,TSC22D3,DIP; DSIPI; GILZ; TSC-22R,TSC22 domain family member 3,Xq22.3,protein-coding,/
CWITA012319,TCMBANKGE012319,TLNRD1,MESDC1,talin rod domain containing 1,15q25.1,protein-coding,/
CWITA012320,TCMBANKGE012320,STK3,KRS1; MST2,serine/threonine kinase 3,8q22.2,protein-coding,/
CWITA012321,TCMBANKGE012321,CPEB3,-,cytoplasmic polyadenylation element binding protein 3,10q23.32,protein-coding,/
CWITA012322,TCMBANKGE012322,STRIP2,FAM40B; FAR11B,striatin interacting protein 2,7q32.1,protein-coding,/
CWITA012323,TCMBANKGE012323,ASNSD1,NBLA00058; NS3TP1,asparagine synthetase domain containing 1,2q32.2,protein-coding,/
CWITA012324,TCMBANKGE012324,LARS,FLJ10595; FLJ21788; HSPC192; KIAA1352; LARS1; LEURS; LEUS; LRS; PIG44; RNTLS; hr025Cl,leucyl-tRNA synthetase,5q32,protein-coding,
CWITA012325,TCMBANKGE012325,ACSM2A,A-923A4.1; ACSM2,acyl-CoA synthetase medium chain family member 2A,16p12.3,protein-coding,/
CWITA012326,TCMBANKGE012326,CNOT4,CLONE243; NOT4; NOT4H,CCR4-NOT transcription complex subunit 4,7q33,protein-coding,/
CWITA012327,TCMBANKGE012327,ANKDD1B,-,ankyrin repeat and death domain containing 1B,5q13.3,protein-coding,/
CWITA012328,TCMBANKGE012328,SLC2A12,GLUT12; GLUT8,"solute carrier family 2 (facilitated glucose transporter), member 12",6q23.2,protein-coding,
CWITA012329,TCMBANKGE012329,AGRP,AGRT; ART; ASIP2,agouti related neuropeptide,16q22.1,protein-coding,Clinical Trial target
CWITA012330,TCMBANKGE012330,LIMK1,LIMK; LIMK-1,LIM domain kinase 1,7q11.23,protein-coding,Research target
CWITA012331,TCMBANKGE012331,UBA3,NAE2; UBE1C; hUBA3,ubiquitin like modifier activating enzyme 3,3p14.1,protein-coding,Research target
CWITA012332,TCMBANKGE012332,CORO1C,HCRNN4,coronin 1C,12q24.11,protein-coding,/
CWITA012333,TCMBANKGE012333,PBDC1,CXorf26,polysaccharide biosynthesis domain containing 1,Xq13.3,protein-coding,/
CWITA012334,TCMBANKGE012334,GIT2,CAT-2; CAT2; PKL,GIT ArfGAP 2,12q24.11,protein-coding,/
CWITA012335,TCMBANKGE012335,HAGH,GLO2; GLX2; GLXII; HAGH1,hydroxyacylglutathione hydrolase,16p13.3,protein-coding,/
CWITA012336,TCMBANKGE012336,DOLK,CDG1M; DK; DK1; SEC59; TMEM15,dolichol kinase,9q34.11,protein-coding,/
CWITA012337,TCMBANKGE012337,ACTC1,ACTC; ASD5; CMD1R; CMH11; LVNC4,actin alpha cardiac muscle 1,15q14,protein-coding,/
CWITA012338,TCMBANKGE012338,SCEL,-,sciellin,13q22.3,protein-coding,/
CWITA012339,TCMBANKGE012339,H3P17,p23,H3 histone pseudogene 17,5p15.1,unknown,/
CWITA012340,TCMBANKGE012340,SMAD2,JV18; JV18N1; MADH2; MADR2; MGC22139; MGC34440; hMADN2; hSMAD2,SMAD family member 2,18q21.1,protein-coding,
CWITA012341,TCMBANKGE012341,POLR1A,A190; AFDCIN; RPA1; RPA194; RPO1-4; RPO14,RNA polymerase I subunit A,2p11.2,protein-coding,/
CWITA012342,TCMBANKGE012342,QPCTL,gQC,glutaminyl-peptide cyclotransferase like,19q13.32,protein-coding,/
CWITA012343,TCMBANKGE012343,TMEM54,BCLP; CAC-1; CAC1,transmembrane protein 54,1p35.1,protein-coding,/
CWITA012344,TCMBANKGE012344,PDGFRA,CD140A; MGC74795; PDGFR2; RHEPDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",4q12,protein-coding,
CWITA012345,TCMBANKGE012345,DRD3,D3DR; ETM1; FET1,dopamine receptor D3,3q13.31,protein-coding,Successful target
CWITA012346,TCMBANKGE012346,RPL11,DBA7; GIG34; L11,ribosomal protein L11,1p36.1-p35,protein-coding,
CWITA012347,TCMBANKGE012347,PPP1R12C,AAVS1; LENG3; MBS85; p84; p85,protein phosphatase 1 regulatory subunit 12C,19q13.42,protein-coding,/
CWITA012348,TCMBANKGE012348,PHACTR2,C6orf56,phosphatase and actin regulator 2,6q24.2,protein-coding,/
CWITA012349,TCMBANKGE012349,NDUFC1,KFYI; MGC117464; MGC126847; MGC138266,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa",4q31.1,protein-coding,
CWITA012350,TCMBANKGE012350,GPR148,BTR; PGR6,G protein-coupled receptor 148,2q21.1,protein-coding,/
CWITA012351,TCMBANKGE012351,CCDC191,KIAA1407,coiled-coil domain containing 191,3q13.31,protein-coding,/
CWITA012352,TCMBANKGE012352,CYP4X1,CYPIVX1,cytochrome P450 family 4 subfamily X member 1,1p33|1,protein-coding,/
CWITA012353,TCMBANKGE012353,STN1,AAF-44; AAF44; OBFC1; RPA-32; bA541N10.2,STN1 subunit of CST complex,10q24.33,protein-coding,/
CWITA012354,TCMBANKGE012354,ANKRD24,-,ankyrin repeat domain 24,19p13.3,protein-coding,/
CWITA012355,TCMBANKGE012355,ACOT1,ACH2; CTE-1; LACH2,acyl-CoA thioesterase 1,14q24.3,protein-coding,/
CWITA012356,TCMBANKGE012356,TGM5,PSS2; TGASE5; TGASEX; TGM6; TGMX; TGX,transglutaminase 5,15q15.2,protein-coding,/
CWITA012357,TCMBANKGE012357,ZDHHC11,ZNF399,zinc finger DHHC-type containing 11,5p15.33,protein-coding,/
CWITA012358,TCMBANKGE012358,LTF,GIG12; HLF2; LF,lactotransferrin,3p21.31,protein-coding,
CWITA012359,TCMBANKGE012359,TRMT13,CCDC76,tRNA methyltransferase 13 homolog,1p21.2,protein-coding,/
CWITA012360,TCMBANKGE012360,TRAPPC8,GSG1; HsT2706; KIAA1012; TRS85,trafficking protein particle complex 8,18q12.1,protein-coding,/
CWITA012361,TCMBANKGE012361,GIMAP8,IAN-9; IAN6; IAN9; IANT,"GTPase, IMAP family member 8",7q36.1,protein-coding,/
CWITA012362,TCMBANKGE012362,DPY30,Cps25; HDPY-30; Saf19,dpy-30 histone methyltransferase complex regulatory subunit,2p22.3,protein-coding,/
CWITA012363,TCMBANKGE012363,TUBGCP4,76P; GCP-4; GCP4; Grip76; MCCRP3,tubulin gamma complex associated protein 4,15q15.3,protein-coding,/
CWITA012364,TCMBANKGE012364,AFM,ALB2; ALBA; ALF,afamin,4q13.3,protein-coding,/
CWITA012365,TCMBANKGE012365,CCT3,CCTNgamma; CCTG; PIG48; TCPN1Ngamma; TRIC5,"chaperonin containing TCP1, subunit 3 (gamma)",1q23,protein-coding,
CWITA012366,TCMBANKGE012366,NPPA,ANF; ANP; ATFB6; ATRST2; CDD; CDD-ANF; CDP; PND,Natriuretic_Peptide_A,1p36.22,protein-coding,
CWITA012367,TCMBANKGE012367,GPR160,GPCR1; GPCR150,G protein-coupled receptor 160,3q26.2,protein-coding,/
CWITA012368,TCMBANKGE012368,EDA2R,EDA-A2R; EDAA2R; TNFRSF27; XEDAR,ectodysplasin A2 receptor,Xq12,protein-coding,/
CWITA012369,TCMBANKGE012369,TIE1,JTK14; TIE,tyrosine kinase with immunoglobulin like and EGF like domains 1,1p34.2,protein-coding,Research target
CWITA012370,TCMBANKGE012370,ADA,N,adenosine deaminase,20q13.12,protein-coding,
CWITA012371,TCMBANKGE012371,PARP14,ARTD8; BAL2; PARP-14; pART8,poly(ADP-ribose) polymerase family member 14,3q21.1,protein-coding,/
CWITA012372,TCMBANKGE012372,KYNU,N,kynureninase,2q22.2,protein-coding,
CWITA012373,TCMBANKGE012373,HSDL1,SDR12C3,hydroxysteroid dehydrogenase like 1,16q24.1,protein-coding,/
CWITA012374,TCMBANKGE012374,CMTM4,CKLFSF4,CKLF like MARVEL transmembrane domain containing 4,16q21-q22.1,protein-coding,/
CWITA012375,TCMBANKGE012375,ZNF609,-,zinc finger protein 609,15q22.31,protein-coding,/
CWITA012376,TCMBANKGE012376,ALPK1,8430410J10Rik; LAK,alpha kinase 1,4q25,protein-coding,/
CWITA012377,TCMBANKGE012377,MNS1,SPATA40,meiosis specific nuclear structural 1,15q21.3,protein-coding,/
CWITA012378,TCMBANKGE012378,MUL1,C1orf166; GIDE; MAPL; MULAN; RNF218,mitochondrial E3 ubiquitin protein ligase 1,1p36.12,protein-coding,/
CWITA012379,TCMBANKGE012379,SRR,ILV1; ISO1,serine racemase,17p13.3,protein-coding,Research target
CWITA012380,TCMBANKGE012380,DIO1,5DI; TXDI1,iodothyronine deiodinase 1,1p32.3,protein-coding,Successful target
CWITA012381,TCMBANKGE012381,COX7A2,COX7AL; COX7AL1; COXVIIAL; COXVIIa-L; VIIAL,cytochrome c oxidase subunit 7A2,6q14.1,protein-coding,/
CWITA012382,TCMBANKGE012382,DMWD,D19S593E; DMR-N9; DMRN9; gene59,"DM1 locus, WD repeat containing",19q13.32,protein-coding,/
CWITA012383,TCMBANKGE012383,CEP350,CAP350; GM133,centrosomal protein 350,1q25.2,protein-coding,/
CWITA012384,TCMBANKGE012384,UBE2D1,E2(17)KB1; SFT; UBC4/5; UBCH5; UBCH5A,ubiquitin conjugating enzyme E2 D1,10q21.1,protein-coding,/
CWITA012385,TCMBANKGE012385,ZNF235,ANF270; HZF6; ZFP93; ZNF270,zinc finger protein 235,19q13.31,protein-coding,/
CWITA012386,TCMBANKGE012386,ACSS1,ACAS2L; AceCS2L; FLJ45659; MGC33843,acyl-CoA synthetase short-chain family member 1,20p11.23-p11.21,protein-coding,
CWITA012387,TCMBANKGE012387,H1-4,H1.4; H1E; H1F4; H1s-4; HIST1H1E; RMNS; dJ221C16.5,"H1.4 linker histone, cluster member",6p22.2,protein-coding,/
CWITA012388,TCMBANKGE012388,KCNA7,HAK6; KV1.7,"potassium voltage-gated channel, shaker-related subfamily, member 7",19q13.3,protein-coding,
CWITA012389,TCMBANKGE012389,XKR8,XRG8; hXkr8,XK related 8,1p35.3,protein-coding,/
CWITA012390,TCMBANKGE012390,KHSRP,FBP2; FUBP2; KSRP; MGC99676,KH-type splicing regulatory protein,19p13.3,protein-coding,
CWITA012391,TCMBANKGE012391,PHKA2,GSD9A; PHK; PYK; PYKL; XLG; XLG2,phosphorylase kinase regulatory subunit alpha 2,Xp22.13,protein-coding,/
CWITA012392,TCMBANKGE012392,SAR1B,ANDD; CMRD; GTBPB; SARA2,SAR1 homolog B (S. cerevisiae),5q31.1,protein-coding,
CWITA012393,TCMBANKGE012393,TMEM14C,C6orf53; HSPC194; MSTP073; NET26; bA421M1.6,transmembrane protein 14C,6p24.2,protein-coding,/
CWITA012394,TCMBANKGE012394,SQLE,FLJ30795,squalene epoxidase,8q24.1,protein-coding,
CWITA012395,TCMBANKGE012395,STXBP5,LGL3; LLGL3; Nbla04300,syntaxin binding protein 5,6q24.3,protein-coding,/
CWITA012396,TCMBANKGE012396,ARHGAP36,-,Rho GTPase activating protein 36,Xq26.1,protein-coding,/
CWITA012397,TCMBANKGE012397,ISG15,G1P2; IFI15; IMD38; IP17; UCRP; hUCRP,ISG15 ubiquitin like modifier,1p36.33,protein-coding,Research target
CWITA012398,TCMBANKGE012398,WASHC5,KIAA0196; RTSC; RTSC1; SPG8,WASH complex subunit 5,8q24.13,protein-coding,/
CWITA012399,TCMBANKGE012399,NPM2,-,nucleophosmin/nucleoplasmin 2,8p21.3,protein-coding,/
CWITA012400,TCMBANKGE012400,CST11,CST8L; CTES2; SC13; dJ322G13.6,cystatin 11,20p11.21,protein-coding,/
CWITA012401,TCMBANKGE012401,RPS6KC1,RPK118; RSKL1; S6K-delta-1; S6PKh1; humS6PKh1,ribosomal protein S6 kinase C1,1q32.3,protein-coding,/
CWITA012402,TCMBANKGE012402,NTRK1,MTC; TRK; TRK1; TRKA; Trk-A; p140-TrkA,neurotrophic receptor tyrosine kinase 1,1q23.1,protein-coding,Successful target
CWITA012403,TCMBANKGE012403,FAF2,ETEA; UBXD8; UBXN3B,Fas associated factor family member 2,5q35.2,protein-coding,/
CWITA012404,TCMBANKGE012404,NLGN2,-,neuroligin 2,17p13.1,protein-coding,/
CWITA012405,TCMBANKGE012405,NLRP14,CLR11.2; GC-LRR; NALP14; NOD5; PAN8,NLR family pyrin domain containing 14,11p15.4,protein-coding,/
CWITA012406,TCMBANKGE012406,FGF7,HBGF-7; KGF,fibroblast growth factor 7,15q21.2,protein-coding,Clinical Trial target
CWITA012407,TCMBANKGE012407,BMP8A,OP-2,bone morphogenetic protein 8a,1p34.3,protein-coding,/
CWITA012408,TCMBANKGE012408,IRF1-AS1,C5orf56,IRF1 antisense RNA 1,5q31.1,ncRNA,/
CWITA012409,TCMBANKGE012409,NUP188,KIAA0169; SANDSTEF; hNup188,nucleoporin 188,9q34.11,protein-coding,/
CWITA012410,TCMBANKGE012410,ARC,Arg3.1; hArc,activity regulated cytoskeleton associated protein,8q24.3,protein-coding,/
CWITA012411,TCMBANKGE012411,DDX3X,CAP-Rf; DBX; DDX14; DDX3; HLP2; MRX102; MRXSSB,DEAD-box helicase 3 X-linked,Xp11.4,protein-coding,/
CWITA012412,TCMBANKGE012412,DPP4,ADABP; ADCP2; CD26; DPPIV; TP103,dipeptidyl-peptidase 4,2q24.3,protein-coding,
CWITA012413,TCMBANKGE012413,CDK2AP1,DOC1; DORC1; ST19; doc-1; p12DOC-1,cyclin dependent kinase 2 associated protein 1,12q24.31,protein-coding,/
CWITA012414,TCMBANKGE012414,PIK3AP1,BCAP,phosphoinositide-3-kinase adaptor protein 1,10q24.1,protein-coding,/
CWITA012415,TCMBANKGE012415,PSEN2,AD3L; AD4; CMD1V; PS2; STM2,presenilin 2,1q42.13,protein-coding,Clinical Trial target
CWITA012416,TCMBANKGE012416,RPS15,RIG; S15,ribosomal protein S15,19p13.3,protein-coding,/
CWITA012417,TCMBANKGE012417,SNX7,-,sorting nexin 7,1p21.3,protein-coding,/
CWITA012418,TCMBANKGE012418,GPC6,OMIMD1,glypican 6,13q31.3-q32.1,protein-coding,/
CWITA012419,TCMBANKGE012419,IL17RB,CRL4; EVI27; IL17BR; IL17RH1,interleukin 17 receptor B,3p21.1,protein-coding,/
CWITA012420,TCMBANKGE012420,TMEM67,JBTS6; MECKELIN; MKS3; NPHP11; TNEM67,transmembrane protein 67,8q22.1,protein-coding,/
CWITA012421,TCMBANKGE012421,CHIA,AMCASE; CHIT2; DKFZp313J1722; TSA1902,"chitinase, acidic",1p13.2,protein-coding,
CWITA012422,TCMBANKGE012422,PRODH,FLJ33744; HSPOX2; MGC148078; MGC148079; PIG6; POX; PRODH1; PRODH2; SCZD4; TP53I6,proline dehydrogenase (oxidase) 1,22q11.21,protein-coding,
CWITA012423,TCMBANKGE012423,PRNP,ASCR; AltPrP; CD230; CJD; GSS; KURU; PRIP; PrP; PrP27-30; PrP33-35C; PrPc; p27-30,prion protein,20p13,protein-coding,Research target
CWITA012424,TCMBANKGE012424,SLC35A3,AMRS,solute carrier family 35 member A3,1p21.2,protein-coding,/
CWITA012425,TCMBANKGE012425,TRAP,-,triiodothyronine receptor auxiliary protein,-,protein-coding,/
CWITA012426,TCMBANKGE012426,ZNF141,D4S90; pHZ-44,zinc finger protein 141,4p16.3,protein-coding,/
CWITA012427,TCMBANKGE012427,PAPPA,ASBABP2; DIPLA1; IGFBP-4ase; PAPA; PAPP-A; PAPPA1,pappalysin 1,9q33.1,protein-coding,/
CWITA012428,TCMBANKGE012428,SKA3,C13orf3; RAMA1,spindle and kinetochore associated complex subunit 3,13q12.11,protein-coding,/
CWITA012429,TCMBANKGE012429,MAPK15,ERK7; ERK8,mitogen-activated protein kinase 15,8q24.3,protein-coding,/
CWITA012430,TCMBANKGE012430,CLIP4,RSNL2,CAP-Gly domain containing linker protein family member 4,2p23.2,protein-coding,/
CWITA012431,TCMBANKGE012431,SFTPD,COLEC7; PSPND; SFTP4; SPND,surfactant protein D,10q22.2-q23.1,protein-coding,
CWITA012432,TCMBANKGE012432,GSS,GSHS; MGC14098,glutathione synthetase,20q11.2,protein-coding,
CWITA012433,TCMBANKGE012433,PPM1J,PP2CZ; PP2Czeta; PPP2CZ,"protein phosphatase, Mg2+/Mn2+ dependent 1J",1p13.2,protein-coding,/
CWITA012434,TCMBANKGE012434,MORN4,C10orf83; UTA; bA548K23.4; rtp,MORN repeat containing 4,10q24.2,protein-coding,/
CWITA012435,TCMBANKGE012435,ANKRD36C,-,ankyrin repeat domain 36C,2q11.1,protein-coding,/
CWITA012436,TCMBANKGE012436,ALDH9A1,ALDH4; ALDH7; ALDH9; E3; TMABADH,"aldehyde dehydrogenase 9 family, member A1",1q23.1,protein-coding,
CWITA012437,TCMBANKGE012437,DHX37,DDX37; Dhr1; NEDBAVC; SRXY11,DEAH-box helicase 37,12q24.31,protein-coding,/
CWITA012438,TCMBANKGE012438,NPY2R,NPY2-R,neuropeptide Y receptor Y2,4q32.1,protein-coding,Clinical Trial target
CWITA012439,TCMBANKGE012439,GABRP,MGC126386; MGC126387,"gamma-aminobutyric acid (GABA) A receptor, pi",5q33-q34,protein-coding,
CWITA012440,TCMBANKGE012440,EFCAB3,-,EF-hand calcium binding domain 3,17q23.2,protein-coding,/
CWITA012441,TCMBANKGE012441,VCP,IBMPFD; MGC131997; MGC148092; MGC8560; TERA; p97,valosin containing protein,9p13.3,protein-coding,
CWITA012442,TCMBANKGE012442,OLIG1,BHLHB6; BHLHE21,oligodendrocyte transcription factor 1,21q22.11,protein-coding,/
CWITA012443,TCMBANKGE012443,C3orf20,-,chromosome 3 open reading frame 20,3p25.1,protein-coding,/
CWITA012444,TCMBANKGE012444,TUBE1,FLJ22589; FLJ44203; TUBE; dJ142L7.2,"tubulin, epsilon 1",6q21,protein-coding,
CWITA012445,TCMBANKGE012445,HSPA2,HSP70N2; HSP70N3,heat shock 70kDa protein 2,14q24.1,protein-coding,
CWITA012446,TCMBANKGE012446,IL2RG,CD132; CIDX; IL-2RG; IMD4; P64; SCIDX; SCIDX1,interleukin 2 receptor subunit gamma,Xq13.1,protein-coding,/
CWITA012447,TCMBANKGE012447,OC90,PLA2L,otoconin 90,8q24.22,protein-coding,/
CWITA012448,TCMBANKGE012448,MIDEAS,C14orf117; C14orf43; ELMSAN1; LSR68; c14_5541,mitotic deacetylase associated SANT domain protein,14q24.3,protein-coding,/
CWITA012449,TCMBANKGE012449,MAPK3,ERK1; HS44KDAP; HUMKER1A; MGC20180; P44ERK1; P44MAPK; PRKM3,mitogen-activated protein kinase 3,16p11.2,protein-coding,
CWITA012450,TCMBANKGE012450,ECHDC2,-,enoyl-CoA hydratase domain containing 2,1p32.3,protein-coding,/
CWITA012451,TCMBANKGE012451,KMT2C,HALR; KLEFS2; MLL3,lysine methyltransferase 2C,7q36.1,protein-coding,/
CWITA012452,TCMBANKGE012452,ADSS2,ADEH; ADSS; ADSS 2,adenylosuccinate synthase 2,1q44,protein-coding,/
CWITA012453,TCMBANKGE012453,EP400,CAGH32; P400; TNRC12,E1A binding protein p400,12q24.33,protein-coding,/
CWITA012454,TCMBANKGE012454,WNT8B,-,Wnt family member 8B,10q24.31,protein-coding,/
CWITA012455,TCMBANKGE012455,FOCAD,KIAA1797,focadhesin,9p21.3,protein-coding,/
CWITA012456,TCMBANKGE012456,CYP19A1,ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; MGC104309; PN450AROM,"cytochrome P450, family 19, subfamily A, polypeptide 1",15q21.1,protein-coding,
CWITA012457,TCMBANKGE012457,RABAC1,PRA1; PRAF1; YIP3,Rab acceptor 1,19q13.2,protein-coding,/
CWITA012458,TCMBANKGE012458,TUBG1,CDCBM4; GCP-1; TUBG; TUBGCP1,tubulin gamma 1,17q21.2,protein-coding,/
CWITA012459,TCMBANKGE012459,PON2,-,paraoxonase 2,7q21.3,protein-coding,/
CWITA012460,TCMBANKGE012460,ADAMTSL1,ADAMTSL-1; ADAMTSR1; C9orf94; PUNCTIN,ADAMTS like 1,9p22.2-p22.1,protein-coding,/
CWITA012461,TCMBANKGE012461,HPSE,HPA; HPA1; HPR1; HPSE1; HSE1,heparanase,4q21.23,protein-coding,Successful target
CWITA012462,TCMBANKGE012462,RAX,MCOP3; RX,retina and anterior neural fold homeobox,18q21.32,protein-coding,/
CWITA012463,TCMBANKGE012463,PGR,NR3C3; PR,progesterone receptor,11q22-q23,protein-coding,
CWITA012464,TCMBANKGE012464,GLS,AAD20; CASGID; EIEE71; GAC; GAM; GDPAG; GLS1; KGA,glutaminase,2q32.2,protein-coding,/
CWITA012465,TCMBANKGE012465,FTO,ALKBH9; BMIQ14; GDFD,FTO alpha-ketoglutarate dependent dioxygenase,16q12.2,protein-coding,/
CWITA012466,TCMBANKGE012466,NPIPB11,NPIP,nuclear pore complex interacting protein family member B11,16p11.2,protein-coding,/
CWITA012467,TCMBANKGE012467,COG2,CDG2Q; LDLC,component of oligomeric golgi complex 2,1q42.2,protein-coding,/
CWITA012468,TCMBANKGE012468,OSM,-,oncostatin M,22q12.2,protein-coding,Clinical Trial target
CWITA012469,TCMBANKGE012469,ZYG11B,ZYG11,"zyg-11 family member B, cell cycle regulator",1p32.3,protein-coding,/
CWITA012470,TCMBANKGE012470,HIVEP1,CIRIP; CRYBP1; GAAP; MBP-1; PRDII-BF1; Schnurri-1; ZAS1; ZNF40; ZNF40A,HIVEP zinc finger 1,6p24.1,protein-coding,/
CWITA012471,TCMBANKGE012471,LY86,MD-1; MD1; MMD-1; dJ80N2.1,lymphocyte antigen 86,6p25.1,protein-coding,/
CWITA012472,TCMBANKGE012472,APCS,HEL-S-92n; PTX2; SAP,"amyloid P component, serum",1q23.2,protein-coding,Clinical Trial target
CWITA012473,TCMBANKGE012473,LACC1,C13orf31; FAMIN; JUVAR,laccase domain containing 1,13q14.11,protein-coding,/
CWITA012474,TCMBANKGE012474,GATM,AGAT; AT,glycine amidinotransferase (L-arginine:glycine amidinotransferase),15q21.1,protein-coding,
CWITA012475,TCMBANKGE012475,C6orf52,-,chromosome 6 open reading frame 52,6p24.2,protein-coding,/
CWITA012476,TCMBANKGE012476,STBD1,GENEX3414; GENX-3414,starch binding domain 1,4q21.1,protein-coding,/
CWITA012477,TCMBANKGE012477,MMP20,AI2A2; MMP-20,matrix metallopeptidase 20,11q22.2,protein-coding,/
CWITA012478,TCMBANKGE012478,DNAL1,C14orf168; CILD16; LC1,dynein axonemal light chain 1,14q24.3,protein-coding,/
CWITA012479,TCMBANKGE012479,THG1L,ICF45; IHG-1; IHG1; SCAR28; THG1; hTHG1,tRNA-histidine guanylyltransferase 1 like,5q33.3,protein-coding,/
CWITA012480,TCMBANKGE012480,DCHS1,CDH19; CDH25; CDHR6; FIB1; MVP2; PCDH16; VMLDS1,dachsous cadherin-related 1,11p15.4,protein-coding,/
CWITA012481,TCMBANKGE012481,OSR2,-,odd-skipped related transciption factor 2,8q22.2,protein-coding,/
CWITA012482,TCMBANKGE012482,MOCS1,MIG11; MOCOD; MOCS1A; MOCS1B,molybdenum cofactor synthesis 1,6p21.2,protein-coding,Clinical Trial target
CWITA012483,TCMBANKGE012483,HEXIM2,L3,HEXIM P-TEFb complex subunit 2,17q21.31,protein-coding,/
CWITA012484,TCMBANKGE012484,ZNF16,HZF1; KOX9,zinc finger protein 16,8q24.3,protein-coding,/
CWITA012485,TCMBANKGE012485,PTGR1,LTB4DH; PGR1; ZADH3,prostaglandin reductase 1,9q31.3,protein-coding,/
CWITA012486,TCMBANKGE012486,BDH2,DHRS6; EFA6R; PRO20933; SDR15C1; UCPA-OR; UNQ6308,3-hydroxybutyrate dehydrogenase 2,4q24,protein-coding,/
CWITA012487,TCMBANKGE012487,ZNF613,-,zinc finger protein 613,19q13.41,protein-coding,/
CWITA012488,TCMBANKGE012488,ISOC1,CGI-111,isochorismatase domain containing 1,5q23.3,protein-coding,/
CWITA012489,TCMBANKGE012489,IGFBP3,BPN53; IBP3,insulin-like growth factor binding protein 3,7p13-p12,protein-coding,
CWITA012490,TCMBANKGE012490,SF3B4,AFD1; Hsh49; SAP49; SF3b49,splicing factor 3b subunit 4,1q21.2,protein-coding,/
CWITA012491,TCMBANKGE012491,SPATA13,ARHGEF29; ASEF2,spermatogenesis associated 13,13q12.12,protein-coding,/
CWITA012492,TCMBANKGE012492,RAB25,CATX-8; RAB11C,"RAB25, member RAS oncogene family",1q22,protein-coding,/
CWITA012493,TCMBANKGE012493,ANKMY2,ZMYND20,ankyrin repeat and MYND domain containing 2,7p21.1,protein-coding,/
CWITA012494,TCMBANKGE012494,HAS1,HAS,hyaluronan synthase 1,19q13.41,protein-coding,/
CWITA012495,TCMBANKGE012495,PECR,DCRRP; HPDHASE; HSA250303; PVIARL; SDR29C1; TERP,peroxisomal trans-2-enoyl-CoA reductase,2q35,protein-coding,/
CWITA012496,TCMBANKGE012496,ARL13B,ARL2L1; JBTS8,ADP ribosylation factor like GTPase 13B,3q11.1-q11.2,protein-coding,/
CWITA012497,TCMBANKGE012497,SLC26A5,DFNB61; PRES,solute carrier family 26 member 5,7q22.1,protein-coding,/
CWITA012498,TCMBANKGE012498,ETHE1,HSCO; YF13H12,ETHE1 persulfide dioxygenase,19q13.31,protein-coding,/
CWITA012499,TCMBANKGE012499,EMP1,CL-20; EMP-1; TMP,epithelial membrane protein 1,12p13.1,protein-coding,/
CWITA012500,TCMBANKGE012500,LRP10,LRP-10; LRP9; MST087; MSTP087,LDL receptor related protein 10,14q11.2,protein-coding,/
CWITA012501,TCMBANKGE012501,VPS45,H1; H1VPS45; SCN5; VPS45A; VPS45B; VPS54A; VSP45; VSP45A,vacuolar protein sorting 45 homolog,1q21.2,protein-coding,/
CWITA012502,TCMBANKGE012502,H2BC1,H2BFU; HIST1H2BA; STBP; TH2B; TSH2B; TSH2B.1; bA317E16.3; hTSH2B,H2B clustered histone 1,6p22.2,protein-coding,/
CWITA012503,TCMBANKGE012503,ANAPC2,APC2,anaphase promoting complex subunit 2,9q34.3,protein-coding,/
CWITA012504,TCMBANKGE012504,STIM1,D11S4896E; GOK; IMD10; STRMK; TAM; TAM1,stromal interaction molecule 1,11p15.4,protein-coding,/
CWITA012505,TCMBANKGE012505,KAT2B,CAF; P; P/CAF; PCAF,K(lysine) acetyltransferase 2B,3p24,protein-coding,
CWITA012506,TCMBANKGE012506,DDX49,Dbp8; R27090_2,DEAD-box helicase 49,19p13.11,protein-coding,/
CWITA012507,TCMBANKGE012507,NNT,GCCD4,nicotinamide nucleotide transhydrogenase,5p12,protein-coding,Research target
CWITA012508,TCMBANKGE012508,MTCP1,P13MTCP1; TCL1C; p8MTCP1,mature T cell proliferation 1,Xq28,protein-coding,/
CWITA012509,TCMBANKGE012509,MOGAT1,DGAT2L; DGAT2L1; MGAT1,monoacylglycerol O-acyltransferase 1,2q36.1,protein-coding,/
CWITA012510,TCMBANKGE012510,SGF29,CCDC101; STAF36; TDRD29,SAGA complex associated factor 29,16p11.2,protein-coding,/
CWITA012511,TCMBANKGE012511,LRRC8C,AD158; FAD158,leucine rich repeat containing 8 VRAC subunit C,1p22.2,protein-coding,/
CWITA012512,TCMBANKGE012512,ZNF445,ZFP445; ZKSCAN15; ZNF168; ZSCAN47,zinc finger protein 445,3p21.31,protein-coding,/
CWITA012513,TCMBANKGE012513,SNHG32,C6orf48; D6S57; G8,small nucleolar RNA host gene 32,6p21.33,ncRNA,/
CWITA012514,TCMBANKGE012514,PHF13,PHF5; SPOC1,PHD finger protein 13,1p36.31,protein-coding,/
CWITA012515,TCMBANKGE012515,ZFP42,REX-1; REX1; ZNF754; zfp-42,ZFP42 zinc finger protein,4q35.2,protein-coding,/
CWITA012516,TCMBANKGE012516,DSP,DCWHKTA; DP,desmoplakin,6p24.3,protein-coding,/
CWITA012517,TCMBANKGE012517,FLCN,BHD; DENND8B; FLCL,folliculin,17p11.2,protein-coding,/
CWITA012518,TCMBANKGE012518,ZNF775,-,zinc finger protein 775,7q36.1,protein-coding,/
CWITA012519,TCMBANKGE012519,FEZF2,FEZ; FEZL; FKSG36; TOF; ZFP312; ZNF312,FEZ family zinc finger 2,3p14.2,protein-coding,/
CWITA012520,TCMBANKGE012520,SLC28A1,CNT1; HCNT1,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 1",15q25.3,protein-coding,
CWITA012521,TCMBANKGE012521,SNED1,IRE-BP1; SST3; Snep,"sushi, nidogen and EGF like domains 1",2q37.3,protein-coding,/
CWITA012522,TCMBANKGE012522,MAB21L3,C1orf161,mab-21 like 3,1p13.1,protein-coding,/
CWITA012523,TCMBANKGE012523,VSTM4,C10orf72,V-set and transmembrane domain containing 4,10q11.23,protein-coding,/
CWITA012524,TCMBANKGE012524,CHKA,CHK; CK; CKI; EK,choline kinase alpha,11q13.2,protein-coding,Clinical Trial target
CWITA012525,TCMBANKGE012525,GHDC,D11LGP1; LGP1,GH3 domain containing,17q21.2,protein-coding,/
CWITA012526,TCMBANKGE012526,ABCA3,ABCNC; ABC3; EST111653; LBM180; MGC166979; MGC72201; SMDP3,"ATP-binding cassette, sub-family A (ABC1), member 3",16p13.3,protein-coding,
CWITA012527,TCMBANKGE012527,ZNF716,-,zinc finger protein 716,7p11.2,protein-coding,/
CWITA012528,TCMBANKGE012528,TSHB,TSH-B; TSH-BETA,thyroid stimulating hormone subunit beta,1p13.2,protein-coding,/
CWITA012529,TCMBANKGE012529,TOM1,-,target of myb1 membrane trafficking protein,22q12.3,protein-coding,/
CWITA012530,TCMBANKGE012530,SLC16A9,C10orf36; MCT9,solute carrier family 16 member 9,10q21.2,protein-coding,/
CWITA012531,TCMBANKGE012531,PSMB11,BETA5T,proteasome subunit beta 11,14q11.2,protein-coding,/
CWITA012532,TCMBANKGE012532,LRR1,4-1BBLRR; LRR-1; PPIL5,leucine rich repeat protein 1,14q21.3,protein-coding,/
CWITA012533,TCMBANKGE012533,SLC25A2,MGC119151; MGC119153; ORC2; ORNT2,solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2,5q31,protein-coding,
CWITA012534,TCMBANKGE012534,CERS6,CERS5; LASS6,ceramide synthase 6,2q24.3,protein-coding,/
CWITA012535,TCMBANKGE012535,CATSPER4,-,cation channel sperm associated 4,1p36.11,protein-coding,/
CWITA012536,TCMBANKGE012536,ZNF90,HTF9,zinc finger protein 90,19p12,protein-coding,/
CWITA012537,TCMBANKGE012537,CCDC69,-,coiled-coil domain containing 69,5q33.1,protein-coding,/
CWITA012538,TCMBANKGE012538,MAD2L2,FANCV; MAD2B; POLZ2; REV7,mitotic arrest deficient 2 like 2,1p36.22,protein-coding,/
CWITA012539,TCMBANKGE012539,RHBDL3,RHBDL4; VRHO,rhomboid like 3,17q11.2,protein-coding,/
CWITA012540,TCMBANKGE012540,ARHGEF3,GEF3; STA3; XPLN,Rho guanine nucleotide exchange factor 3,3p14.3,protein-coding,Research target
CWITA012541,TCMBANKGE012541,PNPO,HEL-S-302; PDXPO,pyridoxamine 5'-phosphate oxidase,17q21.32,protein-coding,/
CWITA012542,TCMBANKGE012542,PDE8A,HsT19550,phosphodiesterase 8A,15q25.3,protein-coding,Research target
CWITA012543,TCMBANKGE012543,XYLT2,PXYLT2; SOS; XT-II; XT2; xylT-II,xylosyltransferase 2,17q21.33,protein-coding,/
CWITA012544,TCMBANKGE012544,MED16,DRIP92; THRAP5; TRAP95,mediator complex subunit 16,19p13.3,protein-coding,/
CWITA012545,TCMBANKGE012545,ALKBH5,ABH5; OFOXD; OFOXD1,"alkB homolog 5, RNA demethylase",17p11.2|17p11.2,protein-coding,/
CWITA012546,TCMBANKGE012546,TTLL1,C22orf7; HS323M22B,tubulin tyrosine ligase like 1,22q13.2,protein-coding,/
CWITA012547,TCMBANKGE012547,CPNE4,COPN4; CPN4,copine 4,3q22.1,protein-coding,/
CWITA012548,TCMBANKGE012548,FMOD,FM; SLRR2E,fibromodulin,1q32.1,protein-coding,/
CWITA012549,TCMBANKGE012549,ARHGEF7,BETA-PIX; COOL-1; COOL1; Nbla10314; P50; P50BP; P85; P85COOL1; P85SPR; PAK3; PIXB,Rho guanine nucleotide exchange factor 7,13q34,protein-coding,/
CWITA012550,TCMBANKGE012550,BTBD10,GMRP-1; GMRP1,BTB domain containing 10,11p15.3,protein-coding,/
CWITA012551,TCMBANKGE012551,DHX40,ARG147; DDX40; PAD,DEAH-box helicase 40,17q23.1,protein-coding,/
CWITA012552,TCMBANKGE012552,ATP5C1,ATP5C; ATP5CL1,"ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1",10p15.1,protein-coding,
CWITA012553,TCMBANKGE012553,TNC,150-225; DFNA56; GMEM; GP; HXB; JI; TN; TN-C,tenascin C,9q33.1,protein-coding,Clinical Trial target
CWITA012554,TCMBANKGE012554,ELAC2,COXPD17; ELC2; HPC2,elaC ribonuclease Z 2,17p12,protein-coding,/
CWITA012555,TCMBANKGE012555,IGHMBP2,CATF1; CMT2S; HCSA; HMN6; SMARD1; SMUBP2; ZFAND7,immunoglobulin mu DNA binding protein 2,11q13.3,protein-coding,/
CWITA012556,TCMBANKGE012556,CFDP1,BCNT; BUCENTAUR; CENP-29; CP27; SWC5; Yeti; p97,craniofacial development protein 1,16q23.1,protein-coding,/
CWITA012557,TCMBANKGE012557,SLC39A5,LZT-Hs7; MYP24; ZIP5,solute carrier family 39 member 5,12q13.3,protein-coding,/
CWITA012558,TCMBANKGE012558,TMPRSS11B,HATL5,transmembrane serine protease 11B,4q13.2,protein-coding,/
CWITA012559,TCMBANKGE012559,CRHR2,CRF-RB; CRF2; CRFR2; HM-CRF,corticotropin releasing hormone receptor 2,7p14.3,protein-coding,Clinical Trial target
CWITA012560,TCMBANKGE012560,MBD3,-,methyl-CpG binding domain protein 3,19p13.3,protein-coding,/
CWITA012561,TCMBANKGE012561,PANK3,-,pantothenate kinase 3,5q34,protein-coding,/
CWITA012562,TCMBANKGE012562,ANKRD44,PP6-ARS-B,ankyrin repeat domain 44,2q33.1,protein-coding,/
CWITA012563,TCMBANKGE012563,NT5E,CD73; E5NT; NT; NT5; NTE; eN; eNT,"5'-nucleotidase, ecto (CD73)",6q14-q21,protein-coding,
CWITA012564,TCMBANKGE012564,QKI,Hqk; QK; QK1; QK3; hqkI,"QKI, KH domain containing RNA binding",6q26,protein-coding,/
CWITA012565,TCMBANKGE012565,KCND2,KV4.2; RK5,potassium voltage-gated channel subfamily D member 2,7q31.31,protein-coding,/
CWITA012566,TCMBANKGE012566,MYL2,CMH10; MLC-2s/v; MLC2,myosin light chain 2,12q24.11,protein-coding,/
CWITA012567,TCMBANKGE012567,DDO,DASOX; DDO-1; DDO-2,D-aspartate oxidase,6q21,protein-coding,/
CWITA012568,TCMBANKGE012568,CYP4B1,CYPIVB1; PN450HP,"cytochrome P450, family 4, subfamily B, polypeptide 1",1p34-p12,protein-coding,
CWITA012569,TCMBANKGE012569,LDHC,CT32; LDH3; LDHX; MGC111073,lactate dehydrogenase C,11p15.1,protein-coding,
CWITA012570,TCMBANKGE012570,Ncf2-rs,EG668181; Gm1820; Gm9025; Ncf-2rs,neutrophil cytosolic factor 2 related sequence,13 D2.2|13,pseudo,/
CWITA012571,TCMBANKGE012571,MTSS1,MIM; MIMA; MIMB,MTSS I-BAR domain containing 1,8q24.13,protein-coding,/
CWITA012572,TCMBANKGE012572,CA5B,CA-VB; CAVB,carbonic anhydrase 5B,Xp22.2,protein-coding,/
CWITA012573,TCMBANKGE012573,ZNF30,KOX28,zinc finger protein 30,19q13.11,protein-coding,/
CWITA012574,TCMBANKGE012574,MAPK12,ERK-6; ERK3; ERK6; MAPK 12; P38GAMMA; PRKM12; SAPK-3; SAPK3,mitogen-activated protein kinase 12,22q13.33,protein-coding,Successful target
CWITA012575,TCMBANKGE012575,IARS1,GRIDHH; IARS; ILERS; ILRS; IRS; PRO0785,isoleucyl-tRNA synthetase 1,9q22.31,protein-coding,/
CWITA012576,TCMBANKGE012576,SYMPK,SPK; SYM,symplekin,19q13.32,protein-coding,/
CWITA012577,TCMBANKGE012577,ZCCHC9,PPP1R41,zinc finger CCHC-type containing 9,5q14.1,protein-coding,/
CWITA012578,TCMBANKGE012578,TUFT1,-,tuftelin 1,1q21.3,protein-coding,/
CWITA012579,TCMBANKGE012579,LHPP,HDHD2B,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,10q26.13,protein-coding,/
CWITA012580,TCMBANKGE012580,ZBTB17,MIZ-1; ZNF151; ZNF60; pHZ-67,zinc finger and BTB domain containing 17,1p36.13,protein-coding,/
CWITA012581,TCMBANKGE012581,HTR2C,5NHT2C; 5NHTR2C; HTR1C,5-hydroxytryptamine (serotonin) receptor 2C,Xq24,protein-coding,
CWITA012582,TCMBANKGE012582,SNRPD3,SMD3; Sm-D3,small nuclear ribonucleoprotein D3 polypeptide,22q11.23,protein-coding,/
CWITA012583,TCMBANKGE012583,IDH3A,-,isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha,15q25.1,protein-coding,/
CWITA012584,TCMBANKGE012584,AK1,N,adenylate kinase 1,9q34.1,protein-coding,
CWITA012585,TCMBANKGE012585,METTL21C,C13orf39,methyltransferase like 21C,13q33.1,protein-coding,/
CWITA012586,TCMBANKGE012586,LPXN,LDPL,leupaxin,11q12.1,protein-coding,/
CWITA012587,TCMBANKGE012587,NDFIP1,N4WBP5,Nedd4 family interacting protein 1,5q31.3,protein-coding,/
CWITA012588,TCMBANKGE012588,FAM117A,-,family with sequence similarity 117 member A,17q21.33,protein-coding,/
CWITA012589,TCMBANKGE012589,GRIA1,GLUH1; GLUR1; GLURA; GluA1; HBGR1; MGC133252,"glutamate receptor, ionotropic, AMPA 1",5q33|5q31.1,protein-coding,
CWITA012590,TCMBANKGE012590,CDH9,-,cadherin 9,5p14.1,protein-coding,/
CWITA012591,TCMBANKGE012591,RPL3,L3; MGC104284; TARBPNB,ribosomal protein L3,22q13,protein-coding,
CWITA012592,TCMBANKGE012592,ART5,ARTC5,ADP-ribosyltransferase 5,11p15.4,protein-coding,/
CWITA012593,TCMBANKGE012593,IFT74,CCDC2; CMG-1; CMG1,intraflagellar transport 74,9p21.2,protein-coding,/
CWITA012594,TCMBANKGE012594,RHO,CSNBAD1; OPN2; RP4,rhodopsin,3q22.1,protein-coding,Research target
CWITA012595,TCMBANKGE012595,NHLRC4,-,NHL repeat containing 4,16p13.3,protein-coding,/
CWITA012596,TCMBANKGE012596,PCTP,PCNTP; STARD2,phosphatidylcholine transfer protein,17q21-q24,protein-coding,
CWITA012597,TCMBANKGE012597,UTP25,C1orf107; DEF; DIEXF; DJ434O14.5,UTP25 small subunit processor component,1q32.2,protein-coding,/
CWITA012598,TCMBANKGE012598,DMPK,DM; DM1; DM1PK; DMK; MDPK; MTNPK,dystrophia myotonica-protein kinase,19q13.3,protein-coding,
CWITA012599,TCMBANKGE012599,PRR15,-,proline rich 15,7p14.3,protein-coding,/
CWITA012600,TCMBANKGE012600,SRD5A1,S5AR 1,steroid 5 alpha-reductase 1,5p15.31,protein-coding,Clinical Trial target
CWITA012601,TCMBANKGE012601,NAXD,CARKD; LP3298; PEBEL2,NAD(P)HX dehydratase,13q34,protein-coding,/
CWITA012602,TCMBANKGE012602,GP1BB,BDPLT1; BS; CD42C; GPIBB; GPIbbeta,glycoprotein Ib platelet subunit beta,22q11.21,protein-coding,/
CWITA012603,TCMBANKGE012603,NPVF,C7orf9; RFRP,neuropeptide VF precursor,7p15.3,protein-coding,/
CWITA012604,TCMBANKGE012604,MBNL1,EXP; MBNL,muscleblind like splicing regulator 1,3q25.1-q25.2,protein-coding,/
CWITA012605,TCMBANKGE012605,FEM1C,EUROIMAGE686608; EUROIMAGE783647; FEM1A,fem-1 homolog C,5q22.3,protein-coding,/
CWITA012606,TCMBANKGE012606,CLSTN3,CDHR14; CSTN3; alcbeta,calsyntenin 3,12p13.31,protein-coding,/
CWITA012607,TCMBANKGE012607,HPCAL4,HLP4,hippocalcin like 4,1p34.2,protein-coding,/
CWITA012608,TCMBANKGE012608,PHTF1,PHTF,putative homeodomain transcription factor 1,1p13.2,protein-coding,/
CWITA012609,TCMBANKGE012609,ZNF639,ANC-2H01; ANC_2H01; ZASC1,zinc finger protein 639,3q26.33,protein-coding,/
CWITA012610,TCMBANKGE012610,MRPS5,MRP-S5; S5mt,mitochondrial ribosomal protein S5,2q11.1,protein-coding,/
CWITA012611,TCMBANKGE012611,NPHS1,CNF; NPHN; nephrin,"NPHS1 adhesion molecule, nephrin",19q13.12,protein-coding,/
CWITA012612,TCMBANKGE012612,PTER,HPHRP; RPR-1,phosphotriesterase related,10p13,protein-coding,/
CWITA012613,TCMBANKGE012613,PSMD6,Rpn7; S10; SGA-113M; p42A; p44S10,"proteasome 26S subunit, non-ATPase 6",3p14.1,protein-coding,/
CWITA012614,TCMBANKGE012614,PTGIS,CYP8; CYP8A1; PGIS; PTGI,prostaglandin I2 synthase,20q13.13,protein-coding,Research target
CWITA012615,TCMBANKGE012615,NCBP1,CBP80; NCBP; Sto1,nuclear cap binding protein subunit 1,9q22.33,protein-coding,/
CWITA012616,TCMBANKGE012616,CNGA1,CNCG; CNCG1; CNG1; RCNC1; RCNCa; RCNCalpha; RP49,cyclic nucleotide gated channel alpha 1,4p12,protein-coding,
CWITA012617,TCMBANKGE012617,ZNF792,-,zinc finger protein 792,19q13.11,protein-coding,/
CWITA012618,TCMBANKGE012618,PRSS57,NSP4; PRSSL1; UNQ782,serine protease 57,19p13.3,protein-coding,/
CWITA012619,TCMBANKGE012619,GPN1,ATPBD1A; MBDIN; NTPBP; RPAP4; XAB1,GPN-loop GTPase 1,2p23.3,protein-coding,/
CWITA012620,TCMBANKGE012620,GPHN,GEPH; GPH; GPHRYN; KIAA1385,gephyrin,14q23.3,protein-coding,
CWITA012621,TCMBANKGE012621,TFF3,ITF; P1B; TFI,trefoil factor 3,21q22.3,protein-coding,/
CWITA012622,TCMBANKGE012622,SLC25A11,OGC; PGL6; SLC20A4,solute carrier family 25 member 11,17p13.2,protein-coding,/
CWITA012623,TCMBANKGE012623,FARSA,CML33; FARSL; FARSLA; FRSA; PheHA,"phenylalanyl-tRNA synthetase, alpha subunit",19p13.2,protein-coding,
CWITA012624,TCMBANKGE012624,MAGI3,MAGI-3; dJ730K3.2,"membrane associated guanylate kinase, WW and PDZ domain containing 3",1p13.2,protein-coding,/
CWITA012625,TCMBANKGE012625,BGN,DSPG1; MRLS; PG-S1; PGI; SEMDX; SLRR1A,biglycan,Xq28,protein-coding,Research target
CWITA012626,TCMBANKGE012626,RBPMS,HERMES,"RNA binding protein, mRNA processing factor",8p12,protein-coding,/
CWITA012627,TCMBANKGE012627,GPR183,EBI2; hEBI2,G protein-coupled receptor 183,13q32.3,protein-coding,Research target
CWITA012628,TCMBANKGE012628,IGKV1-16,IGKV116; L1,Immunoglobulin_Kappa_Variable_1-16,2p11.2,other,
CWITA012629,TCMBANKGE012629,BCAR3,AND-34; NSP2; SH2D3B,"BCAR3 adaptor protein, NSP family member",1p22.1,protein-coding,/
CWITA012630,TCMBANKGE012630,SIGLEC1,CD169; DKFZp667F058; FLJ00051; FLJ00055; FLJ00073; FLJ00411; FLJ32150; SIGLECN1; SN; dJ1009E24.1,"sialic acid binding Ig-like lectin 1, sialoadhesin",20p13,protein-coding,
CWITA012631,TCMBANKGE012631,GSG2,HASPIN,germ cell associated 2 (haspin),17p13,protein-coding,
CWITA012632,TCMBANKGE012632,INHBB,-,inhibin subunit beta B,2q14.2,protein-coding,/
CWITA012633,TCMBANKGE012633,BANP,BEND1; SMAR1; SMARBP1,BTG3 associated nuclear protein,16q24.2,protein-coding,/
CWITA012634,TCMBANKGE012634,CRABP2,CRABP-II; RBP6,cellular retinoic acid binding protein 2,1q23.1,protein-coding,/
CWITA012635,TCMBANKGE012635,C11orf45,-,chromosome 11 open reading frame 45,11q24.3,protein-coding,/
CWITA012636,TCMBANKGE012636,GNG3,-,G protein subunit gamma 3,11q12.3,protein-coding,/
CWITA012637,TCMBANKGE012637,RPH3AL,NOC2,rabphilin 3A like (without C2 domains),17p13.3,protein-coding,/
CWITA012638,TCMBANKGE012638,DHX15,DBP1; DDX15; HRH2; PRP43; PRPF43; PrPp43p,DEAH-box helicase 15,4p15.2,protein-coding,/
CWITA012639,TCMBANKGE012639,FGF12,EIEE47; FGF12B; FHF1,fibroblast growth factor 12,3q28-q29,protein-coding,/
CWITA012640,TCMBANKGE012640,LGALS16,-,galectin 16,19q13.2,protein-coding,/
CWITA012641,TCMBANKGE012641,ESYT2,CHR2SYT; E-Syt2; FAM62B,extended synaptotagmin 2,7q36.3,protein-coding,/
CWITA012642,TCMBANKGE012642,COL18A1,GLCC; KNO; KNO1; KS,collagen type XVIII alpha 1 chain,21q22.3,protein-coding,Clinical Trial target
CWITA012643,TCMBANKGE012643,ZNF429,-,zinc finger protein 429,19p12,protein-coding,/
CWITA012644,TCMBANKGE012644,PCDHA5,CNR6; CNRN6; CNRS6; CRNR6; PCDH-ALPHA5,protocadherin alpha 5,5q31.3,protein-coding,/
CWITA012645,TCMBANKGE012645,JAK2,JTK10,Janus kinase 2,9p24,protein-coding,
CWITA012646,TCMBANKGE012646,RTCB,C22orf28; DJ149A16.6; FAAP; HSPC117,"Rna_2',3'-Cyclic_Phosphate_And_5'-Oh_Ligase",22q12.3,protein-coding,
CWITA012647,TCMBANKGE012647,KIF26A,-,kinesin family member 26A,14q32.33,protein-coding,/
CWITA012648,TCMBANKGE012648,GSTT1,N,glutathione S-transferase theta 1,22q11.23,protein-coding,
CWITA012649,TCMBANKGE012649,APOA2,Apo-AII; ApoA-II; apoAII,apolipoprotein A2,1q23.3,protein-coding,Research target
CWITA012650,TCMBANKGE012650,KCNH5,EAG2; H-EAG2; Kv10.2; hEAG2,potassium voltage-gated channel subfamily H member 5,14q23.2,protein-coding,Research target
CWITA012651,TCMBANKGE012651,RND2,ARHN; RHO7; RhoN,Rho family GTPase 2,17q21.31,protein-coding,/
CWITA012652,TCMBANKGE012652,RHEX,C1orf186,regulator of hemoglobinization and erythroid cell expansion,1q32.1,protein-coding,/
CWITA012653,TCMBANKGE012653,SLCO1B3,LSTN3TM13; LST3; OATP1B3; OATP8; SLC21A8,"solute carrier organic anion transporter family, member 1B3",12p12,protein-coding,
CWITA012654,TCMBANKGE012654,SLC12A4,FLJ17069; FLJ40489; KCC1,"solute carrier family 12 (potassium/chloride transporters), member 4",16q22.1,protein-coding,
CWITA012655,TCMBANKGE012655,CLDN19,HOMG5,claudin 19,1p34.2,protein-coding,/
CWITA012656,TCMBANKGE012656,P4HTM,EGLN4; HIDEA; HIFPH4; P4H-TM; PH-4; PH4; PHD4,"prolyl 4-hydroxylase, transmembrane",3p21.31|3p21.3,protein-coding,/
CWITA012657,TCMBANKGE012657,SLCO1B7,LST-3; LST-3TM12; LST3; SLC21A21,solute carrier organic anion transporter family member 1B7 (putative),12p12.2,protein-coding,/
CWITA012658,TCMBANKGE012658,HSBP1L1,-,heat shock factor binding protein 1 like 1,18q23,protein-coding,/
CWITA012659,TCMBANKGE012659,EGLN3,HIFP4H3; HIFPH3; PHD3,egl-9 family hypoxia inducible factor 3,14q13.1,protein-coding,/
CWITA012660,TCMBANKGE012660,POLR2E,RPABC1; RPB5; XAP4; hRPB25; hsRPB5,"RNA polymerase II, I and III subunit E",19p13.3,protein-coding,/
CWITA012661,TCMBANKGE012661,PSMA3,HC8; MGC12306; MGC32631; PSC3,"proteasome (prosome, macropain) subunit, alpha type, 3",14q23,protein-coding,
CWITA012662,TCMBANKGE012662,PTPRZ1,HPTPZ; HPTPzeta; PTP-ZETA; PTP18; PTPRZ; PTPZ; R-PTP-zeta-2; RPTPB; RPTPbeta; phosphacan,protein tyrosine phosphatase receptor type Z1,7q31.32,protein-coding,Research target
CWITA012663,TCMBANKGE012663,ZNF140,pHZ-39,zinc finger protein 140,12q24.33,protein-coding,/
CWITA012664,TCMBANKGE012664,OPTC,OPT,opticin,1q32.1,protein-coding,/
CWITA012665,TCMBANKGE012665,NR1H4,BAR; FXR; HRRN1; HRR1; MGC163445; RIP14,"nuclear receptor subfamily 1, group H, member 4",12q23.1,protein-coding,
CWITA012666,TCMBANKGE012666,DCAF8,GAN2; H326; WDR42A,DDB1 and CUL4 associated factor 8,1q23.2,protein-coding,/
CWITA012667,TCMBANKGE012667,ZFPM1,FOG; FOG1; ZC2HC11A; ZNF408; ZNF89A,"zinc finger protein, FOG family member 1",16q24.2,protein-coding,/
CWITA012668,TCMBANKGE012668,XRN2,-,5'-3' exoribonuclease 2,20p11.22,protein-coding,/
CWITA012669,TCMBANKGE012669,PRIM1,p49,DNA primase subunit 1,12q13.3,protein-coding,/
CWITA012670,TCMBANKGE012670,ELL,C19orf17; ELL1; MEN; PPP1R68,elongation factor for RNA polymerase II,19p13.11,protein-coding,/
CWITA012671,TCMBANKGE012671,GBP3,-,guanylate binding protein 3,1p22.2,protein-coding,/
CWITA012672,TCMBANKGE012672,SLC9A1,APNH; LIKNS; NHE-1; NHE1; PPP1R143,solute carrier family 9 member A1,1p36.11,protein-coding,Clinical Trial target
CWITA012673,TCMBANKGE012673,AKR7A3,AFAR2,aldo-keto reductase family 7 member A3,1p36.13,protein-coding,/
CWITA012674,TCMBANKGE012674,PLEKHM1,AP162; B2; OPTA3; OPTB6,pleckstrin homology and RUN domain containing M1,17q21.31,protein-coding,/
CWITA012675,TCMBANKGE012675,FNBP4,FBP30,formin binding protein 4,11p11.2,protein-coding,/
CWITA012676,TCMBANKGE012676,GAPDH,G3PD; GAPD; MGC88685,glyceraldehyde-3-phosphate dehydrogenase,12p13,protein-coding,
CWITA012677,TCMBANKGE012677,ZAP70,ADMIO2; IMD48; SRK; STCD; STD; TZK; ZAP-70,zeta chain of T cell receptor associated protein kinase 70,2q11.2,protein-coding,Research target
CWITA012678,TCMBANKGE012678,CELA1,ELA1,"chymotrypsin-like elastase family, member 1",12q13,protein-coding,
CWITA012679,TCMBANKGE012679,Gpx4-ps2,GPx-4; GSHPx-4; Gm7338; Gpx4; PHGPx,"glutathione peroxidase 4, pseudogene 2",10 B2|10,pseudo,/
CWITA012680,TCMBANKGE012680,TARS1,TARS; TTD7; ThrRS,threonyl-tRNA synthetase 1,5p13.3,protein-coding,/
CWITA012681,TCMBANKGE012681,CTRB1,CTRB; FLJ42412; MGC88037,chymotrypsinogen B1,16q23.1,protein-coding,
CWITA012682,TCMBANKGE012682,TXNDC8,SPTRX-3; SPTRX3; TRX6; bA427L11.2,thioredoxin domain containing 8,9q31.3,protein-coding,/
CWITA012683,TCMBANKGE012683,H3P42,p52,H3 histone pseudogene 42,17q23.2,pseudo,/
CWITA012684,TCMBANKGE012684,PDE5A,CGBNPDE; CN5A; PDE5,"phosphodiesterase 5A, cGMP-specific",4q27,protein-coding,
CWITA012685,TCMBANKGE012685,NKIRAS1,KBRAS1; kappaB-Ras1,NFKB inhibitor interacting Ras like 1,3p24.2,protein-coding,/
CWITA012686,TCMBANKGE012686,TSPYL2,CDA1; CINAP; CTCL; DENTT; HRIHFB2216; NP79; SE204; TSPX,TSPY like 2,Xp11.22,protein-coding,/
CWITA012687,TCMBANKGE012687,C8orf58,-,chromosome 8 open reading frame 58,8p21.3,protein-coding,/
CWITA012688,TCMBANKGE012688,C8orf76,-,chromosome 8 open reading frame 76,8q24.13,protein-coding,/
CWITA012689,TCMBANKGE012689,ZNF184,kr-ZNF3,zinc finger protein 184,6p22.1,protein-coding,/
CWITA012690,TCMBANKGE012690,ZNF793,-,zinc finger protein 793,19q13.12,protein-coding,/
CWITA012691,TCMBANKGE012691,PADI4,PAD; PAD4; PADI5; PDI4; PDI5,"peptidyl arginine deiminase, type IV",1p36.13,protein-coding,
CWITA012692,TCMBANKGE012692,LRRC38,-,leucine rich repeat containing 38,1p36.21,protein-coding,/
CWITA012693,TCMBANKGE012693,SGO2,SGOL2; TRIPIN,shugoshin 2,2q33.1,protein-coding,/
CWITA012694,TCMBANKGE012694,PSMB2,HC7NI; MGC104215; MGC126885,"proteasome (prosome, macropain) subunit, beta type, 2",1p34.2,protein-coding,
CWITA012695,TCMBANKGE012695,FARP2,FIR; FRG; PLEKHC3,"FERM, ARH/RhoGEF and pleckstrin domain protein 2",2q37.3,protein-coding,/
CWITA012696,TCMBANKGE012696,RAD17,CCYC; HRAD17; R24L; RAD17SP; RAD24,RAD17 checkpoint clamp loader component,5q13.2,protein-coding,/
CWITA012697,TCMBANKGE012697,ABCB8,EST328128; M-ABC1; MABC1; MITOSUR,ATP binding cassette subfamily B member 8,7q36.1,protein-coding,/
CWITA012698,TCMBANKGE012698,WNT2B,WNT13,Wnt family member 2B,1p13.2,protein-coding,/
CWITA012699,TCMBANKGE012699,LAT2,HSPC046; LAB; NTAL; WBSCR15; WBSCR5; WSCR5,linker for activation of T cells family member 2,7q11.23,protein-coding,/
CWITA012700,TCMBANKGE012700,PTPRE,HPTPE; PTPE; R-PTP-EPSILON,protein tyrosine phosphatase receptor type E,10q26.2,protein-coding,/
CWITA012701,TCMBANKGE012701,HOXB6,HOX2; HOX2B; HU-2; Hox-2.2,homeobox B6,17q21.32,protein-coding,/
CWITA012702,TCMBANKGE012702,NR1I2,BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR,"nuclear receptor subfamily 1, group I, member 2",3q12-q13.3,protein-coding,
CWITA012703,TCMBANKGE012703,LIPC,HDLCQ12; HL; HTGL; LIPH,"lipase C, hepatic type",15q21.3,protein-coding,/
CWITA012704,TCMBANKGE012704,MYH1,HEL71; MYHSA1; MYHa; MyHC-2X/D; MyHC-2x,myosin heavy chain 1,17p13.1,protein-coding,/
CWITA012705,TCMBANKGE012705,GGT5,GGL; GGT 5; GGT-REL; GGTLA1,gamma-glutamyltransferase 5,22q11.23,protein-coding,/
CWITA012706,TCMBANKGE012706,A1CF,ACF; ACF64; ACF65; APOBEC1CF; ASP,APOBEC1 complementation factor,10q11.23,protein-coding,/
CWITA012707,TCMBANKGE012707,QARS1,GLNRS; MSCCA; PRO2195; QARS,glutaminyl-tRNA synthetase 1,3p21.31,protein-coding,/
CWITA012708,TCMBANKGE012708,OTOF,AUNB1; DFNB6; DFNB9; FER1L2; NSRD9,otoferlin,2p23.3,protein-coding,/
CWITA012709,TCMBANKGE012709,N4BP2L2,92M18.3; CG005; CG016; PFAAP5,NEDD4 binding protein 2 like 2,13q13.1,protein-coding,/
CWITA012710,TCMBANKGE012710,B4GALT1,B4GALNT1; CDG2D; DKFZp686N19253; GGTB2; GT1; GTB; MGC50983; beta4GalNT1,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1",9p13,protein-coding,
CWITA012711,TCMBANKGE012711,SH3BP2,3BP-2; 3BP2; CRBM; CRPM; RES4-23,SH3 domain binding protein 2,4p16.3,protein-coding,/
CWITA012712,TCMBANKGE012712,PCDHA9,PCDH-ALPHA9,protocadherin alpha 9,5q31.3,protein-coding,/
CWITA012713,TCMBANKGE012713,UNC13C,-,unc-13 homolog C,15q21.3,protein-coding,/
CWITA012714,TCMBANKGE012714,FABP5,ENFABP; EFABP; PANFABP; PAFABP,fatty acid binding protein 5 (psoriasis-associated),8q21.13,protein-coding,
CWITA012715,TCMBANKGE012715,ZNF777,-,zinc finger protein 777,7q36.1,protein-coding,/
CWITA012716,TCMBANKGE012716,SLU7,9G8; hSlu7,"SLU7 homolog, splicing factor",5q33.3,protein-coding,/
CWITA012717,TCMBANKGE012717,TRAPPC5,TRS31,trafficking protein particle complex 5,19p13.2,protein-coding,/
CWITA012718,TCMBANKGE012718,COX6A2,COX6AH; COXVIAH,cytochrome c oxidase subunit VIa polypeptide 2,16p,protein-coding,
CWITA012719,TCMBANKGE012719,AP2A2,ADTAB; CLAPA2; HIP-9; HIP9; HYPJ,adaptor related protein complex 2 subunit alpha 2,11p15.5,protein-coding,/
CWITA012720,TCMBANKGE012720,TNKS2,ARTD6; PARP-5b; PARP-5c; PARP5B; PARP5C; TANK2; TNKL; pART6,tankyrase 2,10q23.32,protein-coding,Patented target
CWITA012721,TCMBANKGE012721,SLC35A2,CDG2M; CDGX; UDP-Gal-Tr; UGALT; UGAT; UGT; UGT1; UGT2; UGTL,solute carrier family 35 member A2,Xp11.23,protein-coding,/
CWITA012722,TCMBANKGE012722,HYPK,C15orf63; HSPC136,huntingtin interacting protein K,15q15.3,protein-coding,/
CWITA012723,TCMBANKGE012723,S100A12,CAAF1; CAGC; CGRP; ENRAGE; MRP6; p6,S100 calcium binding protein A12,1q21,protein-coding,
CWITA012724,TCMBANKGE012724,PRDM15,C21orf83; PFM15; ZNF298,PR/SET domain 15,21q22.3,protein-coding,/
CWITA012725,TCMBANKGE012725,RGS9,PERRS; RGS9L,regulator of G protein signaling 9,17q24.1,protein-coding,/
CWITA012726,TCMBANKGE012726,MTTP,ABL; MTP,microsomal triglyceride transfer protein,4q23,protein-coding,Successful target
CWITA012727,TCMBANKGE012727,DMAC2L,ATP5S; ATPW; FB; HSU79253,distal membrane arm assembly complex 2 like,14q21.3,protein-coding,/
CWITA012728,TCMBANKGE012728,SH3PXD2B,FAD49; FTHS; HOFI; KIAA1295; TKS4; TSK4,SH3 and PX domains 2B,5q35.1,protein-coding,/
CWITA012729,TCMBANKGE012729,CSAD,CSD; PCAP,cysteine sulfinic acid decarboxylase,12q13.13,protein-coding,/
CWITA012730,TCMBANKGE012730,FBXO2,FBG1; FBX2; Fbs1; NFB42; OCP1,F-box protein 2,1p36.22,protein-coding,/
CWITA012731,TCMBANKGE012731,PIK3IP1,HGFL; TrIP; hHGFL(S),phosphoinositide-3-kinase interacting protein 1,22q12.2,protein-coding,/
CWITA012732,TCMBANKGE012732,BRCC3,BRCC36; C6.1A; CXorf53,BRCA1/BRCA2-containing complex subunit 3,Xq28,protein-coding,/
CWITA012733,TCMBANKGE012733,DAPP1,BAM32; DKFZp667E0716,dual adaptor of phosphotyrosine and 3-phosphoinositides,4q25-q27,protein-coding,
CWITA012734,TCMBANKGE012734,POLA1,NSX; POLA; VEODS; p180,"DNA polymerase alpha 1, catalytic subunit",Xp22.11-p21.3,protein-coding,Discontinued target
CWITA012735,TCMBANKGE012735,SLC39A12,LZT-Hs8; ZIP-12; bA570F3.1,solute carrier family 39 member 12,10p12.33,protein-coding,/
CWITA012736,TCMBANKGE012736,CA9,CAIX; MN,carbonic anhydrase 9,9p13.3,protein-coding,Clinical Trial target
CWITA012737,TCMBANKGE012737,IYD,C6orf71; DEHAL1; TDH4; dJ422F24.1,iodotyrosine deiodinase,6q25.1,protein-coding,
CWITA012738,TCMBANKGE012738,ANKRD53,-,ankyrin repeat domain 53,2p13.3,protein-coding,/
CWITA012739,TCMBANKGE012739,FBXO22,FBX22; FISTC1,F-box protein 22,15q24.2,protein-coding,/
CWITA012740,TCMBANKGE012740,FGF17,FGF-13; FGF-17; HH20,fibroblast growth factor 17,8p21.3,protein-coding,/
CWITA012741,TCMBANKGE012741,RNF220,C1orf164,ring finger protein 220,1p34.1,protein-coding,/
CWITA012742,TCMBANKGE012742,MTHFD1,CIMAH; MTHFC; MTHFD,"methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",14q23.3,protein-coding,/
CWITA012743,TCMBANKGE012743,ECSIT,SITPEC,ECSIT signaling integrator,19p13.2,protein-coding,/
CWITA012744,TCMBANKGE012744,NRTN,NTN,neurturin,19p13.3,protein-coding,/
CWITA012745,TCMBANKGE012745,TPD52L2,D54; TPD54,TPD52 like 2,20q13.33,protein-coding,/
CWITA012746,TCMBANKGE012746,ZNF112,ZFP112; ZNF228,zinc finger protein 112,19q13.31,protein-coding,/
CWITA012747,TCMBANKGE012747,HK3,HKIII; HXK3,hexokinase 3,5q35.2,protein-coding,/
CWITA012748,TCMBANKGE012748,FAM43A,-,family with sequence similarity 43 member A,3q29,protein-coding,/
CWITA012749,TCMBANKGE012749,UGT2A1,UDPGT2A1,UDP glucuronosyltransferase family 2 member A1 complex locus,4q13.3,protein-coding,/
CWITA012750,TCMBANKGE012750,EDA,ECTD1; ED1; ED1-A1; ED1-A2; EDA-A1; EDA-A2; EDA1; EDA2; HED; HED1; ODT1; STHAGX1; TNLG7C; XHED; XLHED,ectodysplasin A,Xq13.1,protein-coding,/
CWITA012751,TCMBANKGE012751,NSMAF,FAN; GRAMD5,neutral sphingomyelinase activation associated factor,8q12.1,protein-coding,/
CWITA012752,TCMBANKGE012752,TENT2,APD4; GLD2; PAPD4; TUT2,terminal nucleotidyltransferase 2,5q14.1,protein-coding,/
CWITA012753,TCMBANKGE012753,ZNF772,-,zinc finger protein 772,19q13.43,protein-coding,/
CWITA012754,TCMBANKGE012754,NAGPA,APAA; UCE,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,16p13.3,protein-coding,
CWITA012755,TCMBANKGE012755,TXK,BTKL; PSCTK5; PTK4; RLK; TKL,TXK tyrosine kinase,4p12,protein-coding,Research target
CWITA012756,TCMBANKGE012756,SLC19A1,CHMD; FOLT; IFC-1; IFC1; REFC; RFC; RFC1; RFT-1; hRFC; hSLC19A1,solute carrier family 19 member 1,21q22.3,protein-coding,Successful target
CWITA012757,TCMBANKGE012757,GEMIN6,-,gem nuclear organelle associated protein 6,2p22.1,protein-coding,/
CWITA012758,TCMBANKGE012758,ANAPC4,APC4,anaphase promoting complex subunit 4,4p15.2,protein-coding,/
CWITA012759,TCMBANKGE012759,CCNY,C10orf9; CBCP1; CCNX; CFP1,cyclin Y,10p11.21,protein-coding,/
CWITA012760,TCMBANKGE012760,DKK3,REIC; RIG,dickkopf WNT signaling pathway inhibitor 3,11p15.3,protein-coding,Clinical Trial target
CWITA012761,TCMBANKGE012761,CHRM5,HM5; MGC41838,"cholinergic receptor, muscarinic 5",15q26,protein-coding,
CWITA012762,TCMBANKGE012762,TM6SF1,-,transmembrane 6 superfamily member 1,15q25.2,protein-coding,/
CWITA012763,TCMBANKGE012763,P2RY12,ADPGNR; HORK3; P2T(AC); P2Y(AC); P2Y(ADP); P2Y(cyc); P2Y12; SP1999,"purinergic receptor P2Y, G-protein coupled, 12",3q24-q25,protein-coding,
CWITA012764,TCMBANKGE012764,CKMT1A,CKMT1; CKMT1B; FLJ50967; UMTCK,"creatine kinase, mitochondrial 1A",15q15,protein-coding,
CWITA012765,TCMBANKGE012765,STK24,HEL-S-95; MST3; MST3B; STE20; STK3,serine/threonine kinase 24,13q32.2,protein-coding,/
CWITA012766,TCMBANKGE012766,FURIN,FUR; PACE; PCSK3; SPC1,furin (paired basic amino acid cleaving enzyme),15q26.1,protein-coding,
CWITA012767,TCMBANKGE012767,ATP7B,PWD; WC1; WD; WND,ATPase copper transporting beta,13q14.3,protein-coding,/
CWITA012768,TCMBANKGE012768,PITPNA,HEL-S-36; PI-TPalpha; PITPN; VIB1A,phosphatidylinositol transfer protein alpha,17p13.3,protein-coding,/
CWITA012769,TCMBANKGE012769,TRIP11,ACG1A; CEV14; GMAP-210; GMAP210; ODCD; TRIP-11; TRIP230,thyroid hormone receptor interactor 11,14q32.12,protein-coding,/
CWITA012770,TCMBANKGE012770,PLD2,N,phospholipase D2,17p13.1,protein-coding,
CWITA012771,TCMBANKGE012771,PTGR1,FLJ99229; LTB4DH; MGC34943; PGR1; ZADH3,prostaglandin reductase 1,9q31.3,protein-coding,
CWITA012772,TCMBANKGE012772,PTK2,FADK; FAK; FAK1; FRNK; pp125FAK,PTK2 protein tyrosine kinase 2,8q24.3,protein-coding,
CWITA012773,TCMBANKGE012773,MIF,GIF; GLIF; MMIF,macrophage migration inhibitory factor,22q11.23,protein-coding,Research target
CWITA012774,TCMBANKGE012774,NXF3,-,nuclear RNA export factor 3,Xq22.1,protein-coding,/
CWITA012775,TCMBANKGE012775,IFNW1,-,interferon omega 1,9p21.3,protein-coding,Clinical Trial target
CWITA012776,TCMBANKGE012776,DECR2,PDCR; SDR17C1,"2,4-dienoyl-CoA reductase 2",16p13.3,protein-coding,/
CWITA012777,TCMBANKGE012777,BIN1,AMPH2; AMPHL; CNM2; SH3P9,bridging integrator 1,2q14.3,protein-coding,/
CWITA012778,TCMBANKGE012778,DCLRE1C,A-SCID; DCLREC1C; RS-SCID; SCIDA; SNM1C,DNA cross-link repair 1C,10p13,protein-coding,/
CWITA012779,TCMBANKGE012779,ATM,AT1; ATA; ATC; ATD; ATDC; ATE; DKFZp781A0353; MGC74674; TEL1; TELO1,ataxia telangiectasia mutated,11q22-q23,protein-coding,
CWITA012780,TCMBANKGE012780,ZNF669,-,zinc finger protein 669,1q44,protein-coding,/
CWITA012781,TCMBANKGE012781,SETD1B,KMT2G; Set1B,"SET domain containing 1B, histone lysine methyltransferase",12q24.31,protein-coding,/
CWITA012782,TCMBANKGE012782,PIGZ,GPI-MT-IV; PIG-Z; SMP3,phosphatidylinositol glycan anchor biosynthesis class Z,3q29,protein-coding,/
CWITA012783,TCMBANKGE012783,RNASE4,MGC9306; RNS4,"ribonuclease, RNase A family, 4",14q11.1,protein-coding,
CWITA012784,TCMBANKGE012784,RASL12,RIS,RAS like family 12,15q22.31,protein-coding,/
CWITA012785,TCMBANKGE012785,RARRES1,LXNL; PERG-1; TIG1,retinoic acid receptor responder 1,3q25.32,protein-coding,/
CWITA012786,TCMBANKGE012786,RDH13,SDR7C3,retinol dehydrogenase 13,19q13.42,protein-coding,/
CWITA012787,TCMBANKGE012787,ICAM3,CD50; CDW50; ICAM-R,intercellular adhesion molecule 3,19p13.2,protein-coding,/
CWITA012788,TCMBANKGE012788,PRSS22,BSSP-4; SP001LA; hBSSP-4,serine protease 22,16p13.3,protein-coding,/
CWITA012789,TCMBANKGE012789,TASOR,C3orf63; FAM208A; RAP140; TASOR1; se89-1,transcription activation suppressor,3p14.3,protein-coding,/
CWITA012790,TCMBANKGE012790,PDE7A,HCP1; PDE7,phosphodiesterase 7A,8q13,protein-coding,
CWITA012791,TCMBANKGE012791,TNNC1,CMD1Z; CMH13; TN-C; TNC; TNNC,"troponin C1, slow skeletal and cardiac type",3p21.1,protein-coding,Successful target
CWITA012792,TCMBANKGE012792,KPNA7,IPOA8,karyopherin subunit alpha 7,7q22.1,protein-coding,/
CWITA012793,TCMBANKGE012793,PTPRN,IA-2; IA-2/PTP; IA2; ICA512; R-PTP-N,protein tyrosine phosphatase receptor type N,2q35,protein-coding,/
CWITA012794,TCMBANKGE012794,CATSPER3,CACRC,cation channel sperm associated 3,5q31.1,protein-coding,Research target
CWITA012795,TCMBANKGE012795,SFRP4,FRPN4; FRPHE; MGC26498,secreted frizzled-related protein 4,7p14.1,protein-coding,
CWITA012796,TCMBANKGE012796,CAMK4,CaMK_IV; CaMKNGR; IV; MGC36771; caMK,calcium/calmodulin-dependent protein kinase IV,5q21.3,protein-coding,
CWITA012797,TCMBANKGE012797,DAAM2,dJ90A20A.1,dishevelled associated activator of morphogenesis 2,6p21.2,protein-coding,Research target
CWITA012798,TCMBANKGE012798,RAVER2,-,"ribonucleoprotein, PTB binding 2",1p31.3,protein-coding,/
CWITA012799,TCMBANKGE012799,GRPEL1,GrpE; HMGE; mt-GrpE#1,"GrpE like 1, mitochondrial",4p16.1,protein-coding,/
CWITA012800,TCMBANKGE012800,ZNF790,-,zinc finger protein 790,19q13.12,protein-coding,/
CWITA012801,TCMBANKGE012801,ZNF660,-,zinc finger protein 660,3p21.31,protein-coding,/
CWITA012802,TCMBANKGE012802,TES,TESS; TESS-2,testin LIM domain protein,7q31.2,protein-coding,/
CWITA012803,TCMBANKGE012803,BUD23,HASJ4442; HUSSY-3; MERM1; PP3381; WBMT; WBSCR22,BUD23 rRNA methyltransferase and ribosome maturation factor,7q11.23,protein-coding,/
CWITA012804,TCMBANKGE012804,MBIP,-,MAP3K12 binding inhibitory protein 1,14q13.3,protein-coding,/
CWITA012805,TCMBANKGE012805,RPL19,DKFZp779D216; FLJ27452; L19; MGC71997,ribosomal protein L19,17q11.2-q12,protein-coding,
CWITA012806,TCMBANKGE012806,BLCAP,BC10,BLCAP apoptosis inducing factor,20q11.23,protein-coding,/
CWITA012807,TCMBANKGE012807,EIF2B5,CACH; CLE; EIF-2B; EIF2Bepsilon; LVWM,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1,protein-coding,/
CWITA012808,TCMBANKGE012808,NUSAP1,ANKT; BM037; LNP; NUSAP; PRO0310p1; Q0310; SAPL,nucleolar and spindle associated protein 1,15q15.1,protein-coding,/
CWITA012809,TCMBANKGE012809,OR10AG1,OR11-160,olfactory receptor family 10 subfamily AG member 1,11q12.1,protein-coding,/
CWITA012810,TCMBANKGE012810,SCML2,-,Scm polycomb group protein like 2,Xp22.13,protein-coding,/
CWITA012811,TCMBANKGE012811,HR,ALUNC; AU; HSA277165; HYPT4; MUHH; MUHH1,HR lysine demethylase and nuclear receptor corepressor,8p21.3,protein-coding,/
CWITA012812,TCMBANKGE012812,TPRG1,FAM79B,tumor protein p63 regulated 1,3q28,protein-coding,/
CWITA012813,TCMBANKGE012813,RGCC,C13orf15; RGC-32; RGC32; bA157L14.2,regulator of cell cycle,13q14.11,protein-coding,/
CWITA012814,TCMBANKGE012814,PRKAG2,AAKG; AAKG2; CMH6; H91620p; WPWS,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",7q36.1,protein-coding,
CWITA012815,TCMBANKGE012815,CACNB4,CAB4; CACNLB4; EA5; EIG9; EJM; EJM4; EJM6,"calcium channel, voltage-dependent, beta 4 subunit",2q22-q23,protein-coding,
CWITA012816,TCMBANKGE012816,RHOBTB1,-,Rho related BTB domain containing 1,10q21.2,protein-coding,/
CWITA012817,TCMBANKGE012817,PRR11,-,proline rich 11,17q22,protein-coding,/
CWITA012818,TCMBANKGE012818,CYP2C8,CPC8; CYPIIC8; MPN12/MPN20,"cytochrome P450, family 2, subfamily C, polypeptide 8",10q23.33,protein-coding,
CWITA012819,TCMBANKGE012819,CA4,CAIV; Car4; RP17,carbonic anhydrase IV,17q23,protein-coding,
CWITA012820,TCMBANKGE012820,ITGA4,CD49D; IA4,integrin subunit alpha 4,2q31.3,protein-coding,Successful target
CWITA012821,TCMBANKGE012821,CCDC85B,DIPA,coiled-coil domain containing 85B,11q13.1,protein-coding,/
CWITA012822,TCMBANKGE012822,PDLIM1,CLIM1; CLP-36; CLP36; HEL-S-112; hCLIM1,PDZ and LIM domain 1,10q23.33,protein-coding,/
CWITA012823,TCMBANKGE012823,UGT1A8,GNT1; UDPGT; UDPGT 1-8; UGT-1A; UGT-1H; UGT1; UGT1-01; UGT1-08; UGT1.1; UGT1.8; UGT1A; UGT1A1; UGT1A8S; UGT1H; hUG-BR1,UDP glucuronosyltransferase family 1 member A8,2q37.1,protein-coding,/
CWITA012824,TCMBANKGE012824,SLC29A2,DER12; ENT2; HNP36,"solute carrier family 29 (nucleoside transporters), member 2",11q13,protein-coding,
CWITA012825,TCMBANKGE012825,HMGB2,HMG2,high mobility group box 2,4q34.1,protein-coding,Research target
CWITA012826,TCMBANKGE012826,MRPL49,C11orf4; L49mt; MRP-L49; NOF; NOF1,mitochondrial ribosomal protein L49,11q13.1,protein-coding,/
CWITA012827,TCMBANKGE012827,JDP2,JUNDM2,Jun dimerization protein 2,14q24.3,protein-coding,
CWITA012828,TCMBANKGE012828,C2CD4A,FAM148A; NLF1,C2 calcium dependent domain containing 4A,15q22.2,protein-coding,/
CWITA012829,TCMBANKGE012829,MAN2C1,MAN6A8; MANA; MANA1,Mannosidase_Alpha_Class_2C_Member_1,15q24.2,protein-coding,
CWITA012830,TCMBANKGE012830,ATP6V0E1,ATP6H; ATP6V0E; M9.2; Vma21; Vma21p,ATPase H+ transporting V0 subunit e1,5q35.1,protein-coding,/
CWITA012831,TCMBANKGE012831,AARS,CMT2N,alanyl-tRNA synthetase,16q22,protein-coding,
CWITA012832,TCMBANKGE012832,LSS,APMR4; CTRCT44; HYPT14; OSC,lanosterol synthase,21q22.3,protein-coding,Research target
CWITA012833,TCMBANKGE012833,PDE9A,HSPDE9A2,phosphodiesterase 9A,21q22.3,protein-coding,Clinical Trial target
CWITA012834,TCMBANKGE012834,XCL2,SCM-1b; SCM1B; SCYC2,X-C motif chemokine ligand 2,1q24.2,protein-coding,/
CWITA012835,TCMBANKGE012835,STK38,NDR; NDR1,serine/threonine kinase 38,6p21.31,protein-coding,Research target
CWITA012836,TCMBANKGE012836,CEP70,BITE,centrosomal protein 70,3q22.3,protein-coding,/
CWITA012837,TCMBANKGE012837,ATP6V1E1,ARCL2C; ATP6E; ATP6E2; ATP6V1E; P31; Vma4,ATPase H+ transporting V1 subunit E1,22q11.21,protein-coding,/
CWITA012838,TCMBANKGE012838,INHA,-,inhibin subunit alpha,2q35,protein-coding,/
CWITA012839,TCMBANKGE012839,STRADA,LYK5; NY-BR-96; PMSE; STRAD; STRAD alpha; Stlk,STE20 related adaptor alpha,17q23.3,protein-coding,/
CWITA012840,TCMBANKGE012840,TOX,TOX1,thymocyte selection associated high mobility group box,8q12.1,protein-coding,/
CWITA012841,TCMBANKGE012841,HLA-A,HLAA,"major histocompatibility complex, class I, A",6p22.1,protein-coding,Research target
CWITA012842,TCMBANKGE012842,ZNF518B,-,zinc finger protein 518B,4p16.1,protein-coding,/
CWITA012843,TCMBANKGE012843,EDN3,ET-3; ET3; HSCR4; PPET3; WS4B,endothelin 3,20q13.32,protein-coding,/
CWITA012844,TCMBANKGE012844,PPP3R2,PPP3RL,"protein phosphatase 3 regulatory subunit B, beta",9q31.1,protein-coding,/
CWITA012845,TCMBANKGE012845,ADH6,ADHN5,alcohol dehydrogenase 6 (class V),4q23,protein-coding,
CWITA012846,TCMBANKGE012846,LEO1,RDL,"LEO1 homolog, Paf1/RNA polymerase II complex component",15q21.2,protein-coding,/
CWITA012847,TCMBANKGE012847,JCHAIN,IGCJ; IGJ; JCH,joining chain of multimeric IgA and IgM,4q13.3,protein-coding,/
CWITA012848,TCMBANKGE012848,ZNF510,-,zinc finger protein 510,9q22.33,protein-coding,/
CWITA012849,TCMBANKGE012849,CHRNB3,N,"cholinergic receptor, nicotinic, beta 3",8p11.2,protein-coding,
CWITA012850,TCMBANKGE012850,LAP3,LAP; LAPEP; PEPS,leucine aminopeptidase 3,4p15.32,protein-coding,
CWITA012851,TCMBANKGE012851,SCIMP,C17orf87; UNQ5783,SLP adaptor and CSK interacting membrane protein,17p13.2,protein-coding,/
CWITA012852,TCMBANKGE012852,XRCC6,CTC75; CTCBF; G22P1; KU70; ML8; TLAA,X-ray repair cross complementing 6,22q13.2,protein-coding,/
CWITA012853,TCMBANKGE012853,HSD17B10,17b-HSD10; ABAD; CAMR; DUPXp11.22; ERAB; HADH2; HCD2; HSD10MD; MHBD; MRPP2; MRX17; MRX31; MRXS10; SCHAD; SDR5C1,hydroxysteroid 17-beta dehydrogenase 10,Xp11.22,protein-coding,/
CWITA012854,TCMBANKGE012854,LIPH,AH; ARWH2; HYPT7; LAH2; LPDLR; PLA1B; mPA-PLA1,lipase H,3q27.2,protein-coding,/
CWITA012855,TCMBANKGE012855,CYP3A43,MGC119315; MGC119316,cytochrome P450 family 3 subfamily A member 43,7q22.1,protein-coding,/
CWITA012856,TCMBANKGE012856,ATXN3,AT3; ATX3; JOS; MJD; MJD1; SCA3,ataxin 3,14q32.12,protein-coding,/
CWITA012857,TCMBANKGE012857,SLBP,HBP,stem-loop binding protein,4p16.3,protein-coding,/
CWITA012858,TCMBANKGE012858,ST6GAL1,SIAT1; ST6GalI; ST6N,"ST6 beta-galactoside alpha-2,6-sialyltransferase 1",3q27.3,protein-coding,/
CWITA012859,TCMBANKGE012859,KCTD17,-,potassium channel tetramerization domain containing 17,22q12.3,protein-coding,/
CWITA012860,TCMBANKGE012860,CFD,ADIPSIN; ADN; DF; PFD,complement factor D (adipsin),19p13.3,protein-coding,
CWITA012861,TCMBANKGE012861,ABHD4,ABH4,"abhydrolase domain containing 4, N-acyl phospholipase B",14q11.2,protein-coding,/
CWITA012862,TCMBANKGE012862,DHRS4,CR; NRDR; PHCR; PSCD; SCAD-SRL; SDR-SRL; SDR25C1; SDR25C2,dehydrogenase/reductase 4,14q11.2,protein-coding,/
CWITA012863,TCMBANKGE012863,HOXD12,HOX4H,homeobox D12,2q31.1,protein-coding,/
CWITA012864,TCMBANKGE012864,HS3ST4,3-OST-4; 30ST4; 3OST4; h3-OST-4,heparan sulfate-glucosamine 3-sulfotransferase 4,16p12.1,protein-coding,/
CWITA012865,TCMBANKGE012865,MRM2,FJH1; FTSJ2; HEL97; MTDPS17; RRMJ2,mitochondrial rRNA methyltransferase 2,7p22.3,protein-coding,Successful target
CWITA012866,TCMBANKGE012866,MYC,MRTL; bHLHe39; c-Myc,V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian),8q24.21,protein-coding,
CWITA012867,TCMBANKGE012867,AGA,AGU; ASRG; GA,aspartylglucosaminidase,4q34.3,protein-coding,/
CWITA012868,TCMBANKGE012868,OGDH,AKGDH; E1k; KGD1; OGDC; OGDH2,oxoglutarate dehydrogenase,7p13,protein-coding,Clinical Trial target
CWITA012869,TCMBANKGE012869,ZNF808,-,zinc finger protein 808,19q13.41,protein-coding,/
CWITA012870,TCMBANKGE012870,RSPO3,CRISTIN1; PWTSR; THSD2,R-spondin 3,6q22.33,protein-coding,Clinical Trial target
CWITA012871,TCMBANKGE012871,CTNNAL1,ACRP; CLLP; alpha-CATU,catenin alpha like 1,9q31.3,protein-coding,/
CWITA012872,TCMBANKGE012872,BABAM1,C19orf62; HSPC142; MERIT40; NBA1,BRISC and BRCA1 A complex member 1,19p13.11,protein-coding,/
CWITA012873,TCMBANKGE012873,WNT11,HWNT11,Wnt family member 11,11q13.5,protein-coding,/
CWITA012874,TCMBANKGE012874,ARPC2,ARC34; PNASN139; p34NArc,"actin related protein 2/3 complex, subunit 2, 34kDa",2q36.1,protein-coding,
CWITA012875,TCMBANKGE012875,MAT2A,MATA2; MATII; SAMS2,"methionine adenosyltransferase II, alpha",2p11.2,protein-coding,
CWITA012876,TCMBANKGE012876,KATNIP,JBTS26; KIAA0556,katanin interacting protein,16p12.1,protein-coding,/
CWITA012877,TCMBANKGE012877,CHRND,ACHRD; CMS2A; FCCMS; SCCMS,"cholinergic receptor, nicotinic, delta",2q33-q34,protein-coding,
CWITA012878,TCMBANKGE012878,PDE6D,JBTS22; PDED,phosphodiesterase 6D,2q37.1,protein-coding,/
CWITA012879,TCMBANKGE012879,DEFB1,BD1; DEFB-1; DEFB101; HBD1,defensin beta 1,8p23.1,protein-coding,/
CWITA012880,TCMBANKGE012880,SH3RF3,POSH2; SH3MD4,SH3 domain containing ring finger 3,2q13,protein-coding,/
CWITA012881,TCMBANKGE012881,ZXDA,ZNF896,zinc finger X-linked duplicated A,Xp11.21,protein-coding,/
CWITA012882,TCMBANKGE012882,LGSN,GLULD1; LGS; MGC163238; MGC163240,"lengsin, lens protein with glutamine synthetase domain",6pter-q22.33,protein-coding,
CWITA012883,TCMBANKGE012883,SPTBN1,ELF; HEL102; SPTB2; betaSpII,"spectrin beta, non-erythrocytic 1",2p16.2,protein-coding,Clinical Trial target
CWITA012884,TCMBANKGE012884,FLOT1,-,flotillin 1,6p21.33,protein-coding,/
CWITA012885,TCMBANKGE012885,XIRP2,CMYA3,xin actin binding repeat containing 2,2q24.3,protein-coding,/
CWITA012886,TCMBANKGE012886,DBF4,ASK; CHIF; DBF4A; ZDBF1,DBF4 zinc finger,7q21.12,protein-coding,/
CWITA012887,TCMBANKGE012887,ANK3,ANKYRIN-G; MRT37,ankyrin 3,10q21.2,protein-coding,/
CWITA012888,TCMBANKGE012888,SGSM3,CIP85; MAP; RABGAP5; RUSC3; RUTBC3; RabGAP-5; rabGAPLP,small G protein signaling modulator 3,22q13.1,protein-coding,/
CWITA012889,TCMBANKGE012889,OPRL1,KOR-3; KOR3; NOCIR; NOP; NOPr; OOR; OPRL; ORL1,opioid related nociceptin receptor 1,20q13.33,protein-coding,Clinical Trial target
CWITA012890,TCMBANKGE012890,IFNA2,IFN-alpha-2; IFN-alphaA; IFNA; IFNA2B; leIF A,interferon alpha 2,9p21.3,protein-coding,Successful target
CWITA012891,TCMBANKGE012891,GIPC2,SEMCAP-2; SEMCAP2,GIPC PDZ domain containing family member 2,1p31.1,protein-coding,/
CWITA012892,TCMBANKGE012892,ZMYM3,DXS6673E; MYM; XFIM; ZNF198L2; ZNF261,zinc finger MYM-type containing 3,Xq13.1,protein-coding,/
CWITA012893,TCMBANKGE012893,RPL10A,CSA19; Csa-19; L10A; NEDD6,ribosomal protein L10a,6p21.31,protein-coding,/
CWITA012894,TCMBANKGE012894,SPTLC1,HSAN; HSAN1; HSN1; LBC1; LCB1; MGC14645; SPT1; SPTI,"serine palmitoyltransferase, long chain base subunit 1",9q22.2,protein-coding,
CWITA012895,TCMBANKGE012895,TBC1D7,MGCPH; PIG51; TBC7,TBC1 domain family member 7,6p24.1,protein-coding,/
CWITA012896,TCMBANKGE012896,ZNF329,-,zinc finger protein 329,19q13.43,protein-coding,/
CWITA012897,TCMBANKGE012897,PTEN,10q23del; BZS; DEC; GLM2; MGC11227; MHAM; MMAC1; PTEN1; TEP1,phosphatase and tensin homolog,10q23.3,protein-coding,
CWITA012898,TCMBANKGE012898,CCDC9B,C15orf52,coiled-coil domain containing 9B,15q15.1,protein-coding,/
CWITA012899,TCMBANKGE012899,ADAMTSL4,ADAMTSL-4; ECTOL2; TSRC1,ADAMTS like 4,1q21.2,protein-coding,/
CWITA012900,TCMBANKGE012900,KLF5,BTEB2; CKLF; IKLF,Kruppel like factor 5,13q22.1,protein-coding,/
CWITA012901,TCMBANKGE012901,ANKRD61,-,ankyrin repeat domain 61,7p22.1,protein-coding,/
CWITA012902,TCMBANKGE012902,GMPPA,AAMR,GDP-mannose pyrophosphorylase A,2q35,protein-coding,/
CWITA012903,TCMBANKGE012903,RBM47,NET18,RNA binding motif protein 47,4p14,protein-coding,/
CWITA012904,TCMBANKGE012904,BAIAP2,BAP2; FLAF3; IRSP53; WAML,BAR/IMD domain containing adaptor protein 2,17q25.3,protein-coding,/
CWITA012905,TCMBANKGE012905,ECE2,EEF1AKMT4,endothelin converting enzyme 2,3q27.1,protein-coding,Research target
CWITA012906,TCMBANKGE012906,PCDHAC2,PCDH-ALPHA-C2,"protocadherin alpha subfamily C, 2",5q31.3,protein-coding,/
CWITA012907,TCMBANKGE012907,MCUB,CCDC109B,mitochondrial calcium uniporter dominant negative subunit beta,4q25,protein-coding,/
CWITA012908,TCMBANKGE012908,PCDHGC4,PCDH-GAMMA-C4,"protocadherin gamma subfamily C, 4",5q31.3,protein-coding,/
CWITA012909,TCMBANKGE012909,CLCN7,CLC-7; CLC7; HOD; OPTA2; OPTB4; PPP1R63,chloride voltage-gated channel 7,16p13.3,protein-coding,Research target
CWITA012910,TCMBANKGE012910,TOR1AIP1,LAP1; LAP1B; LAP1C; LGMD2Y,torsin 1A interacting protein 1,1q25.2,protein-coding,/
CWITA012911,TCMBANKGE012911,SLC29A4,ENT4; PMAT,solute carrier family 29 member 4,7p22.1,protein-coding,Research target
CWITA012912,TCMBANKGE012912,TTPA,ATTP; AVED; TTP1; alphaTTP,tocopherol (alpha) transfer protein,8q12.3,protein-coding,
CWITA012913,TCMBANKGE012913,DPYS,DHP; DHPase,dihydropyrimidinase,8q22.3,protein-coding,/
CWITA012914,TCMBANKGE012914,UGT1A10,UDPGT; UGTN1J; UGT1N10; UGT1.10; UGT1J,"UDP glucuronosyltransferase 1 family, polypeptide A10",2q37,protein-coding,
CWITA012915,TCMBANKGE012915,TBX19,TBS19; TPIT; dJ747L4.1,T-box transcription factor 19,1q24.2,protein-coding,/
CWITA012916,TCMBANKGE012916,CSMD3,-,CUB and Sushi multiple domains 3,8q23.3,protein-coding,/
CWITA012917,TCMBANKGE012917,ATP6V0E2,ATP6V0E2L; C7orf32,ATPase H+ transporting V0 subunit e2,7q36.1,protein-coding,/
CWITA012918,TCMBANKGE012918,SERPINA10,PZI; ZPI,serpin family A member 10,14q32.13,protein-coding,/
CWITA012919,TCMBANKGE012919,B3GAT3,GLCATI,"beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)",11q12.3,protein-coding,
CWITA012920,TCMBANKGE012920,EPHA3,EK4; ETK; ETK1; HEK; HEK4; TYRO4,EPH receptor A3,3p11.1,protein-coding,Clinical Trial target
CWITA012921,TCMBANKGE012921,KBTBD3,BKLHD3,kelch repeat and BTB domain containing 3,11q22.3,protein-coding,/
CWITA012922,TCMBANKGE012922,TPSAB1,MGC104064; TPS1; TPS2; TPSB1,tryptase alpha/beta 1,16p13.3,protein-coding,
CWITA012923,TCMBANKGE012923,TSR1,-,TSR1 ribosome maturation factor,17p13.3,protein-coding,/
CWITA012924,TCMBANKGE012924,TSNAXIP1,TXI1,translin associated factor X interacting protein 1,16q22.1,protein-coding,/
CWITA012925,TCMBANKGE012925,TRPA1,ANKTM1,"transient receptor potential cation channel, subfamily A, member 1",8q13,protein-coding,
CWITA012926,TCMBANKGE012926,SLC25A13,ARALAR2; CITRIN; CTLN2; NICCD,solute carrier family 25 member 13,7q21.3,protein-coding,/
CWITA012927,TCMBANKGE012927,PRRC2A,BAT2; D6S51; D6S51E; G2,proline rich coiled-coil 2A,6p21.33,protein-coding,/
CWITA012928,TCMBANKGE012928,MT1H,MT-0; MT-1H; MT-IH; MT1,metallothionein 1H,16q13,protein-coding,/
CWITA012929,TCMBANKGE012929,EFS,CAS3; CASS3; EFS1; EFS2; HEFS; SIN,embryonal Fyn-associated substrate,14q11.2,protein-coding,/
CWITA012930,TCMBANKGE012930,PLD6,ZUC,phospholipase D family member 6,17p11.2,protein-coding,/
CWITA012931,TCMBANKGE012931,MAP3K3,MAPKKK3; MEKK3,mitogen-activated protein kinase kinase kinase 3,17q23.3,protein-coding,Research target
CWITA012932,TCMBANKGE012932,GCHFR,GFRP; HsT16933; P35,GTP cyclohydrolase I feedback regulator,15q15.1,protein-coding,/
CWITA012933,TCMBANKGE012933,ZNF274,HFB101; ZF2; ZKSCAN19; ZSCAN51,zinc finger protein 274,19q13.43,protein-coding,/
CWITA012934,TCMBANKGE012934,PLA2G12A,GXII; PLA2G12; ROSSY,phospholipase A2 group XIIA,4q25,protein-coding,/
CWITA012935,TCMBANKGE012935,MS4A7,4SPAN2; CD20L4; CFFM4; MS4A8,membrane spanning 4-domains A7,11q12.2,protein-coding,/
CWITA012936,TCMBANKGE012936,MOBP,-,myelin associated oligodendrocyte basic protein,3p22.1,protein-coding,Research target
CWITA012937,TCMBANKGE012937,EEF2K,CaMKIII; HSU93850; eEF-2K,eukaryotic elongation factor 2 kinase,16p12.2,protein-coding,Successful target
CWITA012938,TCMBANKGE012938,TCN1,HC; TC-1; TC1; TCI,transcobalamin 1,11q12.1,protein-coding,/
CWITA012939,TCMBANKGE012939,ZFP3,ZNF752,ZFP3 zinc finger protein,17p13.2,protein-coding,/
CWITA012940,TCMBANKGE012940,MAP3K20,AZK; CNM6; MLK7; MLT; MLTK; MLTKalpha; MLTKbeta; MRK; SFMMP; ZAK; mlklak; pk,mitogen-activated protein kinase kinase kinase 20,2q31.1,protein-coding,Research target
CWITA012941,TCMBANKGE012941,MYO6,DFNA22; DFNB37,myosin VI,6q14.1,protein-coding,/
CWITA012942,TCMBANKGE012942,COG3,SEC34,component of oligomeric golgi complex 3,13q14.13,protein-coding,/
CWITA012943,TCMBANKGE012943,ZNF234,HZF4; ZNF269,zinc finger protein 234,19q13.31,protein-coding,/
CWITA012944,TCMBANKGE012944,PSMD7,MOV34; P40; Rpn8; S12,"proteasome 26S subunit, non-ATPase 7",16q23.1,protein-coding,/
CWITA012945,TCMBANKGE012945,RPS6KA5,MSK1; MSPK1; RLPK,ribosomal protein S6 kinase A5,14q32.11,protein-coding,Research target
CWITA012946,TCMBANKGE012946,CARNS1,ATPGD1,carnosine synthase 1,11q13.2,protein-coding,/
CWITA012947,TCMBANKGE012947,CDK9,CN2k; CDC2L4; CTK1; PITALRE; TAK,cyclin-dependent kinase 9,9q34.1,protein-coding,
CWITA012948,TCMBANKGE012948,APIP,APIP2; CGI-29; CGI29; MMRP19; hAPIP,APAF1 interacting protein,11p13,protein-coding,/
CWITA012949,TCMBANKGE012949,NOL8,C9orf34; NOP132; bA62C3.3; bA62C3.4,nucleolar protein 8,9q22.31,protein-coding,/
CWITA012950,TCMBANKGE012950,ADRA2B,ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR,"adrenergic, alpha-2B-, receptor",2p13-q13,protein-coding,
CWITA012951,TCMBANKGE012951,MYLK,AAT7; KRP; MLCK; MLCK1; MLCK108; MLCK210; MMIHS; MSTP083; MYLK1; smMLCK,myosin light chain kinase,3q21.1,protein-coding,Clinical Trial target
CWITA012952,TCMBANKGE012952,ARPC4-TTLL3,ARC20; ARPC4; p20-ARC,ARPC4-TTLL3 readthrough,3p25.3,protein-coding,/
CWITA012953,TCMBANKGE012953,PGM3,AGM1; IMD23; PAGM; PGM 3,phosphoglucomutase 3,6q14.1,protein-coding,/
CWITA012954,TCMBANKGE012954,DPP7,DPP2; DPPII; QPP,dipeptidyl peptidase 7,9q34.3,protein-coding,Research target
CWITA012955,TCMBANKGE012955,RAB6A,RAB6,"RAB6A, member RAS oncogene family",11q13.4,protein-coding,/
CWITA012956,TCMBANKGE012956,KRTAP5-3,KRTAP5-9; KRTAP5.3,keratin associated protein 5-3,11p15.5,protein-coding,/
CWITA012957,TCMBANKGE012957,NEO1,IGDCC2; NGN; NTN1R2,neogenin 1,15q24.1,protein-coding,/
CWITA012958,TCMBANKGE012958,KTN1,CG1; KNT; MU-RMS-40.19,Kinectin_1,14q22.3,protein-coding,
CWITA012959,TCMBANKGE012959,SAC3D1,HSU79266; SHD1,SAC3 domain containing 1,11q13.1,protein-coding,/
CWITA012960,TCMBANKGE012960,UBE2D2,E2(17)KB2; PUBC1; UBC4; UBC4/5; UBCH5B,ubiquitin-conjugating enzyme E2D 2,5q31.2,protein-coding,
CWITA012961,TCMBANKGE012961,KDM4A,JHDM3A; JMJD2; JMJD2A; TDRD14A,lysine demethylase 4A,1p34.2-p34.1,protein-coding,Patented target
CWITA012962,TCMBANKGE012962,LIPM,LIPL3; bA304I5.1,lipase family member M,10q23.31,protein-coding,/
CWITA012963,TCMBANKGE012963,NIBAN1,C1orf24; FAM129A; GIG39; NIBAN,niban apoptosis regulator 1,1q25.3,protein-coding,/
CWITA012964,TCMBANKGE012964,PDXP,CIN; FLJ32703; PLP; dJ37E16.5,"pyridoxal (pyridoxine, vitamin B6) phosphatase",22cen-q12.3,protein-coding,
CWITA012965,TCMBANKGE012965,DSG1,CDHF4; DG1; DSG; EPKHE; EPKHIA; PPKS1; SPPK1,desmoglein 1,18q12.1,protein-coding,/
CWITA012966,TCMBANKGE012966,FAM110C,-,family with sequence similarity 110 member C,2p25.3,protein-coding,/
CWITA012967,TCMBANKGE012967,CNDP2,CN2; CPGL; HEL-S-13; HsT2298; PEPA,carnosine dipeptidase 2,18q22.3,protein-coding,/
CWITA012968,TCMBANKGE012968,PPP2R2A,B55A; B55ALPHA; DKFZp686N05117; FLJ26613; FLJ41727; MGC52248; PR52A; PR55A,"protein phosphatase 2, regulatory subunit B, alpha",8p21.2,protein-coding,
CWITA012969,TCMBANKGE012969,KIF12,-,kinesin family member 12,9q32,protein-coding,/
CWITA012970,TCMBANKGE012970,ZSCAN10,ZFP206; ZNF206,zinc finger and SCAN domain containing 10,16p13.3,protein-coding,/
CWITA012971,TCMBANKGE012971,NDFIP2,N4WBP5A,Nedd4 family interacting protein 2,13q31.1,protein-coding,/
CWITA012972,TCMBANKGE012972,HAO2,GIG16; HAOX2,hydroxyacid oxidase 2 (long chain),1p13.3-p13.1,protein-coding,
CWITA012973,TCMBANKGE012973,DNASE2,DNASE2A; DNL; DNL2,"deoxyribonuclease 2, lysosomal",19p13.13,protein-coding,/
CWITA012974,TCMBANKGE012974,SLC17A9,C20orf59; POROK8; VNUT,solute carrier family 17 member 9,20q13.33,protein-coding,/
CWITA012975,TCMBANKGE012975,EXOSC4,RRP41; RRP41A; Rrp41p; SKI6; Ski6p; hRrp41p; p12A,exosome component 4,8q24.3,protein-coding,/
CWITA012976,TCMBANKGE012976,CDH12,CDHB,cadherin 12,5p14.3,protein-coding,/
CWITA012977,TCMBANKGE012977,DHFRL1,DHFRP4; FLJ16119,dihydrofolate reductase-like 1,3q11.1,protein-coding,
CWITA012978,TCMBANKGE012978,CSMD1,PPP1R24,CUB and Sushi multiple domains 1,8p23.2,protein-coding,/
CWITA012979,TCMBANKGE012979,CDC73,C1orf28; FIHP; HPTJT; HRPT1; HRPT2; HYX,cell division cycle 73,1q31.2,protein-coding,/
CWITA012980,TCMBANKGE012980,PIGG,GPI7; LAS21; MRT53; PRO4405; RLGS1930,phosphatidylinositol glycan anchor biosynthesis class G,4p16.3,protein-coding,/
CWITA012981,TCMBANKGE012981,LDHB,HEL-S-281; LDH-B; LDH-H; LDHBD; TRG-5,lactate dehydrogenase B,12p12.1,protein-coding,/
CWITA012982,TCMBANKGE012982,HTR5A,5-HT5A,5-hydroxytryptamine receptor 5A,7q36.2,protein-coding,Successful target
CWITA012983,TCMBANKGE012983,CSNK1A1,CK1; CK1a; CKIa; HEL-S-77p; HLCDGP1; PRO2975,casein kinase 1 alpha 1,5q32,protein-coding,Research target
CWITA012984,TCMBANKGE012984,AARSD1,-,alanyl-tRNA synthetase domain containing 1,17q21.31,protein-coding,/
CWITA012985,TCMBANKGE012985,TBC1D8B,GRAMD8B; NPHS20,TBC1 domain family member 8B,Xq22.3,protein-coding,/
CWITA012986,TCMBANKGE012986,ZNF175,OTK18,zinc finger protein 175,19q13.41,protein-coding,/
CWITA012987,TCMBANKGE012987,PAK3,ARA; MRX30; MRX47; OPHN3; PAK-3; PAK3beta; bPAK; beta-PAK,p21 (RAC1) activated kinase 3,Xq23,protein-coding,/
CWITA012988,TCMBANKGE012988,PEX1,HMLR1; PBD1A; PBD1B; ZWS; ZWS1,peroxisomal biogenesis factor 1,7q21.2,protein-coding,/
CWITA012989,TCMBANKGE012989,VIT,VIT1,vitrin,2p22.2,protein-coding,/
CWITA012990,TCMBANKGE012990,MXD1,BHLHC58; MAD; MAD1,MAX dimerization protein 1,2p13.3,protein-coding,/
CWITA012991,TCMBANKGE012991,RIPOR2,C6orf32; DFNB104; DIFF40; DIFF48; FAM65B; MYONAP; PL48,RHO family interacting cell polarization regulator 2,6p22.3,protein-coding,/
CWITA012992,TCMBANKGE012992,KIR2DL3,CD158B2; CD158b; GL183; KIR-023GB; KIR-K7b; KIR-K7c; KIR2DL; KIR2DS5; KIRCL23; NKAT; NKAT2; NKAT2A; NKAT2B; p58,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3",19q13.42,protein-coding,Clinical Trial target
CWITA012993,TCMBANKGE012993,ASIC5,ACCN5; HINAC; INAC,acid sensing ion channel subunit family member 5,4q32.1,protein-coding,/
CWITA012994,TCMBANKGE012994,H2AC4,H2A/m; H2AC8; H2AFM; HIST1H2AB,H2A clustered histone 4,6p22.2,protein-coding,/
CWITA012995,TCMBANKGE012995,PCDHA2,PCDH-ALPHA2,protocadherin alpha 2,5q31.3,protein-coding,/
CWITA012996,TCMBANKGE012996,DMTN,DMT; EPB49,dematin actin binding protein,8p21.3,protein-coding,/
CWITA012997,TCMBANKGE012997,FEV,HSRNAFEV; PET-1,"FEV transcription factor, ETS family member",2q35,protein-coding,/
CWITA012998,TCMBANKGE012998,PNLIP,PL; PTL,pancreatic lipase,10q26.1,protein-coding,
CWITA012999,TCMBANKGE012999,CHP1,CHP; SLC9A1BP; SPAX9; Sid470p; p22; p24,calcineurin like EF-hand protein 1,15q15.1,protein-coding,/
CWITA013000,TCMBANKGE013000,DDX39A,BAT1; BAT1L; DDX39; DDXL; URH49,DExD-box helicase 39A,19p13.12,protein-coding,/
CWITA013001,TCMBANKGE013001,SMC1A,CDLS2; DXS423E; EIEE85; SB1.8; SMC1; SMC1L1; SMC1alpha; SMCB,structural maintenance of chromosomes 1A,Xp11.22,protein-coding,/
CWITA013002,TCMBANKGE013002,NNMT,-,nicotinamide N-methyltransferase,11q23.2,protein-coding,/
CWITA013003,TCMBANKGE013003,AHNAK2,C14orf78,AHNAK nucleoprotein 2,14q32.33,protein-coding,/
CWITA013004,TCMBANKGE013004,TSPY1,CT78; DYS14; TSPY; pJA923,testis specific protein Y-linked 1,Yp11.2,protein-coding,/
CWITA013005,TCMBANKGE013005,SYT12,SYT11; sytXII,synaptotagmin 12,11q13.2,protein-coding,/
CWITA013006,TCMBANKGE013006,COL1A1,OI4,"collagen, type I, alpha 1",17q21.33,protein-coding,
CWITA013007,TCMBANKGE013007,PHYHIPL,-,phytanoyl-CoA 2-hydroxylase interacting protein like,10q21.1,protein-coding,/
CWITA013008,TCMBANKGE013008,KCNJ14,IRK4; KIR2.4,potassium inwardly rectifying channel subfamily J member 14,19q13.33,protein-coding,/
CWITA013009,TCMBANKGE013009,CD1E,CD1A; R2,CD1e molecule,1q23.1,protein-coding,/
CWITA013010,TCMBANKGE013010,COX2,COII; MTCO2,cytochrome c oxidase subunit II,-,protein-coding,/
CWITA013011,TCMBANKGE013011,STK17B,DRAK2,serine/threonine kinase 17b,2q32.3,protein-coding,/
CWITA013012,TCMBANKGE013012,Hst3,Hst-3,hybrid sterility 3,-,unknown,/
CWITA013013,TCMBANKGE013013,UAP1L1,-,UDP-N-acetylglucosamine pyrophosphorylase 1 like 1,9q34.3,protein-coding,/
CWITA013014,TCMBANKGE013014,KDM7A,JHDM1D,lysine demethylase 7A,7q34,protein-coding,Research target
CWITA013015,TCMBANKGE013015,FBXO11,FBX11; IDDFBA; PRMT9; UBR6; UG063H01; VIT1,F-box protein 11,2p16.3,protein-coding,Research target
CWITA013016,TCMBANKGE013016,LIPG,EDL; EL; PRO719,"lipase G, endothelial type",18q21.1,protein-coding,Clinical Trial target
CWITA013017,TCMBANKGE013017,CSK,MGC117393,c-src tyrosine kinase,15q24.1,protein-coding,
CWITA013018,TCMBANKGE013018,CFHR3,CFHL3; DOWN16; FHR-3; FHR3; HLF4,complement factor H related 3,1q31.3,protein-coding,/
CWITA013019,TCMBANKGE013019,SLC26A3,CLD; DRA,solute carrier family 26 member 3,7q22.3-q31.1,protein-coding,/
CWITA013020,TCMBANKGE013020,IL21R,CD360; IMD56; NILR,interleukin 21 receptor,16p12.1,protein-coding,Clinical Trial target
CWITA013021,TCMBANKGE013021,LDLRAD4,C18orf1,low density lipoprotein receptor class A domain containing 4,18p11.21,protein-coding,/
CWITA013022,TCMBANKGE013022,CLEC2D,CLAX; LLT1; OCIL,C-type lectin domain family 2 member D,12p13.31,protein-coding,/
CWITA013023,TCMBANKGE013023,OGN,OG; OIF; SLRR3A,osteoglycin,9q22.31,protein-coding,/
CWITA013024,TCMBANKGE013024,TUFM,COXPD4; EF-TuMT; EFTU; P43,"Tu translation elongation factor, mitochondrial",16p11.2,protein-coding,/
CWITA013025,TCMBANKGE013025,TMLHE,BBOX2; FLJ10727; TMLD; TMLH; XAP130,"trimethyllysine hydroxylase, epsilon",Xq28,protein-coding,
CWITA013026,TCMBANKGE013026,HSPD1,CPN60; GROEL; HLD4; HSP-60; HSP60; HSP65; HuCHA60; SPG13,heat shock protein family D (Hsp60) member 1,2q33.1,protein-coding,Clinical Trial target
CWITA013027,TCMBANKGE013027,MUCL3,C6orf37; DPCR1; PBLT,mucin like 3,6p21.33,protein-coding,/
CWITA013028,TCMBANKGE013028,GLYR1,BM045; HIBDL; N-PAC; NP60; hNDF,glyoxylate reductase 1 homolog,16p13.3,protein-coding,/
CWITA013029,TCMBANKGE013029,ANXA3,ANX3,annexin A3,4q21.21,protein-coding,
CWITA013030,TCMBANKGE013030,SOX17,VUR3,SRY-box transcription factor 17,8q11.23,protein-coding,/
CWITA013031,TCMBANKGE013031,SRPX,DRS; ETX1; HEL-S-83p; SRPX1,sushi repeat containing protein X-linked,Xp11.4,protein-coding,/
CWITA013032,TCMBANKGE013032,NMU,-,neuromedin U,4q12,protein-coding,/
CWITA013033,TCMBANKGE013033,NANS,HEL-S-100; SAS; SEMDCG; SEMDG,N-acetylneuraminate synthase,9q22.33,protein-coding,/
CWITA013034,TCMBANKGE013034,DSPP,DFNA39; DGI1; DMP3; DPP; DSP,dentin sialophosphoprotein,4q22.1,protein-coding,/
CWITA013035,TCMBANKGE013035,ZNF133,ZNF150; pHZ-13; pHZ-66,zinc finger protein 133,20p11.23,protein-coding,/
CWITA013036,TCMBANKGE013036,LIG3,LIG2; LIG3alpha,DNA ligase 3,17q12,protein-coding,/
CWITA013037,TCMBANKGE013037,SPNS3,SLC62A3,sphingolipid transporter 3 (putative),17p13.2,protein-coding,/
CWITA013038,TCMBANKGE013038,AFP,AFPD; FETA; HPAFP,alpha fetoprotein,4q13.3,protein-coding,Clinical Trial target
CWITA013039,TCMBANKGE013039,HBP1,-,HMG-box transcription factor 1,7q22.3,protein-coding,/
CWITA013040,TCMBANKGE013040,EFCAB13,C17orf57,EF-hand calcium binding domain 13,17q21.32,protein-coding,/
CWITA013041,TCMBANKGE013041,ABCC11,EWWD; MRP8; WW,ATP binding cassette subfamily C member 11,16q12.1,protein-coding,/
CWITA013042,TCMBANKGE013042,MIPEP,COXPD31; HMIP; MIP,mitochondrial intermediate peptidase,13q12.12,protein-coding,/
CWITA013043,TCMBANKGE013043,TCN1,TCN1; TC1; TCI,"transcobalamin I (vitamin B12 binding protein, R binder family)",11q11-q12,protein-coding,
CWITA013044,TCMBANKGE013044,GBA2,AD035; NLGase; SPG46,glucosylceramidase beta 2,9p13.3,protein-coding,/
CWITA013045,TCMBANKGE013045,ACOT13,HT012; PNAS-27; THEM2,acyl-CoA thioesterase 13,6p22.3,protein-coding,/
CWITA013046,TCMBANKGE013046,BRD1,BRL; BRPF1; BRPF2,bromodomain containing 1,22q13.33,protein-coding,Research target
CWITA013047,TCMBANKGE013047,IFNGR2,AF-1; IFGR2; IFNGT1; IMD28,interferon gamma receptor 2,21q22.11,protein-coding,Successful target
CWITA013048,TCMBANKGE013048,CALCB,CALC2; CGRP-II; CGRP2,calcitonin related polypeptide beta,11p15.2,protein-coding,Research target
CWITA013049,TCMBANKGE013049,DNAH12,DHC3; DLP12; DLP3; DNAH12L; DNAH7L; DNAHC12; DNAHC3; DNHD2; HDHC3; HL-19; HL19,dynein axonemal heavy chain 12,3p14.3,protein-coding,/
CWITA013050,TCMBANKGE013050,LETM1,SLC55A1,leucine zipper and EF-hand containing transmembrane protein 1,4p16.3,protein-coding,/
CWITA013051,TCMBANKGE013051,GPR87,FKSG78; GPR95; KPG_002,G protein-coupled receptor 87,3q25.1,protein-coding,Research target
CWITA013052,TCMBANKGE013052,EID2B,EID-2B; EID-3,EP300 interacting inhibitor of differentiation 2B,19q13.2,protein-coding,/
CWITA013053,TCMBANKGE013053,ALKBH3,ABH3; DEPC-1; DEPC1; PCA1; hABH3,"alkB homolog 3, alpha-ketoglutarate dependent dioxygenase",11p11.2,protein-coding,/
CWITA013054,TCMBANKGE013054,CCNB3,-,cyclin B3,Xp11.22,protein-coding,/
CWITA013055,TCMBANKGE013055,FZD10,CD350; FZ-10; Fz10; FzE7; hFz10,frizzled class receptor 10,12q24.33,protein-coding,/
CWITA013056,TCMBANKGE013056,SPTB,EL3; HS2; HSPTB1; SPH2,"spectrin beta, erythrocytic",14q23.3,protein-coding,/
CWITA013057,TCMBANKGE013057,ZNF540,Nbla10512,zinc finger protein 540,19q13.12,protein-coding,/
CWITA013058,TCMBANKGE013058,GRIK4,EAA1; GRIK; KA1,"glutamate receptor, ionotropic, kainate 4",11q22.3,protein-coding,
CWITA013059,TCMBANKGE013059,RORB,EIG15; NR1F2; ROR-BETA; RZR-BETA; RZRB; bA133M9.1,RAR related orphan receptor B,9q21.13,protein-coding,Research target
CWITA013060,TCMBANKGE013060,HSD17B8,D6S2245E; FABG; FABGL; H2-KE6; HKE6; KE6; RING2; SDR30C1; dJ1033B10.9,hydroxysteroid 17-beta dehydrogenase 8,6p21.32,protein-coding,/
CWITA013061,TCMBANKGE013061,FNDC11,C20orf195,fibronectin type III domain containing 11,20q13.33,protein-coding,/
CWITA013062,TCMBANKGE013062,ADCY5,AC5; FDFM,adenylate cyclase 5,3q21.1,protein-coding,Research target
CWITA013063,TCMBANKGE013063,KCNS2,KV9.2,potassium voltage-gated channel modifier subfamily S member 2,8q22.2,protein-coding,/
CWITA013064,TCMBANKGE013064,KDM1B,AOF1; C6orf193; LSD2,lysine demethylase 1B,6p22.3,protein-coding,Patented target
CWITA013065,TCMBANKGE013065,HBB,CD113tNC; betaNglobin,"hemoglobin, beta",11p15.5,protein-coding,
CWITA013066,TCMBANKGE013066,NUP210,GP210; POM210,nucleoporin 210,3p25.1,protein-coding,/
CWITA013067,TCMBANKGE013067,TASOR2,C10orf18; FAM208B; bA318E3.2,transcription activation suppressor family member 2,10p15.1,protein-coding,/
CWITA013068,TCMBANKGE013068,BMP3,BMP-3A,bone morphogenetic protein 3,4q21.21,protein-coding,/
CWITA013069,TCMBANKGE013069,PCDHB5,PCDH-BETA5,protocadherin beta 5,5q31.3,protein-coding,/
CWITA013070,TCMBANKGE013070,FAM53C,C5orf6,family with sequence similarity 53 member C,5q31.2,protein-coding,/
CWITA013071,TCMBANKGE013071,CDC45,CDC45L; CDC45L2; MGORS7; PORC-PI-1,cell division cycle 45,22q11.21,protein-coding,/
CWITA013072,TCMBANKGE013072,ACTR3,ARP3,ARP3 actin-related protein 3 homolog (yeast),2q14.1,protein-coding,
CWITA013073,TCMBANKGE013073,ERVK-10,PR; Protease; Proteinase,endogenous retrovirus group K member 10,5q33.3,other,/
CWITA013074,TCMBANKGE013074,HOXC13,ECTD9; HOX3; HOX3G,homeobox C13,12q13.13,protein-coding,/
CWITA013075,TCMBANKGE013075,MEMO1,C2orf4; CGI-27; MEMO; NS5ATP7,mediator of cell motility 1,2p22.3,protein-coding,/
CWITA013076,TCMBANKGE013076,CBS,CBSL; HIP4,cystathionine beta-synthase,21q22.3,protein-coding,Research target
CWITA013077,TCMBANKGE013077,FRMD3,4.1O; EPB41L4O; EPB41LO; P410,FERM domain containing 3,9q21.32,protein-coding,/
CWITA013078,TCMBANKGE013078,RAD51,BRCC5; HRAD51; HsRad51; HsT16930; RAD51A; RECA,RAD51 homolog (S. cerevisiae),15q15.1,protein-coding,
CWITA013079,TCMBANKGE013079,ZKSCAN8,LD5-1; ZNF192; ZSCAN40,zinc finger with KRAB and SCAN domains 8,6p22.1,protein-coding,/
CWITA013080,TCMBANKGE013080,MLXIPL,CHREBP; MIO; MLX; MONDOB; WBSCR14; WS-bHLH; bHLHd14,MLX interacting protein like,7q11.23,protein-coding,/
CWITA013081,TCMBANKGE013081,FAM122B,SPACIA2,family with sequence similarity 122B,Xq26.3,protein-coding,/
CWITA013082,TCMBANKGE013082,Ccpg1os,EG546143; Gm5918,"cell cycle progression 1, opposite strand",9|9 D,protein-coding,/
CWITA013083,TCMBANKGE013083,SLC19A1,CHMD; FOLT; IFC1; REFC; RFC1,"solute carrier family 19 (folate transporter), member 1",21q22.3,protein-coding,
CWITA013084,TCMBANKGE013084,TAMALIN,GRASP,trafficking regulator and scaffold protein tamalin,12q13.13,protein-coding,/
CWITA013085,TCMBANKGE013085,LGALS7,GAL7; LGALS7A,"lectin, galactoside-binding, soluble, 7",19q13.2,protein-coding,
CWITA013086,TCMBANKGE013086,CARS2,COXPD27; cysRS,"cysteinyl-tRNA synthetase 2, mitochondrial",13q34,protein-coding,/
CWITA013087,TCMBANKGE013087,ALPI,IAP,"alkaline phosphatase, intestinal",2q37.1,protein-coding,/
CWITA013088,TCMBANKGE013088,NT5M,dNTN2; dNT2; mdN,"5',3'-nucleotidase, mitochondrial",17p11.2,protein-coding,
CWITA013089,TCMBANKGE013089,UPP1,UDRPASE; UP; UPASE; UPP,uridine phosphorylase 1,7p12.3,protein-coding,/
CWITA013090,TCMBANKGE013090,DUOX2,LNOX2; NOXEF2; P138-TOX; TDH6; THOX2,dual oxidase 2,15q21.1,protein-coding,/
CWITA013091,TCMBANKGE013091,S100A11,HEL-S-43; MLN70; S100C,S100 calcium binding protein A11,1q21.3,protein-coding,/
CWITA013092,TCMBANKGE013092,H2BC12,H2B/S; H2BFAiii; H2BFT; H2BK; HIST1H2BK,H2B clustered histone 12,6p22.1,protein-coding,/
CWITA013093,TCMBANKGE013093,OXER1,GPCR; GPR170; TG1019,oxoeicosanoid receptor 1,2p21,protein-coding,Research target
CWITA013094,TCMBANKGE013094,GLI4,HKR4; ZNF928,GLI family zinc finger 4,8q24.3,protein-coding,/
CWITA013095,TCMBANKGE013095,PRKAB2,MGC61468,"protein kinase, AMP-activated, beta 2 non-catalytic subunit",1q21.1,protein-coding,
CWITA013096,TCMBANKGE013096,MYBL2,B-MYB; BMYB,MYB proto-oncogene like 2,20q13.12,protein-coding,/
CWITA013097,TCMBANKGE013097,ZNF490,-,zinc finger protein 490,19p13.2-p13.13,protein-coding,/
CWITA013098,TCMBANKGE013098,KIF14,MCPH20; MKS12,kinesin family member 14,1q32.1,protein-coding,/
CWITA013099,TCMBANKGE013099,SMAD6,AOVD2; HsT17432; MADH6; MADH7,SMAD family member 6,15q22.31,protein-coding,Research target
CWITA013100,TCMBANKGE013100,SPINT3,HKIB9,"serine peptidase inhibitor, Kunitz type 3",20q13.12,protein-coding,/
CWITA013101,TCMBANKGE013101,CD81,CVID6; S5.7; TAPA1; TSPAN28,CD81 molecule,11p15.5,protein-coding,/
CWITA013102,TCMBANKGE013102,CENPJ,BM032; CENP-J; CPAP; LAP; LIP1; MCPH6; SASS4; SCKL4; Sas-4,centromere protein J,13q12.12-q12.13,protein-coding,/
CWITA013103,TCMBANKGE013103,ZCWPW2,ZCW2,zinc finger CW-type and PWWP domain containing 2,3p24.1,protein-coding,/
CWITA013104,TCMBANKGE013104,TSEN15,C1orf19; PCH2F; sen15,tRNA splicing endonuclease subunit 15,1q25.3,protein-coding,/
CWITA013105,TCMBANKGE013105,PLA2G2E,GIIE sPLA2; sPLA2-IIE,phospholipase A2 group IIE,1p36.13,protein-coding,/
CWITA013106,TCMBANKGE013106,TIMP3,HSMRK222; K222; K222TA2; SFD,TIMP metallopeptidase inhibitor 3,22q12.3,protein-coding,/
CWITA013107,TCMBANKGE013107,MYOD1,MYF3; MYOD; PUM; bHLHc1,myogenic differentiation 1,11p15.1,protein-coding,/
CWITA013108,TCMBANKGE013108,BAHD1,-,bromo adjacent homology domain containing 1,15q15.1,protein-coding,/
CWITA013109,TCMBANKGE013109,PSPH,PSP; PSPHD,phosphoserine phosphatase,7p11.2,protein-coding,/
CWITA013110,TCMBANKGE013110,OLFML2A,PRO34319,olfactomedin like 2A,9q33.3,protein-coding,/
CWITA013111,TCMBANKGE013111,KLRD1,CD94,killer cell lectin like receptor D1,12p13.2,protein-coding,/
CWITA013112,TCMBANKGE013112,KCNK6,K2p6.1; KCNK8; TOSS; TWIK-2; TWIK2,potassium two pore domain channel subfamily K member 6,19q13.2,protein-coding,/
CWITA013113,TCMBANKGE013113,NLGN4X,ASPGX2; AUTSX2; HLNX; HNL4X; NLGN4,neuroligin 4 X-linked,Xp22.32-p22.31,protein-coding,/
CWITA013114,TCMBANKGE013114,CCDC70,-,coiled-coil domain containing 70,13q14.3,protein-coding,/
CWITA013115,TCMBANKGE013115,METAP2,MAP2; MNPEP; p67; p67eIF2,methionyl aminopeptidase 2,12q22,protein-coding,
CWITA013116,TCMBANKGE013116,PUS3,2610020J05Rik; FKSG32; MRT55,pseudouridine synthase 3,11q24.2,protein-coding,/
CWITA013117,TCMBANKGE013117,DCN,CSCD; DSPG2; PG40; PGII; PGS2; SLRR1B,decorin,12q21.33,protein-coding,
CWITA013118,TCMBANKGE013118,SLC30A7,ZNT7; ZnT-7; ZnTL2,solute carrier family 30 member 7,1p21.2,protein-coding,/
CWITA013119,TCMBANKGE013119,COX4I1,COX IV-1; COX4; COX4-1; COXIV; COXIV-1,cytochrome c oxidase subunit 4I1,16q24.1,protein-coding,/
CWITA013120,TCMBANKGE013120,PLAU,ATF; UPA; URK; uNPA,"plasminogen activator, urokinase",10q24,protein-coding,
CWITA013121,TCMBANKGE013121,ATP10A,ATP10C; ATPVA; ATPVC,ATPase phospholipid transporting 10A (putative),15q12,protein-coding,/
CWITA013122,TCMBANKGE013122,ADRBK1,BARK1; BETANARK1; FLJ16718; GRK2,"adrenergic, beta, receptor kinase 1",11q13.1,protein-coding,
CWITA013123,TCMBANKGE013123,COL14A1,UND,collagen type XIV alpha 1 chain,8q24.12,protein-coding,/
CWITA013124,TCMBANKGE013124,FBXL7,FBL6; FBL7,F-box and leucine rich repeat protein 7,5p15.1,protein-coding,/
CWITA013125,TCMBANKGE013125,H1-10,H1.10; H1FX; H1X,H1.10 linker histone,3q21.3,protein-coding,/
CWITA013126,TCMBANKGE013126,ZNF703,NLZ1; ZEPPO1; ZNF503L; ZPO1,zinc finger protein 703,8p11.23,protein-coding,/
CWITA013127,TCMBANKGE013127,PFKM,ATP-PFK; GSD7; PFK-1; PFK-A; PFK1; PFKA; PFKX; PPP1R122,"phosphofructokinase, muscle",12q13.11,protein-coding,/
CWITA013128,TCMBANKGE013128,SCN8A,CERIII; MED; NaCh6; Nav1.6; PN4,"sodium channel, voltage gated, type VIII, alpha subunit",12q13,protein-coding,
CWITA013129,TCMBANKGE013129,P3H2,LEPREL1; MCVD; MLAT4,Prolyl_3-Hydroxylase_2,3q28,protein-coding,
CWITA013130,TCMBANKGE013130,TRAPPC9,IBP; IKBKBBP; MRT13; NIBP; T1; TRS120,trafficking protein particle complex 9,8q24.3,protein-coding,/
CWITA013131,TCMBANKGE013131,CGREF1,CGR11,cell growth regulator with EF-hand domain 1,2p23.3,protein-coding,/
CWITA013132,TCMBANKGE013132,SLC43A1,LAT3; PB39; POV1; R00504,"Solute Carrier Family 43, Member 1",11p11.2-p11.1,protein-coding,
CWITA013133,TCMBANKGE013133,TPR,-,"translocated promoter region, nuclear basket protein",1q31.1,protein-coding,/
CWITA013134,TCMBANKGE013134,NHP2,DKCB2; NHP2P; NOLA2,NHP2 ribonucleoprotein,5q35.3,protein-coding,/
CWITA013135,TCMBANKGE013135,LDLRAD3,LRAD3,low density lipoprotein receptor class A domain containing 3,11p13,protein-coding,/
CWITA013136,TCMBANKGE013136,CHIT1,CHI3; CHIT; FLJ00314; MGC125322,chitinase 1 (chitotriosidase),1q31-q32,protein-coding,
CWITA013137,TCMBANKGE013137,TNFAIP8L3,TIPE3,TNF alpha induced protein 8 like 3,15q21.2,protein-coding,/
CWITA013138,TCMBANKGE013138,RBL1,CP107; PRB1; p107,RB transcriptional corepressor like 1,20q11.23,protein-coding,/
CWITA013139,TCMBANKGE013139,GNGT1,GNG1,G protein subunit gamma transducin 1,7q21.3,protein-coding,/
CWITA013140,TCMBANKGE013140,WDR4,GAMOS6; MIGSB; TRM82; TRMT82; hWH,WD repeat domain 4,21q22.3,protein-coding,/
CWITA013141,TCMBANKGE013141,ZNF844,-,zinc finger protein 844,19p13.2,protein-coding,/
CWITA013142,TCMBANKGE013142,NEDD1,GCP-WD; TUBGCP7,NEDD1 gamma-tubulin ring complex targeting factor,12q23.1,protein-coding,/
CWITA013143,TCMBANKGE013143,C1QB,-,complement C1q B chain,1p36.12,protein-coding,Research target
CWITA013144,TCMBANKGE013144,SLC52A3,BVVLS; BVVLS1; C20orf54; RFT2; RFVT3; bA371L19.1; hRFT2,solute carrier family 52 member 3,20p13,protein-coding,/
CWITA013145,TCMBANKGE013145,CYSLTR2,CYSLT2; CYSLT2R; GPCR21; HG57; HPN321; KPG_011; PSEC0146; hGPCR21,cysteinyl leukotriene receptor 2,13q14.2,protein-coding,Clinical Trial target
CWITA013146,TCMBANKGE013146,VGLL4,VGL-4,vestigial like family member 4,3p25.3-p25.2,protein-coding,/
CWITA013147,TCMBANKGE013147,PYGL,GSD6,"phosphorylase, glycogen, liver",14q21-q22,protein-coding,
CWITA013148,TCMBANKGE013148,ZNF880,-,zinc finger protein 880,19q13.41,protein-coding,/
CWITA013149,TCMBANKGE013149,INTS8,C8orf52; INT8; NEDCHS,integrator complex subunit 8,8q22.1,protein-coding,/
CWITA013150,TCMBANKGE013150,ZNF224,BMZF-2; BMZF2; KOX22; ZNF233; ZNF255; ZNF27,zinc finger protein 224,19q13.31,protein-coding,/
CWITA013151,TCMBANKGE013151,TM7SF2,ANG1; C14SR; DHCR14A; NET47,transmembrane 7 superfamily member 2,11q13.1,protein-coding,/
CWITA013152,TCMBANKGE013152,MYO1D,PPP1R108; myr4,myosin ID,17q11.2,protein-coding,/
CWITA013153,TCMBANKGE013153,IL1R2,CD121b; CDw121b; IL-1R-2; IL-1RT-2; IL-1RT2; IL1R2c; IL1RB,interleukin 1 receptor type 2,2q11.2,protein-coding,Clinical Trial target
CWITA013154,TCMBANKGE013154,TARSL2,FLJ25005,Threonyl-Trna Synthetase-Like 2,15q26.3,protein-coding,
CWITA013155,TCMBANKGE013155,RGS12,-,regulator of G protein signaling 12,4p16.3,protein-coding,Research target
CWITA013156,TCMBANKGE013156,PTPN3,PTP-H1; PTPH1,protein tyrosine phosphatase non-receptor type 3,9q31.3,protein-coding,/
CWITA013157,TCMBANKGE013157,OBP2A,OBP; OBP2C; OBPIIa; hOBPIIa,odorant binding protein 2A,9q34,protein-coding,
CWITA013158,TCMBANKGE013158,GPRIN2,GRIN2; KIAA0514,G protein regulated inducer of neurite outgrowth 2,10q11.22,protein-coding,/
CWITA013159,TCMBANKGE013159,MRPL38,HSPC262; L38MT; MRP-L3; MRP-L38; RPML3,mitochondrial ribosomal protein L38,17q25.1,protein-coding,/
CWITA013160,TCMBANKGE013160,LAMA1,LAMA; PTBHS; S-LAM-alpha,laminin subunit alpha 1,18p11.31,protein-coding,/
CWITA013161,TCMBANKGE013161,GLT6D1,GLTDC1; GT6M7,Glycosyltransferase_6_Domain_Containing_1,9q34.3,protein-coding,
CWITA013162,TCMBANKGE013162,DCXR,DCR; HCR2; HCRII; KIDCR; P34H; SDR20C1; XR,dicarbonyl/L-xylulose reductase,17q25.3,protein-coding,
CWITA013163,TCMBANKGE013163,TRMU,LCAL3; MTO2; MTU1; TRMT; TRMT1,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,22q13.31,protein-coding,/
CWITA013164,TCMBANKGE013164,DERA,CGI-26; DEOC,deoxyribose-phosphate aldolase,12p12.3,protein-coding,/
CWITA013165,TCMBANKGE013165,VSTM2L,C20orf102; dJ1118M15.2,V-set and transmembrane domain containing 2 like,20q11.23,protein-coding,/
CWITA013166,TCMBANKGE013166,LANCL1,GPR69A; p40,LanC like 1,2q34,protein-coding,Research target
CWITA013167,TCMBANKGE013167,NT5C1B,AIRP; CN-IB; CN1B,"5'-nucleotidase, cytosolic IB",2p24.2,protein-coding,/
CWITA013168,TCMBANKGE013168,PPP1R13B,ASPP1; p53BP2-like; p85,protein phosphatase 1 regulatory subunit 13B,14q32.33,protein-coding,/
CWITA013169,TCMBANKGE013169,ZNF132,pHZ-12,zinc finger protein 132,19q13.43,protein-coding,/
CWITA013170,TCMBANKGE013170,ELANE,ELA2; GE; HLE; HNE; NE; PMN-E; SCN1,"elastase, neutrophil expressed",19p13.3,protein-coding,Clinical Trial target
CWITA013171,TCMBANKGE013171,FIGN,-,"fidgetin, microtubule severing factor",2q24.3,protein-coding,/
CWITA013172,TCMBANKGE013172,ZNF343,dJ734P14.5,zinc finger protein 343,20p13,protein-coding,/
CWITA013173,TCMBANKGE013173,MICALL1,MICAL-L1; MIRAB13,MICAL like 1,22q13.1,protein-coding,/
CWITA013174,TCMBANKGE013174,PGM2,MSTP006,phosphoglucomutase 2,4p14,protein-coding,/
CWITA013175,TCMBANKGE013175,SCN11A,FEPS3; HSAN7; NAV1.9; NaN; PN5; SCN12A; SNS-2,sodium voltage-gated channel alpha subunit 11,3p22.2,protein-coding,Successful target
CWITA013176,TCMBANKGE013176,TUBD1,FLJ12709; TUBD,"tubulin, delta 1",17q23.1,protein-coding,
CWITA013177,TCMBANKGE013177,ENOPH1,E1; MASA; MST145; mtnC,enolase-phosphatase 1,4q21.22,protein-coding,/
CWITA013178,TCMBANKGE013178,ZFP14,ZNF531,ZFP14 zinc finger protein,19q13.12,protein-coding,/
CWITA013179,TCMBANKGE013179,RTL5,6430402L03Rik; MAR5; MART5; RGAG4; SIRH8,retrotransposon Gag like 5,Xq13.1,protein-coding,/
CWITA013180,TCMBANKGE013180,EGLN1,C1orf12; DKFZp761F179; ECYT3; HIFPH2; HPH2; PHD2; SM20; ZMYND6,egl nine homolog 1 (C. elegans),1q42.1,protein-coding,
CWITA013181,TCMBANKGE013181,RAD1,HRAD1; REC1,RAD1 checkpoint DNA exonuclease,5p13.2,protein-coding,/
CWITA013182,TCMBANKGE013182,MARS2,COXPD25; MetRS; mtMetRS,"methionyl-tRNA synthetase 2, mitochondrial",2q33.1,protein-coding,/
CWITA013183,TCMBANKGE013183,TRIM10,HERF1; RFB30; RNF9,tripartite motif containing 10,6p22.1,protein-coding,/
CWITA013184,TCMBANKGE013184,HP,BP; HP2ALPHA2; HPA1S,haptoglobin,16q22.2,protein-coding,Clinical Trial target
CWITA013185,TCMBANKGE013185,DYNLT1,CW-1; TCTEL1; tctex-1,dynein light chain Tctex-type 1,6q25.3,protein-coding,/
CWITA013186,TCMBANKGE013186,EIPR1,EIPR-1; TSSC1,EARP complex and GARP complex interacting protein 1,2p25.3,protein-coding,/
CWITA013187,TCMBANKGE013187,ENPP2,ATX; ATX-X; AUTOTAXIN; LysoPLD; NPP2; PD-IALPHA; PDNP2,ectonucleotide pyrophosphatase/phosphodiesterase 2,8q24.12,protein-coding,Patented target
CWITA013188,TCMBANKGE013188,MICB,PERB11.2,MHC class I polypeptide-related sequence B,6p21.33,protein-coding,/
CWITA013189,TCMBANKGE013189,KLHL42,Ctb9; KLHDC5,kelch like family member 42,12p11.22,protein-coding,/
CWITA013190,TCMBANKGE013190,ZFYVE16,PPP1R69,zinc finger FYVE-type containing 16,5q14.1,protein-coding,/
CWITA013191,TCMBANKGE013191,WNT8A,WNT8D,Wnt family member 8A,5q31.2,protein-coding,/
CWITA013192,TCMBANKGE013192,KIAA1109,ALKKUCS; FSA; Tweek,KIAA1109,4q27,protein-coding,/
CWITA013193,TCMBANKGE013193,ZNF561,-,zinc finger protein 561,19p13.2,protein-coding,/
CWITA013194,TCMBANKGE013194,PARD3,ASIP; Baz; PAR3; PAR3alpha; PARD-3; PARD3A; PPP1R118; SE2-5L16; SE2-5LT1; SE2-5T2,par-3 family cell polarity regulator,10p11.22-p11.21,protein-coding,/
CWITA013195,TCMBANKGE013195,HNRNPU,EIEE54; GRIP120; HNRNPU-AS1; HNRPU; SAF-A; SAFA; U21.1; hnRNP U; pp120,heterogeneous nuclear ribonucleoprotein U,1q44,protein-coding,/
CWITA013196,TCMBANKGE013196,ISG20L2,HSD38,interferon stimulated exonuclease gene 20 like 2,1q23.1,protein-coding,/
CWITA013197,TCMBANKGE013197,FCGR3A,CD16; CD16A; FCG3; FCGR3; FCGRIII; FCR-10; FCRIII; FCRIIIA; IGFR3; IMD20,Fc fragment of IgG receptor IIIa,1q23.3,protein-coding,Clinical Trial target
CWITA013198,TCMBANKGE013198,GSN,DKFZp313L0718,gelsolin,9q33,protein-coding,
CWITA013199,TCMBANKGE013199,VNN2,FOAP-4; GPI-80,vanin 2,6q23.2,protein-coding,/
CWITA013200,TCMBANKGE013200,PIK3CD,P110DELTA; PI3K; p110D,"phosphoinositide-3-kinase, catalytic, delta polypeptide",1p36.2,protein-coding,
CWITA013201,TCMBANKGE013201,AAGAB,KPPP1; PPKP1; PPKP1A; p34,alpha and gamma adaptin binding protein,15q23,protein-coding,/
CWITA013202,TCMBANKGE013202,TNK2,ACK; ACK1; FLJ44758; FLJ45547; p21cdc42Hs,"tyrosine kinase, non-receptor, 2",3q29,protein-coding,
CWITA013203,TCMBANKGE013203,CSDE1,D1S155E; UNR,cold shock domain containing E1,1p13.2,protein-coding,/
CWITA013204,TCMBANKGE013204,FCGRT,FCRN; alpha-chain,Fc fragment of IgG receptor and transporter,19q13.33,protein-coding,Research target
CWITA013205,TCMBANKGE013205,ATP5F1E,ATP5E; ATPE; MC5DN3,Atp_Synthase_F1_Subunit_Epsilon,20q13.32,protein-coding,
CWITA013206,TCMBANKGE013206,BPIFA1,LUNX; NASG; PLUNC; SPLUNC1; SPURT; bA49G10.5,BPI fold containing family A member 1,20q11.21,protein-coding,/
CWITA013207,TCMBANKGE013207,SLC24A3,NCKX3,solute carrier family 24 member 3,20p11.23,protein-coding,/
CWITA013208,TCMBANKGE013208,RNF149,DNAPTP2,ring finger protein 149,2q11.2,protein-coding,/
CWITA013209,TCMBANKGE013209,DSCAML1,DSCAM2,DS cell adhesion molecule like 1,11q23.3,protein-coding,/
CWITA013210,TCMBANKGE013210,HNRNPA0,HNRPA0,heterogeneous nuclear ribonucleoprotein A0,5q31.2,protein-coding,/
CWITA013211,TCMBANKGE013211,RSAD1,HemW,radical S-adenosyl methionine domain containing 1,17q21.33,protein-coding,/
CWITA013212,TCMBANKGE013212,TRAPPC2B,MIP-2A; SEDLP; SEDLP1; TRAPPC2P1,trafficking protein particle complex 2B,19q13.43,protein-coding,/
CWITA013213,TCMBANKGE013213,ONECUT1,HNF-6; HNF6; HNF6A,one cut homeobox 1,15q21.3,protein-coding,/
CWITA013214,TCMBANKGE013214,FUCA2,dJ20N2.5,alpha-L-fucosidase 2,6q24.2,protein-coding,/
CWITA013215,TCMBANKGE013215,VNN1,HDLCQ8; Tiff66,vanin 1,6q23.2,protein-coding,/
CWITA013216,TCMBANKGE013216,CPE,CPH,carboxypeptidase E,4q32.3,protein-coding,Research target
CWITA013217,TCMBANKGE013217,ZSCAN9,PRD51; ZNF193,zinc finger and SCAN domain containing 9,6p22.1,protein-coding,/
CWITA013218,TCMBANKGE013218,ADRA1B,ADRA1; ALPHA1BAR,"adrenergic, alpha-1B-, receptor",5q33.3,protein-coding,
CWITA013219,TCMBANKGE013219,TRNAU1AP,PRO1902; SECP43; TRSPAP1,tRNA selenocysteine 1 associated protein 1,1p35.3,protein-coding,/
CWITA013220,TCMBANKGE013220,AOX1,AO; AOH1,aldehyde oxidase 1,2q33.1,protein-coding,Successful target
CWITA013221,TCMBANKGE013221,APMAP,BSCv; C20orf3,adipocyte plasma membrane associated protein,20p11.21,protein-coding,/
CWITA013222,TCMBANKGE013222,LIN37,F25965; ZK418.4; lin-37,lin-37 DREAM MuvB core complex component,19q13.12,protein-coding,/
CWITA013223,TCMBANKGE013223,SPNS1,HSpin1; LAT; PP2030; SLC62A1; SPIN1; SPINL; nrs,sphingolipid transporter 1 (putative),16p11.2,protein-coding,/
CWITA013224,TCMBANKGE013224,E2F8,E2F-8,E2F transcription factor 8,11p15.1,protein-coding,/
CWITA013225,TCMBANKGE013225,FBXO10,FBX10; PRMT11,F-box protein 10,9p13.2,protein-coding,/
CWITA013226,TCMBANKGE013226,DRD4,D4DR,dopamine receptor D4,11p15.5,protein-coding,Successful target
CWITA013227,TCMBANKGE013227,FBXO44,FBG3; FBX30; FBX6A; Fbx44; Fbxo6a,F-box protein 44,1p36.22,protein-coding,/
CWITA013228,TCMBANKGE013228,G6pd2,G6pdx-ps1; Gpd-2; Gpd2,glucose-6-phosphate dehydrogenase 2,5 C3.1|5 31.99 cM,protein-coding,/
CWITA013229,TCMBANKGE013229,GPT2,ALT2,glutamic pyruvate transaminase (alanine aminotransferase) 2,16q12.1,protein-coding,
CWITA013230,TCMBANKGE013230,ANKRD50,-,ankyrin repeat domain 50,4q28.1,protein-coding,/
CWITA013231,TCMBANKGE013231,ABCC10,EST182763; MRP7; SIMRP7,"ATP-binding cassette, sub-family C (CFTR/MRP), member 10",6p21.1,protein-coding,
CWITA013232,TCMBANKGE013232,CMTM8,CKLFSF8; CKLFSF8-V2,CKLF like MARVEL transmembrane domain containing 8,3p22.3,protein-coding,/
CWITA013233,TCMBANKGE013233,ZNF70,Cos17,zinc finger protein 70,22q11.23,protein-coding,/
CWITA013234,TCMBANKGE013234,ZNF878,-,zinc finger protein 878,19p13.2,protein-coding,/
CWITA013235,TCMBANKGE013235,TMEM64,-,transmembrane protein 64,8q21.3,protein-coding,/
CWITA013236,TCMBANKGE013236,CABIN1,CAIN; KB-318B8.7; PPP3IN,calcineurin binding protein 1,22q11.23,protein-coding,/
CWITA013237,TCMBANKGE013237,ASB8,PP14212,ankyrin repeat and SOCS box containing 8,12q13.11,protein-coding,/
CWITA013238,TCMBANKGE013238,KDR,CD309; FLK1; VEGFR; VEGFR2,kinase insert domain receptor (a type III receptor tyrosine kinase),4q11-q12,protein-coding,
CWITA013239,TCMBANKGE013239,TNKS1BP1,TAB182,tankyrase 1 binding protein 1,11q12.1,protein-coding,/
CWITA013240,TCMBANKGE013240,ZBTB18,C2H2-171; MRD22; RP58; TAZ-1; ZNF238,zinc finger and BTB domain containing 18,1q44,protein-coding,/
CWITA013241,TCMBANKGE013241,APOL3,APOLIII; CG121; CG12_1; apoL-III,apolipoprotein L3,22q12.3,protein-coding,/
CWITA013242,TCMBANKGE013242,ARL5C,ARL12,ADP ribosylation factor like GTPase 5C,17q12,protein-coding,/
CWITA013243,TCMBANKGE013243,SLC16A3,MCT_3; MCT_4; MCTN3; MCTN4; MCT3; MCT4; MGC138472; MGC138474,"solute carrier family 16, member 3 (monocarboxylic acid transporter 4)",17q25,protein-coding,
CWITA013244,TCMBANKGE013244,APH1B,APH-1B; PRO1328; PSFL; TAAV688,"aph-1 homolog B, gamma-secretase subunit",15q22.2,protein-coding,/
CWITA013245,TCMBANKGE013245,TMEM106C,-,transmembrane protein 106C,12q13.11,protein-coding,/
CWITA013246,TCMBANKGE013246,ABHD11,PP1226; WBSCR21,abhydrolase domain containing 11,7q11.23,protein-coding,/
CWITA013247,TCMBANKGE013247,PACSIN3,SDPIII,protein kinase C and casein kinase substrate in neurons 3,11p11.2,protein-coding,/
CWITA013248,TCMBANKGE013248,MORN2,BLOCK27; MOPT,MORN repeat containing 2,2p22.1,protein-coding,/
CWITA013249,TCMBANKGE013249,DHFR,DHFRP1; DYR,dihydrofolate reductase,5q11.2-q13.2,protein-coding,
CWITA013250,TCMBANKGE013250,UFSP2,BHD; C4orf20; SEMDDR,UFM1 specific peptidase 2,4q35.1,protein-coding,/
CWITA013251,TCMBANKGE013251,CHST7,C6ST-2; GST-5,carbohydrate sulfotransferase 7,Xp11.3,protein-coding,/
CWITA013252,TCMBANKGE013252,PLD3,AD19; HU-K4; HUK4; SCA46,phospholipase D family member 3,19q13.2,protein-coding,/
CWITA013253,TCMBANKGE013253,Gm10925,Atp6; Atpase6; Mtatp6; mt-Atp6,ATP synthase F0 subunit 6 pseudogene,1|1 A5,pseudo,/
CWITA013254,TCMBANKGE013254,MEIS1,-,Meis homeobox 1,2p14,protein-coding,/
CWITA013255,TCMBANKGE013255,MRPL1,BM022; L1MT; MRP-L1,mitochondrial ribosomal protein L1,4q21.1,protein-coding,/
CWITA013256,TCMBANKGE013256,RCHY1,ARNIP; CHIMP; PIRH2; PRO1996; RNF199; ZCHY; ZNF363,ring finger and CHY zinc finger domain containing 1,4q21.1,protein-coding,/
CWITA013257,TCMBANKGE013257,NUDT12,-,nudix hydrolase 12,5q21.2,protein-coding,/
CWITA013258,TCMBANKGE013258,PCDHGA4,PCDH-GAMMA-A4,"protocadherin gamma subfamily A, 4",5q31.3,protein-coding,/
CWITA013259,TCMBANKGE013259,STRN4,PPP2R6C; ZIN; zinedin,striatin 4,19q13.32,protein-coding,/
CWITA013260,TCMBANKGE013260,HRG,HPRG; HRGP; THPH11,histidine rich glycoprotein,3q27.3,protein-coding,/
CWITA013261,TCMBANKGE013261,SDCBP,MDA-9; MDA9; ST1; SYCL; TACIP18,syndecan binding protein,8q12.1,protein-coding,/
CWITA013262,TCMBANKGE013262,ADCY2,AC2; FLJ16822; FLJ45092; HBAC2; KIAA1060; MGC133314,adenylate cyclase 2 (brain),5p15.3,protein-coding,
CWITA013263,TCMBANKGE013263,MYL6,ESMLC; LC17; LC17-GI; LC17-NM; LC17A; LC17B; MLC-3; MLC1SM; MLC3NM; MLC3SM,myosin light chain 6,12q13.2,protein-coding,/
CWITA013264,TCMBANKGE013264,PLXDC2,TEM7R,plexin domain containing 2,10p12.31,protein-coding,/
CWITA013265,TCMBANKGE013265,TDG,hTDG,thymine DNA glycosylase,12q23.3,protein-coding,Research target
CWITA013266,TCMBANKGE013266,HSP90B1,ECGP; GP96; GRP94; TRA1,"heat shock protein 90kDa beta (Grp94), member 1",12q24.2-q24.3,protein-coding,
CWITA013267,TCMBANKGE013267,ARHGEF9,COLLYBISTIN; EIEE8; HPEM-2; PEM-2; PEM2,Cdc42 guanine nucleotide exchange factor 9,Xq11.1,protein-coding,/
CWITA013268,TCMBANKGE013268,SLC3A1,ATR1; CSNU1; D2H; FLJ34681; NBAT; RBAT,"solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1",2p16.3,protein-coding,
CWITA013269,TCMBANKGE013269,ASH1L,ASH1; ASH1L1; KMT2H; MRD52,ASH1 like histone lysine methyltransferase,1q22,protein-coding,/
CWITA013270,TCMBANKGE013270,EPRS1,EARS; EPRS; GLUPRORS; HLD15; PARS; PIG32; QARS; QPRS,glutamyl-prolyl-tRNA synthetase 1,1q41,protein-coding,/
CWITA013271,TCMBANKGE013271,IRF8,H-ICSBP; ICSBP; ICSBP1; IMD32A; IMD32B; IRF-8,interferon regulatory factor 8,16q24.1,protein-coding,Research target
CWITA013272,TCMBANKGE013272,TTL,-,tubulin tyrosine ligase,2q14.1,protein-coding,/
CWITA013273,TCMBANKGE013273,PRDX4,AOE37-2; AOE372; HEL-S-97n; PRX-4,peroxiredoxin 4,Xp22.11,protein-coding,Research target
CWITA013274,TCMBANKGE013274,NKAIN2,FAM77B; NKAIP2; TCBA; TCBA1,sodium/potassium transporting ATPase interacting 2,6q22.31,protein-coding,/
CWITA013275,TCMBANKGE013275,ENTPD3,CD39L3; HB6; NTPDase-3,ectonucleoside triphosphate diphosphohydrolase 3,3p22.1,protein-coding,/
CWITA013276,TCMBANKGE013276,KCNC2,KV3.2; MGC138196,"potassium voltage-gated channel, Shaw-related subfamily, member 2",12q14.1,protein-coding,
CWITA013277,TCMBANKGE013277,GRP,BN; GRP-10; preproGRP; proGRP,gastrin releasing peptide,18q21.32,protein-coding,/
CWITA013278,TCMBANKGE013278,RAB33A,RabS10,"RAB33A, member RAS oncogene family",Xq26.1,protein-coding,/
CWITA013279,TCMBANKGE013279,PSME1,HEL-S-129m; IFI5111; PA28A; PA28alpha; REGalpha,proteasome activator subunit 1,14q12,protein-coding,/
CWITA013280,TCMBANKGE013280,UNG,DGU; DKFZp781L1143; HIGM4; UDG; UNG1; UNG15; UNG2,uracil-DNA glycosylase,12q23-q24.1,protein-coding,
CWITA013281,TCMBANKGE013281,AADAT,KAT2; KATII; KYAT2,aminoadipate aminotransferase,4q33,protein-coding,Research target
CWITA013282,TCMBANKGE013282,GSTM5,GSTM5-5; GTM5,glutathione S-transferase mu 5,1p13.3,protein-coding,
CWITA013283,TCMBANKGE013283,ALAD,ALADH; MGC5057; PBGS,aminolevulinate dehydratase,9q33.1,protein-coding,
CWITA013284,TCMBANKGE013284,ACBD4,HMFT0700,acyl-CoA binding domain containing 4,17q21.31,protein-coding,/
CWITA013285,TCMBANKGE013285,NTSR2,NTR2,neurotensin receptor 2,2p25.1,protein-coding,
CWITA013286,TCMBANKGE013286,DLAT,DLTA; E2; PBC; PDC-E2; PDCE2,dihydrolipoamide S-acetyltransferase,11q23.1,protein-coding,/
CWITA013287,TCMBANKGE013287,KCNIP2,KCHIP2,potassium voltage-gated channel interacting protein 2,10q24.32,protein-coding,/
CWITA013288,TCMBANKGE013288,PTPN23,HD-PTP; HDPTP; PTP-TD14,protein tyrosine phosphatase non-receptor type 23,3p21.31,protein-coding,/
CWITA013289,TCMBANKGE013289,VAMP7,SYBL1; TI-VAMP; TIVAMP; VAMP-7,vesicle associated membrane protein 7,Xq28 and Yq12,protein-coding,/
CWITA013290,TCMBANKGE013290,OSBPL10,ORP10; OSBP9,oxysterol binding protein like 10,3p23,protein-coding,/
CWITA013291,TCMBANKGE013291,C7orf50,YCR016W,chromosome 7 open reading frame 50,7p22.3,protein-coding,/
CWITA013292,TCMBANKGE013292,DSCC1,DCC1,DNA replication and sister chromatid cohesion 1,8q24.12,protein-coding,/
CWITA013293,TCMBANKGE013293,ELOVL4,ADMD; CT118; ISQMR; SCA34; STGD2; STGD3,ELOVL fatty acid elongase 4,6q14.1,protein-coding,/
CWITA013294,TCMBANKGE013294,SLC3A2,4F2; 4F2HC; 4T2HC; CD98; CD98HC; MDU1; NACAE,solute carrier family 3 member 2,11q12.3,protein-coding,Clinical Trial target
CWITA013295,TCMBANKGE013295,USP8,HumORF8; PITA4; SPG59; UBPY,ubiquitin specific peptidase 8,15q21.2,protein-coding,Research target
CWITA013296,TCMBANKGE013296,UNC13A,Munc13-1,unc-13 homolog A,19p13.11,protein-coding,/
CWITA013297,TCMBANKGE013297,ADPRS,ADPRHL2; ARH3; CONDSIAS,ADP-ribosylserine hydrolase,1p34.3,protein-coding,/
CWITA013298,TCMBANKGE013298,ACBD7,bA455B2.2,acyl-CoA binding domain containing 7,10p13,protein-coding,/
CWITA013299,TCMBANKGE013299,F3,CD142; TF; TFA,"coagulation factor III, tissue factor",1p21.3,protein-coding,Clinical Trial target
CWITA013300,TCMBANKGE013300,MED28,1500003D12Rik; EG1; magicin,mediator complex subunit 28,4p15.32,protein-coding,/
CWITA013301,TCMBANKGE013301,SATB1,-,SATB homeobox 1,3p24.3,protein-coding,Research target
CWITA013302,TCMBANKGE013302,OR10J1,HGMP07J; HSHGMP07J,olfactory receptor family 10 subfamily J member 1,1q23.2,protein-coding,/
CWITA013303,TCMBANKGE013303,CACNA2D3,HSA272268,"calcium channel, voltage-dependent, alpha 2/delta subunit 3",3p21.1,protein-coding,
CWITA013304,TCMBANKGE013304,HSDL2,C9orf99; SDR13C1,hydroxysteroid dehydrogenase like 2,9q32,protein-coding,/
CWITA013305,TCMBANKGE013305,C4orf3,ALN; HCVFTP1,chromosome 4 open reading frame 3,4q26,protein-coding,/
CWITA013306,TCMBANKGE013306,NPAS3,MOP6; PASD6; bHLHe12,neuronal PAS domain protein 3,14q13.1,protein-coding,/
CWITA013307,TCMBANKGE013307,LARP4,PP13296,La ribonucleoprotein 4,12q13.12,protein-coding,/
CWITA013308,TCMBANKGE013308,SDHD,CBT1; CII-4; CWS3; PGL; PGL1; QPs3; SDH4; cybS,succinate dehydrogenase complex subunit D,11q23.1,protein-coding,Research target
CWITA013309,TCMBANKGE013309,SLC17A7,BNPI; VGLUT1,solute carrier family 17 member 7,19q13.33,protein-coding,/
CWITA013310,TCMBANKGE013310,HOXB8,HOX2; HOX2D; Hox-2.4,homeobox B8,17q21.32,protein-coding,/
CWITA013311,TCMBANKGE013311,SGPL1,FLJ13811; KIAA1252; S1PL; SPL,sphingosine-1-phosphate lyase 1,10q21,protein-coding,
CWITA013312,TCMBANKGE013312,FPR1,FMLP; FPR,formyl peptide receptor 1,19q13.4,protein-coding,
CWITA013313,TCMBANKGE013313,DNAJC14,DNAJ; DRIP78; HDJ3; LIP6,DnaJ heat shock protein family (Hsp40) member C14,12q13.2,protein-coding,/
CWITA013314,TCMBANKGE013314,FSCN3,-,fascin actin-bundling protein 3,7q32.1,protein-coding,/
CWITA013315,TCMBANKGE013315,KIF16B,C20orf23; KISC20ORF; SNX23,kinesin family member 16B,20p12.1,protein-coding,/
CWITA013316,TCMBANKGE013316,GUCA1B,GCAP 2; GCAP2; GUCA2; RP48,guanylate cyclase activator 1B,6p21.1,protein-coding,/
CWITA013317,TCMBANKGE013317,TMEM161B,FLB3342; PRO1313,transmembrane protein 161B,5q14.3,protein-coding,/
CWITA013318,TCMBANKGE013318,PLA2G1B,PLA2; PLA2A; PPLA2,phospholipase A2 group IB,12q24.31,protein-coding,Successful target
CWITA013319,TCMBANKGE013319,CIDEC,CIDE-3; CIDE3; FPLD5; FSP27,cell death inducing DFFA like effector c,3p25.3,protein-coding,/
CWITA013320,TCMBANKGE013320,HDAC6,CPBHM; HD6; JM21; PPP1R90,histone deacetylase 6,Xp11.23,protein-coding,Clinical Trial target
CWITA013321,TCMBANKGE013321,POGLUT2,EP58; ERp58; KDEL1; KDELC1,protein O-glucosyltransferase 2,13q33.1,protein-coding,/
CWITA013322,TCMBANKGE013322,FXR1,FXR1P; MYOPMIL; MYORIBF,FMR1 autosomal homolog 1,3q26.33,protein-coding,/
CWITA013323,TCMBANKGE013323,BCKDHB,E1B; FLJ17880; dJ279A18.1,"Branched Chain Keto Acid Dehydrogenase E1, Beta Polypeptide",6q14.1,protein-coding,
CWITA013324,TCMBANKGE013324,GBE1,APBD; GBE; GSD4,"1,4-alpha-glucan branching enzyme 1",3p12.2,protein-coding,/
CWITA013325,TCMBANKGE013325,PLN,CMD1P; CMH18; PLB,phospholamban,6q22.31,protein-coding,Research target
CWITA013326,TCMBANKGE013326,ZNF181,HHZ181,zinc finger protein 181,19q13.11,protein-coding,/
CWITA013327,TCMBANKGE013327,AKIRIN2,C6orf166; FBI1; dJ486L4.2,akirin 2,6q15,protein-coding,/
CWITA013328,TCMBANKGE013328,OAZ2,AZ2,ornithine decarboxylase antizyme 2,15q22.31,protein-coding,/
CWITA013329,TCMBANKGE013329,CDK5,PSSALRE,cyclin-dependent kinase 5,7q36,protein-coding,
CWITA013330,TCMBANKGE013330,FAT4,CDHF14; CDHR11; FAT-J; FATJ; HKLLS2; NBLA00548; VMLDS2,FAT atypical cadherin 4,4q28.1,protein-coding,/
CWITA013331,TCMBANKGE013331,TMPRSS15,ENTK; PRSS7,transmembrane serine protease 15,21q21.1,protein-coding,Research target
CWITA013332,TCMBANKGE013332,ZNF565,-,zinc finger protein 565,19q13.12,protein-coding,/
CWITA013333,TCMBANKGE013333,AZIN1,AZI; AZI1; AZIA1; OAZI; OAZIN; ODC1L,antizyme inhibitor 1,8q22.3,protein-coding,/
CWITA013334,TCMBANKGE013334,PON3,-,paraoxonase 3,7q21.3,protein-coding,/
CWITA013335,TCMBANKGE013335,KDM5C,DXS1272E; JARID1C; MRX13; MRXJ; MRXSCJ; MRXSJ; SMCX; XE169,lysine demethylase 5C,Xp11.22,protein-coding,Research target
CWITA013336,TCMBANKGE013336,FURIN,FUR; PACE; PCSK3; SPC1,"furin, paired basic amino acid cleaving enzyme",15q26.1,protein-coding,Research target
CWITA013337,TCMBANKGE013337,GSTM2,GST4; GSTM; GSTM2-2; GTHMUS,glutathione S-transferase mu 2,1p13.3,protein-coding,/
CWITA013338,TCMBANKGE013338,CTNNA1,CAP102; MDPT2,catenin alpha 1,5q31.2,protein-coding,/
CWITA013339,TCMBANKGE013339,ZNF256,BMZF-3; BMZF3,zinc finger protein 256,19q13.43,protein-coding,/
CWITA013340,TCMBANKGE013340,NCDN,-,neurochondrin,1p34.3,protein-coding,/
CWITA013341,TCMBANKGE013341,ANP32B,APRIL; PHAPI2; SSP29,acidic nuclear phosphoprotein 32 family member B,9q22.33,protein-coding,/
CWITA013342,TCMBANKGE013342,ZNF222,-,zinc finger protein 222,19q13.31,protein-coding,/
CWITA013343,TCMBANKGE013343,TMF1,ARA160; TMF,TATA element modulatory factor 1,3p14.1,protein-coding,/
CWITA013344,TCMBANKGE013344,ZNF17,HPF3; KOX10,zinc finger protein 17,19q13.43,protein-coding,/
CWITA013345,TCMBANKGE013345,P2RY13,FKSG77; GPCR1; GPR86; GPR94; P2Y13; SP174,purinergic receptor P2Y13,3q25.1,protein-coding,Research target
CWITA013346,TCMBANKGE013346,ZNF549,-,zinc finger protein 549,19q13.43,protein-coding,/
CWITA013347,TCMBANKGE013347,PROZ,PZ,"protein Z, vitamin K dependent plasma glycoprotein",13q34,protein-coding,/
CWITA013348,TCMBANKGE013348,TRAPPC1,BET5; MUM2,trafficking protein particle complex 1,17p13.1,protein-coding,
CWITA013349,TCMBANKGE013349,DCSTAMP,FIND; TM7SF4; hDC-STAMP,dendrocyte expressed seven transmembrane protein,8q22.3,protein-coding,/
CWITA013350,TCMBANKGE013350,Cyp2a,-,"cytochrome P450, family 2, subfamily a",-,other,/
CWITA013351,TCMBANKGE013351,ESD,FGH,esterase D,13q14.2,protein-coding,/
CWITA013352,TCMBANKGE013352,WNT16,-,Wnt family member 16,7q31.31,protein-coding,/
CWITA013353,TCMBANKGE013353,ATF5,ATFX; FLJ34666; HMFN0395,activating transcription factor 5,19q13.3,protein-coding,
CWITA013354,TCMBANKGE013354,ARHGAP42,AD031; GRAF3; TMEM133,Rho GTPase activating protein 42,11q22.1,protein-coding,/
CWITA013355,TCMBANKGE013355,KDM5D,HY; HYA; JARID1D; SMCY,lysine demethylase 5D,Yq11.223,protein-coding,/
CWITA013356,TCMBANKGE013356,IL4R,CD124; IL-4RA; IL4RA,interleukin 4 receptor,16p12.1,protein-coding,Research target
CWITA013357,TCMBANKGE013357,VAC14,ArPIKfyve; TAX1BP2; TRX,VAC14 component of PIKFYVE complex,16q22.1-q22.2,protein-coding,/
CWITA013358,TCMBANKGE013358,GCA,GCL,grancalcin,2q24.2,protein-coding,/
CWITA013359,TCMBANKGE013359,LUC7L3,CRA; CREAP-1; CROP; LUC7A; OA48-18; hLuc7A,LUC7 like 3 pre-mRNA splicing factor,17q21.33,protein-coding,/
CWITA013360,TCMBANKGE013360,SH3YL1,RAY,SH3 and SYLF domain containing 1,2p25.3,protein-coding,/
CWITA013361,TCMBANKGE013361,GRIN2C,GluN2C; NMDAR2C; NR2C,glutamate ionotropic receptor NMDA type subunit 2C,17q25.1,protein-coding,Research target
CWITA013362,TCMBANKGE013362,TTC28,TPRBK,tetratricopeptide repeat domain 28,22q12.1,protein-coding,/
CWITA013363,TCMBANKGE013363,RBM7,-,RNA binding motif protein 7,11q23.2,protein-coding,/
CWITA013364,TCMBANKGE013364,EIF4E2,4E-LP; 4EHP; EIF4EL3; IF4e; h4EHP,eukaryotic translation initiation factor 4E family member 2,2q37.1,protein-coding,/
CWITA013365,TCMBANKGE013365,EFL1,EFTUD1; FAM42A; HsT19294; RIA1; SDS2,elongation factor like GTPase 1,15q25.2,protein-coding,/
CWITA013366,TCMBANKGE013366,CYP11B2,ALDOS; CPN2; CYP11B; CYP11BL; PN450C18; P450C18; P450aldo,"cytochrome P450, family 11, subfamily B, polypeptide 2",8q21-q22,protein-coding,
CWITA013367,TCMBANKGE013367,CHRNA9,HSA243342; NACHRA9,cholinergic receptor nicotinic alpha 9 subunit,4p14,protein-coding,Research target
CWITA013368,TCMBANKGE013368,NDUFA8,CIN19KD; CINPGIV; MGC793; PGIV,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa",9q33.2,protein-coding,
CWITA013369,TCMBANKGE013369,ST8SIA6,SIA8F; SIAT8-F; SIAT8F; ST8SIA-VI; ST8SiaVI,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6",10p12.33,protein-coding,/
CWITA013370,TCMBANKGE013370,CHI3L2,CHIL2; YKL-39; YKL39,chitinase 3 like 2,1p13.2,protein-coding,/
CWITA013371,TCMBANKGE013371,PEA15,HMAT1; HUMMAT1H; MAT1; MAT1H; PEA-15; PED; PED-PEA15; PED/PEA15,proliferation and apoptosis adaptor protein 15,1q23.2,protein-coding,/
CWITA013372,TCMBANKGE013372,RBP2,CRABP-II; CRBP2; CRBPII; RBPC2,retinol binding protein 2,3q23,protein-coding,/
CWITA013373,TCMBANKGE013373,PLEKHA1,TAPP1,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1",10q26.13,protein-coding,
CWITA013374,TCMBANKGE013374,CEP78,C9orf81; CRDHL; IP63,centrosomal protein 78,9q21.2,protein-coding,/
CWITA013375,TCMBANKGE013375,LTB4R,BLT1; BLTR; CMKRL1; GPR16; LTB4R1; LTBR1; P2RY7; P2Y7,leukotriene B4 receptor,14q12,protein-coding,Clinical Trial target
CWITA013376,TCMBANKGE013376,ZNF589,SZF1,zinc finger protein 589,3p21.31,protein-coding,/
CWITA013377,TCMBANKGE013377,ZSCAN32,HCCS-5; ZNF434,zinc finger and SCAN domain containing 32,16p13.3,protein-coding,/
CWITA013378,TCMBANKGE013378,CACNA2D2,CACNA2D; KIAA0558; LUAC11.1,"calcium channel, voltage-dependent, alpha 2/delta subunit 2",3p21.3,protein-coding,
CWITA013379,TCMBANKGE013379,PIGL,CHIME,phosphatidylinositol glycan anchor biosynthesis class L,17p11.2,protein-coding,Research target
CWITA013380,TCMBANKGE013380,RAB30,-,"RAB30, member RAS oncogene family",11q14.1,protein-coding,/
CWITA013381,TCMBANKGE013381,MICAL3,MICAL-3,"microtubule associated monooxygenase, calponin and LIM domain containing 3",22q11.21,protein-coding,/
CWITA013382,TCMBANKGE013382,ADA,-,adenosine deaminase,20q13.12,protein-coding,Successful target
CWITA013383,TCMBANKGE013383,VCP,CDC48; TERA; p97,valosin containing protein,9p13.3,protein-coding,Clinical Trial target
CWITA013384,TCMBANKGE013384,AKT1,AKT; MGC99656; PKB; PKBNALPHA; PRKBA; RAC; RACNALPHA,v-akt murine thymoma viral oncogene homolog 1,14q32.32|14q32.32,protein-coding,
CWITA013385,TCMBANKGE013385,SP2,-,Sp2 transcription factor,17q21.32,protein-coding,/
CWITA013386,TCMBANKGE013386,TMED6,PRO34237; SPLL9146; p24g5,transmembrane p24 trafficking protein 6,16q22.1,protein-coding,/
CWITA013387,TCMBANKGE013387,AKR1C4,3NalphaNHSD; C11; CDR; CHDR; DDN4; DD4; HAKRA; MGC22581,"aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)",10p15.1,protein-coding,
CWITA013388,TCMBANKGE013388,CABLES1,CABL1; CABLES; HsT2563; IK3-1,Cdk5 and Abl enzyme substrate 1,18q11.2,protein-coding,/
CWITA013389,TCMBANKGE013389,SPIRE2,Spir-2,spire type actin nucleation factor 2,16q24.3,protein-coding,/
CWITA013390,TCMBANKGE013390,CASP2,CASP-2; ICH1; NEDD-2; NEDD2; PPP1R57,caspase 2,7q34,protein-coding,Clinical Trial target
CWITA013391,TCMBANKGE013391,GMNN,Gem; MGORS6,geminin DNA replication inhibitor,6p22.3,protein-coding,Research target
CWITA013392,TCMBANKGE013392,BOC,CDON2,"BOC cell adhesion associated, oncogene regulated",3q13.2,protein-coding,/
CWITA013393,TCMBANKGE013393,PDCD1LG2,B7DC; Btdc; CD273; PD-L2; PDCD1L2; PDL2; bA574F11.2,programmed cell death 1 ligand 2,9p24.1,protein-coding,Patented target
CWITA013394,TCMBANKGE013394,ERGIC2,CDA14; Erv41; PTX1; cd002,ERGIC and golgi 2,12p11.22,protein-coding,/
CWITA013395,TCMBANKGE013395,DNAJC5,CLN4; CLN4B; CSP; DNAJC5A; NCL; mir-941-2; mir-941-3; mir-941-4; mir-941-5,DnaJ heat shock protein family (Hsp40) member C5,20q13.33,protein-coding,/
CWITA013396,TCMBANKGE013396,CHGA,CGA,chromogranin A,14q32.12,protein-coding,/
CWITA013397,TCMBANKGE013397,GATAD2A,p66alpha,GATA zinc finger domain containing 2A,19p13.11,protein-coding,/
CWITA013398,TCMBANKGE013398,B3GNTL1,3-Gn-T8; B3GNT8; BGnT-8; beta-1; beta3Gn-T8; beta3GnTL1,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1",17q25.3,protein-coding,/
CWITA013399,TCMBANKGE013399,ALDH3A1,ALDH3; ALDHIII; MGC10406,"aldehyde dehydrogenase 3 family, member A1",17p11.2,protein-coding,
CWITA013400,TCMBANKGE013400,COX5A,COX; COX-VA; VA,cytochrome c oxidase subunit 5A,15q24.2,protein-coding,/
CWITA013401,TCMBANKGE013401,NR2F6,EAR-2; EAR2; ERBAL2,nuclear receptor subfamily 2 group F member 6,19p13.11,protein-coding,/
CWITA013402,TCMBANKGE013402,FNDC4,FRCP1,fibronectin type III domain containing 4,2p23.3,protein-coding,/
CWITA013403,TCMBANKGE013403,EPHB3,EK2; ETK2; HEK2; TYRO6,EPH receptor B3,3q27.1,protein-coding,Research target
CWITA013404,TCMBANKGE013404,XRCC3,CMM6,X-ray repair cross complementing 3,14q32.33,protein-coding,/
CWITA013405,TCMBANKGE013405,SPZ1,CILD38; NYD-TSP1; PPP1R148,spermatogenic leucine zipper 1,5q14.1,protein-coding,/
CWITA013406,TCMBANKGE013406,VAMP1,CMS25; SPAX1; SYB1; VAMP-1,vesicle associated membrane protein 1,12p13.31,protein-coding,/
CWITA013407,TCMBANKGE013407,VCPIP1,DUBA3; VCIP135,valosin containing protein interacting protein 1,8q13.1,protein-coding,/
CWITA013408,TCMBANKGE013408,MACROH2A2,H2AFY2,macroH2A.2 histone,10q22.1,protein-coding,/
CWITA013409,TCMBANKGE013409,GSR,GR; GSRD; HEL-75; HEL-S-122m,glutathione-disulfide reductase,8p12,protein-coding,Patented target
CWITA013410,TCMBANKGE013410,DUSP19,DUSP17; LMWDSP3; SKRP1; TS-DSP1,dual specificity phosphatase 19,2q32.1,protein-coding,/
CWITA013411,TCMBANKGE013411,IFI30,GILT; IFI-30; IP-30; IP30,IFI30 lysosomal thiol reductase,19p13.11,protein-coding,/
CWITA013412,TCMBANKGE013412,C7orf25,-,chromosome 7 open reading frame 25,7p14.1,protein-coding,/
CWITA013413,TCMBANKGE013413,TAPBP,NGS17; TAPA; TPN; TPSN,TAP binding protein,6p21.32,protein-coding,/
CWITA013414,TCMBANKGE013414,KDM3B,5qNCA; C5orf7; DIJOS; JMJD1B; NET22,lysine demethylase 3B,5q31.2,protein-coding,/
CWITA013415,TCMBANKGE013415,FRMPD2,PDZD5C; PDZK4; PDZK5C,FERM and PDZ domain containing 2,10q11.22,protein-coding,/
CWITA013416,TCMBANKGE013416,PRSS2,MGC111183; MGC120174; MGC120175; TRY2; TRY8; TRYP2,"protease, serine, 2 (trypsin 2)",7q34,protein-coding,
CWITA013417,TCMBANKGE013417,KLHL2,ABP-KELCH; MAV; MAYVEN,kelch like family member 2,4q32.3,protein-coding,/
CWITA013418,TCMBANKGE013418,ZBTB37,D430004I08Rik; ZNF908,zinc finger and BTB domain containing 37,1q25.1,protein-coding,/
CWITA013419,TCMBANKGE013419,TARS2,FLJ12528; TARSL1,"threonyl-tRNA synthetase 2, mitochondrial (putative)",1q21.3,protein-coding,
CWITA013420,TCMBANKGE013420,H2AC14,H2A/E; H2AFE; HIST1H2AJ; dJ160A22.4,H2A clustered histone 14,6p22.1,protein-coding,/
CWITA013421,TCMBANKGE013421,ARHGEF10,GEF10; SNCV,Rho guanine nucleotide exchange factor 10,8p23.3,protein-coding,/
CWITA013422,TCMBANKGE013422,CD109,CPAMD7; p180; r150,CD109 molecule,6q13,protein-coding,/
CWITA013423,TCMBANKGE013423,IDO2,INDOL1,"indoleamine 2,3-dioxygenase 2",8p11.21,protein-coding,Patented target
CWITA013424,TCMBANKGE013424,LCT,LAC; LPH; LPH1,lactase,2q21.3,protein-coding,Research target
CWITA013425,TCMBANKGE013425,AP1S2,DC22; MRX59; MRXS21; MRXS5; MRXSF; PGS; SIGMA1B,adaptor related protein complex 1 subunit sigma 2,Xp22.2,protein-coding,/
CWITA013426,TCMBANKGE013426,AKR1B1,ADR; ALDR1; ALR2; AR; MGC1804,"aldo-keto reductase family 1, member B1 (aldose reductase)",7q35,protein-coding,
CWITA013427,TCMBANKGE013427,THADA,ARMC13; GITA,THADA armadillo repeat containing,2p21,protein-coding,/
CWITA013428,TCMBANKGE013428,ALOX15B,15-LOX-2,arachidonate 15-lipoxygenase type B,17p13.1,protein-coding,/
CWITA013429,TCMBANKGE013429,SEMA6D,-,semaphorin 6D,15q21.1,protein-coding,/
CWITA013430,TCMBANKGE013430,MAD2L1,HSMAD2; MAD2,mitotic arrest deficient 2 like 1,4q27,protein-coding,/
CWITA013431,TCMBANKGE013431,UBE2L3,E2-F1; L-UBC; UBCH7; UbcM4,ubiquitin conjugating enzyme E2 L3,22q11.21,protein-coding,/
CWITA013432,TCMBANKGE013432,TRIM33,ECTO; PTC7; RFG7; TF1G; TIF1G; TIF1GAMMA; TIFGAMMA,tripartite motif containing 33,1p13.2,protein-coding,/
CWITA013433,TCMBANKGE013433,FLII,FLI; FLIL; Fli1,FLII actin remodeling protein,17p11.2,protein-coding,/
CWITA013434,TCMBANKGE013434,TRIML2,SPRYD6,tripartite motif family like 2,4q35.2,protein-coding,/
CWITA013435,TCMBANKGE013435,PECR,DCRRP; HPDHASE; HSA250303; PVIARL; SDR29C1; TERP,peroxisomal trans-2-enoyl-CoA reductase,2q35,protein-coding,
CWITA013436,TCMBANKGE013436,SLC4A7,NBC2; NBC3; NBCN1; SBC2; SLC4A6,solute carrier family 4 member 7,3p24.1,protein-coding,/
CWITA013437,TCMBANKGE013437,CREBL2,-,cAMP responsive element binding protein like 2,12p13.1,protein-coding,/
CWITA013438,TCMBANKGE013438,EGLN2,DKFZp434E026; EIT6; FLJ95603; HIFNPH1; HIFPH1; HPHN1; HPHN3; PHD1,egl nine homolog 2 (C. elegans),19q13.2,protein-coding,
CWITA013439,TCMBANKGE013439,RBCK1,C20orf18; HOIL-1; HOIL1; PBMEI; PGBM1; RBCK2; RNF54; UBCE7IP3; XAP3; XAP4; ZRANB4,RANBP2-type and C3HC4-type zinc finger containing 1,20p13,protein-coding,Research target
CWITA013440,TCMBANKGE013440,FCER1A,FCE1A; FcERI,Fc fragment of IgE receptor Ia,1q23.2,protein-coding,/
CWITA013441,TCMBANKGE013441,SUB1,P15; PC4; p14,SUB1 regulator of transcription,5p13.3,protein-coding,/
CWITA013442,TCMBANKGE013442,ITLN1,HL-1; HL1; INTL; ITLN; LFR; hIntL; omentin,intelectin 1,1q23.3,protein-coding,/
CWITA013443,TCMBANKGE013443,ZNF541,-,zinc finger protein 541,19q13.33,protein-coding,/
CWITA013444,TCMBANKGE013444,XPNPEP3,APP3; ICP55; NPHPL1,X-prolyl aminopeptidase 3,22q13.2,protein-coding,/
CWITA013445,TCMBANKGE013445,RFPL4B,RNF211,ret finger protein like 4B,6q21,protein-coding,/
CWITA013446,TCMBANKGE013446,CYB5A,CYB5; MCB5; METAG,cytochrome b5 type A,18q22.3,protein-coding,/
CWITA013447,TCMBANKGE013447,SNRNP25,C16orf33,small nuclear ribonucleoprotein U11/U12 subunit 25,16p13.3,protein-coding,/
CWITA013448,TCMBANKGE013448,C1GALT1,C1GALT; T-synthase,"core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1",7p22.1-p21.3,protein-coding,/
CWITA013449,TCMBANKGE013449,ARSB,ASB; G4S; MPS6,arylsulfatase B,5q14.1,protein-coding,Successful target
CWITA013450,TCMBANKGE013450,PIH1D2,-,PIH1 domain containing 2,11q23.1,protein-coding,/
CWITA013451,TCMBANKGE013451,OGFOD2,DKFZp686H15154; FLJ13491; FLJ37501; MGC120434; MGC120436,2-oxoglutarate and iron-dependent oxygenase domain containing 2,12q24.31,protein-coding,
CWITA013452,TCMBANKGE013452,FKBP9,FKBP60; FKBP63; PPIase,FKBP prolyl isomerase 9,7p14.3,protein-coding,/
CWITA013453,TCMBANKGE013453,WDR53,-,WD repeat domain 53,3q29,protein-coding,/
CWITA013454,TCMBANKGE013454,IQGAP1,HUMORFA01; SAR1; p195,IQ motif containing GTPase activating protein 1,15q26.1,protein-coding,/
CWITA013455,TCMBANKGE013455,ICOSLG,B7-H2; B7H2; B7RP-1; B7RP1; B7h; CD275; GL50; ICOS-L; ICOSL; LICOS,inducible T cell costimulator ligand,21q22.3,protein-coding,Clinical Trial target
CWITA013456,TCMBANKGE013456,ACAP2,CENTB2; CNT-B2,"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2",3q29,protein-coding,/
CWITA013457,TCMBANKGE013457,SNRNP35,HM-1; U1SNRNPBP,small nuclear ribonucleoprotein U11/U12 subunit 35,12q24.31,protein-coding,/
CWITA013458,TCMBANKGE013458,RHOT1,ARHT1; MIRO-1; MIRO1,ras homolog family member T1,17q11.2,protein-coding,/
CWITA013459,TCMBANKGE013459,IQCK,-,IQ motif containing K,16p12.3,protein-coding,/
CWITA013460,TCMBANKGE013460,SYT9,-,synaptotagmin 9,11p15.4,protein-coding,/
CWITA013461,TCMBANKGE013461,ANO3,C11orf25; DYT23; DYT24; GENX-3947; TMEM16C,anoctamin 3,11p14.3-p14.2,protein-coding,/
CWITA013462,TCMBANKGE013462,EEF1G,EF1G; GIG35,eukaryotic translation elongation factor 1 gamma,11q12.3,protein-coding,/
CWITA013463,TCMBANKGE013463,PLA2G4A,MGC126350; PLA2G4; cPLA2Nalpha,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",1q25,protein-coding,
CWITA013464,TCMBANKGE013464,DHDH,2DD; HUM2DD,dihydrodiol dehydrogenase,19q13.33,protein-coding,/
CWITA013465,TCMBANKGE013465,NPIPA1,NPIP; NPIPA; morpheus,nuclear pore complex interacting protein family member A1,16p13.11,protein-coding,/
CWITA013466,TCMBANKGE013466,MOSPD1,DJ473B4,motile sperm domain containing 1,Xq26.3,protein-coding,/
CWITA013467,TCMBANKGE013467,HTR3C,N,"5-hydroxytryptamine (serotonin) receptor 3, family member C",3q27.1,protein-coding,
CWITA013468,TCMBANKGE013468,NMBR,BB1; BB1R; NMB-R,neuromedin B receptor,6q24.1,protein-coding,/
CWITA013469,TCMBANKGE013469,FOXP2,CAGH44; SPCH1; TNRC10,forkhead box P2,7q31.1,protein-coding,/
CWITA013470,TCMBANKGE013470,F12,HAE3; HAEX; HAF,coagulation factor XII (Hageman factor),5q33-qter,protein-coding,
CWITA013471,TCMBANKGE013471,SERPINB9,CAPN3; CAP3; PI9,"serpin peptidase inhibitor, clade B (ovalbumin), member 9",6p25,protein-coding,
CWITA013472,TCMBANKGE013472,DKK2,DKK-2,dickkopf WNT signaling pathway inhibitor 2,4q25,protein-coding,Research target
CWITA013473,TCMBANKGE013473,F2R,CF2R; HTR; PAR-1; PAR1; TR,coagulation factor II thrombin receptor,5q13.3,protein-coding,Successful target
CWITA013474,TCMBANKGE013474,KIAA1191,p33MONOX; p60MONOX,KIAA1191,5q35.2,protein-coding,/
CWITA013475,TCMBANKGE013475,CFAP100,CCDC37; MIA1,cilia and flagella associated protein 100,3q21.3,protein-coding,/
CWITA013476,TCMBANKGE013476,MTMR4,FYVE-DSP2; ZFYVE11,myotubularin related protein 4,17q22,protein-coding,/
CWITA013477,TCMBANKGE013477,ABL1,ABL; JTK7; bcr/abl; cNABL; p150; vNabl,"c-abl oncogene 1, non-receptor tyrosine kinase",9q34.1,protein-coding,
CWITA013478,TCMBANKGE013478,RAET1E,LETAL; N2DL-4; NKG2DL4; RAET1E2; RL-4; ULBP4; bA350J20.7,retinoic acid early transcript 1E,6q25.1,protein-coding,/
CWITA013479,TCMBANKGE013479,TSPYL1,TSPYL,TSPY like 1,6q22.1,protein-coding,/
CWITA013480,TCMBANKGE013480,NEIL1,FPG1; NEI1; hFPG1,nei like DNA glycosylase 1,15q24.2,protein-coding,/
CWITA013481,TCMBANKGE013481,SERPINI2,MEPI; PANCPIN; PI14; TSA2004,serpin family I member 2,3q26.1,protein-coding,Research target
CWITA013482,TCMBANKGE013482,ADGRD2,GPR144; PGR24,adhesion G protein-coupled receptor D2,9q33.3,protein-coding,/
CWITA013483,TCMBANKGE013483,TNFSF13,APRIL; CD256; TALL-2; TALL2; TNLG7B; TRDL-1; UNQ383/PRO715; ZTNF2,TNF superfamily member 13,17p13.1,protein-coding,Clinical Trial target
CWITA013484,TCMBANKGE013484,UTP11,CGI-94; CGI94; UTP11L,UTP11 small subunit processome component,1p34.3,protein-coding,/
CWITA013485,TCMBANKGE013485,STK32B,HSA250839; STK32; STKG6; YANK2,serine/threonine kinase 32B,4p16.2,protein-coding,Research target
CWITA013486,TCMBANKGE013486,ASB4,ASB-4,ankyrin repeat and SOCS box containing 4,7q21.3,protein-coding,/
CWITA013487,TCMBANKGE013487,AKR1B10,AKR1B11; AKR1B12; ALDRLn; ARLN1; ARL1; HIS; HSI; MGC14103,"aldo-keto reductase family 1, member B10 (aldose reductase)",7q33,protein-coding,
CWITA013488,TCMBANKGE013488,SYNE1,8B; AMCM; ARCA1; C6orf98; CPG2; EDMD4; KASH1; MYNE1; Nesp1; SCAR8; dJ45H2.2,spectrin repeat containing nuclear envelope protein 1,6q25.2,protein-coding,/
CWITA013489,TCMBANKGE013489,SEMA7A,CD108; CDw108; H-SEMA-K1; H-Sema-L; JMH; SEMAK1; SEMAL,semaphorin 7A (John Milton Hagen blood group),15q24.1,protein-coding,/
CWITA013490,TCMBANKGE013490,SPOPL,BTBD33,speckle type BTB/POZ protein like,2q22.1,protein-coding,/
CWITA013491,TCMBANKGE013491,RHOXF2,CT107; PEPP-2; PEPP2; THG1,Rhox homeobox family member 2,Xq24,protein-coding,/
CWITA013492,TCMBANKGE013492,ZNF333,-,zinc finger protein 333,19p13.12,protein-coding,/
CWITA013493,TCMBANKGE013493,ABI1,ABI-1; ABLBP4; E3B1; NAP1BP; SSH3BP; SSH3BP1,abl interactor 1,10p12.1,protein-coding,/
CWITA013494,TCMBANKGE013494,SLC22A8,OAT3,solute carrier family 22 member 8,11q12.3,protein-coding,Successful target
CWITA013495,TCMBANKGE013495,SAFB,HAP; HET; SAB-B1; SAF-B; SAF-B1; SAFB1,scaffold attachment factor B,19p13.3,protein-coding,/
CWITA013496,TCMBANKGE013496,BMP2K,BIKE; HRIHFB2017,BMP2 inducible kinase,4q21.21,protein-coding,Research target
CWITA013497,TCMBANKGE013497,MLEC,KIAA0152,malectin,12q24.31,protein-coding,/
CWITA013498,TCMBANKGE013498,FGF2,BFGF; FGFB; HBGFN2,fibroblast growth factor 2 (basic),4q26,protein-coding,
CWITA013499,TCMBANKGE013499,PFDN5,MM-1; MM1; PFD5,prefoldin subunit 5,12q13.13,protein-coding,/
CWITA013500,TCMBANKGE013500,ECHS1,ECHS1D; SCEH,"enoyl-CoA hydratase, short chain 1",10q26.3,protein-coding,/
CWITA013501,TCMBANKGE013501,CRYZL1,4P11; QOH-1,crystallin zeta like 1,21q22.11,protein-coding,/
CWITA013502,TCMBANKGE013502,EFNA1,B61; ECKLG; EFL1; EPLG1; LERK-1; LERK1; TNFAIP4,Ephrin_A1,1q22,protein-coding,
CWITA013503,TCMBANKGE013503,PURA,PURNALPHA; PUR1; PURALPHA,purine-rich element binding protein A,5q31,protein-coding,
CWITA013504,TCMBANKGE013504,RXRG,NR2B3; RXRC,retinoid X receptor gamma,1q23.3,protein-coding,Successful target
CWITA013505,TCMBANKGE013505,NOSTRIN,DaIP2,nitric oxide synthase trafficking,2q24.3,protein-coding,/
CWITA013506,TCMBANKGE013506,CLCN5,CLC5; CLCK2; ClC-5; DENTS; NPHL1; NPHL2; XLRH; XRN; hCIC-K2,chloride voltage-gated channel 5,Xp11.23,protein-coding,/
CWITA013507,TCMBANKGE013507,ZNF676,-,zinc finger protein 676,19p12,protein-coding,/
CWITA013508,TCMBANKGE013508,IFNA21,IFN-alphaI; LeIF F; leIF-F,interferon alpha 21,9p21.3,protein-coding,/
CWITA013509,TCMBANKGE013509,LGR4,BNMD17; GPR48,leucine rich repeat containing G protein-coupled receptor 4,11p14.1,protein-coding,/
CWITA013510,TCMBANKGE013510,KLK4,AI2A1; ARM1; EMSP; EMSP1; KLK-L1; PRSS17; PSTS; kallikrein,kallikrein related peptidase 4,19q13.41,protein-coding,Patented target
CWITA013511,TCMBANKGE013511,BEND3,KIAA1553,BEN domain containing 3,6q21,protein-coding,/
CWITA013512,TCMBANKGE013512,MYLK2,KMLC; MLCK; MLCK2; skMLCK,myosin light chain kinase 2,20q11.21,protein-coding,Research target
CWITA013513,TCMBANKGE013513,F2,PT,coagulation factor II (thrombin),11p11,protein-coding,
CWITA013514,TCMBANKGE013514,ACTA1,ACTA; ASMA; CFTD; CFTD1; CFTDM; MPFD; NEM1; NEM2; NEM3; SHPM,"actin alpha 1, skeletal muscle",1q42.13,protein-coding,/
CWITA013515,TCMBANKGE013515,ARG2,N,"arginase, type II",14q24.1,protein-coding,
CWITA013516,TCMBANKGE013516,GBA,GBA1; GCB; GLUC,"glucosidase, beta, acid",1q21,protein-coding,
CWITA013517,TCMBANKGE013517,YTHDC2,CAHL; hYTHDC2,YTH domain containing 2,5q22.2,protein-coding,/
CWITA013518,TCMBANKGE013518,SLC38A1,ATA1; NAT2; SAT1; SNAT1,solute carrier family 38 member 1,12q13.11,protein-coding,Research target
CWITA013519,TCMBANKGE013519,CENPW,C6orf173; CENP-W; CUG2,centromere protein W,6q22.32,protein-coding,/
CWITA013520,TCMBANKGE013520,NPPC,CNP; CNP2,natriuretic peptide C,2q37.1,protein-coding,Clinical Trial target
CWITA013521,TCMBANKGE013521,GRIN1,NMDA1; NMDAR1; NR1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",9q34.3,protein-coding,
CWITA013522,TCMBANKGE013522,PRMT7,SBIDDS,protein arginine methyltransferase 7,16q22.1,protein-coding,Research target
CWITA013523,TCMBANKGE013523,ENG,END; HHT1; ORW1,endoglin,9q34.11,protein-coding,Clinical Trial target
CWITA013524,TCMBANKGE013524,SOWAHC,ANKRD57; C2orf26,sosondowah ankyrin repeat domain family member C,2q13,protein-coding,/
CWITA013525,TCMBANKGE013525,GNB1L,DGCRK3; FKSG1; GY2; WDR14; WDVCF,G protein subunit beta 1 like,22q11.21,protein-coding,/
CWITA013526,TCMBANKGE013526,DDX50,GU2; GUB; RH-II/GuB; mcdrh,DExD-box helicase 50,10q22.1,protein-coding,/
CWITA013527,TCMBANKGE013527,AKT3,MPPH; MPPH2; PKB-GAMMA; PKBG; PRKBG; RAC-PK-gamma; RAC-gamma; STK-2,AKT serine/threonine kinase 3,1q43-q44,protein-coding,Research target
CWITA013528,TCMBANKGE013528,DERL1,DER-1; DER1; derlin-1,derlin 1,8q24.13,protein-coding,/
CWITA013529,TCMBANKGE013529,CCDC90B,MDS011; MDS025,coiled-coil domain containing 90B,11q14.1,protein-coding,/
CWITA013530,TCMBANKGE013530,OSER1,C20orf111; HSPC207; Osr1; Perit1; dJ1183I21.1,oxidative stress responsive serine rich 1,20q13.12,protein-coding,/
CWITA013531,TCMBANKGE013531,ARL10,ARL10A,ADP ribosylation factor like GTPase 10,5q35.2,protein-coding,/
CWITA013532,TCMBANKGE013532,GOT2,FLJ40994; KAT4; KATIV; mitAAT,"glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)",16q21,protein-coding,
CWITA013533,TCMBANKGE013533,RPAP3,Tah1; hSpagh,RNA polymerase II associated protein 3,12q13.11,protein-coding,/
CWITA013534,TCMBANKGE013534,S100B,NEF; S100; S100NB; S100beta,S100 calcium binding protein B,21q22.3,protein-coding,
CWITA013535,TCMBANKGE013535,OSBPL7,ORP7,oxysterol binding protein like 7,17q21.32,protein-coding,/
CWITA013536,TCMBANKGE013536,KLF7,UKLF,Kruppel like factor 7,2q33.3,protein-coding,/
CWITA013537,TCMBANKGE013537,PIM1,PIM,pim-1 oncogene,6p21.2,protein-coding,
CWITA013538,TCMBANKGE013538,KLHL20,KHLHX; KLEIP; KLHLX,kelch like family member 20,1q25.1,protein-coding,/
CWITA013539,TCMBANKGE013539,CCDC86,-,coiled-coil domain containing 86,11q12.2,protein-coding,/
CWITA013540,TCMBANKGE013540,REEP3,C10orf74; Yip2b,receptor accessory protein 3,10q21.3,protein-coding,/
CWITA013541,TCMBANKGE013541,SLC35E1,-,solute carrier family 35 member E1,19p13.11,protein-coding,/
CWITA013542,TCMBANKGE013542,GLRA2,GLR,"glycine receptor, alpha 2",Xp22.1-p21.3,protein-coding,
CWITA013543,TCMBANKGE013543,HSD17B3,EDH17B3; SDR12C2,hydroxysteroid (17-beta) dehydrogenase 3,9q22,protein-coding,
CWITA013544,TCMBANKGE013544,UCMA,C10orf49; GRP; GRP/UCMA,upper zone of growth plate and cartilage matrix associated,10p13,protein-coding,/
CWITA013545,TCMBANKGE013545,DHPS,DHS; DS; MIG13,deoxyhypusine synthase,19p13,protein-coding,
CWITA013546,TCMBANKGE013546,SLC4A1AP,HLC3,solute carrier family 4 member 1 adaptor protein,2p23.3,protein-coding,/
CWITA013547,TCMBANKGE013547,SH3RF2,HEPP1; POSHER; PPP1R39; RNF158,SH3 domain containing ring finger 2,5q32,protein-coding,/
CWITA013548,TCMBANKGE013548,SLC6A18,Xtrp2,solute carrier family 6 member 18,5p15.33,protein-coding,/
CWITA013549,TCMBANKGE013549,MFAP2,MAGP; MAGP-1; MAGP1,microfibril associated protein 2,1p36.13,protein-coding,/
CWITA013550,TCMBANKGE013550,NDUFS1,CI-75Kd; CI-75k; MC1DN5; PRO1304,NADH:ubiquinone oxidoreductase core subunit S1,2q33.3,protein-coding,/
CWITA013551,TCMBANKGE013551,GSPT1,551G9.2; ETF3A; GST1; eRF3a,G1 to S phase transition 1,16p13.13,protein-coding,/
CWITA013552,TCMBANKGE013552,ATP1B3,ATPB-3; CD298,ATPase Na+/K+ transporting subunit beta 3,3q23,protein-coding,/
CWITA013553,TCMBANKGE013553,DNASE1,DNL1; DRNI,deoxyribonuclease 1,16p13.3,protein-coding,Research target
CWITA013554,TCMBANKGE013554,RTN4RL1,NGRH2; NgR3,reticulon 4 receptor like 1,17p13.3,protein-coding,/
CWITA013555,TCMBANKGE013555,MRPL13,L13; L13A; L13mt; RPL13; RPML13,mitochondrial ribosomal protein L13,8q24.12,protein-coding,/
CWITA013556,TCMBANKGE013556,ZNF136,pHZ-20,zinc finger protein 136,19p13.2,protein-coding,/
CWITA013557,TCMBANKGE013557,TXLNA,IL14; TXLN,taxilin alpha,1p35.2,protein-coding,/
CWITA013558,TCMBANKGE013558,TP53INP2,C20orf110; DOR; PIG-U; PIGU; PINH; dJ1181N3.1,tumor protein p53 inducible nuclear protein 2,20q11.22,protein-coding,/
CWITA013559,TCMBANKGE013559,ANKK1,PKK2; sgK288,ankyrin repeat and kinase domain containing 1,11q23.2,protein-coding,/
CWITA013560,TCMBANKGE013560,ZNF789,-,zinc finger protein 789,7q22.1,protein-coding,/
CWITA013561,TCMBANKGE013561,ACIN1,ACINUS; ACN; fSAP152,apoptotic chromatin condensation inducer 1,14q11.2,protein-coding,/
CWITA013562,TCMBANKGE013562,FAM133A,CT115,family with sequence similarity 133 member A,Xq21.32,protein-coding,/
CWITA013563,TCMBANKGE013563,SERPINA11,-,serpin family A member 11,14q32.13,protein-coding,/
CWITA013564,TCMBANKGE013564,PYY,PYY-I; PYY1,peptide YY,17q21.31,protein-coding,Clinical Trial target
CWITA013565,TCMBANKGE013565,CHCHD10,C22orf16; FTDALS2; IMMD; MIX17A; N27C7-4; SMAJ,coiled-coil-helix-coiled-coil-helix domain containing 10,22q11.23,protein-coding,/
CWITA013566,TCMBANKGE013566,GLUD2,GDH2; GLUDP1,glutamate dehydrogenase 2,Xq24,protein-coding,/
CWITA013567,TCMBANKGE013567,SLC12A6,ACCPN; KCC3; KCC3A; KCC3B,solute carrier family 12 member 6,15q14,protein-coding,Research target
CWITA013568,TCMBANKGE013568,ZNF667,MIPU1,zinc finger protein 667,19q13.43,protein-coding,/
CWITA013569,TCMBANKGE013569,GNPTAB,GNPTA; ICD,N-acetylglucosamine-1-phosphate transferase subunits alpha and beta,12q23.2,protein-coding,/
CWITA013570,TCMBANKGE013570,CELA3A,ELA3; ELA3A,chymotrypsin like elastase 3A,1p36.12,protein-coding,/
CWITA013571,TCMBANKGE013571,CELSR3,ADGRC3; CDHF11; EGFL1; FMI1; HFMI1; MEGF2; RESDA1,cadherin EGF LAG seven-pass G-type receptor 3,3p21.31,protein-coding,/
CWITA013572,TCMBANKGE013572,HOXA10,HOX1; HOX1.8; HOX1H; MGC12859; PL,homeobox A10,7p15.2,protein-coding,
CWITA013573,TCMBANKGE013573,SNRK,HSNFRK,SNF related kinase,3p22.1,protein-coding,/
CWITA013574,TCMBANKGE013574,PLAA,DOA1; NDMSBA; PLA2P; PLAP,phospholipase A2 activating protein,9p21.2,protein-coding,/
CWITA013575,TCMBANKGE013575,RASSF6,-,Ras association domain family member 6,4q13.3,protein-coding,/
CWITA013576,TCMBANKGE013576,HSPA13,STCH,heat shock protein family A (Hsp70) member 13,21q11.2,protein-coding,/
CWITA013577,TCMBANKGE013577,MSH5,G7; MUTSH5; NG23; POF13,mutS homolog 5,6p21.33,protein-coding,/
CWITA013578,TCMBANKGE013578,SLC19A3,THTR2,"solute carrier family 19, member 3",2q37,protein-coding,
CWITA013579,TCMBANKGE013579,ZC3H7A,HSPC055; ZC3H7; ZC3HDC7,zinc finger CCCH-type containing 7A,16p13.13,protein-coding,/
CWITA013580,TCMBANKGE013580,SH3GLB2,PP6569; PP9455; RRIG1,"SH3 domain containing GRB2 like, endophilin B2",9q34.11,protein-coding,/
CWITA013581,TCMBANKGE013581,TNNC1,CMD1Z; CMH13; TNNC; TNC; TNNC,troponin C type 1 (slow),3p21.1,protein-coding,
CWITA013582,TCMBANKGE013582,SOD3,EC-SOD,superoxide dismutase 3,4p15.2,protein-coding,/
CWITA013583,TCMBANKGE013583,SMARCD2,BAF60B; CRACD2; PRO2451; Rsc6p; SGD2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2",17q23.3,protein-coding,/
CWITA013584,TCMBANKGE013584,GDAP1L1,dJ881L22.1; dJ995J12.1.1,ganglioside induced differentiation associated protein 1 like 1,20q13.12,protein-coding,/
CWITA013585,TCMBANKGE013585,EVC2,LBN; WAD,EvC ciliary complex subunit 2,4p16.2,protein-coding,/
CWITA013586,TCMBANKGE013586,PASK,PASKIN; STK37,PAS domain containing serine/threonine kinase,2q37.3,protein-coding,Research target
CWITA013587,TCMBANKGE013587,TMEM121B,CECR6,transmembrane protein 121B,22q11.1,protein-coding,/
CWITA013588,TCMBANKGE013588,KCNG3,KV10.1; KV6.3,potassium voltage-gated channel modifier subfamily G member 3,2p21,protein-coding,/
CWITA013589,TCMBANKGE013589,LRIG3,LIG3,leucine rich repeats and immunoglobulin like domains 3,12q14.1,protein-coding,/
CWITA013590,TCMBANKGE013590,TALDO1,TAL; TAL-H; TALDOR; TALH,transaldolase 1,11p15.5,protein-coding,/
CWITA013591,TCMBANKGE013591,PNOC,N/OFQ; NOP; OFQ; PPNOC; ppN/OFQ,prepronociceptin,8p21.1,protein-coding,/
CWITA013592,TCMBANKGE013592,MRPL33,C2orf1; L33mt; MRP-L33; RPL33L,mitochondrial ribosomal protein L33,2p23.2,protein-coding,/
CWITA013593,TCMBANKGE013593,DCAF11,GL014; PRO2389; WDR23,DDB1 and CUL4 associated factor 11,14q12,protein-coding,/
CWITA013594,TCMBANKGE013594,KCNJ13,KIR1.4; KIR7.1; LCA16; SVD,potassium inwardly rectifying channel subfamily J member 13,2q37.1,protein-coding,/
CWITA013595,TCMBANKGE013595,FCGR1A,CD64; CD64A; FCRI; FLJ18345; IGFR1,"Fc fragment of IgG, high affinity Ia, receptor (CD64)",1q21.2-q21.3,protein-coding,
CWITA013596,TCMBANKGE013596,HPR,A-259H10.2; HP,haptoglobin-related protein,16q22.2,protein-coding,/
CWITA013597,TCMBANKGE013597,TANGO2,C22orf25; MECRCN,transport and golgi organization 2 homolog,22q11.21,protein-coding,/
CWITA013598,TCMBANKGE013598,CASD1,C7orf12; NBLA04196; SOAT,CAS1 domain containing 1,7q21.3,protein-coding,/
CWITA013599,TCMBANKGE013599,ARGLU1,-,arginine and glutamate rich 1,13q33.3,protein-coding,/
CWITA013600,TCMBANKGE013600,DEFB4A,BD-2; DEFB-2; DEFB102; DEFB2; DEFB4; HBD-2; SAP1,defensin beta 4A,8p23.1,protein-coding,Research target
CWITA013601,TCMBANKGE013601,ZNF557,-,zinc finger protein 557,19p13.2,protein-coding,/
CWITA013602,TCMBANKGE013602,MTMR9,C8orf9; LIP-STYX; MTMR8,myotubularin related protein 9,8p23.1,protein-coding,/
CWITA013603,TCMBANKGE013603,GSTZ1,GSTZ1N1; MAAI; MAI; MGC2029,glutathione transferase zeta 1,14q24.3,protein-coding,
CWITA013604,TCMBANKGE013604,PLOD2,BRKS2; LH2; TLH,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",3q24,protein-coding,/
CWITA013605,TCMBANKGE013605,KLHL24,DRE1; EBSSH; KRIP6,kelch like family member 24,3q27.1,protein-coding,/
CWITA013606,TCMBANKGE013606,SH3BGRL,HEL-S-115; SH3BGR,SH3 domain binding glutamate rich protein like,Xq21.1,protein-coding,/
CWITA013607,TCMBANKGE013607,SLC16A5,MCT5; MCT6,solute carrier family 16 member 5,17q25.1,protein-coding,/
CWITA013608,TCMBANKGE013608,PRCP,HUMPCP; PCP,Prolylcarboxypeptidase,11q14.1,protein-coding,
CWITA013609,TCMBANKGE013609,ANAPC16,APC16; C10orf104; CENP-27; MSAG; bA570G20.3,anaphase promoting complex subunit 16,10q22.1,protein-coding,/
CWITA013610,TCMBANKGE013610,RTF1,GTL7; KIAA0252,"RTF1 homolog, Paf1/RNA polymerase II complex component",15q15.1,protein-coding,/
CWITA013611,TCMBANKGE013611,DDAH1,DDAH; DDAH-1; DDAHI; HEL-S-16,dimethylarginine dimethylaminohydrolase 1,1p22.3,protein-coding,/
CWITA013612,TCMBANKGE013612,RHOXF2B,-,Rhox homeobox family member 2B,Xq24,protein-coding,/
CWITA013613,TCMBANKGE013613,DNAJC27,RBJ; RabJS,DnaJ heat shock protein family (Hsp40) member C27,2p23.3,protein-coding,/
CWITA013614,TCMBANKGE013614,EMC6,RAB5IFL; TMEM93,ER membrane protein complex subunit 6,17p13.2,protein-coding,/
CWITA013615,TCMBANKGE013615,NOS3,ECNOS; eNOS,nitric oxide synthase 3 (endothelial cell),7q36,protein-coding,
CWITA013616,TCMBANKGE013616,CACNA1A,APCA; CACNL1A4; CAV2.1; EA2; FHM; HPCA; MHP; MHP1; SCA6,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",19p13,protein-coding,
CWITA013617,TCMBANKGE013617,GTPBP4,CRFG; NGB; NOG1,GTP binding protein 4,10p15.3,protein-coding,/
CWITA013618,TCMBANKGE013618,SIRPA,BIT; CD172A; MFR; MYD-1; P84; PTPNS1; SHPS1; SIRP,signal regulatory protein alpha,20p13,protein-coding,/
CWITA013619,TCMBANKGE013619,MRPL15,HSPC145; L15mt; MRP-L15; MRP-L7; RPML7,mitochondrial ribosomal protein L15,8q11.23,protein-coding,/
CWITA013620,TCMBANKGE013620,USP21,USP16; USP23,ubiquitin specific peptidase 21,1q23.3,protein-coding,/
CWITA013621,TCMBANKGE013621,SUCNR1,GPR91,succinate receptor 1,3q25.1,protein-coding,Research target
CWITA013622,TCMBANKGE013622,GADL1,MGC138191,glutamate decarboxylase-like 1,3p24.1-p23,protein-coding,
CWITA013623,TCMBANKGE013623,UBE2D3,E2(17)KB3; UBC4/5; UBCH5C,ubiquitin conjugating enzyme E2 D3,4q24,protein-coding,/
CWITA013624,TCMBANKGE013624,CORO1A,CLABP; CLIPINA; HCORO1; IMD8; TACO; p57,coronin 1A,16p11.2,protein-coding,/
CWITA013625,TCMBANKGE013625,RPUSD1,C16orf40; RLUCL,RNA pseudouridine synthase domain containing 1,16p13.3,protein-coding,/
CWITA013626,TCMBANKGE013626,PTMS,ParaT,parathymosin,12p13.31,protein-coding,/
CWITA013627,TCMBANKGE013627,PHKB,-,phosphorylase kinase regulatory subunit beta,16q12.1,protein-coding,/
CWITA013628,TCMBANKGE013628,LPCAT1,AGPAT10; AGPAT9; AYTL2; LPCAT-1; PFAAP3; lpcat; lysoPAFAT,lysophosphatidylcholine acyltransferase 1,5p15.33,protein-coding,/
CWITA013629,TCMBANKGE013629,CTNNBL1,C20orf33; NAP; P14L; PP8304; dJ633O20.1,catenin beta like 1,20q11.23,protein-coding,/
CWITA013630,TCMBANKGE013630,KIF25,KNSL3,kinesin family member 25,6q27,protein-coding,/
CWITA013631,TCMBANKGE013631,CRABP2,CRABPNII; RBP6,cellular retinoic acid binding protein 2,1q21.3,protein-coding,
CWITA013632,TCMBANKGE013632,ALG6,CDG1C,"ALG6 alpha-1,3-glucosyltransferase",1p31.3,protein-coding,/
CWITA013633,TCMBANKGE013633,ZNF473,ZFP100; ZN473,zinc finger protein 473,19q13.33,protein-coding,/
CWITA013634,TCMBANKGE013634,PLCL1,PLCE; PLCL; PLDL1; PPP1R127; PRIP,phospholipase C like 1 (inactive),2q33.1,protein-coding,/
CWITA013635,TCMBANKGE013635,ATF2,CRENBP1; CREB2; HB16; MGC111558; TREB7,activating transcription factor 2,2q32,protein-coding,
CWITA013636,TCMBANKGE013636,GSTA3,GSTA3-3; GTA3,glutathione S-transferase alpha 3,6p12.2,protein-coding,Research target
CWITA013637,TCMBANKGE013637,INHBC,IHBC,inhibin subunit beta C,12q13.3,protein-coding,/
CWITA013638,TCMBANKGE013638,SPATA21,spergen-2; spergen2,spermatogenesis associated 21,1p36.13,protein-coding,/
CWITA013639,TCMBANKGE013639,TRAPPC6B,FLJ17772; FLJ79549; TPC6,trafficking protein particle complex 6B,14q21.1,protein-coding,
CWITA013640,TCMBANKGE013640,CYP39A1,-,cytochrome P450 family 39 subfamily A member 1,6p12.3,protein-coding,/
CWITA013641,TCMBANKGE013641,ZNF791,-,zinc finger protein 791,19p13.13,protein-coding,/
CWITA013642,TCMBANKGE013642,ZFAND2A,AIRAP,zinc finger AN1-type containing 2A,7p22.3,protein-coding,/
CWITA013643,TCMBANKGE013643,RETREG2,C2orf17; FAM134A; MAG-2,reticulophagy regulator family member 2,2q35,protein-coding,/
CWITA013644,TCMBANKGE013644,PNPT1,COXPD13; DFNB70; OLD35; PNPASE; old-35,polyribonucleotide nucleotidyltransferase 1,2p16.1,protein-coding,/
CWITA013645,TCMBANKGE013645,PBX3,-,PBX homeobox 3,9q33.3,protein-coding,/
CWITA013646,TCMBANKGE013646,RFK,FLJ11149; RIFK,riboflavin kinase,9q21.13,protein-coding,
CWITA013647,TCMBANKGE013647,PNISR,C6orf111; HSPC306; SFRS18; SRrp130; bA98I9.2,PNN interacting serine and arginine rich protein,6q16.2,protein-coding,/
CWITA013648,TCMBANKGE013648,IQCN,KIAA1683,IQ motif containing N,19p13.11,protein-coding,/
CWITA013649,TCMBANKGE013649,ARPC1B,ARC41; p40NARC; p41NARC,"actin related protein 2/3 complex, subunit 1B, 41kDa",7q22.1,protein-coding,
CWITA013650,TCMBANKGE013650,NLGN1,NL1,neuroligin 1,3q26.31,protein-coding,/
CWITA013651,TCMBANKGE013651,ABCE1,ABC38; OABP; RLI; RLI1; RNASEL1; RNASELI; RNS4I,ATP binding cassette subfamily E member 1,4q31.21,protein-coding,/
CWITA013652,TCMBANKGE013652,TTLL5,CORD19; KIAA0998; STAMP,tubulin tyrosine ligase like 5,14q24.3,protein-coding,/
CWITA013653,TCMBANKGE013653,TSHZ1,CAA; NY-CO-33; SDCCAG33; TSH1,teashirt zinc finger homeobox 1,18q22.3,protein-coding,/
CWITA013654,TCMBANKGE013654,CCNP,CNTD2,cyclin P,19q13.2,protein-coding,/
CWITA013655,TCMBANKGE013655,SLC33A1,ACATN; AT-1; AT1; CCHLND; SPG42,solute carrier family 33 member 1,3q25.31,protein-coding,Successful target
CWITA013656,TCMBANKGE013656,TMEM154,-,transmembrane protein 154,4q31.3,protein-coding,/
CWITA013657,TCMBANKGE013657,VWCE,URG11; VWC1,von Willebrand factor C and EGF domains,11q12.2,protein-coding,/
CWITA013658,TCMBANKGE013658,PCMTD2,C20orf36,protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2,20q13.33,protein-coding,/
CWITA013659,TCMBANKGE013659,KCNQ1,ATFB1; ATFB3; FLJ26167; JLNS1; KCNA8; KCNA9; KVLQT1; Kv1.9; Kv7.1; LQT; LQT1; RWS; SQT2; WRS,"potassium voltage-gated channel, KQT-like subfamily, member 1",11p15.5,protein-coding,
CWITA013660,TCMBANKGE013660,REG1A,ICRF; MGC12447; P19; PSP; PSPS; PSPS1; PTP; REG,regenerating islet-derived 1 alpha,2p12,protein-coding,
CWITA013661,TCMBANKGE013661,CIB4,KIP4,calcium and integrin binding family member 4,2p23.3,protein-coding,/
CWITA013662,TCMBANKGE013662,KLRK1,CD314; D12S2489E; KLR; NKG2-D; NKG2D,killer cell lectin like receptor K1,12p13.2,protein-coding,Clinical Trial target
CWITA013663,TCMBANKGE013663,B3GLCT,B3GALTL; B3GTL; B3Glc-T; Gal-T; beta3Glc-T,beta 3-glucosyltransferase,13q12.3,protein-coding,/
CWITA013664,TCMBANKGE013664,KLHL15,HEL-S-305,kelch like family member 15,Xp22.11,protein-coding,/
CWITA013665,TCMBANKGE013665,CACNA2D1,CACNA2; CACNL2A; CCHL2A,"calcium channel, voltage-dependent, alpha 2/delta subunit 1",7q21-q22,protein-coding,
CWITA013666,TCMBANKGE013666,PYCARD,ASC; CARD5; TMS; TMS-1; TMS1,PYD and CARD domain containing,16p11.2,protein-coding,/
CWITA013667,TCMBANKGE013667,RPS20,S20; uS10,ribosomal protein S20,8q12.1,protein-coding,/
CWITA013668,TCMBANKGE013668,CEP68,KIAA0582,centrosomal protein 68,2p14,protein-coding,/
CWITA013669,TCMBANKGE013669,PPIAL4G,COAS-2,peptidylprolyl isomerase A like 4G,1q21.2,protein-coding,/
CWITA013670,TCMBANKGE013670,HTR3E,5-HT3-E; 5-HT3E; 5-HT3c1,5-hydroxytryptamine receptor 3E,3q27.1,protein-coding,/
CWITA013671,TCMBANKGE013671,ALDH6A1,MGC40271; MMSADHA; MMSDH,"aldehyde dehydrogenase 6 family, member A1",14q24.3,protein-coding,
CWITA013672,TCMBANKGE013672,HDHD2,3110052N05Rik; HEL-S-301,haloacid dehalogenase like hydrolase domain containing 2,18q21.1,protein-coding,/
CWITA013673,TCMBANKGE013673,EPX,EPO; EPP; EPXNPEN,eosinophil peroxidase,17q23.1,protein-coding,
CWITA013674,TCMBANKGE013674,SLC26A9,-,solute carrier family 26 member 9,1q32.1,protein-coding,Research target
CWITA013675,TCMBANKGE013675,PHGDH,3NPGDH; 3PGDH; MGC3017; PDG; PGAD; PGD; PGDH; SERA,phosphoglycerate dehydrogenase,1p12,protein-coding,
CWITA013676,TCMBANKGE013676,CENPU,CENP50; CENPU50; KLIP1; MLF1IP; PBIP1,centromere protein U,4q35.1,protein-coding,/
CWITA013677,TCMBANKGE013677,SCNN1B,BESC1; ENaCb; ENaCbeta; SCNEB,"sodium channel, nonvoltage-gated 1, beta",16p12.2-p12.1,protein-coding,
CWITA013678,TCMBANKGE013678,NECTIN1,CD111; CLPED1; ED4; HIgR; HV1S; HVEC; OFC7; PRR; PRR1; PVRL1; PVRR; PVRR1; SK-12; nectin-1,nectin cell adhesion molecule 1,11q23.3,protein-coding,/
CWITA013679,TCMBANKGE013679,DICER1,DCR1; Dicer; Dicer1e; GLOW; HERNA; K12H4.8-LIKE; MNG1; RMSE2,"dicer 1, ribonuclease III",14q32.13,protein-coding,Research target
CWITA013680,TCMBANKGE013680,ITPR3,FLJ36205; IP3R; IP3R3,"inositol 1,4,5-trisphosphate receptor, type 3",6p21,protein-coding,
CWITA013681,TCMBANKGE013681,SERPINE3,-,serpin family E member 3,13q14.3,protein-coding,/
CWITA013682,TCMBANKGE013682,GNPAT,DAP-AT; DAPAT; DHAPAT; RCDP2,glyceronephosphate O-acyltransferase,1q42.2,protein-coding,/
CWITA013683,TCMBANKGE013683,DAZ1,DAZ; SPGY,deleted in azoospermia 1,Yq11.223,protein-coding,/
CWITA013684,TCMBANKGE013684,ACOX2,BCOX; BRCACOX; BRCOX; CBAS6; THCCox,acyl-CoA oxidase 2,3p14.3,protein-coding,/
CWITA013685,TCMBANKGE013685,SLC22A12,OAT4L; RST; URAT1,solute carrier family 22 member 12,11q13.1,protein-coding,Successful target
CWITA013686,TCMBANKGE013686,ZNF81,HFZ20; MRX45; dJ54B20.6,zinc finger protein 81,Xp11.23,protein-coding,/
CWITA013687,TCMBANKGE013687,NPFFR1,GPR147; NPFF1; NPFF1R1; OT7T022,neuropeptide FF receptor 1,10q22.1,protein-coding,Research target
CWITA013688,TCMBANKGE013688,FOS,APN1; CNFOS,FBJ murine osteosarcoma viral oncogene homolog,14q24.3,protein-coding,
CWITA013689,TCMBANKGE013689,SLC20A2,GLVR-2; GLVR2; IBGC1; IBGC2; IBGC3; MLVAR; PIT-2; PIT2; RAM1; Ram-1,solute carrier family 20 member 2,8p11.21,protein-coding,/
CWITA013690,TCMBANKGE013690,LCN15,PRO6093; UNQ2541,lipocalin 15,9q34.3,protein-coding,/
CWITA013691,TCMBANKGE013691,CXCL5,ENA-78; SCYB5,C-X-C motif chemokine ligand 5,4q13.3,protein-coding,/
CWITA013692,TCMBANKGE013692,E2F5,E2F-5,E2F transcription factor 5,8q21.2,protein-coding,/
CWITA013693,TCMBANKGE013693,JAML,AMICA; AMICA1; CREA7-1; CREA7-4; Gm638,junction adhesion molecule like,11q23.3,protein-coding,/
CWITA013694,TCMBANKGE013694,STK39,DCHT; PASK; SPAK,serine/threonine kinase 39,2q24.3,protein-coding,Research target
CWITA013695,TCMBANKGE013695,PCBP2,HNRNPE2; HNRPE2; hnRNP-E2,poly(rC) binding protein 2,12q13.13,protein-coding,/
CWITA013696,TCMBANKGE013696,SERPINB7,MEGSIN; PPKN; TP55,serpin family B member 7,18q21.33,protein-coding,/
CWITA013697,TCMBANKGE013697,TAAR5,PNR,trace amine associated receptor 5,6q23.2,protein-coding,Research target
CWITA013698,TCMBANKGE013698,SHANK2,AUTS17; CORTBP1; CTTNBP1; ProSAP1; SHANK; SPANK-3,SH3 and multiple ankyrin repeat domains 2,11q13.3-q13.4,protein-coding,/
CWITA013699,TCMBANKGE013699,PDE6B,CSNB3; CSNBAD2; PDEB; RP40; rd1,"phosphodiesterase 6B, cGMP-specific, rod, beta",4p16.3,protein-coding,
CWITA013700,TCMBANKGE013700,TPH2,ADHD7; FLJ37295; MGC138871; MGC138872; NTPH,tryptophan hydroxylase 2,12q21.1,protein-coding,
CWITA013701,TCMBANKGE013701,DOK2,p56DOK; p56dok-2,docking protein 2,8p21.3,protein-coding,/
CWITA013702,TCMBANKGE013702,IGKV2-30,A17; IGKV230,Immunoglobulin_Kappa_Variable_2-30,2p11.2,other,
CWITA013703,TCMBANKGE013703,AGR2,AG-2; AG2; GOB-4; HAG-2; HEL-S-116; HPC8; PDIA17; XAG-2,"anterior gradient 2, protein disulphide isomerase family member",7p21.1,protein-coding,Research target
CWITA013704,TCMBANKGE013704,GSPT1,551G9.2; ETF3A; FLJ38048; FLJ39067; GST1; eRF3a,G1 to S phase transition 1,16p13.1,protein-coding,
CWITA013705,TCMBANKGE013705,LINC01194,CT49; TAG,Long_Intergenic_Non-Protein_Coding_Rna_1194,5p15.2,ncRNA,
CWITA013706,TCMBANKGE013706,KCNV2,KV11.1; Kv8.2; RCD3B,potassium voltage-gated channel modifier subfamily V member 2,9p24.2,protein-coding,/
CWITA013707,TCMBANKGE013707,IRAK1BP1,AIP70; SIMPL,interleukin 1 receptor associated kinase 1 binding protein 1,6q14.1,protein-coding,/
CWITA013708,TCMBANKGE013708,SNN,-,stannin,16p13.13,protein-coding,/
CWITA013709,TCMBANKGE013709,KIAA1586,-,KIAA1586,6p12.1,protein-coding,/
CWITA013710,TCMBANKGE013710,DPYSL5,CRAM; CRMP-5; CRMP5; CV2; Ulip6,dihydropyrimidinase like 5,2p23.3,protein-coding,/
CWITA013711,TCMBANKGE013711,RHBDL1,RHBDL; RRP,rhomboid like 1,16p13.3,protein-coding,/
CWITA013712,TCMBANKGE013712,MPO,N,myeloperoxidase,17q23.1,protein-coding,
CWITA013713,TCMBANKGE013713,SHBG,ABP; SBP; TEBG,sex hormone binding globulin,17p13.1,protein-coding,/
CWITA013714,TCMBANKGE013714,AKT2,PKBB; PKBBETA; PRKBB; RACNBETA,v-akt murine thymoma viral oncogene homolog 2,19q13.1-q13.2,protein-coding,
CWITA013715,TCMBANKGE013715,C1orf53,-,chromosome 1 open reading frame 53,1q31.3,protein-coding,/
CWITA013716,TCMBANKGE013716,SLCO2B1,DKFZp686E0517; KIAA0880; OATPNB; OATP2B1; OATPB; SLC21A9,"solute carrier organic anion transporter family, member 2B1",11q13,protein-coding,
CWITA013717,TCMBANKGE013717,ABCB11,ABC16; BRIC2; BSEP; PFICN2; PFIC2; PGY4; SPGP,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",2q24,protein-coding,
CWITA013718,TCMBANKGE013718,ARRDC2,CLONE24945; PP2703,arrestin domain containing 2,19p13.11,protein-coding,/
CWITA013719,TCMBANKGE013719,ANKRD46,ANK-S; GENX-115279,ankyrin repeat domain 46,8q22.3,protein-coding,/
CWITA013720,TCMBANKGE013720,UBA52,CEP52; HUBCEP52; L40; RPL40,ubiquitin A-52 residue ribosomal protein fusion product 1,19p13.11,protein-coding,/
CWITA013721,TCMBANKGE013721,LRRC6,CILD19; LRTP; TSLRP; tilB,leucine rich repeat containing 6,8q24.22,protein-coding,/
CWITA013722,TCMBANKGE013722,ALKBH3,ABH3; DEPCN1; DEPC1; FLJ43614; MGC118790; MGC118792; MGC118793; PCA1,"alkB, alkylation repair homolog 3 (E. coli)",11p11.2,protein-coding,
CWITA013723,TCMBANKGE013723,MAD2L1BP,CMT2,MAD2L1 binding protein,6p21.1,protein-coding,/
CWITA013724,TCMBANKGE013724,CLCN1,CLC1,chloride voltage-gated channel 1,7q34,protein-coding,Research target
CWITA013725,TCMBANKGE013725,BICD2,SMALED2; SMALED2A; SMALED2B; bA526D8.1,BICD cargo adaptor 2,9q22.31,protein-coding,/
CWITA013726,TCMBANKGE013726,SLC12A4,CTC-479C5.17; KCC1; hKCC1,solute carrier family 12 member 4,16q22.1,protein-coding,Research target
CWITA013727,TCMBANKGE013727,HS3ST1,3OST; 3OST1,heparan sulfate (glucosamine) 3-O-sulfotransferase 1,4p16,protein-coding,
CWITA013728,TCMBANKGE013728,DCXR,DCR; HCR2; HCRII; KIDCR; P34H; PNTSU; SDR20C1; XR,dicarbonyl and L-xylulose reductase,17q25.3,protein-coding,/
CWITA013729,TCMBANKGE013729,OPN1LW,CBBM; CBP; COD5; RCP; ROP,"opsin 1, long wave sensitive",Xq28,protein-coding,/
CWITA013730,TCMBANKGE013730,STYX,-,serine/threonine/tyrosine interacting protein,14q22.1,protein-coding,/
CWITA013731,TCMBANKGE013731,KRT2,CK-2e; K2e; KRT2A; KRT2E; KRTE,keratin 2,12q13.13,protein-coding,/
CWITA013732,TCMBANKGE013732,PRSS46P,PRSS46; TESSP6,"serine protease 46, pseudogene",3p21.31,pseudo,/
CWITA013733,TCMBANKGE013733,SRP14,ALURBP,signal recognition particle 14,15q15.1,protein-coding,/
CWITA013734,TCMBANKGE013734,SORCS1,hSorCS,sortilin related VPS10 domain containing receptor 1,10q25.1,protein-coding,/
CWITA013735,TCMBANKGE013735,ADAT2,DEADC1; TAD2; dJ20N2; dJ20N2.1,adenosine deaminase tRNA specific 2,6q24.2,protein-coding,/
CWITA013736,TCMBANKGE013736,TMTC2,IBDBP1,transmembrane O-mannosyltransferase targeting cadherins 2,12q21.31,protein-coding,/
CWITA013737,TCMBANKGE013737,TCP11L2,-,t-complex 11 like 2,12q23.3,protein-coding,/
CWITA013738,TCMBANKGE013738,LTBR,D12S370; LT-BETA-R; TNF-R-III; TNFCR; TNFR-RP; TNFR2-RP; TNFR3; TNFRSF3,lymphotoxin beta receptor,12p13.31,protein-coding,Clinical Trial target
CWITA013739,TCMBANKGE013739,PRKCQ,PRKCT; nPKC-theta,protein kinase C theta,10p15.1,protein-coding,Research target
CWITA013740,TCMBANKGE013740,RAD54B,RDH54,RAD54 homolog B,8q22.1,protein-coding,/
CWITA013741,TCMBANKGE013741,NOLC1,KIAA0035; NOPP130; NOPP140; NS5ATP13; P130,nucleolar and coiled-body phosphoprotein 1,10q24.32,protein-coding,
CWITA013742,TCMBANKGE013742,CMPK2,NDK; TMPK2; TYKi; UMP-CMPK2,cytidine/uridine monophosphate kinase 2,2p25.2,protein-coding,/
CWITA013743,TCMBANKGE013743,ABCB4,ABC21; GBD1; MDR2; MDR2/3; MDR3; PFICN3; PGY3,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",7q21.1,protein-coding,
CWITA013744,TCMBANKGE013744,RALGAPB,KIAA1219; RalGAPbeta,Ral GTPase activating protein non-catalytic subunit beta,20q11.23,protein-coding,/
CWITA013745,TCMBANKGE013745,SLC25A28,MFRN2; MRS3/4; MRS4L; NPD016,solute carrier family 25 member 28,10q24.2,protein-coding,/
CWITA013746,TCMBANKGE013746,E2F4,E2F-4,E2F transcription factor 4,16q22.1,protein-coding,/
CWITA013747,TCMBANKGE013747,ADAM22,ADAM 22; EIEE61; MDC2,ADAM metallopeptidase domain 22,7q21.12,protein-coding,/
CWITA013748,TCMBANKGE013748,ARHGAP29,PARG1,Rho GTPase activating protein 29,1p22.1,protein-coding,/
CWITA013749,TCMBANKGE013749,TMEM116,-,transmembrane protein 116,12q24.12-q24.13,protein-coding,/
CWITA013750,TCMBANKGE013750,PIF1,C15orf20; PIF,PIF1 5'-to-3' DNA helicase,15q22.31,protein-coding,/
CWITA013751,TCMBANKGE013751,ZNF551,-,zinc finger protein 551,19q13.43,protein-coding,/
CWITA013752,TCMBANKGE013752,SPIN1,SPIN; TDRD24,spindlin 1,9q22.1,protein-coding,/
CWITA013753,TCMBANKGE013753,GSR,MGC78522,glutathione reductase,8p21.1,protein-coding,
CWITA013754,TCMBANKGE013754,TRH,Pro-TRH; TRF,thyrotropin releasing hormone,3q22.1,protein-coding,Clinical Trial target
CWITA013755,TCMBANKGE013755,ANKRD22,-,ankyrin repeat domain 22,10q23.31,protein-coding,/
CWITA013756,TCMBANKGE013756,UGGT2,HUGT2; UGCGL2; UGT2,UDP-glucose glycoprotein glucosyltransferase 2,13q32.1,protein-coding,/
CWITA013757,TCMBANKGE013757,LIPT2,-,lipoyl(octanoyl) transferase 2,11q13.4,protein-coding,/
CWITA013758,TCMBANKGE013758,KRTAP5-3,KRTAP5N/A9; KRTAP5.3,Keratin_Associated_Protein_5-3,11p15.5,protein-coding,
CWITA013759,TCMBANKGE013759,EML4,C2orf2; ELP120; EMAP-4; EMAPL4; ROPP120,EMAP like 4,2p21,protein-coding,Research target
CWITA013760,TCMBANKGE013760,SERPINA3,AACT; ACT; GIG24; GIG25,serpin family A member 3,14q32.13,protein-coding,/
CWITA013761,TCMBANKGE013761,DDB2,DDBB; UV-DDB2; XPE,damage specific DNA binding protein 2,11p11.2,protein-coding,/
CWITA013762,TCMBANKGE013762,ERCC6,ARMD5; CKN2; COFS; COFS1; CSB; CSB-PGBD3; POF11; RAD26; UVSS1,"ERCC excision repair 6, chromatin remodeling factor",10q11.23,protein-coding,/
CWITA013763,TCMBANKGE013763,SPRYD7,C13orf1; CLLD6,SPRY domain containing 7,13q14.2,protein-coding,/
CWITA013764,TCMBANKGE013764,LAMB1,CLM; LIS5,laminin subunit beta 1,7q31.1,protein-coding,/
CWITA013765,TCMBANKGE013765,CDH17,CDH16; HPT-1; HPT1,cadherin 17,8q22.1,protein-coding,/
CWITA013766,TCMBANKGE013766,ESRRB,DFNB35; ERR2; ERRb; ESRL2; NR3B2,estrogen-related receptor beta,14q24.3,protein-coding,
CWITA013767,TCMBANKGE013767,CBSL,CBS,cystathionine beta-synthase like,21p12,protein-coding,/
CWITA013768,TCMBANKGE013768,TNFSF13B,BAFF; BLYS; CD257; DTL; TALLN1; TALL1; THANK; TNFSF20; ZTNF4,"tumor necrosis factor (ligand) superfamily, member 13b",13q32-q34,protein-coding,
CWITA013769,TCMBANKGE013769,SLIT2,SLIL3; Slit-2,slit guidance ligand 2,4p15.31,protein-coding,/
CWITA013770,TCMBANKGE013770,TOM1L1,SRCASM,target of myb1 like 1 membrane trafficking protein,17q22,protein-coding,/
CWITA013771,TCMBANKGE013771,FBXL20,Fbl2; Fbl20,F-box and leucine rich repeat protein 20,17q12,protein-coding,/
CWITA013772,TCMBANKGE013772,CRCT1,C1orf42; NICE-1; NICE1,cysteine rich C-terminal 1,1q21.3,protein-coding,/
CWITA013773,TCMBANKGE013773,KIAA0513,-,KIAA0513,16q24.1,protein-coding,/
CWITA013774,TCMBANKGE013774,RAB3C,-,"RAB3C, member RAS oncogene family",5q11.2,protein-coding,/
CWITA013775,TCMBANKGE013775,FAT2,CDHF8; CDHR9; HFAT2; MEGF1; SCA45,FAT atypical cadherin 2,5q33.1,protein-coding,/
CWITA013776,TCMBANKGE013776,HDAC4,AHO3; BDMR; HA6116; HD4; HDACNA; HDACA; KIAA0288,histone deacetylase 4,2q37.3,protein-coding,
CWITA013777,TCMBANKGE013777,SLURP1,ANUP; ARS; ArsB; LY6-MT; LY6LS; MDM,secreted LY6/PLAUR domain containing 1,8q24.3,protein-coding,/
CWITA013778,TCMBANKGE013778,ADSSL1,FLJ38602,adenylosuccinate synthase like 1,14q32.33,protein-coding,
CWITA013779,TCMBANKGE013779,SERPINB1,EI; ELANH2; HEL-S-27; HEL57; LEI; M/NEI; MNEI; PI-2; PI2,serpin family B member 1,6p25.2,protein-coding,/
CWITA013780,TCMBANKGE013780,TUBA1A,BNALPHAN1; FLJ25113; LIS3; TUBA3,"tubulin, alpha 1a",12q13.12,protein-coding,
CWITA013781,TCMBANKGE013781,EFEMP2,ARCL1B; FBLN4; MBP1; UPH1,EGF containing fibulin extracellular matrix protein 2,11q13.1,protein-coding,/
CWITA013782,TCMBANKGE013782,LTBP2,C14orf141; GLC3D; LTBP3; MSPKA; MSTP031; WMS3,latent transforming growth factor beta binding protein 2,14q24.3,protein-coding,/
CWITA013783,TCMBANKGE013783,MGST3,GSTNIII,microsomal glutathione S-transferase 3,1q23,protein-coding,
CWITA013784,TCMBANKGE013784,ACKR1,CCBP1; CD234; DARC; DARC/ACKR1; Dfy; FY; GPD; GpFy; WBCQ1,atypical chemokine receptor 1 (Duffy blood group),1q23.2,protein-coding,Successful target
CWITA013785,TCMBANKGE013785,CCDC68,SE57-1,coiled-coil domain containing 68,18q21.2,protein-coding,/
CWITA013786,TCMBANKGE013786,ASIC3,ACCN3; DRASIC; SLNAC1; TNaC1,acid sensing ion channel subunit 3,7q36.1,protein-coding,Research target
CWITA013787,TCMBANKGE013787,NOLC1,NOPP130; NOPP140; NS5ATP13; P130; Srp40,nucleolar and coiled-body phosphoprotein 1,10q24.32,protein-coding,/
CWITA013788,TCMBANKGE013788,POLK,DINB1; DINP; POLQ,polymerase (DNA directed) kappa,5q13,protein-coding,
CWITA013789,TCMBANKGE013789,MCCC1,MCC-B; MCCA,methylcrotonoyl-CoA carboxylase 1,3q27.1,protein-coding,/
CWITA013790,TCMBANKGE013790,BPTF,FAC1; FALZ; NEDDFL; NURF301,bromodomain PHD finger transcription factor,17q24.2,protein-coding,/
CWITA013791,TCMBANKGE013791,DHDDS,CIT; CPT; DEDSM; DS; HDS; RP59; hCIT,dehydrodolichyl diphosphate synthase subunit,1p36.11,protein-coding,/
CWITA013792,TCMBANKGE013792,CTR9,SH2BP1; TSBP; p150; p150TSP,"CTR9 homolog, Paf1/RNA polymerase II complex component",11p15.4,protein-coding,/
CWITA013793,TCMBANKGE013793,NUDT8,-,nudix hydrolase 8,11q13.2,protein-coding,/
CWITA013794,TCMBANKGE013794,CMAS,CSS,cytidine monophosphate N-acetylneuraminic acid synthetase,12p12.1,protein-coding,/
CWITA013795,TCMBANKGE013795,SP140,LYSP100; LYSP100-A; LYSP100-B,SP140 nuclear body protein,2q37.1,protein-coding,/
CWITA013796,TCMBANKGE013796,HMGXB4,HMG2L1; HMGBCG; THC211630,HMG-box containing 4,22q12.3,protein-coding,/
CWITA013797,TCMBANKGE013797,Akr1c12,AI266976; Akra,"aldo-keto reductase family 1, member C12",13|13 A1,protein-coding,/
CWITA013798,TCMBANKGE013798,MT1B,MT-1B; MT-IB; MT1; MT1Q; MTP,metallothionein 1B,16q13,protein-coding,/
CWITA013799,TCMBANKGE013799,BAG2,BAG-2; dJ417I1.2,BAG cochaperone 2,6p12.1,protein-coding,/
CWITA013800,TCMBANKGE013800,EPG5,HEEW1; KIAA1632; VICIS,ectopic P-granules autophagy protein 5 homolog,18q12.3-q21.1,protein-coding,/
CWITA013801,TCMBANKGE013801,KCNC1,FLJ41162; FLJ42249; FLJ43491; KV3.1; KV4; MGC129855; NGK2,"potassium voltage-gated channel, Shaw-related subfamily, member 1",11p15,protein-coding,
CWITA013802,TCMBANKGE013802,SRPRB,APMCF1; SR-beta,SRP receptor subunit beta,3q22.1,protein-coding,/
CWITA013803,TCMBANKGE013803,PCLO,ACZ; PCH3,piccolo presynaptic cytomatrix protein,7q21.11,protein-coding,/
CWITA013804,TCMBANKGE013804,PLA2G10,GXPLA2; GXSPLA2; SPLA2; sPLA2-X,phospholipase A2 group X,16p13.12,protein-coding,/
CWITA013805,TCMBANKGE013805,PPCDC,FLJ14585,phosphopantothenoylcysteine decarboxylase,15q24.2,protein-coding,
CWITA013806,TCMBANKGE013806,LAMA5,-,laminin subunit alpha 5,20q13.33,protein-coding,/
CWITA013807,TCMBANKGE013807,ATP6AP2,APT6M8-9; ATP6IP2; ATP6M8-9; CDG2R; ELDF10; HT028; M8-9; MRXE; MRXSH; MSTP009; PRR; RENR; XMRE; XPDS,ATPase H+ transporting accessory protein 2,Xp11.4,protein-coding,/
CWITA013808,TCMBANKGE013808,DCP1B,DCP1,decapping mRNA 1B,12p13.33,protein-coding,/
CWITA013809,TCMBANKGE013809,TUBA1A,B-ALPHA-1; LIS3; TUBA3,tubulin alpha 1a,12q13.12,protein-coding,/
CWITA013810,TCMBANKGE013810,BOK,BCL2L9; BOKL,BCL2 family apoptosis regulator BOK,2q37.3,protein-coding,/
CWITA013811,TCMBANKGE013811,MRPS14,COXPD38; DJ262D12.2; HSMRPS14; MRP-S14; S14mt,mitochondrial ribosomal protein S14,1q25.1,protein-coding,/
CWITA013812,TCMBANKGE013812,POLQ,PRO0327,DNA polymerase theta,3q13.33,protein-coding,/
CWITA013813,TCMBANKGE013813,FZR1,CDC20C; CDH1; FZR; FZR2; HCDH; HCDH1,fizzy and cell division cycle 20 related 1,19p13.3,protein-coding,/
CWITA013814,TCMBANKGE013814,TIMM8B,DDP2; TIM8B,translocase of inner mitochondrial membrane 8 homolog B,11q23.1,protein-coding,/
CWITA013815,TCMBANKGE013815,ETV1,ER81,ETS variant transcription factor 1,7p21.2,protein-coding,/
CWITA013816,TCMBANKGE013816,AP2M1,AP50; CLAPM1; MRD60; mu2,adaptor related protein complex 2 subunit mu 1,3q27.1,protein-coding,/
CWITA013817,TCMBANKGE013817,MTCO2P12,COII; COX2; COXII; MT-CO2; MTCO2,Mt-Co2_Pseudogene_12,1p36.33,pseudo,
CWITA013818,TCMBANKGE013818,ITGB7,-,integrin subunit beta 7,12q13.13,protein-coding,Successful target
CWITA013819,TCMBANKGE013819,PMCH,MCH; ppMCH,pro-melanin concentrating hormone,12q23.2,protein-coding,/
CWITA013820,TCMBANKGE013820,RNASE2,EDN; RAF3; RNS2,ribonuclease A family member 2,14q11.2,protein-coding,/
CWITA013821,TCMBANKGE013821,NAA20,NAT3; NAT3P; NAT5; NAT5P; dJ1002M8.1,"N-alpha-acetyltransferase 20, NatB catalytic subunit",20p11.23,protein-coding,/
CWITA013822,TCMBANKGE013822,SMC1B,SMC1BETA; SMC1L2,structural maintenance of chromosomes 1B,22q13.31,protein-coding,/
CWITA013823,TCMBANKGE013823,FGFR1,BFGFR; CD331; CEK; FGFBR; FGFRN1; FLG; FLJ99988; FLTN2; FLT2; HBGFR; KAL2; NNSAM; OGD; bFGFNRN1,fibroblast growth factor receptor 1,8p12,protein-coding,
CWITA013824,TCMBANKGE013824,LRRC25,MAPA,leucine rich repeat containing 25,19p13.11,protein-coding,/
CWITA013825,TCMBANKGE013825,CBFB,PEBP2B,core-binding factor subunit beta,16q22.1,protein-coding,/
CWITA013826,TCMBANKGE013826,DRD5,DBDR; DRD1B; DRD1L2,dopamine receptor D5,4p16.1,protein-coding,Successful target
CWITA013827,TCMBANKGE013827,ZNF264,-,zinc finger protein 264,19q13.43,protein-coding,/
CWITA013828,TCMBANKGE013828,APLN,APEL; XNPEP2,apelin,Xq26.1,protein-coding,Research target
CWITA013829,TCMBANKGE013829,CETN2,CALT; CEN2,centrin 2,Xq28,protein-coding,/
CWITA013830,TCMBANKGE013830,PRPF8,HPRP8; PRP8; PRPC8; RP13; SNRNP220,pre-mRNA processing factor 8,17p13.3,protein-coding,/
CWITA013831,TCMBANKGE013831,NMI,-,N-myc and STAT interactor,2q23.3,protein-coding,/
CWITA013832,TCMBANKGE013832,AP3D1,ADTD; HPS10; hBLVR,adaptor related protein complex 3 subunit delta 1,19p13.3,protein-coding,/
CWITA013833,TCMBANKGE013833,RPS6KB2,KLS; P70-beta; P70-beta-1; P70-beta-2; S6K-beta2; S6K2; S6KB; S6KI(2); S6Kbeta; SRK; STK14B; p70(S6K)-beta; p70S6Kb,ribosomal protein S6 kinase B2,11q13.2,protein-coding,/
CWITA013834,TCMBANKGE013834,MGEA5,FLJ11229; FLJ23355; KIAA0679; MEA5; NCOAT; OGA,meningioma expressed antigen 5 (hyaluronidase),10q24.1-q24.3,protein-coding,
CWITA013835,TCMBANKGE013835,CENPO,CENP-O; ICEN-36; MCM21R,centromere protein O,2p23.3,protein-coding,/
CWITA013836,TCMBANKGE013836,JAZF1,TIP27; ZNF802,JAZF zinc finger 1,7p15.2-p15.1,protein-coding,/
CWITA013837,TCMBANKGE013837,CNGB3,ACHM1,cyclic nucleotide gated channel subunit beta 3,8q21.3,protein-coding,Research target
CWITA013838,TCMBANKGE013838,CLTC,CHC; CHC17; CLH-17; CLTCL2; Hc; MRD56,clathrin heavy chain,17q23.1,protein-coding,/
CWITA013839,TCMBANKGE013839,NDUFAF6,C8orf38; MC1DN17,NADH:ubiquinone oxidoreductase complex assembly factor 6,8q22.1,protein-coding,/
CWITA013840,TCMBANKGE013840,CORO2A,CLIPINB; IR10; WDR2,coronin 2A,9q22.33,protein-coding,/
CWITA013841,TCMBANKGE013841,HGF,DFNB39; FNTCF; HGFB; HPTA; SF,hepatocyte growth factor (hepapoietin A; scatter factor),7q21.1,protein-coding,
CWITA013842,TCMBANKGE013842,CNOT9,CAF40; CT129; RCD-1; RCD1; RQCD1,CCR4-NOT transcription complex subunit 9,2q35,protein-coding,/
CWITA013843,TCMBANKGE013843,ATP4B,ATP6B,ATPase H+/K+ transporting subunit beta,13q34,protein-coding,/
CWITA013844,TCMBANKGE013844,UBQLN1,DA41; DSK2; PLIC-1; UBQN; XDRP1,ubiquilin 1,9q21.32|9q21.2-q21.3,protein-coding,/
CWITA013845,TCMBANKGE013845,UGCG,GCS; GLCT1,UDP-glucose ceramide glucosyltransferase,9q31,protein-coding,
CWITA013846,TCMBANKGE013846,CYB561,CYB561A1; FRRS2; ORTHYP2,cytochrome b561,17q23.3,protein-coding,/
CWITA013847,TCMBANKGE013847,PGA4,-,pepsinogen A4,11q12.2,protein-coding,/
CWITA013848,TCMBANKGE013848,RPS5,S5,ribosomal protein S5,19q13.43,protein-coding,/
CWITA013849,TCMBANKGE013849,ANO2,C12orf3; TMEM16B,anoctamin 2,12p13.31,protein-coding,/
CWITA013850,TCMBANKGE013850,RAC1,MGC111543; TCN25; p21NRac1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",7p22,protein-coding,
CWITA013851,TCMBANKGE013851,NSUN5,NOL1; NOL1R; NSUN5A; WBSCR20; WBSCR20A; p120; p120(NOL1),NOP2/Sun RNA methyltransferase 5,7q11.23,protein-coding,/
CWITA013852,TCMBANKGE013852,APOO,FAM121B; MIC26; MICOS26; Mic23; My025,apolipoprotein O,Xp22.11,protein-coding,/
CWITA013853,TCMBANKGE013853,PSMC4,MIP224; RPT3; S6; TBP-7; TBP7,"proteasome 26S subunit, ATPase 4",19q13.2,protein-coding,/
CWITA013854,TCMBANKGE013854,FBXO8,DC10; FBS; FBX8,F-box protein 8,4q34.1,protein-coding,/
CWITA013855,TCMBANKGE013855,GLRA3,N,"glycine receptor, alpha 3",4q33-q34,protein-coding,
CWITA013856,TCMBANKGE013856,FBXO41,FBX41,F-box protein 41,2p13.2,protein-coding,/
CWITA013857,TCMBANKGE013857,PMPCA,Alpha-MPP; CLA1; CPD3; INPP5E; P-55; SCAR2,"peptidase, mitochondrial processing subunit alpha",9q34.3,protein-coding,/
CWITA013858,TCMBANKGE013858,PITHD1,C1orf128; HT014; TXNL1CL,PITH domain containing 1,1p36.11,protein-coding,/
CWITA013859,TCMBANKGE013859,AGBL4,CCP6,ATP/GTP binding protein like 4,1p33,protein-coding,/
CWITA013860,TCMBANKGE013860,EDNRA,ET-A; ETA; ETA-R; ETAR; ETRA; MFDA; hET-AR,endothelin receptor type A,4q31.22-q31.23,protein-coding,Successful target
CWITA013861,TCMBANKGE013861,ZNF841,-,zinc finger protein 841,19q13.41,protein-coding,/
CWITA013862,TCMBANKGE013862,SMARCE1,BAF57; CSS5,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",17q21.2,protein-coding,/
CWITA013863,TCMBANKGE013863,SLC13A5,EIEE25; INDY; NACT; mIndy,solute carrier family 13 member 5,17p13.1,protein-coding,Research target
CWITA013864,TCMBANKGE013864,DGKI,DGK-IOTA,diacylglycerol kinase iota,7q33,protein-coding,/
CWITA013865,TCMBANKGE013865,UBIAD1,SCCD; TERE1,UbiA prenyltransferase domain containing 1,1p36.22,protein-coding,/
CWITA013866,TCMBANKGE013866,JMJD1C,KDM3C; TRIP-8; TRIP8,jumonji domain containing 1C,10q21.3,protein-coding,Research target
CWITA013867,TCMBANKGE013867,SNX16,-,sorting nexin 16,8q21.13,protein-coding,/
CWITA013868,TCMBANKGE013868,DYM,DMC; SMC,dymeclin,18q21.1,protein-coding,/
CWITA013869,TCMBANKGE013869,SERPINB10,PI-10; PI10,serpin family B member 10,18q22.1,protein-coding,/
CWITA013870,TCMBANKGE013870,PNP,FLJ94043; FLJ97288; FLJ97312; MGC117396; MGC125915; MGC125916; NP; PRO1837; PUNP,purine nucleoside phosphorylase,14q13.1,protein-coding,
CWITA013871,TCMBANKGE013871,IFNA4,IFN-alpha4a; INFA4,interferon alpha 4,9p21.3,protein-coding,/
CWITA013872,TCMBANKGE013872,HSPG2,HSPG; PLC; PRCAN; SJA; SJS; SJS1,heparan sulfate proteoglycan 2,1p36.12,protein-coding,Discontinued target
CWITA013873,TCMBANKGE013873,OPRM1,KIAA0403; LMOR; MOR; MOR1; OPRM,"opioid receptor, mu 1",6q24-q25,protein-coding,
CWITA013874,TCMBANKGE013874,GHSR,GHDP,growth hormone secretagogue receptor,3q26.31,protein-coding,Successful target
CWITA013875,TCMBANKGE013875,ZNF555,-,zinc finger protein 555,19p13.3,protein-coding,/
CWITA013876,TCMBANKGE013876,FMNL3,FHOD3; FRL2; WBP-3; WBP3,formin like 3,12q13.12,protein-coding,/
CWITA013877,TCMBANKGE013877,LDHB,LDHNH; TRGN5,lactate dehydrogenase B,12p12.2-p12.1,protein-coding,
CWITA013878,TCMBANKGE013878,AFF4,AF5Q31; CHOPS; MCEF,AF4/FMR2 family member 4,5q31.1,protein-coding,/
CWITA013879,TCMBANKGE013879,ZFP37,ZNF906; zfp-37,ZFP37 zinc finger protein,9q32,protein-coding,/
CWITA013880,TCMBANKGE013880,ZIK1,ZNF762,zinc finger protein interacting with K protein 1,19q13.43,protein-coding,Research target
CWITA013881,TCMBANKGE013881,Braf-rs1,Braf,"Braf transforming gene, related sequence 1",-,other,/
CWITA013882,TCMBANKGE013882,TSTD1,KAT; TST,thiosulfate sulfurtransferase like domain containing 1,1q23.3,protein-coding,/
CWITA013883,TCMBANKGE013883,RIMKLA,FAM80A; NAAGS; NAAGS-II,ribosomal modification protein rimK like family member A,1p34.2,protein-coding,/
CWITA013884,TCMBANKGE013884,RMI1,BLAP75; C9orf76; FAAP75,RecQ mediated genome instability 1,9q21.32,protein-coding,/
CWITA013885,TCMBANKGE013885,PLA2G7,LDL-PLA2; LP-PLA2; PAFAD; PAFAH,phospholipase A2 group VII,6p12.3,protein-coding,Clinical Trial target
CWITA013886,TCMBANKGE013886,CSNK2A1,CK2A1; CKII; Cka1; Cka2; OCNDS,casein kinase 2 alpha 1,20p13,protein-coding,Clinical Trial target
CWITA013887,TCMBANKGE013887,COL5A2,EDSC; EDSCL2,collagen type V alpha 2 chain,2q32.2,protein-coding,/
CWITA013888,TCMBANKGE013888,SDHA,CMD1GG; FP; SDH1; SDH2; SDHF,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",5p15,protein-coding,
CWITA013889,TCMBANKGE013889,ANKRD65,-,ankyrin repeat domain 65,1p36.33,protein-coding,/
CWITA013890,TCMBANKGE013890,SCGN,CALBL; DJ501N12.8; SECRET; SEGN; setagin,"secretagogin, EF-hand calcium binding protein",6p22.2,protein-coding,/
CWITA013891,TCMBANKGE013891,GLS,AAD20; DKFZp686O15119; FLJ10358; GLS1; KIAA0838,glutaminase,2q32-q34,protein-coding,
CWITA013892,TCMBANKGE013892,TSHR,CHNG1; LGR3; hTSHR-I,thyroid stimulating hormone receptor,14q31.1,protein-coding,Successful target
CWITA013893,TCMBANKGE013893,IVL,-,involucrin,1q21.3,protein-coding,/
CWITA013894,TCMBANKGE013894,KAT6A,ARTHS; MOZ; MRD32; MYST-3; MYST3; RUNXBP2; ZC2HC6A; ZNF220,lysine acetyltransferase 6A,8p11.21,protein-coding,/
CWITA013895,TCMBANKGE013895,PDCD6IP,AIP1; ALIX; DRIP4; HP95,programmed cell death 6 interacting protein,3p22.3,protein-coding,/
CWITA013896,TCMBANKGE013896,MAP3K13,LZK; MEKK13; MLK,mitogen-activated protein kinase kinase kinase 13,3q27.2,protein-coding,/
CWITA013897,TCMBANKGE013897,ADGRL4,ELTD1; ETL; KPG_003,adhesion G protein-coupled receptor L4,1p31.1,protein-coding,/
CWITA013898,TCMBANKGE013898,Cd3e,AI504783; CD3; CD3epsilon; T3e,"CD3 antigen, epsilon polypeptide",9 A5.2|9 24.84 cM,protein-coding,
CWITA013899,TCMBANKGE013899,PCDHGA12,CDH21; FIB3; PCDH-GAMMA-A12,"protocadherin gamma subfamily A, 12",5q31.3,protein-coding,/
CWITA013900,TCMBANKGE013900,RFC4,A1; RFC37,replication factor C subunit 4,3q27.3,protein-coding,/
CWITA013901,TCMBANKGE013901,PRMT3,HRMT1L3,protein arginine methyltransferase 3,11p15.1,protein-coding,
CWITA013902,TCMBANKGE013902,HDAC9,HD7; HD7b; HD9; HDAC; HDAC7; HDAC7B; HDAC9B; HDAC9FL; HDRP; MITR,histone deacetylase 9,7p21.1,protein-coding,Patented target
CWITA013903,TCMBANKGE013903,B3GAT1,CD57; GLCATP; GLCUATP; HNK1; LEU7; NKN1; NK1,"beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)",11q25,protein-coding,
CWITA013904,TCMBANKGE013904,COX7B,APLCC; LSDMCA2,cytochrome c oxidase subunit 7B,Xq21.1,protein-coding,/
CWITA013905,TCMBANKGE013905,C1orf115,RDD1,chromosome 1 open reading frame 115,1q41,protein-coding,/
CWITA013906,TCMBANKGE013906,PLOD1,FLJ42041; LH; LH1; LLH; PLOD,"procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1",1p36.22,protein-coding,
CWITA013907,TCMBANKGE013907,GLDC,GCE; GCSP; HYGN1; MGC138198; MGC138200,glycine dehydrogenase (decarboxylating),9p22,protein-coding,
CWITA013908,TCMBANKGE013908,NKD1,Naked1,NKD inhibitor of WNT signaling pathway 1,16q12.1,protein-coding,/
CWITA013909,TCMBANKGE013909,DACT1,DAPPER; DAPPER1; DPR1; FRODO; HDPR1; TBS2; THYEX3,dishevelled binding antagonist of beta catenin 1,14q23.1,protein-coding,/
CWITA013910,TCMBANKGE013910,ERVW-1,ENV; ENVW; ERVWE1; HERV-7q; HERV-W-ENV; HERV7Q; HERVW; HERVWENV,"endogenous retrovirus group W member 1, envelope",7q21.2,protein-coding,/
CWITA013911,TCMBANKGE013911,TATDN3,-,TatD DNase domain containing 3,1q32.3,protein-coding,/
CWITA013912,TCMBANKGE013912,DDX39B,BAT1; D6S81E; UAP56,DExD-box helicase 39B,6p21.33,protein-coding,/
CWITA013913,TCMBANKGE013913,NGF,BetaNNGF; HSAN5; MGC161426; MGC161428; NGFB,nerve growth factor (beta polypeptide),1p13.1,protein-coding,
CWITA013914,TCMBANKGE013914,CLIC1,CL1C1; CLCNL1; G6; NCC27,chloride intracellular channel 1,6p21.33,protein-coding,Research target
CWITA013915,TCMBANKGE013915,MYOM1,SKELEMIN,myomesin 1,18p11.31,protein-coding,/
CWITA013916,TCMBANKGE013916,D2HGDH,D2HGD,D-2-hydroxyglutarate dehydrogenase,2q37.3,protein-coding,/
CWITA013917,TCMBANKGE013917,ADAMTS3,ADAMTS-4; HKLLS3,ADAM metallopeptidase with thrombospondin type 1 motif 3,4q13.3,protein-coding,/
CWITA013918,TCMBANKGE013918,STON2,STN2; STNB; STNB2,stonin 2,14q31.1,protein-coding,/
CWITA013919,TCMBANKGE013919,ECM1,URBWD,extracellular matrix protein 1,1q21.2,protein-coding,/
CWITA013920,TCMBANKGE013920,PCOLCE,PCPE; PCPE-1; PCPE1,procollagen C-endopeptidase enhancer,7q22.1,protein-coding,/
CWITA013921,TCMBANKGE013921,MPDU1,CDGIF; HBEBP2BPA; Lec35; My008; PP3958; PQLC5; SL15; SLC66A5,mannose-P-dolichol utilization defect 1,17p13.1,protein-coding,/
CWITA013922,TCMBANKGE013922,GABRA2,FLJ97076,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",4p12,protein-coding,
CWITA013923,TCMBANKGE013923,ACSL4,ACS4; FACL4; LACS4; MRX63; MRX68,acyl-CoA synthetase long chain family member 4,Xq23,protein-coding,/
CWITA013924,TCMBANKGE013924,CGA,CG-ALPHA; FSHA; GPA1; GPHA1; GPHa; HCG; LHA; TSHA,"glycoprotein hormones, alpha polypeptide",6q14.3,protein-coding,Research target
CWITA013925,TCMBANKGE013925,TOP3A,MGRISCE2; PEOB5; TOP3; ZGRF7,DNA topoisomerase III alpha,17p11.2,protein-coding,/
CWITA013926,TCMBANKGE013926,RXRB,DAUDI6; H-2RIIBP; NR2B2; RCoR-1,retinoid X receptor beta,6p21.32,protein-coding,Successful target
CWITA013927,TCMBANKGE013927,TBPL2,TBP2; TRF3,TATA-box binding protein like 2,14q22.3,protein-coding,/
CWITA013928,TCMBANKGE013928,TLE1,ESG; ESG1; GRG1,"TLE family member 1, transcriptional corepressor",9q21.32,protein-coding,/
CWITA013929,TCMBANKGE013929,GNA12,NNX3; RMP; gep,G protein subunit alpha 12,7p22.3-p22.2,protein-coding,/
CWITA013930,TCMBANKGE013930,TYR,ATN; CMM8; OCA1; OCA1A; OCAIA; SHEP3,tyrosinase,11q14.3,protein-coding,Successful target
CWITA013931,TCMBANKGE013931,PPY,PNP; PP,pancreatic polypeptide,17q21.31,protein-coding,Clinical Trial target
CWITA013932,TCMBANKGE013932,CYP4F3,CPF3; CYP4F; CYPIVF3; LTB4H,cytochrome P450 family 4 subfamily F member 3,19p13.12,protein-coding,/
CWITA013933,TCMBANKGE013933,CDK15,ALS2CR7; PFTAIRE2; PFTK2,cyclin dependent kinase 15,2q33.1,protein-coding,/
CWITA013934,TCMBANKGE013934,ECT2,ARHGEF31,epithelial cell transforming 2,3q26.31,protein-coding,/
CWITA013935,TCMBANKGE013935,ARSF,ASF,arylsulfatase F,Xp22.33,protein-coding,/
CWITA013936,TCMBANKGE013936,FGF6,HBGF-6; HST2,fibroblast growth factor 6,12p13.32,protein-coding,/
CWITA013937,TCMBANKGE013937,LURAP1L,C9orf150; HYST0841; LRAP35b; bA3L8.2,leucine rich adaptor protein 1 like,9p23,protein-coding,/
CWITA013938,TCMBANKGE013938,ETNK2,EKI2; HMFT1716,ethanolamine kinase 2,1q32.1,protein-coding,/
CWITA013939,TCMBANKGE013939,VWA5B2,-,von Willebrand factor A domain containing 5B2,3q27.1,protein-coding,/
CWITA013940,TCMBANKGE013940,SOAT1,ACACT; ACAT; ACAT-1; ACAT1; SOAT; STAT,sterol O-acyltransferase 1,1q25.2,protein-coding,/
CWITA013941,TCMBANKGE013941,CYTH2,ARNO; CTS18; CTS18.1; PSCD2; PSCD2L; SEC7L; Sec7pNL; Sec7pNlike,cytohesin 2,19q13.33,protein-coding,
CWITA013942,TCMBANKGE013942,PERP,KCP1; KRTCAP1; PIGPC1; THW; dJ496H19.1,p53 apoptosis effector related to PMP22,6q23.3,protein-coding,/
CWITA013943,TCMBANKGE013943,GET1,CHD5; WRB,guided entry of tail-anchored proteins factor 1,21q22.2,protein-coding,/
CWITA013944,TCMBANKGE013944,UGT1A4,GNT1; HUG-BR2; UDPGT; UDPGT 1-4; UGT-1A; UGT-1D; UGT1; UGT1-01; UGT1-04; UGT1.1; UGT1.4; UGT1A; UGT1A1; UGT1A4S; UGT1D; hUG-BR1,UDP glucuronosyltransferase family 1 member A4,2q37.1,protein-coding,/
CWITA013945,TCMBANKGE013945,RTN4RL2,NGRH1; NgR2,reticulon 4 receptor like 2,11q12.1,protein-coding,/
CWITA013946,TCMBANKGE013946,ANKRD39,-,ankyrin repeat domain 39,2q11.2,protein-coding,/
CWITA013947,TCMBANKGE013947,RPS11,S11,ribosomal protein S11,19q13.33,protein-coding,/
CWITA013948,TCMBANKGE013948,TGFB3,ARVD; ARVD1; LDS5; RNHF; TGF-beta3,transforming growth factor beta 3,14q24.3,protein-coding,Clinical Trial target
CWITA013949,TCMBANKGE013949,CYP4F2,CPF2,"cytochrome P450, family 4, subfamily F, polypeptide 2",19p13.12,protein-coding,
CWITA013950,TCMBANKGE013950,SLC25A29,C14orf69; CACL; ORNT3,solute carrier family 25 member 29,14q32.2,protein-coding,/
CWITA013951,TCMBANKGE013951,TTC6,C14orf25; NCRNA00291,tetratricopeptide repeat domain 6,14q21.1,protein-coding,/
CWITA013952,TCMBANKGE013952,GALNT4,GALNAC-T4; GALNACT4,polypeptide N-acetylgalactosaminyltransferase 4,12q21.33,protein-coding,/
CWITA013953,TCMBANKGE013953,PPP5D1,-,PPP5 tetratricopeptide repeat domain containing 1,19q13.32,protein-coding,/
CWITA013954,TCMBANKGE013954,MED1,CRSP1; CRSP200; DRIP205; DRIP230; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2,mediator complex subunit 1,17q12,protein-coding,/
CWITA013955,TCMBANKGE013955,AKR1B15,"AKR1B10L; AKR1B10L, AK1R1B7; AKR1R1B7",aldo-keto reductase family 1 member B15,7q33,protein-coding,/
CWITA013956,TCMBANKGE013956,DYNC1H1,CMT2O; DHC1; DHC1a; DNCH1; DNCL; DNECL; DYHC; Dnchc1; HL-3; SMALED1; p22,dynein cytoplasmic 1 heavy chain 1,14q32.31,protein-coding,/
CWITA013957,TCMBANKGE013957,SLC6A12,BGTN1; BGT1; FLJ38727; GAT2,"solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12",12p13,protein-coding,
CWITA013958,TCMBANKGE013958,RAB3GAP2,RAB3-GAP150; RAB3GAP150; SPG69; WARBM2; p150,RAB3 GTPase activating non-catalytic protein subunit 2,1q41,protein-coding,/
CWITA013959,TCMBANKGE013959,C7orf33,-,chromosome 7 open reading frame 33,7q36.1,protein-coding,/
CWITA013960,TCMBANKGE013960,FNTB,FPTB,"farnesyltransferase, CAAX box, beta",14q23.3,protein-coding,Research target
CWITA013961,TCMBANKGE013961,SEMA6C,SEMAY; m-SemaY; m-SemaY2,semaphorin 6C,1q21.3,protein-coding,/
CWITA013962,TCMBANKGE013962,SLC4A11,BTR1; CDPD1; CHED; CHED2; NABC1; dJ794I6.2,solute carrier family 4 member 11,20p13,protein-coding,/
CWITA013963,TCMBANKGE013963,KCNU1,KCNMC1; KCa5; KCa5.1; Kcnma3; Slo3,potassium calcium-activated channel subfamily U member 1,8p11.23,protein-coding,Research target
CWITA013964,TCMBANKGE013964,KHK,-,ketohexokinase,2p23.3,protein-coding,Research target
CWITA013965,TCMBANKGE013965,MED1,CRSP1; CRSP200; DRIP205; DRIP230; MGC71488; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2,mediator complex subunit 1,17q12,protein-coding,
CWITA013966,TCMBANKGE013966,SLC22A7,NLT; OAT2; hOAT11,solute carrier family 22 member 7,6p21.1,protein-coding,/
CWITA013967,TCMBANKGE013967,TKT,HEL-S-48; HEL107; SDDHD; TK; TKT1,Transketolase,3p21.1,protein-coding,
CWITA013968,TCMBANKGE013968,CA5A,CA5; CAV; CAVA,"carbonic anhydrase VA, mitochondrial",16q24.3,protein-coding,
CWITA013969,TCMBANKGE013969,TRIB1,C8FW; GIG-2; GIG2; SKIP1; TRB-1; TRB1,tribbles pseudokinase 1,8q24.13,protein-coding,/
CWITA013970,TCMBANKGE013970,NAA15,Ga19; MRD50; NARG1; NAT1P; NATH; TBDN; TBDN100,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",4q31.1,protein-coding,/
CWITA013971,TCMBANKGE013971,ANXA3,ANX3,annexin A3,4q21.21,protein-coding,/
CWITA013972,TCMBANKGE013972,ZYX,ESP-2; HED-2,zyxin,7q34,protein-coding,/
CWITA013973,TCMBANKGE013973,SLC7A9,BAT1; CSNU3,solute carrier family 7 member 9,19q13.11,protein-coding,/
CWITA013974,TCMBANKGE013974,BBS9,B1; C18; D1; PTHB1,Bardet-Biedl syndrome 9,7p14.3,protein-coding,/
CWITA013975,TCMBANKGE013975,TRIAP1,HSPC132; MDM35; P53CSV; WF-1,TP53 regulated inhibitor of apoptosis 1,12q24.31,protein-coding,/
CWITA013976,TCMBANKGE013976,CAP2,-,cyclase associated actin cytoskeleton regulatory protein 2,6p22.3,protein-coding,/
CWITA013977,TCMBANKGE013977,ANKRD66,-,ankyrin repeat domain 66,6p12.3,protein-coding,/
CWITA013978,TCMBANKGE013978,SLC16A8,MCT3; REMP,solute carrier family 16 member 8,22q13.1,protein-coding,/
CWITA013979,TCMBANKGE013979,ELOVL6,FACE; FAE; LCE,ELOVL fatty acid elongase 6,4q25,protein-coding,/
CWITA013980,TCMBANKGE013980,ANAPC10,APC10; DOC1,anaphase promoting complex subunit 10,4q31.21,protein-coding,/
CWITA013981,TCMBANKGE013981,HIF1AN,FIH1,hypoxia inducible factor 1 subunit alpha inhibitor,10q24.31,protein-coding,/
CWITA013982,TCMBANKGE013982,HOXC6,CP25; HHO.C8; HOX3; HOX3C,homeobox C6,12q13.13,protein-coding,/
CWITA013983,TCMBANKGE013983,TARS2,COXPD21; TARSL1; thrRS,"threonyl-tRNA synthetase 2, mitochondrial",1q21.2,protein-coding,/
CWITA013984,TCMBANKGE013984,EPOR,EPONR; MGC138358,erythropoietin receptor,19p13.3-p13.2,protein-coding,
CWITA013985,TCMBANKGE013985,ZNF674,MRX92; ZNF673B,zinc finger protein 674,Xp11.3,protein-coding,/
CWITA013986,TCMBANKGE013986,MAN1C1,HMIC; MAN1A3; MAN1C; pp6318,mannosidase alpha class 1C member 1,1p36.11,protein-coding,/
CWITA013987,TCMBANKGE013987,CNGA3,ACHM2; CCNC1; CCNCa; CCNCalpha; CNCG3; CNG3,cyclic nucleotide gated channel subunit alpha 3,2q11.2,protein-coding,Research target
CWITA013988,TCMBANKGE013988,SPOCK3,HSAJ1454; TES-3; TICN3,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3",4q32.3,protein-coding,/
CWITA013989,TCMBANKGE013989,CYP2C19,CPCJ; CYP2C; P450C2C; P450IIC19,"cytochrome P450, family 2, subfamily C, polypeptide 19",10q24,protein-coding,
CWITA013990,TCMBANKGE013990,PTS,PTPS,6-pyruvoyltetrahydropterin synthase,11q23.1,protein-coding,/
CWITA013991,TCMBANKGE013991,PSTPIP2,MAYP,proline-serine-threonine phosphatase interacting protein 2,18q21.1|tdb7990,protein-coding,/
CWITA013992,TCMBANKGE013992,PAK2,PAK65; PAKgamma,p21 (RAC1) activated kinase 2,3q29,protein-coding,Research target
CWITA013993,TCMBANKGE013993,PDSS1,COQ1; DPS; MGC70953; RP13-16H11.3; SPS; TPRT; TPT; TPT_1; hDPS1,"Prenyl (Decaprenyl) Diphosphate Synthase, Subunit 1",10p12.1,protein-coding,
CWITA013994,TCMBANKGE013994,FAM102B,SYM-3B,family with sequence similarity 102 member B,1p13.3,protein-coding,/
CWITA013995,TCMBANKGE013995,CYC1,UQCR4,cytochrome c-1,8q24.3,protein-coding,
CWITA013996,TCMBANKGE013996,ESRRG,ERR-gamma; ERR3; ERRg; ERRgamma; NR3B3,estrogen related receptor gamma,1q41,protein-coding,Research target
CWITA013997,TCMBANKGE013997,GTDC1,Hmat-Xa; mat-Xa,glycosyltransferase like domain containing 1,2q22.3,protein-coding,/
CWITA013998,TCMBANKGE013998,PGLYRP3,MGC149197; PGRPNIalpha; PGRPIA,peptidoglycan recognition protein 3,1q21,protein-coding,
CWITA013999,TCMBANKGE013999,CYTH1,B2-1; CYTOHESIN-1; D17S811E; PSCD1; SEC7,cytohesin 1,17q25.3,protein-coding,/
CWITA014000,TCMBANKGE014000,POTED,A26B3; ANKRD21; CT104.1; POTE; POTE-21; POTE21,POTE ankyrin domain family member D,21q11.2,protein-coding,/
CWITA014001,TCMBANKGE014001,UBR1,JBS,ubiquitin protein ligase E3 component n-recognin 1,15q15.2,protein-coding,/
CWITA014002,TCMBANKGE014002,MKL1,BSAC; MAL; MRTFNA,megakaryoblastic leukemia (translocation) 1,22q13,protein-coding,
CWITA014003,TCMBANKGE014003,IGFBP2,IBP2; IGF-BP53,insulin like growth factor binding protein 2,2q35,protein-coding,Research target
CWITA014004,TCMBANKGE014004,CORT,CST-14; CST-17; CST-29,cortistatin,1p36.22,protein-coding,/
CWITA014005,TCMBANKGE014005,PRRC2B,BAT2L; BAT2L1; KIAA0515; LQFBS-1,proline rich coiled-coil 2B,9q34.13,protein-coding,/
CWITA014006,TCMBANKGE014006,CDC42BPB,MRCKB,CDC42 binding protein kinase beta,14q32.32,protein-coding,/
CWITA014007,TCMBANKGE014007,EDEM3,C1orf22,ER degradation enhancing alpha-mannosidase like protein 3,1q25.3,protein-coding,/
CWITA014008,TCMBANKGE014008,PRDM8,EPM10; KMT8D; PFM5,PR/SET domain 8,4q21.21,protein-coding,/
CWITA014009,TCMBANKGE014009,CCKAR,CCK-A; CCK1-R; CCK1R; CCKRA,cholecystokinin A receptor,4p15.2,protein-coding,Clinical Trial target
CWITA014010,TCMBANKGE014010,PRSS23,SIG13; SPUVE; ZSIG13,serine protease 23,11q14.2,protein-coding,/
CWITA014011,TCMBANKGE014011,KCTD14,-,potassium channel tetramerization domain containing 14,11q14.1,protein-coding,/
CWITA014012,TCMBANKGE014012,RPH3A,-,rabphilin 3A,12q24.13,protein-coding,Research target
CWITA014013,TCMBANKGE014013,BPI,N,bactericidal/permeability-increasing protein,20q11.23,protein-coding,
CWITA014014,TCMBANKGE014014,NUAK1,ARK5,NUAK family kinase 1,12q23.3,protein-coding,Research target
CWITA014015,TCMBANKGE014015,BCHE,BCHED; CHE1; CHE2; E1,butyrylcholinesterase,3q26.1,protein-coding,Successful target
CWITA014016,TCMBANKGE014016,ZNF18,HDSG1; KOX11; ZKSCAN6; ZNF535; ZSCAN38; Zfp535,zinc finger protein 18,17p12,protein-coding,/
CWITA014017,TCMBANKGE014017,MCCC2,MCCB,methylcrotonoyl-CoA carboxylase 2 (beta),5q12-q13,protein-coding,
CWITA014018,TCMBANKGE014018,ISM2,TAIL1; THSD3,isthmin 2,14q24.3,protein-coding,/
CWITA014019,TCMBANKGE014019,NR3C2,FLJ41052; MCR; MGC133092; MLR; MR; NR3C2VIT,"nuclear receptor subfamily 3, group C, member 2",4q31.1,protein-coding,
CWITA014020,TCMBANKGE014020,IL27RA,CRL1; IL-27RA; IL27R; TCCR; WSX1; zcytor1,interleukin 27 receptor subunit alpha,19p13.12,protein-coding,/
CWITA014021,TCMBANKGE014021,TBCD,PEBAT; SSD-1; tfcD,tubulin folding cofactor D,17q25.3,protein-coding,/
CWITA014022,TCMBANKGE014022,ZDHHC6,DHHC-6; DHHC6; ZNF376,zinc finger DHHC-type palmitoyltransferase 6,10q25.2,protein-coding,/
CWITA014023,TCMBANKGE014023,SLC2A7,GLUT7,"solute carrier family 2 (facilitated glucose transporter), member 7",1p36.2,protein-coding,
CWITA014024,TCMBANKGE014024,AGTR1,AG2S; AGTR1A; AGTR1B; AT1; AT1B; AT1R; AT2R1; AT2R1A; AT2R1B; HAT1R,"angiotensin II receptor, type 1",3q24,protein-coding,
CWITA014025,TCMBANKGE014025,BHLHE23,BETA4; BHLHB4; Beta3b; bA305P22.3,basic helix-loop-helix family member e23,20q13.33,protein-coding,/
CWITA014026,TCMBANKGE014026,PGAM4,PGAM-B; PGAM1; PGAM3; dJ1000K24.1,phosphoglycerate mutase family member 4,Xq21.1,protein-coding,/
CWITA014027,TCMBANKGE014027,FABP1,FABPL; L-FABP,fatty acid binding protein 1,2p11.2,protein-coding,Successful target
CWITA014028,TCMBANKGE014028,IGF2R,CD222; CIMPR; M6PNR; MPR1; MPRI,insulin-like growth factor 2 receptor,6q26,protein-coding,
CWITA014029,TCMBANKGE014029,SLC15A1,HPECT1; HPEPT1; PEPT1,solute carrier family 15 member 1,13q32.2-q32.3,protein-coding,Research target
CWITA014030,TCMBANKGE014030,ZNF83,HPF1; ZNF816B,zinc finger protein 83,19q13.41,protein-coding,/
CWITA014031,TCMBANKGE014031,GCNT1,C2GNT; C2GNT-L; C2GNT1; G6NT; NACGT2; NAGCT2,glucosaminyl (N-acetyl) transferase 1,9q21.13,protein-coding,/
CWITA014032,TCMBANKGE014032,RNF146,-,ring finger protein 146,6q22.33,protein-coding,/
CWITA014033,TCMBANKGE014033,MAT2B,MAT-II; MATIIbeta; Nbla02999; SDR23E1; TGR,methionine adenosyltransferase 2B,5q34,protein-coding,/
CWITA014034,TCMBANKGE014034,TOE1,PCH7; hCaf1z,"target of EGR1, exonuclease",1p34.1,protein-coding,/
CWITA014035,TCMBANKGE014035,SLC44A2,CTL2; DKFZp666A071; FLJ44586; PP1292,"solute carrier family 44, member 2",19p13.1,protein-coding,
CWITA014036,TCMBANKGE014036,ZNF705D,ZNF705C,zinc finger protein 705D,8p23.1,protein-coding,/
CWITA014037,TCMBANKGE014037,GZMM,LMET1; MET1,granzyme M,19p13.3,protein-coding,/
CWITA014038,TCMBANKGE014038,C12orf60,-,chromosome 12 open reading frame 60,12p13.1-p12.3,protein-coding,/
CWITA014039,TCMBANKGE014039,20S,-,"DNA segment, 20S",-,unknown,/
CWITA014040,TCMBANKGE014040,PLXNA1,NOV; NOVP; PLEXIN-A1; PLXN1,plexin A1,3q21.3,protein-coding,/
CWITA014041,TCMBANKGE014041,LSM2,C6orf28; G7B; YBL026W; snRNP,"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated",6p21.33,protein-coding,/
CWITA014042,TCMBANKGE014042,INPP5D,SHIP; SHIP-1; SHIP1; SIP-145; hp51CN; p150Ship,inositol polyphosphate-5-phosphatase D,2q37.1,protein-coding,Clinical Trial target
CWITA014043,TCMBANKGE014043,UCN,UI; UROC,urocortin,2p23.3,protein-coding,/
CWITA014044,TCMBANKGE014044,SF1,BBP; D11S636; MBBP; ZCCHC25; ZFM1; ZNF162,splicing factor 1,11q13.1,protein-coding,/
CWITA014045,TCMBANKGE014045,ATF5,ATFX; HMFN0395,activating transcription factor 5,19q13.33,protein-coding,/
CWITA014046,TCMBANKGE014046,PDC,MEKA; PHD; PhLOP; PhLP,phosducin,1q25.2,protein-coding,
CWITA014047,TCMBANKGE014047,FKBP1A,FKBPN12; FKBP1; FKBP12; PKC12; PKCI2; PPIASE,"FK506 binding protein 1A, 12kDa",20p13,protein-coding,
CWITA014048,TCMBANKGE014048,SLC7A11,CCBR1; xCT,"solute carrier family 7, (cationic amino acid transporter, y+ system) member 11",4q28-q32,protein-coding,
CWITA014049,TCMBANKGE014049,MAP3K10,MEKK10; MLK2; MST,mitogen-activated protein kinase kinase kinase 10,19q13.2,protein-coding,Research target
CWITA014050,TCMBANKGE014050,GABRA1,ECA4; EIEE19; EJM; EJM5,gamma-aminobutyric acid type A receptor subunit alpha1,5q34,protein-coding,Successful target
CWITA014051,TCMBANKGE014051,CHRNA7,CHRNA7N2; NACHRA7,"cholinergic receptor, nicotinic, alpha 7",15q14,protein-coding,
CWITA014052,TCMBANKGE014052,FOLR3,FRNG; FRNgamma; gammaNhFR,folate receptor 3 (gamma),11q13,protein-coding,
CWITA014053,TCMBANKGE014053,PTPN2,PTN2; PTPT; TC-PTP; TCELLPTP; TCPTP,"Protein Tyrosine Phosphatase, Non-Receptor Type 2",18p11.3-p11.2,protein-coding,
CWITA014054,TCMBANKGE014054,ZBTB6,ZID; ZNF482,zinc finger and BTB domain containing 6,9q33.2,protein-coding,/
CWITA014055,TCMBANKGE014055,AMY2A,AMY2; PA,amylase alpha 2A,1p21.1,protein-coding,Clinical Trial target
CWITA014056,TCMBANKGE014056,RIMKLB,FAM80B; NAAGS; NAAGS-I,ribosomal modification protein rimK like family member B,12p13.31,protein-coding,/
CWITA014057,TCMBANKGE014057,NOMO1,NOMO3; Nomo; PM5,NODAL modulator 1,16p13.11,protein-coding,
CWITA014058,TCMBANKGE014058,SIGIRR,IL-1R8; TIR8,single Ig and TIR domain containing,11p15.5,protein-coding,/
CWITA014059,TCMBANKGE014059,ZNFX1,-,zinc finger NFX1-type containing 1,20q13.13,protein-coding,/
CWITA014060,TCMBANKGE014060,SLC12A1,BSC1; MGC48843; NKCC2,"solute carrier family 12 (sodium/potassium/chloride transporters), member 1",15q15-q21.1,protein-coding,
CWITA014061,TCMBANKGE014061,PRPF31,NY-BR-99; PRP31; RP11; SNRNP61,pre-mRNA processing factor 31,19q13.42,protein-coding,/
CWITA014062,TCMBANKGE014062,CAPN5,ADNIV; HTRA3; VRNI; nCL-3,calpain 5,11q13.5,protein-coding,/
CWITA014063,TCMBANKGE014063,OR8U1,-,olfactory receptor family 8 subfamily U member 1,11q12.1,protein-coding,/
CWITA014064,TCMBANKGE014064,RNF24,G1L,ring finger protein 24,20p13,protein-coding,/
CWITA014065,TCMBANKGE014065,SERPINB8,C18orf53; CAP2; PI-8; PI8; PSS5,serpin family B member 8,18q22.1,protein-coding,/
CWITA014066,TCMBANKGE014066,C2orf76,AIM29,chromosome 2 open reading frame 76,2q14.2,protein-coding,/
CWITA014067,TCMBANKGE014067,AGXT,AGT; AGT1; AGXT1; PH1; SPAT; SPT; TLH6,alanine-glyoxylate aminotransferase,2q37.3,protein-coding,
CWITA014068,TCMBANKGE014068,ADORA3,A3AR; AD026; bA552M11.5,adenosine A3 receptor,1p13.2,protein-coding,
CWITA014069,TCMBANKGE014069,ANKS4B,HARP,ankyrin repeat and sterile alpha motif domain containing 4B,16p12.2,protein-coding,/
CWITA014070,TCMBANKGE014070,SNX5,-,sorting nexin 5,20p11.23,protein-coding,/
CWITA014071,TCMBANKGE014071,STAC,STAC1,SH3 and cysteine rich domain,3p22.3-p22.2,protein-coding,/
CWITA014072,TCMBANKGE014072,SARS,FLJ36399; SERRS; SERS,seryl-tRNA synthetase,1p13.3,protein-coding,
CWITA014073,TCMBANKGE014073,MCM8,C20orf154; POF10; dJ967N21.5,minichromosome maintenance 8 homologous recombination repair factor,20p12.3,protein-coding,/
CWITA014074,TCMBANKGE014074,ELMO3,CED-12; CED12; ELMO-3,engulfment and cell motility 3,16q22.1,protein-coding,/
CWITA014075,TCMBANKGE014075,NECAB3,APBA2BP; EFCBP3; NIP1; STIP3; SYTIP2; XB51; dJ63M2.4; dJ63M2.5,N-terminal EF-hand calcium binding protein 3,20q11.22,protein-coding,/
CWITA014076,TCMBANKGE014076,GTPBP2,JABELS,GTP binding protein 2,6p21.1,protein-coding,/
CWITA014077,TCMBANKGE014077,PURA,MRD31; PUR-ALPHA; PUR1; PURALPHA,purine rich element binding protein A,5q31.3,protein-coding,/
CWITA014078,TCMBANKGE014078,ZNF43,HTF6; KOX27; ZNF39L1,zinc finger protein 43,19p12,protein-coding,/
CWITA014079,TCMBANKGE014079,ACSL5,ACS2; ACS5; FACL5,acyl-CoA synthetase long chain family member 5,10q25.2,protein-coding,/
CWITA014080,TCMBANKGE014080,RECK,ST15,reversion inducing cysteine rich protein with kazal motifs,9p13.3,protein-coding,Research target
CWITA014081,TCMBANKGE014081,LANCL2,GPR69B; TASP,LanC like 2,7p11.2,protein-coding,/
CWITA014082,TCMBANKGE014082,CCT2,99D8.1; CCT-beta; CCTB; HEL-S-100n; PRO1633; TCP-1-beta,chaperonin containing TCP1 subunit 2,12q15,protein-coding,/
CWITA014083,TCMBANKGE014083,RSU1,RSP-1,Ras suppressor protein 1,10p13,protein-coding,/
CWITA014084,TCMBANKGE014084,SLC22A6,HOAT1; OAT1; PAHT; ROAT1,solute carrier family 22 member 6,11q12.3,protein-coding,/
CWITA014085,TCMBANKGE014085,PPP1R13L,IASPP; NKIP1; RAI; RAI4,protein phosphatase 1 regulatory subunit 13 like,19q13.32,protein-coding,/
CWITA014086,TCMBANKGE014086,SNF8,Dot3; EAP30; VPS22,SNF8 subunit of ESCRT-II,17q21.32,protein-coding,/
CWITA014087,TCMBANKGE014087,EPX,EPO; EPP; EPX-PEN; EPXD,eosinophil peroxidase,17q22,protein-coding,Research target
CWITA014088,TCMBANKGE014088,SLC22A2,MGC32628; OCT2,"solute carrier family 22 (organic cation transporter), member 2",6q26,protein-coding,
CWITA014089,TCMBANKGE014089,GSDMA,FKSG9; GSDM; GSDM1,gasdermin A,17q21.1,protein-coding,/
CWITA014090,TCMBANKGE014090,TSSK4,C14orf20; STK22E; TSK-4; TSK4; TSSK5,testis specific serine kinase 4,14q12,protein-coding,/
CWITA014091,TCMBANKGE014091,PROCR,CCCA; CCD41; CD201; EPCR; MGC23024; bA42O4.2,"protein C receptor, endothelial",20q11.2,protein-coding,
CWITA014092,TCMBANKGE014092,LRRIQ1,-,leucine rich repeats and IQ motif containing 1,12q21.31,protein-coding,/
CWITA014093,TCMBANKGE014093,ZNF286B,FOXO3B; ZNF286C; ZNF286L; ZNF590,zinc finger protein 286B (pseudogene),17p11.2,pseudo,/
CWITA014094,TCMBANKGE014094,CMC2,2310061C15Rik; C16orf61; DC13,C-X9-C motif containing 2,16q23.2,protein-coding,/
CWITA014095,TCMBANKGE014095,SLC32A1,VGAT; VIAAT,solute carrier family 32 member 1,20q11.23,protein-coding,/
CWITA014096,TCMBANKGE014096,TMEM159,-,transmembrane protein 159,16p12.3,protein-coding,/
CWITA014097,TCMBANKGE014097,PFAS,FGAMS; FGARAT; KIAA0361; PURL,phosphoribosylformylglycinamidine synthase,17p13.1,protein-coding,
CWITA014098,TCMBANKGE014098,HAUS8,DGT4; HICE1; NY-SAR-48,HAUS augmin like complex subunit 8,19p13.11,protein-coding,/
CWITA014099,TCMBANKGE014099,CDC42,CDC42Hs; G25K; TKS,cell division cycle 42,1p36.12,protein-coding,/
CWITA014100,TCMBANKGE014100,PMS2,HNPCC4; MLH4; PMS2CL; PMSL2,"PMS1 homolog 2, mismatch repair system component",7p22.1,protein-coding,/
CWITA014101,TCMBANKGE014101,CD8A,CD8; Leu2; p32,CD8a molecule,2p11.2,protein-coding,/
CWITA014102,TCMBANKGE014102,CYTH3,ARNO3; GRP1; PSCD3; cytohesin-3,cytohesin 3,7p22.1,protein-coding,/
CWITA014103,TCMBANKGE014103,FBXL6,FBL6; FBL6A; PP14630,F-box and leucine rich repeat protein 6,8q24.3,protein-coding,/
CWITA014104,TCMBANKGE014104,NDUFV2,CI-24k; MC1DN7,NADH:ubiquinone oxidoreductase core subunit V2,18p11.22,protein-coding,/
CWITA014105,TCMBANKGE014105,QTRT1,FP3235; TGT; TGUT,queuine tRNA-ribosyltransferase catalytic subunit 1,19p13.2,protein-coding,/
CWITA014106,TCMBANKGE014106,LPAR2,EDG-4; EDG4; LPA-2; LPA2,lysophosphatidic acid receptor 2,19p13.11,protein-coding,Research target
CWITA014107,TCMBANKGE014107,ANGPTL7,AngX; CDT6; dJ647M16.1,angiopoietin like 7,1p36.22,protein-coding,/
CWITA014108,TCMBANKGE014108,GSTM3,GST5; GSTB; GSTM3-3; GTM3,glutathione S-transferase mu 3,1p13.3,protein-coding,/
CWITA014109,TCMBANKGE014109,ADK,AK,adenosine kinase,10q22.2|10q11-q24,protein-coding,Clinical Trial target
CWITA014110,TCMBANKGE014110,C3,AHUS5; ARMD9; ASP; C3a; C3b; CPAMD1; HEL-S-62p,complement C3,19p13.3,protein-coding,Clinical Trial target
CWITA014111,TCMBANKGE014111,UBL7,BMSC-UbP; TCBA1,ubiquitin like 7,15q24.1,protein-coding,/
CWITA014112,TCMBANKGE014112,RAB3A,-,"RAB3A, member RAS oncogene family",19p13.11,protein-coding,/
CWITA014113,TCMBANKGE014113,FRAT2,FRAT-2,FRAT regulator of WNT signaling pathway 2,10q24.1,protein-coding,/
CWITA014114,TCMBANKGE014114,ZDHHC20,4933421L13Rik; DHHC-20; DHHC20,zinc finger DHHC-type palmitoyltransferase 20,13q12.11,protein-coding,/
CWITA014115,TCMBANKGE014115,CTSH,ACC-4; ACC-5; ACC4; ACC5; CPSB,cathepsin H,15q25.1,protein-coding,Research target
CWITA014116,TCMBANKGE014116,CD55,CHAPLE; CR; CROM; DAF; TC,CD55 molecule (Cromer blood group),1q32.2,protein-coding,Clinical Trial target
CWITA014117,TCMBANKGE014117,SLCO4C1,OATPNH; OATPNM1; OATP4C1; OATPX; PRO2176; SLC21A20,"solute carrier organic anion transporter family, member 4C1",5q21.2,protein-coding,
CWITA014118,TCMBANKGE014118,LHB,CGB4; HH23; LSH-B; LSH-beta,luteinizing hormone subunit beta,19q13.33,protein-coding,/
CWITA014119,TCMBANKGE014119,Ctsm-ps,-,"cathepsin M, pseudogene",13|13,pseudo,/
CWITA014120,TCMBANKGE014120,TRIM41,RINCK,tripartite motif containing 41,5q35.3,protein-coding,/
CWITA014121,TCMBANKGE014121,DUSP16,MKP-7; MKP7,dual specificity phosphatase 16,12p13.2,protein-coding,/
CWITA014122,TCMBANKGE014122,CYP26A1,CP26; CYP26; P450RAI; P450RAI1,cytochrome P450 family 26 subfamily A member 1,10q23.33,protein-coding,Clinical Trial target
CWITA014123,TCMBANKGE014123,CAMK2G,CAMK; CAMKNII; CAMKG; FLJ16043; MGC26678,calcium/calmodulin-dependent protein kinase II gamma,10q22,protein-coding,
CWITA014124,TCMBANKGE014124,PTK6,BRK,protein tyrosine kinase 6,20q13.33,protein-coding,Clinical Trial target
CWITA014125,TCMBANKGE014125,SLC35F5,-,solute carrier family 35 member F5,2q14.1,protein-coding,/
CWITA014126,TCMBANKGE014126,ARSK,TSULF,arylsulfatase family member K,5q15,protein-coding,/
CWITA014127,TCMBANKGE014127,ZNF687,PDB6,zinc finger protein 687,1q21.3,protein-coding,/
CWITA014128,TCMBANKGE014128,CA9,CAIX; MN,carbonic anhydrase IX,9p12,protein-coding,
CWITA014129,TCMBANKGE014129,ARHGAP25,HEL-S-308; KAIA0053,Rho GTPase activating protein 25,2p13.3,protein-coding,/
CWITA014130,TCMBANKGE014130,DIPK1A,FAM69A,divergent protein kinase domain 1A,1p22.1,protein-coding,/
CWITA014131,TCMBANKGE014131,PPIAL4D,-,peptidylprolyl isomerase A like 4D,1q21.1,protein-coding,/
CWITA014132,TCMBANKGE014132,NR1D1,EAR1; REVERBA; REVERBalpha; THRA1; THRAL; ear-1; hRev,nuclear receptor subfamily 1 group D member 1,17q21.1,protein-coding,Research target
CWITA014133,TCMBANKGE014133,ADSL,AMPS; ASASE; ASL,adenylosuccinate lyase,22q13.1,protein-coding,/
CWITA014134,TCMBANKGE014134,GRM4,GPRC1D; MGC177594; MGLUR4; mGlu4,"glutamate receptor, metabotropic 4",6p21.3,protein-coding,
CWITA014135,TCMBANKGE014135,HSD17B14,DHRS10; SDR47C1; retSDR3,hydroxysteroid 17-beta dehydrogenase 14,19q13.33,protein-coding,/
CWITA014136,TCMBANKGE014136,LTF,GIG12; HEL110; HLF2; LF,lactotransferrin,3p21.31,protein-coding,Clinical Trial target
CWITA014137,TCMBANKGE014137,CLEC2B,AICL; CLECSF2; HP10085; IFNRG1,C-type lectin domain family 2 member B,12p13.31,protein-coding,/
CWITA014138,TCMBANKGE014138,MTHFD2,NMDMC,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase",2p13.1,protein-coding,
CWITA014139,TCMBANKGE014139,HIRIP3,-,HIRA interacting protein 3,16p11.2,protein-coding,/
CWITA014140,TCMBANKGE014140,IGF1R,CD221; IGFIR; IGFR; JTK13; MGC142170; MGC142172; MGC18216,insulin-like growth factor 1 receptor,15q26.3,protein-coding,
CWITA014141,TCMBANKGE014141,ZNF624,-,zinc finger protein 624,17p11.2,protein-coding,/
CWITA014142,TCMBANKGE014142,KCTD8,-,potassium channel tetramerization domain containing 8,4p13,protein-coding,/
CWITA014143,TCMBANKGE014143,TNNT2,CMD1D; CMH2; CMPD2; LVNC6; RCM3; TnTC; cTnT,"troponin T2, cardiac type",1q32.1,protein-coding,Research target
CWITA014144,TCMBANKGE014144,LEMD3,MAN1,LEM domain containing 3,12q14.3,protein-coding,/
CWITA014145,TCMBANKGE014145,APEX1,APE; APE1; APEN; APEX; APX; HAP1; REF1,APEX nuclease (multifunctional DNA repair enzyme) 1,14q11.2,protein-coding,
CWITA014146,TCMBANKGE014146,HACL1,2-HPCL; HPCL; HPCL2; PHYH2,2-hydroxyacyl-CoA lyase 1,3p25.1,protein-coding,/
CWITA014147,TCMBANKGE014147,UGT1A10,GNT1; UDPGT; UGT-1A; UGT-1J; UGT1; UGT1-01; UGT1-10; UGT1.1; UGT1.10; UGT1A; UGT1A1; UGT1J; hUG-BR1,UDP glucuronosyltransferase family 1 member A10,2q37.1,protein-coding,/
CWITA014148,TCMBANKGE014148,PTPRB,HPTP-BETA; HPTPB; PTPB; R-PTP-BETA; VEPTP,protein tyrosine phosphatase receptor type B,12q15,protein-coding,Clinical Trial target
CWITA014149,TCMBANKGE014149,TEKT3,-,tektin 3,17p12,protein-coding,/
CWITA014150,TCMBANKGE014150,AANAT,SNAT,aralkylamine N-acetyltransferase,17q25,protein-coding,
CWITA014151,TCMBANKGE014151,ZBTB7A,FBI-1; FBI1; LRF; TIP21; ZBTB7; ZNF857A; pokemon,zinc finger and BTB domain containing 7A,19p13.3,protein-coding,/
CWITA014152,TCMBANKGE014152,USP14,TGT,Ubiquitin_Specific_Peptidase_14,18p11.32,protein-coding,
CWITA014153,TCMBANKGE014153,ZNF746,PARIS,zinc finger protein 746,7q36.1,protein-coding,/
CWITA014154,TCMBANKGE014154,DYNLRB1,BITH; BLP; DNCL2A; DNLC2A; ROBLD1,dynein light chain roadblock-type 1,20q11.22,protein-coding,/
CWITA014155,TCMBANKGE014155,STAG1,MRD47; SA1; SCC3A,stromal antigen 1,3q22.3,protein-coding,/
CWITA014156,TCMBANKGE014156,APOH,B2G1; B2GP1; BG,apolipoprotein H (beta-2-glycoprotein I),17q23-qter,protein-coding,
CWITA014157,TCMBANKGE014157,KIAA0408,-,KIAA0408,6q22.33,protein-coding,/
CWITA014158,TCMBANKGE014158,VIP,PHM27,vasoactive intestinal peptide,6q25.2,protein-coding,Research target
CWITA014159,TCMBANKGE014159,GNPDA1,GNP1; GNPDA; GNPI; GPI; HLN; KIAA0060,glucosamine-6-phosphate deaminase 1,5q21,protein-coding,
CWITA014160,TCMBANKGE014160,PDGFC,FALLOTEIN; SCDGF,platelet derived growth factor C,4q32.1,protein-coding,Research target
CWITA014161,TCMBANKGE014161,RAPH1,ALS2CR18; ALS2CR9; LPD; PREL-2; PREL2; RMO1; RalGDS/AF-6,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,2q33.2,protein-coding,/
CWITA014162,TCMBANKGE014162,THADA,FLJ21877; FLJ44016; FLJ44876; FLJ77530; GITA; KIAA1767,Thyroid Adenoma Associated,2p21,protein-coding,
CWITA014163,TCMBANKGE014163,MBTD1,SA49P01,mbt domain containing 1,17q21.33,protein-coding,/
CWITA014164,TCMBANKGE014164,KLK8,HNP; NP; NRPN; PRSS19; TADG14,kallikrein related peptidase 8,19q13.41,protein-coding,Research target
CWITA014165,TCMBANKGE014165,NDUFA4,CIN9k; CINMLRQ; FLJ27440; MGC104422; MGC126843; MGC126845; MLRQ,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa",7p21.3,protein-coding,
CWITA014166,TCMBANKGE014166,RCVRN,RCV1,recoverin,17p13.1,protein-coding,
CWITA014167,TCMBANKGE014167,TAS2R60,T2R56; T2R60,taste 2 receptor member 60,7q35,protein-coding,/
CWITA014168,TCMBANKGE014168,ECI2,ACBD2; DRS-1; DRS1; HCA88; PECI; dJ1013A10.3,enoyl-CoA delta isomerase 2,6p25.2,protein-coding,/
CWITA014169,TCMBANKGE014169,CACNA1G,Ca(V)T.1; Cav3.1; NBR13; SCA42; SCA42ND,calcium voltage-gated channel subunit alpha1 G,17q21.33,protein-coding,Successful target
CWITA014170,TCMBANKGE014170,PNPLA1,ARCI10; dJ50J22.1,patatin like phospholipase domain containing 1,6p21.31,protein-coding,/
CWITA014171,TCMBANKGE014171,MRPL39,C21orf92; L39mt; L5mt; MRP-L5; MRPL5; MSTP003; PRED22; PRED66; RPML5,mitochondrial ribosomal protein L39,21q21.3,protein-coding,/
CWITA014172,TCMBANKGE014172,SSH3,SSH3L,slingshot protein phosphatase 3,11q13.2,protein-coding,/
CWITA014173,TCMBANKGE014173,IRF2BPL,C14orf4; EAP1; NEDAMSS,interferon regulatory factor 2 binding protein like,14q24.3,protein-coding,/
CWITA014174,TCMBANKGE014174,WRN,RECQ3; RECQL2; RECQL3,WRN RecQ like helicase,8p12,protein-coding,/
CWITA014175,TCMBANKGE014175,ARSJ,ASJ,arylsulfatase family member J,4q26,protein-coding,/
CWITA014176,TCMBANKGE014176,ANGPT2,AGPT2; ANG2,angiopoietin 2,8p23.1,protein-coding,Clinical Trial target
CWITA014177,TCMBANKGE014177,ADGRL2,CIRL2; CL2; LEC1; LPHH1; LPHN2,adhesion G protein-coupled receptor L2,1p31.1,protein-coding,/
CWITA014178,TCMBANKGE014178,MGMT,N,O-6-methylguanine-DNA methyltransferase,10q26,protein-coding,
CWITA014179,TCMBANKGE014179,TMEM132C,PPP1R152,transmembrane protein 132C,12q24.32-q24.33,protein-coding,/
CWITA014180,TCMBANKGE014180,LINGO1,LERN1; LRRN6A; MRT64; UNQ201,leucine rich repeat and Ig domain containing 1,15q24.3,protein-coding,Clinical Trial target
CWITA014181,TCMBANKGE014181,ZNF227,-,zinc finger protein 227,19q13.31,protein-coding,/
CWITA014182,TCMBANKGE014182,ABHD17B,C9orf77; CGI-67; FAM108B1,"abhydrolase domain containing 17B, depalmitoylase",9q21.13,protein-coding,/
CWITA014183,TCMBANKGE014183,UBL4A,DX254E; DXS254E; G6PD; GDX; GET5; MDY2; TMA24; UBL4,ubiquitin like 4A,Xq28,protein-coding,/
CWITA014184,TCMBANKGE014184,MTERF1,MTERF,mitochondrial transcription termination factor 1,7q21.2,protein-coding,/
CWITA014185,TCMBANKGE014185,SEC22C,SEC22L3,"SEC22 homolog C, vesicle trafficking protein",3p22.1,protein-coding,/
CWITA014186,TCMBANKGE014186,PPP1R3D,PPP1R6,protein phosphatase 1 regulatory subunit 3D,20q13.33,protein-coding,/
CWITA014187,TCMBANKGE014187,FGF16,FGF-16; MF4,fibroblast growth factor 16,Xq21.1,protein-coding,/
CWITA014188,TCMBANKGE014188,HRH4,AXOR35; BG26; GPCR105; GPRv53; H4; H4R; HH4R,histamine receptor H4,18q11.2,protein-coding,Clinical Trial target
CWITA014189,TCMBANKGE014189,TRAM1L1,-,translocation associated membrane protein 1 like 1,4q26,protein-coding,/
CWITA014190,TCMBANKGE014190,TBRG1,NIAM; TB-5,transforming growth factor beta regulator 1,11q24.2,protein-coding,/
CWITA014191,TCMBANKGE014191,COL24A1,-,collagen type XXIV alpha 1 chain,1p22.3,protein-coding,/
CWITA014192,TCMBANKGE014192,XCR1,CCXCR1; GPR5,X-C motif chemokine receptor 1,3p21.31,protein-coding,/
CWITA014193,TCMBANKGE014193,VEGFB,VEGFL; VRF,vascular endothelial growth factor B,11q13.1,protein-coding,Successful target
CWITA014194,TCMBANKGE014194,SNORD12C,E2; E2-1; E3; RNU106; SNORD106; U106,"small nucleolar RNA, C/D box 12C",20q13.13,snoRNA,/
CWITA014195,TCMBANKGE014195,MMP9,CLG4B; GELB; MANDP2; MMPN9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",20q11.2-q13.1,protein-coding,
CWITA014196,TCMBANKGE014196,CPN1,CPN; SCPN,carboxypeptidase N subunit 1,10q24.2,protein-coding,Research target
CWITA014197,TCMBANKGE014197,CD84,LY9B; SLAMF5; hCD84; mCD84,CD84 molecule,1q23.3,protein-coding,/
CWITA014198,TCMBANKGE014198,C4orf19,-,chromosome 4 open reading frame 19,4p14,protein-coding,/
CWITA014199,TCMBANKGE014199,PCDHGA10,PCDH-GAMMA-A10,"protocadherin gamma subfamily A, 10",5q31.3,protein-coding,/
CWITA014200,TCMBANKGE014200,CPLX1,CPX-I; CPX1; EIEE63,complexin 1,4p16.3,protein-coding,/
CWITA014201,TCMBANKGE014201,SERPINI1,PI12; neuroserpin,serpin family I member 1,3q26.1,protein-coding,/
CWITA014202,TCMBANKGE014202,HMGCS1,HMGCS; MGC90332,3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble),5p14-p13,protein-coding,
CWITA014203,TCMBANKGE014203,ZNF680,-,zinc finger protein 680,7q11.21,protein-coding,/
CWITA014204,TCMBANKGE014204,UBXN4,UBXD2; UBXDC1; erasin,UBX domain protein 4,2q21.3,protein-coding,/
CWITA014205,TCMBANKGE014205,HOXB3,HOX2; HOX2G; Hox-2.7,homeobox B3,17q21.32,protein-coding,/
CWITA014206,TCMBANKGE014206,ELAVL1,ELAV1; HUR; Hua; MelG,ELAV like RNA binding protein 1,19p13.2,protein-coding,Research target
CWITA014207,TCMBANKGE014207,EIF4B,EIF-4B; PRO1843,eukaryotic translation initiation factor 4B,12q13.13,protein-coding,/
CWITA014208,TCMBANKGE014208,CAD,CDG1Z; EIEE50; GATD4,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",2p23.3,protein-coding,Research target
CWITA014209,TCMBANKGE014209,PARP10,ARTD10,poly(ADP-ribose) polymerase family member 10,8q24.3,protein-coding,/
CWITA014210,TCMBANKGE014210,ST3GAL5,SATI; SIAT9; SIATGM3S; SPDRS; ST3Gal V; ST3GalV,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",2p11.2,protein-coding,Research target
CWITA014211,TCMBANKGE014211,ANKRD30A,NY-BR-1,ankyrin repeat domain 30A,10p11.21,protein-coding,/
CWITA014212,TCMBANKGE014212,HBG1,HBG-T2; HBGA; HBGR; HSGGL1; PRO2979,hemoglobin subunit gamma 1,11p15.4,protein-coding,/
CWITA014213,TCMBANKGE014213,TMEM260,C14orf101; SHDRA,transmembrane protein 260,14q22.3,protein-coding,/
CWITA014214,TCMBANKGE014214,CSPG4,CSPG4A; HMW-MAA; MCSP; MCSPG; MEL-CSPG; MSK16; NG2,chondroitin sulfate proteoglycan 4,15q24.2,protein-coding,Research target
CWITA014215,TCMBANKGE014215,ST14,HAI; MTNSP1; MTSP1; PRSS14; SNC19; TADG15; TMPRSS14,suppression of tumorigenicity 14 (colon carcinoma),11q24-q25,protein-coding,
CWITA014216,TCMBANKGE014216,GTF3A,AP2; TFIIIA,general transcription factor IIIA,13q12.2,protein-coding,/
CWITA014217,TCMBANKGE014217,GNRH1,GNRH; GRH; LHRH; LNRH,gonadotropin releasing hormone 1,8p21.2,protein-coding,Successful target
CWITA014218,TCMBANKGE014218,TRA2B,Htra2-beta; PPP1R156; SFRS10; SRFS10; TRA2-BETA; TRAN2B,transformer 2 beta homolog,3q27.2,protein-coding,/
CWITA014219,TCMBANKGE014219,CIZ1,LSFR1; NP94; ZNF356,CDKN1A interacting zinc finger protein 1,9q34.11,protein-coding,/
CWITA014220,TCMBANKGE014220,POLR1B,A135; RPA135; RPA2; Rpo1-2,RNA polymerase I subunit B,2q14.1,protein-coding,/
CWITA014221,TCMBANKGE014221,OPN3,ECPN; PPP1R116,opsin 3,1q43,protein-coding,/
CWITA014222,TCMBANKGE014222,ATF3,FLJ41705,activating transcription factor 3,1q32.3,protein-coding,
CWITA014223,TCMBANKGE014223,VEPH1,MELT; VEPH,ventricular zone expressed PH domain containing 1,3q25.31-q25.32,protein-coding,/
CWITA014224,TCMBANKGE014224,LIG1,-,DNA ligase 1,19q13.33,protein-coding,/
CWITA014225,TCMBANKGE014225,ERAP2,L-RAP; LRAP,endoplasmic reticulum aminopeptidase 2,5q15,protein-coding,Research target
CWITA014226,TCMBANKGE014226,ACSM4,-,acyl-CoA synthetase medium chain family member 4,12p13.31,protein-coding,/
CWITA014227,TCMBANKGE014227,ZNF599,-,zinc finger protein 599,19q13.11,protein-coding,/
CWITA014228,TCMBANKGE014228,TSPAN15,2700063A19Rik; NET-7; NET7; TM4SF15,tetraspanin 15,10q22.1,protein-coding,/
CWITA014229,TCMBANKGE014229,TCEAL8,WEX3,transcription elongation factor A like 8,Xq22.1,protein-coding,/
CWITA014230,TCMBANKGE014230,RIT2,RIBA; RIN; ROC2,Ras like without CAAX 2,18q12.3,protein-coding,/
CWITA014231,TCMBANKGE014231,NAT2,AAC2; PNAT,N-acetyltransferase 2 (arylamine N-acetyltransferase),8p22,protein-coding,
CWITA014232,TCMBANKGE014232,BAIAP2L1,IRTKS,BAR/IMD domain containing adaptor protein 2 like 1,7q21.3-q22.1,protein-coding,/
CWITA014233,TCMBANKGE014233,TUBA4A,FLJ30169; H2NALPHA; TUBA1,"tubulin, alpha 4a",2q35,protein-coding,
CWITA014234,TCMBANKGE014234,DLL4,AOS6; delta4; hdelta2,delta like canonical Notch ligand 4,15q15.1,protein-coding,Clinical Trial target
CWITA014235,TCMBANKGE014235,HPD,4NHPPD; 4HPPD; GLOD3; HPPDASE; PPD,4-hydroxyphenylpyruvate dioxygenase,12q24-qter,protein-coding,
CWITA014236,TCMBANKGE014236,SLIRP,C14orf156; DC50; PD04872,SRA stem-loop interacting RNA binding protein,14q24.3,protein-coding,/
CWITA014237,TCMBANKGE014237,MAMDC2,-,MAM domain containing 2,9q21.12,protein-coding,/
CWITA014238,TCMBANKGE014238,SGTA,SGT; alphaSGT; hSGT,small glutamine rich tetratricopeptide repeat containing alpha,19p13.3,protein-coding,/
CWITA014239,TCMBANKGE014239,IFNAR2,IFN-R; IFN-alpha-REC; IFNABR; IFNARB; IMD45,interferon alpha and beta receptor subunit 2,21q22.11,protein-coding,Successful target
CWITA014240,TCMBANKGE014240,NF2,ACN; BANF; SCH,neurofibromin 2,22q12.2,protein-coding,Research target
CWITA014241,TCMBANKGE014241,MYH8,DA7; MyHC-peri; MyHC-pn; gtMHC-F,myosin heavy chain 8,17p13.1,protein-coding,/
CWITA014242,TCMBANKGE014242,FBXL16,C16orf22; Fbl16; c380A1.1,F-box and leucine rich repeat protein 16,16p13.3,protein-coding,/
CWITA014243,TCMBANKGE014243,EHD1,H-PAST; HPAST1; PAST; PAST1,EH domain containing 1,11q13.1,protein-coding,/
CWITA014244,TCMBANKGE014244,NDC1,NET3; TMEM48,NDC1 transmembrane nucleoporin,1p32.3,protein-coding,/
CWITA014245,TCMBANKGE014245,LRIT1,FIGLER9; LRRC21; PAL,"leucine rich repeat, Ig-like and transmembrane domains 1",10q23.1,protein-coding,/
CWITA014246,TCMBANKGE014246,CDH22,C20orf25; dJ998H6.1,cadherin 22,20q13.12,protein-coding,/
CWITA014247,TCMBANKGE014247,ZNF391,dJ153G14.3,zinc finger protein 391,6p22.1,protein-coding,/
CWITA014248,TCMBANKGE014248,QPRT,QPRTase,quinolinate phosphoribosyltransferase,16p11.2,protein-coding,
CWITA014249,TCMBANKGE014249,GSTA1,GST-epsilon; GST2; GSTA1-1; GTH1,glutathione S-transferase alpha 1,6p12.2,protein-coding,Research target
CWITA014250,TCMBANKGE014250,TANGO6,TMCO7,transport and golgi organization 6 homolog,16q22.1,protein-coding,/
CWITA014251,TCMBANKGE014251,ACSF2,ACSMW; AVYV493,acyl-CoA synthetase family member 2,17q21.33,protein-coding,/
CWITA014252,TCMBANKGE014252,IL15,IL-15,interleukin 15,4q31.21,protein-coding,Clinical Trial target
CWITA014253,TCMBANKGE014253,SPTBN5,BSPECV; HUBSPECV; HUSPECV,"spectrin beta, non-erythrocytic 5",15q15.1,protein-coding,/
CWITA014254,TCMBANKGE014254,SERPINB13,HSHUR7SEQ; HUR7; PI13; headpin,serpin family B member 13,18q21.33,protein-coding,/
CWITA014255,TCMBANKGE014255,CACNG1,CACNLG,calcium voltage-gated channel auxiliary subunit gamma 1,17q24.2,protein-coding,/
CWITA014256,TCMBANKGE014256,SEMA3D,Sema-Z2; coll-2,semaphorin 3D,7q21.11,protein-coding,/
CWITA014257,TCMBANKGE014257,HIBADH,MGC40361; NS5ATP1,3-hydroxyisobutyrate dehydrogenase,7p15.2,protein-coding,
CWITA014258,TCMBANKGE014258,PEAK1,SGK269,pseudopodium enriched atypical kinase 1,15q24.3,protein-coding,/
CWITA014259,TCMBANKGE014259,PCDH17,PCDH68; PCH68,protocadherin 17,13q21.1,protein-coding,/
CWITA014260,TCMBANKGE014260,GNMT,HEL-S-182mP,glycine N-methyltransferase,6p21.1,protein-coding,/
CWITA014261,TCMBANKGE014261,PTRH2,BIT1; CFAP37; CGI-147; IMNEPD; PTH; PTH 2; PTH2,peptidyl-tRNA hydrolase 2,17q23.1,protein-coding,/
CWITA014262,TCMBANKGE014262,CYP11B1,CPN1; CYP11B; FHI; P450C11,cytochrome P450 family 11 subfamily B member 1,8q24.3,protein-coding,Successful target
CWITA014263,TCMBANKGE014263,KEAP1,INrf2; KIAA0132; KLHL19; MGC10630; MGC1114; MGC20887; MGC4407; MGC9454,kelch-like ECH-associated protein 1,19p13.2,protein-coding,
CWITA014264,TCMBANKGE014264,TADA2B,ADA2(beta); ADA2B,transcriptional adaptor 2B,4p16.1,protein-coding,/
CWITA014265,TCMBANKGE014265,NDUFV3,CIN10k; CIN9KD,"NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa",21q22.3,protein-coding,
CWITA014266,TCMBANKGE014266,KCNK1,DPK; HOHO; K2P1; K2p1.1; KCNO1; TWIKN1; TWIK1,"potassium channel, subfamily K, member 1",1q42-q43,protein-coding,
CWITA014267,TCMBANKGE014267,MRPL55,AAVG5835; L55nt; MRP-L55; PRO19675,mitochondrial ribosomal protein L55,1q42.13,protein-coding,/
CWITA014268,TCMBANKGE014268,GNAT1,CSNBAD3; GBT1; GNATR,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1",3p21,protein-coding,
CWITA014269,TCMBANKGE014269,AKR1C1,2-ALPHA-HSD; 20-ALPHA-HSD; C9; DD1; DD1/DD2; DDH; DDH1; H-37; HAKRC; HBAB; MBAB,aldo-keto reductase family 1 member C1,10p15.1,protein-coding,/
CWITA014270,TCMBANKGE014270,PPP1R18,HKMT1098; KIAA1949,protein phosphatase 1 regulatory subunit 18,6p21.33,protein-coding,/
CWITA014271,TCMBANKGE014271,TMPRSS3,DFNB10; DFNB8; ECHOS1; TADG12,transmembrane serine protease 3,21q22.3,protein-coding,/
CWITA014272,TCMBANKGE014272,ZNF799,HIT-40; ZNF842,zinc finger protein 799,19p13.2,protein-coding,/
CWITA014273,TCMBANKGE014273,IL1RL1,DER4; FIT-1; IL33R; ST2; ST2L; ST2V; T1,interleukin 1 receptor like 1,2q12.1,protein-coding,/
CWITA014274,TCMBANKGE014274,PDIA3,ER60; ERp57; ERp60; ERp61; GRP57; GRP58; HEL-S-269; HEL-S-93n; HsT17083; P58; PI-PLC,protein disulfide isomerase family A member 3,15q15.3,protein-coding,/
CWITA014275,TCMBANKGE014275,MIS12,2510025F08Rik; KNTC2AP; MTW1; hMis12,MIS12 kinetochore complex component,17p13.2,protein-coding,/
CWITA014276,TCMBANKGE014276,NCALD,-,neurocalcin delta,8q22.3,protein-coding,/
CWITA014277,TCMBANKGE014277,RPLP2,D11S2243E; LP2; P2; RPP2,ribosomal protein lateral stalk subunit P2,11p15.5,protein-coding,/
CWITA014278,TCMBANKGE014278,Cc2d1a,BC016188; Freud-1; Tape,coiled-coil and C2 domain containing 1A,8|8 C2,protein-coding,/
CWITA014279,TCMBANKGE014279,ZBTB3,-,zinc finger and BTB domain containing 3,11q12.3,protein-coding,/
CWITA014280,TCMBANKGE014280,JAG1,AGS; AGS1; AHD; AWS; CD339; DCHE; HJ1; JAGL1,jagged canonical Notch ligand 1,20p12.2,protein-coding,/
CWITA014281,TCMBANKGE014281,SCGB2B2,SCGB4A2; SCGBL,secretoglobin family 2B member 2,19q13.11,protein-coding,/
CWITA014282,TCMBANKGE014282,ID2,GIG8; ID2A; ID2H; bHLHb26,inhibitor of DNA binding 2,2p25.1,protein-coding,Research target
CWITA014283,TCMBANKGE014283,NMNAT3,FKSG76; PNAT-3; PNAT3,nicotinamide nucleotide adenylyltransferase 3,3q23,protein-coding,/
CWITA014284,TCMBANKGE014284,ZNF646,-,zinc finger protein 646,16p11.2,protein-coding,/
CWITA014285,TCMBANKGE014285,CYB5R4,NCB5OR; cb5/cb5R; dJ676J13.1,cytochrome b5 reductase 4,6q14.2,protein-coding,/
CWITA014286,TCMBANKGE014286,WLS,C1orf139; EVI; GPR177; MRP; mig-14,Wnt ligand secretion mediator,1p31.3,protein-coding,/
CWITA014287,TCMBANKGE014287,LAMB4,-,laminin subunit beta 4,7q31.1,protein-coding,/
CWITA014288,TCMBANKGE014288,ME3,FLJ34862,"malic enzyme 3, NADP(+)-dependent, mitochondrial",11cen-q22.3,protein-coding,
CWITA014289,TCMBANKGE014289,MMP2,CLG4; CLG4A; MMPNII; MONA; TBEN1,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",16q13-q21,protein-coding,
CWITA014290,TCMBANKGE014290,FBXL4,FBL4; FBL5; MTDPS13,F-box and leucine rich repeat protein 4,6q16.1-q16.2,protein-coding,/
CWITA014291,TCMBANKGE014291,RTN3,ASYIP; HAP; NSPL2; NSPLII; RTN3-A1,reticulon 3,11q13.1,protein-coding,/
CWITA014292,TCMBANKGE014292,COL25A1,AMY; CFEOM5; CLAC; CLAC-P; CLACP,collagen type XXV alpha 1 chain,4q25,protein-coding,/
CWITA014293,TCMBANKGE014293,HEXB,ENC-1AS; HEL-248; HEL-S-111,hexosaminidase subunit beta,5q13.3,protein-coding,/
CWITA014294,TCMBANKGE014294,MRPL40,L40mt; MRP-L22; MRP-L40; MRPL22; NLVCF; URIM,mitochondrial ribosomal protein L40,22q11.21,protein-coding,/
CWITA014295,TCMBANKGE014295,GFY,Goofy,golgi associated olfactory signaling regulator,19q13.33,protein-coding,/
CWITA014296,TCMBANKGE014296,DPH3,DELGIP; DELGIP1; DESR1; DPH3A; KTI11; ZCSL2,diphthamide biosynthesis 3,3p25.1,protein-coding,/
CWITA014297,TCMBANKGE014297,KRIT1,CAM; CCM1,KRIT1 ankyrin repeat containing,7q21.2,protein-coding,/
CWITA014298,TCMBANKGE014298,UTS2,PRO1068; U-II; UCN2; UII,urotensin 2,1p36.23,protein-coding,Research target
CWITA014299,TCMBANKGE014299,LY6D,E48; Ly-6D,lymphocyte antigen 6 family member D,8q24.3,protein-coding,Research target
CWITA014300,TCMBANKGE014300,RAB13,GIG4,"RAB13, member RAS oncogene family",1q21.3,protein-coding,/
CWITA014301,TCMBANKGE014301,CDK8,IDDHBA; K35,cyclin dependent kinase 8,13q12.13,protein-coding,Patented target
CWITA014302,TCMBANKGE014302,ZDHHC13,HIP14L; HIP3RP,zinc finger DHHC-type palmitoyltransferase 13,11p15.1,protein-coding,/
CWITA014303,TCMBANKGE014303,AN,-,blood group Ahonen,-,unknown,/
CWITA014304,TCMBANKGE014304,MPP6,PALS2; VAM-1; VAM1; p55T,membrane palmitoylated protein 6,7p15.3,protein-coding,/
CWITA014305,TCMBANKGE014305,PPIB,CYPNS1; CYPB; MGC14109; MGC2224; OI9; SCYLP,peptidylprolyl isomerase B (cyclophilin B),15q21-q22,protein-coding,
CWITA014306,TCMBANKGE014306,TRMT9B,C8orf79; KIAA1456; TRM9L; hTRM9L,tRNA methyltransferase 9B (putative),8p22,protein-coding,/
CWITA014307,TCMBANKGE014307,MIEF1,AltMIEF1; HSU79252; MID51; MIEF1-MP; SMCR7L; dJ1104E15.3,mitochondrial elongation factor 1,22q13.1,protein-coding,/
CWITA014308,TCMBANKGE014308,LRRC28,-,leucine rich repeat containing 28,15q26.3,protein-coding,/
CWITA014309,TCMBANKGE014309,TRIM68,GC109; RNF137; SS-56; SS56,tripartite motif containing 68,11p15.4,protein-coding,/
CWITA014310,TCMBANKGE014310,STAB2,FEEL2; FELE-2; FELL2; FEX2; HARE; SCARH1,stabilin 2,12q23.3,protein-coding,Research target
CWITA014311,TCMBANKGE014311,COL13A1,CMS19; COLXIIIA1,collagen type XIII alpha 1 chain,10q22.1,protein-coding,/
CWITA014312,TCMBANKGE014312,ESPL1,ESP1; SEPA,"extra spindle pole bodies like 1, separase",12q13.13,protein-coding,/
CWITA014313,TCMBANKGE014313,KYAT1,CCBL1; GTK; KAT1; KATI,kynurenine aminotransferase 1,9q34.11,protein-coding,/
CWITA014314,TCMBANKGE014314,POLR2L,RBP10; RPABC5; RPB10; RPB10beta; RPB7.6; hRPB7.6,"RNA polymerase II, I and III subunit L",11p15.5,protein-coding,/
CWITA014315,TCMBANKGE014315,DRG2,-,developmentally regulated GTP binding protein 2,17p11.2,protein-coding,/
CWITA014316,TCMBANKGE014316,AMER1,FAM123B; OSCS; WTX,APC membrane recruitment protein 1,Xq11.2,protein-coding,/
CWITA014317,TCMBANKGE014317,PACSIN1,SDPI,protein kinase C and casein kinase substrate in neurons 1,6p21.31,protein-coding,/
CWITA014318,TCMBANKGE014318,USP33,VDU1,ubiquitin specific peptidase 33,1p31.1,protein-coding,Patented target
CWITA014319,TCMBANKGE014319,GPR150,PGR11,G protein-coupled receptor 150,5q15,protein-coding,/
CWITA014320,TCMBANKGE014320,RARA,NR1B1; RAR,"retinoic acid receptor, alpha",17q21,protein-coding,
CWITA014321,TCMBANKGE014321,ATP1A2,FHM2; MGC59864; MHP2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",1q21-q23,protein-coding,
CWITA014322,TCMBANKGE014322,IL23A,IL-23; IL-23A; IL23P19; P19; SGRF,interleukin 23 subunit alpha,12q13.3,protein-coding,Successful target
CWITA014323,TCMBANKGE014323,SCYL1,GKLP; HT019; NKTL; NTKL; P105; SCAR21; TAPK; TEIF; TRAP,SCY1 like pseudokinase 1,11q13.1,protein-coding,/
CWITA014324,TCMBANKGE014324,HAVCR1,CD365; HAVCR; HAVCR-1; KIM-1; KIM1; TIM; TIM-1; TIM1; TIMD-1; TIMD1,hepatitis A virus cellular receptor 1,5q33.3,protein-coding,/
CWITA014325,TCMBANKGE014325,SCN2A,BFIC3; BFIS3; BFNIS; EIEE11; HBA; HBSCI; HBSCII; NAC2; Na(v)1.2; Nav1.2; SCN2A1; SCN2A2,sodium voltage-gated channel alpha subunit 2,2q24.3,protein-coding,Research target
CWITA014326,TCMBANKGE014326,PDP1,PDH; PDP; PDPC; PPM2A; PPM2C,Pyruvate_Dehyrogenase_Phosphatase_Catalytic_Subunit_1,8q22.1,protein-coding,
CWITA014327,TCMBANKGE014327,PDE7B,MGC88256; bA472E5.1,phosphodiesterase 7B,6q23-q24,protein-coding,
CWITA014328,TCMBANKGE014328,TCEAL7,WEX5,transcription elongation factor A like 7,Xq22.2,protein-coding,/
CWITA014329,TCMBANKGE014329,H2AC12,H2A/S; H2AFALii; H2AH; HIST1H2AH; dJ86C11.1,H2A clustered histone 12,6p22.1,protein-coding,/
CWITA014330,TCMBANKGE014330,GOLGB1,GCP; GCP372; GOLIM1,golgin B1,3q13.33,protein-coding,/
CWITA014331,TCMBANKGE014331,PGA5,Pg5,pepsinogen A5,11q12.2,protein-coding,Research target
CWITA014332,TCMBANKGE014332,CDIP1,C16orf5; CDIP; I1; LITAFL,cell death inducing p53 target 1,16p13.3,protein-coding,/
CWITA014333,TCMBANKGE014333,LRRC24,LRRC14OS,leucine rich repeat containing 24,8q24.3,protein-coding,/
CWITA014334,TCMBANKGE014334,PCDHB3,PCDH-BETA3,protocadherin beta 3,5q31.3,protein-coding,/
CWITA014335,TCMBANKGE014335,CD180,LY64; Ly78; RP105,CD180 molecule,5q12.3,protein-coding,/
CWITA014336,TCMBANKGE014336,AMIGO1,ALI2; AMIGO; AMIGO-1,adhesion molecule with Ig like domain 1,1p13.3,protein-coding,/
CWITA014337,TCMBANKGE014337,PPM1M,PP2C-eta; PP2CE; PP2Ceta,"protein phosphatase, Mg2+/Mn2+ dependent 1M",3p21.2,protein-coding,/
CWITA014338,TCMBANKGE014338,IL2RB,CD122; IL15RB; IMD63; P70-75,interleukin 2 receptor subunit beta,22q12.3,protein-coding,Clinical Trial target
CWITA014339,TCMBANKGE014339,THBS3,TSP3,thrombospondin 3,1q22,protein-coding,/
CWITA014340,TCMBANKGE014340,MACF1,ABP620; ACF7; LIS9; MACF; OFC4,microtubule actin crosslinking factor 1,1p34.3,protein-coding,/
CWITA014341,TCMBANKGE014341,COX6A1,CMTRID; COX6A; COX6AL,cytochrome c oxidase subunit 6A1,12q24.31|12q24.2,protein-coding,/
CWITA014342,TCMBANKGE014342,GGTLC2,GGTL4,gamma-glutamyltransferase light chain 2,22q11.22,protein-coding,/
CWITA014343,TCMBANKGE014343,PTPDC1,PTP9Q22,protein tyrosine phosphatase domain containing 1,9q22.32,protein-coding,/
CWITA014344,TCMBANKGE014344,NAT1,AAC1; MNAT; NAT-1; NATI,N-acetyltransferase 1,8p22,protein-coding,/
CWITA014345,TCMBANKGE014345,MGAM2,-,maltase-glucoamylase 2 (putative),7q34,protein-coding,/
CWITA014346,TCMBANKGE014346,PTGS2,COXN2; COX2; GRIPGHS; PGG/HS; PGHSN2; PHSN2; hCoxN2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1q25.2-q25.3,protein-coding,
CWITA014347,TCMBANKGE014347,FGF11,FGF-11; FHF-3; FHF3,fibroblast growth factor 11,17p13.1,protein-coding,/
CWITA014348,TCMBANKGE014348,TTN,CMD1G; CMH9; CMPD4; EOMFC; HMERF; LGMD2J; MYLK5; SALMY; TMD,Titin,2q31.2,protein-coding,
CWITA014349,TCMBANKGE014349,SLC7A5,4F2LC; CD98; D16S469E; E16; LAT1; MPE16; hLAT1,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 5",16q24.3,protein-coding,
CWITA014350,TCMBANKGE014350,AQP8,AQP-8,aquaporin 8,16p12.1,protein-coding,/
CWITA014351,TCMBANKGE014351,SERPING1,C1IN; C1INH; C1NH; HAE1; HAE2,serpin family G member 1,11q12.1,protein-coding,Successful target
CWITA014352,TCMBANKGE014352,LMBR1,ACHP; C7orf2; DIF14; LSS; PPD2; THYP; TPT; ZRS,limb development membrane protein 1,7q36.3,protein-coding,/
CWITA014353,TCMBANKGE014353,ERBB3,ErbB-3; FERLK; HER3; LCCS2; MDA-BF-1; c-erbB-3; c-erbB3; erbB3-S; p180-ErbB3; p45-sErbB3; p85-sErbB3,erb-b2 receptor tyrosine kinase 3,12q13.2,protein-coding,Clinical Trial target
CWITA014354,TCMBANKGE014354,PPP2CB,PP2Abeta; PP2CB,"protein phosphatase 2, catalytic subunit, beta isozyme",8p12,protein-coding,
CWITA014355,TCMBANKGE014355,DAPK3,DLK; ZIP; ZIPK,death associated protein kinase 3,19p13.3,protein-coding,Research target
CWITA014356,TCMBANKGE014356,OTP,-,orthopedia homeobox,5q14.1,protein-coding,/
CWITA014357,TCMBANKGE014357,CHFR,RNF116; RNF196,checkpoint with forkhead and ring finger domains,12q24.33,protein-coding,/
CWITA014358,TCMBANKGE014358,KTI12,SBBI81; TOT4,KTI12 chromatin associated homolog,1p32.3,protein-coding,/
CWITA014359,TCMBANKGE014359,TUBA3C,TUBA2; bA408E5.3,tubulin alpha 3c,13q12.11,protein-coding,/
CWITA014360,TCMBANKGE014360,XIC,SXI1; XCE; XIST,X chromosome inactivation center,Xq12-q13,other,/
CWITA014361,TCMBANKGE014361,LRAT,LCA14,lecithin retinol acyltransferase,4q32.1,protein-coding,/
CWITA014362,TCMBANKGE014362,TMA7,CCDC72; HSPC016,translation machinery associated 7 homolog,3p21.31,protein-coding,/
CWITA014363,TCMBANKGE014363,BIK,BIP1; BP4; NBK,BCL2 interacting killer,22q13.2,protein-coding,/
CWITA014364,TCMBANKGE014364,CNOT3,IDDSADF; LENG2; NOT3; NOT3H,CCR4-NOT transcription complex subunit 3,19q13.42,protein-coding,/
CWITA014365,TCMBANKGE014365,STXBP5L,LLGL4,syntaxin binding protein 5 like,3q13.33,protein-coding,/
CWITA014366,TCMBANKGE014366,ZNF75A,-,zinc finger protein 75a,16p13.3,protein-coding,/
CWITA014367,TCMBANKGE014367,SUN1,UNC84A,Sad1 and UNC84 domain containing 1,7p22.3,protein-coding,/
CWITA014368,TCMBANKGE014368,HESX1,ANF; CPHD5; RPX,HESX homeobox 1,3p14.3,protein-coding,/
CWITA014369,TCMBANKGE014369,MEPE,OF45,matrix extracellular phosphoglycoprotein,4q22.1,protein-coding,/
CWITA014370,TCMBANKGE014370,Reg2,PSP; PTP; REG-2,regenerating islet-derived 2,6|6 C3,protein-coding,/
CWITA014371,TCMBANKGE014371,ADRB3,BETA3AR; FLJ99960,"adrenergic, beta-3-, receptor",8p12,protein-coding,
CWITA014372,TCMBANKGE014372,PAM,PAL; PHM,peptidylglycine alpha-amidating monooxygenase,5q21.1,protein-coding,/
CWITA014373,TCMBANKGE014373,DTX3L,BBAP; RNF143,deltex E3 ubiquitin ligase 3L,3q21.1,protein-coding,/
CWITA014374,TCMBANKGE014374,SLC9C1,NHE; NHE-10; SLC9A10; sperm-NHE,solute carrier family 9 member C1,3q13.2,protein-coding,/
CWITA014375,TCMBANKGE014375,KRCC1,CHBP2,lysine rich coiled-coil 1,2p11.2,protein-coding,/
CWITA014376,TCMBANKGE014376,B3GAT1,CD57; GLCATP; GLCUATP; HNK1; LEU7; NK-1; NK1,"beta-1,3-glucuronyltransferase 1",11q25,protein-coding,/
CWITA014377,TCMBANKGE014377,SLC1A1,EAAC1; EAAT3,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",9p24,protein-coding,
CWITA014378,TCMBANKGE014378,SGCZ,ZSG1,sarcoglycan zeta,8p22,protein-coding,/
CWITA014379,TCMBANKGE014379,LTB,TNFC; TNFSF3; TNLG1C; p33,lymphotoxin beta,6p21.33,protein-coding,Research target
CWITA014380,TCMBANKGE014380,DHCR24,DCE; KIAA0018; Nbla03646; SELADIN1; seladin-1,24-Dehydrocholesterol Reductase,1p32.3,protein-coding,
CWITA014381,TCMBANKGE014381,PTGDR2,CD294; CRTH2; DL1R; DP2; GPR44,prostaglandin D2 receptor 2,11q12.2,protein-coding,Clinical Trial target
CWITA014382,TCMBANKGE014382,TYRO3,BYK; Dtk; Etk-2; RSE; Rek; Sky; Tif,TYRO3 protein tyrosine kinase,15q15.1,protein-coding,Research target
CWITA014383,TCMBANKGE014383,FAU,FAU1; Fub1; Fubi; MNSFbeta; RPS30; S30; asr1,FAU ubiquitin like and ribosomal protein S30 fusion,11q13.1,protein-coding,/
CWITA014384,TCMBANKGE014384,LALBA,LYZG,lactalbumin alpha,12q13.11,protein-coding,Research target
CWITA014385,TCMBANKGE014385,CHRNA4,BFNC; EBN; EBN1; NACHR; NACHRA4; NACRA4,cholinergic receptor nicotinic alpha 4 subunit,20q13.33,protein-coding,Successful target
CWITA014386,TCMBANKGE014386,NCR3,1C7; CD337; LY117; MALS; NKp30,natural cytotoxicity triggering receptor 3,6p21.33,protein-coding,/
CWITA014387,TCMBANKGE014387,EXOSC6,EAP4; MTR3; Mtr3p; hMtr3p; p11,exosome component 6,16q22.1,protein-coding,/
CWITA014388,TCMBANKGE014388,RPS4Y1,RPS4Y; S4,ribosomal protein S4 Y-linked 1,Yp11.2,protein-coding,/
CWITA014389,TCMBANKGE014389,CYP4F11,CYPIVF11,cytochrome P450 family 4 subfamily F member 11,19p13.12,protein-coding,/
CWITA014390,TCMBANKGE014390,EMSY,C11orf30; GL002,"EMSY transcriptional repressor, BRCA2 interacting",11q13.5,protein-coding,/
CWITA014391,TCMBANKGE014391,SUGP1,F23858; RBP; SF4,SURP and G-patch domain containing 1,19p13.11,protein-coding,/
CWITA014392,TCMBANKGE014392,TFDP2,DP2,transcription factor Dp-2,3q23,protein-coding,/
CWITA014393,TCMBANKGE014393,IRAK4,IPD1; NYNRENN64; REN64,interleukin-1 receptor-associated kinase 4,12q12,protein-coding,
CWITA014394,TCMBANKGE014394,RWDD2B,C21orf6; GL011,RWD domain containing 2B,21q21.3,protein-coding,/
CWITA014395,TCMBANKGE014395,CUZD1,ERG-1; ERG1; ITMAP1; UO-44,CUB and zona pellucida like domains 1,10q26.13,protein-coding,/
CWITA014396,TCMBANKGE014396,C2CD2,C21orf25; C21orf258; TMEM24L,C2 calcium dependent domain containing 2,21q22.3,protein-coding,/
CWITA014397,TCMBANKGE014397,TMEM41B,-,transmembrane protein 41B,11p15.4,protein-coding,/
CWITA014398,TCMBANKGE014398,GABRB3,ECA5; MGC9051,"gamma-aminobutyric acid (GABA) A receptor, beta 3",15q11.2-q12,protein-coding,
CWITA014399,TCMBANKGE014399,FREM1,BNAR; C9orf143; C9orf145; C9orf154; MOTA; TILRR; TRIGNO2,FRAS1 related extracellular matrix 1,9p22.3,protein-coding,/
CWITA014400,TCMBANKGE014400,PEX5L,PEX5R; PEX5RP; PXR2; PXR2B; TRIP8b,peroxisomal biogenesis factor 5 like,3q26.33,protein-coding,/
CWITA014401,TCMBANKGE014401,AP4M1,CPSQ3; MU-4; MU-ARP2; SPG50,adaptor related protein complex 4 subunit mu 1,7q22.1,protein-coding,/
CWITA014402,TCMBANKGE014402,SRM,PAPT; SPDSY; SPS1; SRML1,spermidine synthase,1p36.22,protein-coding,/
CWITA014403,TCMBANKGE014403,H6PD,DKFZp686A01246; G6PDH; GDH; MGC87643,hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase),1p36,protein-coding,
CWITA014404,TCMBANKGE014404,HMGA2,BABL; HMGI-C; HMGIC; LIPO; STQTL9,high mobility group AT-hook 2,12q14.3,protein-coding,Research target
CWITA014405,TCMBANKGE014405,SLC1A5,AAAT; ASCT2; ATBO; FLJ31068; M7V1; M7VS1; R16; RDRC,"solute carrier family 1 (neutral amino acid transporter), member 5",19q13.3,protein-coding,
CWITA014406,TCMBANKGE014406,TBC1D8,AD3; GRAMD8; HBLP1; TBC1D8A; VRP,TBC1 domain family member 8,2q11.2,protein-coding,/
CWITA014407,TCMBANKGE014407,FSTL1,FRP; FSL1; MIR198; OCC-1; OCC1; tsc36,Follistatin_Like_1,3q13.33,protein-coding,
CWITA014408,TCMBANKGE014408,CIT,CITK; CRIK; MCPH17; STK21,citron rho-interacting serine/threonine kinase,12q24.23,protein-coding,Research target
CWITA014409,TCMBANKGE014409,MRPS2,CGI-91; COXPD36; MRP-S2; S2mt,mitochondrial ribosomal protein S2,9q34.3,protein-coding,/
CWITA014410,TCMBANKGE014410,FCRL5,BXMAS1; CD307; CD307e; FCRH5; IRTA2; PRO820,Fc receptor like 5,1q23.1,protein-coding,/
CWITA014411,TCMBANKGE014411,CST6,ECTD15,cystatin E/M,11q13.1,protein-coding,/
CWITA014412,TCMBANKGE014412,ZNF813,-,zinc finger protein 813,19q13.42,protein-coding,/
CWITA014413,TCMBANKGE014413,P3H3,GRCB; HSU47926; LEPREL2,Prolyl_3-Hydroxylase_3,12p13.31,protein-coding,
CWITA014414,TCMBANKGE014414,TGFBI,BIGH3; CDB1; CDG2; CDGG1; CSD; CSD1; CSD2; CSD3; EBMD; LCD1,Transforming_Growth_Factor_Beta_Induced,5q31.1,protein-coding,
CWITA014415,TCMBANKGE014415,TMEM230,C20orf30; HSPC274; dJ1116H23.2.1,transmembrane protein 230,20p13-p12.3,protein-coding,/
CWITA014416,TCMBANKGE014416,LENG1,-,leukocyte receptor cluster member 1,19q13.42,protein-coding,/
CWITA014417,TCMBANKGE014417,RBMXL3,CXorf55,RBMX like 3,Xq23,protein-coding,/
CWITA014418,TCMBANKGE014418,DHPS,DHS; DS; MIG13; NEDSSWI,deoxyhypusine synthase,19p13.13,protein-coding,Research target
CWITA014419,TCMBANKGE014419,PIK3C2B,C2-PI3K,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,1q32.1,protein-coding,/
CWITA014420,TCMBANKGE014420,GNB3,CSNB1H,G protein subunit beta 3,12p13.31,protein-coding,/
CWITA014421,TCMBANKGE014421,PMM1,PMM 1; PMMH-22; Sec53,phosphomannomutase 1,22q13.2,protein-coding,/
CWITA014422,TCMBANKGE014422,SLC16A1,HHF7; MCT; MCT1; MCT1D,solute carrier family 16 member 1,1p13.2,protein-coding,Research target
CWITA014423,TCMBANKGE014423,ADRA1A,ADRA1C; ADRA1L1; ALPHA1AAR,adrenoceptor alpha 1A,8p21.2,protein-coding,Successful target
CWITA014424,TCMBANKGE014424,CEP85,CCDC21,centrosomal protein 85,1p36.11,protein-coding,/
CWITA014425,TCMBANKGE014425,TPMT,N,thiopurine S-methyltransferase,6p22.3,protein-coding,
CWITA014426,TCMBANKGE014426,DBNDD1,-,dysbindin domain containing 1,16q24.3,protein-coding,/
CWITA014427,TCMBANKGE014427,RB1CC1,ATG17; CC1; FIP200; PPP1R131,RB1 inducible coiled-coil 1,8q11.23,protein-coding,/
CWITA014428,TCMBANKGE014428,CPB2,CPU; PCPB; TAFI,carboxypeptidase B2,13q14.13,protein-coding,Clinical Trial target
CWITA014429,TCMBANKGE014429,ZNF567,-,zinc finger protein 567,19q13.12,protein-coding,/
CWITA014430,TCMBANKGE014430,DOLPP1,LSFR2,dolichyldiphosphatase 1,9q34.11,protein-coding,/
CWITA014431,TCMBANKGE014431,STT3A,ITM1; STT3-A; TMC,STT3 oligosaccharyltransferase complex catalytic subunit A,11q24.2,protein-coding,/
CWITA014432,TCMBANKGE014432,N6AMT1,C21orf127; HEMK2; KMT9; MTQ2; N6AMT; PRED28; PrmC; m.HsaHemK2P,N-6 adenine-specific DNA methyltransferase 1,21q21.3,protein-coding,/
CWITA014433,TCMBANKGE014433,MAN1A2,MAN1B,mannosidase alpha class 1A member 2,1p12,protein-coding,/
CWITA014434,TCMBANKGE014434,TAB3,MAP3K7IP3; NAP1,TGF-beta activated kinase 1 (MAP3K7) binding protein 3,Xp21.2,protein-coding,/
CWITA014435,TCMBANKGE014435,SECISBP2L,SBP2L; SLAN,SECIS binding protein 2 like,15q21.1,protein-coding,/
CWITA014436,TCMBANKGE014436,SIAH2,hSiah2,siah E3 ubiquitin protein ligase 2,3q25.1,protein-coding,/
CWITA014437,TCMBANKGE014437,KRTAP10-3,KAP10.3; KAP18-3; KAP18.3; KRTAP10.3; KRTAP18-3; KRTAP18.3,keratin associated protein 10-3,21q22.3,protein-coding,/
CWITA014438,TCMBANKGE014438,TAS2R38,PTC; T2R38; T2R61; THIOT,taste 2 receptor member 38,7q34,protein-coding,/
CWITA014439,TCMBANKGE014439,FOLH1,FGCP; FOLH; GCP2; GCPII; NAALAD1; NAALAdase; PSM; PSMA; mGCP,folate hydrolase (prostate-specific membrane antigen) 1,11p11.2,protein-coding,
CWITA014440,TCMBANKGE014440,ITIH3,H3P; ITI-HC3; SHAP,inter-alpha-trypsin inhibitor heavy chain 3,3p21.1,protein-coding,/
CWITA014441,TCMBANKGE014441,TTK,CT96; ESK; FLJ38280; MPS1; MPS1L1; PYT,TTK protein kinase,6q13-q21,protein-coding,
CWITA014442,TCMBANKGE014442,MVP,LRP; VAULT1,major vault protein,16p11.2,protein-coding,/
CWITA014443,TCMBANKGE014443,HGS,HRS,hepatocyte growth factor-regulated tyrosine kinase substrate,17q25.3,protein-coding,/
CWITA014444,TCMBANKGE014444,HLA-E,HLA-6.2; QA1,"major histocompatibility complex, class I, E",6p22.1,protein-coding,/
CWITA014445,TCMBANKGE014445,SPATA5,AFG2; EHLMRS; SPAF,spermatogenesis associated 5,4q28.1,protein-coding,/
CWITA014446,TCMBANKGE014446,OGT,HINCUT-1; HRNT1; MRX106; O-GLCNAC; OGT1,O-linked N-acetylglucosamine (GlcNAc) transferase,Xq13.1,protein-coding,/
CWITA014447,TCMBANKGE014447,SUCLG1,FLJ21114; FLJ43513; GALPHA; MTDPS9; SUCLA1,"succinate-CoA ligase, alpha subunit",2p11.2,protein-coding,
CWITA014448,TCMBANKGE014448,FGF23,ADHR; FGFN; HFTC2; HPDR2; HYPF; PHPTC,fibroblast growth factor 23,12p13.32,protein-coding,Successful target
CWITA014449,TCMBANKGE014449,TANK,I-TRAF; ITRAF; TRAF2,TRAF family member associated NFKB activator,2q24.2,protein-coding,/
CWITA014450,TCMBANKGE014450,IFNA8,IFN-alphaB,interferon alpha 8,9p21.3,protein-coding,/
CWITA014451,TCMBANKGE014451,JARID2,JMJ,jumonji and AT-rich interaction domain containing 2,6p22.3,protein-coding,/
CWITA014452,TCMBANKGE014452,ARHGAP10,GRAF2; PS-GAP; PSGAP,Rho GTPase activating protein 10,4q31.23,protein-coding,/
CWITA014453,TCMBANKGE014453,TRIM4,RNF87,tripartite motif containing 4,7q22.1,protein-coding,/
CWITA014454,TCMBANKGE014454,CDO1,N,"cysteine dioxygenase, type I",5q23.2,protein-coding,
CWITA014455,TCMBANKGE014455,RAI1,SMCR; SMS,retinoic acid induced 1,17p11.2,protein-coding,/
CWITA014456,TCMBANKGE014456,RBP5,CRBP-III; CRBP3; CRBPIII; HRBPiso,retinol binding protein 5,12p13.31,protein-coding,Research target
CWITA014457,TCMBANKGE014457,NKD2,Naked2,NKD inhibitor of WNT signaling pathway 2,5p15.33,protein-coding,/
CWITA014458,TCMBANKGE014458,RNF43,RNF124; SSPCS; URCC,ring finger protein 43,17q22,protein-coding,Clinical Trial target
CWITA014459,TCMBANKGE014459,ACTN4,ACTININ-4; FSGS; FSGS1,actinin alpha 4,19q13.2,protein-coding,/
CWITA014460,TCMBANKGE014460,RTEL1-TNFRSF6B,-,RTEL1-TNFRSF6B readthrough (NMD candidate),20q13.33,ncRNA,/
CWITA014461,TCMBANKGE014461,PDLIM4,RIL,PDZ and LIM domain 4,5q31.1,protein-coding,/
CWITA014462,TCMBANKGE014462,FETUB,16G2; Gugu; IRL685,fetuin B,3q27.3,protein-coding,/
CWITA014463,TCMBANKGE014463,FMO1,N,flavin containing monooxygenase 1,1q24.3,protein-coding,
CWITA014464,TCMBANKGE014464,SHOX2,OG12; OG12X; SHOT,short stature homeobox 2,3q25.32,protein-coding,/
CWITA014465,TCMBANKGE014465,TRIM21,RNF81; RO52; Ro/SSA; SSA; SSA1,tripartite motif containing 21,11p15.4,protein-coding,/
CWITA014466,TCMBANKGE014466,TPP1,CLN2; GIG1; LPIC; SCAR7; TPP-1,tripeptidyl peptidase 1,11p15.4,protein-coding,Successful target
CWITA014467,TCMBANKGE014467,USP6NL,RNTRE; TRE2NL; USP6NL-IT1,USP6 N-terminal like,10p14,protein-coding,/
CWITA014468,TCMBANKGE014468,LCMT2,PPM2; TYW4,leucine carboxyl methyltransferase 2,15q15.3,protein-coding,/
CWITA014469,TCMBANKGE014469,ANKRD49,FGIF; GBIF,ankyrin repeat domain 49,11q21,protein-coding,/
CWITA014470,TCMBANKGE014470,COL4A3,ATS2; ATS3,collagen type IV alpha 3 chain,2q36.3,protein-coding,/
CWITA014471,TCMBANKGE014471,FAM107B,C10orf45; HITS,family with sequence similarity 107 member B,10p13,protein-coding,/
CWITA014472,TCMBANKGE014472,B4GALNT1,GALGT; GALNACT; GalNAc-T; SPG26,"beta-1,4-N-acetyl-galactosaminyltransferase 1",12q13.3,protein-coding,/
CWITA014473,TCMBANKGE014473,CRH,CRF; CRH1,corticotropin releasing hormone,8q13.1,protein-coding,Research target
CWITA014474,TCMBANKGE014474,LRP2BP,-,LRP2 binding protein,4q35.1,protein-coding,/
CWITA014475,TCMBANKGE014475,TAS2R63P,PS6; T2R63,taste 2 receptor member 63 pseudogene,12p13.2,pseudo,/
CWITA014476,TCMBANKGE014476,NCF1,FLJ79451; NCF1A; NOXO2; SH3PXD1A; p47phox,neutrophil cytosolic factor 1,7q11.23,protein-coding,
CWITA014477,TCMBANKGE014477,SEC31A,ABP125; ABP130; HSPC275; HSPC334; NEDSOSB; SEC31L1,"SEC31 homolog A, COPII coat complex component",4q21.22,protein-coding,/
CWITA014478,TCMBANKGE014478,MEP1B,-,meprin A subunit beta,18q12.1,protein-coding,/
CWITA014479,TCMBANKGE014479,RAB5A,RAB5,"RAB5A, member RAS oncogene family",3p24-p22,protein-coding,
CWITA014480,TCMBANKGE014480,CCL7,FIC; MARC; MCP-3; MCP3; NC28; SCYA6; SCYA7,C-C motif chemokine ligand 7,17q12,protein-coding,/
CWITA014481,TCMBANKGE014481,PRMT1,ANM1; HCP1; HRMT1L2; IR1B4,protein arginine methyltransferase 1,19q13.33,protein-coding,Research target
CWITA014482,TCMBANKGE014482,NLGN4Y,HNL4Y,neuroligin 4 Y-linked,Yq11.221,protein-coding,/
CWITA014483,TCMBANKGE014483,CYP2E1,CPE1; CYP2E; P450NJ; P450C2E,"cytochrome P450, family 2, subfamily E, polypeptide 1",10q24.3-qter,protein-coding,
CWITA014484,TCMBANKGE014484,RPL31,L31,ribosomal protein L31,2q11.2,protein-coding,/
CWITA014485,TCMBANKGE014485,ARNTL2,BMAL2; CLIF; MOP9; PASD9; bHLHe6,aryl hydrocarbon receptor nuclear translocator like 2,12p11.23,protein-coding,/
CWITA014486,TCMBANKGE014486,DNAJC16,-,DnaJ heat shock protein family (Hsp40) member C16,1p36.21,protein-coding,/
CWITA014487,TCMBANKGE014487,H1-2,H1.2; H1C; H1F2; H1s-1; HIST1H1C,"H1.2 linker histone, cluster member",6p22.2,protein-coding,/
CWITA014488,TCMBANKGE014488,ACYP1,ACYPE,acylphosphatase 1,14q24.3,protein-coding,/
CWITA014489,TCMBANKGE014489,CYP11A1,CYP11A; CYPXIA1; P450SCC,cytochrome P450 family 11 subfamily A member 1,15q24.1,protein-coding,Successful target
CWITA014490,TCMBANKGE014490,CUEDC2,C10orf66; bA18I14.5,CUE domain containing 2,10q24.32,protein-coding,/
CWITA014491,TCMBANKGE014491,TACC1,Ga55,transforming acidic coiled-coil containing protein 1,8p11.22,protein-coding,/
CWITA014492,TCMBANKGE014492,WTAP,Mum2,WT1 associated protein,6q25.3,protein-coding,/
CWITA014493,TCMBANKGE014493,METAP1,DKFZp781C0419; KIAA0094; MAP1A; MetAP1A,methionyl aminopeptidase 1,4q23,protein-coding,
CWITA014494,TCMBANKGE014494,BMP8B,BMP8; OP2,bone morphogenetic protein 8b,1p34.2,protein-coding,/
CWITA014495,TCMBANKGE014495,ATIC,AICAR; AICARFT; HEL-S-70p; IMPCHASE; PURH,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,2q35,protein-coding,Research target
CWITA014496,TCMBANKGE014496,STEAP2,IPCA1; PCANAP1; PUMPCn; STAMP1; STMP,STEAP2 metalloreductase,7q21.13,protein-coding,Research target
CWITA014497,TCMBANKGE014497,NAB2,MADER,NGFI-A binding protein 2,12q13.3,protein-coding,/
CWITA014498,TCMBANKGE014498,XDH,XAN1; XO; XOR,xanthine dehydrogenase,2p23.1,protein-coding,Successful target
CWITA014499,TCMBANKGE014499,LDB2,CLIM1; LDB-2; LDB1,LIM domain binding 2,4p15.32,protein-coding,/
CWITA014500,TCMBANKGE014500,SUMO4,IDDM5; SMT3H4; SUMO-4; dJ281H8.4,small ubiquitin like modifier 4,6q25.1,protein-coding,/
CWITA014501,TCMBANKGE014501,GALNT3,GalNAc-T3; HFTC; HFTC1; HHS,polypeptide N-acetylgalactosaminyltransferase 3,2q24.3,protein-coding,/
CWITA014502,TCMBANKGE014502,PADI3,PAD3; PDI3; UHS1,peptidyl arginine deiminase 3,1p36.13,protein-coding,Research target
CWITA014503,TCMBANKGE014503,SON,BASS1; C21orf50; DBP-5; NREBP; SON3; TOKIMS,SON DNA and RNA binding protein,21q22.11,protein-coding,/
CWITA014504,TCMBANKGE014504,ST14,ARCI11; HAI; MT-SP1; MTSP1; PRSS14; SNC19; TADG15; TMPRSS14,ST14 transmembrane serine protease matriptase,11q24.3,protein-coding,Research target
CWITA014505,TCMBANKGE014505,ADRB2,ADRB2R; ADRBR; B2AR; BAR; BETA2AR,"adrenergic, beta-2-, receptor, surface",5q31-q32,protein-coding,
CWITA014506,TCMBANKGE014506,MYH7B,MHC14; MYH14,myosin heavy chain 7B,20q11.22,protein-coding,/
CWITA014507,TCMBANKGE014507,CRYBG2,AIM1L,crystallin beta-gamma domain containing 2,1p36.11,protein-coding,/
CWITA014508,TCMBANKGE014508,PRRX1,AGOTC; PHOX1; PMX1; PRX-1; PRX1,paired related homeobox 1,1q24.2,protein-coding,/
CWITA014509,TCMBANKGE014509,CTSF,CATSF; CLN13,cathepsin F,11q13.2,protein-coding,Patented target
CWITA014510,TCMBANKGE014510,HOXA3,HOX1; HOX1E,homeobox A3,7p15.2,protein-coding,/
CWITA014511,TCMBANKGE014511,PAM,PAL; PHM,peptidylglycine alpha-amidating monooxygenase,5q14-q21,protein-coding,
CWITA014512,TCMBANKGE014512,GBP7,GBP4L,guanylate binding protein 7,1p22.2,protein-coding,/
CWITA014513,TCMBANKGE014513,FNDC5,FRCP2; irisin,fibronectin type III domain containing 5,1p35.1,protein-coding,/
CWITA014514,TCMBANKGE014514,ANKRD17,GTAR; MASK2; NY-BR-16,ankyrin repeat domain 17,4q13.3,protein-coding,/
CWITA014515,TCMBANKGE014515,SLC6A9,GCENSG; GLYT1,solute carrier family 6 member 9,1p34.1,protein-coding,Clinical Trial target
CWITA014516,TCMBANKGE014516,GPRIN3,GRIN3,GPRIN family member 3,4q22.1,protein-coding,/
CWITA014517,TCMBANKGE014517,MTERF2,MTERFD3; mTERFL,mitochondrial transcription termination factor 2,12q23.3,protein-coding,/
CWITA014518,TCMBANKGE014518,ARFGEF2,BIG2; PVNH2; dJ1164I10.1,ADP ribosylation factor guanine nucleotide exchange factor 2,20q13.13,protein-coding,/
CWITA014519,TCMBANKGE014519,NAGLU,MPSNIIIB; MPS3B; NAG; UFHSD,"N-acetylglucosaminidase, alpha",17q21,protein-coding,
CWITA014520,TCMBANKGE014520,ZNF684,-,zinc finger protein 684,1p34.2,protein-coding,/
CWITA014521,TCMBANKGE014521,EFR3B,KIAA0953,EFR3 homolog B,2p23.3,protein-coding,/
CWITA014522,TCMBANKGE014522,PPARA,MGC2237; MGC2452; NR1C1; PPAR; PPARalpha; hPPAR,peroxisome proliferator-activated receptor alpha,22q12-q13.1|22q13.31,protein-coding,
CWITA014523,TCMBANKGE014523,LPO,SPO,lactoperoxidase,17q22,protein-coding,/
CWITA014524,TCMBANKGE014524,SNORC,ASCL830; C2orf82; UNQ830,secondary ossification center associated regulator of chondrocyte maturation,2q37.1,protein-coding,/
CWITA014525,TCMBANKGE014525,PSMB6,DELTA; LMPY; MGC5169; Y,"proteasome (prosome, macropain) subunit, beta type, 6",17p13,protein-coding,
CWITA014526,TCMBANKGE014526,MAPK14,CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA,mitogen-activated protein kinase 14,6p21.3-p21.2,protein-coding,
CWITA014527,TCMBANKGE014527,SLC25A4,AAC1; ANT; ANT 1; ANT1; MTDPS12; MTDPS12A; PEO2; PEO3; PEOA2; T1,solute carrier family 25 member 4,4q35.1,protein-coding,Successful target
CWITA014528,TCMBANKGE014528,HHIPL1,KIAA1822; UNQ9245,HHIP like 1,14q32.2,protein-coding,/
CWITA014529,TCMBANKGE014529,ENO1,ENO1L1; HEL-S-17; MPB1; NNE; PPH,enolase 1,1p36.23,protein-coding,/
CWITA014530,TCMBANKGE014530,TRIM60,RNF129; RNF33,tripartite motif containing 60,4q32.3,protein-coding,/
CWITA014531,TCMBANKGE014531,ENPP1,ARHR2; COLED; M6S1; NPP1; NPPS; PC-1; PCA1; PDNP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q23.2,protein-coding,/
CWITA014532,TCMBANKGE014532,ABHD13,BEM46L1; C13orf6; bA153I24.2,abhydrolase domain containing 13,13q33.3,protein-coding,/
CWITA014533,TCMBANKGE014533,CACNA1D,CACH3; CACN4; CACNL1A2; CCHL1A2; Cav1.3,"calcium channel, voltage-dependent, L type, alpha 1D subunit",3p14.3,protein-coding,
CWITA014534,TCMBANKGE014534,ADAM17,ADAM18; CD156B; CSVP; MGC71942; TACE,ADAM metallopeptidase domain 17,2p25,protein-coding,
CWITA014535,TCMBANKGE014535,ZNF805,-,zinc finger protein 805,19q13.43,protein-coding,/
CWITA014536,TCMBANKGE014536,DUSP22,JKAP; JSP-1; JSP1; LMW-DSP2; LMWDSP2; MKP-x; MKPX; VHX,dual specificity phosphatase 22,6p25.3,protein-coding,/
CWITA014537,TCMBANKGE014537,CAMSAP1,-,calmodulin regulated spectrin associated protein 1,9q34.3,protein-coding,/
CWITA014538,TCMBANKGE014538,LGSN,GLULD1; LGS,"lengsin, lens protein with glutamine synthetase domain",6q12,protein-coding,/
CWITA014539,TCMBANKGE014539,ARSL,ARSE; ASE; CDPX; CDPX1; CDPXR,arylsulfatase L,Xp22.33,protein-coding,/
CWITA014540,TCMBANKGE014540,ZNF117,H-plk; HPF9,zinc finger protein 117,7q11.21,protein-coding,/
CWITA014541,TCMBANKGE014541,SELENOO,SELO,selenoprotein O,22q13.33,protein-coding,/
CWITA014542,TCMBANKGE014542,ALG13,CDG1S; CXorf45; EIEE36; GLT28D1; MDS031; TDRD13; YGL047W,ALG13 UDP-N-acetylglucosaminyltransferase subunit,Xq23,protein-coding,/
CWITA014543,TCMBANKGE014543,KCNQ2,BFNC; EBN; EBN1; ENB1; HNSPC; KCNA11; KV7.2,potassium voltage-gated channel subfamily Q member 2,20q13.33,protein-coding,Research target
CWITA014544,TCMBANKGE014544,ELAVL3,HUC; HUCL; PLE21,ELAV like RNA binding protein 3,19p13.2,protein-coding,/
CWITA014545,TCMBANKGE014545,KLHDC7B,-,kelch domain containing 7B,22q13.33,protein-coding,/
CWITA014546,TCMBANKGE014546,ZSCAN30,ZNF-WYM; ZNF397OS; ZNF917,zinc finger and SCAN domain containing 30,18q12.2,protein-coding,/
CWITA014547,TCMBANKGE014547,PDIA5,PDIR,protein disulfide isomerase family A member 5,3q21.1,protein-coding,/
CWITA014548,TCMBANKGE014548,FGF9,FGF-9; GAF; HBFG-9; HBGF-9; SYNS3,fibroblast growth factor 9,13q12.11,protein-coding,/
CWITA014549,TCMBANKGE014549,PDE6C,COD4; PDEA2,"phosphodiesterase 6C, cGMP-specific, cone, alpha prime",10q24,protein-coding,
CWITA014550,TCMBANKGE014550,Yars,AL024047; AU018965; Yars1,tyrosyl-tRNA synthetase,4|4 D2.2,protein-coding,/
CWITA014551,TCMBANKGE014551,TRIP13,16E1BP; MVA3,thyroid hormone receptor interactor 13,5p15.33,protein-coding,/
CWITA014552,TCMBANKGE014552,Saa,-,serum amyloid A cluster,-,other,/
CWITA014553,TCMBANKGE014553,SETD7,FLJ21193; KIAA1717; KMT7; SET7; SET7/9; SET9,SET domain containing (lysine methyltransferase) 7,4q28,protein-coding,
CWITA014554,TCMBANKGE014554,ILF3,CBTF; DRBF; DRBP76; MMP4; MPHOSPH4; MPP4; MPP4110; NF-AT-90; NF110; NF110b; NF90; NF90a; NF90b; NF90c; NF90ctv; NFAR; NFAR-1; NFAR-2; NFAR110; NFAR2; NFAR90; TCP110; TCP80,interleukin enhancer binding factor 3,19p13.2,protein-coding,/
CWITA014555,TCMBANKGE014555,P2RX1,P2X1,purinergic receptor P2X 1,17p13.2,protein-coding,Research target
CWITA014556,TCMBANKGE014556,CBX7,-,chromobox 7,22q13.1,protein-coding,Research target
CWITA014557,TCMBANKGE014557,ANXA1,ANX1; LPC1,annexin A1,9q21.13,protein-coding,Successful target
CWITA014558,TCMBANKGE014558,TTC3,DCRR1; RNF105; TPRDIII,tetratricopeptide repeat domain 3,21q22.13,protein-coding,/
CWITA014559,TCMBANKGE014559,GUSBP1,-,GUSB pseudogene 1,5p14.3,pseudo,/
CWITA014560,TCMBANKGE014560,CKMT2,SMTCK,"creatine kinase, mitochondrial 2 (sarcomeric)",5q13.3,protein-coding,
CWITA014561,TCMBANKGE014561,ANXA2,ANX2; ANX2L4; CAL1H; HEL-S-270; LIP2; LPC2; LPC2D; P36; PAP-IV,annexin A2,15q22.2,protein-coding,Research target
CWITA014562,TCMBANKGE014562,PXN,-,paxillin,12q24.23,protein-coding,/
CWITA014563,TCMBANKGE014563,GNG2,-,G protein subunit gamma 2,14q22.1,protein-coding,/
CWITA014564,TCMBANKGE014564,ZNF738,-,zinc finger protein 738,19p12,protein-coding,/
CWITA014565,TCMBANKGE014565,GGACT,A2LD1,Gamma-Glutamylamine_Cyclotransferase,13q32.3,protein-coding,
CWITA014566,TCMBANKGE014566,PPT1,CLN1; INCL; PPT,palmitoyl-protein thioesterase 1,1p34.2,protein-coding,Clinical Trial target
CWITA014567,TCMBANKGE014567,SLC12A3,NCC; NCCT; TSC,solute carrier family 12 member 3,16q13,protein-coding,Successful target
CWITA014568,TCMBANKGE014568,HCAR2,GPR109A; HCA2; HM74a; HM74b; NIACR1; PUMAG; PumaNg,hydroxycarboxylic acid receptor 2,12q24.31,protein-coding,
CWITA014569,TCMBANKGE014569,SPIN3,SPIN-3; TDRD27; bA445O16.1,spindlin family member 3,Xp11.21,protein-coding,/
CWITA014570,TCMBANKGE014570,CACNA1I,Cav3.3; ca(v)3.3,calcium voltage-gated channel subunit alpha1 I,22q13.1,protein-coding,Research target
CWITA014571,TCMBANKGE014571,SLC25A32,FLJ23872; MFT; MFTC,"solute carrier family 25, member 32",8q22.3,protein-coding,
CWITA014572,TCMBANKGE014572,TPO,MSA; TDH2A; TPX,thyroid peroxidase,2p25.3,protein-coding,Successful target
CWITA014573,TCMBANKGE014573,QRSL1,COXPD40; GatA,glutaminyl-tRNA amidotransferase subunit QRSL1,6q21,protein-coding,/
CWITA014574,TCMBANKGE014574,CD209,CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1,CD209 molecule,19p13.2,protein-coding,Research target
CWITA014575,TCMBANKGE014575,SRSF7,9G8; AAG3; SFRS7,serine and arginine rich splicing factor 7,2p22.1,protein-coding,/
CWITA014576,TCMBANKGE014576,GFI1B,BDPLT17; ZNF163B,growth factor independent 1B transcriptional repressor,9q34.13,protein-coding,/
CWITA014577,TCMBANKGE014577,TIMELESS,TIM; TIM1; hTIM,timeless circadian regulator,12q13.3,protein-coding,/
CWITA014578,TCMBANKGE014578,SLC5A1,D22S675; NAGT; SGLT1,"solute carrier family 5 (sodium/glucose cotransporter), member 1",22q13.1|22q12.3,protein-coding,
CWITA014579,TCMBANKGE014579,CCDC30,PFD6L; PFDN6L,coiled-coil domain containing 30,1p34.2,protein-coding,/
CWITA014580,TCMBANKGE014580,SAMHD1,CHBL2; DCIP; HDDC1; MOP-5; SBBI88; hSAMHD1,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,20q11.23,protein-coding,/
CWITA014581,TCMBANKGE014581,RACGAP1,CYK4; HsCYK-4; ID-GAP; MgcRacGAP,Rac GTPase activating protein 1,12q13.12,protein-coding,/
CWITA014582,TCMBANKGE014582,CLIC4,CLIC4L; H1; MTCLIC; huH1; p64H1,chloride intracellular channel 4,1p36.11,protein-coding,/
CWITA014583,TCMBANKGE014583,RTEL1,C20orf41; DKCA4; DKCB5; NHL; PFBMFT3; RTEL,regulator of telomere elongation helicase 1,20q13.33,protein-coding,/
CWITA014584,TCMBANKGE014584,PABPC3,PABP3; PABPL3; tPABP,poly(A) binding protein cytoplasmic 3,13q12.13,protein-coding,/
CWITA014585,TCMBANKGE014585,ZNF37A,KOX21; ZNF37,zinc finger protein 37A,10p11.1,protein-coding,/
CWITA014586,TCMBANKGE014586,CHRNG,ACHRG,cholinergic receptor nicotinic gamma subunit,2q37.1,protein-coding,/
CWITA014587,TCMBANKGE014587,PSMF1,PI31,proteasome inhibitor subunit 1,20p13,protein-coding,/
CWITA014588,TCMBANKGE014588,PCYOX1L,-,prenylcysteine oxidase 1 like,5q32,protein-coding,/
CWITA014589,TCMBANKGE014589,RTN2,NSP2; NSPL1; NSPLI; SPG12,reticulon 2,19q13.32,protein-coding,/
CWITA014590,TCMBANKGE014590,WSB1,SWIP1; WSB-1,WD repeat and SOCS box containing 1,17q11.1,protein-coding,/
CWITA014591,TCMBANKGE014591,SGPL1,NPHS14; S1PL; SPL,sphingosine-1-phosphate lyase 1,10q22.1,protein-coding,Clinical Trial target
CWITA014592,TCMBANKGE014592,ALDH3A2,ALDH10; FALDH; SLS,aldehyde dehydrogenase 3 family member A2,17p11.2,protein-coding,Successful target
CWITA014593,TCMBANKGE014593,CDK6,MGC59692; PLSTIRE,cyclin-dependent kinase 6,7q21-q22,protein-coding,
CWITA014594,TCMBANKGE014594,POLR3H,C25; RPC22.9; RPC8,RNA polymerase III subunit H,22q13.2,protein-coding,/
CWITA014595,TCMBANKGE014595,RHOF,ARHF; RIF,"ras homolog family member F, filopodia associated",12q24.31,protein-coding,/
CWITA014596,TCMBANKGE014596,LIG3,LIG2,"ligase III, DNA, ATP-dependent",17q11.2-q12,protein-coding,
CWITA014597,TCMBANKGE014597,TNNI3,CMD1FF; CMD2A; CMH7; RCM1; TNNC1; cTnI,"troponin I3, cardiac type",19q13.42,protein-coding,Research target
CWITA014598,TCMBANKGE014598,GRIK2,EAA4; GLR6; GLUK6; GLUR6; GluK2; MRT6,glutamate ionotropic receptor kainate type subunit 2,6q16.3,protein-coding,Research target
CWITA014599,TCMBANKGE014599,PLCG2,APLAID; FCAS3; PLC-IV; PLC-gamma-2,phospholipase C gamma 2,16q23.3,protein-coding,/
CWITA014600,TCMBANKGE014600,ZNF568,ZFP568,zinc finger protein 568,19q13.12,protein-coding,/
CWITA014601,TCMBANKGE014601,LONRF2,RNF192,LON peptidase N-terminal domain and ring finger 2,2q11.2,protein-coding,/
CWITA014602,TCMBANKGE014602,ITGAV,CD51; MSK8; VNRA; VTNR,integrin subunit alpha V,2q32.1,protein-coding,Clinical Trial target
CWITA014603,TCMBANKGE014603,ZKSCAN4,P1P373C6; ZNF307; ZNF427; ZSCAN36,zinc finger with KRAB and SCAN domains 4,6p22.1,protein-coding,/
CWITA014604,TCMBANKGE014604,GEN1,Gen,GEN1 Holliday junction 5' flap endonuclease,2p24.2,protein-coding,/
CWITA014605,TCMBANKGE014605,EPN3,-,epsin 3,17q21.33,protein-coding,/
CWITA014606,TCMBANKGE014606,ERCC5,COFS3; ERCC5-201; ERCM2; UVDR; XPG; XPGC,"ERCC excision repair 5, endonuclease",13q33.1,protein-coding,/
CWITA014607,TCMBANKGE014607,SSTR5,SSN5NR,somatostatin receptor 5,16p13.3,protein-coding,
CWITA014608,TCMBANKGE014608,ZSCAN4,ZNF494,zinc finger and SCAN domain containing 4,19q13.43,protein-coding,/
CWITA014609,TCMBANKGE014609,STK32C,PKE; YANK3,serine/threonine kinase 32C,10q26.3,protein-coding,/
CWITA014610,TCMBANKGE014610,PTPN11,BPTP3; CFC; MGC14433; NS1; PTPN1D; PTP2C; SHNPTP2; SHNPTP3; SHP2,"protein tyrosine phosphatase, non-receptor type 11",12q24,protein-coding,
CWITA014611,TCMBANKGE014611,RABGGTB,GGTB,Rab geranylgeranyltransferase subunit beta,1p31.1,protein-coding,/
CWITA014612,TCMBANKGE014612,TRMT5,COXPD26; KIAA1393; TRM5,tRNA methyltransferase 5,14q23.1,protein-coding,/
CWITA014613,TCMBANKGE014613,NDUFA7,B14.5a,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa",19p13.2,protein-coding,
CWITA014614,TCMBANKGE014614,SERPINH1,AsTP3; CBP1; CBP2; HSP47; OI10; PIG14; PPROM; RA-A47; SERPINH2; gp46,serpin family H member 1,11q13.5,protein-coding,Research target
CWITA014615,TCMBANKGE014615,PPP6R2,KIAA0685; PP6R2; SAP190; SAPS2,protein phosphatase 6 regulatory subunit 2,22q13.33,protein-coding,/
CWITA014616,TCMBANKGE014616,DPEP3,MBD3,dipeptidase 3,16q22.1,protein-coding,/
CWITA014617,TCMBANKGE014617,GABRA1,ECA4; EJM; EJM5,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",5q34,protein-coding,
CWITA014618,TCMBANKGE014618,XPO7,EXP7; RANBP16,exportin 7,8p21.3,protein-coding,/
CWITA014619,TCMBANKGE014619,HES4,bHLHb42,hes family bHLH transcription factor 4,1p36.33,protein-coding,/
CWITA014620,TCMBANKGE014620,HRH4,AXOR35; BG26; GPCR105; GPRv53; H4; H4R; HH4R; MGC133027,histamine receptor H4,18q11.2,protein-coding,
CWITA014621,TCMBANKGE014621,PARVB,CGI-56,parvin beta,22q13.31,protein-coding,/
CWITA014622,TCMBANKGE014622,CTBP2,-,C-terminal binding protein 2,10q26.13,protein-coding,/
CWITA014623,TCMBANKGE014623,TADA3,ADA3; NGG1; STAF54; TADA3L; hADA3,transcriptional adaptor 3,3p25.3,protein-coding,/
CWITA014624,TCMBANKGE014624,ZNF280D,SUHW4; ZNF634,zinc finger protein 280D,15q21.3,protein-coding,/
CWITA014625,TCMBANKGE014625,OPRD1,DOP; DOR; DOR1; OPRD,opioid receptor delta 1,1p35.3,protein-coding,Successful target
CWITA014626,TCMBANKGE014626,FGF10,-,fibroblast growth factor 10,5p12,protein-coding,Discontinued target
CWITA014627,TCMBANKGE014627,GRHL1,LBP32; MGR; NH32; TFCP2L2,grainyhead like transcription factor 1,2p25.1,protein-coding,/
CWITA014628,TCMBANKGE014628,LRRC57,-,leucine rich repeat containing 57,15q15.2,protein-coding,/
CWITA014629,TCMBANKGE014629,Pla2g4c-ps,EG666225; Gm38689; Gm7989,"phospholipase A2, group IVC (cytosolic, calcium-independent), pseudogene",7|7 A1,pseudo,/
CWITA014630,TCMBANKGE014630,KCTD2,-,potassium channel tetramerization domain containing 2,17q25.1,protein-coding,/
CWITA014631,TCMBANKGE014631,RABL2A,-,"RAB, member of RAS oncogene family like 2A",2q14.1,protein-coding,/
CWITA014632,TCMBANKGE014632,TGDS,CATMANS; SDR2E1; TDPGD,"TDP-glucose 4,6-dehydratase",13q32.1,protein-coding,/
CWITA014633,TCMBANKGE014633,SRSF4,SFRS4; SRP75,serine and arginine rich splicing factor 4,1p35.3,protein-coding,/
CWITA014634,TCMBANKGE014634,UPRT,FUR1; UPP,Uracil_Phosphoribosyltransferase_Homolog,Xq13.3,protein-coding,
CWITA014635,TCMBANKGE014635,MMAA,MGC120010; MGC120011; MGC120012; MGC120013; cblA,methylmalonic aciduria (cobalamin deficiency) cblA type,4q31.21,protein-coding,
CWITA014636,TCMBANKGE014636,ABL2,ABLL; ARG; FLJ22224; FLJ31718; FLJ41441,v-abl Abelson murine leukemia viral oncogene homolog 2,1q25.2,protein-coding,
CWITA014637,TCMBANKGE014637,GPRC5C,RAIG-3; RAIG3,G protein-coupled receptor class C group 5 member C,17q25.1,protein-coding,/
CWITA014638,TCMBANKGE014638,CELA2B,ELA2B,chymotrypsin like elastase 2B,1p36.21,protein-coding,/
CWITA014639,TCMBANKGE014639,TTC19,2010204O13Rik; MC3DN2,tetratricopeptide repeat domain 19,17p12,protein-coding,/
CWITA014640,TCMBANKGE014640,TIMP4,TIMP-4,TIMP metallopeptidase inhibitor 4,3p25.2,protein-coding,/
CWITA014641,TCMBANKGE014641,SLC44A3,CTL3,solute carrier family 44 member 3,1p21.3,protein-coding,/
CWITA014642,TCMBANKGE014642,PCSK5,PC5; PC6; PC6A; SPC6,proprotein convertase subtilisin/kexin type 5,9q21.13,protein-coding,Research target
CWITA014643,TCMBANKGE014643,LHX9,-,LIM homeobox 9,1q31.3,protein-coding,/
CWITA014644,TCMBANKGE014644,ANKRD1,ALRP; C-193; CARP; CVARP; MCARP; bA320F15.2,ankyrin repeat domain 1,10q23.31,protein-coding,/
CWITA014645,TCMBANKGE014645,SI,-,sucrase-isomaltase,3q26.1,protein-coding,/
CWITA014646,TCMBANKGE014646,TGM4,FLJ26776; TGP; hTGP,transglutaminase 4 (prostate),3p22-p21.33,protein-coding,
CWITA014647,TCMBANKGE014647,IL7R,CD127; CDW127; IL-7R-alpha; IL7RA; ILRA,interleukin 7 receptor,5p13.2,protein-coding,Clinical Trial target
CWITA014648,TCMBANKGE014648,CES2,CEN2; CES2A1; PCEN2; iCE,carboxylesterase 2,16q22.1,protein-coding,
CWITA014649,TCMBANKGE014649,PGD,6PGD,phosphogluconate dehydrogenase,1p36.22,protein-coding,
CWITA014650,TCMBANKGE014650,ZNF160,F11; HKr18; HZF5; KR18,zinc finger protein 160,19q13.41-q13.42,protein-coding,/
CWITA014651,TCMBANKGE014651,SLCO1C1,OATPNF; OATP1; OATP14; OATP1C1; OATPF; OATPRP5; SLC21A14,"solute carrier organic anion transporter family, member 1C1",12p12.2,protein-coding,
CWITA014652,TCMBANKGE014652,SLC39A10,LZT-Hs2,solute carrier family 39 member 10,2q32.3,protein-coding,/
CWITA014653,TCMBANKGE014653,ITGB5,-,integrin subunit beta 5,3q21.2,protein-coding,/
CWITA014654,TCMBANKGE014654,SPATA19,CT132; SPAS1; spergen1,spermatogenesis associated 19,11q25,protein-coding,/
CWITA014655,TCMBANKGE014655,ABCB9,EST122234; TAPL,ATP binding cassette subfamily B member 9,12q24.31,protein-coding,/
CWITA014656,TCMBANKGE014656,ABAT,GABA-AT; GABAT; NPD009,4-aminobutyrate aminotransferase,16p13.2,protein-coding,Successful target
CWITA014657,TCMBANKGE014657,INSL4,EPIL; PLACENTIN,insulin like 4,9p24.1,protein-coding,/
CWITA014658,TCMBANKGE014658,EDA,ED1; ED1NA1; ED1NA2; EDA1; EDA2; HED; ODT1; STHAGX1; XHED; XLHED,ectodysplasin A,Xq12-q13.1,protein-coding,
CWITA014659,TCMBANKGE014659,ABHD12B,BEM46L3; C14orf29; c14_5314,abhydrolase domain containing 12B,14q22.1,protein-coding,/
CWITA014660,TCMBANKGE014660,MINK1,B55; MAP4K6; MINK; YSK2; ZC3,misshapen like kinase 1,17p13.2,protein-coding,/
CWITA014661,TCMBANKGE014661,ZIC2,HPE5,Zic family member 2,13q32.3,protein-coding,/
CWITA014662,TCMBANKGE014662,DNAJC9,HDJC9; JDD1; SB73,DnaJ heat shock protein family (Hsp40) member C9,10q22.2,protein-coding,/
CWITA014663,TCMBANKGE014663,ARNT,HIF-1-beta; HIF-1beta; HIF1-beta; HIF1B; HIF1BETA; TANGO; bHLHe2,aryl hydrocarbon receptor nuclear translocator,1q21.3,protein-coding,/
CWITA014664,TCMBANKGE014664,LIMA1,EPLIN; LDLCQ8; SREBP3,LIM domain and actin binding 1,12q13.12,protein-coding,/
CWITA014665,TCMBANKGE014665,CERK,LK4; dA59H18.2; dA59H18.3; hCERK,ceramide kinase,22q13.31,protein-coding,Research target
CWITA014666,TCMBANKGE014666,FERD3L,N-TWIST; NATO3; NTWIST; PTFB; bHLHa31,Fer3 like bHLH transcription factor,7p21.1,protein-coding,/
CWITA014667,TCMBANKGE014667,CDA,CDD,cytidine deaminase,1p36.12,protein-coding,Clinical Trial target
CWITA014668,TCMBANKGE014668,KLC4,KNSL8; bA387M24.3,kinesin light chain 4,6p21.1,protein-coding,/
CWITA014669,TCMBANKGE014669,RNF114,PSORS12; ZNF313,ring finger protein 114,20q13.13,protein-coding,/
CWITA014670,TCMBANKGE014670,NCOR2,CTG26; N-CoR2; SMAP270; SMRT; SMRTE; SMRTE-tau; TNRC14; TRAC; TRAC-1; TRAC1,nuclear receptor corepressor 2,12q24.31,protein-coding,/
CWITA014671,TCMBANKGE014671,ADAR,ADAR1; AGS6; DRADA; DSH; DSRAD; G1P1; IFI-4; IFI4; K88DSRBP; P136,adenosine deaminase RNA specific,1q21.3,protein-coding,/
CWITA014672,TCMBANKGE014672,FTH1,FHC; FTH; FTHL6; HFE5; PIG15; PLIF,ferritin heavy chain 1,11q12.3,protein-coding,Clinical Trial target
CWITA014673,TCMBANKGE014673,NCF2,FLJ93058; NCFN2; NOXA2; P67NPHOX; P67PHOX,neutrophil cytosolic factor 2,1q25,protein-coding,
CWITA014674,TCMBANKGE014674,GRID1,GluD1,glutamate ionotropic receptor delta type subunit 1,10q23.1-q23.2,protein-coding,/
CWITA014675,TCMBANKGE014675,RORA,IDDECA; NR1F1; ROR1; ROR2; ROR3; RZR-ALPHA; RZRA,RAR related orphan receptor A,15q22.2,protein-coding,Research target
CWITA014676,TCMBANKGE014676,ADHFE1,ADH8; HMFT2263; HOT,alcohol dehydrogenase iron containing 1,8q13.1,protein-coding,/
CWITA014677,TCMBANKGE014677,ALB,DKFZp779N1935; PRO0883; PRO0903; PRO1341,albumin,4q13.3,protein-coding,
CWITA014678,TCMBANKGE014678,ZNF709,-,zinc finger protein 709,19p13.2,protein-coding,/
CWITA014679,TCMBANKGE014679,SLC5A9,SGLT4,solute carrier family 5 member 9,1p33,protein-coding,/
CWITA014680,TCMBANKGE014680,PLK3,CNK; FNK; PLK-3; PRK,polo like kinase 3,1p34.1,protein-coding,/
CWITA014681,TCMBANKGE014681,DCLRE1B,APOLLO; SNM1B; SNMIB,DNA cross-link repair 1B,1p13.2,protein-coding,/
CWITA014682,TCMBANKGE014682,GBX1,Huh-17,gastrulation brain homeobox 1,7q36.1,protein-coding,/
CWITA014683,TCMBANKGE014683,OCM2,OCM; OM,oncomodulin 2,7q21.3,protein-coding,/
CWITA014684,TCMBANKGE014684,AIFM1,AIF; COXPD6; MGC111425; PDCD8,"apoptosis-inducing factor, mitochondrion-associated, 1",Xq26.1,protein-coding,
CWITA014685,TCMBANKGE014685,KNSTRN,C15orf23; HSD11; SKAP; TRAF4AF1,kinetochore localized astrin (SPAG5) binding protein,15q15.1,protein-coding,/
CWITA014686,TCMBANKGE014686,CALCRL,CGRPR; CRLR,calcitonin receptor-like,2q32.1,protein-coding,
CWITA014687,TCMBANKGE014687,TERF2,TRBF2; TRF2,telomeric repeat binding factor 2,16q22.1,protein-coding,Research target
CWITA014688,TCMBANKGE014688,CTSW,LYPN,cathepsin W,11q13.1,protein-coding,/
CWITA014689,TCMBANKGE014689,CD38,ADPRC 1; ADPRC1,CD38 molecule,4p15.32,protein-coding,Successful target
CWITA014690,TCMBANKGE014690,POU3F2,BRN2; N-Oct3; OCT7; OTF-7; OTF7; POUF3; brn-2; oct-7,POU class 3 homeobox 2,6q16.1,protein-coding,/
CWITA014691,TCMBANKGE014691,ZNF444,EZF-2; EZF2; ZSCAN17,zinc finger protein 444,19q13.43,protein-coding,/
CWITA014692,TCMBANKGE014692,ZFPL1,D11S750; MCG4,zinc finger protein like 1,11q13.1,protein-coding,/
CWITA014693,TCMBANKGE014693,ADRB3,BETA3AR,adrenoceptor beta 3,8p11.23,protein-coding,Successful target
CWITA014694,TCMBANKGE014694,ADGRF4,GPR115; PGR18,adhesion G protein-coupled receptor F4,6p12.3,protein-coding,/
CWITA014695,TCMBANKGE014695,MRM3,RMTL1; RNMTL1,mitochondrial rRNA methyltransferase 3,17p13.3,protein-coding,/
CWITA014696,TCMBANKGE014696,OMA1,2010001O09Rik; DAB1; MPRP-1; MPRP1; YKR087C; ZMPOMA1; peptidase,OMA1 zinc metallopeptidase,1p32.2-p32.1,protein-coding,/
CWITA014697,TCMBANKGE014697,TRIO,ARHGEF23; MEBAS; MRD44; MRD63; tgat,trio Rho guanine nucleotide exchange factor,5p15.2,protein-coding,/
CWITA014698,TCMBANKGE014698,DDX3Y,DBY,DEAD-box helicase 3 Y-linked,Yq11.221,protein-coding,/
CWITA014699,TCMBANKGE014699,COL9A1,DJ149L1.1.2; EDM6; MED; STL4,collagen type IX alpha 1 chain,6q13,protein-coding,/
CWITA014700,TCMBANKGE014700,TM6SF2,-,transmembrane 6 superfamily member 2,19p13.11,protein-coding,Research target
CWITA014701,TCMBANKGE014701,SYNE4,C19orf46; DFNB76; KASH4; Nesp4,spectrin repeat containing nuclear envelope family member 4,19q13.12,protein-coding,/
CWITA014702,TCMBANKGE014702,CYSTM1,C5orf32; ORF1-FL49,cysteine rich transmembrane module containing 1,5q31.3,protein-coding,/
CWITA014703,TCMBANKGE014703,REG3G,LPPM429; PAP IB; PAP-1B; PAP1B; PAPIB; REG III; REG-III; UNQ429,regenerating family member 3 gamma,2p12,protein-coding,/
CWITA014704,TCMBANKGE014704,MYORG,IBGC7; KIAA1161; NET37,myogenesis regulating glycosidase (putative),9p13.3,protein-coding,/
CWITA014705,TCMBANKGE014705,SLC28A2,CNT2; FLJ21468; HCNT2; HsT17153; MGC138252; SPNT1,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 2",15q15,protein-coding,
CWITA014706,TCMBANKGE014706,TAS1R3,T1R3,"taste receptor, type 1, member 3",1p36.33,protein-coding,
CWITA014707,TCMBANKGE014707,CYB5R1,B5R.1; B5R1; B5R2; NQO3A2; humb5R2,cytochrome b5 reductase 1,1q32.1,protein-coding,/
CWITA014708,TCMBANKGE014708,CDC6,CDC18L; HsCDC18; HsCDC6; MGORS5,cell division cycle 6,17q21.2,protein-coding,/
CWITA014709,TCMBANKGE014709,KRTAP5-2,KRTAP5N/A8; KRTAP5.2,Keratin_Associated_Protein_5-2,11p15.5,protein-coding,
CWITA014710,TCMBANKGE014710,GSDMB,GSDMB-1; GSDML; PP4052; PRO2521,gasdermin B,17q21.1,protein-coding,/
CWITA014711,TCMBANKGE014711,SKA2,FAM33A,spindle and kinetochore associated complex subunit 2,17q22,protein-coding,/
CWITA014712,TCMBANKGE014712,SEMA3F,SEMA-IV; SEMA4; SEMAK,semaphorin 3F,3p21.31,protein-coding,/
CWITA014713,TCMBANKGE014713,KIF2C,CT139; KNSL6; MCAK,kinesin family member 2C,1p34.1,protein-coding,/
CWITA014714,TCMBANKGE014714,ZNF747,-,zinc finger protein 747,16p11.2,protein-coding,/
CWITA014715,TCMBANKGE014715,HIVEP2,HIV-EP2; MBP-2; MIBP1; MRD43; SHN2; ZAS2; ZNF40B,HIVEP zinc finger 2,6q24.2,protein-coding,/
CWITA014716,TCMBANKGE014716,TLK2,HsHPK; MRD57; PKU-ALPHA,tousled like kinase 2,17q23.2,protein-coding,/
CWITA014717,TCMBANKGE014717,ASF1A,CGI-98; CIA; HSPC146,anti-silencing function 1A histone chaperone,6q22.31,protein-coding,/
CWITA014718,TCMBANKGE014718,KEL,CD238; ECE3; Kell,Kell metallo-endopeptidase (Kell blood group),7q34,protein-coding,/
CWITA014719,TCMBANKGE014719,ZFC3H1,CCDC131; CSRC2; PSRC2,zinc finger C3H1-type containing,12q21.1,protein-coding,/
CWITA014720,TCMBANKGE014720,ZNF843,-,zinc finger protein 843,16p11.2,protein-coding,/
CWITA014721,TCMBANKGE014721,CASP7,CMHN1; ICENLAP3; MCH3,"caspase 7, apoptosis-related cysteine peptidase",10q25,protein-coding,
CWITA014722,TCMBANKGE014722,CMC1,C3orf68,C-X9-C motif containing 1,3p24.1,protein-coding,/
CWITA014723,TCMBANKGE014723,CD93,C1QR1; C1qR(P); C1qRP; CDw93; ECSM3; MXRA4; dJ737E23.1,CD93 molecule,20p11.21,protein-coding,/
CWITA014724,TCMBANKGE014724,MC3R,BMIQ9; MC3; MC3-R; OB20; OQTL,melanocortin 3 receptor,20q13.2,protein-coding,Research target
CWITA014725,TCMBANKGE014725,MFNG,-,MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,22q13.1,protein-coding,/
CWITA014726,TCMBANKGE014726,ERI3,PINT1; PRNPIP,ERI1 exoribonuclease family member 3,1p34.1,protein-coding,/
CWITA014727,TCMBANKGE014727,CWC27,NY-CO-10; RPSKA; SDCCAG-10; SDCCAG10,CWC27 spliceosome associated cyclophilin,5q12.3,protein-coding,/
CWITA014728,TCMBANKGE014728,PLPPR2,LPPR2; PRG4,phospholipid phosphatase related 2,19p13.2,protein-coding,/
CWITA014729,TCMBANKGE014729,HEPHL1,HJDD; ZP,hephaestin like 1,11q21,protein-coding,/
CWITA014730,TCMBANKGE014730,SMC6,SMC-6; SMC6L1; hSMC6,structural maintenance of chromosomes 6,2p24.2,protein-coding,/
CWITA014731,TCMBANKGE014731,ZNF324B,-,zinc finger protein 324B,19q13.43,protein-coding,/
CWITA014732,TCMBANKGE014732,UNC50,GMH1; HSD23; PDLs22; UNCL; URP,unc-50 inner nuclear membrane RNA binding protein,2q11.2,protein-coding,/
CWITA014733,TCMBANKGE014733,ZNF180,HHZ168,zinc finger protein 180,19q13.31,protein-coding,/
CWITA014734,TCMBANKGE014734,TMEM134,-,transmembrane protein 134,11q13.2,protein-coding,/
CWITA014735,TCMBANKGE014735,PLCD1,N,"phospholipase C, delta 1",3p22-p21.3,protein-coding,
CWITA014736,TCMBANKGE014736,SLC35F6,ANT2BP; C2orf18; TANGO9,solute carrier family 35 member F6,2p23.3,protein-coding,/
CWITA014737,TCMBANKGE014737,APBB2,FE65L; FE65L1,amyloid beta precursor protein binding family B member 2,4p14-p13,protein-coding,/
CWITA014738,TCMBANKGE014738,CDH24,CDH11L,cadherin 24,14q11.2,protein-coding,/
CWITA014739,TCMBANKGE014739,PRKCI,DXS1179E; PKCI; nPKC-iota,protein kinase C iota,3q26.2,protein-coding,Research target
CWITA014740,TCMBANKGE014740,PLTP,BPIFE; HDLCQ9,phospholipid transfer protein,20q13.12,protein-coding,Research target
CWITA014741,TCMBANKGE014741,ZNF574,FP972,zinc finger protein 574,19q13.2,protein-coding,/
CWITA014742,TCMBANKGE014742,PPP1R14C,CPI17-like; KEPI; NY-BR-81,protein phosphatase 1 regulatory inhibitor subunit 14C,6q25.1,protein-coding,/
CWITA014743,TCMBANKGE014743,MFHAS1,LRRC65; MASL1; ROCO4,malignant fibrous histiocytoma amplified sequence 1,8p23.1,protein-coding,/
CWITA014744,TCMBANKGE014744,RND3,ARHE; Rho8; RhoE; memB,Rho family GTPase 3,2q23.3,protein-coding,/
CWITA014745,TCMBANKGE014745,SCN4A,HOKPP2; HYKPP; HYPP; NAC1A; Na(V)1.4; Nav1.4; SkM1,"sodium channel, voltage-gated, type IV, alpha subunit",17q23.3,protein-coding,
CWITA014746,TCMBANKGE014746,CES1,ACAT; CE-1; CEH; CES2; HMSE; HMSE1; PCE-1; REH; SES1; TGH; hCE-1,carboxylesterase 1,16q12.2,protein-coding,Successful target
CWITA014747,TCMBANKGE014747,UNC119,HRG4; IMD13; POC7; POC7A,unc-119 lipid binding chaperone,17q11.2,protein-coding,/
CWITA014748,TCMBANKGE014748,NACA,HSD48; NAC-alpha; NACA1; skNAC,nascent polypeptide associated complex subunit alpha,12q13.3,protein-coding,/
CWITA014749,TCMBANKGE014749,KCTD20,C6orf69; dJ108K11.3,potassium channel tetramerization domain containing 20,6p21.31,protein-coding,/
CWITA014750,TCMBANKGE014750,DOK6,DOK5L; HsT3226,docking protein 6,18q22.2,protein-coding,/
CWITA014751,TCMBANKGE014751,MED30,MED30S; THRAP6; TRAP25,mediator complex subunit 30,8q24.11,protein-coding,/
CWITA014752,TCMBANKGE014752,NAA11,ARD1B; ARD2; hARD2,"N-alpha-acetyltransferase 11, NatA catalytic subunit",4q21.21,protein-coding,/
CWITA014753,TCMBANKGE014753,PLS3,BMND18; T-plastin,plastin 3,Xq23,protein-coding,/
CWITA014754,TCMBANKGE014754,ADCY6,AC6; LCCS8,adenylate cyclase 6,12q13.12,protein-coding,/
CWITA014755,TCMBANKGE014755,CRYGS,CRYG8; CTRCT20,crystallin gamma S,3q27.3,protein-coding,/
CWITA014756,TCMBANKGE014756,HCRTR2,OX2R,hypocretin receptor 2,6p12.1,protein-coding,Successful target
CWITA014757,TCMBANKGE014757,IDH2,D2HGA2; ICD-M; IDH; IDHM; IDP; IDPM; mNADP-IDH,isocitrate dehydrogenase (NADP(+)) 2,15q26.1,protein-coding,/
CWITA014758,TCMBANKGE014758,DUSP23,DUSP25; FLJ20442; LDPN3; MOSP; RP11N190A12.1; VHZ,dual specificity phosphatase 23,1q23.2,protein-coding,
CWITA014759,TCMBANKGE014759,OXCT1,OXCT; SCOT,3-oxoacid CoA-transferase 1,5p13.1,protein-coding,/
CWITA014760,TCMBANKGE014760,EMILIN1,EMI; EMILIN; gp115,elastin microfibril interfacer 1,2p23.3,protein-coding,/
CWITA014761,TCMBANKGE014761,FASTKD3,-,FAST kinase domains 3,5p15.31,protein-coding,/
CWITA014762,TCMBANKGE014762,ACAD8,ACADN8; ARC42; FLJ22590,"acyl-CoA dehydrogenase family, member 8",11q25,protein-coding,
CWITA014763,TCMBANKGE014763,S100A4,18A2; 42A; CAPL; FSP1; MTS1; P9KA; PEL98,S100 calcium binding protein A4,1q21.3,protein-coding,Research target
CWITA014764,TCMBANKGE014764,EPOR,EPO-R,erythropoietin receptor,19p13.2,protein-coding,Successful target
CWITA014765,TCMBANKGE014765,RBAK,ZNF769,RB associated KRAB zinc finger,7p22.1,protein-coding,/
CWITA014766,TCMBANKGE014766,Gh,Gh1; Ghb1,growth hormone,11 E1|11 68.89 cM,protein-coding,/
CWITA014767,TCMBANKGE014767,TACR2,NK2R; NKNAR; SKR; TAC2R,tachykinin receptor 2,10q22.1,protein-coding,Clinical Trial target
CWITA014768,TCMBANKGE014768,CLCNKB,CLCKB; ClC-K2; ClC-Kb,chloride voltage-gated channel Kb,1p36.13,protein-coding,Research target
CWITA014769,TCMBANKGE014769,POSTN,OSF-2; OSF2; PDLPOSTN; PN,periostin,13q13.3,protein-coding,Research target
CWITA014770,TCMBANKGE014770,ASIC2,ACCN; ACCN1; ASIC2a; BNC1; BNaC1; MDEG; hBNaC1,acid sensing ion channel subunit 2,17q11.2-q12,protein-coding,Research target
CWITA014771,TCMBANKGE014771,ING3,Eaf4; ING2; MEAF4; p47ING3,inhibitor of growth family member 3,7q31.31,protein-coding,/
CWITA014772,TCMBANKGE014772,ADORA3,A3AR,adenosine A3 receptor,1p13.2,protein-coding,Clinical Trial target
CWITA014773,TCMBANKGE014773,TMPRSS5,SPINESIN,transmembrane serine protease 5,11q23.2,protein-coding,/
CWITA014774,TCMBANKGE014774,FZD9,CD349; FZD3,frizzled class receptor 9,7q11.23,protein-coding,/
CWITA014775,TCMBANKGE014775,HEG1,HEG; MST112; MSTP112,heart development protein with EGF like domains 1,3q21.2,protein-coding,/
CWITA014776,TCMBANKGE014776,ABHD3,LABH3,"abhydrolase domain containing 3, phospholipase",18q11.2,protein-coding,/
CWITA014777,TCMBANKGE014777,NEU1,NANH; NEU; SIAL1,neuraminidase 1,6p21.33,protein-coding,/
CWITA014778,TCMBANKGE014778,BPIFB1,C20orf114; LPLUNC1,BPI fold containing family B member 1,20q11.21,protein-coding,/
CWITA014779,TCMBANKGE014779,ANKS3,-,ankyrin repeat and sterile alpha motif domain containing 3,16p13.3,protein-coding,/
CWITA014780,TCMBANKGE014780,DAND5,CER2; CERL2; CKTSF1B3; COCO; CRL2; DANTE; GREM3; SP1,DAN domain BMP antagonist family member 5,19p13.13,protein-coding,/
CWITA014781,TCMBANKGE014781,ASMTL,ASMTLX; ASMTLY; ASTML,acetylserotonin O-methyltransferase like,Xp22.33 and Yp11.2,protein-coding,/
CWITA014782,TCMBANKGE014782,SLC11A2,AHMIO1; DCT1; DMT1; NRAMP2,solute carrier family 11 member 2,12q13.12,protein-coding,Research target
CWITA014783,TCMBANKGE014783,OR8H3,OR11-172,olfactory receptor family 8 subfamily H member 3,11q12.1,protein-coding,/
CWITA014784,TCMBANKGE014784,MAPKAPK2,MK2,mitogen-activated protein kinase-activated protein kinase 2,1q32,protein-coding,
CWITA014785,TCMBANKGE014785,ZNF579,-,zinc finger protein 579,19q13.42,protein-coding,/
CWITA014786,TCMBANKGE014786,PLCD1,NDNC3; PLC-III,phospholipase C delta 1,3p22.2,protein-coding,/
CWITA014787,TCMBANKGE014787,ACER1,ALKCDase1; ASAH3,alkaline ceramidase 1,19p13.3,protein-coding,/
CWITA014788,TCMBANKGE014788,CDHR2,PCDH24; PCLKC,cadherin related family member 2,5q35.2,protein-coding,/
CWITA014789,TCMBANKGE014789,TMEM165,CDG2K; FT27; GDT1; TMPT27; TPARL,transmembrane protein 165,4q12,protein-coding,/
CWITA014790,TCMBANKGE014790,ADRB1,ADRB1R; B1AR; BETA1AR; FNSS2; RHR,adrenoceptor beta 1,10q25.3,protein-coding,Successful target
CWITA014791,TCMBANKGE014791,LCA5L,C21orf13,lebercilin LCA5 like,21q22.2,protein-coding,/
CWITA014792,TCMBANKGE014792,CUTA,ACHAP; C6orf82,cutA divalent cation tolerance homolog,6p21.32,protein-coding,/
CWITA014793,TCMBANKGE014793,LRRC61,HSPC295,leucine rich repeat containing 61,7q36.1,protein-coding,/
CWITA014794,TCMBANKGE014794,MUTYH,MYH,mutY DNA glycosylase,1p34.1,protein-coding,Research target
CWITA014795,TCMBANKGE014795,PCDHGA7,PCDH-GAMMA-A7,"protocadherin gamma subfamily A, 7",5q31.3,protein-coding,/
CWITA014796,TCMBANKGE014796,NPTX1,NP1,neuronal pentraxin 1,17q25.3,protein-coding,/
CWITA014797,TCMBANKGE014797,1520401A03Rik,-,RIKEN cDNA 1520401A03 gene,17|17 A3.3,protein-coding,/
CWITA014798,TCMBANKGE014798,SERPINF2,A2AP; AAP; ALPHA-2-PI; API; PLI,serpin family F member 2,17p13.3,protein-coding,/
CWITA014799,TCMBANKGE014799,GALNT10,GALNACT10; PPGALNACT10; PPGANTASE10,polypeptide N-acetylgalactosaminyltransferase 10,5q33.2,protein-coding,/
CWITA014800,TCMBANKGE014800,ZNF530,-,zinc finger protein 530,19q13.43,protein-coding,/
CWITA014801,TCMBANKGE014801,HMCN1,ARMD1; FBLN6; FIBL-6; FIBL6,hemicentin 1,1q25.3-q31.1,protein-coding,/
CWITA014802,TCMBANKGE014802,CDH15,CDH14; CDH3; CDHM; MCAD; MRD3,cadherin 15,16q24.3,protein-coding,/
CWITA014803,TCMBANKGE014803,GLIPR2,C9orf19; GAPRN1,GLI pathogenesis-related 2,9p13.3,protein-coding,
CWITA014804,TCMBANKGE014804,H2BC11,H2B/r; H2BFR; H2BJ; HIST1H2BJ,H2B clustered histone 11,6p22.1,protein-coding,/
CWITA014805,TCMBANKGE014805,TLE2,ESG; ESG2; GRG2,"TLE family member 2, transcriptional corepressor",19p13.3,protein-coding,/
CWITA014806,TCMBANKGE014806,ST20,HCCS-1,suppressor of tumorigenicity 20,15q25.1,ncRNA,/
CWITA014807,TCMBANKGE014807,GK,GK1; GKD,glycerol kinase,Xp21.2,protein-coding,/
CWITA014808,TCMBANKGE014808,CACNA1S,CACNL1A3; CCHL1A3; Cav1.1; HOKPP; HOKPP1; MHS5; TTPP1; hypoPP,"calcium channel, voltage-dependent, L type, alpha 1S subunit",1q32,protein-coding,
CWITA014809,TCMBANKGE014809,UBTF,CONDBA; NOR-90; UBF; UBF-1; UBF1; UBF2,upstream binding transcription factor,17q21.31,protein-coding,/
CWITA014810,TCMBANKGE014810,SLC6A20,SIT1; XT3; Xtrp3,solute carrier family 6 member 20,3p21.31,protein-coding,/
CWITA014811,TCMBANKGE014811,CEP112,CCDC46; MACOCO,centrosomal protein 112,17q24.1,protein-coding,/
CWITA014812,TCMBANKGE014812,SSTR2,-,somatostatin receptor 2,17q25.1,protein-coding,Successful target
CWITA014813,TCMBANKGE014813,FNTA,FPTA; MGC99680; PGGT1A; PTAR2,"farnesyltransferase, CAAX box, alpha",8p11,protein-coding,
CWITA014814,TCMBANKGE014814,VPS54,HCC8; PPP1R164; SLP-8p; VPS54L; WR; hVps54L,VPS54 subunit of GARP complex,2p15-p14,protein-coding,/
CWITA014815,TCMBANKGE014815,ABHD6,-,"abhydrolase domain containing 6, acylglycerol lipase",3p14.3,protein-coding,Patented target
CWITA014816,TCMBANKGE014816,FGD6,ZFYVE24,"FYVE, RhoGEF and PH domain containing 6",12q22,protein-coding,/
CWITA014817,TCMBANKGE014817,KMT2E,HDCMC04P; MLL5; NKp44L; ODLURO,lysine methyltransferase 2E (inactive),7q22.3,protein-coding,/
CWITA014818,TCMBANKGE014818,STC1,STC,stanniocalcin 1,8p21.2,protein-coding,Research target
CWITA014819,TCMBANKGE014819,GNG7,-,G protein subunit gamma 7,19p13.3,protein-coding,Research target
CWITA014820,TCMBANKGE014820,MUC6,MUC-6,"mucin 6, oligomeric mucus/gel-forming",11p15.5,protein-coding,/
CWITA014821,TCMBANKGE014821,PRKAA1,AMPK; AMPKa1; MGC33776; MGC57364,"protein kinase, AMP-activated, alpha 1 catalytic subunit",5p12,protein-coding,
CWITA014822,TCMBANKGE014822,NDUFA4,CI-9k; CI-MLRQ; COXFA4; MLRQ,NDUFA4 mitochondrial complex associated,7p21.3,protein-coding,/
CWITA014823,TCMBANKGE014823,EXOSC7,EAP1; RRP42; Rrp42p; hRrp42p; p8,exosome component 7,3p21.31,protein-coding,/
CWITA014824,TCMBANKGE014824,TNFSF15,TL1; TL1A; TNLG1B; VEGI; VEGI192A,TNF superfamily member 15,9q32,protein-coding,Research target
CWITA014825,TCMBANKGE014825,TRPM7,CHAK; CHAK1; FLJ20117; FLJ25718; LTRPC7; TRPNPLIK,"transient receptor potential cation channel, subfamily M, member 7",15q21,protein-coding,
CWITA014826,TCMBANKGE014826,C8A,-,complement C8 alpha chain,1p32.2,protein-coding,/
CWITA014827,TCMBANKGE014827,IL3,ILN3; MCGF; MGC79398; MGC79399; MULTINCSF,"interleukin 3 (colony-stimulating factor, multiple)",5q31.1,protein-coding,
CWITA014828,TCMBANKGE014828,GPR180,ITR,G protein-coupled receptor 180,13q32.1,protein-coding,/
CWITA014829,TCMBANKGE014829,CREBRF,C5orf41; LRF,CREB3 regulatory factor,5q35.1,protein-coding,/
CWITA014830,TCMBANKGE014830,PXMP4,PMP24,peroxisomal membrane protein 4,20q11.22,protein-coding,/
CWITA014831,TCMBANKGE014831,USF3,KIAA2018,upstream transcription factor family member 3,3q13.2,protein-coding,/
CWITA014832,TCMBANKGE014832,DHCR24,DCE; Nbla03646; SELADIN1; seladin-1,24-dehydrocholesterol reductase,1p32.3,protein-coding,Research target
CWITA014833,TCMBANKGE014833,PAPOLA,MGC5378; PAP,poly(A) polymerase alpha,14q32.31,protein-coding,
CWITA014834,TCMBANKGE014834,TMEM187,CXorf12; DXS9878E; ITBA1,transmembrane protein 187,Xq28,protein-coding,/
CWITA014835,TCMBANKGE014835,ZFP57,C6orf40; TNDM1; ZNF698; bA145L22; bA145L22.2,ZFP57 zinc finger protein,6p22.1,protein-coding,/
CWITA014836,TCMBANKGE014836,PDE6A,CGPR-A; PDEA; RP43,phosphodiesterase 6A,5q32,protein-coding,/
CWITA014837,TCMBANKGE014837,LEPR,CD295; LEP-R; LEPRD; OB-R; OBR,leptin receptor,1p31.3,protein-coding,Successful target
CWITA014838,TCMBANKGE014838,ERAP1,A-LAP; ALAP; APPILS; ARTS-1; ARTS1; ERAAP; ERAAP1; KIAA0525; PILS-AP; PILSAP,Endoplasmic Reticulum Aminopeptidase 1,5q15,protein-coding,
CWITA014839,TCMBANKGE014839,TPSG1,PRSS31; TMT; trpA,tryptase gamma 1,16p13.3,protein-coding,/
CWITA014840,TCMBANKGE014840,IRF9,IRF-9; ISGF3; ISGF3G; p48,interferon regulatory factor 9,14q12,protein-coding,/
CWITA014841,TCMBANKGE014841,PAPSS1,ATPSK1; PAPSS; SK1,3'-phosphoadenosine 5'-phosphosulfate synthase 1,4q24,protein-coding,
CWITA014842,TCMBANKGE014842,ZNF454,-,zinc finger protein 454,5q35.3,protein-coding,/
CWITA014843,TCMBANKGE014843,EXTL2,EXTR2,exostoses (multiple)-like 2,1p21,protein-coding,
CWITA014844,TCMBANKGE014844,CCNC,CycC; SRB11; hSRB11,cyclin C,6q16.2,protein-coding,/
CWITA014845,TCMBANKGE014845,MSRA,PMSR,methionine sulfoxide reductase A,8p23.1,protein-coding,
CWITA014846,TCMBANKGE014846,VAV3,-,vav guanine nucleotide exchange factor 3,1p13.3,protein-coding,/
CWITA014847,TCMBANKGE014847,PUDP,DXF68S1E; FAM16AX; GS1; HDHD1; HDHD1A,pseudouridine 5'-phosphatase,Xp22.31,protein-coding,/
CWITA014848,TCMBANKGE014848,SLC9A6,MRSA; NHE6,solute carrier family 9 member A6,Xq26.3,protein-coding,/
CWITA014849,TCMBANKGE014849,ITGA2,BR; CD49B; GPIa; HPA-5; VLA-2; VLAA2,integrin subunit alpha 2,5q11.2,protein-coding,Clinical Trial target
CWITA014850,TCMBANKGE014850,SSH2,SSH-2; SSH-2L,slingshot protein phosphatase 2,17q11.2,protein-coding,/
CWITA014851,TCMBANKGE014851,TRPC3,SCA41; TRP3,transient receptor potential cation channel subfamily C member 3,4q27,protein-coding,Research target
CWITA014852,TCMBANKGE014852,KLRG2,CLEC15B,killer cell lectin like receptor G2,7q34,protein-coding,/
CWITA014853,TCMBANKGE014853,AQP10,AQPA_HUMAN,aquaporin 10,1q21.3,protein-coding,/
CWITA014854,TCMBANKGE014854,COMMD6,Acrg,COMM domain containing 6,13q22.2,protein-coding,/
CWITA014855,TCMBANKGE014855,GMDS,GMD; SDR3E1,"GDP-mannose 4,6-dehydratase",6p25.3,protein-coding,/
CWITA014856,TCMBANKGE014856,ZBTB43,ZBTB22B; ZNF-X; ZNF297B,zinc finger and BTB domain containing 43,9q33.3,protein-coding,/
CWITA014857,TCMBANKGE014857,NPTN,GP55; GP65; SDFR1; SDR1; np55; np65,neuroplastin,15q24.1,protein-coding,/
CWITA014858,TCMBANKGE014858,WDR24,C16orf21; JFP7,WD repeat domain 24,16p13.3,protein-coding,/
CWITA014859,TCMBANKGE014859,HGFAC,HGFA,HGF activator,4p16.3,protein-coding,Research target
CWITA014860,TCMBANKGE014860,FAM177B,-,family with sequence similarity 177 member B,1q41,protein-coding,/
CWITA014861,TCMBANKGE014861,TMEM186,C16orf51,transmembrane protein 186,16p13.2,protein-coding,/
CWITA014862,TCMBANKGE014862,CT45A8,CT45-2; CT45A2; CT45A9,cancer/testis antigen family 45 member A8,Xq26.3,protein-coding,/
CWITA014863,TCMBANKGE014863,CYP3A5,CP35; CYPIIIA5; DKFZp686L16231; FLJ31317; P450PCN3; PCN3,"cytochrome P450, family 3, subfamily A, polypeptide 5",7q21.1,protein-coding,
CWITA014864,TCMBANKGE014864,ZNF470,CZF-1,zinc finger protein 470,19q13.43,protein-coding,/
CWITA014865,TCMBANKGE014865,ATP2A2,ATP2B; DAR; DD; SERCA2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,12q24.11,protein-coding,Clinical Trial target
CWITA014866,TCMBANKGE014866,AMY2B,AMY2,"amylase, alpha 2B (pancreatic)",1p21,protein-coding,
CWITA014867,TCMBANKGE014867,ERBB2,CD340; HERN2; HERN2/neu; HER2; MLN_19; NEU; NGL; TKR1,"v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",17q11.2-q12|17q21.1,protein-coding,
CWITA014868,TCMBANKGE014868,BCAT2,BCAM; BCATM; BCT2; HVLI; PP18,branched chain amino acid transaminase 2,19q13.33,protein-coding,Research target
CWITA014869,TCMBANKGE014869,HTR1B,5-HT-1B; 5-HT-1D-beta; 5-HT1B; 5-HT1DB; HTR1D2; HTR1DB; S12,5-hydroxytryptamine receptor 1B,6q14.1,protein-coding,Successful target
CWITA014870,TCMBANKGE014870,ST8SIA5,SIAT8-E; SIAT8E; ST8SiaV,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5",18q21.1,protein-coding,/
CWITA014871,TCMBANKGE014871,ZNF19,KOX12,zinc finger protein 19,16q22.2,protein-coding,/
CWITA014872,TCMBANKGE014872,SCARA5,NET33; Tesr,scavenger receptor class A member 5,8p21.1,protein-coding,/
CWITA014873,TCMBANKGE014873,OPN1MW2,GOP,"opsin 1, medium wave sensitive 2",Xq28,protein-coding,/
CWITA014874,TCMBANKGE014874,RAB17,-,"RAB17, member RAS oncogene family",2q37.3,protein-coding,/
CWITA014875,TCMBANKGE014875,CAMK1G,CLICK3; CLICKIII; VWS1; dJ272L16.1,calcium/calmodulin dependent protein kinase IG,1q32.2,protein-coding,/
CWITA014876,TCMBANKGE014876,TUBGCP3,104p; ALP6; GCP3; Grip104; SPBC98; Spc98; Spc98p,tubulin gamma complex associated protein 3,13q34,protein-coding,/
CWITA014877,TCMBANKGE014877,TMEM92,-,transmembrane protein 92,17q21.33,protein-coding,/
CWITA014878,TCMBANKGE014878,PAF1,F23149_1; PD2,"PAF1 homolog, Paf1/RNA polymerase II complex component",19q13.2,protein-coding,/
CWITA014879,TCMBANKGE014879,OR5T2,OR11-177,olfactory receptor family 5 subfamily T member 2,11q12.1,protein-coding,/
CWITA014880,TCMBANKGE014880,PARP15,BAL3; FLJ40196; FLJ40597; MGC126750; MGC126752; pART7,"poly (ADP-ribose) polymerase family, member 15",3q21.1,protein-coding,
CWITA014881,TCMBANKGE014881,MCAT,FASN2C; MCT; MCT1; MT; NET62; fabD,malonyl-CoA-acyl carrier protein transacylase,22q13.2,protein-coding,/
CWITA014882,TCMBANKGE014882,RAN,ARA24; Gsp1; TC4,"RAN, member RAS oncogene family",12q24.3,protein-coding,
CWITA014883,TCMBANKGE014883,AK1,HTL-S-58j,adenylate kinase 1,9q34.11,protein-coding,/
CWITA014884,TCMBANKGE014884,RNASE9,HEL128; RAK1; h461,ribonuclease A family member 9 (inactive),14q11.2,protein-coding,/
CWITA014885,TCMBANKGE014885,CISH,BACTS2; CIS; CIS-1; G18; SOCS,cytokine inducible SH2 containing protein,3p21.2,protein-coding,/
CWITA014886,TCMBANKGE014886,SLCO6A1,CT48; GST; OATP-I; OATP6A1; OATPY,Solute_Carrier_Organic_Anion_Transporter_Family_Member_6A1,5q21.1,protein-coding,
CWITA014887,TCMBANKGE014887,SLC66A3,C2orf22; PQLC3,solute carrier family 66 member 3,2p25.1,protein-coding,/
CWITA014888,TCMBANKGE014888,ADAMTS15,-,ADAM metallopeptidase with thrombospondin type 1 motif 15,11q24.3,protein-coding,/
CWITA014889,TCMBANKGE014889,TRUB1,PUS4,TruB pseudouridine synthase family member 1,10q25.3,protein-coding,/
CWITA014890,TCMBANKGE014890,GLG1,CFR-1; ESL-1; MG-160; MG160,golgi glycoprotein 1,16q23.1,protein-coding,/
CWITA014891,TCMBANKGE014891,MMP19,CODA; MMP18; RASI-1,matrix metallopeptidase 19,12q13.2,protein-coding,/
CWITA014892,TCMBANKGE014892,URB1,C21orf108; NPA1,URB1 ribosome biogenesis homolog,21q22.11,protein-coding,/
CWITA014893,TCMBANKGE014893,MAK,RP62,male germ cell associated kinase,6p24.2,protein-coding,/
CWITA014894,TCMBANKGE014894,NDRG2,SYLD,NDRG family member 2,14q11.2,protein-coding,/
CWITA014895,TCMBANKGE014895,TBL3,SAZD; UTP13,transducin beta like 3,16p13.3,protein-coding,/
CWITA014896,TCMBANKGE014896,EGFR,ERBB; ERBB1; HER1; PIG61; mENA,epidermal growth factor receptor,7p12,protein-coding,
CWITA014897,TCMBANKGE014897,RETREG1,FAM134B; JK-1; JK1,reticulophagy regulator 1,5p15.1,protein-coding,/
CWITA014898,TCMBANKGE014898,DNMBP,ARHGEF36; CTRCT48; TUBA,dynamin binding protein,10q24.2,protein-coding,/
CWITA014899,TCMBANKGE014899,TRIOBP,DFNB28; HRIHFB2122; TAP68; TARA; dJ37E16.4,TRIO and F-actin binding protein,22q13.1,protein-coding,/
CWITA014900,TCMBANKGE014900,PKN2,PAK2; PRK2; PRKCL2; PRO2042; Pak-2; STK7,protein kinase N2,1p22.2,protein-coding,Research target
CWITA014901,TCMBANKGE014901,TYRP1,CAS2; CATB; GP75; OCA3; TRP; TRP1; TYRP; b-PROTEIN,tyrosinase related protein 1,9p23,protein-coding,Clinical Trial target
CWITA014902,TCMBANKGE014902,Aym1,-,activator of yeast meiotic promoters 1,5 F|5 55.54 cM,protein-coding,/
CWITA014903,TCMBANKGE014903,GPAM,GPAT; GPAT1,"glycerol-3-phosphate acyltransferase, mitochondrial",10q25.2,protein-coding,/
CWITA014904,TCMBANKGE014904,DBI,ACBD1; ACBP; CCK-RP; EP,"diazepam binding inhibitor, acyl-CoA binding protein",2q14.2,protein-coding,/
CWITA014905,TCMBANKGE014905,RALBP1,RIP1; RLIP1; RLIP76,ralA binding protein 1,18p11.22,protein-coding,Research target
CWITA014906,TCMBANKGE014906,ASTN2,bA67K19.1,astrotactin 2,9q33.1,protein-coding,/
CWITA014907,TCMBANKGE014907,FEZ1,UNC-76,fasciculation and elongation protein zeta 1,11q24.2,protein-coding,/
CWITA014908,TCMBANKGE014908,SLC22A5,CDSP; OCTN2,solute carrier family 22 member 5,5q31.1,protein-coding,/
CWITA014909,TCMBANKGE014909,KBTBD4,BKLHD4; HSPC252,kelch repeat and BTB domain containing 4,11p11.2,protein-coding,/
CWITA014910,TCMBANKGE014910,STX5,SED5; STX5A,syntaxin 5,11q12.3,protein-coding,/
CWITA014911,TCMBANKGE014911,DSC1,CDHF1; DG2/DG3,desmocollin 1,18q12.1,protein-coding,/
CWITA014912,TCMBANKGE014912,SCG5,7B2; P7B2; SGNE1; SgV,secretogranin V,15q13.3,protein-coding,/
CWITA014913,TCMBANKGE014913,CD5L,AIM; API6; CT-2; PRO229; SP-ALPHA; Spalpha; hAIM,CD5 molecule like,1q23.1,protein-coding,/
CWITA014914,TCMBANKGE014914,HAPLN2,BRAL1,hyaluronan and proteoglycan link protein 2,1q23.1,protein-coding,/
CWITA014915,TCMBANKGE014915,TSPAN5,NET-4; NET4; TM4SF9; TSPAN-5,tetraspanin 5,4q23,protein-coding,/
CWITA014916,TCMBANKGE014916,BTF3,BETA-NAC; BTF3a; BTF3b; NACB,basic transcription factor 3,5q13.2,protein-coding,/
CWITA014917,TCMBANKGE014917,NANP,C20orf147; HDHD4; dJ694B14.3,N-acetylneuraminic acid phosphatase,20p11.21,protein-coding,/
CWITA014918,TCMBANKGE014918,DCBLD2,CLCP1; ESDN,"discoidin, CUB and LCCL domain containing 2",3q12.1|3,protein-coding,/
CWITA014919,TCMBANKGE014919,SCNN1G,BESC3; ENaCg; ENaCgamma; PHA1; SCNEG,"sodium channel, nonvoltage-gated 1, gamma",16p12,protein-coding,
CWITA014920,TCMBANKGE014920,NRXN2,-,neurexin 2,11q13.1,protein-coding,/
CWITA014921,TCMBANKGE014921,RXYLT1,HP10481; MDDGA10; TMEM5,ribitol xylosyltransferase 1,12q14.2,protein-coding,/
CWITA014922,TCMBANKGE014922,NFKB1,DKFZp686C01211; EBPN1; KBF1; MGC54151; NFNkappaNB; NFNkappaB; NFKBNp105; NFKBNp50; p105; p50,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,4q24,protein-coding,
CWITA014923,TCMBANKGE014923,ZNF619,-,zinc finger protein 619,3p22.1,protein-coding,/
CWITA014924,TCMBANKGE014924,ASB1,ASB-1,ankyrin repeat and SOCS box containing 1,2q37.3,protein-coding,/
CWITA014925,TCMBANKGE014925,C2,ARMD14; CO2,complement C2,6p21.33,protein-coding,/
CWITA014926,TCMBANKGE014926,RSPO1,CRISTIN3; RSPO,R-spondin 1,1p34.3,protein-coding,Clinical Trial target
CWITA014927,TCMBANKGE014927,HSPA9,CRP40; CSA; EVPLS; GRP-75; GRP75; HEL-S-124m; HSPA9B; MOT; MOT2; MTHSP75; PBP74; SAAN; SIDBA4,heat shock protein family A (Hsp70) member 9,5q31.2,protein-coding,Clinical Trial target
CWITA014928,TCMBANKGE014928,PAQR3,RKTG,progestin and adipoQ receptor family member 3,4q21.21,protein-coding,/
CWITA014929,TCMBANKGE014929,GALK1,GALK; GK1,galactokinase 1,17q24,protein-coding,
CWITA014930,TCMBANKGE014930,IL36A,FIL1; FIL1(EPSILON); FIL1E; IL-1F6; IL1(EPSILON); IL1F6,interleukin 36 alpha,2q14.1,protein-coding,/
CWITA014931,TCMBANKGE014931,GFRA2,GDNFRB; NRTNR-ALPHA; NTNRA; RETL2; TRNR2,GDNF family receptor alpha 2,8p21.3,protein-coding,/
CWITA014932,TCMBANKGE014932,COMT,HEL-S-98n,catechol-O-methyltransferase,22q11.21,protein-coding,Successful target
CWITA014933,TCMBANKGE014933,GC,DBP; DBP-maf; DBP/GC; GRD3; Gc-MAF; GcMAF; HEL-S-51; VDB; VDBG; VDBP,GC vitamin D binding protein,4q13.3,protein-coding,/
CWITA014934,TCMBANKGE014934,TMEM18,lncND,transmembrane protein 18,2p25.3,protein-coding,/
CWITA014935,TCMBANKGE014935,ELF1,EFTUD1; RIA1,E74 like ETS transcription factor 1,13q14.11,protein-coding,/
CWITA014936,TCMBANKGE014936,GPD1,GPD-C; GPDH-C; HTGTI,glycerol-3-phosphate dehydrogenase 1,12q13.12,protein-coding,Research target
CWITA014937,TCMBANKGE014937,CBX1,CBX; HP1-BETA; HP1Hs-beta; HP1Hsbeta; M31; MOD1; p25beta,chromobox 1,17q21.32,protein-coding,/
CWITA014938,TCMBANKGE014938,DHRS2,HEP27; SDR25C1,dehydrogenase/reductase 2,14q11.2,protein-coding,/
CWITA014939,TCMBANKGE014939,MYOT,LGMD1; LGMD1A; MFM3; TTID; TTOD,myotilin,5q31.2,protein-coding,/
CWITA014940,TCMBANKGE014940,NFS1,HUSSY-08; IscS; NIFS,NFS1 cysteine desulfurase,20q11.22,protein-coding,/
CWITA014941,TCMBANKGE014941,DPEP1,MBD1; MDP; RDP,dipeptidase 1,16q24.3,protein-coding,Successful target
CWITA014942,TCMBANKGE014942,NKRF,ITBA4; NRF,NFKB repressing factor,Xq24,protein-coding,/
CWITA014943,TCMBANKGE014943,SEM1,C7orf76; DSS1; ECD; SHFD1; SHFM1; SHSF1; Shfdg1,SEM1 26S proteasome complex subunit,7q21.3,protein-coding,/
CWITA014944,TCMBANKGE014944,SLC5A6,SMVT,solute carrier family 5 member 6,2p23.3,protein-coding,Successful target
CWITA014945,TCMBANKGE014945,GMPR,GMPR 1; GMPR1,guanosine monophosphate reductase,6p22.3,protein-coding,/
CWITA014946,TCMBANKGE014946,ALK,CD246; NBLST3,ALK receptor tyrosine kinase,2p23.2-p23.1,protein-coding,Successful target
CWITA014947,TCMBANKGE014947,NDUFB10,PDSW,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa",16p13.3,protein-coding,
CWITA014948,TCMBANKGE014948,FAM241B,C10orf35,family with sequence similarity 241 member B,10q22.1,protein-coding,/
CWITA014949,TCMBANKGE014949,ROBO4,AOVD3; ECSM4; MRB,roundabout guidance receptor 4,11q24.2,protein-coding,Research target
CWITA014950,TCMBANKGE014950,IP6K3,IHPK3; INSP6K3,inositol hexakisphosphate kinase 3,6p21.31,protein-coding,/
CWITA014951,TCMBANKGE014951,RPL24,HEL-S-310; L24,ribosomal protein L24,3q12.3,protein-coding,/
CWITA014952,TCMBANKGE014952,CEP57,MVA2; PIG8; TSP57,centrosomal protein 57,11q21,protein-coding,/
CWITA014953,TCMBANKGE014953,SASS6,MCPH14; SAS-6; SAS6,SAS-6 centriolar assembly protein,1p21.2,protein-coding,/
CWITA014954,TCMBANKGE014954,SLC14A1,FLJ33745; FLJ41687; HUT11; HsT1341; JK; RACH1; UTNB1; UT1; UTE,"solute carrier family 14 (urea transporter), member 1 (Kidd blood group)",18q11-q12,protein-coding,
CWITA014955,TCMBANKGE014955,OSBPL3,ORP-3; ORP3; OSBP3,oxysterol binding protein like 3,7p15.3,protein-coding,/
CWITA014956,TCMBANKGE014956,MIP,AQP0; CTRCT15; LIM1; MIP26; MP26,major intrinsic protein of lens fiber,12q13.3,protein-coding,/
CWITA014957,TCMBANKGE014957,ZNF630,dJ54B20.2,zinc finger protein 630,Xp11.23,protein-coding,/
CWITA014958,TCMBANKGE014958,RYBP,AAP1; APAP-1; DEDAF; YEAF1,RING1 and YY1 binding protein,3p13,protein-coding,/
CWITA014959,TCMBANKGE014959,ANKRD54,LIAR,ankyrin repeat domain 54,22q13.1,protein-coding,/
CWITA014960,TCMBANKGE014960,IGKC,HCAK1; Km; MGC111575; MGC62011; MGC72072; MGC88770; MGC88771; MGC88809,immunoglobulin kappa constant,2p12,other,
CWITA014961,TCMBANKGE014961,MYCBP,AMY-1,MYC binding protein,1p34.3,protein-coding,Clinical Trial target
CWITA014962,TCMBANKGE014962,COX8A,COX; COX8; COX8-2; COX8L; VIII; VIII-L,cytochrome c oxidase subunit 8A,11q13.1,protein-coding,/
CWITA014963,TCMBANKGE014963,EPHB2,CAPB; DRT; EK5; EPHT3; ERK; Hek5; MGC87492; PCBC; Tyro5,EPH receptor B2,1p36.1-p35,protein-coding,
CWITA014964,TCMBANKGE014964,GC,DBP; DBP/GC; GRD3; VDBG; VDBP,group-specific component (vitamin D binding protein),4q12-q13,protein-coding,
CWITA014965,TCMBANKGE014965,SIPA1L2,SPAL2; SPAR2,signal induced proliferation associated 1 like 2,1q42.2,protein-coding,/
CWITA014966,TCMBANKGE014966,ARMC3,CT81; KU-CT-1,armadillo repeat containing 3,10p12.2,protein-coding,/
CWITA014967,TCMBANKGE014967,GATA5,CHTD5; GATAS; bB379O24.1,GATA binding protein 5,20q13.33,protein-coding,/
CWITA014968,TCMBANKGE014968,EEF1A2,EEF1AL; EF-1-alpha-2; EF1A; EIEE33; HS1; MRD38; STN; STNL,eukaryotic translation elongation factor 1 alpha 2,20q13.33,protein-coding,/
CWITA014969,TCMBANKGE014969,SLC38A7,SNAT7,solute carrier family 38 member 7,16q21,protein-coding,Research target
CWITA014970,TCMBANKGE014970,VPS50,CCDC132; VPS54L,VPS50 subunit of EARP/GARPII complex,7q21.2-q21.3,protein-coding,/
CWITA014971,TCMBANKGE014971,RRP15,CGI-115; KIAA0507,ribosomal RNA processing 15 homolog,1q41,protein-coding,/
CWITA014972,TCMBANKGE014972,RSL1D1,CSIG; L12; PBK1; UTP30,ribosomal L1 domain containing 1,16p13.13,protein-coding,/
CWITA014973,TCMBANKGE014973,ZNF300,-,zinc finger protein 300,5q33.1,protein-coding,/
CWITA014974,TCMBANKGE014974,KLK7,PRSS6; SCCE; hK7,kallikrein related peptidase 7,19q13.41,protein-coding,Patented target
CWITA014975,TCMBANKGE014975,PTAFR,PAFR,platelet activating factor receptor,1p35.3,protein-coding,Successful target
CWITA014976,TCMBANKGE014976,TNS1,MST091; MST122; MST127; MSTP091; MSTP122; MSTP127; MXRA6; PPP1R155; TNS,tensin 1,2q35,protein-coding,/
CWITA014977,TCMBANKGE014977,WFDC2,EDDM4; HE4; WAP5; dJ461P17.6,WAP four-disulfide core domain 2,20q13.12,protein-coding,/
CWITA014978,TCMBANKGE014978,CLDN23,CLDNL; hCG1646163,claudin 23,8p23.1,protein-coding,/
CWITA014979,TCMBANKGE014979,NOD2,ACUG; BLAU; BLAUS; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1; YAOS,nucleotide binding oligomerization domain containing 2,16q12.1,protein-coding,Clinical Trial target
CWITA014980,TCMBANKGE014980,COL6A2,BTHLM1; PP3610; UCMD1,collagen type VI alpha 2 chain,21q22.3,protein-coding,/
CWITA014981,TCMBANKGE014981,ESRP2,RBM35B,epithelial splicing regulatory protein 2,16q22.1,protein-coding,/
CWITA014982,TCMBANKGE014982,ANKFY1,ANKHZN; BTBD23; ZFYVE14,ankyrin repeat and FYVE domain containing 1,17p13.2,protein-coding,/
CWITA014983,TCMBANKGE014983,RDH11,ARSDR1; CGI82; FLJ32633; HCBP12; MDT1; PSDR1; RALR1; SCALD; SDR7C1,retinol dehydrogenase 11 (all-trans/9-cis/11-cis),14q24.1,protein-coding,
CWITA014984,TCMBANKGE014984,SPHK1,SPHK,sphingosine kinase 1,17q25.2,protein-coding,
CWITA014985,TCMBANKGE014985,PTH,FIH1; PTH1,parathyroid hormone,11p15.3,protein-coding,Successful target
CWITA014986,TCMBANKGE014986,SLC5A6,SMVT,"solute carrier family 5 (sodium-dependent vitamin transporter), member 6",2p23,protein-coding,
CWITA014987,TCMBANKGE014987,LARP1B,LARP2,La ribonucleoprotein 1B,4q28.2,protein-coding,/
CWITA014988,TCMBANKGE014988,INPP5A,5PTASE,inositol polyphosphate-5-phosphatase A,10q26.3,protein-coding,/
CWITA014989,TCMBANKGE014989,TACO1,CCDC44,translational activator of cytochrome c oxidase I,17q23.3,protein-coding,/
CWITA014990,TCMBANKGE014990,QTRT2,QTRTD1,queuine tRNA-ribosyltransferase accessory subunit 2,3q13.31,protein-coding,/
CWITA014991,TCMBANKGE014991,LCT,LAC; LPH; LPH1,lactase,2q21,protein-coding,
CWITA014992,TCMBANKGE014992,UFL1,KIAA0776; Maxer; NLBP; RCAD,UFM1 specific ligase 1,6q16.1,protein-coding,/
CWITA014993,TCMBANKGE014993,KCNMA1,BKTM; DKFZp686K1437; KCa1.1; MGC71881; MaxiK; SAKCA; SLO; SLONALPHA; SLO1; bA205K10.1; mSLO1,"potassium large conductance calcium-activated channel, subfamily M, alpha member 1",10q22.3,protein-coding,
CWITA014994,TCMBANKGE014994,SAFB2,-,scaffold attachment factor B2,19p13.3,protein-coding,/
CWITA014995,TCMBANKGE014995,CYP3A5,CP35; CYPIIIA5; P450PCN3; PCN3,cytochrome P450 family 3 subfamily A member 5,7q22.1,protein-coding,/
CWITA014996,TCMBANKGE014996,POU2AF1,BOB1; OBF-1; OBF1; OCAB,POU class 2 homeobox associating factor 1,11q23.1,protein-coding,/
CWITA014997,TCMBANKGE014997,NPPB,BNP,natriuretic peptide B,1p36.2,protein-coding,
CWITA014998,TCMBANKGE014998,PSMB1,FLJ25321; HC5; KIAA1838; PMSB1; PSC5,"proteasome (prosome, macropain) subunit, beta type, 1",6q27,protein-coding,
CWITA014999,TCMBANKGE014999,CFD,ADIPSIN; ADN; DF; PFD,complement factor D,19p13.3,protein-coding,Clinical Trial target
CWITA015000,TCMBANKGE015000,BHMT,BHMT1; HEL-S-61p,betaine--homocysteine S-methyltransferase,5q14.1,protein-coding,/
CWITA015001,TCMBANKGE015001,PAICS,ADE2; ADE2H1; AIRC; DKFZp781N1372; MGC1343; MGC5024; PAIS,"phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase",4q12,protein-coding,
CWITA015002,TCMBANKGE015002,IL10RA,CD210; CD210a; CDW210A; HIL-10R; IL-10R1; IL10R,interleukin 10 receptor subunit alpha,11q23.3,protein-coding,/
CWITA015003,TCMBANKGE015003,ASIC4,ACCN4; BNAC4,acid sensing ion channel subunit family member 4,2q35,protein-coding,/
CWITA015004,TCMBANKGE015004,PARP6,ARTD17; PARP-6-B1; PARP-6-C; pART17,poly(ADP-ribose) polymerase family member 6,15q23,protein-coding,/
CWITA015005,TCMBANKGE015005,ORMDL1,-,ORMDL sphingolipid biosynthesis regulator 1,2q32.2,protein-coding,/
CWITA015006,TCMBANKGE015006,MXRA8,ASP3,matrix remodeling associated 8,1p36.33,protein-coding,/
CWITA015007,TCMBANKGE015007,ZWILCH,KNTC1AP; hZwilch,zwilch kinetochore protein,15q22.31,protein-coding,/
CWITA015008,TCMBANKGE015008,ZSCAN29,ZNF690; Zfp690,zinc finger and SCAN domain containing 29,15q15.3,protein-coding,/
CWITA015009,TCMBANKGE015009,SORT1,Gp95; LDLCQ6; NT3; NTR3,sortilin 1,1p13.3|1p21.3-p13.1,protein-coding,/
CWITA015010,TCMBANKGE015010,ZFP64,ZNF338,ZFP64 zinc finger protein,20q13.2,protein-coding,/
CWITA015011,TCMBANKGE015011,KLK10,NES1; PRSSL1,kallikrein related peptidase 10,19q13.41,protein-coding,/
CWITA015012,TCMBANKGE015012,RAPH1,ALS2CR18; ALS2CR9; LPD; PREL-2; PREL2; RMO1; RalGDS/AF-6,Ras_Association_(Ralgds/Af-6)_And_Pleckstrin_Homology_Domains_1,2q33.2,protein-coding,
CWITA015013,TCMBANKGE015013,ANK1,ANK; SPH1; SPH2,ankyrin 1,8p11.21,protein-coding,Research target
CWITA015014,TCMBANKGE015014,GP1BA,BDPLT1; BDPLT3; BSS; CD42B; CD42b-alpha; DBPLT3; GP1B; GPIbA; GPIbalpha; VWDP,glycoprotein Ib platelet subunit alpha,17p13.2,protein-coding,Clinical Trial target
CWITA015015,TCMBANKGE015015,MRPL27,L27mt,mitochondrial ribosomal protein L27,17q21.33,protein-coding,/
CWITA015016,TCMBANKGE015016,DOHH,HLRC1; hDOHH,deoxyhypusine hydroxylase,19p13.3,protein-coding,/
CWITA015017,TCMBANKGE015017,ZNF616,-,zinc finger protein 616,19q13.41,protein-coding,/
CWITA015018,TCMBANKGE015018,BCAT1,BCATC; BCT1; ECA39; MECA39; PNAS121; PP18,branched chain amino acid transaminase 1,12p12.1,protein-coding,Research target
CWITA015019,TCMBANKGE015019,HTR1D,5-HT1D; HT1DA; HTR1DA; HTRL; RDC4,5-hydroxytryptamine receptor 1D,1p36.12,protein-coding,Successful target
CWITA015020,TCMBANKGE015020,Cphx3,Gm2135,cytoplasmic polyadenylated homeobox 3,14 A3|14,protein-coding,/
CWITA015021,TCMBANKGE015021,ATP6V1D,ATP6M; VATD; VMA8,Atpase_H+_Transporting_V1_Subunit_D,14q23.3,protein-coding,
CWITA015022,TCMBANKGE015022,AMDHD1,HMFT1272,amidohydrolase domain containing 1,12q23.1,protein-coding,/
CWITA015023,TCMBANKGE015023,ZNF705B,-,zinc finger protein 705B,8p23.1,protein-coding,/
CWITA015024,TCMBANKGE015024,ABCA4,ABC10; ABCR; ARMD2; CORD3; FFM; RMP; RP19; STGD; STGD1,ATP binding cassette subfamily A member 4,1p22.1,protein-coding,Clinical Trial target
CWITA015025,TCMBANKGE015025,CHKB,CHETK; CHKL; CK; CKB; CKEKB; EK; EKB; MDCMC,choline kinase beta,22q13.33,protein-coding,/
CWITA015026,TCMBANKGE015026,PSMC6,SUG2; p42,"proteasome 26S subunit, ATPase 6",14q22.1,protein-coding,/
CWITA015027,TCMBANKGE015027,KRT222,KA21; KRT222P,keratin 222,17q21.2,protein-coding,/
CWITA015028,TCMBANKGE015028,MMP16,C8orf57; MMP-X2; MT-MMP2; MT-MMP3; MT3-MMP,matrix metallopeptidase 16,8q21.3,protein-coding,Research target
CWITA015029,TCMBANKGE015029,TPPP,TPPP/p25; TPPP1; p24; p25; p25alpha,tubulin polymerization promoting protein,5p15.33,protein-coding,/
CWITA015030,TCMBANKGE015030,CCT4,CCT-DELTA; Cctd; SRB,chaperonin containing TCP1 subunit 4,2p15,protein-coding,/
CWITA015031,TCMBANKGE015031,MZF1,MZF-1; MZF1B; ZFP98; ZNF42; ZSCAN6,myeloid zinc finger 1,19q13.43,protein-coding,/
CWITA015032,TCMBANKGE015032,PSME4,PA200,proteasome activator subunit 4,2p16.2,protein-coding,/
CWITA015033,TCMBANKGE015033,QDPR,DHPR; HDHPR; PKU2; SDR33C1,quinoid dihydropteridine reductase,4p15.32,protein-coding,/
CWITA015034,TCMBANKGE015034,GLCE,HSEPI,glucuronic acid epimerase,15q23,protein-coding,/
CWITA015035,TCMBANKGE015035,CREB3L3,CREB-H; CREBH; HYST1481,cAMP responsive element binding protein 3 like 3,19p13.3,protein-coding,/
CWITA015036,TCMBANKGE015036,SLC38A2,ATA2; PRO1068; SAT2; SNAT2,solute carrier family 38 member 2,12q13.11,protein-coding,Research target
CWITA015037,TCMBANKGE015037,TSC1,LAM; TSC,TSC complex subunit 1,9q34.13,protein-coding,/
CWITA015038,TCMBANKGE015038,KRT8,CARD2; CK-8; CK8; CYK8; K2C8; K8; KO,keratin 8,12q13.13,protein-coding,/
CWITA015039,TCMBANKGE015039,KATNA1,-,katanin catalytic subunit A1,6q25.1,protein-coding,/
CWITA015040,TCMBANKGE015040,DR1,NC2; NC2-BETA; NC2B; NCB2,down-regulator of transcription 1,1p22.1,protein-coding,/
CWITA015041,TCMBANKGE015041,UQCRC1,D3S3191; QCR1; UQCR1,ubiquinol-cytochrome c reductase core protein I,3p21.3,protein-coding,
CWITA015042,TCMBANKGE015042,UBE2L6,RIG-B; UBCH8,ubiquitin conjugating enzyme E2 L6,11q12.1,protein-coding,/
CWITA015043,TCMBANKGE015043,AFF1,AF4; MLLT2; PBM1,AF4/FMR2 family member 1,4q21.3-q22.1,protein-coding,/
CWITA015044,TCMBANKGE015044,PHACTR1,EIEE70; RPEL; RPEL1; dJ257A7.2,phosphatase and actin regulator 1,6p24.1,protein-coding,/
CWITA015045,TCMBANKGE015045,CIDEA,CIDE-A,cell death inducing DFFA like effector a,18p11.21|18,protein-coding,/
CWITA015046,TCMBANKGE015046,RCCD1,-,RCC1 domain containing 1,15q26.1,protein-coding,/
CWITA015047,TCMBANKGE015047,ADORA2B,ADORA2,adenosine A2b receptor,17p12,protein-coding,
CWITA015048,TCMBANKGE015048,SAP30,-,Sin3A associated protein 30,4q34.1,protein-coding,/
CWITA015049,TCMBANKGE015049,IFIT5,ISG58; P58; RI58,interferon induced protein with tetratricopeptide repeats 5,10q23.31,protein-coding,/
CWITA015050,TCMBANKGE015050,CHPF,CHSY2; CSS2,chondroitin polymerizing factor,2q35,protein-coding,Research target
CWITA015051,TCMBANKGE015051,ZSCAN1,MZF-1; ZNF915,zinc finger and SCAN domain containing 1,19q13.43,protein-coding,/
CWITA015052,TCMBANKGE015052,ROM1,ROM; ROSP1; RP7; TSPAN23,retinal outer segment membrane protein 1,11q12.3,protein-coding,/
CWITA015053,TCMBANKGE015053,SLC16A2,AHDS; DXS128; DXS128E; MCT_7; MCT_8; MCT7; MCT8; MRX22; XPCT,"solute carrier family 16, member 2 (monocarboxylic acid transporter 8)",Xq13.2,protein-coding,
CWITA015054,TCMBANKGE015054,DUOX1,LNOX1; NOXEF1; THOX1,dual oxidase 1,15q21.1,protein-coding,/
CWITA015055,TCMBANKGE015055,AMBRA1,DCAF3; WDR94,autophagy and beclin 1 regulator 1,11p11.2,protein-coding,/
CWITA015056,TCMBANKGE015056,PILRA,FDF03,paired immunoglobin like type 2 receptor alpha,7q22.1,protein-coding,/
CWITA015057,TCMBANKGE015057,HTR7,5-HT7,5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled),10q21-q24,protein-coding,
CWITA015058,TCMBANKGE015058,DLK1,DLK; DLK-1; Delta1; FA1; PREF1; Pref-1; ZOG; pG2,delta like non-canonical Notch ligand 1,14q32.2,protein-coding,Clinical Trial target
CWITA015059,TCMBANKGE015059,TTC30B,IFT70; IFT70B; fleer,tetratricopeptide repeat domain 30B,2q31.2,protein-coding,/
CWITA015060,TCMBANKGE015060,OLFML1,MVAL564; UNQ564,olfactomedin like 1,11p15.4,protein-coding,/
CWITA015061,TCMBANKGE015061,GABARAPL1,APG8-LIKE; APG8L; ATG8; ATG8B; ATG8L; GEC1,GABA type A receptor associated protein like 1,12p13.2,protein-coding,/
CWITA015062,TCMBANKGE015062,AKR1D1,3o5bred; CBAS2; SRD5B1,aldo-keto reductase family 1 member D1,7q33,protein-coding,/
CWITA015063,TCMBANKGE015063,SLC6A13,GATN2; GAT2,"solute carrier family 6 (neurotransmitter transporter, GABA), member 13",12p13.3,protein-coding,
CWITA015064,TCMBANKGE015064,FBL,FIB; FLRN; Nop1; RNU3IP1,fibrillarin,19q13.2,protein-coding,/
CWITA015065,TCMBANKGE015065,CUBN,FLJ90055; FLJ90747; IFCR; MGA1; gp280,cubilin (intrinsic factor-cobalamin receptor),10p12.31,protein-coding,
CWITA015066,TCMBANKGE015066,HARS,FLJ20491; HRS,histidyl-tRNA synthetase,5q31.3,protein-coding,
CWITA015067,TCMBANKGE015067,POLR1D,AC19; POLR1C; RPA16; RPA9; RPAC2; RPC16; RPO1-3; TCS2,RNA polymerase I and III subunit D,13q12.2,protein-coding,/
CWITA015068,TCMBANKGE015068,HIGD2A,RCF1b,HIG1 hypoxia inducible domain family member 2A,5q35.2,protein-coding,/
CWITA015069,TCMBANKGE015069,GPX4,MCSP; PHGPx; snGPx; snPHGPx,glutathione peroxidase 4 (phospholipid hydroperoxidase),19p13.3,protein-coding,
CWITA015070,TCMBANKGE015070,HCLS1,CTTNL; HS1; lckBP1; p75,hematopoietic cell-specific Lyn substrate 1,3q13.33,protein-coding,/
CWITA015071,TCMBANKGE015071,TGOLN2,TGN38; TGN46; TGN48; TGN51; TTGN2; hTGN46; hTGN48; hTGN51,trans-golgi network protein 2,2p11.2,protein-coding,/
CWITA015072,TCMBANKGE015072,PNLIP,PL; PNLIPD; PTL,pancreatic lipase,10q25.3,protein-coding,Successful target
CWITA015073,TCMBANKGE015073,CFAP298,C21orf48; C21orf59; CILD26; FBB18; Kur,cilia and flagella associated protein 298,21q22.11,protein-coding,/
CWITA015074,TCMBANKGE015074,ZNF706,HSPC038; PNAS-106; PNAS-113,zinc finger protein 706,8q22.3,protein-coding,/
CWITA015075,TCMBANKGE015075,SEMG1,CT103; SEMG; SGI; dJ172H20.2,semenogelin 1,20q13.12,protein-coding,/
CWITA015076,TCMBANKGE015076,MYH14,DFNA4; DFNA4A; FP17425; MHC16; MYH17; NMHC II-C; NMHC-II-C; PNMHH; myosin,myosin heavy chain 14,19q13.33,protein-coding,/
CWITA015077,TCMBANKGE015077,STK38L,NDR2,serine/threonine kinase 38 like,12p11.23,protein-coding,Research target
CWITA015078,TCMBANKGE015078,Cd1d1,AI747460; CD1.1; Cd1a; Cd1d; Ly-38,CD1d1 antigen,3 F1|3 37.91 cM,protein-coding,/
CWITA015079,TCMBANKGE015079,PAEP,GD; GdA; GdF; GdS; MGC138509; MGC142288; PAEG; PEP; PP14,progestagen-associated endometrial protein,9q34,protein-coding,
CWITA015080,TCMBANKGE015080,SPHK2,SK 2; SK-2; SPK 2; SPK-2,sphingosine kinase 2,19q13.33,protein-coding,Clinical Trial target
CWITA015081,TCMBANKGE015081,ZBED5,Buster1,zinc finger BED-type containing 5,11p15.4,protein-coding,/
CWITA015082,TCMBANKGE015082,CPB1,CPB; DKFZp779K1333; PASP; PCPB,carboxypeptidase B1 (tissue),3q24,protein-coding,
CWITA015083,TCMBANKGE015083,CAMK1,CAMKI,calcium/calmodulin dependent protein kinase I,3p25.3,protein-coding,/
CWITA015084,TCMBANKGE015084,UTS2R,GPR14; UR-2-R; UTR; UTR2,urotensin 2 receptor,17q25.3,protein-coding,Clinical Trial target
CWITA015085,TCMBANKGE015085,METTL5,HSPC133; MRT72,methyltransferase like 5,2q31.1,protein-coding,/
CWITA015086,TCMBANKGE015086,NAGA,D22S674; GALB,alpha-N-acetylgalactosaminidase,22q13.2,protein-coding,/
CWITA015087,TCMBANKGE015087,MRC1,CD206; CLEC13D; CLEC13DL; MMR; MRC1L1; bA541I19.1; hMR,mannose receptor C-type 1,10p12.33,protein-coding,Research target
CWITA015088,TCMBANKGE015088,PGLS,6PGL; HEL-S-304,6-phosphogluconolactonase,19p13.11,protein-coding,/
CWITA015089,TCMBANKGE015089,LGALS1,GAL1; GBP,galectin 1,22q13.1,protein-coding,Research target
CWITA015090,TCMBANKGE015090,CYP1A2,CP12; CYPIA2; P3-450; P450(PA),cytochrome P450 family 1 subfamily A member 2,15q24.1,protein-coding,/
CWITA015091,TCMBANKGE015091,LSMEM1,C7orf53,leucine rich single-pass membrane protein 1,7q31.1,protein-coding,/
CWITA015092,TCMBANKGE015092,UQCRH,MGC111572; QCR6; UQCR8,ubiquinol-cytochrome c reductase hinge protein,1p34.1,protein-coding,
CWITA015093,TCMBANKGE015093,MAPK1,ERK; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk,mitogen-activated protein kinase 1,22q11.2|22q11.21,protein-coding,
CWITA015094,TCMBANKGE015094,GDPD5,GDE2; PP1665,glycerophosphodiester phosphodiesterase domain containing 5,11q13.4-q13.5,protein-coding,/
CWITA015095,TCMBANKGE015095,AMY1C,AMY1,amylase alpha 1C,1p21.1,protein-coding,/
CWITA015096,TCMBANKGE015096,NMT1,NMT,N-myristoyltransferase 1,17q21.31,protein-coding,/
CWITA015097,TCMBANKGE015097,CTDSPL,C3orf8; HYA22; PSR1; RBSP3; SCP3,CTD small phosphatase like,3p22.2,protein-coding,/
CWITA015098,TCMBANKGE015098,FABP6,IN15P; INBABP; INBALB; INBAP; ILBP; ILBP3; ILLBP,"fatty acid binding protein 6, ileal",5q33.3-q34,protein-coding,
CWITA015099,TCMBANKGE015099,HSCB,DNAJC20; HSC20; JAC1,HscB mitochondrial iron-sulfur cluster cochaperone,22q12.1,protein-coding,/
CWITA015100,TCMBANKGE015100,XPO5,exp5,exportin 5,6p21.1,protein-coding,/
CWITA015101,TCMBANKGE015101,KIF5C,CDCBM2; KINN; NKHC; NKHC-2; NKHC2,kinesin family member 5C,2q23.1-q23.2,protein-coding,/
CWITA015102,TCMBANKGE015102,NPM3,PORMIN; TMEM123,nucleophosmin/nucleoplasmin 3,10q24.32,protein-coding,/
CWITA015103,TCMBANKGE015103,IDH3A,N,isocitrate dehydrogenase 3 (NAD+) alpha,15q25.1-q25.2,protein-coding,
CWITA015104,TCMBANKGE015104,P4HA3,-,prolyl 4-hydroxylase subunit alpha 3,11q13.4,protein-coding,/
CWITA015105,TCMBANKGE015105,USP36,DUB1,ubiquitin specific peptidase 36,17q25.3,protein-coding,/
CWITA015106,TCMBANKGE015106,LHFPL1,-,LHFPL tetraspan subfamily member 1,Xq23,protein-coding,/
CWITA015107,TCMBANKGE015107,PROS1,PROS; PS21; PS22; PS23; PS24; PS25; PSA,protein S (alpha),3q11.2,protein-coding,
CWITA015108,TCMBANKGE015108,AMY1A,AMY1; AMY1B; AMY1C,"amylase, alpha 1A (salivary)",1p21,protein-coding,
CWITA015109,TCMBANKGE015109,RFK,RIFK,riboflavin kinase,9q21.13,protein-coding,/
CWITA015110,TCMBANKGE015110,JMJD6,PSR; PTDSR; PTDSR1,"jumonji domain containing 6, arginine demethylase and lysine hydroxylase",17q25.1,protein-coding,/
CWITA015111,TCMBANKGE015111,MRPL20,L20mt; MRP-L20,mitochondrial ribosomal protein L20,1p36.33,protein-coding,/
CWITA015112,TCMBANKGE015112,DEPDC1,DEP.8; DEPDC1-V2; DEPDC1A; SDP35,DEP domain containing 1,1p31.3,protein-coding,Research target
CWITA015113,TCMBANKGE015113,H2AZ1,H2A.Z-1; H2A.z; H2A/z; H2AFZ; H2AZ,H2A.Z variant histone 1,4q23,protein-coding,/
CWITA015114,TCMBANKGE015114,WBP1L,C10orf26; OPA1L; OPAL1,WW domain binding protein 1 like,10q24.32,protein-coding,/
CWITA015115,TCMBANKGE015115,GEMIN4,HC56; HCAP1; HHRF-1; NEDMCR; p97,gem nuclear organelle associated protein 4,17p13.3,protein-coding,/
CWITA015116,TCMBANKGE015116,KANSL2,C12orf41; NSL2,KAT8 regulatory NSL complex subunit 2,12q13.11,protein-coding,/
CWITA015117,TCMBANKGE015117,CD1D,CD1A; R3; R3G1,CD1d molecule,1q23.1,protein-coding,/
CWITA015118,TCMBANKGE015118,CEMIP,CCSP1; HYBID; KIAA1199; TMEM2L,cell migration inducing hyaluronidase 1,15q25.1,protein-coding,/
CWITA015119,TCMBANKGE015119,TEX30,C13orf27,testis expressed 30,13q33.1,protein-coding,/
CWITA015120,TCMBANKGE015120,NAA50,MAK3; NAT13; NAT13P; NAT5; NAT5P; SAN; hNaa50p,"N-alpha-acetyltransferase 50, NatE catalytic subunit",3q13.31,protein-coding,/
CWITA015121,TCMBANKGE015121,SLC24A2,NCKX2,solute carrier family 24 member 2,9p22.1-p21.3,protein-coding,/
CWITA015122,TCMBANKGE015122,LIN52,C14orf46; c14_5549,lin-52 DREAM MuvB core complex component,14q24.3,protein-coding,/
CWITA015123,TCMBANKGE015123,RLF,ZN-15L; ZNF292L,RLF zinc finger,1p34.2,protein-coding,/
CWITA015124,TCMBANKGE015124,C1orf216,-,chromosome 1 open reading frame 216,1p34.3,protein-coding,/
CWITA015125,TCMBANKGE015125,MTF1,MTF-1; ZRF,metal regulatory transcription factor 1,1p34.3,protein-coding,Research target
CWITA015126,TCMBANKGE015126,SH3BGRL2,-,SH3 domain binding glutamate rich protein like 2,6q14.1,protein-coding,/
CWITA015127,TCMBANKGE015127,TESK2,-,testis associated actin remodelling kinase 2,1p34.1,protein-coding,Research target
CWITA015128,TCMBANKGE015128,BTBD7,FUP1,BTB domain containing 7,14q32.12,protein-coding,/
CWITA015129,TCMBANKGE015129,CHRFAM7A,CHRNA7; CHRNA7-DR1; D-10; NACHRA7,CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion,15q13.2,protein-coding,/
CWITA015130,TCMBANKGE015130,PLA2G5,FRFB; GV-PLA2; PLA2-10; hVPLA(2),phospholipase A2 group V,1p36.13,protein-coding,/
CWITA015131,TCMBANKGE015131,ZNF69,Cos5; hZNF3,zinc finger protein 69,19p13.2,protein-coding,/
CWITA015132,TCMBANKGE015132,TUFM,COXPD4; EFNTuMT; EFTU; P43,"Tu translation elongation factor, mitochondrial",16p11.2,protein-coding,
CWITA015133,TCMBANKGE015133,TBC1D5,-,TBC1 domain family member 5,3p24.3,protein-coding,/
CWITA015134,TCMBANKGE015134,PPP1R7,SDS22,protein phosphatase 1 regulatory subunit 7,2q37.3,protein-coding,/
CWITA015135,TCMBANKGE015135,LPCAT3,C3F; LPCAT; LPLAT 5; LPSAT; MBOAT5; OACT5; nessy,lysophosphatidylcholine acyltransferase 3,12p13.31,protein-coding,/
CWITA015136,TCMBANKGE015136,ZNF446,ZKSCAN20; ZSCAN30; ZSCAN52,zinc finger protein 446,19q13.43,protein-coding,/
CWITA015137,TCMBANKGE015137,ARTN,ART; ENOVIN; EVN; NBN,artemin,1p34.1,protein-coding,/
CWITA015138,TCMBANKGE015138,COL5A1,EDSC; EDSCL1,collagen type V alpha 1 chain,9q34.3,protein-coding,/
CWITA015139,TCMBANKGE015139,HYAL1,HYAL-1; LUCA1; MPS9; NAT6,hyaluronidase 1,3p21.31,protein-coding,/
CWITA015140,TCMBANKGE015140,SLC25A39,CGI-69; CGI69,solute carrier family 25 member 39,17q21.31,protein-coding,/
CWITA015141,TCMBANKGE015141,ETFDH,ETFQO; MADD,electron-transferring-flavoprotein dehydrogenase,4q32-q35,protein-coding,
CWITA015142,TCMBANKGE015142,KIFC1,HSET; KNSL2,kinesin family member C1,6p21.32,protein-coding,/
CWITA015143,TCMBANKGE015143,DOT1L,DOT1; KMT4,DOT1 like histone lysine methyltransferase,19p13.3,protein-coding,Clinical Trial target
CWITA015144,TCMBANKGE015144,PXDNL,PMR1; PRM1; VPO2,peroxidasin like,8q11.22-q11.23,protein-coding,/
CWITA015145,TCMBANKGE015145,GALNT17,GALNACT17; GALNT16; GALNT20; GALNTL3; GalNAc-T17; GalNAc-T19; GalNAc-T5L; WBSCR17,polypeptide N-acetylgalactosaminyltransferase 17,7q11.22,protein-coding,/
CWITA015146,TCMBANKGE015146,UBN1,VT; VT4,ubinuclein 1,16p13.3,protein-coding,/
CWITA015147,TCMBANKGE015147,CIAPIN1,Anamorsin; CIAE2; DRE2; PRO0915,cytokine induced apoptosis inhibitor 1,16q21,protein-coding,/
CWITA015148,TCMBANKGE015148,PLLP,PMLP; TM4SF11,plasmolipin,16q13,protein-coding,/
CWITA015149,TCMBANKGE015149,CACNB1,CAB1; CACNLB1; CCHLB1,calcium voltage-gated channel auxiliary subunit beta 1,17q12,protein-coding,/
CWITA015150,TCMBANKGE015150,SLC22A25,HIMTP; UST6,solute carrier family 22 member 25,11q12.3,protein-coding,/
CWITA015151,TCMBANKGE015151,HPGDS,GSTS; GSTS1; GSTS1-1; PGD2; PGDS,hematopoietic prostaglandin D synthase,4q22.3,protein-coding,Successful target
CWITA015152,TCMBANKGE015152,KAT8,MOF; MYST1; ZC2HC8; hMOF,lysine acetyltransferase 8,16p11.2,protein-coding,/
CWITA015153,TCMBANKGE015153,SLIT3,MEGF5; SLIL2; SLIT1; Slit-3; slit2,slit guidance ligand 3,5q34-q35.1,protein-coding,/
CWITA015154,TCMBANKGE015154,C1QL1,C1QRF; C1QTNF14; CRF; CTRP14,complement C1q like 1,17q21.31,protein-coding,/
CWITA015155,TCMBANKGE015155,RBP7,CRBP4; CRBPIV; MGC70641,"retinol binding protein 7, cellular",1p36.22,protein-coding,
CWITA015156,TCMBANKGE015156,PLEKHA1,TAPP1,pleckstrin homology domain containing A1,10q26.13,protein-coding,/
CWITA015157,TCMBANKGE015157,ZNF284,ZNF284L,zinc finger protein 284,19q13.31,protein-coding,/
CWITA015158,TCMBANKGE015158,SENP5,-,SUMO specific peptidase 5,3q29,protein-coding,/
CWITA015159,TCMBANKGE015159,TRMT2B,CXorf34; dJ341D10.3,tRNA methyltransferase 2 homolog B,Xq22.1,protein-coding,/
CWITA015160,TCMBANKGE015160,IER2,ETR101,immediate early response 2,19p13.13,protein-coding,/
CWITA015161,TCMBANKGE015161,PSMA4,HC9; HsT17706; MGC111191; MGC12467; MGC24813; PSC9,"proteasome (prosome, macropain) subunit, alpha type, 4",15q25.1,protein-coding,
CWITA015162,TCMBANKGE015162,PRKAB2,-,protein kinase AMP-activated non-catalytic subunit beta 2,1q21.1,protein-coding,/
CWITA015163,TCMBANKGE015163,TSPAN14,DC-TM4F2; TM4SF14; tspan-14,tetraspanin 14,10q23.1,protein-coding,/
CWITA015164,TCMBANKGE015164,Crry-ps,Crrx; Gm38435; Mcp-ps; mCRX,"complement receptor related protein, pseudogene",8 35.31 cM|8 B3.3,pseudo,/
CWITA015165,TCMBANKGE015165,KDM1A,AOF2; BHC110; CPRF; KDM1; LSD1,lysine demethylase 1A,1p36.12,protein-coding,Clinical Trial target
CWITA015166,TCMBANKGE015166,UGDH,GDH; UDPNGlcDH; UDPGDH; UGD,UDP-glucose 6-dehydrogenase,4p15.1,protein-coding,
CWITA015167,TCMBANKGE015167,SOST,CDD; DAND6; SOST1; VBCH,Sclerostin,17q21.31,protein-coding,
CWITA015168,TCMBANKGE015168,MMS19,CIAO4; MET18; MMS19L; hMMS19,"MMS19 homolog, cytosolic iron-sulfur assembly component",10q24.1,protein-coding,/
CWITA015169,TCMBANKGE015169,TTLL2,C6orf104; NYD-TSPG; dJ366N23.3,tubulin tyrosine ligase like 2,6q27,protein-coding,/
CWITA015170,TCMBANKGE015170,RILPL2,RLP2,Rab interacting lysosomal protein like 2,12q24.31,protein-coding,/
CWITA015171,TCMBANKGE015171,PRKACB,DKFZp781I2452; MGC41879; MGC9320; PKACB,"protein kinase, cAMP-dependent, catalytic, beta",1p31.1,protein-coding,
CWITA015172,TCMBANKGE015172,TMCC1,-,transmembrane and coiled-coil domain family 1,3q22.1,protein-coding,/
CWITA015173,TCMBANKGE015173,NDUFS2,CI-49; MC1DN6,NADH:ubiquinone oxidoreductase core subunit S2,1q23.3,protein-coding,/
CWITA015174,TCMBANKGE015174,TRERF1,BCAR2; HSA277276; RAPA; TREP132; TReP-132; dJ139D8.5,transcriptional regulating factor 1,6p21.1,protein-coding,/
CWITA015175,TCMBANKGE015175,DGKQ,DAGK; DAGK4; DAGK7,diacylglycerol kinase theta,4p16.3,protein-coding,/
CWITA015176,TCMBANKGE015176,ITGB3,CD61; GP3A; GPIIIa,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",17q21.32,protein-coding,
CWITA015177,TCMBANKGE015177,CLRN3,TMEM12; USH3AL1,clarin 3,10q26.2,protein-coding,/
CWITA015178,TCMBANKGE015178,DAG1,156DAG; A3a; AGRNR; DAG; LGMDR16; MDDGA9; MDDGC7; MDDGC9,dystroglycan 1,3p21.31,protein-coding,Research target
CWITA015179,TCMBANKGE015179,HAS3,-,hyaluronan synthase 3,16q22.1,protein-coding,/
